PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Murakami, K; Elmlund, H; Kalisman, N; Bushnell, DA; Adams, CM; Azubel, M; Elmlund, D; Levi-Kalisman, Y; Liu, X; Gibbons, BJ; Levitt, M; Kornberg, RD				Murakami, Kenji; Elmlund, Hans; Kalisman, Nir; Bushnell, David A.; Adams, Christopher M.; Azubel, Maia; Elmlund, Dominika; Levi-Kalisman, Yael; Liu, Xin; Gibbons, Brian J.; Levitt, Michael; Kornberg, Roger D.			Architecture of an RNA Polymerase II Transcription Pre-Initiation Complex	SCIENCE			English	Article							ELONGATION-FACTOR TFIIS; PREINITIATION COMPLEX; STRUCTURAL BASIS; CRYSTAL-STRUCTURE; CROSS-LINKING; ANGSTROM RESOLUTION; MASS-SPECTROMETRY; DNA; MECHANISM; SUBUNIT	The protein density and arrangement of subunits of a complete, 32-protein, RNA polymerase II (pol II) transcription pre-initiation complex (PIC) were determined by means of cryogenic electron microscopy and a combination of chemical cross-linking and mass spectrometry. The PIC showed a marked division in two parts, one containing all the general transcription factors (GTFs) and the other pol II. Promoter DNA was associated only with the GTFs, suspended above the pol II cleft and not in contact with pol II. This structural principle of the PIC underlies its conversion to a transcriptionally active state; the PIC is poised for the formation of a transcription bubble and descent of the DNA into the pol II cleft.	[Murakami, Kenji; Elmlund, Hans; Kalisman, Nir; Bushnell, David A.; Azubel, Maia; Elmlund, Dominika; Levi-Kalisman, Yael; Liu, Xin; Gibbons, Brian J.; Levitt, Michael; Kornberg, Roger D.] Stanford Univ, Dept Biol Struct, Stanford, CA 94305 USA; [Adams, Christopher M.] Stanford Univ, Stanford Univ Mass Spectrometry, Stanford, CA 94305 USA	Stanford University; Stanford University	Kornberg, RD (corresponding author), Stanford Univ, Dept Biol Struct, Stanford, CA 94305 USA.	kornberg@stanford.edu	ELMLUND, HANS/AAA-6625-2021	Elmlund, Dominika/0000-0002-1910-8017; Kalisman, Nir/0000-0003-1615-7136; Elmlund, Hans/0000-0002-6992-0601	NIH [GM49885, AI21144, GM063817]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR028096] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI021144] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063817, R01GM036659] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by NIH grants GM49885 and AI21144 to R.D.K. and GM063817 to M.L. The EM map has been deposited in the EMDataBank under accession code EMD-2394.	BURATOWSKI S, 1989, CELL, V56, P549, DOI 10.1016/0092-8674(89)90578-3; Burley SK, 1996, ANNU REV BIOCHEM, V65, P769, DOI 10.1146/annurev.bi.65.070196.004005; Bushnell DA, 2004, SCIENCE, V303, P983, DOI 10.1126/science.1090838; Bushnell DA, 2003, P NATL ACAD SCI USA, V100, P6969, DOI 10.1073/pnas.1130601100; Chang WH, 2000, CELL, V102, P609, DOI 10.1016/S0092-8674(00)00083-0; Chen ZA, 2010, EMBO J, V29, P717, DOI 10.1038/emboj.2009.401; Chung WH, 2003, MOL CELL, V12, P1003, DOI 10.1016/S1097-2765(03)00387-3; CONAWAY RC, 1993, ANNU REV BIOCHEM, V62, P161; Cramer P, 2000, SCIENCE, V288, P640, DOI 10.1126/science.288.5466.640; Cramer Patrick, 2001, Science (Washington D C), V292, P1863, DOI 10.1126/science.1059493; Elmlund D, 2012, J STRUCT BIOL, V180, P420, DOI 10.1016/j.jsb.2012.07.010; Elmlund D, 2010, STRUCTURE, V18, P777, DOI 10.1016/j.str.2010.06.001; FEAVER WJ, 1991, CELL, V67, P1223, DOI 10.1016/0092-8674(91)90298-D; Forget D, 2004, MOL CELL BIOL, V24, P1122, DOI 10.1128/MCB.24.3.1122-1131.2004; Gaiser F, 2000, J MOL BIOL, V302, P1119, DOI 10.1006/jmbi.2000.4110; Gibbons BJ, 2012, P NATL ACAD SCI USA, V109, P1949, DOI 10.1073/pnas.1105266109; Gnatt AL, 2001, SCIENCE, V292, P1876, DOI 10.1126/science.1059495; GUZDER SN, 1994, NATURE, V369, P578, DOI 10.1038/369578a0; He Y, 2013, NATURE, V495, P481, DOI 10.1038/nature11991; Holstege FCP, 1997, EMBO J, V16, P7468, DOI 10.1093/emboj/16.24.7468; Jawhari A, 2006, EMBO REP, V7, P500, DOI 10.1038/sj.embor.7400663; Kainov DE, 2008, NAT STRUCT MOL BIOL, V15, P980, DOI 10.1038/nsmb.1478; Kalisman N, 2012, P NATL ACAD SCI USA, V109, P2884, DOI 10.1073/pnas.1119472109; Kastner B, 2008, NAT METHODS, V5, P53, DOI 10.1038/NMETH1139; Kettenberger H, 2004, MOL CELL, V16, P955, DOI 10.1016/j.molcel.2004.11.040; Kim B, 2007, P NATL ACAD SCI USA, V104, P16068, DOI 10.1073/pnas.0704573104; Kim TK, 2000, SCIENCE, V288, P1418, DOI 10.1126/science.288.5470.1418; Kim TK, 1997, P NATL ACAD SCI USA, V94, P12268, DOI 10.1073/pnas.94.23.12268; KIM YJ, 1994, CELL, V77, P599, DOI 10.1016/0092-8674(94)90221-6; Kornberg RD, 2005, TRENDS BIOCHEM SCI, V30, P235, DOI 10.1016/j.tibs.2005.03.011; Kornberg RD, 2007, P NATL ACAD SCI USA, V104, P12955, DOI 10.1073/pnas.0704138104; Kostrewa D, 2009, NATURE, V462, P323, DOI 10.1038/nature08548; Lasker K, 2012, P NATL ACAD SCI USA, V109, P1380, DOI 10.1073/pnas.1120559109; Liu X, 2010, SCIENCE, V327, P206, DOI 10.1126/science.1182015; Mekler V, 2002, CELL, V108, P599, DOI 10.1016/S0092-8674(02)00667-0; Miller G, 2006, NAT STRUCT MOL BIOL, V13, P603, DOI 10.1038/nsmb1117; Murakami K, 2013, J BIOL CHEM, V288, P6325, DOI 10.1074/jbc.M112.433623; Murakami K, 2012, P NATL ACAD SCI USA, V109, P4816, DOI 10.1073/pnas.1201448109; NIKOLOV DB, 1995, NATURE, V377, P119, DOI 10.1038/377119a0; Okuda M, 2000, EMBO J, V19, P1346, DOI 10.1093/emboj/19.6.1346; Okuda M, 2008, EMBO J, V27, P1161, DOI 10.1038/emboj.2008.47; Pal M, 2005, MOL CELL, V19, P101, DOI 10.1016/j.molcel.2005.05.024; Prather DA, 2005, MOL CELL BIOL, V25, P2650, DOI 10.1128/MCB.25.7.2650-2659.2005; Schultz P, 2000, CELL, V102, P599, DOI 10.1016/S0092-8674(00)00082-9; Tan S, 1996, NATURE, V381, P127, DOI 10.1038/381127a0	45	120	120	2	76	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 8	2013	342	6159					709	+		10.1126/science.1238724	http://dx.doi.org/10.1126/science.1238724			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247UK	24072820	Green Accepted			2022-12-24	WOS:000326647600034
J	Qu, S; Kolodziej, EP; Long, SA; Gloer, JB; Patterson, EV; Baltrusaitis, J; Jones, GD; Benchetler, PV; Cole, EA; Kimbrough, KC; Tarnoff, MD; Cwiertny, DM				Qu, Shen; Kolodziej, Edward P.; Long, Sarah A.; Gloer, James B.; Patterson, Eric V.; Baltrusaitis, Jonas; Jones, Gerrad D.; Benchetler, Peter V.; Cole, Emily A.; Kimbrough, Kaitlin C.; Tarnoff, Matthew D.; Cwiertny, David M.			Product-to-Parent Reversion of Trenbolone: Unrecognized Risks for Endocrine Disruption	SCIENCE			English	Article							REPRODUCTIVE ENDOCRINOLOGY; GROWTH PROMOTERS; AQUEOUS-SOLUTION; FATHEAD MINNOW; ACETATE; IDENTIFICATION; POPULATIONS; METABOLITES; FEEDLOT; SYSTEMS	Trenbolone acetate (TBA) is a high-value steroidal growth promoter often administered to beef cattle, whose metabolites are potent endocrine-disrupting compounds. We performed laboratory and field phototransformation experiments to assess the fate of TBA metabolites and their photoproducts. Unexpectedly, we observed that the rapid photohydration of TBA metabolites is reversible under conditions representative of those in surface waters (pH 7, 25 degrees C). This product-to-parent reversion mechanism results in diurnal cycling and substantial regeneration of TBA metabolites at rates that are strongly temperature-and pH-dependent. Photoproducts can also react to produce structural analogs of TBA metabolites. These reactions also occur in structurally similar steroids, including human pharmaceuticals, which suggests that predictive fate models and regulatory risk assessment paradigms must account for transformation products of high-risk environmental contaminants such as endocrine-disrupting steroids.	[Qu, Shen; Tarnoff, Matthew D.; Cwiertny, David M.] Univ Iowa, Dept Civil & Environm Engn, Seamans Ctr Engn Arts & Sci 4105, Iowa City, IA 52242 USA; [Kolodziej, Edward P.; Jones, Gerrad D.; Benchetler, Peter V.; Cole, Emily A.; Kimbrough, Kaitlin C.] Univ Nevada, Dept Civil & Environm Engn, Reno, NV 89557 USA; [Long, Sarah A.; Gloer, James B.] Univ Iowa, Dept Chem, Iowa City, IA 52242 USA; [Patterson, Eric V.] Truman State Univ, Dept Chem, Kirksville, MO 63501 USA; [Baltrusaitis, Jonas] Univ Twente, Fac Sci & Technol, MESA Inst Nanotechnol, PhotoCatalyt Synth Grp, NL-7500 AE Enschede, Netherlands; [Baltrusaitis, Jonas] Univ Iowa, Coll Publ Hlth, Dept Occupat & Environm Hlth, Iowa City, IA 52242 USA; [Cwiertny, David M.] Univ Iowa, Seamans Ctr Engn Arts & Sci 4133, Dept Chem & Biochem Engn, Iowa City, IA 52242 USA	University of Iowa; Nevada System of Higher Education (NSHE); University of Nevada Reno; University of Iowa; University of Twente; University of Iowa; University of Iowa	Kolodziej, EP (corresponding author), Univ Nevada, Dept Civil & Environm Engn, Mail Stop 258, Reno, NV 89557 USA.	koloj@unr.edu; david-cwiertny@uiowa.edu	Baltrusaitis, Jonas/AAW-6072-2021; Baltrusaitis, Jonas/AAT-3166-2020; Qu, Shen/B-3405-2014; Kolodziej, Edward/I-8416-2017	Baltrusaitis, Jonas/0000-0001-5634-955X; Kolodziej, Edward/0000-0002-7968-4198; Patterson, Eric/0000-0002-0310-7626	U.S. Department of Agriculture [2010-65102-20425, 2010-65102-20407]; NIH [S10-RR025500]; National Center for Research Resources, NIH [UL1RR024979]; National Institute of General Medical Sciences, NIH [8 P20 GM103440-11]; NSF [CHE-074096, CHE-1039925, CHE-1044356]; Direct For Mathematical & Physical Scien [1229354] Funding Source: National Science Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024979, S10RR025500] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES005605] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103440] Funding Source: NIH RePORTER	U.S. Department of Agriculture(United States Department of Agriculture (USDA)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute of General Medical Sciences, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NSF(National Science Foundation (NSF)); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by U.S. Department of Agriculture grants 2010-65102-20425 and 2010-65102-20407. NMR instrumentation was supported in part by NIH grant S10-RR025500, with additional support from National Center for Research Resources, NIH, grant UL1RR024979. LC/MS/MS instrumentation was supported by National Institute of General Medical Sciences, NIH, grant 8 P20 GM103440-11. Computational resources were provided in part by NSF grants CHE-074096, CHE-1039925, and CHE-1044356. Any opinions, findings, conclusions, or recommendations expressed here are those of the authors and do not necessarily represent the official views of sponsoring agencies. The authors acknowledge D. Latch, Y. P. Chin, D. Quilici, J. Bristow, the Sierra Foothill Research and Extension Center and its personnel, and the suggestions of two anonymous reviewers. All data are available in the supplementary materials. The authors declare no conflict of interest.	Ankley GT, 2003, ENVIRON TOXICOL CHEM, V22, P1350, DOI [10.1897/1551-5028(2003)022&lt;1350:EOTAGP&gt;2.0.CO;2, 10.1002/etc.5620220623]; Blazer VS, 2012, ENVIRON MONIT ASSESS, V184, P4309, DOI 10.1007/s10661-011-2266-5; De Marco R, 2011, CHEM BIOL DRUG DES, V78, P269, DOI 10.1111/j.1747-0285.2011.01147.x; Durhan EJ, 2006, ENVIRON HEALTH PERSP, V114, P65, DOI 10.1289/ehp.8055; Fenner K, 2013, SCIENCE, V341, P752, DOI 10.1126/science.1236281; Gall HE, 2011, ENVIRON SCI TECHNOL, V45, P8755, DOI 10.1021/es2011435; Guillette LJ, 2001, REPRODUCTION, V122, P857, DOI 10.1530/reprod/122.6.857; Ibarburu M.A., 2007, P NCCC 134 M APPL CO; Jensen KM, 2006, ENVIRON SCI TECHNOL, V40, P3112, DOI 10.1021/es052174s; Kidd KA, 2007, P NATL ACAD SCI USA, V104, P8897, DOI 10.1073/pnas.0609568104; Kolodziej EP, 2013, ENVIRON SCI TECHNOL, V47, P5031, DOI 10.1021/es3052069; Latch DE, 2003, J PHOTOCH PHOTOBIO A, V158, P63, DOI 10.1016/S1010-6030(03)00103-5; Leet JK, 2012, ENVIRON SCI TECHNOL, V46, P13440, DOI 10.1021/es302599t; LONG ER, 1995, ENVIRON MANAGE, V19, P81, DOI 10.1007/BF02472006; OETTEL M, 1980, CONTRACEPTION, V21, P61, DOI 10.1016/0010-7824(80)90140-7; Qu S, 2012, ENVIRON SCI TECHNOL, V46, P13202, DOI 10.1021/es303091c; Schiffer B, 2001, ENVIRON HEALTH PERSP, V109, P1145, DOI 10.2307/3454862; Stackhouse KR, 2012, J ANIM SCI, V90, P4656, DOI 10.2527/jas.2011-4654; Stavreva DA, 2012, SCI REP-UK, V2, DOI 10.1038/srep00937; Syntex Animal Health, 1995, SYN PLUS TRENB AC ES	21	64	66	6	186	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 18	2013	342	6156					347	351		10.1126/science.1243192	http://dx.doi.org/10.1126/science.1243192			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	235XG	24072818	Green Accepted			2022-12-24	WOS:000325755100041
J	Huang, J				Huang, Jing			Tracking Drugs	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material								A method for measuring the extent to which a drug binds its intended target in vivo involves determining the thermostability of the target. Historically, knowledge of drug targets has largely lagged far behind the administration of drugs to patients, often with harmful or even deadly results. Various advances suggest that the identification and validation of drug-target interactions can be made with greater ease, efficiency, and accuracy.(1) A new label-free strategy (one that uses the native drug without requiring chemical tagging or modification) devised by Molina and colleagues,(2) dubbed the cellular thermal shift assay (CETSA), is capable of measuring drug-target binding inside cells, facilitating the studies of variables such as drug transport, activation, tissue distribution, target specificity, and resistance. When proteins in their native ...	[Huang, Jing] Univ Calif Los Angeles, David Geffen Sch Med, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA; [Huang, Jing] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90024 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles	Huang, J (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA.							Ellis R. John, 1999, Current Opinion in Structural Biology, V9, P102, DOI 10.1016/S0959-440X(99)80013-X; Lomenick B, 2009, P NATL ACAD SCI USA, V106, P21984, DOI 10.1073/pnas.0910040106; Molina DM, 2013, SCIENCE, V341, P84, DOI 10.1126/science.1233606; Senisterra G, 2012, ASSAY DRUG DEV TECHN, V10, P128, DOI 10.1089/adt.2011.0390; West GM, 2010, P NATL ACAD SCI USA, V107, P9078, DOI 10.1073/pnas.1000148107	5	3	3	0	14	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 19	2013	369	12					1168	1169		10.1056/NEJMcibr1308868	http://dx.doi.org/10.1056/NEJMcibr1308868			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	220BD	24047067				2022-12-24	WOS:000324554800018
J	Miller, P				Miller, Peter			Energy drinks and alcohol: research supported by industry may be downplaying harms	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							CONSUMPTION; PATTERNS; RISK		Deakin Univ, Sch Psychol, Geelong, Vic 3220, Australia	Deakin University	Miller, P (corresponding author), Deakin Univ, Sch Psychol, Geelong, Vic 3220, Australia.	Peter.Miller@deakin.edu.au		Miller, Peter/0000-0002-6896-5437				Alford C, 2012, DRUG ALCOHOL REV, V31, P46; [Anonymous], 1979, BMJ-BRIT MED J, V1, P532; Arria AM, 2011, ALCOHOL CLIN EXP RES, V35, P365, DOI 10.1111/j.1530-0277.2010.01352.x; Benson S, 2012, DRUG ALCOHOL REV, V31, P47; Brache K, 2011, ADDICT BEHAV, V36, P1133, DOI 10.1016/j.addbeh.2011.07.003; De Haan L, 2012, DRUG ALCOHOL REV, V31, P50; Malinauskas BM, 2007, NUTR J, V6, DOI 10.1186/1475-2891-6-35; Miller P.G., 2013, PATRON OFFENDING INT; Oteri A, 2007, ALCOHOL CLIN EXP RES, V31, P1677, DOI 10.1111/j.1530-0277.2007.00464.x; Peacock A, 2011, MOTIVATIONS CONSEQUE; Pennay A, 2011, AUST FAM PHYSICIAN, V40, P104; Thombs DL, 2010, ADDICT BEHAV, V35, P325, DOI 10.1016/j.addbeh.2009.11.004; Verster J, 2012, DRUG ALCOHOL REV, V31, P7	13	13	13	0	15	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 12	2013	347								f5345	10.1136/bmj.f5345	http://dx.doi.org/10.1136/bmj.f5345			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	219SU	24030480				2022-12-24	WOS:000324530500003
J	Bird, A				Bird, Adrian			Genome Biology: Not Drowning but Waving	CELL			English	Editorial Material							EPIGENETIC MEMORY; C. ELEGANS; GERMLINE		Univ Edinburgh, Wellcome Trust Ctr Cell Biol, Edinburgh EH9 3JR, Midlothian, Scotland	University of Edinburgh	Bird, A (corresponding author), Univ Edinburgh, Wellcome Trust Ctr Cell Biol, Kings Bldg,Mayfield Rd, Edinburgh EH9 3JR, Midlothian, Scotland.	apbird@staffmail.ed.ac.uk		Bird, Adrian/0000-0002-8600-0372	Wellcome Trust [092076] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Ashe A, 2012, CELL, V150, P88, DOI 10.1016/j.cell.2012.06.018; Ball P, 2013, NATURE, V496, P419, DOI 10.1038/496419a; Bird A, 2007, NATURE, V447, P396, DOI 10.1038/nature05913; Clark MB, 2012, GENOME RES, V22, P885, DOI 10.1101/gr.131037.111; Daxinger L, 2010, GENOME RES, V20, P1623, DOI 10.1101/gr.106138.110; Doolittle WF, 2013, P NATL ACAD SCI USA, V110, P5294, DOI 10.1073/pnas.1221376110; Katz DJ, 2009, CELL, V137, P308, DOI 10.1016/j.cell.2009.02.015; Lee JT, 2013, CELL, V152, P1308, DOI 10.1016/j.cell.2013.02.016; Pembrey ME, 2006, EUR J HUM GENET, V14, P159, DOI 10.1038/sj.ejhg.5201538; Ponting CP, 2011, GENOME RES, V21, P1769, DOI 10.1101/gr.116814.110; Rando OJ, 2012, CELL, V151, P702, DOI 10.1016/j.cell.2012.10.020	11	12	12	0	22	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	AUG 29	2013	154	5					951	952		10.1016/j.cell.2013.08.010	http://dx.doi.org/10.1016/j.cell.2013.08.010			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	209OE	23993086	Bronze			2022-12-24	WOS:000323767300006
J	Garrott, RA; Oli, MK				Garrott, Robert A.; Oli, Madan K.			A Critical Crossroad for BLM's Wild Horse Program	SCIENCE			English	Editorial Material									[Garrott, Robert A.] Montana State Univ, Dept Ecol, Fish & Wildlife Ecol & Management Program, Bozeman, MT 59717 USA; [Oli, Madan K.] Univ Florida, Dept Wildlife Ecol & Conservat, Gainesville, FL 32611 USA	Montana State University System; Montana State University Bozeman; State University System of Florida; University of Florida	Garrott, RA (corresponding author), Montana State Univ, Dept Ecol, Fish & Wildlife Ecol & Management Program, Bozeman, MT 59717 USA.	rgarrott@montana.edu						[Anonymous], 2013, AUSTRALIAN; BLM, 2011, CAR AM WILD HORS BUR; Csurhes S., 2009, PEST ANIMAL RISK ASS; GAO, 1990, RECD90110 GAO; National Research Council (NRC), 1991, WILD HORS POP FIELD; National Research Council (NRC), 2013, EST ADJ APPR MAN LEV, P195; NRC, 1980, WILD FREE ROAM HORS; NRC, 1982, WILD FREE ROAM HORS; U.S. General Accounting Office, 2008, GAO0977; Walters C., 1986, ADAPTIVE MANAGEMENT	10	37	37	0	57	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 23	2013	341	6148					847	848		10.1126/science.1240280	http://dx.doi.org/10.1126/science.1240280			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	204MY	23970685				2022-12-24	WOS:000323370600025
J	Moon, KA; Guallar, E; Umans, JG; Devereux, RB; Best, LG; Francesconi, KA; Goessler, W; Pollak, J; Silbergeld, EK; Howard, BV; Navas-Acien, A				Moon, Katherine A.; Guallar, Eliseo; Umans, Jason G.; Devereux, Richard B.; Best, Lyle G.; Francesconi, Kevin A.; Goessler, Walter; Pollak, Jonathan; Silbergeld, Ellen K.; Howard, Barbara V.; Navas-Acien, Ana			Association Between Exposure to Low to Moderate Arsenic Levels and Incident Cardiovascular Disease	ANNALS OF INTERNAL MEDICINE			English	Article							DRINKING-WATER; WELL-WATER; CAROTID ATHEROSCLEROSIS; METHYLATION CAPABILITY; HYPERENDEMIC AREAS; BLACKFOOT DISEASE; VASCULAR-DISEASE; HEART-DISEASE; MORTALITY; POPULATION	Background: Long-term exposure to high levels of arsenic is associated with increased risk for cardiovascular disease, whereas risk from long-term exposure to low to moderate arsenic levels (< 100 mu g/L in drinking water) is unclear. Objective: To evaluate the association between long-term exposure to low to moderate arsenic levels and incident cardiovascular disease. Design: Prospective cohort study. Setting: The Strong Heart Study baseline visit between 1989 and 1991, with follow-up through 2008. Patients: 3575 American Indian men and women aged 45 to 74 years living in Arizona, Oklahoma, and North and South Dakota. Measurements: The sum of inorganic and methylated arsenic species in urine at baseline was used as a biomarker of long-term arsenic exposure. Outcomes were incident fatal and nonfatal cardiovascular disease. Results: A total of 1184 participants developed fatal and nonfatal cardiovascular disease. When the highest and lowest quartiles of arsenic concentrations (> 15.7 vs. < 5.8 mu g/g creatinine) were compared, the hazard ratios for cardiovascular disease, coronary heart disease, and stroke mortality after adjustment for sociodemographic factors, smoking, body mass index, and lipid levels were 1.65 (95% CI, 1.20 to 2.27; P for trend < 0.001), 1.71 (CI, 1.19 to 2.44; P for trend < 0.001), and 3.03 (CI, 1.08 to 8.50; P for trend = 0.061), respectively. The corresponding hazard ratios for incident cardiovascular disease, coronary heart disease, and stroke were 1.32 (CI, 1.09 to 1.59; P for trend = 0.002), 1.30 (CI, 1.04 to 1.62; P for trend = 0.006), and 1.47 (CI, 0.97 to 2.21; P for trend = 0.032). These associations varied by study region and were attenuated after further adjustment for diabetes, hypertension, and kidney disease measures. Limitation: Direct measurement of individual arsenic levels in drinking water was unavailable. Conclusion: Long-term exposure to low to moderate arsenic levels was associated with cardiovascular disease incidence and mortality.	Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD 21205 USA; Johns Hopkins Med Inst, Baltimore, MD 21205 USA; Natl Ctr Cardiovasc Res, Madrid, Spain; MedStar Hlth Res Inst, Hyattsville, MD USA; Georgetown Univ, Washington, DC USA; Georgetown Howard Univ Ctr Clin & Translat Sci, Washington, DC USA; Cornell Med Ctr, Weill Med Coll, New York Presbyterian Hosp, New York, NY USA; Missouri Breaks Ind Res, Timber Lake, SD USA; Karl Franzens Univ Graz, Graz, Austria	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Medicine; Centro Nacional de Investigaciones Cardiovasculares (CNIC); MedStar Health Research Institute; Georgetown University; Cornell University; NewYork-Presbyterian Hospital; University of Graz	Navas-Acien, A (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Environm Hlth Sci, 615 North Wolfe St,Room W7513D, Baltimore, MD 21205 USA.	anavas@jhsph.edu	Guallar, Eliseo/D-3807-2014; Goessler, Walter/A-1084-2016	Guallar, Eliseo/0000-0002-4471-9565; Goessler, Walter/0000-0002-0142-9373	National Heart, Lung, and Blood Institute; National Institute of Environmental Health Sciences; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL041654, R01HL109319, U01HL041642, U01HL041652, U01HL065521, R01HL090863, R01HL109284, T32HL007024] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES021367, P30ES003819] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	National Heart, Lung, and Blood Institute and National Institute of Environmental Health Sciences.	Abhyankar LN, 2012, ENVIRON HEALTH PERSP, V120, P494, DOI 10.1289/ehp.1103988; Afridi HI, 2011, BIOL TRACE ELEM RES, V141, P26, DOI 10.1007/s12011-010-8713-2; Afridi HI, 2010, BIOL TRACE ELEM RES, V134, P1, DOI 10.1007/s12011-009-8450-6; Alaerts G., 2001, ARSENIC DRINKING WAT; Balakumar P, 2009, CARDIOVASC TOXICOL, V9, P169, DOI 10.1007/s12012-009-9050-6; Bunderson M, 2004, TOXICOL APPL PHARM, V201, P32, DOI 10.1016/j.taap.2004.04.008; Center for American Indian Health Research, 2001, STRONG HEART STUD OP, VII; Chen CJ, 1996, ARTERIOSCL THROM VAS, V16, P504, DOI 10.1161/01.ATV.16.4.504; Chen Y, 2011, INT J EPIDEMIOL, V40, P828, DOI 10.1093/ije/dyr022; Chen Y, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d2431; Cheng TJ, 2010, WATER RES, V44, P5770, DOI 10.1016/j.watres.2010.05.040; CULLEN WR, 1989, CHEM REV, V89, P713, DOI 10.1021/cr00094a002; ENGEL RR, 1994, ARCH ENVIRON HEALTH, V49, P418, DOI 10.1080/00039896.1994.9954996; Focazio M.J., 2000, RETROSPECTIVE ANAL O; Gong G, 2012, ENVIRON RES, V113, P52, DOI 10.1016/j.envres.2012.01.003; GRAMBSCH PM, 1994, BIOMETRIKA, V81, P515; Gribble MO, 2012, AM J EPIDEMIOL, V176, P865, DOI 10.1093/aje/kws153; Howard BV, 1999, CIRCULATION, V99, P2389, DOI 10.1161/01.CIR.99.18.2389; HOWARD BV, 1992, DIABETES, V41, P4, DOI 10.2337/diab.41.2.S4; Hsieh YC, 2011, ENVIRON RES, V111, P804, DOI 10.1016/j.envres.2011.05.003; Huang YL, 2009, SCI TOTAL ENVIRON, V407, P2608, DOI 10.1016/j.scitotenv.2008.12.061; Huang YK, 2007, TOXICOL APPL PHARM, V218, P135, DOI 10.1016/j.taap.2006.10.022; Hughes MF, 2006, ENVIRON HEALTH PERSP, V114, P1790, DOI 10.1289/ehp.9058; James KA, 2013, ENVIRON RES, V123, P33, DOI 10.1016/j.envres.2013.02.005; James K, 2013, AM J KIDNEY DIS, V61, P364, DOI 10.1053/j.ajkd.2012.12.004; Medrano MJ, 2010, ENVIRON RES, V110, P448, DOI 10.1016/j.envres.2009.10.002; Karagas M R, 2001, Int J Occup Med Environ Health, V14, P171; Kim NH, 2013, AM J EPIDEMIOL, V177, P962, DOI 10.1093/aje/kws329; Kurzius-Spencer M, 2013, J EXPO SCI ENV EPID, V23, P442, DOI 10.1038/jes.2012.120; LEE ET, 1990, AM J EPIDEMIOL, V132, P1141, DOI 10.1093/oxfordjournals.aje.a115757; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Lewis DR, 1999, ENVIRON HEALTH PERSP, V107, P359, DOI 10.2307/3434539; Lisabeth LD, 2010, STROKE, V41, P2499, DOI 10.1161/STROKEAHA.110.585281; Marchiset-Ferlay N, 2012, ENVIRON INT, V39, P150, DOI 10.1016/j.envint.2011.07.015; Maull EA, 2012, ENVIRON HEALTH PERSP, V120, P1658, DOI 10.1289/ehp.1104579; Meliker JR, 2007, ENVIRON HEALTH-GLOB, V6, DOI 10.1186/1476-069X-6-4; Moon K, 2012, CURR ATHEROSCLER REP, V14, P542, DOI 10.1007/s11883-012-0280-x; National Research Council, 1999, ARS DRINK WAT; Navas-Acien A, 2005, AM J EPIDEMIOL, V162, P1037, DOI 10.1093/aje/kwi330; Navas-Acien Ana, 2013, JAMA Intern Med, V173, P1395, DOI 10.1001/jamainternmed.2013.6405; Navas-Acien A, 2009, ENVIRON HEALTH PERSP, V117, P1428, DOI 10.1289/ehp.0800509; Nermell B, 2008, ENVIRON RES, V106, P212, DOI 10.1016/j.envres.2007.08.005; Parvez F, 2006, ENVIRON HEALTH PERSP, V114, P355, DOI 10.1289/ehp.7903; POMROY C, 1980, TOXICOL APPL PHARM, V53, P550, DOI 10.1016/0041-008X(80)90368-3; Rapant S, 2009, ENVIRON GEOCHEM HLTH, V31, P11, DOI 10.1007/s10653-008-9152-2; Ruiz-Navarro ML, 1998, SCI TOTAL ENVIRON, V216, P55, DOI 10.1016/S0048-9697(98)00136-3; Ryan PB, 2000, ENVIRON HEALTH PERSP, V108, P731, DOI 10.2307/3434726; Scheer J, 2012, ANAL METHODS-UK, V4, P406, DOI 10.1039/c2ay05638k; Simeonova PP, 2003, ENVIRON HEALTH PERSP, V111, P1744, DOI 10.1289/ehp.6332; Sohel N, 2009, EPIDEMIOLOGY, V20, P824, DOI 10.1097/EDE.0b013e3181bb56ec; Srivastava S, 2009, TOXICOL APPL PHARM, V241, P90, DOI 10.1016/j.taap.2009.08.004; States JC, 2009, TOXICOL SCI, V107, P312, DOI 10.1093/toxsci/kfn236; Steinmaus CM, 2005, ENVIRON RES, V99, P164, DOI 10.1016/j.envres.2004.10.003; Stoddart M L, 2000, Am Indian Alsk Native Ment Health Res, V9, P20; Tellez-Plaza M, 2013, ENVIRON HEALTH PERSP, V121, P345, DOI 10.1289/ehp.1205305; Tseng CH, 2005, TOXICOL APPL PHARM, V206, P299, DOI 10.1016/j.taap.2004.11.022; Tseng CH, 2005, J ENVIRON SCI HEAL C, V23, P55, DOI 10.1081/GNC-200051860; USEPA, 2001, FED REGISTER, V66, P6976; Vahter M, 2007, ENVIRON RES, V104, P85, DOI 10.1016/j.envres.2006.08.003; VARSANYI I, 1991, ENVIRON GEOCHEM HLTH, V13, P14, DOI 10.1007/BF01783491; Voinescu GC, 2002, AM J MED SCI, V323, P39, DOI 10.1097/00000441-200201000-00007; Wade TJ, 2009, INT J ENV RES PUB HE, V6, P1107, DOI 10.3390/ijerph6031107; Wolf G, 2002, AM J KIDNEY DIS, V39, P1, DOI 10.1053/ajkd.2002.29865; Xia YJ, 2009, INT J ENV RES PUB HE, V6, P1010, DOI 10.3390/ijerph6031010; Yoshikawa Masaharu, 2008, Environmental Health and Preventive Medicine, V13, P207, DOI 10.1007/s12199-008-0032-2; Yuan Y, 2007, AM J EPIDEMIOL, V166, P1381, DOI 10.1093/aje/kwm238; ZALDIVAR R, 1980, ZBL BAKT MIK HYG B, V170, P44; Zheng LY, 2013, AM J KIDNEY DIS, V61, P385, DOI 10.1053/j.ajkd.2012.09.011; Zierold KM, 2004, AM J PUBLIC HEALTH, V94, P1936, DOI 10.2105/AJPH.94.11.1936	69	193	198	3	36	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 19	2013	159	10					649	+		10.7326/0003-4819-159-10-201311190-00719	http://dx.doi.org/10.7326/0003-4819-159-10-201311190-00719			17	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	276FB	24061511	Green Accepted			2022-12-24	WOS:000328732700013
J	Wilcken, B				Wilcken, Bridget			Newborn Screening: Gaps in the Evidence	SCIENCE			English	Editorial Material							CYSTIC-FIBROSIS; OUTCOMES; DISEASE		[Wilcken, Bridget] Childrens Hosp Westmead, Westmead, NSW 2145, Australia; [Wilcken, Bridget] Univ Sydney, Sydney, NSW 2008, Australia	University of Sydney; University of Sydney	Wilcken, B (corresponding author), Childrens Hosp Westmead, Westmead, NSW 2145, Australia.	bridget.wilcken@health.nsw.gov.au						Bonham J. R., 2012, EXPANDED NEWBORN SCR; Chace DH, 2003, CLIN CHEM, V49, P1797, DOI 10.1373/clinchem.2003.022178; Comeau AM, 2002, SCIENCE, V295, P44; Dees RH, 2013, PUBLIC HEALTH ETH-UK, V6, P114, DOI 10.1093/phe/phs033; Duffner PK, 2009, GENET MED, V11, P450, DOI 10.1097/GIM.0b013e3181a16e04; DUSSAULT JH, 1975, J PEDIATR-US, V86, P670, DOI 10.1016/S0022-3476(75)80349-0; Farrell PM, 2005, J PEDIATR-US, V147, pS30, DOI 10.1016/j.jpeds.2005.08.012; Grosse Scott D., 2004, Morbidity and Mortality Weekly Report, V53, P1; GUTHRIE R, 1963, PEDIATRICS, V32, P338; Guthrie R., 1964, PUBLICATION US DEP H, V419; Heringer J, 2010, ANN NEUROL, V68, P743, DOI 10.1002/ana.22095; HHS, NOM COND; McKay KO, 2007, J INHERIT METAB DIS, V30, P544, DOI 10.1007/s10545-007-0620-0; Pollitt RJ, 2007, J INHERIT METAB DIS, V30, P423, DOI 10.1007/s10545-007-0647-2; Ross LF, 2012, J INHERIT METAB DIS, V35, P627, DOI 10.1007/s10545-011-9435-0; Watson M.S., 2006, PEDIATRICS, V117, pS296, DOI DOI 10.1542/PEDS.2005-26331; Wilcken B, 2012, PATHOLOGY, V44, P73, DOI 10.1097/PAT.0b013e32834e843f; Wilcken B, 2009, PEDIATRICS, V124, pE241, DOI 10.1542/peds.2008-0586; Wilson MM, 1968, PUBLIC HLTH PAPERS, V34	19	17	17	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 11	2013	342	6155					197	198		10.1126/science.1243944	http://dx.doi.org/10.1126/science.1243944			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	232EV	24115426				2022-12-24	WOS:000325475200028
J	Mather, AE; Reid, SWJ; Maskell, DJ; Parkhill, J; Fookes, MC; Harris, SR; Brown, DJ; Coia, JE; Mulvey, MR; Gilmour, MW; Petrovska, L; de Pinna, E; Kuroda, M; Akiba, M; Izumiya, H; Connor, TR; Suchard, MA; Lemey, P; Mellor, DJ; Haydon, DT; Thomson, NR				Mather, A. E.; Reid, S. W. J.; Maskell, D. J.; Parkhill, J.; Fookes, M. C.; Harris, S. R.; Brown, D. J.; Coia, J. E.; Mulvey, M. R.; Gilmour, M. W.; Petrovska, L.; de Pinna, E.; Kuroda, M.; Akiba, M.; Izumiya, H.; Connor, T. R.; Suchard, M. A.; Lemey, P.; Mellor, D. J.; Haydon, D. T.; Thomson, N. R.			Distinguishable Epidemics of Multidrug-Resistant Salmonella Typhimurium DT104 in Different Hosts	SCIENCE			English	Article							NONTYPHOIDAL SALMONELLA; ENTERICA; INFECTIONS; OUTBREAK; ANIMALS	The global epidemic of multidrug-resistant Salmonella Typhimurium DT104 provides an important example, both in terms of the agent and its resistance, of a widely disseminated zoonotic pathogen. Here, with an unprecedented national collection of isolates collected contemporaneously from humans and animals and including a sample of internationally derived isolates, we have used whole-genome sequencing to dissect the phylogenetic associations of the bacterium and its antimicrobial resistance genes through the course of an epidemic. Contrary to current tenets supporting a single homogeneous epidemic, we demonstrate that the bacterium and its resistance genes were largely maintained within animal and human populations separately and that there was limited transmission, in either direction. We also show considerable variation in the resistance profiles, in contrast to the largely stable bacterial core genome, which emphasizes the critical importance of integrated genotypic data sets in understanding the ecology of bacterial zoonoses and antimicrobial resistance.	[Mather, A. E.; Parkhill, J.; Fookes, M. C.; Harris, S. R.; Connor, T. R.; Thomson, N. R.] Wellcome Trust Sanger Inst, Hinxton CB10 1SA, England; [Reid, S. W. J.] Royal Vet Coll, Hatfield AL9 7TA, Herts, England; [Maskell, D. J.] Univ Cambridge, Dept Vet Med, Cambridge CB3 0ES, England; [Brown, D. J.; Coia, J. E.] Stobhill Gen Hosp, Scottish Salmonella Shigella & Clostridium Diffic, Glasgow G21 3UW, Lanark, Scotland; [Mulvey, M. R.; Gilmour, M. W.] Publ Hlth Agcy Canada, Natl Microbiol Lab, Winnipeg, MB R3E 3R2, Canada; [Petrovska, L.] Anim Hlth & Vet Labs Agcy, Weybridge KT15 3NB, Surrey, England; [de Pinna, E.] Publ Hlth England, Gastrointestinal Bacteria Reference Unit, London NW9 5EQ, England; [Kuroda, M.] Natl Inst Infect Dis, Pathogen Genom Ctr, Tokyo 1628640, Japan; [Akiba, M.] Natl Inst Anim Hlth, Bacterial & Parasit Dis Res Div, Ibaraki 3050856, Japan; [Izumiya, H.] Natl Inst Infect Dis, Dept Bacteriol 1, Tokyo 1628640, Japan; [Suchard, M. A.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Biomath, Los Angeles, CA 90095 USA; [Suchard, M. A.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Human Genet, Los Angeles, CA 90095 USA; [Suchard, M. A.] Univ Calif Los Angeles, UCLA Fielding Sch Publ Hlth, Dept Biostat, Los Angeles, CA 90095 USA; [Lemey, P.] Katholieke Univ Leuven, Rega Inst, Dept Microbiol & Immunol, B-3000 Louvain, Belgium; [Mellor, D. J.; Haydon, D. T.] Univ Glasgow, Coll Med Vet & Life Sci, Boyd Orr Ctr Populat & Ecosyst Hlth, Glasgow G12 8QQ, Lanark, Scotland	Wellcome Trust Sanger Institute; University of London; University of London Royal Veterinary College; University of Cambridge; Public Health Agency of Canada; Veterinary Laboratories Agency; Public Health England; National Institute of Infectious Diseases (NIID); National Agriculture & Food Research Organization - Japan; National Institute of Animal Health - Japan; National Institute of Infectious Diseases (NIID); University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; KU Leuven; University of Glasgow	Reid, SWJ (corresponding author), Royal Vet Coll, Hatfield AL9 7TA, Herts, England.	swjreid@rvc.ac.uk; nrt@sanger.ac.uk	Connor, Thomas/ABE-5989-2020; Thomson, Nicholas R/P-5988-2014; Lemey, Philippe/C-3755-2018; Parkhill, Julian/G-4703-2011; Connor, Thomas/ABD-6533-2021; Petrovska, Liljana/D-7319-2011; Coia, John/AAP-5379-2020; Brown, Derek/AAE-5597-2020; Harris, Simon R/K-1318-2013	Connor, Thomas/0000-0003-2394-6504; Thomson, Nicholas R/0000-0002-4432-8505; Lemey, Philippe/0000-0003-2826-5353; Parkhill, Julian/0000-0002-7069-5958; Coia, John/0000-0002-4966-8453; Brown, Derek/0000-0003-3742-8257; Harris, Simon R/0000-0003-1512-6194; Gilmour, Matthew/0000-0002-6005-3628; Haydon, Daniel/0000-0002-1240-1886; Reid, Stuart/0000-0002-6872-9071	William Stewart Fellowship; Wellcome Trust [098051]; European Union under European Research Council [260864]; NIH [AI107034, HG006139]; NSF [DMS-1264153]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG006139] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI107034] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086887] Funding Source: NIH RePORTER	William Stewart Fellowship; Wellcome Trust(Wellcome TrustEuropean Commission); European Union under European Research Council; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	A.E.M. was funded by the William Stewart Fellowship while at the University of Glasgow. A.E.M., S.R.H., M.C.F., T.R.C., J.P., and N.R.T. are supported by Wellcome Trust grant 098051. P.L. and M.A.S. acknowledge funding from the European Union Seventh Framework Programme (FP7/2007-2013) under European Research Council Grant agreement no. 260864. M.A.S. is supported in part by NIH R01 grants AI107034 and HG006139 and NSF grant DMS-1264153. The authors would like to thank J. Cotton (Wellcome Trust Sanger Institute) for helpful discussions and assistance. Genome sequences are deposited with the European Nucleotide Archive (study accessions ERP000244, ERP000270, ERP000994) and DNA Data Bank of Japan (accession DRA000942). The finished chromosome and plasmid for Salmonella Typhimurium DT104 are submitted to the European Molecular Biology Laboratory, accessions HF937208 and HF937209, respectively.	Angulo FJ, 2000, MICROB DRUG RESIST, V6, P77, DOI 10.1089/mdr.2000.6.77; [Anonymous], 2012, FOOD DRINK SCOTL KEY; Besser TE, 2000, EPIDEMIOL INFECT, V124, P193, DOI 10.1017/S0950268899003283; Boyd D, 2001, J BACTERIOL, V183, P5725, DOI 10.1128/JB.183.19.5725-5732.2001; Cacciolatti, 2009, ANAL RED PROCESSED M; Calvert N, 1998, VET REC, V143, P351, DOI 10.1136/vr.143.13.351; Davies S. C, 2014, ANN REPORT CHIEF MED; Davis MA, 2002, J LAB CLIN MED, V140, P135, DOI 10.1067/mlc.2002.126411; Dechet AM, 2006, CLIN INFECT DIS, V42, P747, DOI 10.1086/500320; Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075; Engemann JJ, 2003, CLIN INFECT DIS, V36, P592, DOI 10.1086/367653; European Food Safety Authority (EFSA), 2011, SALM; Fone D L, 1994, Commun Dis Rep CDR Rev, V4, pR136; Glynn MK, 1998, NEW ENGL J MED, V338, P1333, DOI 10.1056/NEJM199805073381901; Helms M, 2005, EMERG INFECT DIS, V11, P859, DOI 10.3201/eid1106.041017; Herikstad H, 2002, EPIDEMIOL INFECT, V129, P1, DOI 10.1017/S0950268802006842; Lemey P, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000520; Majowicz SE, 2010, CLIN INFECT DIS, V50, P882, DOI 10.1086/650733; Mather AE, 2012, P ROY SOC B-BIOL SCI, V279, P1630, DOI 10.1098/rspb.2011.1975; Molbak K, 1999, NEW ENGL J MED, V341, P1420, DOI 10.1056/NEJM199911043411902; Mulvey MR, 2006, MICROBES INFECT, V8, P1915, DOI 10.1016/j.micinf.2005.12.028; Okoro CK, 2012, NAT GENET, V44, P1215, DOI 10.1038/ng.2423; S Department of Agriculture, 2011, FOODB ILLN COST CALC; Skjot-Rasmussen L, 2009, INT J FOOD MICROBIOL, V131, P277, DOI 10.1016/j.ijfoodmicro.2009.03.006; Summers AO, 2006, ANIM BIOTECHNOL, V17, P125, DOI 10.1080/10495390600957217; Threlfall EJ, 2000, J ANTIMICROB CHEMOTH, V46, P7, DOI 10.1093/jac/46.1.7; WALL PG, 1995, VET REC, V136, P591, DOI 10.1136/vr.136.23.591; Wallis T. S., 2005, ECOSAL ESCHERICHIA C; Zhao S, 2006, J FOOD PROTECT, V69, P500, DOI 10.4315/0362-028X-69.3.500	29	226	230	0	90	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 27	2013	341	6153					1514	1517		10.1126/science.1240578	http://dx.doi.org/10.1126/science.1240578			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	224NS	24030491	Green Accepted			2022-12-24	WOS:000324894600051
J	Padmanabhan, N; Jia, DX; Geary-Joo, C; Wu, XC; Ferguson-Smith, AC; Fung, E; Bieda, MC; Snyder, FF; Gravel, RA; Cross, JC; Watson, ED				Padmanabhan, Nisha; Jia, Dongxin; Geary-Joo, Colleen; Wu, Xuchu; Ferguson-Smith, Anne C.; Fung, Ernest; Bieda, Mark C.; Snyder, Floyd F.; Gravel, Roy A.; Cross, James C.; Watson, Erica D.			Mutation in Folate Metabolism Causes Epigenetic Instability and Transgenerational Effects on Development	CELL			English	Article							TANDEM MASS-SPECTROMETRY; METHIONINE SYNTHASE REDUCTASE; METHYLENETETRAHYDROFOLATE REDUCTASE; IMPRINTED GENES; MICE DEFICIENT; DNA METHYLTRANSFERASES; METHYLATION; MOUSE; HOMOCYSTEINE; DEFECTS	The importance of maternal folate consumption for normal development is well established, yet the molecular mechanism linking folate metabolism to development remains poorly understood. The enzyme methionine synthase reductase (Mtrr) is necessary for utilization of methyl groups from the folate cycle. We found that a hypomorphic mutation of the mouse Mtrr gene results in intrauterine growth restriction, developmental delay, and congenital malformations, including neural tube, heart, and placental defects. Importantly, these defects were dependent upon the Mtrr genotypes of the maternal grandparents. Furthermore, we observed widespread epigenetic instability associated with altered gene expression in the placentas of wild-type grand-progeny of Mtrr-deficient maternal grandparents. Embryo transfer experiments revealed that Mtrr deficiency in mice lead to two distinct, separable phenotypes: adverse effects on their wild-type daughters' uterine environment, leading to growth defects in wild-type grandprogeny, and the appearance of congenital malformations independent of maternal environment that persist for five generations, likely through transgenerational epigenetic inheritance.	[Padmanabhan, Nisha; Ferguson-Smith, Anne C.; Watson, Erica D.] Univ Cambridge, Dept Physiol Dev & Neurosci, Ctr Trophoblast Res, Cambridge CB2 3EG, England; [Jia, Dongxin; Wu, Xuchu; Bieda, Mark C.; Snyder, Floyd F.; Gravel, Roy A.; Cross, James C.; Watson, Erica D.] Univ Calgary, Dept Biochem & Mol Biol, Calgary, AB T2N 4N1, Canada; [Geary-Joo, Colleen] Univ Calgary, Clara Christie Ctr Mouse Genom, Transgen Serv, Calgary, AB T2N 4N1, Canada; [Ferguson-Smith, Anne C.] Univ Cambridge, Dept Genet, Cambridge CB2 3EH, England; [Fung, Ernest; Snyder, Floyd F.; Gravel, Roy A.; Cross, James C.] Univ Calgary, Dept Med Genet, Calgary, AB T2N 4N1, Canada; [Bieda, Mark C.; Snyder, Floyd F.; Gravel, Roy A.; Cross, James C.] Univ Calgary, Alberta Childrens Hosp Res Inst Child & Maternal, Calgary, AB T2N 4N1, Canada; [Cross, James C.; Watson, Erica D.] Univ Calgary, Dept Comparat Biol & Expt Med, Calgary, AB T2N 4N1, Canada	University of Cambridge; University of Calgary; University of Calgary; University of Cambridge; University of Calgary; University of Calgary; University of Calgary	Watson, ED (corresponding author), Univ Cambridge, Dept Physiol Dev & Neurosci, Ctr Trophoblast Res, Cambridge CB2 3EG, England.	edw23@cam.ac.uk	Padmanabhan, Nisha/ABE-4879-2020; Cross, James/AAU-2973-2020; Cross, James/F-4814-2011	Padmanabhan, Nisha/0000-0003-1253-2162; Cross, James/0000-0003-0956-9378; Cross, James/0000-0003-0956-9378; Watson, Erica/0000-0003-4496-2271; Ferguson-Smith, Anne/0000-0002-7608-5894	CIHR; NIH-NHLBI; Centre for Trophoblast Research (CTR); CTR graduate studentship; EpiHealth and Epigenesys; MRC; Wellcome Trust; CIHR Training Program in Genetics, Child Development and Health; NSERC; MRC [MR/J001597/1] Funding Source: UKRI; Medical Research Council [MR/J001597/1] Funding Source: researchfish; Wellcome Trust [095606/Z/11/Z] Funding Source: researchfish; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL058955] Funding Source: NIH RePORTER	CIHR(Canadian Institutes of Health Research (CIHR)); NIH-NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Centre for Trophoblast Research (CTR); CTR graduate studentship; EpiHealth and Epigenesys; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); CIHR Training Program in Genetics, Child Development and Health(Canadian Institutes of Health Research (CIHR)); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank Cameron Fielding, Xiang Zhao, Frances Snider, and Nuala Daw for their technical assistance. This work was supported by grants from the CIHR (to R.A.G. and J.C.C.), NIH-NHLBI (to R.A.G.), and Centre for Trophoblast Research (CTR) (to E.D.W.). N.P. was funded by a CTR graduate studentship. A.C.F.-S. was supported by FP7 grants from EpiHealth and Epigenesys, MRC, and Wellcome Trust. E.D.W. was funded by the CIHR Training Program in Genetics, Child Development and Health and fellowships from the CTR, NSERC, and CIHR.	AGELL N, 1983, FEBS LETT, V155, P209, DOI 10.1016/0014-5793(82)80604-2; Anway MD, 2005, SCIENCE, V308, P1466, DOI 10.1126/science.1108190; Castro R, 2004, J MED GENET, V41, P454, DOI 10.1136/jmg.2003.017244; Chan D, 2010, ENDOCRINOLOGY, V151, P3363, DOI 10.1210/en.2009-1340; Chen ZT, 2001, HUM MOL GENET, V10, P433, DOI 10.1093/hmg/10.5.433; Coan PM, 2005, PLACENTA, V26, pS10, DOI 10.1016/j.placenta.2004.12.009; Deng L, 2008, MOL GENET METAB, V94, P336, DOI 10.1016/j.ymgme.2008.03.004; Elmore CL, 2007, MOL GENET METAB, V91, P85, DOI 10.1016/j.ymgme.2007.02.001; Friso S, 2002, P NATL ACAD SCI USA, V99, P5606, DOI 10.1073/pnas.062066299; Ghandour H, 2004, J NUTR, V134, P2975, DOI 10.1093/jn/134.11.2975; Ghandour H, 2002, J NUTR, V132, P1357, DOI 10.1093/jn/132.6.1357; Grishok A, 2000, SCIENCE, V287, P2494, DOI 10.1126/science.287.5462.2494; Hague WM, 2003, BEST PRACT RES CL OB, V17, P459, DOI 10.1016/S1521-6934(03)00009-9; Hart DJ, 2002, ANAL BIOCHEM, V305, P206, DOI 10.1006/abio.2002.5662; Hata K, 2002, DEVELOPMENT, V129, P1983; Hemberger M, 2010, EPIGENETICS-US, V5, P24, DOI 10.4161/epi.5.1.10589; LI E, 1992, CELL, V69, P915, DOI 10.1016/0092-8674(92)90611-F; Magera MJ, 1999, CLIN CHEM, V45, P1517; Messerschmidt DM, 2012, SCIENCE, V335, P1499, DOI 10.1126/science.1216154; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Pickell L, 2009, BIRTH DEFECTS RES A, V85, P531, DOI 10.1002/bdra.20575; Piedrahita JA, 1999, NAT GENET, V23, P228, DOI 10.1038/13861; Rampersaud E, 2003, CLIN GENET, V63, P210, DOI 10.1034/j.1399-0004.2003.00043.x; Rassoulzadegan M, 2006, NATURE, V441, P469, DOI 10.1038/nature04674; Rozen S, 2000, Methods Mol Biol, V132, P365; Saitou M, 2012, DEVELOPMENT, V139, P15, DOI 10.1242/dev.050849; SHANE B, 1985, ANNU REV NUTR, V5, P115, DOI 10.1146/annurev.nu.05.070185.000555; Sinclair KD, 2007, P NATL ACAD SCI USA, V104, P19351, DOI 10.1073/pnas.0707258104; Smith DEC, 2006, CLIN CHEM LAB MED, V44, P450, DOI 10.1515/CCLM.2006.085; Stouder C, 2010, REPRODUCTION, V139, P373, DOI 10.1530/REP-09-0340; Swanson DA, 2001, MOL CELL BIOL, V21, P1058, DOI 10.1128/MCB.21.4.1058-1065.2001; Tunster SJ, 2013, REPRODUCTION, V145, pR117, DOI 10.1530/REP-12-0511; Ueda O, 2003, BIOL REPROD, V69, P1085, DOI 10.1095/biolreprod.103.017608; VANDERPUT NMJ, 1995, LANCET, V346, P1070, DOI 10.1016/S0140-6736(95)91743-8; Vastenhouw NL, 2006, NATURE, V442, P882, DOI 10.1038/442882a; Waes JGV, 2008, BIRTH DEFECTS RES A, V82, P494, DOI 10.1002/bdra.20453; WAINFAN E, 1975, CANCER RES, V35, P2830; Weaving G, 2006, ANN CLIN BIOCHEM, V43, P474, DOI 10.1258/000456306778904605; Yamada K, 2006, P NATL ACAD SCI USA, V103, P9476, DOI 10.1073/pnas.0603694103	39	180	181	0	57	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 26	2013	155	1					81	93		10.1016/j.cell.2013.09.002	http://dx.doi.org/10.1016/j.cell.2013.09.002			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	224UX	24074862	Bronze, Green Accepted			2022-12-24	WOS:000324916700011
J	Liang, Y; Cao, YR; Tanaka, K; Thibivilliers, S; Wan, JR; Choi, J; Kang, CH; Qiu, J; Stacey, G				Liang, Yan; Cao, Yangrong; Tanaka, Kiwamu; Thibivilliers, Sandra; Wan, Jinrong; Choi, Jeongmin; Kang, Chang Ho; Qiu, Jing; Stacey, Gary			Nonlegumes Respond to Rhizobial Nod Factors by Suppressing the Innate Immune Response	SCIENCE			English	Article							DEFENSE RESPONSES; RECEPTOR KINASE; NODULATION; ARABIDOPSIS; LEGUME; RECOGNITION; EXPRESSION; PERCEPTION; RESISTANCE; MOLECULES	Virtually since the discovery of nitrogen-fixing Rhizobium-legume symbioses, researchers have dreamed of transferring this capability into nonlegume crop species (for example, corn). In general, nonlegumes were assumed to lack the ability to respond to the rhizobial lipo-chitin Nod factors, which are the essential signal molecules that trigger legume nodulation. However, our data indicate that Arabidopsis thaliana plants, as well as other nonlegumes, recognize the rhizobial Nod factor via a mechanism that results in strong suppression of microbe-associated molecular pattern (MAMP)-triggered immunity. The mechanism of action leads to reduced levels of pattern-recognition receptors on the plasma membrane involved in MAMP recognition.	[Liang, Yan; Cao, Yangrong; Tanaka, Kiwamu; Thibivilliers, Sandra; Choi, Jeongmin; Stacey, Gary] Univ Missouri, Christopher S Bond Life Sci Ctr, Natl Ctr Soybean Biotechnol, Div Plant Sci, Columbia, MO 65211 USA; [Liang, Yan; Cao, Yangrong; Tanaka, Kiwamu; Thibivilliers, Sandra; Choi, Jeongmin; Stacey, Gary] Univ Missouri, Christopher S Bond Life Sci Ctr, Natl Ctr Soybean Biotechnol, Div Biochem, Columbia, MO 65211 USA; [Wan, Jinrong] Univ Missouri, Div Plant Sci, Columbia, MO 65211 USA; [Kang, Chang Ho] Gyeongsang Natl Univ, Plant Mol Biol & Biotechnol Res Ctr, Jinju 660701, Gyeongsangnam D, South Korea; [Qiu, Jing] Univ Missouri, Dept Stat, Columbia, MO 65211 USA	University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; Gyeongsang National University; University of Missouri System; University of Missouri Columbia	Stacey, G (corresponding author), Univ Missouri, Christopher S Bond Life Sci Ctr, Natl Ctr Soybean Biotechnol, Div Plant Sci, Columbia, MO 65211 USA.	staceyg@missouri.edu	Tanaka, Kiwamu/E-9942-2013; poinssot, benoit/B-2569-2009	Tanaka, Kiwamu/0000-0001-5045-560X; poinssot, benoit/0000-0001-5890-4318; Kang, Chang Ho/0000-0003-4342-5247	Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences of the U.S. Department of Energy [DE-FG02-08ER15309]; Next-Generation BioGreen 21 Program Systems and Synthetic Agrobiotech Center, Rural Development Administration, Republic of Korea [PJ009068]; Novozymes	Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences of the U.S. Department of Energy(United States Department of Energy (DOE)); Next-Generation BioGreen 21 Program Systems and Synthetic Agrobiotech Center, Rural Development Administration, Republic of Korea; Novozymes	We thank A. Bent for providing the anti-FLS2 antibody and EFR::EFR:HA transgenic seeds, M. R. Knight for aequorin transgenic seeds, S. Robatzek for FLS2::FLS2:GFP transgenic seeds, Novozymes (Bagsvaerd, Denmark) for the purified Nod factor, and S. Peck for critical comments to improve the manuscript. This work was supported by the Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences of the U.S. Department of Energy through grant DE-FG02-08ER15309 and by the Next-Generation BioGreen 21 Program Systems and Synthetic Agrobiotech Center, Rural Development Administration, Republic of Korea (grant PJ009068 to G. S). Additional support was provided by Novozymes.	Asai T, 2002, NATURE, V415, P977, DOI 10.1038/415977a; Beatty PH, 2011, SCIENCE, V333, P416, DOI 10.1126/science.1209467; BELIVEAU C, 1991, J BACTERIOL, V173, P5619, DOI 10.1128/jb.173.18.5619-5623.1991; Broghammer A, 2012, P NATL ACAD SCI USA, V109, P13859, DOI 10.1073/pnas.1205171109; Clay NK, 2009, SCIENCE, V323, P95, DOI 10.1126/science.1164627; Dangl JL, 2001, NATURE, V411, P826, DOI 10.1038/35081161; DENARIE J, 1993, CELL, V74, P951, DOI 10.1016/0092-8674(93)90717-5; Denoux C, 2008, MOL PLANT, V1, P423, DOI 10.1093/mp/ssn019; El Yahyaoui F, 2004, PLANT PHYSIOL, V136, P3159, DOI 10.1104/pp.104.043612; Geurts R, 2002, PLANT CELL, V14, pS239, DOI 10.1105/tpc.002451; Indrasumunar A, 2011, PLANT J, V65, P39, DOI 10.1111/j.1365-313X.2010.04398.x; Indrasumunar A, 2010, PLANT CELL PHYSIOL, V51, P201, DOI 10.1093/pcp/pcp178; Kaku H, 2006, P NATL ACAD SCI USA, V103, P11086, DOI 10.1073/pnas.0508882103; Kouchi H, 2004, DNA RES, V11, P263, DOI 10.1093/dnares/11.4.263; Limpens E, 2003, SCIENCE, V302, P630, DOI 10.1126/science.1090074; Long SR, 1996, PLANT CELL, V8, P1885, DOI 10.1105/tpc.8.10.1885; Lu DP, 2011, SCIENCE, V332, P1439, DOI 10.1126/science.1204903; Madsen EB, 2003, NATURE, V425, P637, DOI 10.1038/nature02045; Minami E, 1996, MOL PLANT MICROBE IN, V9, P574, DOI 10.1094/MPMI-9-0574; Miya A, 2007, P NATL ACAD SCI USA, V104, P19613, DOI 10.1073/pnas.0705147104; Nakagawa T, 2011, PLANT J, V65, P169, DOI 10.1111/j.1365-313X.2010.04411.x; Op den Camp R., 2011, SCIENCE, V331, P909; Radutoiu S, 2003, NATURE, V425, P585, DOI 10.1038/nature02039; Ranf S, 2011, PLANT J, V68, P100, DOI 10.1111/j.1365-313X.2011.04671.x; REMY W, 1994, P NATL ACAD SCI USA, V91, P11841, DOI 10.1073/pnas.91.25.11841; Torres MA, 2005, CURR OPIN PLANT BIOL, V8, P397, DOI 10.1016/j.pbi.2005.05.014; Walker SA, 2000, P NATL ACAD SCI USA, V97, P13413, DOI 10.1073/pnas.230440097; Wan JR, 2008, PLANT CELL, V20, P471, DOI 10.1105/tpc.107.056754; Zipfel C, 2004, NATURE, V428, P764, DOI 10.1038/nature02485	29	159	164	7	185	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 20	2013	341	6152					1384	1387		10.1126/science.1242736	http://dx.doi.org/10.1126/science.1242736			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	220PK	24009356				2022-12-24	WOS:000324597200044
J	Le Couteur, DG; Doust, J; Creasey, H; Brayne, C				Le Couteur, David G.; Doust, Jenny; Creasey, Helen; Brayne, Carol			Political drive to screen for pre-dementia: not evidence based and ignores the harms of diagnosis	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							MILD COGNITIVE IMPAIRMENT; ALZHEIMERS-DISEASE; CHOLINESTERASE-INHIBITORS; PRIMARY-CARE; PATIENTS ATTITUDES; MEMORY CLINICS; PROGRESSION; RISK; RECOMMENDATIONS; METAANALYSIS		[Le Couteur, David G.] Univ Sydney & Sydney Res, Ctr Educ & Res Ageing, ANZAC Med Res Inst, Concord 2139, Australia; [Le Couteur, David G.] Univ Sydney & Sydney Res, Charles Perkins Ctr, Concord 2139, Australia; [Doust, Jenny] Bond Univ, Ctr Res Evidence Based Practice, Robina, Australia; [Creasey, Helen] Concord RG Hosp, Ctr Educ & Res Ageing, Concord, NSW, Australia; [Brayne, Carol] Univ Cambridge, Dept Publ Hlth & Primary Care, Cambridge, England	University of Sydney; ANZAC Research Institute; University of Sydney; Bond University; Concord Repatriation General Hospital; University of Cambridge	Le Couteur, DG (corresponding author), Univ Sydney & Sydney Res, Ctr Educ & Res Ageing, ANZAC Med Res Inst, Concord 2139, Australia.	david.lecouteur@sydney.edu.au	Research Institute, ANZAC/CAE-9030-2022; Doust, Jenny/AGI-8773-2022; Brayne, Carol/AAA-4285-2020; Ekanayake, Kanchana/P-8817-2016	Doust, Jenny/0000-0002-4024-9308; Brayne, Carol/0000-0001-5307-663X; Le Couteur, David/0000-0002-4227-5817	National Institute for Health Research [NF-SI-0611-10084] Funding Source: researchfish	National Institute for Health Research(National Institute for Health Research (NIHR))		American Psychiatric Association, 2013, DIAGN STAT MAN MENT, V5, DOI 10.1176/appi.books.9780890425596; Ashford JW, 2007, ALZHEIMERS DEMENT, V3, P75, DOI 10.1016/j.jalz.2006.02.005; Ballard C, 2011, LANCET, V377, P1019, DOI 10.1016/S0140-6736(10)61349-9; Barnes DE, 2011, LANCET NEUROL, V10, P819, DOI 10.1016/S1474-4422(11)70072-2; Borson S, 2013, ALZHEIMERS DEMENT, V9, P151, DOI 10.1016/j.jalz.2012.08.008; Boustani M, 2005, J GEN INTERN MED, V20, P572, DOI 10.1007/s11606-005-0103-7; Boustani M, 2008, INT J GERIATR PSYCH, V23, P812, DOI 10.1002/gps.1983; Brakhus Anne, 2011, Tidsskr Nor Laegeforen, V131, P2254, DOI 10.4045/tidsskr.11.0786; Brayne C, 2006, PLOS MED, V3, P1922, DOI 10.1371/journal.pmed.0030397; Brayne C, 2012, LANCET, V380, P1441, DOI 10.1016/S0140-6736(12)61803-0; Brunet MD, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e8588; Brunet MD, 2012, EARLY DIAGNOSIS DEME; Bunn F, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001331; Carrillo MC, 2012, ALZHEIMERS DEMENT, V8, P337, DOI 10.1016/j.jalz.2012.04.007; Chinthapalli K, 2012, BRIT MED J, V345, DOI 10.1136/bmj.e8533; Connolly A, 2011, AGING MENT HEALTH, V15, P978, DOI 10.1080/13607863.2011.596805; Coombes R., 2009, BMJ-BRIT MED J, V338, P375; Corbyn Z, 2013, LANCET, V381, P614, DOI 10.1016/S0140-6736(13)60330-X; Department of Health, 2013, POL IMPR CAR PEOPL D; Draper B, 2010, ALZHEIMERS DEMENT, V6, P75, DOI 10.1016/j.jalz.2009.04.1229; Dubois B, 2013, INT PSYCHOGERIATR, V25, P175, DOI 10.1017/S1041610212002098; Dubois B, 2010, LANCET NEUROL, V9, P1118, DOI 10.1016/S1474-4422(10)70223-4; Eaton J., 2009, BMJ-BRIT MED J, V338, pb464; Esiri MM, 2001, LANCET, V357, P169; Flicker LA, 2012, MED J AUSTRALIA, V196, P114, DOI 10.5694/mja11.11399; Gill SS, 2009, ARCH INTERN MED, V169, P867, DOI 10.1001/archinternmed.2009.43; Hilmer SN, 2007, FUND CLIN PHARMACOL, V21, P217, DOI 10.1111/j.1472-8206.2007.00473.x; Justiss MD, 2009, INT J GERIATR PSYCH, V24, P632, DOI 10.1002/gps.2173; Kmietowicz Z, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e2347; Knopman DS, NEUROLOGY IN PRESS; Lane HP, 2013, AGE AGEING, V42, P281, DOI 10.1093/ageing/aft011; Le Couteur DG, 2012, AUSTRALAS J AGEING, V31, P164, DOI 10.1111/j.1741-6612.2011.00564.x; Lind S, 2013, PULSE           0124; Lindesay J, 2002, INT J GERIATR PSYCH, V17, P41, DOI 10.1002/gps.522; Lopez OL, 2011, CURR OPIN NEUROL, V24, P532, DOI 10.1097/WCO.0b013e32834cd45b; Manthorpe J, 2013, BRIT J GEN PRACT, V63, DOI 10.3399/bjgp13X660805; Marchant NL, 2013, JAMA NEUROL, V70, P488, DOI 10.1001/2013.jamaneurol.405; Masoodi N, 2013, ANN INTERN MED, V158, DOI 10.7326/0003-4819-158-4-201302190-02003; Mattsson N, 2012, NEUROLOGY, V78, P468, DOI 10.1212/WNL.0b013e3182477eed; Meeuwsen EJ, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e3086; Meulen EFJ, 2004, J NEUROL NEUROSUR PS, V75, P700, DOI 10.1136/jnnp.2003.021055; Mitchell AJ, 2008, J NEUROL NEUROSUR PS, V79, P1386, DOI 10.1136/jnnp.2007.142679; Mitchell AJ, 2009, ACTA PSYCHIAT SCAND, V119, P252, DOI 10.1111/j.1600-0447.2008.01326.x; Mitchell AJ, 2011, ACTA PSYCHIAT SCAND, V124, P165, DOI 10.1111/j.1600-0447.2011.01730.x; Mitka M, 2013, JAMA-J AM MED ASSOC, V309, P1099, DOI 10.1001/jama.2013.2101; Naylor MD, 2012, ALZHEIMERS DEMENT, V8, P445, DOI 10.1016/j.jalz.2012.08.001; Noel-Storr Anna H, 2013, Alzheimers Dement, V9, pe96, DOI 10.1016/j.jalz.2012.01.014; O'Brien JT, 2011, J PSYCHOPHARMACOL, V25, P997, DOI 10.1177/0269881110387547; Prince M, WORLD ALZHEIMER REPO; Richards M, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c4670; Ritchie LJ, 2013, INT ENCY REHABILITAT; Rosness TA, 2009, INT J GERIATR PSYCH, V24, P1143, DOI 10.1002/gps.2238; Rowe CC, 2010, NEUROBIOL AGING, V31, P1275, DOI 10.1016/j.neurobiolaging.2010.04.007; Schneider LS, 2013, LANCET NEUROL, V12, P327, DOI 10.1016/S1474-4422(13)70050-4; Senior PsychCare, 2013, EARL DIAGN 7 MIN ALZ; Social Market Foundation, 2012, THINK TANK CALLS FIN; Song XW, 2013, J NEUROL NEUROSUR PS, V84, P71, DOI 10.1136/jnnp-2012-303579; Sperling RA, 2013, NAT REV NEUROL, V9, P54, DOI 10.1038/nrneurol.2012.241; Sperling RA, 2011, ALZHEIMERS DEMENT, V7, P280, DOI 10.1016/j.jalz.2011.03.003; Spies PE, 2011, EUR J NEUROL, V18, P1014, DOI 10.1111/j.1468-1331.2010.03222.x; Stephan BCM, 2012, MOL PSYCHIATR, V17, P1056, DOI 10.1038/mp.2011.147; Stephan BCM, 2008, INT J GERIATR PSYCH, V23, P863, DOI 10.1002/gps.2013; The Royal Australian College of General Practitioners, 2012, GUID PREV ACT GEN PR; UK National Screening Committee, 2010, UK NSC POL ALZH DIS; US Preventive Services Task Force, 2003, SCREEN DEM; Waldorff FB, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e4693; Ward A, 2012, ALZHEIMERS DEMENT, V8, P14, DOI 10.1016/j.jalz.2011.01.002; Wharton SB, 2011, J ALZHEIMERS DIS, V25, P359, DOI 10.3233/JAD-2011-091402; WILSON JMG, 1968, B OFIC SANIT PANAM, V65, P281; Wimo A, 2013, INT J GERIATR PSYCHI; Winblad B, 2008, NEUROLOGY, V70, P2024, DOI 10.1212/01.wnl.0000303815.69777.26	71	138	140	1	29	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 9	2013	347								f5125	10.1136/bmj.f5125	http://dx.doi.org/10.1136/bmj.f5125			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	219RJ	24018000				2022-12-24	WOS:000324526000004
J	Hawkes, N				Hawkes, Nigel			Use of beta blockers during surgery may have caused 10 000 deaths in the UK	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Bouri S, 2013, HEART; Huston L, 2013, FORBES           JUL	2	1	1	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 5	2013	347								f4914	10.1136/bmj.f4914	http://dx.doi.org/10.1136/bmj.f4914			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	201CN	23918611				2022-12-24	WOS:000323118400004
J	Ferraro, PM; Taylor, EN; Eisner, BH; Gambaro, G; Rimm, EB; Mukamal, KJ; Curhan, GC				Ferraro, Pietro Manuel; Taylor, Eric N.; Eisner, Brian H.; Gambaro, Giovanni; Rimm, Eric B.; Mukamal, Kenneth J.; Curhan, Gary C.			History of Kidney Stones and the Risk of Coronary Heart Disease	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							METABOLIC SYNDROME; DIETARY CALCIUM; BLOOD-PRESSURE; HYPERTENSION; NEPHROLITHIASIS; POPULATION; OSTEOPONTIN; PREVALENCE; HEALTH; REPRODUCIBILITY	IMPORTANCE Kidney stone disease is common and may be associated with an increased risk of coronary heart disease (CHD). Previous studies of the association between kidney stones and CHD have often not controlled for important risk factors, and the results have been inconsistent. OBJECTIVE To examine the association between a history of kidney stones and the risk of CHD in 3 large prospective cohorts. DESIGN, SETTING, AND PARTICIPANTS A prospective study of 45 748 men and 196 357 women in the United States without a history of CHD at baseline who were participants in the Health Professionals Follow-up Study (HPFS) (45 748 men aged 40-75 years; follow-up from 1986 to 2010), Nurses' Health Study I (NHS I) (90 235 women aged 30-55 years; follow-up from 1992 to 2010), and Nurses' Health Study II (NHS II) (106 122 women aged 25-42 years; follow-up from 1991 to 2009). The diagnoses of kidney stones and CHD were updated biennially during follow-up. MAIN OUTCOMES AND MEASURES Coronary heart disease was defined as fatal or nonfatal myocardial infarction (MI) or coronary revascularization. The outcome was identified by biennial questionnaires and confirmed through review of medical records. RESULTS Of a total of 242 105 participants, 19 678 reported a history of kidney stones. After up to 24 years of follow-up in men and 18 years in women, 16 838 incident cases of CHD occurred. After adjusting for potential confounders, among women, those with a reported history of kidney stones had an increased risk of CHD than those without a history of kidney stones in NHS I (incidence rate [IR], 754 vs 514 per 100 000 person-years; multivariable hazard ratio [HR], 1.18 [95% CI, 1.08-1.28]) and NHS II (IR, 144 vs 55 per 100 000 person-years; multivariable HR, 1.48 [95% CI, 1.23-1.78]). There was no significant association in men (IR, 1355 vs 1022 per 100 000 person-years; multivariable HR, 1.06 [95% CI, 0.99-1.13]). Similar results were found when analyzing the individual end points (fatal and nonfatal MI and revascularization). CONCLUSIONS AND RELEVANCE Among the 2 cohorts of women, a history of kidney stones was associated with a modest but statistically significantly increased risk of CHD; there was no significant association in a separate cohort of men. Further research is needed to determine whether the association is sex-specific.	[Ferraro, Pietro Manuel; Gambaro, Giovanni] Columbus Gemelli Hosp, Dept Internal Med & Med Specialties, Div Nephrol, Renal Program, Rome, Italy; [Ferraro, Pietro Manuel; Taylor, Eric N.; Rimm, Eric B.; Curhan, Gary C.] Brigham & Womens Hosp, Dept Med, Channing Div Network Med, Boston, MA 02115 USA; [Eisner, Brian H.] Massachusetts Gen Hosp, Dept Urol, Boston, MA 02114 USA; [Mukamal, Kenneth J.] Beth Israel Deaconess Med Ctr, Dept Med, Boston, MA 02215 USA; [Curhan, Gary C.] Brigham & Womens Hosp, Dept Med, Div Renal, Boston, MA 02115 USA	Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Harvard University; Brigham & Women's Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Brigham & Women's Hospital	Ferraro, PM (corresponding author), Univ Cattolica Sacro Cuore, Dept Internal Med & Med Specialties, Via G Moscati 31, I-00168 Rome, Italy.	manuel.ferraro@channing.harvard.edu	Ferraro, Manuel/H-1517-2012; Mukamal, Kenneth/GVR-7978-2022	Ferraro, Manuel/0000-0002-1379-022X; Gambaro, Giovanni/0000-0001-5733-2370	National Institutes of Health [DK91417, DK70756, CA087969, CA50385, CA055075, HL034594, HL35464]; NATIONAL CANCER INSTITUTE [UM1CA167552, R01CA050385, P01CA055075, P01CA087969, UM1CA176726] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL035464, R01HL034594] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK070756, K24DK091417] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grants DK91417, DK70756, CA087969, CA50385, CA055075, HL034594, and HL35464 from the National Institutes of Health.	Alexander RT, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e5287; Ando R, 2011, INT J UROL, V18, P131, DOI 10.1111/j.1442-2042.2010.02690.x; Aydin H, 2011, UROL RES, V39, P451, DOI 10.1007/s00240-011-0383-9; Borghi L, 1999, KIDNEY INT, V55, P2397, DOI 10.1046/j.1523-1755.1999.00483.x; CAPPUCCIO FP, 1990, BRIT MED J, V300, P1234, DOI 10.1136/bmj.300.6734.1234; Centers for Disease Control and Prevention, 2008, NATL VITAL STAT REPO, V59; Chung SD, 2011, J UROLOGY, V186, P1888, DOI 10.1016/j.juro.2011.07.011; CIRILLO M, 1988, J HYPERTENS, V6, pS485, DOI 10.1097/00004872-198812040-00153; Curhan GC, 2004, ARCH INTERN MED, V164, P885, DOI 10.1001/archinte.164.8.885; Curhan GC, 1997, ANN INTERN MED, V126, P497, DOI 10.7326/0003-4819-126-7-199704010-00001; CURHAN GC, 1993, NEW ENGL J MED, V328, P833, DOI 10.1056/NEJM199303253281203; Domingos F, 2011, NEPHROL DIAL TRANSPL, V26, P864, DOI 10.1093/ndt/gfq501; ELMFELDT D, 1976, J CHRON DIS, V29, P221, DOI 10.1016/0021-9681(76)90076-X; FESKANICH D, 1993, J AM DIET ASSOC, V93, P790, DOI 10.1016/0002-8223(93)91754-E; Fung TT, 2008, ARCH INTERN MED, V168, P713, DOI 10.1001/archinte.168.7.713; Gillen DL, 2005, AM J KIDNEY DIS, V46, P263, DOI 10.1053/j.ajkd.2005.04.030; Hamano S, 2005, INT J UROL, V12, P859, DOI 10.1111/j.1442-2042.2005.01160.x; Hippisley-Cox J, 2010, BMC FAM PRACT, V11, DOI 10.1186/1471-2296-11-49; Jeong IG, 2011, AM J KIDNEY DIS, V58, P383, DOI 10.1053/j.ajkd.2011.03.021; Kleinman JG, 2004, NEPHRON PHYSIOL, V98, P43, DOI DOI 10.1159/000080263; LJUNGHALL S, 1976, ACTA MED SCAND, V199, P481; Madore F, 1998, AM J KIDNEY DIS, V32, P802, DOI 10.1016/S0272-6386(98)70136-2; MCCARRON DA, 1984, SCIENCE, V226, P386, DOI 10.1126/science.226.4673.386; Ohmori R, 2003, ATHEROSCLEROSIS, V170, P333, DOI 10.1016/S0021-9150(03)00298-3; Reilly RF, 2010, CLIN J AM SOC NEPHRO, V5, P1893, DOI 10.2215/CJN.04670510; Reiner AP, 2011, J UROLOGY, V185, P920, DOI 10.1016/j.juro.2010.10.086; Rendina D, 2009, NEPHROL DIAL TRANSPL, V24, P900, DOI 10.1093/ndt/gfn548; RIMM EB, 1992, AM J EPIDEMIOL, V135, P1114, DOI 10.1093/oxfordjournals.aje.a116211; RIMM EB, 1991, LANCET, V338, P464, DOI 10.1016/0140-6736(91)90542-W; Rule AD, 2011, CLIN J AM SOC NEPHRO, V6, P2069, DOI 10.2215/CJN.10651110; Rule AD, 2010, J AM SOC NEPHROL, V21, P1641, DOI 10.1681/ASN.2010030253; Scales CD, 2012, EUR UROL, V62, P160, DOI 10.1016/j.eururo.2012.03.052; Stamatelou KK, 2003, KIDNEY INT, V63, P1817, DOI 10.1046/j.1523-1755.2003.00917.x; Stoller ML, 2004, J UROLOGY, V171, P1920, DOI 10.1097/01.ju.0000120291.90839.49; Taylor EN, 2005, KIDNEY INT, V68, P1230, DOI 10.1111/j.1523-1755.2005.00516.x; Taylor EN, 2009, J AM SOC NEPHROL, V20, P2253, DOI 10.1681/ASN.2009030276; US Renal Data System, USRDS 2010 ANN DAT R; Wang L, 2012, AM J CARDIOVASC DRUG, V12, P105, DOI 10.2165/11595400-000000000-00000; Wesson JA, 2003, J AM SOC NEPHROL, V14, P139, DOI 10.1097/01.ASN.0000040593.93815.9D; West B, 2008, AM J KIDNEY DIS, V51, P741, DOI 10.1053/j.ajkd.2007.12.030; WESTLUND K, 1973, AM J EPIDEMIOL, V97, P167, DOI 10.1093/oxfordjournals.aje.a121497; Yasui T, 1999, UROL RES, V27, P225, DOI 10.1007/s002400050114	42	138	146	0	12	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 24	2013	310	4					408	415		10.1001/jama.2013.8780	http://dx.doi.org/10.1001/jama.2013.8780			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	187LV	23917291	Bronze, Green Accepted			2022-12-24	WOS:000322121500018
J	Wang, C; Chang, WC; Guo, YS; Huang, H; Peck, SC; Pandelia, ME; Lin, GM; Liu, HW; Krebs, C; Bollinger, JM				Wang, Chen; Chang, Wei-chen; Guo, Yisong; Huang, Hui; Peck, Spencer C.; Pandelia, Maria E.; Lin, Geng-min; Liu, Hung-wen; Krebs, Carsten; Bollinger, J. Martin, Jr.			Evidence that the Fosfomycin-Producing Epoxidase, HppE, Is a Non-Heme-Iron Peroxidase	SCIENCE			English	Article							ISOPENICILLIN-N-SYNTHASE; KETOGLUTARATE DIOXYGENASE TAUD; SPIN FE(IV) COMPLEX; ANTIBIOTIC FOSFOMYCIN; OXYGEN-ACTIVATION; ESCHERICHIA-COLI; PSEUDOMONAS-SYRINGAE; ALIPHATIC HALOGENASE; ELECTRONIC-STRUCTURE; CATALYTIC MECHANISM	The iron-dependent epoxidase HppE converts (S)-2-hydroxypropyl-1-phosphonate (S-HPP) to the antibiotic fosfomycin [(1R,2S)-epoxypropylphosphonate] in an unusual 1,3-dehydrogenation of a secondary alcohol to an epoxide. HppE has been classified as an oxidase, with proposed mechanisms differing primarily in the identity of the O-2-derived iron complex that abstracts hydrogen (H center dot) from C1 of S-HPP to initiate epoxide ring closure. We show here that the preferred cosubstrate is actually H2O2 and that HppE therefore almost certainly uses an iron(IV)-oxo complex as the H center dot abstractor. Reaction with H2O2 is accelerated by bound substrate and produces fosfomycin catalytically with a stoichiometry of unity. The ability of catalase to suppress the HppE activity previously attributed to its direct utilization of O-2 implies that reduction of O-2 and utilization of the resultant H2O2 were actually operant.	[Wang, Chen; Krebs, Carsten; Bollinger, J. Martin, Jr.] Penn State Univ, Dept Biochem & Mol Biol, University Pk, PA 16802 USA; [Chang, Wei-chen; Guo, Yisong; Pandelia, Maria E.; Krebs, Carsten; Bollinger, J. Martin, Jr.] Penn State Univ, Dept Chem, University Pk, PA 16802 USA; [Huang, Hui; Lin, Geng-min; Liu, Hung-wen] Univ Texas Austin, Coll Pharm, Div Med Chem, Austin, TX 78712 USA; [Huang, Hui; Lin, Geng-min; Liu, Hung-wen] Univ Texas Austin, Dept Chem & Biochem, Austin, TX 78712 USA; [Peck, Spencer C.] Univ Illinois, Dept Chem, Urbana, IL USA; [Peck, Spencer C.] Univ Illinois, Howard Hughes Med Inst, Urbana, IL USA; [Peck, Spencer C.] Univ Illinois, Inst Genom Biol, Urbana, IL USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; University of Illinois System; University of Illinois Urbana-Champaign; Howard Hughes Medical Institute; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Liu, HW (corresponding author), Univ Texas Austin, Coll Pharm, Div Med Chem, Austin, TX 78712 USA.	h.w.liu@mail.utexas.edu; ckrebs@psu.edu; jmb21@psu.edu	Bollinger, Joseph/C-1425-2016; Guo, Yisong/C-7785-2009; Krebs, Carsten/D-4773-2009	Guo, Yisong/0000-0002-4132-3565; Krebs, Carsten/0000-0002-3302-7053; Lin, Geng-Min/0000-0001-8123-0921; Peck, Spencer/0000-0002-1599-6635; CHANG, WEI-CHEN/0000-0002-2341-9846	NIH [GM 040541, GM 069657]; Welch Foundation [F-1511]; NSF [MCB-0642058]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069657, R01GM040541] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Welch Foundation(The Welch Foundation); NSF(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from the NIH (GM 040541 to H.-w.L. and GM 069657 to C.K. and J.M.B.), the Welch Foundation (F-1511 to H.-w.L.), and the NSF (MCB-0642058 to C.K. and J.M.B.). We thank M. T. Green for helpful discussions.	Bollinger JM, 2006, J INORG BIOCHEM, V100, P586, DOI 10.1016/j.jinorgbio.2006.01.022; Borowski T, 2010, J AM CHEM SOC, V132, P12887, DOI 10.1021/ja101877a; Broadwater JA, 1999, BIOCHEMISTRY-US, V38, P12197, DOI 10.1021/bi9914199; Brown CD, 2007, J AM CHEM SOC, V129, P7427, DOI 10.1021/ja071364v; Chang WC, 2013, NATURE, V496, P114, DOI 10.1038/nature11998; Christian GJ, 2012, CHEM SCI, V3, P1600, DOI 10.1039/c2sc00754a; Cicchillo RM, 2009, NATURE, V459, P871, DOI 10.1038/nature07972; Dassama LMK, 2012, BIOCHEMISTRY-US, V51, P1607, DOI 10.1021/bi201906x; De Faveri G, 2011, CHEM SOC REV, V40, P1722, DOI 10.1039/c0cs00077a; Fujimori DG, 2007, J AM CHEM SOC, V129, P13408, DOI 10.1021/ja076454e; Galonic DP, 2007, NAT CHEM BIOL, V3, P113, DOI 10.1038/nchembio856; HAMMERSCHMIDT F, 1991, J CHEM SOC PERK T 1, P1993, DOI 10.1039/p19910001993; HANAUSKEABEL HM, 1982, J THEOR BIOL, V94, P421, DOI 10.1016/0022-5193(82)90320-4; HIDAKA T, 1995, MOL GEN GENET, V249, P274, DOI 10.1007/BF00290527; Higgins LJ, 2005, NATURE, V437, P838, DOI 10.1038/nature03924; Hirao H, 2011, INORG CHEM, V50, P6637, DOI 10.1021/ic200522r; Hoffart LM, 2006, P NATL ACAD SCI USA, V103, P14738, DOI 10.1073/pnas.0604005103; Kim DH, 1996, BIOCHEMISTRY-US, V35, P4923, DOI 10.1021/bi952937w; Kim SY, 2012, ANTIMICROB AGENTS CH, V56, P4175, DOI 10.1128/AAC.06478-11; Krebs C, 2007, ACCOUNTS CHEM RES, V40, P484, DOI 10.1021/ar700066p; Krebs C, 2013, COORDIN CHEM REV, V257, P234, DOI 10.1016/j.ccr.2012.06.020; Lehnert N, 2002, J AM CHEM SOC, V124, P10810, DOI 10.1021/ja012621d; Li FF, 2010, J AM CHEM SOC, V132, P2134, DOI 10.1021/ja9101908; Liu PH, 2001, J AM CHEM SOC, V123, P4619, DOI 10.1021/ja004153y; Lundberg M, 2008, BIOCHEMISTRY-US, V47, P1031, DOI 10.1021/bi701577q; MARQUARDT JL, 1994, BIOCHEMISTRY-US, V33, P10646, DOI 10.1021/bi00201a011; MASSEY V, 1994, J BIOL CHEM, V269, P22459; Matthews ML, 2009, P NATL ACAD SCI USA, V106, P17723, DOI 10.1073/pnas.0909649106; Matthews ML, 2009, BIOCHEMISTRY-US, V48, P4331, DOI 10.1021/bi900109z; Mbughuni MM, 2010, P NATL ACAD SCI USA, V107, P16788, DOI 10.1073/pnas.1010015107; Milaczewska A, 2013, CHEM-EUR J, V19, P770, DOI 10.1002/chem.201202825; Miller EW, 2007, NAT CHEM BIOL, V3, P263, DOI 10.1038/nchembio871; MILLER VP, 1993, BIOCHEMISTRY-US, V32, P11934, DOI 10.1021/bi00095a025; MORELLO JA, 1964, J APPL PHYSIOL, V19, P522, DOI 10.1152/jappl.1964.19.3.522; Munos JW, 2008, BIOCHEMISTRY-US, V47, P8726, DOI 10.1021/bi800877v; Price JC, 2003, BIOCHEMISTRY-US, V42, P7497, DOI 10.1021/bi030011f; Price JC, 2005, BIOCHEMISTRY-US, V44, P8138, DOI 10.1021/bi050227c; Roach PL, 1997, NATURE, V387, P827, DOI 10.1038/42990; Solomon EI, 2000, CHEM REV, V100, P235, DOI 10.1021/cr9900275; Switala J, 2002, ARCH BIOCHEM BIOPHYS, V401, P145, DOI 10.1016/S0003-9861(02)00049-8; Tarasev M, 2004, BIOCHEMISTRY-US, V43, P12799, DOI 10.1021/bi0490587; Thibodeaux CJ, 2012, CHEM REV, V112, P1681, DOI 10.1021/cr200073d; van der Donk WA, 2010, CURR OPIN STRUC BIOL, V20, P673, DOI 10.1016/j.sbi.2010.08.005; Veal EA, 2007, MOL CELL, V26, P1, DOI 10.1016/j.molcel.2007.03.016; Whitteck JT, 2009, J AM CHEM SOC, V131, P16225, DOI 10.1021/ja906238r; Yan F, 2006, BIOCHEMISTRY-US, V45, P11473, DOI 10.1021/bi060839c; Ye SF, 2012, CHEM-EUR J, V18, P6555, DOI 10.1002/chem.201102829; Yun D, 2011, J AM CHEM SOC, V133, P11262, DOI 10.1021/ja2025728; Zhao ZB, 2002, ANGEW CHEM INT EDIT, V41, P4529, DOI 10.1002/1521-3773(20021202)41:23<4529::AID-ANIE4529>3.0.CO;2-2	49	56	57	0	77	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 22	2013	342	6161					991	995		10.1126/science.1240373	http://dx.doi.org/10.1126/science.1240373			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EZ	24114783	Green Accepted			2022-12-24	WOS:000327223500046
J	Zhao, SW; Kumar, R; Sakai, A; Vetting, MW; Wood, BM; Brown, S; Bonanno, JB; Hillerich, BS; Seidel, RD; Babbitt, PC; Almo, SC; Sweedler, JV; Gerlt, JA; Cronan, JE; Jacobson, MP				Zhao, Suwen; Kumar, Ritesh; Sakai, Ayano; Vetting, Matthew W.; Wood, B. McKay; Brown, Shoshana; Bonanno, Jeffery B.; Hillerich, Brandan S.; Seidel, Ronald D.; Babbitt, Patricia C.; Almo, Steven C.; Sweedler, Jonathan V.; Gerlt, John A.; Cronan, John E.; Jacobson, Matthew P.			Discovery of new enzymes and metabolic pathways by using structure and genome context	NATURE			English	Article							PROLINE BETAINE; ENOLASE SUPERFAMILY; GLYCINE BETAINE; PARACOCCUS-DENITRIFICANS; SINORHIZOBIUM-MELILOTI; DIVERGENT EVOLUTION; COMPATIBLE SOLUTES; PROTEIN-PRODUCTION; MASS-SPECTROMETRY; GENE-EXPRESSION	Assigning valid functions to proteins identified in genome projects is challenging: overprediction and database annotation errors are the principal concerns(1). We and others(2) are developing computation-guided strategies for functional discovery with 'metabolite docking' to experimentally derived(3) or homology-based(4) three-dimensional structures. Bacterial metabolic pathways often are encoded by 'genome neighbourhoods' (gene clusters and/or operons), which can provide important clues for functional assignment. We recently demonstrated the synergy of docking and pathway context by 'predicting' the intermediates in the glycolytic pathway in Escherichia coli(5). Metabolite docking to multiple binding proteins and enzymes in the same pathway increases the reliability of in silico predictions of substrate specificities because the pathway intermediates are structurally similar. Here we report that structure-guided approaches for predicting the substrate specificities of several enzymes encoded by a bacterial gene cluster allowed the correct prediction of the in vitro activity of a structurally characterized enzyme of unknown function (PDB 2PMQ), 2-epimerization of trans-4-hydroxy-L-proline betaine (tHyp-B) and cis-4-hydroxy-D-proline betaine (cHyp-B), and also the correct identification of the catabolic pathway in which Hyp-B 2-epimerase participates. The substrate-liganded pose predicted by virtual library screening (docking) was confirmed experimentally. The enzymatic activities in the predicted pathway were confirmed by in vitro assays and genetic analyses; the intermediates were identified by metabolomics; and repression of the genes encoding the pathway by high salt concentrations was established by transcriptomics, confirming the osmolyte role of tHyp-B. This study establishes the utility of structure-guided functional predictions to enable the discovery of new metabolic pathways.	[Zhao, Suwen; Jacobson, Matthew P.] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94143 USA; [Kumar, Ritesh; Sakai, Ayano; Wood, B. McKay; Sweedler, Jonathan V.; Gerlt, John A.; Cronan, John E.] Univ Illinois, Inst Genom Biol, Urbana, IL 61801 USA; [Vetting, Matthew W.; Bonanno, Jeffery B.; Hillerich, Brandan S.; Seidel, Ronald D.; Almo, Steven C.] Albert Einstein Coll Med, Dept Biochem, Bronx, NY 10461 USA; [Brown, Shoshana; Babbitt, Patricia C.] Univ Calif San Francisco, Dept Bioengn & Therapeut Sci, San Francisco, CA 94143 USA; [Sweedler, Jonathan V.; Gerlt, John A.] Univ Illinois, Dept Chem, Urbana, IL 61801 USA; [Gerlt, John A.; Cronan, John E.] Univ Illinois, Dept Biochem, Urbana, IL 61801 USA; [Cronan, John E.] Univ Illinois, Dept Microbiol, Urbana, IL 61801 USA	University of California System; University of California San Francisco; University of Illinois System; University of Illinois Urbana-Champaign; Yeshiva University; Albert Einstein College of Medicine; University of California System; University of California San Francisco; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Babbitt, PC (corresponding author), Univ Calif San Francisco, Dept Bioengn & Therapeut Sci, San Francisco, CA 94143 USA.	babbitt@cgl.ucsf.edu; steve.almo@einstein.yu.edu; jsweedle@illinois.edu; j-gerlt@illinois.edu; j-cronan@life.uiuc.edu; matt.jacobson@ucsf.edu	KUMAR, RITESH/P-3347-2018; Jacobson, Matthew/Y-5161-2018; Cronan, John/V-6626-2019; Sweedler, Jonathan V/A-9405-2009; KUMAR, RITESH/P-1265-2019	KUMAR, RITESH/0000-0001-7170-8645; Jacobson, Matthew/0000-0001-6262-655X; Sweedler, Jonathan V/0000-0003-3107-9922; KUMAR, RITESH/0000-0001-7170-8645; Zhao, Suwen/0000-0001-5609-434X	US National Institutes of Health [U54GM093342, U54GM074945, U54GM094662]; National Institutes of Health [P41-GM103311]; US DOE [DE-AC02-06CH11357]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM074945, U54GM093342, U54GM094662, P41GM103311] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US DOE(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by cooperative agreements from the US National Institutes of Health (U54GM093342, U54GM074945 and U54GM094662). Molecular graphics and analyses were performed with the University of California, San Francisco (UCSF) Chimera package. Chimera is developed by the Resource for Biocomputing, Visualization, and Informatics at UCSF (supported by National Institutes of Health P41-GM103311). Use of the Advanced Photon Source, an Office of Science User Facility operated for the US Department of Energy (DOE) Office of Science by Argonne National Laboratory, was supported by the US DOE under contract no. DE-AC02-06CH11357. Use of the Lilly Research Laboratories Collaborative Access Team (LRL-CAT) beamline at Sector 31 of the Advanced Photon Source was provided by Eli Lilly Company, which operates the facility.	Alloing G, 2006, J BACTERIOL, V188, P6308, DOI 10.1128/JB.00585-06; AMIN US, 1995, ARCH MICROBIOL, V163, P138, DOI 10.1007/s002030050183; Babbitt PC, 1996, BIOCHEMISTRY-US, V35, P16489, DOI 10.1021/bi9616413; Babbitt PC, 1997, J BIOL CHEM, V272, P30591, DOI 10.1074/jbc.272.49.30591; Bar-Even A, 2011, BIOCHEMISTRY-US, V50, P4402, DOI 10.1021/bi2002289; Barber AE, 2012, BIOINFORMATICS, V28, P2845, DOI 10.1093/bioinformatics/bts532; BERNARD T, 1986, ARCH MICROBIOL, V143, P359, DOI 10.1007/BF00412803; Burg MB, 1997, ANNU REV PHYSIOL, V59, P437, DOI 10.1146/annurev.physiol.59.1.437; Burnet MW, 2000, GENE, V244, P151, DOI 10.1016/S0378-1119(99)00554-5; CHAMBERS ST, 1987, J CLIN INVEST, V79, P731, DOI 10.1172/JCI112878; Daughtry KD, 2012, J AM CHEM SOC, V134, P2823, DOI 10.1021/ja2111898; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Erb TJ, 2012, NAT CHEM BIOL, V8, P926, DOI [10.1038/NCHEMBIO.1087, 10.1038/nchembio.1087]; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Fox B. G., 2009, CURR PROTOCOLS PROTE; Friesner RA, 2006, J MED CHEM, V49, P6177, DOI 10.1021/jm051256o; Gerlt JA, 2005, ARCH BIOCHEM BIOPHYS, V433, P59, DOI 10.1016/j.abb.2004.07.034; Gerlt JA, 2012, J BIOL CHEM, V287, P29, DOI 10.1074/jbc.R111.240945; Gerlt JA, 2011, BIOCHEMISTRY-US, V50, P9950, DOI 10.1021/bi201312u; GLOUX K, 1989, ARCH MICROBIOL, V151, P143, DOI 10.1007/BF00414429; GOLDMANN A, 1994, FEMS MICROBIOL LETT, V115, P305, DOI 10.1016/0378-1097(94)90031-0; HANSON AD, 1994, P NATL ACAD SCI USA, V91, P306, DOI 10.1073/pnas.91.1.306; Hermann JC, 2007, NATURE, V448, P775, DOI 10.1038/nature05981; Hermann JC, 2006, J AM CHEM SOC, V128, P15882, DOI 10.1021/ja065860f; Kalyanaraman C, 2005, BIOCHEMISTRY-US, V44, P2059, DOI 10.1021/bi0481186; Kalyanaraman C, 2010, BIOCHEMISTRY-US, V49, P4003, DOI 10.1021/bi100445g; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; Kempf B, 1998, ARCH MICROBIOL, V170, P319, DOI 10.1007/s002030050649; LARSEN PI, 1987, ARCH MICROBIOL, V147, P1, DOI 10.1007/BF00492896; Lenky CC, 2012, ANAL BIOCHEM, V420, P7, DOI 10.1016/j.ab.2011.09.013; Leslie AGW, 2006, ACTA CRYSTALLOGR D, V62, P48, DOI 10.1107/S0907444905039107; Li C, 2010, J CHROMATOGR B, V878, P1809, DOI 10.1016/j.jchromb.2010.05.014; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Matsson M, 1998, ARCH MICROBIOL, V170, P27, DOI 10.1007/s002030050611; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Oufir M, 2009, J CHROMATOGR A, V1216, P1094, DOI 10.1016/j.chroma.2008.12.030; Sauder Michael J., 2008, V426, P561, DOI 10.1007/978-1-60327-058-8_37; Schiefner A, 2004, J BIOL CHEM, V279, P5588, DOI 10.1074/jbc.M309771200; Schnoes AM, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000605; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; SIMON R, 1983, BIO-TECHNOL, V1, P784, DOI 10.1038/nbt1183-784; Song L, 2007, NAT CHEM BIOL, V3, P486, DOI 10.1038/nchembio.2007.11; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Suite S, 2009, LIGPREP VERSION 2 3; Suite S., 2009, PROTEIN PREPARATION; Tanabe M., 2012, BIOINFORMATICS, V38; VANSPANNING RJM, 1991, J BACTERIOL, V173, P6962, DOI 10.1128/jb.173.21.6962-6970.1991; Wargo MJ, 2008, J BACTERIOL, V190, P2690, DOI 10.1128/JB.01393-07; Watanabe S, 2012, J BIOL CHEM, V287, P32674, DOI 10.1074/jbc.M112.374272; White CE, 2012, MOL MICROBIOL, V85, P1133, DOI 10.1111/j.1365-2958.2012.08164.x; Zwart Peter H., 2008, V426, P419, DOI 10.1007/978-1-60327-058-8_28	51	99	102	1	175	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 31	2013	502	7473					698	+		10.1038/nature12576	http://dx.doi.org/10.1038/nature12576			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243CC	24056934	Green Submitted, Green Accepted			2022-12-24	WOS:000326293200051
J	Eisenstein, M				Eisenstein, Michael			PLANT BREEDING Discovery in a dry spell	NATURE			English	Editorial Material							MAIZE											BOYER JS, 1982, SCIENCE, V218, P443, DOI 10.1126/science.218.4571.443; Castiglioni P, 2008, PLANT PHYSIOL, V147, P446, DOI 10.1104/pp.108.118828; Lobell DB, 2013, NAT CLIM CHANGE, V3, P497, DOI [10.1038/nclimate1832, 10.1038/NCLIMATE1832]	3	31	31	0	30	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 26	2013	501	7468					S7	S9		10.1038/501S7a	http://dx.doi.org/10.1038/501S7a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	223RP	24067764	Bronze			2022-12-24	WOS:000324826300004
J	Baytekin, HT; Baytekin, B; Hermans, TM; Kowalczyk, B; Grzybowski, BA				Baytekin, H. Tarik; Baytekin, Bilge; Hermans, Thomas M.; Kowalczyk, Bartlomiej; Grzybowski, Bartosz A.			Control of Surface Charges by Radicals as a Principle of Antistatic Polymers Protecting Electronic Circuitry	SCIENCE			English	Article								Even minute quantities of electric charge accumulating on polymer surfaces can cause shocks, explosions, and multibillion-dollar losses to electronic circuitry. This paper demonstrates that to remove static electricity, it is not at all necessary to "target" the charges themselves. Instead, the way to discharge a polymer is to remove radicals from its surface. These radicals colocalize with and stabilize the charges; when they are scavenged, the surfaces discharge rapidly. This radical-charge interplay allows for controlling static electricity by doping common polymers with small amounts of radical-scavenging molecules, including the familiar vitamin E. The effectiveness of this approach is demonstrated by rendering common polymers dust-mitigating and also by using them as coatings that prevent the failure of electronic circuitry.	[Grzybowski, Bartosz A.] Northwestern Univ, Dept Chem, Evanston, IL 60208 USA; Northwestern Univ, Dept Chem & Biol Engn, Evanston, IL 60208 USA	Northwestern University; Northwestern University	Grzybowski, BA (corresponding author), Northwestern Univ, Dept Chem, 2145 Sheridan Rd, Evanston, IL 60208 USA.	grzybor@northwestern.edu	Grzybowski, Bartosz A/H-5741-2017; Baytekin, Bilge/O-1823-2019; Baytekin, Bilge/K-4719-2014; Hermans, Thomas/D-5629-2012	Baytekin, Bilge/0000-0002-3867-3863; Baytekin, Bilge/0000-0002-3867-3863; Grzybowski, Bartosz/0000-0001-6613-4261; Hermans, Thomas/0000-0003-1121-1754	Non-Equilibrium Energy Research Center (NERC), an Energy Frontier Research Center; U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-SC0000989]; Human Frontier Science Program	Non-Equilibrium Energy Research Center (NERC), an Energy Frontier Research Center(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); Human Frontier Science Program(Human Frontier Science Program)	This work was supported by the Non-Equilibrium Energy Research Center (NERC), which is an Energy Frontier Research Center funded by the U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences under award DE-SC0000989. T.M.H. acknowledges a grant from the Human Frontier Science Program. We thank T. Aytun for help in measuring transistor characteristics.	Angelopoulos M, 2001, IBM J RES DEV, V45, P57, DOI 10.1147/rd.451.0057; Baytekin B, 2012, J AM CHEM SOC, V134, P7223, DOI 10.1021/ja300925h; Baytekin HT, 2011, SCIENCE, V333, P308, DOI 10.1126/science.1201512; Baytekin HT, 2012, ANGEW CHEM INT EDIT, V51, P4843, DOI 10.1002/anie.201200057; Burgo TAL, 2012, LANGMUIR, V28, P7407, DOI 10.1021/la301228j; Fergusson D. C., 2011, SPACECRAFT CHARGING, V237; Gibson N, 1997, J ELECTROSTAT, V40-1, P21, DOI 10.1016/S0304-3886(97)00010-7; GREASON WD, 1987, IEEE T IND APPL, V23, P205, DOI 10.1109/TIA.1987.4504895; KUZUYA M, 1993, MACROMOLECULES, V26, P1990, DOI 10.1021/ma00060a030; Lacks DJ, 2012, ANGEW CHEM INT EDIT, V51, P6822, DOI 10.1002/anie.201202896; Loeb L.B., 1965, ELECT CORONAS, V1st; LOWELL J, 1980, ADV PHYS, V29, P947, DOI 10.1080/00018738000101466; Miyasaka M, 2003, ADV FUNCT MATER, V13, P113, DOI 10.1002/adfm.200390016; Orlando JJ, 2012, CHEM SOC REV, V41, P6294, DOI 10.1039/c2cs35166h; SALANECK WR, 1976, J APPL PHYS, V47, P144, DOI 10.1063/1.322306; Shinbrot T, 2008, EPL-EUROPHYS LETT, V83, DOI 10.1209/0295-5075/83/24004; SOLOMON DH, 1965, J POLYM SCI PART A, V3, P3107, DOI 10.1002/pol.1965.100030906; Tolinski M, 2009, PDL HANDB SER, P79; Voldman S. H., 2009, ESD FAILURE MECH MOD; Volta A., 1800, PHILOS T R SOC LONDO, V90, P403, DOI DOI 10.1098/RSTL.1800.0018; Waltman MJ, 2008, TALANTA, V77, P249, DOI 10.1016/j.talanta.2008.06.014; Williams MW, 2012, AIP ADV, V2, DOI 10.1063/1.3687233	22	102	106	6	206	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 20	2013	341	6152					1368	1371		10.1126/science.1241326	http://dx.doi.org/10.1126/science.1241326			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	220PK	24052302				2022-12-24	WOS:000324597200039
J	Macfarlane, RJ; Jones, MR; Lee, B; Auyeung, E; Mirkin, CA				Macfarlane, Robert J.; Jones, Matthew R.; Lee, Byeongdu; Auyeung, Evelyn; Mirkin, Chad A.			Topotactic Interconversion of Nanoparticle Superlattices	SCIENCE			English	Article							DNA; BINARY; SHAPE	The directed assembly of nanoparticle building blocks is a promising method for generating sophisticated three-dimensional materials by design. In this work, we have used DNA linkers to synthesize nanoparticle superlattices that have greater complexity than simple binary systems using the process of topotactic intercalation-the insertion of a third nanoparticle component at predetermined sites within a preformed binary lattice. Five distinct crystals were synthesized with this methodology, three of which have no equivalent in atomic or molecular crystals, demonstrating a general approach for assembling highly ordered ternary nanoparticle superlattices whose structures can be predicted before their synthesis. Additionally, the intercalation process was demonstrated to be completely reversible; the inserted nanoparticles could be expelled into solution by raising the temperature, and the ternary superlattice could be recovered by cooling.	[Macfarlane, Robert J.; Mirkin, Chad A.] Northwestern Univ, Dept Chem, Evanston, IL 60208 USA; [Macfarlane, Robert J.; Jones, Matthew R.; Auyeung, Evelyn; Mirkin, Chad A.] Int Inst Nanotechnol, Evanston, IL 60208 USA; [Jones, Matthew R.; Auyeung, Evelyn; Mirkin, Chad A.] Northwestern Univ, Dept Mat Sci & Engn, Evanston, IL 60208 USA; [Lee, Byeongdu] Argonne Natl Lab, Xray Sci Div, Adv Photon Source, Argonne, IL 60439 USA	Northwestern University; Northwestern University; United States Department of Energy (DOE); Argonne National Laboratory	Mirkin, CA (corresponding author), Northwestern Univ, Dept Chem, 2145 Sheridan Rd, Evanston, IL 60208 USA.	chadnano@northwestern.edu	Mirkin, Chad A/E-3911-2010	Mirkin, Chad/0000-0002-6634-7627; Jones, Matthew/0000-0002-9289-291X	Air Force Office of Scientific Research [FA9550-11-1-0275, FA9550-12-1-0280, FA9550-09-1-0294]; Defense Advanced Research Projects Agency [HR0011-13-2-0002]; NSF-Materials Research Science and Engineering Center (MRSEC) [DMR-0520513]; Non-equilibrium Energy Research Center, an Energy Frontier Research Center; Department of Energy (DOE), Office of Science, Office of Basic Energy Sciences [DE-SC0000989]; NSF; Department of Defense; E. I. DuPont de Nemours Co.; Dow Chemical Company; state of Illinois; U.S. DOE, Office of Science, Office of Basic Energy Sciences [DE-AC02-06CH11357]; NSF-Nanoscale Science and Engineering Center; NSF-MRSEC; Keck Foundation; NU; NU Office for Research; Division Of Materials Research [1121262] Funding Source: National Science Foundation	Air Force Office of Scientific Research(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); Defense Advanced Research Projects Agency(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); NSF-Materials Research Science and Engineering Center (MRSEC)(National Science Foundation (NSF)); Non-equilibrium Energy Research Center, an Energy Frontier Research Center; Department of Energy (DOE), Office of Science, Office of Basic Energy Sciences; NSF(National Science Foundation (NSF)); Department of Defense(United States Department of Defense); E. I. DuPont de Nemours Co.; Dow Chemical Company; state of Illinois; U.S. DOE, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); NSF-Nanoscale Science and Engineering Center(National Science Foundation (NSF)); NSF-MRSEC(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)); Keck Foundation(W.M. Keck Foundation); NU; NU Office for Research; Division Of Materials Research(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	We thank M. Kanatzidis for helpful discussions regarding the ternary crystal structures synthesized and their corresponding atomic analogs. This material is based on work supported by Air Force Office of Scientific Research awards FA9550-11-1-0275, FA9550-12-1-0280, and FA9550-09-1-0294; Defense Advanced Research Projects Agency award HR0011-13-2-0002; NSF-Materials Research Science and Engineering Center (MRSEC) program DMR-0520513; and the Non-equilibrium Energy Research Center, an Energy Frontier Research Center funded by Department of Energy (DOE), Office of Science, Office of Basic Energy Sciences award DE-SC0000989. M.R.J. acknowledges a Graduate Research Fellowship from NSF; E. A. acknowledges the Department of Defense for a National Defense Science and Engineering Graduate Fellowship. Portions of this work were carried out at the DuPont-Northwestern-Dow Collaborative Access Team (DND-CAT) beamline located at Sector 5 of the Advanced Photon Source (APS). DND-CAT is supported by E. I. DuPont de Nemours & Co., Dow Chemical Company, and the state of Illinois. Use of the APS was supported by the U.S. DOE, Office of Science, Office of Basic Energy Sciences, under contract DE-AC02-06CH11357. The TEM work was carried out in the Electron Probe Instrumentation Center facility of the Northwestern University (NU) Atomic and Nanoscale Characterization Experimental Center, which is supported by NSF-Nanoscale Science and Engineering Center, NSF-MRSEC, Keck Foundation, the state of Illinois, and NU. Ultrathin sectioning was carried out at the NU Biological Imaging Facility, supported by the NU Office for Research.	Auyeung E, 2012, ADV MATER, V24, P5181, DOI 10.1002/adma.201202069; Auyeung E, 2012, NAT NANOTECHNOL, V7, P24, DOI [10.1038/nnano.2011.222, 10.1038/NNANO.2011.222]; Bell AT, 2003, SCIENCE, V299, P1688, DOI 10.1126/science.1083671; BRESLAUER KJ, 1986, P NATL ACAD SCI USA, V83, P3746, DOI 10.1073/pnas.83.11.3746; Cutler JI, 2012, J AM CHEM SOC, V134, P1376, DOI 10.1021/ja209351u; Dong AG, 2011, NANO LETT, V11, P1804, DOI 10.1021/nl200468p; Ellis BL, 2010, CHEM MATER, V22, P691, DOI 10.1021/cm902696j; Evers WH, 2009, ANGEW CHEM INT EDIT, V48, P9655, DOI 10.1002/anie.200904821; Jones MR, 2013, ANGEW CHEM INT EDIT, V52, P2886, DOI 10.1002/anie.201209504; Jones MR, 2011, J AM CHEM SOC, V133, P18865, DOI 10.1021/ja206777k; Jones MR, 2011, CHEM REV, V111, P3736, DOI 10.1021/cr1004452; Jones MR, 2010, NAT MATER, V9, P913, DOI [10.1038/NMAT2870, 10.1038/nmat2870]; Kelly KL, 2003, J PHYS CHEM B, V107, P668, DOI 10.1021/jp026731y; Kim Y, 2013, J AM CHEM SOC, V135, P10342, DOI 10.1021/ja405988r; Knorowski C, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.215501; Macfarlane RJ, 2013, ANGEW CHEM INT EDIT, V52, P5688, DOI 10.1002/anie.201209336; Macfarlane RJ, 2011, SCIENCE, V334, P204, DOI 10.1126/science.1210493; Macfarlane RJ, 2010, ANGEW CHEM INT EDIT, V49, P4589, DOI 10.1002/anie.201000633; Macfarlane RJ, 2009, P NATL ACAD SCI USA, V106, P10493, DOI 10.1073/pnas.0900630106; Maye MM, 2010, NAT NANOTECHNOL, V5, P116, DOI [10.1038/NNANO.2009.378, 10.1038/nnano.2009.378]; Mirkin CA, 1996, NATURE, V382, P607, DOI 10.1038/382607a0; Mladek BM, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.268301; Nykypanchuk D, 2008, NATURE, V451, P549, DOI 10.1038/nature06560; Park SY, 2008, NATURE, V451, P553, DOI 10.1038/nature06508; Pryce IM, 2010, NANO LETT, V10, P4222, DOI 10.1021/nl102684x; Rao CNR, 1998, TRANSITION METAL OXI; Shevchenko EV, 2006, NATURE, V439, P55, DOI 10.1038/nature04414; Srivastava S, 2010, SCIENCE, V327, P1355, DOI 10.1126/science.1177218; Stebe KJ, 2009, SCIENCE, V325, P159, DOI 10.1126/science.1174401; Talapin DV, 2010, CHEM REV, V110, P389, DOI 10.1021/cr900137k; Wang YF, 2012, NATURE, V491, P51, DOI 10.1038/nature11564; Ye XC, 2011, J AM CHEM SOC, V133, P2613, DOI 10.1021/ja108708v; Zhang C, 2013, NAT MATER, V12, P741, DOI [10.1038/NMAT3647, 10.1038/nmat3647]	33	115	118	6	318	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 13	2013	341	6151					1222	1225		10.1126/science.1241402	http://dx.doi.org/10.1126/science.1241402			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	215ZA	23970559				2022-12-24	WOS:000324248800038
J	Bhutta, ZA				Bhutta, Zulfiqar A.			Conflict and Polio Winning the Polio Wars	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Bhutta, Zulfiqar A.] Sick Kids Ctr Global Child Hlth, Toronto, ON M5G 1X8, Canada; [Bhutta, Zulfiqar A.] Aga Khan Univ, Ctr Excellence Women & Child Hlth, Karachi, Pakistan	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Aga Khan University	Bhutta, ZA (corresponding author), Sick Kids Ctr Global Child Hlth, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	zulfiqar.bhutta@sickkids.ca						[Anonymous], 2013, SCI AM, V308, P12; Bhutta ZA, 2013, BMJ-BRIT MED J, V346, P280, DOI [10.1136/bmj.f280, DOI 10.1136/BMJ.F280]; Larson HJ, 2013, JAMA INTERN MED, V173, P1393, DOI 10.1001/jamainternmed.2013.7191; Mach A, 1999, BRIT MED J, V318, P756, DOI 10.1136/bmj.318.7186.756; SAGEWorking Group on Vaccination in Humanitarian Emergencies, VACCINATION IN ACUTE; World Health Assembly, GLOBAL ERADICATION O; World Health Organization, GLOBAL POLIO ERADICA; World Health Organization, SOMALIA EMERGENCY HE; World Health Organization, ACTION TO STOP POLIO	9	25	25	0	14	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 4	2013	310	9					905	906		10.1001/jama.2013.276583	http://dx.doi.org/10.1001/jama.2013.276583			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	211DT	24002271				2022-12-24	WOS:000323885700015
J	Siponen, MI; Legrand, P; Widdrat, M; Jones, SR; Zhang, WJ; Chang, MCY; Faivre, D; Arnoux, P; Pignol, D				Siponen, Marina I.; Legrand, Pierre; Widdrat, Marc; Jones, Stephanie R.; Zhang, Wei-Jia; Chang, Michelle C. Y.; Faivre, Damien; Arnoux, Pascal; Pignol, David			Structural insight into magnetochrome-mediated magnetite biomineralization	NATURE			English	Article							C-TYPE CYTOCHROME; MAGNETOSPIRILLUM-GRYPHISWALDENSE; SMALL-ANGLE; PROTEIN; REFINEMENT; SCATTERING; REVEALS	Magnetotactic bacteria align along the Earth's magnetic field using an organelle called the magnetosome, a biomineralized magnetite (Fe(II)Fe(III)(2)O-4) or greigite (Fe(II)Fe(III)(2)S-4) crystal embedded in a lipid vesicle. Although the need for both iron(II) and iron(III) is clear, little is known about the biological mechanisms controlling their ratio(1). Here we present the structure of the magnetosome-associated protein MamP and find that it is built on a unique arrangement of a self-plugged PDZ domain fused to two magnetochrome domains, defining a new class of c-type cytochrome exclusively found in magnetotactic bacteria. Mutational analysis, enzyme kinetics, co-crystallization with iron(II) and an in vitro MamP-assisted magnetite production assay establish MamP as an iron oxidase that contributes to the formation of iron(III) ferrihydrite eventually required for magnetite crystal growth in vivo. These results demonstrate the molecular mechanisms of iron management taking place inside the magnetosome and highlight the role of magnetochrome in iron biomineralization.	[Siponen, Marina I.; Arnoux, Pascal; Pignol, David] Commissariat Energie Atom & Energies Alternat, Direct Sci Vivant, Inst Biol Environm & Biotechnol, Lab Bioenerget Cellulaire, F-13108 St Paul Les Durance, France; [Siponen, Marina I.; Arnoux, Pascal; Pignol, David] CNRS, Unite Mixte Rech Biol Vegetaleet Microbiol Enviro, F-13108 St Paul Les Durance, France; [Siponen, Marina I.; Arnoux, Pascal; Pignol, David] Aix Marseille Univ, F-13108 St Paul Les Durance, France; [Legrand, Pierre] Synchrotron SOLEIL, F-91192 Gif Sur Yvette, France; [Widdrat, Marc; Faivre, Damien] Max Planck Inst Colloids & Interfaces, Dept Biomat, D-14424 Potsdam, Germany; [Jones, Stephanie R.; Chang, Michelle C. Y.] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Jones, Stephanie R.; Chang, Michelle C. Y.] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Zhang, Wei-Jia] Aix Marseille Univ, Lab Chim Bacterienne, Inst Microbiol Mediterranee, UMR7283,CNRS, F-13402 Marseille 20, France; [Zhang, Wei-Jia; Arnoux, Pascal; Pignol, David] CNRS, Lab Int Assoc Biomineralisat & Nanostruct, F-13402 Marseille 20, France	CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; SOLEIL Synchrotron; Max Planck Society; University of California System; University of California Berkeley; University of California System; University of California Berkeley; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS)	Pignol, D (corresponding author), Commissariat Energie Atom & Energies Alternat, Direct Sci Vivant, Inst Biol Environm & Biotechnol, Lab Bioenerget Cellulaire, F-13108 St Paul Les Durance, France.	pascal.arnoux@cea.fr; david.pignol@cea.fr	faivre, damien/D-3713-2009; LEGRAND, Pierre/G-7709-2011	faivre, damien/0000-0001-6191-3389; LEGRAND, Pierre/0000-0003-2431-2255; PIGNOL, David/0000-0002-8070-0319; ARNOUX, Pascal/0000-0003-4609-4893	Eurotalent program; ToxNuc-E program; Max Planck Society; ERC [256915-MB2]; Defense Advanced Research Projects Agency [N66001-12-1-4230]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM066698] Funding Source: NIH RePORTER	Eurotalent program; ToxNuc-E program; Max Planck Society(Max Planck SocietyFoundation CELLEX); ERC(European Research Council (ERC)European Commission); Defense Advanced Research Projects Agency(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work received institutional support from the Commissariat a l'Energie Atomique et aux Energies Alternatives, the Centre National de la Recherche Scientifique, Aix-Marseille University and the Max Planck Society. We are grateful to BM-30 (ESRF, Grenoble, France) and X06SA (SLS, Villigen, Switzerland) staff for technical assistance in synchrotron data collection. We thank J. Perez (SOLEIL, GIF-sur-Yvette) for help in SAXS data collection, and A. Komeili for the gift of the wild-type and Delta mamP AMB-1 strains. We acknowledge S. Siegel and C. Li for their support at the mu Spot beamline of BESSY II, Helmholtz Zentrum Berlin. We thank the AFMB laboratory (Marseille) for circular dichroism measurements. M. I. S. was supported by a grant from the Eurotalent and ToxNuc-E programs. D. F. is supported by the Max Planck Society and a Starting Grant from the ERC (256915-MB2). S. R. J. and M.C.Y.C. thank the Defense Advanced Research Projects Agency (N66001-12-1-4230) for support.	Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Baumgartner J, 2013, P NATL ACAD SCI USA, V110, P14883, DOI 10.1073/pnas.1307119110; Baumgartner J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057070; Baumgartner J, 2013, NAT MATER, V12, P310, DOI [10.1038/NMAT3558, 10.1038/nmat3558]; BELL PE, 1987, APPL ENVIRON MICROB, V53, P2610, DOI 10.1128/AEM.53.11.2610-2616.1987; BLAKEMORE R, 1975, SCIENCE, V190, P377, DOI 10.1126/science.170679; Clausen T, 2011, NAT REV MOL CELL BIO, V12, P152, DOI 10.1038/nrm3065; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Fischer A, 2011, J R SOC INTERFACE, V8, P1011, DOI 10.1098/rsif.2010.0576; Fischer H, 2010, J APPL CRYSTALLOGR, V43, P101, DOI 10.1107/S0021889809043076; FRANKEL RB, 1984, PHILOS T R SOC B, V304, P567, DOI 10.1098/rstb.1984.0047; HOLM L, 1995, TRENDS BIOCHEM SCI, V20, P478, DOI 10.1016/S0968-0004(00)89105-7; Jolivet JP, 2004, CHEM COMMUN, P481, DOI 10.1039/b304532n; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P133, DOI 10.1107/S0907444909047374; Komeili A, 2012, FEMS MICROBIOL REV, V36, P232, DOI 10.1111/j.1574-6976.2011.00315.x; Krojer T, 2002, NATURE, V416, P455, DOI 10.1038/416455a; Lee HJ, 2010, CELL COMMUN SIGNAL, V8, DOI 10.1186/1478-811X-8-8; Leslie AGW, 2007, NATO SCI SER II-MATH, V245, P41, DOI 10.1007/978-1-4020-6316-9_4; Li H, 2005, PROTEINS, V61, P704, DOI 10.1002/prot.20660; Liu J, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00037; Lohse I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021486; Fdez-Gubieda ML, 2013, ACS NANO, V7, P3297, DOI 10.1021/nn3059983; Murat D, 2010, P NATL ACAD SCI USA, V107, P5593, DOI 10.1073/pnas.0914439107; Murshudov GN, 1999, ACTA CRYSTALLOGR D, V55, P247, DOI 10.1107/S090744499801405X; Paris O, 2007, J APPL CRYSTALLOGR, V40, pS466, DOI 10.1107/S0021889806045444; Quinlan A, 2011, MOL MICROBIOL, V80, P1075, DOI 10.1111/j.1365-2958.2011.07631.x; Schuler D, 2008, FEMS MICROBIOL REV, V32, P654, DOI 10.1111/j.1574-6976.2008.00116.x; Siponen MI, 2012, BIOCHEM SOC T, V40, P1319, DOI 10.1042/BST20120104; Smith LJ, 2010, PROTEINS, V78, P2349, DOI 10.1002/prot.22747; Uebe R, 2011, MOL MICROBIOL, V82, P818, DOI 10.1111/j.1365-2958.2011.07863.x; Vonrhein Clemens, 2007, Methods Mol Biol, V364, P215, DOI 10.1385/1-59745-266-1:215; Zhang C, 2013, J BACTERIOL, V195, P876, DOI 10.1128/JB.01750-12	32	95	104	7	237	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 31	2013	502	7473					681	+		10.1038/nature12573	http://dx.doi.org/10.1038/nature12573			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243CC	24097349				2022-12-24	WOS:000326293200047
J	Poorey, K; Viswanathan, R; Carver, MN; Karpova, TS; Cirimotich, SM; McNally, JG; Bekiranov, S; Auble, DT				Poorey, Kunal; Viswanathan, Ramya; Carver, Melissa N.; Karpova, Tatiana S.; Cirimotich, Shana M.; McNally, James G.; Bekiranov, Stefan; Auble, David T.			Measuring Chromatin Interaction Dynamics on the Second Time Scale at Single-Copy Genes	SCIENCE			English	Article							TRANSCRIPTION ACTIVATION; GAL4 TURNOVER; GENOME; PROMOTER; LOCALIZATION; ORGANIZATION; KINETICS; MOT1	The chromatin immunoprecipitation (ChIP) assay is widely used to capture interactions between chromatin and regulatory proteins, but it is unknown how stable most native interactions are. Although live-cell imaging suggests short-lived interactions at tandem gene arrays, current methods cannot measure rapid binding dynamics at single-copy genes. We show, by using a modified ChIP assay with subsecond temporal resolution, that the time dependence of formaldehyde cross-linking can be used to extract in vivo on and off rates for site-specific chromatin interactions varying over a similar to 100-fold dynamic range. By using the method, we show that a regulatory process can shift weakly bound TATA-binding protein to stable promoter interactions, thereby facilitating transcription complex formation. This assay provides an approach for systematic, quantitative analyses of chromatin binding dynamics in vivo.	[Poorey, Kunal; Viswanathan, Ramya; Carver, Melissa N.; Cirimotich, Shana M.; Bekiranov, Stefan; Auble, David T.] Univ Virginia Hlth Syst, Dept Biochem & Mol Genet, Charlottesville, VA 22908 USA; [Karpova, Tatiana S.; McNally, James G.] NCI, Ctr Canc Res Core Fluorescence Imaging Facil, Lab Receptor Biol & Gene Express, NIH, Bethesda, MD 20892 USA	University of Virginia; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Bekiranov, S (corresponding author), Univ Virginia Hlth Syst, Dept Biochem & Mol Genet, Charlottesville, VA 22908 USA.	sb3de@virginia.edu; auble@virginia.edu	Viswanathan, Ramya/L-5935-2019	Karpova, Tatiana/0000-0001-6025-2128	NIH, National Cancer Institute, Center for Cancer Research; NIH [GM55763]; NATIONAL CANCER INSTITUTE [ZICBC011574] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM055763] Funding Source: NIH RePORTER	NIH, National Cancer Institute, Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank K. Struhl, F. Pugh, S. Hahn, and P. deHaseth for discussion; R. Nakamoto and M. Galkin for discussions and help with the KinTek instrument; and J. Muldoon, J. Hopper, F. Pugh, and S. Hahn for strains and plasmids. J. G. M. and T. S. K. were supported by the intramural program of the NIH, National Cancer Institute, Center for Cancer Research. Supported by NIH grant GM55763 to D.T.A.	Collins GA, 2009, NATURE, V461, pE7, DOI 10.1038/nature08406; Deal RB, 2010, SCIENCE, V328, P1161, DOI 10.1126/science.1186777; Hager GL, 2009, MOL CELL, V35, P741, DOI 10.1016/j.molcel.2009.09.005; Karpova TS, 2008, SCIENCE, V319, P466, DOI 10.1126/science.1150559; Larson DR, 2011, SCIENCE, V332, P475, DOI 10.1126/science.1202142; Lickwar CR, 2012, NATURE, V484, P251, DOI 10.1038/nature10985; Nalley K, 2009, NATURE, V461, pE8, DOI 10.1038/nature08407; Rhee HS, 2011, CELL, V147, P1408, DOI 10.1016/j.cell.2011.11.013; Roberts DN, 2003, P NATL ACAD SCI USA, V100, P14695, DOI 10.1073/pnas.2435566100; Robinett CC, 1996, J CELL BIOL, V135, P1685, DOI 10.1083/jcb.135.6.1685; Sprouse RO, 2008, P NATL ACAD SCI USA, V105, P13304, DOI 10.1073/pnas.0801901105; Sprouse RO, 2008, J BIOL CHEM, V283, P24935, DOI 10.1074/jbc.M803749200; Suter DM, 2011, SCIENCE, V332, P472, DOI 10.1126/science.1198817; Traven A, 2006, EMBO REP, V7, P496, DOI 10.1038/sj.embor.7400679; van Royen ME, 2011, CHROMOSOME RES, V19, P83, DOI 10.1007/s10577-010-9172-5; van Werven FJ, 2009, NAT STRUCT MOL BIOL, V16, P1043, DOI 10.1038/nsmb.1674; Viswanathan R, 2011, BBA-GENE REGUL MECH, V1809, P488, DOI 10.1016/j.bbagrm.2011.05.012	17	65	65	0	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 18	2013	342	6156					369	372		10.1126/science.1242369	http://dx.doi.org/10.1126/science.1242369			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	235XG	24091704	Green Accepted			2022-12-24	WOS:000325755100048
J	Katz, IT; Bassett, IV; Wright, AA				Katz, Ingrid T.; Bassett, Ingrid V.; Wright, Alexi A.			PEPFAR in Transition - Implications for HIV Care in South Africa	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material								With the U.S. government halving the budget for the President's Emergency Plan for AIDS Relief in South Africa by 2017, the country is transitioning to full ownership of its HIV program. Will the move jeopardize the health of 1.7 million South Africans being treated for HIV? This summer marked the 10th anniversary of the creation of the President's Emergency Plan for AIDS Relief (PEPFAR), widely considered the most ambitious and successful global public health program since smallpox eradication. Over the past decade, PEPFAR has funded HIV-AIDS treatment for more than 5 million people in resource-limited settings in sub-Saharan Africa. Now, the U.S. government has reached a turning point in its emergency response and has decided to reduce funding to many of these countries, including South Africa, recipient of the most PEPFAR dollars. In August 2012, the U.S. government announced it would cut South Africa's PEPFAR budget ...	[Katz, Ingrid T.] Massachusetts Gen Hosp, Div Womens Hlth, Brigham & Womens Hosp, Ctr Global Hlth, Boston, MA 02114 USA; [Katz, Ingrid T.; Bassett, Ingrid V.; Wright, Alexi A.] Harvard Univ, Sch Med, Boston, MA USA; [Bassett, Ingrid V.] Massachusetts Gen Hosp, Div Infect Dis, Boston, MA 02114 USA; [Bassett, Ingrid V.] Massachusetts Gen Hosp, Div Gen Med, Boston, MA 02114 USA; [Bassett, Ingrid V.] Massachusetts Gen Hosp, Med Practice Evaluat Ctr, Boston, MA 02114 USA; [Wright, Alexi A.] Dana Farber Canc Ctr, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Dana-Farber Cancer Institute	Katz, IT (corresponding author), Massachusetts Gen Hosp, Div Womens Hlth, Brigham & Womens Hosp, Ctr Global Hlth, Boston, MA 02114 USA.		Bassett, Ingrid V./ABI-7674-2020; Wright, Alexi/T-5793-2019	Bassett, Ingrid V./0000-0001-6920-6080; Katz, Ingrid/0000-0002-3014-238X	NIMH NIH HHS [K23 MH097667, R01 MH090326] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [K23MH097667, R01MH090326] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Bassett Ingrid, 2013, 8 INT C HIV TREATM P; Bendavid E, 2012, JAMA-J AM MED ASSOC, V307, P2060, DOI 10.1001/jama.2012.2001; Bor J, 2013, SCIENCE, V339, P961, DOI 10.1126/science.1230413; Chigwedere P, 2008, JAIDS-J ACQ IMM DEF, V49, P410, DOI 10.1097/QAI.0b013e31818a6cd5; Katz IT, 2011, AIDS, V25, P2177, DOI 10.1097/QAD.0b013e32834b6464	5	39	39	0	23	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 10	2013	369	15					1385	1387		10.1056/NEJMp1310982	http://dx.doi.org/10.1056/NEJMp1310982			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	231QE	24106930	Green Accepted			2022-12-24	WOS:000325431500002
J	Heffernan, O				Heffernan, Olive			THE DRY FACTS	NATURE			English	Editorial Material																			0	18	18	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 26	2013	501	7468					S2	S3		10.1038/501S2a	http://dx.doi.org/10.1038/501S2a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	223RP	24067762	Bronze			2022-12-24	WOS:000324826300002
J	Spence, D				Spence, Des			Make children move	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												destwo@yahoo.co.uk						Griffiths LJ, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-002893; National Health Executive, 2013, YAWNING GAP BETWEEN; Public Health England, 2013, HOW HEALTHY BEHAVIOU; Waters E, 2010, COCHRANE REVIEW, V3	4	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 19	2013	347								f5618	10.1136/bmj.f5618	http://dx.doi.org/10.1136/bmj.f5618			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	223SY	24052586				2022-12-24	WOS:000324831500007
J	Evans, T				Evans, Timothy			The Future Hospital Commission	LANCET			English	Editorial Material									Royal Coll Physicians, Future Hosp Commiss, London NW1 4LE, England	Royal College of Physicians	Evans, T (corresponding author), Royal Coll Physicians, Future Hosp Commiss, London NW1 4LE, England.	Linda.Cuthbertson@rcplondon.ac.uk						Fulop N, 2013, BMJ-BRIT MED J, V347, P4711; Future Hospital Commission Royal College of Physicians of London, 2013, FUT HOSP CAR MED PAT; Goddard A, 2012, BMJ-BRIT MED J, V344, P67; Gregory A, 2013, MIRROR          0801; NHS England, 2019, NHS INT PEOPL PLAN; Robert Francis QC, 2013, REP MIDST NHS FDN TR; Royal College of Physicians, 2013, MED REG EMP UNS HER	7	1	1	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	SEP 14	2013	382	9896					922	924		10.1016/S0140-6736(13)61894-2	http://dx.doi.org/10.1016/S0140-6736(13)61894-2			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	215VD	24034285				2022-12-24	WOS:000324238000008
J	Nakaki, F; Hayashi, K; Ohta, H; Kurimoto, K; Yabuta, Y; Saitou, M				Nakaki, Fumio; Hayashi, Katsuhiko; Ohta, Hiroshi; Kurimoto, Kazuki; Yabuta, Yukihiro; Saitou, Mitinori			Induction of mouse germ-cell fate by transcription factors in vitro	NATURE			English	Article							GROUND-STATE; SPECIFICATION; EXPRESSION; DYNAMICS; LINEAGE; TRANSPLANTATION; PRDM14; BLIMP1; MICE	The germ-cell lineage ensures the continuity of life through the generation of male and female gametes, which unite to form a totipotent zygote. We have previously demonstrated that, by using cytokines, embryonic stem cells and induced pluripotent stem cells can be induced into epiblast-like cells (EpiLCs) and then into primordial germcell (PGC)-like cells with the capacity for both spermatogenesis and oogenesis(1,2), creating an opportunity for understanding and regulating mammalian germ-cell development in both sexes in vitro. Here we show that, without cytokines, simultaneous overexpression of three transcription factors, Blimp1 (also known as Prdm1), Prdm14 and Tfap2c (also known as AP2c), directs EpiLCs, but not embryonic stem cells, swiftly and efficiently into a PGC state. Notably, Prdm14 alone, but not Blimp1 or Tfap2c, suffices for the induction of the PGC state in EpiLCs. The transcription-factor-induced PGC state, irrespective of the transcription factors used, reconstitutes key transcriptome and epigenetic reprogramming in PGCs, but bypasses a mesodermal program that accompanies PGC or PGC-like-cell specification by cytokines including bone morphogenetic protein 4. Notably, the transcription-factor-induced PGC-like cells contribute to spermatogenesis and fertile offspring. Our findings provide a new insight into the transcriptional logic for PGC specification, and create a foundation for the transcription-factor-based reconstitution and regulation of mammalian gametogenesis.	[Nakaki, Fumio; Hayashi, Katsuhiko; Ohta, Hiroshi; Kurimoto, Kazuki; Yabuta, Yukihiro; Saitou, Mitinori] Kyoto Univ, Grad Sch Med, Dept Anat & Cell Biol, Sakyo Ku, Kyoto 6068501, Japan; [Hayashi, Katsuhiko; Saitou, Mitinori] Kyoto Univ, Ctr iPS Cell Res & Applicat, Sakyo Ku, Kyoto 6068507, Japan; [Hayashi, Katsuhiko] JST, PRESTO, Sakyo Ku, Kyoto 6068501, Japan; [Ohta, Hiroshi; Kurimoto, Kazuki; Yabuta, Yukihiro; Saitou, Mitinori] JST, ERATO, Sakyo Ku, Kyoto 6068501, Japan; [Saitou, Mitinori] Kyoto Univ, Inst Integrated Cell Mat Sci, Sakyo Ku, Kyoto 6068501, Japan	Kyoto University; Kyoto University; Japan Science & Technology Agency (JST); Japan Science & Technology Agency (JST); Kyoto University	Saitou, M (corresponding author), Kyoto Univ, Grad Sch Med, Dept Anat & Cell Biol, Sakyo Ku, Yoshida Konoe Cho, Kyoto 6068501, Japan.	saitou@anat2.med.kyoto-u.ac.jp	Nakaki, Fumio/B-8284-2015	Nakaki, Fumio/0000-0003-4332-7735	Ministry of Education, Culture, Sports, Science, and Technology of Japan; JST-CREST/ERATO; Takeda Science Foundation; Academia for Repro-regenerative Medicine; Grants-in-Aid for Scientific Research [24681039] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); JST-CREST/ERATO; Takeda Science Foundation(Takeda Science Foundation (TSF)); Academia for Repro-regenerative Medicine; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank A. Bradley, A. Smith, G. Guo, H. Niwa and G. Nagamatsu for providing plasmids. We are grateful to the Center for Anatomical Studies (Graduate School of Medicine, Kyoto University) for performing the histological analyses. We thank M. Yamaji for advice and T. Mori for encouragement. F.N. is a Japan Society for the Promotion of Science (JSPS) Research Fellow. This study was supported in part by a Grant-in-Aid from the Ministry of Education, Culture, Sports, Science, and Technology of Japan; by JST-CREST/ERATO; by the Takeda Science Foundation; and by the Academia for Repro-regenerative Medicine.	Chuma S, 2005, DEVELOPMENT, V132, P117, DOI 10.1242/dev.01555; Guo G, 2010, DEVELOPMENT, V137, P3185, DOI 10.1242/dev.052753; Hayashi K, 2012, SCIENCE, V338, P971, DOI 10.1126/science.1226889; Hayashi K, 2011, CELL, V146, P519, DOI 10.1016/j.cell.2011.06.052; Hochedlinger K, 2005, CELL, V121, P465, DOI 10.1016/j.cell.2005.02.018; Kanatsu-Shinohara M, 2003, BIOL REPROD, V68, P167, DOI 10.1095/biolreprod.102.008516; KIMURA Y, 1995, BIOL REPROD, V52, P709, DOI 10.1095/biolreprod52.4.709; Kumaki Y, 2008, NUCLEIC ACIDS RES, V36, pW170, DOI 10.1093/nar/gkn294; Kurimoto K, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl050; Kurimoto K, 2008, GENE DEV, V22, P1617, DOI 10.1101/gad.1649908; Li C, 2001, P NATL ACAD SCI USA, V98, P31, DOI 10.1073/pnas.011404098; Lucifero D, 2002, GENOMICS, V79, P530, DOI 10.1006/geno.2002.6732; Niwa H, 2002, MOL CELL BIOL, V22, P1526, DOI 10.1128/MCB.22.5.1526-1536.2002; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Ohinata Y, 2005, NATURE, V436, P207, DOI 10.1038/nature03813; Ohinata Y, 2008, REPRODUCTION, V136, P503, DOI 10.1530/REP-08-0053; R Development Core Team, 2012, R LANG ENV STAT COMP; Saitou M, 2002, NATURE, V418, P293, DOI 10.1038/nature00927; Saitou M., 2012, COLD SPRING HARB PER, V4, P223; Sato M, 2002, MECH DEVELOP, V113, P91, DOI 10.1016/S0925-4773(02)00002-3; Seki Y, 2007, DEVELOPMENT, V134, P2627, DOI 10.1242/dev.005611; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Vincent SD, 2005, DEVELOPMENT, V132, P1315, DOI 10.1242/dev.01711; Weber S, 2010, BIOL REPROD, V82, P214, DOI 10.1095/biolreprod.109.078717; Woltjen K, 2009, NATURE, V458, P766, DOI 10.1038/nature07863; Yabuta Y, 2006, BIOL REPROD, V75, P705, DOI 10.1095/biolreprod.106.053686; Yamaji M, 2008, NAT GENET, V40, P1016, DOI 10.1038/ng.186; Yamaji M, 2013, CELL STEM CELL, V12, P368, DOI 10.1016/j.stem.2012.12.012; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968	30	203	212	1	66	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 12	2013	501	7466					222	+		10.1038/nature12417	http://dx.doi.org/10.1038/nature12417			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	215XR	23913270	Green Submitted			2022-12-24	WOS:000324244900041
J	Kesselheim, AS; Green, MD; Avorn, J				Kesselheim, Aaron S.; Green, Michael D.; Avorn, Jerry			Who Is Now Responsible for Discovering and Warning About Adverse Effects of Generic Drugs?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Kesselheim, Aaron S.; Avorn, Jerry] Harvard Univ, Brigham & Womens Hosp, Div Pharmacoepidemiol & Pharmacoecon, Sch Med,Dept Med, Boston, MA 02120 USA; [Green, Michael D.] Wake Forest Univ, Sch Law, Winston Salem, NC 27109 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Wake Forest University	Kesselheim, AS (corresponding author), Harvard Univ, Brigham & Womens Hosp, Div Pharmacoepidemiol & Pharmacoecon, Sch Med,Dept Med, 1620 Tremont St,Ste 3030, Boston, MA 02120 USA.	akesselheim@partners.org	Kesselheim, Aaron/R-6793-2017	Kesselheim, Aaron/0000-0002-8867-2666	AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [K08HS018465] Funding Source: NIH RePORTER; AHRQ HHS [K08HS18465-01] Funding Source: Medline	AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); AHRQ HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)		HATCH OG, COMMUNICATION; Keelan J, 2011, AM J PUBLIC HEALTH, V101, P2016, DOI 10.2105/AJPH.2011.300198; Kesselheim AS, 2012, NEW ENGL J MED, V367, P1679, DOI 10.1056/NEJMp1208781; US Food and Drug Administration, 2013, SUPPLEMENTAL APPLICA	4	5	5	0	4	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 11	2013	310	10					1023	1024		10.1001/jama.2013.228349	http://dx.doi.org/10.1001/jama.2013.228349			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	214KZ	23922000				2022-12-24	WOS:000324133400015
J	Gastanaduy, PA; Curns, AT; Parashar, UD; Lopman, BA				Gastanaduy, Paul A.; Curns, Aaron T.; Parashar, Umesh D.; Lopman, Ben A.			Gastroenteritis Hospitalizations in Older Children and Adults in the United States Before and After Implementation of Infant Rotavirus Vaccination	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter							INDIRECT PROTECTION; NOROVIRUS		[Gastanaduy, Paul A.; Curns, Aaron T.; Parashar, Umesh D.; Lopman, Ben A.] Ctr Dis Control & Prevent, Div Viral Dis, Atlanta, GA 30333 USA	Centers for Disease Control & Prevention - USA	Gastanaduy, PA (corresponding author), Ctr Dis Control & Prevent, Div Viral Dis, 1600 Clifton Rd NE,Mailstop A-47, Atlanta, GA 30333 USA.	vid7@cdc.gov						Anderson EJ, 2013, CLIN INFECT DIS, V56, P755, DOI 10.1093/cid/cis1010; Anderson EJ, 2012, J INFECTION, V64, P89, DOI 10.1016/j.jinf.2011.09.003; Bresee JS, 2012, J INFECT DIS, V205, P1374, DOI 10.1093/infdis/jis206; Gastanaduy PA, 2013, J INFECT DIS, V207, P1058, DOI 10.1093/infdis/jis942; Lopman BA, 2011, J INFECT DIS, V204, P980, DOI 10.1093/infdis/jir492; Lopman BA, 2011, CLIN INFECT DIS, V52, P466, DOI 10.1093/cid/ciq163	6	64	65	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 28	2013	310	8					851	853		10.1001/jama.2013.170800	http://dx.doi.org/10.1001/jama.2013.170800			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	206YA	23982372				2022-12-24	WOS:000323561400026
J	Hong, JL; Meier, CR; Sandler, RS; Jick, SS; Sturmer, T				Hong, Jin-Liern; Meier, Christoph R.; Sandler, Robert S.; Jick, Susan S.; Stuermer, Til			Risk of colorectal cancer after initiation of orlistat: matched cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							ABERRANT CRYPT FOCI; WEIGHT CHANGE; COLON-CANCER; METAANALYSIS; ADULTS	Objective To examine the risk of colorectal cancer after orlistat initiation in the UK population. Design Retrospective matched cohort study. Setting Data from the UK Clinical Practice Research Datalink from September 1998 to December 2008. Participants 33 625 adults aged 18 years or over who started treatment with orlistat; each orlistat initiator was matched to up to five non-initiators (n=160 347) on age, sex, body mass index, and calendar time. Main outcome measures Associations between orlistat initiation and the risk of colorectal cancer, assessed by calculating hazard ratios with propensity score adjusted Cox proportional hazard models. Results Of 193 972 patients with a median age of 47 (interquartile range 37-57) years, 77% were women and approximately 90% were obese (body mass index >= 30). Orlistat initiators were more likely to have a previous history of diabetes or hypertension and to receive prescriptions for anti-diabetes drugs, statins, and aspirin compared with non-initiators. In the intention to treat analysis, 57 colorectal cancer events were identified among orlistat initiators and 246 among non-initiators, with median follow-up times of 2.96 and 2.86 years, respectively. The calculated incidence rate of colorectal cancer per 100 000 person years was 53 (95% confidence interval 41 to 69) for orlistat initiators and 50 (44 to 57) for non-initiators. Orlistat initiation was not associated with a higher risk of colorectal cancer (adjusted hazard ratio 1.11, 95% confidence interval 0.84 to 1.47). Findings were robust in the as treated analyses and in patients who were aged 50 years or over, were morbidly obese, or had a history of diabetes. Conclusions This study found no evidence of an increased risk of colorectal cancer after the initiation of orlistat. It is limited by the relatively short follow-up time, and the possibility of adverse effects of long term orlistat use on risk of colorectal cancer cannot be excluded.	[Hong, Jin-Liern; Sandler, Robert S.; Stuermer, Til] Univ N Carolina, Dept Epidemiol, UNC Gillings Sch Global Publ Hlth, Chapel Hill, NC 27599 USA; [Meier, Christoph R.] Univ Basel, Dept Pharmaceut Sci, Div Clin Pharm & Epidemiol, Basel Pharmacoepidemiol Unit, Basel, Switzerland; [Meier, Christoph R.] Univ Basel Hosp, Hosp Pharm, CH-4031 Basel, Switzerland; [Meier, Christoph R.; Jick, Susan S.] Boston Univ, Sch Publ Hlth, Boston Collaborat Drug Surveillance Program, Boston, MA 02421 USA; [Sandler, Robert S.] Univ N Carolina, UNC Sch Med, Dept Med, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of Basel; University of Basel; Boston University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Hong, JL (corresponding author), Univ N Carolina, Dept Epidemiol, UNC Gillings Sch Global Publ Hlth, CB 7435, Chapel Hill, NC 27599 USA.	jlhongtw@email.unc.edu	Stürmer, Til/AAB-5459-2022	Jick, Susan/0000-0002-2215-1067	Lineberger Comprehensive Cancer Center (LCCC) at the University of North Carolina at Chapel Hill; National Institute of Aging at the National Institutes of Health [R01 AG023178]; NATIONAL CANCER INSTITUTE [P30CA016086] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG023178] Funding Source: NIH RePORTER	Lineberger Comprehensive Cancer Center (LCCC) at the University of North Carolina at Chapel Hill; National Institute of Aging at the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The study was funded by the population research award from the Lineberger Comprehensive Cancer Center (LCCC) at the University of North Carolina at Chapel Hill and R01 AG023178 from the National Institute of Aging at the National Institutes of Health. The funding agencies had no role in the design of the study; in the analysis and interpretation of the data; in the writing of the report; or in the decision to submit the paper for publication.	[Anonymous], 2006, ORLISTAT ZENICAL PRE; Bassett JK, 2010, CANCER EPIDEM BIOMAR, V19, P2978, DOI 10.1158/1055-9965.EPI-10-0543; Birks S, 2012, OBES REV, V13, P868, DOI 10.1111/j.1467-789X.2012.01010.x; Evaluate, 2011, ANT AG TOP 3 MARK PR; Garcia SB, 2006, CANCER LETT, V240, P221, DOI 10.1016/j.canlet.2005.09.011; Gupta AK, 2007, CLIN GASTROENTEROL H, V5, P526, DOI 10.1016/j.cgh.2007.02.014; Hutton B, 2004, AM J CLIN NUTR, V80, P1461, DOI 10.1093/ajcn/80.6.1461; Jacob S, 2009, DIABETES OBES METAB, V11, P361, DOI 10.1111/j.1463-1326.2008.00970.x; Johansson K, 2010, OBES REV, V11, P777, DOI 10.1111/j.1467-789X.2009.00693.x; Moghaddam AA, 2007, CANCER EPIDEM BIOMAR, V16, P2533, DOI 10.1158/1055-9965.EPI-07-0708; Moore LL, 2004, INT J OBESITY, V28, P559, DOI 10.1038/sj.ijo.0802606; Mutch MG, 2009, CLIN GASTROENTEROL H, V7, P568, DOI 10.1016/j.cgh.2009.01.016; Nairooz S, EGYPT J HISTOL, V33, P635; O'Meara S, 2004, Obes Rev, V5, P51, DOI 10.1111/j.1467-789X.2004.00125.x; Rapp K, 2008, ANN ONCOL, V19, P641, DOI 10.1093/annonc/mdm549; ROSENBAUM PR, 1983, BIOMETRIKA, V70, P41, DOI 10.1093/biomet/70.1.41; Sato T, 2003, EPIDEMIOLOGY, V14, P680, DOI 10.1097/01.EDE.0000081989.82616.7d; Takayama T, 1998, NEW ENGL J MED, V339, P1277, DOI 10.1056/NEJM199810293391803; Torgerson JS, 2004, DIABETES CARE, V27, P155, DOI 10.2337/diacare.27.1.155	19	15	15	0	11	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 27	2013	347								f5039	10.1136/bmj.f5039	http://dx.doi.org/10.1136/bmj.f5039			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	211BW	23982291	Green Published, hybrid			2022-12-24	WOS:000323880100001
J	Maillard, PV; Ciaudo, C; Marchais, A; Li, Y; Jay, F; Ding, SW; Voinnet, O				Maillard, P. V.; Ciaudo, C.; Marchais, A.; Li, Y.; Jay, F.; Ding, S. W.; Voinnet, Olivier			Antiviral RNA Interference in Mammalian Cells	SCIENCE			English	Article							DOUBLE-STRANDED-RNA; GENE-EXPRESSION; SUPPRESSION; IMMUNITY; DICER; MICRORNAS; VIRUSES; ARABIDOPSIS; BIOGENESIS; MECHANISM	In antiviral RNA interference (RNAi), the DICER enzyme processes virus-derived double-stranded RNA (dsRNA) into small interfering RNAs (siRNAs) that guide ARGONAUTE proteins to silence complementary viral RNA. As a counterdefense, viruses deploy viral suppressors of RNAi (VSRs). Well-established in plants and invertebrates, the existence of antiviral RNAi remains unknown in mammals. Here, we show that undifferentiated mouse cells infected with encephalomyocarditis virus (EMCV) or Nodamura virus (NoV) accumulate similar to 22-nucleotide RNAs with all the signature features of siRNAs. These derive from viral dsRNA replication intermediates, incorporate into AGO2, are eliminated in Dicer knockout cells, and decrease in abundance upon cell differentiation. Furthermore, genetically ablating a NoV-encoded VSR that antagonizes DICER during authentic infections reduces NoV accumulation, which is rescued in RNAi-deficient mouse cells. We conclude that antiviral RNAi operates in mammalian cells.	[Maillard, P. V.; Ciaudo, C.; Marchais, A.; Jay, F.; Voinnet, Olivier] Swiss Fed Inst Technol ETH Z, Dept Biol, CH-8092 Zurich, Switzerland; [Li, Y.; Ding, S. W.] Univ Calif Riverside, Dept Plant Pathol & Microbiol, Riverside, CA 92521 USA	Swiss Federal Institutes of Technology Domain; ETH Zurich; University of California System; University of California Riverside	Voinnet, O (corresponding author), Swiss Fed Inst Technol ETH Z, Dept Biol, CH-8092 Zurich, Switzerland.	voinneto@ethz.ch	Ciaudo, Constance/A-2014-2012; Marchais, Antonin/GLV-6267-2022; Ding, Shou Wei/AAC-2533-2020; Maillard, Pierre V/V-4305-2019; Li, Yang/GVT-7396-2022; Marchais, Antonin/G-2627-2013	Ciaudo, Constance/0000-0002-0857-4506; Marchais, Antonin/0000-0003-0954-8294; Maillard, Pierre V/0000-0003-4611-388X; Li, Yang/0000-0002-6065-4706; Marchais, Antonin/0000-0003-0954-8294; JAY, Florence/0000-0001-7353-8299; Voinnet, Olivier/0000-0001-6982-9544; Ding, SW/0000-0002-4697-8413	Swiss National Foundation; Federation of European Biochemical Societies; Bettencourt Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI052447] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM094396, RC1GM091896] Funding Source: NIH RePORTER	Swiss National Foundation(Swiss National Science Foundation (SNSF)); Federation of European Biochemical Societies; Bettencourt Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the Voinnet laboratory for advice and discussions and L. Bakkali-Kassimi, G. Meister, E. Brocchi, and J.-C. Paillart for reagents. Supported by a Prospective Researchers Fellowship from the Swiss National Foundation to P. V. M., a fellowship from the Federation of European Biochemical Societies to C. C., and an award from the Bettencourt Foundation to O.V.	Aliyari R, 2008, CELL HOST MICROBE, V4, P387, DOI 10.1016/j.chom.2008.09.001; Allen E, 2005, CELL, V121, P207, DOI 10.1016/j.cell.2005.04.004; Babiarz JE, 2008, GENE DEV, V22, P2773, DOI 10.1101/gad.1705308; Billy E, 2001, P NATL ACAD SCI USA, V98, P14428, DOI 10.1073/pnas.261562698; Chalupnikova Katerina, 2013, Methods Mol Biol, V942, P291, DOI 10.1007/978-1-62703-119-6_16; Chao JA, 2005, NAT STRUCT MOL BIOL, V12, P952, DOI 10.1038/nsmb1005; Deleris A, 2006, SCIENCE, V313, P68, DOI 10.1126/science.1128214; Diaz-Pendon JA, 2007, PLANT CELL, V19, P2053, DOI 10.1105/tpc.106.047449; Ding SW, 2007, CELL, V130, P413, DOI 10.1016/j.cell.2007.07.039; Gan L, 2002, J NEUROSCI METH, V121, P151, DOI 10.1016/S0165-0270(02)00230-3; Goubau D, 2013, IMMUNITY, V38, P855, DOI 10.1016/j.immuni.2013.05.007; Haasnoot J, 2007, NAT BIOTECHNOL, V25, P1435, DOI 10.1038/nbt1369; Kim VN, 2009, NAT REV MOL CELL BIO, V10, P126, DOI 10.1038/nrm2632; Li Y, 2013, SCIENCE, V342, P231, DOI 10.1126/science.1241911; Ma E, 2008, J MOL BIOL, V380, P237, DOI 10.1016/j.jmb.2008.05.005; Murchison EP, 2005, P NATL ACAD SCI USA, V102, P12135, DOI 10.1073/pnas.0505479102; Paddison PJ, 2002, P NATL ACAD SCI USA, V99, P1443, DOI 10.1073/pnas.032652399; Parameswaran P, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000764; Pfeffer S, 2005, NAT METHODS, V2, P269, DOI 10.1038/NMETH746; Su H, 2009, GENE DEV, V23, P304, DOI 10.1101/gad.1749809; Sullivan CS, 2005, J VIROL, V79, P7371, DOI 10.1128/JVI.79.12.7371-7379.2005; Tay Y, 2008, NATURE, V455, P1124, DOI 10.1038/nature07299; Umbach JL, 2009, GENE DEV, V23, P1151, DOI 10.1101/gad.1793309; Wang XH, 2006, SCIENCE, V312, P452, DOI 10.1126/science.1125694; Wang XB, 2011, PLANT CELL, V23, P1625, DOI 10.1105/tpc.110.082305; Weber F, 2006, J VIROL, V80, P5059, DOI 10.1128/JVI.80.10.5059-5064.2006; Yi CE, 2003, J BIOL CHEM, V278, P934, DOI 10.1074/jbc.M205946200	27	280	292	1	101	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 11	2013	342	6155					235	238		10.1126/science.1241930	http://dx.doi.org/10.1126/science.1241930			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232EV	24115438	Green Accepted			2022-12-24	WOS:000325475200042
J	Lam, TTY; Wang, J; Shen, YY; Zhou, BP; Duan, L; Cheung, CL; Ma, C; Lycett, SJ; Leung, CYH; Chen, XC; Li, LF; Hong, WS; Chai, YJ; Zhou, LL; Liang, HY; Ou, ZH; Liu, YM; Farooqui, A; Kelvin, DJ; Poon, LLM; Smith, DK; Pybus, OG; Leung, GM; Shu, YL; Webster, RG; Webby, RJ; Peiris, JSM; Rambaut, A; Zhu, HC; Guan, Y				Lam, Tommy Tsan-Yuk; Wang, Jia; Shen, Yongyi; Zhou, Boping; Duan, Lian; Cheung, Chung-Lam; Ma, Chi; Lycett, Samantha J.; Leung, Connie Yin-Hung; Chen, Xinchun; Li, Lifeng; Hong, Wenshan; Chai, Yujuan; Zhou, Linlin; Liang, Huyi; Ou, Zhihua; Liu, Yongmei; Farooqui, Amber; Kelvin, David J.; Poon, Leo L. M.; Smith, David K.; Pybus, Oliver G.; Leung, Gabriel M.; Shu, Yuelong; Webster, Robert G.; Webby, Richard J.; Peiris, Joseph S. M.; Rambaut, Andrew; Zhu, Huachen; Guan, Yi			The genesis and source of the H7N9 influenza viruses causing human infections in China	NATURE			English	Article							PHYLOGENETIC ANALYSIS; RECEPTOR-BINDING; SOUTHERN CHINA; ESTABLISHMENT; TRANSMISSION; SEQUENCES; ACCURACY; MODELS; ORIGIN; DUCKS	A novel H7N9 influenza A virus first detected in March 2013 has since caused more than 130 human infections in China, resulting in 40 deaths(1,2). Preliminary analyses suggest that the virus is a reassortant of H7, N9 and H9N2 avian influenza viruses, and carries some amino acids associated with mammalian receptor binding, raising concerns of a new pandemic(1,3,4). However, neither the source populations of the H7N9 outbreak lineage nor the conditions for its genesis are fully known(5). Using a combination of active surveillance, screening of virus archives, and evolutionary analyses, here we show that H7 viruses probably transferred from domestic duck to chicken populations in China on at least two independent occasions. We show that the H7 viruses subsequently reassorted with enzootic H9N2 viruses to generate the H7N9 outbreak lineage, and a related previously unrecognized H7N7 lineage. The H7N9 outbreak lineage has spread over a large geographic region and is prevalent in chickens at live poultry markets, which are thought to be the immediate source of human infections. Whether the H7N9 outbreak lineage has, or will, become enzootic in China and neighbouring regions requires further investigation. The discovery here of a related H7N7 influenza virus in chickens that has the ability to infect mammals experimentally, suggests that H7 viruses may pose threats beyond the current outbreak. The continuing prevalence of H7 viruses in poultry could lead to the generation of highly pathogenic variants and further sporadic human infections, with a continued risk of the virus acquiring human-to-human transmissibility.	[Lam, Tommy Tsan-Yuk; Wang, Jia; Shen, Yongyi; Ma, Chi; Li, Lifeng; Hong, Wenshan; Liang, Huyi; Ou, Zhihua; Liu, Yongmei; Smith, David K.; Leung, Gabriel M.; Zhu, Huachen; Guan, Yi] Shantou Univ, Coll Med, Joint Influenza Res Ctr SUMC HKU, Shantou 515041, Peoples R China; [Lam, Tommy Tsan-Yuk; Zhou, Boping; Duan, Lian; Chen, Xinchun; Li, Lifeng; Chai, Yujuan; Liang, Huyi; Ou, Zhihua; Poon, Leo L. M.; Peiris, Joseph S. M.; Zhu, Huachen; Guan, Yi] Shenzhen Third Peoples Hosp, HKU Shenzhen Branch, State Key Lab Emerging Infect Dis, Shenzhen 518112, Peoples R China; [Lam, Tommy Tsan-Yuk; Wang, Jia; Shen, Yongyi; Duan, Lian; Cheung, Chung-Lam; Ma, Chi; Leung, Connie Yin-Hung; Li, Lifeng; Chai, Yujuan; Zhou, Linlin; Liang, Huyi; Ou, Zhihua; Liu, Yongmei; Poon, Leo L. M.; Smith, David K.; Leung, Gabriel M.; Peiris, Joseph S. M.; Zhu, Huachen; Guan, Yi] Univ Hong Kong, Sch Publ Hlth, Influenza Res Ctr, State Key Lab Emerging Infect Dis, Hong Kong, Hong Kong, Peoples R China; [Shen, Yongyi] Xiamen Univ, Sch Life Sci, State Key Lab Cellular Stress Biol, Xiamen 361102, Peoples R China; [Lycett, Samantha J.; Rambaut, Andrew] Univ Edinburgh, Inst Evolutionary Biol, Edinburgh EH9 3JT, Midlothian, Scotland; [Farooqui, Amber; Kelvin, David J.] Shantou Univ, Coll Med, Joint Vaccine Res Ctr SUMC UHN, Shantou 515041, Peoples R China; [Pybus, Oliver G.] Univ Oxford, Dept Zool, Oxford OX1 3PS, England; [Pybus, Oliver G.] Metabiota, San Francisco, CA 94104 USA; [Shu, Yuelong] Natl Hlth & Family Planning Commiss, Chinese Ctr Dis Control & Prevent, Natl Inst Viral Dis Control & Prevent, Key Lab Med Virol, Beijing 102206, Peoples R China; [Webster, Robert G.; Webby, Richard J.] St Jude Childrens Res Hosp, Dept Infect Dis, Div Virol, Memphis, TN 38105 USA; [Rambaut, Andrew] NIH, Fogarty Int Ctr, Bethesda, MD 20892 USA	Shantou University; University of Hong Kong; Xiamen University; University of Edinburgh; Shantou University; University of Oxford; Chinese Center for Disease Control & Prevention; National Institute for Viral Disease Control & Prevention, Chinese Center for Disease Control & Prevention; St Jude Children's Research Hospital; National Institutes of Health (NIH) - USA; NIH Fogarty International Center (FIC)	Zhu, HC (corresponding author), Shantou Univ, Coll Med, Joint Influenza Res Ctr SUMC HKU, Shantou 515041, Peoples R China.	zhuhch@hku.hk; yguan@hku.hk	Zhu, Huachen/A-8252-2017; Poon, Leo/AAP-6887-2020; Ou, Zhihua/AAX-1882-2020; Cheung, Yiu Man/T-2708-2019; Poon, Leo Lit Man/C-4382-2009; Lycett, Samantha/F-9598-2013; Rambaut, Andrew/B-2481-2009; Pybus, Oliver G/B-2640-2012; Shen, Yongyi/GWU-8031-2022; Webby, Richard J/N-5657-2018; Lam, Tsan Yuk/D-4837-2012	Zhu, Huachen/0000-0003-2711-0501; Ou, Zhihua/0000-0002-1479-9007; Poon, Leo Lit Man/0000-0002-9101-7953; Lycett, Samantha/0000-0003-3159-596X; Rambaut, Andrew/0000-0003-4337-3707; Pybus, Oliver G/0000-0002-8797-2667; Shen, Yongyi/0000-0001-7660-5522; Farooqui, Amber/0000-0002-6031-9561; Lam, Tsan Yuk/0000-0002-9769-1527; Leung, Connie YH/0000-0003-1102-4684; Rambaut FRSE, Professor Andrew/0000-0002-1278-598X; Guan, Yi/0000-0001-6057-9243; Leung, Gabriel/0000-0002-2503-6283; Smith, David/0000-0003-3608-0586	National Institutes of Health (National Institute of Allergy and Infectious Diseases) [HSN266200700005C]; Li Ka Shing Foundation; University Grants Committee of the Hong Kong SAR [AoE/M-12/06]; Shenzhen Peacock Plan High-End Talents Program [KQTD201203]; University Development Fund (HKU); Innovation and Technology Commission of the Hong Kong Government; Newton International Fellowship of the Royal Society; US Agency for International Development (USAID) Emerging Pandemic Threats Program, PREDICT project [GHN-A-OO-09-00010-00]; European Union [278433-PREDEMICS]; ERC [260864]; Wellcome Trust [092807]; BBSRC [BB/E009670/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/E009670/1] Funding Source: researchfish	National Institutes of Health (National Institute of Allergy and Infectious Diseases)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Li Ka Shing Foundation; University Grants Committee of the Hong Kong SAR; Shenzhen Peacock Plan High-End Talents Program; University Development Fund (HKU); Innovation and Technology Commission of the Hong Kong Government; Newton International Fellowship of the Royal Society; US Agency for International Development (USAID) Emerging Pandemic Threats Program, PREDICT project(United States Agency for International Development (USAID)); European Union(European Commission); ERC(European Research Council (ERC)European Commission); Wellcome Trust(Wellcome TrustEuropean Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We thank our colleagues from the Joint Influenza Research Centre (SUMC/HKU) and the State Key Laboratory of Emerging Infectious Diseases for their technical assistance. This study was supported by the National Institutes of Health (National Institute of Allergy and Infectious Diseases contract HSN266200700005C), Li Ka Shing Foundation, the Area of Excellence Scheme of the University Grants Committee of the Hong Kong SAR (grant AoE/M-12/06), Shenzhen Peacock Plan High-End Talents Program (KQTD201203), the University Development Fund (HKU) and the Innovation and Technology Commission of the Hong Kong Government. T.T.-Y.L. was supported in part by a Newton International Fellowship of the Royal Society. Metabiota's involvement was supported by the US Agency for International Development (USAID) Emerging Pandemic Threats Program, PREDICT project, under the terms of Cooperative Agreement Number GHN-A-OO-09-00010-00. The research leading to these results has received funding from the European Union Seventh Framework Programme (FP7/2007-2013) under Grant Agreement no. 278433-PREDEMICS, ERC Grant agreement no. 260864 and the Wellcome Trust (grant 092807) to A. R. and S.J.L.	Anisimova M, 2011, SYST BIOL, V60, P685, DOI 10.1093/sysbio/syr041; Cheung CL, 2007, J VIROL, V81, P10402, DOI 10.1128/JVI.01157-07; Delport W, 2010, BIOINFORMATICS, V26, P2455, DOI 10.1093/bioinformatics/btq429; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075; Duan LA, 2011, INFLUENZA OTHER RESP, V5, P65; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Gao RB, 2013, NEW ENGL J MED, V368, P1888, DOI 10.1056/NEJMoa1304459; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Guo YJ, 2000, VIROLOGY, V267, P279, DOI 10.1006/viro.1999.0115; Huang K, 2012, J VIROL, V86, P6075, DOI 10.1128/JVI.06389-11; Hvistendahl M, 2013, SCIENCE, V340, P414, DOI 10.1126/science.340.6131.414; Kageyama T, 2013, EUROSURVEILLANCE, V18, P7; Lam TTY, 2013, INFECT GENET EVOL, V18, P367, DOI 10.1016/j.meegid.2013.03.015; Liu D, 2013, LANCET, V381, P1926, DOI 10.1016/S0140-6736(13)60938-1; Minin VN, 2008, MOL BIOL EVOL, V25, P1459, DOI 10.1093/molbev/msn090; Murrell B, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002764; Pond SLK, 2005, BIOINFORMATICS, V21, P676, DOI 10.1093/bioinformatics/bti079; Pupko T, 2000, MOL BIOL EVOL, V17, P890, DOI 10.1093/oxfordjournals.molbev.a026369; Shapiro B, 2006, MOL BIOL EVOL, V23, P7, DOI 10.1093/molbev/msj021; Shortridge KF, 2000, VET MICROBIOL, V74, P141, DOI 10.1016/S0378-1135(00)00174-7; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Tharakaraman K, 2013, CELL, V153, P1486, DOI 10.1016/j.cell.2013.05.034; World Health Organization, 2013, NUMB CONF HUM CAS AV; Xiong XL, 2013, NATURE, V499, P496, DOI 10.1038/nature12372; Xu JG, 2013, LANCET, V381, P1815, DOI 10.1016/S0140-6736(13)60950-2; Yamada S, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001034; Zhu H, 2013, SCIENCE, V341, P183, DOI 10.1126/science.1239844	28	336	370	5	238	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 10	2013	502	7470					241	+		10.1038/nature12515	http://dx.doi.org/10.1038/nature12515			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231RU	23965623	Green Accepted			2022-12-24	WOS:000325436100052
J	Stange, DE; Koo, BK; Huch, M; Sibbel, G; Basak, O; Lyubimova, A; Kujala, P; Bartfeld, S; Koster, J; Geahlen, JH; Peters, PJ; van Es, JH; van de Wetering, M; Mills, JC; Clevers, H				Stange, Daniel E.; Koo, Bon-Kyoung; Huch, Meritxell; Sibbel, Greg; Basak, Onur; Lyubimova, Anna; Kujala, Pekka; Bartfeld, Sina; Koster, Jan; Geahlen, Jessica H.; Peters, Peter J.; van Es, Johan H.; van de Wetering, Marc; Mills, Jason C.; Clevers, Hans			Differentiated Troy(+) Chief Cells Act as Reserve Stem Cells to Generate All Lineages of the Stomach Epithelium	CELL			English	Article							RECEPTOR FAMILY-MEMBER; MOUSE STOMACH; ZYMOGENIC CELLS; LIVER-REGENERATION; PROGENITOR CELLS; SMALL-INTESTINE; PARIETAL-CELLS; ADULT STEM; IN-VITRO; METAPLASIA	Proliferation of the self-renewing epithelium of the gastric corpus occurs almost exclusively in the isthmus of the glands, from where cells migrate bidirectionally toward pit and base. The isthmus is therefore generally viewed as the stem cell zone. We find that the stem cell marker Troy is expressed at the gland base by a small subpopulation of fully differentiated chief cells. By lineage tracing with a Troy-eGFP-ires-CreERT2 allele, single marked chief cells are shown to generate entirely labeled gastric units over periods of months. This phenomenon accelerates upon tissue damage. Troy(+) chief cells can be cultured to generate long-lived gastric organoids. Troy marks a specific subset of chief cells that display plasticity in that they are capable of replenishing entire gastric units, essentially serving as quiescent "reserve" stem cells. These observations challenge the notion that stem cell hierarchies represent a "one-way street."	[Stange, Daniel E.; Koo, Bon-Kyoung; Huch, Meritxell; Basak, Onur; Lyubimova, Anna; Bartfeld, Sina; van Es, Johan H.; van de Wetering, Marc; Clevers, Hans] Hubrecht Inst Dev Biol & Stem Cell Res, NL-3584 CT Utrecht, Netherlands; [Stange, Daniel E.; Koo, Bon-Kyoung; Huch, Meritxell; Basak, Onur; Lyubimova, Anna; Bartfeld, Sina; van Es, Johan H.; van de Wetering, Marc; Clevers, Hans] Univ Med Ctr Utrecht, NL-3584 CT Utrecht, Netherlands; [Stange, Daniel E.] Univ Dresden, Univ Hosp Carl Gustav Carus, Dept Gen Thorac & Vasc Surg, D-01307 Dresden, Germany; [Koo, Bon-Kyoung] Univ Cambridge, Wellcome Trust Med Res Council Stem Cell Inst, Cambridge CB2 1QR, England; [Sibbel, Greg; Geahlen, Jessica H.; Mills, Jason C.] Washington Univ, Sch Med, Dept Med, Div Gastroenterol, St Louis, MO 63110 USA; [Lyubimova, Anna] MIT, Dept Phys & Biol, Cambridge, MA 02139 USA; [Kujala, Pekka; Peters, Peter J.] Antoni van Leeuwenhoek Hosp, Netherlands Canc Inst, Div Cell Biol 2, NL-1066 CX Amsterdam, Netherlands; [Koster, Jan] Univ Amsterdam, Acad Med Ctr, Dept Oncogen, NL-1100 DE Amsterdam, Netherlands	Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Utrecht University; Utrecht University Medical Center; Technische Universitat Dresden; Carl Gustav Carus University Hospital; University of Cambridge; Washington University (WUSTL); Massachusetts Institute of Technology (MIT); Netherlands Cancer Institute; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam	Clevers, H (corresponding author), Hubrecht Inst Dev Biol & Stem Cell Res, NL-3584 CT Utrecht, Netherlands.	h.clevers@hubrecht.eu	van+Es, Johan/ABD-5411-2021; Stange, Daniel E/O-1837-2015; Basak, Onur/GLV-6113-2022; Koo, Bon-Kyoung/V-5219-2017; Mills, Jason/AAA-6688-2021; Koster, Jan/C-5934-2008	Stange, Daniel E/0000-0003-4246-2230; Basak, Onur/0000-0002-6864-3403; Koo, Bon-Kyoung/0000-0002-4134-8033; Mills, Jason/0000-0002-0402-4662; Koster, Jan/0000-0002-0890-7585; Bartfeld, Sina/0000-0003-2493-8282	Centre for Biomedical Genetics (CBG); European Research Council [EU/232814-StemCellMark, EU/Health-F4-2007-200720]; National Research Foundation of Korea [NRF2011-357-C00093]; Wellcome Trust [097922/C/11/Z]; EU Marie Curie Fellowship [EU/236954-ICSC-Lgr5, EU/300686-InfO]; Cancer Genomics Center (CGCII); TI Pharma [T3-106, DK094989, 2P30 DK052574]; NATIONAL CANCER INSTITUTE [T32CA113275] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK052574, R01DK094989] Funding Source: NIH RePORTER	Centre for Biomedical Genetics (CBG); European Research Council(European Research Council (ERC)European Commission); National Research Foundation of Korea(National Research Foundation of Korea); Wellcome Trust(Wellcome TrustEuropean Commission); EU Marie Curie Fellowship(European Commission); Cancer Genomics Center (CGCII); TI Pharma; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grants from the Centre for Biomedical Genetics (CBG) to D.E.S.; the European Research Council (EU/232814-StemCellMark), the National Research Foundation of Korea (NRF2011-357-C00093), and the Wellcome Trust (097922/C/11/Z) to B.-K.K.; an EU Marie Curie Fellowship (EU/236954-ICSC-Lgr5) to M.H.; the Cancer Genomics Center (CGCII) to O.B.; an EU Marie Curie Fellowship (EU/300686-InfO) to S.B.; a grant from TI Pharma (T3-106) to J.H.v.E.; the European Research Council (EU/Health-F4-2007-200720) to M.v.d.W.; and DK094989, 2P30 DK052574 to J.C.M. We would like to thank R. Siegmund for graphical abstract design, Mark J. Miller and the Washington University School of Medicine In vivo Imaging Core (IVIC) for help with two-photon imaging, the Washington University Digestive Disease Core Center (DDRCC) Advanced Imaging and Tissue Analysis Core and Shradha Khurana for help in figure preparation, James Goldenring for constructive discussion, and Frederic J. de Sauvage for Lgr5-DTR:eGFP mice.	Arnold K, 2011, CELL STEM CELL, V9, P317, DOI 10.1016/j.stem.2011.09.001; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Barker N, 2010, CELL STEM CELL, V6, P25, DOI 10.1016/j.stem.2009.11.013; Batlle E, 2002, CELL, V111, P251, DOI 10.1016/S0092-8674(02)01015-2; Bredemeyer AJ, 2009, DEV BIOL, V325, P211, DOI 10.1016/j.ydbio.2008.10.025; Capoccia BJ, 2013, J CLIN INVEST, V123, P1475, DOI 10.1172/JCI65703; CHEN KY, 1975, J ANAT, V120, P421; Fafilek B, 2013, GASTROENTEROLOGY, V144, P381, DOI 10.1053/j.gastro.2012.10.048; Fausto N, 2000, J HEPATOL, V32, P19, DOI 10.1016/S0168-8278(00)80412-2; Goldenring JR, 2011, EXP CELL RES, V317, P2759, DOI 10.1016/j.yexcr.2011.08.017; Hashimoto T, 2008, CELL CYCLE, V7, P106, DOI 10.4161/cc.7.1.5135; Huh WJ, 2012, GASTROENTEROLOGY, V142, P21, DOI 10.1053/j.gastro.2011.09.050; Huh WJ, 2010, GASTROENTEROLOGY, V139, P2038, DOI 10.1053/j.gastro.2010.08.050; Itzkovitz S, 2012, NAT CELL BIOL, V14, P106, DOI 10.1038/ncb2384; Jaks V, 2008, NAT GENET, V40, P1291, DOI 10.1038/ng.239; Kao JY, 2010, GASTROENTEROLOGY, V138, P1046, DOI 10.1053/j.gastro.2009.11.043; KARAM SM, 1993, ANAT REC, V236, P314, DOI 10.1002/ar.1092360205; KARAM SM, 1993, ANAT REC, V236, P297, DOI 10.1002/ar.1092360204; KARAM SM, 1993, ANAT REC, V236, P259, DOI 10.1002/ar.1092360202; Koo BK, 2012, NATURE, V488, P665, DOI 10.1038/nature11308; LERNER C, 1990, EXP HEMATOL, V18, P114; Li LH, 2010, SCIENCE, V327, P542, DOI 10.1126/science.1180794; Lustig B, 2002, MOL CELL BIOL, V22, P1184, DOI 10.1128/MCB.22.4.1184-1193.2002; Masaki T, 2013, CELL, V152, P51, DOI 10.1016/j.cell.2012.12.014; Michalopoulos GK, 1997, SCIENCE, V276, P60, DOI 10.1126/science.276.5309.60; Mills JC, 2011, GASTROENTEROLOGY, V140, P412, DOI 10.1053/j.gastro.2010.12.001; Munoz J, 2012, EMBO J, V31, P3079, DOI 10.1038/emboj.2012.166; Muzumdar MD, 2007, GENESIS, V45, P593, DOI 10.1002/dvg.20335; Nam KT, 2010, GASTROENTEROLOGY, V139, P2028, DOI 10.1053/j.gastro.2010.09.005; Nomura S, 2004, GASTROENTEROLOGY, V127, P582, DOI 10.1053/j.gastro.2004.05.029; Peters PJ, 2006, CURR PROTOC CELL BIO, DOI [10.1002/0471143030.CB0407S30, DOI 10.1002/0471143030.CB0407S30]; Qiao XTT, 2011, J GASTROENTEROL, V46, P855, DOI 10.1007/s00535-011-0413-y; Quante M, 2010, GASTROENTEROLOGY, V139, P2018, DOI 10.1053/j.gastro.2010.08.003; Raj A, 2008, NAT METHODS, V5, P877, DOI 10.1038/NMETH.1253; Ramsey VG, 2007, DEVELOPMENT, V134, P211, DOI 10.1242/dev.02700; Shao ZH, 2005, NEURON, V45, P353, DOI 10.1016/j.neuron.2004.12.050; Shi GL, 2009, GASTROENTEROLOGY, V136, P1368, DOI 10.1053/j.gastro.2008.12.066; Tashima K, 2009, AM J PHYSIOL-GASTR L, V296, pG319, DOI 10.1152/ajpgi.90355.2008; Tian H, 2011, NATURE, V478, P255, DOI 10.1038/nature10408; Van Der Flier LG, 2007, GASTROENTEROLOGY, V132, P628, DOI 10.1053/j.gastro.2006.08.039; van der Flier LG, 2009, CELL, V136, P903, DOI 10.1016/j.cell.2009.01.031; WILLEMS G, 1972, Z ZELLFORSCH MIK ANA, V134, P505, DOI 10.1007/BF00307670; Wong VWY, 2012, NAT CELL BIOL, V14, P401, DOI 10.1038/ncb2464	43	343	353	1	28	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 10	2013	155	2					357	368		10.1016/j.cell.2013.09.008	http://dx.doi.org/10.1016/j.cell.2013.09.008			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	235LH	24120136	Green Accepted, Bronze			2022-12-24	WOS:000325719800013
J	Niu, DW; Willoughby, PH; Woods, BP; Baire, B; Hoye, TR				Niu, Dawen; Willoughby, Patrick H.; Woods, Brian P.; Baire, Beeraiah; Hoye, Thomas R.			Alkane desaturation by concerted double hydrogen atom transfer to benzyne	NATURE			English	Article							DIELS-ALDER REACTION; CYCLOAROMATIZATION; INTERMEDIATE; GENERATION; ARYNES	The removal of two vicinal hydrogen atoms from an alkane to produce an alkene is a challenge for synthetic chemists(1,2). In nature, desaturases and acetylenases are adept at achieving this essential oxidative functionalization reaction, for example during the biosynthesis of unsaturated fatty acids(3), eicosanoids, gibberellins(4) and carotenoids(5). Alkane-to-alkene conversion almost always involves one or more chemical intermediates in a multistep reaction pathway; these may be either isolable species (such as alcohols or alkyl halides) or reactive intermediates (such as carbocations, alkyl radicals, or sigma-alkyl-metal species). Here we report a desaturation reaction of simple, unactivated alkanes that is mechanistically unique. We show that benzynes are capable of the concerted removal of two vicinal hydrogen atoms from a hydrocarbon. The discovery of this exothermic, net redox process was enabled by the simple thermal generation of reactive benzyne intermediates through the hexadehydro-Diels-Alder cycloisomerization reaction of triyne substrates(6). We are not aware of any single-step, bimolecular reaction in which two hydrogen atoms are simultaneously transferred from a saturated alkane. Computational studies indicate a preferred geometry with eclipsed vicinal C-H bonds in the alkane donor.	[Niu, Dawen; Willoughby, Patrick H.; Woods, Brian P.; Baire, Beeraiah; Hoye, Thomas R.] Univ Minnesota, Dept Chem, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities	Hoye, TR (corresponding author), Univ Minnesota, Dept Chem, 207 Pleasant St SE, Minneapolis, MN 55455 USA.	hoye@umn.edu	Niu, Dawen/M-4910-2013; Baire, Beeraiah/Q-1284-2019	Baire, Beeraiah/0000-0001-8810-1620; Willoughby, Patrick/0000-0001-5163-0502; Niu, Dawen/0000-0002-5114-4413	University of Minnesota Graduate School Doctoral Dissertation Fellowship; National Science Foundation Graduate Research Fellowship program; National Institute of General Medical Sciences [GM65597]; National Cancer Institute of the US Department of Health and Human Services [CA76497]; NATIONAL CANCER INSTITUTE [R01CA076497] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065597] Funding Source: NIH RePORTER	University of Minnesota Graduate School Doctoral Dissertation Fellowship(University of Minnesota System); National Science Foundation Graduate Research Fellowship program(National Science Foundation (NSF)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Cancer Institute of the US Department of Health and Human Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank C. J. Cramer for helpful discussions about the computational studies. D.N. and P. H. W. thank the University of Minnesota Graduate School Doctoral Dissertation Fellowship and National Science Foundation Graduate Research Fellowship program, respectively. Financial support from the National Institute of General Medical Sciences (GM65597) and the National Cancer Institute (CA76497) of the US Department of Health and Human Services is acknowledged. Portions of this work were performed with hardware and software resources available through the University of Minnesota Supercomputing Institute (MSI).	Ajaz A, 2011, J ORG CHEM, V76, P9320, DOI 10.1021/jo201567d; Baire B, 2013, NAT PROTOC, V8, P501, DOI 10.1038/nprot.2013.017; Bhattacharya A, 2012, PLANT PHYSIOL, V160, P837, DOI 10.1104/pp.112.201756; BLOOMFIELD DK, 1960, J BIOL CHEM, V235, P337; Bradley AZ, 1997, J AM CHEM SOC, V119, P9917, DOI 10.1021/ja972141f; Buist PH, 2004, NAT PROD REP, V21, P249, DOI 10.1039/b302094k; COREY EJ, 1961, J AM CHEM SOC, V83, P2957, DOI 10.1021/ja01474a043; Davies HML, 2011, CHEM SOC REV, V40, P1855, DOI 10.1039/c1cs90010b; de Almeida G, 2013, ORG LETT, V15, P3038, DOI 10.1021/ol401225n; Fernandez I, 2007, J ORG CHEM, V72, P1488, DOI 10.1021/jo062310r; Fernandez I, 2009, CHEM REV, V109, P6687, DOI 10.1021/cr900209c; HIMESHIMA Y, 1983, CHEM LETT, P1211, DOI 10.1246/cl.1983.1211; Hoffmann R. W., 2013, ANGEW CHEM INT EDIT, V52, P2; Hoffmann R. W., 1967, ORGANIC CHEM, V11; Hoye TR, 2012, NATURE, V490, P208, DOI 10.1038/nature11518; Hoye TR, 2004, ORG LETT, V6, P953, DOI 10.1021/ol049979+; Hunig S., 1961, TETRAHEDRON LETT, V2, P353; LINSTEAD RP, 1952, NATURE, V169, P100, DOI 10.1038/169100a0; Ma ZX, 2012, ORG LETT, V14, P2742, DOI 10.1021/ol300967a; Miyawaki K, 1997, TETRAHEDRON LETT, V38, P3943, DOI 10.1016/S0040-4039(97)00785-5; Moran NA, 2010, SCIENCE, V328, P624, DOI 10.1126/science.1187113; Pauli GF, 2007, J NAT PROD, V70, P589, DOI 10.1021/np060535r; Sumida Y, 2013, ORG LETT, V15, P2806, DOI 10.1021/ol401140d; Tadross PM, 2012, CHEM REV, V112, P3550, DOI 10.1021/cr200478h; Tsui JA, 2009, ORGANOMETALLICS, V28, P4906, DOI 10.1021/om900578d; Voica AF, 2012, NAT CHEM, V4, P629, DOI [10.1038/nchem.1385, 10.1038/NCHEM.1385]; Yun SY, 2013, J AM CHEM SOC, V135, P4668, DOI 10.1021/ja400477r	27	114	114	4	177	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 26	2013	501	7468					531	534		10.1038/nature12492	http://dx.doi.org/10.1038/nature12492			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	223RP	24067712	Green Accepted			2022-12-24	WOS:000324826300054
J	Oullier, O				Oullier, Olivier			Behavioural insights are vital to policy-making	NATURE			English	Editorial Material									[Oullier, Olivier] Aix Marseille Univ, Marseilles, France	UDICE-French Research Universities; Aix-Marseille Universite	Oullier, O (corresponding author), Aix Marseille Univ, Marseilles, France.	olivier@oullier.fr							0	15	15	0	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 26	2013	501	7468					463	463		10.1038/501463a	http://dx.doi.org/10.1038/501463a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	223RP	24067675	Bronze			2022-12-24	WOS:000324826300021
J	Hu, DJK; Baffet, AD; Nayak, T; Akhmanova, A; Doye, V; Vallee, RB				Hu, Daniel Jun-Kit; Baffet, Alexandre Dominique; Nayak, Tania; Akhmanova, Anna; Doye, Valerie; Vallee, Richard Bert			Dynein Recruitment to Nuclear Pores Activates Apical Nuclear Migration and Mitotic Entry in Brain Progenitor Cells	CELL			English	Article							NEURAL STEM-CELLS; CYTOPLASMIC DYNEIN; ENVELOPE BREAKDOWN; LIS1; NEUROGENESIS; MICROTUBULE; CENTROSOMES; MECHANISMS; COMPLEXES; INTERACTS	Radial glial progenitors (RGPs) are elongated epithelial cells that give rise to neurons, glia, and adult stem cells during brain development. RGP nuclei migrate basally during G1, apically using cytoplasmic dynein during G2, and undergo mitosis at the ventricular surface. By live imaging of in utero electroporated rat brain, we find that two distinct G2-specific mechanisms for dynein nuclear pore recruitment are essential for apical nuclear migration. The "RanBP2-BicD2'' and "Nup133-CENP-F'' pathways act sequentially, with Nup133 or CENP-F RNAi arresting nuclei close to the ventricular surface in a premitotic state. Forced targeting of dynein to the nuclear envelope rescues nuclear migration and cell-cycle progression, demonstrating that apical nuclear migration is not simply correlated with cell-cycle progression from G2 to mitosis, but rather, is a required event. These results reveal that cell-cycle control of apical nuclear migration occurs by motor protein recruitment and identify a role for nucleus- and centrosome-associated forces in mitotic entry.	[Hu, Daniel Jun-Kit; Baffet, Alexandre Dominique; Nayak, Tania; Vallee, Richard Bert] Columbia Univ, Dept Pathol & Cell Biol, New York, NY 10032 USA; [Akhmanova, Anna] Univ Utrecht, Cell Biol Program, NL-3584 Utrecht, Netherlands; [Doye, Valerie] Univ Paris Diderot, Sorbonne Paris Cite, CNRS, UMR 7592,Inst Jacques Monod, F-75205 Paris 13, France	Columbia University; Utrecht University; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite	Vallee, RB (corresponding author), Columbia Univ, Dept Pathol & Cell Biol, New York, NY 10032 USA.	rv2025@columbia.edu	BAFFET, Alexandre/I-7687-2017	Baffet, Alexandre/0000-0001-9194-4258	NIH [HD40182, GM102347]; ARC; NWO [ALW-VIC1]; AHA;  [ANR-12-BSV2-0008-01]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD040182] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM102347] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ARC(Australian Research Council); NWO(Netherlands Organization for Scientific Research (NWO)); AHA(American Heart Association); ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Drs. G. Gundersen, G. Luxton, H. Worman, C. Ostlund, and A. Laufer for advice and reagents; the Rockefeller University BIRC for 3D-SIM imaging; and the Foundation des Treilles for providing a venue for stimulating scientific discussions. This project was supported by NIH HD40182 and GM102347 to R.B.V.; ARC and ANR-12-BSV2-0008-01 to V.D.; NWO ALW-VIC1 to A.A.; and AHA postdoctoral fellowships to T.N. and A.D.B.	Beaudouin J, 2002, CELL, V108, P83, DOI 10.1016/S0092-8674(01)00627-4; Bolhy S, 2011, J CELL BIOL, V192, P855, DOI 10.1083/jcb.201007118; Cadot B, 2012, EMBO REP, V13, P741, DOI 10.1038/embor.2012.89; Del Bene F, 2008, CELL, V134, P1055, DOI 10.1016/j.cell.2008.07.017; Fridolfsson HN, 2010, J CELL BIOL, V191, P115, DOI 10.1083/jcb.201004118; Fridolfsson HN, 2010, DEV BIOL, V338, P237, DOI 10.1016/j.ydbio.2009.12.004; Ge XC, 2010, NEURON, V65, P191, DOI 10.1016/j.neuron.2010.01.011; Gotz M, 2005, NAT REV MOL CELL BIO, V6, P777, DOI 10.1038/nrm1739; Hachet V, 2007, DEV CELL, V12, P531, DOI 10.1016/j.devcel.2007.02.015; Hebbar S, 2008, J CELL BIOL, V182, P1063, DOI 10.1083/jcb.200803071; Jodoin JN, 2012, MOL BIOL CELL, V23, P4713, DOI 10.1091/mbc.E12-07-0558; Kishimoto T., 2013, MED MOL MORPHOL; Kosodo Y, 2012, CELL MOL LIFE SCI, V69, P2727, DOI 10.1007/s00018-012-0952-2; Kosodo Y, 2011, EMBO J, V30, P1690, DOI 10.1038/emboj.2011.81; Kriegstein A, 2009, ANNU REV NEUROSCI, V32, P149, DOI 10.1146/annurev.neuro.051508.135600; Lee HO, 2013, TRENDS CELL BIOL, V23, P141, DOI 10.1016/j.tcb.2012.11.001; Leung L, 2011, DEVELOPMENT, V138, P5003, DOI 10.1242/dev.071522; Lupu F, 2008, DEV CELL, V14, P831, DOI 10.1016/j.devcel.2008.03.011; Luxton GWG, 2010, SCIENCE, V329, P956, DOI 10.1126/science.1189072; McKenney RJ, 2010, CELL, V141, P304, DOI 10.1016/j.cell.2010.02.035; Meyer EJ, 2011, CURR BIOL, V21, P485, DOI 10.1016/j.cub.2011.02.002; Niethammer M, 2000, NEURON, V28, P697, DOI 10.1016/S0896-6273(00)00147-1; Noctor SC, 2001, NATURE, V409, P714, DOI 10.1038/35055553; Norden C, 2009, CELL, V138, P1195, DOI 10.1016/j.cell.2009.06.032; Raaijmakers JA, 2012, EMBO J, V31, P4179, DOI 10.1038/emboj.2012.272; Salina D, 2002, CELL, V108, P97, DOI 10.1016/S0092-8674(01)00628-6; Sasaki S, 2000, NEURON, V28, P681, DOI 10.1016/S0896-6273(00)00146-X; Sauer FC, 1935, J COMP NEUROL, V62, P377, DOI 10.1002/cne.900620207; Schenk J, 2009, P NATL ACAD SCI USA, V106, P16487, DOI 10.1073/pnas.0908928106; Shu TZ, 2004, NEURON, V44, P263, DOI 10.1016/j.neuron.2004.09.030; Spear PC, 2012, DEV GROWTH DIFFER, V54, P306, DOI 10.1111/j.1440-169X.2012.01342.x; Splinter D, 2012, MOL BIOL CELL, V23, P4226, DOI 10.1091/mbc.E12-03-0210; Splinter D, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000350; Starr DA, 2010, ANNU REV CELL DEV BI, V26, P421, DOI 10.1146/annurev-cellbio-100109-104037; Taverna E, 2010, NEURON, V67, P906, DOI 10.1016/j.neuron.2010.08.027; Tsai JW, 2010, NAT NEUROSCI, V13, P1463, DOI 10.1038/nn.2665; Tsai JW, 2005, J CELL BIOL, V170, P935, DOI 10.1083/jcb.200505166; Vergnolle MAS, 2007, CURR BIOL, V17, P1173, DOI 10.1016/j.cub.2007.05.077; Wilson MH, 2012, J CELL SCI, V125, P4158, DOI 10.1242/jcs.108688; Yang YT, 2012, NAT NEUROSCI, V15, P1201, DOI 10.1038/nn.3171; Zhang XC, 2009, NEURON, V64, P173, DOI 10.1016/j.neuron.2009.08.018	41	107	107	0	24	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	SEP 12	2013	154	6					1300	1313		10.1016/j.cell.2013.08.024	http://dx.doi.org/10.1016/j.cell.2013.08.024			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	215VQ	24034252	Bronze, Green Accepted			2022-12-24	WOS:000324239300018
J	Brown, SGA; Macdonald, SPJ; Hankey, GJ				Brown, Simon G. A.; Macdonald, Stephen P. J.; Hankey, Graeme J.			Do risks outweigh benefits in thrombolysis for stroke?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							ACUTE ISCHEMIC-STROKE; TISSUE-PLASMINOGEN ACTIVATOR; INTRACEREBRAL HEMORRHAGE; SAFE IMPLEMENTATION; CANADIAN ALTEPLASE; COST-EFFECTIVENESS; TRIAL; ONSET; REANALYSIS		[Brown, Simon G. A.; Macdonald, Stephen P. J.] Univ Western Australia, Sch Primary Aboriginal & Rural Hlth Care, Perth, WA 6009, Australia; [Brown, Simon G. A.] Royal Perth Hosp, Emergency Dept, Perth, WA 6847, Australia; [Macdonald, Stephen P. J.] Armadale Hlth Serv, Emergency Dept, Armadale, WA 6992, Australia; [Hankey, Graeme J.] Univ Western Australia, Sch Med & Pharmacol, Perth, WA 6009, Australia; [Hankey, Graeme J.] Sir Charles Gairdner Hosp, Dept Neurol, Nedlands, WA 6009, Australia	University of Western Australia; Royal Perth Hospital; University of Western Australia; University of Western Australia; University of Western Australia	Brown, SGA (corresponding author), Univ Western Australia, Sch Primary Aboriginal & Rural Hlth Care, Perth, WA 6009, Australia.	simon.brown@uwa.edu.au; graeme.hankey@uwa.edu.au	Macdonald, Stephen PJ/H-5339-2014; Hankey, Graeme J/H-4968-2014	Hankey, Graeme J/0000-0002-6044-7328; Macdonald, Stephen/0000-0001-9921-4620				Ahmed N, 2013, JAMA NEUROL, V70, P837, DOI 10.1001/jamaneurol.2013.406; Ahmed N, 2010, LANCET NEUROL, V9, P866, DOI 10.1016/S1474-4422(10)70165-4; Boudreau DM, 2013, ANN EMERG MED, V61, P46, DOI 10.1016/j.annemergmed.2012.04.020; Clark WM, 1999, JAMA-J AM MED ASSOC, V282, P2019, DOI 10.1001/jama.282.21.2019; Clark WM, 2000, STROKE, V31, P811, DOI 10.1161/01.STR.31.4.811; Collins R, 2001, LANCET, V357, P373, DOI 10.1016/S0140-6736(00)03651-5; Emberson J, 2013, INT J STROKE, V8, P278, DOI 10.1111/ijs.12040; Fatovich DM, 2012, EMERG MED AUSTRALAS, V24, P477, DOI 10.1111/j.1742-6723.2012.01605.x; Ferguson C, 2010, EMERG MED J, V27, P245, DOI 10.1136/emj.2009.089656c; Hacke W, 2008, NEW ENGL J MED, V359, P1317, DOI 10.1056/NEJMoa0804656; Hill MD, 2005, CAN MED ASSOC J, V172, P1307, DOI 10.1503/cmaj.1041561; Hoffman JR, 2012, EMERG MED AUSTRALAS, V24, P473, DOI 10.1111/j.1742-6723.2012.01604.x; Hoffman JR, 2009, ANN EMERG MED, V54, P329, DOI 10.1016/j.annemergmed.2009.03.019; Ingall TJ, 2004, STROKE, V35, P2418, DOI 10.1161/01.STR.0000140891.70547.56; Lyden PD, 2012, STROKE, V43, P1691, DOI 10.1161/STROKEAHA.112.656876; MARLER JR, 1995, NEW ENGL J MED, V333, P1581, DOI 10.1056/nejm199512143332401; Mazya MV, 2013, STROKE, V44, P1595, DOI 10.1161/STROKEAHA.113.000794; Pocock SJ, 2002, STAT MED, V21, P2917, DOI 10.1002/sim.1296; Quinn TJ, 2009, STROKE, V40, P762, DOI [10.1161/STROKEAHA.109.557256, 10.1161/STROKEAHA.108.522516]; Radecki RP, 2013, ANN EMERG MED, V61, P489, DOI 10.1016/j.annemergmed.2012.12.008; Radecki RP, 2012, NAT REV NEUROL, V8, P176, DOI 10.1038/nrneurol.2011.89-c1; Rocco A, 2013, STROKE, V44, P2134, DOI 10.1161/STROKEAHA.111.675918; Sandercock P, 2013, LANCET NEUROL, V12, P768, DOI 10.1016/S1474-4422(13)70130-3; Sandercock P, 2012, LANCET, V379, P2352, DOI 10.1016/S0140-6736(12)60768-5; Saposnik G, 2013, NEUROLOGY, V80, P21, DOI 10.1212/WNL.0b013e31827b1ace; Saposnik G, 2012, STROKE, V43, P1315, DOI 10.1161/STROKEAHA.111.646265; Saver JL, 2013, JAMA-J AM MED ASSOC, V309, P2480, DOI 10.1001/jama.2013.6959; Saver JL, 2010, STROKE, V41, P2381, DOI 10.1161/STROKEAHA.110.583807; Shobha N, 2011, CEREBROVASC DIS, V31, P223, DOI 10.1159/000321893; Shy BD, 2012, J EMERG MED; Strbian D, 2012, NEUROLOGY, V78, P427, DOI 10.1212/WNL.0b013e318245d2a9; Sung SF, 2013, STROKE, V44, P1561, DOI 10.1161/STROKEAHA.111.000651; Tanny SPT, 2013, STROKE, V44, P2269, DOI 10.1161/STROKEAHA.113.001295; Wahlgren N, 2007, LANCET, V369, P275, DOI 10.1016/S0140-6736(07)60149-4; Wardlaw JM, 2012, LANCET, V379, P2364, DOI 10.1016/S0140-6736(12)60738-7; Whiteley WN, 2012, STROKE, V43, P2904, DOI 10.1161/STROKEAHA.112.665331	36	12	12	0	10	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 29	2013	347								f5215	10.1136/bmj.f5215	http://dx.doi.org/10.1136/bmj.f5215			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	211CI	23990634				2022-12-24	WOS:000323881300009
J	Pagoto, SL; Appelhans, BM				Pagoto, Sherry L.; Appelhans, Bradley M.			A Call for an End to the Diet Debates	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							LOW-FAT DIETS; DIABETES PREVENTION; LIFE-STYLE; FOLLOW-UP; METAANALYSIS; RISK		[Pagoto, Sherry L.] Univ Massachusetts, Sch Med, Worcester, MA 01655 USA; [Appelhans, Bradley M.] Rush Univ, Med Ctr, Chicago, IL 60612 USA	University of Massachusetts System; University of Massachusetts Worcester; Rush University	Pagoto, SL (corresponding author), Univ Massachusetts, Sch Med, Dept Med, Div Prevent & Behav Med, 55 Lake Ave N, Worcester, MA 01655 USA.	sherry.pagoto@umassmed.edu	Pagoto, Sherry L/L-2014-2013	Pagoto, Sherry L/0000-0002-2462-8797				Ajala O, 2013, AM J CLIN NUTR, V97, P505, DOI 10.3945/ajcn.112.042457; Bacon L, 2011, NUTR J, V10, DOI 10.1186/1475-2891-10-9; Bray GA, 2009, LANCET, V374, P1677, DOI 10.1016/S0140-6736(09)61457-4; Bueno NB, 2013, BRIT J NUTR, V110, P1178, DOI 10.1017/S0007114513000548; Hu T, 2012, AM J EPIDEMIOL, V176, pS44, DOI 10.1093/aje/kws264; Kraschnewski JL, 2013, MED CARE, V51, P186, DOI 10.1097/MLR.0b013e3182726c33; Li GW, 2008, LANCET, V371, P1783, DOI 10.1016/S0140-6736(08)60766-7; Lindstrom J, 2013, DIABETOLOGIA, V56, P284, DOI 10.1007/s00125-012-2752-5; Wycherley TP, 2012, AM J CLIN NUTR, V96, P1281, DOI 10.3945/ajcn.112.044321	9	73	74	0	21	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 21	2013	310	7					687	688		10.1001/jama.2013.8601	http://dx.doi.org/10.1001/jama.2013.8601			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	202XP	23989081				2022-12-24	WOS:000323254500013
J	Ferrero, DM; Moeller, LM; Osakada, T; Horio, N; Li, Q; Roy, DS; Cichy, A; Spehr, M; Touhara, K; Liberles, SD				Ferrero, David M.; Moeller, Lisa M.; Osakada, Takuya; Horio, Nao; Li, Qian; Roy, Dheeraj S.; Cichy, Annika; Spehr, Marc; Touhara, Kazushige; Liberles, Stephen D.			A juvenile mouse pheromone inhibits sexual behaviour through the vomeronasal system	NATURE			English	Article							CHEMOSENSORY RECEPTORS; OLFACTORY EPITHELIUM; AGGRESSIVE-BEHAVIOR; PROTEIN PHEROMONES; MUTANT MICE; NEURONS; ORGAN; PEPTIDES; HYPOTHALAMUS; EXPRESSION	Animals display a repertoire of different social behaviours. Appropriate behavioural responses depend on sensory input received during social interactions. In mice, social behaviour is driven by pheromones, chemical signals that encode information related to age, sex and physiological state(1). However, although mice show different social behaviours towards adults, juveniles and neonates, sensory cues that enable specific recognition of juvenile mice are unknown. Here we describe a juvenile pheromone produced by young mice before puberty, termed exocrine-gland secreting peptide 22 (ESP22). ESP22 is secreted from the lacrimal gland and released into tears of 2- to 3-week-old mice. Upon detection, ESP22 activates high-affinity sensory neurons in the vomeronasal organ, and down-stream limbic neurons in the medial amygdala. Recombinant ESP22, painted on mice, exerts a powerful inhibitory effect on adult male mating behaviour, which is abolished in knockout mice lacking TRPC2, a key signalling component of the vomeronasal organ(2,3). Furthermore, knockout of TRPC2 or loss of ESP22 production results in increased sexual behaviour of adult males towards juveniles, and sexual responses towards ESP22-deficient juveniles are suppressed by ESP22 painting. Thus, we describe a pheromone of sexually immature mice that controls an innate social behaviour, a response pathway through the accessory olfactory system and a new role for vomeronasal organ signalling in inhibiting sexual behaviour towards young. These findings provide a molecular framework for understanding how a sensory system can regulate behaviour.	[Ferrero, David M.; Li, Qian; Roy, Dheeraj S.; Liberles, Stephen D.] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; [Moeller, Lisa M.; Cichy, Annika; Spehr, Marc] Rhein Westfal TH Aachen, Dept Chemosensat, Inst Biol 2, Aachen, Germany; [Osakada, Takuya; Horio, Nao; Touhara, Kazushige] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Appl Biol Chem, Tokyo 1138657, Japan; [Touhara, Kazushige] Univ Tokyo, Japan Sci & Technol Agcy, ERATO Touhara Chemosensory Signal Project, Tokyo 1138657, Japan	Harvard University; Harvard Medical School; RWTH Aachen University; University of Tokyo; Japan Science & Technology Agency (JST); University of Tokyo	Liberles, SD (corresponding author), Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA.	Stephen_Liberles@hms.harvard.edu	Li, Qian/AAE-8688-2022; Spehr, Marc/AAK-3162-2021; Osakada, Takuya/GLV-1245-2022; Spehr, Marc/B-3140-2011; Li, Qian/P-4417-2015	Li, Qian/0000-0003-1300-3377; Spehr, Marc/0000-0001-6616-4196; Spehr, Marc/0000-0001-6616-4196; Li, Qian/0000-0003-1300-3377; Osakada, Takuya/0000-0003-3752-6594; Cichy, Annika/0000-0002-4620-7854; Liberles, Stephen/0000-0002-2177-9741	National Institutes of Health [R01 DC010155]; Japan Society for the Promotion of Science; ERATO Touhara Chemosensory Signal Project from the Japan Science and Technology Agency; Boehringer Ingelheim Fonds PhD Fellowship; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD018655] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC010155] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); ERATO Touhara Chemosensory Signal Project from the Japan Science and Technology Agency; Boehringer Ingelheim Fonds PhD Fellowship(Boehringer Ingelheim); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We thank M. Albers and S. R. Datta for reading the manuscript, J. Yang, C. Mark Fletcher and Y. Tachie-Baffour for experimental assistance, and the Taplin Mass Spectrometry Facility for mass spectrometry analysis. This work was supported by a grant from the National Institutes of Health (to S.D.L., award number R01 DC010155) and in part by a Grant-in-Aid for Young Scientists (S) from the Japan Society for the Promotion of Science, and by ERATO Touhara Chemosensory Signal Project from the Japan Science and Technology Agency (to K.T.). N.H. is supported by a Grant-in-Aid for JSPS Fellows, M.S. is a Lichtenberg-Professor of the Volkswagen Foundation and D.M.F. is supported by a Boehringer Ingelheim Fonds PhD Fellowship.	Chamero P, 2007, NATURE, V450, P899, DOI 10.1038/nature05997; Chamero P, 2011, P NATL ACAD SCI USA, V108, P12898, DOI 10.1073/pnas.1107770108; Choi GB, 2005, NEURON, V46, P647, DOI 10.1016/j.neuron.2005.04.011; Dulac C, 2006, ANNU REV GENET, V40, P449, DOI 10.1146/annurev.genet.39.073003.093937; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Ferrero DM, 2010, WIRES SYST BIOL MED, V2, P23, DOI 10.1002/wsbm.39; Franklin K.B.J., 2008, MOUSE BRAIN STEREOTA; Haga S, 2010, NATURE, V466, P118, DOI 10.1038/nature09142; Hagendorf S, 2009, J NEUROSCI, V29, P206, DOI 10.1523/JNEUROSCI.3656-08.2009; He J, 2010, J NEUROSCI, V30, P7473, DOI 10.1523/JNEUROSCI.0825-10.2010; Karn RC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047697; Kimoto H, 2005, NATURE, V437, P898, DOI 10.1038/nature04033; Kimoto H, 2007, CURR BIOL, V17, P1879, DOI 10.1016/j.cub.2007.09.042; Leypold BG, 2002, P NATL ACAD SCI USA, V99, P6376, DOI 10.1073/pnas.082127599; Li Q, 2013, CURR BIOL, V23, P11, DOI 10.1016/j.cub.2012.10.047; Liberles SD, 2006, NATURE, V442, P645, DOI 10.1038/nature05066; Liberles SD, 2009, P NATL ACAD SCI USA, V106, P9842, DOI 10.1073/pnas.0904464106; Logan DW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003280; Mandiyan VS, 2005, NAT NEUROSCI, V8, P1660, DOI 10.1038/nn1589; Montmayeur JP, 2001, NAT NEUROSCI, V4, P492, DOI 10.1038/87440; Nodari F, 2008, J NEUROSCI, V28, P6407, DOI 10.1523/JNEUROSCI.1425-08.2008; NOVOTNY M, 1985, P NATL ACAD SCI USA, V82, P2059, DOI 10.1073/pnas.82.7.2059; Novotny MV, 2003, BIOCHEM SOC T, V31, P117, DOI 10.1042/BST0310117; Papes F, 2010, CELL, V141, P692, DOI 10.1016/j.cell.2010.03.037; Peng JM, 2001, J MASS SPECTROM, V36, P1083, DOI 10.1002/jms.229; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Spehr J, 2009, J NEUROSCI, V29, P2125, DOI 10.1523/JNEUROSCI.5416-08.2009; Stowers L, 2002, SCIENCE, V295, P1493, DOI 10.1126/science.1069259; Tirindelli R, 2009, PHYSIOL REV, V89, P921, DOI 10.1152/physrev.00037.2008; Touhara K, 2008, CURR OPIN PHARMACOL, V8, P759, DOI 10.1016/j.coph.2008.09.001; Wang ZS, 2006, J NEUROSCI, V26, P7375, DOI 10.1523/JNEUROSCI.1967-06.2006; Yang CF, 2013, CELL, V153, P896, DOI 10.1016/j.cell.2013.04.017	32	109	117	0	96	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 17	2013	502	7471					368	+		10.1038/nature12579	http://dx.doi.org/10.1038/nature12579			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	235GY	24089208	Green Accepted, Green Submitted			2022-12-24	WOS:000325706300052
J	Frank, DA; de Cuba, SE; Sandel, M; Black, MM				Frank, Deborah A.; de Cuba, Stephanie Ettinger; Sandel, Megan; Black, Maureen M.			SNAP cuts will harm children in the USA	LANCET			English	Editorial Material							STAMP-PROGRAM PARTICIPATION; HEALTH OUTCOMES; FOOD		[Frank, Deborah A.] Boston Med Ctr, Dept Pediat, Div Growth & Dev, Boston, MA 02118 USA; [de Cuba, Stephanie Ettinger] Boston Univ, Sch Publ Hlth, Data Coordinating Ctr, Boston, MA USA; [Black, Maureen M.] Univ Maryland, Sch Med, Dept Pediat, Growth & Nutr Div, Baltimore, MD 21201 USA	Boston Medical Center; Boston University; University System of Maryland; University of Maryland Baltimore	Frank, DA (corresponding author), Boston Med Ctr, Dept Pediat, Div Growth & Dev, Boston, MA 02118 USA.	dafrank@bu.edu		Ettinger de Cuba, Stephanie/0000-0003-1789-1009; Black, Maureen/0000-0002-6427-4639				Almond D, 2011, REV ECON STAT, V93, P387, DOI 10.1162/REST_a_00089; Cook JT, 2013, ADV NUTR, V4, P51, DOI 10.3945/an.112.003228; Frongillo EA, 2006, J NUTR, V136, P1077, DOI 10.1093/jn/136.4.1077; Institute of Medicine and National Resource Council, 2013, SUPPL NUTR ASS PROGR; Jones SJ, 2003, ARCH PEDIAT ADOL MED, V157, P780, DOI 10.1001/archpedi.157.8.780; Keith-Jennings B., 2012, SNAP PLAYS CRITICAL; Kreider B, 2012, J AM STAT ASSOC, V107, P958, DOI 10.1080/01621459.2012.682828; Lee BJ, 2007, CHILD YOUTH SERV REV, V29, P501, DOI 10.1016/j.childyouth.2006.10.005; Leung CW, 2013, PEDIATRICS, V131, P463, DOI 10.1542/peds.2012-0889; Nord M, 2011, ERR116; Schanzenbach DW, 2012, 1766718535 NBER; Strayer M, 2012, CHARACTERISTICS SUPP	12	3	3	0	19	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	OCT 5	2013	382	9899					1155	1156		10.1016/S0140-6736(13)61805-X	http://dx.doi.org/10.1016/S0140-6736(13)61805-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	228SL	24095184				2022-12-24	WOS:000325209100005
J	Bretschneider, T; Heim, JB; Heine, D; Winkler, R; Busch, B; Kusebauch, B; Stehle, T; Zocher, G; Hertweck, C				Bretschneider, Tom; Heim, Joel B.; Heine, Daniel; Winkler, Robert; Busch, Benjamin; Kusebauch, Bjoern; Stehle, Thilo; Zocher, Georg; Hertweck, Christian			Vinylogous chain branching catalysed by a dedicated polyketide synthase module	NATURE			English	Article							COMBINATORIAL BIOSYNTHESIS; BACTERIAL ENDOSYMBIONT; CRYSTAL-STRUCTURE; ENZYMOLOGY; EVOLUTION; LOGIC	Bacteria use modular polyketide synthases (PKSs) to assemble complex polyketides, many of which are leads for the development of clinical drugs, in particular anti-infectives and anti-tumoral agents(1). Because these multifarious compounds are notoriously difficult to synthesize, they are usually produced by microbial fermentation. During the past two decades, an impressive body of knowledge on modular PKSs(2,3) has been gathered that not only provides detailed insight into the biosynthetic pathways but also allows the rational engineering of enzymatic processing lines to yield structural analogues(4,5). Notably, a hallmark of all PKS modules studied so far is the head-to-tail fusion of acyl and malonyl building blocks, which leads to linear backbones. Yet, structural diversity is limited by this uniform assembly mode. Here we demonstrate a new type of PKS module from the endofungal bacterium Burkholderia rhizoxinica that catalyses a Michael-type acetyl addition to generate a branch in the carbon chain. In vitro reconstitution of the entire PKS module, X-ray structures of a ketosynthase-branching didomain and mutagenesis experiments revealed a crucial role of the ketosynthase domain in branching the carbon chain. We present a trapped intermediary state in which acyl carrier protein and ketosynthase are covalently linked by the branched polyketide and suggest a new mechanism for chain alkylation, which is functionally distinct from terpenoid-like beta-branching. For the rice seedling blight toxin rhizoxin, one of the strongest known anti-mitotic agents, the non-canonical polyketide modification is indispensable for phytotoxic and anti-tumoral activities. We propose that the formation of related pharmacophoric groups follows the same general scheme and infer a unifying vinylogous branching reaction for PKS modules with a ketosynthase-branching-acyl-carrier-protein architecture. This study unveils the structure and function of a new PKS module that broadens the biosynthetic scope of polyketide biosynthesis and sets the stage for rationally creating structural diversity.	[Bretschneider, Tom; Heine, Daniel; Winkler, Robert; Busch, Benjamin; Kusebauch, Bjoern; Hertweck, Christian] Leibniz Inst Nat Prod Res & Infect Biol HKI, Dept Biomol Chem, D-07745 Jena, Germany; [Heim, Joel B.; Stehle, Thilo; Zocher, Georg] Univ Tubingen, Interfac Inst Biochem, D-72076 Tubingen, Germany; [Stehle, Thilo] Vanderbilt Univ, Sch Med, Dept Pediat, Nashville, TN 37232 USA; [Hertweck, Christian] Univ Jena, Chair Nat Prod Chem, D-07737 Jena, Germany	Hans Knoll Institute (HKI); Eberhard Karls University of Tubingen; Vanderbilt University; Friedrich Schiller University of Jena	Hertweck, C (corresponding author), Leibniz Inst Nat Prod Res & Infect Biol HKI, Dept Biomol Chem, D-07745 Jena, Germany.	georg.zocher@uni-tuebingen.de; christian.hertweck@hki-jena.de	Hertweck, Christian/AAZ-8452-2021; Heim, Joel Benjamin/K-3615-2016; Hertweck, Christian/G-1896-2014; Winkler, Robert/A-1500-2009	Hertweck, Christian/0000-0002-0367-337X; Heim, Joel Benjamin/0000-0001-9702-9480; Hertweck, Christian/0000-0002-0367-337X; Winkler, Robert/0000-0001-6732-1958; Kusebauch, Bjorn/0000-0003-0223-7987	DFG [SFB 766]; Studienstiftung des Deutschen Volkes	DFG(German Research Foundation (DFG)); Studienstiftung des Deutschen Volkes	We thank A. Perner for mass specrometry analyses, H. Heineke for NMR measurements, S. Schneider for preliminary studies on the PPTase, and U. Knupfer for help in protein production. We thank the DFG for financial support (SFB 766) and the Swiss Light Source beamline X06DA for offering beamtime. D. H. is financially supported by a stipend of the Studienstiftung des Deutschen Volkes.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Bretschneider T, 2012, NAT CHEM BIOL, V8, P154, DOI 10.1038/nchembio.746; Calderone CT, 2008, NAT PROD REP, V25, P845, DOI 10.1039/b807243d; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Crawford JM, 2009, NATURE, V461, P1139, DOI 10.1038/nature08475; Dorrestein PC, 2006, BIOCHEMISTRY-US, V45, P12756, DOI 10.1021/bi061169d; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fischbach MA, 2006, CHEM REV, V106, P3468, DOI 10.1021/cr0503097; Fuchs SW, 2013, ANGEW CHEM INT EDIT, V52, P4108, DOI 10.1002/anie.201210116; Hertweck C, 2009, ANGEW CHEM INT EDIT, V48, P4688, DOI 10.1002/anie.200806121; Hong J, 2004, TETRAHEDRON, V60, P5653, DOI 10.1016/j.tet.2004.04.032; Horn U, 1996, APPL MICROBIOL BIOT, V46, P524, DOI 10.1007/s002530050855; Jez JM, 2000, BIOCHEMISTRY-US, V39, P890, DOI 10.1021/bi991489f; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Keatinge-Clay AT, 2012, NAT PROD REP, V29, P1050, DOI 10.1039/c2np20019h; Khosla C, 2009, J ORG CHEM, V74, P6416, DOI 10.1021/jo9012089; Khosla C, 2009, CURR OPIN CHEM BIOL, V13, P135, DOI 10.1016/j.cbpa.2008.12.018; Kusebauch B, 2011, CHEMMEDCHEM, V6, P1998, DOI 10.1002/cmdc.201100319; Kusebauch B, 2009, ANGEW CHEM INT EDIT, V48, P5001, DOI 10.1002/anie.200900277; Lackner G, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-210; Lackner G, 2011, J BACTERIOL, V193, P783, DOI 10.1128/JB.01318-10; Lim SK, 2009, J BIOL CHEM, V284, P29746, DOI 10.1074/jbc.M109.046805; Maier T, 2008, SCIENCE, V321, P1315, DOI 10.1126/science.1161269; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Partida-Martinez LP, 2007, CHEMBIOCHEM, V8, P41, DOI 10.1002/cbic.200600393; Partida-Martinez LP, 2005, NATURE, V437, P884, DOI 10.1038/nature03997; Piel J, 2010, NAT PROD REP, V27, P996, DOI 10.1039/b816430b; Rajski SR, 2010, CHEMBIOCHEM, V11, P1951, DOI 10.1002/cbic.201000370; Scherlach K, 2006, J AM CHEM SOC, V128, P11529, DOI 10.1021/ja062953o; Scherlach K, 2012, ANGEW CHEM INT EDIT, V51, P9615, DOI 10.1002/anie.201204540; Schmitt I, 2008, ISME J, V2, P632, DOI 10.1038/ismej.2008.19; Schrodinger L. L. C., 2010, PYMOL MOL GRAPH SYST; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; Tang YY, 2006, P NATL ACAD SCI USA, V103, P11124, DOI 10.1073/pnas.0601924103; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; Tsai SC, 2009, METHOD ENZYMOL, V459, P17, DOI 10.1016/S0076-6879(09)04602-3; Wang B, 2013, ORG LETT, V15, P1278, DOI 10.1021/ol400224n; Weissman KJ, 2005, NAT REV MICROBIOL, V3, P925, DOI 10.1038/nrmicro1287; Wilson MC, 2012, NAT PROD REP, V29, P72, DOI 10.1039/c1np00082a; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736; Wong FT, 2012, CURR OPIN CHEM BIOL, V16, P117, DOI 10.1016/j.cbpa.2012.01.018	43	83	84	6	122	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 3	2013	502	7469					124	+		10.1038/nature12588	http://dx.doi.org/10.1038/nature12588			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	227IM	24048471				2022-12-24	WOS:000325106000044
J	Bourzac, K				Bourzac, Katherine			WATER The flow of technology	NATURE			English	Editorial Material							GROUNDWATER DEPLETION											Burney J, 2010, P NATL ACAD SCI USA, V107, P1848, DOI 10.1073/pnas.0909678107; Famiglietti JS, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2010GL046442; O'Shaughnessy SA, 2012, T ASABE, V55, P451; O'Shaughnessy SA, 2010, AGR WATER MANAGE, V97, P1310, DOI 10.1016/j.agwat.2010.03.012; Rodell M, 2009, NATURE, V460, P999, DOI 10.1038/nature08238; Segal E, 2006, PLANT SOIL, V282, P333, DOI 10.1007/s11104-006-0003-6; Voss KA, 2013, WATER RESOUR RES, V49, P904, DOI 10.1002/wrcr.20078	7	17	17	0	38	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 26	2013	501	7468					S4	S6		10.1038/501S4a	http://dx.doi.org/10.1038/501S4a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	223RP	24067763	Bronze			2022-12-24	WOS:000324826300003
J	East, R				East, Roger			MICROBIOME Soil science comes to life	NATURE			English	Editorial Material																		Barrow Jerry R, 2008, Commun Integr Biol, V1, P69; Marasco R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048479; Redman RS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014823; Zolla G, 2013, APPL SOIL ECOL, V68, P1, DOI 10.1016/j.apsoil.2013.03.007	4	42	47	3	141	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 26	2013	501	7468					S18	S19		10.1038/501S18a	http://dx.doi.org/10.1038/501S18a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	223RP	24067761				2022-12-24	WOS:000324826300015
J	Juang, BT; Gu, C; Starnes, L; Palladino, F; Goga, A; Kennedy, S; L'Etoile, ND				Juang, Bi-Tzen; Gu, Chen; Starnes, Linda; Palladino, Francesca; Goga, Andrei; Kennedy, Scott; L'Etoile, Noelle D.			Endogenous Nuclear RNAi Mediates Behavioral Adaptation to Odor	CELL			English	Article							C-ELEGANS; CAENORHABDITIS-ELEGANS; EPIGENETIC MEMORY; POLYMERASE-II; GERM-LINE; IN-VITRO; INTERFERENCE; GENES; HETEROCHROMATIN; PLASTICITY	Most eukaryotic cells express small regulatory RNAs. The purpose of one class, the somatic endogenous siRNAs (endo-siRNAs), remains unclear. Here, we show that the endo-siRNA pathway promotes odor adaptation in C. elegans AWC olfactory neurons. In adaptation, the nuclear Argonaute NRDE-3, which acts in AWC, is loaded with siRNAs targeting odr-1, a gene whose downregulation is required for adaptation. Concomitant with increased odr-1 siRNA in AWC, we observe increased binding of the HP1 homolog HPL-2 at the odr-1 locus in AWC and reduced odr-1 mRNA in adapted animals. Phosphorylation of HPL-2, an in vitro substrate of the EGL-4 kinase that promotes adaption, is necessary and sufficient for behavioral adaptation. Thus, environmental stimulation amplifies an endo-siRNA negative feedback loop to dynamically repress cognate gene expression and shape behavior. This class of siRNA may act broadly as a rheostat allowing prolonged stimulation to dampen gene expression and promote cellular memory formation.	[Juang, Bi-Tzen; Gu, Chen; Starnes, Linda; Goga, Andrei; L'Etoile, Noelle D.] Univ Calif San Francisco, Dept Cell & Tissue Biol, San Francisco, CA 94143 USA; [Juang, Bi-Tzen; Gu, Chen; Starnes, Linda; Goga, Andrei; L'Etoile, Noelle D.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Gu, Chen] Amunix Inc, Mountain View, CA 94043 USA; [Starnes, Linda] Univ Copenhagen, Fac Hlth Sci, NNF Ctr Prot Res, Chromatin Struct & Funct Grp, DK-2200 Copenhagen N, Denmark; [Palladino, Francesca] Univ Lyon 1, Ecole Normale Super Lyon, CNRS, Mol Cell Biol Lab,UMR5239, F-69007 Lyon, France; [Kennedy, Scott] Univ Wisconsin, Genet Lab, Madison, WI 53706 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of Copenhagen; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; Ecole Normale Superieure de Lyon (ENS de LYON); Universite Jean Monnet; University of Wisconsin System; University of Wisconsin Madison	L'Etoile, ND (corresponding author), Univ Calif San Francisco, Dept Cell & Tissue Biol, 513 Parnassus Ave, San Francisco, CA 94143 USA.	noelle.letoile@ucsf.edu		Kennedy, Scott/0000-0002-7974-8155; Starnes, Linda/0000-0002-7322-9928	NSF [0954258]; NIH [R01DC005991]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM088289, R01GM104232] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC005991] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We thank Maria Gallegos, Mehrdad Matloubian, Bassem Al-Sady, Jonathan Isaiah Gent, Georgia Woods, and Robert Blelloch; members of the L'Etoile lab: Damien O'Halloran, Scott Hamilton, Sarah Gerhart, Mary Bethke, and Chantal Brueggemann; and members of the Kennedy lab: Bethany Buckley and Kirk Burkhart, for critical reading and helpful discussions. We thank ShiYu Chen for purified MUT-7 and HPL-2. We thank Ahmed Elewa and Craig Mello for good discussions, worm strains, and odr-1 22G RNA sequences; Ebenezer Yamoah for use of his qPCR system; and Kohta Ikegami and Susan Strome for ChIP protocols and advice. We also thank Nadia Gronachon, Kim Collins, Christopher Morales, Anu Gupta, and Aarati Asundi for help with worm culture; Bethany Buckley, the Caenorhabditis Genetics Center and the National Bioresource Project for numerous strains, and Yuji Kohara for yk cDNA clones. We thank Leah Frater (Anderson lab), Derek Pavelec (Kennedy lab), Jay Maniar, and Jonathan Gent (Fire lab) for producing and sharing unpublished sequencing reads. N. D. L. acknowledges support from NSF 0954258 and NIH R01DC005991. B.-T. J. conceived of and carried out experiments and cowrote the manuscript. L. S. developed, optimized, and performed kinase assays. CG performed RNA and DNA analysis. L. S. and C. G. contributed equally to the manuscript. A. G., F. P., and S. K. provided unpublished protocols, reagents, support and insight. N. L. analyzed data and wrote the manuscript.	Aoki K, 2007, EMBO J, V26, P5007, DOI 10.1038/sj.emboj.7601910; Ashe A, 2012, CELL, V150, P88, DOI 10.1016/j.cell.2012.06.018; Aygun O, 2010, COLD SH Q B, V75, P259, DOI 10.1101/sqb.2010.75.055; Babiarz JE, 2011, RNA, V17, P1489, DOI 10.1261/rna.2442211; BARGMANN CI, 1993, CELL, V74, P515, DOI 10.1016/0092-8674(93)80053-H; Black JC, 2011, EPIGENETICS-US, V6, P13, DOI 10.4161/epi.6.1.13331; Buckley BA, 2012, NATURE, V489, P447, DOI 10.1038/nature11352; Burkhart KB, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002249; Burton NO, 2011, P NATL ACAD SCI USA, V108, P19683, DOI 10.1073/pnas.1113310108; Claycomb JM, 2009, CELL, V139, P123, DOI 10.1016/j.cell.2009.09.014; Colbert HA, 1997, LEARN MEMORY, V4, P179, DOI 10.1101/lm.4.2.179; COLBERT HA, 1995, NEURON, V14, P803, DOI 10.1016/0896-6273(95)90224-4; Colon-Ramos DA, 2007, SCIENCE, V318, P103, DOI 10.1126/science.1143762; Coustham V, 2006, DEV BIOL, V297, P308, DOI 10.1016/j.ydbio.2006.04.474; Cowieson NP, 2000, CURR BIOL, V10, P517, DOI 10.1016/S0960-9822(00)00467-X; Dash PK, 2007, LEARN MEMORY, V14, P554, DOI 10.1101/lm.558707; Denli AM, 2004, NATURE, V432, P231, DOI 10.1038/nature03049; Dernburg AF, 2000, GENE DEV, V14, P1578; Duchaine TF, 2006, CELL, V124, P343, DOI [10.1016/j.cell.2005.11.036, 10.1016/j.cel.2005.11.036]; Etchberger JF, 2007, GENE DEV, V21, P1653, DOI 10.1101/gad.1560107; Filipovska J, 2000, RNA, V6, P41, DOI 10.1017/S1355838200991167; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Gao J, 2010, NATURE, V466, P1105, DOI 10.1038/nature09271; Gent JI, 2010, MOL CELL, V37, P679, DOI 10.1016/j.molcel.2010.01.012; Gerstein MB, 2010, SCIENCE, V330, P1775, DOI 10.1126/science.1196914; Gerstner JR, 2009, J NEUROSCI, V29, P12824, DOI 10.1523/JNEUROSCI.3353-09.2009; Ghildiyal M, 2009, NAT REV GENET, V10, P94, DOI 10.1038/nrg2504; Greco-Stewart VS, 2009, VIROLOGY, V386, P12, DOI 10.1016/j.virol.2009.02.007; Grishok A, 2001, CELL, V106, P23, DOI 10.1016/S0092-8674(01)00431-7; Grishok A, 2005, GENE DEV, V19, P683, DOI 10.1101/gad.1247705; Gu SG, 2012, NAT GENET, V44, P157, DOI 10.1038/ng.1039; Gu WF, 2009, MOL CELL, V36, P231, DOI 10.1016/j.molcel.2009.09.020; Guang S, 2008, SCIENCE, V321, P537, DOI 10.1126/science.1157647; Guang SH, 2010, NATURE, V465, P1097, DOI 10.1038/nature09095; Hao Y, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002065; Hayashi A, 2012, P NATL ACAD SCI USA, V109, P6159, DOI 10.1073/pnas.1116972109; HEDGECOCK EM, 1990, NEURON, V4, P61, DOI 10.1016/0896-6273(90)90444-K; Kaye JA, 2009, NEURON, V61, P57, DOI 10.1016/j.neuron.2008.11.012; Kennedy S, 2004, NATURE, V427, P645, DOI 10.1038/nature02302; Ketting RF, 2011, DEV CELL, V20, P148, DOI 10.1016/j.devcel.2011.01.012; Ketting RF, 1999, CELL, V99, P133, DOI 10.1016/S0092-8674(00)81645-1; Knight SW, 2001, SCIENCE, V293, P2269, DOI 10.1126/science.1062039; L'Etoile ND, 2000, NEURON, V25, P575, DOI 10.1016/S0896-6273(00)81061-2; Le Thomas A, 2013, GENE DEV, V27, P390, DOI 10.1101/gad.209841.112; Lee HC, 2012, CELL, V150, P78, DOI 10.1016/j.cell.2012.06.016; Lee JI, 2010, P NATL ACAD SCI USA, V107, P6016, DOI 10.1073/pnas.1000866107; Lee RC, 2006, RNA, V12, P589, DOI 10.1261/rna.2231506; Lehmann E, 2007, NATURE, V450, P445, DOI 10.1038/nature06290; MACIEJEWSKI PM, 1995, J BIOL CHEM, V270, P27661, DOI 10.1074/jbc.270.46.27661; Magklara A, 2011, CELL, V145, P555, DOI 10.1016/j.cell.2011.03.040; MANSOUR SJ, 1994, SCIENCE, V265, P966, DOI 10.1126/science.8052857; Maze I, 2010, SCIENCE, V327, P213, DOI 10.1126/science.1179438; McNeill E, 2012, NEURON, V75, P363, DOI 10.1016/j.neuron.2012.07.005; O'Halloran DM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031614; O'Halloran DM, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000761; Pak J, 2012, CELL, V151, P885, DOI 10.1016/j.cell.2012.10.022; Rajasethupathy P, 2012, CELL, V149, P693, DOI 10.1016/j.cell.2012.02.057; Renthal W, 2009, NEURON, V62, P335, DOI 10.1016/j.neuron.2009.03.026; Rougemaille M, 2012, P NATL ACAD SCI USA, V109, P11258, DOI 10.1073/pnas.1204947109; Shimada A, 2010, EPIGENETICS-US, V5, P30, DOI 10.4161/epi.5.1.10605; Shirayama M, 2012, CELL, V150, P65, DOI 10.1016/j.cell.2012.06.015; Simmer F, 2002, CURR BIOL, V12, P1317, DOI 10.1016/S0960-9822(02)01041-2; STRINGHAM EG, 1992, MOL BIOL CELL, V3, P221, DOI 10.1091/mbc.3.2.221; Tabara H, 1999, CELL, V99, P123, DOI 10.1016/S0092-8674(00)81644-X; Tabara H, 2002, CELL, V109, P861, DOI 10.1016/S0092-8674(02)00793-6; Thiru A, 2004, EMBO J, V23, P489, DOI 10.1038/sj.emboj.7600088; Tops BBJ, 2005, NUCLEIC ACIDS RES, V33, P347, DOI 10.1093/nar/gki183; Vasquez-Rifo A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033750; Vastenhouw NL, 2006, NATURE, V442, P882, DOI 10.1038/442882a; Wes PD, 2001, NATURE, V410, P698, DOI 10.1038/35070581; Yamanaka S, 2013, NATURE, V493, P557, DOI 10.1038/nature11716; Yigit E, 2006, CELL, V127, P747, DOI 10.1016/j.cell.2006.09.033; Zhang C, 2011, P NATL ACAD SCI USA, V108, P1201, DOI 10.1073/pnas.1018695108; Zhao T, 2001, J BIOL CHEM, V276, P9512, DOI 10.1074/jbc.M010098200	74	52	63	0	31	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 29	2013	154	5					1010	1022		10.1016/j.cell.2013.08.006	http://dx.doi.org/10.1016/j.cell.2013.08.006			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	209OE	23993094	Bronze, Green Accepted			2022-12-24	WOS:000323767300015
J	Ahima, RS; Lazar, MA				Ahima, Rexford S.; Lazar, Mitchell A.			The Health Risk of Obesity-Better Metrics Imperative	SCIENCE			English	Editorial Material							BODY-MASS INDEX; NORMAL-WEIGHT; MORTALITY; ASSOCIATION; DISEASE; METAANALYSIS; POPULATION; FITNESS; PARADOX; COHORT		[Ahima, Rexford S.] Univ Penn, Perelman Sch Med, Dept Med, Div Endocrinol Diabet & Metab, Philadelphia, PA 19104 USA; Univ Penn, Perelman Sch Med, Inst Diabet Obes & Metab, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine	Ahima, RS (corresponding author), Univ Penn, Perelman Sch Med, Dept Med, Div Endocrinol Diabet & Metab, Philadelphia, PA 19104 USA.	ahima@mail.med.upenn.edu; lazar@mail.med.upenn.edu	Ahima, Rexford/W-1394-2019; Lazar, Mitchell A/AAF-3738-2019		NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK049210] Funding Source: NIH RePORTER; NIDDK NIH HHS [P01-DK-049210] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Boffetta P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019930; Carnethon MR, 2012, JAMA-J AM MED ASSOC, V308, P2085, DOI 10.1001/jama.2012.14669; Carnethon MR, 2012, JAMA-J AM MED ASSOC, V308, P581, DOI 10.1001/jama.2012.9282; de Gonzalez AB, 2010, NEW ENGL J MED, V363, P2211, DOI 10.1056/NEJMoa1000367; Doehner W, 2012, INT J CARDIOL, V162, P20, DOI 10.1016/j.ijcard.2011.09.039; Flegal KM, 2013, JAMA-J AM MED ASSOC, V309, P71, DOI 10.1001/jama.2012.113905; Fogelholm M, 2010, OBES REV, V11, P202, DOI 10.1111/j.1467-789X.2009.00653.x; Hughes V, 2013, NATURE, V497, P428, DOI 10.1038/497428a; Kokkinos P, 2012, DIABETES CARE, V35, P1021, DOI 10.2337/dc11-2407; Krakauer NY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039504; Lee SH, 2011, CLIN ENDOCRINOL, V75, P475, DOI 10.1111/j.1365-2265.2011.04085.x; Oreopoulos A, 2008, AM HEART J, V156, P13, DOI 10.1016/j.ahj.2008.02.014; Romero-Corral A, 2006, LANCET, V368, P666, DOI 10.1016/S0140-6736(06)69251-9; Tseng CH, 2013, ATHEROSCLEROSIS, V226, P186, DOI 10.1016/j.atherosclerosis.2012.09.004; Unger RH, 2010, TRENDS ENDOCRIN MET, V21, P345, DOI 10.1016/j.tem.2010.01.009; Whitlock G, 2009, LANCET, V373, P1083, DOI 10.1016/S0140-6736(09)60318-4; Wildman RP, 2008, ARCH INTERN MED, V168, P1617, DOI 10.1001/archinte.168.15.1617; Wing R, 2013, NEW ENGL J MED, V369, P145, DOI 10.1056/NEJMoa1212914	18	225	235	1	62	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 23	2013	341	6148					856	858		10.1126/science.1241244	http://dx.doi.org/10.1126/science.1241244			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	204MY	23970691				2022-12-24	WOS:000323370600031
J	Gutierrez, OM; Khodneva, YA; Muntner, P; Rizk, DV; McClellan, WM; Cushman, M; Warnock, DG; Safford, MM				Gutierrez, Orlando M.; Khodneva, Yulia A.; Muntner, Paul; Rizk, Dana V.; McClellan, William M.; Cushman, Mary; Warnock, David G.; Safford, Monika M.		REGARDS Investigators	Association Between Urinary Albumin Excretion and Coronary Heart Disease in Black vs White Adults	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							RACIAL-DIFFERENCES; ETHNIC-DIFFERENCES; KIDNEY-FUNCTION; BLOOD-PRESSURE; ESTIMATED GFR; CYSTATIN C; ALL-CAUSE; RISK; MICROALBUMINURIA; POPULATION	IMPORTANCE Excess urinary albumin excretion is more common in black than white individuals and is more strongly associated with incident stroke risk in black vs white individuals. Whether similar associations extend to coronary heart disease (CHD) is unclear. OBJECTIVE To determine whether the association of urinary albumin excretion with CHD events differs by race. DESIGN, SETTING, AND PARTICIPANTS Prospective cohort study of black and white US adults aged 45 years and older who were enrolled within the Reasons for Geographic and Racial Differences in Stroke (REGARDS) study between 2003 and 2007 with follow-up through December 31, 2009. We examined race-stratified associations of urinary albumin-to-creatinine ratio (ACR) in 2 groups: (1) incident CHD among 23 273 participants free of CHD at baseline; and (2) first recurrent CHD event among 4934 participants with CHD at baseline. MAIN OUTCOMES AND MEASURES Expert-adjudicated incident and recurrent myocardial infarction and acute CHD death. RESULTS A total of 616 incident CHD events (421 nonfatal MIs and 195 CHD deaths) and 468 recurrent CHD events (279 nonfatal MIs and 189 CHD deaths) were observed over a mean time of 4.4 years of follow-up. Among those free of CHD at baseline, age-and sex-adjusted incidence rates of CHD per 1000 person-years of follow-up increased with increasing categories of ACR in black and white participants, with rates being nearly 1.5-fold greater in the highest category of ACR (> 300 mg/g) in black participants (20.59; 95% CI, 14.36-29.51) vs white participants (13.60; 95% CI, 7.60-24.25). In proportional hazards models adjusted for traditional cardiovascular risk factors and medications, higher baseline urinary ACR was associated with greater risk of incident CHD among black participants (hazard ratio [HR] comparing ACR > 300 vs < 10 mg/g, 3.21 [95% CI, 2.02-5.09]) but not white participants (HR comparing ACR > 300 vs < 10 mg/g, 1.49 [95% CI, 0.80-2.76]) (P value for interaction = .03). Among those with CHD at baseline, fully adjusted associations of baseline urinary ACR with first recurrent CHD event were similar between black participants (HR comparing ACR > 300 vs < 10 mg/g, 2.21 [95% CI, 1.22-4.00]) vs white participants (HR comparing ACR > 300 vs < 10 mg/g, 2.48 [95% CI, 1.61-3.78]) (P value for interaction = .53). CONCLUSIONS AND RELEVANCE Higher urinary ACR was associated with greater risk of incident but not recurrent CHD in black individuals when compared with white individuals. These data confirm that black individuals appear more susceptible to vascular injury.	[Gutierrez, Orlando M.; Khodneva, Yulia A.; Muntner, Paul; Rizk, Dana V.; Safford, Monika M.] Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA; [Gutierrez, Orlando M.; Muntner, Paul; Warnock, David G.] Univ Alabama Birmingham, Dept Epidemiol, Birmingham, AL 35294 USA; [McClellan, William M.] Emory Univ, Dept Med, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA; [McClellan, William M.] Emory Univ, Dept Epidemiol, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA; [Cushman, Mary] Univ Vermont, Dept Med, Burlington, VT 05405 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; Emory University; Rollins School Public Health; Emory University; Rollins School Public Health; University of Vermont	Gutierrez, OM (corresponding author), Univ Alabama Birmingham, ZRB 614,1720 2nd Ave S, Birmingham, AL 35294 USA.	ogutierr@uab.edu	Cushman, Mary/K-1157-2019; Soliman, Elsayed Z/AAD-7135-2020	Cushman, Mary/0000-0002-7871-6143; Soliman, Elsayed Z/0000-0001-5632-8150; Rizk, Dana/0000-0002-6877-2811	National Institute of Neurological Disorders and Stroke (NINDS) [U01 NS041588]; National Heart, Lung, and Blood Institute (NHLBI) [R01 HL080477]; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) [K23DK081673, R03DK095005]; NINDS [R01NS080850]; Amgen; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL080477] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R03DK095005, K23DK081673] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS080850, U01NS041588] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke (NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Amgen(Amgen); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was supported by a cooperative agreement from the National Institute of Neurological Disorders and Stroke (NINDS, U01 NS041588) and from the National Heart, Lung, and Blood Institute (NHLBI, R01 HL080477). Dr Gutierrez was supported by grants from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK, K23DK081673 and R03DK095005) and from NINDS (R01NS080850). Additional funding was provided by an investigator-initiated grant-in-aid from Amgen.	Bambs C, 2011, CIRCULATION, V123, P850, DOI 10.1161/CIRCULATIONAHA.110.980151; Coresh J, 2007, JAMA-J AM MED ASSOC, V298, P2038, DOI 10.1001/jama.298.17.2038; DECKERT T, 1989, DIABETOLOGIA, V32, P219, DOI 10.1007/BF00285287; Foster MC, 2008, AM J KIDNEY DIS, V52, P859, DOI 10.1053/j.ajkd.2008.04.027; Gutierrez OM, 2012, NEUROLOGY, V79, P1686, DOI 10.1212/WNL.0b013e31826e9af8; Hanevold CD, 2008, HYPERTENSION, V51, P334, DOI 10.1161/HYPERTENSIONAHA.107.098095; Howard G, 2013, JAMA INTERN MED, V173, P46, DOI 10.1001/2013.jamainternmed.857; Howard VJ, 2005, NEUROEPIDEMIOLOGY, V25, P135, DOI 10.1159/000086678; JIANG XZ, 1994, AM J HYPERTENS, V7, P794, DOI 10.1093/ajh/7.9.794; Jolly SE, 2010, AM J KIDNEY DIS, V55, pS15, DOI 10.1053/j.ajkd.2009.09.034; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Luepker RV, 2003, CIRCULATION, V108, P2543, DOI 10.1161/01.CIR.0000100560.46946.EA; Matsushita K, 2010, LANCET, V375, P2073, DOI 10.1016/S0140-6736(10)60674-5; McClellan WM, 2011, J AM SOC NEPHROL, V22, P1721, DOI 10.1681/ASN.2010101085; Peralta CA, 2006, J AM SOC NEPHROL, V17, P2892, DOI 10.1681/ASN.2005101122; Peralta CA, 2011, J AM SOC NEPHROL, V22, P1327, DOI 10.1681/ASN.2010090960; Plantinga L, 2013, INT J HEALTH GEOGR, P12; Prineas R., 1982, MINNESOTA CODE MANUA; Safford MM, 2012, JAMA-J AM MED ASSOC, V308, P1768, DOI 10.1001/jama.2012.14306; Shara NM, 2011, AM J CARDIOL, V107, P399, DOI 10.1016/j.amjcard.2010.09.036; Silva AMV, 2010, J ENDOCRINOL INVEST, V33, P696, DOI [10.1007/BF03346672, 10.3275/6955]; Solbu MD, 2009, METABOLISM, V58, P408, DOI 10.1016/j.metabol.2008.10.016; Thygesen K, 2007, CIRCULATION, V116, P2634, DOI 10.1161/CIRCULATIONAHA.107.187397; Vaccarino V, 2005, NEW ENGL J MED, V353, P671, DOI 10.1056/NEJMsa032214; Waheed S, 2013, CLIN J AM SOC NEPHRO, V8, P434, DOI 10.2215/CJN.04960512; Waheed S, 2012, AM J KIDNEY DIS, V60, P207, DOI 10.1053/j.ajkd.2012.03.011; Wu I, 2008, CLIN J AM SOC NEPHRO, V3, P1895, DOI 10.2215/CJN.02030408	27	31	31	0	9	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 21	2013	310	7					706	713		10.1001/jama.2013.8777	http://dx.doi.org/10.1001/jama.2013.8777			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	202XP	23989654	Green Accepted			2022-12-24	WOS:000323254500020
J	Shi, Y; Zhang, W; Wang, F; Qi, JX; Wu, Y; Song, H; Gao, F; Bi, YH; Zhang, YF; Fan, Z; Qin, CF; Sun, HL; Liu, JH; Haywood, J; Liu, WJ; Gong, WM; Wang, DY; Shu, YL; Wang, Y; Yan, JH; Gao, GF				Shi, Yi; Zhang, Wei; Wang, Fei; Qi, Jianxun; Wu, Ying; Song, Hao; Gao, Feng; Bi, Yuhai; Zhang, Yanfang; Fan, Zheng; Qin, Chengfeng; Sun, Honglei; Liu, Jinhua; Haywood, Joel; Liu, Wenjun; Gong, Weimin; Wang, Dayan; Shu, Yuelong; Wang, Yu; Yan, Jinghua; Gao, George F.			Structures and Receptor Binding of Hemagglutinins from Human-Infecting H7N9 Influenza Viruses	SCIENCE			English	Article							A VIRUS; CONFORMATIONAL-ANALYSIS; TRANSMISSION; ORIGIN; COMPLEXES; OUTBREAK; H1	An avian-origin human-infecting influenza (H7N9) virus was recently identified in China. We have evaluated the viral hemagglutinin (HA) receptor-binding properties of two human H7N9 isolates, A/Shanghai/1/2013 (SH-H7N9) (containing the avian-signature residue Gln(226)) and A/Anhui/1/2013 (AH-H7N9) (containing the mammalian-signature residue Leu(226)). We found that SH-H7N9 HA preferentially binds the avian receptor analog, whereas AH-H7N9 HA binds both avian and human receptor analogs. Furthermore, an AH-H7N9 mutant HA (Leu(226) -> Gln) was found to exhibit dual receptor-binding property, indicating that other amino acid substitutions contribute to the receptor-binding switch. The structures of SH-H7N9 HA, AH-H7N9 HA, and its mutant in complex with either avian or human receptor analogs show how AH-H7N9 can bind human receptors while still retaining the avian receptor-binding property.	[Shi, Yi; Gao, George F.] Chinese Acad Sci, Beijing Inst Life Sci, Res Network Immun & Hlth, Beijing 100101, Peoples R China; [Shi, Yi; Zhang, Wei; Wang, Fei; Qi, Jianxun; Wu, Ying; Song, Hao; Bi, Yuhai; Haywood, Joel; Liu, Wenjun; Yan, Jinghua; Gao, George F.] Chinese Acad Sci, Inst Microbiol, CAS Key Lab Pathogen Microbiol & Immunol, Beijing 100101, Peoples R China; [Zhang, Wei; Song, Hao; Gao, George F.] Univ Chinese Acad Sci, Beijing 100049, Peoples R China; [Wang, Fei; Sun, Honglei; Liu, Jinhua; Gao, George F.] China Agr Univ, Coll Vet Med, Beijing 100193, Peoples R China; [Gao, Feng; Gong, Weimin] Chinese Acad Sci, Inst Biophys, Lab Noncoding RNA, Beijing 100101, Peoples R China; [Zhang, Yanfang; Gao, George F.] Chinese Acad Sci, Tianjin Inst Ind Biotechnol, Lab Prot Engn & Vaccines, Tianjin 300308, Peoples R China; [Fan, Zheng] Chinese Acad Sci, Inst Microbiol, Core Facil, Beijing 100101, Peoples R China; [Qin, Chengfeng] Beijing Inst Microbiol & Epidemiol, Dept Virol, Beijing 100071, Peoples R China; [Wang, Dayan; Shu, Yuelong; Gao, George F.] Chinese Ctr Dis Control & Prevent China CDC, Natl Inst Viral Dis Control & Prevent, Beijing 102206, Peoples R China; [Wang, Yu; Gao, George F.] China CDC, Off Director Gen, Beijing 102206, Peoples R China	Chinese Academy of Sciences; Chinese Academy of Sciences; Institute of Microbiology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; China Agricultural University; Chinese Academy of Sciences; Institute of Biophysics, CAS; Chinese Academy of Sciences; Tianjin Institute of Industrial Biotechnology, CAS; Chinese Academy of Sciences; Institute of Microbiology, CAS; Beijing Institute of Microbiology & Epidemiology; Chinese Center for Disease Control & Prevention; National Institute for Viral Disease Control & Prevention, Chinese Center for Disease Control & Prevention; Chinese Center for Disease Control & Prevention	Gao, GF (corresponding author), Chinese Acad Sci, Beijing Inst Life Sci, Res Network Immun & Hlth, Beijing 100101, Peoples R China.	gaogf@mail.biols.ac.cn	Qin, Cheng-Feng/I-6839-2019; Song, Hao/AAG-2110-2021; Haywood, Joel/G-8311-2016; Qi, Jianxun/ABF-1646-2021; Gao, George Fu/ABD-5229-2021	Qin, Cheng-Feng/0000-0002-0632-2807; Song, Hao/0000-0002-2811-0370; Haywood, Joel/0000-0003-1576-9704; Bi, Yuhai/0000-0002-5595-363X	China Ministry of Science and Technology National 973 Project [2011CB504703]; National Natural Science Foundation of China (NSFC) [81290342]; Chinese Academy of Sciences [KSZD-EW-Z-002]; NSFC Innovative Research Group [81021003]; NSFC Medical Science Department [81341002]	China Ministry of Science and Technology National 973 Project; National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences); NSFC Innovative Research Group; NSFC Medical Science Department	Supported by the China Ministry of Science and Technology National 973 Project (grant 2011CB504703), the National Natural Science Foundation of China (NSFC, grant 81290342), and Chinese Academy of Sciences intramural special grant KSZD-EW-Z-002 for influenza virus research. G. F. G. is a leading principal investigator of the NSFC Innovative Research Group (grant 81021003). We thank E. Dong for NSFC Medical Science Department director's special grant 81341002; staff at the Shanghai Synchrotron Radiation Facility (beamline 17U), especially J. He and S. Huang, for assistance; the Genewiz Corporation for rapid synthesis of HA genes; and the Consortium for Functional Glycomics for providing the biotinylated SA analogs. Coordinates and structure factors are deposited in the Protein Data Bank (PDB) with the following codes: 4KOL (AH-H7N9 HA), 4KOM (AH-H7N9 HA-3'SLNLN), 4KON (AH-H7N9 HA-6'SLNLN), 4LCX (SH-H7N9 HA), 4LKG (SH-H7N9 HA-3'SLNLN), 4LKH (SH-H7N9 HA-6'SLNLN), 4LKI (AH-H7N9 mutant HA), 4LKJ (AH-H7N9 mutant HA-3'SLNLN), and 4LKK (AH-H7N9 mutant HA-6'SLNLN).	Belser JA, 2013, J VIROL, V87, P5746, DOI 10.1128/JVI.00154-13; BREG J, 1989, EUR J BIOCHEM, V178, P727, DOI 10.1111/j.1432-1033.1989.tb14504.x; Chen Y, 2013, LANCET, V381, P1916, DOI 10.1016/S0140-6736(13)60903-4; deJong JC, 1997, NATURE, V389, P554, DOI 10.1038/39218; Eisen MB, 1997, VIROLOGY, V232, P19, DOI 10.1006/viro.1997.8526; Fouchier RAM, 2004, P NATL ACAD SCI USA, V101, P1356, DOI 10.1073/pnas.0308352100; Gambaryan AS, 2012, J VIROL, V86, P4370, DOI 10.1128/JVI.06959-11; Gambaryan AS, 1997, VIROLOGY, V232, P345, DOI 10.1006/viro.1997.8572; Gamblin SJ, 2004, SCIENCE, V303, P1838, DOI 10.1126/science.1093155; Gao RB, 2013, NEW ENGL J MED, V368, P1888, DOI 10.1056/NEJMoa1304459; Ha Y, 2001, P NATL ACAD SCI USA, V98, P11181, DOI 10.1073/pnas.201401198; Herfst S, 2012, SCIENCE, V336, P1534, DOI 10.1126/science.1213362; Hirst M, 2004, EMERG INFECT DIS, V10, P2192, DOI 10.3201/eid1012.040743; Imai M, 2012, NATURE, V486, P420, DOI 10.1038/nature10831; Koopmans M, 2004, LANCET, V363, P587, DOI 10.1016/S0140-6736(04)15589-X; Li JE, 2013, SCI CHINA LIFE SCI, V56, P619, DOI 10.1007/s11427-013-4504-2; Li Q., 2013, NEW ENGL J MED, V368; Liu D, 2013, LANCET, V381, P1926, DOI 10.1016/S0140-6736(13)60938-1; Lu XS, 2013, PROTEIN CELL, V4, P502, DOI 10.1007/s13238-013-3906-z; Matrosovich M, 2000, J VIROL, V74, P8502, DOI 10.1128/JVI.74.18.8502-8512.2000; MERRITT EA, 1994, PROTEIN SCI, V3, P166; NELSON J, 1993, VIRUS RES, V29, P155, DOI 10.1016/0168-1702(93)90056-S; Nguyen-Van-Tam JS, 2006, EUROSURVEILLANCE, V11; POPPE L, 1992, J BIOMOL NMR, V2, P109, DOI 10.1007/BF01875524; ROGERS GN, 1985, J BIOL CHEM, V260, P7362; ROGERS GN, 1983, NATURE, V304, P76, DOI 10.1038/304076a0; Russell RJ, 2006, GLYCOCONJUGATE J, V23, P85, DOI 10.1007/s10719-006-5440-1; SABESAN S, 1991, CARBOHYD RES, V218, P27, DOI 10.1016/0008-6215(91)84084-R; Skehel JJ, 2000, ANNU REV BIOCHEM, V69, P531, DOI 10.1146/annurev.biochem.69.1.531; Srinivasan K, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0059550, 10.1371/journal.pone.0049597]; Stehle T, 1996, STRUCTURE, V4, P183, DOI 10.1016/S0969-2126(96)00021-4; Stevens J, 2006, J MOL BIOL, V355, P1143, DOI 10.1016/j.jmb.2005.11.002; WRIGHT CS, 1993, J MOL BIOL, V232, P620, DOI 10.1006/jmbi.1993.1415; Wu Y, 2013, SCI CHINA LIFE SCI, V56, P493, DOI 10.1007/s11427-013-4496-y; Xiong XL, 2013, NATURE, V497, P392, DOI 10.1038/nature12144; Yang H, 2012, J VIROL, V86, P8645, DOI 10.1128/JVI.00281-12; Zhang W, 2013, SCIENCE, V340, P1463, DOI 10.1126/science.1236787; Zhang W, 2013, J VIROL, V87, P5949, DOI 10.1128/JVI.00545-13	38	209	236	4	163	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 11	2013	342	6155					243	247		10.1126/science.1242917	http://dx.doi.org/10.1126/science.1242917			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232EV	24009358				2022-12-24	WOS:000325475200044
J	DeWeerdt, S				DeWeerdt, Sarah			An age-old problem	NATURE			English	Editorial Material							TUBERCULOSIS VACCINE											Day CL, 2013, AM J RESP CRIT CARE, V188, P492, DOI 10.1164/rccm.201208-1385OC; Ottenhoff THM, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002607; Tameris M, 2013, TUBERCULOSIS, V93, P143, DOI 10.1016/j.tube.2013.01.003; Tameris MD, 2013, LANCET, V381, P1021, DOI 10.1016/S0140-6736(13)60177-4	4	4	4	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 10	2013	502	7470					S8	S9		10.1038/502S8a	http://dx.doi.org/10.1038/502S8a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231RU	24108081	Bronze			2022-12-24	WOS:000325436100005
J	Humphries, C				Humphries, Courtney			A sleeping giant	NATURE			English	Editorial Material							TUBERCULOSIS											Esmail H, 2012, DRUG DISCOV TODAY, V17, P514, DOI 10.1016/j.drudis.2011.12.013; Pethe K, 2013, NAT MED, V19, P1157, DOI 10.1038/nm.3262; Ramakrishnan L, 2012, NAT REV IMMUNOL, V12, P352, DOI 10.1038/nri3211; Zumla A, 2013, NEW ENGL J MED, V368, P745, DOI 10.1056/NEJMra1200894	4	4	4	0	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 10	2013	502	7470					S14	S15		10.1038/502S14a	http://dx.doi.org/10.1038/502S14a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231RU	24108076	Bronze			2022-12-24	WOS:000325436100008
J	Ferrante, JM; Lee, JH; McCarthy, EP; Fisher, KJ; Chen, R; Gonzalez, EC; Love-Jackson, K; Roetzheim, RG				Ferrante, Jeanne M.; Lee, Ji-Hyun; McCarthy, Ellen P.; Fisher, Kate J.; Chen, Ren; Gonzalez, Eduardo C.; Love-Jackson, Kymia; Roetzheim, Richard G.			Primary Care Utilization and Colorectal Cancer Incidence and Mortality Among Medicare Beneficiaries	ANNALS OF INTERNAL MEDICINE			English	Article							STAGE; STATISTICS; DIAGNOSIS; SERVICES; QUALITY	Background: Utilization of primary care may decrease colorectal cancer (CRC) incidence and death through greater receipt of CRC screening tests. Objective: To examine the association of primary care utilization with CRC incidence, CRC deaths, and all-cause mortality. Design: Population-based, case-control study. Setting: Medicare program. Participants: Persons aged 67 to 85 years diagnosed with CRC between 1994 and 2005 in U. S. Surveillance, Epidemiology, and End Results (SEER) regions matched with control patients (n = 205 804 for CRC incidence, 54 160 for CRC mortality, and 121 070 for all-cause mortality). Measurements: Primary care visits in the 4- to 27-month period before CRC diagnosis, CRC incidence, CRC mortality, and all-cause mortality. Results: Compared with persons having 0 or 1 primary care visit, persons with 5 to 10 visits had lower CRC incidence (adjusted odds ratio [OR], 0.94 [95% CI, 0.91 to 0.96]) and mortality (adjusted OR, 0.78 [CI, 0.75 to 0.82]) and lower all-cause mortality (adjusted OR, 0.79 [CI, 0.76 to 0.82]). Associations were stronger in patients with late-stage CRC diagnosis, distal lesions, and diagnosis in more recent years when there was greater Medicare screening coverage. Ever receipt of CRC screening and polypectomy mediated the association of primary care utilization with CRC incidence. Limitation: This study used administrative data, which made it difficult to identify potential confounders and prevented examination of the content of primary care visits. Conclusion: Medicare beneficiaries with higher utilization of primary care have lower CRC incidence and mortality and lower overall mortality. Increasing and promoting access to primary care in the United States for Medicare beneficiaries may help decrease the national burden of CRC. Primary Funding Source: American Cancer Society.	Rutgers Robert Wood Johnson Med Sch, New Brunswick, NJ USA; Canc Inst New Jersey, New Brunswick, NJ USA; Univ S Florida, H Lee Moffitt Canc Ctr, Tampa, FL 33682 USA; Univ S Florida, Tampa, FL USA; Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Boston, MA 02215 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers Cancer Institute of New Jersey; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; State University System of Florida; University of South Florida; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Ferrante, JM (corresponding author), Rutgers Robert Wood Johnson Med Sch, Dept Family Med & Community Hlth, 1 Worlds Fair Dr,Suite 1500, Somerset, NJ 08873 USA.	jeanne.ferrante@rutgers.edu	Gonzalez, Eduardo C/I-4975-2012; Roetzheim, Richard/J-4696-2012; Ferrante, Jeanne/C-7452-2014	Ferrante, Jeanne/0000-0003-0222-5396	American Cancer Society; NATIONAL CANCER INSTITUTE [P30CA076292] Funding Source: NIH RePORTER	American Cancer Society(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	American Cancer Society.	[Anonymous], HCPCS GEN INF; [Anonymous], 2010, CANC TRENDS PROGR RE; Baldwin LM, 2002, MED CARE, V40, P82; Beebe M, 2004, CURR PROC TERM CPT 2; Brookhart MA, 2007, AM J EPIDEMIOL, V166, P348, DOI 10.1093/aje/kwm070; Calonge N, 2008, ANN INTERN MED, V149, P627, DOI 10.7326/0003-4819-149-9-200811040-00243; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Collwill JM, 2008, HEALTH AFFAIR, V27, pW232, DOI 10.1377/hlthaff.27.3.w232; Cormen T., 2009, INTRO ALGORITHMS; Edmonds Jack, 1971, MATH PROGRAM, V1, P127, DOI [10.1007/BF01584082, DOI 10.1007/BF01584082]; Ferrante JM, 2011, ARCH INTERN MED, V171, P1747, DOI 10.1001/archinternmed.2011.470; Ferrante JM, 2010, ANN FAM MED, V8, P108, DOI 10.1370/afm.1080; Friedberg MW, 2010, HEALTH AFFAIR, V29, P766, DOI 10.1377/hlthaff.2010.0025; Gonzalez EC, 2001, DIS COLON RECTUM, V44, P251, DOI 10.1007/BF02234301; Gornick ME, 2004, HEALTH SERV RES, V39, P1403, DOI 10.1111/j.1475-6773.2004.00296.x; Gross CP, 2006, JAMA-J AM MED ASSOC, V296, P2815, DOI 10.1001/jama.296.23.2815; Hao YP, 2009, CANCER CAUSE CONTROL, V20, P1855, DOI 10.1007/s10552-009-9379-y; Hughes Cindy, 2011, Fam Pract Manag, V18, P22; Iglehart John K, 2010, Health Aff (Millwood), V29, P758, DOI 10.1377/hlthaff.2010.0411; Kirschner CG, 1994, PHYS CURR PROC TERM; Klabunde CN, 2006, AM J PREV MED, V30, P313, DOI 10.1016/j.amepre.2005.11.006; Lang K, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-227; Lin DY, 1998, BIOMETRICS, V54, P948, DOI 10.2307/2533848; McCarthy EP, 1998, ANN INTERN MED, V128, P729, DOI 10.7326/0003-4819-128-9-199805010-00005; Neugut AI, 2010, JAMA-J AM MED ASSOC, V304, P461, DOI 10.1001/jama.2010.1001; Ogle KS, 2000, CANCER, V88, P653, DOI 10.1002/(SICI)1097-0142(20000201)88:3<653::AID-CNCR24>3.0.CO;2-1; Okie S, 2012, NEW ENGL J MED, V366, P1849, DOI 10.1056/NEJMp1201526; Roetzheim RG, 1999, J FAM PRACTICE, V48, P850; Schoen RE, 2012, NEW ENGL J MED, V366, P2345, DOI 10.1056/NEJMoa1114635; Schonberg MA, 2011, J CLIN ONCOL, V29, P1570, DOI 10.1200/JCO.2010.33.0472; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Starfield B, 2010, HEALTH AFFAIR, V29, P1030, DOI 10.1377/hlthaff.2010.0002; Starfield B, 2009, J AMBUL CARE MANAG, V32, P216, DOI 10.1097/JAC.0b013e3181ac9ca2; U.S. Department of Health and Human Services and Office of Disease Prevention and Health Promotion, 2010, HLTH PEOPL 2020; Valderas JM, 2009, ANN FAM MED, V7, P104, DOI 10.1370/afm.949; Warren JL, 2002, MED CARE, V40, P3; Wee CC, 2005, PREV MED, V41, P23, DOI 10.1016/j.ypmed.2004.11.004; Yabroff KR, 2008, JNCI-J NATL CANCER I, V100, P630, DOI 10.1093/jnci/djn103	39	35	36	0	8	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 1	2013	159	7					437	U136		10.7326/0003-4819-159-7-201310010-00003	http://dx.doi.org/10.7326/0003-4819-159-7-201310010-00003			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	234FQ	24081284	Green Accepted			2022-12-24	WOS:000325628000001
J	Lichterfeld, M; Rosenberg, ES				Lichterfeld, Mathias; Rosenberg, Eric S.			Acute HIV-1 Infection: A Call to Action	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							ANTIRETROVIRAL THERAPY		[Lichterfeld, Mathias; Rosenberg, Eric S.] Massachusetts Gen Hosp, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital	Rosenberg, ES (corresponding author), Massachusetts Gen Hosp, Div Infect Dis, Gray J-504,55 Fruit St, Boston, MA 02114 USA.	erosenberg1@partners.org	Lichterfeld, Mathias/B-2042-2008	Lichterfeld, Mathias/0000-0001-9865-8350	National Institutes of Health [AI098487, AI093203, AI071915]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI071915, R21AI093203, R01AI098487] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Dr. Lichterfeld is supported by grants AI098487 and AI093203 from the National Institutes of Health. Dr. Rosenberg is supported by grant AI071915 from the National Institutes of Health.	Cohen MS, 2011, NEW ENGL J MED, V365, P493, DOI [10.1056/NEJMoa1105243, 10.1056/NEJMoa1600693]; Fidler S, 2013, NEW ENGL J MED, V368, P207, DOI 10.1056/NEJMoa1110039; Grijsen ML, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001196; Hecht FM, 2002, AIDS, V16, P1119, DOI 10.1097/00002030-200205240-00005; Hecht FM, 2006, J INFECT DIS, V194, P725, DOI 10.1086/506616; Hogan CM, 2012, J INFECT DIS, V205, P87, DOI 10.1093/infdis/jir699; Kahn JO, 1998, NEW ENGL J MED, V339, P33, DOI 10.1056/NEJM199807023390107; Le T, 2013, NEW ENGL J MED, V368, P218, DOI 10.1056/NEJMoa1110187; Schacker T, 1996, ANN INTERN MED, V125, P257, DOI 10.7326/0003-4819-125-4-199608150-00001; Thompson MA, 2012, JAMA-J AM MED ASSOC, V308, P387, DOI 10.1001/jama.2012.7961	10	2	2	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 17	2013	159	6					425	+		10.7326/0003-4819-159-6-201309170-00010	http://dx.doi.org/10.7326/0003-4819-159-6-201309170-00010			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	234EY	24042369				2022-12-24	WOS:000325625900020
J	Van Brabandt, H; Neyt, M; Devos, C				Van Brabandt, Hans; Neyt, Mattias; Devos, Carl			Caution over use of catheter ablation for atrial fibrillation	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							ANTIARRHYTHMIC-DRUG THERAPY; PULMONARY-VEIN ABLATION; FOLLOW-UP; RADIOFREQUENCY ABLATION; RHYTHM-CONTROL; GUIDELINES; MANAGEMENT; FAILURE; IMPACT; TRIAL		[Van Brabandt, Hans; Neyt, Mattias; Devos, Carl] Belgian Hlth Care Knowledge Ctr, B-1000 Brussels, Belgium; [Van Brabandt, Hans] Belgian Ctr Evidence Based Med, Leuven, Netherlands; [Van Brabandt, Hans] Branch Dutch Cochrane Ctr, Leuven, Netherlands		Van Brabandt, H (corresponding author), Belgian Hlth Care Knowledge Ctr, B-1000 Brussels, Belgium.	hans.vanbrabandt@kce.fgov.be		Devos, Carl/0000-0002-1110-2366				Atrial Fibrillation Association, 2011, AF REP PREV STROK CR; Bhargava M, 2009, HEART RHYTHM, V6, P1403, DOI 10.1016/j.hrthm.2009.06.014; Camm AJ, 2012, EUROPACE, V14, P1385, DOI [10.1093/europace/eus305, 10.1093/eurheartj/ehs253]; Camm AJ, 2010, EUROPACE, V12, P1360, DOI [10.1093/europace/euq350, 10.1093/eurheartj/ehq278]; Chugh SS, 2001, J AM COLL CARDIOL, V37, P371, DOI 10.1016/S0735-1097(00)01107-4; de Denus S, 2005, ARCH INTERN MED, V165, P258, DOI 10.1001/archinte.165.3.258; Forleo GB, 2009, J CARDIOVASC ELECTR, V20, P22, DOI 10.1111/j.1540-8167.2008.01275.x; Gaita F, 2008, CIRC-ARRHYTHMIA ELEC, V1, P269, DOI 10.1161/CIRCEP.108.774885; Haissaguerre M, 1998, NEW ENGL J MED, V339, P659, DOI 10.1056/NEJM199809033391003; Hunter RJ, 2010, HEART, V96, P1372, DOI 10.1136/hrt.2009.188128; Jahangir A, 2007, CIRCULATION, V115, P3050, DOI 10.1161/CIRCULATIONAHA.106.644484; Jais P, 2008, CIRCULATION, V118, P2498, DOI 10.1161/CIRCULATIONAHA.108.772582; Katritsis D, 2008, EUROPACE, V10, P419, DOI 10.1093/europace/eun018; Koch L, 2012, EUROPACE, V14, P1441, DOI 10.1093/europace/eus084; Kojodjojo P, 2011, HEART, V97, P610, DOI 10.1136/hrt.2010.206888; Krittayaphong Rungroj, 2003, J Med Assoc Thai, V86 Suppl 1, pS8; Kung J, 2012, ARCH INTERN MED, V172, P1628, DOI 10.1001/2013.jamainternmed.56; Lafuente-Lafuente C, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005049.pub3; MacDonald MR, 2011, HEART, V97, P740, DOI 10.1136/hrt.2010.207340; Medi C, 2011, J CARDIOVASC ELECTR, V22, P137, DOI 10.1111/j.1540-8167.2010.01885.x; Morillo C, 2012, HEART RHYTHM SOC 201; Neven K, 2010, CIRC-ARRHYTHMIA ELEC, V3, P260, DOI 10.1161/CIRCEP.109.922930; Nielsen JC, 2012, NEW ENGL J MED, V367, P1587, DOI 10.1056/NEJMoa1113566; Oral H, 2006, NEW ENGL J MED, V354, P934, DOI 10.1056/NEJMoa050955; Ouyang F, 2010, CIRCULATION, V122, P2368, DOI 10.1161/CIRCULATIONAHA.110.946806; Pappone C, 2006, J AM COLL CARDIOL, V48, P2340, DOI 10.1016/j.jacc.2006.08.037; Pappone C, 2011, CIRC-ARRHYTHMIA ELEC, V4, P808, DOI 10.1161/CIRCEP.111.966408; Potpara Tatjana S, 2011, Hosp Pract (1995), V39, P17, DOI 10.3810/hp.2011.10.919; Shaneyfelt T, 2012, ARCH INTERN MED, V172, P1633, DOI 10.1001/2013.jamainternmed.335; Sorgente A, 2012, AM J CARDIOL, V109, P1179, DOI 10.1016/j.amjcard.2011.11.058; Stabile G, 2006, EUR HEART J, V27, P216, DOI 10.1093/eurheartj/ehi583; Testa L, 2005, EUR HEART J, V26, P2000, DOI 10.1093/eurheartj/ehi306; Van Brabandt H, 2012, CATHETER ABLATION AT; Van Brabandt H, 2013, EUROPACE, V15, P663, DOI 10.1093/europace/eut004; Van Brabandt H, 2013, EUROPACE, V15, P461, DOI 10.1093/europace/eus393; Vinck I, 2011, EUR J HEALTH LAW, V18, P477, DOI 10.1163/157180911X598735; Wazni OM, 2005, JAMA-J AM MED ASSOC, V293, P2634, DOI 10.1001/jama.293.21.2634; Wilber DJ, 2010, JAMA-J AM MED ASSOC, V303, P333, DOI 10.1001/jama.2009.2029	38	7	8	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 6	2013	347								f5277	10.1136/bmj.f5277	http://dx.doi.org/10.1136/bmj.f5277			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	215NK	24014443				2022-12-24	WOS:000324216700002
J	Ezzati, M; Riboli, E				Ezzati, Majid; Riboli, Elio			GLOBAL HEALTH Behavioral and Dietary Risk Factors for Noncommunicable Diseases	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							BODY-MASS INDEX; CAUSE-SPECIFIC MORTALITY; ISCHEMIC-HEART-DISEASE; SYSTEMATIC ANALYSIS; WEIGHT-LOSS; CARDIOVASCULAR-DISEASE; ALCOHOL-CONSUMPTION; RUSSIAN MORTALITY; PHYSICAL-ACTIVITY; STOMACH-CANCER		[Ezzati, Majid; Riboli, Elio] Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, London W2 1PG, England	Imperial College London	Ezzati, M (corresponding author), Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, Norfolk Pl, London W2 1PG, England.	majid.ezzati@imperial.ac.uk; e.riboli@imperial.ac.uk		Riboli, Elio/0000-0001-6795-6080	Medical Research Council [G0801056B] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)		Allamani A., 2007, CONTEMP DRUG PROBL, V34, P187, DOI DOI 10.1177/009145090703400203; [Anonymous], 2011, GLOB STAT REP NONC C; Asaria P, 2007, LANCET, V370, P2004; Asaria P, 2007, LANCET, V370, P2044, DOI 10.1016/S0140-6736(07)61698-5; Cipriani F., 2007, CONTEMP DRUG PROBL, V34, P361; Cobiac LJ, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000110; Danaei G, 2013, CIRCULATION, V127, P1493, DOI 10.1161/CIRCULATIONAHA.113.001470; Danaei G, 2011, LANCET, V378, P31, DOI 10.1016/S0140-6736(11)60679-X; Danaei G, 2011, LANCET, V377, P568, DOI 10.1016/S0140-6736(10)62036-3; Danaei G, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000058; Department of Health and Human Services, 2006, DHHS PUBL; Department of Health and Human Services, 2010, DHHS PUBL, V[CDC] 89-8411; Di Cesare M, 2013, INT J EPIDEMIOL, V42, P838, DOI 10.1093/ije/dyt063; Di Cesare M, 2013, LANCET, V381, P585, DOI 10.1016/S0140-6736(12)61851-0; Douketis JD, 2005, INT J OBESITY, V29, P1153, DOI 10.1038/sj.ijo.0802982; Estruch R, 2013, NEW ENGL J MED, V368, P1279, DOI 10.1056/NEJMoa1200303; Ezzati M, 2002, LANCET, V360, P1347, DOI 10.1016/S0140-6736(02)11403-6; Ezzati M, 2012, SCIENCE, V337, P1482, DOI 10.1126/science.1227001; Farzadfar F, 2011, LANCET, V377, P578, DOI 10.1016/S0140-6736(10)62038-7; Finucane MM, 2011, LANCET, V377, P557, DOI 10.1016/S0140-6736(10)62037-5; Gortmaker SL, 2011, LANCET, V378, P838, DOI 10.1016/S0140-6736(11)60815-5; Gu DF, 2010, NEW ENGL J MED, V363, P2273; Gu DF, 2009, NEW ENGL J MED, V360, P150, DOI 10.1056/NEJMsa0802902; He F. J., 2013, BMJ, V346; HIRAYAMA T, 1984, JPN J CLIN ONCOL, V14, P159; Jha P, 2008, NEW ENGL J MED, V358, P1137, DOI 10.1056/NEJMsa0707719; Leon DA, 1997, LANCET, V350, P383, DOI 10.1016/S0140-6736(97)03360-6; Leon DA, 2009, ADDICTION, V104, P1630, DOI 10.1111/j.1360-0443.2009.02655.x; Levine JA, 2001, SCIENCE, V294, P812, DOI 10.1126/science.1064627; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Lin HH, 2007, PLOS MED, V4, P173, DOI 10.1371/journal.pmed.0040020; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Mathurin P, 2009, GUT, V58, P613, DOI 10.1136/gut.2007.145573; Mhurchu CN, 2006, ASIA PAC J CLIN NUTR, V15, P127; Mhurchu CN, 2004, INT J EPIDEMIOL, V33, P751, DOI 10.1093/ije/dyh163; MORRIS JN, 1953, LANCET, V265, P1053; Mozaffarian D, 2012, CIRCULATION, V126, P1514, DOI 10.1161/CIR.0b013e318260a20b; Mozaffarian D, 2011, CIRCULATION, V123, P2870, DOI 10.1161/CIRCULATIONAHA.110.968735; Mozaffarian D, 2011, NEW ENGL J MED, V364, P2392, DOI 10.1056/NEJMoa1014296; Mozaffarian D, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000252; Nakamura K, 2009, TOB CONTROL, V18, P345, DOI 10.1136/tc.2008.028795; Nordmann AJ, 2006, ARCH INTERN MED, V166, P285, DOI 10.1001/archinte.166.3.285; Olshansky SJ, 2005, NEW ENGL J MED, V352, P1138, DOI 10.1056/NEJMsr043743; Pischon T, 2010, NEW ENGL J MED, V362, P2433; Puska P, 2010, ANNU REV PUBL HEALTH, V31, P315, DOI 10.1146/annurev.publhealth.012809.103658; Rehm J, 2010, ADDICTION, V105, P817, DOI 10.1111/j.1360-0443.2010.02899.x; Renehan AG, 2008, LANCET, V371, P569, DOI 10.1016/S0140-6736(08)60269-X; Roerecke M, 2012, ADDICTION, V107, P1246, DOI 10.1111/j.1360-0443.2012.03780.x; Roerecke M, 2010, AM J EPIDEMIOL, V171, P633, DOI 10.1093/aje/kwp451; Sacks FM, 2009, NEW ENGL J MED, V360, P859, DOI 10.1056/NEJMoa0804748; Sattelmair J, 2011, CIRCULATION, V124, P789, DOI 10.1161/CIRCULATIONAHA.110.010710; Secretan B, 2009, LANCET ONCOL, V10, P1033, DOI 10.1016/S1470-2045(09)70326-2; Stevens G, 2008, PLOS MED, V5, P900, DOI 10.1371/journal.pmed.0050125; Stevens GA, 2012, POPUL HEALTH METR, V10, DOI 10.1186/1478-7954-10-22; Thun M, 2012, TOB CONTROL, V21, P96, DOI 10.1136/tobaccocontrol-2011-050294; TUOMILEHTO J, 1984, STROKE, V15, P823, DOI 10.1161/01.STR.15.5.823; Wang HD, 2012, LANCET, V380, P2071, DOI 10.1016/S0140-6736(12)61719-X; Whitlock G, 2009, LANCET, V373, P1083, DOI 10.1016/S0140-6736(09)60318-4; Willi C, 2007, JAMA-J AM MED ASSOC, V298, P2654, DOI 10.1001/jama.298.22.2654; World Cancer Research Fund/American Institute for Cancer Research, 2007, FOOD NUTR PHYS ACT P; Wormser D, 2011, LANCET, V377, P1085, DOI 10.1016/S0140-6736(11)60105-0; Zaridze D, 2009, LANCET, V373, P2201, DOI 10.1016/S0140-6736(09)61034-5	62	430	452	10	93	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 5	2013	369	10					954	964		10.1056/NEJMra1203528	http://dx.doi.org/10.1056/NEJMra1203528			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	211KV	24004122				2022-12-24	WOS:000323906900012
J	Wichterle, H; Gifford, D; Mazzoni, E				Wichterle, Hynek; Gifford, David; Mazzoni, Esteban			Mapping Neuronal Diversity One Cell at a Time	SCIENCE			English	Editorial Material							GABAERGIC INTERNEURONS; NERVOUS-SYSTEM; CLASSIFICATION; NOMENCLATURE; SINGLE; ATLAS		[Wichterle, Hynek] Columbia Univ, Med Ctr, Columbia Stem Cell Initiat, Ctr Motor Neuron Biol & Dis,Dept Pathol & Cell Bi, New York, NY 10032 USA; [Wichterle, Hynek] Columbia Univ, Med Ctr, Columbia Stem Cell Initiat, Ctr Motor Neuron Biol & Dis,Dept Neurol, New York, NY 10032 USA; [Wichterle, Hynek] Columbia Univ, Med Ctr, Columbia Stem Cell Initiat, Ctr Motor Neuron Biol & Dis,Dept Neurosci, New York, NY 10032 USA; [Gifford, David] MIT, Comp Sci & Artificial Intelligence Lab, Cambridge, MA 02139 USA; [Mazzoni, Esteban] NYU, Dept Biol, New York, NY 10003 USA	Columbia University; Columbia University; Columbia University; Massachusetts Institute of Technology (MIT); New York University	Wichterle, H (corresponding author), Columbia Univ, Med Ctr, Columbia Stem Cell Initiat, Ctr Motor Neuron Biol & Dis,Dept Pathol & Cell Bi, 630 168 St, New York, NY 10032 USA.	hw350@columbia.edu	Young, Richard A/F-6495-2012	Young, Richard A/0000-0001-8855-8647; mazzoni, esteban/0000-0001-8994-681X; Wichterle, Hynek/0000-0002-7817-0080	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS078097, P01NS055923] Funding Source: NIH RePORTER; NINDS NIH HHS [P01NS055923, R01NS078097] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Ascoli GA, 2008, NAT REV NEUROSCI, V9, P557, DOI 10.1038/nrn2402; DeFelipe J, 2013, NAT REV NEUROSCI, V14, P202, DOI 10.1038/nrn3444; Gerber GK, 2007, PLOS COMPUT BIOL, V3, P1426, DOI 10.1371/journal.pcbi.0030148; Gong SC, 2003, NATURE, V425, P917, DOI 10.1038/nature02033; HALL DH, 1991, J NEUROSCI, V11, P1; Hawrylycz MJ, 2012, NATURE, V489, P391, DOI 10.1038/nature11405; Kodama T, 2012, J NEUROSCI, V32, P7819, DOI 10.1523/JNEUROSCI.0543-12.2012; Margolin AA, 2006, NAT PROTOC, V1, P663, DOI 10.1038/nprot.2006.106; Qiu P, 2011, NAT BIOTECHNOL, V29, P886, DOI 10.1038/nbt.1991; Qiu Shenfeng, 2012, Frontiers in Genetics, V3, P124, DOI 10.3389/fgene.2012.00124; Shen-Orr SS, 2010, NAT METHODS, V7, P287, DOI [10.1038/NMETH.1439, 10.1038/nmeth.1439]; Siegert S, 2012, NAT NEUROSCI, V15, P487, DOI 10.1038/nn.3032; Sugino K, 2006, NAT NEUROSCI, V9, P99, DOI 10.1038/nn1618; Tian L, 2009, NAT METHODS, V6, P875, DOI 10.1038/nmeth.1398; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Wickersham IR, 2007, NEURON, V53, P639, DOI 10.1016/j.neuron.2007.01.033; Winden KD, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.46	17	28	28	0	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 16	2013	341	6147					726	727		10.1126/science.1235884	http://dx.doi.org/10.1126/science.1235884			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201DZ	23950522				2022-12-24	WOS:000323122200030
J	Daugla, DM; Gami, JP; Gamougam, K; Naibei, N; Mbainadji, L; Narbe, M; Toralta, J; Kodbesse, B; Ngadoua, C; Coldiron, ME; Fermon, F; Page, AL; Djingarey, MH; Hugonnet, S; Harrison, OB; Rebbetts, LS; Tekletsion, Y; Watkins, ER; Hill, D; Caugant, DA; Chandramohan, D; Hassan-King, M; Manigart, O; Nascimento, M; Woukeu, A; Trotter, C; Stuart, JM; Maiden, MCJ; Greenwood, BM				Daugla, D. M.; Gami, J. P.; Gamougam, K.; Naibei, N.; Mbainadji, L.; Narbe, M.; Toralta, J.; Kodbesse, B.; Ngadoua, C.; Coldiron, M. E.; Fermon, F.; Page, A-L; Djingarey, M. H.; Hugonnet, S.; Harrison, O. B.; Rebbetts, L. S.; Tekletsion, Y.; Watkins, E. R.; Hill, D.; Caugant, D. A.; Chandramohan, D.; Hassan-King, M.; Manigart, O.; Nascimento, M.; Woukeu, A.; Trotter, C.; Stuart, J. M.; Maiden, M. C. J.; Greenwood, B. M.			Effect of a serogroup A meningococcal conjugate vaccine (PsA-TT) on serogroup A meningococcal meningitis and carriage in Chad: a community study	LANCET			English	Article							EPIDEMIC; TIME	Background A serogroup A meningococcal poly saccharide-tetanus toxoid conjugate vaccine (PsA-TT, MenAfriVac) was licensed in India in 2009, and pre-qualified by WHO in 2010, on the basis of its safety and immunogenicity. This vaccine is now being deployed across the African meningitis belt. We studied the effect of PsA-TT on meningococcal meningitis and carriage in Chad during a serogroup A meningococcal meningitis epidemic. Methods We obtained data for the incidence of meningitis before and after vaccination from national records between January, 2009, and June, 2012. In 2012, surveillance was enhanced in regions where vaccination with PsA-TT had been undertaken in 2011, and in one district where a reactive vaccination campaign in response to an outbreak of meningitis was undertaken. Meningococcal carriage was studied in an age-stratified sample of residents aged 1-29 years of a rural area roughly 13-15 and 2-4 months before and 4-6 months after vaccination. Meningococci obtained from cerebrospinal fluid or oropharyngeal swabs were characterised by conventional microbiological and molecular methods. Findings Roughly 1.8 million individuals aged 1-29 years received one dose of PsA-TT during a vaccination campaign in three regions of Chad in and around the capital N'Djamena during 10 days in December, 2011. The incidence of meningitis during the 2012 meningitis season in these three regions was 2.48 per 100 000 (57 cases in the 2.3 million population), whereas in regions without mass vaccination, incidence was 43.8 per 100 000 (3809 cases per 8.7 million population), a 94% difference in crude incidence (p<0.0001), and an incidence rate ratio of 0.096 (95% CI 0.046-0.198). Despite enhanced surveillance, no case of serogroup A meningococcal meningitis was reported in the three vaccinated regions. 32 serogroup A carriers were identified in 4278 age-stratified individuals (0.75%) living in a rural area near the capital 2-4 months before vaccination, whereas only one serogroup A meningococcus was isolated in 5001 people living in the same community 4-6 months after vaccination (adjusted odds ratio 0.019, 95% CI 0.002-0.138; p<0.0001). Interpretation PSA-TT was highly effective at prevention of serogroup A invasive meningococcal disease and carriage in Chad. How long this protection will persist needs to be established.	[Daugla, D. M.; Gami, J. P.; Gamougam, K.; Naibei, N.; Mbainadji, L.; Narbe, M.; Toralta, J.; Kodbesse, B.] CSSI, Ndjamena, Chad; [Ngadoua, C.] Minist Publ Hlth, Ndjamena, Chad; [Coldiron, M. E.; Fermon, F.; Page, A-L] Epictr, Paris, France; [Djingarey, M. H.] WHO Intercountry Support Team, Ouagadougou, Burkina Faso; [Hugonnet, S.] WHO, Dept Pandem & Epidem Dis, CH-1211 Geneva, Switzerland; [Harrison, O. B.; Rebbetts, L. S.; Tekletsion, Y.; Watkins, E. R.; Hill, D.; Maiden, M. C. J.] Univ Oxford, Dept Zool, Oxford OX1 3PS, England; [Caugant, D. A.] Norwegian Inst Publ Hlth, Oslo, Norway; [Trotter, C.] Univ Cambridge, Dept Vet Med, Cambridge, England; [Chandramohan, D.; Hassan-King, M.; Manigart, O.; Nascimento, M.; Woukeu, A.; Stuart, J. M.; Greenwood, B. M.] Univ London London Sch Hyg & Trop Med, Fac Infect & Trop Dis, London WC1E 7HT, England	World Health Organization; University of Oxford; Norwegian Institute of Public Health (NIPH); University of Cambridge; University of London; London School of Hygiene & Tropical Medicine	Greenwood, BM (corresponding author), Univ London London Sch Hyg & Trop Med, Fac Infect & Trop Dis, Keppel St, London WC1E 7HT, England.	brian.greenwood@lshtm.ac.uk	Maiden, Martin/N-6805-2019; , dcaugant/AAH-6843-2019; Trotter, Caroline L/H-5077-2013; Maiden, Martin C J/C-5055-2014	Maiden, Martin/0000-0001-6321-5138; , dcaugant/0000-0003-2765-9844; Maiden, Martin C J/0000-0001-6321-5138; Trotter, Caroline/0000-0003-4000-2708	The Bill & Melinda Gates Foundation; Wellcome Trust; Medecins Sans Frontieres; M�decins Sans Fronti�res [EPI_pilot_00_Coldiron] Funding Source: researchfish	The Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation); Wellcome Trust(Wellcome TrustEuropean Commission); Medecins Sans Frontieres; M�decins Sans Fronti�res	The Bill & Melinda Gates Foundation, the Wellcome Trust, and Medecins Sans Frontieres.	Ali O, 2013, TROP MED INT HEALTH, V18, P968, DOI 10.1111/tmi.12125; Bennett JS, 2012, MICROBIOL-SGM, V158, P1570, DOI 10.1099/mic.0.056077-0; Borrow R, 2012, TROP MED INT HEALTH, V17, P1478, DOI 10.1111/j.1365-3156.2012.03085.x; Bregani E R, 2006, Minerva Med, V97, P161; Caini S, 2013, VACCINE, V31, P1597, DOI 10.1016/j.vaccine.2013.01.015; Caugant DA, 2009, VACCINE, V27, pB64, DOI 10.1016/j.vaccine.2009.04.061; Caugant DA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046019; Claus H, 2002, MICROBIOL-SGM, V148, P1813, DOI 10.1099/00221287-148-6-1813; Djingarey MH, 2012, VACCINE, V30, pB40, DOI 10.1016/j.vaccine.2011.12.073; Garcia V, 2004, Bull Soc Pathol Exot, V97, P183; Greenwood B, 2013, VACCINE, V31, P1453, DOI 10.1016/j.vaccine.2012.12.035; Harmsen D, 2001, J CLIN MICROBIOL, V39, P936, DOI 10.1128/JCM.39.3.936-942.2001; Kim SH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029116; Kristiansen PA, 2013, CLIN INFECT DIS, V56, P354, DOI 10.1093/cid/cis892; Labrie JE, 2010, HUM VACCINES, V6, P360, DOI 10.4161/hv.6.4.11055; LAPEYSSONNIE L, 1963, Bull World Health Organ, V28 Suppl, P1; Ledentu Blanchard, 1941, BULL OFF INT DHYG PU, V3, P421; LENGELER C, 1995, ACTA TROP, V59, P211, DOI 10.1016/0001-706X(95)00081-O; Maiden MCJ, 2002, LANCET, V359, P1829, DOI 10.1016/S0140-6736(02)08679-8; Massenet D, 2011, EMERG INFECT DIS, V17, P2070, DOI 10.3201/eid1711.110468; Medah Isaie, 2012, Morbidity and Mortality Weekly Report, V61, P1022; Nicolas P, 2005, J CLIN MICROBIOL, V43, P5129, DOI 10.1128/JCM.43.10.5129-5135.2005; Novak RT, 2012, LANCET INFECT DIS, V12, P757, DOI 10.1016/S1473-3099(12)70168-8; Patterson KD, 1984, CEREBROSPINAL MENING; Riou JY, 1996, B WORLD HEALTH ORGAN, V74, P181; Sirol J, 1969, Med Trop (Mars), V29, P443; Sow SO, 2011, NEW ENGL J MED, V364, P2293, DOI 10.1056/NEJMoa1003812; SPIEGEL A, 1993, B WORLD HEALTH ORGAN, V71, P311; SUKER J, 1994, MOL MICROBIOL, V12, P253, DOI 10.1111/j.1365-2958.1994.tb01014.x; Wang X, 2012, J CLIN MICROBIOL, V50, P702, DOI 10.1128/JCM.06087-11; World Health Organization, 2010, Weekly Epidemiological Record, V85, P57	31	182	185	0	13	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 4	2014	383	9911					40	47		10.1016/S0140-6736(13)61612-8	http://dx.doi.org/10.1016/S0140-6736(13)61612-8			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	284SP	24035220	hybrid, Green Published, Green Accepted			2022-12-24	WOS:000329341200034
J	Tierney, JE; deMenocal, PB				Tierney, Jessica E.; deMenocal, Peter B.			Abrupt Shifts in Horn of Africa Hydroclimate Since the Last Glacial Maximum	SCIENCE			English	Article							SEA-SURFACE TEMPERATURE; INDIAN MONSOON; VEGETATION RESPONSE; ARABIAN PENINSULA; CLIMATE; SAHARA; OCEAN; VARIABILITY; DYNAMICS; MIDHOLOCENE	The timing and abruptness of the initiation and termination of the Early Holocene African Humid Period are subjects of ongoing debate, with direct consequences for our understanding of abrupt climate change, paleoenvironments, and early human cultural development. Here, we provide proxy evidence from the Horn of Africa region that documents abrupt transitions into and out of the African Humid Period in northeast Africa. Similar and generally synchronous abrupt transitions at other East African sites suggest that rapid shifts in hydroclimate are a regionally coherent feature. Our analysis suggests that the termination of the African Humid Period in the Horn of Africa occurred within centuries, underscoring the nonlinearity of the region's hydroclimate.	[Tierney, Jessica E.] Woods Hole Oceanog Inst, Woods Hole, MA 02540 USA; [deMenocal, Peter B.] Lamont Doherty Earth Observ, Palisades, NY 10964 USA	Woods Hole Oceanographic Institution; Columbia University	Tierney, JE (corresponding author), Woods Hole Oceanog Inst, 266 Woods Hole Rd, Woods Hole, MA 02540 USA.	tierney@whoi.edu	; deMenocal, Peter/B-1386-2013	Tierney, Jessica/0000-0002-9080-9289; deMenocal, Peter/0000-0002-7191-717X	National Science Foundation [OCE-1203892]; National Oceanic and Atmospheric Administration [NAO80AR4320912]; Lamont-Doherty Earth Observatory (LDEO) Climate and Life Initiative; Directorate For Geosciences [1203295] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); National Oceanic and Atmospheric Administration(National Oceanic Atmospheric Admin (NOAA) - USA); Lamont-Doherty Earth Observatory (LDEO) Climate and Life Initiative; Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	This study was supported by National Science Foundation grant OCE-1203892 to J.E.T., National Oceanic and Atmospheric Administration award NAO80AR4320912 to P.B.d.M., and the Lamont-Doherty Earth Observatory (LDEO) Climate and Life Initiative. We thank E. Hamilton and C. Johnson for assistance with the stable isotope measurements; J.-B. Stuut, G. Ganssen, and C. Cleroux for assistance with core sampling; J. Fang and T. Guilderson for assistance with the radiocarbon dating; and C. Ummenhofer for comments on the initial versions of the manuscript. We thank the Captain and crew of the R/V Pelagia for their remarkable professionalism during the penultimate leg (Cruise 178; April to May 2001) of the scientific circumnavigation of the African continent. With co-chief scientist G. Ganssen, we were able to obtain valuable samples from this remote and geopolitically challenging region. This is LDEO contribution number 7739.	Anand P, 2008, PALEOCEANOGRAPHY, V23, DOI 10.1029/2007PA001564; Anchukaitis KJ, 2013, CLIM DYNAM, V41, P1291, DOI 10.1007/s00382-012-1483-0; Bathiany S, 2012, CLIM DYNAM, V38, P1775, DOI 10.1007/s00382-011-1037-x; Berke MA, 2012, QUATERNARY SCI REV, V55, P59, DOI 10.1016/j.quascirev.2012.08.014; Black E, 2003, MON WEATHER REV, V131, P74, DOI 10.1175/1520-0493(2003)131<0074:AOSOTR>2.0.CO;2; Brovkin V, 1998, J GEOPHYS RES-ATMOS, V103, P31613, DOI 10.1029/1998JD200006; Brovkin V, 2008, SCIENCE, V322, DOI 10.1126/science.1163381; Chakraborty A, 2006, MON WEATHER REV, V134, P598, DOI 10.1175/MWR3085.1; CHARNEY JG, 1975, Q J ROY METEOR SOC, V101, P193, DOI 10.1002/qj.49710142802; Claussen M, 1999, GEOPHYS RES LETT, V26, P2037, DOI 10.1029/1999GL900494; Claussen M, 1997, GLOBAL ECOL BIOGEOGR, V6, P369, DOI 10.2307/2997337; deMenocal P, 2000, QUATERNARY SCI REV, V19, P347, DOI 10.1016/S0277-3791(99)00081-5; Fleitmann D, 2003, SCIENCE, V300, P1737, DOI 10.1126/science.1083130; Fleitmann D, 2007, QUATERNARY SCI REV, V26, P170, DOI 10.1016/j.quascirev.2006.04.012; Francus P, 2013, SEDIMENTOLOGY, V60, P911, DOI 10.1111/j.1365-3091.2012.01370.x; Friedrich M, 1999, QUATERN INT, V61, P27, DOI 10.1016/S1040-6182(99)00015-4; Garcin Y, 2012, EARTH PLANET SC LETT, V331, P322, DOI 10.1016/j.epsl.2012.03.016; Hoelzmann P, 2001, PALAEOGEOGR PALAEOCL, V169, P193, DOI 10.1016/S0031-0182(01)00211-5; Holmes JA, 2008, SCIENCE, V320, P752, DOI 10.1126/science.1158105; Hughen KA, 2004, SCIENCE, V304, P1955, DOI 10.1126/science.1092995; Jolly D, 1998, J BIOGEOGR, V25, P1007, DOI 10.1046/j.1365-2699.1998.00238.x; Jung SJA, 2004, EARTH PLANET SC LETT, V221, P27, DOI 10.1016/S0012-821X(04)00095-0; Kalnay E, 1996, B AM METEOROL SOC, V77, P437, DOI 10.1175/1520-0477(1996)077<0437:TNYRP>2.0.CO;2; Kropelin S, 2008, SCIENCE, V320, P765, DOI 10.1126/science.1154913; Kuper R, 2006, SCIENCE, V313, P803, DOI 10.1126/science.1130989; KUTZBACH JE, 1982, J ATMOS SCI, V39, P1177, DOI 10.1175/1520-0469(1982)039<1177:TSOTAA>2.0.CO;2; Lezine AM, 2011, QUATERNARY SCI REV, V30, P3001, DOI 10.1016/j.quascirev.2011.07.006; LONG A, 1974, AM ANTIQUITY, V39, P205, DOI 10.2307/279583; Mohtadi M, 2010, EARTH PLANET SC LETT, V292, P89, DOI 10.1016/j.epsl.2010.01.024; Parker AG, 2004, J QUATERNARY SCI, V19, P665, DOI 10.1002/jqs.880; Pausata FSR, 2011, NAT GEOSCI, V4, P474, DOI [10.1038/NGEO1169, 10.1038/ngeo1169]; Rostek F, 1997, DEEP-SEA RES PT II, V44, P1461, DOI 10.1016/S0967-0645(97)00008-8; Schefuss E, 2005, NATURE, V437, P1003, DOI 10.1038/nature03945; SHUKLA J, 1982, SCIENCE, V215, P1498, DOI 10.1126/science.215.4539.1498; Slingo J, 2005, PHILOS T R SOC A, V363, P25, DOI 10.1098/rsta.2004.1473; Stager JC, 2011, SCIENCE, V331, P1299, DOI 10.1126/science.1198322; Staubwasser M, 2002, PALEOCEANOGRAPHY, V17, DOI 10.1029/2000PA000608; Street-Perrott F. A., 1989, 46 US DEP EN; Tierney JE, 2008, SCIENCE, V322, P252, DOI 10.1126/science.1160485; Tierney JE, 2013, NATURE, V493, P389, DOI 10.1038/nature11785; Tierney JE, 2011, EARTH PLANET SC LETT, V307, P103, DOI 10.1016/j.epsl.2011.04.038; Tierney JE, 2011, QUATERNARY SCI REV, V30, P798, DOI 10.1016/j.quascirev.2011.01.017; Tierney JE, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL029508; Weldeab S, 2007, SCIENCE, V316, P1303, DOI 10.1126/science.1140461; ZHANG CD, 1993, J CLIMATE, V6, P1898, DOI 10.1175/1520-0442(1993)006<1898:LSVOAD>2.0.CO;2; Zhao Y, 2005, CLIM DYNAM, V25, P777, DOI 10.1007/s00382-005-0075-7	46	162	164	3	98	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 15	2013	342	6160					843	846		10.1126/science.1240411	http://dx.doi.org/10.1126/science.1240411			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	251IY	24114782	Green Submitted			2022-12-24	WOS:000326923000034
J	Hiatt, WR; Kaul, S; Smith, RJ				Hiatt, William R.; Kaul, Sanjay; Smith, Robert J.			The Cardiovascular Safety of Diabetes Drugs - Insights from the Rosiglitazone Experience	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							RISK	A signal of cardiovascular harm with rosiglitazone led to a new FDA policy on diabetes-drug approval. As that signal has faded in recent analyses, should FDA policy change? The management of type 2 diabetes has been challenged by uncertainty about possible cardiovascular effects related to treatment intensity and choice of drug. Although the Food and Drug Administration (FDA) considers a decrease in glycated hemoglobin an approvable end point, very intensive glycemic control is associated with increased cardiovascular and all-cause mortality.(1) The safety of specific drugs for type 2 diabetes particularly the thiazolidinediones has also been questioned. After rosiglitazone had been approved in the United States in 1999 and in Europe in 2000, a highly publicized meta-analysis in 2007 reported a 43% increase in myocardial infarction (P=0.03) ...	[Hiatt, William R.] Univ Colorado, Div Cardiol, Sch Med, Aurora, CO USA; [Hiatt, William R.] Univ Colorado, Colorado Prevent Ctr Clin Res, Dept Med, Sch Med, Aurora, CO USA; [Kaul, Sanjay] Univ Calif Los Angeles, Div Cardiol, Los Angeles, CA USA; [Kaul, Sanjay] Cedars Sinai Med Ctr, Los Angeles, CA 90048 USA; [Smith, Robert J.] Brown Univ, Ocean State Res Inst, Alpert Med Sch, Providence, RI 02912 USA; [Smith, Robert J.] Providence Vet Affairs Med Ctr, Providence, RI USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University of California System; University of California Los Angeles; Cedars Sinai Medical Center; Brown University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Providence VA Medical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Providence VA Medical Center	Hiatt, WR (corresponding author), Univ Colorado, Div Cardiol, Sch Med, Aurora, CO USA.							Gerstein HC, 2011, NEW ENGL J MED, V364, P818, DOI 10.1056/NEJMoa1006524; Guidance For Industry, 2008, GUID IND DIAB MELL E; Home PD, 2009, LANCET, V373, P2125, DOI 10.1016/S0140-6736(09)60953-3; Kaul S, 2011, CLIN PHARMACOL THER, V89, P773, DOI 10.1038/clpt.2011.65; Nissen SE, 2007, NEW ENGL J MED, V356, P2457, DOI 10.1056/NEJMoa072761	5	138	138	2	13	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 3	2013	369	14					1285	1287		10.1056/NEJMp1309610	http://dx.doi.org/10.1056/NEJMp1309610			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	227KI	23992603				2022-12-24	WOS:000325111200002
J	Tarlinton, D; Good-Jacobson, K				Tarlinton, David; Good-Jacobson, Kim			Diversity Among Memory B Cells: Origin, Consequences, and Utility	SCIENCE			English	Review							LIVED PLASMA-CELLS; FOLLICULAR DENDRITIC CELLS; GERMINAL CENTER FORMATION; PRIMARY IMMUNE-RESPONSE; ANTIBODY-FORMING-CELLS; T-CELLS; HUMORAL IMMUNITY; AFFINITY MATURATION; SEROLOGICAL MEMORY; CLONAL SELECTION	Immunological memory is the residuum of a successful immune response that in the B cell lineage comprises long-lived plasma cells and long-lived memory B cells. It is apparent that distinct classes of memory B cells exist, distinguishable by, among other things, immunoglobulin isotype, location, and passage through the germinal center. Some of this variation is due to the nature of the antigen, and some appears to be inherent to the process of forming memory. Here, we consider the heterogeneity in development and phenotype of memory B cells and whether particular functions are partitioned into distinct subsets. We consider also how understanding the details of generating memory may provide opportunities to develop better, functionally targeted vaccines.	[Tarlinton, David; Good-Jacobson, Kim] Walter & Eliza Hall Inst Med Res, Parkville, Vic 3052, Australia; [Tarlinton, David; Good-Jacobson, Kim] Univ Melbourne, Dept Med Biol, Parkville, Vic 3010, Australia	Walter & Eliza Hall Institute; University of Melbourne	Tarlinton, D (corresponding author), Walter & Eliza Hall Inst Med Res, 1G Royal Parade, Parkville, Vic 3052, Australia.	tarlinton@wehi.edu.au		Good-Jacobson, Kim/0000-0003-1891-7274; Tarlinton, David/0000-0001-9928-686X	National Health and Medical Research Council (NHMRC) of Australia; NHMRC; Leukaemia Foundation of Australia; Victorian State Government; NHMRC Independent Research Institute Infrastructure Support Scheme (IRIISS)	National Health and Medical Research Council (NHMRC) of Australia(National Health and Medical Research Council (NHMRC) of Australia); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Leukaemia Foundation of Australia; Victorian State Government; NHMRC Independent Research Institute Infrastructure Support Scheme (IRIISS)(National Health and Medical Research Council (NHMRC) of Australia)	We foremost apologize to any colleagues whose work we have not referenced directly due to space constraints. The authors are supported by fellowships from the National Health and Medical Research Council (NHMRC) of Australia. Work from the authors' laboratory is made possible through grants from the NHMRC, the Leukaemia Foundation of Australia, the Victorian State Government Operational Infrastructure Support, and the NHMRC Independent Research Institute Infrastructure Support Scheme (IRIISS).	Ahuja A, 2008, P NATL ACAD SCI USA, V105, P4802, DOI 10.1073/pnas.0800555105; Aiba Y, 2010, P NATL ACAD SCI USA, V107, P12192, DOI 10.1073/pnas.1005443107; Amanna IJ, 2010, IMMUNOL REV, V236, P125, DOI 10.1111/j.1600-065X.2010.00912.x; Benckert J, 2011, J CLIN INVEST, V121, P1946, DOI 10.1172/JCI44447; Benson MJ, 2009, J EXP MED, V206, P2013, DOI 10.1084/jem.20090667; Bernasconi NL, 2002, SCIENCE, V298, P2199, DOI 10.1126/science.1076071; Blink EJ, 2005, J EXP MED, V201, P545, DOI 10.1084/jem.20042060; Carrington EM, 2010, P NATL ACAD SCI USA, V107, P10967, DOI 10.1073/pnas.1005256107; Cassese G, 2003, J IMMUNOL, V171, P1684, DOI 10.4049/jimmunol.171.4.1684; Chan TD, 2009, J IMMUNOL, V183, P3139, DOI 10.4049/jimmunol.0901690; Chappell CP, 2012, J EXP MED, V209, P1825, DOI 10.1084/jem.20120774; Chu VT, 2013, IMMUNOL REV, V251, P177, DOI 10.1111/imr.12011; Coffey F, 2009, IMMUNITY, V30, P599, DOI 10.1016/j.immuni.2009.01.011; COUTELIER JP, 1987, J EXP MED, V165, P64, DOI 10.1084/jem.165.1.64; Crotty S, 2011, ANNU REV IMMUNOL, V29, P621, DOI 10.1146/annurev-immunol-031210-101400; Cunningham AF, 2007, J IMMUNOL, V178, P6200, DOI 10.4049/jimmunol.178.10.6200; Defrance T, 2011, CURR OPIN IMMUNOL, V23, P330, DOI 10.1016/j.coi.2011.03.004; Dent AL, 1997, SCIENCE, V276, P589, DOI 10.1126/science.276.5312.589; DiLillo DJ, 2008, J IMMUNOL, V180, P361, DOI 10.4049/jimmunol.180.1.361; Dogan I, 2009, NAT IMMUNOL, V10, P1292, DOI 10.1038/ni.1814; DUNNWALTERS DK, 1995, J EXP MED, V182, P559, DOI 10.1084/jem.182.2.559; Ehrhardt GRA, 2008, J EXP MED, V205, P1807, DOI 10.1084/jem.20072682; Ehrhardt GRA, 2005, J EXP MED, V202, P783, DOI 10.1084/jem.20050879; Engels N, 2009, NAT IMMUNOL, V10, P1018, DOI 10.1038/ni.1764; Fukuda T, 1997, J EXP MED, V186, P439, DOI 10.1084/jem.186.3.439; Garside P, 1998, SCIENCE, V281, P96, DOI 10.1126/science.281.5373.96; Good KL, 2007, P NATL ACAD SCI USA, V104, P13420, DOI 10.1073/pnas.0703872104; Good KL, 2009, J IMMUNOL, V182, P890, DOI 10.4049/jimmunol.182.2.890; Good-Jacobson KL, 2010, J IMMUNOL, V185, P3117, DOI 10.4049/jimmunol.1001155; Horikawa K, 2007, J EXP MED, V204, P759, DOI 10.1084/jem.20061923; Hou BD, 2011, IMMUNITY, V34, P375, DOI 10.1016/j.immuni.2011.01.011; Inamine A, 2005, INT IMMUNOL, V17, P581, DOI 10.1093/intimm/dxh241; JACOB J, 1991, NATURE, V354, P389, DOI 10.1038/354389a0; JACOB J, 1992, J EXP MED, V176, P679, DOI 10.1084/jem.176.3.679; JACOB J, 1991, J EXP MED, V173, P1165, DOI 10.1084/jem.173.5.1165; Joo HM, 2008, P NATL ACAD SCI USA, V105, P3485, DOI 10.1073/pnas.0800003105; Kaisho T, 1997, SCIENCE, V276, P412, DOI 10.1126/science.276.5311.412; Kaji T, 2012, J EXP MED, V209, P2079, DOI 10.1084/jem.20120127; Kardava L, 2011, J CLIN INVEST, V121, P2614, DOI 10.1172/JCI45685; Kashiwada M, 2010, P NATL ACAD SCI USA, V107, P821, DOI 10.1073/pnas.0909235107; Kasturi SP, 2011, NATURE, V470, P543, DOI 10.1038/nature09737; Kerfoot SM, 2011, IMMUNITY, V34, P947, DOI 10.1016/j.immuni.2011.03.024; Kitano M, 2011, IMMUNITY, V34, P961, DOI 10.1016/j.immuni.2011.03.025; Kometani K, 2013, IMMUNITY, V39, P136, DOI 10.1016/j.immuni.2013.06.011; Krautler NJ, 2012, CELL, V150, P194, DOI 10.1016/j.cell.2012.05.032; LALOR PA, 1992, EUR J IMMUNOL, V22, P3001, DOI 10.1002/eji.1830221136; Lanzavecchia A, 2002, NAT REV IMMUNOL, V2, P982, DOI 10.1038/nri959; Liu WL, 2010, IMMUNITY, V32, P778, DOI 10.1016/j.immuni.2010.06.006; LIU YJ, 1988, EUR J IMMUNOL, V18, P355, DOI 10.1002/eji.1830180306; Martin SW, 2002, NAT IMMUNOL, V3, P182, DOI 10.1038/ni752; Maruyama M, 2000, NATURE, V407, P636, DOI 10.1038/35036600; Mohr E, 2010, P NATL ACAD SCI USA, V107, P17292, DOI 10.1073/pnas.1004879107; Moir S, 2008, J EXP MED, V205, P1797, DOI 10.1084/jem.20072683; Muellenbeck MF, 2013, J EXP MED, V210, P389, DOI 10.1084/jem.20121970; Okada T, 2012, IMMUNOL REV, V247, P120, DOI 10.1111/j.1600-065X.2012.01120.x; Onodera T, 2012, P NATL ACAD SCI USA, V109, P2485, DOI 10.1073/pnas.1115369109; Pape KA, 2011, SCIENCE, V331, P1203, DOI 10.1126/science.1201730; Pauli NT, 2011, FRONT IMMUNOL, V2, DOI 10.3389/fimmu.2011.00077; Paus D, 2006, J EXP MED, V203, P1081, DOI 10.1084/jem.20060087; Peperzak V, 2013, NAT IMMUNOL, V14, P290, DOI 10.1038/ni.2527; Phan TG, 2006, J EXP MED, V203, P2419, DOI 10.1084/jem.20061254; Portugal S, 2013, J IMMUNOL, V190, P3039, DOI 10.4049/jimmunol.1203067; PULENDRAN B, 1995, J IMMUNOL, V155, P1141; Purtha WE, 2011, J EXP MED, V208, P2599, DOI 10.1084/jem.20110740; Rajewsky K, 1996, NATURE, V381, P751, DOI 10.1038/381751a0; Ridderstad A, 1998, J IMMUNOL, V160, P4688; Rothaeusler K, 2010, EUR J IMMUNOL, V40, P366, DOI 10.1002/eji.200939798; Scheid JF, 2011, P NATL ACAD SCI USA, V108, P18044, DOI 10.1073/pnas.1113395108; Scheid JF, 2009, J IMMUNOL METHODS, V343, P65, DOI 10.1016/j.jim.2008.11.012; SCHITTEK B, 1992, J EXP MED, V176, P427, DOI 10.1084/jem.176.2.427; Scholz JL, 2008, P NATL ACAD SCI USA, V105, P15517, DOI 10.1073/pnas.0807841105; Shlomchik MJ, 2012, IMMUNOL REV, V247, P52, DOI 10.1111/j.1600-065X.2012.01124.x; Slifka MK, 1998, IMMUNITY, V8, P363, DOI 10.1016/S1074-7613(00)80541-5; Smith K, 2009, NAT PROTOC, V4, P372, DOI 10.1038/nprot.2009.3; Smith KGC, 1996, EUR J IMMUNOL, V26, P444, DOI 10.1002/eji.1830260226; Smith KGC, 2000, J EXP MED, V191, P475, DOI 10.1084/jem.191.3.475; Smith KGC, 1997, EMBO J, V16, P2996, DOI 10.1093/emboj/16.11.2996; Sohn HW, 2011, BLOOD, V118, P6332, DOI 10.1182/blood-2011-05-353102; Stavnezer J, 1996, CURR OPIN IMMUNOL, V8, P199, DOI 10.1016/S0952-7915(96)80058-6; Takahashi Y, 2001, IMMUNITY, V14, P181, DOI 10.1016/S1074-7613(01)00100-5; Tangye SG, 2003, J IMMUNOL, V170, P686, DOI 10.4049/jimmunol.170.2.686; Tangye SG, 2007, J IMMUNOL, V179, P13, DOI 10.4049/jimmunol.179.1.13; Tarlinton D, 2008, CURR OPIN IMMUNOL, V20, P162, DOI 10.1016/j.coi.2008.03.016; Tarlinton D, 2006, NAT REV IMMUNOL, V6, P785, DOI 10.1038/nri1938; Taylor JJ, 2012, J EXP MED, V209, P597, DOI 10.1084/jem.20111696; Tomaras GD, 2013, P NATL ACAD SCI USA, V110, P9019, DOI 10.1073/pnas.1301456110; Tomayko MM, 2008, J IMMUNOL, V181, P27, DOI 10.4049/jimmunol.181.1.27; Tomayko MM, 2010, J IMMUNOL, V185, P7146, DOI 10.4049/jimmunol.1002163; Toyama H, 2002, IMMUNITY, V17, P329, DOI 10.1016/S1074-7613(02)00387-4; VANROOIJEN N, 1986, IMMUNOL TODAY, V7, P193, DOI 10.1016/0167-5699(86)90100-3; Victora GD, 2010, CELL, V143, P592, DOI 10.1016/j.cell.2010.10.032; VIEIRA P, 1990, INT IMMUNOL, V2, P487, DOI 10.1093/intimm/2.6.487; Vikstrom I, 2010, SCIENCE, V330, P1095, DOI 10.1126/science.1191793; Vinuesa CG, 2010, IMMUNOL REV, V237, P72, DOI 10.1111/j.1600-065X.2010.00937.x; Wang NS, 2012, NAT IMMUNOL, V13, P604, DOI 10.1038/ni.2294; Weill JC, 2013, CURR OPIN IMMUNOL, V25, P334, DOI 10.1016/j.coi.2013.05.004; Weiss GE, 2009, J IMMUNOL, V183, P2176, DOI 10.4049/jimmunol.0901297; Weller S, 2004, BLOOD, V104, P3647, DOI 10.1182/blood-2004-01-0346; Williams MB, 1998, J IMMUNOL, V161, P4227; Wrammert J, 2011, J EXP MED, V208, P181, DOI 10.1084/jem.20101352; Wu YC, 2010, BLOOD, V116, P1070, DOI 10.1182/blood-2010-03-275859; Xu HP, 2013, NATURE, V496, P523, DOI 10.1038/nature12058; Zielinski CE, 2011, IMMUNOL REV, V240, P40, DOI 10.1111/j.1600-065X.2010.01000.x	103	145	148	0	52	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 13	2013	341	6151					1205	1211		10.1126/science.1241146	http://dx.doi.org/10.1126/science.1241146			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	215ZA	24031013				2022-12-24	WOS:000324248800033
J	van Geen, A; Bostick, BC; Trang, PTK; Lan, VM; Mai, NN; Manh, PD; Viet, PH; Radloff, K; Aziz, Z; Mey, JL; Stahl, MO; Harvey, CF; Oates, P; Weinman, B; Stengel, C; Frei, F; Kipfer, R; Berg, M				van Geen, Alexander; Bostick, Benjamin C.; Pham Thi Kim Trang; Vi Mai Lan; Nguyen-Ngoc Mai; Phu Dao Manh; Pham Hung Viet; Radloff, Kathleen; Aziz, Zahid; Mey, Jacob L.; Stahl, Mason O.; Harvey, Charles F.; Oates, Peter; Weinman, Beth; Stengel, Caroline; Frei, Felix; Kipfer, Rolf; Berg, Michael			Retardation of arsenic transport through a Pleistocene aquifer	NATURE			English	Article							RIVER FLOOD-PLAIN; GEOCHEMICAL PROCESSES; DRINKING-WATER; NOBLE-GASES; GROUNDWATER; BANGLADESH; VIETNAM; RELEASE; DELTA; MIGRATION	Groundwater drawn daily from shallow alluvial sands by millions of wells over large areas of south and southeast Asia exposes an estimated population of over a hundred million people to toxic levels of arsenic(1). Holocene aquifers are the source of widespread arsenic poisoning across the region(2,3). In contrast, Pleistocene sands deposited in this region more than 12,000 years ago mostly do not host groundwater with high levels of arsenic. Pleistocene aquifers are increasingly used as a safe source of drinking water(4) and it is therefore important to understand under what conditions low levels of arsenic can be maintained. Here we reconstruct the initial phase of contamination of a Pleistocene aquifer near Hanoi, Vietnam. We demonstrate that changes in groundwater flow conditions and the redox state of the aquifer sands induced by groundwater pumping caused the lateral intrusion of arsenic contamination more than 120 metres from a Holocene aquifer into a previously uncontaminated Pleistocene aquifer. We also find that arsenic adsorbs onto the aquifer sands and that there is a 16-20-fold retardation in the extent of the contamination relative to the reconstructed lateral movement of groundwater over the same period. Our findings suggest that arsenic contamination of Pleistocene aquifers in south and southeast Asia as a consequence of increasing levels of groundwater pumping may have been delayed by the retardation of arsenic transport.	[van Geen, Alexander; Bostick, Benjamin C.; Radloff, Kathleen; Aziz, Zahid; Mey, Jacob L.] Columbia Univ, Lamont Doherty Earth Observ, Palisades, NY 10964 USA; [Pham Thi Kim Trang; Vi Mai Lan; Nguyen-Ngoc Mai; Phu Dao Manh; Pham Hung Viet] Vietnam Natl Univ, Hanoi Univ Sci, Res Ctr Environm Technol & Sustainable Dev CETASD, Hanoi, Vietnam; [Mey, Jacob L.] Kingsborough Community Coll, Dept Phys Sci, Brooklyn, NY 11235 USA; [Stahl, Mason O.; Harvey, Charles F.] MIT, Cambridge, MA 02139 USA; [Oates, Peter] Anchor QEA, Montvale, NJ 07645 USA; [Weinman, Beth] Vanderbilt Univ, Nashville, TN 37235 USA; [Stengel, Caroline; Frei, Felix; Kipfer, Rolf; Berg, Michael] Eawag, Swiss Fed Inst Aquat Sci & Technol, CH-8600 Dubendorf, Switzerland; [Kipfer, Rolf] Zurich ETHZ, Swiss Fed Inst Technol, Inst Geochem & Petrol, CH-8092 Zurich, Switzerland	Columbia University; Vietnam National University Hanoi; City University of New York (CUNY) System; Massachusetts Institute of Technology (MIT); Vanderbilt University; Swiss Federal Institutes of Technology Domain; Swiss Federal Institute of Aquatic Science & Technology (EAWAG); Swiss Federal Institutes of Technology Domain; ETH Zurich	van Geen, A (corresponding author), Columbia Univ, Lamont Doherty Earth Observ, Palisades, NY 10964 USA.	avangeen@ldeo.columbia.edu	harvey, charles F/A-8601-2012; Bostick, Benjamin C/F-6299-2018; Mey, Jacob/D-5957-2014; Stahl, Mason/AGT-7430-2022; Hung, Viet Pham/AAB-5775-2022; Weinman, Beth/AAY-4156-2020; Pham, Viet H./C-8027-2017; Berg, Michael/C-3738-2012	harvey, charles F/0000-0002-7759-4447; Bostick, Benjamin C/0000-0002-7513-6469; Mey, Jacob/0000-0003-0116-4149; Stahl, Mason/0000-0001-6379-9890; Berg, Michael/0000-0002-7342-4061	NSF [EAR 09-11557]; Swiss Agency for Development and Cooperation [NAFOSTED 105-09-59-09]; NIEHS [P42 ES010349, P42 ES016454]; Directorate For Geosciences [0911557] Funding Source: National Science Foundation; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P42ES010349, P42ES016454] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); Swiss Agency for Development and Cooperation; NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This study was supported by NSF grant EAR 09-11557, the Swiss Agency for Development and Cooperation, grant NAFOSTED 105-09-59-09 to CETASD, and NIEHS grants P42 ES010349 and P42 ES016454. This is Lamont-Doherty Earth Observatory contribution number 7698.	Ahmed MF, 2006, SCIENCE, V314, P1687, DOI 10.1126/science.1133146; Berg M, 2008, CHEM GEOL, V249, P91, DOI 10.1016/j.chemgeo.2007.12.007; Berg M, 2007, SCI TOTAL ENVIRON, V372, P413, DOI 10.1016/j.scitotenv.2006.09.010; Beyerle U, 2000, ENVIRON SCI TECHNOL, V34, P2042, DOI 10.1021/es990840h; *BGS DPHE, 2001, ARS CONT GROUNDW BAN; Cheng Z, 2004, ANAL BIOANAL CHEM, V379, P512, DOI 10.1007/s00216-004-2618-x; Dhar RK, 2011, ENVIRON SCI TECHNOL, V45, P2648, DOI 10.1021/es1022015; Eiche E, 2008, APPL GEOCHEM, V23, P3143, DOI 10.1016/j.apgeochem.2008.06.023; Fendorf S, 2010, SCIENCE, V328, P1123, DOI 10.1126/science.1172974; Frei F., 2007, THESIS ETH ZURICH; Funabiki A, 2007, J ASIAN EARTH SCI, V30, P518, DOI 10.1016/j.jseaes.2006.11.013; Horneman A, 2004, GEOCHIM COSMOCHIM AC, V68, P3459, DOI 10.1016/j.gca.2004.01.026; Islam FS, 2004, NATURE, V430, P68, DOI 10.1038/nature02638; Itai T, 2010, APPL GEOCHEM, V25, P34, DOI 10.1016/j.apgeochem.2009.09.026; Jessen S, 2012, GEOCHIM COSMOCHIM AC, V98, P186, DOI 10.1016/j.gca.2012.07.014; Kipfer R, 2002, REV MINERAL GEOCHEM, V47, P615, DOI 10.2138/rmg.2002.47.14; Klump S, 2006, ENVIRON SCI TECHNOL, V40, P243, DOI 10.1021/es051284w; Koroleff F., 1974, METHODS SEAWATER ANA, P126; Larsen F, 2008, APPL GEOCHEM, V23, P3099, DOI 10.1016/j.apgeochem.2008.06.014; Mailloux BJ, 2013, P NATL ACAD SCI USA, V110, P5331, DOI 10.1073/pnas.1213141110; McArthur JM, 2010, WATER RES, V44, P4171, DOI 10.1016/j.watres.2010.05.010; McArthur JM, 2008, WATER RESOUR RES, V44, DOI 10.1029/2007WR006552; Mukherjee A, 2011, APPL GEOCHEM, V26, P600, DOI 10.1016/j.apgeochem.2011.01.017; Nath B, 2009, J HYDROL, V364, P236, DOI 10.1016/j.jhydrol.2008.10.025; Neumann RB, 2010, NAT GEOSCI, V3, P46, DOI 10.1038/NGEO685; Polizzotto ML, 2008, NATURE, V454, P505, DOI 10.1038/nature07093; Postma D, 2007, GEOCHIM COSMOCHIM AC, V71, P5054, DOI 10.1016/j.gca.2007.08.020; Postma D, 2012, NAT GEOSCI, V5, P656, DOI [10.1038/ngeo1540, 10.1038/NGEO1540]; Radloff KA, 2011, NAT GEOSCI, V4, P793, DOI [10.1038/ngeo1283, 10.1038/NGEO1283]; Ravenscroft P., 2009, RGS IBG BOOK SERIES; Stollenwerk KG, 2007, SCI TOTAL ENVIRON, V379, P133, DOI 10.1016/j.scitotenv.2006.11.029; Stute M, 2007, WATER RESOUR RES, V43, DOI 10.1029/2005WR004499; Thu TM, 2000, CAN GEOTECH J, V37, P621, DOI 10.1139/t99-126; van Geen A, 2008, ENVIRON SCI TECHNOL, V42, P2283, DOI 10.1021/es702316k; van Geen A, 2008, APPL GEOCHEM, V23, P3244, DOI 10.1016/j.apgeochem.2008.07.005; Van Geen A, 2007, J ENVIRON SCI HEAL A, V42, P1729, DOI 10.1080/10934520701564236; Winkel LHE, 2011, P NATL ACAD SCI USA, V108, P1246, DOI 10.1073/pnas.1011915108; Zheng Y, 2005, GEOCHIM COSMOCHIM AC, V69, P5203, DOI 10.1016/j.gca.2005.06.001	38	115	115	5	244	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 12	2013	501	7466					204	+		10.1038/nature12444	http://dx.doi.org/10.1038/nature12444			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	215XR	24025840	Green Submitted, Green Accepted			2022-12-24	WOS:000324244900037
J	Antoine, MW; Hubner, CA; Arezzo, JC; Hebert, JM				Antoine, Michelle W.; Huebner, Christian A.; Arezzo, Joseph C.; Hebert, Jean M.			A Causative Link Between Inner Ear Defects and Long-Term Striatal Dysfunction	SCIENCE			English	Article							COTRANSPORTER; CHILDREN; ERK; IDENTIFICATION; AMPHETAMINE; ACTIVATION; DOPAMINE; DEAFNESS; CASCADE; RAT	There is a high prevalence of behavioral disorders that feature hyperactivity in individuals with severe inner ear dysfunction. What remains unknown is whether inner ear dysfunction can alter the brain to promote pathological behavior. Using molecular and behavioral assessments of mice that carry null or tissue-specific mutations of Slc12a2, we found that inner ear dysfunction causes motor hyperactivity by increasing in the nucleus accumbens the levels of phosphorylated adenosine 3',5'-monophosphate response element-binding protein (pCREB) and phosphorylated extracellular signal-regulated kinase (pERK), key mediators of neurotransmitter signaling and plasticity. Hyperactivity was remedied by local administration of the pERK inhibitor SL327. These findings reveal that a sensory impairment, such as inner ear dysfunction, can induce specific molecular changes in the brain that cause maladaptive behaviors, such as hyperactivity, that have been traditionally considered exclusively of cerebral origin.	[Antoine, Michelle W.; Arezzo, Joseph C.; Hebert, Jean M.] Albert Einstein Coll Med, Dept Neurosci, Bronx, NY 10461 USA; [Huebner, Christian A.] Jena Univ Hosp, Inst Human Genet, D-07743 Jena, Germany; [Hebert, Jean M.] Albert Einstein Coll Med, Dept Genet, Bronx, NY 10461 USA	Yeshiva University; Albert Einstein College of Medicine; Friedrich Schiller University of Jena; Yeshiva University; Albert Einstein College of Medicine	Hebert, JM (corresponding author), Albert Einstein Coll Med, Dept Neurosci, Bronx, NY 10461 USA.	jean.hebert@einstein.yu.edu	Hübner, Christian/A-2950-2017	Hübner, Christian/0000-0002-1030-4943	Tourette Syndrome Association; NIH [R21NS073761, R01MH083804]; Deutsche Forschungsgemeinschaft [HU 800/5-1]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH070596, R01MH083804] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS073761] Funding Source: NIH RePORTER	Tourette Syndrome Association; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank K. Khodakhah and P. Calderon for support with surgical approaches, rotarod, and early inputs to the project; G. Fishell for the Nestin-CreER mice in which Slc12a2<SUP>K842*</SUP> arose; S. Zukin for Western blotting; C. Heinze for Slc12a2<SUP>fx</SUP> genotyping; University of California at Davis and NIH NeuroMab for antibodies; and the Developmental Studies Hybridoma Bank for the T4 antibody developed by Lytle and Forbush. This work was supported by the Tourette Syndrome Association (J.M.H. and K. Khodakhah), NIH R21NS073761 and R01MH083804 (J.H.), and Deutsche Forschungsgemeinschaft HU 800/5-1 (C.A.H.).	Atkins CM, 1998, NAT NEUROSCI, V1, P602, DOI 10.1038/2836; Baldessarini R. J., 2006, GOODMAN GILMANS TXB, P317; Choe ES, 2002, NEUROREPORT, V13, P1013, DOI 10.1097/00001756-200206120-00006; Crouch JJ, 1997, J HISTOCHEM CYTOCHEM, V45, P773, DOI 10.1177/002215549704500601; Cushing SL, 2008, LARYNGOSCOPE, V118, P1814, DOI 10.1097/MLG.0b013e31817fadfa; Delpire E, 1999, NAT GENET, V22, P192, DOI 10.1038/9713; Deol M S, 1968, J Med Genet, V5, P137, DOI 10.1136/jmg.5.2.137; Dixon MJ, 1999, HUM MOL GENET, V8, P1579, DOI 10.1093/hmg/8.8.1579; Dubois NC, 2006, GENESIS, V44, P355, DOI 10.1002/dvg.20226; Favata MF, 1998, J BIOL CHEM, V273, P18623, DOI 10.1074/jbc.273.29.18623; Flagella M, 1999, J BIOL CHEM, V274, P26946, DOI 10.1074/jbc.274.38.26946; Gerdjikov TV, 2004, BEHAV NEUROSCI, V118, P740, DOI 10.1037/0735-7044.118.4.740; Gorski JA, 2002, J NEUROSCI, V22, P6309; Hindley P, 1998, J Deaf Stud Deaf Educ, V3, P64; Kimmel RA, 2000, GENE DEV, V14, P1377; Lambert FM, 2012, CURR BIOL, V22, P1649, DOI 10.1016/j.cub.2012.07.019; Pace AJ, 2000, J CLIN INVEST, V105, P441, DOI 10.1172/JCI8553; Plotkin MD, 1997, AM J PHYSIOL-CELL PH, V272, pC173, DOI 10.1152/ajpcell.1997.272.1.C173; Salzmann J, 2003, BRIT J PHARMACOL, V140, P831, DOI 10.1038/sj.bjp.0705506; Schirmer M, 2007, BRAIN RES, V1155, P179, DOI 10.1016/j.brainres.2007.04.012; Selcher JC, 1999, LEARN MEMORY, V6, P478, DOI 10.1101/lm.6.5.478; Selz PA, 1996, OTOLARYNG HEAD NECK, V115, P70, DOI 10.1016/S0194-5998(96)70139-0; Shiroyama T, 1999, J COMP NEUROL, V407, P318; Silva AJ, 1998, ANNU REV NEUROSCI, V21, P127, DOI 10.1146/annurev.neuro.21.1.127; Stenman J, 2003, J NEUROSCI, V23, P167; Stiles L, 2012, BEHAV BRAIN RES, V227, P150, DOI 10.1016/j.bbr.2011.11.006; Valjent E, 2005, P NATL ACAD SCI USA, V102, P491, DOI 10.1073/pnas.0408305102; Van Eldik T, 2004, AM ANN DEAF, V148, P390, DOI 10.1353/aad.2004.0002; van Gent T, 2007, J CHILD PSYCHOL PSYC, V48, P950, DOI 10.1111/j.1469-7610.2007.01775.x; Vostanis P, 1997, CHILD CARE HLTH DEV, V23, P233, DOI 10.1111/j.1365-2214.1997.tb00966.x	30	25	25	0	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 6	2013	341	6150					1120	1123		10.1126/science.1240405	http://dx.doi.org/10.1126/science.1240405			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	211TG	24009395	Green Accepted			2022-12-24	WOS:000323933100047
J	Whittier, SK; Hengge, AC; Loria, JP				Whittier, Sean K.; Hengge, Alvan C.; Loria, J. Patrick			Conformational Motions Regulate Phosphoryl Transfer in Related Protein Tyrosine Phosphatases	SCIENCE			English	Article							TRIOSEPHOSPHATE ISOMERASE; DIHYDROFOLATE-REDUCTASE; CHEMICAL-EXCHANGE; ENZYME CATALYSIS; LOOP DYNAMICS; STATE; 1B	Many studies have implicated a role for conformational motions during the catalytic cycle, acting to optimize the binding pocket or facilitate product release, but a more intimate role in the chemical reaction has not been described. We address this by monitoring active-site loop motion in two protein tyrosine phosphatases (PTPs) using nuclear magnetic resonance spectroscopy. The PTPs, YopH and PTP1B, have very different catalytic rates; however, we find in both that the active-site loop closes to its catalytically competent position at rates that mirror the phosphotyrosine cleavage kinetics. This loop contains the catalytic acid, suggesting that loop closure occurs concomitantly with the protonation of the leaving group tyrosine and explains the different kinetics of two otherwise chemically and mechanistically indistinguishable enzymes.	[Whittier, Sean K.; Loria, J. Patrick] Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA; [Hengge, Alvan C.] Utah State Univ, Dept Chem & Biochem, Logan, UT 84322 USA; [Loria, J. Patrick] Yale Univ, Dept Chem, New Haven, CT 06520 USA	Yale University; Utah System of Higher Education; Utah State University; Yale University	Loria, JP (corresponding author), Yale Univ, Dept Mol Biophys & Biochem, 260 Whitney Ave, New Haven, CT 06520 USA.	patrick.loria@yale.edu	Hengge, Alvan/C-8667-2011	Hengge, Alvan/0000-0002-5696-2087	 [NIH-T32GM008283];  [NIH-GM47297];  [NSF-MCB1121372]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM047297, T32GM008283, R29GM047297] Funding Source: NIH RePORTER	; ; ; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank J. Hoch, D. Korzhnev, M. Maciejewski, and G. Armstrong for access to their high-field NMR instruments and G. Khirich for running Monte Carlo simulations. S.K.W., A.C.H., and J.PL. acknowledge support from grants NIH-T32GM008283, NIH-GM47297, and NSF-MCB1121372.	Adamczyk AJ, 2011, P NATL ACAD SCI USA, V108, P14115, DOI 10.1073/pnas.1111252108; Antoniou D, 2012, J PHYS CHEM LETT, V3, P3538, DOI 10.1021/jz301670s; BARFORD D, 1994, SCIENCE, V263, P1397, DOI 10.1126/science.8128219; Beach H, 2005, J AM CHEM SOC, V127, P9167, DOI 10.1021/ja0514949; Bhabha G, 2011, SCIENCE, V332, P234, DOI 10.1126/science.1198542; Boehr DD, 2006, SCIENCE, V313, P1638, DOI 10.1126/science.1130258; Brandao TAS, 2010, J BIOL CHEM, V285, P15874, DOI 10.1074/jbc.M109.066951; BRUBAKER RR, 1991, CLIN MICROBIOL REV, V4, P309, DOI 10.1128/CMR.4.3.309-324.1991; BURKE TR, 1994, BIOCHEM BIOPH RES CO, V204, P129, DOI 10.1006/bbrc.1994.2435; Desamero R, 2003, BIOCHEMISTRY-US, V42, P2941, DOI 10.1021/bi026994i; Eichmuller C, 2005, J BIOMOL NMR, V32, P281, DOI 10.1007/s10858-005-0658-y; Eisenmesser EZ, 2005, NATURE, V438, P117, DOI 10.1038/nature04105; HENGGE AC, 1995, BIOCHEMISTRY-US, V34, P13982, DOI 10.1021/bi00043a003; Henzler-Wildman KA, 2007, NATURE, V450, P838, DOI 10.1038/nature06410; Hu X, 2006, BIOPHYS J, V91, P948, DOI 10.1529/biophysj.105.080259; JOSEPH D, 1990, SCIENCE, V249, P1425, DOI 10.1126/science.2402636; Juszczak LJ, 1997, BIOCHEMISTRY-US, V36, P2227, DOI 10.1021/bi9622130; Kamerlin SCL, 2010, PROTEINS, V78, P1339, DOI 10.1002/prot.22654; Keng YF, 1999, EUR J BIOCHEM, V259, P809, DOI 10.1046/j.1432-1327.1999.00090.x; Khajehpour M, 2007, BIOCHEMISTRY-US, V46, P4370, DOI 10.1021/bi602335x; Liu SJ, 2008, J AM CHEM SOC, V130, P17075, DOI 10.1021/ja8068177; Loria JP, 1999, J BIOMOL NMR, V15, P151, DOI 10.1023/A:1008355631073; Pedersen AK, 2004, ACTA CRYSTALLOGR D, V60, P1527, DOI 10.1107/S0907444904015094; Rozovsky S, 2007, P NATL ACAD SCI USA, V104, P2080, DOI 10.1073/PNAS.0608876104; Silva RG, 2011, P NATL ACAD SCI USA, V108, P18661, DOI 10.1073/pnas.1114900108; Wang CY, 2003, J AM CHEM SOC, V125, P8968, DOI 10.1021/ja035139z; Wolf-Watz M, 2004, NAT STRUCT MOL BIOL, V11, P945, DOI 10.1038/nsmb821; ZHANG ZY, 1993, P NATL ACAD SCI USA, V90, P4446, DOI 10.1073/pnas.90.10.4446; ZHANG ZY, 1995, J BIOL CHEM, V270, P11199, DOI 10.1074/jbc.270.19.11199; Zhang ZY, 2001, CURR OPIN CHEM BIOL, V5, P416, DOI 10.1016/S1367-5931(00)00223-4	30	115	115	1	65	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 23	2013	341	6148					899	903		10.1126/science.1241735	http://dx.doi.org/10.1126/science.1241735			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204MY	23970698	Green Accepted			2022-12-24	WOS:000323370600046
J	Colbert, JA				Colbert, James A.			Experiments in Continuity Rethinking Residency Training in Ambulatory Care	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							INTERNAL-MEDICINE		[Colbert, James A.] Newton Wellesley Hosp, Dept Med, Newton, MA USA; [Colbert, James A.] Brigham & Womens Hosp, Div Med Commun, Boston, MA 02115 USA	Newton Wellesley Hospital; Harvard University; Brigham & Women's Hospital	Colbert, JA (corresponding author), Newton Wellesley Hosp, Dept Med, Newton, MA USA.							Bodenheimer T, 2011, NEW ENGL J MED, V365, P5, DOI 10.1056/NEJMp1104942; Chang A, 2013, J GEN INTERN MED, V28, P801, DOI 10.1007/s11606-012-2193-3; Meyers FJ, 2007, ACAD MED, V82, P1211, DOI 10.1097/ACM.0b013e318159d010; Mladenovic J, 2008, J GEN INTERN MED, V23, P914, DOI 10.1007/s11606-008-0511-6; Warm EJ, 2008, J GEN INTERN MED, V23, P921, DOI 10.1007/s11606-008-0588-y	5	8	8	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 8	2013	369	6					504	505		10.1056/NEJMp1301604	http://dx.doi.org/10.1056/NEJMp1301604			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	197HX	23924001				2022-12-24	WOS:000322842000005
J	Steventon, A; Tunkel, S; Blunt, I; Bardsley, M				Steventon, Adam; Tunkel, Sarah; Blunt, Ian; Bardsley, Martin			Effect of telephone health coaching (Birmingham OwnHealth) on hospital use and associated costs: cohort study with matched controls	BMJ-BRITISH MEDICAL JOURNAL			English	Article							PROPENSITY-SCORE; CORONARY-ANGIOGRAPHY; MEDICAL LITERATURE; CRITICAL-APPRAISAL; CARE; PEOPLE; INTERVENTION; MORTALITY; ADMISSION; SERVICE	Objectives To test the effect of a telephone health coaching service (Birmingham OwnHealth) on hospital use and associated costs. Design Analysis of person level administrative data. Difference-in-difference analysis was done relative to matched controls. Setting Community based intervention operating in a large English city with industry. Participants 2698 patients recruited from local general practices before 2009 with heart failure, coronary heart disease, diabetes, or chronic obstructive pulmonary disease; and a history of inpatient or outpatient hospital use. These individuals were matched on a 1:1 basis to control patients from similar areas of England with respect to demographics, diagnoses of health conditions, previous hospital use, and a predictive risk score. Intervention Telephone health coaching involved a personalised care plan and a series of outbound calls usually scheduled monthly. Median length of time enrolled on the service was 25.5 months. Control participants received usual healthcare in their areas, which did not include telephone health coaching. Main outcome measures Number of emergency hospital admissions per head over 12 months after enrolment. Secondary metrics calculated over 12 months were: hospital bed days, elective hospital admissions, outpatient attendances, and secondary care costs. Results In relation to diagnoses of health conditions and other baseline variables, matched controls and intervention patients were similar before the date of enrolment. After this point, emergency admissions increased more quickly among intervention participants than matched controls (difference 0.05 admissions per head, 95% confidence interval 0.00 to 0.09, P=0.046). Outpatient attendances also increased more quickly in the intervention group (difference 0.37 attendances per head, 0.16 to 0.58, P<0.001), as did secondary care costs (difference 175 pound per head, 22 pound to 328 pound, P=0.025). Checks showed that we were unlikely to have missed reductions in emergency admissions because of unobserved differences between intervention and matched control groups. Conclusions The Birmingham OwnHealth telephone health coaching intervention did not lead to the expected reductions in hospital admissions or secondary care costs over 12 months, and could have led to increases.	[Steventon, Adam; Blunt, Ian; Bardsley, Martin] Nuffield Trust, London W1G 7LP, England; [Tunkel, Sarah] Ernst & Young, London SE1 2AF, England		Steventon, A (corresponding author), Nuffield Trust, London W1G 7LP, England.	adam.steventon@nuffieldtrust.org.uk			Department of Health in England	Department of Health in England	This study was funded by the Department of Health in England, which reviewed the study protocol as part of the application for funding and agreed to publication. The views expressed are those of the authors and not of the Department of Health and does not constitute any form of assurance, legal opinion or advice. The organisations at which the authors are based shall have no liability to any third party in respect to the contents of this article.	Alkema GE, 2007, HEALTH SERV RES, V42, P1632, DOI 10.1111/j.1475-6773.2006.00668.x; Austin PC, 2008, STAT MED, V27, P2037, DOI 10.1002/sim.3150; Austin PC, 2008, STAT MED, V27, P2066, DOI 10.1002/sim.3243; Azarmina P, 2007, J TELEMED TELECARE, V13, pS3; Bardsley M, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2012-002007; Billings J, 2006, BRIT MED J, V333, P327, DOI 10.1136/bmj.38870.657917.AE; Birmingham East and North NHS NHS Direct and Pfizer Health Solutions, 2007, OWNHEALTH BIRM SUCC; Communities and Local Government, 2008, ENGLISH INDICES DEPR; Direct NHS, 2011, CHIEF EX REP AG IT 6; Fouche Eveline, 2009, RAMZI ADAM; Govan L, 2011, DIABETES CARE, V34, P1992, DOI 10.2337/dc10-2099; Gravelle H, 2006, BMJ; Groenwold RHH, 2009, J CLIN EPIDEMIOL, V62, P22, DOI 10.1016/j.jclinepi.2008.02.011; Haynes B, 1999, BRIT MED J, V319, P652, DOI 10.1136/bmj.319.7211.652; Higashi T, 2005, ANN INTERN MED, V143, P274, DOI 10.7326/0003-4819-143-4-200508160-00008; Ho DE, 2007, POLIT ANAL, V15, P199, DOI 10.1093/pan/mpl013; Hutchison AJ, 2011, J TELEMED TELECARE, V17, P451, DOI 10.1258/jtt.2011.110513; Imai K, 2008, J R STAT SOC A STAT, V171, P481, DOI 10.1111/j.1467-985X.2007.00527.x; Information Centre for health and social care, 2012, QUAL OUTC FRAM ACH P; Jordan RE, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-707; Kim SE, 2013, HEALTH SERV RES, V48, P1730, DOI 10.1111/1475-6773.12060; Lin WC, 2012, MED CARE, V50, P91, DOI 10.1097/MLR.0b013e31822dcedf; Lucas FL, 2008, CIRCULATION, V118, P2797, DOI 10.1161/CIRCULATIONAHA.108.789446; McLean S, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d120; Motheral Brenda R, 2011, Am J Manag Care, V17, pe10; Normand SLT, 2001, J CLIN EPIDEMIOL, V54, P387, DOI 10.1016/S0895-4356(00)00321-8; Office for National Statistics, NAT STAT 2001 AR CLA; Richards SH, 2003, HEALTH SOC CARE COMM, V11, P510, DOI 10.1046/j.1365-2524.2003.00457.x; Roland M, 2005, BRIT MED J, V330, P289, DOI 10.1136/bmj.330.7486.289; ROOS LL, 1993, MED CARE, V31, P201, DOI 10.1097/00005650-199303000-00002; ROSENBAUM PR, 1983, BIOMETRIKA, V70, P41, DOI 10.1093/biomet/70.1.41; ROSENBAUM PR, 1985, AM STAT, V39, P33, DOI 10.2307/2683903; Rothwell PM, 2005, LANCET, V365, P82, DOI 10.1016/S0140-6736(04)17670-8; Steventon Adam, 2012, BMJ, V344, pe3874, DOI 10.1136/bmj.e3874; Steventon A, 2012, HEALTH SERV RES, V47, P1679, DOI 10.1111/j.1475-6773.2011.01367.x; Subramanian U, 2004, TELEMED J E-HEALTH, V10, P155, DOI 10.1089/1530562041641345; The Health and Social Care information Centre, 2012, HOSP EP STAT; Wennberg DE, 2010, NEW ENGL J MED, V363, P1245, DOI 10.1056/NEJMsa0902321; Wennberg JE, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f549; West SG, 2008, AM J PUBLIC HEALTH, V98, P1359, DOI 10.2105/AJPH.2007.124446	41	26	27	0	18	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 6	2013	347								f4585	10.1136/bmj.f4585	http://dx.doi.org/10.1136/bmj.f4585			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	201CT	23920348	hybrid, Green Published			2022-12-24	WOS:000323119000001
J	Uzureau, P; Uzureau, S; Lecordier, L; Fontaine, F; Tebabi, P; Homble, F; Grelard, A; Zhendre, V; Nolan, DP; Lins, L; Crowet, JM; Pays, A; Felu, C; Poelvoorde, P; Vanhollebeke, B; Moestrup, SK; Lyngso, J; Pedersen, JS; Mottram, JC; Dufourc, EJ; Perez-Morga, D; Pays, E				Uzureau, Pierrick; Uzureau, Sophie; Lecordier, Laurence; Fontaine, Frederic; Tebabi, Patricia; Homble, Fabrice; Grelard, Axelle; Zhendre, Vanessa; Nolan, Derek P.; Lins, Laurence; Crowet, Jean-Marc; Pays, Annette; Felu, Cecile; Poelvoorde, Philippe; Vanhollebeke, Benoit; Moestrup, Soren K.; Lyngso, Jeppe; Pedersen, Jan Skov; Mottram, Jeremy C.; Dufourc, Erick J.; Perez-Morga, David; Pays, Etienne			Mechanism of Trypanosoma brucei gambiense resistance to human serum	NATURE			English	Article							BLOOD-STREAM FORMS; HAPTOGLOBIN-HEMOGLOBIN RECEPTOR; LYTIC FACTOR; TRYPANOLYTIC FACTOR; EXPRESSION; GENE; DIFFERENTIATION; GLYCOPROTEIN; AGGREGATION; MEMBRANES	The African parasite Trypanosoma brucei gambiense accounts for 97% of human sleeping sickness cases(1). T. b. gambiense resists the specific human innate immunity acting against several other tsetsefly-transmitted trypanosome species such as T. b. brucei, the causative agent of nagana disease in cattle. Human immunity to some African trypanosomes is due to two serum complexes designated trypanolytic factors (TLF-1 and -2), which both contain haptoglobin-related protein (HPR) and apolipoprotein LI (APOL1)(2-4). Whereas HPR association with haemoglobin (Hb) allows TLF-1 binding and uptake via the trypanosome receptor TbHpHbR (ref. 5), TLF-2 enters trypanosomes independently of TbHpHbR (refs 4, 5). APOL1 kills trypanosomes after insertion into endosomal/lysosomal membranes(2,6,7). Here we report that T. b. gambiense resists TLFs via a hydrophobic beta-sheet of the T. b. gambiense-specific glycoprotein (TgsGP)(8), which prevents APOL1 toxicity and induces stiffening of membranes upon interaction with lipids. Two additional features contribute to resistance to TLFs: reduction of sensitivity to APOL1 requiring cysteine protease activity, and TbHpHbR inactivation due to a L210S substitution. According to such a multifactorial defence mechanism, transgenic expression of T. b. brucei TbHpHbR in T. b. gambiense did not cause parasite lysis in normal human serum. However, these transgenic parasites were killed in hypohaptoglobinaemic serum, after high TLF-1 uptake in the absence of haptoglobin (Hp) that competes for Hb and receptor binding. TbHpHbR inactivation preventing high APOL1 loading in hypohaptoglobinaemic serum may have evolved because of the overlapping endemic area of T. b. gambiense infection and malaria, the main cause of haemolysis-induced hypohaptoglobinaemia in western and central Africa(9).	[Uzureau, Pierrick; Uzureau, Sophie; Lecordier, Laurence; Fontaine, Frederic; Tebabi, Patricia; Pays, Annette; Felu, Cecile; Poelvoorde, Philippe; Vanhollebeke, Benoit] Univ Libre Bruxelles ULB, IBMM, Lab Mol Parasitol, B-6041 Gosselies, Belgium; [Homble, Fabrice] Univ Libre Bruxelles, B-1050 Brussels, Belgium; [Grelard, Axelle; Zhendre, Vanessa; Dufourc, Erick J.] Univ Bordeaux, Inst Polytech Bordeaux, Inst Chem & Biol Membranes & Nanoobjects, CNRS,UMR 5248, F-33600 Pessac, France; [Nolan, Derek P.] Trinity Coll Dublin, Sch Biochem & Immunol, Mol Parasitol Grp, Dublin 2, Ireland; [Lins, Laurence; Crowet, Jean-Marc] Univ Liege, Ctr Numer Mol Biophys, B-5030 Gembloux, Belgium; [Moestrup, Soren K.] Univ Aarhus, Dept Biomed, DK-8000 Aarhus, Denmark; [Lyngso, Jeppe; Pedersen, Jan Skov] Univ Aarhus, Interdisciplinary Nanosci Ctr INANO, DK-8000 Aarhus, Denmark; [Lyngso, Jeppe; Pedersen, Jan Skov] Univ Aarhus, Dept Chem, DK-8000 Aarhus, Denmark; [Mottram, Jeremy C.] Univ Glasgow, Wellcome Trust Ctr Mol Parasitol, Glasgow G12 8TA, Lanark, Scotland; [Perez-Morga, David] Univ Libre Bruxelles, Ctr Microscopy & Mol Imaging CMMI, B-6041 Gosselies, Belgium; [Perez-Morga, David; Pays, Etienne] Univ Libre Bruxelles, Mol Parasitol Lab, IBMM, B-6041 Gosselies, Belgium; [Pays, Etienne] Univ Libre Bruxelles, Walloon Excellence Life Sci & Biotechnol WELBIO, B-6041 Gosselies, Belgium	Universite Libre de Bruxelles; Universite Libre de Bruxelles; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Universite de Bordeaux; Trinity College Dublin; University of Liege; Aarhus University; Aarhus University; Aarhus University; University of Glasgow; Universite Libre de Bruxelles; Universite Libre de Bruxelles; Universite Libre de Bruxelles; WELBIO	Pays, E (corresponding author), Univ Libre Bruxelles, Walloon Excellence Life Sci & Biotechnol WELBIO, B-6041 Gosselies, Belgium.	epays@ulb.ac.be	Pedersen, Jan Skov/A-8346-2008; Lyngsø, Jeppe/N-4163-2018; LINS, LAURENCE/Y-1661-2019; DUFOURC, Erick Joel/AAA-4992-2020; Moestrup, Søren Kragh/A-1403-2014; Moestrup, Søren Kragh/AAD-1735-2019; Homble, Fabrice/AAH-3780-2020; crowet, jean-marc/E-3989-2012	Pedersen, Jan Skov/0000-0002-7768-0206; Lyngsø, Jeppe/0000-0002-6301-1300; LINS, LAURENCE/0000-0001-7772-6748; DUFOURC, Erick Joel/0000-0002-8221-9326; Moestrup, Søren Kragh/0000-0003-3862-2107; Homble, Fabrice/0000-0001-6031-136X; Vanhollebeke, Benoit/0000-0002-0353-365X; GRELARD, Axelle/0000-0002-6708-2253; Nolan, Derek/0000-0002-3742-4304; Perez-Morga, David/0000-0002-7168-1865; crowet, jean-marc/0000-0002-9252-2396; Mottram, Jeremy/0000-0001-5574-3766; Uzureau, sophie/0000-0002-6444-2815	Belgian Fund for Scientific Research; Walloon WELBIO excellence programme; Interuniversity Attraction Poles Programme-Belgian Science Policy; ERC [233312 TROJA]; European Regional Development Fund; Walloon Region; TGIR-RMN-THC Fr3050 (French high-field NMR network); Welcome Trust; Lundbeck Foundation [R54-2010-5637] Funding Source: researchfish	Belgian Fund for Scientific Research(Fonds de la Recherche Scientifique - FNRS); Walloon WELBIO excellence programme(WELBIO); Interuniversity Attraction Poles Programme-Belgian Science Policy(Belgian Federal Science Policy Office); ERC(European Research Council (ERC)European Commission); European Regional Development Fund(European Commission); Walloon Region; TGIR-RMN-THC Fr3050 (French high-field NMR network); Welcome Trust(Wellcome Trust); Lundbeck Foundation(Lundbeckfonden)	We thank M. Prevost for advice, C. Giroud and T. Baltz for help with T. b. gambiense culture adaptation, D. Horn for the gift of pTMF plasmid and E. Dupont for technical assistance. This work was supported by the Belgian Fund for Scientific Research, the Walloon WELBIO excellence programme, the Interuniversity Attraction Poles Programme-Belgian Science Policy, and the ERC grant 233312 TROJA. The CMMI is supported by the European Regional Development Fund and the Walloon Region. Financial support from the TGIR-RMN-THC Fr3050 (French high-field NMR network) and the Welcome Trust is also acknowledged.	BALTZ T, 1985, EMBO J, V4, P1273, DOI 10.1002/j.1460-2075.1985.tb03772.x; Berberof M, 2001, MOL BIOCHEM PARASIT, V113, P127, DOI 10.1016/S0166-6851(01)00208-0; BLUM ML, 1993, NATURE, V362, P603, DOI 10.1038/362603a0; Burkard G, 2007, MOL BIOCHEM PARASIT, V153, P220, DOI 10.1016/j.molbiopara.2007.02.008; Bussler H, 1998, J BIOL CHEM, V273, P32582, DOI 10.1074/jbc.273.49.32582; Callebaut I, 1997, CELL MOL LIFE SCI, V53, P621, DOI 10.1007/s000180050082; DeJesus E, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003317; Devaux S, 2007, MOL BIOL CELL, V18, P1293, DOI 10.1091/mbc.E06-09-0841; DOULIEZ JP, 1994, J CHIM PHYS PCB, V91, P874, DOI 10.1051/jcp/1994910874; Felu C, 2007, AM J TROP MED HYG, V76, P922, DOI 10.4269/ajtmh.2007.76.922; FOLCH J, 1957, J BIOL CHEM, V226, P497; Genovese G, 2010, SCIENCE, V329, P841, DOI 10.1126/science.1193032; Gibson W, 2007, INT J PARASITOL, V37, P829, DOI 10.1016/j.ijpara.2007.03.002; Gibson W, 2010, INFECT GENET EVOL, V10, P453, DOI 10.1016/j.meegid.2010.03.005; Glover L, 2007, NUCLEIC ACIDS RES, V35, P872, DOI 10.1093/nar/gkl1100; Goormaghtigh E, 1994, Subcell Biochem, V23, P405; Harrington JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044384; Higgins MK, 2013, P NATL ACAD SCI USA, V110, P1905, DOI 10.1073/pnas.1214943110; Jean-Francois F, 2008, BIOCHEMISTRY-US, V47, P6394, DOI 10.1021/bi800448h; Kieft R, 2010, P NATL ACAD SCI USA, V107, P16137, DOI 10.1073/pnas.1007074107; Klose A, 2006, ANAL BIOCHEM, V353, P57, DOI 10.1016/j.ab.2006.01.037; Lecordier L, 2007, MOL MICROBIOL, V64, P1164, DOI 10.1111/j.1365-2958.2007.05725.x; Lecordier L, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000685; Nolan DP, 2000, EUR J BIOCHEM, V267, P4601, DOI 10.1046/j.1432-1327.2000.01476.x; O'Brien TC, 2008, J BIOL CHEM, V283, P28934, DOI 10.1074/jbc.M805824200; Overath P, 2004, MOL MICROBIOL, V53, P735, DOI 10.1111/j.1365-2958.2004.04224.x; Pays E, 2006, NAT REV MICROBIOL, V4, P477, DOI 10.1038/nrmicro1428; Pedersen JS, 2004, J APPL CRYSTALLOGR, V37, P369, DOI 10.1107/S0021889804004170; Perez-Morga D, 2005, SCIENCE, V309, P469, DOI 10.1126/science.1114566; Radwanska M, 2002, AM J TROP MED HYG, V67, P289, DOI 10.4269/ajtmh.2002.67.289; Raper J, 1999, INFECT IMMUN, V67, P1910; Raper J, 1996, J EXP MED, V183, P1023, DOI 10.1084/jem.183.3.1023; ROUGEMONT A, 1988, LANCET, V2, P709; Ruepp S, 1997, J CELL BIOL, V137, P1369, DOI 10.1083/jcb.137.6.1369; SALMON D, 1994, CELL, V78, P75, DOI 10.1016/0092-8674(94)90574-6; Salmon D, 2012, MOL MICROBIOL, V84, P225, DOI 10.1111/j.1365-2958.2012.08013.x; Sani MA, 2008, FEBS J, V275, P561, DOI 10.1111/j.1742-4658.2007.06222.x; Santos CC, 2007, MOL MICROBIOL, V66, P991, DOI 10.1111/j.1365-2958.2007.05970.x; Simarro PP, 2010, INT J HEALTH GEOGR, V9, DOI 10.1186/1476-072X-9-57; SOMMER JM, 1993, FEBS LETT, V316, P53, DOI 10.1016/0014-5793(93)81735-I; Symula RE, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001728; Vanhamme L, 2003, NATURE, V422, P83, DOI 10.1038/nature01461; Vanhollebeke B, 2008, SCIENCE, V320, P677, DOI 10.1126/science.1156296; Vanhollebeke B, 2010, EUKARYOT CELL, V9, P1272, DOI 10.1128/EC.00076-10; Vanhollebeke B, 2010, MOL MICROBIOL, V76, P806, DOI 10.1111/j.1365-2958.2010.07156.x; Wirtz E, 1999, MOL BIOCHEM PARASIT, V99, P89, DOI 10.1016/S0166-6851(99)00002-X; Xong HV, 1998, CELL, V95, P839, DOI 10.1016/S0092-8674(00)81706-7	47	109	109	1	110	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 19	2013	501	7467					430	+		10.1038/nature12516	http://dx.doi.org/10.1038/nature12516			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219XT	23965626				2022-12-24	WOS:000324545700048
J	Bindman, AB; Blum, JD; Kronick, R				Bindman, Andrew B.; Blum, Jonathan D.; Kronick, Richard			Medicare Payment for Chronic Care Delivered in a Patient-Centered Medical Home	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Bindman, Andrew B.; Kronick, Richard] US Dept HHS, Off Assistant Secretary Planning & Evaluat, Washington, DC 20201 USA; [Bindman, Andrew B.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94118 USA; [Blum, Jonathan D.] US Dept HHS, Ctr Medicare Serv, Washington, DC 20201 USA; [Blum, Jonathan D.] US Dept HHS, Ctr Medicaid Serv, Washington, DC 20201 USA	University of California System; University of California San Francisco; Centers for Medicare & Medicaid Services; Centers for Medicare & Medicaid Services	Bindman, AB (corresponding author), Univ Calif San Francisco, Dept Med, 3333 Calif St,Ste 265, San Francisco, CA 94118 USA.	abindman@medsfgh.ucsf.edu						American Academy of Family Physicians (AAFP) American Academy of Pediatrics (AAP) American College of Physicians (ACP) American Osteopathic Association (AOA), 2007, JOINT PRINCIPLES OF; [Anonymous], RECOMMENDATIONS RELA; Centers for Medicare and Medicaid Services, 2012, CHRONIC CONDITIONS A; Centers for Medicare and Medicaid Services, INNOVATION MODELS; McWilliams JM, 2013, JAMA INTERN MED, V173, P1447, DOI 10.1001/jamainternmed.2013.6886	5	9	9	2	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 18	2013	310	11					1125	1126		10.1001/jama.2013.276525	http://dx.doi.org/10.1001/jama.2013.276525			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	219IU	23929029	Green Submitted			2022-12-24	WOS:000324500300015
J	Gostin, LO				Gostin, Lawrence O.			PEPFAR's Antiprostitution Pledge Spending Power and Free Speech in Tension	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									Georgetown Univ, Ctr Law, ONeill Inst Natl & Global Hlth Law, Washington, DC 20001 USA	Georgetown University	Gostin, LO (corresponding author), Georgetown Univ, Ctr Law, ONeill Inst Natl & Global Hlth Law, 600 New Jersey Ave NW, Washington, DC 20001 USA.	gostin@law.georgetown.edu						Joint United Nations Programme on HIV/AIDS (UNAIDS), 2012, PREVENTION AND TREAT	1	2	2	0	2	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 18	2013	310	11					1127	1128		10.1001/jama.2013.276527	http://dx.doi.org/10.1001/jama.2013.276527			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	219IU	23990033				2022-12-24	WOS:000324500300016
J	Burrows, M; Sutton, G				Burrows, Malcolm; Sutton, Gregory			Interacting Gears Synchronize Propulsive Leg Movements in a Jumping Insect	SCIENCE			English	Article							FLY ORMIA OCHRACEA; DIRECTIONAL HEARING; FROGHOPPER INSECTS; CLOCKWORK CRICKET; HEMIPTERA; ISSIDAE; MECHANICS	Gears are found rarely in animals and have never been reported to intermesh and rotate functionally like mechanical gears. We now demonstrate functional gears in the ballistic jumping movements of the flightless planthopper insect Issus. The nymphs, but not adults, have a row of cuticular gear (cog) teeth around the curved medial surfaces of their two hindleg trochantera. The gear teeth on one trochanter engaged with and sequentially moved past those on the other trochanter during the preparatory cocking and the propulsive phases of jumping. Close registration between the gears ensured that both hindlegs moved at the same angular velocities to propel the body without yaw rotation. At the final molt to adulthood, this synchronization mechanism is jettisoned.	[Burrows, Malcolm; Sutton, Gregory] Univ Cambridge, Dept Zool, Cambridge CB2 3EJ, England	University of Cambridge	Burrows, M (corresponding author), Univ Cambridge, Dept Zool, Downing St, Cambridge CB2 3EJ, England.	mb135@hermes.cam.ac.uk			Human Frontiers Research Program; Alexander von Humboldt Foundation, Germany	Human Frontiers Research Program; Alexander von Humboldt Foundation, Germany(Alexander von Humboldt Foundation)	G.S. was supported by the Human Frontiers Research Program. Experimental work at the Institut fur Biologie II (Zoologie), Rheinisch-Westfaelische Technische Hochschule Aachen University, Germany, was supported by a grant to M.B. from the Alexander von Humboldt Foundation, Germany. M.B. is especially grateful to P. Braunig for the hospitality of his laboratory. The data presented in this paper and more videos and images are stored on a server at the Department of Zoology, University of Cambridge, CB2 3EJ UK. We thank S. Rogers for comments on the text.	Bennet-Clark HC, 2002, J EXP BIOL, V205, P613; Burrows M, 2010, J EXP BIOL, V213, P469, DOI 10.1242/jeb.037861; Burrows M, 2007, J NEUROPHYSIOL, V97, P320, DOI 10.1152/jn.00719.2006; Burrows M, 2010, J COMP NEUROL, V518, P1349, DOI 10.1002/cne.22280; Burrows M, 2009, J EXP BIOL, V212, P2844, DOI 10.1242/jeb.032326; ELLIOTT CJH, 1985, NATURWISSENSCHAFTEN, V72, P150, DOI 10.1007/BF00490404; Farrel A.P., 1998, BIOL REPTILIA, V19, P375; GREENFIELD LAZAR J., 1961, JOUR SURG RES, V1, P97, DOI 10.1016/S0022-4804(61)80003-6; Heilig S., 1986, Zoologische Jahrbuecher Abteilung fuer Systematik Oekologie und Geographie der Tiere, V113, P307; Juvinall R.V, 1991, FUNDAMENTALS MACHINE, VSecond; Mhatre N, 2012, P NATL ACAD SCI USA, V109, pE1444, DOI 10.1073/pnas.1200192109; Miles RN, 1995, J ACOUST SOC AM, V98, P3059, DOI 10.1121/1.413830; Montealegre-Z F, 2005, J EXP BIOL, V208, P1219, DOI 10.1242/jeb.01526; Montealegre ZF, 2009, J EXP BIOL, V212, P257, DOI 10.1242/jeb.022731; Riddiford LM, 2012, GEN COMP ENDOCR, V179, P477, DOI 10.1016/j.ygcen.2012.06.001; Robert D, 1996, J COMP PHYSIOL A, V179, P29, DOI 10.1007/BF00193432; Sander K., 1956, Zoologische Jahrbuecher Jena Anatomie, V75, P383; Sutton GP, 2010, J EXP BIOL, V213, P1406, DOI 10.1242/jeb.036921; Syme DA, 2002, J EXP BIOL, V205, P1843; van de Kamp T, 2011, SCIENCE, V333, P52, DOI 10.1126/science.1204245; WEBB GJW, 1979, J MORPHOL, V161, P221, DOI 10.1002/jmor.1051610209	21	73	76	5	129	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 13	2013	341	6151					1254	1256		10.1126/science.1240284	http://dx.doi.org/10.1126/science.1240284			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	215ZA	24031019	Green Submitted			2022-12-24	WOS:000324248800047
J	Marco, E; Dorn, JF; Hsu, PH; Jaqaman, K; Sorger, PK; Danuser, G				Marco, Eugenio; Dorn, Jonas F.; Hsu, Pei-hsin; Jaqaman, Khuloud; Sorger, Peter K.; Danuser, Gaudenz			S. cerevisiae Chromosomes Biorient via Gradual Resolution of Syntely between S Phase and Anaphase	CELL			English	Article							KINETOCHORE-MICROTUBULE ATTACHMENT; SPINDLE POLE BODY; BUDDING YEAST; SACCHAROMYCES-CEREVISIAE; MITOTIC SPINDLE; PROTEIN-KINASE; BI-ORIENTATION; DYNAMICS; METAPHASE; SEGREGATION	Following DNA replication, eukaryotic cells must biorient all sister chromatids prior to cohesion cleavage at anaphase. In animal cells, sister chromatids gradually biorient during prometaphase, but current models of mitosis in S. cerevisiae assume that biorientation is established shortly after S phase. This assumption is based on the observation of a bilobed distribution of yeast kinetochores early in mitosis and suggests fundamental differences between yeast mitosis and mitosis in animal cells. By applying super-resolution imaging methods, we show that yeast and animal cells share the key property of gradual and stochastic chromosome biorientation. The characteristic bilobed distribution of yeast kinetochores, hitherto considered synonymous for biorientation, arises from kinetochores in mixed attachment states to microtubules, the length of which discriminates bioriented from syntelic attachments. Our results offer a revised view of mitotic progression in S. cerevisiae that augments the relevance of mechanistic information obtained in this powerful genetic system for mammalian mitosis.	[Marco, Eugenio; Hsu, Pei-hsin; Danuser, Gaudenz] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; [Marco, Eugenio; Jaqaman, Khuloud; Sorger, Peter K.] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA; [Dorn, Jonas F.] Univ Montreal, Inst Res Immunol & Canc, Montreal, PQ H3C 3J7, Canada	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Universite de Montreal	Danuser, G (corresponding author), Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA.	gaudenz_danuser@hms.harvard.edu	Marco, Eugenio/F-4583-2011	Jaqaman, Khuloud/0000-0003-3471-1911; Marco, Eugenio/0000-0002-3675-263X; Danuser, Gaudenz/0000-0001-8583-2014; Dorn, Jonas/0000-0001-6696-0117; Sorger, Peter/0000-0002-3364-1838	NIH [R01 GM068956]; Human Frontier Science Program; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068956] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Human Frontier Science Program(Human Frontier Science Program); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank T. Warsi, E. Gillett, M. C. Hou, M. Niepel, S. Ventz, A. W. Murray, D. Needleman, and L. Serrano for discussions. E. M. gratefully acknowledges Guo-Cheng Yuan for his encouragement. This work was funded by the grant NIH R01 GM068956 to P. K. S. and G. D. E. M. was supported in part by a long-term fellowship from the Human Frontier Science Program.	Bakhoum SF, 2009, CURR BIOL, V19, P1937, DOI 10.1016/j.cub.2009.09.055; Biggins S, 1999, GENE DEV, V13, P532, DOI 10.1101/gad.13.5.532; Brouhard GJ, 2008, CELL, V132, P79, DOI 10.1016/j.cell.2007.11.043; CHAN CSM, 1993, GENETICS, V135, P677; Cimini D, 2006, CURR BIOL, V16, P1711, DOI 10.1016/j.cub.2006.07.022; Dorn JF, 2005, BIOPHYS J, V89, P2835, DOI 10.1529/biophysj.104.058461; Draviam VM, 2004, CURR OPIN GENET DEV, V14, P120, DOI 10.1016/j.gde.2004.02.007; Fujiwara T, 2005, NATURE, V437, P1043, DOI 10.1038/nature04217; Gardner MK, 2008, CELL, V135, P894, DOI 10.1016/j.cell.2008.09.046; Gardner MK, 2005, MOL BIOL CELL, V16, P3764, DOI 10.1091/mbc.E05-04-0275; Geiser JR, 1997, MOL BIOL CELL, V8, P1035, DOI 10.1091/mbc.8.6.1035; Gillett ES, 2004, J CELL BIOL, V164, P535, DOI 10.1083/jcb.200308100; Goshima G, 2000, CELL, V100, P619, DOI 10.1016/S0092-8674(00)80699-6; He XW, 2000, CELL, V101, P763, DOI 10.1016/S0092-8674(00)80888-0; He XW, 2001, CELL, V106, P195, DOI 10.1016/S0092-8674(01)00438-X; Hyland KM, 1999, J CELL BIOL, V145, P15, DOI 10.1083/jcb.145.1.15; Indjeian VB, 2007, CURR BIOL, V17, P1837, DOI 10.1016/j.cub.2007.09.056; Jaqaman K, 2006, BIOPHYS J, V91, P2312, DOI 10.1529/biophysj.106.080333; Jaspersen SL, 2004, ANNU REV CELL DEV BI, V20, P1, DOI 10.1146/annurev.cellbio.20.022003.114106; Joglekar AP, 2009, CURR BIOL, V19, P694, DOI 10.1016/j.cub.2009.02.056; Kim JH, 1999, J CELL BIOL, V145, P1381, DOI 10.1083/jcb.145.7.1381; Kitagawa K, 2001, NAT REV MOL CELL BIO, V2, P678, DOI 10.1038/35089568; Kosco KA, 2001, MOL BIOL CELL, V12, P2870, DOI 10.1091/mbc.12.9.2870; Maure JF, 2007, CURR BIOL, V17, P2175, DOI 10.1016/j.cub.2007.11.032; MAYER VW, 1990, MUTAT RES, V231, P177, DOI 10.1016/0027-5107(90)90024-X; Meyer RE, 2013, SCIENCE, V339, P1071, DOI 10.1126/science.1232518; O'Toole ET, 1999, MOL BIOL CELL, V10, P2017, DOI 10.1091/mbc.10.6.2017; Pearson CG, 2004, CURR BIOL, V14, P1962, DOI 10.1016/j.cub.2004.09.086; Pearson CG, 2003, MOL BIOL CELL, V14, P4181, DOI 10.1091/mbc.e03-03-0180; Pearson CG, 2001, J CELL BIOL, V152, P1255, DOI 10.1083/jcb.152.6.1255; Pinsky BA, 2003, DEV CELL, V5, P735, DOI 10.1016/S1534-5807(03)00322-8; Pinsky BA, 2005, TRENDS CELL BIOL, V15, P486, DOI 10.1016/j.tcb.2005.07.005; RINES D, 2004, LIVE CELL IMAGING LA, P631; Rudner AD, 1996, CURR OPIN CELL BIOL, V8, P773, DOI 10.1016/S0955-0674(96)80077-9; Severin F, 2001, J CELL BIOL, V153, P435, DOI 10.1083/jcb.153.2.435; Sprague BL, 2003, BIOPHYS J, V84, P3529, DOI 10.1016/S0006-3495(03)75087-5; Storchova Z, 2006, NATURE, V443, P541, DOI 10.1038/nature05178; Su XL, 2011, MOL CELL, V43, P751, DOI 10.1016/j.molcel.2011.06.027; Tanaka TU, 2002, CELL, V108, P317, DOI 10.1016/S0092-8674(02)00633-5; Thomann D, 2003, J MICROSC-OXFORD, V211, P230, DOI 10.1046/j.1365-2818.2003.01223.x; Thomann D, 2002, J MICROSC-OXFORD, V208, P49, DOI 10.1046/j.1365-2818.2002.01066.x; Thompson SL, 2010, CURR BIOL, V20, pR285, DOI 10.1016/j.cub.2010.01.034; Tytell JD, 2006, J CELL BIOL, V172, P861, DOI 10.1083/jcb.200509101; Varga V, 2009, CELL, V138, P1174, DOI 10.1016/j.cell.2009.07.032; VASQUEZ RJ, 1994, J CELL BIOL, V127, P985, DOI 10.1083/jcb.127.4.985; Wang PJJ, 1997, J CELL BIOL, V139, P1271, DOI 10.1083/jcb.139.5.1271; WINEY M, 1995, J CELL BIOL, V129, P1601, DOI 10.1083/jcb.129.6.1601; Yeh E, 2008, CURR BIOL, V18, P81, DOI 10.1016/j.cub.2007.12.019; Zeng XM, 1999, J CELL BIOL, V146, P415, DOI 10.1083/jcb.146.2.415	49	20	21	0	12	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	AUG 29	2013	154	5					1127	1139		10.1016/j.cell.2013.08.008	http://dx.doi.org/10.1016/j.cell.2013.08.008			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	209OE	23993100	Bronze, Green Accepted			2022-12-24	WOS:000323767300024
J	Tingley, MW; Estes, LD; Wilcove, DS				Tingley, Morgan W.; Estes, Lyndon D.; Wilcove, David S.			Climate change must not blow conservation off course	NATURE			English	Editorial Material							SHIFTS		[Tingley, Morgan W.; Estes, Lyndon D.; Wilcove, David S.] Princeton Univ, Woodrow Wilson Sch, Princeton, NJ 08544 USA; [Wilcove, David S.] Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA	Princeton University; Princeton University	Tingley, MW (corresponding author), Princeton Univ, Woodrow Wilson Sch, Princeton, NJ 08544 USA.	mtingley@princeton.edu; lestes@princeton.edu; dwilcove@princeton.edu	Tingley, Morgan W/F-8519-2011	Tingley, Morgan W/0000-0002-1477-2218; Wilcove, David S./0000-0002-1354-0503				Chen IC, 2011, SCIENCE, V333, P1024, DOI 10.1126/science.1206432; Game ET, 2011, GLOBAL CHANGE BIOL, V17, P3150, DOI 10.1111/j.1365-2486.2011.02457.x; Hagerman S, 2010, GLOBAL ENVIRON CHANG, V20, P192, DOI 10.1016/j.gloenvcha.2009.10.005; Jetz W, 2007, PLOS BIOL, V5, P1211, DOI 10.1371/journal.pbio.0050157; Joppa LN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008273; Loarie SR, 2009, NATURE, V462, P1052, DOI 10.1038/nature08649; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Silva JF, 2006, J BIOGEOGR, V33, P536, DOI 10.1111/j.1365-2699.2005.01422.x; Tingley MW, 2012, GLOBAL CHANGE BIOL, V18, P3279, DOI 10.1111/j.1365-2486.2012.02784.x	9	29	29	0	71	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	AUG 15	2013	500	7462					271	272		10.1038/500271a	http://dx.doi.org/10.1038/500271a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	201AF	23955216	Bronze			2022-12-24	WOS:000323112400009
J	Caplan, A; Shah, NR				Caplan, Arthur; Shah, Nirav R.			Managing the Human Toll Caused by Seasonal Influenza New York State's Mandate to Vaccinate or Mask	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							HEALTH-CARE WORKERS		[Caplan, Arthur] NYU, Langone Med Ctr, Div Med Eth, New York, NY 10016 USA; [Shah, Nirav R.] New York State Dept Hlth, New York, NY USA	New York University; NYU Langone Medical Center	Caplan, A (corresponding author), NYU, Langone Med Ctr, Div Med Eth, 227 E 30th St,7th Floor, New York, NY 10016 USA.	arthur.caplan@nyumc.org	Shah, Nirav R./B-6622-2008	Shah, Nirav R./0000-0003-2044-7865				[Anonymous], VACCINE EFFECTIVENES; Bureau of Communicable Disease Control, STATEWIDE INFLUENZA; Caban-Martinez AJ, 2010, PREV MED, V50, P210, DOI 10.1016/j.ypmed.2010.01.001; Caplan A, 2011, LANCET, V378, P310, DOI 10.1016/S0140-6736(11)61156-2; CDC, WHAT YOU SHOULD KNOW; Lemaitre M, 2009, J AM GERIATR SOC, V57, P1580, DOI 10.1111/j.1532-5415.2009.02402.x; Rakita RM, 2010, INFECT CONT HOSP EP, V31, P881, DOI 10.1086/656210; Salgado CD, 2004, INFECT CONT HOSP EP, V25, P923, DOI 10.1086/502321	8	8	8	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 6	2013	310	17					1797	1798		10.1001/jama.2013.280633	http://dx.doi.org/10.1001/jama.2013.280633			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	246PH	24081030				2022-12-24	WOS:000326550900008
J	Thomas, CD				Thomas, Chris D.			The Anthropocene could raise biological diversity	NATURE			English	Editorial Material									Univ York, York YO10 5DD, N Yorkshire, England	University of York - UK	Thomas, CD (corresponding author), Univ York, York YO10 5DD, N Yorkshire, England.	chris.thomas@york.ac.uk	Thomas, Chris D/A-1894-2012; Thomas, Chris D/A-1460-2014	Thomas, Chris D/0000-0003-2822-1334; Thomas, Chris D/0000-0003-2822-1334					0	72	77	1	170	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 3	2013	502	7469					7	7		10.1038/502007a	http://dx.doi.org/10.1038/502007a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	227IM	24091946	Bronze			2022-12-24	WOS:000325106000004
J	Berry, SD; Samelson, EJ; Pencina, MJ; McLean, RR; Cupples, LA; Broe, KE; Kiel, DP				Berry, Sarah D.; Samelson, Elizabeth J.; Pencina, Michael J.; McLean, Robert R.; Cupples, L. Adrienne; Broe, Kerry E.; Kiel, Douglas P.			Repeat Bone Mineral Density Screening and Prediction of Hip and Major Osteoporotic Fracture	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							POSTMENOPAUSAL WOMEN; OLDER WOMEN; RISK; MEN; PERSPECTIVE; SERVICES; EFFICACY; SAFETY; BMD	IMPORTANCE Screening for osteoporosis with bone mineral density (BMD) is recommended for older adults. It is unclear whether repeating a BMD screening test improves fracture risk assessment. OBJECTIVES To determine whether changes in BMD after 4 years provide additional information on fracture risk beyond baseline BMD and to quantify the change in fracture risk classification after a second BMD measure. DESIGN, SETTING, AND PARTICIPANTS Population-based cohort study involving 310 men and 492 women from the Framingham Osteoporosis Study with 2 measures of femoral neck BMD taken from 1987 through 1999. MAIN OUTCOMES AND MEASURES Risk of hip or major osteoporotic fracture through 2009 or 12 years following the second BMD measure. RESULTS Mean age was 74.8 years. The mean (SD) BMD change was -0.6% per year (1.8%). Throughout a median follow-up of 9.6 years, 76 participants experienced an incident hip fracture and 113 participants experienced a major osteoporotic fracture. Annual percent BMD change per SD decrease was associated with risk of hip fracture (hazard ratio [HR], 1.43 [95% CI, 1.16 to 1.78]) and major osteoporotic fracture (HR, 1.21 [95% CI, 1.01 to 1.45]) after adjusting for baseline BMD. At 10 years' follow-up, 1 SD decrease in annual percent BMD change compared with the mean BMD change was associated with 3.9 excess hip fractures per 100 persons. In receiver operating characteristic (ROC) curve analyses, the addition of BMD change to a model with baseline BMD did not meaningfully improve performance. The area under the curve (AUC) was 0.71 (95% CI, 0.65 to 0.78) for the baseline BMD model compared with 0.68 (95% CI, 0.62 to 0.75) for the BMD percent change model. Moreover, the addition of BMD change to a model with baseline BMD did not meaningfully improve performance (AUC, 0.72 [95% CI, 0.66 to 0.79]). Using the net reclassification index, a second BMD measure increased the proportion of participants reclassified as high risk of hip fracture by 3.9% (95% CI, -2.2% to 9.9%), whereas it decreased the proportion classified as low risk by -2.2%(95% CI, -4.5% to 0.1%). CONCLUSIONS AND RELEVANCE In untreated men and women of mean age 75 years, a second BMD measure after 4 years did not meaningfully improve the prediction of hip or major osteoporotic fracture. Repeating a BMD measure within 4 years to improve fracture risk stratification may not be necessary in adults this age untreated for osteoporosis.	[Berry, Sarah D.; Samelson, Elizabeth J.; McLean, Robert R.; Broe, Kerry E.; Kiel, Douglas P.] Hebrew SeniorLife, Inst Aging Res, Boston, MA 02131 USA; [Berry, Sarah D.; Samelson, Elizabeth J.; McLean, Robert R.; Kiel, Douglas P.] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Boston, MA 02215 USA; [Pencina, Michael J.; Cupples, L. Adrienne] Boston Univ, Sch Publ Hlth, Boston, MA USA; [Pencina, Michael J.] Duke Clin Res Inst, Durham, NC USA; [Pencina, Michael J.] Duke Dept Biostat & Bioinformat, Durham, NC USA; [Cupples, L. Adrienne] Framingham Heart Dis Epidemiol Study, Framingham, MA USA	Harvard University; Hebrew SeniorLife; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Boston University; Duke University; Framingham Heart Study	Berry, SD (corresponding author), Hebrew SeniorLife, Inst Aging Res, 1200 Ctr St, Boston, MA 02131 USA.	sarahberry@hsl.harvard.edu		Kiel, Douglas/0000-0001-8474-0310; Samelson, Elizabeth/0000-0003-1086-1560; Cupples, L. Adrienne/0000-0003-0273-7965	National Institutes of Health [R01-AR/AG 41398, NIA K23 AG033204]; National Heart, Lung, and Blood Institute's Framingham Heart Study [N01-HC-25195]; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC025195] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR041398] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K23AG033204] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Heart, Lung, and Blood Institute's Framingham Heart Study(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was funded in part through grants R01-AR/AG 41398 and NIA K23 AG033204 from the National Institutes of Health, N01-HC-25195 from the National Heart, Lung, and Blood Institute's Framingham Heart Study, and contributions from the Friends of Hebrew SeniorLife.	Austin PC, 2010, J CLIN EPIDEMIOL, V63, P46, DOI 10.1016/j.jclinepi.2009.03.012; Berger C, 2009, J BONE MINER RES, V24, P361, DOI [10.1359/jbmr.081004, 10.1359/JBMR.081004]; Black DM, 2012, J CLIN ENDOCR METAB, V97, P1176, DOI 10.1210/jc.2012-1528; Boonen S, 2011, J CLIN ENDOCR METAB, V96, P1727, DOI 10.1210/jc.2010-2784; Boonen S, 2006, J AM GERIATR SOC, V54, P782, DOI 10.1111/j.1532-5415.2006.00695.x; Boonen S, 2010, J AM GERIATR SOC, V58, P292, DOI 10.1111/j.1532-5415.2009.02673.x; Boonen S, 2010, J AM GERIATR SOC, V58, P658, DOI 10.1111/j.1532-5415.2010.02763.x; Calonge N, 2011, ANN INTERN MED, V154, P356, DOI 10.7326/0003-4819-154-5-201103010-00307; Cawthon PM, 2012, J BONE MINER RES, V27, P2179, DOI 10.1002/jbmr.1671; DAWBER TR, 1951, AM J PUBLIC HLTH NAT, V41, P279; Gourlay ML, 2012, NEW ENGL J MED, V366, P225, DOI 10.1056/NEJMoa1107142; Hillier TA, 2007, ARCH INTERN MED, V167, P155, DOI 10.1001/archinte.167.2.155; Kanis JA, 2008, OSTEOPOROSIS INT, V19, P385, DOI 10.1007/s00198-007-0543-5; KIEL DP, 1995, J BONE MINER RES, V10, P1130; KIEL DP, 1987, NEW ENGL J MED, V317, P1169, DOI 10.1056/NEJM198711053171901; Leslie WD, 2012, J CLIN ENDOCR METAB, V97, P1211, DOI 10.1210/jc.2011-2871; Lewiecki EM, 2012, J BONE MINER RES, V27, P739, DOI 10.1002/jbmr.1580; McAdam-Marx C, 2012, J AM GERIATR SOC, V60, P511, DOI 10.1111/j.1532-5415.2011.03837.x; National Osteoporosis Foundation, 2013, CLIN GUID PREV TREAT; Nguyen TV, 2005, J BONE MINER RES, V20, P1195, DOI 10.1359/JBMR.050215; Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929; Riis BJ, 1996, BONE, V19, P9, DOI 10.1016/8756-3282(96)00102-0; Tosteson ANA, 2008, AM J MANAG CARE, V14, P605; Yu EW, 2012, JAMA-J AM MED ASSOC, V307, P2591, DOI 10.1001/jama.2012.6977; Zhang J, 2012, J BONE MINER RES, V27, P858, DOI 10.1002/jbmr.1534	25	53	54	0	8	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 25	2013	310	12					1256	1262		10.1001/jama.2013.277817	http://dx.doi.org/10.1001/jama.2013.277817			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	222SO	24065012	Green Accepted, Bronze			2022-12-24	WOS:000324751800022
J	Tucker, JD; von Zinkernagel, DJ; Goosby, EP				Tucker, Joseph D.; von Zinkernagel, Deborah J.; Goosby, Eric P.			An inclusive rights-based foreign policy for health	LANCET			English	Editorial Material							HIV PREVENTION; SEX; MEN		[Tucker, Joseph D.] UNC Project China, Guangzhou 510095, Guangdong, Peoples R China; [von Zinkernagel, Deborah J.; Goosby, Eric P.] US Off Global Hlth Diplomacy, Washington, DC USA		Tucker, JD (corresponding author), UNC Project China, Guangzhou 510095, Guangdong, Peoples R China.	jdtucker@med.unc.edu		Tucker, Joseph/0000-0003-2804-1181	FOGARTY INTERNATIONAL CENTER [K01TW008200] Funding Source: NIH RePORTER; FIC NIH HHS [K01 TW008200] Funding Source: Medline	FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); FIC NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))		Beyrer C, 2012, LANCET, V380, P424, DOI 10.1016/S0140-6736(12)61022-8; Dee TS, 2008, ECON J, V118, P1055, DOI 10.1111/j.1468-0297.2008.02160.x; Francis SA, 2009, J RELIG HEALTH, V48, P6, DOI 10.1007/s10943-008-9171-4; Human Rights Campaign, 2013, STAT EMPL LAWS POL; Itaborahy LP, 2013, STATE SPONSORED HOMO; Obama Barack, 2011, COMMUNICATION; Sullivan PS, 2012, LANCET, V380, P388, DOI 10.1016/S0140-6736(12)60955-6; Trapence G, 2012, LANCET, V380, P400, DOI 10.1016/S0140-6736(12)60834-4; United Nations Human Rights Council, 2011, DISCR LAWS PRACT ACT	9	1	1	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	AUG 31	2013	382	9894					745	746		10.1016/S0140-6736(13)61462-2	http://dx.doi.org/10.1016/S0140-6736(13)61462-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	215VP	23993176	Green Accepted			2022-12-24	WOS:000324239200004
J	Tang, JCY; Szikra, T; Kozorovitskiy, Y; Teixiera, M; Sabatini, BL; Roska, B; Cepko, CL				Tang, Jonathan C. Y.; Szikra, Tamas; Kozorovitskiy, Yevgenia; Teixiera, Miguel; Sabatini, Bernardo L.; Roska, Botond; Cepko, Constance L.			A Nanobody-Based System Using Fluorescent Proteins as Scaffolds for Cell-Specific Gene Manipulation	CELL			English	Article							RNA INTERFERENCE; NERVOUS-SYSTEM; BIPOLAR CELLS; IN-VIVO; EXPRESSION; TRANSCRIPTION; OTX2; RECOMBINASE; ACTIVATION; DISSECTION	Fluorescent proteins are commonly used to label cells across organisms, but the unmodified forms cannot control biological activities. Using GFP-binding proteins derived from Camelid antibodies, we co-opted GFP as a scaffold for inducing formation of biologically active complexes, developing a library of hybrid transcription factors that control gene expression only in the presence of GFP or its derivatives. The modular design allows for variation in key properties such as DNA specificity, transcriptional potency, and drug dependency. Production of GFP controlled cell-specific gene expression and facilitated functional perturbations in the mouse retina and brain. Further, retrofitting existing transgenic GFP mouse and zebrafish lines for GFP-dependent transcription enabled applications such as optogenetic probing of neural circuits. This work establishes GFP as a multifunctional scaffold and opens the door to selective manipulation of diverse GFP-labeled cells across transgenic lines. This approach may also be extended to exploit other intracellular products as cell-specific scaffolds in multicellular organisms.	[Tang, Jonathan C. Y.; Kozorovitskiy, Yevgenia; Sabatini, Bernardo L.; Cepko, Constance L.] Harvard Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02115 USA; [Tang, Jonathan C. Y.; Cepko, Constance L.] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Tang, Jonathan C. Y.; Cepko, Constance L.] Harvard Univ, Sch Med, Dept Ophthalmol, Boston, MA 02115 USA; [Kozorovitskiy, Yevgenia; Sabatini, Bernardo L.] Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA; [Szikra, Tamas; Teixiera, Miguel; Roska, Botond] Friedrich Miescher Inst Biomed Res, Neural Circuit Labs, CH-4058 Basel, Switzerland; [Teixiera, Miguel] Univ Basel, CH-4003 Basel, Switzerland	Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Friedrich Miescher Institute for Biomedical Research; University of Basel	Cepko, CL (corresponding author), Harvard Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02115 USA.	cepko@genetics.med.harvard.edu	Roska, Botond/AAD-7268-2021; Kozorovitskiy, Yevgenia/GOP-1185-2022	Kozorovitskiy, Yevgenia/0000-0002-3710-1484	Leonard and Isabelle Goldenson Research Fellowship; European Research Council; Swiss-Hungarian grant; TREATRUSH grant from the European Union; SEEBETTER grant from the European Union; OPTONEURO grant from the European Union; Howard Hughes Medical Institute	Leonard and Isabelle Goldenson Research Fellowship; European Research Council(European Research Council (ERC)European Commission); Swiss-Hungarian grant; TREATRUSH grant from the European Union; SEEBETTER grant from the European Union; OPTONEURO grant from the European Union; Howard Hughes Medical Institute(Howard Hughes Medical Institute)	We thank Matt Harris and Katrin Henke for assistance with zebrafish injections; Mark Emerson for discussions of Otx2 experiment; Quentin Gilly of Perrimon lab for access to microplate reader; James deMelo for help with mouse transfer; Tim Cherry for contributing to illustrations; and Kailun Jiang, Jonathan Coleman, Susan Dymecki, Jacob Hodgson, Douglas Allan, Andreas Mayer, Jesse Gray, Michael Springer, Kevin Struhl, Ben Huang, and members of the Cepko/Tabin/Dymecki lab for comments. We are grateful to Heinrich Leonhardt and Ulrich Rothbauer for advice and GBP reagents. We thank Liqun Luo, David Bartel, Gerald Rubin, Benjamin White, Dominic Esposito, Warner Greene, and Matija Peterlin for plasmids from Addgene, Robert Margolskee for Tg(GUS8.4GFP) line, and Leonard Zon for Tg(Ubi-GFP) line. Y.K. was supported by the Leonard and Isabelle Goldenson Research Fellowship. B. R. was supported by a European Research Council grant, a Swiss-Hungarian grant, and TREATRUSH, SEEBETTER, and OPTONEURO grants from the European Union. C. L. C. and B. L. S. were supported by the Howard Hughes Medical Institute.	Baron U, 1997, NUCLEIC ACIDS RES, V25, P2723, DOI 10.1093/nar/25.14.2723; Butala M, 2009, CELL MOL LIFE SCI, V66, P82, DOI 10.1007/s00018-008-8378-6; Campbell RE, 2002, P NATL ACAD SCI USA, V99, P7877, DOI 10.1073/pnas.082243699; Caussinus E, 2012, NAT STRUCT MOL BIOL, V19, P117, DOI 10.1038/nsmb.2180; Chang AL, 2012, CURR OPIN BIOTECH, V23, P679, DOI 10.1016/j.copbio.2012.01.005; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Culler SJ, 2010, SCIENCE, V330, P1251, DOI 10.1126/science.1192128; Dickins RA, 2007, NAT GENET, V39, P914, DOI 10.1038/ng2045; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; Dymecki SM, 2010, METHOD ENZYMOL, V477, P183, DOI 10.1016/S0076-6879(10)77011-7; Emerson MM, 2011, DEV BIOL, V360, P241, DOI 10.1016/j.ydbio.2011.09.012; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Ghosh KK, 2004, J COMP NEUROL, V469, P70, DOI 10.1002/cne.10985; GILL G, 1988, NATURE, V334, P721, DOI 10.1038/334721a0; Gohl DM, 2011, NAT METHODS, V8, P231, DOI 10.1038/NMETH.1561; Gong SC, 2003, NATURE, V425, P917, DOI 10.1038/nature02033; Ho SN, 1996, NATURE, V382, P822, DOI 10.1038/382822a0; Hsu PD, 2012, ACS CHEM NEUROSCI, V3, P603, DOI 10.1021/cn300089k; Huang LQ, 2003, J COMP NEUROL, V455, P1, DOI 10.1002/cne.10396; Jullien N, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng131; Kim DS, 2008, J NEUROSCI, V28, P7748, DOI 10.1523/JNEUROSCI.0397-08.2008; Kinoshita M, 2012, NATURE, V487, P235, DOI 10.1038/nature11206; Kirchhofer A, 2010, NAT STRUCT MOL BIOL, V17, P133, DOI 10.1038/nsmb.1727; Kumagai A, 2013, CELL, V153, P1602, DOI 10.1016/j.cell.2013.05.038; Luan HJ, 2006, NEURON, V52, P425, DOI 10.1016/j.neuron.2006.08.028; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Masland RH, 2004, CURR BIOL, V14, pR497, DOI 10.1016/j.cub.2004.06.035; Matsuda T, 2004, P NATL ACAD SCI USA, V101, P16, DOI 10.1073/pnas.2235688100; Miyamichi K, 2011, NATURE, V472, P191, DOI 10.1038/nature09714; Mizuguchi H, 2000, MOL THER, V1, P376, DOI 10.1006/mthe.2000.0050; Nagel G, 2005, CURR BIOL, V15, P2279, DOI 10.1016/j.cub.2005.11.032; Nishida A, 2003, NAT NEUROSCI, V6, P1255, DOI 10.1038/nn1155; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Pollock R, 2002, CURR OPIN BIOTECH, V13, P459, DOI 10.1016/S0958-1669(02)00373-7; Rothbauer U, 2008, MOL CELL PROTEOMICS, V7, P282, DOI 10.1074/mcp.M700342-MCP200; Rothbauer U, 2006, NAT METHODS, V3, P887, DOI 10.1038/NMETH953; SADOWSKI I, 1988, NATURE, V335, P563, DOI 10.1038/335563a0; Samson M, 2009, DEV DYNAM, V238, P3218, DOI 10.1002/dvdy.22138; SCHMITZ ML, 1991, EMBO J, V10, P3805, DOI 10.1002/j.1460-2075.1991.tb04950.x; Schonig K, 2010, METHOD ENZYMOL, V477, P429, DOI 10.1016/S0076-6879(10)77022-1; Shaner NC, 2005, NAT METHODS, V2, P905, DOI 10.1038/NMETH819; Siegert S, 2012, NAT NEUROSCI, V15, P487, DOI 10.1038/nn.3032; Siegert S, 2009, NAT NEUROSCI, V12, P1197, DOI 10.1038/nn.2370; SLAUGHTER MM, 1981, SCIENCE, V211, P182, DOI 10.1126/science.6255566; Tian E, 2002, DEV BIOL, V242, P204, DOI 10.1006/dbio.2001.0531; Trinkle-Mulcahy L, 2008, J CELL BIOL, V183, P223, DOI 10.1083/jcb.200805092; Tsien RY, 1998, ANNU REV BIOCHEM, V67, P509, DOI 10.1146/annurev.biochem.67.1.509; Venken KJT, 2011, NEURON, V72, P202, DOI 10.1016/j.neuron.2011.09.021; Wassle H, 2009, J NEUROSCI, V29, P106, DOI 10.1523/JNEUROSCI.4442-08.2009; Watanabe S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054146; Wehr MC, 2006, NAT METHODS, V3, P985, DOI 10.1038/nmeth967; Wickersham IR, 2012, CURR OPIN NEUROBIOL, V22, P121, DOI 10.1016/j.conb.2011.12.001; Wurch T, 2012, TRENDS BIOTECHNOL, V30, P575, DOI 10.1016/j.tibtech.2012.07.006; Yizhar O, 2011, NEURON, V71, P9, DOI 10.1016/j.neuron.2011.06.004	55	82	83	3	79	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 15	2013	154	4					928	939		10.1016/j.cell.2013.07.021	http://dx.doi.org/10.1016/j.cell.2013.07.021			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	202GQ	23953120	Bronze, Green Accepted			2022-12-24	WOS:000323202500021
J	Zhou, CF; Wu, SY; Martin, T; Luo, ZX				Zhou, Chang-Fu; Wu, Shaoyuan; Martin, Thomas; Luo, Zhe-Xi			A Jurassic mammaliaform and the earliest mammalian evolutionary adaptations	NATURE			English	Article							ALLOTHERIAN MAMMALS; NORTHEASTERN CHINA; MIDDLE-EAR; TEETH; DIVERSIFICATION; EUTRICONODONT	The earliest evolution of mammals and origins of mammalian features can be traced to the mammaliaforms of the Triassic and Jurassic periods that are extinct relatives to living mammals. Here we describe a new fossil from the Middle Jurassic that has a mandibular middle ear, a gradational transition of thoracolumbar vertebrae and primitive ankle features, but highly derived molars with a high crown and multiple roots that are partially fused. The upper molars have longitudinal cusp rows that occlude alternately with those of the lower molars. This specialization for masticating plants indicates that herbivory evolved among mammaliaforms, before the rise of crown mammals. The new species shares the distinctive dental features of the eleutherodontid clade, previously represented only by isolated teeth despite its extensive geographic distribution during the Jurassic. This eleutherodontid was terrestrial and had ambulatory gaits, analogous to extant terrestrial mammals such as armadillos or rock hyrax. Its fur corroborates that mammalian integument had originated well before the common ancestor of living mammals.	[Zhou, Chang-Fu; Wu, Shaoyuan] Shenyang Normal Univ, Paleontol Museum Liaoning, Shenyang 110034, Liaoning, Peoples R China; [Martin, Thomas; Luo, Zhe-Xi] Univ Bonn, Steinmann Inst Geol Mineral & Palaontol, D-53115 Bonn, Germany; [Luo, Zhe-Xi] Univ Chicago, Dept Organismal Biol & Anat, Chicago, IL 60637 USA	Shenyang Normal University; University of Bonn; University of Chicago	Luo, ZX (corresponding author), Univ Bonn, Steinmann Inst Geol Mineral & Palaontol, Nussallee 8, D-53115 Bonn, Germany.	zxluo@uchicago.edu	Luo, Zhe-XI/AAU-2263-2021	Zhou, Chang-Fu/0000-0002-3744-7573	Key Lab for Paleobiological Evolution of Northeastern Asia, Ministry of Land Resources of China; Shenyang Normal University and Paleontological Museum of Liaoning; Deutsche Forschungsmeinschaft (DFG); Alexander von Humboldt-Foundation; National Science Foundation; University of Chicago	Key Lab for Paleobiological Evolution of Northeastern Asia, Ministry of Land Resources of China; Shenyang Normal University and Paleontological Museum of Liaoning; Deutsche Forschungsmeinschaft (DFG)(German Research Foundation (DFG)); Alexander von Humboldt-Foundation(Alexander von Humboldt Foundation); National Science Foundation(National Science Foundation (NSF)); University of Chicago(University of Chicago)	We thank G. Sun for proposing this research, and for his encouragement and support throughout; O. Dulfer for preparation of the fossil; P. Goddertz and K. Jager for their CT scanning and virtual reconstructions; G. Oleschinski for SEM photography; and A. Isch for graphics support. We benefited from discussion with K. C. Beard, W. A. Clemens, M. R. Dawson, D. Y. Hu, W. v. Koenigswald, G. Sun and J.R. Wible. J. R. Wible and M. R. Dawson helped to improve the manuscript. Support was from the Key Lab for Paleobiological Evolution of Northeastern Asia, Ministry of Land Resources of China, and Shenyang Normal University and Paleontological Museum of Liaoning (C.Z. and S. W.), Deutsche Forschungsmeinschaft (DFG) (T. M.), Alexander von Humboldt-Foundation, National Science Foundation and the University of Chicago (Z.-X.L.). This is publication no. 60 from DFG Research Unit 771, Universitat Bonn.	Averianov A O, 2011, Dokl Biol Sci, V437, P103, DOI 10.1134/S0012496611020074; Butler PM, 2000, ACTA PALAEONTOL POL, V45, P317; Butler PM, 2005, ACTA PALAEONTOL POL, V50, P185; Clemens W.A., 1980, Zitteliana, V5, P51; Crompton A.W., 1972, B BRIT MUS NAT HIST, V21, P29; Hahn G., 1989, Geologica et Palaeontologica, V23, P205; Hahn Gerhard, 2006, Geologica et Palaeontologica, V40, P173; Hildebrand M., 2001, ANAL VERTEBRATE STRU; Hu Y., 2006, THESIS CITY U NEW YO; Jenkins FA, 1997, NATURE, V385, P715, DOI 10.1038/385715a0; JENKINS FA, 1983, SCIENCE, V220, P712, DOI 10.1126/science.220.4598.712; Jenkins Jr F. A., 1971, PEABODY MUS NAT HIST, V36, P1; Ji Q, 2006, SCIENCE, V311, P1123, DOI 10.1126/science.1123026; Ji Q, 1999, NATURE, V398, P326; Ji Q, 2009, SCIENCE, V326, P278, DOI 10.1126/science.1178501; Kermack KA, 1998, ACTA PALAEONTOL POL, V43, P581; KERMACK KA, 1981, ZOOL J LINN SOC-LOND, V71, P1, DOI 10.1111/j.1096-3642.1981.tb01127.x; Kielan-Jaworowska Z., 2005, MAMMALS AGE DINOSAUR; Kielan-Jaworowska Zofia, 1994, Fossils and Strata, V36, P1; KRAUSE DW, 1982, PALEOBIOLOGY, V8, P265, DOI 10.1017/S0094837300006989; Lazzari V, 2010, J MAMM EVOL, V17, P177, DOI 10.1007/s10914-010-9139-5; Lessertisseur J., 1967, TRAITE ZOOLOGIE, P709; Lillegraven J.A., 1991, Contributions to Geology University of Wyoming, V28, P39; Liu YQ, 2012, PALAEOGEOGR PALAEOCL, V323, P1, DOI 10.1016/j.palaeo.2012.01.017; Liu YQ, 2006, CHINESE SCI BULL, V51, P2634, DOI 10.1007/s11434-006-2165-2; Luo ZX, 2007, NATURE, V450, P93, DOI 10.1038/nature06221; Luo ZX, 2007, NATURE, V446, P288, DOI 10.1038/nature05627; Luo ZX, 2011, ANNU REV ECOL EVOL S, V42, P355, DOI 10.1146/annurev-ecolsys-032511-142302; Luo ZX, 2011, NATURE, V476, P442, DOI 10.1038/nature10291; Luo ZX, 2005, SCIENCE, V308, P103, DOI 10.1126/science.1108875; Martin Thomas, 2010, Palaeobiodiversity Palaeoenvironments, V90, P295, DOI 10.1007/s12549-010-0030-4; Meng J, 2006, NATURE, V444, P889, DOI 10.1038/nature05234; Meng J, 2011, NATURE, V472, P181, DOI 10.1038/nature09921; Narita Y, 2005, J EXP ZOOL PART B, V304B, P91, DOI 10.1002/jez.b.21029; Peng N, 2012, ACTA GEOL SIN-ENGL, V86, P1326, DOI 10.1111/1755-6724.12003; Rougier Guillermo W., 1996, American Museum Novitates, V3187, P1; Rowe T., 1988, Journal of Vertebrate Paleontology, V8, P241; SIGOGNEAU-RUSSELL D, 1989, Palaeontographica Abteilung A Palaeozoologie-Stratigraphie, V206, P137; Szalay F. S., 1994, EVOLUTIONARY HIST MA; von Koenigswald W, 2011, PALAEONTOGR ABT A, V294, P63	40	124	133	0	109	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 8	2013	500	7461					163	167		10.1038/nature12429	http://dx.doi.org/10.1038/nature12429			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	197CH	23925238				2022-12-24	WOS:000322825500026
J	Yamaguchi, Y; Suzuki, T; Mizoro, Y; Kori, H; Okada, K; Chen, YL; Fustin, JM; Yamazaki, F; Mizuguchi, N; Zhang, J; Dong, X; Tsujimoto, G; Okuno, Y; Doi, M; Okamura, H				Yamaguchi, Yoshiaki; Suzuki, Toru; Mizoro, Yasutaka; Kori, Hiroshi; Okada, Kazuki; Chen, Yulin; Fustin, Jean-Michel; Yamazaki, Fumiyoshi; Mizuguchi, Naoki; Zhang, Jing; Dong, Xin; Tsujimoto, Gozoh; Okuno, Yasushi; Doi, Masao; Okamura, Hitoshi			Mice Genetically Deficient in Vasopressin V1a and V1b Receptors Are Resistant to Jet Lag	SCIENCE			English	Article							SUPRACHIASMATIC NUCLEUS; CIRCADIAN-RHYTHMS; EXPRESSION; SYNCHRONY; STRESS	Jet-lag symptoms arise from temporal misalignment between the internal circadian clock and external solar time. We found that circadian rhythms of behavior (locomotor activity), clock gene expression, and body temperature immediately reentrained to phase-shifted light-dark cycles in mice lacking vasopressin receptors V1a and V1b (V1a(-/-)V1b(-/-)). Nevertheless, the behavior of V1a(-/-)V1b(-/-) mice was still coupled to the internal clock, which oscillated normally under standard conditions. Experiments with suprachiasmatic nucleus (SCN) slices in culture suggested that interneuronal communication mediated by V1a and V1b confers on the SCN an intrinsic resistance to external perturbation. Pharmacological blockade of V1a and V1b in the SCN of wild-type mice resulted in accelerated recovery from jet lag, which highlights the potential of vasopressin signaling as a therapeutic target for management of circadian rhythm misalignment, such as jet lag and shift work.	[Yamaguchi, Yoshiaki; Suzuki, Toru; Mizoro, Yasutaka; Okada, Kazuki; Chen, Yulin; Fustin, Jean-Michel; Yamazaki, Fumiyoshi; Mizuguchi, Naoki; Doi, Masao; Okamura, Hitoshi] Kyoto Univ, Grad Sch Pharmaceut Sci, Dept Syst Biol, Sakyo Ku, Kyoto 6068501, Japan; [Kori, Hiroshi] Ochanomizu Univ, Dept Informat Sci, Tokyo 1128620, Japan; [Kori, Hiroshi] Japan Sci & Technol Agcy, CREST, Kawaguchi, Saitama 3320012, Japan; [Zhang, Jing; Dong, Xin; Okamura, Hitoshi] Kobe Univ, Grad Sch Med, Dept Brain Sci, Div Mol Brain Sci,Chuo Ku, Kobe, Hyogo 6500017, Japan; [Tsujimoto, Gozoh] Kyoto Univ, Grad Sch Pharmaceut Sci, Dept Genom Drug Discovery Sci, Kyoto 6068501, Japan; [Okuno, Yasushi] Kyoto Univ, Grad Sch Pharmaceut Sci, Dept Syst Biosci Drug Discovery, Kyoto 6068501, Japan	Kyoto University; Ochanomizu University; Japan Science & Technology Agency (JST); Kobe University; Kyoto University; Kyoto University	Okamura, H (corresponding author), Kyoto Univ, Grad Sch Pharmaceut Sci, Dept Syst Biol, Sakyo Ku, Kyoto 6068501, Japan.	okamurah@pharm.kyoto-u.ac.jp	Kori, Hiroshi/AAD-3700-2019; Fustin, Jean-Michel/R-6621-2019; Yamaguchi, Yoshiaki/K-9418-2013; Doi, Masao/J-9267-2019	Fustin, Jean-Michel/0000-0002-6200-6075; Yamaguchi, Yoshiaki/0000-0003-4126-542X; Doi, Masao/0000-0001-6264-9217; Okamura, Hitoshi/0000-0002-3013-4881; Mizoro, Yasutaka/0000-0002-5081-4884; Suzuki, Toru/0000-0003-2973-190X	Ministry of Education, Science, Sports and Culture of Japan; Takeda Science Foundation; SRF; Kanae Science Foundation	Ministry of Education, Science, Sports and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Takeda Science Foundation(Takeda Science Foundation (TSF)); SRF; Kanae Science Foundation	This work was supported in part by Grant-in-Aid for Specially Promoted Research (to H.O.) and Scientific Research on Innovative Areas "Brain Environment" (to H.O.) from the Ministry of Education, Science, Sports and Culture of Japan, and by grants from Takeda Science Foundation (to H.O.), SRF (to H.O.), and Kanae Science Foundation (to Y.Y.). H.O. and Kyoto University have applied for a patent (PCT/JP2013/064376) related to the use of V1a and V1b antagonists as circadian rhythm modulators.	Aton SJ, 2005, NAT NEUROSCI, V8, P476, DOI 10.1038/nn1419; Butler MP, 2009, J BIOL RHYTHM, V24, P340, DOI 10.1177/0748730409344800; Buxton OM, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003200; Cao RF, 2013, EUR J NEUROSCI, V37, P130, DOI 10.1111/ejn.12028; CASTEL M, 1990, J COMP NEUROL, V298, P172, DOI 10.1002/cne.902980204; COMPERATORE CA, 1990, OCCUP MED, V5, P323; Doi M, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1316; GROBLEWSKI TA, 1981, BRAIN RES BULL, V6, P125, DOI 10.1016/S0361-9230(81)80036-6; Harmar AJ, 2002, CELL, V109, P497, DOI 10.1016/S0092-8674(02)00736-5; Jin XW, 1999, CELL, V96, P57, DOI 10.1016/S0092-8674(00)80959-9; Kalamatianos T, 2004, J NEUROENDOCRINOL, V16, P493, DOI 10.1111/j.1365-2826.2004.01196.x; Kiessling S, 2010, J CLIN INVEST, V120, P2600, DOI 10.1172/JCI41192; Koshimizu T, 2006, P NATL ACAD SCI USA, V103, P7807, DOI 10.1073/pnas.0600875103; Kuramoto Y., 2003, CHEM OSCILLATIONS WA; Li JD, 2009, AM J PHYSIOL-REG I, V296, pR824, DOI 10.1152/ajpregu.90463.2008; Maywood ES, 2011, P NATL ACAD SCI USA, V108, P14306, DOI 10.1073/pnas.1101767108; Mohawk JA, 2011, TRENDS NEUROSCI, V34, P349, DOI 10.1016/j.tins.2011.05.003; OKAMURA H, 2007, COLD SPRING HARB SYM, V72, P551; Reddy AB, 2002, J NEUROSCI, V22, P7326; Sack RL, 2009, TRAVEL MED INFECT DI, V7, P102, DOI 10.1016/j.tmaid.2009.01.006; Scheer FAJL, 2009, P NATL ACAD SCI USA, V106, P4453, DOI 10.1073/pnas.0808180106; SCHWARTZ WJ, 1985, J NEUROSCI, V5, P2771; SWAAB DF, 1975, J NEURAL TRANSM, V36, P195, DOI 10.1007/BF01253126; Tanoue A, 2004, J CLIN INVEST, V113, P302, DOI 10.1172/JCI200419656; VANDENPOL AN, 1985, NEUROSCIENCE, V15, P1049, DOI 10.1016/0306-4522(85)90254-4; WINFREE AT, 1967, J THEOR BIOL, V16, P15, DOI 10.1016/0022-5193(67)90051-3; Yamaguchi S, 2003, SCIENCE, V302, P1408, DOI 10.1126/science.1089287; Yamazaki S, 2000, SCIENCE, V288, P682, DOI 10.1126/science.288.5466.682; YOUNG WS, 1993, ENDOCRINOLOGY, V133, P585, DOI 10.1210/en.133.2.585	29	210	216	4	66	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 4	2013	342	6154					85	90		10.1126/science.1238599	http://dx.doi.org/10.1126/science.1238599			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	227PP	24092737				2022-12-24	WOS:000325126100050
J	Wissenberg, M; Lippert, FK; Folke, F; Weeke, P; Hansen, CM; Christensen, EF; Jans, H; Hansen, PA; Lang-Jensen, T; Olesen, JB; Lindhardsen, J; Fosbol, EL; Nielsen, SL; Gislason, GH; Kober, L; Torp-Pedersen, C				Wissenberg, Mads; Lippert, Freddy K.; Folke, Fredrik; Weeke, Peter; Hansen, Carolina Malta; Christensen, Erika Frischknecht; Jans, Henning; Hansen, Poul Anders; Lang-Jensen, Torsten; Olesen, Jonas Bjerring; Lindhardsen, Jesper; Fosbol, Emil L.; Nielsen, Soren L.; Gislason, Gunnar H.; Kober, Lars; Torp-Pedersen, Christian			Association of National Initiatives to Improve Cardiac Arrest Management With Rates of Bystander Intervention and Patient Survival After Out-of-Hospital Cardiac Arrest	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							AMERICAN-HEART-ASSOCIATION; PUBLIC-ACCESS DEFIBRILLATION; LONG-TERM SURVIVAL; CARDIOPULMONARY-RESUSCITATION; GUIDELINES; STATEMENT; IMPLEMENTATION; PROFESSIONALS; COMMITTEE; CPR	IMPORTANCE Out-of-hospital cardiac arrest is a major health problem associated with poor outcomes. Early recognition and intervention are critical for patient survival. Bystander cardiopulmonary resuscitation (CPR) is one factor among many associated with improved survival. OBJECTIVE To examine temporal changes in bystander resuscitation attempts and survival during a 10-year period in which several national initiatives were taken to increase rates of bystander resuscitation and improve advanced care. DESIGN, SETTING, AND PARTICIPANTS Patients with out-of-hospital cardiac arrest for which resuscitation was attempted were identified between 2001 and 2010 in the nationwide Danish Cardiac Arrest Registry. Of 29 111 patients with cardiac arrest, we excluded those with presumed noncardiac cause of arrest (n = 7390) and those with cardiac arrests witnessed by emergency medical services personnel (n = 2253), leaving a study population of 19 468 patients. MAIN OUTCOMES AND MEASURES Temporal trends in bystander CPR, bystander defibrillation, 30-day survival, and 1-year survival. RESULTS The median age of patients was 72 years; 67.4% were men. Bystander CPR increased significantly during the study period, from 21.1%(95% CI, 18.8%-23.4%) in 2001 to 44.9% (95% CI, 42.6%-47.1%) in 2010 (P<.001), whereas use of defibrillation by bystanders remained low (1.1% [95% CI, 0.6%-1.9%] in 2001 to 2.2% [95% CI, 1.5%-2.9%] in 2010; P=.003). More patients achieved survival on hospital arrival (7.9% [95% CI, 6.4%-9.5%] in 2001 to 21.8% [95% CI, 19.8%-23.8%] in 2010; P<.001). Also, 30-day survival improved (3.5% [95% CI, 2.5%-4.5%] in 2001 to 10.8% [95% CI, 9.4%-12.2%] in 2010; P<.001), as did 1-year survival (2.9% [95% CI, 2.0%-3.9%] in 2001 to 10.2% [95% CI, 8.9%-11.6%] in 2010; P<.001). Despite a decrease in the incidence of out-of-hospital cardiac arrests during the study period (40.4 to 34.4 per 100 000 persons in 2001 and 2010, respectively; P=.002), the number of survivors per 100 000 persons increased significantly (P<.001). For the entire study period, bystander CPR was positively associated with 30-day survival, regardless of witnessed status (30-day survival for nonwitnessed cardiac arrest, 4.3% [95% CI, 3.4%-5.2%] with bystander CPR and 1.0% [95% CI, 0.8%-1.3%] without; odds ratio, 4.38 [95% CI, 3.17-6.06]). For witnessed arrest the corresponding values were 19.4%(95% CI, 18.1%-20.7%) vs 6.1% (95% CI, 5.4%-6.7%); odds ratio, 3.74 (95% CI, 3.26-4.28). CONCLUSIONS AND RELEVANCE In Denmark between 2001 and 2010, an increase in survival following out-of-hospital cardiac arrest was significantly associated with a concomitant increase in bystander CPR. Because of the co-occurrence of other related initiatives, a causal relationship remains uncertain.	[Wissenberg, Mads; Folke, Fredrik; Weeke, Peter; Hansen, Carolina Malta; Olesen, Jonas Bjerring; Lindhardsen, Jesper; Gislason, Gunnar H.] Univ Copenhagen, Gentofte Hosp, Dept Cardiol, DK-2900 Hellerup, Denmark; [Fosbol, Emil L.; Kober, Lars] Copenhagen Univ Hosp, Rigshosp, Ctr Heart, Copenhagen, Denmark; [Torp-Pedersen, Christian] Aalborg Univ, Inst Hlth Sci & Technol, Aalborg, Denmark	University of Copenhagen; Herlev & Gentofte Hospital; Rigshospitalet; University of Copenhagen; Aalborg University	Wissenberg, M (corresponding author), Univ Copenhagen, Gentofte Hosp, Dept Cardiol, Niels Andersens Vej 65,Post 635, DK-2900 Hellerup, Denmark.	mads.wissenberg.joergensen@regionh.dk	Christensen, Erika Frischknecht/H-8753-2017; Gislason, Gunnar/B-7561-2009; Folke, Fredrik/P-3601-2014	Christensen, Erika Frischknecht/0000-0003-3673-9694; Gislason, Gunnar/0000-0002-0548-402X; Folke, Fredrik/0000-0002-2284-7857; Lippert, Freddy/0000-0002-2356-8809; Wissenberg, Mads/0000-0001-7067-3372; Kober, Lars/0000-0002-6635-1466; Fosbol, Emil/0000-0002-2048-4167	Danish foundation TrygFonden (Denmark); Danish Heart Foundation (Denmark); Health Insurance Foundation (Denmark); TrygFonden; Novo Nordisk Foundation	Danish foundation TrygFonden (Denmark); Danish Heart Foundation (Denmark); Health Insurance Foundation (Denmark); TrygFonden; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited)	This study was supported by the Danish foundation TrygFonden, the Danish Heart Foundation, and the Health Insurance Foundation (all from Denmark). The Danish Cardiac Arrest Registry and the Automated External Defibrillator (AED) Network are supported by TrygFonden, which has no commercial interests in the field of cardiac arrest. Dr Gislason is supported by an independent research scholarship from the Novo Nordisk Foundation.	Abella BS, 2008, CIRCULATION, V117, P704, DOI 10.1161/CIRCULATIONAHA.107.188486; [Anonymous], DAN LEARN CARD RES; [Anonymous], 2011, AUT EXT DEF AED PLAC; [Anonymous], SUMM VIT STAT; [Anonymous], INCR NUMB DAN CIT WH; Berdowski J, 2010, RESUSCITATION, V81, P1479, DOI 10.1016/j.resuscitation.2010.08.006; Bhanji F, 2010, CIRCULATION, V122, pS920, DOI 10.1161/CIRCULATIONAHA.110.971135; Buch P, 2003, TREATMENT OUT OF HOS; Caffrey SL, 2002, NEW ENGL J MED, V347, P1242, DOI 10.1056/NEJMoa020932; CUMMINS RO, 1991, CIRCULATION, V83, P1832, DOI 10.1161/01.CIR.83.5.1832; Davies CS, 2005, HEART, V91, P1299, DOI 10.1136/hrt.2003.032631; Field JM, 2010, CIRCULATION, V122, pS640, DOI 10.1161/CIRCULATIONAHA.110.970889; Hallstrom AP, 2004, NEW ENGL J MED, V351, P637; Hollenberg J, 2008, CIRCULATION, V118, P389, DOI 10.1161/CIRCULATIONAHA.107.734137; Holler NG, 2007, RESUSCITATION, V75, P23, DOI 10.1016/j.resuscitation.2007.03.015; Iwami T, 2009, CIRCULATION, V119, P728, DOI 10.1161/CIRCULATIONAHA.108.802058; Jacobs I, 2004, CIRCULATION, V110, P3385, DOI 10.1161/01.CIR.0000147236.85306.15; Kitamura T, 2012, CIRCULATION, V126, P2834, DOI 10.1161/CIRCULATIONAHA.112.109496; Kitamura T, 2010, NEW ENGL J MED, V362, P994, DOI 10.1056/NEJMoa0906644; Kuilman M, 1999, RESUSCITATION, V41, P25, DOI 10.1016/S0300-9572(99)00016-7; Kuramoto N, 2008, RESUSCITATION, V79, P475, DOI 10.1016/j.resuscitation.2008.07.005; Lindner TW, 2011, RESUSCITATION, V82, P1508, DOI 10.1016/j.resuscitation.2011.06.016; McNally Bryan, 2011, Morbidity and Mortality Weekly Report, V60, P1; Neumar RW, 2010, CIRCULATION, V122, pS729, DOI 10.1161/CIRCULATIONAHA.110.970988; Nichol G, 2008, JAMA-J AM MED ASSOC, V300, P1423, DOI 10.1001/jama.300.12.1423; Nielsen AM, 2013, RESUSCITATION, V84, P430, DOI 10.1016/j.resuscitation.2012.11.008; Nielsen AM, 2012, RESUSCITATION, V83, P1067, DOI 10.1016/j.resuscitation.2012.04.012; Rea TD, 2010, ANN EMERG MED, V55, P249, DOI 10.1016/j.annemergmed.2009.09.018; Rea TD, 2010, CIRCULATION, V121, P1134, DOI 10.1161/CIRCULATIONAHA.109.899799; Roger VL, 2011, CIRCULATION, V123, pE18, DOI 10.1161/CIR.0b013e3182009701; Sasson C, 2010, CIRC-CARDIOVASC QUAL, V3, P63, DOI 10.1161/CIRCOUTCOMES.109.889576; Vaillancourt C, 2008, CAN J EMERG MED, V10, P51, DOI 10.1017/S1481803500010010; Valenzuela TD, 2000, NEW ENGL J MED, V343, P1206, DOI 10.1056/NEJM200010263431701	33	769	782	4	38	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 2	2013	310	13					1377	1384		10.1001/jama.2013.278483	http://dx.doi.org/10.1001/jama.2013.278483			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	227GB	24084923	Bronze			2022-12-24	WOS:000325098100023
J	Bocklisch, C; Pascoli, V; Wong, JCY; House, DRC; Yvon, C; de Roo, M; Tan, KR; Luscher, C				Bocklisch, Christina; Pascoli, Vincent; Wong, Jovi C. Y.; House, David R. C.; Yvon, Cedric; de Roo, Mathias; Tan, Kelly R.; Luescher, Christian			Cocaine Disinhibits Dopamine Neurons by Potentiation of GABA Transmission in the Ventral Tegmental Area	SCIENCE			English	Article							EVOKED SYNAPTIC PLASTICITY; LONG-TERM POTENTIATION; NUCLEUS-ACCUMBENS; IN-VIVO; ACTIVATION	Drug-evoked synaptic plasticity in the mesolimbic system reshapes circuit function and drives drug-adaptive behavior. Much research has focused on excitatory transmission in the ventral tegmental area (VTA) and the nucleus accumbens (NAc). How drug-evoked synaptic plasticity of inhibitory transmission affects circuit adaptations remains unknown. We found that medium spiny neurons expressing dopamine (DA) receptor type 1 (D1R-MSNs) of the NAc project to the VTA, strongly preferring the GABA neurons of the VTA. Repeated in vivo exposure to cocaine evoked synaptic potentiation at this synapse, occluding homosynaptic inhibitory long-term potentiation. The activity of the VTA GABA neurons was thus reduced and DA neurons were disinhibited. Cocaine-evoked potentiation of GABA release from D1R-MSNs affected drug-adaptive behavior, which identifies these neurons as a promising target for novel addiction treatments.	[Bocklisch, Christina; Pascoli, Vincent; Wong, Jovi C. Y.; House, David R. C.; Yvon, Cedric; de Roo, Mathias; Tan, Kelly R.; Luescher, Christian] Univ Geneva, Fac Med, Dept Basic Neurosci, CH-1211 Geneva, Switzerland; [Luescher, Christian] Univ Hosp Geneva, Dept Clin Neurosci, Neurol Clin, CH-1211 Geneva, Switzerland	University of Geneva; University of Geneva	Luscher, C (corresponding author), Univ Geneva, Fac Med, Dept Basic Neurosci, CH-1211 Geneva, Switzerland.	christian.luscher@unige.ch	Lüscher, Christian/A-2496-2011	Lüscher, Christian/0000-0001-7917-4596; De Roo, Mathias/0000-0001-9912-6954; Wong, Jovi/0000-0001-7980-9352	Swiss National Science Foundation; European Research Council; Synapsy; National Competence Center in Research; Swiss Confederation scholarship	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); European Research Council(European Research Council (ERC)European Commission); Synapsy; National Competence Center in Research; Swiss Confederation scholarship	We thank M. Serafin and the members of the Luscher laboratory for suggestions on the manuscript, M. Brown for support during the in vivo electrophysiology experiments, G. Miesenbock for GADCre mice, and S. Schoch for Rim1 alpha<SUP>-/-</SUP> mice. Supported by the Swiss National Science Foundation, the European Research Council, and "Synapsy," a National Competence Center in Research (C. L.) and by a Swiss Confederation scholarship (J.C.Y.W.).	Belin D, 2008, NEURON, V57, P432, DOI 10.1016/j.neuron.2007.12.019; Bellone C, 2006, NAT NEUROSCI, V9, P636, DOI 10.1038/nn1682; Bertran-Gonzalez J, 2008, J NEUROSCI, V28, P5671, DOI 10.1523/JNEUROSCI.1039-08.2008; BRODIE MS, 1990, N-S ARCH PHARMACOL, V342, P660, DOI 10.1007/BF00175709; Brown MTC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015870; Castillo PE, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a005728; Castillo PE, 2002, NATURE, V415, P327, DOI 10.1038/415327a; Chandra R, 2013, FRONT MOL NEUROSCI, V6, DOI 10.3389/fnmol.2013.00013; Chen R, 2006, P NATL ACAD SCI USA, V103, P9333, DOI 10.1073/pnas.0600905103; Cruz HG, 2004, NAT NEUROSCI, V7, P153, DOI 10.1038/nn1181; Fields HL, 2007, ANNU REV NEUROSCI, V30, P289, DOI 10.1146/annurev.neuro.30.051606.094341; Froemke RC, 2007, NATURE, V450, P425, DOI 10.1038/nature06289; Gambino F, 2012, NEURON, V75, P490, DOI 10.1016/j.neuron.2012.05.020; Grimm JW, 2001, NATURE, V412, P141, DOI 10.1038/35084134; JOHNSON SW, 1992, J NEUROSCI, V12, P483; Letzkus JJ, 2011, NATURE, V480, P331, DOI 10.1038/nature10674; Liu QS, 2005, NATURE, V437, P1027, DOI 10.1038/nature04050; Lobo MK, 2010, SCIENCE, V330, P385, DOI 10.1126/science.1188472; Luscher C, 2011, NEURON, V69, P650, DOI 10.1016/j.neuron.2011.01.017; Mameli M, 2009, NAT NEUROSCI, V12, P1036, DOI 10.1038/nn.2367; Nagel G, 2005, CURR BIOL, V15, P2279, DOI 10.1016/j.cub.2005.11.032; Pan B, 2008, J NEUROSCI, V28, P1385, DOI 10.1523/JNEUROSCI.4033-07.2008; Pascoli V, 2012, NATURE, V481, P71, DOI 10.1038/nature10709; ROBINSON TE, 1993, BRAIN RES REV, V18, P247, DOI 10.1016/0165-0173(93)90013-P; Self DW, 1998, J NEUROSCI, V18, P1848; Sesack SR, 2010, NEUROPSYCHOPHARMACOL, V35, P27, DOI 10.1038/npp.2009.93; Smidt MP, 1997, P NATL ACAD SCI USA, V94, P13305, DOI 10.1073/pnas.94.24.13305; Tan KR, 2012, NEURON, V73, P1173, DOI 10.1016/j.neuron.2012.02.015; Tan KR, 2010, NATURE, V463, P769, DOI 10.1038/nature08758; Ungless MA, 2001, NATURE, V411, P583, DOI 10.1038/35079077; Watabe-Uchida M, 2012, NEURON, V74, P858, DOI 10.1016/j.neuron.2012.03.017; WEISSKOPF MG, 1994, SCIENCE, V265, P1878, DOI 10.1126/science.7916482; Xia YF, 2011, J NEUROSCI, V31, P7811, DOI 10.1523/JNEUROSCI.1504-11.2011	33	197	202	0	55	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 27	2013	341	6153					1521	1525		10.1126/science.1237059	http://dx.doi.org/10.1126/science.1237059			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	224NS	24072923				2022-12-24	WOS:000324894600053
J	Smith, MP; Harper, DAT				Smith, M. Paul; Harper, David A. T.			Causes of the Cambrian Explosion	SCIENCE			English	Editorial Material							EVOLUTION; ANIMALS		[Smith, M. Paul] Univ Oxford, Museum Nat Hist, Oxford OX1 3PW, England; [Harper, David A. T.] Univ Durham, Dept Earth Sci, Durham DH1 3LE, England	University of Oxford; Durham University	Smith, MP (corresponding author), Univ Oxford, Museum Nat Hist, Parks Rd, Oxford OX1 3PW, England.	paul.smith@oum.ox.ac.uk	Harper, David/AAX-7473-2020; Harper, David A.T./C-6888-2012	Harper, David/0000-0003-1315-9494; Harper, David A.T./0000-0003-1315-9494; Smith, Paul/0000-0002-5141-1577				Brasier Martin D., 2007, Memoir of the Association of Australasian Palaeontologists, V34, P377; Brennan ST, 2004, GEOLOGY, V32, P473, DOI 10.1130/g20251.1; Butterfield NJ, 2011, TRENDS ECOL EVOL, V26, P81, DOI 10.1016/j.tree.2010.11.012; Callow RHT, 2009, EARTH-SCI REV, V96, P207, DOI 10.1016/j.earscirev.2009.07.002; COOK PJ, 1984, NATURE, V308, P231, DOI 10.1038/308231a0; Erwin D. H., 2013, CAMBRIAN EXPLOSION; Erwin DH, 2002, DEVELOPMENT, V129, P3021; Erwin DH, 2011, SCIENCE, V334, P1091, DOI 10.1126/science.1206375; Lowe CJ, 2013, SCIENCE, V340, P1170, DOI 10.1126/science.1237431; Marshall CR, 2006, ANNU REV EARTH PL SC, V34, P355, DOI 10.1146/annurev.earth.33.031504.103001; Murdock DJE, 2011, CELLS TISSUES ORGANS, V194, P98, DOI 10.1159/000324245; Peters SE, 2012, NATURE, V484, P363, DOI 10.1038/nature10969; Peterson KJ, 2005, PALEOBIOLOGY, V31, P36, DOI 10.1666/0094-8373(2005)031[0036:TAMOEA]2.0.CO;2; Wood R, 2012, EARTH-SCI REV, V115, P249, DOI 10.1016/j.earscirev.2012.10.002	14	61	63	4	241	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 20	2013	341	6152					1355	1356		10.1126/science.1239450	http://dx.doi.org/10.1126/science.1239450			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	220PK	24052300	Green Accepted			2022-12-24	WOS:000324597200034
J	Pandit, MK				Pandit, Maharaj K.			The Himalayas must be protected	NATURE			English	Editorial Material									[Pandit, Maharaj K.] Univ Delhi, Dept Environm Studies, Delhi 110007, India; [Pandit, Maharaj K.] Univ Delhi, Ctr Interdisciplinary Studies Mt & Hill Environm, Delhi 110007, India	University of Delhi; University of Delhi	Pandit, MK (corresponding author), Univ Delhi, Dept Environm Studies, Delhi 110007, India.	rajkpandit@gmail.com	Pandit, Maharaj K/A-4065-2014	Pandit, Maharaj K/0000-0001-6611-560X					0	16	17	1	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 19	2013	501	7467					283	283		10.1038/501283a	http://dx.doi.org/10.1038/501283a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	219XT	24048033	Bronze			2022-12-24	WOS:000324545700004
J	Erickson, KF; Chertow, GM; Goldhaber-Fiebert, JD				Erickson, Kevin F.; Chertow, Glenn M.; Goldhaber-Fiebert, Jeremy D.			Cost-Effectiveness of Tolvaptan in Autosomal Dominant Polycystic Kidney Disease	ANNALS OF INTERNAL MEDICINE			English	Article							QUALITY-OF-LIFE; RENAL-DISEASE; HEALTH; PROGRESSION; SURVIVAL	Background: In the TEMPO (Tolvaptan Efficacy and Safety in Management of Autosomal Dominant Polycystic Kidney Disease and Its Outcomes) trial, tolvaptan significantly reduced expansion of kidney volume and loss of kidney function. Objective: To determine how the benefits of tolvaptan seen in TEMPO may relate to longer-term health outcomes, such as progression to end-stage renal disease (ESRD) and death, and cost-effectiveness. Design: A decision-analytic model. Data Sources: Published literature from 1993 to 2012. Target Population: Persons with early autosomal dominant polycystic kidney disease. Time Horizon: Lifetime. Perspective: Societal. Intervention: Patients received tolvaptan therapy until death, development of ESRD, or liver complications or no tolvaptan therapy. Outcome Measures: Median age at ESRD onset, life expectancy, discounted quality-adjusted life-years and lifetime costs (in 2010 U.S. dollars), and incremental cost-effectiveness ratios. Results of Base-Case Analysis: Tolvaptan prolonged the median age at ESRD onset by 6.5 years and increased life expectancy by 2.6 years. At $5760 per month, tolvaptan cost $744 100 per quality-adjusted life-year gained compared with standard care. Results of Sensitivity Analysis: For patients with autosomal dominant polycystic kidney disease that progressed more slowly, the cost per quality-adjusted life-year gained was even greater for tolvaptan. Limitation: Although TEMPO followed patients for 3 years, the main analysis assumed that clinical benefits persisted over patients' lifetimes. Conclusion: Assuming that the benefits of tolvaptan persist in the longer term, the drug may slow progression to ESRD and reduce mortality rates. However, barring an approximately 95% reduction in price, cost-effectiveness does not compare favorably with many other commonly accepted medical interventions.	Stanford Univ, Sch Med, Ctr Hlth Policy, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Ctr Primary Care & Outcomes Res, Stanford, CA 94305 USA	Stanford University; Stanford University	Erickson, KF (corresponding author), Stanford Univ, Sch Med, 117 Encina Commons, Stanford, CA 94305 USA.	kevine1@stanford.edu		Chertow, Glenn/0000-0002-7599-0534; Goldhaber-Fiebert, Jeremy/0000-0002-4007-5192	Agency for Healthcare Research and Quality [F32 HS019178]; National Institutes of Health [DK085446, AG037593]; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [F32HS019178] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R33CA094304] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K24DK085446] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K01AG037593] Funding Source: NIH RePORTER	Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Grant Support: By the Agency for Healthcare Research and Quality (F32 HS019178) and National Institutes of Health (DK085446 and AG037593).	[Anonymous], 2012, NEPHROLOGY NEWS 1205; [Anonymous], 2010, CLIN LAB FEE SCHED; Arias Elizabeth, 2010, Natl Vital Stat Rep, V58, P1; Centers for Medicare and Medicaid Services, 2011, PHYS FEE SCHED; Congressional Budget Office, 2005, PRIC BRAND NAM DRUGS; Fick-Brosnahan GM, 2002, AM J KIDNEY DIS, V39, P1127, DOI 10.1053/ajkd.2002.33379; FRYBACK DG, 1993, MED DECIS MAKING, V13, P89, DOI 10.1177/0272989X9301300202; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; Gorodetskaya I, 2005, KIDNEY INT, V68, P2801, DOI 10.1111/j.1523-1755.2005.00752.x; KLAHR S, 1994, NEW ENGL J MED, V330, P877, DOI 10.1056/NEJM199403313301301; Levy M, 2000, KIDNEY INT, V58, P925, DOI 10.1046/j.1523-1755.2000.00250.x; Maschio G, 1996, NEW ENGL J MED, V334, P939, DOI 10.1056/NEJM199604113341502; Meara E, 2004, HEALTH AFFAIR, V23, P176, DOI 10.1377/hlthaff.23.4.176; NKF, 2012, NEPHROLOGY NEWS 1127; Perkovic V, 2012, NEW ENGL J MED, V367, P2541, DOI 10.1056/NEJMe1212368; Perrone RD, 2001, AM J KIDNEY DIS, V38, P777, DOI 10.1053/ajkd.2001.27720; Rizk D, 2009, CLIN J AM SOC NEPHRO, V4, P560, DOI 10.2215/CJN.02410508; Schrier RW, 2003, KIDNEY INT, V63, P678, DOI 10.1046/j.1523-1755.2003.00776.x; Smith DH, 2007, INTERNET J NEPHROLOG, V4; Thomson PDR, 2010, RED BOOK PHARM FUNDA; Tokiwa S, 2011, CLIN EXP NEPHROL, V15, P539, DOI 10.1007/s10157-011-0428-y; Torres VE, 2012, NEW ENGL J MED, V367, P2407, DOI 10.1056/NEJMoa1205511; U.S. Food and Drug Administration, 2013, FDA DRUG SAF PODC FD; U.S. Renal Data System, 2011, US REN DAT SYST 2011, VOne; US Department of Labor Bureau of Labor Statistics, 2011, CONS PRIC IND ALL UR; Weinstein MC, 1996, JAMA-J AM MED ASSOC, V276, P1253, DOI 10.1001/jama.276.15.1253	26	41	44	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819			ANN INTERN MED	Ann. Intern. Med.	SEP 17	2013	159	6					382	+		10.7326/0003-4819-159-6-201309170-00004	http://dx.doi.org/10.7326/0003-4819-159-6-201309170-00004			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	234EY	24042366	Green Accepted			2022-12-24	WOS:000325625900014
J	Van Laethem, F; Tikhonova, AN; Pobezinsky, LA; Tai, XG; Kimura, MY; Le Saout, C; Guinter, TI; Adams, A; Sharrow, SO; Bernhardt, G; Feigenbaum, L; Singer, A				Van Laethem, Francois; Tikhonova, Anastasia N.; Pobezinsky, Leonid A.; Tai, Xuguang; Kimura, Motoko Y.; Le Saout, Cecile; Guinter, Terry I.; Adams, Anthony; Sharrow, Susan O.; Bernhardt, Guenter; Feigenbaum, Lionel; Singer, Alfred			Lck Availability during Thymic Selection Determines the Recognition Specificity of the T Cell Repertoire	CELL			English	Article							MAJOR HISTOCOMPATIBILITY COMPLEX; TYROSINE KINASE P56(LCK); ANTIGEN RECEPTOR; AMINO-ACIDS; GAMMA-DELTA; CD4; MHC; ACTIVATION; ADHESION; P56LCK	Thymic selection requires signaling by the protein tyrosine kinase Lck to generate T cells expressing alpha beta T cell antigen receptors (TCR). For reasons not understood, the thymus selects only alpha beta TCR that are restricted by major histocompatibility complex (MHC)-encoded determinants. Here, we report that Lck proteins that were coreceptor associated promoted thymic selection of conventionally MHC-restricted TCR, but Lck proteins that were coreceptor free promoted thymic selection of MHC-independent TCR. Transgenic TCR with MHC-independent specificity for CD155 utilized coreceptor-free Lck to signal thymic selection in the absence of MHC, unlike any transgenic TCR previously described. Thus, the thymus can select either MHC-restricted or MHC-independent alpha beta TCR depending on whether Lck is coreceptor associated or coreceptor free. We conclude that the intracellular state of Lck determines the specificity of thymic selection and that Lck association with coreceptor proteins during thymic selection is the mechanism by which MHC restriction is imposed on a randomly generated alpha beta TCR repertoire.	[Van Laethem, Francois; Tikhonova, Anastasia N.; Pobezinsky, Leonid A.; Tai, Xuguang; Kimura, Motoko Y.; Guinter, Terry I.; Adams, Anthony; Sharrow, Susan O.; Singer, Alfred] NCI, Expt Immunol Branch, Bethesda, MD 20892 USA; [Le Saout, Cecile] NIAID, Immunoregulat Lab, NIH, Bethesda, MD 20892 USA; [Bernhardt, Guenter] Hannover Med Sch, Inst Immunol, D-30625 Hannover, Germany; [Feigenbaum, Lionel] NCI Frederick Canc Res & Dev Ctr, Sci Applicat Int Corp Frederick, Frederick, MD 21702 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Hannover Medical School; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC)	Singer, A (corresponding author), NCI, Expt Immunol Branch, Bethesda, MD 20892 USA.	singera@nih.gov	Tikhonova, Anastasia/F-1186-2015; Bernhardt, Günter/F-6946-2012	Bernhardt, Günter/0000-0002-0510-2853	National Institutes of Health, National Cancer Institute, Center for Cancer Research; NATIONAL CANCER INSTITUTE [ZIABC009273, ZIABC011114, ZIABC011112, ZIABC011116, ZIABC011111, ZIABC011106, ZIABC011113] Funding Source: NIH RePORTER	National Institutes of Health, National Cancer Institute, Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Richard Hodes, Hyun Park, and Ruth Etzensperger for critically reading the manuscript; Joy Williams for thymic epithelial cell preparations; and Peter Sun and Jinghua Lu for helpful discussion. This work was supported by the Intramural Research Program of the National Institutes of Health, National Cancer Institute, Center for Cancer Research.	ABRAHAM N, 1991, NATURE, V350, P62, DOI 10.1038/350062a0; Acuto O, 2000, ANNU REV IMMUNOL, V18, P165, DOI 10.1146/annurev.immunol.18.1.165; BARND DL, 1989, P NATL ACAD SCI USA, V86, P7159, DOI 10.1073/pnas.86.18.7159; Chien YH, 2007, IMMUNOL REV, V215, P46, DOI 10.1111/j.1600-065X.2006.00470.x; Collins EJ, 2008, IMMUNOL RES, V41, P267, DOI 10.1007/s12026-008-8040-2; Constantinides MG, 2013, CURR OPIN IMMUNOL, V25, P161, DOI 10.1016/j.coi.2013.01.003; DAVIS MM, 1988, NATURE, V334, P395, DOI 10.1038/334395a0; DOYLE C, 1987, NATURE, V330, P256, DOI 10.1038/330256a0; Feng D, 2007, NAT IMMUNOL, V8, P975, DOI 10.1038/ni1502; Garcia KC, 2009, NAT IMMUNOL, V10, P143, DOI 10.1038/ni.f.219; Gray DHD, 2008, J IMMUNOL METHODS, V329, P56, DOI 10.1016/j.jim.2007.09.010; Hanada KI, 2011, BLOOD, V117, P4816, DOI 10.1182/blood-2010-11-317743; HAUGHN L, 1992, NATURE, V358, P328, DOI 10.1038/358328a0; Holdorf AD, 2002, NAT IMMUNOL, V3, P259, DOI 10.1038/ni761; Holland SJ, 2012, P NATL ACAD SCI USA, V109, pE3111, DOI 10.1073/pnas.1210882109; KAYE J, 1989, NATURE, V341, P746, DOI 10.1038/341746a0; Lee YJ, 2011, TRENDS IMMUNOL, V32, P50, DOI 10.1016/j.it.2010.12.004; Linette GP, 1996, P NATL ACAD SCI USA, V93, P9545, DOI 10.1073/pnas.93.18.9545; Lo WL, 2009, NAT IMMUNOL, V10, P1155, DOI 10.1038/ni.1796; Maier MK, 2007, EUR J IMMUNOL, V37, P2214, DOI 10.1002/eji.200737072; Marrack P, 2008, ANNU REV IMMUNOL, V26, P171, DOI 10.1146/annurev.immunol.26.021607.090421; Melichar HJ, 2007, SCIENCE, V315, P230, DOI 10.1126/science.1135344; Nika K, 2010, IMMUNITY, V32, P766, DOI 10.1016/j.immuni.2010.05.011; NORMENT AM, 1988, NATURE, V336, P79, DOI 10.1038/336079a0; PAIGE LA, 1993, J BIOL CHEM, V268, P8669; Palacios EH, 2004, ONCOGENE, V23, P7990, DOI 10.1038/sj.onc.1208074; PIRCHER H, 1989, NATURE, V342, P559, DOI 10.1038/342559a0; RAO A, 1984, CELL, V36, P879, DOI 10.1016/0092-8674(84)90037-0; RUDD CE, 1988, P NATL ACAD SCI USA, V85, P5190, DOI 10.1073/pnas.85.14.5190; Scott-Browne JP, 2009, NATURE, V458, P1043, DOI 10.1038/nature07812; SHAW AS, 1989, CELL, V59, P627, DOI 10.1016/0092-8674(89)90008-1; Tikhonova AN, 2012, IMMUNITY, V36, P79, DOI 10.1016/j.immuni.2011.11.013; TURNER JM, 1990, CELL, V60, P755, DOI 10.1016/0092-8674(90)90090-2; Van Laethem F, 2012, TRENDS IMMUNOL, V33, P437, DOI 10.1016/j.it.2012.05.006; Van Laethem F, 2007, IMMUNITY, V27, P735, DOI 10.1016/j.immuni.2007.10.007; VEILLETTE A, 1988, CELL, V55, P301, DOI 10.1016/0092-8674(88)90053-0; Wiest DL, 1996, IMMUNITY, V4, P495, DOI 10.1016/S1074-7613(00)80415-X	38	79	80	0	20	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	SEP 12	2013	154	6					1326	1341		10.1016/j.cell.2013.08.009	http://dx.doi.org/10.1016/j.cell.2013.08.009			16	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	215VQ	24034254	Green Accepted, Bronze			2022-12-24	WOS:000324239300020
J	Yuan, CX; Ji, Q; Meng, QJ; Tabrum, AR; Luo, ZX				Yuan, Chong-Xi; Ji, Qiang; Meng, Qing-Jin; Tabrum, Alan R.; Luo, Zhe-Xi			Earliest Evolution of Multituberculate Mammals Revealed by a New Jurassic Fossil	SCIENCE			English	Article							INTRINSIC HAND PROPORTIONS; ALLOTHERIAN MAMMALS; LOCOMOTOR BEHAVIOR; ADAPTATIONS; MARSUPIALS; CHINA	Multituberculates were successful herbivorous mammals and were more diverse and numerically abundant than any other mammal groups in Mesozoic ecosystems. The clade also developed diverse locomotor adaptations in the Cretaceous and Paleogene. We report a new fossil skeleton from the Late Jurassic of China that belongs to the basalmost multituberculate family. Dental features of this new Jurassic multituberculate show omnivorous adaptation, and its well-preserved skeleton sheds light on ancestral skeletal features of all multituberculates, especially the highly mobile joints of the ankle, crucial for later evolutionary success of multituberculates in the Cretaceous and Paleogene.	[Yuan, Chong-Xi; Ji, Qiang] Chinese Acad Geol Sci, Inst Geol, Beijing 100037, Peoples R China; [Meng, Qing-Jin] Beijing Museum Nat Hist, Beijing 100050, Peoples R China; [Tabrum, Alan R.] Carnegie Museum Nat Hist, Sect Vertebrate Paleontol, Pittsburgh, PA 15213 USA; [Luo, Zhe-Xi] Univ Chicago, Dept Organismal Biol & Anat, Chicago, IL 60637 USA	Chinese Academy of Geological Sciences; University of Chicago	Luo, ZX (corresponding author), Univ Chicago, Dept Organismal Biol & Anat, Chicago, IL 60637 USA.	zxluo@uchicago.edu	Luo, Zhe-XI/AAU-2263-2021; Meng, Q./GSI-6185-2022		Ministry of Land Resources; Ministry of Science and Technology of China; Scientific Commission of Beijing; Beijing Museum of Natural History; NSF; Carnegie Museum; University of Chicago	Ministry of Land Resources; Ministry of Science and Technology of China(Ministry of Science and Technology, China); Scientific Commission of Beijing; Beijing Museum of Natural History; NSF(National Science Foundation (NSF)); Carnegie Museum; University of Chicago(University of Chicago)	We thank Z. Zeng, D. Liu, X. Xia (BMNH), M. A. Klingler, and A. M. Isch for assistance for research and graphics, and J. R. Wible and M. R. Dawson for improving the manuscript. Authors benefited from discussion with R. L. Cifelli, W. A. Clemens, M. R. Dawson, G. Hahn, J. A. Hopson, Y.-Q. Liu, T. Martin, P. C. Sereno, and J. R. Wible. Support was received from Ministry of Land Resources and Ministry of Science and Technology of China 973 Project Funding (C.-X.Y. and Q. J.), Scientific Commission of Beijing and Beijing Museum of Natural History (Q.-J.M.), NSF, Carnegie Museum, and University of Chicago (Z.-X.L.).	Badiola A, 2011, CRETACEOUS RES, V32, P45, DOI 10.1016/j.cretres.2010.10.003; Butler PM, 2000, ACTA PALAEONTOL POL, V45, P317; Butler PM, 2005, ACTA PALAEONTOL POL, V50, P185; Chen M, 2013, J MAMM EVOL, V20, P159, DOI 10.1007/s10914-012-9199-9; Cifelli RL, 2013, CAN J EARTH SCI, V50, P315, DOI 10.1139/e2012-051; Greenwald N. S., 1988, J VERTEBR PALEONTOL, V8, P265; Hahn Gerhard, 1998, Berliner Geowissenschaftliche Abhandlungen Reihe E Palaeobiologie, V28, P39; Hahn Gerhard, 2000, P97; JENKINS FA, 1983, SCIENCE, V220, P712, DOI 10.1126/science.220.4598.712; Ji Q, 2009, SCIENCE, V326, P278, DOI 10.1126/science.1178501; Kielan-Jaworowska Z, 2001, PALAEONTOLOGY, V44, P389, DOI 10.1111/1475-4983.00185; Kielan-Jaworowska Z., 1994, POSTCRANIAL ANATOMY, V36; Kielan-Jaworowska Z., 2005, MAMMALS AGE DINOSAUR; Kirk EC, 2008, J HUM EVOL, V55, P278, DOI 10.1016/j.jhevol.2008.02.008; KRAUSE D W, 1983, Bulletin of the Museum of Comparative Zoology, V150, P199; Kusuhashi N, 2009, J VERTEBR PALEONTOL, V29, P1264, DOI 10.1671/039.029.0433; Liu YQ, 2012, PALAEOGEOGR PALAEOCL, V323, P1, DOI 10.1016/j.palaeo.2012.01.017; Luo ZX, 2007, NATURE, V450, P93, DOI 10.1038/nature06221; Luo ZX, 2011, NATURE, V476, P442, DOI 10.1038/nature10291; Luo ZX, 2005, SCIENCE, V308, P103, DOI 10.1126/science.1108875; MACLEOD N, 1993, AM J SCI, V293A, P300, DOI 10.2475/ajs.293.A.300; Martin Thomas, 2010, Palaeobiodiversity Palaeoenvironments, V90, P295, DOI 10.1007/s12549-010-0030-4; Nowak R.M., 1999, WALKERS MAMMALS WORL, P680; ROSE KD, 2006, BEGINNING AGE MAMMAL; ROUGIER GW, 1997, AM MUS NOVIT, P1; Sereno Paul C., 2006, P315; Szalay F. S., 1994, EVOLUTIONARY HIST MA; Szalay Frederick S., 2001, Geodiversitas, V23, P139; Weisbecker V, 2006, J MORPHOL, V267, P1469, DOI 10.1002/jmor.10495; Wilson GP, 2012, NATURE, V483, P457, DOI 10.1038/nature10880	30	79	88	1	46	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 16	2013	341	6147					779	783		10.1126/science.1237970	http://dx.doi.org/10.1126/science.1237970			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201DZ	23950536				2022-12-24	WOS:000323122200046
J	Coyle, SM; Flores, J; Lim, WA				Coyle, Scott M.; Flores, Jonathan; Lim, Wendell A.			Exploitation of Latent Allostery Enables the Evolution of New Modes of MAP Kinase Regulation	CELL			English	Article							CATALYTIC PROMISCUITY; PROTEIN; SUPERFAMILY; BINDING; OUTPUT; SITES	Allosteric interactions provide precise spatiotemporal control over signaling proteins, but how allosteric activators and their targets coevolve is poorly understood. Here, we trace the evolution of two allosteric activator motifs within the yeast scaffold protein Ste5 that specifically target the mating MAP kinase Fus3. One activator (Ste5-VWA) provides pathway insulation and dates to the divergence of Fus3 from its paralog, Kss1; a second activator (Ste5-FBD) that tunes mating behavior is, in contrast, not conserved in most lineages. Surprisingly, both Ste5 activator motifs could regulate MAP kinases that diverged from Fus3 prior to the emergence of Ste5, suggesting that Ste5 activators arose by exploiting latent regulatory features already present in the MAPK ancestor. The magnitude of this latent allosteric potential drifts widely among pre-Ste5 MAP kinases, providing a pool of hidden phenotypic diversity that, when revealed by new activators, could lead to functional divergence and to the evolution of distinct signaling behaviors.	[Coyle, Scott M.; Flores, Jonathan; Lim, Wendell A.] Univ Calif San Francisco, Howard Hughes Med Inst, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA; [Coyle, Scott M.] Univ Calif San Francisco, Program Biol Sci, San Francisco, CA 94143 USA; [Lim, Wendell A.] UCSF Ctr Syst & Synthet Biol, San Francisco, CA 94143 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Lim, WA (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA.	lim@cmp.ucsf.edu			National Science Foundation; NIH [RO1 GM55040, PN2 EY016546, P50 6M081879]; Howard Hughes Medical Institute; NATIONAL EYE INSTITUTE [PN2EY016546] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM055040, P50GM081879, T32GM007810] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	S.M.C. is supported by a National Science Foundation Graduate Research Fellowship. This work was supported by NIH grants RO1 GM55040, PN2 EY016546, and P50 6M081879 (to W. A. L.), and the Howard Hughes Medical Institute (to W. A. L.). We thank R. Almeida, P. Dumesic, J. Fraser, R. Gordley, A. Johnson, I. Nocadel, L. Pack, S. Peisajovich, T. Sorrels, J. Walter, A. Weeks, P. Wei, E. Woods, and J. Zalatan for helpful discussions. S. Rajan, S. S. Sidhu, T. Sorrels, and J. Zalatan provided strains and reagents.	Afriat L, 2006, BIOCHEMISTRY-US, V45, P13677, DOI 10.1021/bi061268r; Aharoni A, 2005, NAT GENET, V37, P73, DOI 10.1038/ng1482; Baker CR, 2012, CELL, V151, P80, DOI 10.1016/j.cell.2012.08.018; Bhattacharyya RP, 2006, SCIENCE, V311, P822, DOI 10.1126/science.1120941; Booth LN, 2010, NATURE, V468, P959, DOI 10.1038/nature09560; Bridgham JT, 2006, SCIENCE, V312, P97, DOI 10.1126/science.1123348; Dujon B, 2006, TRENDS GENET, V22, P375, DOI 10.1016/j.tig.2006.05.007; Erlanson DA, 2004, ANNU REV BIOPH BIOM, V33, P199, DOI 10.1146/annurev.biophys.33.110502.140409; Gerlt JA, 2001, ANNU REV BIOCHEM, V70, P209, DOI 10.1146/annurev.biochem.70.1.209; Good M, 2009, CELL, V136, P1085, DOI 10.1016/j.cell.2009.01.049; Halabi N, 2009, CELL, V138, P774, DOI 10.1016/j.cell.2009.07.038; Hardy JA, 2004, CURR OPIN STRUC BIOL, V14, P706, DOI 10.1016/j.sbi.2004.10.009; Hardy JA, 2004, P NATL ACAD SCI USA, V101, P12461, DOI 10.1073/pnas.0404781101; Huse M, 2002, CELL, V109, P275, DOI 10.1016/S0092-8674(02)00741-9; Khersonsky O, 2010, ANNU REV BIOCHEM, V79, P471, DOI 10.1146/annurev-biochem-030409-143718; Kornev AP, 2006, P NATL ACAD SCI USA, V103, P17783, DOI 10.1073/pnas.0607656103; Kuriyan J, 2007, NATURE, V450, P983, DOI 10.1038/nature06524; Lee J, 2008, SCIENCE, V322, P438, DOI 10.1126/science.1159052; Ma BY, 1999, PROTEIN ENG, V12, P713, DOI 10.1093/protein/12.9.713; Madhani HD, 1998, TRENDS GENET, V14, P151, DOI 10.1016/S0168-9525(98)01425-5; Malleshaiah MK, 2010, NATURE, V465, P101, DOI 10.1038/nature08946; O'Brien PJ, 1999, CHEM BIOL, V6, pR91, DOI 10.1016/S1074-5521(99)80033-7; O'Brien PJ, 2001, BIOCHEMISTRY-US, V40, P5691, DOI 10.1021/bi0028892; Remenyi A, 2005, MOL CELL, V20, P951, DOI 10.1016/j.molcel.2005.10.030; Reynolds KA, 2011, CELL, V147, P1564, DOI 10.1016/j.cell.2011.10.049; Ringia EAT, 2004, BIOCHEMISTRY-US, V43, P224, DOI 10.1021/bi035815+; Roodveldt C, 2005, BIOCHEMISTRY-US, V44, P12728, DOI 10.1021/bi051021e; Schindler T, 2000, SCIENCE, V289, P1938, DOI 10.1126/science.289.5486.1938; Tanoue T, 2000, NAT CELL BIOL, V2, P110, DOI 10.1038/35000065; Taylor JW, 2006, MYCOLOGIA, V98, P838, DOI 10.3852/mycologia.98.6.838; Tuch BB, 2008, PLOS BIOL, V6, P352, DOI 10.1371/journal.pbio.0060038; Tuch BB, 2008, SCIENCE, V319, P1797, DOI 10.1126/science.1152398; Wise EL, 2005, BIOCHEMISTRY-US, V44, P1816, DOI 10.1021/bi0478143; Zalatan JG, 2012, SCIENCE, V337, P1218, DOI 10.1126/science.1220683	34	37	37	0	25	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 15	2013	154	4					875	887		10.1016/j.cell.2013.07.019	http://dx.doi.org/10.1016/j.cell.2013.07.019			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	202GQ	23953117	Green Accepted, Bronze			2022-12-24	WOS:000323202500017
J	Liu, Z; Guan, DB; Crawford-Brown, D; Zhang, Q; He, KB; Liu, JG				Liu, Zhu; Guan, Dabo; Crawford-Brown, Douglas; Zhang, Qiang; He, Kebin; Liu, Jianguo			A low-carbon road map for China	NATURE			English	Editorial Material									[Liu, Zhu] Harvard Univ, Sustainabil Sci Program, Cambridge, MA 02138 USA; [Liu, Zhu] Chinese Acad Sci, Inst Appl Ecol, Shenyang 110016, Peoples R China; [Guan, Dabo] Univ Leeds, Leeds LS2 9JT, W Yorkshire, England; [Crawford-Brown, Douglas] Univ Cambridge, Cambridge Ctr Climate Change Mitigat Res, Cambridge CB2 1TN, England; [Zhang, Qiang] Tsinghua Univ, Beijing 100084, Peoples R China; [He, Kebin] Tsinghua Univ, Sch Environm, Beijing 100084, Peoples R China; [Liu, Jianguo] Michigan State Univ, Ctr Syst Integrat & Sustainabil, E Lansing, MI 48824 USA	Harvard University; Chinese Academy of Sciences; Shenyang Institute of Applied Ecology, CAS; University of Leeds; University of Cambridge; Tsinghua University; Tsinghua University; Michigan State University	Liu, Z (corresponding author), Harvard Univ, Sustainabil Sci Program, Cambridge, MA 02138 USA.	d.guan@leeds.ac.uk	He, Kebin/ABF-5224-2020; Guan, Dabo/Y-2406-2019; Liu, Zhu/A-4634-2013; Zhang, Qiang/D-9034-2012; Liu, Jianguo/G-5211-2015; Guan, Dabo/K-5534-2017	Guan, Dabo/0000-0003-3773-3403; Liu, Zhu/0000-0002-8968-7050; Liu, Jianguo/0000-0001-6344-0087; Guan, Dabo/0000-0003-3773-3403				Feng KS, 2013, P NATL ACAD SCI USA, V110, P11654, DOI 10.1073/pnas.1219918110; Liang S, 2013, BIORESOURCE TECHNOL, V131, P139, DOI 10.1016/j.biortech.2012.12.008; Liu Z, 2012, ENERG POLICY, V49, P751, DOI 10.1016/j.enpol.2012.07.016; Liu Z, 2012, ENERGY, V45, P1059, DOI 10.1016/j.energy.2012.06.007; Liu Z, 2012, ENERGY, V37, P245, DOI 10.1016/j.energy.2011.11.040; McElroy MB, 2009, SCIENCE, V325, P1378, DOI 10.1126/science.1175706; National Bureau of Statistics of China, 2012, CHIN STAT YB 2012; Pan YD, 2011, SCIENCE, V333, P988, DOI 10.1126/science.1201609; Pauliuk S, 2012, ENVIRON SCI TECHNOL, V46, P148, DOI 10.1021/es201904c; Peters GP, 2012, NAT CLIM CHANGE, V2, P2, DOI 10.1038/nclimate1332	10	290	313	15	345	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 8	2013	500	7461					143	145		10.1038/500143a	http://dx.doi.org/10.1038/500143a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	197CH	23925225				2022-12-24	WOS:000322825500012
J	Zheng, XT; Bi, SD; Wang, XL; Meng, J				Zheng, Xiaoting; Bi, Shundong; Wang, Xiaoli; Meng, Jin			A new arboreal haramiyid shows the diversity of crown mammals in the Jurassic period	NATURE			English	Article							ALLOTHERIAN MAMMALS; DIVERSIFICATION; EVOLUTION; ORIGINS; TEETH; TAIL	A major unsolved problem in mammalian evolution is the origin of Allotheria, including Multituberculata and Haramiyida(1-5). Multituberculates are the most diverse and best known Mesozoic era mammals and ecologically resemble rodents, but haramiyids are known mainly from isolated teeth, hampering our search for their phylogenetic relationships. Here we report a new haramiyid from the Jurassic period of China, which is, to our knowledge the largest reported so far. It has a novel dentition, a mandible resembling advanced multituberculates and postcranial features adapted for arboreal life. Our phylogenetic analysis places Haramiyida within crown Mammalia, suggesting the origin of crown Mammalia in the Late Triassic period and diversification in the Jurassic, which contrasts other estimated divergence times of crown Mammalia(6-8). The new haramiyid reveals additional mammalian features of the group, helps to identify other haramiyids represented by isolated teeth, and shows again that, regardless of various phylogenetic scenarios, a complex pattern of evolution involving many convergences and/or reversals existed in Mesozoic mammals. [GRAPHICS] .	[Zheng, Xiaoting; Wang, Xiaoli] Linyi Univ, Inst Geol & Paleontol, Linyi 276005, Shandong, Peoples R China; [Zheng, Xiaoting; Wang, Xiaoli] Shandong Tianyu Museum Nat, Pingyi 273300, Shandong, Peoples R China; [Bi, Shundong; Meng, Jin] Chinese Acad Sci, Inst Vertebrate Paleontol & Paleoanthropol, Key Lab Vertebrate Evolut & Human Origin, Beijing 100044, Peoples R China; [Bi, Shundong] Indiana Univ Penn, Dept Biol, Indiana, PA 15705 USA; [Meng, Jin] Amer Museum Nat Hist, Div Paleontol, New York, NY 10024 USA	Linyi University; Chinese Academy of Sciences; Institute of Vertebrate Paleontology & Paleoanthropology, CAS; Pennsylvania State System of Higher Education (PASSHE); Indiana University of Pennsylvania; American Museum of Natural History (AMNH)	Bi, SD (corresponding author), Chinese Acad Sci, Inst Vertebrate Paleontol & Paleoanthropol, Key Lab Vertebrate Evolut & Human Origin, Beijing 100044, Peoples R China.	bishundong@ivpp.ac.cn; jmeng@amnh.org	Xiaoli, Wang/H-1079-2014		National Basic Research Program of China 973 Program [2012CB821906]; National Natural Science Foundation of China [41172016, 41128002]; Hundred Talents Programs of the Chinese Academy of Sciences	National Basic Research Program of China 973 Program(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Hundred Talents Programs of the Chinese Academy of Sciences(Chinese Academy of Sciences)	We thank C. Zhao for illustrations, J. R. Wible for access to comparative specimens, W. Zhang for scanning electron microscope photography and T. Qiao for help with PAUP analyses. This work was supported by the National Basic Research Program of China 973 Program 2012CB821906, National Natural Science Foundation of China 41172016 and 41128002, and the Hundred Talents Programs of the Chinese Academy of Sciences.	Averianov A O, 2011, Dokl Biol Sci, V437, P103, DOI 10.1134/S0012496611020074; Bininda-Emonds ORP, 2007, NATURE, V446, P507, DOI 10.1038/nature05634; Butler PM, 2000, ACTA PALAEONTOL POL, V45, P317; Butler PM, 2005, ACTA PALAEONTOL POL, V50, P185; CROMPTON AW, 1995, FUNCTIONAL MORPHOLOGY IN VERTEBRATE PALEONTOLOGY, P55; Dagosto M, 1996, J HUM EVOL, V30, P29, DOI 10.1006/jhev.1996.0003; Hahn G., 1989, Geologica et Palaeontologica, V23, P205; Hahn Gerhard, 2006, Geologica et Palaeontologica, V40, P173; Hunt T, 2007, SCIENCE, V318, P1913, DOI 10.1126/science.1146954; Jenkins FA, 1997, NATURE, V385, P715, DOI 10.1038/385715a0; Kermack KA, 1998, ACTA PALAEONTOL POL, V43, P581; Kielan-Jaworowska Z., 2005, MAMMALS AGE DINOSAUR; Kirk EC, 2008, J HUM EVOL, V55, P278, DOI 10.1016/j.jhevol.2008.02.008; Lemelin P, 1999, J ZOOL, V247, P165, DOI 10.1017/S0952836999002046; Luo ZX, 2007, NATURE, V450, P1011, DOI 10.1038/nature06277; Luo ZX, 2007, NATURE, V446, P288, DOI 10.1038/nature05627; Magallon SA, 2005, EVOLUTION, V59, P1653, DOI 10.1554/04-565.1; Martin Thomas, 2010, Palaeobiodiversity Palaeoenvironments, V90, P295, DOI 10.1007/s12549-010-0030-4; Meredith RW, 2011, SCIENCE, V334, P521, DOI 10.1126/science.1211028; Napier J. R., 1993, HANDS; O'Leary MA, 2013, SCIENCE, V339, P662, DOI 10.1126/science.1229237; Ogg JG, 2012, GEOLOGIC TIME SCALE 2012, VOLS 1 & 2, P681, DOI 10.1016/B978-0-444-59425-9.00025-1; Rowe T, 2008, P NATL ACAD SCI USA, V105, P1238, DOI 10.1073/pnas.0706385105; Schmitt D, 2005, AM J PHYS ANTHROPOL, V126, P435, DOI 10.1002/ajpa.20075; SIGOGNEAU-RUSSELL D, 1989, Palaeontographica Abteilung A Palaeozoologie-Stratigraphie, V206, P137; SIMPSON GG, 1945, B AM MUS NAT HIST, V85, P1; Smith SA, 2010, P NATL ACAD SCI USA, V107, P5897, DOI 10.1073/pnas.1001225107; Sullivan C., J VERTEBR P IN PRESS; Wiegmann BM, 2011, P NATL ACAD SCI USA, V108, P5690, DOI 10.1073/pnas.1012675108; Youlatos D, 2003, J ZOOL, V259, P423, DOI 10.1017/S0952836903003431	30	89	98	0	65	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 8	2013	500	7461					199	202		10.1038/nature12353	http://dx.doi.org/10.1038/nature12353			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	197CH	23925244				2022-12-24	WOS:000322825500033
J	Manley, GT; Maas, AIR				Manley, Geoffrey T.; Maas, Andrew I. R.			Traumatic Brain Injury An International Knowledge-Based Approach	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Manley, Geoffrey T.] Univ Calif San Francisco, Dept Neurosurg, San Francisco, CA 94110 USA; [Maas, Andrew I. R.] Univ Antwerp, Dept Neurosurg, B-2020 Antwerp, Belgium	University of California System; University of California San Francisco; University of Antwerp	Manley, GT (corresponding author), Univ Calif San Francisco, 1001 Potrero Ave,Bldg 1,Room 101, San Francisco, CA 94110 USA.	manleyg@neurosurg.ucsf.edu						[Anonymous], INJURY PREVENTION AN; [Anonymous], BRAIN RESEARCH THROU; [Anonymous], J NEUROTRAUMA, DOI DOI 10.1089/NEU.2013.2970; [Anonymous], NINDS COMMON DATA EL; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; Giza CC, 2013, NEUROLOGY, V80, P2250, DOI 10.1212/WNL.0b013e31828d57dd; Lingsma HF, 2011, NEUROSURGERY, V68, P601, DOI 10.1227/NEU.0b013e318209333b; Okonkwo DO, 2013, J NEUROTRAUM, V30, P1490, DOI 10.1089/neu.2013.2883; Yuh EL, 2013, ANN NEUROL, V73, P224, DOI 10.1002/ana.23783	9	84	85	0	8	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 7	2013	310	5					473	474		10.1001/jama.2013.169158	http://dx.doi.org/10.1001/jama.2013.169158			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	196OZ	23925611				2022-12-24	WOS:000322786400013
J	Maxmen, A				Maxmen, Amy			CROP PESTS Under attack	NATURE			English	Editorial Material																		Battisti DS, 2009, SCIENCE, V323, P240, DOI 10.1126/science.1164363; Chapman TB, 2012, ECOLOGY, V93, P2175, DOI 10.1890/11-1055.1; Huberty AF, 2004, ECOLOGY, V85, P1383, DOI 10.1890/03-0352; Kroschel J, 2013, AGR FOREST METEOROL, V170, P228, DOI 10.1016/j.agrformet.2012.06.017; Yudelman M., 1998, PEST MANAGEMENT FOOD	5	54	56	0	41	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 26	2013	501	7468					S15	S17		10.1038/501S15a	http://dx.doi.org/10.1038/501S15a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	223RP	24067760	Bronze			2022-12-24	WOS:000324826300014
J	Thomas, MA; Roemer, GW; Donlan, CJ; Dickson, BG; Matocq, M; Malaney, J				Thomas, Michael A.; Roemer, Gary W.; Donlan, C. Josh; Dickson, Brett G.; Matocq, Marjorie; Malaney, Jason			Gene tweaking for conservation	NATURE			English	Editorial Material									[Thomas, Michael A.] Idaho State Univ, Pocatello, ID 83209 USA	Idaho; Idaho State University	Thomas, MA (corresponding author), Idaho State Univ, Pocatello, ID 83209 USA.	mthomas@isu.edu	Thomas, Michael A/B-7489-2008	Thomas, Michael A/0000-0003-2982-0291; Matocq, Marjorie/0000-0003-4829-3749				Cretekos CJ, 2008, GENE DEV, V22, P141, DOI 10.1101/gad.1620408; Donlan J, 2005, NATURE, V436, P913, DOI 10.1038/436913a; Hoegh-Guldberg O, 2008, SCIENCE, V321, P345, DOI 10.1126/science.1157897; Johnson WE, 2010, SCIENCE, V329, P1641, DOI 10.1126/science.1192891; Madsen T, 1996, BIOL CONSERV, V75, P113, DOI 10.1016/0006-3207(95)00067-4; Rebl A, 2013, MAR BIOTECHNOL, V15, P445, DOI 10.1007/s10126-013-9501-8; Redford KH, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001530; Thomas CD, 2012, NATURE, V482, pE4, DOI 10.1038/nature10858; Whitehead A, 2012, J EXP BIOL, V215, P884, DOI 10.1242/jeb.058735; Zhang JX, 2000, IN VITRO CELL DEV-PL, V36, P108, DOI 10.1007/s11627-000-0022-6	10	49	49	0	73	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 26	2013	501	7468					485	486		10.1038/501485a	http://dx.doi.org/10.1038/501485a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	223RP	24073449	Bronze			2022-12-24	WOS:000324826300032
J	Ridker, PM; Wilson, PWF				Ridker, Paul M.; Wilson, Peter W. F.			A Trial-Based Approach to Statin Guidelines	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							THERAPY; RISK; CHOLESTEROL		[Ridker, Paul M.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Ctr Cardiovasc Dis Prevent, Boston, MA 02115 USA; [Wilson, Peter W. F.] Emory Clin Cardiovasc Res Inst, Atlanta, GA USA; [Wilson, Peter W. F.] Atlanta Vet Adm Med Ctr, Atlanta, GA USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School	Ridker, PM (corresponding author), Brigham & Womens Hosp, Ctr Cardiovasc Dis Prevent, 900 Commonwealth Ave E, Boston, MA 02215 USA.	pridker@partners.org	Wilson, Peter W.F./J-2455-2016	Venkatasubramanian, Siddharth/0000-0002-5860-0768				Gibbons GH, 2013, CIRCULATION, V128, P1713, DOI 10.1161/CIRCULATIONAHA.113.004587; Grundy SM, 2004, CIRCULATION, V110, P227, DOI 10.1161/01.CIR.0000133317.49796.0E; Hlatky Mark A, 2009, Circulation, V119, P2408, DOI 10.1161/CIRCULATIONAHA.109.192278; Mihaylova B, 2012, LANCET, V380, P581, DOI 10.1016/S0140-6736(12)60367-5; Preiss D, 2011, JAMA-J AM MED ASSOC, V305, P2556, DOI 10.1001/jama.2011.860; Rajpathak SN, 2009, DIABETES CARE, V32, P1924, DOI 10.2337/dc09-0738; Ridker PM, 2012, CIRC-CARDIOVASC QUAL, V5, P592, DOI 10.1161/CIRCOUTCOMES.112.966556	7	44	45	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 18	2013	310	11					1123	1124		10.1001/jama.2013.276529	http://dx.doi.org/10.1001/jama.2013.276529			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	219IU	23942579				2022-12-24	WOS:000324500300014
J	Pronin, SV; Reiher, CA; Shenvi, RA				Pronin, Sergey V.; Reiher, Christopher A.; Shenvi, Ryan A.			Stereoinversion of tertiary alcohols to tertiary-alkyl isonitriles and amines	NATURE			English	Article							DERIVATIVES; SOLVOLYSIS; CATALYSTS; EXCHANGE; CARBON	The S(N)2 reaction (bimolecular nucleophilic substitution) is a well-known chemical transformation that can be used to join two smaller molecules together into a larger molecule or to exchange one functional group for another. The S(N)2 reaction proceeds in a very predictable manner: substitution occurs with inversion of stereochemistry, resulting from the 'backside attack' of the electrophilic carbon by the nucleophile. A significant limitation of the S(N)2 reaction is its intolerance for tertiary carbon atoms: whereas primary and secondary alcohols are viable precursor substrates, tertiary alcohols and their derivatives usually either fail to react or produce stereochemical mixtures of products(1-3). Here we report the stereochemical inversion of chiral tertiary alcohols with a nitrogenous nucleophile facilitated by a Lewis-acid-catalysed solvolysis. The method is chemoselective against secondary and primary alcohols, thereby complementing the selectivity of the S(N)2 reaction. Furthermore, this method for carbon-nitrogen bond formation mimics a putative biosynthetic step in the synthesis of marine terpenoids(4) and enables their preparation from the corresponding terrestrial terpenes. We expect that the general attributes of the methodology will allow chiral tertiary alcohols to be considered viable substrates for stereoinversion reactions.	[Pronin, Sergey V.; Reiher, Christopher A.; Shenvi, Ryan A.] Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA	Scripps Research Institute	Shenvi, RA (corresponding author), Scripps Res Inst, Dept Chem, 10550 North Torrey Pines Rd, La Jolla, CA 92037 USA.	rshenvi@scripps.edu	Shenvi, Ryan/AAT-9451-2021	Shenvi, Ryan/0000-0001-8353-6449; Reiher, Christopher/0000-0002-6171-3480	Eli Lilly; Boehringer Ingelheim; Scripps Research Institute	Eli Lilly(Eli Lilly); Boehringer Ingelheim(Boehringer Ingelheim); Scripps Research Institute	We thank C. Moore and A. L. Rheingold for X-ray crystallographic analysis. We thank the Yu laboratory for the use of their liquid chromatography-mass spectrometry equipment, the Boger laboratory for the use of their polarimeter, the Baran laboratory for the use of their cold room. Financial support for this work was provided by Eli Lilly, Boehringer Ingelheim and the Scripps Research Institute.	BUNTON CA, 1950, NATURE, V166, P680, DOI 10.1038/166680a0; Castellanos L, 2007, TETRAHEDRON, V63, P1544, DOI 10.1016/j.tet.2006.12.019; COREY EJ, 1987, J AM CHEM SOC, V109, P287, DOI 10.1021/ja00235a052; Dewick P.M., 2009, MED NATURAL PRODUCTS; Ferraris D, 1997, J AM CHEM SOC, V119, P4319, DOI 10.1021/ja963090+; Garson MJ, 2004, NAT PROD REP, V21, P164, DOI 10.1039/b302359c; HAGADONE MR, 1984, J AM CHEM SOC, V106, P2447, DOI 10.1021/ja00320a044; HUGHES ED, 1950, NATURE, V166, P679, DOI 10.1038/166679a0; Jewett J.G., 1965, J AM CHEM SOC, V87, P1384; Kitano Y, 2002, J CHEM SOC PERK T 1, P2251, DOI 10.1039/b206705f; Kitano Y, 1998, TETRAHEDRON LETT, V39, P1911, DOI 10.1016/S0040-4039(98)00045-8; KOBAYASHI S, 1993, TETRAHEDRON LETT, V34, P3755, DOI 10.1016/S0040-4039(00)79220-3; Kobayashi S, 1998, J AM CHEM SOC, V120, P8287, DOI 10.1021/ja980715q; Kochi T, 2004, J AM CHEM SOC, V126, P15652, DOI 10.1021/ja044753n; Lanza G, 2000, J AM CHEM SOC, V122, P12764, DOI 10.1021/ja000571r; Mascal M, 2010, J AM CHEM SOC, V132, P10662, DOI 10.1021/ja103880c; Masutani K, 2006, B CHEM SOC JPN, V79, P1106, DOI 10.1246/bcsj.79.1106; Miyaoka H, 1998, TETRAHEDRON, V54, P13467, DOI 10.1016/S0040-4020(98)00818-7; Nishikawa K, 2010, ORG LETT, V12, P904, DOI 10.1021/ol9027336; Pronin SV, 2012, J AM CHEM SOC, V134, P19604, DOI 10.1021/ja310129b; Pronin SV, 2012, NAT CHEM, V4, P915, DOI [10.1038/nchem.1458, 10.1038/NCHEM.1458]; Rauk A, 2001, J CHEM SOC PERK T 2, P869, DOI 10.1039/b102019f; Richard JP, 2001, ORG LETT, V3, P2225, DOI 10.1021/ol016103j; Rubenbauer P, 2009, CHEM COMMUN, P2130, DOI 10.1039/b901937e; SASAKI T, 1981, J ORG CHEM, V46, P5445, DOI 10.1021/jo00339a050; Srikrishna A, 2009, SYNLETT, P32, DOI 10.1055/s-0028-1087382; Stevens PG, 1939, J AM CHEM SOC, V61, P1295, DOI 10.1021/ja01874a508; White RD, 2004, ORG LETT, V6, P1123, DOI 10.1021/ol049918b; WINSTEIN S, 1956, J AM CHEM SOC, V78, P328, DOI 10.1021/ja01583a022; WINSTEIN S, 1955, J AM CHEM SOC, V77, P5562, DOI 10.1021/ja01626a037	30	107	107	5	111	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 12	2013	501	7466					195	199		10.1038/nature12472	http://dx.doi.org/10.1038/nature12472			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	215XR	24025839				2022-12-24	WOS:000324244900035
J	Feudtner, C; Schreiner, M; Lantos, JD				Feudtner, Chris; Schreiner, Mark; Lantos, John D.			Risks (and Benefits) in Comparative Effectiveness Research Trials	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Feudtner, Chris] Childrens Hosp Philadelphia, Dept Med Eth, Philadelphia, PA 19104 USA; [Schreiner, Mark] Childrens Hosp Philadelphia, Committees Prot Human Subjects, Philadelphia, PA 19104 USA; [Lantos, John D.] Childrens Mercy Hosp, Childrens Mercy Bioeth Ctr, Kansas City, MO 64108 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Children's Mercy Hospital	Feudtner, C (corresponding author), Childrens Hosp Philadelphia, Dept Med Eth, Philadelphia, PA 19104 USA.		Feudtner, Chris/AAI-1126-2019	Feudtner, Chris/0000-0002-5879-0434; Schreiner, Mark/0000-0002-0062-1232				Department of Health and Human Services, 2013, FED REGISTER, V78, P38343; Feudtner C, 2008, ARCH PEDIAT ADOL MED, V162, P854, DOI 10.1001/archpedi.162.9.854; Kass N, 2012, JAMA-J AM MED ASSOC, V307, P1589, DOI 10.1001/jama.2012.491; Schreiner MS, 2013, JAMA PEDIATR, V167, P603, DOI 10.1001/jamapediatrics.2013.152; Vist G. E., 2008, COCHRANE DATABASE SY, V3	5	22	22	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 5	2013	369	10					892	894		10.1056/NEJMp1309322	http://dx.doi.org/10.1056/NEJMp1309322			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	211KV	23964898				2022-12-24	WOS:000323906900003
J	von Hillebrandt-Andrade, C				von Hillebrandt-Andrade, Christa			Minimizing Caribbean Tsunami Risk	SCIENCE			English	Editorial Material									US Natl Ocean & Atmospher Adm NOAA, Natl Weather Serv, Caribbean Tsunami Warning Program, Mayaguez, PR 00680 USA	National Oceanic Atmospheric Admin (NOAA) - USA	von Hillebrandt-Andrade, C (corresponding author), US Natl Ocean & Atmospher Adm NOAA, Natl Weather Serv, Caribbean Tsunami Warning Program, 259 Alfonso Valdes Residences 1B-2A, Mayaguez, PR 00680 USA.	christa.vonh@noaa.gov						Braun J. J., 2012, EOS T AGU, V93, P89, DOI [10. 1029/2012EO090001, DOI 10.1029/2012EO090001]; Hoechner A, 2013, NAT HAZARD EARTH SYS, V13, P1285, DOI 10.5194/nhess-13-1285-2013; IOC, 2013, IOC TECHN SER, V73; IOC, 2013, EWS7 ICGCARIBE IOC; McNamara DE, 2009, SEISMOL RES LETT, V80, P628, DOI 10.1785/gssrl.80.4.628; NOAA National Geophysical Data Center, NOAA WDS GLOB HIST T; Proenza XW, 2010, J TSUNAMI SOC INT, V29, P70; UNESCO Intergovernmental Oceanographic Commission (IOC), 2005, 21 SESS ASS REP GOV	8	11	11	0	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 30	2013	341	6149					966	968		10.1126/science.1238943	http://dx.doi.org/10.1126/science.1238943			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	208BZ	23990549				2022-12-24	WOS:000323652300028
J	Prokopenko, MG; Hirst, MB; De Brabandere, L; Lawrence, DJP; Berelson, WM; Granger, J; Chang, BX; Dawson, S; Crane, EJ; Chong, L; Thamdrup, B; Townsend-Small, A; Sigman, DM				Prokopenko, M. G.; Hirst, M. B.; De Brabandere, L.; Lawrence, D. J. P.; Berelson, W. M.; Granger, J.; Chang, B. X.; Dawson, S.; Crane, E. J., III; Chong, L.; Thamdrup, B.; Townsend-Small, A.; Sigman, D. M.			Nitrogen losses in anoxicmarine sediments driven by Thioploca-anammox bacterial consortia	NATURE			English	Article							CONTINENTAL-MARGIN; METHANE OXIDATION; SULFUR BACTERIA; NORTH PACIFIC; FRESH-WATER; MARINE; DENITRIFICATION; NITRATE; DIAGENESIS; CARBON	Ninety per cent of marine organic matter burial occurs in continental margin sediments, where a substantial fraction of organic carbon escapes oxidation and enters long-term geologic storage within sedimentary rocks. In such environments, microbial metabolism is limited by the diffusive supply of electron acceptors. One strategy to optimize energy yields in a resource-limited habitat is symbiotic metabolite exchange among microbial associations(1,2). Thermodynamic and geochemical considerations indicate that microbial cometabolisms are likely to play a critical part in sedimentary organic carbon cycling(3-5). Yet only one association, between methanotrophic archaea and sulphate-reducing bacteria, has been demonstrated in marine sedimentsin situ(6,7), and little is known of the role of microbial symbiotic interactions in other sedimentary biogeochemical cycles(8). Here we report in situ molecular and incubation-based evidence for a novel symbiotic consortium between two chemolithotrophic bacteria-anaerobic ammonium-oxidizing (anammox) bacteria and the nitrate-sequestering sulphur-oxidizing Thioploca species-in anoxic sediments of the Soledad basin at the Mexican Pacific margin. A mass balance of benthic solute fluxes and the corresponding nitrogen isotope composition of nitrate and ammonium fluxes indicate that anammox bacteria rely on Thioploca species for the supply of metabolic substrates and account for about 57 +/- 21 per cent of the total benthic N-2 production. We show that Thioploca-anammox symbiosis intensifies benthic fixed nitrogen losses in anoxic sediments, bypassing diffusion-imposed limitations by efficiently coupling the carbon, nitrogen and sulphur cycles.	[Prokopenko, M. G.] Pomona Coll, Dept Geol, Claremont, CA 91711 USA; [Prokopenko, M. G.; Berelson, W. M.; Chong, L.] Univ So Calif, Dept Earth Sci, Los Angeles, CA 90089 USA; [Hirst, M. B.; Dawson, S.] Univ Calif Davis, Dept Microbiol & Mol Genet, Davis, CA 95616 USA; [De Brabandere, L.; Thamdrup, B.] Univ Southern Denmark, Dept Biol, Nord Ctr Earth Evolut, DK-5230 Odense M, Denmark; [Lawrence, D. J. P.; Crane, E. J., III] Pomona Coll, Dept Biol, Claremont, CA 91711 USA; [Granger, J.] Univ Connecticut, Dept Marine Sci, Groton, CT 06340 USA; [Chang, B. X.; Sigman, D. M.] Princeton Univ, Dept Geosci, Princeton, NJ 08544 USA; [Townsend-Small, A.] Univ Cincinnati, Dept Geol, Cincinnati, OH 45221 USA	Claremont Colleges; Pomona College; University of Southern California; University of California System; University of California Davis; University of Southern Denmark; Claremont Colleges; Pomona College; University of Connecticut; Princeton University; University System of Ohio; University of Cincinnati	Prokopenko, MG (corresponding author), Pomona Coll, Dept Geol, Claremont, CA 91711 USA.	prokopen@usc.edu	Sigman, Daniel M/A-2649-2008; De Brabandere, Loreto C/A-8134-2014; Thamdrup, Bo/F-3889-2016	Sigman, Daniel M/0000-0002-7923-1973; Thamdrup, Bo/0000-0002-1221-7077; Crane, Edward/0000-0002-9910-9502; Dawson, Scott/0000-0002-0843-1759; Lawrence, Daniel/0000-0002-2181-9352	NSF OCE [OCE-0727123]	NSF OCE(National Science Foundation (NSF))	This work was supported by NSF OCE grant number OCE-0727123 to W. M. B. and D. M. S. We thank the captain and crew of the RV New Horizon, as well as the members of the at-sea and shore-based science party, N. Rollins, T. Riedel, S. Loyd and H. Gron Jensen for their assistance during the cruise. We thank P. Rafter for delta<SUP>15</SUP>N measurements of bottom water NO<INF>3</INF><SUP>-</SUP>. We thank M. Schmid and G. Kuenen for discussions. We are grateful to D. Valentine for suggestions that improved the manuscript.	Ashelford KE, 2006, APPL ENVIRON MICROB, V72, P5734, DOI 10.1128/AEM.00556-06; Berelson WM, 1996, J MAR RES, V54, P731, DOI 10.1357/0022240963213673; Berelson WM, 2005, GEOCHIM COSMOCHIM AC, V69, P4611, DOI 10.1016/j.gca.2005.05.011; Bernhard J.M., 2004, SULFUR BIOGEOCHEMIST, V379, P35; Bernhard JM, 2012, ISME J, V6, P951, DOI 10.1038/ismej.2011.171; BIEBL H, 1978, ARCH MICROBIOL, V117, P9, DOI 10.1007/BF00689344; Boetius A, 2000, NATURE, V407, P623, DOI 10.1038/35036572; Carpenter EJ, 1999, MAR ECOL PROG SER, V185, P273, DOI 10.3354/meps185273; Chong LS, 2012, MAR CHEM, V128, P13, DOI 10.1016/j.marchem.2011.10.007; Christensen JP, 1987, GLOBAL BIOGEOCHEM CY, V1, P97, DOI 10.1029/GB001i002p00097; Dembo M, 1999, BIOPHYS J, V76, P2307, DOI 10.1016/S0006-3495(99)77386-8; Devol AH, 1997, CONT SHELF RES, V17, P1029, DOI 10.1016/S0278-4343(97)00003-4; FOSSING H, 1995, NATURE, V374, P713, DOI 10.1038/374713a0; Foster RA, 2006, ENVIRON MICROBIOL, V8, P1913, DOI 10.1111/j.1462-2920.2006.01068.x; Gruber N., 2004, OCEAN CARBON CYCLE C, VIV, P97, DOI [10.1007/978-1-4020-2087-2_4, DOI 10.1007/978-1-4020-2087-2_4]; HALL PO, 1992, LIMNOL OCEANOGR, V37, P1113, DOI 10.4319/lo.1992.37.5.1113; Hartnett HE, 2003, GEOCHIM COSMOCHIM AC, V67, P247, DOI 10.1016/S0016-7037(02)01076-1; Hirsch MD, 2011, MICROB ECOL, V61, P264, DOI 10.1007/s00248-010-9743-1; HOEHLER TM, 1994, GLOBAL BIOGEOCHEM CY, V8, P451, DOI 10.1029/94GB01800; Hogslund S, 2009, ISME J, V3, P647, DOI 10.1038/ismej.2009.17; Jayakumar A, 2009, MICROB ECOL, V58, P350, DOI 10.1007/s00248-009-9487-y; Jensen MM, 2011, ISME J, V5, P1660, DOI 10.1038/ismej.2011.44; Jorgensen BB, 1999, FEMS MICROBIOL ECOL, V28, P301, DOI 10.1016/S0168-6496(98)00122-6; Kojima H, 2003, APPL ENVIRON MICROB, V69, P390, DOI 10.1128/AEM.69.1.390-398.2003; Kuenen JG, 2008, NAT REV MICROBIOL, V6, P320, DOI 10.1038/nrmicro1857; Ludwig W, 2004, NUCLEIC ACIDS RES, V32, P1363, DOI 10.1093/nar/gkh293; Middelburg JJ, 1996, GLOBAL BIOGEOCHEM CY, V10, P661, DOI 10.1029/96GB02562; Orphan VJ, 2011, ENV MICROBIOL REP, V3, P16; Orphan VJ, 2001, SCIENCE, V293, P484, DOI 10.1126/science.1061338; Otte S, 1999, APPL ENVIRON MICROB, V65, P3148; Penton CR, 2006, APPL ENVIRON MICROB, V72, P6829, DOI 10.1128/AEM.01254-06; Prokopenko MG, 2011, GEOCHIM COSMOCHIM AC, V75, P7180, DOI 10.1016/j.gca.2011.09.023; Prokopenko MG, 2006, EARTH PLANET SC LETT, V242, P186, DOI 10.1016/j.epsl.2005.11.044; RISGAARDPETERSEN N, 1995, SOIL SCI SOC AM J, V59, P1077, DOI 10.2136/sssaj1995.03615995005900040018x; Salman V, 2011, SYST APPL MICROBIOL, V34, P243, DOI 10.1016/j.syapm.2011.02.001; SCHINK B, 2006, PROKARYOTES, V2, P309; Schmid MC, 2005, APPL ENVIRON MICROB, V71, P1677, DOI 10.1128/AEM.71.4.1677-1684.2005; Teske A, 1996, SYST APPL MICROBIOL, V18, P517; Thamdrup B, 2002, APPL ENVIRON MICROB, V68, P1312, DOI 10.1128/AEM.68.3.1312-1318.2002; Valentine DL, 2002, ANTON LEEUW INT J G, V81, P271, DOI 10.1023/A:1020587206351; van Geen A, 2006, J GEOPHYS RES-OCEANS, V111, DOI 10.1029/2005JC003192; Wang GZ, 2010, GEOCHIM COSMOCHIM AC, V74, P3938, DOI 10.1016/j.gca.2010.03.034; Webster NS, 2010, ENVIRON MICROBIOL, V12, P2070, DOI 10.1111/j.1462-2920.2009.02065.x	43	73	79	8	321	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 8	2013	500	7461					194	+		10.1038/nature12365	http://dx.doi.org/10.1038/nature12365			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	197CH	23925243				2022-12-24	WOS:000322825500032
J	Sokol, DK				Sokol, Daniel K.			Waking up to the effects of fatigue in doctors	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Sokol, Daniel K.] Kings Coll London, London, England; [Sokol, Daniel K.] 12 Kings Bench Walk, London, England	University of London; King's College London	Sokol, DK (corresponding author), Kings Coll London, London, England.	daniel.sokol@talk21.com						Gander P, 2007, OCCUP ENVIRON MED, V64, P733, DOI 10.1136/oem.2006.030916; Murrow G, 2012, IMPACT WORKING TIME; Smith GCS, 2003, BRIT MED J, V327, P1459, DOI 10.1136/bmj.327.7429.1459; Sullenberger CB, 2009, HIGHEST DUTY; Worrall M, 2009, DO REDUCED DOCTORS W	5	8	8	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 5	2013	347								f4906	10.1136/bmj.f4906	http://dx.doi.org/10.1136/bmj.f4906			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	201CN	23918610				2022-12-24	WOS:000323118400003
J	Bommert, P; Il Je, B; Goldshmidt, A; Jackson, D				Bommert, Peter; Il Je, Byoung; Goldshmidt, Alexander; Jackson, David			The maize G alpha gene COMPACT PLANT2 functions in CLAVATA signalling to control shoot meristem size	NATURE			English	Article							HETEROTRIMERIC G-PROTEIN; RECEPTOR-LIKE PROTEIN; ARABIDOPSIS; ENCODES; IDENTIFICATION; PROLIFERATION; SUBUNIT; KINASE; FLOWER	Shoot growth depends on meristems, pools of stem cells that are maintained by a negative feedback loop between the CLAVATA pathway and the WUSCHEL homeobox gene(1). CLAVATA signalling involves a secreted peptide, CLAVATA3 (CLV3)(2), and its perception by cell surface leucine-rich repeat (LRR) receptors, including the CLV1 receptor kinase(3) and a LRR receptor-like protein, CLV2 (ref. 4). However, the signalling mechanisms downstream of these receptors are poorly understood, especially for LRR receptor-like proteins, which lack a signalling domain(5). Here we show that maize COMPACT PLANT2 (CT2) encodes the predicted alpha-subunit (G alpha) of a heterotrimeric GTP binding protein. Maize ct2 phenotypes resemble Arabidopsis thaliana clavata mutants, and genetic, biochemical and functional assays indicate that CT2/G alpha transmits a stem-cell-restrictive signal from a CLAVATA LRR receptor, suggesting a new function for G alpha signalling in plants. Heterotrimeric GTP-binding proteins are membrane-associated molecular switches that are commonly activated by ligand binding to an associated seven-pass transmembrane (7TM) G-protein-coupled receptor (GPCR)(6). Recent studies have questioned the idea that plant heterotrimeric G proteins interact with canonical GPCRs(7), and our findings suggest that single pass transmembrane receptors act as GPCRs in plants, challenging the dogma that GPCRs are exclusively 7TM proteins.	[Bommert, Peter; Il Je, Byoung; Goldshmidt, Alexander; Jackson, David] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA	Cold Spring Harbor Laboratory	Jackson, D (corresponding author), Cold Spring Harbor Lab, POB 100, Cold Spring Harbor, NY 11724 USA.	jacksond@cshl.edu		Goldshmidt, Alexander/0000-0001-7468-6779	DFG [Bo 3012/1-1]; BARD [FI-431-2008]; Dupont-Pioneer; National Science Foundation [DBI-0604923]; Division Of Integrative Organismal Systems [1238202] Funding Source: National Science Foundation	DFG(German Research Foundation (DFG)); BARD(US-Israel Binational Science Foundation); Dupont-Pioneer; National Science Foundation(National Science Foundation (NSF)); Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	The authors thank T. Mulligan for plant care; T. Rocheford for growing the ct2 targeted EMS screens; F. Albeanu for help with two-photon microscopy; P. Yin for assistance with genotyping; K. Rivera and D. Pappin for performing proteomic experiments; and T. Zadrozny, Q. Wu and W. Boss for assistance and advice with two-phase partitioning. P.B. was supported by DFG grant Bo 3012/1-1, A.G. was supported by the BARD Postdoctoral award no FI-431-2008, B.I.J was supported by Dupont-Pioneer (CSHL-Collaborative agreement), P.B. and D.J. were supported by the National Science Foundation Plant Genome Program, DBI-0604923.	Ashikari M, 1999, P NATL ACAD SCI USA, V96, P10284, DOI 10.1073/pnas.96.18.10284; Assmann SM, 2005, SCIENCE, V310, P71, DOI 10.1126/science.1118580; Bommert P, 2005, DEVELOPMENT, V132, P1235, DOI 10.1242/dev.01671; Bommert P, 2013, NAT GENET, V45, P334, DOI 10.1038/ng.2534; Brown PJ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002383; Chen JG, 2006, PLANT PHYSIOL, V141, P887, DOI 10.1104/pp.106.079202; Clark SE, 1997, CELL, V89, P575, DOI 10.1016/S0092-8674(00)80239-1; DENNEHEY BK, 1994, PLANT CELL TISS ORG, V36, P1, DOI 10.1007/BF00048308; Fiers M, 2005, PLANT CELL, V17, P2542, DOI 10.1105/tpc.105.034009; Fletcher LC, 1999, SCIENCE, V283, P1911, DOI 10.1126/science.283.5409.1911; Freeling M., 1994, MAIZE HDB; Gallavotti A, 2008, PLANT PHYSIOL, V147, P1913, DOI 10.1104/pp.108.121541; Harlow E., 1988, ANTIBODIES LAB MANUA; Iyer-Pascuzzi AS, 2010, PLANT PHYSIOL, V152, P1148, DOI 10.1104/pp.109.150748; JACKSON D, 1994, DEVELOPMENT, V120, P405; Jeong S, 1999, PLANT CELL, V11, P1925, DOI 10.1105/tpc.11.10.1925; Katritch V, 2013, ANNU REV PHARMACOL, V53, P531, DOI 10.1146/annurev-pharmtox-032112-135923; Larsson C, 2000, METH BIOTEC, V11, P159; Lease KA, 2001, PLANT CELL, V13, P2631, DOI 10.1105/tpc.13.12.2631; McDonald WH, 2002, INT J MASS SPECTROM, V219, P245, DOI 10.1016/S1387-3806(02)00563-8; Mohanty A, 2009, PLANT PHYSIOL, V149, P601, DOI 10.1104/pp.108.130146; Muller R, 2008, PLANT CELL, V20, P934, DOI 10.1105/tpc.107.057547; Nimchuk ZL, 2011, PLANT CELL, V23, P851, DOI 10.1105/tpc.110.075622; Pandey S, 2009, CELL, V136, P136, DOI 10.1016/j.cell.2008.12.026; Perfus-Barbeoch L, 2004, CURR OPIN PLANT BIOL, V7, P719, DOI 10.1016/j.pbi.2004.09.013; Shiu S.H., 2001, STKE, V2001, pR, DOI DOI 10.1126/SCISIGNAL.1132001RE22; Shpak ED, 2004, DEVELOPMENT, V131, P1491, DOI 10.1242/dev.01028; Stahl Y, 2010, CURR OPIN PLANT BIOL, V13, P53, DOI 10.1016/j.pbi.2009.09.008; Taguchi-Shiobara F, 2001, GENE DEV, V15, P2755, DOI 10.1101/gad.208501; Taylor P, 2009, J PROTEOME RES, V8, P1610, DOI 10.1021/pr800986c; Ullah H, 2001, SCIENCE, V292, P2066, DOI 10.1126/science.1059040; Urano D, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002756; van der Hoorn RAL, 2005, PLANT CELL, V17, P1000, DOI 10.1105/tpc.104.028118; Washburn MP, 2001, NAT BIOTECHNOL, V19, P242, DOI 10.1038/85686	34	176	185	8	124	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 24	2013	502	7472					555	+		10.1038/nature12583	http://dx.doi.org/10.1038/nature12583			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	238YN	24025774				2022-12-24	WOS:000325988400055
J	Gunderson, EW				Gunderson, Erik W.			Synthetic Cannabinoids: A New Frontier of Designer Drugs	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							SPICE		[Gunderson, Erik W.] Univ Virginia, Charlottesville, VA USA; [Gunderson, Erik W.] Ctr Wellness & Change, Charlottesville, VA USA; Columbia Univ, New York, NY USA	University of Virginia; Columbia University	Gunderson, EW (corresponding author), Univ Virginia Hlth Syst, Box 800623, Charlottesville, VA 22908 USA.	erikgunderson@virginia.edu						American Association of Poison Control Centers, FACTS SYNTH MAR SYNT; Drug Enforcement Administration, 2013, FED REGISTER, V78, P28735; European Monitoring Centre for Drugs and Drug Addiction, 2009, UND SPIC PHEN; Gunderson EW, 2012, AM J ADDICTION, V21, P320, DOI 10.1111/j.1521-0391.2012.00240.x; Gunderson EW, 2013, SUBST ABUS IN PRESS; Gunderson EW, 2012, S 11 EM DRUGS SYNTH; Hermanns-Clausen M, 2013, ADDICTION, V108, P534, DOI 10.1111/j.1360-0443.2012.04078.x; Johnston L.D., 2013, MONITORING FUTURE NA; Substance Abuse and Mental Health Services Administration  Center for Behavioral Health Statistics and Quality, 2012, DRUG REL EM DEP VIS; United Nations Office on Drugs and Crime, WORLD DRUG REP 2013; Vandrey R, 2012, DRUG ALCOHOL DEPEN, V120, P238, DOI 10.1016/j.drugalcdep.2011.07.011	11	15	16	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 15	2013	159	8					563	+		10.7326/0003-4819-159-8-201310150-00707	http://dx.doi.org/10.7326/0003-4819-159-8-201310150-00707			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	249BH	24018791				2022-12-24	WOS:000326751200021
J	Jukam, D; Xie, BT; Rister, J; Terrell, D; Charlton-Perkins, M; Pis-Tillo, D; Gebelein, B; Desplan, C; Cook, T				Jukam, David; Xie, Baotong; Rister, Jens; Terrell, David; Charlton-Perkins, Mark; Pis-Tillo, Daniela; Gebelein, Brian; Desplan, Claude; Cook, Tiffany			Opposite Feedbacks in the Hippo Pathway for Growth Control and Neural Fate	SCIENCE			English	Article								Signaling pathways are reused for multiple purposes in plant and animal development. The Hippo pathway in mammals and Drosophila coordinates proliferation and apoptosis via the coactivator and oncoprotein YAP/Yorkie (Yki), which is homeostatically regulated through negative feedback. In the Drosophila eye, cross-repression between the Hippo pathway kinase LATS/Warts (Wts) and growth regulator Melted generates mutually exclusive photoreceptor subtypes. Here, we show that this all-or-nothing neuronal differentiation results from Hippo pathway positive feedback: Yki both represses its negative regulator, warts, and promotes its positive regulator, melted. This postmitotic Hippo network behavior relies on a tissue-restricted transcription factor network-including a conserved Otx/Orthodenticle-Nri/Traffic Jam feedforward module-that allows Warts-Yki-Melted to operate as a bistable switch. Altering feedback architecture provides an efficient mechanism to co-opt conserved signaling networks for diverse purposes in development and evolution.	[Jukam, David; Rister, Jens; Pis-Tillo, Daniela; Desplan, Claude] NYU, Dept Biol, Ctr Dev Genet, New York, NY 10003 USA; [Xie, Baotong; Terrell, David; Charlton-Perkins, Mark; Cook, Tiffany] Cincinnati Childrens Hosp Med Ctr, Div Pediat Ophthalmol, Cincinnati, OH 45229 USA; [Gebelein, Brian; Cook, Tiffany] Cincinnati Childrens Hosp Med Ctr, Div Dev Biol, Cincinnati, OH 45229 USA	New York University; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Medical Center	Desplan, C (corresponding author), NYU, Dept Biol, Ctr Dev Genet, New York, NY 10003 USA.	claude.desplan@nyu.edu; tiffany.cook@cchmc.org	Pistillo, Daniela/AAC-2367-2020	Pistillo, Daniela/0000-0002-7665-3783; Charlton-Perkins, Mark/0000-0002-5602-6109; Charlton-Perkins, Mark/0000-0002-7597-1130; Jukam, David/0000-0003-4167-2754; Rister, Jens/0000-0002-0023-7417; Cook, Tiffany/0000-0002-3100-5248; Desplan, Claude/0000-0002-6914-1413	New York University (NYU) Dean's Dissertation Award; University of Cincinnati Postdoctoral Research Fellowship; European Molecular Biology Organization (EMBO) long-term fellowships [ALTF 506-2002, ALTF 462-2008]; NIH [RO1 EY13012, RO1-EY017907]; Research to Prevent Blindness; NATIONAL EYE INSTITUTE [R01EY013012] Funding Source: NIH RePORTER	New York University (NYU) Dean's Dissertation Award; University of Cincinnati Postdoctoral Research Fellowship; European Molecular Biology Organization (EMBO) long-term fellowships; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research to Prevent Blindness(Research to Prevent Blindness (RPB)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We thank J. Bell, S. Britt, R. Carthew, S. Cohen, I. Davis, B. Dickson, R. Fehon, D. Godt, G. Halder, I. Hariharan, K. Irvine, J. Jiang, D. J. Pan, N. Tapon, J. Treisman, T. Xu, C. Zuker, the Bloomington Stock Center, the Kyoto Stock Center, the Vienna Drosophila RNAi Center, and the Exelixis Collection at Harvard Medical School for providing fly stocks and antibodies. G. Mardon generously provided sens-Gal4 flies and S. Sprecher kindly shared Pph13 results prior to publication. We thank T. Blackman and C. Tsanis for transgenic injections and members of the Desplan and Cook labs for discussions and comments. Supported by a New York University (NYU) Dean's Dissertation Award (D. J.), a University of Cincinnati Postdoctoral Research Fellowship (B.X.), European Molecular Biology Organization (EMBO) long-term fellowships (ALTF 506-2002 and ALTF 462-2008) (D.P. and J. R.), NIH grants RO1 EY13012 (C. D.) and RO1-EY017907 (T. C.), and Research to Prevent Blindness (T.C.).	Bunt J, 2012, INT J CANCER, V131, pE21, DOI 10.1002/ijc.26474; Dong JX, 2007, CELL, V130, P1120, DOI 10.1016/j.cell.2007.07.019; Evans CJ, 2009, NAT METHODS, V6, P603, DOI 10.1038/nmeth.1356; Eychene A, 2008, NAT REV CANCER, V8, P683, DOI 10.1038/nrc2460; Frankfort BJ, 2001, NEURON, V32, P403, DOI 10.1016/S0896-6273(01)00480-9; Genevet A, 2010, DEV CELL, V18, P300, DOI 10.1016/j.devcel.2009.12.011; Goulev Y, 2008, CURR BIOL, V18, P435, DOI 10.1016/j.cub.2008.02.034; Halder G, 2011, DEVELOPMENT, V138, P9, DOI 10.1242/dev.045500; Hall AB, 2003, CURR BIOL, V13, P308, DOI 10.1016/S0960-9822(03)00086-1; Hamaratoglu F, 2006, NAT CELL BIOL, V8, P27, DOI 10.1038/ncb1339; Hao H, 2012, PLOS GENET, V8, P380, DOI 10.1371/journal.pgen.1002649; Hardie R.C., 1985, Progress in Sensory Physiology, V5, P1; Huang JB, 2005, CELL, V122, P421, DOI 10.1016/j.cell.2005.06.007; Jukam D, 2011, DEV CELL, V21, P874, DOI 10.1016/j.devcel.2011.10.004; Kataoka K, 2007, J BIOCHEM, V141, P775, DOI 10.1093/jb/mvm105; Li MA, 2003, NAT CELL BIOL, V5, P994, DOI 10.1038/ncb1058; McDonald EC, 2010, DEV BIOL, V347, P122, DOI 10.1016/j.ydbio.2010.08.016; Mears AJ, 2001, NAT GENET, V29, P447, DOI 10.1038/ng774; Mikeladze-Dvali T, 2005, CELL, V122, P775, DOI 10.1016/j.cell.2005.07.026; Mishra M, 2010, DEVELOPMENT, V137, P2895, DOI 10.1242/dev.051722; Morey M, 2008, NATURE, V456, P795, DOI 10.1038/nature07419; Neto-Silva RM, 2010, DEV CELL, V19, P507, DOI 10.1016/j.devcel.2010.09.009; Oh H, 2008, DEVELOPMENT, V135, P1081, DOI 10.1242/dev.015255; Oh H, 2011, DEV CELL, V20, P109, DOI 10.1016/j.devcel.2010.12.002; Overholtzer M, 2006, P NATL ACAD SCI USA, V103, P12405, DOI 10.1073/pnas.0605579103; Peng HW, 2009, GENE DEV, V23, P2307, DOI 10.1101/gad.1820009; Pires-daSilva A, 2003, NAT REV GENET, V4, P39, DOI 10.1038/nrg977; Pomerening JR, 2003, NAT CELL BIOL, V5, P346, DOI 10.1038/ncb954; Rister J, 2013, DEVELOPMENT, V140, P493, DOI 10.1242/dev.079095; Rubin C, 2003, CURR BIOL, V13, P297, DOI 10.1016/S0960-9822(03)00053-8; Skotheim JM, 2008, NATURE, V454, P291, DOI 10.1038/nature07118; SWAROOP A, 1992, P NATL ACAD SCI USA, V89, P266, DOI 10.1073/pnas.89.1.266; Swaroop A, 2010, NAT REV NEUROSCI, V11, P563, DOI 10.1038/nrn2880; Tahayato A, 2003, DEV CELL, V5, P391, DOI 10.1016/S1534-5807(03)00239-9; Teleman AA, 2005, DEV CELL, V9, P271, DOI 10.1016/j.devcel.2005.07.004; Vandendries ER, 1996, DEV BIOL, V173, P243, DOI 10.1006/dbio.1996.0020; Wernet MF, 2003, CELL, V115, P267, DOI 10.1016/S0092-8674(03)00848-1; Wu S, 2008, DEV CELL, V14, P388, DOI 10.1016/j.devcel.2008.01.007; Xie B, 2007, DEVELOPMENT, V134, P4243, DOI 10.1242/dev.012781; Xiong W, 2003, NATURE, V426, P460, DOI 10.1038/nature02089; Zender L, 2006, CELL, V125, P1253, DOI 10.1016/j.cell.2006.05.030; Zhang L, 2008, DEV CELL, V14, P377, DOI 10.1016/j.devcel.2008.01.006; Zhao B, 2007, GENE DEV, V21, P2747, DOI 10.1101/gad.1602907; Zhao B, 2010, GENE DEV, V24, P862, DOI 10.1101/gad.1909210	44	60	60	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 11	2013	342	6155					211	+	1238016	10.1126/science.1238016	http://dx.doi.org/10.1126/science.1238016			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	VG1HS	23989952	Green Accepted			2022-12-24	WOS:000445355800001
J	Zhu, M; Yu, XB; Ahlberg, PE; Choo, B; Lu, J; Qiao, T; Qu, QM; Zhao, WJ; Jia, LT; Blom, H; Zhu, YA				Zhu, Min; Yu, Xiaobo; Ahlberg, Per Erik; Choo, Brian; Lu, Jing; Qiao, Tuo; Qu, Qingming; Zhao, Wenjin; Jia, Liantao; Blom, Henning; Zhu, You'an			A Silurian placoderm with osteichthyan-like marginal jaw bones	NATURE			English	Article							FISHES; PTYCTODONTIDA; INFORMATION; INFERENCE; MRBAYES; ORIGIN	The gnathostome (jawed vertebrate) crown group comprises two extant clades with contrasting character complements. Notably, Chondrichthyes (cartilaginous fish) lack the large dermal bones that characterize Osteichthyes (bony fish and tetrapods). The polarities of these differences, and the morphology of the last common ancestor of crown gnathostomes, are the subject of continuing debate. Here we describe a three-dimensionally preserved 419-million-year-old placoderm fish from the Silurian of China that represents the first stem gnathostome with dermal marginal jaw bones (premaxilla, maxilla and dentary), features previously restricted to Osteichthyes. A phylogenetic analysis places the new form near the top of the gnathostome stem group but does not fully resolve its relationships to other placoderms. The analysis also assigns all acanthodians to the chondrichthyan stem group. These results suggest that the last common ancestor of Chondrichthyes and Osteichthyes had a macromeric dermal skeleton, and provide a new framework for studying crown gnathostome divergence.	[Zhu, Min; Yu, Xiaobo; Choo, Brian; Lu, Jing; Qiao, Tuo; Zhao, Wenjin; Jia, Liantao; Zhu, You'an] Chinese Acad Sci, Inst Vertebrate Paleontol & Paleoanthropol, Key Lab Vertebrate Evolut & Human Origins, Beijing 100044, Peoples R China; [Yu, Xiaobo] Kean Univ, Dept Biol Sci, Union, NJ 07083 USA; [Ahlberg, Per Erik; Qu, Qingming; Blom, Henning] Uppsala Univ, Dept Organismal Biol, Evolutionary Biol Ctr, Subdept Evolut & Dev, S-75236 Uppsala, Sweden	Chinese Academy of Sciences; Institute of Vertebrate Paleontology & Paleoanthropology, CAS; Uppsala University	Zhu, M (corresponding author), Chinese Acad Sci, Inst Vertebrate Paleontol & Paleoanthropol, Key Lab Vertebrate Evolut & Human Origins, Beijing 100044, Peoples R China.	zhumin@ivpp.ac.cn	Qiao, Tuo/AAJ-6317-2021; Zhu, Min/E-8728-2012; min, zhu/AAL-6712-2021; Yu, Xiaobo/G-7160-2011; Qu, Qingming/R-7194-2016	Qiao, Tuo/0000-0002-0488-7265; Zhu, Min/0000-0002-4786-0898; Yu, Xiaobo/0000-0001-9600-7888; Qu, Qingming/0000-0002-8291-8493; Choo, Brian/0000-0002-9983-0762; Zhao, Wenjin/0000-0002-9649-2171; Ahlberg, Per/0000-0001-9054-2900	Major State Basic Research Projects of MST of China [2012CB821902]; National Natural Science Foundation of China [40930208]; ERC [233111]; Knut and Alice Wallenberg Foundation	Major State Basic Research Projects of MST of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); ERC(European Research Council (ERC)European Commission); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation)	We thank M.-M. Chang, J. Long, G. Young, D. Goujet and J.-Q. Wang for discussions, X.-F. Lu, J. Zhang and C.-H. Xiong for specimen preparation, Y.-M. Hou for X-ray micro-computerized tomography. This work was supported by the Major State Basic Research Projects (2012CB821902) of MST of China, and the National Natural Science Foundation of China (40930208). P. E. A. and Q. Q. were supported by ERC Advanced Investigator Grant 233111 and a Wallenberg Scholarship from the Knut and Alice Wallenberg Foundation, both awarded to P.E.A.	[Anonymous], 2011, RISE FISHES 500 MILL; Botella H, 2007, NATURE, V448, P583, DOI 10.1038/nature05989; Brazeau MD, 2009, NATURE, V457, P305, DOI 10.1038/nature07436; Burrow CJ, 2011, PALAEONTOLOGY, V54, P207, DOI 10.1111/j.1475-4983.2010.01003.x; Davis SP, 2012, NATURE, V486, P247, DOI 10.1038/nature11080; Denison R., 1978, Handbook of Paleoichthyology, V2, P1; FOREY PL, 1986, ZOOL J LINN SOC-LOND, V86, P43, DOI 10.1111/j.1096-3642.1986.tb01807.x; Friedman M, 2010, J VERTEBR PALEONTOL, V30, P36, DOI 10.1080/02724630903409071; Gardiner B.G., 1984, Bulletin of the British Museum (Natural History) Geology, V37, P173; Gardiner B.G., 1984, Journal of Vertebrate Paleontology, V4, P379; Goujet D., 1973, Palaeontographica Abt A, V143, P73; Goujet D, 2001, SYST ASSOC SPEC VOL, V61, P209; Goujet D, 1984, POISSONS PLACODERMES; Goujet D.F., 1984, Proceedings of the Linnean Society of New South Wales, V107, P211; Gross W., 1962, C INT CTR NATL RECHE, V104, P69; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Janvier P., 1996, EARLY VERTEBRATES; Jarvik E., 1980, BASIC STRUCTURE EVOL, V1; Johanson Z, 2002, LETHAIA, V35, P169, DOI 10.1080/002411602320184024; Liu Yu-hai, 1991, P139; Maddison W.P., 2008, MESQUITE MODULAR SYS; MAISEY J G, 1986, Cladistics, V2, P201, DOI 10.1111/j.1096-0031.1986.tb00462.x; Miles R. S., 1971, PALAEOZOIC FISHES; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Schaeffer B., 1975, PROBLEMES ACTUELS PA, V218, P101; Schultze HP, 2001, SYST ASSOC SPEC VOL, V61, P315; SCHULTZE HP, 1993, SKULL, V2, P189; Sorenson M. D., 1999, TREEROT PROGRAM DOCU, V2; Stensio E., 1963, Kungliga Svenska Vetenskapsakademiens Handlingar (4), V9, P1; Swofford D.L., 2002, PAUP PHYLOGENETIC AN; Trinajstic K, 2012, J VERTEBR PALEONTOL, V32, P757, DOI 10.1080/02724634.2012.661379; Young GC, 2010, ANNU REV EARTH PL SC, V38, P523, DOI 10.1146/annurev-earth-040809-152507; YOUNG GC, 1986, ZOOL J LINN SOC-LOND, V88, P1, DOI 10.1111/j.1096-3642.1986.tb00876.x; YOUNG GC, 1979, ZOOL J LINN SOC-LOND, V66, P309, DOI 10.1111/j.1096-3642.1979.tb01912.x; Zhao Wen-Jin, 2010, Palaeoworld, V19, P4, DOI 10.1016/j.palwor.2009.11.007; Zhu M, 2001, SYST ASSOC SPEC VOL, V61, P289; Zhu M, 1999, NATURE, V397, P607, DOI 10.1038/17594; Zhu Min, 2012, Vertebrata Palasiatica, V50, P1; Zhu M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035103; Zhu M, 2009, NATURE, V458, P469, DOI 10.1038/nature07855	40	185	198	2	101	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 10	2013	502	7470					188	+		10.1038/nature12617	http://dx.doi.org/10.1038/nature12617			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231RU	24067611				2022-12-24	WOS:000325436100041
J	Reed, M; Huang, J; Brand, R; Graetz, I; Neugebauer, R; Fireman, B; Jaffe, M; Ballard, DW; Hsu, J				Reed, Mary; Huang, Jie; Brand, Richard; Graetz, Ilana; Neugebauer, Romain; Fireman, Bruce; Jaffe, Marc; Ballard, Dustin W.; Hsu, John			Implementation of an Outpatient Electronic Health Record and Emergency Department Visits, Hospitalizations, and Office Visits Among Patients With Diabetes	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							INFORMATION-TECHNOLOGY; AMBULATORY-CARE; MEDICAL-RECORD; QUALITY; SYSTEMS; IMPACT; PHYSICIANS; BENEFITS; OUTCOMES; COSTS	IMPORTANCE The US federal government is spending billions of dollars in physician incentives to encourage the meaningful use of electronic health records (EHRs). Although the use of EHRs has potential to improve patient health outcomes, the existing evidence has been limited and inconsistent. OBJECTIVE To examine the association between implementing a commercially available outpatient EHR and emergency department (ED) visits, hospitalizations, and office visits for patients with diabetes mellitus. DESIGN, SETTING, AND POPULATION Staggered EHR implementation across outpatient clinics in an integrated delivery system (Kaiser Permanente Northern California) between 2005 and 2008 created an opportunity for studying changes associated with EHR use. Among a population-based sample of 169 711 patients with diabetes between 2004 and 2009, we analyzed 4 997 585 person-months before EHR implementation and 4 648 572 person-months after an EHR was being used by patients' physicians. MAIN OUTCOMES AND MEASURES We examined the association between EHR use and unfavorable clinical events (ED visits and hospitalizations) and office visit use among patients with diabetes, using multivariable regression with patient-level fixed-effect analyses and adjustment for trends over time. RESULTS In multivariable analyses, use of the EHR was associated with a statistically significantly decreased number of ED visits, 28.80 fewer visits per 1000 patients annually (95% CI, 20.28 to 37.32), from a mean of 519.12 visits per 1000 patients annually without using the EHR to 490.32 per 1000 patients when using the EHR. The EHR was also associated with 13.10 fewer hospitalizations per 1000 patients annually (95% CI, 7.37 to 18.82), from a mean of 251.60 hospitalizations per 1000 patients annually with no EHR to 238.50 per 1000 patients annually when using the EHR. There were similar statistically significant reductions in nonelective hospitalizations (10.92 fewer per 1000 patients annually) and hospitalizations for ambulatory care-sensitive conditions (7.08 fewer per 1000 patients annually). There was no statistically significant association between EHR use and office visit rates. CONCLUSIONS AND RELEVANCE Among patients with diabetes, use of an outpatient EHR in an integrated delivery system was associated with modest reductions in ED visits and hospitalizations but not office visit rates. Further studies are needed to quantify the association of EHR use with changes in costs.	[Reed, Mary; Huang, Jie; Graetz, Ilana; Neugebauer, Romain; Fireman, Bruce] Kaiser Permanente No Calif, Div Res, Oakland, CA USA; [Brand, Richard] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; [Jaffe, Marc] Permanente Med Grp Inc, Dept Med & Endocrinol, San Francisco, CA USA; [Ballard, Dustin W.] Permanente Med Grp Inc, Dept Emergency Med, San Rafael, CA USA; [Hsu, John] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Mongan Inst Hlth Policy, Boston, MA USA; [Hsu, John] Harvard Univ, Sch Med, Dept Hlth Care Policy, Boston, MA 02115 USA	Kaiser Permanente; University of California System; University of California San Francisco; Permanente Medical Groups; Permanente Medical Groups; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School	Reed, M (corresponding author), Kaiser Permanente, Div Res, 2000 Broadway, Oakland, CA 94610 USA.	mary.e.reed@kp.org	Graetz, Ilana/N-1189-2016	Graetz, Ilana/0000-0003-3664-5815; Jaffe, Marc/0000-0002-5049-7815	National Institute of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health [R01DK085070]; Agency for Healthcare Research and Quality [R01HS015280]; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [R01HS015280] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK085070] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Research reported herein was supported by the National Institute of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health under award R01DK085070 and the Agency for Healthcare Research and Quality under award R01HS015280.	Adler-Milstein J, 2011, AM J MANAG CARE, V17, P761; Agency for Healthcare Research and Quality, 2004, QUALITY INDICATORS G; Agency for Healthcare Research and Quality, 2012, QUALITY INDICATORS Q; Agency for Healthcare Research and Quality Center for Delivery Organization and Markets, STATISTICS ON HOSPIT; Agency for Healthcare Research and Quality Center for Financing Access and Cost Trends, MEDICAL EXPENDITURE; Buntin MB, 2011, HEALTH AFFAIR, V30, P464, DOI 10.1377/hlthaff.2011.0178; Cebul RD, 2011, NEW ENGL J MED, V365, P825, DOI 10.1056/NEJMsa1102519; Centers for Disease Control and Prevention, 2011, RISING HEALTH CARE C; Centers for Medicare & Medicaid Services, 2010, MEDICARE AND MEDICAI, P44314; Chaudhry B, 2006, ANN INTERN MED, V144, P742, DOI 10.7326/0003-4819-144-10-200605160-00125; Crosson JC, 2012, ANN FAM MED, V10, P221, DOI 10.1370/afm.1370; Herrin J, 2012, HEALTH SERV RES, V47, P1522, DOI 10.1111/j.1475-6773.2011.01370.x; Hillestad R, 2005, HEALTH AFFAIR, V24, P1103, DOI 10.1377/hlthaff.24.5.1103; Hsiao C-J, 2010, ELECTRONIC MEDICAL R; Hsiao CJ, 2012, HEALTH AFFAIR, V31, P1100, DOI 10.1377/hlthaff.2011.1315; KRIEGER N, 1992, AM J PUBLIC HEALTH, V82, P703, DOI 10.2105/AJPH.82.5.703; Linder JA, 2007, ARCH INTERN MED, V167, P1400, DOI 10.1001/archinte.167.13.1400; Martin AB, 2012, HEALTH AFFAIR, V31, P208, DOI 10.1377/hlthaff.2011.1135; O'Connor PJ, 2005, ANN FAM MED, V3, P300, DOI 10.1370/afm.327; O'Reilly D, 2012, J AM MED INFORM ASSN, V19, P423, DOI 10.1136/amiajnl-2011-000310; Reed M, 2012, ANN INTERN MED, V157, P482, DOI 10.7326/0003-4819-157-7-201210020-00004; Romano MJ, 2011, ARCH INTERN MED, V171, P897, DOI 10.1001/archinternmed.2010.527; StataCorp LP, 2007, STATA BASE REFERENCE; Woodridge JM, 2002, ECONOMETRIC ANAL CRO; Zhao Yang, 2002, Health Care Manag Sci, V5, P211, DOI 10.1023/A:1019711617120; Zhou L, 2009, J AM MED INFORM ASSN, V16, P457, DOI 10.1197/jamia.M3128; Zhou YY, 2010, HEALTH AFFAIR, V29, P1370, DOI 10.1377/hlthaff.2010.0048	27	53	53	0	18	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 11	2013	310	10					1060	1065		10.1001/jama.2013.276733	http://dx.doi.org/10.1001/jama.2013.276733			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	214KZ	24026601	Green Accepted, Bronze			2022-12-24	WOS:000324133400023
J	Leichsenring, M; Maes, J; Mossner, R; Driever, W; Onichtchouk, D				Leichsenring, Manuel; Maes, Julia; Moessner, Rebecca; Driever, Wolfgang; Onichtchouk, Daria			Pou5f1 Transcription Factor Controls Zygotic Gene Activation In Vertebrates	SCIENCE			English	Article							EMBRYONIC STEM-CELLS; REGULATORY NETWORK; ENDODERM FORMATION; ZEBRAFISH; EXPRESSION; DROSOPHILA; PLURIPOTENCY; TRANSITION; EVOLUTION; REGIONS	The development of multicellular animals is initially controlled by maternal gene products deposited in the oocyte. During the maternal-to-zygotic transition, transcription of zygotic genes commences, and developmental control starts to be regulated by zygotic gene products. In Drosophila, the transcription factor Zelda specifically binds to promoters of the earliest zygotic genes and primes them for activation. It is unknown whether a similar regulation exists in other animals. We found that zebrafish Pou5f1, a homolog of the mammalian pluripotency transcription factor Oct4, occupies SOX-POU binding sites before the onset of zygotic transcription and activates the earliest zygotic genes. Our data position Pou5f1 and SOX-POU sites at the center of the zygotic gene activation network of vertebrates and provide a link between zygotic gene activation and pluripotency control.	[Leichsenring, Manuel; Maes, Julia; Moessner, Rebecca; Driever, Wolfgang; Onichtchouk, Daria] Univ Freiburg, Fac Biol, Inst Biol 1, Dev Biol Unit, D-79085 Freiburg, Germany; [Driever, Wolfgang; Onichtchouk, Daria] Univ Freiburg, Ctr Biol Signaling Studies BIOSS, D-79085 Freiburg, Germany	University of Freiburg; University of Freiburg	Driever, W (corresponding author), Univ Freiburg, Fac Biol, Inst Biol 1, Dev Biol Unit, D-79085 Freiburg, Germany.	driever@biologie.uni-freiburg.de; daria.onichtchouk@biologie.uni-freiburg.de	Onichtchouk, Daria/E-1741-2012	Onichtchouk, Daria/0000-0001-6497-1445; Driever, Wolfgang/0000-0002-9551-9141	Deutsche Forschungsgemeinschaft [DFG-EXC294, DFG-SFB592]; Bundesministerium fur Bildung und Forschung [BMBF-0313921FRISYS]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF))	We thank S. Shvartsman for scientific discussion; S. Arnold, G. Pyrowolakis, V. Taylor, A. Fuchs, S. Eckerle, and M. Fernandes for comments; B. Wendik and J. Paddeken for participating in initial stages of this work; Y. Kamachi for Sox3/19a/19b antibody; L. Yampolsky for help with statistics; and S. Gotter for fish care. Supported by Deutsche Forschungsgemeinschaft grants DFG-EXC294 and DFG-SFB592 (W. D. and D.O.) and Bundesministerium fur Bildung und Forschung grant BMBF-0313921FRISYS (W. D.). Microarray and ChIP-Seq data GEO (www.ncbi.nlm.nih.gov/geo) accession numbers: CHIP-seq data, GSE39780; microarray data, GSE41107, GSE17655, and GSE17656.	Aanes H, 2011, GENOME RES, V21, P1328, DOI 10.1101/gr.116012.110; Belting HG, 2011, DEV BIOL, V356, P323, DOI 10.1016/j.ydbio.2011.05.660; Belting HG, 2001, DEVELOPMENT, V128, P4165; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Fernandez-Tresguerres B, 2010, P NATL ACAD SCI USA, V107, P19955, DOI 10.1073/pnas.1010708107; Giraldez AJ, 2006, SCIENCE, V312, P75, DOI 10.1126/science.1122689; Harrison MM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002266; KANE DA, 1993, DEVELOPMENT, V119, P447; Kim JW, 2008, CELL, V132, P1049, DOI 10.1016/j.cell.2008.02.039; Kvon EZ, 2012, GENE DEV, V26, P908, DOI 10.1101/gad.188052.112; Lagha M, 2012, TRENDS GENET, V28, P409, DOI 10.1016/j.tig.2012.03.006; Liang HL, 2008, NATURE, V456, P400, DOI 10.1038/nature07388; Lindeman LC, 2011, DEV CELL, V21, P993, DOI 10.1016/j.devcel.2011.10.008; Liu ZT, 2011, J BIOL CHEM, V286, P28520, DOI 10.1074/jbc.M111.236307; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; Lunde K, 2004, CURR BIOL, V14, P48, DOI 10.1016/j.cub.2003.11.022; McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630; Morley RH, 2009, P NATL ACAD SCI USA, V106, P3829, DOI 10.1073/pnas.0808382106; Nien CY, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002339; Okuda Y, 2006, DEV DYNAM, V235, P811, DOI 10.1002/dvdy.20678; Okuda Y, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000936; Onichtchouk D, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.9; Papatsenko I, 2010, BIOINFORMATICS, V26, P2731, DOI 10.1093/bioinformatics/btq513; Reim G, 2004, DEV CELL, V6, P91, DOI 10.1016/S1534-5807(03)00396-4; Reim G, 2006, DEVELOPMENT, V133, P2757, DOI 10.1242/dev.02391; Satija R, 2012, GENOME RES, V22, P656, DOI 10.1101/gr.130682.111; Tadros W, 2009, DEVELOPMENT, V136, P3033, DOI 10.1242/dev.033183; ten Bosch JR, 2006, DEVELOPMENT, V133, P1967, DOI 10.1242/dev.02373; Xu C, 2012, DEV CELL, V22, P625, DOI 10.1016/j.devcel.2012.01.003	29	142	148	0	29	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 30	2013	341	6149					1005	1009		10.1126/science.1242527	http://dx.doi.org/10.1126/science.1242527			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	208BZ	23950494				2022-12-24	WOS:000323652300044
J	Reimer, LJ; Thomsen, EK; Tisch, DJ; Henry-Halldin, CN; Zimmerman, PA; Baea, ME; Dagoro, H; Susapu, M; Hetzel, MW; Bockarie, MJ; Michael, E; Siba, PM; Kazura, JW				Reimer, Lisa J.; Thomsen, Edward K.; Tisch, Daniel J.; Henry-Halldin, Cara N.; Zimmerman, Peter A.; Baea, Manasseh E.; Dagoro, Henry; Susapu, Melinda; Hetzel, Manuel W.; Bockarie, Moses J.; Michael, Edwin; Siba, Peter M.; Kazura, James W.			Insecticidal Bed Nets and Filariasis Transmission in Papua New Guinea	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ELIMINATE LYMPHATIC FILARIASIS; WUCHERERIA-BANCROFTI INFECTION; GLOBAL PROGRAM; VECTOR-CONTROL; END-POINTS; MALARIA; DISEASE; IMPACT; PREVALENCE; IVERMECTIN	BACKGROUND Global efforts to eliminate lymphatic filariasis are based on the annual mass administration of antifilarial drugs to reduce the microfilaria reservoir available to the mosquito vector. Insecticide-treated bed nets are being widely used in areas in which filariasis and malaria are coendemic. METHODS We studied five villages in which five annual mass administrations of antifilarial drugs, which were completed in 1998, reduced the transmission of Wuchereria bancrofti, one of the nematodes that cause lymphatic filariasis. A total of 21,899 anopheles mosquitoes were collected for 26 months before and 11 to 36 months after bed nets treated with long-lasting insecticide were distributed in 2009. We evaluated the status of filarial infection and the presence of W. bancrofti DNA in anopheline mosquitoes before and after the introduction of insecticide-treated bed nets. We then used a model of population dynamics to estimate the probabilities of transmission cessation. RESULTS Village-specific rates of bites from anopheline mosquitoes ranged from 6.4 to 61.3 bites per person per day before the bed-net distribution and from 1.1 to 9.4 bites for 11 months after distribution (P<0.001). During the same period, the rate of detection of W. bancrofti in anopheline mosquitoes decreased from 1.8% to 0.4% (P=0.005), and the rate of detection of filarial DNA decreased from 19.4% to 14.9% (P=0.13). The annual transmission potential was 5 to 325 infective larvae inoculated per person per year before the bed-net distribution and 0 after the distribution. Among all five villages with a prevalence of microfilariae of 2 to 38%, the probability of transmission cessation increased from less than 1.0% before the bed-net distribution to a range of 4.9 to 95% in the 11 months after distribution. CONCLUSIONS Vector control with insecticide-treated bed nets is a valuable tool for W. bancrofti elimination in areas in which anopheline mosquitoes transmit the parasite.	[Reimer, Lisa J.; Thomsen, Edward K.; Baea, Manasseh E.; Dagoro, Henry; Hetzel, Manuel W.; Siba, Peter M.] Papua New Guinea Inst Med Res, Goroka, Papua N Guinea; [Reimer, Lisa J.; Thomsen, Edward K.; Baea, Manasseh E.; Dagoro, Henry; Hetzel, Manuel W.; Siba, Peter M.] Papua New Guinea Inst Med Res, Madang, Papua N Guinea; [Susapu, Melinda] Papua New Guinea Dept Hlth, Port Moresby, Papua N Guinea; [Reimer, Lisa J.; Thomsen, Edward K.; Tisch, Daniel J.; Henry-Halldin, Cara N.; Zimmerman, Peter A.; Kazura, James W.] Case Western Reserve Univ, Cleveland, OH 44106 USA; [Reimer, Lisa J.; Thomsen, Edward K.; Susapu, Melinda; Bockarie, Moses J.] Univ Liverpool, Liverpool Sch Trop Med, Liverpool L3 5QA, Merseyside, England; [Hetzel, Manuel W.] Univ Queensland, Sch Populat Hlth, Herston, Qld, Australia; [Michael, Edwin] Univ Notre Dame, South Bend, IN USA	PNG Institute Of Medical Research; PNG Institute Of Medical Research; Case Western Reserve University; Liverpool School of Tropical Medicine; University of Liverpool; University of Queensland; University of Notre Dame	Kazura, JW (corresponding author), Case Western Reserve Univ, Ctr Global Hlth & Dis, Sch Med, 2109 Adelbert Rd,Suite 431, Cleveland, OH 44106 USA.	jxk14@case.edu; jxk14@case.edu	Bockarie, Moses/AAV-4578-2020; Tisch, Daniel/Q-5044-2019; Thomsen, Edward/AAH-3299-2020; Bockarie, Moses/AAW-3130-2021; Michael, Edwin/D-3388-2014	Thomsen, Edward/0000-0003-1136-6430; Reimer, Lisa/0000-0002-9711-4981; Hetzel, Manuel W./0000-0002-5285-3254; Zimmerman, Peter/0000-0002-5349-4513; Halldin, Cara/0000-0002-8050-8407	U.S. Public Health Service; National Institutes of Health [U19 AI065717]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI097262, U19AI089686, U19AI065717] Funding Source: NIH RePORTER	U.S. Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funded by the U.S. Public Health Service and a grant (U19 AI065717) from the National Institutes of Health.	Alexander NDE, 2001, T ROY SOC TROP MED H, V95, P277, DOI 10.1016/S0035-9203(01)90233-0; [Anonymous], 2007, Wkly Epidemiol Rec, V82, P361; [Anonymous], 2011, Wkly Epidemiol Rec, V86, P121; [Anonymous], 2007, NAT STRAT PLAN ACT P; Backhouse T. C., 1934, Transactions of the Royal Society of Tropical Medicine and Hygiene, V27, P365, DOI 10.1016/S0035-9203(34)90052-3; BEEBE NW, 1995, AM J TROP MED HYG, V53, P478, DOI 10.4269/ajtmh.1995.53.478; Belkin JN., 1962, MOSQUITOES S PACIFIC; Bockarie MJ, 1998, LANCET, V351, P162, DOI 10.1016/S0140-6736(97)07081-5; Bockarie MJ, 2002, NEW ENGL J MED, V347, P1841, DOI 10.1056/NEJMoa021309; Bockarie MJ, 2002, MED VET ENTOMOL, V16, P116, DOI 10.1046/j.0269-283x.2002.00352.x; Bockarie MJ, 2009, ANNU REV ENTOMOL, V54, P469, DOI 10.1146/annurev.ento.54.110807.090626; Brockarie M, 1996, AM J TROP MED HYG, V54, P577, DOI 10.4269/ajtmh.1996.54.577; Burkot T R, 2006, Filaria J, V5, P10, DOI 10.1186/1475-2883-5-10; Farid HA, 2007, AM J TROP MED HYG, V77, P593, DOI 10.4269/ajtmh.2007.77.593; Gambhir M, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-22; Gambhir M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002874; Gass K, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001479; Gyapong M, 1996, SOC SCI MED, V43, P235, DOI 10.1016/0277-9536(95)00365-7; Henry-Halldin CN, 2011, AM J TROP MED HYG, V84, P166, DOI 10.4269/ajtmh.2011.10-0438; Kazura JW, 2005, REPORT SCI WORKING G, P58; Kyelem D, 2008, AM J TROP MED HYG, V79, P480; Maxwell CA, 1999, B WORLD HEALTH ORGAN, V77, P138; Michael E, 2004, LANCET INFECT DIS, V4, P223, DOI 10.1016/S1473-3099(04)00973-9; Michael E, 1996, PARASITOLOGY, V112, P409, DOI 10.1017/S0031182000066646; Michael E, 2006, TRENDS PARASITOL, V22, P226, DOI 10.1016/j.pt.2006.03.005; NELSON G S, 1958, Bull World Health Organ, V19, P204; NELSON G. S., 1959, JOUR HEL MINTHOL, V33, P233, DOI 10.1017/S0022149X00033484; Ottesen EA, 2000, TROP MED INT HEALTH, V5, P591, DOI 10.1046/j.1365-3156.2000.00620.x; Ottesen EA, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000317; Pedersen EM, 2002, ANN TROP MED PARASIT, V96, pS91, DOI 10.1179/000349802125002437; Prasittisuk C, 2002, ANN TROP MED PARASIT, V96, pS133, DOI 10.1179/000349802125002482; Schwab AE, 2005, AM J TROP MED HYG, V73, P234, DOI 10.4269/ajtmh.2005.73.234; SOUTHGATE BA, 1992, T ROY SOC TROP MED H, V86, P523, DOI 10.1016/0035-9203(92)90096-U; Stolk WA, 2003, J INFECT DIS, V188, P1371, DOI 10.1086/378354; Sunish IP, 2007, B WORLD HEALTH ORGAN, V85, P138, DOI 10.2471/BLT.06.029389; Sunish IP, 2003, TROP MED INT HEALTH, V8, P316, DOI 10.1046/j.1365-3156.2003.01033.x; Takken W, 2002, TROP MED INT HEALTH, V7, P1022, DOI 10.1046/j.1365-3156.2002.00983.x; van den Berg H, 2013, LANCET INFECT DIS, V13, P89, DOI 10.1016/S1473-3099(12)70148-2; WEBBER RH, 1979, T ROY SOC TROP MED H, V73, P722, DOI 10.1016/0035-9203(79)90031-2; Yamey G, 2000, BRIT MED J, V320, P269, DOI 10.1136/bmj.320.7230.269	40	62	63	0	24	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 22	2013	369	8					745	753		10.1056/NEJMoa1207594	http://dx.doi.org/10.1056/NEJMoa1207594			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	204FA	23964936	Green Accepted			2022-12-24	WOS:000323349300011
J	Peterson, PN; Greiner, MA; Qualls, LG; Al-Khatib, SM; Curtis, JP; Fonarow, GC; Hammill, SC; Heidenreich, PA; Hammill, BG; Piccini, JP; Hernandez, AF; Curtis, LH; Masoudi, FA				Peterson, Pamela N.; Greiner, Melissa A.; Qualls, Laura G.; Al-Khatib, Sana M.; Curtis, Jeptha P.; Fonarow, Gregg C.; Hammill, Stephen C.; Heidenreich, Paul A.; Hammill, Bradley G.; Piccini, Jonathan P.; Hernandez, Adrian F.; Curtis, Lesley H.; Masoudi, Frederick A.			QRS Duration, Bundle-Branch Block Morphology, and Outcomes Among Older Patients With Heart Failure Receiving Cardiac Resynchronization Therapy	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ASSOCIATION TASK-FORCE; DEVICE-BASED THERAPY; RHYTHM ABNORMALITIES; AMERICAN-COLLEGE; 2008 GUIDELINES; MORTALITY; DYSFUNCTION; UPDATE; IMPACT	IMPORTANCE The benefits of cardiac resynchronization therapy (CRT) in clinical trials were greater among patients with left bundle-branch block (LBBB) or longer QRS duration. OBJECTIVE To measure associations between QRS duration and morphology and outcomes among patients receiving a CRT defibrillator (CRT-D) in clinical practice. DESIGN, SETTING, AND PARTICIPANTS Retrospective cohort study of Medicare beneficiaries in the National Cardiovascular Data Registry's ICD Registry between 2006 and 2009 who underwent CRT-D implantation. Patients were stratified according to whether they were admitted for CRT-D implantation or for another reason, then categorized as having either LBBB or no LBBB and QRS duration of either 150 ms or greater or 120 to 149 ms. MAIN OUTCOMES AND MEASURES All-cause mortality; all-cause, cardiovascular, and heart failure readmission; and complications. Patients underwent follow-up for up to 3 years, with follow-up through December 2011. RESULTS Among 24 169 patients admitted for CRT-D implantation, 1-year and 3-year mortality rates were 9.2% and 25.9%, respectively. All-cause readmission rates were 10.2% at 30 days and 43.3% at 1 year. The unadjusted rate and adjusted risk of both 3-year mortality and of 1-year all-cause readmission were lowest among patients with LBBB and QRS duration of 150 ms or greater. There were no observed associations with complications. [GRAPHICS] . CONCLUSIONS AND RELEVANCE Among fee-for-service Medicare beneficiaries undergoing CRT-D implantation in clinical practice, LBBB and QRS duration of 150 ms or greater, compared with LBBB and QRS duration less than 150 ms or no LBBB regardless of QRS duration, was associated with lower risk of all-cause mortality and of all-cause, cardiovascular, and heart failure readmissions.	[Peterson, Pamela N.] Denver Hlth Med Ctr, Denver, CO 80204 USA; [Peterson, Pamela N.; Masoudi, Frederick A.] Univ Colorado Denver, Aurora, CO USA; [Peterson, Pamela N.; Masoudi, Frederick A.] Kaiser Permanente Colorado, Inst Hlth Res, Denver, CO USA; [Greiner, Melissa A.; Qualls, Laura G.; Al-Khatib, Sana M.; Hammill, Bradley G.; Piccini, Jonathan P.; Hernandez, Adrian F.; Curtis, Lesley H.] Duke Clin Res Inst, Durham, NC USA; [Al-Khatib, Sana M.; Piccini, Jonathan P.; Hernandez, Adrian F.; Curtis, Lesley H.] Duke Univ, Dept Med, Sch Med, Durham, NC 27706 USA; [Curtis, Jeptha P.] Yale Univ, Sch Med, Dept Med, New Haven, CT 06510 USA; [Fonarow, Gregg C.] Univ Calif Los Angeles, Dept Med, Ahmanson UCLA Cardiomyopathy Ctr, Los Angeles, CA 90024 USA; [Hammill, Stephen C.] Mayo Clin, Div Cardiovasc Dis, Rochester, MN USA; [Heidenreich, Paul A.] VA Palo Alto Healthcare Syst, Palo Alto, CA USA	Denver Health Medical Center; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Kaiser Permanente; Duke University; Duke University; Yale University; University of California System; University of California Los Angeles; Mayo Clinic; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System	Peterson, PN (corresponding author), Denver Hlth Med Ctr, Dept Med, Div Cardiol, 777 Bannock St,MC 0960, Denver, CO 80204 USA.	pamela.peterson@ucdenver.edu	Fonarow, Gregg C/D-5988-2014; Heidenreich, Paul/AAU-6864-2021; Hernandez, Adrian F/A-7818-2016; Masoudi, Frederick/Q-7467-2019	Fonarow, Gregg C/0000-0002-3192-8093; Heidenreich, Paul/0000-0001-7730-8490; Hernandez, Adrian F/0000-0003-3387-9616; 	Agency for Healthcare Research and Quality (AHRQ), US Department of Health and Human Services [HHSA29020050032I]; AHRQ [K08 HS019814-01]; American College of Cardiology Foundation; American College of Cardiology Foundation's National Cardiovascular Data Registry	Agency for Healthcare Research and Quality (AHRQ), US Department of Health and Human Services; AHRQ(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); American College of Cardiology Foundation(General Electric); American College of Cardiology Foundation's National Cardiovascular Data Registry	This study was funded under contract number HHSA29020050032I (Duke University Developing Evidence to Inform Decisions about Effectiveness [DEcIDE] Center) from the Agency for Healthcare Research and Quality (AHRQ), US Department of Health and Human Services, as part of the DEcIDE program. Dr Peterson was supported by grant K08 HS019814-01 from the AHRQ. Dr Masoudi has a contract with the American College of Cardiology Foundation. This research was also supported by the American College of Cardiology Foundation's National Cardiovascular Data Registry. The ICD Registry is an initiative of the American College of Cardiology Foundation and the Heart Rhythm Society.	Abraham WT, 2002, NEW ENGL J MED, V346, P1845, DOI 10.1056/NEJMoa013168; Adelstein EC, 2009, AM J CARDIOL, V103, P238, DOI 10.1016/j.amjcard.2008.08.069; Baldasseroni S, 2002, AM HEART J, V143, P398, DOI 10.1067/mhj.2002.121264; Bilchick KC, 2010, CIRCULATION, V122, P2022, DOI 10.1161/CIRCULATIONAHA.110.956011; Birnie DH, 2006, CURR OPIN CARDIOL, V21, P20, DOI 10.1097/01.hco.0000198983.93755.99; Bristow MR, 2004, NEW ENGL J MED, V350, P2140, DOI 10.1056/NEJMoa032423; Cleland JGF, 2005, NEW ENGL J MED, V352, P1539, DOI 10.1056/NEJMoa050496; Dupont M, 2012, J AM COLL CARDIOL, V60, P592, DOI 10.1016/j.jacc.2012.03.059; Epstein AE, 2008, CIRCULATION, V117, pE350, DOI 10.1161/CIRCUALTIONAHA.108.189742; Hammill BG, 2009, AM HEART J, V157, P995, DOI 10.1016/j.ahj.2009.04.002; Hammill SC, 2007, HEART RHYTHM, V4, P1260, DOI 10.1016/j.hrthm.2007.07.021; Harrell FE, 2001, REGRESSION MODELING, P53; Iuliano S, 2002, AM HEART J, V143, P1085, DOI 10.1067/mhj.2002.122516; Linde C, 2008, J AM COLL CARDIOL, V52, P1834, DOI 10.1016/j.jacc.2008.08.027; McAlister FA, 2007, JAMA-J AM MED ASSOC, V297, P2502, DOI 10.1001/jama.297.22.2502; Messenger JC, 2012, J AM COLL CARDIOL, V60, P1484, DOI 10.1016/j.jacc.2012.07.020; Moss AJ, 2009, NEW ENGL J MED, V361, P1329, DOI 10.1056/NEJMoa0906431; Rickard J, 2010, PACE, V33, P590, DOI 10.1111/j.1540-8159.2009.02649.x; Sipahi I, 2011, ARCH INTERN MED, V171, P1454, DOI 10.1001/archinternmed.2011.247; Tracy, 2013, CIRCULATION, V127, pE357, DOI 10.1161/CIR.0b013e318283168f; Tracy CM, 2012, CIRCULATION, V126, P1784, DOI 10.1161/CIR.0b013e3182618569; Wokhlu A, 2009, HEART RHYTHM, V6, P1439, DOI 10.1016/j.hrthm.2009.07.009	22	67	68	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 14	2013	310	6					617	626		10.1001/jama.2013.8641	http://dx.doi.org/10.1001/jama.2013.8641			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	200HI	23942680	Bronze			2022-12-24	WOS:000323058400017
J	Lee, JH; Ryu, HS; Chung, KS; Pose, D; Kim, S; Schmid, M; Ahn, JH				Lee, Jeong Hwan; Ryu, Hak-Seung; Chung, Kyung Sook; Pose, David; Kim, Soonkap; Schmid, Markus; Ahn, Ji Hoon			Regulation of Temperature-Responsive Flowering by MADS-Box Transcription Factor Repressors	SCIENCE			English	Article							AMBIENT-TEMPERATURE; PHENOTYPIC PLASTICITY; ARABIDOPSIS-THALIANA; CLIMATE-CHANGE; TIME; PLANTS; VERNALIZATION; PROTEIN; SVP; ENCODES	Changes in ambient temperature affect flowering time in plants; understanding this phenomenon will be crucial for buffering agricultural systems from the effects of climate change. Here, we show that levels of FLM-beta, an alternatively spliced form of the flowering repressor FLOWERING LOCUS M, increase at lower temperatures, repressing flowering. FLM-beta interacts with SHORT VEGETATIVE PHASE (SVP); SVP is degraded at high temperatures, reducing the abundance of the SVP-FLM-beta repressor complex and, thus, allowing the plant to flower. The svp and flm mutants show temperature-insensitive flowering in different temperature ranges. Control of SVP-FLM-beta repressor complex abundance via transcriptional and splicing regulation of FLM and posttranslational regulation of SVP protein stability provides an efficient, rapid mechanism for plants to respond to ambient temperature changes.	[Lee, Jeong Hwan; Ryu, Hak-Seung; Chung, Kyung Sook; Kim, Soonkap; Ahn, Ji Hoon] Korea Univ, Dept Life Sci, Creat Res Initiat, Seoul 136701, South Korea; [Pose, David; Schmid, Markus] Max Planck Inst Dev Biol, Dept Mol Biol, D-72076 Tubingen, Germany	Korea University; Max Planck Society	Ahn, JH (corresponding author), Korea Univ, Dept Life Sci, Creat Res Initiat, Seoul 136701, South Korea.	jahn@korea.ac.kr	Posé, David/A-3424-2014; Schmid, Markus/I-4384-2015; Ahn, Ji Hoon/A-4141-2011	Posé, David/0000-0003-3332-4661; Schmid, Markus/0000-0002-0068-2967; Ahn, Ji Hoon/0000-0003-0347-3922	Korea University; ERA-NET Plant Genomics BLOOMNET project [SCHM1560/7-1]; National Research Foundation of Korea; Korea government (Ministry of Science, ICT, and Future Planning) [2008-0061988]	Korea University; ERA-NET Plant Genomics BLOOMNET project; National Research Foundation of Korea(National Research Foundation of Korea); Korea government (Ministry of Science, ICT, and Future Planning)	We thank R. Amasino, C. Dean, I. Lee, I. Hwang, C. M. Park, J. Puterill, D. Weigel, and P. Wigge for kindly providing research materials and D. H. Kim, B. R. Kim, H. J. Cho, S. H. Kim, S. M. Hong, H. S. Jung, and S. J. Yoo for their technical assistance. J. H. L. was supported by a Korea University Grant. D. P. and M. S. were supported by the ERA-NET Plant Genomics BLOOMNET project (SCHM1560/7-1). This work was supported by a National Research Foundation of Korea grant funded by the Korea government (Ministry of Science, ICT, and Future Planning) (2008-0061988) to J. H. A. The authors declare no conflicts of interest. GenBank accession numbers are KF496888 to KF496899 (FLM sequences of Arabidopsis WT accessions). Materials described here are available from J. H. A. The genomic FLM-GFP line will be distributed for noncommercial research under a standard materials transfer agreement by the Max Planck Institute for Developmental Biology.	Anderson JT, 2012, P ROY SOC B-BIOL SCI, V279, P3843, DOI 10.1098/rspb.2012.1051; Balasubramanian S, 2006, PLOS GENET, V2, P980, DOI 10.1371/journal.pgen.0020106; Balasubramanian S, 2006, PLANT SIGNAL BEHAV, V1, P227, DOI 10.4161/psb.1.5.3452; Baurle I, 2006, CELL, V125, P655, DOI 10.1016/j.cell.2006.05.005; Bond DM, 2011, PLANT CELL ENVIRON, V34, P1737, DOI 10.1111/j.1365-3040.2011.02370.x; Cho HJ, 2012, FEBS LETT, V586, P2332, DOI 10.1016/j.febslet.2012.05.035; Cook BI, 2012, P NATL ACAD SCI USA, V109, P9000, DOI 10.1073/pnas.1118364109; Craufurd PQ, 2009, J EXP BOT, V60, P2529, DOI 10.1093/jxb/erp196; de Folter S, 2005, PLANT CELL, V17, P1424, DOI 10.1105/tpc.105.031831; Delk NA, 2005, PLANT PHYSIOL, V139, P240, DOI 10.1104/pp.105.062612; Fitter AH, 2002, SCIENCE, V296, P1689, DOI 10.1126/science.1071617; Gu XF, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2947; Helliwell CA, 2006, PLANT J, V46, P183, DOI 10.1111/j.1365-313X.2006.02686.x; Johanson U, 2000, SCIENCE, V290, P344, DOI 10.1126/science.290.5490.344; Kim JJ, 2012, PLANT PHYSIOL, V159, P461, DOI 10.1104/pp.111.192369; Kobayashi Y, 2007, GENE DEV, V21, P2371, DOI 10.1101/gad.1589007; Lee JH, 2008, J PLANT BIOL, V51, P321, DOI 10.1007/BF03036133; Lee JH, 2007, GENE DEV, V21, P397, DOI 10.1101/gad.1518407; Lee JH, 2012, PLANT SCI, V185, P97, DOI 10.1016/j.plantsci.2011.09.003; Lempe J, 2005, PLOS GENET, V1, P109, DOI 10.1371/journal.pgen.0010006; Michaels SD, 1999, PLANT CELL, V11, P949, DOI 10.1105/tpc.11.5.949; Nicotra AB, 2010, TRENDS PLANT SCI, V15, P684, DOI 10.1016/j.tplants.2010.09.008; Penfield S, 2008, NEW PHYTOL, V179, P615, DOI 10.1111/j.1469-8137.2008.02478.x; Scortecci KC, 2001, PLANT J, V26, P229, DOI 10.1046/j.1365-313x.2001.01024.x; Sheldon CC, 1999, PLANT CELL, V11, P445, DOI 10.1105/tpc.11.3.445; Srikanth A, 2011, CELL MOL LIFE SCI, V68, P2013, DOI 10.1007/s00018-011-0673-y; Sung S, 2005, ANNU REV PLANT BIOL, V56, P491, DOI 10.1146/annurev.arplant.56.032604.144307; Trevaskis B, 2007, PLANT PHYSIOL, V143, P225, DOI 10.1104/pp.106.090860; Wang JW, 2009, CELL, V138, P738, DOI 10.1016/j.cell.2009.06.014; Werner JD, 2005, P NATL ACAD SCI USA, V102, P2460, DOI 10.1073/pnas.0409474102; Wilczek AM, 2009, SCIENCE, V323, P930, DOI 10.1126/science.1165826	31	212	230	13	207	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 1	2013	342	6158					628	632		10.1126/science.1241097	http://dx.doi.org/10.1126/science.1241097			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243RJ	24030492				2022-12-24	WOS:000326334300051
J	Taqueti, VR				Taqueti, Viviany R.			No Easy Fixes	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material								Ms. D. has received 10 drug-eluting stents, primarily for atypical chest discomfort, with one stenting begetting another. In our system, it's somehow easier to provide 10 state-of-the-art stents than access to a generic pill and social, financial, and psychiatric support. Ms. D., a middle-aged Jamaican-American woman from the Hyde Park neighborhood of Boston, sits amidst many other patients in the waiting room. It's not evident from her outward appearance, but her coronary arteries house 10 drug-eluting stents. Six of them had been placed over the course of a year, now 6 years ago, when she underwent seven cardiac catheterizations at the age of 49. Yes, Ms. D. has terrible coronary artery disease. Yes, with a body-mass index of 41, she is morbidly obese, with type 2 diabetes, high blood pressure, and high cholesterol. Nonetheless, given that she was a nonsmoking ...	[Taqueti, Viviany R.] Brigham & Womens Hosp, Div Cardiovasc Med, Boston, MA 02115 USA; [Taqueti, Viviany R.] Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Taqueti, VR (corresponding author), Brigham & Womens Hosp, Div Cardiovasc Med, 75 Francis St, Boston, MA 02115 USA.				NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL094301] Funding Source: NIH RePORTER; NHLBI NIH HHS [T32 HL094301] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837	1	0	0	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 10	2013	369	15					1392	1393		10.1056/NEJMp1303484	http://dx.doi.org/10.1056/NEJMp1303484			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	231QE	24106933	Green Accepted			2022-12-24	WOS:000325431500005
J	Baker, CR; Hanson-Smith, V; Johnson, AD				Baker, Christopher R.; Hanson-Smith, Victor; Johnson, Alexander D.			Following Gene Duplication, Paralog Interference Constrains Transcriptional Circuit Evolution	SCIENCE			English	Article							DNA-BINDING; BOX PROTEIN; ARGININE; MCM1; SPECIFICITY; METABOLISM; COFACTORS	Most models of gene duplication assume that the ancestral functions of the preduplication gene are independent and can therefore be neatly partitioned between descendant paralogs. However, many gene products, such as transcriptional regulators, are components within cooperative assemblies; here, we show that a natural consequence of duplication and divergence of such proteins can be competitive interference between the paralogs. Our example is based on the duplication of the essential MADS-box transcriptional regulator Mcm1, which is found in all fungi and regulates a large set of genes. We show that a set of historical amino acid sequence substitutions minimized paralog interference in contemporary species and, in doing so, increased the molecular complexity of this gene regulatory network. We propose that paralog interference is a common constraint on gene duplicate evolution, and its resolution, which can generate additional regulatory complexity, is needed to stabilize duplicated genes in the genome.	[Baker, Christopher R.; Hanson-Smith, Victor; Johnson, Alexander D.] Univ Calif San Francisco, Dept Immunol & Microbiol, San Francisco, CA 94143 USA; [Baker, Christopher R.; Hanson-Smith, Victor; Johnson, Alexander D.] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Johnson, AD (corresponding author), Univ Calif San Francisco, Dept Immunol & Microbiol, San Francisco, CA 94143 USA.	ajohnson@cgl.ucsf.edu			NIH [RO1 GM057049]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM037049, R01GM057049, F32GM108299] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank B. Tuch for assistance and comments; O. Homann for assistance on experimental techniques; and C. Nobile, C. Dalal, S. Devika, R. Bennett, L. Mera, and T. Sorrells for comments. This work was funded by grant RO1 GM057049 from the NIH.	Acton TB, 2000, MOL CELL BIOL, V20, P1, DOI 10.1128/MCB.20.1.1-11.2000; Amar N, 2000, MOL CELL BIOL, V20, P2087, DOI 10.1128/MCB.20.6.2087-2097.2000; Baker CR, 2011, P NATL ACAD SCI USA, V108, P7493, DOI 10.1073/pnas.1019177108; BENDER A, 1987, CELL, V50, P681, DOI 10.1016/0092-8674(87)90326-6; BOONCHIRD C, 1991, MOL GEN GENET, V226, P154, DOI 10.1007/BF00273599; Bridgham JT, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000191; Dennis MY, 2012, CELL, V149, DOI 10.1016/j.cell.2012.03.033; Finnigan GC, 2012, NATURE, V481, P360, DOI 10.1038/nature10724; Force A, 1999, GENETICS, V151, P1531; Harms MJ, 2010, CURR OPIN STRUC BIOL, V20, P360, DOI 10.1016/j.sbi.2010.03.005; HAYES TE, 1988, GENE DEV, V2, P1713, DOI 10.1101/gad.2.12b.1713; Innan H, 2010, NAT REV GENET, V11, P97, DOI 10.1038/nrg2689; Jamai A, 2002, MOL CELL BIOL, V22, P5741, DOI 10.1128/MCB.22.16.5741-5752.2002; Lynch M, 2003, SCIENCE, V302, P1401, DOI 10.1126/science.1089370; Mead J, 2002, MOL CELL BIOL, V22, P4607, DOI 10.1128/MCB.22.13.4607-4621.2002; MESSENGUY F, 1991, MOL CELL BIOL, V11, P2852, DOI 10.1128/MCB.11.5.2852; Messenguy F, 2003, GENE, V316, P1, DOI 10.1016/S0378-1119(03)00747-9; MESSENGUY F, 1993, MOL CELL BIOL, V13, P2586, DOI 10.1128/MCB.13.4.2586; Tan S, 1998, NATURE, V391, P660, DOI 10.1038/35563; Tsong AE, 2003, CELL, V115, P389, DOI 10.1016/S0092-8674(03)00885-7; Tuch BB, 2008, PLOS BIOL, V6, P352, DOI 10.1371/journal.pbio.0060038; Wagner A, 2003, P ROY SOC B-BIOL SCI, V270, P457, DOI 10.1098/rspb.2002.2269; Wagner A, 2002, GENOME BIOL, V3	23	74	74	1	37	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 4	2013	342	6154					104	108		10.1126/science.1240810	http://dx.doi.org/10.1126/science.1240810			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	227PP	24092741	Green Accepted			2022-12-24	WOS:000325126100055
J	Bowling, CB; Sharma, P; Fox, CS; O'Hare, AM; Muntner, P				Bowling, C. Barrett; Sharma, Pradeep; Fox, Caroline S.; O'Hare, Ann M.; Muntner, Paul			Prevalence of Reduced Estimated Glomerular Filtration Rate Among the Oldest Old From 1988-1994 Through 2005-2010	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter							CHRONIC KIDNEY-DISEASE; AGE		[Bowling, C. Barrett] Vet Affairs Med Ctr, Birmingham Atlanta Geriatr Res Educ & Clin Ctr, Atlanta, GA 30033 USA; [Sharma, Pradeep; Muntner, Paul] Univ Alabama Birmingham, Sch Publ Hlth, Dept Epidemiol, Birmingham, AL USA; [Fox, Caroline S.] NHLBI, Ctr Populat Studies, Bethesda, MD 20892 USA; [O'Hare, Ann M.] VA Puget Sound Hlth Care Syst, Dept Med, Seattle, WA USA	Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Atlanta VA Health Care System; University of Alabama System; University of Alabama Birmingham; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); US Department of Veterans Affairs; Veterans Health Administration (VHA); Vet Affairs Puget Sound Health Care System	Bowling, CB (corresponding author), Atlanta Vet Affairs Med Ctr, 1670 Clairmont Rd 11B, Decatur, GA 30033 USA.	cbbowli@emory.edu	Sharma, Pradeep/N-5439-2019		NHLBI NIH HHS [Y1-HC-8039] Funding Source: Medline; NIA NIH HHS [R03 AG042336, R03AG042336-01] Funding Source: Medline; CSRD VA [IK2 CX000856] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL006094] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R03AG042336] Funding Source: NIH RePORTER; Veterans Affairs [IK2CX000856] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); CSRD VA; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Veterans Affairs(US Department of Veterans Affairs)		Bowling CB, 2011, CLIN J AM SOC NEPHRO, V6, P2822, DOI 10.2215/CJN.06770711; Centers for Disease Control and Prevention, NAT HLTH NUTR EX SUR; Coresh J, 2007, JAMA-J AM MED ASSOC, V298, P2038, DOI 10.1001/jama.298.17.2038; Hallan SI, 2012, JAMA-J AM MED ASSOC, V308, P2349, DOI 10.1001/jama.2012.16817; Institute of Medicine (US) Committee on the Future Health Care Workforce for Older Americans, 2008, RET AG AM BUILD HLTH, DOI DOI 10.17226/12089; Selvin E, 2007, AM J KIDNEY DIS, V50, P918, DOI 10.1053/j.ajkd.2007.08.020	6	24	24	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 25	2013	310	12					1284	1286		10.1001/jama.2013.252441	http://dx.doi.org/10.1001/jama.2013.252441			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	222SO	24065016	Bronze, Green Accepted			2022-12-24	WOS:000324751800026
J	Bateman, BT; Bykov, K; Choudhry, NK; Schneeweiss, S; Gagne, JJ; Polinski, JM; Franklin, JM; Doherty, M; Fischer, MA; Rassen, JA				Bateman, Brian T.; Bykov, Katsiaryna; Choudhry, Niteesh K.; Schneeweiss, Sebastian; Gagne, Joshua J.; Polinski, Jennifer M.; Franklin, Jessica M.; Doherty, Michael; Fischer, Michael A.; Rassen, Jeremy A.			Type of stress ulcer prophylaxis and risk of nosocomial pneumonia in cardiac surgical patients: cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							PROTON-PUMP INHIBITORS; VENTILATOR-ASSOCIATED PNEUMONIA; INSTRUMENTAL VARIABLE ANALYSIS; COMMUNITY-ACQUIRED PNEUMONIA; CRITICALLY III PATIENTS; 2 RECEPTOR ANTAGONISTS; ADMINISTRATIVE DATA; HEART-SURGERY; OMEPRAZOLE; CIMETIDINE	Objective To examine the relation between the type of stress ulcer prophylaxis administered and the risk of postoperative pneumonia in patients undergoing coronary artery bypass grafting. Design Retrospective cohort study. Setting Premier Research Database. Participants: 21 214 patients undergoing coronary artery bypass graft surgery between 2004 and 2010; 9830 (46.3%) started proton pump inhibitors and 11 384 (53.7%) started H-2 receptor antagonists in the immediate postoperative period. Main outcome measure Occurrence of postoperative pneumonia, assessed using appropriate diagnostic codes. Results Overall, 492 (5.0%) of the 9830 patients receiving a proton pump inhibitor and 487 (4.3%) of the 11 384 patients receiving an H2 receptor antagonist developed postoperative pneumonia during the index hospital admission. After propensity score adjustment, an elevated risk of pneumonia associated with treatment with proton pump inhibitors compared with H2 receptor antagonists remained (relative risk 1.19, 95% confidence interval 1.03 to 1.38). In the instrumental variable analysis, use of a proton pump inhibitor (compared with an H-2 receptor antagonist) was associated with an increased risk of pneumonia of 8.2 (95% confidence interval 0.5 to 15.9) cases per 1000 patients. Conclusions Patients treated with proton pump inhibitors for stress ulcer had a small increase in the risk of postoperative pneumonia compared with patients treated with H-2 receptor antagonists; this risk remained after confounding was accounted for using multiple analytic approaches.	[Bateman, Brian T.; Bykov, Katsiaryna; Choudhry, Niteesh K.; Schneeweiss, Sebastian; Gagne, Joshua J.; Polinski, Jennifer M.; Franklin, Jessica M.; Doherty, Michael; Fischer, Michael A.; Rassen, Jeremy A.] Brigham & Womens Hosp, Dept Med, Div Pharmacoepidemiol & Pharmacoecon, Boston, MA 02115 USA; [Bateman, Brian T.; Bykov, Katsiaryna; Choudhry, Niteesh K.; Schneeweiss, Sebastian; Gagne, Joshua J.; Polinski, Jennifer M.; Franklin, Jessica M.; Doherty, Michael; Fischer, Michael A.; Rassen, Jeremy A.] Harvard Univ, Sch Med, Boston, MA USA; [Bateman, Brian T.] Massachusetts Gen Hosp, Dept Anesthesia Crit Care & Pain Med, Boston, MA 02120 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital	Bateman, BT (corresponding author), Brigham & Womens Hosp, Dept Med, Div Pharmacoepidemiol & Pharmacoecon, 75 Francis St, Boston, MA 02115 USA.	bbateman@partners.org	Schneeweiss, Sebastian/C-2125-2013	Schneeweiss, Sebastian/0000-0003-2575-467X; Rassen, Jeremy/0000-0003-4369-7381; Franklin, Jessica/0000-0002-8941-4116; Bykov, Katsiaryna/0000-0003-3336-5412	Agency for Healthcare Research and Quality [K01 HS018088]; Agency for Healthcare Research and Quality; Harvard-Brigham Drug Safety and Risk Management Research Center; Food and Drug Administration; WHISCON LLC; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [K01HS018088] Funding Source: NIH RePORTER	Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); Harvard-Brigham Drug Safety and Risk Management Research Center; Food and Drug Administration(United States Department of Health & Human Services); WHISCON LLC; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	JAR is a recipient of a career development award from the Agency for Healthcare Research and Quality (K01 HS018088). Competing interests: All authors have completed the ICMJE uniform disclosure form at www.icmje.org/coi_disclosure.pdf (available on request from the corresponding author) and declare: SS is principal investigator of the Brigham and Women's Hospital DEcIDE Center on Comparative Effectiveness Research and the DEcIDE Methods Center, both funded by the Agency for Healthcare Research and Quality, and of the Harvard-Brigham Drug Safety and Risk Management Research Center funded by the Food and Drug Administration; SS is a paid consultant to WHISCON LLC and Booz & Co, and he is principal investigator of investigator initiated grants to the Brigham and Women's Hospital from Pfizer, Novartis, and Boehringer-Ingelheim unrelated to the topic of this study; JAR is a paid consultant to WHISCON LLC; no other relationships or activities that could appear to have influenced the submitted work.	Alhazzani W, 2013, CRIT CARE MED, V41, P693, DOI 10.1097/CCM.0b013e3182758734; Aronsky D, 2005, AM J MED QUAL, V20, P319, DOI 10.1177/1062860605280358; AYBAY C, 1995, GEN PHARMACOL-VASC S, V26, P1413, DOI 10.1016/0306-3623(94)00301-3; Barkun AN, 2012, AM J GASTROENTEROL, V107, P507, DOI 10.1038/ajg.2011.474; Beaulieu M, 2008, J CRIT CARE, V23, P513, DOI 10.1016/j.jcrc.2007.11.003; Bouza E, 2003, CRIT CARE MED, V31, P1964, DOI [10.1097/01.ccm.0000084807.15352.93, 10.1097/01.CCM.0000084807.15352.93]; Brookhart MA, 2006, EPIDEMIOLOGY, V17, P373, DOI 10.1097/01.ede.0000222026.42077.ee; Brookhart MA, 2010, PHARMACOEPIDEM DR S, V19, P537, DOI 10.1002/pds.1908; Capodicasa E, 1999, IMMUNOPHARM IMMUNOT, V21, P357, DOI 10.3109/08923979909052768; Dellinger RP, 2013, INTENS CARE MED, V41, P580, DOI [DOI 10.1007/s00134-012-2769-8, 10.1007/s00134-012-2769-8]; DONOWITZ LG, 1986, INFECT CONT HOSP EP, V7, P23, DOI 10.1017/S0195941700063748; DRIKS MR, 1987, NEW ENGL J MED, V317, P1376, DOI 10.1056/NEJM198711263172204; DUMOULIN GC, 1982, LANCET, V1, P242; Elixhauser A, 1998, MED CARE, V36, P8, DOI 10.1097/00005650-199801000-00004; Rodriguez LAG, 2009, EPIDEMIOLOGY, V20, P800, DOI 10.1097/EDE.0b013e3181b5f27d; Gulmez SE, 2007, ARCH INTERN MED, V167, P950, DOI 10.1001/archinte.167.9.950; Herzig SJ, 2009, JAMA-J AM MED ASSOC, V301, P2120, DOI 10.1001/jama.2009.722; Hortal J, 2009, CRIT CARE, V13, DOI 10.1186/cc7896; Kedika RR, 2009, DIGEST DIS SCI, V54, P2312, DOI 10.1007/s10620-009-0951-9; Kollef MH, 1997, CHEST, V112, P666, DOI 10.1378/chest.112.3.666; Kulik A, 2008, CIRCULATION, V118, P1785, DOI 10.1161/CIRCULATIONAHA.108.799445; Laheij RJF, 2004, JAMA-J AM MED ASSOC, V292, P1955, DOI 10.1001/jama.292.16.1955; Lau JY, 2007, NEW ENGL J MED, V356, P1631, DOI 10.1056/NEJMoa065703; Leal-Noval SR, 2000, CRIT CARE MED, V28, P935, DOI 10.1097/00003246-200004000-00004; Lin S, 2006, DIGEST DIS SCI, V51, P2377, DOI 10.1007/s10620-006-9326-7; Lindenauer PK, 2005, NEW ENGL J MED, V353, P349, DOI 10.1056/NEJMoa041895; Lindenauer PK, 2004, JAMA-J AM MED ASSOC, V291, P2092, DOI 10.1001/jama.291.17.2092; Miano TA, 2009, CHEST, V136, P440, DOI 10.1378/chest.08-1634; Pawar M, 2003, J CARDIOTHOR VASC AN, V17, P22, DOI 10.1053/jcan.2003.4; Rassen JA, 2009, AM J EPIDEMIOL, V169, P273, DOI 10.1093/aje/kwn299; Redelmeier DA, 2010, BRIT MED J, V340, DOI 10.1136/bmj.c2608; ROMANO PS, 1993, J CLIN EPIDEMIOL, V46, P1075, DOI 10.1016/0895-4356(93)90103-8; ROMANO PS, 1993, J CLIN EPIDEMIOL, V46, P1081; Rothman KJ., 2008, MODERN EPIDEMIOLOGY, V3rd ed; Sarkar M, 2008, ANN INTERN MED, V149, P391, DOI 10.7326/0003-4819-149-6-200809160-00005; Schneeweiss S, 2008, NEW ENGL J MED, V358, P771, DOI 10.1056/NEJMoa0707571; Schneeweiss S, 2006, PHARMACOEPIDEM DR S, V15, P291, DOI 10.1002/pds.1200; Skull SA, 2008, EPIDEMIOL INFECT, V136, P232, DOI 10.1017/S0950268807008564; Sturmer T, 2010, AM J EPIDEMIOL, V172, P843, DOI 10.1093/aje/kwq198; Thorens J, 1996, GUT, V39, P54, DOI 10.1136/gut.39.1.54; Zedtwitz-Liebenstein K, 2002, CRIT CARE MED, V30, P1118, DOI 10.1097/00003246-200205000-00026	41	56	60	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 19	2013	347								f5416	10.1136/bmj.f5416	http://dx.doi.org/10.1136/bmj.f5416			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	223SY	24052582	Green Published, hybrid			2022-12-24	WOS:000324831500003
J	Pearson, JS; Giogha, C; Ong, SY; Kennedy, CL; Kelly, M; Robinson, KS; Lung, TWF; Mansell, A; Riedmaier, P; Oates, CVL; Zaid, A; Muhlen, S; Crepin, VF; Marches, O; Ang, CS; Williamson, NA; O'Reilly, LA; Bankovacki, A; Nachbur, U; Infusini, G; Webb, AI; Silke, J; Strasser, A; Frankel, G; Hartland, EL				Pearson, Jaclyn S.; Giogha, Cristina; Ong, Sze Ying; Kennedy, Catherine L.; Kelly, Michelle; Robinson, Keith S.; Lung, Tania Wong Fok; Mansell, Ashley; Riedmaier, Patrice; Oates, Clare V. L.; Zaid, Ali; Muehlen, Sabrina; Crepin, Valerie F.; Marches, Olivier; Ang, Ching-Seng; Williamson, Nicholas A.; O'Reilly, Lorraine A.; Bankovacki, Aleksandra; Nachbur, Ueli; Infusini, Giuseppe; Webb, Andrew I.; Silke, John; Strasser, Andreas; Frankel, Gad; Hartland, Elizabeth L.			A type III effector antagonizes death receptor signalling during bacterial gut infection	NATURE			English	Article							APOPTOSIS; VIRULENCE; PROTEINS; ROLES; NLEB	Successful infection by enteric bacterial pathogens depends on the ability of the bacteria to colonize the gut, replicate in host tissues and disseminate to other hosts. Pathogens such as Salmonella, Shigella and enteropathogenic and enterohaemorrhagic (EPEC and EHEC, respectively) Escherichia coli use a type III secretion system(T3SS) to deliver virulence effector proteins into host cells during infection that promote colonization and interfere with antimicrobial host responses(1-3). Here we report that the T3SS effector NleB1 from EPEC binds to host cell death-domain-containing proteins and thereby inhibits death receptor signalling. Protein interaction studies identified FADD, TRADD and RIPK1 as binding partners of NleB1. NleB1 expressed ectopically or injected by the bacterial T3SS prevented Fas ligand or TNF-induced formation of the canonical death-inducing signalling complex (DISC) and proteolytic activation of caspase-8, an essential step in death-receptor-induced apoptosis. This inhibition depended on the N-acetylglucosamine transferase activity of NleB1, which specifically modified Arg 117 in the death domain of FADD. The importance of the death receptor apoptotic pathway to host defence was demonstrated using mice deficient in the FAS signalling pathway, which showed delayed clearance of the EPEC-like mouse pathogen Citrobacter rodentium and reversion to virulence of an nleB mutant. The activity of NleB suggests that EPEC and other attaching and effacing pathogens antagonize death-receptor-induced apoptosis of infected cells, thereby blocking a major antimicrobial host response.	[Pearson, Jaclyn S.; Giogha, Cristina; Ong, Sze Ying; Kennedy, Catherine L.; Kelly, Michelle; Lung, Tania Wong Fok; Riedmaier, Patrice; Oates, Clare V. L.; Zaid, Ali; Muehlen, Sabrina; Hartland, Elizabeth L.] Univ Melbourne, Dept Microbiol & Immunol, Melbourne, Vic 3010, Australia; [Robinson, Keith S.; Crepin, Valerie F.; Frankel, Gad] Univ London Imperial Coll Sci Technol & Med, MRC Ctr Mol Bacteriol & Infect, Dept Life Sci, London SW7 2AZ, England; [Mansell, Ashley] Monash Inst Med Res, Ctr Innate Immun & Infect Dis, Melbourne, Vic 3010, Australia; [Marches, Olivier] Queen Mary Univ London, Barts & London Sch Med & Dent, Blizard Inst, Ctr Immunol & Infect Dis, London E1 2AT, England; [Ang, Ching-Seng; Williamson, Nicholas A.] Univ Melbourne, Mol Sci & Biotechnol Inst Bio21, Melbourne, Vic 3010, Australia; [O'Reilly, Lorraine A.; Bankovacki, Aleksandra; Nachbur, Ueli; Infusini, Giuseppe; Webb, Andrew I.; Silke, John; Strasser, Andreas] Walter & Eliza Hall Inst Med Res, Parkville, Vic 3052, Australia; [O'Reilly, Lorraine A.; Webb, Andrew I.; Silke, John; Strasser, Andreas] Univ Melbourne, Dept Med Biol, Melbourne, Vic 3010, Australia; [Hartland, Elizabeth L.] Royal Childrens Hosp, Murdoch Childrens Res Inst, Parkville, Vic 3052, Australia	University of Melbourne; Imperial College London; University of London; Queen Mary University London; University of Melbourne; Walter & Eliza Hall Institute; University of Melbourne; Murdoch Children's Research Institute; Royal Children's Hospital Melbourne	Hartland, EL (corresponding author), Univ Melbourne, Dept Microbiol & Immunol, Melbourne, Vic 3010, Australia.	hartland@unimelb.edu.au	Ang, Ching-Seng/O-9811-2016; Silke, John/B-7622-2008; Williamson, Nicholas A/O-9812-2016; Mansell, Ashley/B-9553-2008; Strasser, Andreas/C-7581-2013; Lung, Tania Wong Fok/ABD-3992-2020; Hartland, Elizabeth/O-2569-2014	Ang, Ching-Seng/0000-0001-7861-6719; Silke, John/0000-0002-7611-5774; Williamson, Nicholas A/0000-0002-2173-3452; Mansell, Ashley/0000-0002-6540-1281; Strasser, Andreas/0000-0002-5020-4891; Lung, Tania Wong Fok/0000-0002-9318-9572; Hartland, Elizabeth/0000-0003-4254-2863; Muehlen, Sabrina/0000-0001-7474-705X; Zaid, Ali/0000-0002-2528-2783; Giogha, Cristina/0000-0002-9075-9840; Pearson, Jaclyn/0000-0002-7358-4479; Kennedy, Catherine/0000-0001-6359-6161; Oates, Clare/0000-0002-3858-019X; Nachbur, Ueli/0000-0001-5968-2235	Australian National Health and Medical Research Council [606788, 637332, 1009145]; Wellcome Trust; Juvenile Diabetes Foundation; Leukaemia; Lymphoma Society (New York; SCOR grant) [7413]; Australian Research Council Future Fellowship; Australian Postgraduate Awards; MRC [MR/J006874/1] Funding Source: UKRI	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Wellcome Trust(Wellcome TrustEuropean Commission); Juvenile Diabetes Foundation(Juvenile Diabetes Research Foundation); Leukaemia; Lymphoma Society (New York; SCOR grant); Australian Research Council Future Fellowship(Australian Research Council); Australian Postgraduate Awards(Australian Government); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We gratefully acknowledge P. Bouillet for the gift of Bid<SUP>-/-</SUP> mice and T. Cumming for assistance with animal work. This work was supported by the Australian National Health and Medical Research Council (Program Grant no. 606788 to E. L. H., Project Grants no. 637332, no. 1009145 to A. S., no. 1009145 to L.O.R., Australia Fellowship to A. S.), the Wellcome Trust to G. F., the Juvenile Diabetes Foundation; the Leukaemia and the Lymphoma Society (New York; SCOR grant no. 7413) to A. S. E. L. H was supported by an Australian Research Council Future Fellowship. J.S.P., M. K., T. W., C. G. and P. R. were supported by Australian Postgraduate Awards. This work was made possible through Victorian State Government Operational Infrastructure Support and Australian Government NHMRC IRIISS.	Ashida H, 2011, CURR OPIN MICROBIOL, V14, P16, DOI 10.1016/j.mib.2010.08.014; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Deng WY, 2004, P NATL ACAD SCI USA, V101, P3597, DOI 10.1073/pnas.0400326101; Gao XF, 2013, CELL HOST MICROBE, V13, P87, DOI 10.1016/j.chom.2012.11.010; Imtiyaz HZ, 2005, J BIOL CHEM, V280, P31360, DOI 10.1074/jbc.M504138200; Isono T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018959; Jost PJ, 2009, NATURE, V460, P1035, DOI 10.1038/nature08229; Jostins L, 2012, NATURE, V491, P119, DOI 10.1038/nature11582; Karmali MA, 2003, J CLIN MICROBIOL, V41, P4930, DOI 10.1128/JCM.41.11.4930-4940.2003; Kaufmann T, 2007, CELL, V129, P423, DOI 10.1016/j.cell.2007.03.017; Kelly M, 2006, INFECT IMMUN, V74, P2328, DOI 10.1128/IAI.74.4.2328-2337.2006; Micheau O, 2003, CELL, V114, P181, DOI 10.1016/S0092-8674(03)00521-X; Mundy R, 2004, INFECT IMMUN, V72, P2288, DOI 10.1128/IAI.72.4.2288-2302.2004; Newton HJ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000898; Park HH, 2007, ANNU REV IMMUNOL, V25, P561, DOI 10.1146/annurev.immunol.25.022106.141656; Schneider-Brachert W, 2004, IMMUNITY, V21, P415, DOI 10.1016/j.immuni.2004.08.017; Srikanth CV, 2011, CELL MOL LIFE SCI, V68, P3687, DOI 10.1007/s00018-011-0841-0; Strasser A, 1995, EMBO J, V14, P6136, DOI 10.1002/j.1460-2075.1995.tb00304.x; Strasser A, 2009, IMMUNITY, V30, P180, DOI 10.1016/j.immuni.2009.01.001; Wang LW, 2010, NAT STRUCT MOL BIOL, V17, P1324, DOI 10.1038/nsmb.1920; Wickham ME, 2007, CURR BIOL, V17, P783, DOI 10.1016/j.cub.2007.03.067; Wickham ME, 2006, J INFECT DIS, V194, P819, DOI 10.1086/506620; Wong ARC, 2011, MOL MICROBIOL, V80, P1420, DOI 10.1111/j.1365-2958.2011.07661.x; Zhang L, 2012, NATURE, V481, P204, DOI 10.1038/nature10690	24	196	207	0	55	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 12	2013	501	7466					247	+		10.1038/nature12524	http://dx.doi.org/10.1038/nature12524			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	215XR	24025841	Green Accepted, Green Published			2022-12-24	WOS:000324244900046
J	Wei, YJ; Zou, ZJ; Becker, N; Anderson, M; Sumpter, R; Xiao, GH; Kinch, L; Koduru, P; Christudass, CS; Veltri, RW; Grishin, NV; Peyton, M; Minna, J; Bhagat, G; Levine, B				Wei, Yongjie; Zou, Zhongju; Becker, Nils; Anderson, Matthew; Sumpter, Rhea; Xiao, Guanghua; Kinch, Lisa; Koduru, Prasad; Christudass, Christhunesa S.; Veltri, Robert W.; Grishin, Nick V.; Peyton, Michael; Minna, John; Bhagat, Govind; Levine, Beth			EGFR-Mediated Beclin 1 Phosphorylation in Autophagy Suppression, Tumor Progression, and Tumor Chemoresistance	CELL			English	Article							EPIDERMAL-GROWTH-FACTOR; CELL LUNG-CANCER; ADENOCARCINOMA; MUTATIONS; CARCINOMA; SERIES	Cell surface growth factor receptors couple environmental cues to the regulation of cytoplasmic homeostatic processes, including autophagy, and aberrant activation of such receptors is a common feature of human malignancies. Here, we defined the molecular basis by which the epidermal growth factor receptor (EGFR) tyrosine kinase regulates autophagy. Active EGFR binds the autophagy protein Beclin 1, leading to its multisite tyrosine phosphorylation, enhanced binding to inhibitors, and decreased Beclin 1-associated VPS34 kinase activity. EGFR tyrosine kinase inhibitor (TKI) therapy disrupts Beclin 1 tyrosine phosphorylation and binding to its inhibitors and restores autophagy in non-small-cell lung carcinoma (NSCLC) cells with a TKI-sensitive EGFR mutation. In NSCLC tumor xenografts, the expression of a tyrosine phosphomimetic Beclin 1 mutant leads to reduced autophagy, enhanced tumor growth, tumor dedifferentiation, and resistance to TKI therapy. Thus, oncogenic receptor tyrosine kinases directly regulate the core autophagy machinery, which may contribute to tumor progression and chemoresistance.	[Wei, Yongjie; Zou, Zhongju; Sumpter, Rhea; Levine, Beth] Univ Texas SW Med Ctr Dallas, Ctr Autophagy Res, Dallas, TX 75390 USA; [Wei, Yongjie; Zou, Zhongju; Becker, Nils; Anderson, Matthew; Sumpter, Rhea; Peyton, Michael; Minna, John; Levine, Beth] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA; [Xiao, Guanghua] Univ Texas SW Med Ctr Dallas, Dept Clin Sci, Dallas, TX 75390 USA; [Kinch, Lisa; Grishin, Nick V.] Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA; [Koduru, Prasad] Univ Texas SW Med Ctr Dallas, Dept Pathol, Dallas, TX 75390 USA; [Peyton, Michael; Minna, John] Univ Texas SW Med Ctr Dallas, Hamon Ctr Therapeut Oncol, Dallas, TX 75390 USA; [Levine, Beth] Univ Texas SW Med Ctr Dallas, Dept Microbiol, Dallas, TX 75390 USA; [Wei, Yongjie; Zou, Zhongju; Becker, Nils; Kinch, Lisa; Grishin, Nick V.; Levine, Beth] Univ Texas SW Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA; [Christudass, Christhunesa S.; Veltri, Robert W.] Johns Hopkins Univ, Sch Med, Brady Urol Inst, Dept Urol, Baltimore, MD 21287 USA; [Bhagat, Govind] Columbia Univ, Med Ctr, Dept Pathol & Cell Biol, New York, NY 10032 USA; [Bhagat, Govind] New York Presbyterian Hosp, New York, NY 10032 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas; Johns Hopkins University; Columbia University; NewYork-Presbyterian Hospital	Levine, B (corresponding author), Univ Texas SW Med Ctr Dallas, Ctr Autophagy Res, Dallas, TX 75390 USA.	beth.levine@utsouthwestern.edu	Bhagat, Govind/AAE-9493-2021; Sumpter, Jr., Rhea/N-8152-2018	Bhagat, Govind/0000-0001-6250-048X; Kinch, Lisa/0000-0003-3041-2615	National Institutes of Health [NCI RO1 84254, NCI RO1 109618]; Lung Cancer SPORE [P50CA70907]; NATIONAL CANCER INSTITUTE [R01CA109618, P50CA070907, R01CA084254] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Lung Cancer SPORE; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Noboru Mizushima, Tamotsu Yoshimori, and Sandra Schmid for supplying critical reagents, Haley Harrington for assistance with manuscript preparation, and Lori Nguyen for technical assistance. This work was supported by National Institutes of Health grants NCI RO1 84254 and NCI RO1 109618 to B.L. and the Lung Cancer SPORE P50CA70907 to J.M.	Amaravadi RK, 2011, CLIN CANCER RES, V17, P654, DOI 10.1158/1078-0432.CCR-10-2634; Botti J, 2006, AUTOPHAGY, V2, P67, DOI 10.4161/auto.2.2.2458; CARPENTER G, 1987, ANNU REV BIOCHEM, V56, P881, DOI 10.1146/annurev.biochem.56.1.881; Ciardiello F, 2008, NEW ENGL J MED, V358, P1160, DOI 10.1056/NEJMra0707704; Fung C, 2012, CANCER BIOL THER, V13, P1417, DOI 10.4161/cbt.22002; Gazdar AF, 1996, J CELL BIOCHEM, P1; Gorzalczany Y, 2011, CANCER LETT, V310, P207, DOI 10.1016/j.canlet.2011.07.002; Han WD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018691; He CC, 2010, CURR OPIN CELL BIOL, V22, P140, DOI 10.1016/j.ceb.2010.01.001; Lemmon MA, 2010, CELL, V141, P1117, DOI 10.1016/j.cell.2010.06.011; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Matsunaga K, 2009, NAT CELL BIOL, V11, P385, DOI 10.1038/ncb1846; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Pao W, 2010, NAT REV CANCER, V10, P760, DOI 10.1038/nrc2947; Rekhtman N, 2011, MODERN PATHOL, V24, P1348, DOI 10.1038/modpathol.2011.92; Rubinsztein DC, 2012, NAT REV DRUG DISCOV, V11, P709, DOI 10.1038/nrd3802; Saad RS, 2004, HUM PATHOL, V35, P3, DOI 10.1016/j.humpath.2003.08.011; Sato T, 2010, ONCOGENE, V29, P2746, DOI 10.1038/onc.2010.28; Shim HS, 2011, ARCH PATHOL LAB MED, V135, P1329, DOI 10.5858/arpa.2010-0493-OA; Tang XM, 2011, CLIN CANCER RES, V17, P2434, DOI 10.1158/1078-0432.CCR-10-1412; VanMeter AJ, 2008, MOL CELL PROTEOMICS, V7, P1902, DOI 10.1074/mcp.M800204-MCP200; Wang RC, 2012, SCIENCE, V338, P956, DOI 10.1126/science.1225967; Wang Y, 2002, MOL CELL BIOL, V22, P7279, DOI 10.1128/MCB.22.20.7279-7290.2002; Yao YA, 2010, ACTA BIOCH BIOPH SIN, V42, P763, DOI 10.1093/abbs/gmq090	25	375	399	0	110	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 12	2013	154	6					1269	1284		10.1016/j.cell.2013.08.015	http://dx.doi.org/10.1016/j.cell.2013.08.015			16	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	215VQ	24034250	Green Accepted, Bronze			2022-12-24	WOS:000324239300016
J	McCollum, JT; Cronquist, AB; Silk, BJ; Jackson, KA; O'Connor, KA; Cosgrove, S; Gossack, JP; Parachini, SS; Jain, NS; Ettestad, P; Ibraheem, M; Cantu, V; Joshi, M; DuVernoy, T; Fogg, NW; Gorny, JR; Mogen, KM; Spires, C; Teitell, P; Joseph, LA; Tarr, CL; Imanishi, M; Neil, KP; Tauxe, RV; Mahon, BE				McCollum, Jeffrey T.; Cronquist, Alicia B.; Silk, Benjamin J.; Jackson, Kelly A.; O'Connor, Katherine A.; Cosgrove, Shaun; Gossack, Joe P.; Parachini, Susan S.; Jain, Neena S.; Ettestad, Paul; Ibraheem, Mam; Cantu, Venessa; Joshi, Manjiri; DuVernoy, Tracy; Fogg, Norman W., Jr.; Gorny, James R.; Mogen, Kathryn M.; Spires, Charlotte; Teitell, Paul; Joseph, Lavin A.; Tarr, Cheryl L.; Imanishi, Maho; Neil, Karen P.; Tauxe, Robert V.; Mahon, Barbara E.			Multistate Outbreak of Listeriosis Associated with Cantaloupe	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							SURVEILLANCE NETWORK FOODNET; UNITED-STATES; MONOCYTOGENES VIRULENCE; FOODBORNE ILLNESS; FRESH PRODUCE; PULSENET; ESTABLISHMENT; EVOLUTION; MELON	BACKGROUND Although new pathogen-vehicle combinations are increasingly being identified in produce-related disease outbreaks, fresh produce is a rarely recognized vehicle for listeriosis. We investigated a nationwide listeriosis outbreak that occurred in the United States during 2011. METHODS We defined an outbreak-related case as a laboratory-confirmed infection with any of five outbreak-related subtypes of Listeria monocytogenes isolated during the period from August 1 through October 31, 2011. Multistate epidemiologic, trace-back, and environmental investigations were conducted, and outbreak-related cases were compared with sporadic cases reported previously to the Listeria Initiative, an enhanced surveillance system that routinely collects detailed information about U.S. cases of listeriosis. RESULTS We identified 147 outbreak-related cases in 28 states. The majority of patients (127 of 147, 86%) were 60 years of age or older. Seven infections among pregnant women and newborns and one related miscarriage were reported. Of 145 patients for whom information about hospitalization was available, 143 (99%) were hospitalized. Thirty-three of the 147 patients (22%) died. Patients with outbreak-related illness were significantly more likely to have eaten cantaloupe than were patients 60 years of age or older with sporadic illness (odds ratio, 8.5; 95% confidence interval, 1.3 to infinity). Cantaloupe and environmental samples collected during the investigation yielded isolates matching all five outbreak-related subtypes, confirming that whole cantaloupe produced by a single Colorado farm was the outbreak source. Unsanitary conditions identified in the processing facility operated by the farm probably resulted in contamination of cantaloupes with L. monocytogenes. CONCLUSIONS Raw produce, including cantaloupe, can serve as a vehicle for listeriosis. This outbreak highlights the importance of preventing produce contamination within farm and processing environments.	[McCollum, Jeffrey T.; O'Connor, Katherine A.; Jain, Neena S.; Ibraheem, Mam; Imanishi, Maho] Ctr Dis Control & Prevent, Epidem Intelligence Serv, Atlanta, GA 30329 USA; [Silk, Benjamin J.; Jackson, Kelly A.; O'Connor, Katherine A.; Joseph, Lavin A.; Tarr, Cheryl L.; Imanishi, Maho; Neil, Karen P.; Tauxe, Robert V.; Mahon, Barbara E.] Ctr Dis Control & Prevent, Natl Ctr Emerging & Zoonot Infect Dis, Div Foodborne Waterborne & Environm Dis, Atlanta, GA USA; Ctr Dis Control & Prevent, Sci Educ & Profess Dev Program Off, Atlanta, GA USA; [McCollum, Jeffrey T.; Cronquist, Alicia B.; Cosgrove, Shaun; Gossack, Joe P.; Parachini, Susan S.] Colorado Dept Publ Hlth & Environm, Denver, CO USA; [Ettestad, Paul; Ibraheem, Mam] New Mexico Dept Hlth, Santa Fe, NM USA; [Cantu, Venessa] Dept State Hlth Serv, Austin, TX USA; [Joshi, Manjiri] Nebraska Dept Hlth & Human Serv, Lincoln, NE USA; [DuVernoy, Tracy; Fogg, Norman W., Jr.; Gorny, James R.; Mogen, Kathryn M.; Spires, Charlotte; Teitell, Paul] US FDA, Silver Spring, MD USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Colorado Department of Public Health & Environment; New Mexico Department of Health; US Food & Drug Administration (FDA)	McCollum, JT (corresponding author), Ctr Dis Control & Prevent, Epidem Intelligence Serv, Atlanta, GA 30329 USA.	jeffrey.mccollum@us.army.mil						[Anonymous], 2011, COL LIST INV NOW MUL; [Anonymous], 2009, GUID IND GUID MIN MI; [Anonymous], 2007, LISTERIOSIS FOOD SAF; [Anonymous], 2012, RAW PROD SEL SERV IT; Behravesh CB, 2011, J INFECT DIS, V204, P263, DOI 10.1093/infdis/jir263; Bell R, 2010, COMMUN DIS INTELL, V34, P345; Bowen A, 2006, EPIDEMIOL INFECT, V134, P675, DOI 10.1017/S0950268805005480; Cartwright EJ, 2013, EMERG INFECT DIS, V19, P1, DOI [10.3201/eid1901.120393, 10.3201/eid1908.121511]; Centers for Disease Control and Prevention, 2011, NAT ENT DIS SURV LIS; de Valk H, 2001, AM J EPIDEMIOL, V154, P944, DOI 10.1093/aje/154.10.944; Food and Drug Administration, 2011, ENV ASS FACT POT CON; Food and Drug Administration, 1998, GUID IND GUID MIN MI; Gagliardi JV, 2003, J FOOD PROTECT, V66, P82, DOI 10.4315/0362-028X-66.1.82; Graves LM, 2005, J CLIN MICROBIOL, V43, P2350, DOI 10.1128/JCM.43.5.2350-2355.2005; Halpin JL, 2010, FOODBORNE PATHOG DIS, V7, P293, DOI 10.1089/fpd.2009.0394; Hitchins AD, 2011, BACTERIOLOGICAL ANAL; Jackson KA, 2011, J FOOD PROTECT, V74, P949, DOI 10.4315/0362-028X.JFP-10-536; Jackson KA, 2010, EPIDEMIOL INFECT, V138, P1503, DOI 10.1017/S0950268810000294; Johnston LM, 2005, J FOOD PROTECT, V68, P1840, DOI 10.4315/0362-028X-68.9.1840; Kathariou S, 2002, J FOOD PROTECT, V65, P1811, DOI 10.4315/0362-028X-65.11.1811; Laksanalamai P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042448; Lynch MF, 2009, EPIDEMIOL INFECT, V137, P307, DOI 10.1017/S0950268808001969; McCarthy N, 1999, INT J EPIDEMIOL, V28, P764, DOI 10.1093/ije/28.4.764; Mead PS, 2006, EPIDEMIOL INFECT, V134, P744, DOI 10.1017/S0950268805005376; Orsi RH, 2011, INT J MED MICROBIOL, V301, P79, DOI 10.1016/j.ijmm.2010.05.002; Penteado AL, 2004, INT J FOOD MICROBIOL, V92, P89, DOI 10.1016/j.ijfoodmicro.2003.08.020; Scallan E, 2011, EMERG INFECT DIS, V17, P16, DOI [10.3201/eid1701.P21101, 10.3201/eid1701.091101p2]; Silk BJ, 2012, CLIN INFECT DIS, V54, pS396, DOI 10.1093/cid/cis268; Sivapalasingam S, 2004, J FOOD PROTECT, V67, P2342, DOI 10.4315/0362-028X-67.10.2342; Swaminathan B, 2001, EMERG INFECT DIS, V7, P382; Swaminathan B, 2007, MICROBES INFECT, V9, P1236, DOI 10.1016/j.micinf.2007.05.011; Tompkin RB, 2002, J FOOD PROTECT, V65, P709, DOI 10.4315/0362-028X-65.4.709; Ukuku DO, 2002, J FOOD PROTECT, V65, P924, DOI 10.4315/0362-028X-65.6.924; Varma JK, 2007, CLIN INFECT DIS, V44, P521, DOI 10.1086/509920; Velge P, 2010, FUTURE MICROBIOL, V5, P1799, DOI 10.2217/FMB.10.134	35	222	233	3	113	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 5	2013	369	10					944	953		10.1056/NEJMoa1215837	http://dx.doi.org/10.1056/NEJMoa1215837			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	211KV	24004121	Bronze			2022-12-24	WOS:000323906900011
J	Nitschke, L				Nitschke, Lars			Suppressing the Antibody Response with Siglec Ligands	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							CD22; ANTIGEN; BINDING	Production of antibodies to self-antigens is a risk factor for autoimmune disease. A potential strategy to suppress production of specific antibodies by B cells may involve stimulation of a class of repressor receptors, the sialic acid-binding immunoglobulin-like lectins. When stimulated by antigens, B cells produce antibodies a crucial response against pathogens and the basis of all successful vaccines. The dark side of this immune response is that it can be directed against self-antigens, potentially resulting in autoimmune disease. Autoreactive B cells are largely eliminated in the bone marrow, but some escape the bone marrow and are found in the periphery as polyreactive or autoreactive B cells. However, a second mechanism guards against autoimmune mayhem: inhibitory receptors expressed on the surface of B cells for example, the sialic acid-binding immunoglobulin-like lectins (Siglecs) prevent autoimmune reactions. Macauley ...	Univ Erlangen Nurnberg, Div Genet, Dept Biol, D-91054 Erlangen, Germany	University of Erlangen Nuremberg	Nitschke, L (corresponding author), Univ Erlangen Nurnberg, Div Genet, Dept Biol, D-91054 Erlangen, Germany.							Kelm S, 2002, J EXP MED, V195, P1207, DOI 10.1084/jem.20011783; Kelm S, 2013, ANGEW CHEM INT EDIT, V52, P3616, DOI 10.1002/anie.201207267; Macauley MS, 2013, J CLIN INVEST, V123, P3074, DOI 10.1172/JCI69187; Pfrengle F, 2013, J IMMUNOL, V191, P1724, DOI 10.4049/jimmunol.1300921; Schweizer A, 2012, EUR J IMMUNOL, V42, P2792, DOI 10.1002/eji.201242574	5	6	7	0	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 3	2013	369	14					1373	1374		10.1056/NEJMcibr1308953	http://dx.doi.org/10.1056/NEJMcibr1308953			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	227KI	24088100				2022-12-24	WOS:000325111200018
J	Ermolaeva, MA; Segref, A; Dakhovnik, A; Ou, HL; Schneider, JI; Utermohlen, O; Hoppe, T; Schumacher, B				Ermolaeva, Maria A.; Segref, Alexandra; Dakhovnik, Alexander; Ou, Hui-Ling; Schneider, Jennifer I.; Utermoehlen, Olaf; Hoppe, Thorsten; Schumacher, Bjoern			DNA damage in germ cells induces an innate immune response that triggers systemic stress resistance	NATURE			English	Article							CAENORHABDITIS-ELEGANS; C-ELEGANS; PATHWAY; ACTIVATION; EVOLUTION; INFECTION; APOPTOSIS; DAF-16	DNA damage responses have been well characterized with regard to their cell-autonomous checkpoint functions leading to cell cycle arrest, senescence and apoptosis(1). In contrast, systemic responses to tissue-specific genome instability remain poorly understood. In adult Caenorhabditis elegans worms germ cells undergo mitotic and meiotic cell divisions, whereas somatic tissues are entirely post-mitotic. Consequently, DNA damage checkpoints function specifically in the germ line(2), whereas somatic tissues in adult C. elegans are highly radio-resistant(3). Some DNA repair systems such as global-genome nucleotide excision repair (GG-NER) remove lesions specifically in germ cells(4). Here we investigated how genome instability in germ cells affects somatic tissues in C. elegans. We show that exogenous and endogenous DNA damage in germ cells evokes elevated resistance to heat and oxidative stress. The somatic stress resistance is mediated by the ERK MAP kinase MPK-1 in germ cells that triggers the induction of putative secreted peptides associated with innate immunity. The innate immune response leads to activation of the ubiquitin-proteasome system (UPS) in somatic tissues, which confers enhanced proteostasis and systemic stress resistance. We propose that elevated systemic stress resistance promotes endurance of somatic tissues to allow delay of progeny production when germ cells are genomically compromised.	[Ermolaeva, Maria A.; Segref, Alexandra; Dakhovnik, Alexander; Ou, Hui-Ling; Schneider, Jennifer I.; Hoppe, Thorsten; Schumacher, Bjoern] Univ Cologne, Inst Genet, Cologne Excellence Cluster Cellular Stress Respon, D-50674 Cologne, Germany; [Utermoehlen, Olaf] Univ Cologne, Med Ctr, Inst Med Microbiol Immunol & Hyg, D-50935 Cologne, Germany; [Utermoehlen, Olaf] Univ Cologne, Ctr Mol Med Cologne CMMC, D-50931 Cologne, Germany; [Schumacher, Bjoern] Univ Cologne, D-50937 Cologne, Germany	University of Cologne; University of Cologne; University of Cologne; University of Cologne	Schumacher, B (corresponding author), Univ Cologne, Inst Genet, Cologne Excellence Cluster Cellular Stress Respon, Zulpicher Str 47A, D-50674 Cologne, Germany.	bjoern.schumacher@uni-koeln.de	Hoppe, Thorsten/AAC-7880-2020; Schumacher, Björn/I-4829-2013	Schumacher, Björn/0000-0001-6097-5238; Segref, Alexandra/0000-0001-8095-4469; Hoppe, Thorsten/0000-0002-4734-9352	US National Institutes of Health (NIH) Office of Research Infrastructure Programs [P40 OD010440]; Mitani laboratory; Deutsche Forschungsgemeinschaft (DFG) [SFB 670-TP4]; EC Network of Excellence RUBICON [LSHC-CT-2005-018683]; DFG [CECAD, FOR885, SFB635, KFO286, HO2541/4-1, SFB 829, KFO 286]; European Research Council [260383]; Marie Curie [FP7 ITN CodeAge 316354, aDDRess 316390, MARRIAGE 316964, ERG239330]; German-Israeli Foundation [GIF 2213-1935.13/2008, 1104-68.11/2010]; Deutsche Krebshilfe [109453]; BMBF (SyBaCol); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD010440] Funding Source: NIH RePORTER	US National Institutes of Health (NIH) Office of Research Infrastructure Programs(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mitani laboratory; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); EC Network of Excellence RUBICON; DFG(German Research Foundation (DFG)); European Research Council(European Research Council (ERC)European Commission); Marie Curie(European Commission); German-Israeli Foundation(German-Israeli Foundation for Scientific Research and Development); Deutsche Krebshilfe(Deutsche Krebshilfe); BMBF (SyBaCol)(Federal Ministry of Education & Research (BMBF)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank S. Torres for technical support, P. Frommolt for advice on statistics, and A. Williams for comments on the manuscript. C. elegans strains were kindly provided by the CGC (funded by the US National Institutes of Health (NIH) Office of Research Infrastructure Programs (P40 OD010440)), and the Mitani laboratory. We thank D. Kim, F. Ausubel and V. Jantsch for strains and reagents. M. A. E. received the European Molecular Biology Organization (EMBO) long-term fellowship, A. D. received the IGS-DHD fellowship, and H.-L.O. received the CECAD fellowship. O.U. acknowledges funding from the Deutsche Forschungsgemeinschaft (DFG) (SFB 670-TP4), and T. H. from the EC Network of Excellence RUBICON (LSHC-CT-2005-018683), DFG (CECAD, FOR885, SFB635, KFO286 and HO2541/4-1). B. S. acknowledges funding from the DFG (CECAD, SFB 829 and KFO 286), European Research Council (starting grant 260383), Marie Curie (FP7 ITN CodeAge 316354, aDDRess 316390, MARRIAGE 316964 and ERG239330), German-Israeli Foundation (GIF 2213-1935.13/2008 and 1104-68.11/2010), Deutsche Krebshilfe (109453) and BMBF (SyBaCol).	Bartek J, 2007, CURR OPIN CELL BIOL, V19, P238, DOI 10.1016/j.ceb.2007.02.009; BRENNER S, 1974, GENETICS, V77, P71; Bush KT, 1997, J BIOL CHEM, V272, P9086; Colaiacovo MP, 2003, DEV CELL, V5, P463, DOI 10.1016/S1534-5807(03)00232-6; Dent P, 2003, ONCOGENE, V22, P5885, DOI 10.1038/sj.onc.1206701; Garcia-Muse T, 2005, EMBO J, V24, P4345, DOI 10.1038/sj.emboj.7600896; Gartner A, 2000, MOL CELL, V5, P435, DOI 10.1016/S1097-2765(00)80438-4; Gasser S, 2005, NATURE, V436, P1186, DOI 10.1038/nature03884; Gregorio J, 2010, J EXP MED, V207, P2921, DOI 10.1084/jem.20101102; Greiss S, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-334; Horton P, 2007, NUCLEIC ACIDS RES, V35, pW585, DOI 10.1093/nar/gkm259; Hsu AL, 2003, SCIENCE, V300, P1142, DOI 10.1126/science.1083701; Iizuka M., 2009, WORLD J GASTROENTERO, V11, P1272; Irazoqui JE, 2010, NAT REV IMMUNOL, V10, P47, DOI 10.1038/nri2689; JOHNSON TE, 1988, J GERONTOL, V43, pB137, DOI 10.1093/geronj/43.5.B137; Karpac J, 2011, DEV CELL, V20, P841, DOI 10.1016/j.devcel.2011.05.011; Kim DH, 2002, SCIENCE, V297, P623, DOI 10.1126/science.1073759; Lans H, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000941; Lin K, 2001, NAT GENET, V28, P139, DOI 10.1038/88850; Moser SC, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000451; Muruve DA, 2008, NATURE, V452, P103, DOI 10.1038/nature06664; Nicholas HR, 2004, CURR BIOL, V14, P1256, DOI 10.1016/j.cub.2004.07.022; O'Rourke D, 2006, GENOME RES, V16, P1005, DOI 10.1101/gr.50823006; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Richardson CE, 2010, NATURE, V463, P1092, DOI 10.1038/nature08762; Rodier F, 2009, NAT CELL BIOL, V11, P973, DOI 10.1038/ncb1909; Rutkowski R, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002238; Segref A, 2011, GENETICS, V187, P1235, DOI 10.1534/genetics.111.126797; Shivers RP, 2008, CURR OPIN MICROBIOL, V11, P251, DOI 10.1016/j.mib.2008.05.014; Shivers RP, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000892; Shivers RP, 2009, CELL HOST MICROBE, V6, P321, DOI 10.1016/j.chom.2009.09.001; Thomas JH, 2006, GENETICS, V172, P2269, DOI 10.1534/genetics.105.052746; Troemel ER, 2006, PLOS GENET, V2, P1725, DOI 10.1371/journal.pgen.0020183; Yamawaki TM, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000468	34	145	146	0	82	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 19	2013	501	7467					416	+		10.1038/nature12452	http://dx.doi.org/10.1038/nature12452			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219XT	23975097	Green Accepted			2022-12-24	WOS:000324545700045
J	Watson, AJ; Ledwell, JR; Messias, MJ; King, BA; Mackay, N; Meredith, MP; Mills, B; Garabato, ACN				Watson, Andrew J.; Ledwell, James R.; Messias, Marie-Jose; King, Brian A.; Mackay, Neill; Meredith, Michael P.; Mills, Benjamin; Garabato, Alberto C. Naveira			Rapid cross-density ocean mixing at mid-depths in the Drake Passage measured by tracer release	NATURE			English	Article							SOUTHERN-OCEAN; SULFUR-HEXAFLUORIDE; SPATIAL VARIABILITY; CIRCULATION; DISSIPATION; TOPOGRAPHY	Diapycnal mixing (across density surfaces) is an important process in the global ocean overturning circulation(1-3). Mixing in the interior of most of the ocean, however, is thought to have a magnitude just one-tenth of that required to close the global circulation by the downward mixing of less dense waters(4). Some of this deficit is made up by intense near-bottom mixing occurring in restricted 'hot-spots' associated with rough ocean-floor topography(5,6), but it is not clear whether the waters at mid-depth, 1,000 to 3,000 metres, are returned to the surface by cross-densitymixing or by along-density flows(7). Here we show that diapycnal mixing of mid-depth (similar to 1,500 metres) waters undergoes a sustained 20-fold increase as the Antarctic Circumpolar Current flows through the Drake Passage, between the southern tip of South America and Antarctica. Our results are based on an open-ocean tracer release of trifluoromethyl sulphur pentafluoride. We ascribe the increased mixing to turbulence generated by the deep-reaching Antarctic Circumpolar Current as it flows over rough bottom topography in the Drake Passage. Scaled to the entire circumpolar current, the mixing we observe is compatible with there being a southern component to the global overturning in which about 20 sverdrups (1 Sv = 10(6) m(3) s(-1)) upwell in the Southern Ocean, with cross-density mixing contributing a significant fraction (20 to 30 per cent) of this total, and the remainder upwelling along constant-density surfaces. The great majority of the diapycnal flux is the result of interaction with restricted regions of rough ocean-floor topography.	[Watson, Andrew J.; Messias, Marie-Jose; Mackay, Neill; Mills, Benjamin] Univ E Anglia, Sch Environm Sci, Norwich NR4 7TJ, Norfolk, England; [Ledwell, James R.] Woods Hole Oceanog Inst, Woods Hole, MA 02543 USA; [King, Brian A.; Garabato, Alberto C. Naveira] Natl Oceanog Ctr, Southampton SO14 3ZH, Hants, England; [Meredith, Michael P.] British Antarctic Survey, Cambridge CB3 0ET, England; [Meredith, Michael P.] Scottish Assoc Marine Sci, Oban PA37 1QA, Argyll, Scotland; [Garabato, Alberto C. Naveira] Univ Southampton, Natl Oceanog Ctr, Southampton SO14 3ZH, Hants, England	University of East Anglia; Woods Hole Oceanographic Institution; NERC National Oceanography Centre; UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); NERC British Antarctic Survey; UHI Millennium Institute; NERC National Oceanography Centre; University of Southampton	Watson, AJ (corresponding author), Univ Exeter, Coll Life & Environm Sci, Laver Bldg, Exeter EX4 4QE, Devon, England.	andrew.watson@exeter.ac.uk	Garabato, Alberto Naveira/AAQ-1114-2020	Garabato, Alberto Naveira/0000-0001-6071-605X; Mills, Benjamin/0000-0002-9141-0931; Messias, Marie-Jose/0000-0002-3852-2854; Meredith, Michael/0000-0002-7342-7756; Watson, Andrew/0000-0002-9654-8147	UK Natural Environment Research Council; US National Science Foundation; Royal Society; NERC [NE/E007058/1, NE/E005985/1, NE/E005985/2, bas0100028] Funding Source: UKRI; Natural Environment Research Council [noc010012, bas0100028, NE/E005985/1, NE/E005985/2, NE/E007058/1] Funding Source: researchfish; Directorate For Geosciences [1232962] Funding Source: National Science Foundation	UK Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); US National Science Foundation(National Science Foundation (NSF)); Royal Society(Royal Society of London); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	We thank the officers and staff of the RV Thomas Thompson, RRS James Cook and RRS James Clark Ross for their assistance in making the observations at sea. We thank the UK Natural Environment Research Council and the US National Science Foundation for funding the DIMES experiment. A.J.W. thanks the Royal Society for support.	Bevington PR., 2002, DATA REDUCTION ERROR; Busenberg E, 2008, WATER RESOUR RES, V44, DOI 10.1029/2007WR006150; Falco P, 2011, J GEOPHYS RES-OCEANS, V116, DOI 10.1029/2010JC006349; Garabato ACN, 2004, SCIENCE, V303, P210, DOI 10.1126/science.1090929; GREGG MC, 1989, J GEOPHYS RES-OCEANS, V94, P9686, DOI 10.1029/JC094iC07p09686; Ho DT, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL032799; Kunze E, 2006, J PHYS OCEANOGR, V36, P1553, DOI 10.1175/JPO2926.1; Laurent LS, 2012, J PHYS OCEANOGR, V42, P2143, DOI 10.1175/JPO-D-12-027.1; LAW CS, 1994, MAR CHEM, V48, P57, DOI 10.1016/0304-4203(94)90062-0; Ledwell JR, 2011, J PHYS OCEANOGR, V41, P241, DOI 10.1175/2010JPO4557.1; Ledwell JR, 2000, NATURE, V403, P179, DOI 10.1038/35003164; Ledwell JR, 1998, J GEOPHYS RES-OCEANS, V103, P21499, DOI 10.1029/98JC01738; LEDWELL JR, 1993, NATURE, V364, P701, DOI 10.1038/364701a0; Lumpkin R, 2007, J PHYS OCEANOGR, V37, P2550, DOI 10.1175/JPO3130.1; Marshall J, 2012, NAT GEOSCI, V5, P171, DOI [10.1038/ngeo1391, 10.1038/NGEO1391]; McClean JL, 2011, OCEAN MODEL, V39, P10, DOI 10.1016/j.ocemod.2011.02.011; Meijers AJS, 2011, J ATMOS OCEAN TECH, V28, P548, DOI 10.1175/2010JTECHO790.1; Munk W, 1998, DEEP-SEA RES PT I, V45, P1977, DOI 10.1016/S0967-0637(98)00070-3; MUNK W., 1966, DEEP SEA RES OCEANOG, V13, P707, DOI [10.1016/0011-7471(66)90602-4, DOI 10.1016/0011-7471(66)90602-4]; Nikurashin M, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL046576; Nikurashin M, 2010, J PHYS OCEANOGR, V40, P2025, DOI 10.1175/2010JPO4315.1; Nikurashin M, 2010, J PHYS OCEANOGR, V40, P1055, DOI 10.1175/2009JPO4199.1; ORSI AH, 1995, DEEP-SEA RES PT I, V42, P641, DOI 10.1016/0967-0637(95)00021-W; POLZIN KL, 1995, J PHYS OCEANOGR, V25, P306, DOI 10.1175/1520-0485(1995)025<0306:FPOTD>2.0.CO;2; Polzin KL, 1997, SCIENCE, V276, P93, DOI 10.1126/science.276.5309.93; SHAPIRO SS, 1965, BIOMETRIKA, V52, P591, DOI 10.1093/biomet/52.3-4.591; Sloyan BM, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL023568; Smethie WM, 2000, J GEOPHYS RES-OCEANS, V105, P1105, DOI 10.1029/1999JC900233; Toggweiler JR, 1998, J PHYS OCEANOGR, V28, P1832, DOI 10.1175/1520-0485(1998)028<1832:OTOSLS>2.0.CO;2; WANNINKHOF R, 1991, J GEOPHYS RES-OCEANS, V96, P8733, DOI 10.1029/91JC00104; Waterman S, 2013, J PHYS OCEANOGR, V43, P259, DOI 10.1175/JPO-D-11-0194.1; Webb DJ, 2001, NATURE, V409, P37, DOI 10.1038/35051171; Wu LX, 2011, NAT GEOSCI, V4, P363, DOI [10.1038/ngeo1156, 10.1038/NGEO1156]; Zika JD, 2009, J PHYS OCEANOGR, V39, P2926, DOI 10.1175/2009JPO4052.1	34	48	48	0	52	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 19	2013	501	7467					408	+		10.1038/nature12432	http://dx.doi.org/10.1038/nature12432			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219XT	24048070	Green Accepted			2022-12-24	WOS:000324545700043
J	Santiago, J; Henzler, C; Hothorn, M				Santiago, Julia; Henzler, Christine; Hothorn, Michael			Molecular Mechanism for Plant Steroid Receptor Activation by Somatic Embryogenesis Co-Receptor Kinases	SCIENCE			English	Article							EXTRACELLULAR DOMAIN; CRYSTAL-STRUCTURE; PERCEPTION; BRASSINOSTEROIDS; COMPLEX; BRI1/BAK1; FLAGELLIN; BINDING; BAK1; BRI1	Brassinosteroids, which control plant growth and development, are sensed by the leucine-rich repeat (LRR) domain of the membrane receptor kinase BRASSINOSTEROID INSENSITIVE 1 (BRI1), but it is unknown how steroid binding at the cell surface activates the cytoplasmic kinase domain of the receptor. A family of somatic embryogenesis receptor kinases (SERKs) has been genetically implicated in mediating early brassinosteroid signaling events. We found a direct and steroid-dependent interaction between the BRI1 and SERK1 LRR domains by analysis of their complex crystal structure at 3.3 angstrom resolution. We show that the SERK1 LRR domain is involved in steroid sensing and, through receptor-co-receptor heteromerization, in the activation of the BRI1 signaling pathway. Our work reveals how known missense mutations in BRI1 and in SERKs modulate brassinosteroid signaling and the targeting mechanism of BRI1 receptor antagonists.	[Santiago, Julia; Henzler, Christine; Hothorn, Michael] Max Planck Gesell, Friedrich Miescher Lab, Struct Plant Biol Lab, D-72076 Tubingen, Germany	Eberhard Karls University of Tubingen; Max Planck Society	Hothorn, M (corresponding author), Max Planck Gesell, Friedrich Miescher Lab, Struct Plant Biol Lab, Spemannstr 39, D-72076 Tubingen, Germany.	mhothorn@tuebingen.mpg.de		Hothorn, Michael/0000-0002-3597-5698; Santiago, Julia/0000-0002-5765-6495	Max Planck Society; Federation of European Biochemical Societies long-term fellowship; International Human Frontier Science Program Organization Career Development Award	Max Planck Society(Max Planck Society); Federation of European Biochemical Societies long-term fellowship; International Human Frontier Science Program Organization Career Development Award(Human Frontier Science Program)	We thank Y. Jaillais and M. Jinek for comments on the manuscript, J. Martinez for help with data collection, A. Pauluhn for providing beam time and staff members of beamline PXII (Swiss Light Source, Villigen, Switzerland), Y. Jaillais for bri1<INF>sud1</INF> and GABI_13E10 transgenic lines, and M. Blazquez for bes1-1D. Atomic coordinates and structure factors have been deposited in the Protein Data Bank with accession codes 4LSA (bri1<INF>sud1</INF>), 4LSC (SERK1), and 4LSX (bri1<INF>sud1</INF>-BL-SERK1). Supported by the Max Planck Society, a Federation of European Biochemical Societies long-term fellowship (J.S.), and an International Human Frontier Science Program Organization Career Development Award (M.H.). M.H. and Joanne Chory (Salk Institute) are inventors on a patent application filed by the Salk Institute for Biological Studies entitled "Structure of the Brassinosteroid Receptor BRI1, and Modulation of BRI1 Signaling" (patent 20130007910).	Asami T, 2000, PLANT PHYSIOL, V123, P93, DOI 10.1104/pp.123.1.93; Back TG, 2003, J PLANT GROWTH REGUL, V22, P350, DOI 10.1007/s00344-003-0057-0; Back TG, 2002, PHYTOCHEMISTRY, V59, P627, DOI 10.1016/S0031-9422(02)00019-5; Belkhadir Y, 2012, P NATL ACAD SCI USA, V109, P297, DOI 10.1073/pnas.1112840108; Chinchilla D, 2007, NATURE, V448, P497, DOI 10.1038/nature05999; Di Matteo A, 2003, P NATL ACAD SCI USA, V100, P10124, DOI 10.1073/pnas.1733690100; Friedrichsen DM, 2000, PLANT PHYSIOL, V123, P1247, DOI 10.1104/pp.123.4.1247; Gomez-Gomez L, 2000, MOL CELL, V5, P1003, DOI 10.1016/S1097-2765(00)80265-8; Gou XP, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002452; He ZH, 2000, SCIENCE, V288, P2360, DOI 10.1126/science.288.5475.2360; Hothorn M, 2011, NATURE, V474, P467, DOI 10.1038/nature10153; Hothorn M, 2010, P NATL ACAD SCI USA, V107, P17427, DOI 10.1073/pnas.1004481107; Jaillais Y, 2011, P NATL ACAD SCI USA, V108, P8503, DOI 10.1073/pnas.1103556108; Jaillais Y, 2011, GENE DEV, V25, P232, DOI 10.1101/gad.2001911; Jin MS, 2007, CELL, V130, P1071, DOI 10.1016/j.cell.2007.09.008; Kang JY, 2009, IMMUNITY, V31, P873, DOI 10.1016/j.immuni.2009.09.018; Karlova R, 2006, PLANT CELL, V18, P626, DOI 10.1105/tpc.105.039412; Kinoshita T, 2005, NATURE, V433, P167, DOI 10.1038/nature03227; Li J, 2002, CELL, V110, P213, DOI 10.1016/S0092-8674(02)00812-7; Li JM, 1997, CELL, V90, P929, DOI 10.1016/S0092-8674(00)80357-8; Muto T, 2013, BIOORGAN MED CHEM, V21, P4413, DOI 10.1016/j.bmc.2013.04.048; Nam KH, 2002, CELL, V110, P203, DOI 10.1016/S0092-8674(02)00814-0; Ogawa M, 2008, SCIENCE, V319, P294, DOI 10.1126/science.1150083; Roux M, 2011, PLANT CELL, V23, P2440, DOI 10.1105/tpc.111.084301; Schwessinger B, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002046; She J, 2011, NATURE, V474, P472, DOI 10.1038/nature10178; Sheard LB, 2010, NATURE, V468, P400, DOI 10.1038/nature09430; Tan X, 2007, NATURE, V446, P640, DOI 10.1038/nature05731; Wang XF, 2008, DEV CELL, V15, P220, DOI 10.1016/j.devcel.2008.06.011; Wang ZY, 2012, ANNU REV GENET, V46, P701, DOI 10.1146/annurev-genet-102209-163450; Wang ZY, 2001, NATURE, V410, P380, DOI 10.1038/35066597	31	231	246	6	107	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 23	2013	341	6148					889	892		10.1126/science.1242468	http://dx.doi.org/10.1126/science.1242468			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204MY	23929946				2022-12-24	WOS:000323370600043
J	Boumil, MM; Curfman, GD				Boumil, Marcia M.; Curfman, Gregory D.			On Access and Accountability - Two Supreme Court Rulings on Generic Drugs	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material								<p id="p002">In June, the U.S. Supreme Court issued two rulings regarding the marketing of generic drugs. The decisions have mixed implications for consumers, but given the size and growth rate of the industry, their impact can be expected to be substantial. <p id="p003">In June, the U.S. Supreme Court issued two rulings regarding the marketing of generic drugs that may alter the pharmaceutical business landscape. First, in Federal Trade Commission v. Actavis, the Court confronted the law governing a controversial pharmaceutical marketing practice known as reverse payment agreements, or pay for delay.(1) This practice occurs when a generic drug company identifies a vulnerable patent held by a brand-name drug manufacturer and seeks approval from the Food and Drug Administration (FDA) for a generic version before the patent expires, provoking a lawsuit for infringement. The two companies then forge a settlement whereby the brand-name ...	[Boumil, Marcia M.] Tufts Univ, Sch Med, Boston, MA 02111 USA	Tufts University	Boumil, MM (corresponding author), Tufts Univ, Sch Med, Boston, MA 02111 USA.								0	3	3	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 22	2013	369	8					696	697		10.1056/NEJMp1308368	http://dx.doi.org/10.1056/NEJMp1308368			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	204FA	23923990				2022-12-24	WOS:000323349300005
J	Hampson, NB; Courtney, TG; Holm, JR				Hampson, Neil B.; Courtney, Todd G.; Holm, James R.			Diffusion of Carbon Monoxide Through Gypsum Wallboard	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Hampson, Neil B.; Courtney, Todd G.; Holm, James R.] Virginia Mason Med Ctr, Ctr Hyperbar Med, Seattle, WA 98101 USA	Virginia Mason Medical Center	Hampson, NB (corresponding author), Virginia Mason Med Ctr, 1100 9th Ave,H4 CHM, Seattle, WA 98101 USA.	neil.hampson@vmmc.org						Anonymous, 2007, Morbidity and Mortality Weekly Report, V56, P1309; Emmerich SJ, MODELING AND MEASURI; Keshishian C, 2012, J PUBLIC HEALTH-UK, V34, P477, DOI 10.1093/pubmed/fds023; National Conference of State Legislation, CARBON MONOXIDE DETE; Rosen G, ANALYSIS OF PHYSICAL; Weaver LK, 2002, NEW ENGL J MED, V347, P1057, DOI 10.1056/NEJMoa013121	6	7	7	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 21	2013	310	7					745	746		10.1001/jama.2013.43127	http://dx.doi.org/10.1001/jama.2013.43127			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	202XP	23989964	Bronze			2022-12-24	WOS:000323254500025
J	Russell, DG; Nathan, CF				Russell, David G.; Nathan, Carl F.			Graduation time	NATURE			English	Editorial Material									[Russell, David G.] Cornell Univ, Coll Vet Med, Dept Microbiol & Immunol, Ithaca, NY 14853 USA; [Nathan, Carl F.] Weill Cornell Med Coll, Dept Microbiol & Immunol, New York, NY 10065 USA	Cornell University; Cornell University	Russell, DG (corresponding author), Cornell Univ, Coll Vet Med, Dept Microbiol & Immunol, Ithaca, NY 14853 USA.		Russell, David G/D-4533-2009; Russell, David G/N-5280-2019	Russell, David G/0000-0002-9748-750X; Russell, David G/0000-0002-9748-750X					0	4	4	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 10	2013	502	7470					S7	S7		10.1038/502S7a	http://dx.doi.org/10.1038/502S7a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231RU	24108080	Bronze			2022-12-24	WOS:000325436100004
J	Cooper, AL; Kazis, LE; Dore, DD; Mor, V; Trivedi, AN				Cooper, Alicia L.; Kazis, Lewis E.; Dore, David D.; Mor, Vincent; Trivedi, Amal N.			Underreporting High-Risk Prescribing Among Medicare Advantage Plans	ANNALS OF INTERNAL MEDICINE			English	Article							QUALITY-OF-CARE	Background: Although Medicare Advantage plans are required to report clinical performance using Healthcare Effectiveness Data and Information Set (HEDIS) quality indicators, the accuracy of plan-reported performance rates is unknown. Objective: To compare calculated and reported rates of high-risk prescribing among Medicare Advantage plans. Design: Cross-sectional comparison. Setting: 172 Medicare Advantage plans. Patients: A random sample of beneficiaries in 172 Medicare Advantage plans in 2006 (n = 177 227) and 2007 (n = 173 655). Measurements: Plan-reported HEDIS rates of high-risk prescribing among elderly persons were compared with rates calculated from Medicare Advantage plans' Part D claims by using the same measure specifications and source population. Results: The mean rate of high-risk prescribing derived from Part D claims was 26.9% (95% CI, 25.9% to 28.0%), whereas the mean plan-reported rate was 21.1% (CI, 20.0% to 22.3%). Approximately 95% of plans underreported rates of high-risk prescribing relative to calculated rates derived from Part D claims. The differences in the calculated and reported rates negatively affected quality rankings for the plans that most accurately reported rates. For example, the 9 plans that reported rates of high-risk prescribing within 1 percentage point of calculated rates were ranked 43.4 positions lower when reported rates were used instead of calculated rates. Among 103 680 individuals present in both the sample of Part D claims and HEDIS data in 2006, Medicare Advantage plans incorrectly excluded 10.3% as ineligible for the HEDIS high-risk prescribing measure. Among those correctly included in the high-risk prescribing denominator, the reported rate of high-risk prescribing was 21.9% and the calculated rate was 26.2%. Limitation: A single quality measure was assessed. Conclusion: Medicare Advantage plans underreport rates of high-risk prescribing, suggesting a role for routine audits to ensure the validity of publicly reported quality measures. Primary Funding Source: Health Assessment Lab and National Institute on Aging.	Dept Vermont Hlth Access, Williston, VT USA; Brown Univ, Providence Vet Affairs Med Ctr, Providence, RI 02912 USA; [Trivedi, Amal N.] Brown Univ, Dept Hlth Serv Policy & Practice, Providence, RI 02912 USA; Boston Univ, Sch Publ Hlth, Ctr Assessment Pharmaceut Practices, Boston, MA USA; Edith Nourse Rogers Mem Vet Adm Hosp, Vet Affairs Med Ctr, Ctr Hlth Qual Outcomes & Econ Res, Bedford, MA 01730 USA	Brown University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Providence VA Medical Center; Brown University; Boston University; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Trivedi, AN (corresponding author), Brown Univ, Dept Hlth Serv Policy & Practice, Box G-S121-6, Providence, RI 02912 USA.	amal_trivedi@brown.edu		Dore, David/0000-0003-0810-6662	Health Assessment Lab; National Institute on Aging; NATIONAL INSTITUTE ON AGING [RC1AG036158] Funding Source: NIH RePORTER	Health Assessment Lab; National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Health Assessment Lab and National Institute on Aging.	[Anonymous], 2008, HEDIS 2008 PAT LEV D; [Anonymous], 2007, HEDIS 2007 PAT LEV D; [Anonymous], 2008, MED HLTH OUTC SURV 2; [Anonymous], 2008, HOSP QUAL DAT ISS CH; [Anonymous], 2006, HOSP QUAL DAT CMS NE; [Anonymous], 2011, HEDIS COMPL AUD PROG; Berwick DM, 2002, JAMA-J AM MED ASSOC, V288, P1523, DOI 10.1001/jama.288.12.1523; Fung CH, 2008, ANN INTERN MED, V148, P111, DOI 10.7326/0003-4819-148-2-200801150-00006; Health Care Financing Administration US Department of Health and Human Services, 1998, MED HEDIS 3 0 1998 D; Jacobson G, 2011, MEDICARE ADVANTAGE P; Kaiser Family Foundation, 2013, TOT MED ADV MA ENR; Kern LM, 2013, ANN INTERN MED, V158, P77, DOI 10.7326/0003-4819-158-2-201301150-00001; Narins CR, 2005, ARCH INTERN MED, V165, P83, DOI 10.1001/archinte.165.1.83; Pawlson LG, 2007, AM J MANAG CARE, V13, P553; Trivedi AN, 2005, NEW ENGL J MED, V353, P692, DOI 10.1056/NEJMsa051207; Werner RM, 2005, JAMA-J AM MED ASSOC, V293, P1239, DOI 10.1001/jama.293.10.1239; Zhang YT, 2010, NEW ENGL J MED, V363, P1985, DOI 10.1056/NEJMp1010220	17	11	11	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819			ANN INTERN MED	Ann. Intern. Med.	OCT 1	2013	159	7					456	U162		10.7326/0003-4819-159-7-201310010-00005	http://dx.doi.org/10.7326/0003-4819-159-7-201310010-00005			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	234FQ	24081286	Green Accepted			2022-12-24	WOS:000325628000003
J	Hirano, M; Guo, P; McCurley, N; Schorpp, M; Das, S; Boehm, T; Cooper, MD				Hirano, Masayuki; Guo, Peng; McCurley, Nathanael; Schorpp, Michael; Das, Sabyasachi; Boehm, Thomas; Cooper, Max D.			Evolutionary implications of a third lymphocyte lineage in lampreys	NATURE			English	Article							GAMMA-DELTA; ADAPTIVE IMMUNITY; T-CELLS; RECEPTOR; ANTIGEN	Jawed vertebrates (gnathostomes) and jawless vertebrates (cyclostomes) have different adaptive immune systems(1,2). Gnathostomes use T- and B-cell antigen receptors belonging to the immunoglobulin superfamily(3,4). Cyclostomes, the lampreys and hagfish, instead use leucine-rich repeat proteins to construct variable lymphocyte receptors (VLRs), two types of which, VLRA and VLRB, are reciprocally expressed by lymphocytes resembling gnathostome T and B cells(5-7). Here we define another lineage of T-cell-like lymphocytes that express the recently identified VLRC receptors(8,9). Both VLRC+ and VLRA(+) lymphocytes express orthologues of genes that gnathostome gamma delta and alpha beta T cells use for their differentiation, undergo VLRC and VLRA assembly and repertoire diversification in the 'thymoid' gill region, and express their VLRs solely as cell-surface proteins. Our findings suggest that the genetic programmes for two primordial T-cell lineages and a prototypic B-cell lineage were already present in the last common vertebrate ancestor approximately 500 million years ago. We propose that functional specialization of distinct T-cell-like lineages was an ancient feature of a primordial immune system.	[Hirano, Masayuki; Guo, Peng; McCurley, Nathanael; Das, Sabyasachi; Cooper, Max D.] Emory Univ, Emory Vaccine Ctr, Atlanta, GA 30322 USA; [Hirano, Masayuki; Guo, Peng; McCurley, Nathanael; Das, Sabyasachi; Cooper, Max D.] Emory Univ, Dept Pathol & Lab Med, Atlanta, GA 30322 USA; [Schorpp, Michael; Boehm, Thomas] Max Planck Inst Immunobiol & Epigenet, Dept Dev Immunol, D-79108 Freiburg, Germany	Emory University; Emory University; Max Planck Society	Cooper, MD (corresponding author), Emory Univ, Emory Vaccine Ctr, 1462 Clifton Rd North East, Atlanta, GA 30322 USA.	max.cooper@emory.edu		Das, Sabyasachi/0000-0002-9116-9623	National Institutes of Health [R01AI072435, R01GM100151]; Georgia Research Alliance; Max Planck Society; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI072435] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM100151] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Georgia Research Alliance; Max Planck Society(Max Planck Society); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank C. L. Turnbough Jr for providing B. anthracis exosporium, H. Yi for help with electron microscopy, S. A. Durham and R. E. Karaffa II for help with cell sorting, S. Holland for help with gene orthology analysis, Q. Han for help with cloning, and B. R. Herrin, M. Kasahara and Y. Sutoh for suggestions and discussion. M. H., P. G., N.M., S. D. and M. D. C. are supported by National Institutes of Health grants (R01AI072435 and R01GM100151) and the Georgia Research Alliance; M. S. and T. B. are supported by the Max Planck Society.	Alder MN, 2008, NAT IMMUNOL, V9, P319, DOI 10.1038/ni1562; Ariotti S, 2012, P NATL ACAD SCI USA, V109, P19739, DOI 10.1073/pnas.1208927109; Bajoghli B, 2011, NATURE, V470, P90, DOI 10.1038/nature09655; Boehm T, 2012, ANNU REV IMMUNOL, V30, P203, DOI 10.1146/annurev-immunol-020711-075038; Das S, 2013, P NATL ACAD SCI USA, V110, P6043, DOI 10.1073/pnas.1302500110; DAVIS MM, 1988, NATURE, V334, P395, DOI 10.1038/334395a0; Flajnik MF, 2010, NAT REV GENET, V11, P47, DOI 10.1038/nrg2703; Guo P, 2009, NATURE, V459, P796, DOI 10.1038/nature08068; Herrin BR, 2008, P NATL ACAD SCI USA, V105, P2040, DOI 10.1073/pnas.0711619105; Hirano M, 2011, ADV IMMUNOL, V109, P125, DOI 10.1016/B978-0-12-387664-5.00004-2; Kasamatsu J, 2010, P NATL ACAD SCI USA, V107, P14304, DOI 10.1073/pnas.1001910107; Litman GW, 2010, NAT REV IMMUNOL, V10, P543, DOI 10.1038/nri2807; Melichar HJ, 2007, SCIENCE, V315, P230, DOI 10.1126/science.1135344; NAKAJIMA S, 1995, J IMMUNOL, V155, P1117; Rothenberg EV, 2008, NAT REV IMMUNOL, V8, P9, DOI 10.1038/nri2232; Smith JJ, 2013, NAT GENET, V45, P415, DOI 10.1038/ng.2568; TONEGAWA S, 1983, NATURE, V302, P575, DOI 10.1038/302575a0; Vantourout P, 2013, NAT REV IMMUNOL, V13, P88, DOI 10.1038/nri3384; Wesch D, 2006, J IMMUNOL, V176, P1348, DOI 10.4049/jimmunol.176.3.1348; Wesch D, 2011, CELL MOL LIFE SCI, V68, P2357, DOI 10.1007/s00018-011-0699-1; Wilson KC, 2004, GROWTH FACTORS, V22, P97, DOI 10.1080/08977190410001704679	21	156	159	2	39	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 19	2013	501	7467					435	+		10.1038/nature12467	http://dx.doi.org/10.1038/nature12467			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219XT	23934109	Green Accepted			2022-12-24	WOS:000324545700049
J	Marx, V				Marx, Vivien			THE GENOME JIGSAW	NATURE			English	Editorial Material							EVOLUTION; SEQUENCE											Bradnam KR, 2013, GIGASCIENCE, V2, DOI 10.1186/2047-217X-2-10; Kirby A, 2013, NAT GENET, V45, P299, DOI 10.1038/ng.2543; Loomis EW, 2013, GENOME RES, V23, P121, DOI 10.1101/gr.141705.112; Nystedt B, 2013, NATURE, V497, P579, DOI 10.1038/nature12211; Parkhill J, 2003, NAT GENET, V35, P32, DOI 10.1038/ng1227; Schatz MC, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-4-243; Shendure J, 2012, NAT BIOTECHNOL, V30, P1084, DOI 10.1038/nbt.2421; Shulaev V, 2011, NAT GENET, V43, P109, DOI 10.1038/ng.740; Singh R, 2013, NATURE, V500, P335, DOI 10.1038/nature12309; Smith JJ, 2013, NAT GENET, V45, P415, DOI 10.1038/ng.2568	10	34	37	0	34	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 12	2013	501	7466					263	268		10.1038/501261a	http://dx.doi.org/10.1038/501261a			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	215XR	24025842	Bronze			2022-12-24	WOS:000324244900052
J	Graven, HD; Keeling, RF; Piper, SC; Patra, PK; Stephens, BB; Wofsy, SC; Welp, LR; Sweeney, C; Tans, PP; Kelley, JJ; Daube, BC; Kort, EA; Santoni, GW; Bent, JD				Graven, H. D.; Keeling, R. F.; Piper, S. C.; Patra, P. K.; Stephens, B. B.; Wofsy, S. C.; Welp, L. R.; Sweeney, C.; Tans, P. P.; Kelley, J. J.; Daube, B. C.; Kort, E. A.; Santoni, G. W.; Bent, J. D.			Enhanced Seasonal Exchange of CO2 by Northern Ecosystems Since 1960	SCIENCE			English	Article							ATMOSPHERIC CO2; AMPLITUDE INCREASE; CARBON-DIOXIDE; PLANT-GROWTH; MAUNA-LOA; VEGETATION; CLIMATE; TRENDS; ALASKA; BALANCE	Seasonal variations of atmospheric carbon dioxide (CO2) in the Northern Hemisphere have increased since the 1950s, but sparse observations have prevented a clear assessment of the patterns of long-term change and the underlying mechanisms. We compare recent aircraft-based observations of CO2 above the North Pacific and Arctic Oceans to earlier data from 1958 to 1961 and find that the seasonal amplitude at altitudes of 3 to 6 km increased by 50% for 45 degrees to 90 degrees N but by less than 25% for 10 degrees to 45 degrees N. An increase of 30 to 60% in the seasonal exchange of CO2 by northern extratropical land ecosystems, focused on boreal forests, is implicated, substantially more than simulated by current land ecosystem models. The observations appear to signal large ecological changes in northern forests and a major shift in the global carbon cycle.	[Graven, H. D.; Keeling, R. F.; Piper, S. C.; Welp, L. R.; Bent, J. D.] Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA; [Patra, P. K.] Res Inst Global Change, Yokohama, Kanagawa, Japan; [Stephens, B. B.] Natl Ctr Atmospher Res, Boulder, CO 80307 USA; [Wofsy, S. C.; Daube, B. C.; Santoni, G. W.] Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA; [Sweeney, C.; Tans, P. P.] NOAA, Boulder, CO USA; [Kelley, J. J.] Univ Alaska, Inst Marine Sci, Fairbanks, AK 99775 USA; [Kort, E. A.] CALTECH, Jet Prop Lab, Pasadena, CA USA	University of California System; University of California San Diego; Scripps Institution of Oceanography; Japan Agency for Marine-Earth Science & Technology (JAMSTEC); National Center Atmospheric Research (NCAR) - USA; Harvard University; National Oceanic Atmospheric Admin (NOAA) - USA; University of Alaska System; University of Alaska Fairbanks; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL)	Graven, HD (corresponding author), Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA.	hgraven@ucsd.edu	Kort, Eric A/F-9942-2012; Sweeney, Colm/AAE-9291-2019; Stephens, Britton B/B-7962-2008; Tans, Pieter/AAG-8273-2019; Patra, Prabir/B-5206-2009	Kort, Eric A/0000-0003-4940-7541; Stephens, Britton B/0000-0002-1966-6182; Tans, Pieter/0000-0002-9883-0787; Patra, Prabir/0000-0001-5700-9389; Sweeney, Colm/0000-0002-4517-0797; Graven, Heather/0000-0003-3934-2502; Welp, Lisa/0000-0001-7125-0478	DOE [DE-SC0005090]; NSF [ATM-0628575, ATM-0628519, ATM-0628388, ATM-0628452, ATM-1036399]; National Center for Atmospheric Research (NCAR); NASA [NNX11AF36G]; U.S. Navy/Office of Naval Research [N00014-67-A-0103-0007]; NSF; Ministry of Education, Culture, Sports, Science and Technology Green Network of Excellence program; Environmental Protection Agency's Science to Achieve Results program	DOE(United States Department of Energy (DOE)); NSF(National Science Foundation (NSF)); National Center for Atmospheric Research (NCAR)(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO)); NASA(National Aeronautics & Space Administration (NASA)); U.S. Navy/Office of Naval Research(Office of Naval Research); NSF(National Science Foundation (NSF)); Ministry of Education, Culture, Sports, Science and Technology Green Network of Excellence program(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Environmental Protection Agency's Science to Achieve Results program	The Scripps CO<INF>2</INF> Program is supported by DOE grant DE-SC0005090. HIPPO was supported by NSF grants ATM-0628575, ATM-0628519, ATM-0628388, ATM-0628452, and ATM-1036399, and by the National Center for Atmospheric Research (NCAR). Recovery and updating of early aircraft, MLO, and BRW data was supported by NSF grant ATM-1036399. L. R. W. was supported by NASA award NNX11AF36G. Early observations at BRW were funded by U.S. Navy/Office of Naval Research contract N00014-67-A-0103-0007. Online access to all observational data is summarized in section SM10 of the supplementary materials. NCAR is supported by the NSF. Any opinions, findings, and conclusions or recommendations expressed in this material are those of the authors and do not necessarily reflect the views of NOAA, NSF, DOE or NASA. We thank the HIPPO science team and the crew and support staff at the NCAR Research Aviation Facility. We acknowledge the World Climate Research Programme's Working Group on Coupled Modelling, which is responsible for CMIP, and we thank the climate modeling groups for producing and making available their model output. Support of the CMIP data sets is provided by the Office of Science, U.S. Department of Energy. C. Roedenbeck provided assistance with the TM3 model. P. K. P. is partially supported by the Ministry of Education, Culture, Sports, Science and Technology Green Network of Excellence program. G. W. S. acknowledges support from the NSF Graduate Research Fellowship Program and the Environmental Protection Agency's Science to Achieve Results program.	BACASTOW RB, 1985, J GEOPHYS RES-ATMOS, V90, P10529, DOI 10.1029/JD090iD06p10529; BISCHOF W, 1966, TELLUS, V18, P155; Elmendorf SC, 2012, NAT CLIM CHANGE, V2, P453, DOI 10.1038/NCLIMATE1465; FRA, 2010, GLOB FOR RES ASS 201; Goetz SJ, 2005, P NATL ACAD SCI USA, V102, P13521, DOI 10.1073/pnas.0506179102; Gurney KR, 2011, TELLUS B, V63, P328, DOI 10.1111/j.1600-0889.2011.00534.x; Gurney KR, 2002, NATURE, V415, P626, DOI 10.1038/415626a; Hansen J, 2010, REV GEOPHYS, V48, DOI 10.1029/2010RG000345; Heimann M, 1989, ASPECTS CLIMATE VARI, V55, P277; HOUGHTON RA, 1987, J GEOPHYS RES-ATMOS, V92, P4223, DOI 10.1029/JD092iD04p04223; Hurtt GC, 2011, CLIMATIC CHANGE, V109, P117, DOI 10.1007/s10584-011-0153-2; Jones PD, 2012, J GEOPHYS RES-ATMOS, V117, DOI 10.1029/2011JD017139; Kasischke ES, 2010, CAN J FOREST RES, V40, P1313, DOI 10.1139/X10-098; KEELING CD, 1960, TELLUS, V12, P200, DOI 10.1111/j.2153-3490.1960.tb01300.x; KEELING CD, 1968, J GEOPHYS RES, V73, P4511, DOI 10.1029/JB073i014p04511; Keeling CD, 1996, NATURE, V382, P146, DOI 10.1038/382146a0; Keeling CD, 2011, TELLUS B, V63, P1, DOI 10.1111/j.1600-0889.2010.00507.x; Keeling R.F., 2009, ATMOSPHERIC CO2 RECO; Kelley J. J., 1969, ANAL CARBON DIOXIDE; Kohlmaier GH, 1989, TELLUS B, V41, P487, DOI 10.1111/j.1600-0889.1989.tb00137.x; McGuire AD, 2001, GLOBAL BIOGEOCHEM CY, V15, P183, DOI 10.1029/2000GB001298; Myneni RB, 1997, NATURE, V386, P698, DOI 10.1038/386698a0; Norby RJ, 2005, P NATL ACAD SCI USA, V102, P18052, DOI 10.1073/pnas.0509478102; Pan YD, 2011, SCIENCE, V333, P988, DOI 10.1126/science.1201609; Patra PK, 2011, ATMOS CHEM PHYS, V11, P4163, DOI [10.5194/acp-11-4163-2011, 10.5194/acp-11-12813-2011]; PEARMAN GI, 1981, J GEOPHYS RES-OCEANS, V86, P9839, DOI 10.1029/JC086iC10p09839; Phillips OL, 2009, SCIENCE, V323, P1344, DOI 10.1126/science.1164033; Randerson JT, 1997, GLOBAL BIOGEOCHEM CY, V11, P535, DOI 10.1029/97GB02268; Rodenbeck C, 2003, TELLUS B, V55, P488, DOI 10.1034/j.1600-0889.2003.00033.x; Rustad LE, 2001, OECOLOGIA, V126, P543, DOI 10.1007/s004420000544; Schaefer K, 2012, J GEOPHYS RES-BIOGEO, V117, DOI 10.1029/2012JG001960; Soja AJ, 2007, GLOBAL PLANET CHANGE, V56, P274, DOI 10.1016/j.gloplacha.2006.07.028; Stephens BB, 2007, SCIENCE, V316, P1732, DOI 10.1126/science.1137004; TANS PP, 1990, SCIENCE, V247, P1431, DOI 10.1126/science.247.4949.1431; Tape K, 2006, GLOBAL CHANGE BIOL, V12, P686, DOI 10.1111/j.1365-2486.2006.01128.x; Taylor KE, 2012, B AM METEOROL SOC, V93, P485, DOI 10.1175/BAMS-D-11-00094.1; Thoning KW, 2012, ATMOSPHERIC CARBON D; Thornton PE, 2007, GLOBAL BIOGEOCHEM CY, V21, DOI 10.1029/2006GB002868; Verbyla D, 2008, GLOBAL ECOL BIOGEOGR, V17, P547, DOI 10.1111/j.1466-8238.2008.00396.x; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; Welp LR, 2006, J GEOPHYS RES-BIOGEO, V111, DOI 10.1029/2005JG000126; Wofsy SC, 2011, PHILOS T R SOC A, V369, P2073, DOI 10.1098/rsta.2010.0313; Zimov SA, 1996, CLIMATIC CHANGE, V33, P111, DOI 10.1007/BF00140516; Zimov SA, 1999, SCIENCE, V284, P1973, DOI 10.1126/science.284.5422.1973	44	260	263	12	328	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 6	2013	341	6150					1085	1089		10.1126/science.1239207	http://dx.doi.org/10.1126/science.1239207			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	211TG	23929948				2022-12-24	WOS:000323933100037
J	Bombard, Y; Robson, M; Offit, K				Bombard, Yvonne; Robson, Mark; Offit, Kenneth			Revealing the Incidentalome When Targeting the Tumor Genome	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							PATIENT AUTONOMY; RISKS; DUTY; WARN		[Bombard, Yvonne; Robson, Mark; Offit, Kenneth] Mem Sloan Kettering Canc Ctr, Clin Genet Serv, Dept Med, New York, NY 10021 USA; [Bombard, Yvonne] Mem Sloan Kettering Canc Ctr, Ctr Hlth Policy & Outcomes, Dept Epidemiol & Biostat, New York, NY 10021 USA; [Bombard, Yvonne] Yale Univ, Dept Epidemiol & Publ Hlth, Sch Publ Hlth, New Haven, CT 06520 USA; [Robson, Mark] Weill Cornell Med Coll, Dept Med, New York, NY USA; [Offit, Kenneth] Weill Cornell Med Coll, Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst, Canc Biol & Genet Program,Dept Med, New York, NY USA; [Offit, Kenneth] Weill Cornell Med Coll, Dept Publ Hlth, New York, NY USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Yale University; Cornell University; Cornell University; Memorial Sloan Kettering Cancer Center; Cornell University	Offit, K (corresponding author), Mem Sloan Kettering Canc Ctr, Clin Genet Serv, 222 E 70th St, New York, NY 10021 USA.	offitk@mskcc.org		Robson, Mark/0000-0002-3109-1692	CIHR Funding Source: Medline; NCATS NIH HHS [UL1 TR000457] Funding Source: Medline; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000457] Funding Source: NIH RePORTER	CIHR(Canadian Institutes of Health Research (CIHR)); NCATS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))		Bombard Y, 2013, EUR J HUM GENET; Bombard Y, 2012, AM J BIOETHICS, V12, P12, DOI 10.1080/15265161.2012.699157; Goddard KAB, 2013, GENET MED, V15, P721, DOI 10.1038/gim.2013.37; Green RC, 2013, GENET MED, V15, P565, DOI 10.1038/gim.2013.73; Klitzman R, 2013, JAMA-J AM MED ASSOC, V310, P369, DOI 10.1001/jama.2013.41709; Offit K, 2004, JAMA-J AM MED ASSOC, V292, P1469, DOI 10.1001/jama.292.12.1469; Pasche B, 2011, JAMA-J AM MED ASSOC, V305, P1596, DOI 10.1001/jama.2011.484; Ross LF, 2013, JAMA-J AM MED ASSOC, V310, P367, DOI 10.1001/jama.2013.41700	8	47	47	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 28	2013	310	8					795	796		10.1001/jama.2013.276573	http://dx.doi.org/10.1001/jama.2013.276573			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	206YA	23982363	Green Accepted			2022-12-24	WOS:000323561400015
J	Ferner, R				Ferner, Robin			A bee in the bonnet about honey and healing	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Birmingham City Hosp, West Midlands Ctr Adverse Drug React, Birmingham B18 7QH, W Midlands, England		Ferner, R (corresponding author), Birmingham City Hosp, West Midlands Ctr Adverse Drug React, Birmingham B18 7QH, W Midlands, England.	R.E.Ferner@bham.ac.uk		Ferner, Robin/0000-0003-3769-1346				Bayram NA, 2012, J EMERG MED, V43, pE389, DOI 10.1016/j.jemermed.2011.02.021; Dat AD, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008762.pub2; Dumville JC, 2013, COCHRANE DB SYST REV, V6, DOI DOI 10.1002/14651858.CD009110.PUB3; Dumville JC, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009111.pub3; Dumville JC, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009099.pub2; Gamgee JS., 1861, BRIT MED J, V1, P211; Gamgee JS., 1857, BRIT MED J; Jull AB, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005083.pub3; Kapadia HM, 2002, J ROY SOC MED, V95, P96, DOI 10.1258/jrsm.95.2.96; Nelson EA, 2007, COCHRANE DB SYST REV, V1; Smith MEB, 2013, ANN INTERN MED, V159, P39, DOI 10.7326/0003-4819-159-1-201307020-00007; Storm-Versloot MN, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006478.pub2; Vermeulen H, 2004, COCHRANE DB SYST REV, V2, pCD003554; Vermeulen H, 2007, COCHRANE DB SYST REV, V1, DOI DOI 10.1002/14651858.CD005486.PUB.2	14	0	0	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 15	2013	347								f5015	10.1136/bmj.f5015	http://dx.doi.org/10.1136/bmj.f5015			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	203ZD	23950196				2022-12-24	WOS:000323332700002
J	Simons, M; Eichmann, A				Simons, Michael; Eichmann, Anne			Lymphatics Are in My Veins	SCIENCE			English	Editorial Material							VASCULATURE; PROX1; DIFFERENTIATION; MATURATION; VESSELS		[Simons, Michael; Eichmann, Anne] Yale Univ, Sch Med, Yale Cardiovasc Res Ctr, New Haven, CT 06510 USA; [Simons, Michael] Yale Univ, Sch Med, Dept Cell Biol, New Haven, CT 06510 USA; [Eichmann, Anne] Yale Univ, Sch Med, Dept Cellular & Mol Physiol, New Haven, CT 06510 USA; [Eichmann, Anne] Coll France, Ctr Interdisciplinary Res Biol, Inserm 1050, F-75231 Paris, France	Yale University; Yale University; Yale University; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; College de France	Simons, M (corresponding author), Yale Univ, Sch Med, Yale Cardiovasc Res Ctr, 333 Cedar St, New Haven, CT 06510 USA.	michael.simons@yale.edu	Simons, Michael/G-8553-2014	Simons, Michael/0000-0003-0348-7734	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL111504] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL111504] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Alitalo K, 2011, NAT MED, V17, P1371, DOI 10.1038/nm.2545; [Anonymous], 2013, YAL N AM VASC BIOL O; Chen CY, 2012, J CLIN INVEST, V122, P2006, DOI 10.1172/JCI57513; Covassin LD, 2006, P NATL ACAD SCI USA, V103, P6554, DOI 10.1073/pnas.0506886103; Deng Y, 2013, J CLIN INVEST, V123, P1202, DOI 10.1172/JCI63034; Francois M, 2008, NATURE, V456, P643, DOI 10.1038/nature07391; Johnson NC, 2008, GENE DEV, V22, P3282, DOI 10.1101/gad.1727208; Koltowska K, 2013, DEVELOPMENT, V140, P1857, DOI 10.1242/dev.089565; Larrivee B, 2012, DEV CELL, V22, P489, DOI 10.1016/j.devcel.2012.02.005; Levet S, 2013, BLOOD, V122, P598, DOI 10.1182/blood-2012-12-472142; Mouta-Bellum C, 2009, DEV DYNAM, V238, P2670, DOI 10.1002/dvdy.22078; Murtomaki A, 2013, DEVELOPMENT, V140, P2365, DOI 10.1242/dev.083865; Niessen K, 2010, BLOOD, V115, P1654, DOI 10.1182/blood-2009-07-235655; Sabine A, 2012, DEV CELL, V22, P430, DOI 10.1016/j.devcel.2011.12.020; Tammela T, 2007, NAT MED, V13, P1458, DOI 10.1038/nm1689; Tammela T, 2011, NAT CELL BIOL, V13, P1202, DOI 10.1038/ncb2331; Wigle JT, 1999, CELL, V98, P769, DOI 10.1016/S0092-8674(00)81511-1; Wiig H, 2013, J CLIN INVEST, V123, P2803, DOI 10.1172/JCI60113; Wiley DM, 2011, NAT CELL BIOL, V13, P686, DOI 10.1038/ncb2232	19	12	12	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 9	2013	341	6146					622	624		10.1126/science.1243452	http://dx.doi.org/10.1126/science.1243452			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	197XC	23929973	Green Accepted			2022-12-24	WOS:000322884800026
J	Sugarman, J				Sugarman, Jeremy			HIV Cure Research: Expanding the Ethical Considerations	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							TRIALS		[Sugarman, Jeremy] Johns Hopkins Univ, Sch Med, Berman Inst Bioeth, Baltimore, MD USA; [Sugarman, Jeremy] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Sugarman, J (corresponding author), Johns Hopkins Berman Inst Bioeth, 1809 Ashland Ave, Baltimore, MD 21205 USA.	jsugarman@jhu.edu		Sugarman, Jeremy/0000-0001-7022-8332	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [UM1AI068619, U01AI068619, P30AI094189] Funding Source: NIH RePORTER; NIAID NIH HHS [P30 AI094189, UM1 AI068619] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Deeks SG, 2012, NAT REV IMMUNOL, V12, P607, DOI 10.1038/nri3262; Henderson GE, 2006, SOC SCI MED, V62, P239, DOI 10.1016/j.socscimed.2005.05.022; Hutter G, 2009, NEW ENGL J MED, V360, P692, DOI 10.1056/NEJMoa0802905; Lo B, 2013, CURR OPIN HIV AIDS, V8, P243, DOI 10.1097/COH.0b013e32835ea1c5; McNeil DG, 2013, NY TIMES, pA10; Pollack A., 2013, NY TIMES; Ryan B., 2013, MISLEADING NEWS REPO; Saez-Cirion A, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003211; Wilson JM, 2009, MOL GENET METAB, V96, P151, DOI 10.1016/j.ymgme.2008.12.016; Woodsong C, 2005, AM J PUBLIC HEALTH, V95, P412, DOI 10.2105/AJPH.2004.041624	10	26	26	0	9	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819			ANN INTERN MED	Ann. Intern. Med.	OCT 1	2013	159	7					490	U104		10.7326/00030003-4819-159-7-201310010-00694	http://dx.doi.org/10.7326/00030003-4819-159-7-201310010-00694			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	234FQ	23938938				2022-12-24	WOS:000325628000007
J	Dejosez, M; Ura, H; Brandt, VL; Zwaka, TP				Dejosez, Marion; Ura, Hiroki; Brandt, Vicky L.; Zwaka, Thomas P.			Safeguards for Cell Cooperation in Mouse Embryogenesis Shown by Genome-Wide Cheater Screen	SCIENCE			English	Article							STEM; MUTANTS; MULTICELLULARITY; TRANSITION; EVOLUTION; DEATH	Ensuring cooperation among formerly autonomous cells has been a central challenge in the evolution of multicellular organisms. One solution is monoclonality, but this option still leaves room for exploitative behavior, as it does not eliminate genetic and epigenetic variability. We therefore hypothesized that embryonic development must be protected by robust regulatory mechanisms that prevent aberrant clones from superseding wild-type cells. Using a genome-wide screen in murine induced pluripotent stem cells, we identified a network of genes (centered on p53, topoisomerase 1, and olfactory receptors) whose down-regulation caused the cells to replace wild-type cells in vitro and in the mouse embryo-without perturbing normal development. These genes thus appear to fulfill an unexpected role in fostering cell cooperation.	[Dejosez, Marion; Brandt, Vicky L.; Zwaka, Thomas P.] Icahn Sch Med Mt Sinai, Black Family Stem Cell Inst, New York, NY 10029 USA; [Dejosez, Marion; Zwaka, Thomas P.] Icahn Sch Med Mt Sinai, Dept Dev & Regenerat Med, New York, NY 10029 USA; [Dejosez, Marion; Ura, Hiroki; Zwaka, Thomas P.] Baylor Coll Med, Houston, TX 77030 USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Baylor College of Medicine	Zwaka, TP (corresponding author), Icahn Sch Med Mt Sinai, Black Family Stem Cell Inst, New York, NY 10029 USA.	thomas.zwaka@mssm.edu	Brandt, Vicky L/J-5202-2014; Ura, Hiroki/ABD-8427-2020	Ura, Hiroki/0000-0002-7600-3481; Brandt, Vicky/0000-0002-5512-3724	Huffington Foundation; NIH [R01 GM077442, P01 GM81627]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM081627, R01GM077442] Funding Source: NIH RePORTER	Huffington Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank G. Shaulsky and J. Gilbert for helpful discussions and experimental suggestions. We thank K. Hochedlinger for providing the Oct4-GFP iPSCs. The work was funded by the Huffington Foundation and by the NIH (grants R01 GM077442 and P01 GM81627). Microarray data have been deposited at Gene Expression Omnibus (GSE49814).	Alvarado AS, 2005, EXP CELL RES, V306, P299, DOI 10.1016/j.yexcr.2005.03.020; ARMSTRONG JF, 1995, CURR BIOL, V5, P931, DOI 10.1016/S0960-9822(95)00183-7; Bondar T, 2010, CELL STEM CELL, V6, P309, DOI 10.1016/j.stem.2010.03.002; Buckley CD, 2005, CELL IMMUNOL, V236, P29, DOI 10.1016/j.cellimm.2005.08.027; Crighton D, 2006, CELL, V126, P121, DOI 10.1016/j.cell.2006.05.034; de la Cova C, 2004, CELL, V117, P107, DOI 10.1016/S0092-8674(04)00214-4; Dreyer WJ, 1998, P NATL ACAD SCI USA, V95, P9072, DOI 10.1073/pnas.95.16.9072; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; Fiegna F, 2006, NATURE, V441, P310, DOI 10.1038/nature04677; Foster KR, 2004, NATURE, V431, P693, DOI 10.1038/nature02894; HAGEN DC, 1978, DEV BIOL, V64, P284, DOI 10.1016/0012-1606(78)90079-9; Hanna JH, 2010, CELL, V143, P508, DOI 10.1016/j.cell.2010.10.008; Johnston LA, 2009, SCIENCE, V324, P1679, DOI 10.1126/science.1163862; KELLER GM, 1995, CURR OPIN CELL BIOL, V7, P862, DOI 10.1016/0955-0674(95)80071-9; Khare A, 2006, NAT REV GENET, V7, P577, DOI 10.1038/nrg1875; MARTIN GR, 1981, P NATL ACAD SCI-BIOL, V78, P7634, DOI 10.1073/pnas.78.12.7634; Marusyk A, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000324; Michod RE, 2007, P NATL ACAD SCI USA, V104, P8613, DOI 10.1073/pnas.0701489104; MORATA G, 1975, DEV BIOL, V42, P211, DOI 10.1016/0012-1606(75)90330-9; Morham SG, 1996, MOL CELL BIOL, V16, P6804; Pankow S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000782; Pfeiffer T, 2003, P NATL ACAD SCI USA, V100, P1095, DOI 10.1073/pnas.0335420100; Rokas A, 2008, ANNU REV GENET, V42, P235, DOI 10.1146/annurev.genet.42.110807.091513; SAH VP, 1995, NAT GENET, V10, P175, DOI 10.1038/ng0695-175; Santorelli LA, 2008, NATURE, V451, P1107, DOI 10.1038/nature06558; Stadtfeld M, 2010, NATURE, V465, P175, DOI 10.1038/nature09017; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024	27	51	53	0	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 27	2013	341	6153					1511	1514		10.1126/science.1241628	http://dx.doi.org/10.1126/science.1241628			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	224NS	24030493				2022-12-24	WOS:000324894600050
J	Ong, CT; Van Bortle, K; Ramos, E; Corces, VG				Ong, Chin-Tong; Van Bortle, Kevin; Ramos, Edward; Corces, Victor G.			Poly(ADP-ribosyl)ation Regulates Insulator Function and Intrachromosomal Interactions in Drosophila	CELL			English	Article							GYPSY CHROMATIN INSULATOR; CCCTC-BINDING-FACTOR; NUCLEAR-ORGANIZATION; INTERACTIONS REVEALS; LINEAGE COMMITMENT; BITHORAX COMPLEX; ELEMENTS MEDIATE; GENE-EXPRESSION; CTCF-BINDING; HUMAN GENOME	Insulators mediate inter- and intrachromosomal contacts to regulate enhancer-promoter interactions and establish chromosome domains. The mechanisms by which insulator activity can be regulated to orchestrate changes in the function and three-dimensional arrangement of the genome remain elusive. Here, we demonstrate that Drosophila insulator proteins are poly(ADP-ribosyl)ated and that mutation of the poly(ADP-ribose) polymerase (Parp) gene impairs their function. This modification is not essential for DNA occupancy of insulator DNA-binding proteins dCTCF and Su(Hw). However, poly(ADP-ribosyl)ation of K566 in CP190 promotes protein-protein interactions with other insulator proteins, association with the nuclear lamina, and insulator activity in vivo. Consistent with these findings, the nuclear clustering of CP190 complexes is disrupted in Parp mutant cells. Importantly, poly(ADP-ribosyl)ation facilitates intrachromosomal interactions between insulator sites measured by 4C. These data suggest that the role of insulators in organizing the three-dimensional architecture of the genome may be modulated by poly(ADP-ribosyl)ation.	[Ong, Chin-Tong; Van Bortle, Kevin; Ramos, Edward; Corces, Victor G.] Emory Univ, Dept Biol, Atlanta, GA 30322 USA	Emory University	Corces, VG (corresponding author), Emory Univ, Dept Biol, 1510 Clifton Rd NE, Atlanta, GA 30322 USA.	vcorces@emory.edu		Ong, Chin-Tong/0000-0002-5450-4760; Corces, Victor/0000-0001-5140-4337	U.S. Public Health Service Award from National Institutes of Health [R01GM035463]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM035463] Funding Source: NIH RePORTER	U.S. Public Health Service Award from National Institutes of Health; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We would like to thank the Genomic Services Lab at the HudsonAlpha Institute for Biotechnology for their help in performing Illumina sequencing of ChIP-seq samples. This work was supported by U.S. Public Health Service Award R01GM035463 from the National Institutes of Health. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ahel I, 2008, NATURE, V451, P81, DOI 10.1038/nature06420; Barges S, 2000, DEVELOPMENT, V127, P779; Bushey AM, 2009, GENE DEV, V23, P1338, DOI 10.1101/gad.1798209; Capelson M, 2005, MOL CELL, V20, P105, DOI 10.1016/j.molcel.2005.08.031; Capelson M, 2006, EMBO J, V25, P1906, DOI 10.1038/sj.emboj.7601068; Chou DM, 2010, P NATL ACAD SCI USA, V107, P18475, DOI 10.1073/pnas.1012946107; Dixon JR, 2012, NATURE, V485, P376, DOI 10.1038/nature11082; El-Kady A, 2005, FEBS LETT, V579, P1424, DOI 10.1016/j.febslet.2005.01.044; Farrar D, 2010, MOL CELL BIOL, V30, P1199, DOI 10.1128/MCB.00827-09; Gerasimova TI, 2007, MOL CELL, V28, P761, DOI 10.1016/j.molcel.2007.09.024; Gerasimova TI, 2000, MOL CELL, V6, P1025, DOI 10.1016/S1097-2765(00)00101-5; Gondor A, 2008, NAT PROTOC, V3, P303, DOI 10.1038/nprot.2007.540; Guo CG, 2011, NATURE, V477, P424, DOI 10.1038/nature10495; Guo Y, 2012, P NATL ACAD SCI USA, V109, P21081, DOI 10.1073/pnas.1219280110; Hagege H, 2007, NAT PROTOC, V2, P1722, DOI 10.1038/nprot.2007.243; Hou CH, 2012, MOL CELL, V48, P471, DOI 10.1016/j.molcel.2012.08.031; Kallappagoudar S, 2010, MOL CELL PROTEOMICS, V9, P2005, DOI 10.1074/mcp.M110.001362; Kharchenko PV, 2011, NATURE, V471, P480, DOI 10.1038/nature09725; Kotova E, 2010, P NATL ACAD SCI USA, V107, P6406, DOI 10.1073/pnas.0914152107; Krishnakumar R, 2008, SCIENCE, V319, P819, DOI 10.1126/science.1149250; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lanzuolo C, 2007, NAT CELL BIOL, V9, P1167, DOI 10.1038/ncb1637; Lei EP, 2006, NAT GENET, V38, P936, DOI 10.1038/ng1850; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Lin YC, 2012, NAT IMMUNOL, V13, P1196, DOI 10.1038/ni.2432; Liu Z, 2011, CELL, V146, P720, DOI 10.1016/j.cell.2011.08.005; MacPherson MJ, 2009, MOL CELL BIOL, V29, P714, DOI 10.1128/MCB.00825-08; Merkenschlager M, 2013, CELL, V152, P1285, DOI 10.1016/j.cell.2013.02.029; Mohan M, 2007, EMBO J, V26, P4203, DOI 10.1038/sj.emboj.7601851; Monahan K, 2012, P NATL ACAD SCI USA, V109, P9125, DOI 10.1073/pnas.1205074109; Nora EP, 2012, NATURE, V485, P381, DOI 10.1038/nature11049; O'Connor M, 1993, Methods Mol Biol, V18, P75, DOI 10.1385/0-89603-245-0:75; Pai CY, 2004, MOL CELL, V16, P737, DOI 10.1016/j.molcel.2004.11.004; Parelho V, 2008, CELL, V132, P422, DOI 10.1016/j.cell.2008.01.011; Petesch SJ, 2012, MOL CELL, V45, P64, DOI 10.1016/j.molcel.2011.11.015; Phillips-Cremins JE, 2013, CELL, V153, P1281, DOI 10.1016/j.cell.2013.04.053; Phillips-Cremins JE, 2013, MOL CELL, V50, P461, DOI 10.1016/j.molcel.2013.04.018; Raab JR, 2012, EMBO J, V31, P330, DOI 10.1038/emboj.2011.406; Rubio ED, 2008, P NATL ACAD SCI USA, V105, P8309, DOI 10.1073/pnas.0801273105; Schwartz YB, 2012, GENOME RES, V22, P2188, DOI 10.1101/gr.138156.112; Sexton T, 2012, CELL, V148, P458, DOI 10.1016/j.cell.2012.01.010; Stedman W, 2008, EMBO J, V27, P654, DOI 10.1038/emboj.2008.1; van Bortle K, 2012, TRANSCR-AUSTIN, V3, P277, DOI 10.4161/trns.21579; Van Bortle K, 2013, CURR OPIN GENET DEV, V23, P212, DOI 10.1016/j.gde.2012.11.003; Van Bortle K, 2012, GENOME RES, V22, P2176, DOI 10.1101/gr.136788.111; Vidakovic M, 2004, J CELL BIOCHEM, V93, P1155, DOI 10.1002/jcb.20289; Wendt KS, 2008, NATURE, V451, P796, DOI 10.1038/nature06634; Witcher M, 2009, MOL CELL, V34, P271, DOI 10.1016/j.molcel.2009.04.001; Wood AM, 2011, MOL CELL, V44, P29, DOI 10.1016/j.molcel.2011.07.035; Xu ZX, 2011, NAT STRUCT MOL BIOL, V18, P372, DOI 10.1038/nsmb.1993; Yu WQ, 2004, NAT GENET, V36, P1105, DOI 10.1038/ng1426; Yusufzai TM, 2004, MOL CELL, V13, P291, DOI 10.1016/S1097-2765(04)00029-2; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	53	57	57	0	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 26	2013	155	1					148	159		10.1016/j.cell.2013.08.052	http://dx.doi.org/10.1016/j.cell.2013.08.052			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	224UX	24055367	Bronze, Green Accepted			2022-12-24	WOS:000324916700016
J	Diringer, E				Diringer, Elliot			A patchwork of emissions cuts	NATURE			English	Editorial Material									Ctr Climate & Energy Solut C2ES, Arlington, VA USA		Diringer, E (corresponding author), Ctr Climate & Energy Solut C2ES, Arlington, VA USA.	diringere@c2es.org							0	12	13	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 19	2013	501	7467					307	309		10.1038/501307a	http://dx.doi.org/10.1038/501307a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	219XT	24058934	Bronze			2022-12-24	WOS:000324545700014
J	Li, S; Zhang, L; Yao, Q; Li, L; Dong, N; Rong, J; Gao, WQ; Ding, XJ; Sun, LM; Chen, X; Chen, S; Shao, F				Li, Shan; Zhang, Li; Yao, Qing; Li, Lin; Dong, Na; Rong, Jie; Gao, Wenqing; Ding, Xiaojun; Sun, Liming; Chen, Xing; Chen, She; Shao, Feng			Pathogen blocks host death receptor signalling by arginine GlcNAcylation of death domains	NATURE			English	Article							NECROSIS-FACTOR RECEPTOR; BACTERIAL EFFECTOR; PROTEIN; TRADD; SUPERFAMILY; NLEB; COLONIZATION; INHIBITION; PATHWAYS	The tumour necrosis factor (TNF) family is crucial for immune homeostasis, cell death and inflammation. These cytokines are recognized by members of the TNF receptor (TNFR) family of death receptors, including TNFR1 and TNFR2, and FAS and TNF-related apoptosis-inducing ligand (TRAIL) receptors(1). Death receptor signalling requires death-domain-mediated homotypic/heterotypic interactions between the receptor and its downstream adaptors, including TNFR1-associated death domain protein (TRADD) and FAS-associated death domain protein (FADD)(2). Here we discover that death domains in several proteins, including TRADD, FADD, RIPK1 and TNFR1, were directly inactivated by NleB, an entero-pathogenic Escherichia coli (EPEC) type III secretion system effector known to inhibit host nuclear factor-kappa B (NF-kappa B) signalling(3,4). NleB contained an unprecedented N-acetylglucosamine (GlcNAc) transferase activity that specifically modified a conserved arginine in these death domains (Arg 235 in the TRADD death domain). NleB GlcNAcylation (the addition of GlcNAc onto a protein side chain) of death domains blocked homotypic/heterotypic death domain interactions and assembly of the oligomeric TNFR1 complex, thereby disrupting TNF signalling in EPEC-infected cells, including NF-kappa B signalling, apoptosis and necroptosis. Type-III-delivered NleB also blocked FAS ligand and TRAIL-induced cell death by preventing formation of a FADD-mediated death-inducing signalling complex (DISC). The arginine GlcNAc transferase activity of NleB was required for bacterial colonization in the mouse model of EPEC infection. The mechanism of action of NleB represents a new model by which bacteria counteract host defences, and also a previously unappreciated post-translational modification.	[Li, Shan; Yao, Qing] China Agr Univ, Coll Biol Sci, Beijing 100094, Peoples R China; [Li, Shan; Zhang, Li; Yao, Qing; Li, Lin; Dong, Na; Gao, Wenqing; Ding, Xiaojun; Sun, Liming; Chen, She; Shao, Feng] Natl Inst Biol Sci, Beijing 102206, Peoples R China; [Zhang, Li] Chinese Acad Med Sci, Grad Sch, Beijing 100730, Peoples R China; [Zhang, Li] Beijing Union Med Coll, Beijing 100730, Peoples R China; [Rong, Jie; Chen, Xing] Peking Univ, Coll Chem & Mol Engn, Dept Biol Chem, Beijing Natl Lab Mol Sci, Beijing 100871, Peoples R China	China Agricultural University; National Institute of Biological Sciences, Beijing; Chinese Academy of Medical Sciences - Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Sciences; Peking University	Chen, S (corresponding author), Natl Inst Biol Sci, Beijing 102206, Peoples R China.	chenshe@nibs.ac.cn; shaofeng@nibs.ac.cn	Chen, Xing/C-1914-2015; Yao, Qing/AAE-1680-2020	Sun, Liming/0000-0002-0136-5605; Li, Shan/0000-0001-8646-3193; Chen, Xing/0000-0002-3058-7370	Howard Hughes Medical Institute; National Basic Research Program of China 973 Programs [2010CB835400, 2012CB518700, 2010CB835204]	Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Basic Research Program of China 973 Programs(National Basic Research Program of China)	We thank I. Rosenshine for providing nleBE deletion EPEC strains, H. Wu for the TNFR1/2 plasmid, K. Iwai for LUBAC antibodies, H. Sakurai for the p-TAK1 antibody, Z. Yang for yeast two-hybrid screen, L. Feng for synthesizing Ac<INF>4</INF>GlcNAc-d<INF>3</INF>, M. Dong for accessing the ETD instrument and X. Liu for assistance with mass spectrometry data analyses. We also thank members of the Shao laboratory for discussions and technical assistance. The research was supported in part by an International Early Career Scientist grant from the Howard Hughes Medical Institute to F. S. This work was also supported by the National Basic Research Program of China 973 Programs 2010CB835400 and 2012CB518700 to F. S. and 2010CB835204 to S.C.	Aggarwal BB, 2003, NAT REV IMMUNOL, V3, P745, DOI 10.1038/nri1184; Baruch K, 2011, EMBO J, V30, P221, DOI 10.1038/emboj.2010.297; Belyi Y, 2006, P NATL ACAD SCI USA, V103, P16953, DOI 10.1073/pnas.0601562103; Belyi Y, 2010, BBA-GEN SUBJECTS, V1800, P134, DOI 10.1016/j.bbagen.2009.07.022; Chen NJ, 2008, P NATL ACAD SCI USA, V105, P12429, DOI 10.1073/pnas.0806585105; Choy SLK, 2004, INFECT IMMUN, V72, P5115, DOI 10.1128/IAI.72.9.5115-5125.2004; Cui JX, 2010, SCIENCE, V329, P1215, DOI 10.1126/science.1193844; Ermolaeva MA, 2008, NAT IMMUNOL, V9, P1037, DOI 10.1038/ni.1638; Gao XF, 2013, CELL HOST MICROBE, V13, P87, DOI 10.1016/j.chom.2012.11.010; Ge JN, 2009, P NATL ACAD SCI USA, V106, P13725, DOI 10.1073/pnas.0907200106; Hart GW, 2011, ANNU REV BIOCHEM, V80, P825, DOI 10.1146/annurev-biochem-060608-102511; HORTON D, 1967, J ORG CHEM, V32, P1073, DOI 10.1021/jo01279a048; Hsu HL, 1996, CELL, V84, P299, DOI 10.1016/S0092-8674(00)80984-8; Kelly M, 2006, INFECT IMMUN, V74, P2328, DOI 10.1128/IAI.74.4.2328-2337.2006; Kersse K, 2011, TRENDS BIOCHEM SCI, V36, P541, DOI 10.1016/j.tibs.2011.06.006; Lairson LL, 2008, ANNU REV BIOCHEM, V77, P521, DOI 10.1146/annurev.biochem.76.061005.092322; Lamkanfi M, 2010, CELL HOST MICROBE, V8, P44, DOI 10.1016/j.chom.2010.06.007; Li HT, 2007, SCIENCE, V315, P1000, DOI 10.1126/science.1138960; Love Dona C, 2005, Sci STKE, V2005, pre13, DOI 10.1126/stke.3122005re13; Misyurina O, 2010, CAN J MICROBIOL, V56, P739, DOI [10.1139/W10-059, 10.1139/w10-059]; Muhlen S, 2011, J BIOL CHEM, V286, P5100, DOI 10.1074/jbc.M110.172254; Nadler C, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000743; Newton HJ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000898; Park HH, 2007, ANNU REV IMMUNOL, V25, P561, DOI 10.1146/annurev.immunol.25.022106.141656; Pearson JS, 2011, MOL MICROBIOL, V80, P219, DOI 10.1111/j.1365-2958.2011.07568.x; Pobezinskaya YL, 2008, NAT IMMUNOL, V9, P1047, DOI 10.1038/ni.1639; Ruchaud-Sparagano MH, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002414; SINGH DG, 1995, FEBS LETT, V376, P61, DOI 10.1016/0014-5793(95)01247-6; Sun LM, 2012, CELL, V148, P213, DOI 10.1016/j.cell.2011.11.031; Vossenkamper A, 2010, J IMMUNOL, V185, P4118, DOI 10.4049/jimmunol.1000500; Wang GL, 2013, NAT CHEM BIOL, V9, P84, DOI [10.1038/NCHEMBIO.1153, 10.1038/nchembio.1153]; Wang L, 2008, CELL, V133, P693, DOI 10.1016/j.cell.2008.03.036; Wang ZG, 2012, CELL, V148, P228, DOI 10.1016/j.cell.2011.11.030; Wickham ME, 2006, J INFECT DIS, V194, P819, DOI 10.1086/506620; Wilson NS, 2009, NAT IMMUNOL, V10, P348, DOI 10.1038/ni.1714; Yan DP, 2012, NAT IMMUNOL, V13, P1063, DOI 10.1038/ni.2417; Yen HL, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001231; Zhang L, 2012, NATURE, V481, P204, DOI 10.1038/nature10690	38	194	211	1	157	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 12	2013	501	7466					242	+		10.1038/nature12436	http://dx.doi.org/10.1038/nature12436			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	215XR	23955153				2022-12-24	WOS:000324244900045
J	Chang, KH; Li, R; Kuri, B; Lotan, Y; Roehrborn, CG; Liu, JY; Vessella, R; Nelson, PS; Kapur, P; Guo, XF; Mirzaei, H; Auchus, RJ; Sharifi, N				Chang, Kai-Hsiung; Li, Rui; Kuri, Barbara; Lotan, Yair; Roehrborn, Claus G.; Liu, Jiayan; Vessella, Robert; Nelson, Peter S.; Kapur, Payal; Guo, Xiaofeng; Mirzaei, Hamid; Auchus, Richard J.; Sharifi, Nima			A Gain-of-Function Mutation in DHT Synthesis in Castration-Resistant Prostate Cancer	CELL			English	Article							CELL LUNG-CANCER; 3-BETA-HYDROXYSTEROID DEHYDROGENASE; INCREASED SURVIVAL; ANDROGEN; ABIRATERONE; PROTEIN; TESTOSTERONE; ASSOCIATION; DEGRADATION; INHIBITION	Growth of prostate cancer cells is dependent upon androgen stimulation of the androgen receptor (AR). Dihydrotestosterone (DHT), the most potent androgen, is usually synthesized in the prostate from testosterone secreted by the testis. Following chemical or surgical castration, prostate cancers usually shrink owing to testosterone deprivation. However, tumors often recur, forming castration-resistant prostate cancer (CRPC). Here, we show that CRPC sometimes expresses a gain-of-stability mutation that leads to a gain-of-function in 3 beta-hydroxysteroid dehydrogenase type 1 (3 beta HSD1), which catalyzes the initial rate-limiting step in conversion of the adrenal-derived steroid dehydroepiandrosterone to DHT. The mutation (N367T) does not affect catalytic function, but it renders the enzyme resistant to ubiquitination and degradation, leading to profound accumulation. Whereas dehydroepiandrosterone conversion to DHT is usually very limited, expression of 367T accelerates this conversion and provides the DHT necessary to activate the AR. We suggest that 3 beta HSD1 is a valid target for the treatment of CRPC.	[Chang, Kai-Hsiung; Kuri, Barbara; Sharifi, Nima] Cleveland Clin, Lerner Res Inst, Dept Canc Biol, Cleveland, OH 44195 USA; [Chang, Kai-Hsiung; Kuri, Barbara; Sharifi, Nima] Cleveland Clin, Taussig Canc Inst, Dept Solid Tumor Oncol, Cleveland, OH 44195 USA; [Chang, Kai-Hsiung; Kuri, Barbara; Sharifi, Nima] Cleveland Clin, Glickman Urol & Kidney Inst, Cleveland, OH 44195 USA; [Chang, Kai-Hsiung; Li, Rui; Sharifi, Nima] UT Southwestern Med Ctr, Dept Internal Med, Div Hematol Oncol, Dallas, TX 75390 USA; [Chang, Kai-Hsiung; Li, Rui; Sharifi, Nima] UT Southwestern Med Ctr, Simmons Canc Ctr, Dallas, TX 75390 USA; [Lotan, Yair; Roehrborn, Claus G.] UT Southwestern Med Ctr, Dept Urol, Dallas, TX 75390 USA; [Kapur, Payal] UT Southwestern Med Ctr, Dept Pathol, Dallas, TX 75390 USA; [Guo, Xiaofeng; Mirzaei, Hamid] UT Southwestern Med Ctr, Dept Biochem, Dallas, TX 75390 USA; [Liu, Jiayan; Auchus, Richard J.] Univ Michigan, Sch Med, Dept Internal Med, Div Endocrinol & Metab, Ann Arbor, MI 48109 USA; [Vessella, Robert; Nelson, Peter S.] Univ Washington, Sch Med, Dept Urol, Seattle, WA 98109 USA; [Nelson, Peter S.] Fred Hutchinson Canc Res Ctr, Div Human Biol, Seattle, WA 98109 USA; [Nelson, Peter S.] Fred Hutchinson Canc Res Ctr, Div Clin Res, Seattle, WA 98109 USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Michigan System; University of Michigan; University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center; Fred Hutchinson Cancer Center	Sharifi, N (corresponding author), Cleveland Clin, Lerner Res Inst, Dept Canc Biol, Cleveland, OH 44195 USA.	sharifn@ccf.org	高, 雨莉/HGU-8187-2022; Chang, Kai-Hsiung/K-3048-2013	Chang, Kai-Hsiung/0000-0002-8392-8319	Howard Hughes Medical Institute; Prostate Cancer Foundation; American Cancer Society [12-038-01-CCE]; U.S. Army Medical Research and Materiel Command [PC080193]; National Cancer Institute [1R01CA168899, 1R01CA172382-01];  [PO1-CA85859];  [PC093509];  [P01CA163227];  [P50CA097186]; NATIONAL CANCER INSTITUTE [R01CA168899, P01CA163227, R01CA172382, P50CA097186, P01CA085859] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); Prostate Cancer Foundation; American Cancer Society(American Cancer Society); U.S. Army Medical Research and Materiel Command(United States Department of DefenseUnited States ArmyU.S. Army Medical Research & Materiel Command (USAMRMC)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); ; ; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Ralph Deberardinis, Mike Brown, Kevin Courtney, George DeMartino, and Eugene Frenkel for helpful comments, Russell DeBose-Boyd for the anti-AFMR antibody, J.T. Hsieh for the anti-SKP2 antibody, Cheng-Ming Chiang for the anti-His antibody and Actinomycin D, David Trudgian for assistance with protein mass spectrometry, and An Jia and Chul Ahn for assistance with statistical analysis. This publication has been funded in part by a Howard Hughes Medical Institute Physician-Scientist Early Career Award (to N. S.), by the Prostate Cancer Foundation (to N. S., R. V., and P. S. N.), by an American Cancer Society Research Scholar Award (12-038-01-CCE [to N. S.]), by a grant from the U.S. Army Medical Research and Materiel Command (PC080193) (to N. S.), and additional grants from the National Cancer Institute (1R01CA168899 and 1R01CA172382-01 [to N. S.]). The acquisition of metastatic tumors through the UW Rapid Autopsy Program was funded in part by grants (PO1-CA85859 [to R. V. and P. S. N.], PC093509 [to P. S. N.], P01CA163227 [P. S. N.], and P50CA097186 [R. V. and P. S. N.]).	Attard G, 2012, J CLIN ENDOCR METAB, V97, P507, DOI 10.1210/jc.2011-2189; Attard G, 2009, CANCER CELL, V16, P458, DOI 10.1016/j.ccr.2009.11.006; BARRIE SE, 1994, J STEROID BIOCHEM, V50, P267, DOI 10.1016/0960-0760(94)90131-7; Chang BL, 2002, CANCER RES, V62, P1784; Chang KH, 2012, NAT REV UROL, V9, P721, DOI 10.1038/nrurol.2012.175; Chang KH, 2011, P NATL ACAD SCI USA, V108, P13728, DOI 10.1073/pnas.1107898108; Chapman PB, 2011, NEW ENGL J MED, V364, P2507, DOI 10.1056/NEJMoa1103782; Cunningham JM, 2007, CANCER EPIDEM BIOMAR, V16, P969, DOI 10.1158/1055-9965.EPI-06-0767; De Bono JS, 2011, NEW ENGL J MED, V364, P1995, DOI 10.1056/NEJMoa1014618; Evaul K, 2010, ENDOCRINOLOGY, V151, P3514, DOI 10.1210/en.2010-0138; GELLER J, 1978, J CLIN ENDOCR METAB, V46, P440; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Knudsen KE, 2010, TRENDS ENDOCRIN MET, V21, P315, DOI 10.1016/j.tem.2010.01.002; Kobayashi S, 2005, NEW ENGL J MED, V352, P786, DOI 10.1056/NEJMoa044238; Li R, 2012, CLIN CANCER RES, V18, P3571, DOI 10.1158/1078-0432.CCR-12-0908; LORENCE MC, 1990, ENDOCRINOLOGY, V126, P2493, DOI 10.1210/endo-126-5-2493; Luu-The V, 2008, BEST PRACT RES CL EN, V22, P207, DOI 10.1016/j.beem.2008.01.008; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Montgomery RB, 2008, CANCER RES, V68, P4447, DOI 10.1158/0008-5472.CAN-08-0249; Ong SE, 2002, MOL CELL PROTEOMICS, V1, P376, DOI 10.1074/mcp.M200025-MCP200; Penning TM, 2010, CURR OPIN ENDOCRINOL, V17, P233, DOI 10.1097/MED.0b013e3283381a31; Scher HI, 2005, J CLIN ONCOL, V23, P8253, DOI 10.1200/JCO.2005.03.4777; Scher HI, 2012, NEW ENGL J MED, V367, P1187, DOI 10.1056/NEJMoa1207506; Sharifi N, 2005, JAMA-J AM MED ASSOC, V294, P238, DOI 10.1001/jama.294.2.238; Sharifi N, 2013, MOL ENDOCRINOL, V27, P708, DOI 10.1210/me.2013-1007; Shimodaira M, 2010, EUR J ENDOCRINOL, V163, P671, DOI 10.1530/EJE-10-0428; Simard J, 2005, ENDOCR REV, V26, P525, DOI 10.1210/er.2002-0050; Song BL, 2005, MOL CELL, V19, P829, DOI 10.1016/j.molcel.2005.08.009; Thomas G, 2008, NAT GENET, V40, P310, DOI 10.1038/ng.91; Titus MA, 2005, CLIN CANCER RES, V11, P4653, DOI 10.1158/1078-0432.CCR-05-0525; Tomlins SA, 2005, SCIENCE, V310, P644, DOI 10.1126/science.1117679; Tran C, 2009, SCIENCE, V324, P787, DOI 10.1126/science.1168175; Wang QY, 2008, J BIOL CHEM, V283, P7445, DOI 10.1074/jbc.M708347200; Wang Q, 2009, P NATL ACAD SCI USA, V106, P2200, DOI 10.1073/pnas.0807611106; Yuan X, 2009, UROL ONCOL-SEMIN ORI, V27, P36, DOI 10.1016/j.urolonc.2008.03.021	35	210	227	2	25	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	AUG 29	2013	154	5					1074	1084		10.1016/j.cell.2013.07.029	http://dx.doi.org/10.1016/j.cell.2013.07.029			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	209OE	23993097	Green Accepted, Bronze			2022-12-24	WOS:000323767300020
J	Miles, BWJ; Stokes, CR; Vieli, A; Cox, NJ				Miles, B. W. J.; Stokes, C. R.; Vieli, A.; Cox, N. J.			Rapid, climate-driven changes in outlet glaciers on the Pacific coast of East Antarctica	NATURE			English	Article							ICE-SHEET; SEA-ICE; ANNULAR MODE; MASS-LOSS; GREENLAND; VARIABILITY; PENINSULA; MARGINS; SHELVES; ADELIE	Observations of ocean-terminating outlet glaciers in Greenland and West Antarctica(1-6) indicate that their contribution to sea level is accelerating as a result of increased velocity, thinning and retreat(7-11). Thinning has also been reported along the margin of the much larger East Antarctic ice sheet(1), but whether glaciers are advancing or retreating there is largely unknown, and there has been no attempt to place such changes in the context of localized mass loss(7,9) or climatic or oceanic forcing. Here we present multidecadal trends in the terminus position of 175 ocean-terminating outlet glaciers along 5,400 kilometres of the margin of the East Antarctic ice sheet, and reveal widespread and synchronous changes. Despite large fluctuations between glaciers-linked to their size-three epochal patterns emerged: 63 per cent of glaciers retreated from 1974 to 1990, 72 per cent advanced from 1990 to 2000, and 58 per cent advanced from 2000 to 2010. These trends were most pronounced along the warmer western South Pacific coast, whereas glaciers along the cooler Ross Sea coast experienced no significant changes. We find that glacier change along the Pacific coast is consistent with a rapid and coherent response to air temperature and sea-ice trends, linked through the dominant mode of atmospheric variability (the Southern Annular Mode). We conclude that parts of the world's largest ice sheet may be more vulnerable to external forcing than recognized previously.	[Miles, B. W. J.; Stokes, C. R.; Vieli, A.; Cox, N. J.] Univ Durham, Dept Geog, Durham DH1 3LE, England	Durham University	Stokes, CR (corresponding author), Univ Durham, Dept Geog, Sci Site,South Rd, Durham DH1 3LE, England.	c.r.stokes@durham.ac.uk	Stokes, Chris R/A-1957-2011	Stokes, Chris R/0000-0003-3355-1573; Miles, Bertie/0000-0002-3388-4688				Amundson JM, 2010, J GEOPHYS RES-EARTH, V115, DOI 10.1029/2009JF001405; Arblaster JM, 2006, J CLIMATE, V19, P2896, DOI 10.1175/JCLI3774.1; Bjork AA, 2012, NAT GEOSCI, V5, P427, DOI [10.1038/NGEO1481, 10.1038/ngeo1481]; Blair RC., 1980, J ED STAT, V5, P309, DOI [10.2307/1164905, DOI 10.2307/1164905]; Cook AJ, 2005, SCIENCE, V308, P541, DOI 10.1126/science.1104235; delaMare WK, 1997, NATURE, V389, P57, DOI 10.1038/37956; Ferraccioli F, 2009, TECTONOPHYSICS, V478, P62, DOI 10.1016/j.tecto.2009.03.013; Frezzotti M, 1998, ANN GLACIOL, V27, P643; Frezzotti M, 2002, ANN GLACIOL-SER, V34, P235, DOI 10.3189/172756402781817897; Hall A, 2002, J CLIMATE, V15, P3043, DOI 10.1175/1520-0442(2002)015<3043:SVITSH>2.0.CO;2; Jacobs S, 2006, PHILOS T R SOC A, V364, P1657, DOI 10.1098/rsta.2006.1794; Joughin I, 2011, NAT GEOSCI, V4, P506, DOI [10.1038/ngeo1194, 10.1038/NGEO1194]; Kim K, 2007, INT J REMOTE SENS, V28, P5357, DOI 10.1080/01431160601105850; King MA, 2012, NATURE, V491, P586, DOI 10.1038/nature11621; MacGregor JA, 2012, J GLACIOL, V58, P458, DOI 10.3189/2012JoG11J262; Massom RA, 2009, MAR ECOL PROG SER, V374, P243, DOI 10.3354/meps07734; Moon T, 2008, J GEOPHYS RES-EARTH, V113, DOI 10.1029/2007JF000927; Nick FM, 2009, NAT GEOSCI, V2, P110, DOI 10.1038/NGEO394; Parkinson CL, 2012, CRYOSPHERE, V6, P871, DOI 10.5194/tc-6-871-2012; Pritchard HD, 2007, J GEOPHYS RES-EARTH, V112, DOI 10.1029/2006JF000597; Pritchard HD, 2012, NATURE, V484, P502, DOI 10.1038/nature10968; Pritchard HD, 2009, NATURE, V461, P971, DOI 10.1038/nature08471; Rignot E, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL020697; Rignot E, 2011, SCIENCE, V333, P1427, DOI 10.1126/science.1208336; Rignot E, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL047109; Rignot E, 2011, MEASURES INSAR BASED; Rignot E, 2008, NAT GEOSCI, V1, P106, DOI 10.1038/ngeo102; Scambos TA, 2000, J GLACIOL, V46, P516, DOI 10.3189/172756500781833043; Shepherd A, 2012, SCIENCE, V338, P1183, DOI 10.1126/science.1228102; Thompson DWJ, 2002, SCIENCE, V296, P895, DOI 10.1126/science.1069270; van den Broeke M, 2009, SCIENCE, V326, P984, DOI 10.1126/science.1178176; van der Veen CJ, 1998, COLD REG SCI TECHNOL, V27, P31, DOI 10.1016/S0165-232X(97)00022-0; Wingham DJ, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL039126; Zwally HJ, 2011, SURV GEOPHYS, V32, P351, DOI 10.1007/s10712-011-9123-5	34	72	73	1	88	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 29	2013	500	7464					563	+		10.1038/nature12382	http://dx.doi.org/10.1038/nature12382			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	207TD	23985874	Green Accepted			2022-12-24	WOS:000323625900031
J	Stack, CB; Localio, AR; Griswold, ME; Goodman, SN; Mulrow, CD				Stack, Catharine B.; Localio, A. Russell; Griswold, Michael E.; Goodman, Steven N.; Mulrow, Cynthia D.			Handling of Rescue and Missing Data Affects Synthesis and Interpretation of Evidence: The Sodium-Glucose Cotransporter 2 Inhibitor Example	ANNALS OF INTERNAL MEDICINE			English	Article							RANDOMIZED-TRIAL; DAPAGLIFLOZIN; EFFICACY; RISK	Confidence in evidence summarized in meta-analyses depends on the strength of the underlying studies. This inherent limitation of syntheses appears in the case of a meta-analysis of sodium-glucose cotransporter 2 inhibitors for the treatment of type 2 diabetes because many of the pertinent randomized trials did not handle patient dropout and "rescue" medication properly. Repudiated statistical methods, such as last observation carried forward, and unsophisticated methods for handling postrescue data produce unreliable summary estimates. Future reports of randomized studies and meta-analyses of those studies must focus on posing precise questions about the treatment effect of interest and then implement appropriate statistical methods to account for missing data, patient dropout, and use of rescue medication.	[Stack, Catharine B.] Amer Coll Physicians, Philadelphia, PA 19106 USA; Univ Penn, Philadelphia, PA 19104 USA; Univ Mississippi, Med Ctr, Jackson, MS 39216 USA; Stanford Univ, Sch Med, Stanford, CA 94305 USA	American College of Physicians; University of Pennsylvania; University of Mississippi; University of Mississippi Medical Center; Stanford University	Stack, CB (corresponding author), Amer Coll Physicians, 190 N Independence Mall West, Philadelphia, PA 19106 USA.	cstack@acponline.org		Goodman, Steven/0000-0002-3872-5723				Bailey CJ, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-43; Daniels MJ, 2008, MONOGR STAT APPL PRO, V109, P1; Fitzmaurice G, 2011, APPL LONGITUDINAL AN, V2nd; Frangakis CE, 2002, BIOMETRICS, V58, P21, DOI 10.1111/j.0006-341X.2002.00021.x; Guyatt G, 2011, J CLIN EPIDEMIOL, V64, P383, DOI 10.1016/j.jclinepi.2010.04.026; Guyatt GH, 2011, J CLIN EPIDEMIOL, V64, P407, DOI 10.1016/j.jclinepi.2010.07.017; Higgins JPT, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5928; Institute of Medicine, 2008, TREATMENT POSTTRAUMA, DOI [10.17226/11955, DOI 10.17226/11955]; Mallinckrodt CH, 2001, DRUG INF J, V35, P1215, DOI 10.1177/009286150103500418; Molenberghs G, 2007, MISSING DATA CLIN ST, P27; Molnar Frank J, 2009, Open Med, V3, pe31; Panel on Handling Missing Data in Clinical Trials National Research Council, 2010, PREV TREATM MISS DAT; Small DS, 2006, STAT MED, V25, P1981, DOI 10.1002/sim.2313; Toh Sengwee, 2008, Int J Biostat, V4, P22, DOI 10.2202/1557-4679.1117; Toh S, 2010, ANN INTERN MED, V152, P211, DOI 10.7326/0003-4819-152-4-201002160-00005; Vasilakou D, 2013, ANN INTERN MED, V159, P262, DOI 10.7326/0003-4819-159-4-201308200-00007; White IR, 2003, STAT MED, V22, P781, DOI 10.1002/sim.1369; Wilding JPH, 2012, ANN INTERN MED, V156, P405, DOI 10.7326/0003-4819-156-6-201203200-00003; Yuan Y, 2009, BIOMETRICS, V65, P487, DOI 10.1111/j.1541-0420.2008.01068.x	19	12	12	0	7	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 20	2013	159	4					285	+		10.7326/0003-4819-159-4-201308200-00009	http://dx.doi.org/10.7326/0003-4819-159-4-201308200-00009			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	205DM	24026261				2022-12-24	WOS:000323421700018
J	Kamel, F				Kamel, Freya			Paths from Pesticides to Parkinson's	SCIENCE			English	Editorial Material							DISEASE; EXPOSURE; RISK; SERUM		NIEHS, Epidemiol Branch, Res Triangle Pk, NC 27709 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Kamel, F (corresponding author), NIEHS, Epidemiol Branch, POB 12233, Res Triangle Pk, NC 27709 USA.	kamel@niehs.nih.gov		Kamel, Freya/0000-0001-5052-6615	Intramural NIH HHS Funding Source: Medline; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES044007] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Baldi I, 2003, NEUROEPIDEMIOLOGY, V22, P305, DOI 10.1159/000071194; Cannon JR, 2013, NEUROBIOL DIS, V57, P38, DOI 10.1016/j.nbd.2012.06.025; Corrigan FM, 2000, J TOXICOL ENV HEAL A, V59, P229, DOI 10.1080/009841000156907; Dexter DT, 2013, FREE RADICAL BIO MED, V62, P132, DOI 10.1016/j.freeradbiomed.2013.01.018; Drolet RE, 2009, NEUROBIOL DIS, V36, P96, DOI 10.1016/j.nbd.2009.06.017; Elbaz A, 2009, ANN NEUROL, V66, P494, DOI 10.1002/ana.21717; Hayden KM, 2010, NEUROLOGY, V74, P1524, DOI 10.1212/WNL.0b013e3181dd4423; Kamel F, 2012, NEUROTOXICOLOGY, V33, P457, DOI 10.1016/j.neuro.2012.04.001; Lee PC, 2012, NEUROLOGY, V79, P2061, DOI 10.1212/WNL.0b013e3182749f28; Mostafalou S, 2013, TOXICOL APPL PHARM, V268, P157, DOI 10.1016/j.taap.2013.01.025; Pezzoli G, 2013, NEUROLOGY, V80, P2035, DOI 10.1212/WNL.0b013e318294b3c8; Richardson JR, 2009, ARCH NEUROL-CHICAGO, V66, P870, DOI 10.1001/archneurol.2009.89; Taetzsch T, 2013, J BIOCHEM MOL TOXIC, V27, P137, DOI 10.1002/jbt.21464; Tanner CM, 2011, ENVIRON HEALTH PERSP, V119, P866, DOI 10.1289/ehp.1002839; Tanner CM, 2009, ARCH NEUROL-CHICAGO, V66, P1106, DOI 10.1001/archneurol.2009.195; Wang A, 2011, EUR J EPIDEMIOL, V26, P547, DOI 10.1007/s10654-011-9574-5; Weisskopf MG, 2010, NEUROLOGY, V74, P1055, DOI 10.1212/WNL.0b013e3181d76a93; Wirdefeldt K, 2011, EUR J EPIDEMIOL, V26, pS1, DOI 10.1007/s10654-011-9581-6	18	91	94	0	53	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 16	2013	341	6147					722	723		10.1126/science.1243619	http://dx.doi.org/10.1126/science.1243619			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201DZ	23950519	Green Published			2022-12-24	WOS:000323122200027
J	Schraml, BU; van Blijswijk, J; Zelenay, S; Whitney, PG; Filby, A; Acton, SE; Rogers, NC; Moncaut, N; Carvajal, JJ; Sousa, CRE				Schraml, Barbara U.; van Blijswijk, Janneke; Zelenay, Santiago; Whitney, Paul G.; Filby, Andrew; Acton, Sophie E.; Rogers, Neil C.; Moncaut, Natalia; Carvajal, Jaime J.; Reis e Sousa, Caetano			Genetic Tracing via DNGR-1 Expression History Defines Dendritic Cells as a Hematopoietic Lineage	CELL			English	Article							TRANSCRIPTION FACTOR ZDC; MACROPHAGES; MONOCYTES; DIFFERENTIATION; IDENTIFICATION; PROGENITORS; ACTIVATION; PRECURSORS; REGULATOR; RECEPTOR	Mononuclear phagocytes are classified as macrophages or dendritic cells (DCs) based on cell morphology, phenotype, or select functional properties. However, these attributes are not absolute and often overlap, leading to difficulties in cell-type identification. To circumvent this issue, we describe a mouse model to define DCs based on their ontogenetic descendence from a committed precursor. We show that precursors of mouse conventional DCs, but not other leukocytes, are marked by expression of DNGR-1. Genetic tracing of DNGR-1 expression history specifically marks cells traditionally ascribed to the DC lineage, and this restriction is maintained after inflammation. Notably, in some tissues, cells previously thought to be monocytes/macrophages are in fact descendants from DC precursors. These studies provide an in vivo model for fate mapping of DCs, distinguishing them from other leukocyte lineages, and thus help to unravel the functional complexity of the mononuclear phagocyte system.	[Schraml, Barbara U.; van Blijswijk, Janneke; Zelenay, Santiago; Whitney, Paul G.; Acton, Sophie E.; Rogers, Neil C.; Reis e Sousa, Caetano] Canc Res UK London Res Inst, Lincolns Inn Fields Labs, Immunobiol Lab, London WC2A 3LY, England; [Filby, Andrew] Canc Res UK London Res Inst, Lincolns Inn Fields Labs, Flow Cytometry Lab, London WC2A 3LY, England; [Acton, Sophie E.] UCL, Dept Cell & Dev Biol, London WC1E 6BT, England; [Moncaut, Natalia; Carvajal, Jaime J.] Inst Canc Res, Chester Beatty Labs, Div Canc Biol, London SW3 6JB, England; [Carvajal, Jaime J.] CSIC UPO JA, Ctr Andaluz Biol Desarrollo, Seville 41013, Spain	Cancer Research UK; Cancer Research UK; University of London; University College London; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; Consejo Superior de Investigaciones Cientificas (CSIC); Universidad Pablo de Olavide; CSIC - Andalusian Center for Developmental Biology (CABD)	Sousa, CRE (corresponding author), Canc Res UK London Res Inst, Lincolns Inn Fields Labs, Immunobiol Lab, 44 Lincolns Inn Fields, London WC2A 3LY, England.	caetano@cancer.org.uk	Acton, Sophie/G-9784-2012; Reis e Sousa, Caetano/O-1657-2014; Reis e Sousa, Caetano/ABD-7322-2021; Carvajal, Jaime J/O-3681-2014	Acton, Sophie/0000-0003-2704-716X; Reis e Sousa, Caetano/0000-0001-7392-2119; Reis e Sousa, Caetano/0000-0001-7392-2119; Carvajal, Jaime J/0000-0002-7277-0317; Rogers, Neil/0000-0001-8977-7585; Whitney, Paul/0000-0003-3836-7601; Schraml, Barbara/0000-0002-5801-0151; Zelenay, Santiago/0000-0002-6865-3978	Cancer Research UK; European Research Council (ERC) [AdG-2010-268670]; EMBO long-term fellowship; Boehringer Ingelheim Fonds; Overseas Biomedical Fellowship from the NHMRC of Australia; Henry Wellcome Fellowship [WT089009MA]; Cancer Research UK [15689] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); European Research Council (ERC)(European Research Council (ERC)); EMBO long-term fellowship(European Molecular Biology Organization (EMBO)); Boehringer Ingelheim Fonds(Boehringer Ingelheim); Overseas Biomedical Fellowship from the NHMRC of Australia; Henry Wellcome Fellowship; Cancer Research UK(Cancer Research UK)	We thank Frederic Geissmann and members of the Immunobiology Laboratory for helpful discussions and suggestions. C. R. S. is funded by Cancer Research UK, a prize from Fondation Bettencourt-Schueller, and a grant from the European Research Council (ERC Advanced Researcher Grant AdG-2010-268670). B. U. S. was supported by an EMBO long-term fellowship, J.v.B. was supported by Boehringer Ingelheim Fonds, P. G. W. was supported by an Overseas Biomedical Fellowship from the NHMRC of Australia, and S. E. A. was supported by a Henry Wellcome Fellowship (WT089009MA). We thank CRUK Transgenic Services for generation of genetically modified mice and the Biological Resources staff for animal care and assistance with mouse experiments. We thank Yasmine Belkaid and John Grainger for their help with the isolation of intestinal lamina propria cells.	Auffray C, 2009, J EXP MED, V206, P595, DOI 10.1084/jem.20081385; Bogunovic M, 2009, IMMUNITY, V31, P513, DOI 10.1016/j.immuni.2009.08.010; Caminschi I, 2008, BLOOD, V112, P3264, DOI 10.1182/blood-2008-05-155176; Chorro L, 2009, J EXP MED, V206, P3089, DOI 10.1084/jem.20091586; Cisse B, 2008, CELL, V135, P37, DOI 10.1016/j.cell.2008.09.016; Desch AN, 2011, J EXP MED, V208, P1789, DOI 10.1084/jem.20110538; Edelson BT, 2010, J EXP MED, V207, P823, DOI 10.1084/jem.20091627; Filby A, 2012, CYTOM PART A, V81A, P637, DOI 10.1002/cyto.a.22091; Fogg DK, 2006, SCIENCE, V311, P83, DOI 10.1126/science.1117729; Gautier EL, 2012, NAT IMMUNOL, V13, P1118, DOI 10.1038/ni.2419; Geissmann F, 2010, SCIENCE, V327, P656, DOI 10.1126/science.1178331; Ginhoux F, 2009, J EXP MED, V206, P3115, DOI 10.1084/jem.20091756; Greter M, 2012, IMMUNITY, V36, P1031, DOI 10.1016/j.immuni.2012.03.027; Haniffa M, 2012, IMMUNITY, V37, P60, DOI 10.1016/j.immuni.2012.04.012; Hashimoto D, 2013, IMMUNITY, V38, P792, DOI 10.1016/j.immuni.2013.04.004; Hashimoto D, 2011, IMMUNITY, V35, P323, DOI 10.1016/j.immuni.2011.09.007; Heath WR, 2009, NAT IMMUNOL, V10, P1237, DOI 10.1038/ni.1822; Hoeffel G, 2012, J EXP MED, V209, P1167, DOI 10.1084/jem.20120340; Hume DA, 2008, J IMMUNOL, V181, P5829, DOI 10.4049/jimmunol.181.9.5829; Jakubzick C, 2008, J EXP MED, V205, P2839, DOI 10.1084/jem.20081430; Lauvau G, 2001, SCIENCE, V294, P1735, DOI 10.1126/science.1064571; Lewis KL, 2011, IMMUNITY, V35, P780, DOI 10.1016/j.immuni.2011.08.013; Liu K, 2009, SCIENCE, V324, P392, DOI 10.1126/science.1170540; Luche H, 2007, EUR J IMMUNOL, V37, P43, DOI 10.1002/eji.200636745; Meredith MM, 2012, J EXP MED, V209, P1583, DOI 10.1084/jem.20121003; Meredith MM, 2012, J EXP MED, V209, P1153, DOI 10.1084/jem.20112675; Miller JC, 2012, NAT IMMUNOL, V13, P888, DOI 10.1038/ni.2370; Milling S, 2010, IMMUNOL REV, V234, P259, DOI 10.1111/j.0105-2896.2009.00866.x; Naik SH, 2006, NAT IMMUNOL, V7, P663, DOI 10.1038/ni1340; Naik SH, 2007, NAT IMMUNOL, V8, P1217, DOI 10.1038/ni1522; Naik SH, 2013, NATURE, V496, P229, DOI 10.1038/nature12013; Onai N, 2007, NAT IMMUNOL, V8, P1207, DOI 10.1038/ni1518; Onai N, 2013, IMMUNITY, V38, P943, DOI 10.1016/j.immuni.2013.04.006; Persson EK, 2013, IMMUNITY, V38, P958, DOI 10.1016/j.immuni.2013.03.009; Plantinga M, 2013, IMMUNITY, V38, P322, DOI 10.1016/j.immuni.2012.10.016; Poulin LF, 2012, BLOOD, V119, P6052, DOI 10.1182/blood-2012-01-406967; Sancho D, 2008, J CLIN INVEST, V118, P2098, DOI 10.1172/JCI34584; Sancho D, 2009, NATURE, V458, P899, DOI 10.1038/nature07750; Satpathy AT, 2012, J EXP MED, V209, P1135, DOI 10.1084/jem.20120030; Satpathy AT, 2011, SEMIN IMMUNOL, V23, P388, DOI 10.1016/j.smim.2011.08.009; Schlenner SM, 2010, IMMUNITY, V32, P426, DOI 10.1016/j.immuni.2010.03.005; Schulz C, 2012, SCIENCE, V336, P86, DOI 10.1126/science.1219179; Serbina NV, 2003, IMMUNITY, V19, P59, DOI 10.1016/S1074-7613(03)00171-7; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Steinman RM, 2010, IMMUNOL REV, V234, P5, DOI 10.1111/j.0105-2896.2009.00888.x; Tamoutounour S, 2012, EUR J IMMUNOL, V42, P3150, DOI 10.1002/eji.201242847; Tussiwand R, 2012, NATURE, V490, P502, DOI 10.1038/nature11531; Varol C, 2009, IMMUNITY, V31, P502, DOI 10.1016/j.immuni.2009.06.025; Wirtz S, 2007, NAT PROTOC, V2, P541, DOI 10.1038/nprot.2007.41; Ye M, 2003, IMMUNITY, V19, P689, DOI 10.1016/S1074-7613(03)00299-1; Yona S, 2013, IMMUNITY, V38, P79, DOI 10.1016/j.immuni.2012.12.001; Zigmond E, 2012, IMMUNITY, V37, P1076, DOI 10.1016/j.immuni.2012.08.026	52	204	208	2	26	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 15	2013	154	4					843	858		10.1016/j.cell.2013.07.014	http://dx.doi.org/10.1016/j.cell.2013.07.014			16	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	202GQ	23953115	Bronze			2022-12-24	WOS:000323202500015
J	Lipsitz, LA				Lipsitz, Lewis A.			The 3-Night Hospital Stay and Medicare Coverage for Skilled Nursing Care	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Lipsitz, Lewis A.] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Hebrew SeniorLife, Boston, MA 02215 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Hebrew SeniorLife	Lipsitz, LA (corresponding author), Hebrew SeniorLife Inst Aging Res, 1200 Ctr St, Boston, MA 02131 USA.	lipsitz@hsl.harvard.edu						AARONSON WE, 1994, J HEALTH POLIT POLIC, V19, P753; Birmingham J, 2008, PROF CASE MANAG, V13, P7; Medicare Payment Advisory Commission (MEDPAC), 2013, REPORT TO CONGRESS M; Medicare Payment Advisory Commission (MEDPAC), 2010, REPORT TO CONGRESS A; Segal M., 2011, ELIGIBLE BENEFICIARI	5	16	16	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 9	2013	310	14					1441	1442		10.1001/jama.2013.254845	http://dx.doi.org/10.1001/jama.2013.254845			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	230PK	24042212				2022-12-24	WOS:000325354100014
J	Hurley, R				Hurley, Richard			MEDICINE AND THE MEDIA Are new technologies in infertility treatment always good news?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												rhurley@bmj.com						[Anonymous], 2013, BBC RADIO 4     0925; Borland F, 2013, DAILY MAIL; Campbell A, 2013, REPROD BIOMED ONLINE, V27, P140, DOI 10.1016/j.rbmo.2013.04.013; Devlin H, 2013, TIMES; Donnelly L., 2013, DAILY TELEGRAPH; Human Fertilisation and Embryology Authority, LAT UK IVF FIG 2010; Johnson J, 2013, DAILY MAIL; Liverpool Women's NHS Foundation Trust, 2013, LIV WOM BEC 1 EUR OF; Macklon NS, 2013, TIMES; Mastenbroek S, 2007, NEW ENGL J MED, V357, P9, DOI 10.1056/NEJMoa067744; National Institute for Health and Care Excellence, 2013, CG156 NICE; Science Media Centre, 2013, EXP REACT NEW IVF ST	12	2	2	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 4	2013	347								f6004	10.1136/bmj.f6004	http://dx.doi.org/10.1136/bmj.f6004			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	231PN	24097131				2022-12-24	WOS:000325429300008
J	de Groot, M; Kollen, BJ				de Groot, Marieke; Kollen, Boudewijn J.			Course of bereavement over 8-10 years in first degree relatives and spouses of people who committed suicide: longitudinal community based cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							RANDOMIZED CONTROLLED-TRIAL; PREVENT COMPLICATED GRIEF; TRAUMATIC GRIEF; BEHAVIOR; THERAPY; RISK; NEUROTICISM; DISORDERS; SURVIVORS; IDEATION	Objective To identify factors predicting the long term course of complicated grief, depression, and suicide ideation in a community based sample of relatives bereaved through suicide. Design Longitudinal cohort study. Included in the multilevel regression models were sociodemographic and personality features, mental health history, records of received help, long term complicated grief, depression, and suicide ideation. Setting Community based sample located in the northern part of the Netherlands. Participants 153 first degree relatives and spouses of 74 people who had committed suicide. Main outcome measures Complicated grief, depression, and suicide ideation assessed at 2.5 months, 13 months and 96-120 months (8-10 years) by means of self report questionnaires. Results Complicated grief, depression, and suicide ideation were mutually associated in relatives and spouses of people who had committed suicide. A history of attempted suicide was associated with long term suicide ideation (odds ratio 5.5, 95% confidence interval 1.8 to 16.7; P=0.003). Depression was more likely to be predicted by female sex and low mastery, whereas complicated grief was more likely to be predicted by the trauma of losing a child. The risk of both complicated grief and depression decreased over time; for complicated grief the change corresponded with a Cohen's d effect size of 0.36 at 13 months and 0.89 at 96-120 months; for depression these figures were 0.28 at 13 months and 0.94 at 96-120 months. The long term course of bereavement was not affected by family based cognitive behavioural therapy, support from a general practitioner, and/or mental healthcare. Mutual support was associated with an increased risk of complicated grief: B regression coefficient=6.4 (95% confidence interval 1.8 to 11.0; P=0.006). Throughout this long term study, selection bias might have affected some outcomes. Conclusion In relatives bereaved by suicide, suicide ideation is associated with an increased risk of long term complicated grief and depression. The risk of complicated grief and depression decreases over time. Although mutual support is associated with an increased risk of complicated grief, we could not draw conclusions about a causal relation.	[de Groot, Marieke] Univ Groningen, Univ Med Ctr Groningen, NL-9700 RB Groningen, Netherlands; [Kollen, Boudewijn J.] Univ Groningen, Univ Med Ctr Groningen, Dept Gen Practice Med, NL-9700 RB Groningen, Netherlands; [de Groot, Marieke] Vrije Univ Amsterdam, NL-1081 BT Amsterdam, Netherlands; [de Groot, Marieke] EMGO Inst Heath & Care Res, Amsterdam, Netherlands	University of Groningen; University of Groningen; Vrije Universiteit Amsterdam	de Groot, M (corresponding author), Univ Groningen, Univ Med Ctr Groningen, POB 30-001, NL-9700 RB Groningen, Netherlands.	m.h.de.groot@med.umcg.nl			ZONMW (Netherlands Organisation for Health Research and Development) [60-60100-98-052]	ZONMW (Netherlands Organisation for Health Research and Development)(Netherlands Organization for Health Research and Development)	This study was funded by ZONMW (Netherlands Organisation for Health Research and Development) No 60-60100-98-052.	Agerbo E, 2005, J EPIDEMIOL COMMUN H, V59, P407, DOI 10.1136/jech.2004.024950; Bernal M, 2007, J AFFECT DISORDERS, V101, P27, DOI 10.1016/j.jad.2006.09.018; Boelen PA, 2003, DEATH STUD, V27, P227, DOI 10.1080/07481180302889; Boelen PA, 2006, BEHAV RES THER, V44, P1657, DOI 10.1016/j.brat.2005.12.006; Boelen PA, 2006, CLIN PSYCHOL-SCI PR, V13, P109, DOI 10.1111/j.1468-2850.2006.00013.x; Brown GK, 2005, JAMA-J AM MED ASSOC, V294, P563, DOI 10.1001/jama.294.5.563; Cerel J, 2009, SUICIDE LIFE-THREAT, V39, P269, DOI 10.1521/suli.2009.39.3.269; De Groot MH, 2006, SUICIDE LIFE-THREAT, V36, P418, DOI 10.1521/suli.2006.36.4.418; de Groot M, 2007, BMJ-BRIT MED J, V334, P994, DOI 10.1136/bmj.39161.457431.55; de Groot M, 2010, SUICIDE LIFE-THREAT, V40, P425, DOI 10.1521/suli.2010.40.5.425; de Groot M, 2009, FAM PRACT, V26, P372, DOI 10.1093/fampra/cmp046; Ellis TE, 2008, INT J COGN THER, V1, P47, DOI 10.1680/ijct.2008.1.1.47; EYSENCK SBG, 1964, LIFE SCI, V3, P1103, DOI 10.1016/0024-3205(64)90125-0; Gopinath S, 2007, J AFFECT DISORDERS, V101, P57, DOI 10.1016/j.jad.2006.10.023; Hawton K, 2009, LANCET, V373, P1372, DOI 10.1016/S0140-6736(09)60372-X; Kissane DW, 1996, AM J PSYCHIAT, V153, P650; Lichtenthal WG, 2004, CLIN PSYCHOL REV, V24, P637, DOI 10.1016/j.cpr.2004.07.002; Mann JJ, 1999, AM J PSYCHIAT, V156, P181; McDaid C, 2008, BRIT J PSYCHIAT, V193, P438, DOI 10.1192/bjp.bp.107.040824; McMenamy JM, 2008, SUICIDE LIFE-THREAT, V38, P375, DOI 10.1521/suli.2008.38.4.375; Middel Berrie, 2002, Int J Integr Care, V2, pe15; Neeleman J, 2004, PSYCHOL MED, V34, P521, DOI 10.1017/S0033291703001193; Nolen-Hoeksema S., 2001, HDB BEREAVEMENT RES, P545, DOI DOI 10.1037/10436-023; PAYKEL ES, 1974, BRIT J PSYCHIAT, V124, P460, DOI 10.1192/bjp.124.5.460; PEARLIN LI, 1978, J HEALTH SOC BEHAV, V19, P2, DOI 10.2307/2136319; Peduzzi P, 1996, J CLIN EPIDEMIOL, V49, P1373, DOI 10.1016/S0895-4356(96)00236-3; Prigerson HG, 1999, AM J PSYCHIAT, V156, P1994; Prigerson HG, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000121; Qin P, 2002, LANCET, V360, P1126, DOI 10.1016/S0140-6736(02)11197-4; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Rosenberg M., 1965, MEASUREMENT SELF EST, P16; Seedat S, 2009, ARCH GEN PSYCHIAT, V66, P785, DOI 10.1001/archgenpsychiatry.2009.36; Stroebe M. S., 2007, J CONSULT CLIN PSYCH, V73, P617; Stroebe M, 2007, LANCET, V370, P1960, DOI 10.1016/S0140-6736(07)61816-9; Stroebe W., 2001, HDB BEREAVEMENT RES, P349, DOI DOI 10.1037/10436-015; Szanto K, 2006, J CLIN PSYCHIAT, V67, P233, DOI 10.4088/JCP.v67n0209; WHO, 2003, MORT DAT; Wittouck C, 2011, CLIN PSYCHOL REV, V31, P69, DOI 10.1016/j.cpr.2010.09.005; World Health Organization, 1992, SCHED CLIN ASS NEUR	39	32	33	1	23	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 2	2013	347								f5519	10.1136/bmj.f5519	http://dx.doi.org/10.1136/bmj.f5519			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	231OU	24089424	Green Published, hybrid			2022-12-24	WOS:000325427400007
J	Krabbenhoft, DP; Sunderland, EM				Krabbenhoft, David P.; Sunderland, Elsie M.			Global Change and Mercury	SCIENCE			English	Editorial Material							EMISSIONS		[Krabbenhoft, David P.] US Geol Survey, Middleton, WI 53562 USA; [Sunderland, Elsie M.] Harvard Univ, Sch Publ Hlth, Dept Environm Hlth, Cambridge, MA 02138 USA; [Sunderland, Elsie M.] Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA	United States Department of the Interior; United States Geological Survey; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University	Krabbenhoft, DP (corresponding author), US Geol Survey, 8505 Res Way, Middleton, WI 53562 USA.	dpkrabbe@usgs.gov	Sunderland, Elsie M/D-5511-2014	Sunderland, Elsie M/0000-0003-0386-9548				Amos HM, 2013, GLOBAL BIOGEOCHEM CY, V27, P410, DOI 10.1002/gbc.20040; Benoit JM, 2003, ACS SYM SER, V835, P262; Blum JD, 2013, NAT GEOSCI, V6, P879, DOI [10.1038/NGEO1918, 10.1038/ngeo1918]; Fitzgerald WF, 1998, ENVIRON SCI TECHNOL, V32, P1, DOI 10.1021/es970284w; Hararuk O, 2013, BIOGEOSCIENCES, V10, P2393, DOI 10.5194/bg-10-2393-2013; Harris RC, 2007, P NATL ACAD SCI USA, V104, P16586, DOI 10.1073/pnas.0704186104; Karagas MR, 2012, ENVIRON HEALTH PERSP, V120, P799, DOI 10.1289/ehp.1104494; Mason RP, 2012, ENVIRON RES, V119, P101, DOI 10.1016/j.envres.2012.03.013; Parks JM, 2013, SCIENCE, V339, P1332, DOI 10.1126/science.1230667; Rafaj P, 2013, ATMOS ENVIRON, V79, P472, DOI 10.1016/j.atmosenv.2013.06.042; Serrano O, 2013, GLOBAL BIOGEOCHEM CY, V27, P21, DOI 10.1029/2012GB004296; Stern GA, 2012, SCI TOTAL ENVIRON, V414, P22, DOI 10.1016/j.scitotenv.2011.10.039; Streets DG, 2011, ENVIRON SCI TECHNOL, V45, P10485, DOI 10.1021/es202765m; Streets DG, 2009, ENVIRON SCI TECHNOL, V43, P2983, DOI 10.1021/es802474j; United Nations Environment Programme, 2013, GLOBAL MERCURY ASSES	15	219	230	13	235	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 27	2013	341	6153					1457	1458		10.1126/science.1242838	http://dx.doi.org/10.1126/science.1242838			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	224NS	24072910				2022-12-24	WOS:000324894600032
J	Pedersen, ME; Snieckute, G; Kagias, K; Nehammer, C; Multhaupt, HAB; Couchman, JR; Pocock, R				Pedersen, Mikael Egebjerg; Snieckute, Goda; Kagias, Konstantinos; Nehammer, Camilla; Multhaupt, Hinke A. B.; Couchman, John R.; Pocock, Roger			An Epidermal MicroRNA Regulates Neuronal Migration Through Control of the Cellular Glycosylation State	SCIENCE			English	Article							CAENORHABDITIS-ELEGANS; HEPARAN-SULFATE; EARLY EMBRYOGENESIS; GLYPICAN LON-2; PROTEOGLYCANS; EXPRESSION; HOMOLOG; PROTEIN	An appropriate balance in glycosylation of proteoglycans is crucial for their ability to regulate animal development. Here, we report that the Caenorhabditis elegans microRNA mir-79, an ortholog of mammalian miR-9, controls sugar-chain homeostasis by targeting two proteins in the proteoglycan biosynthetic pathway: a chondroitin synthase (SQV-5; squashed vulva-5) and a uridine 5'-diphosphate-sugar transporter (SQV-7). Loss of mir-79 causes neurodevelopmental defects through SQV-5 and SQV-7 dysregulation in the epidermis. This results in a partial shutdown of heparan sulfate biosynthesis that impinges on a LON-2/glypican pathway and disrupts neuronal migration. Our results identify a regulatory axis controlled by a conserved microRNA that maintains proteoglycan homeostasis in cells.	[Pedersen, Mikael Egebjerg; Snieckute, Goda; Kagias, Konstantinos; Nehammer, Camilla; Pocock, Roger] Univ Copenhagen, Biotech Res & Innovat Ctr, Copenhagen, Denmark; [Multhaupt, Hinke A. B.; Couchman, John R.] Univ Copenhagen, Dept Biomed Sci, Copenhagen, Denmark	University of Copenhagen; University of Copenhagen	Pocock, R (corresponding author), Univ Copenhagen, Biotech Res & Innovat Ctr, Ole Maaloes Vej 5, Copenhagen, Denmark.	roger.pocock@bric.ku.dk	Pocock, Roger/AAQ-8526-2020	Pocock, Roger/0000-0002-5515-3608; Egebjerg, Mikael Mandrup/0000-0001-5258-2442; Snieckute, Goda/0000-0003-0738-0926	NIH Office of Research Infrastructure Programs [P40 OD010440]; European Research Council (ERC) [260807]; Lundbeck Foundation [R118-A11481, R44-A4407]; Danish National Research Foundation; Novo Nordisk Foundation; Lundbeck Foundation [R118-2012-11481] Funding Source: researchfish; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD010440] Funding Source: NIH RePORTER	NIH Office of Research Infrastructure Programs(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); European Research Council (ERC)(European Research Council (ERC)European Commission); Lundbeck Foundation(Lundbeckfonden); Danish National Research Foundation(Danmarks Grundforskningsfond); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Lundbeck Foundation(Lundbeckfonden); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank O. Hobert, H. Buelow, P. Brodersen, and A. Lund for comments on the manuscript and T. Gumienny for lon-2 strains and reagents. Some strains used in this study were provided by the Caenorhabditis Genetics Center, which is funded by NIH Office of Research Infrastructure Programs (P40 OD010440). This work was supported by grants from the European Research Council (ERC Starting Grant no. 260807 to R.P.), the Lundbeck Foundation (Project nos. R118-A11481 to R.P. and R44-A4407 to J.R.C.), the Danish National Research Foundation, and the Novo Nordisk Foundation (to J.R.C.).	Adler CE, 2006, NAT NEUROSCI, V9, P511, DOI 10.1038/nn1666; Bellaiche Y, 1998, NATURE, V394, P85, DOI 10.1038/27932; Berninsone P, 2001, P NATL ACAD SCI USA, V98, P3738, DOI 10.1073/pnas.061593098; Bulow HE, 2008, CURR BIOL, V18, P1978, DOI 10.1016/j.cub.2008.11.023; Bulow HE, 2006, ANNU REV CELL DEV BI, V22, P375, DOI 10.1146/annurev.cellbio.22.010605.093433; Bulow HE, 2004, NEURON, V41, P723, DOI 10.1016/S0896-6273(04)00084-4; Couchman J R, 1984, Prog Clin Biol Res, V151, P31; Couchman JR, 2010, ANNU REV CELL DEV BI, V26, P89, DOI 10.1146/annurev-cellbio-100109-104126; DAVID G, 1992, J CELL BIOL, V119, P961, DOI 10.1083/jcb.119.4.961; DESAI C, 1988, NATURE, V336, P638, DOI 10.1038/336638a0; Forsberg M, 2012, J BIOL CHEM, V287, P10853, DOI 10.1074/jbc.M111.337030; Gumienny TL, 2007, CURR BIOL, V17, P159, DOI 10.1016/j.cub.2006.11.065; Hafner M, 2010, CELL, V141, P129, DOI 10.1016/j.cell.2010.03.009; Herman T, 1999, P NATL ACAD SCI USA, V96, P968, DOI 10.1073/pnas.96.3.968; Hwang HY, 2003, NATURE, V423, P439, DOI 10.1038/nature01634; Kato M, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-5-r54; Kinnunen T, 2005, P NATL ACAD SCI USA, V102, P1507, DOI 10.1073/pnas.0401591102; Kitagawa H, 2001, J BIOL CHEM, V276, P4834, DOI 10.1074/jbc.C000835200; KJELLEN L, 1991, ANNU REV BIOCHEM, V60, P443, DOI 10.1146/annurev.bi.60.070191.002303; Lehrbach NJ, 2009, NAT STRUCT MOL BIOL, V16, P1016, DOI 10.1038/nsmb.1675; LIDHOLT K, 1992, P NATL ACAD SCI USA, V89, P2267, DOI 10.1073/pnas.89.6.2267; Mizuguchi S, 2003, NATURE, V423, P443, DOI 10.1038/nature01635; Pocock R, 2008, NAT NEUROSCI, V11, P894, DOI 10.1038/nn.2152; Selva EM, 2001, NAT CELL BIOL, V3, P809, DOI 10.1038/ncb0901-809; Sun AX, 2013, CURR OPIN CELL BIOL, V25, P215, DOI 10.1016/j.ceb.2012.12.007; Taneja-Bageshwar S, 2012, DEV BIOL, V371, P66, DOI 10.1016/j.ydbio.2012.08.006; Tian J, 2010, AM J HUM GENET, V87, P768, DOI 10.1016/j.ajhg.2010.11.005	27	57	63	0	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 20	2013	341	6152					1404	1408		10.1126/science.1242528	http://dx.doi.org/10.1126/science.1242528			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	220PK	24052309				2022-12-24	WOS:000324597200049
J	Almaca, J; Faria, D; Sousa, M; Uliyakina, I; Conrad, C; Sirianant, L; Clarke, LA; Martins, JP; Santos, M; Heriche, JK; Huber, W; Schreiber, R; Pepperkok, R; Kunzelmann, K; Amaral, MD				Almaca, Joana; Faria, Diana; Sousa, Marisa; Uliyakina, Inna; Conrad, Christian; Sirianant, Lalida; Clarke, Luka A.; Martins, Jose Paulo; Santos, Miguel; Heriche, Jean-Karim; Huber, Wolfgang; Schreiber, Rainer; Pepperkok, Rainer; Kunzelmann, Karl; Amaral, Margarida D.			High-Content siRNA Screen Reveals Global ENaC Regulators and Potential Cystic Fibrosis Therapy Targets	CELL			English	Article							EPITHELIAL SODIUM-CHANNEL; TRANSMEMBRANE CONDUCTANCE REGULATOR; NA+ CHANNEL; LUNG-DISEASE; ION CHANNELS; HUMAN GENOME; CFTR; TRANSPORT; AMILORIDE; CELLS	Dysfunction of ENaC, the epithelial sodium channel that regulates salt and water reabsorption in epithelia, causes several human diseases, including cystic fibrosis (CF). To develop a global understanding of molecular regulators of ENaC traffic/function and to identify of candidate CF drug targets, we performed a large-scale screen combining high-content live-cell microscopy and siRNAs in human airway epithelial cells. Screening over 6,000 genes identified over 1,500 candidates, evenly divided between channel inhibitors and activators. Genes in the phosphatidylinositol pathway were enriched on the primary candidate list, and these, along with other ENaC activators, were examined further with secondary siRNA validation. Subsequent detailed investigation revealed ciliary neurotrophic factor receptor (CNTFR) as an ENaC modulator and showed that inhibition of (diacylglycerol kinase, iota) DGKi, a protein involved in PiP2 metabolism, downgrades ENaC activity, leading to normalization of both Na+ and fluid absorption in CF airways to non-CF levels in primary human lung cells from CF patients.	[Almaca, Joana; Faria, Diana; Sousa, Marisa; Uliyakina, Inna; Clarke, Luka A.; Amaral, Margarida D.] Univ Lisbon, Fac Sci, BioFIG Ctr Biodivers Funct & Integrat Genom, P-1749016 Lisbon, Portugal; [Faria, Diana; Sirianant, Lalida; Schreiber, Rainer; Kunzelmann, Karl] Univ Regensburg, Dept Physiol, D-93053 Regensburg, Germany; [Conrad, Christian; Heriche, Jean-Karim; Huber, Wolfgang; Pepperkok, Rainer] EMBL, Cell Biol Biophys Unit, D-69117 Heidelberg, Germany; [Martins, Jose Paulo; Santos, Miguel] EcBio R&D Biotechnol SA, P-2700451 Amadora, Portugal	Universidade de Lisboa; University of Regensburg; European Molecular Biology Laboratory (EMBL)	Amaral, MD (corresponding author), Univ Lisbon, Fac Sci, BioFIG Ctr Biodivers Funct & Integrat Genom, C8 Bdg, P-1749016 Lisbon, Portugal.	mdamaral@fc.ul.pt	Amaral, Margarida D/E-5748-2012; Clarke, Luka A/E-5843-2012; Martins, Paulo/P-5735-2014; Santos, Jorge Miguel/B-9967-2018	Amaral, Margarida D/0000-0002-0828-8630; Clarke, Luka A/0000-0003-3254-9121; Martins, Paulo/0000-0002-2360-403X; Santos, Jorge Miguel/0000-0002-9432-3171; Pepperkok, Rainer/0000-0002-9762-3583; SOUSA, MARISA/0000-0003-2305-4813; Kunzelmann, Karl/0000-0002-4583-7037; Huber, Wolfgang/0000-0002-0474-2218; Almaca, Joana/0000-0002-9316-712X; Uliyakina, Inna/0000-0002-7091-2123; Heriche, Jean-Karim/0000-0001-6867-9425; Faria, Diana/0000-0002-9861-0282	EU [LSH-2005-1.2.5-3-037365, PEst-OE/BIA/UI4046/2011, FCT/POCTI-PTDC/SAU-GMG/122299/2010]	EU(European Commission)	This work was supported by EU-grant TargetScreen2 (LSH-2005-1.2.5-3-037365), strategic grant PEst-OE/BIA/UI4046/2011 (BioFIG), and FCT/POCTI-PTDC/SAU-GMG/122299/2010; DFG SFB699 A6; Vs. 28.12.2010. J.A., D. F., M. S., and I. U. were recipients of PhD fellowships SFRH/BD/29134/2006, SFRH/BD/43313/2008, SFRH/BD/35936/2007, and SFRH/BD/69180/2010, respectively, from FCT, Portugal. We acknowledge the scientific support of Drs. Beate Neumann and Thomas Walter as well as the expert technical assistance by Miriam Reiss, Jutta Bulkescher, Brigitte Joggerst-Thomalla, Marta Palma, Tze Heng, and Volker Hilsenstein, assistance with with microscope programming by Siegfrid Winkler, and data analysis by the electronic workshop from EMBL, Heidelberg. The authors are grateful to Professor J. Fragata and his team at the Cardio-Thoracic Surgery Department of the Hospital de Santa Marta (Lisboa) for access to explanted lungs from CF patients, to Professor Jens Leipziger (Aarhus University, Denmark) for critically revising the manuscript, and to Dr. Michael Gray (Newcastle University, UK) for comments. R. P., K. K., and M. D. A. designed the study; J. A., D. F., M. S., I. U., L. S., L. A. C., J. P. M., and M. S. performed experiments and generated data; J. A., D. F., M. S., I. U., L. S., L. A. C., J.-K. H., C. C., W. H., and R. S. analyzed data; L. A. C., C. C., R. S., R. P., K. K., and M. D. A. interpreted data; J. A., K. K., and M. D. A. wrote the article; R. P., K. K., and M. D. A. revised the article; R. P., K. K., and M. D. A. obtained funding. All authors approved the final manuscript.	Almaca J, 2011, METHODS MOL BIOL, V742, P249, DOI 10.1007/978-1-61779-120-8_15; Althaus M, 2011, PULM MED, V2011, DOI 10.1155/2011/830320; Amaral MD, 2007, TRENDS PHARMACOL SCI, V28, P334, DOI 10.1016/j.tips.2007.05.004; Bonny O, 2000, KIDNEY INT, V57, P1313, DOI 10.1046/j.1523-1755.2000.00968.x; BOUCHER RC, 1988, J PHYSIOL-LONDON, V405, P77, DOI 10.1113/jphysiol.1988.sp017322; Boucher RC, 2007, TRENDS MOL MED, V13, P231, DOI 10.1016/j.molmed.2007.05.001; Bryant DM, 2008, NAT REV MOL CELL BIO, V9, P887, DOI 10.1038/nrm2523; Butterworth MB, 2009, AM J PHYSIOL-RENAL, V296, pF10, DOI 10.1152/ajprenal.90248.2008; CANESSA CM, 1994, NATURE, V367, P463, DOI 10.1038/367463a0; Carbon S, 2009, BIOINFORMATICS, V25, P288, DOI 10.1093/bioinformatics/btn615; Chen JH, 2010, CELL, V143, P911, DOI 10.1016/j.cell.2010.11.029; Chung NJ, 2008, J BIOMOL SCREEN, V13, P149, DOI 10.1177/1087057107312035; Clarke LA, 2013, RESP RES, V14, DOI 10.1186/1465-9921-14-38; Clunes LA, 2012, FASEB J, V26, P533, DOI 10.1096/fj.11-192377; Debonneville C, 2001, EMBO J, V20, P7052, DOI 10.1093/emboj/20.24.7052; Donaldson SH, 2007, CHEST, V132, P1631, DOI 10.1378/chest.07-0288; Donaldson SH, 2006, NEW ENGL J MED, V354, P241, DOI 10.1056/NEJMoa043891; Erfle H, 2007, NAT PROTOC, V2, P392, DOI 10.1038/nprot.2006.483; Filigheddu N, 2011, CELL SIGNAL, V23, P1988, DOI 10.1016/j.cellsig.2011.07.009; Gaillard EA, 2010, PFLUG ARCH EUR J PHY, V460, P1, DOI 10.1007/s00424-010-0827-z; Galvez-Santisteban M, 2012, NAT CELL BIOL, V14, P838, DOI 10.1038/ncb2541; Gentzsch M, 2010, J BIOL CHEM, V285, P32227, DOI 10.1074/jbc.M110.155259; Hirsh AJ, 2006, J MED CHEM, V49, P4098, DOI 10.1021/jm051134w; Holden NJ, 2011, MOL MED, V17, P1242, DOI 10.2119/molmed.2011.00028; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Itani OA, 2002, AM J PHYSIOL-LUNG C, V282, pL631, DOI 10.1152/ajplung.00085.2001; Ji HL, 2006, J BIOL CHEM, V281, P8233, DOI 10.1074/jbc.M512293200; Kimura T, 2011, P NATL ACAD SCI USA, V108, P3216, DOI 10.1073/pnas.1010334108; KNOWLES MR, 1990, NEW ENGL J MED, V322, P1189, DOI 10.1056/NEJM199004263221704; Koehl GE, 2010, ONCOGENE, V29, P1553, DOI 10.1038/onc.2009.435; Kunzelmann K, 2004, FASEB J, V18, P142, DOI 10.1096/fj.04-2314fje; KUNZELMANN K, 1995, PFLUG ARCH EUR J PHY, V431, P1, DOI 10.1007/BF00374371; Kunzelmann K, 2012, INT J BIOCHEM CELL B, V44, P1232, DOI 10.1016/j.biocel.2012.04.012; Lifton RP, 2001, CELL, V104, P545, DOI 10.1016/S0092-8674(01)00241-0; Lu M, 2010, J AM SOC NEPHROL, V21, P811, DOI 10.1681/ASN.2009111168; Mall M, 2004, NAT MED, V10, P487, DOI 10.1038/nm1028; Mall M, 1998, J CLIN INVEST, V102, P15, DOI 10.1172/JCI2729; Marumo M, 2012, J PHARM PHARMACOL, V64, P855, DOI 10.1111/j.2042-7158.2012.01485.x; Moniz S, 2013, ACS CHEM BIOL, V8, P432, DOI 10.1021/cb300484r; Neumann B, 2010, NATURE, V464, P721, DOI 10.1038/nature08869; OBRODOVICH H, 1991, AM J PHYSIOL, V261, pC555, DOI 10.1152/ajpcell.1991.261.4.C555; Ogilvie V, 2011, GENOMICS, V98, P327, DOI 10.1016/j.ygeno.2011.06.008; Otulakowski G, 2007, AM J RESP CELL MOL, V37, P457, DOI 10.1165/rcmb.2007-0055OC; Ousingsawat J, 2008, PFLUG ARCH EUR J PHY, V456, P847, DOI 10.1007/s00424-008-0451-3; Pochynyuk O, 2008, CURR OPIN NEPHROL HY, V17, P533, DOI 10.1097/MNH.0b013e328308fff3; Pochynyuk O, 2007, J GEN PHYSIOL, V130, P399, DOI 10.1085/jgp.200709800; Riordan JR, 2008, ANNU REV BIOCHEM, V77, P701, DOI 10.1146/annurev.biochem.75.103004.142532; Ritzerfeld J, 2011, GENOME RES, V21, P1955, DOI 10.1101/gr.116087.110; Ross AJ, 2007, AM J RESP CELL MOL, V37, P169, DOI 10.1165/rcmb.2006-0466OC; Ruffieux-Daidie D, 2008, J AM SOC NEPHROL, V19, P2170, DOI 10.1681/ASN.2007101130; Simpson JC, 2012, NAT CELL BIOL, V14, P764, DOI 10.1038/ncb2510; SNOUWAERT JN, 1992, SCIENCE, V257, P1083, DOI 10.1126/science.257.5073.1083; Staub O, 1997, EMBO J, V16, P6325, DOI 10.1093/emboj/16.21.6325; Stockando JD, 2000, J BIOL CHEM, V275, P25760, DOI 10.1074/jbc.M003615200; Wang XD, 2006, CELL, V127, P803, DOI 10.1016/j.cell.2006.09.043; Yokogami K, 2000, CURR BIOL, V10, P47, DOI 10.1016/S0960-9822(99)00268-7; Yue G, 2002, J BIOL CHEM, V277, P11965, DOI 10.1074/jbc.M108951200	57	42	43	0	30	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 12	2013	154	6					1390	1400		10.1016/j.cell.2013.08.045	http://dx.doi.org/10.1016/j.cell.2013.08.045			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	215VQ	24034256	Bronze			2022-12-24	WOS:000324239300025
J	Lorthongpanich, C; Cheow, LF; Balu, S; Quake, SR; Knowles, BB; Burkholder, WF; Solter, D; Messerschmidt, DM				Lorthongpanich, Chanchao; Cheow, Lih Feng; Balu, Sathish; Quake, Stephen R.; Knowles, Barbara B.; Burkholder, William F.; Solter, Davor; Messerschmidt, Daniel M.			Single-Cell DNA-Methylation Analysis Reveals Epigenetic Chimerism in Preimplantation Embryos	SCIENCE			English	Article							ZINC-FINGER PROTEIN; STEM-CELLS; DISEASE; ZFP57; MAINTENANCE; IMPRINTS; GENE; HYPOMETHYLATION; MAINTAINS; DOMAIN	Epigenetic alterations are increasingly recognized as causes of human cancers and disease. These aberrations are likely to arise during genomic reprogramming in mammalian preimplantation embryos, when their epigenomes are most vulnerable. However, this process is only partially understood because of the experimental inaccessibility of early-stage embryos. Here, we introduce a methodologic advance, probing single cells for various DNA-methylation errors at multiple loci, to reveal failed maintenance of epigenetic mark results in chimeric mice, which display unpredictable phenotypes leading to developmental arrest. Yet we show that mouse pronuclear transfer can be used to ameliorate such reprogramming defects. This study not only details the epigenetic reprogramming dynamics in early mammalian embryos but also suggests diagnostic and potential future therapeutic applications.	[Lorthongpanich, Chanchao; Balu, Sathish; Knowles, Barbara B.; Solter, Davor; Messerschmidt, Daniel M.] ASTAR, Inst Med Biol IMB, Mammalian Dev Grp, Singapore, Singapore; [Cheow, Lih Feng; Quake, Stephen R.; Burkholder, William F.] ASTAR, Inst Mol & Cell Biol IMCB, Microfluid Syst Biol Lab, Singapore, Singapore; [Quake, Stephen R.] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Quake, Stephen R.] Stanford Univ, Dept Appl Phys, Stanford, CA 94305 USA; [Quake, Stephen R.] Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA; [Knowles, Barbara B.] Jackson Lab, Bar Harbor, ME 04609 USA; [Burkholder, William F.] ASTAR, Genome Inst Singapore, Singapore, Singapore; [Burkholder, William F.] Nanyang Technol Univ, Singapore 639798, Singapore; [Solter, Davor] Duke Natl Univ Singapore, Grad Sch Med, Singapore, Singapore; [Messerschmidt, Daniel M.] ASTAR, IMCB, Singapore, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Medical Biology (IMB); Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); Stanford University; Stanford University; Howard Hughes Medical Institute; Stanford University; Jackson Laboratory; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; National University of Singapore; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB)	Burkholder, WF (corresponding author), ASTAR, Inst Mol & Cell Biol IMCB, Microfluid Syst Biol Lab, Singapore, Singapore.	wfburkholder@gmail.com; danielm@imcb.a-star.edu.sg	Solter, Davor/Q-5476-2019; Messerschmidt, Daniel Martin/W-7193-2019; t, lf/AAJ-4924-2020	Messerschmidt, Daniel Martin/0000-0003-2022-4696; Knowles, Barbara B./0000-0002-2597-5619; Cheow, Lih Feng/0000-0003-1766-0024	IMB; IMCB; Joint Council Office, A*STAR [0921100080]	IMB(Centre National de la Recherche Scientifique (CNRS)Agency for Science Technology & Research (A*STAR)); IMCB(Agency for Science Technology & Research (A*STAR)); Joint Council Office, A*STAR	We thank H. Wollmann for scientific input and proofreading the manuscript. This work was supported by IMB, IMCB, and a Visiting Investigator Program grant from the Joint Council Office, A*STAR to S. R. Q. (project 0921100080). S. R. Q. is a founder, consultant, member of the advisory board, and equity holder of Fluidgm.	Craven L, 2010, NATURE, V465, P82, DOI 10.1038/nature08958; Ferguson-Smith AC, 2011, NAT REV GENET, V12, P565, DOI 10.1038/nrg3032; Hajkova P, 2010, CURR OPIN CELL BIOL, V22, P342, DOI 10.1016/j.ceb.2010.04.011; Hirasawa R, 2008, DEV CELL, V15, P487, DOI 10.1016/j.devcel.2008.09.006; Hirasawa R, 2008, GENE DEV, V22, P1607, DOI 10.1101/gad.1667008; Howell CY, 2001, CELL, V104, P829, DOI 10.1016/S0092-8674(01)00280-X; Kantlehner M, 2011, NUCLEIC ACIDS RES, V39, pE44, DOI 10.1093/nar/gkq1357; Kelsey G, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2011.0336; Kohda T, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0353; Lee JT, 2013, CELL, V152, P1308, DOI 10.1016/j.cell.2013.02.016; Li XJ, 2008, DEV CELL, V15, P547, DOI 10.1016/j.devcel.2008.08.014; Liu YW, 2012, GENE DEV, V26, P2374, DOI 10.1101/gad.202200.112; Lorthongpanich C, 2012, DEVELOPMENT, V139, P3722, DOI 10.1242/dev.086454; Mackay DJG, 2006, HUM GENET, V120, P262, DOI 10.1007/s00439-006-0205-2; Mackay DJG, 2008, NAT GENET, V40, P949, DOI 10.1038/ng.187; MCGRATH J, 1983, SCIENCE, V220, P1300, DOI 10.1126/science.6857250; Messerschmidt DM, 2012, EPIGENETICS-US, V7, P969, DOI 10.4161/epi.21337; Messerschmidt DM, 2012, SCIENCE, V335, P1499, DOI 10.1126/science.1216154; Nakamura T, 2007, NAT CELL BIOL, V9, P64, DOI 10.1038/ncb1519; Paull D, 2013, NATURE, V493, P632, DOI 10.1038/nature11800; Quenneville S, 2011, MOL CELL, V44, P361, DOI 10.1016/j.molcel.2011.08.032; Roberts RJ, 2010, NUCLEIC ACIDS RES, V38, pD234, DOI 10.1093/nar/gkp874; Strogantsev R, 2012, BRIEF FUNCT GENOMICS, V11, P227, DOI 10.1093/bfgp/els018; Tachibana M, 2013, NATURE, V493, P627, DOI 10.1038/nature11647; Tomizawa S, 2012, J HUM GENET, V57, P84, DOI 10.1038/jhg.2011.151; Toppings M, 2008, HUM REPROD, V23, P807, DOI 10.1093/humrep/den009; Wossidlo M, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1240; Zuo XP, 2012, J BIOL CHEM, V287, P2107, DOI 10.1074/jbc.M111.322644	28	119	126	2	87	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 6	2013	341	6150					1110	1112		10.1126/science.1240617	http://dx.doi.org/10.1126/science.1240617			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	211TG	24009393	Green Accepted			2022-12-24	WOS:000323933100044
J	McWilliams, JM; Landon, BE; Chernew, ME				McWilliams, J. Michael; Landon, Bruce E.; Chernew, Michael E.			Changes in Health Care Spending and Quality for Medicare Beneficiaries Associated With a Commercial ACO Contract	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ALTERNATIVE QUALITY; MASSACHUSETTS; COSTS	IMPORTANCE In a multipayer system, new payment incentives implemented by one insurer for an accountable care organization (ACO) may also affect spending and quality of care for another insurer's enrollees served by the ACO. Such spillover effects reflect the extent of organizational efforts to reform care delivery and can contribute to the net impact of ACOs. OBJECTIVE We examined whether the Blue Cross Blue Shield (BCBS) of Massachusetts' Alternative Quality Contract (AQC), an early commercial ACO initiative associated with reduced spending and improved quality for BCBS enrollees, was also associated with changes in spending and quality for Medicare beneficiaries, who were not covered by the AQC. DESIGN, SETTING, AND PARTICIPANTS Quasi-experimental comparisons from 2007-2010 of elderly fee-for-service Medicare beneficiaries in Massachusetts (1 761 325 person-years) served by 11 provider organizations entering the AQC in 2009 or 2010 (intervention group) vs beneficiaries served by other providers (control group). Using a difference-in-differences approach, we estimated changes in spending and quality for the intervention group in the first and second years of exposure to the AQC relative to concurrent changes for the control group. Regression and propensity score methods were used to adjust for differences in sociodemographic and clinical characteristics. MAIN OUTCOMES AND MEASURES The primary outcome was total quarterly medical spending per beneficiary. Secondary outcomes included spending by setting and type of service, 5 process measures of quality, potentially avoidable hospitalizations, and 30-day readmissions. RESULTS Before entering the AQC, total quarterly spending per beneficiary for the intervention group was $150 (95% CI, $25-$274) higher than for the control group and increased at a similar rate. In year 2 of the intervention group's exposure to the AQC, this difference was reduced to $51 (95% CI, -$109 to $210; P = .53), constituting a significant differential change of -$99 (95% CI, -$183 to -$16; P = .02) or a 3.4% savings relative to an expected quarterly mean of $2895. Savings in year 1 were not significant (differential change, -$34; 95% CI, -$83 to $16; P = .18). Year 2 savings derived largely from lower spending on outpatient care (differential change, -$73; 95% CI, -$97 to -$50; P < .001), particularly for beneficiaries with 5 or more conditions, and included significant differential changes in spending on procedures, imaging, and tests. Annual rates of low-density lipoprotein cholesterol testing differentially improved for beneficiaries with diabetes in the intervention group by 3.1 percentage points (95% CI, 1.4-4.8 percentage points; P < .001) and for those with cardiovascular disease by 2.5 percentage points (95% CI, 1.1-4.0 percentage points; P < .001), but performance on other quality measures did not differentially change. CONCLUSIONS AND RELEVANCE The AQC was associated with lower spending for Medicare beneficiaries but not with consistently improved quality. Savings among Medicare beneficiaries and previously demonstrated savings among BCBS enrollees varied similarly across settings, services, and time, suggesting that organizational responses were associated with broad changes in patient care.	[McWilliams, J. Michael; Landon, Bruce E.; Chernew, Michael E.] Harvard Univ, Sch Med, Dept Hlth Care Policy, Boston, MA 02115 USA; [McWilliams, J. Michael] Brigham & Womens Hosp, Dept Med, Div Gen Internal Med & Primary Care, Boston, MA 02115 USA; [McWilliams, J. Michael] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Landon, Bruce E.] Beth Israel Deaconess Med Ctr, Dept Med, Div Gen Internal Med & Primary Care, Boston, MA 02215 USA	Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center	McWilliams, JM (corresponding author), Harvard Univ, Sch Med, Dept Hlth Care Policy, 180 Longwood Ave, Boston, MA 02115 USA.	mcwilliams@hcp.med.harvard.edu			Beeson Career Development Award Program (National Institute on Aging) [K08 AG038354]; Beeson Career Development Award Program (American Federation for Aging Research); Doris Duke Charitable Foundation (Clinical Scientist Development Award) [2010053]; National Institute on Aging [P01 AG032952]; Commonwealth Fund [20110391]; NATIONAL INSTITUTE ON AGING [K08AG038354, P01AG032952] Funding Source: NIH RePORTER	Beeson Career Development Award Program (National Institute on Aging); Beeson Career Development Award Program (American Federation for Aging Research); Doris Duke Charitable Foundation (Clinical Scientist Development Award)(American Heart AssociationDoris Duke Charitable Foundation (DDCF)); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Commonwealth Fund; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was supported by grants from the Beeson Career Development Award Program (National Institute on Aging grant K08 AG038354 and the American Federation for Aging Research), the Doris Duke Charitable Foundation (Clinical Scientist Development Award 2010053), the National Institute on Aging (grant P01 AG032952), and the Commonwealth Fund (grant 20110391).	Agency for Healthcare Research and Quality, 2013, PREVENTION QUALITY I; Ayanian JZ, 2012, NEW ENGL J MED, V367, P790, DOI 10.1056/NEJMp1208710; BINDER DA, 1983, INT STAT REV, V51, P279, DOI 10.2307/1402588; Buntin MB, 2004, J HEALTH ECON, V23, P525, DOI 10.1016/j.jhealeco.2003.10.005; Center for Medicare and Medicaid Innovation, 2011, PIONEER ACCOUNTABLE; Centers for Medicare & Medicaid Services, CHRONIC CONDITION DA; Centers for Medicare & Medicaid Services, 2012, CMS NAMES 88 NEW MED; Centers for Medicare & Medicaid Services, 2012, FIRST ACCOUNTABLE CA; Centers for Medicare & Medicaid Services, BERENSON EGGERS TYPE; Centers for Medicare & Medicaid Services, 2013, MORE DOCTORS HOSPITA; Centers for Medicare & Medicaid Services Office of Research Development and Information, 2009, PHYSICIAN GROUP PRAC; Colla CH, 2012, JAMA-J AM MED ASSOC, V308, P1015, DOI 10.1001/2012.jama.10812; Commonwealth of Massachusetts, 2013, AN ACT IMPROVING THE; Department of Health and Human Services, 2004, HIPAA ADMINISTRATIVE; Department of Health and Human Services; Centers for Medicare & Medicaid Services, 2011, MEDICARE SHARED SAVI; Fisher ES, 2009, HEALTH AFFAIR, V28, pW219, DOI 10.1377/hlthaff.28.2.w219; Fisher ES, 2003, ANN INTERN MED, V138, P273, DOI 10.7326/0003-4819-138-4-200302180-00006; Funk MJ, 2011, AM J EPIDEMIOL, V173, P761, DOI 10.1093/aje/kwq439; Ghandi N, 2012, THE ACO SURPRISE; MCGUIRE TG, 1991, J HEALTH ECON, V10, P385, DOI 10.1016/0167-6296(91)90022-F; McWilliams JM, 2007, NEW ENGL J MED, V357, P143, DOI 10.1056/NEJMsa067712; McWilliams JM, 2013, JAMA INTERN MED, V173, P1447, DOI 10.1001/jamainternmed.2013.6886; McWilliams JM, 2013, HEALTH SERV RES, V48, P1526, DOI 10.1111/1475-6773.12032; McWilliams JM, 2004, HEALTH AFFAIR, V23, P223, DOI 10.1377/hlthaff.23.4.223; Mechanic RE, 2011, HEALTH AFFAIR, V30, P1734, DOI 10.1377/hlthaff.2011.0264; Medicare Payment Advisory Commission, 2009, REPORT TO THE CONGRE; Medicare Payment Advisory Commission, 2011, REP C MED PAYM POL; Song ZR, 2013, JAMA INTERN MED, V173, P15, DOI 10.1001/jamainternmed.2013.1125; Song ZR, 2012, HEALTH AFFAIR, V31, P1885, DOI 10.1377/hlthaff.2012.0327; Song Z, 2011, NEW ENGL J MED, V365, P909, DOI 10.1056/NEJMsa1101416; Steinbrook R, 2012, JAMA-J AM MED ASSOC, V308, P1215, DOI 10.1001/2012.jama.11322; US Census Bureau, 2010 AMERICAN COMMUN; Wennberg John E, 2002, Health Aff (Millwood), VSuppl Web Exclusives, pW96; Zuvekas SH, 2010, HEALTH AFFAIR, V29, P1661, DOI 10.1377/hlthaff.2009.0361	34	100	100	0	25	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 28	2013	310	8					829	836		10.1001/jama.2013.276302	http://dx.doi.org/10.1001/jama.2013.276302			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	206YA	23982369	Green Accepted			2022-12-24	WOS:000323561400023
J	Park, JH; Goldstein, AH; Timkovsky, J; Fares, S; Weber, R; Karlik, J; Holzinger, R				Park, J. -H.; Goldstein, A. H.; Timkovsky, J.; Fares, S.; Weber, R.; Karlik, J.; Holzinger, R.			Active Atmosphere-Ecosystem Exchange of the Vast Majority of Detected Volatile Organic Compounds	SCIENCE			English	Article							PROTON-TRANSFER-REACTION; AEROSOL; FOREST; EMISSION	Numerous volatile organic compounds (VOCs) exist in Earth's atmosphere, most of which originate from biogenic emissions. Despite VOCs' critical role in tropospheric chemistry, studies for evaluating their atmosphere-ecosystem exchange (emission and deposition) have been limited to a few dominant compounds owing to a lack of appropriate measurement techniques. Using a high-mass resolution proton transfer reaction-time of flight-mass spectrometer and an absolute value eddy-covariance method, we directly measured 186 organic ions with net deposition, and 494 that have bidirectional flux. This observation of active atmosphere-ecosystem exchange of the vast majority of detected VOCs poses a challenge to current emission, air quality, and global climate models, which do not account for this extremely large range of compounds. This observation also provides new insight for understanding the atmospheric VOC budget.	[Park, J. -H.; Goldstein, A. H.; Fares, S.; Weber, R.] Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA; [Park, J. -H.; Timkovsky, J.; Holzinger, R.] Inst Marine & Atmospher Res Utrecht, NL-3584 CC Utrecht, Netherlands; [Goldstein, A. H.] Univ Calif Berkeley, Dept Civil & Environm Engn, Berkeley, CA 94720 USA; [Fares, S.] Res Ctr Soil Plant Syst, Consiglio Ric & Sperimentaz Agr, Rome, Italy; [Karlik, J.] Univ Calif Cooperat Extens, Bakersfield, CA 93307 USA	University of California System; University of California Berkeley; Utrecht University; University of California System; University of California Berkeley; Consiglio per la Ricerca in Agricoltura e L'analisi Dell'economia Agraria (CREA); University of California System	Goldstein, AH (corresponding author), Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA.	ahg@berkeley.edu	Holzinger, Rupert/C-9160-2009; Goldstein, Allen H/A-6857-2011; Fares, Silvano/H-4322-2011; Park, Jeong-Hoo/I-2923-2013	Holzinger, Rupert/0000-0003-1902-1824; Goldstein, Allen H/0000-0003-4014-4896; Fares, Silvano/0000-0002-1990-0928; 	Netherlands Organization for Scientific Research (NWO) under the ALW-Middelgroot program [834.08.002]; California Air Resources Board [06-329]; Citrus Research Board; University of Utrecht	Netherlands Organization for Scientific Research (NWO) under the ALW-Middelgroot program(Netherlands Organization for Scientific Research (NWO)); California Air Resources Board; Citrus Research Board; University of Utrecht	This work was supported by the Netherlands Organization for Scientific Research (NWO) under the ALW-Middelgroot program (grant 834.08.002), the California Air Resources Board (Award 06-329), the Citrus Research Board, and the University of Utrecht short stay fellowship program. We thank the Gorden Ranch for hosting this study and for the assistance provided by the University of California Lindcove Research and Extension station.	Andreae MO, 1997, SCIENCE, V276, P1052, DOI 10.1126/science.276.5315.1052; CHAMEIDES WL, 1988, SCIENCE, V241, P1473, DOI 10.1126/science.3420404; Di Carlo P, 2004, SCIENCE, V304, P722, DOI 10.1126/science.1094392; Goldstein AH, 2007, ENVIRON SCI TECHNOL, V41, P1514, DOI 10.1021/es072476p; Graus M, 2010, J AM SOC MASS SPECTR, V21, P1037, DOI 10.1016/j.jasms.2010.02.006; GUENTHER A, 1995, J GEOPHYS RES-ATMOS, V100, P8873, DOI 10.1029/94JD02950; Hallquist M, 2009, ATMOS CHEM PHYS, V9, P5155, DOI 10.5194/acp-9-5155-2009; Holzinger R, 2005, ATMOS CHEM PHYS, V5, P67, DOI 10.5194/acp-5-67-2005; Holzinger R, 2010, ATMOS CHEM PHYS, V10, P10111, DOI 10.5194/acp-10-10111-2010; Jang MS, 2002, SCIENCE, V298, P814, DOI 10.1126/science.1075798; Jordan A, 2009, INT J MASS SPECTROM, V286, P122, DOI 10.1016/j.ijms.2009.07.005; Karl T, 2010, SCIENCE, V330, P816, DOI 10.1126/science.1192534; Kurpius MR, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2002GL016785; Lee A, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2006JD007050; Park JH, 2013, ATMOS CHEM PHYS, V13, P1439, DOI 10.5194/acp-13-1439-2013; Ruuskanen TM, 2011, ATMOS CHEM PHYS, V11, P611, DOI 10.5194/acp-11-611-2011	16	164	167	5	287	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 9	2013	341	6146					643	647		10.1126/science.1235053	http://dx.doi.org/10.1126/science.1235053			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	197XC	23929979				2022-12-24	WOS:000322884800035
J	Spence, D				Spence, Des			Bad medicine: atrial fibrillation	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							RISK STRATIFICATION SCHEMES; STROKE; ANTICOAGULATION; WARFARIN					destwo@yahoo.co.uk						Bradley A, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f3719; British Heart Foundation, 2009, STROK STAT 2009; Hart RG, 2012, STROKE, V43, P1511, DOI 10.1161/STROKEAHA.112.650614; Hart RG, 2009, STROKE, V40, P2607, DOI 10.1161/STROKEAHA.109.549428; Lloyd-Jones DM, 2004, CIRCULATION, V110, P1042, DOI 10.1161/01.CIR.0000140263.20897.42; Olesen JB, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d124; Singer DE, 2009, ANN INTERN MED, V151, P297, DOI 10.7326/0003-4819-151-5-200909010-00003; van Staa TP, 2011, J THROMB HAEMOST, V9, P39, DOI 10.1111/j.1538-7836.2010.04085.x	8	0	0	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 7	2013	347								f4910	10.1136/bmj.f4910	http://dx.doi.org/10.1136/bmj.f4910			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	201CY	23924656				2022-12-24	WOS:000323119500014
J	Batterman, SA; Hedin, LO; van Breugel, M; Ransijn, J; Craven, DJ; Hall, JS				Batterman, Sarah A.; Hedin, Lars O.; van Breugel, Michiel; Ransijn, Johannes; Craven, Dylan J.; Hall, Jefferson S.			Key role of symbiotic dinitrogen fixation in tropical forest secondary succession	NATURE			English	Article							NITROGEN-FIXATION; PHOSPHORUS LIMITATION; BIOMASS; DYNAMICS; GROWTH; LAND	Forests contribute a significant portion of the land carbon sink, but their ability to sequester CO2 may be constrained by nitrogen(1-6), a major plant-limiting nutrient. Many tropical forests possess tree species capable of fixing atmospheric dinitrogen (N-2)(7), but it is unclear whether this functional group can supply the nitrogen needed as forests recover from disturbance or previous land use(1), or expand in response to rising CO2 (refs 6, 8). Here we identify a powerful feedback mechanism in which N-2 fixation can overcome ecosystem-scale deficiencies in nitrogen that emerge during periods of rapid biomass accumulation in tropical forests. Over a 300-year chronosequence in Panama, N-2-fixing tree species accumulated carbon up to nine times faster per individual than their non-fixing neighbours (greatest difference in youngest forests), and showed species-specific differences in the amount and timing of fixation. As a result of fast growth and high fixation, fixers provided a large fraction of the nitrogen needed to support net forest growth (50,000 kg carbon per hectare) in the first 12 years. A key element of ecosystem functional diversity was ensured by the presence of different N-2-fixing tree species across the entire forest age sequence. These findings show that symbiotic N-2 fixation can have a central role in nitrogen cycling during tropical forest stand development, with potentially important implications for the ability of tropical forests to sequester CO2.	[Batterman, Sarah A.; Hedin, Lars O.] Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA; [van Breugel, Michiel; Hall, Jefferson S.] Smithsonian Trop Res Inst, Panama City, Panama; [Ransijn, Johannes] Wageningen Univ, Ctr Ecosyst Studies, Forest Ecol & Forest Management Grp, NL-6700 AA Wageningen, Netherlands; [Ransijn, Johannes] Univ Copenhagen, Dept Geosci & Nat Resource Management, DK-1958 Frederiksberg C, Denmark; [Craven, Dylan J.] Yale Univ, Sch Forestry & Environm Studies, New Haven, CT 06511 USA	Princeton University; Smithsonian Institution; Smithsonian Tropical Research Institute; Wageningen University & Research; University of Copenhagen; Yale University	Batterman, SA (corresponding author), Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA.	sbatterm@princeton.edu	Ransijn, Johannes/D-5324-2015; Craven, Dylan/K-2717-2012; van Breugel, Michiel/A-8453-2017	Ransijn, Johannes/0000-0003-0416-2210; Craven, Dylan/0000-0003-3940-833X; Batterman, Sarah/0000-0002-7703-9873; van Breugel, Michiel/0000-0003-2778-7803	National Science Foundation (NSF) [DEB-0614116]; National Oceanic and Atmospheric Association (NOAA) [NA17RJ262-344]; Cooperative Institute for Climate Science of Princeton University; Carbon Mitigation Initiative of Princeton University; Smithsonian Tropical Research Institute (STRI); HSBC; STRI; Frank Levinson Family Foundation; Motta Family Foundation	National Science Foundation (NSF)(National Science Foundation (NSF)); National Oceanic and Atmospheric Association (NOAA)(National Oceanic Atmospheric Admin (NOAA) - USA); Cooperative Institute for Climate Science of Princeton University; Carbon Mitigation Initiative of Princeton University(Princeton University); Smithsonian Tropical Research Institute (STRI)(Smithsonian InstitutionSmithsonian Tropical Research Institute); HSBC; STRI(Smithsonian InstitutionSmithsonian Tropical Research Institute); Frank Levinson Family Foundation; Motta Family Foundation	We thank S. Adelberg and K. Zelazny for assisting with data collection, M. Baillon and A. Hernandez for botanical identifications, N. Wurzburger and A. Barron for species-specific N<INF>2</INF> fixation rates, J. Sprent for advice about N<INF>2</INF>-fixing trees and P. Reich for comments. This work was supported by grants to L.O.H. from the National Science Foundation (NSF; DEB-0614116), the National Oceanic and Atmospheric Association (NOAA; grant NA17RJ262-344), the Cooperative Institute for Climate Science of Princeton University and the Carbon Mitigation Initiative of Princeton University; and to S. A. B. from the Smithsonian Tropical Research Institute (STRI). It is a contribution to the Agua Salud Project (ASP), a collaboration among STRI, the Panama Canal Authority (ACP) and the National Environmental Authority of Panama (ANAM). ASP funding came from the HSBC climate partnership, STRI, the Frank Levinson Family Foundation, the Motta Family Foundation and an anonymous donor.	Amazonas NT, 2011, FOREST ECOL MANAG, V262, P1551, DOI 10.1016/j.foreco.2011.07.003; Barron AR, 2011, OECOLOGIA, V165, P511, DOI 10.1007/s00442-010-1838-3; Barron AR, 2009, NAT GEOSCI, V2, P42, DOI 10.1038/NGEO366; BARRON AR, 2007, THESIS PRINCETON U; Batterman S. A., 2002, J ECOLOGY IN PRESS; Binkley D, 2003, FOREST ECOL MANAG, V186, P171, DOI 10.1016/S0378-1127(03)00240-8; BROWN S, 1990, J TROP ECOL, V6, P1, DOI 10.1017/S0266467400003989; Chave J, 2004, PHILOS T R SOC B, V359, P409, DOI 10.1098/rstb.2003.1425; Chave J, 2009, ECOL LETT, V12, P351, DOI 10.1111/j.1461-0248.2009.01285.x; Craven D. J., 2012, THESIS YALE U; Davidson EA, 2004, ECOL APPL, V14, pS150; Davidson EA, 2007, NATURE, V447, P995, DOI 10.1038/nature05900; Fyllas NM, 2009, BIOGEOSCIENCES, V6, P2677, DOI 10.5194/bg-6-2677-2009; Gehring C, 2005, AGR ECOSYST ENVIRON, V111, P237, DOI 10.1016/j.agee.2005.06.009; Gerber S, 2010, GLOBAL BIOGEOCHEM CY, V24, DOI 10.1029/2008GB003336; Goll DS, 2012, BIOGEOSCIENCES, V9, P3547, DOI 10.5194/bg-9-3547-2012; Hassler SK, 2011, FOREST ECOL MANAG, V261, P1634, DOI 10.1016/j.foreco.2010.06.031; Hedin LO, 2009, ANNU REV ECOL EVOL S, V40, P613, DOI 10.1146/annurev.ecolsys.37.091305.110246; Houghton RA, 2009, J GEOPHYS RES-BIOGEO, V114, DOI 10.1029/2009JG000935; Hungate BA, 2003, SCIENCE, V302, P1512, DOI 10.1126/science.1091390; Isbell F, 2011, NATURE, V477, P199, DOI 10.1038/nature10282; Jackson RB, 1997, P NATL ACAD SCI USA, V94, P7362, DOI 10.1073/pnas.94.14.7362; Martin AR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023533; MARTIUS C, 1992, HOLZ ROH WERKST, V50, P300, DOI 10.1007/BF02615357; Menge DNL, 2009, ECOLOGY, V90, P2190, DOI 10.1890/08-0877.1; Muller-Landau HC, 2006, ECOL LETT, V9, P575, DOI 10.1111/j.1461-0248.2006.00904.x; Neumann-Cosel L, 2011, FOREST ECOL MANAG, V261, P1625, DOI 10.1016/j.foreco.2010.07.023; Pan YD, 2011, SCIENCE, V333, P988, DOI 10.1126/science.1201609; Quesada CA, 2010, BIOGEOSCIENCES, V7, P1515, DOI 10.5194/bg-7-1515-2010; Russell AE, 2012, P NATL ACAD SCI USA, V109, P10398, DOI 10.1073/pnas.1204157109; Sprent J.I., 2009, LEGUME NODULATION GL; Thornton PE, 2007, GLOBAL BIOGEOCHEM CY, V21, DOI 10.1029/2006GB002868; Townsend AR, 2007, ECOLOGY, V88, P107, DOI 10.1890/0012-9658(2007)88[107:COFNRI]2.0.CO;2; van Breugel M, 2011, FOREST ECOL MANAG, V262, P1648, DOI 10.1016/j.foreco.2011.07.018; van Groenigen KJ, 2006, P NATL ACAD SCI USA, V103, P6571, DOI 10.1073/pnas.0509038103; VITOUSEK PM, 1991, BIOGEOCHEMISTRY, V13, P87; Walker LR, 2010, J ECOL, V98, P725, DOI 10.1111/j.1365-2745.2010.01664.x; Wolf A, 2011, ECOL APPL, V21, P1546, DOI 10.1890/10-1201.1; Yang X, 2010, BIOGEOSCIENCES, V7, P3041, DOI 10.5194/bg-7-3041-2010; Zaehle S, 2011, CURR OPIN ENV SUST, V3, P311, DOI 10.1016/j.cosust.2011.08.008	40	220	224	9	309	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 10	2013	502	7470					224	+		10.1038/nature12525	http://dx.doi.org/10.1038/nature12525			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231RU	24037375				2022-12-24	WOS:000325436100048
J	Dye, C; Raviglione, M				Dye, Christopher; Raviglione, Mario			Weigh all TB risks	NATURE			English	Editorial Material									[Dye, Christopher] WHO, CH-1211 Geneva, Switzerland; [Raviglione, Mario] WHO, Global TB Programme HIV AIDS TB Malaria & Neglect, CH-1211 Geneva, Switzerland	World Health Organization; World Health Organization	Dye, C (corresponding author), WHO, CH-1211 Geneva, Switzerland.	dyec@who.int; raviglionem@who.int	Dye, Christopher/AIC-4659-2022	Dye, Christopher/0000-0002-2957-1793; RAVIGLIONE, Mario/0000-0002-9331-2067				[Anonymous], GLOB TUB CONTR WHO R; Dye C, 2013, ANNU REV PUBL HEALTH, V34, P271, DOI 10.1146/annurev-publhealth-031912-114431; Dye C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021161; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; United Nations, 2013, NEW GLOB PARTN ER PO	5	10	10	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 10	2013	502	7470					S13	S13		10.1038/502S13a	http://dx.doi.org/10.1038/502S13a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231RU	24108075				2022-12-24	WOS:000325436100007
J	Kim, T; Vidal, GS; Djurisic, M; William, CM; Birnbaum, ME; Garcia, KC; Hyman, BT; Shatz, CJ				Kim, Taeho; Vidal, George S.; Djurisic, Maja; William, Christopher M.; Birnbaum, Michael E.; Garcia, K. Christopher; Hyman, Bradley T.; Shatz, Carla J.			Human LilrB2 Is a beta-Amyloid Receptor and Its Murine Homolog PirB Regulates Synaptic Plasticity in an Alzheimer's Model	SCIENCE			English	Article							OCULAR-DOMINANCE PLASTICITY; PRION PROTEIN; MOUSE MODEL; MYELIN; DEPRESSION; COFILIN; DISEASE; DEPRIVATION; INHIBITION; IMPAIRMENT	Soluble beta-amyloid (A beta) oligomers impair synaptic plasticity and cause synaptic loss associated with Alzheimer's disease (AD). We report that murine PirB (paired immunoglobulin-like receptor B) and its human ortholog LilrB2 (leukocyte immunoglobulin-like receptor B2), present in human brain, are receptors for A beta oligomers, with nanomolar affinity. The first two extracellular immunoglobulin (Ig) domains of PirB and LilrB2 mediate this interaction, leading to enhanced cofilin signaling, also seen in human AD brains. In mice, the deleterious effect of A beta oligomers on hippocampal long-term potentiation required PirB, and in a transgenic model of AD, PirB not only contributed to memory deficits present in adult mice, but also mediated loss of synaptic plasticity in juvenile visual cortex. These findings imply that LilrB2 contributes to human AD neuropathology and suggest therapeutic uses of blocking LilrB2 function.	[Kim, Taeho; Vidal, George S.; Djurisic, Maja; Shatz, Carla J.] Stanford Univ, James H Clark Ctr, Dept Biol & Neurobiol, Stanford, CA 94305 USA; [Kim, Taeho; Vidal, George S.; Djurisic, Maja; Shatz, Carla J.] Stanford Univ, James H Clark Ctr, Dept BioX, Stanford, CA 94305 USA; [William, Christopher M.; Hyman, Bradley T.] Massachusetts Gen Hosp, Neuropathol Serv, Charlestown, MA 02129 USA; [Birnbaum, Michael E.; Garcia, K. Christopher] Stanford Univ, Sch Med, Howard Hughes Med Inst, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA; [Birnbaum, Michael E.; Garcia, K. Christopher] Stanford Univ, Sch Med, Dept Biol Struct, Stanford, CA 94305 USA	Stanford University; Stanford University; Harvard University; Massachusetts General Hospital; Howard Hughes Medical Institute; Stanford University; Stanford University	Kim, T (corresponding author), Stanford Univ, James H Clark Ctr, Dept Biol & Neurobiol, Stanford, CA 94305 USA.	tkim808@stanford.edu; cshatz@stanford.edu		Vidal, George/0000-0002-8623-7476; Birnbaum, Michael/0000-0002-2281-3518; William, Christopher/0000-0001-8933-1639	NIH [NS069375, EY02858, 5T32EY020485, K08NS069811, 5R01AG041507]; G. Harold and Leila Y. Mathers Charitable Foundation; Ellison Medical Foundation; Regina Casper Stanford Graduate Fellowship; Alzheimer Disease Research Center (NIH) [5P50AG005134]; NSF; HHMI; NATIONAL EYE INSTITUTE [R01EY002858, T32EY020485, R37EY002858] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH071666, T32MH020016] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS069375, K08NS069811] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG041507, P50AG005134] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); G. Harold and Leila Y. Mathers Charitable Foundation; Ellison Medical Foundation(Lawrence Ellison Foundation); Regina Casper Stanford Graduate Fellowship; Alzheimer Disease Research Center (NIH); NSF(National Science Foundation (NSF)); HHMI(Howard Hughes Medical Institute); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank the Human Brain and Spinal Fluid Resource Center for providing human brain specimens; P. Kemper, C. Chechelski, and N. Sotelo-Kury for assistance with mouse husbandry; M. Stern for technical assistance; and C. Cepko (Harvard) for providing the pCAGIG vector. We also thank M. Frosch (MGH/Harvard) and M. Shamloo (Stanford Behavioral and Functional Neuroscience Laboratory, NIH grant NS069375) for helpful suggestions and advice. Supported by NIH grant EY02858 (C.J.S.), the G. Harold and Leila Y. Mathers Charitable Foundation (C.J.S.), the Ellison Medical Foundation (C.J.S.), NIH grant 5T32EY020485 (T.K.), a Regina Casper Stanford Graduate Fellowship (G.S.V.), NIH grant K08NS069811 (C.M.W.), NIH grant 5R01AG041507 (B.T.H.), an Alzheimer Disease Research Center pilot grant (NIH grant 5P50AG005134 to C.M.W.), NSF predoctoral fellowship (M.E.B.), and HHMI (K.C.G.). B.T.H. is on the Scientific Advisory Board of Neurophage and is a consultant and collaborator with Takeda Pharmaceutical Company, Bristol Meyer Squibb, Acumen, AZTherapeutics, Siemens, Sanofi, Neotope, and Fidelity Biosciences, none of which were involved in this study. C.J.S. and T.K. are inventors on a patent application assigned to the Board of Trustees of the Leland Stanford Junior University on methods and compositions for inhibiting the effects of beta-amyloid oligomers (U.S. provisional application no. 61/777,835).	Adelson JD, 2012, NEURON, V73, P1100, DOI 10.1016/j.neuron.2012.01.020; Atwal JK, 2008, SCIENCE, V322, P967, DOI 10.1126/science.1161151; Cisse M, 2011, NATURE, V469, P47, DOI 10.1038/nature09635; Crozier RA, 2007, P NATL ACAD SCI USA, V104, P1383, DOI 10.1073/pnas.0609596104; Faizi M, 2012, BRAIN BEHAV, V2, P142, DOI 10.1002/brb3.41; Fujita Y, 2011, EMBO J, V30, P1389, DOI 10.1038/emboj.2011.55; Garcia-Alloza M, 2006, NEUROBIOL DIS, V24, P516, DOI 10.1016/j.nbd.2006.08.017; Hsieh H, 2006, NEURON, V52, P831, DOI 10.1016/j.neuron.2006.10.035; Jankowsky JL, 2004, HUM MOL GENET, V13, P159, DOI 10.1093/hmg/ddh019; Kam TI, 2013, J CLIN INVEST, V123, P2791, DOI 10.1172/JCI66827; Kamenetz F, 2003, NEURON, V37, P925, DOI 10.1016/S0896-6273(03)00124-7; Kessels HW, 2010, NATURE, V466, pE3, DOI 10.1038/nature09217; Knafo S, 2009, CEREB CORTEX, V19, P586, DOI 10.1093/cercor/bhn111; Lauren J, 2009, NATURE, V457, P1128, DOI 10.1038/nature07761; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; Li SM, 2009, NEURON, V62, P788, DOI 10.1016/j.neuron.2009.05.012; Lindhagen-Persson M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013928; Ma G, 2011, IMMUNITY, V34, P385, DOI 10.1016/j.immuni.2011.02.004; McClean PL, 2011, J NEUROSCI, V31, P6587, DOI 10.1523/JNEUROSCI.0529-11.2011; McGee AW, 2005, SCIENCE, V309, P2222, DOI 10.1126/science.1114362; Meberg PJ, 1998, CELL MOTIL CYTOSKEL, V39, P172, DOI 10.1002/(SICI)1097-0169(1998)39:2<172::AID-CM8>3.0.CO;2-8; Oleinik NV, 2010, ONCOGENE, V29, P6233, DOI 10.1038/onc.2010.356; Palop JJ, 2010, NAT NEUROSCI, V13, P812, DOI 10.1038/nn.2583; Perez-Cruz C, 2011, J NEUROSCI, V31, P3926, DOI 10.1523/JNEUROSCI.6142-10.2011; Raiker SJ, 2010, J NEUROSCI, V30, P12432, DOI 10.1523/JNEUROSCI.0895-10.2010; Rust MB, 2010, EMBO J, V29, P1889, DOI 10.1038/emboj.2010.72; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; Shankar GM, 2007, J NEUROSCI, V27, P2866, DOI 10.1523/JNEUROSCI.4970-06.2007; Sheng M, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a005777; Smith GB, 2009, PHILOS T R SOC B, V364, P357, DOI 10.1098/rstb.2008.0198; Starkey HDV, 2012, J MOL NEUROSCI, V48, P111, DOI 10.1007/s12031-012-9783-8; Syken J, 2006, SCIENCE, V313, P1795, DOI 10.1126/science.1128232; Takai T, 2005, IMMUNOLOGY, V115, P433, DOI 10.1111/j.1365-2567.2005.02177.x; Um JW, 2012, NAT NEUROSCI, V15, P1227, DOI 10.1038/nn.3178; Wang XN, 2012, J ALZHEIMERS DIS, V30, P665, DOI 10.3233/JAD-2012-101869; William CM, 2012, J NEUROSCI, V32, P8004, DOI 10.1523/JNEUROSCI.5369-11.2012; Wu HY, 2010, J NEUROSCI, V30, P2636, DOI 10.1523/JNEUROSCI.4456-09.2010; Wu J, 2011, CELL, V147, P615, DOI 10.1016/j.cell.2011.09.036; Zheng JK, 2012, NATURE, V485, P656, DOI 10.1038/nature11095	39	269	286	2	121	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 20	2013	341	6152					1399	1404		10.1126/science.1242077	http://dx.doi.org/10.1126/science.1242077			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	220PK	24052308	Green Accepted			2022-12-24	WOS:000324597200048
J	Hagar, JA; Powell, DA; Aachoui, Y; Ernst, RK; Miao, EA				Hagar, Jon A.; Powell, Daniel A.; Aachoui, Youssef; Ernst, Robert K.; Miao, Edward A.			Cytoplasmic LPS Activates Caspase-11: Implications in TLR4-Independent Endotoxic Shock	SCIENCE			English	Article							INFLAMMASOME ACTIVATION; FRANCISELLA MUTANT; RECOGNITION; PYROPTOSIS; VIRULENCE; BACTERIA; TLR4	Inflammatory caspases, such as caspase-1 and -11, mediate innate immune detection of pathogens. Caspase-11 induces pyroptosis, a form of programmed cell death, and specifically defends against bacterial pathogens that invade the cytosol. During endotoxemia, however, excessive caspase-11 activation causes shock. We report that contamination of the cytoplasm by lipopolysaccharide (LPS) is the signal that triggers caspase-11 activation in mice. Specifically, caspase-11 responds to penta- and hexa-acylated lipid A, whereas tetra-acylated lipid A is not detected, providing a mechanism of evasion for cytosol-invasive Francisella. Priming the caspase-11 pathway in vivo resulted in extreme sensitivity to subsequent LPS challenge in both wild-type and Tlr4-deficient mice, whereas Casp11-deficient mice were relatively resistant. Together, our data reveal a new pathway for detecting cytoplasmic LPS.	[Hagar, Jon A.; Aachoui, Youssef; Miao, Edward A.] Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC 27599 USA; [Hagar, Jon A.; Aachoui, Youssef; Miao, Edward A.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Powell, Daniel A.; Ernst, Robert K.] Univ Maryland, Sch Dent, Dept Microbial Pathogenesis, Baltimore, MD 21201 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University System of Maryland; University of Maryland Baltimore	Miao, EA (corresponding author), Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC 27599 USA.	emiao@med.unc.edu		Ernst, Robert/0000-0001-5016-8694; Powell, Daniel/0000-0003-0503-3330; Miao, Edward/0000-0001-7295-3490	NIH [AI007273, AI097518, AI057141, AI101685]; NATIONAL CANCER INSTITUTE [P30CA016086] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI101685, R01AI097518, U54AI057141, T32AI007273] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The authors thank V. Dixit for sharing key mouse strains (Casp11<SUP>-/-</SUP> and Nlrc4<SUP>-/-</SUP>Asc<SUP>-/-</SUP> mice were provided under an materials transfer agreement with Genentech). We also thank R. Flavell, M. Heise, and J. Brickey for sharing mice. We thank D. Mao, L. Zhou, and D. Trinh for managing mouse colonies. The data presented in this manuscript are tabulated in the main paper and in the supplementary materials. This work was supported by NIH grants AI007273 (J.A.H.), AI097518 (E.A.M.), AI057141 (E.A.M.), and AI101685 (R.K.E.).	Aachoui Y, 2013, SCIENCE, V339, P975, DOI 10.1126/science.1230751; Broz P, 2012, NATURE, V490, P288, DOI 10.1038/nature11419; Broz P, 2010, CELL HOST MICROBE, V8, P471, DOI 10.1016/j.chom.2010.11.007; Case CL, 2013, P NATL ACAD SCI USA, V110, P1851, DOI 10.1073/pnas.1211521110; Gao H, 2008, CRIT CARE, V12, DOI 10.1186/cc6862; Gunn JS, 2007, ANN NY ACAD SCI, V1105, P202, DOI 10.1196/annals.1409.006; Gurung P, 2012, J BIOL CHEM, V287, P34474, DOI 10.1074/jbc.M112.401406; Kanistanon D, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040024; Kanistanon D, 2012, INFECT IMMUN, V80, P943, DOI 10.1128/IAI.06109-11; Kayagaki N, 2011, NATURE, V479, P117, DOI 10.1038/nature10558; Lamkanfi M, 2010, J IMMUNOL, V185, P4385, DOI 10.4049/jimmunol.1000803; Li YY, 2012, P NATL ACAD SCI USA, V109, P8716, DOI 10.1073/pnas.1202908109; Masters SL, 2012, IMMUNITY, V37, P1009, DOI 10.1016/j.immuni.2012.08.027; Miao EA, 2010, P NATL ACAD SCI USA, V107, P3076, DOI 10.1073/pnas.0913087107; Rathinam VAK, 2012, CELL, V150, P606, DOI 10.1016/j.cell.2012.07.007; Rebeil R, 2004, MOL MICROBIOL, V52, P1363, DOI 10.1111/j.1365-2958.2004.04059.x; Silipo A, 2002, J LIPID RES, V43, P2188, DOI 10.1194/jlr.D200021-JLR200; Takeuchi O, 1999, IMMUNITY, V11, P443, DOI 10.1016/S1074-7613(00)80119-3; von Moltke J, 2013, ANNU REV IMMUNOL, V31, P73, DOI 10.1146/annurev-immunol-032712-095944; von Moltke J, 2012, NATURE, V490, P107, DOI 10.1038/nature11351; Wang XY, 2007, P NATL ACAD SCI USA, V104, P4136, DOI 10.1073/pnas.0611606104	21	759	785	11	139	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 13	2013	341	6151					1250	1253		10.1126/science.1240988	http://dx.doi.org/10.1126/science.1240988			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	215ZA	24031018	Green Submitted, Green Accepted			2022-12-24	WOS:000324248800046
J	Elster, EA; Butler, FK; Rasmussen, TE				Elster, Eric A.; Butler, Frank K.; Rasmussen, Todd E.			Implications of Combat Casualty Care for Mass Casualty Events	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							MORTALITY; DEATH		[Elster, Eric A.; Rasmussen, Todd E.] Uniformed Serv Univ Hlth Sci, Norman M Rich Dept Surg, Bethesda, MD 20814 USA; [Elster, Eric A.] Naval Med Res Ctr, Silver Spring, MD USA; [Butler, Frank K.; Rasmussen, Todd E.] US Army Inst Surg Res, Joint Base San Antonio, Ft Sam Houston, TX USA	Uniformed Services University of the Health Sciences - USA; Naval Medical Research Center (NMRC); United States Department of Defense; United States Army	Elster, EA (corresponding author), Uniformed Serv Univ Hlth Sci, Dept Surg, 4301 Jones Bridge Rd, Bethesda, MD 20814 USA.	eric.elster@usuhs.edu	Elster, Eric/ABG-6091-2021; Rasmussen, Todd/Y-2122-2019	Rasmussen, Todd/0000-0003-1120-4116; Elster, Eric/0000-0002-0981-2748				Borgman MA, 2007, J TRAUMA, V63, P805, DOI 10.1097/TA.0b013e3181271ba3; Butler FK, 2012, J TRAUMA ACUTE CARE, V73, pS395, DOI 10.1097/TA.0b013e3182754850; Eastridge BJ, 2012, J TRAUMA ACUTE CARE, V73, pS431, DOI 10.1097/TA.0b013e3182755dcc; Kotwal RS, 2011, ARCH SURG-CHICAGO, V146, P1349, DOI 10.1001/archsurg.2011.213; Mabry RL, 2012, J TRAUMA ACUTE CARE, V73, pS32, DOI 10.1097/TA.0b013e3182606001; Morrison JJ, 2013, ANN SURG, V257, P330, DOI 10.1097/SLA.0b013e31827eefcf; Morrison JJ, 2012, ARCH SURG-CHICAGO, V147, P113, DOI 10.1001/archsurg.2011.287; Propper BW, 2009, ANN SURG, V250, P311, DOI 10.1097/SLA.0b013e3181ae34a2; Timbie JW, 2012, AHRQ PUBLICATION 12, V12-E006-EF	9	40	40	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 7	2013	310	5					475	476		10.1001/jama.2013.167481	http://dx.doi.org/10.1001/jama.2013.167481			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	196OZ	23925612				2022-12-24	WOS:000322786400014
J	Bekelman, JE; Epstein, AJ; Emanuel, EJ				Bekelman, Justin E.; Epstein, Andrew J.; Emanuel, Ezekiel J.			Single- vs Multiple-Fraction Radiotherapy for Bone Metastases From Prostate Cancer	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Bekelman, Justin E.] Univ Penn, Perelman Sch Med, Dept Radiat Oncol, Philadelphia, PA 19104 USA; [Epstein, Andrew J.] Philadelphia Vet Affairs Med Ctr, Ctr Hlth Equ Res & Promot, Philadelphia, PA USA; [Emanuel, Ezekiel J.] Univ Penn, Perelman Sch Med, Dept Med Eth & Hlth Policy, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; US Department of Veterans Affairs; Veterans Health Administration (VHA); University of Pennsylvania; Pennsylvania Medicine; Philadelphia Veterans Affairs Medical Center; University of Pennsylvania; Pennsylvania Medicine	Bekelman, JE (corresponding author), Univ Penn, Perelman Sch Med, 3400 Civ Ctr Blvd, Philadelphia, PA 19104 USA.	bekelman@uphs.upenn.edu		Epstein, Andrew/0000-0001-5078-6564	NATIONAL CANCER INSTITUTE [K07CA163616] Funding Source: NIH RePORTER; NCI NIH HHS [K07 CA163616, K07-CA163616] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Brown ML, 2002, MED CARE, V40, P104; Elshaug AG, 2013, JAMA-J AM MED ASSOC, V309, P775, DOI 10.1001/jama.2013.828; Fairchild A, 2009, INT J RADIAT ONCOL, V75, P1501, DOI 10.1016/j.ijrobp.2008.12.084; Hartsell WF, 2005, JNCI-J NATL CANCER I, V97, P798, DOI 10.1093/jnci/dji139; POTOSKY AL, 1993, MED CARE, V31, P732; Sze WM, 2004, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD004721	6	69	69	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 9	2013	310	14					1501	1502		10.1001/jama.2013.277081	http://dx.doi.org/10.1001/jama.2013.277081			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	230PK	24104375	Green Accepted			2022-12-24	WOS:000325354100027
J	Spence, D				Spence, Des			Bad medicine: non-ST elevation myocardial infarction	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							POPULATION; DIAGNOSIS; TRENDS					destwo@yahoo.co.uk						Abbott JD, 2007, AM J CARDIOL, V100, P190, DOI 10.1016/j.amjcard.2007.02.083; Bassand JP, 2007, EUR HEART J, V28, P1598, DOI 10.1093/eurheartj/ehm161; Eggers KM, 2013, J AM COLL CARDIOL, V61, P1906, DOI 10.1016/j.jacc.2012.12.048; Enbergs A, 2000, EUR HEART J, V21, P45, DOI 10.1053/euhj.1999.1763; Irfan A, 2013, AM J MED, V126, P781, DOI 10.1016/j.amjmed.2013.02.031; Jennings SM, 2012, HEART, V98, P1285, DOI 10.1136/heartjnl-2012-301822; Moynihan R, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e3502; Shave R, 2007, MED SCI SPORT EXER, V39, P2099, DOI 10.1249/mss.0b013e318153ff78; Tanindi A, 2011, VASC HEALTH RISK MAN, V7, P597, DOI 10.2147/VHRM.S24509; VANSTAA TP, 2013, HEART; Wu JH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067611; Yeh RW, 2010, NEW ENGL J MED, V362, P2155, DOI 10.1056/NEJMoa0908610	12	1	1	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 9	2013	347								f5967	10.1136/bmj.f5967	http://dx.doi.org/10.1136/bmj.f5967			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	235ON	24108160				2022-12-24	WOS:000325729100008
J	Kahan, DM				Kahan, Dan M.			A Risky Science Communication Environment for Vaccines	SCIENCE			English	Editorial Material							VACCINATION; HEALTH		Yale Univ, Sch Law, New Haven, CT 06520 USA	Yale University	Kahan, DM (corresponding author), Yale Univ, Sch Law, POB 20815, New Haven, CT 06520 USA.	dan.kahan@yale.edu						Black CL, 2013, MMWR-MORBID MORTAL W, V62, P733; CDC, 2005, MMWR-MORBID MORTAL W, V54, pRR; Colgrove J, 2006, NEW ENGL J MED, V355, P2389, DOI 10.1056/NEJMp068248; Curtis CR, 2013, MMWR-MORBID MORTAL W, V62, P685; Darling N., 2008, Morbidity and Mortality Weekly Report, V57, P961; Devorak P., 2011, WASHINGTON POST; Frank A., 2013, NEW YORK TIMES  0821, pA27; Gollust SE, 2010, HEALTH AFFAIR, V29, P2041, DOI 10.1377/hlthaff.2010.0174; Gostin LO, 2007, JAMA-J AM MED ASSOC, V297, P1921, DOI 10.1001/jama.297.17.1921; HERSHEY JC, 1994, ORGAN BEHAV HUM DEC, V59, P177, DOI 10.1006/obhd.1994.1055; Kahan DM, 2012, NAT CLIM CHANGE, V2, P732, DOI 10.1038/NCLIMATE1547; Kahan DM, 2010, LAW HUMAN BEHAV, V34, P501, DOI 10.1007/s10979-009-9201-0; Lanska DJ, 1998, J PUBLIC HEALTH POL, V19, P160, DOI 10.2307/3343296; National Public Radio, 2011, TALK OF THE NATION; Slovic P., 2010, THE FEELING OF RISK	15	83	83	1	27	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 4	2013	342	6154					53	54		10.1126/science.1245724	http://dx.doi.org/10.1126/science.1245724			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	227PP	24092722				2022-12-24	WOS:000325126100040
J	Tosi, A; Haas, C; Herzog, F; Gilmozzi, A; Berninghausen, O; Ungewickell, C; Gerhold, CB; Lakomek, K; Aebersold, R; Beckmann, R; Hopfner, KP				Tosi, Alessandro; Haas, Caroline; Herzog, Franz; Gilmozzi, Andrea; Berninghausen, Otto; Ungewickell, Charlotte; Gerhold, Christian B.; Lakomek, Kristina; Aebersold, Ruedi; Beckmann, Roland; Hopfner, Karl-Peter			Structure and Subunit Topology of the INO80 Chromatin Remodeler and Its Nucleosome Complex	CELL			English	Article							ACTIN-RELATED PROTEINS; CROSS-LINKED PEPTIDES; STRAND BREAK REPAIR; SACCHAROMYCES-CEREVISIAE; ELECTRON-MICROSCOPY; YEATS DOMAIN; CONFORMATIONAL FLEXIBILITY; MASS-SPECTROMETRY; CELL-GROWTH; DNA	INO80/SWR1 family chromatin remodelers are complexes composed of >15 subunits and molecular masses exceeding 1 MDa. Their important role in transcription and genome maintenance is exchanging the histone variants H2A and H2A.Z. We report the architecture of S. cerevisiae INO80 using an integrative approach of electron microscopy, crosslinking and mass spectrometry. INO80 has an embryo-shaped head-neck-body-foot architecture and shows dynamic open and closed conformations. We can assign an Rvb1/Rvb2 heterododecamer to the head in close contact with the Ino80 Snf2 domain, Ies2, and the Arp5 module at the neck. The high-affinity nucleosome-binding Nhp10 module localizes to the body, whereas the module that contains actin, Arp4, and Arp8 maps to the foot. Structural and biochemical analyses indicate that the nucleosome is bound at the concave surface near the neck, flanked by the Rvb1/2 and Arp8 modules. Our analysis establishes a structural and functional framework for this family of large remodelers.	[Tosi, Alessandro; Haas, Caroline; Herzog, Franz; Gilmozzi, Andrea; Berninghausen, Otto; Ungewickell, Charlotte; Gerhold, Christian B.; Lakomek, Kristina; Beckmann, Roland; Hopfner, Karl-Peter] Univ Munich, Dept Biochem, D-81377 Munich, Germany; [Tosi, Alessandro; Haas, Caroline; Herzog, Franz; Gilmozzi, Andrea; Berninghausen, Otto; Ungewickell, Charlotte; Gerhold, Christian B.; Lakomek, Kristina; Beckmann, Roland; Hopfner, Karl-Peter] Univ Munich, Gene Ctr, D-81377 Munich, Germany; [Herzog, Franz; Aebersold, Ruedi] ETH, Dept Biol, Inst Mol Syst Biol, CH-8092 Zurich, Switzerland; [Beckmann, Roland; Hopfner, Karl-Peter] Ctr Integrated Prot Sci, D-81377 Munich, Germany; [Aebersold, Ruedi] Univ Zurich, Fac Sci, CH-8057 Zurich, Switzerland	University of Munich; University of Munich; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Munich; University of Zurich	Beckmann, R (corresponding author), Univ Munich, Dept Biochem, Marchioninistr 15, D-81377 Munich, Germany.	beckmann@genzentrum.lmu.de; hopfner@genzentrum.lmu.de	Hopfner, Karl-Peter/B-6864-2014; Herzog, Franz/G-4832-2012	Hopfner, Karl-Peter/0000-0002-4528-8357; Herzog, Franz/0000-0001-8270-1449; Gerhold, Christian-Benedikt/0000-0002-9982-9171	German Research Council [GRK1721, SFB 646, SFB/TR5]; Center for Integrated Protein Science; European Research Council; BioSysNet; Ernst Schering Foundation; European Molecular Biology Organization; European Commission	German Research Council(German Research Foundation (DFG)); Center for Integrated Protein Science; European Research Council(European Research Council (ERC)European Commission); BioSysNet; Ernst Schering Foundation; European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); European Commission(European CommissionEuropean Commission Joint Research Centre)	This project was funded by the German Research Council (GRK1721, SFB 646, and SFB/TR5) and the Center for Integrated Protein Science (to K.-P. H. and R. B.). K.-P. H. acknowledges support by the European Research Council (advanced grant ATMMACHINE). F. H. and K. P. H acknowledge support by the BioSysNet. C. H. was supported by the Ernst Schering Foundation. F. H. was supported by the European Molecular Biology Organization (long-term fellowship) and by the European Commission (FP7-PEOPLE-IEF); R. A. and F. H. were supported in part by the EU FP7 project PROSPECTS; and R. A. was supported by European Research Council advanced grant Proteomics v. 3.0 (233226). We thank the Becker's lab for plasmids and protocols for nucleosome reconstitution and the Hurt's lab for plasmids for DID labeling. The INO80-FLAG strain was a kind gift from the Shen lab. We thank the Cramer's and Thomm's group for fermentation.	Andrews AJ, 2011, ANNU REV BIOPHYS, V40, P99, DOI 10.1146/annurev-biophys-042910-155329; Asturias FJ, 2002, P NATL ACAD SCI USA, V99, P13477, DOI 10.1073/pnas.162504299; Becker T, 2012, NATURE, V482, P501, DOI 10.1038/nature10829; Billon P, 2012, BBA-GENE REGUL MECH, V1819, P290, DOI 10.1016/j.bbagrm.2011.10.004; Bohm V, 2011, NUCLEIC ACIDS RES, V39, P3093, DOI 10.1093/nar/gkq1279; Chaban Y, 2008, NAT STRUCT MOL BIOL, V15, P1272, DOI 10.1038/nsmb.1524; Chen L, 2011, J BIOL CHEM, V286, P11283, DOI 10.1074/jbc.M111.222505; Clapier CR, 2008, PROTEINS, V71, P1, DOI 10.1002/prot.21720; Clapier CR, 2009, ANNU REV BIOCHEM, V78, P273, DOI 10.1146/annurev.biochem.77.062706.153223; Dang WW, 2007, MOL CELL BIOL, V27, P8306, DOI 10.1128/MCB.01351-07; Dechassa ML, 2008, MOL CELL BIOL, V28, P6010, DOI 10.1128/MCB.00693-08; Downs JA, 2004, MOL CELL, V16, P979, DOI 10.1016/j.molcel.2004.12.003; Durr H, 2005, CELL, V121, P363, DOI 10.1016/j.cell.2005.03.026; Fenn S, 2011, EMBO J, V30, P2153, DOI 10.1038/emboj.2011.118; Flemming D, 2010, NAT STRUCT MOL BIOL, V17, P775, DOI 10.1038/nsmb.1811; Gerhold CB, 2012, NUCLEIC ACIDS RES, V40, P11036, DOI 10.1093/nar/gks842; Gorynia S, 2011, J STRUCT BIOL, V176, P279, DOI 10.1016/j.jsb.2011.09.001; Harata M, 1999, MOL BIOL CELL, V10, P2595, DOI 10.1091/mbc.10.8.2595; Herzog F, 2012, SCIENCE, V337, P1348, DOI 10.1126/science.1221483; Hopfner KP, 2012, CURR OPIN STRUC BIOL, V22, P225, DOI 10.1016/j.sbi.2012.02.007; Jha S, 2009, MOL CELL, V34, P521, DOI 10.1016/j.molcel.2009.05.016; Jonsson ZO, 2004, MOL CELL, V16, P465, DOI 10.1016/j.molcel.2004.09.033; Kapoor P, 2013, NAT STRUCT MOL BIOL, V20, P426, DOI 10.1038/nsmb.2529; Leschziner AE, 2005, STRUCTURE, V13, P267, DOI 10.1016/j.str.2004.12.008; Leschziner AE, 2007, P NATL ACAD SCI USA, V104, P4913, DOI 10.1073/pnas.0700706104; Leschziner AE, 2011, CURR OPIN STRUC BIOL, V21, P709, DOI 10.1016/j.sbi.2011.10.002; Li ZY, 2012, CELL, V151, P1608, DOI 10.1016/j.cell.2012.11.018; Lopez-Perrote A, 2012, NUCLEIC ACIDS RES, V40, P11086, DOI 10.1093/nar/gks871; Matias PM, 2006, J BIOL CHEM, V281, P38918, DOI 10.1074/jbc.M605625200; Mizuguchi G, 2004, SCIENCE, V303, P343, DOI 10.1126/science.1090701; Morrison AJ, 2007, CELL, V130, P499, DOI 10.1016/j.cell.2007.06.010; Morrison AJ, 2009, NAT REV MOL CELL BIO, V10, P373, DOI 10.1038/nrm2693; Papamichos-Chronakis M, 2008, NAT STRUCT MOL BIOL, V15, P338, DOI 10.1038/nsmb.1413; Papamichos-Chronakis M, 2013, NAT REV GENET, V14, P62, DOI 10.1038/nrg3345; Papamichos-Chronakis M, 2011, CELL, V144, P200, DOI 10.1016/j.cell.2010.12.021; Petukhov M, 2012, STRUCTURE, V20, P1321, DOI 10.1016/j.str.2012.05.012; Puri T, 2007, J MOL BIOL, V366, P179, DOI 10.1016/j.jmb.2006.11.030; Racki LR, 2009, NATURE, V462, P1016, DOI 10.1038/nature08621; Ray S, 2012, BIOCHEMISTRY-US, V51, P1825, DOI 10.1021/bi201700h; Ray S, 2009, NUCLEIC ACIDS RES, V37, P6389, DOI 10.1093/nar/gkp695; Rinner O, 2008, NAT METHODS, V5, P315, DOI [10.1038/NMETH.1192, 10.1038/nmeth.1192]; Saravanan M, 2012, P NATL ACAD SCI USA, V109, P20883, DOI 10.1073/pnas.1214735109; Schubert HL, 2013, P NATL ACAD SCI USA, V110, P3345, DOI 10.1073/pnas.1215379110; Schulze JM, 2010, MOL GENET GENOMICS, V283, P365, DOI 10.1007/s00438-010-0523-x; Seeber A, 2013, CURR OPIN GENET DEV, V23, P174, DOI 10.1016/j.gde.2012.12.008; Shen XT, 2000, NATURE, V406, P541, DOI 10.1038/35020123; Shen XT, 2003, MOL CELL, V12, P147, DOI 10.1016/S1097-2765(03)00264-8; Skiniotis G, 2007, J BIOL CHEM, V282, P20804, DOI 10.1074/jbc.C700081200; Smith CL, 2003, NAT STRUCT BIOL, V10, P141, DOI 10.1038/nsb888; Szerlong H, 2008, NAT STRUCT MOL BIOL, V15, P469, DOI 10.1038/nsmb.1403; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; Thoma NH, 2005, NAT STRUCT MOL BIOL, V12, P350, DOI 10.1038/nsmb919; Udugama M, 2011, MOL CELL BIOL, V31, P662, DOI 10.1128/MCB.01035-10; van Attikum H, 2004, CELL, V119, P777, DOI 10.1016/j.cell.2004.11.033; Vorobiev S, 2003, P NATL ACAD SCI USA, V100, P5760, DOI 10.1073/pnas.0832273100; Walzthoeni T, 2012, NAT METHODS, V9, P901, DOI 10.1038/nmeth.2103; Wang AY, 2009, P NATL ACAD SCI USA, V106, P21573, DOI 10.1073/pnas.0906539106; Wu WH, 2005, NAT STRUCT MOL BIOL, V12, P1064, DOI 10.1038/nsmb1023; Yamada K, 2011, NATURE, V472, P448, DOI 10.1038/nature09947; Yang ZF, 2012, STRUCTURE, V20, P237, DOI 10.1016/j.str.2011.12.007; Zhang W, 2011, BIOCHEM J, V436, P83, DOI 10.1042/BJ20110004	61	176	180	0	68	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	SEP 12	2013	154	6					1207	1219		10.1016/j.cell.2013.08.016	http://dx.doi.org/10.1016/j.cell.2013.08.016			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	215VQ	24034245	Bronze			2022-12-24	WOS:000324239300011
J	Bates, ER; Jacobs, AK				Bates, Eric R.; Jacobs, Alice K.			Time to Treatment in Patients with STEMI	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Bates, Eric R.] Univ Michigan Hlth Syst, Ann Arbor, MI 48109 USA; [Jacobs, Alice K.] Boston Univ, Med Ctr, Boston, MA USA	University of Michigan System; University of Michigan; Boston University	Bates, ER (corresponding author), Univ Michigan Hlth Syst, Ann Arbor, MI 48109 USA.			Jacobs, Alice/0000-0002-2428-2458				Jacobs AK, 2007, CIRCULATION, V116, P217, DOI 10.1161/CIRCULATIONAHA.107.184043; Krumholz HM, 2008, JACC-CARDIOVASC INTE, V1, P97, DOI 10.1016/j.jcin.2007.10.006; Krumholz HM, 2008, CIRCULATION, V118, P2596, DOI 10.1161/CIRCULATIONAHA.108.191099; Menees DS, 2013, NEW ENGL J MED, V369, P899; O'Gara PT, 2013, J AM COLL CARDIOL, V61, P485, DOI [10.1161/CIR.0b013e3182742c84, 10.1016/j.jacc.2012.11.018]	5	64	64	0	24	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 5	2013	369	10					889	892		10.1056/NEJMp1308772	http://dx.doi.org/10.1056/NEJMp1308772			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	211KV	24004114				2022-12-24	WOS:000323906900002
J	Sachan, D				Sachan, Dinsa			India's problem with girls	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												dinsasachan@gmail.com						Census of India, 2011, SEX RATIO HAS DECLIN; Census of India, 2011, FEMALE LITERACY HAS; Dubuc S, 2007, POPUL DEV REV, V33, P383, DOI 10.1111/j.1728-4457.2007.00173.x; Guilmoto CZ, 2012, DEMOGRAPHY, V49, P77, DOI 10.1007/s13524-011-0083-7; Hesketh T, 2006, P NATL ACAD SCI USA, V103, P13271, DOI 10.1073/pnas.0602203103; Jha P, 2011, LANCET, V377, P1921, DOI 10.1016/S0140-6736(11)60649-1; Krishnan A, 2013, J EPIDEMIOL COMMUN H, V67, P419, DOI 10.1136/jech-2012-201846; Mascarenhas A., 2013, INDIAN EXPRESS; Puri S, 2011, SOC SCI MED, V72, P1169, DOI 10.1016/j.socscimed.2011.01.027; Ray JG, 2012, CAN MED ASSOC J, V184, pE492, DOI 10.1503/cmaj.120165	10	1	1	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 29	2013	347								f4149	10.1136/bmj.f4149	http://dx.doi.org/10.1136/bmj.f4149			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	211CI	23990631				2022-12-24	WOS:000323881300007
J	Davis, M; Tachtatzis, PM				Davis, Mike; Tachtatzis, Phaedra Maria			From haemochromatosis to liver transplant	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Tachtatzis, Phaedra Maria] St James Univ Hosp, Liver Transplant Unit, Leeds LS9 7TF, W Yorkshire, England	Saint James's University Hospital	Tachtatzis, PM (corresponding author), St James Univ Hosp, Liver Transplant Unit, Leeds LS9 7TF, W Yorkshire, England.	phaedratachtatzis@me.com		Davis, Michael/0000-0002-0984-4758					0	0	0	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 20	2013	347								f4423	10.1136/bmj.f4423	http://dx.doi.org/10.1136/bmj.f4423			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	207SC	23963547	Bronze			2022-12-24	WOS:000323623100001
J	Kovesdy, CP; Bleyer, AJ; Molnar, MZ; Ma, JZ; Sim, JJ; Cushman, WC; Quarles, LD; Kalantar-Zadeh, K				Kovesdy, Csaba P.; Bleyer, Anthony J.; Molnar, Miklos Z.; Ma, Jennie Z.; Sim, John J.; Cushman, William C.; Quarles, L. Darryl; Kalantar-Zadeh, Kamyar			Blood Pressure and Mortality in US Veterans With Chronic Kidney Disease A Cohort Study	ANNALS OF INTERNAL MEDICINE			English	Article							STAGE RENAL-DISEASE; RISK-FACTOR; CARDIOVASCULAR OUTCOMES; PULSE PRESSURE; HEART-DISEASE; HYPERTENSION; ASSOCIATION; HEMODIALYSIS; METAANALYSIS; PROGRESSION	Background: The ideal blood pressure (BP) to decrease mortality rates in patients with non-dialysis-dependent chronic kidney disease (CKD) is unclear. Objective: To assess the association of BP (defined as the combination of systolic BP [SBP] and diastolic BP [DBP] at the individual level) with death in patients with CKD. Design: Historical cohort between 2005 and 2012. Setting: All U. S. Department of Veterans Affairs health care facilities. Patients: 651 749 U. S. veterans with CKD. Measurements: All possible combinations of SBP and DBP were examined in 96 categories from lowest (<80/<40 mm Hg) to highest (>210/>120 mm Hg), in 10-mm Hg increments. Associations with all-cause mortality were examined in time-dependent Cox models with adjustment for relevant confounders. Results: Patients with SBP of 130 to 159 mm Hg combined with DBP of 70 to 89 mm Hg had the lowest adjusted mortality rates, and those in whom both SBP and DBP were concomitantly very high or very low had the highest mortality rates. Patients with moderately elevated SBP combined with DBP no less than 70 mm Hg had consistently lower mortality rates than did patients with ideal SBP combined with DBP less than 70 mm Hg. Results were consistent in subgroups of patients with normal and elevated urinary microalbumin-creatinine ratios. Limitation: Mostly male patients, inability to establish causality, and large number of patients missing proteinuria measurement. Conclusion: The optimal BP in patients with CKD seems to be 130 to 159/70 to 89 mm Hg. It may not be advantageous to achieve ideal SBP at the expense of lower-than-ideal DBP in adults with CKD.	Memphis Vet Affairs Med Ctr, Memphis, TN 38104 USA; Univ Tennessee, Ctr Hlth Sci, Memphis, TN 38163 USA; Wake Forest Sch Med, Winston Salem, NC 27157 USA; Univ Toronto, Univ Hlth Network, Toronto, ON, Canada; Semmelweis Univ, H-1089 Budapest, Hungary; Univ Virginia, Charlottesville, VA 22908 USA; Kaiser Permanente Los Angeles Med Ctr, Los Angeles, CA USA; Univ Calif Irvine, Irvine, CA USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Memphis VA Medical Center; University of Tennessee System; University of Tennessee Health Science Center; Wake Forest University; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Semmelweis University; University of Virginia; Kaiser Permanente; University of California System; University of California Irvine	Kovesdy, CP (corresponding author), Memphis Vet Affairs Med Ctr, Div Nephrol 111B, 1030 Jefferson Ave, Memphis, TN 38104 USA.	csaba.kovesdy@va.gov	Kalantar-Zadeh, Kamyar/Q-4734-2018	Kalantar-Zadeh, Kamyar/0000-0002-8666-0725; Molnar, Miklos Z/0000-0002-9665-330X; Quarles, L. Darryl/0000-0002-5082-7896	National Institute of Diabetes and Digestive and Kidney Diseases; National Institutes of Health; U.S. Department of Veterans Affairs; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK078106] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. Department of Veterans Affairs(US Department of Veterans Affairs); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, and U.S. Department of Veterans Affairs.	Agarwal R, 2009, CLIN J AM SOC NEPHRO, V4, P830, DOI 10.2215/CJN.06201208; Arnold N, 2006, 2 AFF INF RES CTR; Bangalore S, 2010, EUR HEART J, V31, P2897, DOI 10.1093/eurheartj/ehq328; Barzilay JI, 2012, DIABETES CARE, V35, P1401, DOI 10.2337/dc11-1827; Berl T, 2005, J AM SOC NEPHROL, V16, P2170, DOI 10.1681/ASN.2004090763; BUSBY WJ, 1994, AGE AGEING, V23, P69, DOI 10.1093/ageing/23.1.69; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Cushman WC, 2010, NEW ENGL J MED, V362, P1575, DOI 10.1056/NEJMoa1001286; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; Domanski M, 2002, JAMA-J AM MED ASSOC, V287, P2677, DOI 10.1001/jama.287.20.2677; Duranti E, 1996, KIDNEY INT, pS173; FARNETT L, 1991, JAMA-J AM MED ASSOC, V265, P489, DOI 10.1001/jama.265.4.489; Fleischmann EH, 2001, ASAIO J, V47, P74, DOI 10.1097/00002480-200101000-00016; Gasowski J, 2002, J HYPERTENS, V20, P145, DOI 10.1097/00004872-200201000-00021; Greenberg JA, 2003, J HYPERTENS, V21, P49, DOI 10.1097/00004872-200301000-00013; Iseki K, 1997, KIDNEY INT, V51, P1212, DOI 10.1038/ki.1997.165; Kidney Disease Improving Global Outcomes (KDIGO) Blood Pressure Work Group, 2012, KIDNEY INT SUPPL, V2, P337, DOI DOI 10.1038/kisup.2012.46; KidneyDisease Outcomes Quality Initiative (K/DOQI), 2004, AM J KIDNEY DIS, V43, pS1; Kim JW, 2005, J GEN INTERN MED, V20, P647, DOI 10.1007/s11606-005-0112-6; KLAHR S, 1994, NEW ENGL J MED, V330, P877, DOI 10.1056/NEJM199403313301301; Klassen PS, 2002, JAMA-J AM MED ASSOC, V287, P1548, DOI 10.1001/jama.287.12.1548; Kovesdy CP, 2006, NEPHROL DIAL TRANSPL, V21, P1257, DOI 10.1093/ndt/gfk057; Kovesdy CP, 2013, J AM COLL CARDIOL, V61, P1626, DOI 10.1016/j.jacc.2012.11.071; Kovesdy CP, 2012, CIRCULATION, V125, P677, DOI 10.1161/CIRCULATIONAHA.111.065391; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Lewington S, 2002, LANCET, V360, P1903, DOI 10.1016/S0140-6736(02)11911-8; Messerli FH, 2006, ANN INTERN MED, V144, P884, DOI 10.7326/0003-4819-144-12-200606200-00005; Peralta CA, 2007, HYPERTENSION, V50, P474, DOI 10.1161/HYPERTENSIONAHA.107.088088; Peralta CA, 2012, ARCH INTERN MED, V172, P41, DOI 10.1001/archinternmed.2011.619; Plantinga LC, 2009, HYPERTENSION, V54, P47, DOI 10.1161/HYPERTENSIONAHA.109.129841; Royston P, 2007, STATA J, V7, P45, DOI 10.1177/1536867X0700700103; Ruggenenti P, 2005, LANCET, V365, P939, DOI 10.1016/S0140-6736(05)71082-5; Somes GW, 1999, ARCH INTERN MED, V159, P2004, DOI 10.1001/archinte.159.17.2004; Thadhani R, 2006, CLIN J AM SOC NEPHRO, V1, P1117, DOI 10.2215/CJN.00080106; U. S. Department of Veterans Affairs, 2008, VIREC RES US VHA PHA; U. S. Department of Veterans Affairs, 2009, VIREC RES US GUID VH; U. S. Department of Veterans Affairs, 2009, DAT QUAL UPD RAC; U. S. Department of Veterans Affairs, 2007, VIREC RES US GUID FY; van den Hoogen PCW, 2000, NEW ENGL J MED, V342, P1, DOI 10.1056/NEJM200001063420101; Vasan RS, 2001, NEW ENGL J MED, V345, P1291, DOI 10.1056/NEJMoa003417; Whelton PK, 2002, JAMA-J AM MED ASSOC, V288, P1882, DOI 10.1001/jama.288.15.1882; Wolf G, 2002, AM J KIDNEY DIS, V39, P1, DOI 10.1053/ajkd.2002.29865; Wright JT, 2002, JAMA-J AM MED ASSOC, V288, P2421, DOI 10.1001/jama.288.19.2421; Zager PG, 1998, KIDNEY INT, V54, P561, DOI 10.1046/j.1523-1755.1998.00005.x	44	159	164	0	25	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 20	2013	159	4					233	+		10.7326/0003-4819-159-4-201308200-00004	http://dx.doi.org/10.7326/0003-4819-159-4-201308200-00004			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	205DM	24026256	Green Accepted			2022-12-24	WOS:000323421700013
J	Kamerow, D				Kamerow, Douglas			How to decrease overtreatment in cancer	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									RTI Int, Res Triangle Pk, NC USA	Research Triangle Institute	Kamerow, D (corresponding author), RTI Int, Res Triangle Pk, NC USA.	dkamerow@rti.org		Kamerow, Douglas/0000-0001-7000-9957				Brownlee S., 2007, OVERTREATED WHY TOO; Esserman L, 2013, JAMA; Glasziou P, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f4247; Kamerow D, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c6544; Preventing Overdiagnosis, PREV OV C 10 12 SEPT; US Preventive Services Task Force, AHRQ PUBL, V13-05196-EF-3; 2002, BMJ, V324, P859	7	2	2	1	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 14	2013	347								f5071	10.1136/bmj.f5071	http://dx.doi.org/10.1136/bmj.f5071			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	203YP	23945466				2022-12-24	WOS:000323331100012
J	Almeida, J; Schobesberger, S; Kurten, A; Ortega, IK; Kupiainen-Maatta, O; Praplan, AP; Adamov, A; Amorim, A; Bianchi, F; Breitenlechner, M; David, A; Dommen, J; Donahue, NM; Downard, A; Dunne, E; Duplissy, J; Ehrhart, S; Flagan, RC; Franchin, A; Guida, R; Hakala, J; Hansel, A; Heinritzi, M; Henschel, H; Jokinen, T; Junninen, H; Kajos, M; Kangasluoma, J; Keskinen, H; Kupc, A; Kurten, T; Kvashin, AN; Laaksonen, A; Lehtipalo, K; Leiminger, M; Leppa, J; Loukonen, V; Makhmutov, V; Mathot, S; McGrath, MJ; Nieminen, T; Olenius, T; Onnela, A; Petaja, T; Riccobono, F; Riipinen, I; Rissanen, M; Rondo, L; Ruuskanen, T; Santos, FD; Sarnela, N; Schallhart, S; Schnitzhofer, R; Seinfeld, JH; Simon, M; Sipila, M; Stozhkov, Y; Stratmann, F; Tome, A; Trostl, J; Tsagkogeorgas, G; Vaattovaara, P; Viisanen, Y; Virtanen, A; Vrtala, A; Wagner, PE; Weingartner, E; Wex, H; Williamson, C; Wimmer, D; Ye, PL; Yli-Juuti, T; Carslaw, KS; Kulmala, M; Curtius, J; Baltensperger, U; Worsnop, DR; Vehkamaki, H; Kirkby, J				Almeida, Joao; Schobesberger, Siegfried; Kuerten, Andreas; Ortega, Ismael K.; Kupiainen-Maatta, Oona; Praplan, Arnaud P.; Adamov, Alexey; Amorim, Antonio; Bianchi, Federico; Breitenlechner, Martin; David, Andre; Dommen, Josef; Donahue, Neil M.; Downard, Andrew; Dunne, Eimear; Duplissy, Jonathan; Ehrhart, Sebastian; Flagan, Richard C.; Franchin, Alessandro; Guida, Roberto; Hakala, Jani; Hansel, Armin; Heinritzi, Martin; Henschel, Henning; Jokinen, Tuija; Junninen, Heikki; Kajos, Maija; Kangasluoma, Juha; Keskinen, Helmi; Kupc, Agnieszka; Kurten, Theo; Kvashin, Alexander N.; Laaksonen, Ari; Lehtipalo, Katrianne; Leiminger, Markus; Leppa, Johannes; Loukonen, Ville; Makhmutov, Vladimir; Mathot, Serge; McGrath, Matthew J.; Nieminen, Tuomo; Olenius, Tinja; Onnela, Antti; Petaja, Tuukka; Riccobono, Francesco; Riipinen, Ilona; Rissanen, Matti; Rondo, Linda; Ruuskanen, Taina; Santos, Filipe D.; Sarnela, Nina; Schallhart, Simon; Schnitzhofer, Ralf; Seinfeld, John H.; Simon, Mario; Sipila, Mikko; Stozhkov, Yuri; Stratmann, Frank; Tome, Antonio; Troestl, Jasmin; Tsagkogeorgas, Georgios; Vaattovaara, Petri; Viisanen, Yrjo; Virtanen, Annele; Vrtala, Aron; Wagner, Paul E.; Weingartner, Ernest; Wex, Heike; Williamson, Christina; Wimmer, Daniela; Ye, Penglin; Yli-Juuti, Taina; Carslaw, Kenneth S.; Kulmala, Markku; Curtius, Joachim; Baltensperger, Urs; Worsnop, Douglas R.; Vehkamaki, Hanna; Kirkby, Jasper			Molecular understanding of sulphuric acid-amine particle nucleation in the atmosphere	NATURE			English	Article							MASS-SPECTROMETER; FORMATION EVENTS; AEROSOL; DIMETHYLAMINE; AMMONIA; WATER	Nucleation of aerosol particles from trace atmospheric vapours is thought to provide up to half of global cloud condensation nuclei(1). Aerosols can cause a net cooling of climate by scattering sunlight and by leading to smaller but more numerous cloud droplets, which makes clouds brighter and extends their lifetimes(2). Atmospheric aerosols derived from human activities are thought to have compensated for a large fraction of the warming caused by greenhouse gases(2). However, despite its importance for climate, atmospheric nucleation is poorly understood. Recently, it has been shown that sulphuric acid and ammonia cannot explain particle formation rates observed in the lower atmosphere(3). It is thought that amines may enhance nucleation(4-16), but until now there has been no direct evidence for amine ternary nucleation under atmospheric conditions. Here we use the CLOUD (Cosmics Leaving OUtdoor Droplets) chamber at CERN and find that dimethylamine above three parts per trillion by volume can enhance particle formation rates more than 1,000-fold compared with ammonia, sufficient to account for the particle formation rates observed in the atmosphere. Molecular analysis of the clusters reveals that the faster nucleation is explained by a base-stabilization mechanism involving acid-amine pairs, which strongly decrease evaporation. The ion-induced contribution is generally small, reflecting the high stability of sulphuric acid-dimethylamine clusters and indicating that galactic cosmic rays exert only a small influence on their formation, except at low overall formation rates. Our experimental measurements are well reproduced by a dynamical model based on quantum chemical calculations of binding energies of molecular clusters, without any fitted parameters. These results show that, in regions of the atmosphere near amine sources, both amines and sulphur dioxide should be considered when assessing the impact of anthropogenic activities on particle formation.	[Almeida, Joao; Kuerten, Andreas; Ehrhart, Sebastian; Leiminger, Markus; Rondo, Linda; Simon, Mario; Williamson, Christina; Wimmer, Daniela; Curtius, Joachim; Kirkby, Jasper] Goethe Univ Frankfurt, Inst Atmospher & Environm Sci, D-60438 Frankfurt, Germany; [Almeida, Joao; David, Andre; Guida, Roberto; Mathot, Serge; Onnela, Antti; Kirkby, Jasper] CERN, CH-1211 Geneva, Switzerland; [Schobesberger, Siegfried; Ortega, Ismael K.; Kupiainen-Maatta, Oona; Adamov, Alexey; Duplissy, Jonathan; Franchin, Alessandro; Hakala, Jani; Henschel, Henning; Jokinen, Tuija; Junninen, Heikki; Kajos, Maija; Kangasluoma, Juha; Lehtipalo, Katrianne; Loukonen, Ville; Nieminen, Tuomo; Olenius, Tinja; Petaja, Tuukka; Rissanen, Matti; Ruuskanen, Taina; Sarnela, Nina; Schallhart, Simon; Sipila, Mikko; Wimmer, Daniela; Yli-Juuti, Taina; Kulmala, Markku; Worsnop, Douglas R.; Vehkamaki, Hanna] Univ Helsinki, Dept Phys, FI-00014 Helsinki, Finland; [Praplan, Arnaud P.; Bianchi, Federico; Dommen, Josef; Riccobono, Francesco; Troestl, Jasmin; Weingartner, Ernest; Baltensperger, Urs] Paul Scherrer Inst, Lab Atmospher Chem, CH-5232 Villigen, Switzerland; [Amorim, Antonio; Santos, Filipe D.; Tome, Antonio] Univ Lisbon, SIM, P-1749016 Lisbon, Portugal; [Amorim, Antonio; Santos, Filipe D.; Tome, Antonio] Univ Beira Interior, P-1749016 Lisbon, Portugal; [Breitenlechner, Martin; Hansel, Armin; Heinritzi, Martin; Schnitzhofer, Ralf] Ionicon Analyt GmbH, A-6020 Innsbruck, Austria; [Breitenlechner, Martin; Hansel, Armin; Heinritzi, Martin; Schnitzhofer, Ralf] Univ Innsbruck, Inst Ion & Appl Phys, A-6020 Innsbruck, Austria; [Donahue, Neil M.; Ye, Penglin] Carnegie Mellon Univ, Ctr Atmospher Particle Studies, Pittsburgh, PA 15213 USA; [Downard, Andrew; Flagan, Richard C.; Seinfeld, John H.] CALTECH, Div Chem & Chem Engn, Pasadena, CA 91125 USA; [Dunne, Eimear; Carslaw, Kenneth S.] Univ Leeds, Sch Earth & Environm, Leeds LS2 9JT, W Yorkshire, England; [Keskinen, Helmi; Laaksonen, Ari; Vaattovaara, Petri; Virtanen, Annele; Worsnop, Douglas R.] Univ Eastern Finland, FI-70211 Kuopio, Finland; [Kupc, Agnieszka; Vrtala, Aron; Wagner, Paul E.] Univ Vienna, Fac Phys, A-1090 Vienna, Austria; [Kurten, Theo] Univ Helsinki, Dept Chem, FI-00014 Helsinki, Finland; [Kvashin, Alexander N.; Makhmutov, Vladimir; Stozhkov, Yuri] PN Lebedev Phys Inst, Solar & Cosm Ray Res Lab, Moscow 119991, Russia; [Laaksonen, Ari; Leppa, Johannes; Viisanen, Yrjo; Worsnop, Douglas R.] Finnish Meteorol Inst, FI-00101 Helsinki, Finland; [McGrath, Matthew J.] Kyoto Univ, Grad Sch Sci, Dept Biophys, Kyoto 6068502, Japan; [Nieminen, Tuomo; Sipila, Mikko; Kulmala, Markku] Univ Helsinki, Helsinki Inst Phys, FI-00014 Helsinki, Finland; [Riipinen, Ilona] Univ Stockholm, Dept Appl Environm Sci, SE-10961 Stockholm, Sweden; [Stratmann, Frank; Tsagkogeorgas, Georgios; Wex, Heike] Leibniz Inst Tropospher Res, D-04318 Leipzig, Germany; [Worsnop, Douglas R.] Aerodyne Res Inc, Billerica, MA 01821 USA	Goethe University Frankfurt; European Organization for Nuclear Research (CERN); University of Helsinki; Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute; Universidade de Lisboa; Universidade da Beira Interior; University of Innsbruck; Carnegie Mellon University; California Institute of Technology; University of Leeds; University of Eastern Finland; University of Vienna; University of Helsinki; Russian Academy of Sciences; Russian Academy of Science Lebedev Physical Institute; Finnish Meteorological Institute; Kyoto University; Helsinki Institute of Physics; University of Helsinki; Stockholm University; Leibniz Institut fur Tropospharenforschung (TROPOS); Aerodyne Research	Kirkby, J (corresponding author), Goethe Univ Frankfurt, Inst Atmospher & Environm Sci, D-60438 Frankfurt, Germany.	jasper.kirkby@cern.ch	Duplissy, Jonathan/A-1723-2010; Virtanen, Annele/E-7699-2010; Yuri, Stozhkov/ABG-7096-2021; Petäjä, Tuukka/A-8009-2008; Dunne, Eimear M/H-1567-2014; Olenius, Tinja/GNP-2324-2022; kangasluoma, juha/W-7450-2019; Nieminen, Tuomo/AAB-8686-2020; Carslaw, Ken S/C-8514-2009; Laaksonen, Ari/B-5094-2011; Breitenlechner, Martin/AAA-3402-2021; Donahue, Neil M/A-2329-2008; Worsnop, Douglas R/D-2817-2009; Riipinen, Ilona/I-9379-2012; Weingartner, Ernest/B-6793-2009; Kangasluoma, Juha/AAY-7941-2021; Sarnela, Nina/AAE-1372-2020; Tinoco Mendes, Andre David/D-4314-2011; Adamov, Alexey/V-2477-2018; Kirkby, Jasper/A-4973-2012; Simon, Mario/AGI-2749-2022; Kürten, Andreas/O-3851-2019; Curtius, Joachim/A-2681-2011; Franchin, Alessandro/AAH-3069-2019; Tome, Antonio R/A-5681-2013; Henschel, Henning/A-5060-2012; Vehkamäki, Hanna/A-8262-2008; Bianchi, Federico/G-8428-2012; Amorim, Antonio/C-8460-2013; Nieminen, Tuomo J/D-1618-2011; Williamson, Christina J/D-1484-2016; Franchin, Alessandro/GVR-8219-2022; Stozhkov, Yuri/M-7433-2015; Kurtén, Theo C/G-2120-2012; Praplan, Arnaud P./F-8357-2011; Schobesberger, Siegfried/L-4454-2014; Makhmutov, Vladimir/N-2086-2015; Yli-Juuti, Taina/O-9496-2018; Kulmala, Markku T/I-7671-2016; Wex, Heike/X-5882-2018; Jokinen, Tuija/B-3365-2014; Santos, Filipe/M-7709-2013; Sipilä, Mikko/G-3024-2010; Viisanen, Yrjö/CAG-3818-2022; Hansel, Armin/F-3915-2010; Riipinen, Ilona/ABD-5564-2021; Junninen, Heikki/C-2157-2014; Ortega Colomer, Ismael Kenneth/A-7930-2008	Duplissy, Jonathan/0000-0001-8819-0264; Virtanen, Annele/0000-0002-2917-5344; Petäjä, Tuukka/0000-0002-1881-9044; Dunne, Eimear M/0000-0001-7085-8473; Nieminen, Tuomo/0000-0002-2713-715X; Carslaw, Ken S/0000-0002-6800-154X; Laaksonen, Ari/0000-0002-1657-2383; Donahue, Neil M/0000-0003-3054-2364; Worsnop, Douglas R/0000-0002-8928-8017; Weingartner, Ernest/0000-0002-2427-4634; Kangasluoma, Juha/0000-0002-1639-1187; Tinoco Mendes, Andre David/0000-0001-5854-7699; Kirkby, Jasper/0000-0003-2341-9069; Kürten, Andreas/0000-0002-8955-4450; Curtius, Joachim/0000-0003-3153-4630; Tome, Antonio R/0000-0001-9144-7120; Henschel, Henning/0000-0001-7196-661X; Vehkamäki, Hanna/0000-0002-5018-1255; Bianchi, Federico/0000-0003-2996-3604; Amorim, Antonio/0000-0003-0638-2321; Williamson, Christina J/0000-0002-5188-9378; Stozhkov, Yuri/0000-0003-1917-0328; Kurtén, Theo C/0000-0002-6416-4931; Praplan, Arnaud P./0000-0002-9944-3084; Schobesberger, Siegfried/0000-0002-5777-4897; Makhmutov, Vladimir/0000-0002-2242-1055; Kulmala, Markku T/0000-0003-3464-7825; Wex, Heike/0000-0003-2129-9323; Jokinen, Tuija/0000-0002-1280-1396; Santos, Filipe/0000-0001-7316-1479; Sipilä, Mikko/0000-0002-8594-7003; Viisanen, Yrjö/0000-0002-9660-3281; Hansel, Armin/0000-0002-1062-2394; Simon, Mario/0000-0002-4900-7460; Lehtipalo, Katrianne/0000-0002-1660-2706; Leiminger, Markus/0000-0003-3343-5425; Ehrhart, Sebastian/0000-0002-6517-5341; Trostl, Jasmin/0000-0002-2807-0348; Sarnela, Nina/0000-0003-1874-3235; Breitenlechner, Martin/0000-0002-2382-6660; Junninen, Heikki/0000-0001-7178-9430; Rissanen, Matti/0000-0003-0463-8098; McGrath, Matthew/0000-0003-3431-8466; Kupc/Straus, Agnieszka/0000-0002-7996-2506; Ortega Colomer, Ismael Kenneth/0000-0002-9299-2013; Keskinen, Helmi/0000-0003-3614-0542	EC [215072, 316662, 57360, 227463]; German Federal Ministry of Education and Research [01LK0902A, 01LK1222A]; Swiss National Science Foundation [200020_135307, 206620_130527]; Academy of Finland [1118615, 135054, 133872, 251427, 139656, 139995, 137749, 141217, 141451]; Finnish Funding Agency for Technology and Innovation; Vaisala Foundation; Nessling Foundation; Austrian Science Fund (FWF) [P19546, L593]; Portuguese Foundation for Science and Technology [CERN/FP/116387/2010]; Swedish Research Council, Vetenskapsradet [2011-5120]; Presidium of the Russian Academy of Sciences; Russian Foundation for Basic Research [08-02-91006-CERN, 12-02-91522-CERN]; US National Science Foundation [AGS1136479, CHE1012293]; Directorate For Geosciences [1136479] Funding Source: National Science Foundation; Division Of Chemistry [1012293] Funding Source: National Science Foundation; Austrian Science Fund (FWF) [L 593] Funding Source: researchfish	EC(European CommissionEuropean Commission Joint Research Centre); German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Academy of Finland(Academy of Finland); Finnish Funding Agency for Technology and Innovation(Finnish Funding Agency for Technology & Innovation (TEKES)); Vaisala Foundation; Nessling Foundation; Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Portuguese Foundation for Science and Technology(Portuguese Foundation for Science and Technology); Swedish Research Council, Vetenskapsradet(Swedish Research Council); Presidium of the Russian Academy of Sciences(Russian Academy of Sciences); Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); US National Science Foundation(National Science Foundation (NSF)); Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO)); Division Of Chemistry(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	We thank J.-L. Agostini, P. Carrie, L.-P. De Menezes, F. Josa, I. Krasin, R. Kristic, O. S. Maksumov, S. V. Mizin, R. Sitals, A. Wasem and M. Wilhelmsson for their contributions to the experiment, and D. Hanson and P. McMurry for discussions on their unpublished measurements of ambient gas-phase amines. We thank the CSC Centre for Scientific Computing in Espoo, Finland, for computer time, and J. Pierce and P. Paasonen for discussions. We thank CERN for supporting CLOUD with technicalandfinancial resources, and for providinga particlebeamfromtheCERN Proton Synchrotron. This research received funding from the EC Seventh Framework Programme (Marie Curie Initial Training Network 'CLOUD-ITN' no. 215072, MC-ITN 'CLOUD-TRAIN' no. 316662, ERC-Starting 'MOCAPAF' grant 57360 and ERC-Advanced 'ATMNUCLE' grant 227463), the German Federal Ministry of Education and Research (projects 01LK0902A and 01LK1222A), the Swiss National Science Foundation (projects 200020_135307 and 206620_130527), the Academy of Finland (Center of Excellence project 1118615), the Academy of Finland (135054, 133872, 251427, 139656, 139995, 137749, 141217 and 141451), the Finnish Funding Agency for Technology and Innovation, the Vaisala Foundation, the Nessling Foundation, the Austrian Science Fund (FWF; projects P19546 and L593), the Portuguese Foundation for Science and Technology (project CERN/FP/116387/2010), the Swedish Research Council, Vetenskapsradet (grant 2011-5120), the Presidium of the Russian Academy of Sciences and Russian Foundation for Basic Research (grants 08-02-91006-CERN and 12-02-91522-CERN), and the US National Science Foundation (grants AGS1136479 and CHE1012293).	Andreae MO, 2005, NATURE, V435, P1187, DOI 10.1038/nature03671; Berndt T, 2010, ATMOS CHEM PHYS, V10, P7101, DOI 10.5194/acp-10-7101-2010; Chen M, 2012, P NATL ACAD SCI USA, V109, P18713, DOI 10.1073/pnas.1210285109; Creamean JM, 2011, ENVIRON SCI TECHNOL, V45, P8208, DOI 10.1021/es103692f; Facchini MC, 2008, ENVIRON SCI TECHNOL, V42, P9116, DOI 10.1021/es8018385; Ge XL, 2011, ATMOS ENVIRON, V45, P524, DOI 10.1016/j.atmosenv.2010.10.012; Graus M, 2010, J AM SOC MASS SPECTR, V21, P1037, DOI 10.1016/j.jasms.2010.02.006; GRONBERG L, 1992, CHEMOSPHERE, V24, P1533, DOI 10.1016/0045-6535(92)90273-T; Hanson DR, 2006, J PHYS CHEM A, V110, P9525, DOI 10.1021/jp062844w; Hanson DR, 2011, ENVIRON SCI TECHNOL, V45, P8881, DOI 10.1021/es201819a; Iida K, 2009, AEROSOL SCI TECH, V43, P81, DOI 10.1080/02786820802488194; Junninen H, 2010, ATMOS MEAS TECH, V3, P1039, DOI 10.5194/amt-3-1039-2010; Kerminen VM, 2002, J AEROSOL SCI, V33, P609, DOI 10.1016/S0021-8502(01)00194-X; Kirkby J, 2011, NATURE, V476, P429, DOI 10.1038/nature10343; Kuang C, 2008, J GEOPHYS RES-ATMOS, V113, DOI 10.1029/2007JD009253; Kurten A, 2011, ATMOS MEAS TECH, V4, P437, DOI 10.5194/amt-4-437-2011; Kurten A, 2012, J PHYS CHEM A, V116, P6375, DOI 10.1021/jp212123n; Kulmala M, 2007, SCIENCE, V318, P89, DOI 10.1126/science.1144124; Kulmala M, 2013, SCIENCE, V339, P943, DOI 10.1126/science.1227385; Kulmala M, 2008, ATMOS RES, V90, P132, DOI 10.1016/j.atmosres.2008.01.005; Kurten T, 2008, ATMOS CHEM PHYS, V8, P4095, DOI 10.5194/acp-8-4095-2008; Laakso L, 2004, ATMOS CHEM PHYS, V4, P2353, DOI 10.5194/acp-4-2353-2004; Loukonen V, 2010, ATMOS CHEM PHYS, V10, P4961, DOI 10.5194/acp-10-4961-2010; Makela JM, 2001, TELLUS B, V53, P380, DOI 10.1034/j.1600-0889.2001.d01-27.x; Merikanto J, 2009, ATMOS CHEM PHYS, V9, P8601, DOI 10.5194/acp-9-8601-2009; Murphy SM, 2007, ATMOS CHEM PHYS, V7, P2313, DOI 10.5194/acp-7-2313-2007; Nielsen CJ, 2012, CHEM SOC REV, V41, P6684, DOI 10.1039/c2cs35059a; Ortega IK, 2012, ATMOS CHEM PHYS, V12, P225, DOI 10.5194/acp-12-225-2012; Paasonen P, 2010, ATMOS CHEM PHYS, V10, P11223, DOI 10.5194/acp-10-11223-2010; Perraud VP, 2020, ENVIRON SCI-PROC IMP, V22, P305, DOI 10.1039/c9em00431a; Petaja T, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.228302; Praplan AP, 2012, ATMOS MEAS TECH, V5, P2161, DOI 10.5194/amt-5-2161-2012; Sipila M, 2010, SCIENCE, V327, P1243, DOI 10.1126/science.1180315; Smith JN, 2010, P NATL ACAD SCI USA, V107, P6634, DOI 10.1073/pnas.0912127107; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Vanhanen J, 2011, AEROSOL SCI TECH, V45, P533, DOI 10.1080/02786826.2010.547889; Wimmer D., 2013, ATMOS MEAS TECH DISC, V6, P2151; Yu H, 2012, ENVIRON CHEM, V9, P190, DOI 10.1071/EN12020; Yu H, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2011GL050099; Zhao J, 2011, ATMOS CHEM PHYS, V11, P10823, DOI 10.5194/acp-11-10823-2011; Zollner JH, 2012, ATMOS CHEM PHYS, V12, P4399, DOI 10.5194/acp-12-4399-2012	41	597	607	19	684	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	OCT 17	2013	502	7471					359	+		10.1038/nature12663	http://dx.doi.org/10.1038/nature12663			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	235GY	24097350	Green Published, Green Submitted, Green Accepted, hybrid			2022-12-24	WOS:000325706300050
J	Rossignol, LN; Paasche-Orlow, MK				Rossignol, Lisa N.; Paasche-Orlow, Michael K.			Empowering Patients Who Have Specific Learning Disabilities	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Rossignol, Lisa N.] Univ New Mexico, Dept Sociol, Albuquerque, NM 87131 USA; [Paasche-Orlow, Michael K.] Boston Univ, Sch Med, Dept Med, Boston, MA 02118 USA	University of New Mexico; Boston University	Rossignol, LN (corresponding author), Univ New Mexico, Dept Sociol, MSC05 3080,1 Univ New Mexico, Albuquerque, NM 87131 USA.	lnrossignol@gmail.com	Paasche-Orlow, Michael/ABF-7919-2020	Paasche-Orlow, Michael/0000-0002-9276-7190				[Anonymous], GUID LEARN DIS PRIM; Hale J, 2010, LEARN DISABILITY Q, V33, P223, DOI 10.1177/073194871003300310; National Center for Education Statistics website, CHAR PUBL PRIV BUR I; Office of Elementary and Secondary Education; Office of Special Education and Rehabilitative Services U.S. Department of Education, 2007, Fed Regist, V72, P17747; Shah RP, 2013, ACAD PEDIATR, V13, P430, DOI 10.1016/j.acap.2013.03.003; Silver LB, 2010, GUIDE LEARNING DISAB; Volandes AE, 2007, AM J BIOETHICS, V7, P5, DOI 10.1080/15265160701638520	7	2	2	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 9	2013	310	14					1445	1446		10.1001/jama.2013.278068	http://dx.doi.org/10.1001/jama.2013.278068			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	230PK	24052008				2022-12-24	WOS:000325354100016
J	Savage, N				Savage, Neil			MODELLING Predictive yield	NATURE			English	Editorial Material																		Asseng S, 2013, NAT CLIM CHANGE, V3, P827, DOI [10.1038/NCLIMATE1916, 10.1038/nclimate1916]	1	3	3	1	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 26	2013	501	7468					S10	S11		10.1038/501S10a	http://dx.doi.org/10.1038/501S10a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	223RP	24067758	Bronze			2022-12-24	WOS:000324826300005
J	Saitta, EKH; Legron-Rodriguez, T; Bowdon, MA				Saitta, Erin. K. H.; Legron-Rodriguez, Tamra; Bowdon, Melody A.			An Inquiry into the Water Around Us	SCIENCE			English	Editorial Material									[Saitta, Erin. K. H.] Univ Cent Florida, Karen L Smith Fac Ctr Teaching & Learning, Orlando, FL 32816 USA; [Saitta, Erin. K. H.; Legron-Rodriguez, Tamra; Bowdon, Melody A.] Univ Cent Florida, Dept Chem, Orlando, FL 32816 USA; [Bowdon, Melody A.] Univ Cent Florida, Dept Writing & Rhetor, Orlando, FL 32816 USA	State University System of Florida; University of Central Florida; State University System of Florida; University of Central Florida; State University System of Florida; University of Central Florida	Saitta, EKH (corresponding author), Univ Cent Florida, Karen L Smith Fac Ctr Teaching & Learning, Orlando, FL 32816 USA.	erin.saitta@ucf.edu		Legron-Rodriguez, Tamra/0000-0002-6608-293X				Alliance for Service-Learning in Educational Reform, 1995, STAND QUAL SCH BAS C; Bowdon M. A., 2011, HIGHER ED EMERGING T; Bybee RW., 2006, COLORADO SPRINGS CO, V5, P88; Eyler J., 1999, WHERES LEARNING SERV; Hill C., 2010, WOMEN SCI TECHNOLOGY, DOI [10.1002/sce.21007, DOI 10.1002/SCE.21007]; Leonard W. H., 2009, SCI TEACH, V76, P40; National Research Council (NRC), 1996, NAT SCI ED STAND; Novak J, 2010, J EDUC TEACHING, V36, P121, DOI 10.1080/02607470903462263; President's Council of Advisors on Science and Technology, 2012, PRES BID PROLGBTQ TI; Saitta EKH, 2011, J SCI EDUC TECHNOL, V20, P790, DOI 10.1007/s10956-010-9273-0	10	1	1	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 30	2013	341	6149					971	972		10.1126/science.1230000	http://dx.doi.org/10.1126/science.1230000			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	208BZ	23990552				2022-12-24	WOS:000323652300031
J	Feder, G; Wathen, CN; MacMillan, HL				Feder, Gene; Wathen, C. Nadine; MacMillan, Harriet L.			An Evidence-Based Response to Intimate Partner Violence WHO Guidelines	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							RANDOMIZED-CONTROLLED-TRIAL		[Feder, Gene] Univ Bristol, Sch Social & Community Med, Ctr Acad Primary Care, Bristol BS8 2PS, Avon, England; [Wathen, C. Nadine] Western Univ, Fac Informat & Media Studies, London, ON, Canada; [MacMillan, Harriet L.] McMaster Univ, Dept Psychiat & Behav Neurosci, Hamilton, ON, Canada; [MacMillan, Harriet L.] McMaster Univ, Dept Pediat, Hamilton, ON, Canada	University of Bristol; Western University (University of Western Ontario); McMaster University; McMaster University	Feder, G (corresponding author), Univ Bristol, Sch Social & Community Med, 39 Whatley Rd,Canynge Hall, Bristol BS8 2PS, Avon, England.	gene.feder@bristol.ac.uk	MacMillan, Harriet/B-4530-2016	MacMillan, Harriet/0000-0002-1223-706X; Feder, Gene/0000-0002-7890-3926				Cohen JA, 2011, ARCH PEDIAT ADOL MED, V165, P16, DOI 10.1001/archpediatrics.2010.247; Feder G, 2011, LANCET, V378, P1788, DOI 10.1016/S0140-6736(11)61179-3; Feder GS, 2006, ARCH INTERN MED, V166, P22, DOI 10.1001/archinte.166.1.22; Klevens J, 2012, JAMA-J AM MED ASSOC, V308, P681, DOI 10.1001/jama.2012.6434; MacMillan HL, 2009, JAMA-J AM MED ASSOC, V302, P493, DOI 10.1001/jama.2009.1089; Moyer VA, 2013, ANN INTERN MED, V158, P478, DOI 10.7326/0003-4819-158-6-201303190-00588; Taft A, 2013, COCHRANE DB SYST REV, V4, DOI DOI 10.1002/14651858.CD007007.PUB2; World Health Organization, RESPONDING TO INTIMA	8	32	33	0	10	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 7	2013	310	5					479	480		10.1001/jama.2013.167453	http://dx.doi.org/10.1001/jama.2013.167453			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	196OZ	23925614				2022-12-24	WOS:000322786400016
J	Selvaraj, S				Selvaraj, Sakthivel			PERSONAL VIEW Africa could learn from India's burgeoning pharma sector	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Publ Hlth Fdn India, New Delhi, India	Public Health Foundation of India	Selvaraj, S (corresponding author), Publ Hlth Fdn India, New Delhi, India.	shakti@phfi.org	Selvaraj, Sakthivel/ABD-5873-2021; Selvaraj, Sakthivel/ABE-6897-2020	Selvaraj, Sakthivel/0000-0001-5940-1958				Centre for Monitoring Indian Economy, 2012, IND TRAD BAS DIR GEN; Emerging Market Information Services, 2012, PHARM SECT IND; Gopakumar KM, 2012, UNPACKING ISSUE COUN; Government of India, 2012, ANN REPORT; Government of India. Central Drugs Standards Control Organisation Directorate General Health Services Ministry of Health and Family Welfare, 2009, REP COUNTR SURV SPUR; Kaplan WA, 2005, LOCAL PRODUCTION PHA; Nakakeeto ON, 2013, GLOBALIZATION HEALTH, V9, DOI 10.1186/1744-8603-9-6; Pecoul B, 1999, JAMA-J AM MED ASSOC, V281, P361, DOI 10.1001/jama.281.4.361; Selvaraj Sakthivel, 2013, HINDU           0407	9	3	3	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 2	2013	347								f4235	10.1136/bmj.f4235	http://dx.doi.org/10.1136/bmj.f4235			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	197BM	23913693				2022-12-24	WOS:000322822800001
J	Callaway, E				Callaway, Ewen			Control issues	NATURE			English	Editorial Material																		Dye C, 2012, INDIAN J MED RES, V135, P737; Gardy JL, 2011, NEW ENGL J MED, V364, P730, DOI 10.1056/NEJMoa1003176; Pareek M, 2012, EMERG INFECT DIS, V18, P1422, DOI 10.3201/eid1809.120128; The World Bank, 2013, INC TUB PER 100 000; Zumla A, 2011, LANCET, V377, P10, DOI 10.1016/S0140-6736(10)62176-9	5	0	0	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 10	2013	502	7470					S16	S17		10.1038/502S16a	http://dx.doi.org/10.1038/502S16a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231RU	24108077	Bronze			2022-12-24	WOS:000325436100009
J	de Lange, C				de Lange, Catherine			Waiting for results	NATURE			English	Editorial Material							TUBERCULOSIS											Lawn SD, 2012, LANCET INFECT DIS, V12, P201, DOI 10.1016/S1473-3099(11)70251-1; Padmapriyadarsini C, 2011, INDIAN J MED RES, V134, P850, DOI 10.4103/0971-5916.92630; World Health Organization, 2013, WHO MON XPERT MTB RI	3	4	4	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 10	2013	502	7470					S10	S12		10.1038/502S10a	http://dx.doi.org/10.1038/502S10a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231RU	24108074	Bronze			2022-12-24	WOS:000325436100006
J	Maxmen, A				Maxmen, Amy			A combined effort	NATURE			English	Editorial Material							TUBERCULOSIS											Frymark, 2010, EVIDENCE BASED SYSTE; Lessem E., 2013, 22261 IBASETAG; Pethe K, 2013, NAT MED, V19, P1157, DOI 10.1038/nm.3262; Pethe K, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1060; Vilcheze C, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2898; World Health Organization, 2013, TUB FACTSH 104	6	4	4	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 10	2013	502	7470					S4	S6		10.1038/502S4a	http://dx.doi.org/10.1038/502S4a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231RU	24108079	Bronze			2022-12-24	WOS:000325436100003
J	Stephens, SL; Agee, JK; Fule, PZ; North, MP; Romme, WH; Swetnam, TW; Turner, MG				Stephens, S. L.; Agee, J. K.; Fule, P. Z.; North, M. P.; Romme, W. H.; Swetnam, T. W.; Turner, M. G.			Managing Forests and Fire in Changing Climates	SCIENCE			English	Editorial Material							WILDFIRE; INCREASE; FUELS		[Stephens, S. L.] Univ Calif Berkeley, Berkeley, CA 94720 USA; [Agee, J. K.] Univ Washington, Seattle, WA 98195 USA; [Fule, P. Z.] No Arizona Univ, Flagstaff, AZ 86011 USA; [North, M. P.] US Forest Serv, USDA, Pacific Southwest Res Stn, Davis, CA 95618 USA; [Romme, W. H.] Colorado State Univ, Ft Collins, CO 80523 USA; [Swetnam, T. W.] Univ Arizona, Tucson, AZ 85721 USA; [Turner, M. G.] Univ Wisconsin, Madison, WI 53706 USA	University of California System; University of California Berkeley; University of Washington; University of Washington Seattle; Northern Arizona University; United States Department of Agriculture (USDA); United States Forest Service; Colorado State University; University of Arizona; University of Wisconsin System; University of Wisconsin Madison	Stephens, SL (corresponding author), Univ Calif Berkeley, Berkeley, CA 94720 USA.	sstephens@berkeley.edu	Turner, Monica G/B-2099-2010; North, Malcolm/AAW-8897-2020; Romme, William H./C-7317-2016	Turner, Monica G/0000-0003-1903-2822; North, Malcolm/0000-0002-9090-784X; 				Attiwill P, 2013, FOREST ECOL MANAG, V294, P1, DOI 10.1016/j.foreco.2012.12.025; Balch JK, 2013, GLOBAL CHANGE BIOL, V19, P173, DOI 10.1111/gcb.12046; Chapin FS, 2008, BIOSCIENCE, V58, P531, DOI 10.1641/B580609; Flannigan M, 2009, GLOBAL CHANGE BIOL, V15, P549, DOI 10.1111/j.1365-2486.2008.01660.x; Hughes TP, 2013, TRENDS ECOL EVOL, V28, P149, DOI 10.1016/j.tree.2012.08.022; Iverson LR, 2013, LANDSCAPE ECOL, V28, P879, DOI 10.1007/s10980-013-9885-x; Littell JS, 2009, ECOL APPL, V19, P1003, DOI 10.1890/07-1183.1; McCaffrey S. M., 2012, GEN TECH REP NRS 104; Moriondo M, 2006, CLIM RES, V31, P85, DOI 10.3354/cr031085; Moritz MA, 2012, ECOSPHERE, V3, DOI 10.1890/ES11-00345.1; North M, 2012, J FOREST, V110, P392, DOI 10.5849/jof.12-021; Schoennagel T, 2004, BIOSCIENCE, V54, P661, DOI 10.1641/0006-3568(2004)054[0661:TIOFFA]2.0.CO;2; Stephens SL, 2012, BIOSCIENCE, V62, P549, DOI 10.1525/bio.2012.62.6.6; Westerling AL, 2011, P NATL ACAD SCI USA, V108, P13165, DOI 10.1073/pnas.1110199108; Williams AP, 2013, NAT CLIM CHANGE, V3, P292, DOI [10.1038/nclimate1693, 10.1038/NCLIMATE1693]	16	311	320	37	333	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 4	2013	342	6154					41	42		10.1126/science.1240294	http://dx.doi.org/10.1126/science.1240294			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	227PP	24092714				2022-12-24	WOS:000325126100032
J	Shaw, DM				Shaw, David M.			Homeopaths Without Borders practice exploitation not humanitarianism	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Univ Basel, Inst Biomed Eth, CH-4056 Basel, Switzerland	University of Basel	Shaw, DM (corresponding author), Univ Basel, Inst Biomed Eth, CH-4056 Basel, Switzerland.	david.shaw@unibas.ch						[Anonymous], 2005, LANCET, V366, P690; Homeopaths Without Borders (Germany), 2013, INT S; Shaw DM, 2010, J MED ETHICS, V36, P130, DOI 10.1136/jme.2009.034959	3	1	1	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 17	2013	347								f5448	10.1136/bmj.f5448	http://dx.doi.org/10.1136/bmj.f5448			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	223SB	24046156				2022-12-24	WOS:000324828300003
J	Oswald, R; Behrendt, T; Ermel, M; Wu, D; Su, H; Cheng, Y; Breuninger, C; Moravek, A; Mougin, E; Delon, C; Loubet, B; Pommerening-Roser, A; Sorgel, M; Poschl, U; Hoffmann, T; Andreae, MO; Meixner, FX; Trebs, I				Oswald, R.; Behrendt, T.; Ermel, M.; Wu, D.; Su, H.; Cheng, Y.; Breuninger, C.; Moravek, A.; Mougin, E.; Delon, C.; Loubet, B.; Pommerening-Roeser, A.; Soergel, M.; Poeschl, U.; Hoffmann, T.; Andreae, M. O.; Meixner, F. X.; Trebs, I.			HONO Emissions from Soil Bacteria as a Major Source of Atmospheric Reactive Nitrogen	SCIENCE			English	Article							NITRIC-OXIDE; EMPIRICAL-MODEL; NO EMISSIONS; RAIN-FOREST; NITRIFICATION; TEMPERATURE; DENITRIFICATION; DEPENDENCE; EXCHANGE	Abiotic release of nitrous acid (HONO) in equilibrium with soil nitrite (NO2-) was suggested as an important contributor to the missing source of atmospheric HONO and hydroxyl radicals (OH). The role of total soil-derived HONO in the biogeochemical and atmospheric nitrogen cycles, however, has remained unknown. In laboratory experiments, we found that for nonacidic soils from arid and arable areas, reactive nitrogen emitted as HONO is comparable with emissions of nitric oxide (NO). We show that ammonia-oxidizing bacteria can directly release HONO in quantities larger than expected from the acid-base and Henry's law equilibria of the aqueous phase in soil. This component of the nitrogen cycle constitutes an additional loss term for fixed nitrogen in soils and a source for reactive nitrogen in the atmosphere.	[Oswald, R.; Behrendt, T.; Ermel, M.; Wu, D.; Breuninger, C.; Moravek, A.; Soergel, M.; Andreae, M. O.; Meixner, F. X.; Trebs, I.] Max Planck Inst Chem, Biogeochem Dept, POB 3060, D-55020 Mainz, Germany; [Oswald, R.; Ermel, M.; Hoffmann, T.] Johannes Gutenberg Univ Mainz, Inst Inorgan & Analyt Chem, D-55128 Mainz, Germany; [Behrendt, T.] Johannes Gutenberg Univ Mainz, Inst Geog, D-55128 Mainz, Germany; [Wu, D.] Chinese Acad Sci, Key Lab Agr Water Res, Ctr Agr Resources Res, Inst Genet & Dev Biol, Shijiazhuang 050021, Peoples R China; [Su, H.; Cheng, Y.; Poeschl, U.] Max Planck Inst Chem, Multiphase Chem Dept, D-55020 Mainz, Germany; [Moravek, A.] Univ Bayreuth, Dept Micrometeorol, D-95447 Bayreuth, Germany; [Mougin, E.] Univ Toulouse, Geosci Environm Toulouse GET, Observ Midi Pyrenees, CNRS,Inst Rech Dev, F-31400 Toulouse, France; [Delon, C.] Univ Toulouse, Lab Aerol, F-31400 Toulouse, France; [Loubet, B.] INRA, Unite Mixte Rech INRA AgroParistech, Environm & Grandes Cultures, F-78850 Thiverval Grignon, France; [Pommerening-Roeser, A.] Univ Hamburg, Dept Microbiol & Biotechnol, D-22609 Hamburg, Germany	Max Planck Society; Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz; Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS; Max Planck Society; University of Bayreuth; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay; University of Hamburg	Oswald, R (corresponding author), Max Planck Inst Chem, Biogeochem Dept, POB 3060, D-55020 Mainz, Germany.	robert.oswald@mpic.de; i.trebs@mpic.de	Hoffmann, Thorsten/A-7490-2012; Andreae, Meinrat O./B-1068-2008; Pöschl, Ulrich/A-6263-2010; Wu, Dianming/A-6583-2012; Su, Hang/A-6226-2010; Trebs, Ivonne/L-9125-2013; Cheng, Yafang/F-9362-2010; Loubet, Benjamin/AAP-5375-2020	Andreae, Meinrat O./0000-0003-1968-7925; Pöschl, Ulrich/0000-0003-1412-3557; Wu, Dianming/0000-0002-0414-9430; Su, Hang/0000-0003-4889-1669; Cheng, Yafang/0000-0003-4912-9879; Trebs, Ivonne/0000-0001-5966-4942; Loubet, Benjamin/0000-0001-8825-8775; Hoffmann, Thorsten/0000-0003-0939-271X; Sorgel, Matthias/0000-0003-1745-8221; Moravek, Alexander/0000-0003-4342-8173	Max Planck Society; Max Planck Graduate Center; Johannes Gutenberg University Mainz (MPGC); European Commission within the framework of PEGASOS [265148]	Max Planck Society(Max Planck SocietyFoundation CELLEX); Max Planck Graduate Center(Max Planck Society); Johannes Gutenberg University Mainz (MPGC); European Commission within the framework of PEGASOS	This project was funded by the Max Planck Society. The work was supported by the Max Planck Graduate Center with the Johannes Gutenberg University Mainz (MPGC). We are grateful to S. Hohlmann, S. Muller, M. Welling, P. Stella, A. Held, B. L. Simmons, N. Mascher, C. Becker, A. C. Hertel, F. Hertel, and Z. Wu for supporting the experiments and helping to collect the soil samples and to S. Bohnke for assistance in creating the global map. We thank K. Emde and team as well as the company Envilytix for analyzing chemical and physical soil properties. Soil sample S7 was collected in Mali at the Agoufou site belonging to the African Multidisciplinary Monsoon Analysis-Couplage de l'Atmosphere Tropicale et du Cycle Hydrologique (AMMA-CATCH) observatory (www.amma-catch.org). The soil sample S11 from Grignon was collected within the framework of the European Commission project NitroEurope-IP (017841). The work of H.S. was supported by the European Commission within the framework of PEGASOS (265148). Supporting soil data are available in the supplementary materials.	Breuer L, 2002, SOIL SCI SOC AM J, V66, P834, DOI 10.2136/sssaj2002.0834; Breuninger C, 2012, ATMOS MEAS TECH, V5, P955, DOI 10.5194/amt-5-955-2012; Davidson EA, 2006, GLOBAL CHANGE BIOL, V12, P154, DOI 10.1111/j.1365-2486.2005.01065.x; Feig GT, 2008, BIOGEOSCIENCES, V5, P1723, DOI 10.5194/bg-5-1723-2008; FIRESTONE MK, 1989, LIFE SCI R, V47, P7; Godde M, 1998, SOIL BIOL BIOCHEM, V30, P433, DOI 10.1016/S0038-0717(97)00197-1; Godde M, 1999, BIOL FERT SOILS, V30, P33, DOI 10.1007/s003740050584; Jiang QQ, 1999, FEMS MICROBIOL ECOL, V30, P171, DOI 10.1111/j.1574-6941.1999.tb00646.x; Kleffmann J, 2007, CHEMPHYSCHEM, V8, P1137, DOI 10.1002/cphc.200700016; Koops HP, 2001, FEMS MICROBIOL ECOL, V37, P1, DOI 10.1111/j.1574-6941.2001.tb00847.x; KUBOTA M, 1985, SOIL SCI PLANT NUTR, V31, P35, DOI 10.1080/17470765.1985.10555215; Levine JS, 1996, J GEOPHYS RES-ATMOS, V101, P23689, DOI 10.1029/96JD01661; Ludwig J, 2001, BIOGEOCHEMISTRY, V52, P225, DOI 10.1023/A:1006424330555; NAGELE W, 1990, FEMS MICROBIOL ECOL, V74, P49, DOI 10.1016/0378-1097(90)90515-R; Park S, 2007, PROCESS BIOCHEM, V42, P1671, DOI 10.1016/j.procbio.2007.09.010; Pilegaard K, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2013.0126; QUASTEL JH, 1965, ANN REV PLANT PHYSIO, V16, P217, DOI 10.1146/annurev.pp.16.060165.001245; REMDE A, 1993, J ATMOS CHEM, V17, P249, DOI 10.1007/BF00694400; Rousk J, 2010, ISME J, V4, P1340, DOI 10.1038/ismej.2010.58; Rummel U, 2002, J GEOPHYS RES-ATMOS, V107, DOI 10.1029/2001JD000520; SAAD OALO, 1993, BIOL FERT SOILS, V15, P21, DOI 10.1007/BF00336283; SKOPP J, 1990, SOIL SCI SOC AM J, V54, P1619, DOI 10.2136/sssaj1990.03615995005400060018x; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Steinkamp J, 2011, ATMOS CHEM PHYS, V11, P6063, DOI 10.5194/acp-11-6063-2011; Stromberger ME, 2005, SOIL SCI SOC AM J, V69, P1987, DOI 10.2136/sssaj2005.0076; Su H, 2011, SCIENCE, V333, P1616, DOI 10.1126/science.1207687; van Dijk SM, 2002, J GEOPHYS RES-ATMOS, V107, DOI 10.1029/2001JD000358; Wiesen P., 2002, ENVIRON SCI POLLUT R, V9, P48; Yan DD, 2013, SOIL SCI PLANT NUTR, V59, P142, DOI 10.1080/00380768.2012.754727; YIENGER JJ, 1995, J GEOPHYS RES-ATMOS, V100, P11447, DOI 10.1029/95JD00370	30	212	221	39	498	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 13	2013	341	6151					1233	1235		10.1126/science.1242266	http://dx.doi.org/10.1126/science.1242266			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	215ZA	24031015	Green Submitted			2022-12-24	WOS:000324248800041
J	Sankilampi, U; Saari, A; Laine, T; Miettinen, PJ; Dunkel, L				Sankilampi, Ulla; Saari, Antti; Laine, Tiina; Miettinen, Paivi J.; Dunkel, Leo			Use of Electronic Health Records for Automated Screening of Growth Disorders in Primary Care	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Sankilampi, Ulla] Kuopio Univ Hosp, Dept Pediat, SF-70210 Kuopio, Finland; [Saari, Antti] Univ Eastern Finland, Dept Pediat, Kuopio, Finland; [Laine, Tiina; Miettinen, Paivi J.] Univ Helsinki, Cent Hosp, Helsinki, Finland; [Dunkel, Leo] Queen Mary Univ London, Ctr Endocrinol, London EC1M 6BQ, England	Kuopio University Hospital; University of Eastern Finland; University of Eastern Finland; University of Helsinki; Helsinki University Central Hospital; University of London; Queen Mary University London	Dunkel, L (corresponding author), Queen Mary Univ London, William Harvey Res Inst, Ctr Endocrinol, Barts & London Charterhouse Sq, London EC1M 6BQ, England.	l.dunkel@qmul.ac.uk		Miettinen, Paivi/0000-0002-5184-9616; Sankilampi, Ulla/0000-0002-0789-9720				Craig D, 2011, HEALTH TECHNOL ASSES, V15, P1, DOI 10.3310/hta15110; Maki P, 2011, HLTH CHECKUPS WELL C; SORVA R, 1989, Archives of Disease in Childhood, V64, P1483, DOI 10.1136/adc.64.10.1483; Wit JM, 2007, HORM RES, V68, pVII	4	35	36	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 11	2013	310	10					1071	1072		10.1001/jama.2013.218793	http://dx.doi.org/10.1001/jama.2013.218793			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	214KZ	24026604	Bronze			2022-12-24	WOS:000324133400026
J	Peng, SS; Piao, SL; Ciais, P; Myneni, RB; Chen, AP; Chevallier, F; Dolman, AJ; Janssens, IA; Penuelas, J; Zhang, GX; Vicca, S; Wan, SQ; Wang, SP; Zeng, H				Peng, Shushi; Piao, Shilong; Ciais, Philippe; Myneni, Ranga B.; Chen, Anping; Chevallier, Frederic; Dolman, Albertus J.; Janssens, Ivan A.; Penuelas, Josep; Zhang, Gengxin; Vicca, Sara; Wan, Shiqiang; Wang, Shiping; Zeng, Hui			Asymmetric effects of daytime and night-time warming on Northern Hemisphere vegetation	NATURE			English	Article							NET PRIMARY PRODUCTION; CARBON-DIOXIDE; RIDGE REGRESSION; LEAF RESPIRATION; CLIMATE-CHANGE; SATELLITE; TEMPERATURE; IMPACT; GROWTH	Temperature data over the past five decades show faster warming of the global land surface during the night than during the day(1). This asymmetric warming is expected to affect carbon assimilation and consumption in plants, because photosynthesis in most plants occurs during daytime and is more sensitive to the maximum daily temperature, T-max, whereas plant respiration occurs throughout the day(2) and is therefore influenced by both T-max and the minimum daily temperature, T-min. Most studies of the response of terrestrial ecosystems to climate warming, however, ignore this asymmetric forcing effect on vegetation growth and carbon dioxide (CO2) fluxes(3-6). Here we analyse the interannual covariations of the satellite-derived normalized difference vegetation index (NDVI, an indicator of vegetation greenness) with Tmax and Tmin over the Northern Hemisphere. After removing the correlation between Tmax and Tmin, we find that the partial correlation between Tmax and NDVI is positive in most wet and cool ecosystems over boreal regions, but negative in dry temperate regions. In contrast, the partial correlation between Tmin and NDVI is negative in boreal regions, and exhibits a more complex behaviour in dry temperate regions. We detect similar patterns in terrestrial net CO2 exchange maps obtained from a global atmospheric inversion model. Additional analysis of the long-term atmospheric CO2 concentration record of the station Point Barrow in Alaska suggests that the peak-to-peak amplitude of CO2 increased by 23 +/- 11% for a +1 degrees C anomaly in T-max from May to September over lands north of 51 degrees N, but decreased by 28 +/- 14% for a +1 degrees C anomaly in T-min. These lines of evidence suggest that asymmetric diurnal warming, a process that is currently not taken into account in many global carbon cycle models, leads to a divergent response of Northern Hemisphere vegetation growth and carbon sequestration to rising temperatures.	[Peng, Shushi; Piao, Shilong] Peking Univ, Coll Urban & Environm Sci, Sinofrench Inst Earth Syst Sci, Beijing 100871, Peoples R China; [Piao, Shilong; Zhang, Gengxin; Wang, Shiping] Chinese Acad Sci, Inst Tibetan Plateau Res, Beijing 100085, Peoples R China; [Ciais, Philippe; Chevallier, Frederic] CEA, CNRS, LSCE, CE, F-91191 Gif Sur Yvette, France; [Myneni, Ranga B.] Boston Univ, Dept Earth & Environm, Boston, MA 02215 USA; [Chen, Anping] Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA; [Dolman, Albertus J.] Vrije Univ Amsterdam, Dept Earth Sci, NL-1081 HV Amsterdam, Netherlands; [Janssens, Ivan A.; Vicca, Sara] Univ Antwerp, Dept Biol, B-2610 Antwerp, Belgium; [Penuelas, Josep] CREAF, Barcelona 08193, Catalonia, Spain; [Penuelas, Josep] UAB, CSIC, CEAB, Global Ecol Unit,CREAF, Barcelona 08193, Catalonia, Spain; [Wan, Shiqiang] Henan Univ, Coll Life Sci, Kaifeng 475001, Peoples R China; [Zeng, Hui] Peking Univ, Shenzhen Grad Sch, Shenzhen 518055, Peoples R China	Peking University; Chinese Academy of Sciences; Institute of Tibetan Plateau Research, CAS; UDICE-French Research Universities; Universite Paris Saclay; CEA; Centre National de la Recherche Scientifique (CNRS); Boston University; Princeton University; Vrije Universiteit Amsterdam; University of Antwerp; Centro de Investigacion Ecologica y Aplicaciones Forestales (CREAF); Autonomous University of Barcelona; Centro de Investigacion Ecologica y Aplicaciones Forestales (CREAF); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centre d'Estudis Avancats de Blanes (CEAB); University of Barcelona; Henan University; Peking University; University Town of Shenzhen	Piao, SL (corresponding author), Peking Univ, Coll Urban & Environm Sci, Sinofrench Inst Earth Syst Sci, Beijing 100871, Peoples R China.	slpiao@pku.edu.cn; zengh@pkusz.edu.cn	Myneni, Ranga B./AAU-6088-2021; Peng, Shushi/J-4779-2014; Myneni, Ranga B/F-5129-2012; Chevallier, Frederic JM/E-9608-2016; Janssens, Ivan A/P-1331-2014; Penuelas, Josep/D-9704-2011; PENG, Shushi/AAS-2603-2020; Vicca, Sara/I-3637-2012; Chen, Anping/H-9960-2014; Wan, Shiqiang/L-9166-2019; Wan, Shiqiang/B-5799-2009; Ciais, Philippe/A-6840-2011	Peng, Shushi/0000-0001-5098-726X; Myneni, Ranga B/0000-0002-0234-6393; Chevallier, Frederic JM/0000-0002-4327-3813; Janssens, Ivan A/0000-0002-5705-1787; Penuelas, Josep/0000-0002-7215-0150; PENG, Shushi/0000-0001-5098-726X; Vicca, Sara/0000-0001-9812-5837; Chen, Anping/0000-0003-2085-3863; Wan, Shiqiang/0000-0003-0631-1232; Wan, Shiqiang/0000-0003-0631-1232; Ciais, Philippe/0000-0001-8560-4943; Dolman, A.J./0000-0003-0099-0457	National Natural Science Foundation of China [41125004, 31021001]; National Basic Research Program of China [2010CB950601, 2013CB956303]; Foundation for Sino-EU Research Cooperation of the Ministry of Science and Technology of China [1003]; Chinese Ministry of Environmental Protection [201209031]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); Foundation for Sino-EU Research Cooperation of the Ministry of Science and Technology of China; Chinese Ministry of Environmental Protection	This study was supported by the National Natural Science Foundation of China (grant numbers 41125004 and 31021001), the National Basic Research Program of China (grant numbers 2010CB950601 and 2013CB956303), the Foundation for Sino-EU Research Cooperation of the Ministry of Science and Technology of China (grant number 1003), and a Chinese Ministry of Environmental Protection Grant (number 201209031). We also acknowledge the GLOBALVIEW-CO<INF>2</INF> project based at NOAA ESRL. S. V. is a postdoctoral research associate of the Fund for Scientific Research (Flanders).	Adler RF, 2003, J HYDROMETEOROL, V4, P1147, DOI 10.1175/1525-7541(2003)004<1147:TVGPCP>2.0.CO;2; Alward RD, 1999, SCIENCE, V283, P229, DOI 10.1126/science.283.5399.229; Atkin OK, 2013, PLANT SOIL, V367, P163, DOI 10.1007/s11104-013-1686-0; Baker DF, 2006, GLOBAL BIOGEOCHEM CY, V20, DOI 10.1029/2004GB002439; Baldocchi D, 2008, AUST J BOT, V56, P1, DOI 10.1071/BT07151; Beer C, 2010, SCIENCE, V329, P834, DOI 10.1126/science.1184984; Behera SK, 2005, J CLIMATE, V18, P4514, DOI 10.1175/JCLI3541.1; Beier C, 2008, SCI TOTAL ENVIRON, V407, P692, DOI 10.1016/j.scitotenv.2008.10.001; Chevallier F, 2010, J GEOPHYS RES-ATMOS, V115, DOI 10.1029/2010JD013887; de Jeu RAM, 2008, SURV GEOPHYS, V29, P399, DOI 10.1007/s10712-008-9044-0; Griffin KL, 2002, GLOBAL CHANGE BIOL, V8, P479, DOI 10.1046/j.1365-2486.2002.00487.x; Gu L, 2008, BIOSCIENCE, V58, P253, DOI 10.1641/B580311; HOERL AE, 1975, COMMUN STAT, V4, P105, DOI 10.1080/03610927508827232; HOERL AE, 1970, TECHNOMETRICS, V12, P55, DOI 10.1080/00401706.1970.10488634; Keeling RF, 1996, NATURE, V381, P218, DOI 10.1038/381218a0; Kim Y, 2012, REMOTE SENS ENVIRON, V121, P472, DOI 10.1016/j.rse.2012.02.014; Kreyling J, 2010, ECOLOGY, V91, P1939, DOI 10.1890/09-1160.1; Lin E., 2007, PHYS SCI BASIS WORKI, V3, P6; Ling P. P., GREENHOUSE CONDENSAT; Lucht W, 2002, SCIENCE, V296, P1687, DOI 10.1126/science.1071828; Melillo JM, 2002, SCIENCE, V298, P2173, DOI 10.1126/science.1074153; Menzel A, 2006, GLOBAL CHANGE BIOL, V12, P1969, DOI 10.1111/j.1365-2486.2006.01193.x; Mitchell TD, 2005, INT J CLIMATOL, V25, P693, DOI 10.1002/joc.1181; Myneni RB, 1997, NATURE, V386, P698, DOI 10.1038/386698a0; Nemani RR, 2003, SCIENCE, V300, P1560, DOI 10.1126/science.1082750; New M, 2000, J CLIMATE, V13, P2217, DOI 10.1175/1520-0442(2000)013<2217:RTCSTC>2.0.CO;2; Owe M, 2008, J GEOPHYS RES-EARTH, V113, DOI 10.1029/2007JF000769; Peng SB, 2004, P NATL ACAD SCI USA, V101, P9971, DOI 10.1073/pnas.0403720101; POTTER CS, 1993, GLOBAL BIOGEOCHEM CY, V7, P811, DOI 10.1029/93GB02725; Prasad PVV, 2008, CROP SCI, V48, P2372, DOI 10.2135/cropsci2007.12.0717; Qian HF, 2010, GLOBAL CHANGE BIOL, V16, P641, DOI 10.1111/j.1365-2486.2009.01989.x; Sitch S, 2003, GLOBAL CHANGE BIOL, V9, P161, DOI 10.1046/j.1365-2486.2003.00569.x; THONING KW, 1989, J GEOPHYS RES-ATMOS, V94, P8549, DOI 10.1029/JD094iD06p08549; Tucker CJ, 2005, INT J REMOTE SENS, V26, P4485, DOI 10.1080/01431160500168686; Turnbull MH, 2002, PLANT CELL ENVIRON, V25, P1729, DOI 10.1046/j.1365-3040.2002.00947.x; Wan SQ, 2009, ECOLOGY, V90, P2700, DOI 10.1890/08-2026.1; Wang H, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL052371; Willmott K., TERRESTRIAL PRECIPIT; Zhang YC, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2005JD006873; Zhao MS, 2010, SCIENCE, V329, P940, DOI [10.1126/science.1192666, 10.1126/science.1189590]; Zhou L, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD002510; Zhou LM, 2001, J GEOPHYS RES-ATMOS, V106, P20069, DOI 10.1029/2000JD000115	42	364	420	63	730	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 5	2013	501	7465					88	+		10.1038/nature12434	http://dx.doi.org/10.1038/nature12434			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	211ER	24005415				2022-12-24	WOS:000323888300037
J	Stein, RS; Toda, S				Stein, Ross S.; Toda, Shinji			Megacity Megaquakes-Two Near Misses	SCIENCE			English	Editorial Material							EARTHQUAKE		[Stein, Ross S.] US Geol Survey, Menlo Pk, CA 94025 USA; [Toda, Shinji] Tohoku Univ, IRIDeS, Sendai, Miyagi 980, Japan	United States Department of the Interior; United States Geological Survey; Tohoku University	Stein, RS (corresponding author), US Geol Survey, 345 Middlefield Rd, Menlo Pk, CA 94025 USA.	rstein@usgs.gov; toda@irides.tohoku.ac.jp						[Anonymous], LOC EARTHQ JAP US JM; Berryman KR, 2012, SCIENCE, V336, P1690, DOI 10.1126/science.1218959; Boyd OS, 2012, B SEISMOL SOC AM, V102, P909, DOI 10.1785/0120110008; Field E. H., 2011, 2011 FALL M 5 9 DEC; Holzer TL, 2013, EARTHQ SPECTRA, V29, P155, DOI 10.1193/1.4000106; Jordan TH, 2011, ANN GEOPHYS-ITALY, V54, P315, DOI 10.4401/ag-5350; Kagan YY, 2000, GEOPHYS J INT, V143, P438, DOI 10.1046/j.1365-246X.2000.01267.x; Lorito S, 2011, NAT GEOSCI, V4, P173, DOI [10.1038/ngeo1073, 10.1038/NGEO1073]; Rhoades DA, 2009, B SEISMOL SOC AM, V99, P636, DOI 10.1785/0120080063; Shearer PM, 2012, J GEOPHYS RES-SOL EA, V117, DOI 10.1029/2011JB008957; Toda S, 2013, GEOPHYS RES LETT, V40, P2562, DOI 10.1002/grl.50524	11	13	13	2	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 23	2013	341	6148					850	852		10.1126/science.1238944	http://dx.doi.org/10.1126/science.1238944			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204MY	23970687				2022-12-24	WOS:000323370600027
J	Fritsch, R; Downward, J				Fritsch, Ralph; Downward, Julian			SnapShot: Class I PI3K Isoform Signaling	CELL			English	Editorial Material							RECEPTOR; ACTIVATION; P110-BETA; CANCER; RAS		[Fritsch, Ralph] Canc Res UK London Res Inst, Signal Transduct Lab, London WC2A 3LY, England; [Downward, Julian] Inst Canc Res, Div Canc Biol, Lung Canc Grp, London SW3 6JB, England	Cancer Research UK; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; University College London	Fritsch, R (corresponding author), Canc Res UK London Res Inst, Signal Transduct Lab, 44 Lincolns Inn Fields, London WC2A 3LY, England.		Fritsch, Ralph/Q-8836-2019	Downward, Julian/0000-0002-2331-4729; Fritsch, Ralph/0000-0001-9639-3213	Cancer Research UK [15680] Funding Source: researchfish; Worldwide Cancer Research [13-0142] Funding Source: Medline	Cancer Research UK(Cancer Research UK); Worldwide Cancer Research		Dbouk HA, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2003264; Dou ZX, 2013, MOL CELL, V50, P29, DOI 10.1016/j.molcel.2013.01.022; Fritsch R, 2013, CELL, V153, P1050, DOI 10.1016/j.cell.2013.04.031; Gupta S, 2007, CELL, V129, P957, DOI 10.1016/j.cell.2007.03.051; Liu PX, 2009, NAT REV DRUG DISCOV, V8, P627, DOI 10.1038/nrd2926; Molina-Arcas M, 2013, CANCER DISCOV, V3, P548, DOI 10.1158/2159-8290.CD-12-0446; Schmid MC, 2011, CANCER CELL, V19, P715, DOI 10.1016/j.ccr.2011.04.016; Vanhaesebroeck B, 2012, NAT REV MOL CELL BIO, V13, P195, DOI 10.1038/nrm3290	8	22	24	0	7	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	AUG 15	2013	154	4					940	+	940.e1	10.1016/j.cell.2013.07.045	http://dx.doi.org/10.1016/j.cell.2013.07.045			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	202GQ	23953121	Bronze			2022-12-24	WOS:000323202500022
J	Gerber, EE; Gallo, EM; Fontana, SC; Davis, EC; Wigley, FM; Huso, DL; Dietz, HC				Gerber, Elizabeth E.; Gallo, Elena M.; Fontana, Stefani C.; Davis, Elaine C.; Wigley, Fredrick M.; Huso, David L.; Dietz, Harry C.			Integrin-modulating therapy prevents fibrosis and autoimmunity in mouse models of scleroderma	NATURE			English	Article							PLASMACYTOID DENDRITIC CELLS; TGF-BETA; EXPRESSION; PATHOGENESIS; DISEASE; SKIN; BETA-1-INTEGRIN; CONTRIBUTES; MECHANISMS; PROTEINS	In systemic sclerosis (SSc), a common and aetiologically mysterious form of scleroderma (defined as pathological fibrosis of the skin), previously healthy adults acquire fibrosis of the skin and viscera in association with autoantibodies(1). Familial recurrence is extremely rare and causal genes have not been identified. Although the onset of fibrosis in SSc typically correlates with the production of autoantibodies, whether they contribute to disease pathogenesis or simply serve as a marker of disease remains controversial and the mechanism for their induction is largely unknown(2). The study of SSc is hindered by a lack of animal models that recapitulate the aetiology of this complex disease. To gain a foothold in the pathogenesis of pathological skin fibrosis, we studied stiff skin syndrome (SSS), a rare but tractable Mendelian disorder leading to childhood onset of diffuse skin fibrosis with autosomal dominant inheritance and complete penetrance. We showed previously that SSS is caused by heterozygous missense mutations in the gene (FBN1) encoding fibrillin-1, the main constituent of extracellular microfibrils(3). SSS mutations all localize to the only domain in fibrillin-1 that harbours an Arg-Gly-Asp (RGD) motif needed to mediate cell-matrix interactions by binding to cell-surface integrins(3). Here we show that mouse lines harbouring analogous amino acid substitutions in fibrillin-1 recapitulate aggressive skin fibrosis that is prevented by integrin-modulating therapies and reversed by antagonism of the pro-fibrotic cytokine transforming growth factor beta (TGF-beta). Mutant mice show skin infiltration of pro-inflammatory immune cells including plasmacytoid dendritic cells, T helper cells and plasma cells, and also autoantibody production; these findings are normalized by integrin-modulating therapies or TGF-beta antagonism. These results show that alterations in cell-matrix interactions are sufficient to initiate and sustain inflammatory and pro-fibrotic programmes and highlight new therapeutic strategies.	[Gerber, Elizabeth E.; Gallo, Elena M.; Fontana, Stefani C.; Dietz, Harry C.] Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, Baltimore, MD 21205 USA; [Davis, Elaine C.] McGill Univ, Montreal, PQ H3A 2K6, Canada; [Wigley, Fredrick M.] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; [Huso, David L.] Johns Hopkins Univ, Sch Med, Dept Mol & Comparat Pathobiol, Baltimore, MD 21205 USA; [Dietz, Harry C.] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA	Johns Hopkins University; McGill University; Johns Hopkins University; Johns Hopkins University; Howard Hughes Medical Institute	Dietz, HC (corresponding author), Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, Baltimore, MD 21205 USA.	hdietz@jhmi.edu			Scleroderma Research Foundation; National Institutes of Health [RO1-AR41135, PO1-AR049698]; National Marfan Foundation; Smilow Center for Marfan Syndrome Research; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P01AR049698, R01AR041135] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007814] Funding Source: NIH RePORTER	Scleroderma Research Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Marfan Foundation; Smilow Center for Marfan Syndrome Research; Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank those who contributed skin biopsies to this study and those who provided reagents for this study, including S. Shattil, K. Flanders, C. J. Thomas, S. Patnaik and J. J. Marugan. This work was supported by grants to H. C. D. from the Scleroderma Research Foundation, the National Institutes of Health (RO1-AR41135 and PO1-AR049698), the National Marfan Foundation, the Smilow Center for Marfan Syndrome Research, and the Howard Hughes Medical Institute.	Asano Y, 2005, J IMMUNOL, V175, P7708, DOI 10.4049/jimmunol.175.11.7708; BONA C, 1994, CURR OPIN IMMUNOL, V6, P931, DOI 10.1016/0952-7915(94)90016-7; Brakebusch C, 2000, EMBO J, V19, P3990, DOI 10.1093/emboj/19.15.3990; Bratke K, 2011, ALLERGY, V66, P386, DOI 10.1111/j.1398-9995.2010.02497.x; Castelino FV, 2011, ARTHRITIS RHEUM-US, V63, P1405, DOI 10.1002/art.30262; Chen YL, 2008, ARTHRITIS RHEUM-US, V58, P577, DOI 10.1002/art.23146; Dardalhon V, 2008, NAT IMMUNOL, V9, P1347, DOI 10.1038/ni.1677; Davis EC, 1999, CONNECT TISSUE RES, V40, P113, DOI 10.3109/03008209909029107; Ding CL, 2009, J IMMUNOL, V183, P7140, DOI 10.4049/jimmunol.0901175; Doyle JJ, 2012, FEBS LETT, V586, P2003, DOI 10.1016/j.febslet.2012.05.027; Fleming JN, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001452; Garfield AS, 2010, METHODS MOL BIOL, V633, P19, DOI 10.1007/978-1-59745-019-5_2; Gehrie E, 2011, METHODS MOL BIOL, V677, P127, DOI 10.1007/978-1-60761-869-0_9; Hall JC, 2010, NAT REV RHEUMATOL, V6, P40, DOI 10.1038/nrrheum.2009.237; Harris ML, 2003, CURR OPIN RHEUMATOL, V15, P778, DOI 10.1097/00002281-200311000-00016; HogenEsch H, 2006, EXP DERMATOL, V15, P808, DOI 10.1111/j.1600-0625.2006.00483.x; Jego G, 2003, IMMUNITY, V19, P225, DOI 10.1016/S1074-7613(03)00208-5; Judge DP, 2004, J CLIN INVEST, V114, P172, DOI 10.1172/JCI200420641; Kawai T, 2006, CELL DEATH DIFFER, V13, P816, DOI 10.1038/sj.cdd.4401850; Kiosses WB, 2001, NAT CELL BIOL, V3, P316, DOI 10.1038/35060120; Lakos G, 2004, METH MOLEC MED, V102, P377; Lindsay ME, 2011, NATURE, V473, P308, DOI 10.1038/nature10145; Liu SX, 2009, ARTHRITIS RHEUM-US, V60, P2817, DOI 10.1002/art.24801; Loeys BL, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000488; Maurer B, 2010, ARTHRITIS RHEUM-US, V62, P1733, DOI 10.1002/art.27443; Mayes MD, 2003, ARTHRITIS RHEUM, V48, P2246, DOI 10.1002/art.11073; Munger JS, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005017; Nakerakanti SS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021911; Pampori N, 1999, J BIOL CHEM, V274, P21609, DOI 10.1074/jbc.274.31.21609; Reynolds LE, 2005, NAT MED, V11, P167, DOI 10.1038/nm1165; Saas P, 2012, CRIT REV IMMUNOL, V32, P529, DOI 10.1615/CritRevImmunol.2013005868; Saito E, 2002, J CLIN INVEST, V109, P1453, DOI 10.1172/JCI200215078; Sakkas LI, 2006, NAT CLIN PRACT RHEUM, V2, P679, DOI 10.1038/ncprheum0346; Swiecki M, 2010, IMMUNOL REV, V234, P142, DOI 10.1111/j.0105-2896.2009.00881.x; van Helden SFG, 2006, J IMMUNOL, V177, P1567, DOI 10.4049/jimmunol.177.3.1567; van Rooij E, 2008, P NATL ACAD SCI USA, V105, P13027, DOI 10.1073/pnas.0805038105; Varga J, 2009, NAT REV RHEUMATOL, V5, P200, DOI 10.1038/nrrheum.2009.26; Watarai H, 2008, P NATL ACAD SCI USA, V105, P2993, DOI 10.1073/pnas.0710351105; Zou WP, 2001, NAT MED, V7, P1339, DOI 10.1038/nm1201-1339	39	135	142	1	38	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 7	2013	503	7474					126	+		10.1038/nature12614	http://dx.doi.org/10.1038/nature12614			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247AS	24107997	Green Accepted			2022-12-24	WOS:000326585600045
J	Adam, S; Polo, SE; Almouzni, G				Adam, Salome; Polo, Sophie E.; Almouzni, Genevieve			Transcription Recovery after DNA Damage Requires Chromatin Priming by the H3.3 Histone Chaperone HIRA	CELL			English	Article							DOUBLE-STRAND BREAKS; HOMOLOGOUS RECOMBINATION; REPAIR; REVEALS; SITES; DEPOSITION; MUTATIONS; EXCISION; VARIANTS; DYNAMICS	Understanding how to recover fully functional and transcriptionally active chromatin when its integrity has been challenged by genotoxic stress is a critical issue. Here, by investigating how chromatin dynamics regulate transcriptional activity in response to DNA damage in human cells, we identify a pathway involving the histone chaperone histone regulator A (HIRA) to promote transcription restart after UVC damage. Our mechanistic studies reveal that HIRA accumulates at sites of UVC irradiation upon detection of DNA damage prior to repair and deposits newly synthesized H3.3 histones. This local action of HIRA depends on ubiquitylation events associated with damage recognition. Furthermore, we demonstrate that the early and transient function of HIRA in response to DNA damage primes chromatin for later reactivation of transcription. We propose that HIRA-dependent histone deposition serves as a chromatin bookmarking system to facilitate transcription recovery after genotoxic stress.	[Adam, Salome; Polo, Sophie E.; Almouzni, Genevieve] Inst Curie, Res Ctr, F-75248 Paris 5, France; [Adam, Salome; Polo, Sophie E.; Almouzni, Genevieve] CNRS, UMR 218, F-75248 Paris 5, France	UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Centre National de la Recherche Scientifique (CNRS)	Polo, SE (corresponding author), Univ Paris Diderot, CNRS, Epigenet & Cell Fate Ctr, UMR7216, F-75205 Paris 13, France.	sophie.polo@univ-paris-diderot.fr; genevieve.almouzni@curie.fr	Almouzni, Genevieve/ABG-1029-2021	Almouzni, Genevieve/0000-0001-5570-0723; Polo, Sophie/0000-0003-4821-9354	la Ligue Nationale contre le Cancer; European Commission Network of Excellence "Epi-GeneSys" [HEALTH-F4-2010-257082]; European Research Council Advanced Grant "Eccentric'' [2009-AdG_20090506]; French National Research Agency (Labex "DEEP''); French National Research Agency [ANR-12-JSV6-0002-01]; "Who am I''? Laboratory of Excellence [ANR-11-LABX-0071]; French Government through its "Investments for the Future'' program [ANR-11-IDEX-0005-01]; Fondation ARC; University Pierre Marie Curie; INSERM (Institut National de la Sante et de la Recherche Medicale); Marie Curie Intra-European fellowship	la Ligue Nationale contre le Cancer(Ligue nationale contre le cancer); European Commission Network of Excellence "Epi-GeneSys"; European Research Council Advanced Grant "Eccentric''; French National Research Agency (Labex "DEEP'')(French National Research Agency (ANR)); French National Research Agency(French National Research Agency (ANR)); "Who am I''? Laboratory of Excellence; French Government through its "Investments for the Future'' program(French National Research Agency (ANR)); Fondation ARC; University Pierre Marie Curie; INSERM (Institut National de la Sante et de la Recherche Medicale)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Marie Curie Intra-European fellowship(European Commission)	We are grateful to J. Haber, M. Papamichos-Chronakis, and D. Ray-Gallet for critical reading of the manuscript and to members of UMR218 for helpful discussions. We thank E. Dunleavy and C. de Noronha for cell lines and reagents and O. Renaud, O. Leroy, and P. LeBaccon from the PICT-IBiSA imaging facility. This work was supported by la Ligue Nationale contre le Cancer (Equipe labellisee Ligue 2010), the European Commission Network of Excellence "Epi-GeneSys'' (HEALTH-F4-2010-257082), the European Research Council Advanced Grant "Eccentric'' (2009-AdG_20090506), and the French National Research Agency (Labex "DEEP'') in G. A.'s laboratory. Research in S.E.P.'s group is supported by the French National Research Agency (ANR-12-JSV6-0002-01), the "Who am I''? Laboratory of Excellence (ANR-11-LABX-0071) funded by the French Government through its "Investments for the Future'' program (ANR-11-IDEX-0005-01), and the Fondation ARC. S.A. is a recipient of a PhD fellowship from University Pierre & Marie Curie, and S. E. P. is funded by INSERM (Institut National de la Sante et de la Recherche Medicale) and a Marie Curie Intra-European fellowship.	Adam S, 2012, INT J MOL SCI, V13, P11895, DOI 10.3390/ijms130911895; Adamson B, 2012, NAT CELL BIOL, V14, P318, DOI 10.1038/ncb2426; Amin AD, 2012, BBA-GENE REGUL MECH, V1819, P264, DOI 10.1016/j.bbagrm.2011.07.008; Anderson HE, 2009, MOL CELL BIOL, V29, P5158, DOI 10.1128/MCB.00698-09; Avvakumov N, 2011, MOL CELL, V41, P502, DOI 10.1016/j.molcel.2011.02.013; Bensaude O, 2011, TRANSCR-AUSTIN, V2, P103, DOI 10.4161/trns.2.3.16172; Bodor D., 2012, CURR PROTOC CELL BIO, V55; Burgess RJ, 2013, NAT STRUCT MOL BIOL, V20, P14, DOI 10.1038/nsmb.2461; Choi SY, 2013, NUCLEIC ACIDS RES, V41, P2180, DOI 10.1093/nar/gks1319; Chou DM, 2010, P NATL ACAD SCI USA, V107, P18475, DOI 10.1073/pnas.1012946107; Chujo M, 2012, J BIOL CHEM, V287, P23440, DOI 10.1074/jbc.M112.349944; Churchman LS, 2011, NATURE, V469, P368, DOI 10.1038/nature09652; Ciccia A, 2010, MOL CELL, V40, P179, DOI 10.1016/j.molcel.2010.09.019; Core LJ, 2008, SCIENCE, V322, P1845, DOI 10.1126/science.1162228; Dantuma NP, 2006, J CELL BIOL, V173, P19, DOI 10.1083/jcb.200510071; De Koning L, 2007, NAT STRUCT MOL BIOL, V14, P997, DOI 10.1038/nsmb1318; Dunleavy EM, 2011, NUCLEUS-PHILA, V2, P146, DOI 10.4161/nucl.2.2.15211; EHMANN UK, 1978, BIOPHYS J, V22, P249, DOI 10.1016/S0006-3495(78)85487-3; Gaillard H, 2013, BBA-GENE REGUL MECH, V1829, P141, DOI 10.1016/j.bbagrm.2012.09.008; Gaillard PHL, 1996, CELL, V86, P887, DOI 10.1016/S0092-8674(00)80164-6; Giglia-Mari G, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a000745; Green CM, 2003, EMBO J, V22, P5163, DOI 10.1093/emboj/cdg478; Hanawalt PC, 2008, NAT REV MOL CELL BIO, V9, P958, DOI 10.1038/nrm2549; Hoeijmakers JHJ, 2009, NEW ENGL J MED, V361, P1475, DOI 10.1056/NEJMra0804615; Iacovoni JS, 2010, EMBO J, V29, P1446, DOI 10.1038/emboj.2010.38; Ishii T, 2010, J BIOL CHEM, V285, P41993, DOI 10.1074/jbc.M110.161661; Jackson SP, 2009, NATURE, V461, P1071, DOI 10.1038/nature08467; Jensen A, 2010, DNA REPAIR, V9, P1142, DOI 10.1016/j.dnarep.2010.08.002; Jullien J, 2012, EPIGENET CHROMATIN, V5, DOI 10.1186/1756-8935-5-17; Kapitzky L, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.107; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Loyola A, 2006, MOL CELL, V24, P309, DOI 10.1016/j.molcel.2006.08.019; Luijsterburg MS, 2011, MOL ONCOL, V5, P349, DOI 10.1016/j.molonc.2011.06.001; Mailand N, 2007, CELL, V131, P887, DOI 10.1016/j.cell.2007.09.040; Michod D, 2012, NEURON, V74, P122, DOI 10.1016/j.neuron.2012.02.021; Mone MJ, 2001, EMBO REP, V2, P1013, DOI 10.1093/embo-reports/kve224; Nakazawa Y, 2010, DNA REPAIR, V9, P506, DOI 10.1016/j.dnarep.2010.01.015; Nouspikel T, 2009, CELL MOL LIFE SCI, V66, P994, DOI 10.1007/s00018-009-8737-y; Nouspikel T, 2011, MECH AGEING DEV, V132, P355, DOI 10.1016/j.mad.2011.03.003; Pankotai T, 2012, NAT STRUCT MOL BIOL, V19, P276, DOI 10.1038/nsmb.2224; Placek BJ, 2009, J VIROL, V83, P1416, DOI 10.1128/JVI.01276-08; Polo SE, 2006, CELL, V127, P481, DOI 10.1016/j.cell.2006.08.049; Povlsen LK, 2012, NAT CELL BIOL, V14, P1089, DOI 10.1038/ncb2579; Ray-Gallet D, 2011, MOL CELL, V44, P928, DOI 10.1016/j.molcel.2011.12.006; Schneiderman JI, 2012, P NATL ACAD SCI USA, V109, P19721, DOI 10.1073/pnas.1206629109; Schwartzentruber J, 2012, NATURE, V482, P226, DOI [10.1038/nature10833, 10.1007/s13311-012-0137-6]; Shanbhag NM, 2010, CELL, V141, P970, DOI 10.1016/j.cell.2010.04.038; Skene PJ, 2013, DEVELOPMENT, V140, P2513, DOI 10.1242/dev.091439; Smerdon MJ, 1991, CURR OPIN CELL BIOL, V3, P422, DOI 10.1016/0955-0674(91)90069-B; Soria G, 2012, MOL CELL, V46, P722, DOI 10.1016/j.molcel.2012.06.002; Sturm D, 2012, CANCER CELL, V22, P425, DOI 10.1016/j.ccr.2012.08.024; Svejstrup JQ, 2010, TRENDS BIOCHEM SCI, V35, P333, DOI 10.1016/j.tibs.2010.02.001; Szenker E, 2012, CELL REP, V1, P730, DOI 10.1016/j.celrep.2012.05.006; Szenker E, 2011, CELL RES, V21, P421, DOI 10.1038/cr.2011.14; Talbert PB, 2010, NAT REV MOL CELL BIO, V11, P264, DOI 10.1038/nrm2861; Tornaletti S, 2009, CELL MOL LIFE SCI, V66, P1010, DOI 10.1007/s00018-009-8738-x; Wu G, 2012, NAT GENET, V44, P251, DOI 10.1038/ng.1102; Yang JH, 2011, P NATL ACAD SCI USA, V108, P85, DOI 10.1073/pnas.1009830108; Yang XH, 2013, J BIOL CHEM, V288, P18271, DOI 10.1074/jbc.M113.473199; Zhang X, 2012, NAT GENET, V44, P593, DOI 10.1038/ng.2228	60	187	189	2	32	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 26	2013	155	1					94	106		10.1016/j.cell.2013.08.029	http://dx.doi.org/10.1016/j.cell.2013.08.029			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	224UX	24074863	Bronze			2022-12-24	WOS:000324916700012
J	He, CC; Wei, YJ; Sun, K; Li, BH; Dong, XN; Zou, ZJ; Liu, Y; Kinch, LN; Khan, S; Sinha, S; Xavier, RJ; Grishin, NV; Xiao, GH; Eskelinen, EL; Scherer, PE; Whistler, JL; Levine, B				He, Congcong; Wei, Yongjie; Sun, Kai; Li, Binghua; Dong, Xiaonan; Zou, Zhongju; Liu, Yang; Kinch, Lisa N.; Khan, Shaheen; Sinha, Sangita; Xavier, Ramnik J.; Grishin, Nick V.; Xiao, Guanghua; Eskelinen, Eeva-Liisa; Scherer, Philipp E.; Whistler, Jennifer L.; Levine, Beth			Beclin 2 Functions in Autophagy, Degradation of G Protein-Coupled Receptors, and Metabolism	CELL			English	Article							MEMBRANE-TRAFFICKING; SORTING PROTEINS; LINKAGE; SYSTEM; CELLS; FAMILY; SCAN	The molecular mechanism of autophagy and its relationship to other lysosomal degradation pathways remain incompletely understood. Here, we identified a previously uncharacterized mammalian-specific protein, Beclin 2, which, like Beclin 1, functions in autophagy and interacts with class III PI3K complex components and Bcl-2. However, Beclin 2, but not Beclin 1, functions in an additional lysosomal degradation pathway. Beclin 2 is required for ligand-induced endolysosomal degradation of several G protein-coupled receptors (GPCRs) through its interaction with GASP1. Beclin 2 homozygous knockout mice have decreased embryonic viability, and heterozygous knockout mice have defective autophagy, increased levels of brain cannabinoid 1 receptor, elevated food intake, and obesity and insulin resistance. Our findings identify Beclin 2 as a converging regulator of autophagy and GPCR turnover and highlight the functional and mechanistic diversity of Beclin family members in autophagy, endolysosomal trafficking, and metabolism.	[He, Congcong; Wei, Yongjie; Zou, Zhongju; Kinch, Lisa N.; Grishin, Nick V.; Levine, Beth] Univ Texas SW Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA; [He, Congcong; Wei, Yongjie; Dong, Xiaonan; Zou, Zhongju; Liu, Yang; Levine, Beth] Univ Texas SW Med Ctr Dallas, Ctr Autophagy Res, Dallas, TX 75390 USA; [Sun, Kai; Scherer, Philipp E.] Univ Texas SW Med Ctr Dallas, Touchstone Diabet Ctr, Dallas, TX 75390 USA; [He, Congcong; Wei, Yongjie; Sun, Kai; Li, Binghua; Dong, Xiaonan; Zou, Zhongju; Liu, Yang; Khan, Shaheen; Scherer, Philipp E.; Levine, Beth] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA; [Kinch, Lisa N.; Grishin, Nick V.] Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA; [Kinch, Lisa N.; Grishin, Nick V.] Univ Texas SW Med Ctr Dallas, Dept Biophys, Dallas, TX 75390 USA; [Xiao, Guanghua] Univ Texas SW Med Ctr Dallas, Dept Clin Sci, Dallas, TX 75390 USA; [Levine, Beth] Univ Texas SW Med Ctr Dallas, Dept Microbiol, Dallas, TX 75390 USA; [Sinha, Sangita] N Dakota State Univ, Dept Chem & Biochem, Fargo, ND 58102 USA; [Xavier, Ramnik J.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Computat & Integrat Biol, Boston, MA 02114 USA; [Xavier, Ramnik J.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Gastrointestinal Unit, Boston, MA 02114 USA; [Xavier, Ramnik J.] Broad Inst Harvard & MIT, Cambridge, MA 02142 USA; [Xavier, Ramnik J.] MIT, Cambridge, MA 02142 USA; [Eskelinen, Eeva-Liisa] Univ Helsinki, Div Biochem & Biotechnol, Dept Biosci, FI-00014 Helsinki, Finland; [Whistler, Jennifer L.] Univ Calif San Francisco, Ernest Gallo Clin & Res Ctr, Emeryville, CA 94608 USA	Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; North Dakota State University Fargo; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT); University of Helsinki; University of California System; University of California San Francisco; Ernest Gallo Clinic & Research Center	Levine, B (corresponding author), Univ Texas SW Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA.	beth.levine@utsouthwestern.edu	Scherer, Philipp E/K-7819-2012; Eskelinen, Eeva-Liisa/AAF-3496-2019	Scherer, Philipp E/0000-0003-0680-3392; Eskelinen, Eeva-Liisa/0000-0003-0006-7785; Kinch, Lisa/0000-0003-3041-2615; Deldicque, Louise/0000-0003-3393-5278; Khan, Shaheen/0000-0002-1472-8129; Sun, Kai/0000-0002-4778-4549; Dong, Xiaonan/0000-0001-7967-2755	NIH [ROI CA109618, ROI GM094575, ROI DK55758, PO1 DK088761, ROI DA019958, ROI DK043351, K99 DK094980, R21 AI078198, P20 RR015566]; Welch Foundation [I-1505]; state of California for medical research on alcohol and substance abuse through the University of California, San Francisco; Academy of Finland; NATIONAL CANCER INSTITUTE [R01CA109618] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR015566] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI078108] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK043351, R01DK055758, K99DK094980, P01DK088761] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM103332, R01GM094575] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA019958] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Welch Foundation(The Welch Foundation); state of California for medical research on alcohol and substance abuse through the University of California, San Francisco(University of California System); Academy of Finland(Academy of Finland); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank Haley Harrington for assistance with manuscript preparation and the Electron Microscopy Unit of the Institute of Biotechnology, University of Helsinki, Finland for providing laboratory facilities. This work was supported by NIH awards ROI CA109618 (B. L.), ROI GM094575 (N. V. G.), ROI DK55758 (P. E. S.), PO1 DK088761 (P. E. S.), ROI DA019958 (J. L. W.), ROI DK043351 (R. J. X.), K99 DK094980 (C. H.), R21 AI078198 (S. S.), and P20 RR015566 (S. S.); a Welch Foundation Award I-1505 (N. V. G.); and funds provided by the state of California for medical research on alcohol and substance abuse through the University of California, San Francisco to J. L. W. E.-L. E. was supported by the Academy of Finland. The authors Y. W., K. S., and B. Li all contributed equally to this manuscript.	Abu-Helo A, 2010, PHARMACOL THERAPEUT, V126, P244, DOI 10.1016/j.pharmthera.2010.03.004; Aissani B, 2006, OBESITY, V14, P1605, DOI 10.1038/oby.2006.185; Bosse Y, 2004, J LIPID RES, V45, P419, DOI 10.1194/jlr.M300401-JLR200; Chen YQ, 2011, J CELL SCI, V124, P161, DOI 10.1242/jcs.064576; Cota D, 2003, J CLIN INVEST, V112, P423, DOI 10.1172/JCI17725; Di Marzo V, 2008, DRUG DISCOV TODAY, V13, P1026, DOI 10.1016/j.drudis.2008.09.001; Dong CH, 2011, HUM GENET, V129, P209, DOI 10.1007/s00439-010-0916-2; Funderburk SF, 2010, TRENDS CELL BIOL, V20, P355, DOI 10.1016/j.tcb.2010.03.002; Gainetdinov RR, 2004, ANNU REV NEUROSCI, V27, P107, DOI 10.1146/annurev.neuro.27.070203.144206; Gentles AJ, 1999, TRENDS GENET, V15, P47, DOI 10.1016/S0168-9525(98)01648-5; Hanyaloglu AC, 2008, ANNU REV PHARMACOL, V48, P537, DOI 10.1146/annurev.pharmtox.48.113006.094830; Heydorn A, 2004, J BIOL CHEM, V279, P54291, DOI 10.1074/jbc.M406169200; Hurley JH, 2006, ANNU REV BIOPH BIOM, V35, P277, DOI 10.1146/annurev.biophys.35.040405.102126; Levine B, 2011, NATURE, V469, P323, DOI 10.1038/nature09782; Maccarrone M, 2010, ANNU REV NUTR, V30, P423, DOI 10.1146/annurev.nutr.012809.104701; Martini L, 2007, FASEB J, V21, P802, DOI 10.1096/fj.06-7132com; Mizushima N, 2011, CELL, V147, P728, DOI 10.1016/j.cell.2011.10.026; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Moser E, 2010, PHARMACOLOGY, V86, P22, DOI 10.1159/000314161; Orvedahl A, 2010, CELL HOST MICROBE, V7, P115, DOI 10.1016/j.chom.2010.01.007; Pattingre S, 2005, CELL, V122, P927, DOI 10.1016/j.cell.2005.07.002; Salazar M, 2009, J CLIN INVEST, V119, P1359, DOI 10.1172/JCI37948; Schelling JR, 2008, DIABETES, V57, P235, DOI 10.2337/db07-0313; Shmulewitz D, 2006, P NATL ACAD SCI USA, V103, P3502, DOI 10.1073/pnas.0510156103; Simonin F, 2004, J NEUROCHEM, V89, P766, DOI 10.1111/j.1471-4159.2004.02411.x; Strappazzon F, 2011, EMBO J, V30, P1195, DOI 10.1038/emboj.2011.49; Tappe-Theodor A, 2007, J NEUROSCI, V27, P4165, DOI 10.1523/JNEUROSCI.5648-06.2007; Tschische P, 2010, TRAFFIC, V11, P660, DOI 10.1111/j.1600-0854.2010.1045.x; Whistler JL, 2002, SCIENCE, V297, P615, DOI 10.1126/science.1073308; Zalckvar E, 2009, EMBO REP, V10, P285, DOI 10.1038/embor.2008.246; Zhao LX, 2010, AUTOPHAGY, V6, P386, DOI 10.4161/auto.6.3.11289	31	113	128	0	42	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	AUG 29	2013	154	5					1085	1099		10.1016/j.cell.2013.07.035	http://dx.doi.org/10.1016/j.cell.2013.07.035			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	209OE	23954414	Bronze, Green Accepted			2022-12-24	WOS:000323767300021
J	Li, Y; Lu, JF; Han, YH; Fan, XX; Ding, SW				Li, Yang; Lu, Jinfeng; Han, Yanhong; Fan, Xiaoxu; Ding, Shou-Wei			RNA Interference Functions as an Antiviral Immunity Mechanism in Mammals	SCIENCE			English	Article							DEFENSE-MECHANISM; NODAMURA-VIRUS; SUPPRESSION; HIV-1; REPLICATION; INDUCTION; PROTEINS	Diverse eukaryotic hosts produce virus-derived small interfering RNAs (siRNAs) to direct antiviral immunity by RNA interference (RNAi). However, it remains unknown whether the mammalian RNAi pathway has a natural antiviral function. Here, we show that infection of hamster cells and suckling mice by Nodamura virus (NoV), a mosquito-transmissible RNA virus, requires RNAi suppression by its B2 protein. Loss of B2 expression or its suppressor activity leads to abundant production of viral siRNAs and rapid clearance of the mutant viruses in mice. However, viral small RNAs detected during virulent infection by NoV do not have the properties of canonical siRNAs. These findings have parallels with the induction and suppression of antiviral RNAi by the related Flock house virus in fruit flies and nematodes and reveal a mammalian antiviral immunity mechanism mediated by RNAi.	[Li, Yang; Lu, Jinfeng; Han, Yanhong; Fan, Xiaoxu; Ding, Shou-Wei] Univ Calif Riverside, Dept Plant Pathol & Microbiol, Riverside, CA 92521 USA; [Li, Yang; Lu, Jinfeng; Han, Yanhong; Fan, Xiaoxu; Ding, Shou-Wei] Univ Calif Riverside, Inst Integrat Genome Biol, Riverside, CA 92521 USA; [Lu, Jinfeng; Ding, Shou-Wei] Univ Calif Riverside, Grad Program Genet Genom & Bioinformat, Riverside, CA 92521 USA	University of California System; University of California Riverside; University of California System; University of California Riverside; University of California System; University of California Riverside	Ding, SW (corresponding author), Univ Calif Riverside, Dept Plant Pathol & Microbiol, Riverside, CA 92521 USA.	shou-wei.ding@ucr.edu	Ding, Shou Wei/AAC-2533-2020; Li, Yang/GVT-7396-2022	Li, Yang/0000-0002-6065-4706; Ding, SW/0000-0002-4697-8413; han, yan-hong/0000-0003-1636-4047	China Scholarship Council; NIH [AI52447, GM94396]; College of Natural and Agricultural Sciences, University of California, Riverside; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI052447] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM094396, RC1GM091896] Funding Source: NIH RePORTER	China Scholarship Council(China Scholarship Council); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); College of Natural and Agricultural Sciences, University of California, Riverside; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank J. Jovel, J. Mai, X, Wang, Q. Wu, W.-X. Li, I.-C. Huang, G. Wang, and J. Pedra for technical assistance or advice; K. Johnson, A. Ball, and C. Basler for cDNA clones; and O. Voinnet for comments on the manuscript. X. F. was supported by China Scholarship Council. This study was supported by NIH grants AI52447 and GM94396 and College of Natural and Agricultural Sciences, University of California, Riverside (to S.-W.D.).	Aliyari R, 2008, CELL HOST MICROBE, V4, P387, DOI 10.1016/j.chom.2008.09.001; BALL LA, 1992, J VIROL, V66, P2326, DOI 10.1128/JVI.66.4.2326-2334.1992; Bennasser Y, 2005, IMMUNITY, V22, P607, DOI 10.1016/j.immuni.2005.03.010; Bitko V, 2001, BMC Microbiol, V1, P34, DOI 10.1186/1471-2180-1-34; Chao JA, 2005, NAT STRUCT MOL BIOL, V12, P952, DOI 10.1038/nsmb1005; Deleris A, 2006, SCIENCE, V313, P68, DOI 10.1126/science.1128214; Diaz-Pendon JA, 2007, PLANT CELL, V19, P2053, DOI 10.1105/tpc.106.047449; Ding SW, 2010, NAT REV IMMUNOL, V10, P632, DOI 10.1038/nri2824; Drinnenberg IA, 2011, SCIENCE, V333, P1592, DOI 10.1126/science.1209575; Fabozzi G, 2011, J VIROL, V85, P2512, DOI 10.1128/JVI.01160-10; Felix MA, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000586; Galiana-Arnoux D, 2006, NAT IMMUNOL, V7, P590, DOI 10.1038/ni1335; Goubau D, 2013, IMMUNITY, V38, P855, DOI 10.1016/j.immuni.2013.05.007; Guo XY, 2012, J VIROL, V86, P11645, DOI 10.1128/JVI.01501-12; Haasnoot J, 2007, PLOS PATHOG, V3, P794, DOI 10.1371/journal.ppat.0030086; Hamilton AJ, 1999, SCIENCE, V286, P950, DOI 10.1126/science.286.5441.950; Han YH, 2011, J VIROL, V85, P13153, DOI 10.1128/JVI.05518-11; Johnson KL, 2003, VIROLOGY, V305, P436, DOI 10.1006/viro.2002.1769; Li HW, 2002, SCIENCE, V296, P1319, DOI 10.1126/science.1070948; Li WX, 2004, P NATL ACAD SCI USA, V101, P1350, DOI 10.1073/pnas.0308308100; Lu R, 2005, NATURE, V436, P1040, DOI 10.1038/nature03870; Maillard PV, 2013, SCIENCE, V342, P235, DOI 10.1126/science.1241930; Parameswaran P, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000764; Qian S, 2009, P NATL ACAD SCI USA, V106, P605, DOI 10.1073/pnas.0806822106; Schneemann A., 2005, VIRUS TAXONOMY, P865; Schnettler E, 2009, EMBO REP, V10, P258, DOI 10.1038/embor.2009.6; Segers GC, 2007, P NATL ACAD SCI USA, V104, P12902, DOI 10.1073/pnas.0702500104; Sullivan CS, 2005, J VIROL, V79, P7371, DOI 10.1128/JVI.79.12.7371-7379.2005; Wang XH, 2006, SCIENCE, V312, P452, DOI 10.1126/science.1125694; Wilkins C, 2005, NATURE, V436, P1044, DOI 10.1038/nature03957	30	263	273	2	124	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 11	2013	342	6155					231	234		10.1126/science.1241911	http://dx.doi.org/10.1126/science.1241911			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232EV	24115437	Green Accepted			2022-12-24	WOS:000325475200041
J	Jiang, JM; Wakimoto, H; Seidman, JG; Seidman, CE				Jiang, Jianming; Wakimoto, Hiroko; Seidman, J. G.; Seidman, Christine E.			Allele-Specific Silencing of Mutant Myh6 Transcripts in Mice Suppresses Hypertrophic Cardiomyopathy	SCIENCE			English	Article							GENE-TRANSFER; MOUSE MODEL; PROGRESS; DISEASE	Dominant mutations in sarcomere proteins such as the myosin heavy chains (MHC) are the leading genetic causes of human hypertrophic cardiomyopathy (HCM) and dilated cardiomyopathy. We found that expression of the HCM-causing cardiac MHC gene (Myh6) R403Q mutation in mice can be selectively silenced by an RNA interference (RNAi) cassette delivered by an adeno-associated virus vector. RNAi-transduced MHC403/+ mice developed neither hypertrophy nor myocardial fibrosis, the pathologic manifestations of HCM, for at least 6 months. Because inhibition of HCM was achieved by only a 25% reduction in the levels of the mutant transcripts, we suggest that the variable clinical phenotype in HCM patients reflects allele-specific expression and that partial silencing of mutant transcripts may have therapeutic benefit.	[Jiang, Jianming; Wakimoto, Hiroko; Seidman, J. G.; Seidman, Christine E.] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Wakimoto, Hiroko] Boston Childrens Hosp, Dept Cardiol, Boston, MA 02115 USA; [Jiang, Jianming; Wakimoto, Hiroko; Seidman, Christine E.] Brigham & Womens Hosp, Div Cardiovasc Med, Boston, MA 02115 USA; [Jiang, Jianming; Seidman, Christine E.] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA	Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard University; Brigham & Women's Hospital; Howard Hughes Medical Institute	Seidman, CE (corresponding author), Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA.	cseidman@genetics.med.harvard.edu	jiang, jianming/B-3421-2012	jiang, jianming/0000-0003-3251-2716	NIH [U01HL098166, R01HL084553]; Howard Hughes Medical Institute; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL066582, U01HL098166, R01HL084553] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank J. Gorham, D. Conner, and S. DePalma for technical and bioinformatic assistance, and C. Cepko for assistance with viral protocols. Supported by NIH grants U01HL098166 and R01HL084553 (J. G. S. and C. E. S.) and the Howard Hughes Medical Institute (C. E. S.). The authors (J. J., C. E. S., J. G. S., and H. W.) and Harvard Medical School plan a patent application related to the use of short hairpin RNAs as therapies for human genetic cardiomyopathies. C. E. S. and J. G. S. are founders of and own shares in MyoKardia, a biotechnology company developing small molecules that target the sarcomere for treatment of inherited cardiomyopathy.	Bish LT, 2008, HUM GENE THER, V19, P1359, DOI 10.1089/hum.2008.123; Christodoulou D. C., 2011, CURR PROTOC MOL BIOL, V94, P4121, DOI DOI 10.1002/0471142727.MB0412S94; de Fougerolles A, 2007, NAT REV DRUG DISCOV, V6, P443, DOI 10.1038/nrd2310; Elmariah Sammy, 2012, Curr Treat Options Cardiovasc Med, V14, P665, DOI 10.1007/s11936-012-0206-5; Fatkin D, 2000, J CLIN INVEST, V106, P1351, DOI 10.1172/JCI11093; Gao GP, 2005, CURR GENE THER, V5, P285, DOI 10.2174/1566523054065057; GEISTERFERLOWRANCE AAT, 1990, CELL, V62, P999, DOI 10.1016/0092-8674(90)90274-I; GeisterferLowrance AAT, 1996, SCIENCE, V272, P731, DOI 10.1126/science.272.5262.731; Ho CY, 2012, CIRCULATION, V125, P1432, DOI 10.1161/CIRCULATIONAHA.110.017277; Ho CY, 2002, CIRCULATION, V105, P2992, DOI 10.1161/01.CIR.0000019070.70491.6D; Jones WK, 1996, J CLIN INVEST, V98, P1906, DOI 10.1172/JCI118992; Kim JB, 2007, SCIENCE, V316, P1481, DOI 10.1126/science.1137325; Lang RM, 2005, J AM SOC ECHOCARDIOG, V18, P1440, DOI 10.1016/j.echo.2005.10.005; Lopes LR, 2013, HEART, V99, P1800, DOI 10.1136/heartjnl-2013-303939; Maron BJ, 2013, LANCET, V381, P242, DOI 10.1016/S0140-6736(12)60397-3; Maron BJ, 2009, CIRCULATION, V119, P1085, DOI 10.1161/CIRCULATIONAHA.108.804617; Mingozzi F, 2011, NAT REV GENET, V12, P341, DOI 10.1038/nrg2988; Prasad KMR, 2011, GENE THER, V18, P43, DOI 10.1038/gt.2010.105; Rodriguez-Lebron E, 2006, GENE THER, V13, P576, DOI 10.1038/sj.gt.3302702; Seidman JG, 2001, CELL, V104, P557, DOI 10.1016/S0092-8674(01)00242-2; Semsarian C, 2002, J CLIN INVEST, V109, P1013, DOI 10.1172/JCI200214677; Spirito P, 1997, NEW ENGL J MED, V336, P775, DOI 10.1056/NEJM199703133361107; Teekakirikul P, 2012, J CELL BIOL, V199, P417, DOI 10.1083/jcb.201207033; Teekakirikul P, 2010, J CLIN INVEST, V120, P3520, DOI 10.1172/JCI42028; Tripathi S, 2011, BASIC RES CARDIOL, V106, P1041, DOI 10.1007/s00395-011-0205-9; Tyska MJ, 2000, CIRC RES, V86, P737, DOI 10.1161/01.RES.86.7.737; Yu DB, 2012, CELL, V150, P895, DOI 10.1016/j.cell.2012.08.002	27	118	137	1	40	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 4	2013	342	6154					111	114		10.1126/science.1236921	http://dx.doi.org/10.1126/science.1236921			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	227PP	24092743	Green Accepted			2022-12-24	WOS:000325126100057
J	Watling, L				Watling, Les			Deep-sea trawling must be banned	NATURE			English	Editorial Material									Univ Hawaii Manoa, Honolulu, HI 96822 USA	University of Hawaii System; University of Hawaii Manoa	Watling, L (corresponding author), Univ Hawaii Manoa, Honolulu, HI 96822 USA.	watling@hawaii.edu							0	9	9	0	43	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 5	2013	501	7465					7	7		10.1038/501007a	http://dx.doi.org/10.1038/501007a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	211ER	24005380	Bronze			2022-12-24	WOS:000323888300004
J	Hu, JC; Stites, EC; Yu, HY; Germino, EA; Meharena, HS; Stork, PJS; Kornev, AP; Taylor, SS; Shaw, AS				Hu, Jiancheng; Stites, Edward C.; Yu, Haiyang; Germino, Elizabeth A.; Meharena, Hiruy S.; Stork, Philip J. S.; Kornev, Alexandr P.; Taylor, Susan S.; Shaw, Andrey S.			Allosteric Activation of Functionally Asymmetric RAF Kinase Dimers	CELL			English	Article							B-RAF; WILD-TYPE; C-RAF; ONCOGENIC RAS; A-RAF; PHOSPHORYLATION; BRAF; ERK; INHIBITORS; MUTATIONS	Although RAF kinases are critical for controlling cell growth, their mechanism of activation is incompletely understood. Recently, dimerization was shown to be important for activation. Here we show that the dimer is functionally asymmetric with one kinase functioning as an activator to stimulate activity of the partner, receiver kinase. The activator kinase did not require kinase activity but did require N-terminal phosphorylation that functioned allosterically to induce cis-autophosphorylation of the receiver kinase. Based on modeling of the hydrophobic spine assembly, we also engineered a constitutively active mutant that was independent of Ras, dimerization, and activation-loop phosphorylation. As N-terminal phosphorylation of BRAF is constitutive, BRAF initially functions to activate CRAF. N-terminal phosphorylation of CRAF was dependent on MEK, suggesting a feedback mechanism and explaining a key difference between BRAF and CRAF. Our work illuminates distinct steps in RAF activation that function to assemble the active conformation of the RAF kinase.	[Hu, Jiancheng; Stites, Edward C.; Yu, Haiyang; Germino, Elizabeth A.; Shaw, Andrey S.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA; [Hu, Jiancheng; Shaw, Andrey S.] Washington Univ, Sch Med, Howard Hughes Med Inst, St Louis, MO 63110 USA; [Meharena, Hiruy S.; Kornev, Alexandr P.; Taylor, Susan S.] Univ Calif San Diego, Dept Chem Biochem, La Jolla, CA 92093 USA; [Meharena, Hiruy S.; Kornev, Alexandr P.; Taylor, Susan S.] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA; [Kornev, Alexandr P.; Taylor, Susan S.] Univ Calif San Diego, Howard Hughes Med Inst, La Jolla, CA 92093 USA; [Stork, Philip J. S.] Oregon Hlth & Sci Univ, Vollum Inst, Portland, OR 97239 USA	Washington University (WUSTL); Howard Hughes Medical Institute; Washington University (WUSTL); University of California System; University of California San Diego; University of California System; University of California San Diego; Howard Hughes Medical Institute; University of California System; University of California San Diego; Oregon Health & Science University	Taylor, SS (corresponding author), Univ Calif San Diego, Dept Chem Biochem, 9500 Gilman Dr,Mail Code 0654, La Jolla, CA 92093 USA.	staylor@ucsd.edu; ashaw@wustl.edu	Hu, Jiancheng/ABE-8133-2021; Yu, Haiyang/AAK-3112-2020; Kornev, Alexandr Petrovich/O-7826-2015; Yu, Houyong/R-1592-2016	Hu, Jiancheng/0000-0003-1615-0030; Yu, Haiyang/0000-0003-3460-6716; Kornev, Alexandr Petrovich/0000-0002-1543-3795; Yu, Houyong/0000-0002-6543-5924	Cancer Research Institute; NSF [DGE1144086]; Howard Hughes Medical Institute; NIH [AI57966, GM19301]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI057966, T32AI007163] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM019301, R01GM019301] Funding Source: NIH RePORTER	Cancer Research Institute; NSF(National Science Foundation (NSF)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Jianping Zhao and Alfred Kim for critical reading of the manuscript and Rafi Kopan and Thomas Graham for helpful discussions. E. G. is supported by a fellowship from the Cancer Research Institute, and H. S. M. by NSF (DGE1144086). The work was supported by the Howard Hughes Medical Institute (A. S. S. and S. S. T.) and by grants from the NIH (AI57966/A.S.S., GM19301/S.S.T.).	Baccarini M, 2005, FEBS LETT, V579, P3271, DOI 10.1016/j.febslet.2005.03.024; Baljuls A, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M702429200; Baljuls A, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.194167; Blom N, 2004, PROTEOMICS, V4, P1633, DOI 10.1002/pmic.200300771; Brennan DF, 2011, NATURE, V472, P366, DOI 10.1038/nature09860; Brose MS, 2002, CANCER RES, V62, P6997; Cacace AM, 1999, MOL CELL BIOL, V19, P229; Chiloeches A, 2001, MOL CELL BIOL, V21, P2423, DOI 10.1128/MCB.21.7.2423-2434.2001; Chong H, 2001, EMBO J, V20, P3716, DOI 10.1093/emboj/20.14.3716; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Diaz B, 1997, MOL CELL BIOL, V17, P4509, DOI 10.1128/MCB.17.8.4509; FABIAN JR, 1993, MOL CELL BIOL, V13, P7170, DOI 10.1128/MCB.13.11.7170; Farrar MA, 1996, NATURE, V383, P178, DOI 10.1038/383178a0; Galabova-Kovacs G, 2006, CELL CYCLE, V5, P1514, DOI 10.4161/cc.5.14.2981; Garnett MJ, 2005, MOL CELL, V20, P963, DOI 10.1016/j.molcel.2005.10.022; Hansen JD, 2008, BIOORG MED CHEM LETT, V18, P4692, DOI 10.1016/j.bmcl.2008.07.002; Hatzivassiliou G, 2010, NATURE, V464, P431, DOI 10.1038/nature08833; Heidorn SJ, 2010, CELL, V140, P209, DOI 10.1016/j.cell.2009.12.040; Hu JC, 2008, MOL IMMUNOL, V45, P1825, DOI 10.1016/j.molimm.2007.11.002; Hu JC, 2011, P NATL ACAD SCI USA, V108, P6067, DOI 10.1073/pnas.1102554108; Huser M, 2001, EMBO J, V20, P1940, DOI 10.1093/emboj/20.8.1940; Joseph RE, 2007, BIOCHEMISTRY-US, V46, P5455, DOI 10.1021/bi602512e; Karreth FA, 2009, MOL CELL, V36, P477, DOI 10.1016/j.molcel.2009.10.017; King AJ, 1998, NATURE, V396, P180, DOI 10.1038/24184; King AJ, 2006, CANCER RES, V66, P11100, DOI 10.1158/0008-5472.CAN-06-2554; KOLCH W, 1993, NATURE, V364, P249, DOI 10.1038/364249a0; Kornev AP, 2008, P NATL ACAD SCI USA, V105, P14377, DOI 10.1073/pnas.0807988105; Kornev AP, 2006, P NATL ACAD SCI USA, V103, P17783, DOI 10.1073/pnas.0607656103; LaFevre-Bernt M, 1998, J BIOL CHEM, V273, P32129, DOI 10.1074/jbc.273.48.32129; Leicht DT, 2013, BBA-MOL CELL RES, V1833, P976, DOI 10.1016/j.bbamcr.2013.01.015; Lin XF, 2005, BIOCHEMISTRY-US, V44, P1561, DOI 10.1021/bi048142j; Lochhead PA, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.254pe4; Marais R, 1997, J BIOL CHEM, V272, P4378, DOI 10.1074/jbc.272.7.4378; MARAIS R, 1995, EMBO J, V14, P3136, DOI 10.1002/j.1460-2075.1995.tb07316.x; Mason CS, 1999, EMBO J, V18, P2137, DOI 10.1093/emboj/18.8.2137; McKay MM, 2011, CURR BIOL, V21, P563, DOI 10.1016/j.cub.2011.02.033; Mikula M, 2001, EMBO J, V20, P1952, DOI 10.1093/emboj/20.8.1952; Morrison DK, 1997, CURR OPIN CELL BIOL, V9, P174, DOI 10.1016/S0955-0674(97)80060-9; Nguyen A, 2002, MOL CELL BIOL, V22, P3035, DOI 10.1128/MCB.22.9.3035-3045.2002; Poulikakos PI, 2010, NATURE, V464, P427, DOI 10.1038/nature08902; Qjn J, 2012, J MED CHEM, V55, P5220, DOI 10.1021/jm3004416; Rajakulendran T, 2009, NATURE, V461, P542, DOI 10.1038/nature08314; Rebocho AP, 2013, ONCOGENE, V32, P3207, DOI 10.1038/onc.2012.330; Taylor SS, 2011, TRENDS BIOCHEM SCI, V36, P65, DOI 10.1016/j.tibs.2010.09.006; Tsai J, 2008, P NATL ACAD SCI USA, V105, P3041, DOI 10.1073/pnas.0711741105; Wan PTC, 2004, CELL, V116, P855, DOI 10.1016/S0092-8674(04)00215-6; Weber CK, 2001, CANCER RES, V61, P3595; Wellbrock C, 2004, NAT REV MOL CELL BIO, V5, P875, DOI 10.1038/nrm1498; Wimmer R, 2010, TRENDS BIOCHEM SCI, V35, P660, DOI 10.1016/j.tibs.2010.06.001; Xu WQ, 1999, MOL CELL, V3, P629, DOI 10.1016/S1097-2765(00)80356-1; Zhang BH, 2000, EMBO J, V19, P5429, DOI 10.1093/emboj/19.20.5429; Zhang BH, 2001, EXP LUNG RES, V27, P269, DOI 10.1080/019021401300054046; Zhang XW, 2006, CELL, V125, P1137, DOI 10.1016/j.cell.2006.05.013	53	183	183	0	25	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 29	2013	154	5					1036	1046		10.1016/j.cell.2013.07.046	http://dx.doi.org/10.1016/j.cell.2013.07.046			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	209OE	23993095	Green Accepted, Bronze			2022-12-24	WOS:000323767300017
J	Bornholdt, ZA; Noda, T; Abelson, DM; Halfmann, P; Wood, MR; Kawaoka, Y; Saphire, EO				Bornholdt, Zachary A.; Noda, Takeshi; Abelson, Dafna M.; Halfmann, Peter; Wood, Malcolm R.; Kawaoka, Yoshihiro; Saphire, Erica Ollmann			Structural Rearrangement of Ebola Virus VP40 Begets Multiple Functions in the Virus Life Cycle	CELL			English	Article							MATRIX PROTEIN VP40; OLIGOMERIZATION; MEMBRANE; ASSOCIATION	Proteins, particularly viral proteins, can be multifunctional, but the mechanisms behind multifunctionality are not fully understood. Here, we illustrate through multiple crystal structures, biochemistry, and cellular microscopy that VP40 rearranges into different structures, each with a distinct function required for the ebolavirus life cycle. A butterfly-shaped VP40 dimer traffics to the cellular membrane. Once there, electrostatic interactions trigger rearrangement of the polypeptide into a linear hexamer. These hexamers construct a multilayered, filamentous matrix structure that is critical for budding and resembles tomograms of authentic virions. A third structure of VP40, formed by a different rearrangement, is not involved in virus assembly but instead uniquely binds RNA to regulate viral transcription inside infected cells. These results provide a functional model for ebolavirus matrix assembly and the other roles of VP40 in the virus life cycle and demonstrate how a single wild-type, unmodified polypeptide can assemble into different structures for different functions.	[Bornholdt, Zachary A.; Abelson, Dafna M.; Saphire, Erica Ollmann] Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA; [Wood, Malcolm R.] Scripps Res Inst, Core Microscopy Facil, La Jolla, CA 92037 USA; [Saphire, Erica Ollmann] Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA; [Noda, Takeshi; Kawaoka, Yoshihiro] Univ Tokyo, Inst Med Sci, Dept Microbiol & Immunol, Div Virol, Tokyo 1088639, Japan; [Kawaoka, Yoshihiro] Univ Tokyo, Inst Med Sci, Int Res Ctr Infect Dis, Tokyo 1088639, Japan; [Halfmann, Peter; Kawaoka, Yoshihiro] Univ Wisconsin, Sch Vet Med, Dept Pathobiol Sci, Madison, WI 53706 USA; [Kawaoka, Yoshihiro] Infect Induced Host Responses Project, Kawaguchi, Saitama 3320012, Japan	Scripps Research Institute; Scripps Research Institute; Scripps Research Institute; University of Tokyo; University of Tokyo; University of Wisconsin System; University of Wisconsin Madison	Saphire, EO (corresponding author), Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA.	erica@scripps.edu	Halfmann, Peter/W-8084-2019	Abelson, Dafna/0000-0003-4627-6902; Saphire, Erica Ollmann/0000-0002-1206-7451; Bornholdt, Zachary/0000-0002-7557-9219	Burroughs Welcome Fund; Skaggs Institute of Chemical Biology; National Institute of Allergy and Infectious Disease [R43 AI1088843]; Region V "Great Lakes" Regional Center for Excellence (RCE) for Biodefense and Emerging Infectious Disease Research Program (National Institutes of Health) [U54 AI057153]; Japan Society for the Promotion of Science; Ministry of Education, Culture, Sports, Science, and Technology;  [2T32AI007244]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007244, R43AI088843, U54AI057153] Funding Source: NIH RePORTER	Burroughs Welcome Fund(Burroughs Wellcome Fund); Skaggs Institute of Chemical Biology; National Institute of Allergy and Infectious Disease(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Region V "Great Lakes" Regional Center for Excellence (RCE) for Biodefense and Emerging Infectious Disease Research Program (National Institutes of Health); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank the beamline scientists at APS 19-ID and GM/CA 23-ID, SSRL 12-2, and ALS 5.0.2, Dr. Jean-Philippe Julien for assistance with the SEC-MALS analysis, Christina Corbaci for the Graphical Abstract, and Drs. Glen Nemerow and B. V. V Prasad for helpful comments and suggestions. E.O.S. was supported by a Career Award in the Biomedical Sciences and an Investigator in the Pathogenesis of Infectious Disease Award from the Burroughs Welcome Fund, as well as The Skaggs Institute of Chemical Biology and a National Institute of Allergy and Infectious Disease award (R43 AI1088843). Z.A.B. was supported by a grant (2T32AI007244) to the TSRI Department of Immunology and Microbial Science. Y.K. acknowledges membership within and support from the Region V "Great Lakes" Regional Center for Excellence (RCE) for Biodefense and Emerging Infectious Disease Research Program (National Institutes of Health award [U54 AI057153]). T.N. was supported by a Grant-in-Aid for Young Scientists from the Japan Society for the Promotion of Science and by a Grant-in-Aid for Scientific Research on Priority Areas from the Ministry of Education, Culture, Sports, Science, and Technology. This is manuscript #21649 from The Scripps Research Institute.	Adams MJ, 2012, ARCH VIROL, V157, P1411, DOI 10.1007/s00705-012-1299-6; Adu-Gyamfi E, 2013, J BIOL CHEM, V288, P5779, DOI 10.1074/jbc.M112.443960; Adu-Gyamfi E, 2012, BIOPHYS J, V102, P2517, DOI 10.1016/j.bpj.2012.04.022; Baudin F, 2001, VIROLOGY, V281, P102, DOI 10.1006/viro.2000.0804; Beniac DR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029608; Bharat TAM, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001196; Bwaka MA, 1999, J INFECT DIS, V179, pS1, DOI 10.1086/514308; Dessen A, 2000, ACTA CRYSTALLOGR D, V56, P758, DOI 10.1107/S0907444900004388; Dessen A, 2000, EMBO J, V19, P4228, DOI 10.1093/emboj/19.16.4228; Geisbert TW, 1995, VIRUS RES, V39, P129, DOI 10.1016/0168-1702(95)00080-1; Gomis-Roth FX, 2003, STRUCTURE, V11, P423, DOI 10.1016/S0969-2126(03)00050-9; Harty RN, 2000, P NATL ACAD SCI USA, V97, P13871, DOI 10.1073/pnas.250277297; Harty RN, 2009, ANTIVIR RES, V81, P189, DOI 10.1016/j.antiviral.2008.12.003; Hoenen T, 2005, J VIROL, V79, P1898, DOI 10.1128/JVI.79.3.1898-1905.2005; Hoenen T, 2010, J VIROL, V84, P7053, DOI 10.1128/JVI.00737-10; Hoenen T, 2010, VIROLOGY, V403, P56, DOI 10.1016/j.virol.2010.04.002; Jasenosky LD, 2001, J VIROL, V75, P5205, DOI 10.1128/JVI.75.11.5205-5214.2001; Johnson RF, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-31; Kuhn Jens H, 2008, Arch Virol Suppl, V20, P13; Kuhn JH, 2011, VIRUS TAXONOMY, P665; Money VA, 2009, P NATL ACAD SCI USA, V106, P4441, DOI 10.1073/pnas.0805740106; Nanbo A., 2013, SCI REP, V3, P1; Noda T, 2002, J VIROL, V76, P4855, DOI 10.1128/JVI.76.10.4855-4865.2002; Panchal RG, 2003, P NATL ACAD SCI USA, V100, P15936, DOI 10.1073/pnas.2533915100; Ruigrok RWH, 2000, J MOL BIOL, V300, P103, DOI 10.1006/jmbi.2000.3822; Scianimanico S, 2000, EMBO J, V19, P6732, DOI 10.1093/emboj/19.24.6732; Timmins J, 2003, VIROLOGY, V312, P359, DOI 10.1016/S0042-6822(03)00260-5; Wyatt PJ, 1998, J COLLOID INTERF SCI, V197, P9, DOI 10.1006/jcis.1997.5215; ZSCHORNIG O, 1993, BIOCHIM BIOPHYS ACTA, V1148, P1, DOI 10.1016/0005-2736(93)90153-Q	29	155	159	0	56	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 15	2013	154	4					763	774		10.1016/j.cell.2013.07.015	http://dx.doi.org/10.1016/j.cell.2013.07.015			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	202GQ	23953110	Bronze, Green Accepted			2022-12-24	WOS:000323202500009
J	Adelman, CA; Lolo, RL; Birkbak, NJ; Murina, O; Matsuzaki, K; Horejsi, Z; Parmar, K; Borel, V; Skehel, JM; Stamp, G; D'Andrea, A; Sartori, AA; Swanton, C; Boulton, SJ				Adelman, Carrie A.; Lolo, Rafal L.; Birkbak, Nicolai J.; Murina, Olga; Matsuzaki, Kenichiro; Horejsi, Zuzana; Parmar, Kalindi; Borel, Valerie; Skehel, J. Mark; Stamp, Gordon; D'Andrea, Alan; Sartori, Alessandro A.; Swanton, Charles; Boulton, Simon J.			HELQ promotes RAD51 paralogue-dependent repair to avert germ cell loss and tumorigenesis	NATURE			English	Article							CROSS-LINK REPAIR; FANCONI-ANEMIA; HEMATOPOIETIC STEM; DNA-REPAIR; CONFER SUSCEPTIBILITY; OVARIAN; MUTATIONS; GENE; DEFICIENCY; DROSOPHILA	Repair of interstrand crosslinks (ICLs) requires the coordinated action of the intra-S-phase checkpoint and the Fanconi anaemia pathway, which promote ICL incision, translesion synthesis and homologous recombination (reviewed in refs 1, 2). Previous studies have implicated the 3'-5' superfamily 2 helicase HELQ in ICL repair in Drosophila melanogaster (MUS301 (ref. 3)) and Caenorhabditis elegans (HELQ-1 (ref. 4)). Although in vitro analysis suggests that HELQ preferentially unwinds synthetic replication fork substrates with 3' single-stranded DNA overhangs and also disrupts protein DNA interactions while translocating along DNA(5,6), little is known regarding its functions in mammalian organisms. Here we report that HELQ helicase-deficient mice exhibit subfertility, germ cell attrition, ICL sensitivity and tumour predisposition, with Helq heterozygous mice exhibiting a similar, albeit less severe, phenotype than the null, indicative of haploinsufficiency. We establish that HELQ interacts directly with the RAD51 paralogue complex BCDX2 and functions in parallel to the Fanconi anaemia pathway to promote efficient homologous recombination at damaged replication forks. Thus, our results reveal a critical role for HELQ in replication-coupled DNA repair, germ cell maintenance and tumour suppression in mammals.	[Adelman, Carrie A.; Lolo, Rafal L.; Matsuzaki, Kenichiro; Horejsi, Zuzana; Borel, Valerie; Boulton, Simon J.] Canc Res UK, London Res Inst, DNA Damage Response Lab, S Mimms EN6 3LD, Herts, England; [Birkbak, Nicolai J.] Tech Univ Denmark, Ctr Biol Sequence Anal, DK-2800 Lyngby, Denmark; [Murina, Olga; Sartori, Alessandro A.] Univ Zurich, Inst Mol Canc Res, CH-8057 Zurich, Switzerland; [Parmar, Kalindi; D'Andrea, Alan] Dana Farber Canc Inst, Dept Radiat Oncol, Boston, MA 02215 USA; [Skehel, J. Mark] Canc Res UK, London Res Inst, Prot Anal & Prote Lab, S Mimms EN6 3LD, Herts, England; [Stamp, Gordon] Canc Res UK, London Res Inst, Expt Histopathol Lab, London WC2A 3LY, England; [Swanton, Charles] Canc Res UK, London Res Inst, Translat Canc Therapeut Lab, London WC2A 3LY, England; [Swanton, Charles] UCL Canc Inst, London WC1E 6DD, England	Cancer Research UK; Technical University of Denmark; University of Zurich; Harvard University; Dana-Farber Cancer Institute; Cancer Research UK; Cancer Research UK; Cancer Research UK; University of London; University College London	Boulton, SJ (corresponding author), Canc Res UK, London Res Inst, DNA Damage Response Lab, Clare Hall, S Mimms EN6 3LD, Herts, England.	simon.boulton@cancer.org.uk	Sartori, Alessandro/AAK-7840-2021	Sartori, Alessandro/0000-0003-2770-0333; Licenikova Horejsi, Zuzana/0000-0002-9943-1649; Murina, Olga/0000-0003-1650-2892; Birkbak, Nicolai/0000-0003-1613-9587; Swanton, Charles/0000-0002-4299-3018	Swiss National Science Foundation [PDFMP3_127523]; Vontobel Foundation; National Institutes of Health [R01-DK43889]; Cancer Research UK; European Research Council; Royal Society; MRC [G0701935] Funding Source: UKRI; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK043889] Funding Source: NIH RePORTER; Cancer Research UK [11581] Funding Source: researchfish; Medical Research Council [G0701935] Funding Source: researchfish	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Vontobel Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Research UK(Cancer Research UK); European Research Council(European Research Council (ERC)European Commission); Royal Society(Royal Society of London); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We wish to thank S. West for purified BCDX2 complexes and antibody reagents; O. Fernandez-Capetillo for ATR inhibitors; D. Cox, G. Martin and H. Chapman for assistance with mouse breeding and maintenance; E. Nye, T. Bunting and B. Spencer-Dene for histopathology services; I. Rosewell for transgenic services; H. Flynn for mass spectrometry services; and M. Petalcorin for assistance with BAC recombineering. O.M. and A.A.S. are supported by grants of the Swiss National Science Foundation (PDFMP3_127523) and the Vontobel Foundation. The laboratory of A.D. is supported by National Institutes of Health grant R01-DK43889. The laboratories of S.J.B. and C.S. are funded by Cancer Research UK. The S.J.B. laboratory is also funded by a European Research Council advanced investigator grant (RecMitMei). S.J.B. is a Royal Society Wolfson Research Merit Award holder.	Aygun O, 2008, P NATL ACAD SCI USA, V105, P8580, DOI 10.1073/pnas.0804424105; BOYD JB, 1981, GENETICS, V97, P607; Bruun D, 2003, DNA REPAIR, V2, P1007, DOI 10.1016/S1568-7864(03)00112-5; Ceccaldi R, 2012, CELL STEM CELL, V11, P36, DOI 10.1016/j.stem.2012.05.013; Dupuy AJ, 2001, GENESIS, V30, P82, DOI 10.1002/gene.1037; Gonzalez-Reyes A, 1997, DEVELOPMENT, V124, P4927; Gunn Amanda, 2012, Methods Mol Biol, V920, P379, DOI 10.1007/978-1-61779-998-3_27; Hanada K, 2006, EMBO J, V25, P4921, DOI 10.1038/sj.emboj.7601344; Horn C, 2007, NAT GENET, V39, P933, DOI 10.1038/ng0807-933; Huehls AM, 2012, MOL PHARMACOL, V82, P767, DOI 10.1124/mol.112.080614; Kim H, 2012, GENE DEV, V26, P1393, DOI 10.1101/gad.195248.112; Kottemann MC, 2013, NATURE, V493, P356, DOI 10.1038/nature11863; Kratz K, 2010, CELL, V142, P77, DOI 10.1016/j.cell.2010.06.022; Loveday C, 2012, NAT GENET, V44, P475, DOI 10.1038/ng.2224; Loveday C, 2011, NAT GENET, V43, P879, DOI 10.1038/ng.893; Masson JY, 2001, P NATL ACAD SCI USA, V98, P8440, DOI 10.1073/pnas.111005698; McKay JD, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001333; Meindl A, 2010, NAT GENET, V42, P410, DOI 10.1038/ng.569; Mirzoeva OK, 2003, MOL CANCER RES, V1, P207; Moldovan GL, 2010, MOL CELL BIOL, V30, P1088, DOI 10.1128/MCB.01124-09; Muzzini DM, 2008, DNA REPAIR, V7, P941, DOI 10.1016/j.dnarep.2008.03.021; Osher DJ, 2012, BRIT J CANCER, V106, P1460, DOI 10.1038/bjc.2012.87; Parmar K, 2010, STEM CELLS, V28, P1186, DOI 10.1002/stem.437; Parmar K, 2009, MUTAT RES-FUND MOL M, V668, P133, DOI 10.1016/j.mrfmmm.2009.03.015; Pelttari LM, 2011, HUM MOL GENET, V20, P3278, DOI 10.1093/hmg/ddr229; PLOEMACHER RE, 1991, BLOOD, V78, P2527; Poser I, 2008, NAT METHODS, V5, P409, DOI 10.1038/NMETH.1199; Richards JD, 2008, J BIOL CHEM, V283, P5118, DOI 10.1074/jbc.M707548200; Seiler JA, 2007, MOL CELL BIOL, V27, P5806, DOI 10.1128/MCB.02278-06; Stolk L, 2012, NAT GENET, V44, P260, DOI 10.1038/ng.1051; Truett GE, 2000, BIOTECHNIQUES, V29, P52, DOI 10.2144/00291bm09; Vaz F, 2010, NAT GENET, V42, P406, DOI 10.1038/ng.570; Vuorela M, 2011, BREAST CANCER RES TR, V130, P1003, DOI 10.1007/s10549-011-1677-x; Ward JD, 2010, MOL CELL, V37, P259, DOI 10.1016/j.molcel.2009.12.026; Wickramanyake A, 2012, GYNECOL ONCOL, V127, P552, DOI 10.1016/j.ygyno.2012.09.009	35	64	69	1	43	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 17	2013	502	7471					381	+		10.1038/nature12565	http://dx.doi.org/10.1038/nature12565			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	235GY	24005329	Green Accepted			2022-12-24	WOS:000325706300055
J	Church, G				Church, George			Improving genome understanding	NATURE			English	Editorial Material									[Church, George] Harvard Univ, Sch Med, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Church, G (corresponding author), Harvard Univ, Sch Med, Boston, MA 02115 USA.	gmc@harvard.edu		church, george/0000-0001-6232-9969					0	5	5	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 10	2013	502	7470					143	143		10.1038/502143a	http://dx.doi.org/10.1038/502143a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231RU	24108012	Bronze			2022-12-24	WOS:000325436100012
J	Kenyon, C; Bonorchis, K; Corcoran, C; Meintjes, G; Locketz, M; Lehloenya, R; Vismer, HF; Naicker, P; Prozesky, H; van Wyk, M; Bamford, C; du Plooy, M; Imrie, G; Dlamini, S; Borman, AM; Colebunders, R; Yansouni, CP; Mendelson, M; Govender, NP				Kenyon, Chris; Bonorchis, Kim; Corcoran, Craig; Meintjes, Graeme; Locketz, Michael; Lehloenya, Rannakoe; Vismer, Hester F.; Naicker, Preneshni; Prozesky, Hans; van Wyk, Marelize; Bamford, Colleen; du Plooy, Moira; Imrie, Gail; Dlamini, Sipho; Borman, Andrew M.; Colebunders, Robert; Yansouni, Cedric P.; Mendelson, Marc; Govender, Nelesh P.			A Dimorphic Fungus Causing Disseminated Infection in South Africa	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							LUNG	BackgroundThe genus emmonsia contains three species that are associated with human disease. Emmonsia crescens and Emmonsia parva are the agents that cause adiaspiromycosis, and one human case of Emmonsia pasteuriana infection has been described. We report a fungal pathogen within the genus emmonsia that is most closely related to E. pasteuriana in human immunodeficiency virus (HIV)-infected adults in South Africa. MethodsBetween July 2008 and July 2011, we conducted enhanced surveillance to identify the cause of systemic, dimorphic fungal infections in patients presenting to Groote Schuur Hospital and other hospitals affiliated with the University of Cape Town, Cape Town, South Africa. DNA sequencing was used to identify pathogenic fungi. ResultsA total of 24 cases of dimorphic fungal infection were diagnosed, 13 of which were caused by an emmonsia species. All 13 patients were HIV-infected, with a median CD4+ T-cell count of 16 cells per cubic millimeter (interquartile range, 10 to 44), and all had evidence of disseminated fungal disease. Three patients died soon after presentation, but the others had a good response to a variety of antifungal agents and antiretroviral therapy. Phylogenetic analysis of five genes (LSU, ITS1-2, and the genes encoding actin, -tubulin, and intein PRP8) revealed that this fungus belongs in the genus emmonsia and is most closely related to E. pasteuriana. ConclusionsThe findings suggest that these isolates of an emmonsia species represent a new species of dimorphic fungus that is pathogenic to humans. The species appears to be an important cause of infections in Cape Town. In the context of immunologic failure associated with advanced HIV infection, a novel dimorphic fungus in the genus emmonsia is identified as an important cause of human disease. This report describes 13 cases of infection with this organism in Cape Town, South Africa. The human immunodeficiency virus (HIV) pandemic in sub-Saharan Africa has resulted in an epidemic of opportunistic fungal diseases, some of which are caused by new and emerging fungal pathogens.(1) Much remains to be learned about the endemic fungi of sub-Saharan Africa. For example, considerable differences have been noted between the African and North American varieties of Histoplasma capsulatum and Blastomyces dermatitidis.(2) The genus emmonsia contains three species associated with human disease. Emmonsia crescens and Emmonsia parva are the agents of adiaspiromycosis, a pulmonary disease of small mammals and occasionally of humans.(3)Emmonsia pasteuriana infection has been described in a ...	[Kenyon, Chris; Meintjes, Graeme; Dlamini, Sipho; Mendelson, Marc] Groote Schuur Hosp, Dept Med, Div Infect Dis & HIV Med, ZA-7925 Cape Town, South Africa; [Corcoran, Craig] Groote Schuur Hosp, Dept Clin Lab Sci, Div Med Virol, Natl Hlth Lab Serv, ZA-7925 Cape Town, South Africa; [Lehloenya, Rannakoe] Groote Schuur Hosp, Div Dermatol, Dept Med, ZA-7925 Cape Town, South Africa; [Bamford, Colleen] Groote Schuur Hosp, Div Med Microbiol, Natl Hlth Lab Serv, ZA-7925 Cape Town, South Africa; [Locketz, Michael] Univ Cape Town, Natl Hlth Lab Serv, Div Anat Pathol, ZA-7925 Cape Town, South Africa; [Meintjes, Graeme] Tygerberg Hosp, Inst Infect Dis & Mol Med, Cape Town, South Africa; Tygerberg Hosp, Div Med Microbiol, Dept Pathol, Natl Hlth Lab Serv, Cape Town, South Africa; [Naicker, Preneshni] Univ Stellenbosch, Cape Town, South Africa; [Prozesky, Hans] Univ Stellenbosch, Dept Med, Div Infect Dis, Cape Town, South Africa; [Prozesky, Hans] Tygerberg Hosp, Cape Town, South Africa; [Bonorchis, Kim] Natl Hlth Lab Serv, Green Point, South Africa; [Vismer, Hester F.; Imrie, Gail] MRC, Programme Mycotoxins & Expt Carcinogenesis, PROMEC Unit, Tygerberg, South Africa; [du Plooy, Moira] Ampath Natl Reference Lab, Dept Clin Microbiol, Centurion, South Africa; [van Wyk, Marelize; Govender, Nelesh P.] Univ Witwatersrand, Natl Inst Communicable Dis, Ctr Opportunist Trop & Hosp Infect, Natl Hlth Lab Serv, Johannesburg, South Africa; [Govender, Nelesh P.] Univ Witwatersrand, Fac Hlth Sci, Johannesburg, South Africa; [Kenyon, Chris; Colebunders, Robert] Inst Trop Med, Div HIV Med, B-2000 Antwerp, Belgium; [Meintjes, Graeme] Univ London Imperial Coll Sci Technol & Med, Dept Med, London, England; [Borman, Andrew M.] Hlth Protect Agcy UK, Natl Mycol Reference Lab, Bristol, Avon, England; [Yansouni, Cedric P.] McGill Univ Hlth Ctr, Div Infect Dis, Montreal, PQ, Canada; [Yansouni, Cedric P.] McGill Univ Hlth Ctr, Dept Med Microbiol, Montreal, PQ, Canada	University of Cape Town; University of Cape Town; University of Cape Town; University of Cape Town; University of Cape Town; Tygerberg Hospital; University of Cape Town; Tygerberg Hospital; University of Cape Town; Stellenbosch University; Stellenbosch University; Tygerberg Hospital; National Health Laboratory Service; National Institute for Communicable Diseases (NICD); University of Witwatersrand; University of Witwatersrand; Institute of Tropical Medicine (ITM); Imperial College London; Health Protection Agency; McGill University; McGill University	Kenyon, C (corresponding author), Groote Schuur Hosp, Dept Med, Main Rd, ZA-7925 Cape Town, South Africa.	chriskenyon0@gmail.com	Borman, Andy/H-3663-2019; Locketz, Michael/AAE-5493-2020; Govender, Nelesh/ABI-6429-2020; Prozesky, Hans Walter/ABE-6956-2020; Lehloenya, Rannakoe J/C-5672-2012	Borman, Andy/0000-0003-0585-5721; Prozesky, Hans Walter/0000-0001-9715-3449; Govender, Nelesh/0000-0001-7869-9462; Meintjes, Graeme/0000-0003-1196-4414; Locketz, Michael/0000-0002-3917-3895; /0000-0002-4765-3469; Lehloenya, Rannakoe J/0000-0002-1281-1789; Kenyon, Chris/0000-0002-2557-8998; Mendelson, Marc/0000-0001-6668-3893				Ampel NM, 1996, EMERG INFECT DIS, V2, P109, DOI 10.3201/eid0202.960205; ENGLAND DM, 1993, AM J SURG PATHOL, V17, P876, DOI 10.1097/00000478-199309000-00003; Gori S, 1998, J MYCOL MED, V8, P57; Gueho E, 1997, MYCOSES, V40, P69, DOI 10.1111/j.1439-0507.1997.tb00191.x; Shaikh N, 2006, SAMJ S AFR MED J, V96, P538; Teixeira MM, 2009, MOL PHYLOGENET EVOL, V52, P273, DOI 10.1016/j.ympev.2009.04.005; Wellinghausen N, 2003, INT J MED MICROBIOL, V293, P441, DOI 10.1078/1438-4221-00281	7	84	88	0	9	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 10	2013	369	15					1416	1424		10.1056/NEJMoa1215460	http://dx.doi.org/10.1056/NEJMoa1215460			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	231QE	24106934				2022-12-24	WOS:000325431500009
J	Malhotra, A				Malhotra, Aseem			Too much angioplasty	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							FRACTIONAL FLOW RESERVE; ACUTE CORONARY SYNDROMES; MYOCARDIAL-INFARCTION; MEDICAL THERAPY; ARTERY-DISEASE; STRATEGIES		Royal Free Hosp, London, England	University of London; University College London; Royal Free London NHS Foundation Trust; UCL Medical School	Malhotra, A (corresponding author), Royal Free Hosp, London, England.	aseem_malhotra@hotmail.com						Cannon CP, 2001, NEW ENGL J MED, V344, P1879, DOI 10.1056/NEJM200106213442501; Cortez FM, 2013, WASHINGTON POST; Curzon N., 2013, DOES ROUTINE PRESSUR; De Bruyne B, 2012, NEW ENGL J MED, V367, P991, DOI 10.1056/NEJMoa1205361; Fearon WF, 2012, TCT 2012 24 OCT MIAM; Fox KAA, 2002, LANCET, V360, P743, DOI 10.1016/S0140-6736(02)09894-X; Koo BK, 2011, J AM COLL CARDIOL, V58, P1989, DOI 10.1016/j.jacc.2011.06.066; Libby P, 2013, NEW ENGL J MED, V368, P2004, DOI 10.1056/NEJMra1216063; Maquet, PAT INF BALL PUMP TH; Mehta SR, 2005, JAMA-J AM MED ASSOC, V293, P2908, DOI 10.1001/jama.293.23.2908; Rothberg MB, 2010, ANN INTERN MED, V153, P307, DOI 10.7326/0003-4819-153-5-201009070-00005; Stergiopoulos K, 2012, ARCH INTERN MED, V172, P312, DOI 10.1001/archinternmed.2011.1484; Thiele H, 2013, LANCET, V382, P1638, DOI 10.1016/S0140-6736(13)61783-3; Thiele H, 2012, NEW ENGL J MED, V367, P1287, DOI 10.1056/NEJMoa1208410; Tonino PAL, 2009, NEW ENGL J MED, V360, P213, DOI 10.1056/NEJMoa0807611; Wallentin L, 1999, LANCET, V354, P708	16	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 24	2013	347								f5741	10.1136/bmj.f5741	http://dx.doi.org/10.1136/bmj.f5741			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	227CT	24065554				2022-12-24	WOS:000325086800007
J	Corder, G; Doolen, S; Donahue, RR; Winter, MK; Jutras, BL; He, Y; Hu, X; Wieskopf, JS; Mogil, JS; Storm, DR; Wang, ZJ; McCarson, KE; Taylor, BK				Corder, G.; Doolen, S.; Donahue, R. R.; Winter, M. K.; Jutras, B. L.; He, Y.; Hu, X.; Wieskopf, J. S.; Mogil, J. S.; Storm, D. R.; Wang, Z. J.; McCarson, K. E.; Taylor, B. K.			Constitutive mu-Opioid Receptor Activity Leads to Long-Term Endogenous Analgesia and Dependence	SCIENCE			English	Article							ADENYLYL-CYCLASE; CENTRAL SENSITIZATION; INFLAMMATORY PAIN; POTENTIATION; HYPERALGESIA; ACTIVATION; WITHDRAWAL; INCREASES; NALOXONE; PROTEIN	Opioid receptor antagonists increase hyperalgesia in humans and animals, which indicates that endogenous activation of opioid receptors provides relief from acute pain; however, the mechanisms of long-term opioid inhibition of pathological pain have remained elusive. We found that tissue injury produced mu-opioid receptor (MOR) constitutive activity (MORCA) that repressed spinal nociceptive signaling for months. Pharmacological blockade during the posthyperalgesia state with MOR inverse agonists reinstated central pain sensitization and precipitated hallmarks of opioid withdrawal (including adenosine 3',5'-monophosphate overshoot and hyperalgesia) that required N-methyl-D-aspartate receptor activation of adenylyl cyclase type 1. Thus, MORCA initiates both analgesic signaling and a compensatory opponent process that generates endogenous opioid dependence. Tonic MORCA suppression of withdrawal hyperalgesia may prevent the transition from acute to chronic pain.	[Corder, G.; Doolen, S.; Donahue, R. R.; Taylor, B. K.] Univ Kentucky, Dept Physiol, Lexington, KY 40536 USA; [Winter, M. K.; McCarson, K. E.] Univ Kansas, Med Ctr, Dept Pharmacol Toxicol & Therapeut, Kansas City, KS 66160 USA; [Jutras, B. L.] Univ Kentucky, Dept Microbiol Immunol & Mol Genet, Lexington, KY 40536 USA; [He, Y.; Hu, X.; Wang, Z. J.] Univ Illinois, Dept Biopharmaceut Sci, Chicago, IL 60612 USA; [Wieskopf, J. S.; Mogil, J. S.] McGill Univ, Dept Psychol, Montreal, PQ H3A 1B1, Canada; [Wieskopf, J. S.; Mogil, J. S.] McGill Univ, Alan Edwards Ctr Res Pain, Montreal, PQ H3A 1B1, Canada; [Storm, D. R.] Univ Washington, Sch Med, Dept Pharmacol, Seattle, WA 98195 USA	University of Kentucky; University of Kansas; University of Kansas Medical Center; University of Kentucky; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; McGill University; McGill University; University of Washington; University of Washington Seattle	Taylor, BK (corresponding author), Univ Kentucky, Dept Physiol, Lexington, KY 40536 USA.	brad.taylor@uky.edu	Donahue, Renee/AAI-3512-2020; Hu, Xiaoyu/AAO-7197-2020; Mogil, Jeffrey/AAA-9611-2019	Mogil, Jeffrey/0000-0003-1359-5720; McCarson, Kenneth/0000-0002-0175-7297; Donahue, Renee/0000-0002-3344-5650; Jutras, Brandon/0000-0002-7989-1031	NIH [F31DA032496, HD02528, R01NS45954, 5K02DA19656]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD002528] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000117] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS045954] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [K02DA019656, F31DA032496] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	The authors thank H. L. Fields, A. I. Basbaum, L. Hough, J. C. Marvizon, E. Bilsky, W. Sadee, G. Scherrer, K. Westlund High, M. Werner, J. Dahl, and B. Solway for critical discussions and J. Grasch, L. Martin, and R. Griggs for technical assistance and blinding. This work was supported by NIH grants F31DA032496 (G.C.), HD02528 (M.K.W. and K.E.M.), R01NS45954 (B.K.T.), and 5K02DA19656 (B.K.T.). Author contributions: G.C. and B.K.T. formulated the hypotheses, designed, analyzed and coordinated all experiments. G.C. performed surgeries, behavioral pharmacology, histology, and fluorescence imaging and analyzed the data. G.C. and B.L.J. carried out the biochemical studies and G.C. analyzed the data. S.D. and G.C. carried out Ca<SUP>2+</SUP> imagining experiments and analyzed the data. M.K.W., K.E.M., G.C., and B.K.T. designed the [<SUP>35</SUP>S]GTP-gamma-S binding studies; M.K.W. collected the data; and G.C., K.E.M., and B.K.T. analyzed the data. D.R.S. supplied the AC1<SUP>-/-</SUP> breeders. Z.J.W., G.C., and B.K.T. designed the conditioned place preference experiments, and Y.H. and X.H. conducted experiments and analyzed the data. J.S.M., J.S.W., G.C., and B.K.T. designed the Mouse Grimace Scale experiments, and J.W. conducted the experiments. R.R.D. conducted the plantar incision studies. G.C. and B.K.T. wrote the manuscript.	Angst MS, 2006, ANESTHESIOLOGY, V104, P570, DOI 10.1097/00000542-200603000-00025; Asiedu MN, 2011, J NEUROSCI, V31, P6646, DOI 10.1523/JNEUROSCI.6286-10.2011; AvidorReiss T, 1997, J BIOL CHEM, V272, P5040, DOI 10.1074/jbc.272.8.5040; BASBAUM AI, 1984, ANNU REV NEUROSCI, V7, P309, DOI 10.1146/annurev.ne.07.030184.001521; Benrath J, 2004, ANESTHESIOLOGY, V100, P1545, DOI 10.1097/00000542-200406000-00030; CHETKOVICH DM, 1993, J NEUROCHEM, V61, P1933, DOI 10.1111/j.1471-4159.1993.tb09836.x; Christie MJ, 2008, BRIT J PHARMACOL, V154, P384, DOI 10.1038/bjp.2008.100; COSTA T, 1989, P NATL ACAD SCI USA, V86, P7321, DOI 10.1073/pnas.86.19.7321; De Felice M, 2010, BRAIN, V133, P2475, DOI 10.1093/brain/awq159; Doolen S, 2012, MOL PAIN, V8, DOI 10.1186/1744-8069-8-56; Drdla R, 2009, SCIENCE, V325, P207, DOI 10.1126/science.1171759; Drdla-Schutting R, 2012, SCIENCE, V335, P235, DOI 10.1126/science.1211726; He Y, 2012, J PAIN, V13, P598, DOI 10.1016/j.jpain.2012.03.011; Heinl C, 2011, J NEUROSCI, V31, P16748, DOI 10.1523/JNEUROSCI.3491-11.2011; Ikeda H, 2006, SCIENCE, V312, P1659, DOI 10.1126/science.1127233; Kauer JA, 2007, NAT REV NEUROSCI, V8, P844, DOI 10.1038/nrn2234; Kenakin T, 2004, TRENDS PHARMACOL SCI, V25, P186, DOI 10.1016/j.tips.2004.02.012; Kenakin T, 2001, FASEB J, V15, P598, DOI 10.1096/fj.00-0438rev; Kest B, 2002, NEUROSCIENCE, V115, P463, DOI 10.1016/S0306-4522(02)00458-X; King T, 2009, NAT NEUROSCI, V12, P1364, DOI 10.1038/nn.2407; KOOB GF, 1992, TRENDS NEUROSCI, V15, P186, DOI 10.1016/0166-2236(92)90171-4; Lam H, 2011, MOL PAIN, V7, DOI 10.1186/1744-8069-7-24; LaneLadd SB, 1997, J NEUROSCI, V17, P7890; Latremoliere A, 2009, J PAIN, V10, P895, DOI 10.1016/j.jpain.2009.06.012; Li S, 2006, MOL PHARMACOL, V70, P1742, DOI 10.1124/mol.106.025783; Liu JG, 2001, J BIOL CHEM, V276, P37779; Liu JG, 2001, MOL PHARMACOL, V60, P53, DOI 10.1124/mol.60.1.53; Lu HC, 2003, NAT NEUROSCI, V6, P939, DOI 10.1038/nn1106; Luo C, 2008, PAIN, V140, P358, DOI 10.1016/j.pain.2008.09.008; Mazei-Robison MS, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a012070; Meye FJ, 2012, J NEUROSCI, V32, P16120, DOI 10.1523/JNEUROSCI.1572-12.2012; Nestler EJ, 1997, SCIENCE, V278, P58, DOI 10.1126/science.278.5335.58; Ossipov MH, 2010, J CLIN INVEST, V120, P3779, DOI 10.1172/JCI43766; Pogatzki EM, 2003, ANESTHESIOLOGY, V99, P1023, DOI 10.1097/00000542-200310000-00041; Raehal KM, 2005, J PHARMACOL EXP THER, V313, P1150, DOI 10.1124/jpet.104.082966; Rivat C, 2002, ANESTHESIOLOGY, V96, P381, DOI 10.1097/00000542-200202000-00025; Rivat C, 2007, NEUROPSYCHOPHARMACOL, V32, P2217, DOI 10.1038/sj.npp.1301340; Ruscheweyh R, 2011, MOL PAIN, V7, DOI 10.1186/1744-8069-7-20; Sadee W, 2005, LIFE SCI, V76, P1427, DOI 10.1016/j.lfs.2004.10.024; Seifert R, 2002, N-S ARCH PHARMACOL, V366, P381, DOI 10.1007/s00210-002-0588-0; Shoblock JR, 2007, NEUROSCIENCE, V149, P642, DOI 10.1016/j.neuroscience.2007.05.011; Shoblock JR, 2006, NEUROPSYCHOPHARMACOL, V31, P171, DOI 10.1038/sj.npp.1300782; SUFKA KJ, 1994, PAIN, V58, P355, DOI 10.1016/0304-3959(94)90130-9; Terman GW, 2001, J NEUROPHYSIOL, V85, P485, DOI 10.1152/jn.2001.85.2.485; Wang DX, 2004, J PHARMACOL EXP THER, V308, P512, DOI 10.1124/jpet.103.054049; Wang HS, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001269; WANG Z, 1994, LIFE SCI, V54, pPL339, DOI 10.1016/0024-3205(94)90022-1; Wei F, 2002, NEURON, V36, P713, DOI 10.1016/S0896-6273(02)01019-X; Xu H, 2008, J NEUROSCI, V28, P7445, DOI 10.1523/JNEUROSCI.1812-08.2008; Zachariou V, 2008, BIOL PSYCHIAT, V63, P1013, DOI 10.1016/j.biopsych.2007.11.021; Zhuo M, 2012, DRUG DISCOV TODAY, V17, P573, DOI 10.1016/j.drudis.2012.01.009	51	149	154	3	22	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 20	2013	341	6152					1394	1399		10.1126/science.1239403	http://dx.doi.org/10.1126/science.1239403			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	220PK	24052307	Green Accepted			2022-12-24	WOS:000324597200047
J	Chiang, CJ; Yang, YW; You, SL; Lai, MS; Chen, CJ				Chiang, Chun-Ju; Yang, Ya-Wen; You, San-Lin; Lai, Mei-Shu; Chen, Chien-Jen			Thirty-Year Outcomes of the National Hepatitis B Immunization Program in Taiwan	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter							VACCINATION PROGRAM; INFANTS		[Chiang, Chun-Ju; Lai, Mei-Shu] Natl Taiwan Univ, Grad Inst Epidemiol & Prevent Med, Taipei 10764, Taiwan; [Yang, Ya-Wen] Taiwan Canc Registry, Taipei, Taiwan; [You, San-Lin; Chen, Chien-Jen] Acad Sinica, Genom Res Ctr, Taipei 11529, Taiwan	National Taiwan University; Academia Sinica - Taiwan	Chen, CJ (corresponding author), Acad Sinica, Genom Res Ctr, 128 Acad Rd,Sec 2, Taipei 11529, Taiwan.	chencj@gate.sinica.edu.tw	Chen, Chien-Jen/N-4723-2019; Chen, Chien-Jen/C-6976-2008	You, San-Lin/0000-0002-3192-3356; CHIANG, CHUN-JU/0000-0002-1330-5319; Lai, Mei-shu/0000-0001-6130-3468; YANG, YA-WEN/0000-0003-0412-584X				Centers for Disease Control Department of Health ROC (Taiwan), 2013, CDC 2012 ANN REP CTR; Chang MH, 2009, JNCI-J NATL CANCER I, V101, P1348, DOI 10.1093/jnci/djp288; CHEN D-S, 1987, Journal of the American Medical Association, V257, P2597, DOI 10.1001/jama.257.19.2597; Chiang CJ, 2010, JPN J CLIN ONCOL, V40, P897, DOI 10.1093/jjco/hyq057; Chien YC, 2006, EPIDEMIOL REV, V28, P126, DOI 10.1093/epirev/mxj010; Kao JH, 2001, J PEDIATR-US, V139, P349, DOI 10.1067/mpd.2001.116277	6	138	146	0	12	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 4	2013	310	9					974	976		10.1001/jama.2013.276701	http://dx.doi.org/10.1001/jama.2013.276701			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	211DT	24002285				2022-12-24	WOS:000323885700029
J	Sheffield, KM; Riall, TS; Han, YM; Kuo, YF; Townsend, CM; Goodwin, JS				Sheffield, Kristin M.; Riall, Taylor S.; Han, Yimei; Kuo, Yong-Fang; Townsend, Courtney M., Jr.; Goodwin, James S.			Association Between Cholecystectomy With vs Without Intraoperative Cholangiography and Risk of Common Duct Injury	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							LAPAROSCOPIC CHOLECYSTECTOMY; OPERATIVE CHOLANGIOGRAPHY; MANAGEMENT; COMPLICATIONS; ROUTINE; MULTICENTER; REPAIR; VOLUME	IMPORTANCE Significant controversy exists regarding routine intraoperative cholangiography in preventing common duct injury during cholecystectomy. OBJECTIVE To investigate the association between intraoperative cholangiography use during cholecystectomy and common duct injury. DESIGN, SETTING, AND PARTICIPANTS Retrospective cohort study of all Texas Medicare claims data from 2000 through 2009. We identified Medicare beneficiaries 66 years or older who underwent inpatient or outpatient cholecystectomy for biliary colic or biliary dyskinesia, acute cholecystitis, or chronic cholecystitis. We compared results from multilevel logistic regression models to the instrumental variable analyses. INTERVENTIONS Intraoperative cholangiography use during cholecystectomy was determined at the level of the patients (yes/no), hospitals (percentage intraoperative cholangiography use for all cholecystectomies at the hospital), and surgeons (percentage use for all cholecystectomies performed by the surgeon). Percentage of use at the hospital and percentage of use by surgeon were the instrumental variables. MAIN OUTCOMES AND MEASURES Patients with claims for common duct repair operations within 1 year of cholecystectomy were considered as having major common duct injury. RESULTS Of 92 932 patients undergoing cholecystectomy, 37 533 (40.4%) underwent concurrent intraoperative cholangiography and 280 (0.30%) had a common duct injury. The common duct injury rate was 0.21% among patients with intraoperative cholangiography and 0.36% among patients without it. In a logistic regression model controlling for patient, surgeon, and hospital characteristics, the odds of common duct injury for cholecystectomies performed without intraoperative cholangiography were increased compared with those performed with it (OR, 1.79 [95% CI, 1.35-2.36]; P < .001). When confounding was controlled with instrumental variable analysis, the association between cholecystectomy performed without intraoperative cholangiography and duct injury was no longer significant (OR, 1.26 [95% CI, 0.81-1.96]; P = .31). CONCLUSIONS AND RELEVANCE When confounders were controlled with instrumental variable analysis, there was no statistically significant association between intraoperative cholangiography and common duct injury. Intraoperative cholangiography is not effective as a preventive strategy against common duct injury during cholecystectomy.	[Sheffield, Kristin M.; Riall, Taylor S.; Han, Yimei; Townsend, Courtney M., Jr.] Univ Texas Med Branch, Dept Surg, Galveston, TX 77555 USA; [Kuo, Yong-Fang; Goodwin, James S.] Univ Texas Med Branch, Dept Internal Med, Galveston, TX 77555 USA	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston	Riall, TS (corresponding author), Univ Texas Med Branch, 301 Univ Blvd,JSA 6-110C, Galveston, TX 77555 USA.	tsriall@utmb.edu			National Institutes of Health [K05CA134923, K07CA130983, UL1TR000071]; NATIONAL CANCER INSTITUTE [K07CA130983, K05CA134923] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000071] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This study is supported by grants K05CA134923, K07CA130983, and UL1TR000071 from the National Institutes of Health.	Mercado MA, 2011, HPB, V13, P767, DOI 10.1111/j.1477-2574.2011.00356.x; Ausania F, 2012, SURG ENDOSC, V26, P1193, DOI 10.1007/s00464-012-2241-4; Barauskas G, 2012, MEDICINA-LITHUANIA, V48, P138, DOI 10.3390/medicina48030019; Birkmeyer JD, 2002, NEW ENGL J MED, V346, P1128, DOI 10.1056/NEJMsa012337; Buddingh KT, 2011, J AM COLL SURGEONS, V213, P267, DOI 10.1016/j.jamcollsurg.2011.03.004; Buddingh KT, 2011, J GASTROINTEST SURG, V15, P1069, DOI 10.1007/s11605-011-1413-1; CLAIR DG, 1993, ARCH SURG-CHICAGO, V128, P551; Cullen KA, 2006, GOLOSINSKIY A NATION; DeFrances CJ, NATIONAL HEALTH STAT; Fletcher DR, 1999, ANN SURG, V229, P449, DOI 10.1097/00000658-199904000-00001; Flum DR, 2003, JAMA-J AM MED ASSOC, V289, P1639, DOI 10.1001/jama.289.13.1639; Flum DR, 2001, ARCH SURG-CHICAGO, V136, P1287, DOI 10.1001/archsurg.136.11.1287; Hamad MA, 2011, SURG ENDOSC, V25, P3747, DOI 10.1007/s00464-011-1780-4; HAUERJENSEN M, 1993, SURGERY, V113, P318; Johnson SR, 2000, SURGERY, V128, P668, DOI 10.1067/msy.2000.108422; Klabunde CN, 2000, J CLIN EPIDEMIOL, V53, P1258, DOI 10.1016/S0895-4356(00)00256-0; Lau WY, 2010, ANZ J SURG, V80, P75, DOI 10.1111/j.1445-2197.2009.05205.x; Massarweh NN, 2007, J AM COLL SURGEONS, V204, P656, DOI 10.1016/j.jamcollsurg.2007.01.038; Mirizzi PL, 1937, SURG GYNECOL OBSTET, V65, P702; Nickkholgh A, 2006, SURG ENDOSC, V20, P868, DOI 10.1007/s00464-005-0425-x; Nuzzo G, 2005, ARCH SURG-CHICAGO, V140, P986, DOI 10.1001/archsurg.140.10.986; Nuzzo G, 2007, J AM COLL SURGEONS, V205, P5; Ozturk E, 2009, HEPATO-GASTROENTEROL, V56, P17; Regoly-Merei J, 1998, SURG ENDOSC-ULTRAS, V12, P294, DOI 10.1007/s004649900657; Sheffield KM, 2012, J AM COLL SURGEONS, V214, P668, DOI 10.1016/j.jamcollsurg.2011.12.033; Staiger D, 1997, ECONOMETRICA, V65, P557, DOI 10.2307/2171753; Strasberg SM, 2010, J AM COLL SURGEONS, V211, P132, DOI 10.1016/j.jamcollsurg.2010.02.053; Stukel TA, 2007, JAMA-J AM MED ASSOC, V297, P278, DOI 10.1001/jama.297.3.278; Tornqvist B, 2012, BMJ-BRIT MED J, V345, pe6457; Traverso LW, 2006, SURG ENDOSC, V20, P1659, DOI 10.1007/s00464-006-0122-4; Waage A, 2006, ARCH SURG-CHICAGO, V141, P1207, DOI 10.1001/archsurg.141.12.1207; Yang Y, UNIFIED APPROACH MEA; Yegiyants S, 2008, AM SURGEON, V74, P985; Z'graggen K, 1998, SURG ENDOSC-ULTRAS, V12, P1303, DOI 10.1007/s004649900846; Zacharakis E, 2007, J LAPAROENDOSC ADV S, V17, P620, DOI 10.1089/lap.2006.0220	35	57	59	0	4	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 28	2013	310	8					812	820		10.1001/jama.2013.276205	http://dx.doi.org/10.1001/jama.2013.276205			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	206YA	23982367	Green Accepted			2022-12-24	WOS:000323561400021
J	Brito, JP; Morris, JC; Montori, VM				Brito, Juan P.; Morris, John C.; Montori, Victor M.			TOO MUCH MEDICINE Thyroid cancer: zealous imaging has increased detection and treatment of low risk tumours	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							UNITED-STATES; PAPILLARY; CARCINOMA; THERAPY; PREVALENCE; MORTALITY; NODULES; IMPACT; US		[Brito, Juan P.; Morris, John C.; Montori, Victor M.] Mayo Clin, Div Endocrinol Diabet Metab & Nutr, Rochester, MN 55905 USA; [Brito, Juan P.; Montori, Victor M.] Mayo Clin, Knowledge & Evaluat Res Unit, Rochester, MN 55905 USA	Mayo Clinic; Mayo Clinic	Montori, VM (corresponding author), Mayo Clin, Div Endocrinol Diabet Metab & Nutr, 200 1st St SW, Rochester, MN 55905 USA.	montori.victor@mayo.edu		Montori, Victor/0000-0003-0595-2898				Alexander C, 1998, J NUCL MED, V39, P1551; Almeida J, 2009, ARCH OTOLARYNGOL, V135, P342, DOI 10.1001/archoto.2009.16; Andriole GL, 2009, NEW ENGL J MED, V360, P1310, DOI 10.1056/NEJMoa0810696; Baker LC, 2008, HEALTH AFFAIR, V27, P1467, DOI 10.1377/hlthaff.27.6.1467; Brito JP, 2013, THYROID, V23, P449, DOI 10.1089/thy.2012.0156; Cooper DS, 2009, THYROID, V19, P1167, DOI 10.1089/thy.2009.0110; Cronan JJ, 2008, RADIOLOGY, V247, P602, DOI 10.1148/radiol.2473072233; Curado MP, 2007, CANC INCIDENCE 5 CON, VIX; Dal Maso L, 2009, CANCER CAUSE CONTROL, V20, P75, DOI 10.1007/s10552-008-9219-5; Davies L, 2006, JAMA-J AM MED ASSOC, V295, P2164, DOI 10.1001/jama.295.18.2164; Davies L, 2010, LARYNGOSCOPE, V120, P2446, DOI 10.1002/lary.21076; Davies L, 2010, ARCH OTOLARYNGOL, V136, P440, DOI 10.1001/archoto.2010.55; Ferlay J., IARC CANCERBASE; Giordano D, 2012, THYROID, V22, P911, DOI 10.1089/thy.2012.0011; HARACH HR, 1985, CANCER-AM CANCER SOC, V56, P531, DOI 10.1002/1097-0142(19850801)56:3<531::AID-CNCR2820560321>3.0.CO;2-3; Haselkorn T, 2000, CANCER CAUSE CONTROL, V11, P163, DOI 10.1023/A:1008932123830; HAY ID, 1993, SURGERY, V114, P1050; Howlader NNA, SEER CANC STAT REV 1; Hundahl SA, 1998, CANCER-AM CANCER SOC, V83, P2638, DOI 10.1002/(SICI)1097-0142(19981215)83:12<2638::AID-CNCR31>3.0.CO;2-1; Ito Y, 2010, WORLD J SURG, V34, P2333, DOI 10.1007/s00268-010-0712-0; Iyer NG, 2011, CANCER-AM CANCER SOC, V117, P4439, DOI 10.1002/cncr.26070; Leenhardt L, 2004, EUR J ENDOCRINOL, V150, P133, DOI 10.1530/eje.0.1500133; Mandel SJ, 2003, THYROID, V13, P265, DOI 10.1089/105072503321582060; MAZZAFERRI EL, 1994, AM J MED, V97, P418, DOI 10.1016/0002-9343(94)90321-2; McIver B, 2001, SURGERY, V130, P1028, DOI 10.1067/msy.2001.118266; Morris LGT, 2013, THYROID, V23, P886, DOI 10.1089/thy.2013.0045; Negri E, 1999, CANCER CAUSE CONTROL, V10, P143, DOI 10.1023/A:1008880429862; Pellegriti G, 2004, J CLIN ENDOCR METAB, V89, P3713, DOI 10.1210/jc.2003-031982; Roche L. M., 2011, J ENV PUBLIC HLTH, V2011; Ross DS, 2006, J CLIN ENDOCR METAB, V91, P4253, DOI 10.1210/jc.2006-1772; Sprague BL, 2008, CANCER CAUSE CONTROL, V19, P585, DOI 10.1007/s10552-008-9122-0; Sun GH, 2013, THYROID, V23, P727, DOI 10.1089/thy.2012.0218; Van Nostrand D, 2009, THYROID, V19, P1381, DOI 10.1089/thy.2009.1611; Xing MZ, 2013, JAMA-J AM MED ASSOC, V309, P1493, DOI 10.1001/jama.2013.3190; Yoon DY, 2008, J COMPUT ASSIST TOMO, V32, P810, DOI 10.1097/RCT.0b013e318157fd38; Yousem DM, 1997, AM J NEURORADIOL, V18, P1423	36	204	209	0	13	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 27	2013	347								f4706	10.1136/bmj.f4706	http://dx.doi.org/10.1136/bmj.f4706			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	211BW	23982465				2022-12-24	WOS:000323880100006
J	Verger, PJP; Boobis, AR				Verger, Philippe J. P.; Boobis, Alan R.			Reevaluate Pesticides for Food Security and Safety	SCIENCE			English	Editorial Material							IPCS FRAMEWORK; RELEVANCE; HUMANS; MODE		[Verger, Philippe J. P.] WHO, CH-1211 Geneva, Switzerland; [Boobis, Alan R.] Univ London Imperial Coll Sci Technol & Med, London W12 0NN, England	World Health Organization; Imperial College London	Verger, PJP (corresponding author), WHO, CH-1211 Geneva, Switzerland.	vergerp@who.int	Boobis, Alan/E-1536-2018	Boobis, Alan/0000-0003-3371-386X; Verger, Philippe/0000-0002-6650-2391	Medical Research Council [G0801056B] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)		Boobis AR, 2008, CRIT REV TOXICOL, V38, P87, DOI 10.1080/10408440701749421; Boobis AR, 2006, CRIT REV TOXICOL, V36, P781, DOI 10.1080/10408440600977677; CCPR, 2013, REPORT OF THE 45TH C; FAO, 2009, FEED WORLD 2050; FAO, 2013, REPORT OF THE JOINT; Phillips McDougall AgriService, 2010, INDUSTRY OVERVIEW 20; Popp J, 2013, AGRON SUSTAIN DEV, V33, P243, DOI 10.1007/s13593-012-0105-x; Solecki R, 2005, FOOD CHEM TOXICOL, V43, P1569, DOI 10.1016/j.fct.2005.04.005; WHO, 2009, ENVIRON HEALTH CRITE, V239, P1; WTO, 1994, THE WTO AGREEMENT ON	10	91	95	8	161	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 16	2013	341	6147					717	718		10.1126/science.1241572	http://dx.doi.org/10.1126/science.1241572			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	201DZ	23950515				2022-12-24	WOS:000323122200023
J	Ladapo, JA; Rodwin, BA; Ryan, AM; Trasande, L; Blustein, J				Ladapo, Joseph A.; Rodwin, Benjamin A.; Ryan, Andrew M.; Trasande, Leonardo; Blustein, Jan			Scientific Publications on Firearms in Youth Before and After Congressional Action Prohibiting Federal Research Funding	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Ladapo, Joseph A.] NYU, Sch Med, Dept Populat Hlth, New York, NY 10016 USA; [Rodwin, Benjamin A.] NYU, Sch Med, Dept Med, New York, NY 10016 USA; [Ryan, Andrew M.] Weill Cornell Med Coll, Div Outcomes & Effectiveness Res, New York, NY USA; [Trasande, Leonardo] NYU, Sch Med, Dept Pediat, New York, NY 10016 USA; [Blustein, Jan] NYU, Wagner Sch Publ Serv, New York, NY 10016 USA	New York University; New York University; Cornell University; New York University; New York University	Ladapo, JA (corresponding author), NYU, Sch Med, 550 1st Ave,VZ30 6th Floor,614, New York, NY 10016 USA.	joseph.ladapo@nyumc.org	Trasande, Leonardo/ABE-6339-2020	Trasande, Leonardo/0000-0002-1928-597X; Ladapo, Joseph/0000-0002-8518-4800				Centers for Disease Control and Prevention, WEB BAS INJ STAT QUE; Gardner HG, 2012, PEDIATRICS, V130, pE1416, DOI 10.1542/peds.2012-2481; Kellermann AL, 1997, AM J PUBLIC HEALTH, V87, P910, DOI 10.2105/AJPH.87.6.910; Kellermann AL, 2013, JAMA-J AM MED ASSOC, V309, P549, DOI 10.1001/jama.2012.208207; Luo M, NRA STYMIES FIREARMS; MEYER BD, 1995, J BUS ECON STAT, V13, P151, DOI 10.2307/1392369	6	23	23	0	10	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 7	2013	310	5					532	534		10.1001/jama.2013.119355	http://dx.doi.org/10.1001/jama.2013.119355			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	196OZ	23925624	Bronze			2022-12-24	WOS:000322786400026
J	Pose, D; Verhage, L; Ott, F; Yant, L; Mathieu, J; Angenent, GC; Immink, RGH; Schmid, M				Pose, David; Verhage, Leonie; Ott, Felix; Yant, Levi; Mathieu, Johannes; Angenent, Gerco C.; Immink, Richard G. H.; Schmid, Markus			Temperature-dependent regulation of flowering by antagonistic FLM variants	NATURE			English	Article							MADS-BOX GENE; CIRCADIAN CLOCK; FUNCTIONAL-ANALYSIS; FLORAL TRANSITION; ARABIDOPSIS; IDENTIFICATION; REPRESSOR; TIME; VERNALIZATION; RESPONSES	The appropriate timing of flowering is crucial for plant reproductive success. It is therefore not surprising that intricate genetic networks have evolved to perceive and integrate both endogenous and environmental signals, such as carbohydrate and hormonal status, photoperiod and temperature(1,2). In contrast to our detailed understanding of the vernalization pathway, little is known about how flowering time is controlled in response to changes in the ambient growth temperature. In Arabidopsis thaliana, the MADS-box transcription factor genes FLOWERING LOCUS M (FLM) and SHORT VEGETATIVE PHASE (SVP) have key roles in this process(3,4). FLM is subject to temperature-dependent alternative splicing(3). Here we report that the two main FLM protein splice variants, FLM-beta and FLM-delta, compete for interaction with the floral repressor SVP. The SVP-FLM-beta complex is predominately formed at low temperatures and prevents precocious flowering. By contrast, the competing SVP-FLM-delta complex is impaired in DNA binding and acts as a dominant-negative activator of flowering at higher temperatures. Our results show a new mechanism that controls the timing of the floral transition in response to changes in ambient temperature. A better understanding of how temperature controls the molecular mechanisms of flowering will be important to cope with current changes in global climate(5,6).	[Pose, David; Ott, Felix; Yant, Levi; Mathieu, Johannes; Schmid, Markus] Max Planck Inst Dev Biol, Dept Mol Biol, D-72076 Tubingen, Germany; [Verhage, Leonie; Angenent, Gerco C.; Immink, Richard G. H.] Plant Res Int, Biosci, NL-6708 PB Wageningen, Netherlands; [Verhage, Leonie; Angenent, Gerco C.] Wageningen Univ, Mol Biol Lab, NL-6708 PB Wageningen, Netherlands	Max Planck Society; Wageningen University & Research	Schmid, M (corresponding author), Max Planck Inst Dev Biol, Dept Mol Biol, Spemannstr 35, D-72076 Tubingen, Germany.	markus.schmid@tuebingen.mpg.de	Immink, Richard G.H./A-9825-2011; Schmid, Markus/I-4384-2015; Posé, David/A-3424-2014; Yant, Levi/ABH-1275-2020	Schmid, Markus/0000-0002-0068-2967; Posé, David/0000-0003-3332-4661; Yant, Levi/0000-0003-3442-0217; Immink, Richard/0000-0002-0182-4138; Verhage, Leonie/0000-0001-6402-3605	ERA-NET PLANT GENOMICS collaborative project BLOOM-NET; Deutsche Forschungsgemeinschaft [SCHM 1560/7-1]; MPI for Developmental Biology; BLOOM-NET related NWO grant; NWO/TTI-Green Genetics THERMOFLOW grant	ERA-NET PLANT GENOMICS collaborative project BLOOM-NET; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); MPI for Developmental Biology; BLOOM-NET related NWO grant; NWO/TTI-Green Genetics THERMOFLOW grant	We thank F. Hohnstein, J. Weirich, C. Martin-Pizarro, J. Busscher-Lange, C. Lanz and J. Reixinger for technical assistance, A. Srikanth for BiFC vectors, and P. Huijser and B. Davies for seeds. Supported through the ERA-NET PLANT GENOMICS collaborative project BLOOM-NET by a grant from the Deutsche Forschungsgemeinschaft (SCHM 1560/7-1) and the MPI for Developmental Biology to M.S., a BLOOM-NET related NWO grant to R.G.H.I. and G.C.A., and a NWO/TTI-Green Genetics THERMOFLOW grant to R.G.H.I., G.C.A. and L.V.	Balasubramanian S, 2006, PLOS GENET, V2, P980, DOI 10.1371/journal.pgen.0020106; CHOUARD P, 1960, ANNU REV PLANT PHYS, V11, P191, DOI 10.1146/annurev.pp.11.060160.001203; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Curtis MD, 2003, PLANT PHYSIOL, V133, P462, DOI 10.1104/pp.103.027979; de Felippes FF, 2010, METHODS MOL BIOL, V592, P255, DOI 10.1007/978-1-60327-005-2_17; de Folter S, 2005, PLANT CELL, V17, P1424, DOI 10.1105/tpc.105.031831; Franklin KA, 2011, P NATL ACAD SCI USA, V108, P20231, DOI 10.1073/pnas.1110682108; Gu XF, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2947; Immink RGH, 2012, PLANT PHYSIOL, V160, P433, DOI 10.1104/pp.112.202614; James AB, 2012, PLANT CELL, V24, P961, DOI 10.1105/tpc.111.093948; James P, 1996, GENETICS, V144, P1425; Jiao YL, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.76; Jones MA, 2012, PLANT CELL, V24, P4066, DOI 10.1105/tpc.112.104828; Kumar SV, 2012, NATURE, V484, P242, DOI 10.1038/nature10928; Kumar SV, 2010, CELL, V140, P136, DOI 10.1016/j.cell.2009.11.006; Lee JH, 2007, GENE DEV, V21, P397, DOI 10.1101/gad.1518407; Mann ME, 2008, P NATL ACAD SCI USA, V105, P13252, DOI 10.1073/pnas.0805721105; Marcott SA, 2013, SCIENCE, V339, P1198, DOI 10.1126/science.1228026; Masiero S, 2004, DEVELOPMENT, V131, P5981, DOI 10.1242/dev.01517; Mendez-Vigo B, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003289; Michaels SD, 1999, PLANT CELL, V11, P949, DOI 10.1105/tpc.11.5.949; Moyroud E, 2011, PLANT CELL, V23, P1293, DOI 10.1105/tpc.111.083329; Pose D, 2012, CURR OPIN PLANT BIOL, V15, P45, DOI 10.1016/j.pbi.2011.09.002; Riechmann JL, 1996, P NATL ACAD SCI USA, V93, P4793, DOI 10.1073/pnas.93.10.4793; Rosloski SM, 2013, PLANT MOL BIOL, V81, P57, DOI 10.1007/s11103-012-9982-2; Scortecci K, 2003, PLANT MOL BIOL, V52, P915, DOI 10.1023/A:1025426920923; Scortecci KC, 2001, PLANT J, V26, P229, DOI 10.1046/j.1365-313x.2001.01024.x; Severing EI, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030524; Sheldon CC, 1999, PLANT CELL, V11, P445, DOI 10.1105/tpc.11.3.445; Srikanth A, 2011, CELL MOL LIFE SCI, V68, P2013, DOI 10.1007/s00018-011-0673-y; Tao Z, 2012, PLANT J, V70, P549, DOI 10.1111/j.1365-313X.2012.04919.x; van Dijk ADJ, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1001017; Wang XX, 2012, PLANT CELL, V24, P3278, DOI 10.1105/tpc.112.100081; Werner JD, 2005, P NATL ACAD SCI USA, V102, P2460, DOI 10.1073/pnas.0409474102; Yant L, 2010, PLANT CELL, V22, P2156, DOI 10.1105/tpc.110.075606	35	279	296	12	213	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 21	2013	503	7476					414	+		10.1038/nature12633	http://dx.doi.org/10.1038/nature12633			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254KG	24067612				2022-12-24	WOS:000327163200045
J	Wagner, J; Gabler, NB; Ratcliffe, SJ; Brown, SES; Strom, BL; Halpern, SD				Wagner, Jason; Gabler, Nicole B.; Ratcliffe, Sarah J.; Brown, Sydney E. S.; Strom, Brian L.; Halpern, Scott D.			Outcomes Among Patients Discharged From Busy Intensive Care Units	ANNALS OF INTERNAL MEDICINE			English	Article							CRITICALLY-ILL PATIENTS; READMISSION RATE; BED NUMBERS; STATES; MORTALITY; ASSOCIATION; MEDICINE; SERVICES; QUALITY; CRISIS	Background: Strains on the capacities of intensive care units (ICUs) may influence the quality of ICU-to-floor transitions. Objective: To determine how 3 metrics of ICU capacity strain (ICU census, new admissions, and average acuity) measured on days of patient discharges influence ICU length of stay (LOS) and post-ICU discharge outcomes. Design: Retrospective cohort study from 2001 to 2008. Setting: 155 ICUs in the United States. Patients: 200 730 adults discharged from ICUs to hospital floors. Measurements: Associations between ICU capacity strain metrics and discharged patient ICU LOS, 72-hour ICU readmissions, subsequent in-hospital death, post-ICU discharge LOS, and hospital discharge destination. Results: Increases in the 3 strain variables on the days of ICU discharge were associated with shorter preceding ICU LOS (all P < 0.001) and increased odds of ICU readmissions (all P < 0.050). Going from the 5th to 95th percentiles of strain was associated with a 6.3-hour reduction in ICU LOS (95% CI, 5.3 to 7.3 hours) and a 1.0% increase in the odds of ICU readmission (CI, 0.6% to 1.5%). No strain variable was associated with increased odds of subsequent death, reduced odds of being discharged home from the hospital, or longer total hospital LOS. Limitation: Long-term outcomes could not be measured. Conclusion: When ICUs are strained, triage decisions seem to be affected such that patients are discharged from the ICU more quickly and, perhaps consequentially, have slightly greater odds of being readmitted to the ICU. However, short-term patient outcomes are unaffected. These results suggest that bed availability pressures may encourage physicians to discharge patients from the ICU more efficiently and that ICU readmissions are unlikely to be causally related to patient outcomes. Primary Funding Source: Agency for Healthcare Research and Quality; National Heart, Lung, and Blood Institute; and Society of Critical Care Medicine.	Univ Penn, Leonard Davis Inst, Ctr Hlth Incent & Behav Econ, Ctr Clin Epidemiol & Biostat, Philadelphia, PA 19104 USA; Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine	Wagner, J (corresponding author), Univ Penn, Perelman Sch Med, Div Pulm Allergy & Crit Care Med, 839 W Gates Bldg,3600 Spruce St, Philadelphia, PA 19104 USA.	jason.wagner@uphs.upenn.edu	Ratcliffe, Sarah J/GYR-1110-2022	Ratcliffe, Sarah J/0000-0002-6644-8284; Brown, Sydney/0000-0003-0374-0824	Agency for Healthcare Research and Quality; National Heart, Lung, and Blood Institute; Society of Critical Care Medicine; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [K08HS018406] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F30HL107020, T32HL098054] Funding Source: NIH RePORTER	Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Society of Critical Care Medicine; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Agency for Healthcare Research and Quality; National Heart, Lung, and Blood Institute; and Society of Critical Care Medicine.	Angus DC, 2006, CRIT CARE MED, V34, P1016, DOI 10.1097/01.CCM.0000206105.05626.15; Angus DC, 2000, JAMA-J AM MED ASSOC, V284, P2762, DOI 10.1001/jama.284.21.2762; Angus DC, 1998, CRIT CARE MED, V26, P1779, DOI 10.1097/00003246-199811000-00008; Baker DR, 2009, CRIT CARE MED, V37, P2882, DOI 10.1097/CCM.0b013e3181b01caf; Brody H, 2012, NEW ENGL J MED, V366, P1949, DOI 10.1056/NEJMp1203365; Brown SES, 2012, AM J RESP CRIT CARE, V185, P955, DOI 10.1164/rccm.201109-1720OC; Chalfin DB, 2007, CRIT CARE MED, V35, P1477, DOI 10.1097/01.CCM.0000266585.74905.5A; Chrusch CA, 2009, CRIT CARE MED, V37, P2753, DOI 10.1097/CCM.0b013e3181a57b0c; CLEVELAND WS, 1979, J AM STAT ASSOC, V74, P829, DOI 10.2307/2286407; Cooper GS, 1999, MED CARE, V37, P399, DOI 10.1097/00005650-199904000-00009; Cooper RA, 2004, ANN INTERN MED, V141, P705, DOI 10.7326/0003-4819-141-9-200411020-00012; Gershengorn HB, 2012, CRIT CARE MED, V40, P2009, DOI 10.1097/CCM.0b013e31824e9eae; Glance LG, 2006, CRIT CARE MED, V34, P1925, DOI 10.1097/01.CCM.0000226415.93237.84; Halpern NA, 2004, CRIT CARE MED, V32, P1254, DOI 10.1097/01.CCM.0000128577.31689.4C; Halpern NA, 2010, CRIT CARE MED, V38, P65, DOI 10.1097/CCM.0b013e3181b090d0; Halpern SD, 2011, CURR OPIN CRIT CARE, V17, P648, DOI 10.1097/MCC.0b013e32834c7a53; Higgins TL, 2007, CRIT CARE MED, V35, P827, DOI 10.1097/01.CCM.0000257337.63529.9F; Howell MD, 2011, CURR OPIN CRIT CARE, V17, P626, DOI 10.1097/MCC.0b013e32834b3e6e; Kahn JM, 2006, CURR OPIN CRIT CARE, V12, P399, DOI 10.1097/01.ccx.0000244117.08753.38; Kelley MA, 2004, CHEST, V125, P1514, DOI 10.1378/chest.125.4.1514; Kelley MA, 2008, CRIT CARE MED, V36, P1385, DOI 10.1097/CCM.0b013e31816a0bd3; Kramer AA, 2013, CRIT CARE MED, V41, P24, DOI 10.1097/CCM.0b013e3182657b8a; Kramer AA, 2012, CRIT CARE MED, V40, P3, DOI 10.1097/CCM.0b013e31822d751e; Levy MM, 2008, ANN INTERN MED, V148, P801, DOI 10.7326/0003-4819-148-11-200806030-00002; Localio AR, 2001, ANN INTERN MED, V135, P112, DOI 10.7326/0003-4819-135-2-200107170-00012; Luce JM, 2002, AM J RESP CRIT CARE, V165, P750, DOI 10.1164/ajrccm.165.6.2109045; Pronovost PJ, 2002, JAMA-J AM MED ASSOC, V288, P2151, DOI 10.1001/jama.288.17.2151; Rhodes A, 2012, INTENS CARE MED, V38, P1647, DOI 10.1007/s00134-012-2627-8; Roberts RR, 1999, JAMA-J AM MED ASSOC, V281, P644, DOI 10.1001/jama.281.7.644; Seymour CW, 2012, ARCH INTERN MED, V172, P1226, DOI 10.1001/archinternmed.2012.3773; Seymour CW, 2012, HEALTH SERV RES, V47, P2060, DOI 10.1111/j.1475-6773.2012.01402.x; SINGER DE, 1983, NEW ENGL J MED, V309, P1155, DOI 10.1056/NEJM198311103091905; STRAUSS MJ, 1986, JAMA-J AM MED ASSOC, V255, P1143, DOI 10.1001/jama.255.9.1143; Truog RD, 2006, CRIT CARE MED, V34, P958, DOI 10.1097/01.CCM.0000206116.10417.D9; Vranas KR, 2012, AM J RESP CRIT CARE, V185, pA1608; Walther SM, 2001, INTENS CARE MED, V27, P700, DOI 10.1007/s001340100899; Ward NS, 2008, CRIT CARE MED, V36, P471, DOI 10.1097/CCM.0B013E3181629511; Wunsch H, 2012, CHEST, V141, P1393, DOI 10.1378/chest.11-2819; Wunsch H, 2009, AM J RESP CRIT CARE, V180, P875, DOI 10.1164/rccm.200902-0201OC; Young MJ, 2012, CRIT CARE MED, V40, P261, DOI 10.1097/CCM.0b013e31822d750d; Zimmerman JE, 2010, J CRIT CARE, V25, P205, DOI 10.1016/j.jcrc.2009.06.010	41	94	96	0	10	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 1	2013	159	7					447	U151		10.7326/0003-4819-159-7-201310010-00004	http://dx.doi.org/10.7326/0003-4819-159-7-201310010-00004			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	234FQ	24081285	Green Accepted			2022-12-24	WOS:000325628000002
J	Tan, QX; Zhu, Y; Li, J; Chen, ZX; Han, GW; Kufareva, I; Li, TT; Ma, LM; Fenalti, G; Li, J; Zhang, WR; Xie, X; Yang, HY; Jiang, HL; Cherezov, V; Liu, H; Stevens, RC; Zhao, Q; Wu, BL				Tan, Qiuxiang; Zhu, Ya; Li, Jian; Chen, Zhuxi; Han, Gye Won; Kufareva, Irina; Li, Tingting; Ma, Limin; Fenalti, Gustavo; Li, Jing; Zhang, Wenru; Xie, Xin; Yang, Huaiyu; Jiang, Hualiang; Cherezov, Vadim; Liu, Hong; Stevens, Raymond C.; Zhao, Qiang; Wu, Beili			Structure of the CCR5 Chemokine Receptor-HIV Entry Inhibitor Maraviroc Complex	SCIENCE			English	Article							CRYSTAL-STRUCTURE; SMALL-MOLECULE; CORECEPTOR; BINDING; DISCOVERY; TERMINUS; ANTIBODY	The CCR5 chemokine receptor acts as a co-receptor for HIV-1 viral entry. Here we report the 2.7 angstrom-resolution crystal structure of human CCR5 bound to the marketed HIV drug maraviroc. The structure reveals a ligand-binding site that is distinct from the proposed major recognition sites for chemokines and the viral glycoprotein gp120, providing insights into the mechanism of allosteric inhibition of chemokine signaling and viral entry. A comparison between CCR5 and CXCR4 crystal structures, along with models of co-receptor-gp120-V3 complexes, suggests that different charge distributions and steric hindrances caused by residue substitutions may be major determinants of HIV-1 co-receptor selectivity. These high-resolution insights into CCR5 can enable structure-based drug discovery for the treatment of HIV-1 infection.	[Tan, Qiuxiang; Zhu, Ya; Li, Jian; Li, Tingting; Ma, Limin; Li, Jing; Zhang, Wenru; Xie, Xin; Liu, Hong; Stevens, Raymond C.; Zhao, Qiang; Wu, Beili] Chinese Acad Sci, Shanghai Inst Mat Med, CAS Key Lab Receptor Res, Shanghai 201203, Peoples R China; [Chen, Zhuxi; Yang, Huaiyu; Jiang, Hualiang] Chinese Acad Sci, Shanghai Inst Mat Med, Drug Discovery & Design Ctr, Shanghai 201203, Peoples R China; [Han, Gye Won; Fenalti, Gustavo; Cherezov, Vadim; Stevens, Raymond C.] Scripps Res Inst, Dept Integrat Struct & Computat Biol, La Jolla, CA 92037 USA; [Kufareva, Irina] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92093 USA; [Stevens, Raymond C.] ShanghaiTech Univ, iHuman Inst, Shanghai 201203, Peoples R China	Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; Scripps Research Institute; University of California System; University of California San Diego; ShanghaiTech University	Wu, BL (corresponding author), Chinese Acad Sci, Shanghai Inst Mat Med, CAS Key Lab Receptor Res, 555 Zuchongzhi Rd, Shanghai 201203, Peoples R China.	beiliwu@simm.ac.cn	Stevens, Raymond/K-7272-2015; Cherezov, Vadim/L-9812-2013; Han, Gye Won/GLT-1531-2022; Han, Gye Won/GLQ-8673-2022; Han, Gye Won/GLQ-8724-2022	Stevens, Raymond/0000-0002-4522-8725; Cherezov, Vadim/0000-0002-5265-3914; Han, Gye Won/0000-0003-4107-835X; Kufareva, Irina/0000-0001-9083-7039	National Basic Research Program of China [2012CB518000, 2012CB910400]; NIH [R01 AI100604, U54 GM094618]; National Science Foundation of China [31270766, 81161120425, 81025017]; Shanghai Science and Technology Committee [11JC1414800, 12PJ1410500];  [U01 GM094612];  [R01 GM071872]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI100604] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM094618, U01GM094612, R01GM071872] Funding Source: NIH RePORTER	National Basic Research Program of China(National Basic Research Program of China); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Science and Technology Committee(Shanghai Science & Technology Committee); ; ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank I. Wilson, V. Katritch, and T. Handel for careful review and scientific feedback on the manuscript; A. Walker for assistance with manuscript preparation; C. Wang and D. Wacker for help on collection of x-ray diffraction data; and E. Kellenberger for providing the CCR5 model. Atomic coordinates and structure facors have been deposited in the Protein Data Bank with identification code 4MBS. This work was supported by "National Basic Research Program of China" grants 2012CB518000 and 2012CB910400; NIH grant R01 AI100604; National Science Foundation of China grants 31270766, 81161120425, and 81025017; and Shanghai Science and Technology Committee grants 11JC1414800 and 12PJ1410500. Additionally, V.C. and R.C.S. acknowledge support from NIH grant U54 GM094618 (Target GPCR-28); I.K. acknowledges support from U01 GM094612, U54 GM094618, and R01 GM071872. The data presented in this paper are tabulated in the main paper and in the supplementary materials.	Baggiolini M, 1998, NATURE, V392, P565, DOI 10.1038/33340; Berger EA, 1999, ANNU REV IMMUNOL, V17, P657, DOI 10.1146/annurev.immunol.17.1.657; Biscone MJ, 2006, VIROLOGY, V351, P226, DOI 10.1016/j.virol.2006.03.017; Blanpain C, 1999, BLOOD, V94, P1899; Blanpain C, 2003, J BIOL CHEM, V278, P5179, DOI 10.1074/jbc.M205684200; Brelot A, 2000, J BIOL CHEM, V275, P23736, DOI 10.1074/jbc.M000776200; Cardozo T, 2007, AIDS RES HUM RETROV, V23, P415, DOI 10.1089/aid.2006.0130; Chien EYT, 2010, SCIENCE, V330, P1091, DOI 10.1126/science.1197410; Coakley E, 2005, CURR OPIN INFECT DIS, V18, P9, DOI 10.1097/00001432-200502000-00003; Duma L, 2007, J MOL BIOL, V365, P1063, DOI 10.1016/j.jmb.2006.10.040; FDA notifications, 2007, AIDS ALERT, V22, P103; Garcia-Perez J, 2011, J BIOL CHEM, V286, P33409, DOI 10.1074/jbc.M111.279596; Garcia-Perez J, 2011, J BIOL CHEM, V286, P4978, DOI 10.1074/jbc.M110.168955; Gerard C, 2001, NAT IMMUNOL, V2, P108, DOI 10.1038/84209; Huang CC, 2007, SCIENCE, V317, P1930, DOI 10.1126/science.1145373; Imamura S, 2006, J MED CHEM, V49, P2784, DOI 10.1021/jm051034q; Katritch V, 2013, ANNU REV PHARMACOL, V53, P531, DOI 10.1146/annurev-pharmtox-032112-135923; Muniz-Medina VM, 2009, MOL PHARMACOL, V75, P490, DOI 10.1124/mol.108.052555; Palani A, 2006, J MED CHEM, V49, P2851, DOI 10.1021/jm060009x; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Scholten DJ, 2012, BRIT J PHARMACOL, V165, P1617, DOI 10.1111/j.1476-5381.2011.01551.x; Speck RF, 1997, J VIROL, V71, P7136, DOI 10.1128/JVI.71.9.7136-7139.1997; Stanfield RL, 2006, J VIROL, V80, P6093, DOI 10.1128/JVI.00205-06; Watson C, 2005, MOL PHARMACOL, V67, P1268, DOI 10.1124/mol.104.008565; Wu BL, 2010, SCIENCE, V330, P1066, DOI 10.1126/science.1194396; Xiang SH, 2013, VIROLOGY, V438, P5, DOI 10.1016/j.virol.2013.01.002	27	499	522	7	307	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 20	2013	341	6152					1387	1390		10.1126/science.1241475	http://dx.doi.org/10.1126/science.1241475			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	220PK	24030490	Green Accepted			2022-12-24	WOS:000324597200045
J	Wang, C; Liu, Q				Wang, Chen; Liu, Qian			A turning point for clinical research in China?	LANCET			English	Editorial Material									[Wang, Chen] Beijing Hosp, Beijing Inst Resp Med, Natl Clin Res Ctr Resp Dis, Beijing 100730, Peoples R China; [Wang, Chen; Liu, Qian] Natl Hlth & Family Planning Commiss Peoples Repub, Beijing, Peoples R China	Beijing Hospital	Wang, C (corresponding author), Beijing Hosp, Beijing Inst Resp Med, Natl Clin Res Ctr Resp Dis, Beijing 100730, Peoples R China.	cyh-birm@263.net						Clive K, 2012, CHEST, V141, pe419S; Wang C, 2010, CHEST, V137, P254, DOI 10.1378/chest.09-0765; Yang GH, 2013, LANCET, V381, P1987, DOI 10.1016/S0140-6736(13)61097-1; Yuan HF, 2013, LANCET, V381, pE4, DOI 10.1016/S0140-6736(13)60174-9	4	17	22	0	12	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 7	2013	382	9895					835	836		10.1016/S0140-6736(13)61804-8	http://dx.doi.org/10.1016/S0140-6736(13)61804-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	215WE	24012257				2022-12-24	WOS:000324240700005
J	Anderson, JS; Rittle, J; Peters, JC				Anderson, John S.; Rittle, Jonathan; Peters, Jonas C.			Catalytic conversion of nitrogen to ammonia by an iron model complex	NATURE			English	Article							MOLECULAR NITROGEN; REDUCTION; MOLYBDENUM; DINITROGEN; N-2; HYDROGENATION; MECHANISM; TRANSFORMATION; CLEAVAGE; CARBON	The reduction of nitrogen (N-2) to ammonia (NH3) is a requisite transformation for life(1). Although it is widely appreciated that the iron-rich cofactors of nitrogenase enzymes facilitate this transformation(2-5), how they do so remains poorly understood. A central element of debate has been the exact site or sites of N-2 coordination and reduction(6,7). In synthetic inorganic chemistry, an early emphasis was placed on molybdenum(8) because it was thought to be an essential element of nitrogenases(3) and because it had been established that well-defined molybdenum model complexes could mediate the stoichiometric conversion of N-2 to NH3 (ref. 9). This chemical transformation can be performed in a catalytic fashion by two well-defined molecular systems that feature molybdenum centres(10,11). However, it is now thought that iron is the only transition metal essential to all nitrogenases(3), and recent biochemical and spectroscopic data have implicated iron instead of molybdenum as the site of N-2 binding in the FeMo-cofactor(12). Here we describe a tris(phosphine) borane-supported iron complex that catalyses the reduction of N-2 to NH3 under mild conditions, and in which more than 40 per cent of the proton and reducing equivalents are delivered to N-2. Our results indicate that a single iron site may be capable of stabilizing the various NxHy intermediates generated during catalytic NH3 formation. Geometric tunability at iron imparted by a flexible iron-boron interaction in our model system seems to be important for efficient catalysis(13-15). We propose that the interstitial carbon atom recently assigned in the nitrogenase cofactor may have a similar role(16,17), perhaps by enabling a single iron site to mediate the enzymatic catalysis through a flexible iron-carbon interaction(18).	[Anderson, John S.; Rittle, Jonathan; Peters, Jonas C.] CALTECH, Div Chem & Chem Engn, Pasadena, CA 91125 USA	California Institute of Technology	Peters, JC (corresponding author), CALTECH, Div Chem & Chem Engn, Pasadena, CA 91125 USA.	jpeters@caltech.edu	Anderson, John/ABF-3019-2021	Anderson, John/0000-0002-0730-3018	NIH [GM 070757]; Gordon and Betty Moore Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM070757] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the NIH (GM 070757) and the Gordon and Betty Moore Foundation. A. Takaoka is thanked for developing the calibration curves used for ammonia and hydrazine quantification. D. Rees and D. Newman are acknowledged for many discussions.	Anderson JS, 2013, J AM CHEM SOC, V135, P534, DOI 10.1021/ja307714m; Arashiba K, 2011, NAT CHEM, V3, P120, DOI 10.1038/NCHEM.906; BELL LG, 1970, J AM CHEM SOC, V92, P4464, DOI 10.1021/ja00717a059; BROOKHART M, 1992, ORGANOMETALLICS, V11, P3920, DOI 10.1021/om00059a071; Burgess BK, 1996, CHEM REV, V96, P2983, DOI 10.1021/cr950055x; CHATT J, 1978, CHEM REV, V78, P589, DOI 10.1021/cr60316a001; Crossland J. L., 2011, COORDIN CHEM REV, V255, P949; Eady RR, 1996, CHEM REV, V96, P3013, DOI 10.1021/cr950057h; Fong H, 2013, ORGANOMETALLICS, V32, P3053, DOI 10.1021/om400281v; Fryzuk MD, 1997, SCIENCE, V275, P1445, DOI 10.1126/science.275.5305.1445; Hall DA, 1996, J CHEM SOC DALTON, P3539, DOI 10.1039/dt9960003539; Hendrich MP, 2006, P NATL ACAD SCI USA, V103, P17107, DOI 10.1073/pnas.0604402103; HILLS A, 1993, J CHEM SOC DALTON, P3041, DOI 10.1039/dt9930003041; Hoffman BM, 2009, ACCOUNTS CHEM RES, V42, P609, DOI 10.1021/ar8002128; Howard JB, 2006, P NATL ACAD SCI USA, V103, P17088, DOI 10.1073/pnas.0603978103; KERN RJ, 1962, J INORG NUCL CHEM, V24, P1105, DOI 10.1016/0022-1902(62)80255-3; Lancaster KM, 2011, SCIENCE, V334, P974, DOI 10.1126/science.1206445; Lee Y, 2010, NAT CHEM, V2, P558, DOI [10.1038/NCHEM.660, 10.1038/nchem.660]; Moret ME, 2011, J AM CHEM SOC, V133, P18118, DOI 10.1021/ja208675p; Moret ME, 2011, ANGEW CHEM INT EDIT, V50, P2063, DOI 10.1002/anie.201006918; Peters J. C., 2006, ACTIVATION SMALL MOL, P81; PICKETT CJ, 1985, NATURE, V317, P652, DOI 10.1038/317652a0; Pool JA, 2004, NATURE, V427, P527, DOI 10.1038/nature02274; Rodriguez MM, 2011, SCIENCE, V334, P780, DOI 10.1126/science.1211906; Schrock RR, 2011, NAT CHEM, V3, P95, DOI 10.1038/nchem.977; Schwarz G, 2009, NATURE, V460, P839, DOI 10.1038/nature08302; Seefeldt LC, 2009, ANNU REV BIOCHEM, V78, P701, DOI 10.1146/annurev.biochem.78.070907.103812; SHILOV A, 1971, NATURE, V231, P460, DOI 10.1038/231460a0; Smil V., 2001, ENRICHING THE EARTH; Spatzal T, 2011, SCIENCE, V334, P940, DOI 10.1126/science.1214025; WEATHERBURN MW, 1967, ANAL CHEM, V39, P971, DOI 10.1021/ac60252a045; WEITZ IS, 1993, J CHEM SOC PERK T 1, P117, DOI 10.1039/p19930000117; Yandulov DV, 2002, J AM CHEM SOC, V124, P6252, DOI 10.1021/ja020186x; Yandulov DV, 2003, SCIENCE, V301, P76, DOI 10.1126/science.1085326; Yuki M, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2264	35	673	675	22	1004	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 5	2013	501	7465					84	+		10.1038/nature12435	http://dx.doi.org/10.1038/nature12435			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	211ER	24005414	Green Accepted, Green Published			2022-12-24	WOS:000323888300036
J	Kunisaki, Y; Bruns, I; Scheiermann, C; Ahmed, J; Pinho, S; Zhang, DC; Mizoguchi, T; Wei, QZ; Lucas, D; Ito, K; Mar, JC; Bergman, A; Frenette, PS				Kunisaki, Yuya; Bruns, Ingmar; Scheiermann, Christoph; Ahmed, Jalal; Pinho, Sandra; Zhang, Dachuan; Mizoguchi, Toshihide; Wei, Qiaozhi; Lucas, Daniel; Ito, Keisuke; Mar, Jessica C.; Bergman, Aviv; Frenette, Paul S.			Arteriolar niches maintain haematopoietic stem cell quiescence	NATURE			English	Article							SELF-RENEWAL; PROGENITOR CELLS; EXPRESSION; MICRODOMAINS; OSTEOPONTIN; COMPONENT; DORMANCY; POOL	Cell cycle quiescence is a critical feature contributing to haematopoietic stem cell (HSC) maintenance. Although various candidate stromal cells have been identified as potential HSC niches, the spatial localization of quiescent HSCs in the bone marrow remains unclear. Here, using a novel approach that combines whole-mount confocal immunofluorescence imaging techniques and computational modelling to analyse significant three-dimensional associations in the mouse bone marrow among vascular structures, stromal cells and HSCs, we show that quiescent HSCs associate specifically with small arterioles that are preferentially found in endosteal bone marrow. These arterioles are ensheathed exclusively by rare NG2 (also known as CSPG4)(+) pericytes, distinct from sinusoid-associated leptin receptor (LEPR)(+) cells. Pharmacological or genetic activation of the HSC cell cycle alters the distribution of HSCs from NG2(+) periarteriolar niches to LEPR+ perisinusoidal niches. Conditional depletion of NG2(+) cells induces HSC cycling and reduces functional long-term repopulating HSCs in the bone marrow. These results thus indicate that arteriolar niches are indispensable for maintaining HSC quiescence.	[Kunisaki, Yuya; Bruns, Ingmar; Scheiermann, Christoph; Ahmed, Jalal; Pinho, Sandra; Zhang, Dachuan; Mizoguchi, Toshihide; Wei, Qiaozhi; Lucas, Daniel; Ito, Keisuke; Frenette, Paul S.] Albert Einstein Coll Med, Ruth L & David S Gottesman Inst Stem Cell & Regen, Bronx, NY 10461 USA; [Kunisaki, Yuya; Bruns, Ingmar; Scheiermann, Christoph; Pinho, Sandra; Zhang, Dachuan; Mizoguchi, Toshihide; Wei, Qiaozhi; Ito, Keisuke; Frenette, Paul S.] Albert Einstein Coll Med, Dept Cell Biol, Bronx, NY 10461 USA; [Bruns, Ingmar] Univ Dusseldorf, Dept Hematol Oncol & Clin Immunol, D-40225 Dusseldorf, Germany; [Ahmed, Jalal] Mt Sinai Sch Med, New York, NY 10029 USA; [Lucas, Daniel; Ito, Keisuke; Frenette, Paul S.] Albert Einstein Coll Med, Dept Med, Bronx, NY 10461 USA; [Mar, Jessica C.; Bergman, Aviv] Albert Einstein Coll Med, Dept Syst & Computat Biol, Bronx, NY 10461 USA; [Mar, Jessica C.] Albert Einstein Coll Med, Dept Epidemiol & Populat Hlth, Bronx, NY 10461 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Heinrich Heine University Dusseldorf; Icahn School of Medicine at Mount Sinai; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Frenette, PS (corresponding author), Albert Einstein Coll Med, Ruth L & David S Gottesman Inst Stem Cell & Regen, Bronx, NY 10461 USA.	paul.frenette@einstein.yu.edu	Lucas, Daniel/ABB-6893-2021; Pinho, Sandra/GWC-8029-2022; Frenette, Paul S/J-8272-2012; Zhang, Dachuan/GZA-8781-2022; Scheiermann, Christoph/B-8261-2014	Lucas, Daniel/0000-0002-0147-5425; Frenette, Paul S/0000-0003-0862-9922; Scheiermann, Christoph/0000-0002-9212-0995; Zhang, Dachuan/0000-0002-1746-275X; Bruns, Ingmar/0000-0001-6316-8378; Mar, Jessica/0000-0002-5147-9299; Pinho, Sandra/0000-0002-5241-7364	New York Stem Cell Foundation-Druckenmiller Fellowship; German Research Foundation (DFG) (Emmy-Noether-Program); National Institutes of Health (R01 grants) [DK056638, HL069438, HL097700];  [T32 063754]; NATIONAL CANCER INSTITUTE [R00CA139009] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL116340, R01HL069438, R01HL097700] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK056638, R01DK100689, R01DK098263] Funding Source: NIH RePORTER	New York Stem Cell Foundation-Druckenmiller Fellowship; German Research Foundation (DFG) (Emmy-Noether-Program)(German Research Foundation (DFG)); National Institutes of Health (R01 grants); ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank P. P. Pandolfi for providing Pml<SUP>-/-</SUP> mice and D. Rowe, J. Butler and S. Rafii for providing Col2.3-GFP mice. We are grateful to L. Tesfa and O. Uche for technical assistance with sorting. S. P. is supported by a New York Stem Cell Foundation-Druckenmiller Fellowship and C. S. by the German Research Foundation (DFG) (Emmy-Noether-Program). J. A. was supported by Training Grant T32 063754. This work was enabled by the National Institutes of Health (R01 grants DK056638, HL069438, HL097700) to P.S.F.	Arai F, 2004, CELL, V118, P149, DOI 10.1016/j.cell.2004.07.004; Baldridge MT, 2010, NATURE, V465, P793, DOI 10.1038/nature09135; Bhattacharya D, 2009, J EXP MED, V206, P2837, DOI 10.1084/jem.20090778; Birbrair A, 2013, STEM CELL RES, V10, P67, DOI 10.1016/j.scr.2012.09.003; Calvi LM, 2003, NATURE, V425, P841, DOI 10.1038/nature02040; Cheng T, 2000, SCIENCE, V287, P1804, DOI 10.1126/science.287.5459.1804; Chi JT, 2003, P NATL ACAD SCI USA, V100, P10623, DOI 10.1073/pnas.1434429100; Chiang EY, 2007, NAT METHODS, V4, P219, DOI 10.1038/nmeth1018; Ding L, 2013, NATURE, V495, P231, DOI 10.1038/nature11885; Ding L, 2012, NATURE, V481, P457, DOI 10.1038/nature10783; Eaves C. J., 2008, CURR PROTOC IMMUNOL, V22; Ema H, 2012, BLOOD, V120, P2174, DOI 10.1182/blood-2012-04-424507; Essers MAG, 2009, NATURE, V458, P904, DOI 10.1038/nature07815; Frenette PS, 2013, ANNU REV IMMUNOL, V31, P285, DOI 10.1146/annurev-immunol-032712-095919; Greenbaum AM, 2011, LEUKEMIA, V25, P211, DOI 10.1038/leu.2010.248; Greenbaum A, 2013, NATURE, V495, P227, DOI 10.1038/nature11926; Hooper AT, 2009, CELL STEM CELL, V4, P263, DOI 10.1016/j.stem.2009.01.006; Hsu YC, 2011, CELL, V144, P92, DOI 10.1016/j.cell.2010.11.049; Ito K, 2008, NATURE, V453, P1072, DOI 10.1038/nature07016; Kalajzic Z, 2002, BONE, V31, P654, DOI 10.1016/S8756-3282(02)00912-2; Katayama Y, 2006, CELL, V124, P407, DOI 10.1016/j.cell.2005.10.041; Kawamoto T, 2003, ARCH HISTOL CYTOL, V66, P123, DOI 10.1679/aohc.66.123; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Li LH, 2010, SCIENCE, V327, P542, DOI 10.1126/science.1180794; Li XM, 2009, CIRCULATION, V120, P1910, DOI 10.1161/CIRCULATIONAHA.109.871574; Liu FL, 2008, J CLIN INVEST, V118, P946, DOI 10.1172/JCI32704; Mendez-Ferrer S, 2008, NATURE, V452, P442, DOI 10.1038/nature06685; Mendez-Ferrer S, 2010, NATURE, V466, P829, DOI 10.1038/nature09262; Mignone JL, 2004, J COMP NEUROL, V469, P311, DOI 10.1002/cne.10964; Naveiras O, 2009, NATURE, V460, P259, DOI 10.1038/nature08099; Nilsson SK, 2005, BLOOD, V106, P1232, DOI 10.1182/blood-2004-11-4422; Nombela-Arrieta C, 2013, NAT CELL BIOL, V15, P533, DOI 10.1038/ncb2730; Omatsu Y, 2010, IMMUNITY, V33, P387, DOI 10.1016/j.immuni.2010.08.017; Orford KW, 2008, NAT REV GENET, V9, P115, DOI 10.1038/nrg2269; Orkin SH, 2008, CELL, V132, P631, DOI 10.1016/j.cell.2008.01.025; Passegue E, 2005, J EXP MED, V202, P1599, DOI 10.1084/jem.20050967; Sato T, 2009, NAT MED, V15, P696, DOI 10.1038/nm.1973; Shen ZM, 2012, NAT METHODS, V9, P273, DOI [10.1038/NMETH.1857, 10.1038/nmeth.1857]; Sipkins DA, 2005, NATURE, V435, P969, DOI 10.1038/nature03703; Stier S, 2005, J EXP MED, V201, P1781, DOI 10.1084/jem.20041992; Sugimura R, 2012, CELL, V150, P351, DOI 10.1016/j.cell.2012.05.041; Sugiyama T, 2006, IMMUNITY, V25, P977, DOI 10.1016/j.immuni.2006.10.016; Takaku T, 2010, BLOOD, V116, pE41, DOI 10.1182/blood-2010-02-268466; Wilson A, 2008, CELL, V135, P1118, DOI 10.1016/j.cell.2008.10.048; Winkler IG, 2012, NAT MED, V18, P1651, DOI 10.1038/nm.2969; Yamazaki S, 2011, CELL, V147, P1146, DOI 10.1016/j.cell.2011.09.053; Zhang JW, 2003, NATURE, V425, P836, DOI 10.1038/nature02041; Zhu XQ, 2011, DEVELOPMENT, V138, P745, DOI 10.1242/dev.047951	48	776	795	7	94	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 31	2013	502	7473					637	+		10.1038/nature12612	http://dx.doi.org/10.1038/nature12612			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243CC	24107994	Green Accepted			2022-12-24	WOS:000326293200038
J	Guenther, UP; Yandek, LE; Niland, CN; Campbell, FE; Anderson, D; Anderson, VE; Harris, ME; Jankowsky, E				Guenther, Ulf-Peter; Yandek, Lindsay E.; Niland, Courtney N.; Campbell, Frank E.; Anderson, David; Anderson, Vernon E.; Harris, Michael E.; Jankowsky, Eckhard			Hidden specificity in an apparently nonspecific RNA-binding protein	NATURE			English	Article							RIBONUCLEASE-P; TRANSCRIPTION FACTORS; QUANTITATIVE-ANALYSIS; ENZYME SPECIFICITY; LANDSCAPES; HOLOENZYME; KINETICS; SEQUENCE; RECOGNITION; CATALYSIS	Nucleic-acid-binding proteins are generally viewed as either specific or nonspecific, depending on characteristics of their binding sites in DNA or RNA(1,2). Most studies have focused on specific proteins, which identify cognate sites by binding with highest affinities to regions with defined signatures in sequence, structure or both(1-4). Proteins that bind to sites devoid of defined sequence or structure signatures are considered nonspecific(1,2,5). Substrate binding by these proteins is poorly understood, and it is not known to what extent seemingly nonspecific proteins discriminate between different binding sites, aside from those sequestered by nucleic acid structures(6). Here we systematically examine substrate binding by the apparently nonspecific RNA-binding protein C5, and find clear discrimination between different binding site variants. C5 is the protein subunit of the transfer RNA processing ribonucleoprotein enzyme RNase P from Escherichia coli. The protein binds 59 leaders of precursor tRNAs at a site without sequence or structure signatures. We measure functional binding of C5 to all possible sequence variants in its substrate binding site, using a high-throughput sequencing kinetics approach (HITS-KIN) that simultaneously follows processing of thousands of RNA species. C5 binds different substrate variants with affinities varying by orders of magnitude. The distribution of functional affinities of C5 for all substrate variants resembles affinity distributions of highly specific nucleic acid binding proteins. Unlike these specific proteins, C5 does not bind its physiological RNA targets with the highest affinity, but with affinities near the median of the distribution, a region that is not associated with a sequence signature. We delineate defined rules governing substrate recognition by C5, which reveal specificity that is hidden in cellular substrates for RNase P. Our findings suggest that apparently nonspecific and specific RNA-binding modes may not differ fundamentally, but represent distinct parts of common affinity distributions.	[Guenther, Ulf-Peter; Campbell, Frank E.; Jankowsky, Eckhard] Case Western Reserve Univ, Ctr RNA Mol Biol, Cleveland, OH 44106 USA; [Guenther, Ulf-Peter; Yandek, Lindsay E.; Niland, Courtney N.; Anderson, Vernon E.; Harris, Michael E.; Jankowsky, Eckhard] Case Western Reserve Univ, Sch Med, Dept Biochem, Cleveland, OH 44106 USA; [Anderson, David] CUNY, Baruch Coll, Zicklin Sch Business, Dept Management, New York, NY 10010 USA	Case Western Reserve University; Case Western Reserve University; City University of New York (CUNY) System; Baruch College (CUNY)	Harris, ME (corresponding author), Case Western Reserve Univ, Sch Med, Dept Biochem, Cleveland, OH 44106 USA.	meh2@case.edu; exj13@case.edu	Anderson, Vernon/W-2673-2019	Anderson, Vernon Emmett/0000-0002-1699-7621; Jankowsky, Eckhard/0000-0001-7677-7412	US National Institutes of Health (NIH) [GM067700, GM099720, CSTA UL1RR024989, GM056740, GM096000, T32 GM008056]; DFG; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000439] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024989] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067700, R01GM099720, T32GM008056, R01GM096000, R01GM056740] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DFG(German Research Foundation (DFG)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We particularly thank T. Nilsen for comments on the manuscript. We are grateful to G. Stormo for discussion, M. Adams for support with the Illumina sequencing, and H.-C. Lin for technical assistance. This work was supported by the US National Institutes of Health (NIH) (GM067700, GM099720 and CSTA UL1RR024989 to E.J.; GM056740 and GM096000 to M.E.H.; T32 GM008056 to C.N.N.). U.-P.G. received a DFG fellowship.	Badis G, 2009, SCIENCE, V324, P1720, DOI 10.1126/science.1162327; BENDEL RB, 1977, J AM STAT ASSOC, V72, P46, DOI 10.2307/2286904; Campbell ZT, 2012, CELL REP, V1, P570, DOI 10.1016/j.celrep.2012.04.003; CHA S, 1968, MOL PHARMACOL, V4, P621; Chan PP, 2009, NUCLEIC ACIDS RES, V37, pD93, DOI 10.1093/nar/gkn787; Christian EL, 1998, BIOCHEMISTRY-US, V37, P17618, DOI 10.1021/bi982050a; Cleland WW, 2006, ISOTOPE EFFECTS CHEM, P915; CORNISHBOWDEN A, 1984, J THEOR BIOL, V108, P451, DOI 10.1016/S0022-5193(84)80045-4; Fersht A., 1985, ENZYME STRUCTURE MEC; Forsdyke DR, 2007, J THEOR BIOL, V248, P745, DOI 10.1016/j.jtbi.2007.07.008; Guo X, 2006, J MOL BIOL, V360, P190, DOI 10.1016/j.jmb.2006.05.001; Gupta A, 2011, J MOL BIOL, V409, P574, DOI 10.1016/j.jmb.2011.04.007; HERSCHLAG D, 1988, BIOORG CHEM, V16, P62, DOI 10.1016/0045-2068(88)90038-7; Kurz JC, 2000, CURR OPIN CHEM BIOL, V4, P553, DOI 10.1016/S1367-5931(00)00131-9; LaRiviere FJ, 2001, SCIENCE, V294, P165, DOI 10.1126/science.1064242; Leontis NB, 2006, CURR OPIN STRUC BIOL, V16, P279, DOI 10.1016/j.sbi.2006.05.009; Lorenz C, 2010, NUCLEIC ACIDS RES, V38, P3794, DOI 10.1093/nar/gkq032; Maerkl SJ, 2007, SCIENCE, V315, P233, DOI 10.1126/science.1131007; Northrop DB, 1999, ADV ENZYMOL RAMB, V73, P25, DOI 10.1002/9780470123195.ch2; NORTHROP DB, 1983, ANAL BIOCHEM, V132, P457, DOI 10.1016/0003-2697(83)90034-9; Nutiu R, 2011, NAT BIOTECHNOL, V29, P659, DOI 10.1038/nbt.1882; Pitt JN, 2010, SCIENCE, V330, P376, DOI 10.1126/science.1192001; Ray D, 2009, NAT BIOTECHNOL, V27, P667, DOI 10.1038/nbt.1550; Reiter NJ, 2010, NATURE, V468, P784, DOI 10.1038/nature09516; Rowe W, 2010, J R SOC INTERFACE, V7, P397, DOI 10.1098/rsif.2009.0193; Rueda D, 2005, BIOCHEMISTRY-US, V44, P16130, DOI 10.1021/bi0519093; SantaLucia J, 1997, BIOPOLYMERS, V44, P309, DOI 10.1002/(SICI)1097-0282(1997)44:3<309::AID-BIP8>3.3.CO;2-Y; SCHELLENBERGER V, 1993, BIOCHEMISTRY-US, V32, P4344, DOI 10.1021/bi00067a025; Singh R, 2005, NAT STRUCT MOL BIOL, V12, P645, DOI 10.1038/nsmb961; Smith JK, 2007, BIOPOLYMERS, V87, P329, DOI 10.1002/bip.20846; Snoussi K, 2001, BIOCHEMISTRY-US, V40, P8898, DOI 10.1021/bi010385d; Stormo GD, 2010, NAT REV GENET, V11, P751, DOI 10.1038/nrg2845; STORMO GD, 1986, NUCLEIC ACIDS RES, V14, P6661, DOI 10.1093/nar/14.16.6661; Sun L, 2010, J MOL BIOL, V395, P1019, DOI 10.1016/j.jmb.2009.11.027; VONHIPPEL PH, 1986, P NATL ACAD SCI USA, V83, P1608; Zhao Y, 2011, NAT BIOTECHNOL, V29, P480, DOI 10.1038/nbt.1893; Zhuang FL, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gkr1263	38	63	63	2	57	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 17	2013	502	7471					385	+		10.1038/nature12543	http://dx.doi.org/10.1038/nature12543			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	235GY	24056935	Green Accepted			2022-12-24	WOS:000325706300056
J	Wilson, MA; Kwon, Y; Xu, YY; Chung, WH; Chi, P; Niu, HY; Mayle, R; Chen, XF; Malkova, A; Sung, P; Ira, G				Wilson, Marenda A.; Kwon, YoungHo; Xu, Yuanyuan; Chung, Woo-Hyun; Chi, Peter; Niu, Hengyao; Mayle, Ryan; Chen, Xuefeng; Malkova, Anna; Sung, Patrick; Ira, Grzegorz			Pif1 helicase and Pol delta promote recombination-coupled DNA synthesis via bubble migration	NATURE			English	Article							BREAK-INDUCED REPLICATION; SACCHAROMYCES-CEREVISIAE; POLYMERASE-DELTA; HOMOLOGOUS RECOMBINATION; RAD51-MEDIATED RECOMBINATION; MITOTIC RECOMBINATION; HALF-CROSSOVERS; YEAST; PROTEINS; RAD51	During DNA repair by homologous recombination (HR), DNA synthesis copies information from a template DNA molecule. Multiple DNA polymerases have been implicated in repair-specific DNA synthesis(1-3), but it has remained unclear whether a DNA helicase is involved in this reaction. A good candidate DNA helicase is Pif1, an evolutionarily conserved helicase in Saccharomyces cerevisiae important for break-induced replication (BIR)(4) as well as HR-dependent telomere maintenance in the absence of telomerase(5) found in 10-15% of all cancers(6). Pif1 has a role in DNA synthesis across hard-to-replicate sites(7,8) and in lagging-strand synthesis with polymerase delta (Pol delta)(9-11). Here we provide evidence that Pif1 stimulates DNA synthesis during BIR and crossover recombination. The initial steps of BIR occur normally in Pif1-deficient cells, but Pol delta recruitment and DNA synthesis are decreased, resulting in premature resolution of DNA intermediates into half-crossovers. Purified Pif1 protein strongly stimulates Pol delta-mediated DNA synthesis from a D-loop made by the Rad51 recombinase. Notably, Pif1 liberates the newly synthesized strand to prevent the accumulation of topological constraint and to facilitate extensive DNA synthesis via the establishment of a migrating D-loop structure. Our results uncover a novel function of Pif1 and provide insights into the mechanism of HR.	[Wilson, Marenda A.; Chung, Woo-Hyun; Mayle, Ryan; Chen, Xuefeng; Ira, Grzegorz] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Kwon, YoungHo; Xu, Yuanyuan; Niu, Hengyao; Sung, Patrick] Yale Univ, Sch Med, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA; [Chung, Woo-Hyun] Duksung Womens Univ, Coll Pharm, Seoul 132714, South Korea; [Chi, Peter] Natl Taiwan Univ, Inst Biochem Sci, Taipei 10617, Taiwan; [Chi, Peter] Acad Sinica, Inst Biol Chem, Taipei 115, Taiwan; [Malkova, Anna] IUPUI, Sch Sci, Dept Biol, Indianapolis, IN 46202 USA	Baylor College of Medicine; Yale University; Duksung Women's University; National Taiwan University; Academia Sinica - Taiwan; Indiana University System; Indiana University-Purdue University Indianapolis	Ira, G (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, 1 Baylor Plaza, Houston, TX 77030 USA.	patrick.sung@yale.edu; gira@bcm.edu	Niu, Hengyao/B-5026-2014; Niu, Hengyao/AAE-9269-2020; Huang, Wenchi/F-3981-2010; Chi, Peter/AAI-1580-2019	Huang, Wenchi/0000-0001-5556-1460; Chi, Peter/0000-0001-9229-8729; Wilson, Marenda/0000-0003-1610-1044	US National Institutes of Health [GM080600, ES007061, GM057814, ES015632, GM084242, T32GM07526-34]; National Research Foundation of Korea [NRF-2012R1A1A1009917]; Academia Sinica; National Taiwan University; National Science Council of Taiwan; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R03ES016434, R01ES015632, R01ES007061] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007526, T32GM008307, R01GM080600, R01GM084242, R01GM057814] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Research Foundation of Korea(National Research Foundation of Korea); Academia Sinica(Academia Sinica - Taiwan); National Taiwan University(National Taiwan University); National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank V. Zakian, K. Labib, W.-D. Heyer, J. Haber, C. Wittenberg, R. Johnson and L. Prakash for the gift of antibodies, strains or plasmids, and D. Camerini-Otero for providing DinG. We are grateful to J. Griffith and S. Wilcox for training in metal shadowing electron microscopy. This work was funded by grants from the US National Institutes of Health (GM080600 to G.I.; ES007061, GM057814, ES015632 to P.S., GM084242 to A.M., T32GM07526-34 to M.A.W.), National Research Foundation of Korea (NRF-2012R1A1A1009917), Academia Sinica, National Taiwan University, and the National Science Council of Taiwan.	Acharya N, 2011, P NATL ACAD SCI USA, V108, P17927, DOI 10.1073/pnas.1109981108; Bochman ML, 2010, DNA REPAIR, V9, P237, DOI 10.1016/j.dnarep.2010.01.008; Boule JB, 2007, NUCLEIC ACIDS RES, V35, P5809, DOI 10.1093/nar/gkm613; Budd ME, 2006, MOL CELL BIOL, V26, P2490, DOI 10.1128/MCB.26.7.2490-2500.2006; Burgers PMJ, 1998, J BIOL CHEM, V273, P19756, DOI 10.1074/jbc.273.31.19756; Busygina V, 2008, GENE DEV, V22, P786, DOI 10.1101/gad.1638708; Cesare AJ, 2010, NAT REV GENET, V11, P319, DOI 10.1038/nrg2763; Chung WH, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000948; Deem A, 2008, GENETICS, V179, P1845, DOI 10.1534/genetics.108.087940; Dewar JM, 2010, EMBO J, V29, P4020, DOI 10.1038/emboj.2010.267; Ferguson DO, 1996, P NATL ACAD SCI USA, V93, P5419, DOI 10.1073/pnas.93.11.5419; FORMOSA T, 1986, CELL, V47, P793, DOI 10.1016/0092-8674(86)90522-2; GRIFFITH JD, 1978, ANNU REV BIOPHYS BIO, V7, P19, DOI 10.1146/annurev.bb.07.060178.000315; Hastings PJ, 2009, NAT REV GENET, V10, P551, DOI 10.1038/nrg2593; Ho CK, 2010, MOL CELL, V40, P988, DOI 10.1016/j.molcel.2010.11.016; Ira G, 2003, CELL, V115, P401, DOI 10.1016/S0092-8674(03)00886-9; Janke R, 2010, NUCLEIC ACIDS RES, V38, P2302, DOI 10.1093/nar/gkp1222; Li X, 2009, MOL CELL, V36, P704, DOI 10.1016/j.molcel.2009.09.036; Lydeard JR, 2007, NATURE, V448, P820, DOI 10.1038/nature06047; Malkova A, 2000, P NATL ACAD SCI USA, V97, P14500, DOI 10.1073/pnas.97.26.14500; Malkova A, 2013, CURR OPIN GENET DEV, V23, P271, DOI 10.1016/j.gde.2013.05.007; Maloisel L, 2008, MOL CELL BIOL, V28, P1373, DOI 10.1128/MCB.01651-07; Paeschke K, 2011, CELL, V145, P678, DOI 10.1016/j.cell.2011.04.015; Petukhova G, 1998, NATURE, V393, P91, DOI 10.1038/30037; Pike JE, 2009, J BIOL CHEM, V284, P25170, DOI 10.1074/jbc.M109.023325; Prakash R, 2009, GENE DEV, V23, P67, DOI 10.1101/gad.1737809; Raschle M, 2004, J BIOL CHEM, V279, P51973, DOI 10.1074/jbc.M410101200; Rossi ML, 2008, J BIOL CHEM, V283, P27483, DOI 10.1074/jbc.M804550200; Sabouri N, 2012, GENE DEV, V26, P581, DOI 10.1101/gad.184697.111; SCHULZ VP, 1994, CELL, V76, P145, DOI 10.1016/0092-8674(94)90179-1; Sebesta M, 2011, DNA REPAIR, V10, P567, DOI 10.1016/j.dnarep.2011.03.003; Smith CE, 2009, MOL CELL BIOL, V29, P1432, DOI 10.1128/MCB.01469-08; Sugawara N, 2003, MOL CELL, V12, P209, DOI 10.1016/S1097-2765(03)00269-7; Sugiyama T, 1997, J BIOL CHEM, V272, P7940, DOI 10.1074/jbc.272.12.7940; Van Komen S, 2002, J BIOL CHEM, V277, P43578, DOI 10.1074/jbc.M205864200; Van Komen S, 2006, METHOD ENZYMOL, V408, P445, DOI 10.1016/S0076-6879(06)08028-1; Wang X, 2004, MOL CELL BIOL, V24, P6891, DOI 10.1128/MCB.24.16.6891-6899.2004; Zierhut C, 2008, EMBO J, V27, P1875, DOI 10.1038/emboj.2008.111	38	212	215	1	59	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 17	2013	502	7471					393	+		10.1038/nature12585	http://dx.doi.org/10.1038/nature12585			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	235GY	24025768	Green Accepted			2022-12-24	WOS:000325706300058
J	Behar, M; Barken, D; Werner, SL; Hoffmann, A				Behar, Marcelo; Barken, Derren; Werner, Shannon L.; Hoffmann, Alexander			The Dynamics of Signaling as a Pharmacological Target	CELL			English	Article							NF-KAPPA-B; GENE-EXPRESSION; TEMPORAL CONTROL; CELL FATE; KINASE; SPECIFICITY; INHIBITION; ACTIVATION; INFLAMMATION; MECHANISMS	Highly networked signaling hubs are often associated with disease, but targeting them pharmacologically has largely been unsuccessful in the clinic because of their functional pleiotropy. Motivated by the hypothesis that a dynamic signaling code confers functional specificity, we investigated whether dynamic features may be targeted pharmacologically to achieve therapeutic specificity. With a virtual screen, we identified combinations of signaling hub topologies and dynamic signal profiles that are amenable to selective inhibition. Mathematical analysis revealed principles that may guide stimulus-specific inhibition of signaling hubs, even in the absence of detailed mathematical models. Using the NFkB signaling module as a test bed, we identified perturbations that selectively affect the response to cytokines or pathogen components. Together, our results demonstrate that the dynamics of signaling may serve as a pharmacological target, and we reveal principles that delineate the opportunities and constraints of developing stimulus-specific therapeutic agents aimed at pleiotropic signaling hubs.	[Behar, Marcelo; Barken, Derren; Werner, Shannon L.; Hoffmann, Alexander] Univ Calif San Diego, Dept Chem & Biochem, Signaling Syst Lab, La Jolla, CA 92093 USA; [Behar, Marcelo; Hoffmann, Alexander] Univ Calif San Diego, San Diego Ctr Syst Biol, La Jolla, CA 92093 USA; [Behar, Marcelo; Hoffmann, Alexander] Univ Calif Los Angeles, Computat Biosci Inst, Los Angeles, CA 90025 USA; [Behar, Marcelo; Hoffmann, Alexander] Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90025 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Hoffmann, A (corresponding author), Univ Calif San Diego, Dept Chem & Biochem, Signaling Syst Lab, La Jolla, CA 92093 USA.	ahoffmann@ucla.edu			NIH [P50 GM085764, R01 GM 089976, R01 GM072024, R01 CA141722, R01 GM071573]; Cancer Research Institute; NATIONAL CANCER INSTITUTE [R01CA141722] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM071862, R01GM089976, R01GM072024, R01GM071573, P50GM085764] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Research Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We acknowledge helpful discussions with members of the San Diego Center of Systems Biology, critical reading by P. Loriaux (UCSD), and helpful suggestions by an anonymous reviewer. The work presented here was supported by grants from the NIH P50 GM085764, R01 GM 089976, R01 GM072024, R01 CA141722, R01 GM071573, and a postdoctoral research fellowship from the Cancer Research Institute.	Bardwell L, 2006, BIOCHEM SOC T, V34, P837, DOI 10.1042/BST0340837; Becker V, 2012, ADV EXP MED BIOL, V736, P313, DOI 10.1007/978-1-4419-7210-1_18; Behar M, 2007, P NATL ACAD SCI USA, V104, P16146, DOI 10.1073/pnas.0703894104; Behar M, 2013, BIOPHYS J, V105, P231, DOI 10.1016/j.bpj.2013.05.013; Behar M, 2010, CURR OPIN GENET DEV, V20, P684, DOI 10.1016/j.gde.2010.09.007; Berger SI, 2011, WIRES SYST BIOL MED, V3, P129, DOI 10.1002/wsbm.114; Bitterman PB, 2012, CELL CYCLE, V11, P1097, DOI 10.4161/cc.11.6.19610; Brennan P, 1996, BIOCHEM J, V320, P975, DOI 10.1042/bj3200975; Chalmers CJ, 2007, CELL SIGNAL, V19, P695, DOI 10.1016/j.cellsig.2006.09.001; Chavali S, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-78; Cohen P, 2002, NAT REV DRUG DISCOV, V1, P309, DOI 10.1038/nrd773; DiDonato JA, 2012, IMMUNOL REV, V246, P379, DOI 10.1111/j.1600-065X.2012.01099.x; Force T, 2007, NAT REV CANCER, V7, P332, DOI 10.1038/nrc2106; Frelin C, 2005, BLOOD, V105, P804, DOI 10.1182/blood-2004-04-1463; Gandhi TKB, 2006, NAT GENET, V38, P285, DOI 10.1038/ng1747; Gao C, 2010, CELL SIGNAL, V22, P717, DOI 10.1016/j.cellsig.2009.11.021; Ghoreschi K, 2009, NAT IMMUNOL, V10, P356, DOI 10.1038/ni.1701; Haney S, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-119; Hao N, 2008, J BIOL CHEM, V283, P33798, DOI 10.1074/jbc.C800179200; Hoffmann A, 2006, IMMUNOL REV, V210, P171, DOI 10.1111/j.0105-2896.2006.00375.x; Hoffmann A, 2002, SCIENCE, V298, P1241, DOI 10.1126/science.1071914; Karin M, 2008, CELL RES, V18, P334, DOI 10.1038/cr.2008.30; Kearns JD, 2006, J CELL BIOL, V173, P659, DOI 10.1083/jcb.200510155; KLUSSMANN E, 2008, PROTEIN PROTEIN INTE; Komarova NL, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100031; Kubota H, 2012, MOL CELL, V46, P820, DOI 10.1016/j.molcel.2012.04.018; Lin WW, 2007, J CLIN INVEST, V117, P1175, DOI 10.1172/JCI31537; Ma'ayan A, 2007, MT SINAI J MED, V74, P27, DOI 10.1002/msj.20002; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; Oda K, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100057; Park SH, 2003, SCIENCE, V299, P1061, DOI 10.1126/science.1076979; Purvis JE, 2013, CELL, V152, P945, DOI 10.1016/j.cell.2013.02.005; Purvis JE, 2012, SCIENCE, V336, P1440, DOI 10.1126/science.1218351; Roering Michael, 2012, Critical Reviews in Oncogenesis, V17, P97; Schneider A, 2012, BIOESSAYS, V34, P542, DOI 10.1002/bies.201100172; Schrofelbauer B, 2012, MOL CELL, V47, P111, DOI 10.1016/j.molcel.2012.04.020; Seki E, 2012, GASTROENTEROLOGY, V143, P307, DOI 10.1053/j.gastro.2012.06.004; Sung MH, 2004, MOL PHARMACOL, V66, P70, DOI 10.1124/mol.66.1.70; Sung MH, 2008, MOL PHARMACOL, V74, P1215, DOI 10.1124/mol.108.049114; Weinberg RA, 2007, BIOL CANC; Werner SL, 2005, SCIENCE, V309, P1857, DOI 10.1126/science.1113319; Zalatan JG, 2012, SCIENCE, V337, P1218, DOI 10.1126/science.1220683; Zhang X, 2008, TRENDS BIOTECHNOL, V26, P295, DOI 10.1016/j.tibtech.2008.02.008	43	94	96	0	35	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 10	2013	155	2					448	461		10.1016/j.cell.2013.09.018	http://dx.doi.org/10.1016/j.cell.2013.09.018			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	235LH	24120141	Green Accepted, Bronze			2022-12-24	WOS:000325719800020
J	Loh, E; Kugelberg, E; Tracy, A; Zhang, Q; Gollan, B; Ewles, H; Chalmers, R; Pelicic, V; Tang, CM				Loh, Edmund; Kugelberg, Elisabeth; Tracy, Alexander; Zhang, Qian; Gollan, Bridget; Ewles, Helen; Chalmers, Ronald; Pelicic, Vladimir; Tang, Christoph M.			Temperature triggers immune evasion by Neisseria meningitidis	NATURE			English	Article							POLYSIALIC ACID CAPSULE; UPPER RESPIRATORY-TRACT; INFLUENZA-A; VIRUS-INFECTION; BIOSYNTHESIS; GENES; COMPLEMENT; MECHANISMS; EXPRESSION; RESISTANCE	Neisseria meningitidis has several strategies to evade complement-mediated killing, and these contribute to its ability to cause septicaemic disease and meningitis. However, the meningococcus is primarily an obligate commensal of the human nasopharynx, and it is unclear why the bacterium has evolved exquisite mechanisms to avoid host immunity. Here we demonstrate that mechanisms of meningococcal immune evasion and resistance against complement increase in response to an increase in ambient temperature. We have identified three independent RNA thermosensors located in the 5' untranslated regions of genes necessary for capsule biosynthesis, the expression of factor H binding protein, and sialylation of lipopolysaccharide, which are essential for meningococcal resistance against immune killing(1,2). Therefore increased temperature (which occurs during inflammation) acts as a 'danger signal' for the meningococcus, enhancing its defence against human immune killing. Infection with viral pathogens, such as influenza, leads to inflammation in the nasopharynx with an increased temperature and recruitment of immune effectors(3,4). Thermoregulation of immune defence could offer an adaptive advantage to the meningococcus during co-infection with other pathogens, and promote the emergence of virulence in an otherwise commensal bacterium.	[Loh, Edmund; Tracy, Alexander; Tang, Christoph M.] Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England; [Kugelberg, Elisabeth; Zhang, Qian; Gollan, Bridget; Ewles, Helen; Pelicic, Vladimir; Tang, Christoph M.] Univ London Imperial Coll Sci Technol & Med, Ctr Mol Microbiol & Infect, London SW7 2AZ, England; [Chalmers, Ronald] Univ Nottingham, Sch Biomed Sci, Nottingham NG7 2NR, England	University of Oxford; Imperial College London; University of Nottingham	Tang, CM (corresponding author), Univ Oxford, Sir William Dunn Sch Pathol, Sir Parks Rd, Oxford OX1 3RE, England.	christoph.tang@path.ox.ac.uk	Pelicic, Vladimir/N-3755-2017; Pelicic, Vladimir/ABD-3102-2021	Pelicic, Vladimir/0000-0002-9456-4995; Pelicic, Vladimir/0000-0002-9456-4995; Tracy, Alexander/0000-0003-4109-3568; Loh, Edmund/0000-0001-7050-566X; Kugelberg, Elisabeth/0000-0002-8302-3595; chalmers, ronald/0000-0002-1395-7173	Wellcome Trust; Medical Research Council; Oxford Martin School; Swedish Research Council [524-2010-6726]; EMBO; MRC [MR/J006874/1, G0900888] Funding Source: UKRI; Medical Research Council [G0900888] Funding Source: researchfish	Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Oxford Martin School; Swedish Research Council(Swedish Research CouncilEuropean Commission); EMBO(European Molecular Biology Organization (EMBO)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Work in C.M.T.'s laboratory is funded by Programme Grants from the Wellcome Trust and the Medical Research Council, and by the Oxford Martin School. E. L. was supported by an International Postdoctoral fellowship from the Swedish Research Council (Dnr: 524-2010-6726) and E. K. was supported by an EMBO long-term fellowship. We are grateful to J. Johansson, S. Busby and other members of the Tang group for discussions, and to B. Kallipolitis for providing E. coli 30S ribosomes.	BJORNSON AB, 1991, AM REV RESPIR DIS, V143, P1062, DOI 10.1164/ajrccm/143.5_Pt_1.1062; Bohme K, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002518; CARTWRIGHT KAV, 1991, LANCET, V338, P554, DOI 10.1016/0140-6736(91)91112-8; Chalmers RM, 1996, EMBO J, V15, P5112, DOI 10.1002/j.1460-2075.1996.tb00892.x; COLE P, 1954, J Laryngol Otol, V68, P295, DOI 10.1017/S0022215100049690; GANGULI S, 1994, J BACTERIOL, V176, P4583, DOI 10.1128/JB.176.15.4583-4589.1994; Gentile D, 1998, CLIN DIAGN LAB IMMUN, V5, P604, DOI 10.1128/CDLI.5.5.604-608.1998; HAMMERSCHMIDT S, 1994, MOL MICROBIOL, V11, P885, DOI 10.1111/j.1365-2958.1994.tb00367.x; HOE NP, 1993, J BACTERIOL, V175, P7901, DOI 10.1128/JB.175.24.7901-7909.1993; Johansson J, 2002, CELL, V110, P551, DOI 10.1016/S0092-8674(02)00905-4; Uria MJ, 2008, J EXP MED, V205, P1423, DOI 10.1084/jem.20072577; Kahler CM, 1998, INFECT IMMUN, V66, P5939, DOI 10.1128/IAI.66.12.5939-5947.1998; Kugelberg E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009413; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; Lijek RS, 2012, CURR OPIN IMMUNOL, V24, P417, DOI 10.1016/j.coi.2012.05.005; Morita M, 1999, J BACTERIOL, V181, P401, DOI 10.1128/JB.181.2.401-410.1999; Rameix-Welti MA, 2009, INFECT IMMUN, V77, P3588, DOI 10.1128/IAI.00155-09; Schneider MC, 2007, TRENDS MICROBIOL, V15, P233, DOI 10.1016/j.tim.2007.03.005; Schneider MC, 2006, J IMMUNOL, V176, P7566, DOI 10.4049/jimmunol.176.12.7566; Schneider MC, 2009, NATURE, V458, P890, DOI 10.1038/nature07769; Stephens DS, 2007, LANCET, V369, P2196, DOI 10.1016/S0140-6736(07)61016-2; STEPHENS DS, 1993, J INFECT DIS, V167, P475, DOI 10.1093/infdis/167.2.475; Tzeng YL, 2001, INFECT IMMUN, V69, P2502, DOI 10.1128/IAI.69.4.2502-2511.2001; van der Ende A, 2000, INFECT IMMUN, V68, P6685, DOI 10.1128/IAI.68.12.6685-6690.2000; von Loewenich FD, 2001, INT J MED MICROBIOL, V291, P361, DOI 10.1078/1438-4221-00142	25	99	99	3	51	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 10	2013	502	7470					237	+		10.1038/nature12616	http://dx.doi.org/10.1038/nature12616			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231RU	24067614	Green Accepted			2022-12-24	WOS:000325436100051
J	Arnheim-Dahlstom, L; Pasternak, B; Svanstrom, H; Sparen, P; Hviid, A				Arnheim-Dahlstrom, Lisen; Pasternak, Bjorn; Svanstrom, Henrik; Sparen, Par; Hviid, Anders			Autoimmune, neurological, and venous thromboembolic adverse events after immunisation of adolescent girls with quadrivalent human papillomavirus vaccine in Denmark and Sweden: cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							SAFETY; REGISTER; SURVEILLANCE; METAANALYSIS; EXPERIENCE; CHILDHOOD; DISEASES	Objective To assess the risk of serious adverse events after vaccination of adolescent girls with quadrivalent human papillomavirus (qHPV) vaccine. Design Register based cohort study. Setting Denmark and Sweden, October 2006 to December 2010. Participants 997 585 girls aged 10-17, among whom 296 826 received a total of 696 420 qHPV vaccine doses. Main outcome measures Incident hospital diagnosed autoimmune, neurological, and venous thromboembolic events (53 different outcomes) up to 180 days after each qHPV vaccine dose. Only events with at least five vaccine exposed cases were considered for further assessment. Rate ratios adjusted for age, country, calendar year, and parental country of birth, education, and socioeconomic status were estimated, comparing vaccinated and unvaccinated person time. For outcomes where the rate ratio was significantly increased, we regarded three criteria as signal strengthening: analysis based on 20 or more vaccine exposed cases (reliability), rate ratio 3.0 or more (strength), and significantly increased rate ratio in country specific analyses (consistency). We additionally assessed clustering of events in time and estimated rate ratios for a risk period that started on day 181. Results Among the 53 outcomes, at least five vaccine exposed cases occurred in 29 and these were analysed further. Whereas the rate ratios for 20 of 23 autoimmune events were not significantly increased, exposure to qHPV vaccine was significantly associated with Behcet's syndrome, Raynaud's disease, and type 1 diabetes. Each of these three outcomes fulfilled only one of three predefined signal strengthening criteria. Furthermore, the pattern of distribution in time after vaccination was random for all three and the rate ratios for these outcomes in the period from day 181 after vaccination were similar to the rate ratios in the primary risk period. The rate ratios for five neurological events were not significantly increased and there were inverse associations with epilepsy (rate ratio 0.66, 95% confidence interval 0.54 to 0.80) and paralysis (0.56, 0.35 to 0.90). There was no association between exposure to qHPV vaccine and venous thromboembolism (0.86, 0.55 to 1.36). Conclusions This large cohort study found no evidence supporting associations between exposure to qHPV vaccine and autoimmune, neurological, and venous thromboembolic adverse events. Although associations for three autoimmune events were initially observed, on further assessment these were weak and not temporally related to vaccine exposure. Furthermore, the findings need to be interpreted considering the multiple outcomes assessed.	[Arnheim-Dahlstrom, Lisen; Sparen, Par] Karolinska Inst, Dept Med Epidemiol & Biostat, S-17177 Stockholm, Sweden; [Pasternak, Bjorn; Svanstrom, Henrik; Hviid, Anders] Statens Serum Inst, Dept Epidemiol Res, DK-2300 Copenhagen, Denmark	Karolinska Institutet; Statens Serum Institut	Arnheim-Dahlstom, L (corresponding author), Karolinska Inst, Dept Med Epidemiol & Biostat, S-17177 Stockholm, Sweden.	lisen.arnheim.dahlstrom@ki.se	Hviid, Anders/AAH-4319-2020; Pasternak, Bjorn/H-5739-2012	Hviid, Anders/0000-0002-7509-9127; Pasternak, Bjorn/0000-0002-2097-8466; Sparen, Par/0000-0002-5184-8971	Swedish Foundation for Strategic Research; Danish Medical Research Council	Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This study was supported by a grant from the Swedish Foundation for Strategic Research and the Danish Medical Research Council. The funding bodies had no role in the study design; the collection, analysis, and interpretation of the data; the writing of the article; and the decision to submit it for publication. All authors are independent from the funding agencies.	Block SL, 2010, PEDIATR INFECT DIS J, V29, P95, DOI 10.1097/INF.0b013e3181b77906; Callreus T, 2009, VACCINE, V27, P2954, DOI 10.1016/j.vaccine.2009.02.106; Chao C, 2012, J INTERN MED, V271, P193, DOI 10.1111/j.1365-2796.2011.02467.x; Chao C, 2012, HUM VACC IMMUNOTHER, V8, P1302, DOI 10.4161/hv.21268; Descamps D, 2009, HUM VACCINES, V5, P332, DOI 10.4161/hv.5.5.7211; Farrington CP, 1996, AM J EPIDEMIOL, V143, P1165; Fridman Simard S, 2013, J NATL CANC IN PRESS; Gee J, 2011, VACCINE, V29, P8279, DOI 10.1016/j.vaccine.2011.08.106; Hviid A, 2006, EXPERT REV VACCINES, V5, P641, DOI 10.1586/14760584.5.5.641; Kildemoes HW, 2011, SCAND J PUBLIC HEALT, V39, P38, DOI 10.1177/1403494810394717; Klein NP, 2012, ARCH PEDIAT ADOL MED, V166, P1140, DOI 10.1001/archpediatrics.2012.1451; Laz TH, 2012, VACCINE, V30, P3534, DOI 10.1016/j.vaccine.2012.03.067; Lu BB, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-13; Ludvigsson JF, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-450; Ludvigsson JF, 2009, EUR J EPIDEMIOL, V24, P659, DOI 10.1007/s10654-009-9350-y; Lynge E, 2011, SCAND J PUBLIC HEALT, V39, P30, DOI 10.1177/1403494811401482; Medical Products Agency, OCC NARC CAT CHILDR; Medical Products Agency, 2012, VACC HUM PAP HPV VAC; Nohynek H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033536; Pedersen CB, 2006, DAN MED BULL, V53, P441; Rasmussen TA, 2012, BRIT MED J, V345, DOI 10.1136/bmj.e5823; Salmon DA, 2013, LANCET, V381, P1461, DOI 10.1016/S0140-6736(12)62189-8; Siegrist CA, 2007, CAN MED ASSOC J, V177, P1352, DOI 10.1503/cmaj.071134; Slade BA, 2009, JAMA-J AM MED ASSOC, V302, P750, DOI 10.1001/jama.2009.1201; Trim K, 2012, OBSTET GYNECOL INT, V2012, DOI 10.1155/2012/921236; van't Klooster TM, 2011, VACCINE, V29, P4601, DOI 10.1016/j.vaccine.2011.04.050; Wettermark B, 2007, PHARMACOEPIDEM DR S, V16, P726, DOI 10.1002/pds.1294; Wraith DC, 2003, LANCET, V362, P1659, DOI 10.1016/S0140-6736(03)14802-7	28	178	186	0	20	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 9	2013	347								f5906	10.1136/bmj.f5906	http://dx.doi.org/10.1136/bmj.f5906			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	235ON	24108159	Green Published, hybrid			2022-12-24	WOS:000325729100007
J	Herzog, BH; Fu, JX; Wilson, SJ; Hess, PR; Sen, A; McDaniel, JM; Pan, YF; Sheng, MJ; Yago, T; Silasi-Mansat, R; McGee, S; May, F; Nieswandt, B; Morris, AJ; Lupu, F; Coughlin, SR; McEver, RP; Chen, H; Kahn, ML; Xia, LJ				Herzog, Brett H.; Fu, Jianxin; Wilson, Stephen J.; Hess, Paul R.; Sen, Aslihan; McDaniel, J. Michael; Pan, Yanfang; Sheng, Minjia; Yago, Tadayuki; Silasi-Mansat, Robert; McGee, Samuel; May, Frauke; Nieswandt, Bernhard; Morris, Andrew J.; Lupu, Florea; Coughlin, Shaun R.; McEver, Rodger P.; Chen, Hong; Kahn, Mark L.; Xia, Lijun			Podoplanin maintains high endothelial venule integrity by interacting with platelet CLEC-2	NATURE			English	Article							VASCULAR INTEGRITY; STROMAL CELLS; VE-CADHERIN; LYMPH-NODES; MICE; SPHINGOSINE-1-PHOSPHATE; LYMPHOCYTES; SELECTIN; MOUSE; BLOOD	Circulating lymphocytes continuously enter lymph nodes for immune surveillance through specialized blood vessels named high endothelial venules(1-5), a process that increases markedly during immune responses. How high endothelial venules (HEVs) permit lymphocyte transmigration while maintaining vascular integrity is unknown. Here we report a role for the transmembrane O-glycoprotein podoplanin (PDPN, also known as gp38 and T1 alpha)(6-8) in maintaining HEV barrier function. Mice with postnatal deletion of Pdpn lost HEV integrity and exhibited spontaneous bleeding in mucosal lymph nodes, and bleeding in the draining peripheral lymph nodes after immunization. Blocking lymphocyte homing rescued bleeding, indicating that PDPN is required to protect the barrier function of HEVs during lymphocyte trafficking. Further analyses demonstrated that PDPN expressed on fibroblastic reticular cells(7), which surround HEVs, functions as an activating ligand for platelet C-type lectin-like receptor 2 (CLEC-2, also known as CLEC1B)(9,10). Mice lacking fibroblastic reticular cell PDPN or platelet CLEC-2 exhibited significantly reduced levels of VE-cadherin (also known as CDH5), which is essential for overall vascular integrity(11,12), on HEVs. Infusion of wild-type platelets restored HEV integrity in Clec-2-deficient mice. Activation of CLEC-2 induced release of sphingosine-1-phosphate(13,14) from platelets, which promoted expression of VE-cadherin on HEVs ex vivo. Furthermore, draining peripheral lymph nodes of immunized mice lacking sphingosine-1-phosphate had impaired HEV integrity similar to Pdpn- and Clec-2-deficient mice. These data demonstrate that local sphingosine-1-phosphate release after PDPN-CLEC-2-mediated platelet activation is critical for HEV integrity during immune responses.	[Herzog, Brett H.; Fu, Jianxin; McDaniel, J. Michael; Pan, Yanfang; Sheng, Minjia; Yago, Tadayuki; Silasi-Mansat, Robert; McGee, Samuel; Lupu, Florea; McEver, Rodger P.; Chen, Hong; Xia, Lijun] Oklahoma Med Res Fdn, Cardiovasc Biol Res Program, Oklahoma City, OK 73104 USA; [Herzog, Brett H.; Pan, Yanfang; McEver, Rodger P.; Chen, Hong; Xia, Lijun] Univ Oklahoma, Hlth Sci Ctr, Dept Biochem & Mol Biol, Oklahoma City, OK 73104 USA; [Fu, Jianxin; Xia, Lijun] Soochow Univ, Affiliated Hosp 1, Jiangsu Inst Hematol, Suzhou 215006, Jiangsu, Peoples R China; [Fu, Jianxin; Xia, Lijun] Soochow Univ, Affiliated Hosp 1, Minist Hlth, Key Lab Thrombosis & Hemostasis, Suzhou 215006, Jiangsu, Peoples R China; [Wilson, Stephen J.; Coughlin, Shaun R.] Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94158 USA; [Hess, Paul R.; Sen, Aslihan; Kahn, Mark L.] Univ Penn, Dept Med, Philadelphia, PA 19104 USA; [Hess, Paul R.; Sen, Aslihan; Kahn, Mark L.] Univ Penn, Div Cardiol, Philadelphia, PA 19104 USA; [May, Frauke; Nieswandt, Bernhard] Univ Hosp Wurzburg, D-97080 Wurzburg, Germany; [May, Frauke; Nieswandt, Bernhard] DFG Res Ctr Expt Biomed, Rudolf Virchow Ctr, D-97080 Wurzburg, Germany; [Morris, Andrew J.] Univ Kentucky, Div Cardiovasc Med, Lexington, KY 40502 USA; [Morris, Andrew J.] Lexington Vet Affairs Med Ctr, Lexington, KY 40502 USA	Oklahoma Medical Research Foundation; University of Oklahoma System; University of Oklahoma Health Sciences Center; Soochow University - China; Soochow University - China; University of California System; University of California San Francisco; University of Pennsylvania; University of Pennsylvania; University of Wurzburg; German Research Foundation (DFG); University of Wurzburg; University of Kentucky; US Department of Veterans Affairs; Veterans Health Administration (VHA); Lexington VA Medical Center	Xia, LJ (corresponding author), Oklahoma Med Res Fdn, Cardiovasc Biol Res Program, Oklahoma City, OK 73104 USA.	Lijun-Xia@omrf.org	Lupu, Florea/AAV-3257-2021; Lupu, Florea/C-3162-2009	Lupu, Florea/0000-0003-1249-9278; Lupu, Florea/0000-0003-1249-9278; Fu, Jianxin/0000-0002-3067-8539; Silasi, Robert/0000-0001-9590-6160	National Institutes of Health [GM103441, GM097747, HL085607, HL093242, HL103432, HL065590, HL112788]; VA Merit Award [BX001984]; American Heart Association [SDG7410022]; Deutsche Forschungsgemeinschaft [SFB688]; National Natural Science Foundation of China [30928010]; Jiangsu Provincial Special Program of Medical Science [BL2012005]; Jiangsu Province's Key Medical Center [ZX201102]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR024598, P20RR018758] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL093242, P01HL085607, R01HL065590, R01HL103432, R01HL112788] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103441, P20GM103527, R01GM097747] Funding Source: NIH RePORTER; Veterans Affairs [I01BX001984] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); VA Merit Award(US Department of Veterans Affairs); American Heart Association(American Heart Association); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jiangsu Provincial Special Program of Medical Science; Jiangsu Province's Key Medical Center; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Veterans Affairs(US Department of Veterans Affairs)	We thank P. Kincade and L. Thompson for critical reading of the manuscript; R. Adams for providing PdgfrbCre mice; and M. Kinter and M. C. Marlin for technical assistance. Work was supported by grants from the National Institutes of Health (GM103441, GM097747, HL085607, HL093242, HL103432, HL065590, HL112788), VA Merit Award (BX001984), the American Heart Association (SDG7410022), the Deutsche Forschungsgemeinschaft (SFB688), National Natural Science Foundation of China (30928010), Jiangsu Provincial Special Program of Medical Science (BL2012005) and Jiangsu Province's Key Medical Center (ZX201102).	Bergmeier W, 2002, CYTOMETRY, V48, P80, DOI 10.1002/cyto.10114; Bertozzi CC, 2010, BLOOD, V116, P661, DOI 10.1182/blood-2010-02-270876; Boulaftali Y, 2013, J CLIN INVEST, V123, P908, DOI 10.1172/JCI65154; BreitenederGeleff S, 1997, AM J PATHOL, V151, P1141; Butcher EC, 1996, SCIENCE, V272, P60, DOI 10.1126/science.272.5258.60; Camerer E, 2009, J CLIN INVEST, V119, P1871, DOI 10.1172/JCI38575; Carmeliet P, 1999, CELL, V98, P147, DOI 10.1016/S0092-8674(00)81010-7; Chyou S, 2008, J IMMUNOL, V181, P3887, DOI 10.4049/jimmunol.181.6.3887; Dejana E, 2009, DEV CELL, V16, P209, DOI 10.1016/j.devcel.2009.01.004; Diacovo TG, 1996, SCIENCE, V273, P252, DOI 10.1126/science.273.5272.252; Drayton DL, 2006, NAT IMMUNOL, V7, P344, DOI 10.1038/ni1330; FARR AG, 1992, J EXP MED, V176, P1477, DOI 10.1084/jem.176.5.1477; Foo SS, 2006, CELL, V124, P161, DOI 10.1016/j.cell.2005.10.034; Fu JX, 2008, J CLIN INVEST, V118, P3725, DOI 10.1172/JCI36077; Gaengel K, 2012, DEV CELL, V23, P587, DOI 10.1016/j.devcel.2012.08.005; GALLATIN WM, 1983, NATURE, V304, P30, DOI 10.1038/304030a0; Girard JP, 2012, NAT REV IMMUNOL, V12, P762, DOI 10.1038/nri3298; Goerge T, 2008, BLOOD, V111, P4958, DOI 10.1182/blood-2007-11-123620; Gretz JE, 1997, IMMUNOL REV, V156, P11, DOI 10.1111/j.1600-065X.1997.tb00955.x; Han ED, 2002, J CLIN INVEST, V109, P1057, DOI 10.1172/JCI200214211; Hayashi S, 2002, DEV BIOL, V244, P305, DOI 10.1006/dbio.2002.0597; Hodivala-Dilke KM, 1999, J CLIN INVEST, V103, P229, DOI 10.1172/JCI5487; Kamala T, 2007, J IMMUNOL METHODS, V328, P204, DOI 10.1016/j.jim.2007.08.004; Katakai T, 2004, J EXP MED, V200, P783, DOI 10.1084/jem.20040254; Kisanuki YY, 2001, DEV BIOL, V230, P230, DOI 10.1006/dbio.2000.0106; Lampugnani MG, 2003, J CELL BIOL, V161, P793, DOI 10.1083/jcb.200209019; Lou JZ, 2006, J CELL BIOL, V174, P1107, DOI 10.1083/jcb.200606056; May F, 2009, BLOOD, V114, P3464, DOI 10.1182/blood-2009-05-222273; MOMBAERTS P, 1992, CELL, V68, P869, DOI 10.1016/0092-8674(92)90030-G; Pappu R, 2007, SCIENCE, V316, P295, DOI 10.1126/science.1139221; Renz H, 2012, NAT REV IMMUNOL, V12, P9, DOI 10.1038/nri3112; Rosen SD, 2004, ANNU REV IMMUNOL, V22, P129, DOI 10.1146/annurev.immunol.21.090501.080131; Selim S, 2011, CLIN SCI, V121, P565, DOI 10.1042/CS20110236; Soderberg KA, 2005, P NATL ACAD SCI USA, V102, P16315, DOI 10.1073/pnas.0506190102; Ulrych T, 2011, J THROMB HAEMOST, V9, P790, DOI 10.1111/j.1538-7836.2011.04194.x; von Andrian UH, 2003, NAT REV IMMUNOL, V3, P867, DOI 10.1038/nri1222; Watson SP, 2010, J THROMB HAEMOST, V8, P1457, DOI 10.1111/j.1538-7836.2010.03875.x; Xia LJ, 2002, J CLIN INVEST, V109, P939	38	210	222	4	57	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 3	2013	502	7469					105	+		10.1038/nature12501	http://dx.doi.org/10.1038/nature12501			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	227IM	23995678	Green Submitted, Green Accepted			2022-12-24	WOS:000325106000040
J	Ross, JS; Kesselheim, AS				Ross, Joseph S.; Kesselheim, Aaron S.			Prescription-Drug Coupons - No Such Thing as a Free Lunch	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material								Many websites for brand-name drugs available in the United States contain links to drug coupons. But since many are for medications for which lower-cost alternatives are available, this marketing practice threatens to increase societal costs in the long run. Visit nearly any official website for a brand-name drug available in the United States and, mixed in with links to prescribing and safety information, you'll find links to drug coupons, including copayment-assistance programs and monthly savings cards. Most offers are variations on Why pay more? With the [drug] savings card, you can get [drug] for only $18 per prescription if eligible or Get a free 30-capsule trial of [drug] with your doctor's prescription and ask your doctor if [drug] is right for you. Why do manufacturers offer drug coupons? Are they good for patients in the long run? Are they ...	[Ross, Joseph S.] Yale Univ, Sch Med, Gen Internal Med Sect, New Haven, CT 06520 USA; [Ross, Joseph S.] Yale Univ, Sch Med, Robert Wood Johnson Clin Scholars Program, New Haven, CT USA; [Ross, Joseph S.] Yale New Haven Med Ctr, Ctr Outcomes Res & Evaluat, New Haven, CT 06504 USA; [Kesselheim, Aaron S.] Brigham & Womens Hosp, Dept Med, Div Pharmacoepidemiol & Pharmacoecon, Boston, MA 02115 USA; [Kesselheim, Aaron S.] Harvard Univ, Sch Med, Boston, MA USA	Yale University; Yale University; Yale University; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Ross, JS (corresponding author), Yale Univ, Sch Med, Gen Internal Med Sect, New Haven, CT 06520 USA.			Ross, Joseph/0000-0002-9218-3320				Grande D, 2012, JAMA-J AM MED ASSOC, V307, P2375, DOI 10.1001/jama.2012.5603; IMS Institute for Healthcare Informatics, 2012, US MED US REV 2011; Kravitz RL, 2005, JAMA-J AM MED ASSOC, V294, P2436; Kravitz RL, 2005, JAMA-J AM MED ASSOC, V293, P1995, DOI 10.1001/jama.293.16.1995; Pharmaceutical Care Management Association, 2011, COP COUP COULD RAIS; Shrank WH, 2010, HEALTH AFFAIR, V29, P1383, DOI 10.1377/hlthaff.2009.0424	6	51	51	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 26	2013	369	13					1188	1189		10.1056/NEJMp1301993	http://dx.doi.org/10.1056/NEJMp1301993			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	224LT	23984672				2022-12-24	WOS:000324888200003
J	Hawkes, N				Hawkes, Nigel			Hospitals without walls	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												nigel.hawkes1@btinternet.com						Future Hospital Programme, 2013, FUT HOSP COMM	1	9	9	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 12	2013	347								f5479	10.1136/bmj.f5479	http://dx.doi.org/10.1136/bmj.f5479			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	219SU	24030563				2022-12-24	WOS:000324530500008
J	Feenstra, B; Geller, F; Carstensen, L; Romitti, PA; Korberg, IB; Bedell, B; Krogh, C; Fan, RZ; Svenningsson, A; Caggana, M; Nordenskjold, A; Mills, JL; Murray, JC; Melbye, M				Feenstra, Bjarke; Geller, Frank; Carstensen, Lisbeth; Romitti, Paul A.; Korberg, Izabella Baranowska; Bedell, Bruce; Krogh, Camilla; Fan, Ruzong; Svenningsson, Anna; Caggana, Michele; Nordenskjold, Agneta; Mills, James L.; Murray, Jeffrey C.; Melbye, Mads			Plasma Lipids, Genetic Variants Near APOA1, and the Risk of Infantile Hypertrophic Pyloric Stenosis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							INTERSTITIAL-CELLS; CHOLESTEROL; ASSOCIATION; EPIDEMIOLOGY; METAANALYSIS; NERVES; CAJAL	IMPORTANCE Infantile hypertrophic pyloric stenosis (IHPS) is a serious condition in which hypertrophy of the pyloric sphincter muscle layer leads to gastric outlet obstruction. Infantile hypertrophic pyloric stenosis shows strong familial aggregation and heritability, but knowledge about specific genetic risk variants is limited. OBJECTIVES To search the genome comprehensively for genetic associations with IHPS and validate findings in 3 independent sample sets. DESIGN, SETTING, AND PARTICIPANTS During stage 1, we used reference data from the 1000 Genomes Project for imputation into a genome-wide data set of 1001 Danish surgery-confirmed samples (cases diagnosed 1987-2008) and 2371 disease-free controls. In stage 2, the 5 most significantly associated loci were tested in independent case-control sample sets from Denmark (cases diagnosed 1983-2010), Sweden (cases diagnosed 1958-2011), and the United States (cases diagnosed 1998-2005), with a total of 1663 cases and 2315 controls. MAIN OUTCOMES AND MEASURES Association of genetic variation with the presence of infantile hypertrophic pyloric stenosis. RESULTS We found a new genome-wide significant locus for IHPS at chromosome 11q23.3. The single-nucleotide polymorphism (SNP) with the lowest P value at the locus, rs12721025 (odds ratio [OR], 1.59; 95% CI, 1.38-1.83; P = 1.9 x 10(-10)), is located 301 bases downstream of the apolipoprotein A-I (APOA1) gene and is correlated (r(2) between 0.46 and 0.80) with SNPs previously found to be associated with levels of circulating cholesterol. For these SNPs, the cholesterol-lowering allele consistently was associated with increased risk of IHPS. CONCLUSIONS AND RELEVANCE This study identified a new genome-wide significant locus for IHPS. Characteristics of this locus suggest the possibility of an inverse relationship between levels of circulating cholesterol in neonates and IHPS risk, which warrants further investigation.	[Feenstra, Bjarke; Geller, Frank; Carstensen, Lisbeth; Krogh, Camilla; Melbye, Mads] Statens Serum Inst, Dept Epidemiol Res, DK-2300 Copenhagen S, Denmark; [Romitti, Paul A.] Univ Iowa, Dept Epidemiol, Iowa City, IA USA; [Korberg, Izabella Baranowska; Svenningsson, Anna; Nordenskjold, Agneta] Karolinska Inst, Dept Womens & Childrens Hlth, Stockholm, Sweden; [Korberg, Izabella Baranowska; Svenningsson, Anna; Nordenskjold, Agneta] Karolinska Inst, Ctr Mol Med, Stockholm, Sweden; [Bedell, Bruce; Murray, Jeffrey C.] Univ Iowa, Dept Pediat, Iowa City, IA 52242 USA; [Fan, Ruzong; Mills, James L.] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, NIH, Bethesda, MD USA; [Caggana, Michele] New York State Dept Hlth, Wadsworth Ctr, Albany, NY 12237 USA	Statens Serum Institut; University of Iowa; Karolinska Institutet; Karolinska Institutet; University of Iowa; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); State University of New York (SUNY) System; Wadsworth Center	Feenstra, B (corresponding author), Statens Serum Inst, Dept Epidemiol Res, Artillerivej 5, DK-2300 Copenhagen S, Denmark.	fee@ssi.dk		Geller, Frank/0000-0002-9238-3269; Nordenskjold, Agneta/0000-0001-6638-4631; Feenstra, Bjarke/0000-0003-1478-649X; melbye, mads/0000-0001-8264-6785; Mills, James/0000-0003-4496-332X	Lundbeck Foundation [R34-A3931]; Novo Nordisk Foundation; Danish Medical Research Council [271-06-0628]; Swedish Research Council; Centers for Disease Control and Prevention [5U01DD000492]; Intramural Research Program of the Eunice Kennedy Shriver National Institute of Child Health and Human Development; National Institutes of Health Genes, Environment, and Health Initiative [U01HG004423]; Oak Foundation Fellowship; MRC [G1001799] Funding Source: UKRI; Medical Research Council [G1001799] Funding Source: researchfish; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD008792] Funding Source: NIH RePORTER; National Center on Birth Defects and Developmental Disabilities [U01DD000492] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG004423] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES005605] Funding Source: NIH RePORTER	Lundbeck Foundation(Lundbeckfonden); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Swedish Research Council(Swedish Research CouncilEuropean Commission); Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Intramural Research Program of the Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institutes of Health Genes, Environment, and Health Initiative(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Oak Foundation Fellowship; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Center on Birth Defects and Developmental Disabilities(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	The study was supported by grants from the Lundbeck Foundation (R34-A3931), the Novo Nordisk Foundation, the Danish Medical Research Council (271-06-0628), the Swedish Research Council, the Centers for Disease Control and Prevention (5U01DD000492), and the Intramural Research Program of the Eunice Kennedy Shriver National Institute of Child Health and Human Development. The GWAS data for the control samples were generated for our study of preterm birth within the GENEVA consortium with funding provided through the National Institutes of Health Genes, Environment, and Health Initiative (U01HG004423). Dr Feenstra is supported by an Oak Foundation Fellowship.	Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; CARLSON LA, 1977, EUR J CLIN INVEST, V7, P133, DOI 10.1111/j.1365-2362.1977.tb01585.x; Cirulli ET, 2010, NAT REV GENET, V11, P415, DOI 10.1038/nrg2779; de Laffolie J, 2012, PEDIATRICS, V129, pE901, DOI 10.1542/peds.2011-2845; Delaneau O, 2012, NAT METHODS, V9, P179, DOI [10.1038/NMETH.1785, 10.1038/nmeth.1785]; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Fan QW, 2002, J NEUROCHEM, V80, P178, DOI 10.1046/j.0022-3042.2001.00686.x; Feenstra B, 2012, NAT GENET, V44, P334, DOI 10.1038/ng.1067; Funfschilling U, 2012, J NEUROSCI, V32, P7632, DOI 10.1523/JNEUROSCI.1352-11.2012; Hennekam RCM, 2001, AM J MED GENET, V99, P256, DOI 10.1002/1096-8628(2001)9999:9999<::AID-AJMG1148>3.0.CO;2-Q; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Honein MA, 1999, LANCET, V354, P2101, DOI 10.1016/S0140-6736(99)10073-4; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; Kelley RI, 2000, J MED GENET, V37, P321, DOI 10.1136/jmg.37.5.321; Krogh C, 2012, PEDIATRICS, V130, pE943, DOI 10.1542/peds.2011-2785; Krogh C, 2010, JAMA-J AM MED ASSOC, V303, P2393, DOI 10.1001/jama.2010.784; Lagerstedt-Robinson K, 2009, J HUM GENET, V54, P706, DOI 10.1038/jhg.2009.101; LANGER JC, 1995, J PEDIATR SURG, V30, P1535, DOI 10.1016/0022-3468(95)90151-5; Magi R, 2010, GENET EPIDEMIOL, V34, P846, DOI 10.1002/gepi.20540; Marchini J, 2010, NAT REV GENET, V11, P499, DOI 10.1038/nrg2796; Mauch DH, 2001, SCIENCE, V294, P1354, DOI 10.1126/science.294.5545.1354; MITCHELL LE, 1993, AM J DIS CHILD, V147, P1203, DOI 10.1001/archpedi.1993.02160350077012; NAT'L HUMAN GENOME RES. INST, CAT PUBL GEN WID ASS; Nielsen JP, 2000, DAN MED BULL, V47, P223; Olsen J, 2001, SCAND J PUBLIC HEALT, V29, P300, DOI 10.1177/14034948010290040201; Owen CG, 2002, PEDIATRICS, V110, P597, DOI 10.1542/peds.110.3.597; Pedersen RN, 2008, J MATERN-FETAL NEO M, V21, P599, DOI 10.1080/14767050802214824; Peeters B, 2012, NAT REV GASTRO HEPAT, V9, P646, DOI 10.1038/nrgastro.2012.133; Persson S, 2001, PEDIATRICS, V108, DOI 10.1542/peds.108.4.e70; Piotrowska AP, 2003, ARCH PATHOL LAB MED, V127, P1182; Pisacane A, 1996, BRIT MED J, V312, P745, DOI 10.1136/bmj.312.7033.745; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Ranells Judith D, 2011, Adv Pediatr, V58, P195, DOI 10.1016/j.yapd.2011.03.005; Ryan AK, 1998, J MED GENET, V35, P558, DOI 10.1136/jmg.35.7.558; Saur D, 2004, P NATL ACAD SCI USA, V101, P1662, DOI 10.1073/pnas.0305473101; Schechter R, 1997, PAEDIATR PERINAT EP, V11, P407, DOI 10.1046/j.1365-3016.1997.d01-32.x; Sommerfield T, 2008, ARCH DIS CHILD, V93, P1007, DOI 10.1136/adc.2007.128090; Svenningsson A, 2008, J PEDIATR SURG, V43, P443, DOI 10.1016/j.jpedsurg.2007.10.006; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; Vanderwinden JM, 1996, GASTROENTEROLOGY, V111, P279, DOI 10.1053/gast.1996.v111.pm8690192; Willer CJ, 2010, BIOINFORMATICS, V26, P2190, DOI 10.1093/bioinformatics/btq340; Yngve A, 2001, PUBLIC HEALTH NUTR, V4, P1306, DOI 10.1079/PHN2001147	42	22	22	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 21	2013	310	7					714	721		10.1001/jama.2013.242978	http://dx.doi.org/10.1001/jama.2013.242978			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	202XP	23989729	Green Accepted, Bronze			2022-12-24	WOS:000323254500021
J	Shan, MM; Gentile, M; Yeiser, JR; Walland, AC; Bornstein, VU; Chen, K; He, B; Cassis, L; Bigas, A; Cols, M; Comerma, L; Huang, BH; Blander, JM; Xiong, HB; Mayer, L; Berin, C; Augenlicht, LH; Velcich, A; Cerutti, A				Shan, Meimei; Gentile, Maurizio; Yeiser, John R.; Walland, A. Cooper; Bornstein, Victor U.; Chen, Kang; He, Bing; Cassis, Linda; Bigas, Anna; Cols, Montserrat; Comerma, Laura; Huang, Bihui; Blander, J. Magarian; Xiong, Huabao; Mayer, Lloyd; Berin, Cecilia; Augenlicht, Leonard H.; Velcich, Anna; Cerutti, Andrea			Mucus Enhances Gut Homeostasis and Oral Tolerance by Delivering Immunoregulatory Signals	SCIENCE			English	Article							CD103(+) DENDRITIC CELLS; T-CELLS; EPITHELIAL-CELLS; BETA-CATENIN; DECTIN-1; DIFFERENTIATION; ASSOCIATION; IMMUNITY; ANTIGEN; MUCIN	A dense mucus layer in the large intestine prevents inflammation by shielding the underlying epithelium from luminal bacteria and food antigens. This mucus barrier is organized around the hyperglycosylated mucin MUC2. Here we show that the small intestine has a porous mucus layer, which permitted the uptake of MUC2 by antigen-sampling dendritic cells (DCs). Glycans associated with MUC2 imprinted DCs with anti-inflammatory properties by assembling a galectin-3-Dectin-1-Fc gamma RIIB receptor complex that activated beta-catenin. This transcription factor interfered with DC expression of inflammatory but not tolerogenic cytokines by inhibiting gene transcription through nuclear factor kappa B. MUC2 induced additional conditioning signals in intestinal epithelial cells. Thus, mucus does not merely form a nonspecific physical barrier, but also constrains the immunogenicity of gut antigens by delivering tolerogenic signals.	[Shan, Meimei; Yeiser, John R.; Walland, A. Cooper; Bornstein, Victor U.; Chen, Kang; He, Bing; Cols, Montserrat; Blander, J. Magarian; Xiong, Huabao; Mayer, Lloyd; Cerutti, Andrea] Icahn Sch Med Mt Sinai, Inst Immunol, Dept Med, New York, NY USA; [Gentile, Maurizio; Cassis, Linda; Comerma, Laura; Cerutti, Andrea] Inst Hosp Mar Invest Med IMIM, Program Inflammatory & Cardiovasc Disorders, Barcelona, Spain; [Chen, Kang] Wayne State Univ, Dept Obstet & Gynecol, Detroit, MI USA; [Bigas, Anna] IMIM, Program Canc Res, Barcelona, Spain; [Comerma, Laura] Hosp del Mar, Dept Pathol, Barcelona, Spain; [Huang, Bihui] Yale Univ, Dept Pharmacol, New Haven, CT USA; [Blander, J. Magarian] Icahn Sch Med Mt Sinai, Tisch Canc Inst, New York, NY USA; [Berin, Cecilia] Icahn Sch Med Mt Sinai, Inst Immunol, Dept Pediat, New York, NY USA; [Augenlicht, Leonard H.; Velcich, Anna] Albert Einstein Coll Med, Dept Med, New York, NY USA; [Cerutti, Andrea] NIH, Mucosal Immunol Studies Team MIST, Bethesda, MD 20892 USA; [Cerutti, Andrea] Catalan Inst Res & Adv Studies ICREA, Barcelona, Spain	Icahn School of Medicine at Mount Sinai; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Wayne State University; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; Yale University; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Yeshiva University; National Institutes of Health (NIH) - USA; ICREA	Cerutti, A (corresponding author), Icahn Sch Med Mt Sinai, Inst Immunol, Dept Med, New York, NY USA.	andrea.cerutti@mssm.edu	Cassis, Linda/K-9633-2014; Bigas, Anna/A-7457-2014; Blesa, Laura Comerma/AAQ-9455-2020	Cassis, Linda/0000-0003-4544-9816; Blesa, Laura Comerma/0000-0002-0249-4636; Blander, Julie Magarian/0000-0001-9207-1700; Huang, Bihui/0000-0003-3084-7096; berin, cecilia/0000-0002-9051-9249; Bigas, Anna/0000-0003-4801-6899; Cerutti, Andrea/0000-0003-3026-4704	National Institute of Allergy and Infectious Diseases, NIH [AI61093, AI57653, AI95613, AI96187, AI74378, AI073899, DK072201, AI095245]; Redes Tematicas de Investigacion Cooperativa en Salud/Fondo Europeo de Desarrollo Regional [RD12/0036/0054]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI095245, R56AI073899, U19AI096187, P01AI061093, U01AI095613, R01AI057653, R01AI074378, R01AI073899, R01AI093577] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK072201] Funding Source: NIH RePORTER; ICREA Funding Source: Custom	National Institute of Allergy and Infectious Diseases, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Redes Tematicas de Investigacion Cooperativa en Salud/Fondo Europeo de Desarrollo Regional; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); ICREA(ICREA)	This study was supported by the National Institute of Allergy and Infectious Diseases, NIH (AI61093, AI57653, AI95613, AI96187 and AI74378 to A. C. and AI073899, DK072201 and AI095245 to J.M.B.) and by Redes Tematicas de Investigacion Cooperativa en Salud/Fondo Europeo de Desarrollo Regional (RD12/0036/0054 to A. B). pRSETb-mRFP used for red bacteria is under a materials transfer agreement with R. Y. Tsien at the University of California, San Francisco, and Howard Hughes Medical Institute. The data presented in this manuscript are tabulated in the main paper and the supplementary materials.	Bogunovic M, 2009, IMMUNITY, V31, P513, DOI 10.1016/j.immuni.2009.08.010; Cerutti A, 2011, ANNU REV IMMUNOL, V29, P273, DOI 10.1146/annurev-immunol-031210-101317; Coombes JL, 2008, NAT REV IMMUNOL, V8, P435, DOI 10.1038/nri2335; Coombes JL, 2007, J EXP MED, V204, P1757, DOI 10.1084/jem.20070590; Deng JO, 2002, CANCER CELL, V2, P323, DOI 10.1016/S1535-6108(02)00154-X; Dennehy KM, 2009, EUR J IMMUNOL, V39, P1379, DOI 10.1002/eji.200838543; Dillon S, 2006, J CLIN INVEST, V116, P916, DOI 10.1172/JCI27203; Esteban A, 2011, P NATL ACAD SCI USA, V108, P14270, DOI 10.1073/pnas.1111415108; Farache J, 2013, IMMUNITY, V38, P581, DOI 10.1016/j.immuni.2013.01.009; Ilarregui JM, 2009, NAT IMMUNOL, V10, P981, DOI 10.1038/ni.1772; Iliev ID, 2009, MUCOSAL IMMUNOL, V2, P340, DOI 10.1038/mi.2009.13; Iliev ID, 2012, SCIENCE, V336, P1314, DOI 10.1126/science.1221789; Johansson MEV, 2011, P NATL ACAD SCI USA, V108, P4659, DOI 10.1073/pnas.1006451107; Karsten CM, 2012, NAT MED, V18, P1401, DOI 10.1038/nm.2862; Kelly EK, 2010, J IMMUNOL, V184, P5545, DOI 10.4049/jimmunol.0901293; Manicassamy S, 2010, SCIENCE, V329, P849, DOI 10.1126/science.1188510; McDole JR, 2012, NATURE, V483, P345, DOI 10.1038/nature10863; Mucida D, 2007, SCIENCE, V317, P256, DOI 10.1126/science.1145697; Niess JH, 2005, SCIENCE, V307, P254, DOI 10.1126/science.1102901; Rabinovich GA, 2009, NAT REV IMMUNOL, V9, P338, DOI 10.1038/nri2536; Rescigno M, 2001, NAT IMMUNOL, V2, P361, DOI 10.1038/86373; Rimoldi M, 2005, NAT IMMUNOL, V6, P507, DOI 10.1038/ni1192; Strasser D, 2012, IMMUNITY, V36, P32, DOI 10.1016/j.immuni.2011.11.015; Vaishnava S, 2011, SCIENCE, V334, P255, DOI 10.1126/science.1209791; Velcich A, 2002, SCIENCE, V295, P1726, DOI 10.1126/science.1069094; Wen AY, 2010, J IMMUNOL, V185, P6413, DOI 10.4049/jimmunol.1001829; Yu CI, 2013, IMMUNITY, V38, P818, DOI 10.1016/j.immuni.2013.03.004; Zhou YF, 2010, NAT MED, V16, P1128, DOI 10.1038/nm.2201	28	373	387	16	153	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 25	2013	342	6157					447	453		10.1126/science.1237910	http://dx.doi.org/10.1126/science.1237910			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239RH	24072822	Green Accepted, Green Submitted			2022-12-24	WOS:000326042600034
J	Choi, YJ; Lee, SY				Choi, Yong Jun; Lee, Sang Yup			Microbial production of short-chain alkanes	NATURE			English	Article							ACYL CARRIER PROTEIN; FATTY-ACID SYNTHESIS; ESCHERICHIA-COLI; ARABIDOPSIS ECERIFERUM1; SYNTHASE-III; BIOSYNTHESIS; GENE; INITIATION; CHEMICALS; MUTANTS	Increasing concerns about limited fossil fuels and global environmental problems have focused attention on the need to develop sustainable biofuels from renewable resources. Although microbial production of diesel has been reported, production of another much in demand transport fuel, petrol (gasoline), has not yet been demonstrated. Here we report the development of platform Escherichia coli strains that are capable of producing short-chain alkanes (SCAs; petrol), free fatty acids (FFAs), fatty esters and fatty alcohols through the fatty acyl (acyl carrier protein (ACP)) to fatty acid to fatty acyl-CoA pathway. First, the beta-oxidation pathway was blocked by deleting the fadE gene to prevent the degradation of fatty acyl-CoAs generated in vivo. To increase the formation of short-chain fatty acids suitable for subsequent conversion to SCAs in vivo, the activity of 3-oxoacyl-ACP synthase (FabH)(1), which is inhibited by unsaturated fatty acyl-ACPs(2), was enhanced to promote the initiation of fatty acid biosynthesis by deleting the fadR gene; deletion of the fadR gene prevents upregulation of the fabA and fabB genes responsible for unsaturated fatty acids biosynthesis(3). A modified thioesterase(4) was used to convert short-chain fatty acyl-ACPs to the corresponding FFAs, which were then converted to SCAs by the sequential reactions of E. coli fatty acyl-CoA synthetase, Clostridium acetobutylicum fatty acyl-CoA reductase and Arabidopsis thaliana fatty aldehyde decarbonylase. The final engineered strain produced up to 580.8 mg l(-1) of SCAs consisting of nonane (327.8 mg l(-1)), dodecane (136.5 mg l(-1)), tridecane (64.8 mg l(-1)), 2-methyl-dodecane (42.8 mg l(-1)) and tetradecane (8.9 mg l(-1)), together with small amounts of other hydrocarbons. Furthermore, this platform strain could produce short-chain FFAs using a fadD-deleted strain, and short-chain fatty esters by introducing the Acinetobacter sp. ADP1 wax ester synthase (atfA)(5) and the E. coli mutant alcohol dehydrogenase (adhE(mut))(6).	[Choi, Yong Jun; Lee, Sang Yup] Korea Adv Inst Sci & Technol, Metab & Biomol Engn Natl Res Lab, Dept Chem & Biomol Engn, BioProc Engn Res Ctr,Program BK21, Taejon 305701, South Korea; [Choi, Yong Jun; Lee, Sang Yup] Korea Adv Inst Sci & Technol, Ctr Syst & Synthet Biotechnol, Taejon 305701, South Korea; [Lee, Sang Yup] Korea Adv Inst Sci & Technol, Bioinformat & BioProc Engn Res Ctr, Taejon 305701, South Korea	Korea Advanced Institute of Science & Technology (KAIST); Korea Advanced Institute of Science & Technology (KAIST); Korea Advanced Institute of Science & Technology (KAIST)	Lee, SY (corresponding author), Korea Adv Inst Sci & Technol, Metab & Biomol Engn Natl Res Lab, Dept Chem & Biomol Engn, BioProc Engn Res Ctr,Program BK21, 291 Daehak Ro, Taejon 305701, South Korea.	leesy@kaist.ac.kr	Lee, Sang Yup/C-1526-2011	Lee, Sang Yup/0000-0003-0599-3091	Advanced Biomass Research and Development Center of Korea through the Global Frontier Research Program of the Ministry of Science, ICT and Future Planning (MSIP) through the National Research Foundation (NRF) [ABC-2010-0029799]; Technology Development Program to Solve Climate Changes on Systems Metabolic Engineering for Biorefineries by MSIP through NRF [NRF-2012-C1AAA001-2012M1A2A2026556]	Advanced Biomass Research and Development Center of Korea through the Global Frontier Research Program of the Ministry of Science, ICT and Future Planning (MSIP) through the National Research Foundation (NRF); Technology Development Program to Solve Climate Changes on Systems Metabolic Engineering for Biorefineries by MSIP through NRF	We would like to thank Y. H. Lee for her assistance in cloning work and S. J. Choi for performing the fermentation experiments for checking reproducibility. This work was supported by the Advanced Biomass Research and Development Center of Korea (ABC-2010-0029799) through the Global Frontier Research Program of the Ministry of Science, ICT and Future Planning (MSIP) through the National Research Foundation (NRF). Systems metabolic engineering work was supported by the Technology Development Program to Solve Climate Changes on Systems Metabolic Engineering for Biorefineries (NRF-2012-C1AAA001-2012M1A2A2026556) by MSIP through NRF.	Aarts MGM, 1995, PLANT CELL, V7, P2115, DOI 10.1105/tpc.7.12.2115; Altin O., 2004, PREPRINTS PAPERS AM, V49, p764 766; Atsumi S, 2008, NATURE, V451, P86, DOI 10.1038/nature06450; Bernard A, 2012, PLANT CELL, V24, P3106, DOI 10.1105/tpc.112.099796; Bourdenx B, 2011, PLANT PHYSIOL, V156, P29, DOI 10.1104/pp.111.172320; Choi YJ, 2012, METAB ENG, V14, P477, DOI 10.1016/j.ymben.2012.07.006; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Gary J.H., 2001, PETROLEUM REFINING T, VFourth; Han L, 1998, J BACTERIOL, V180, P4481, DOI 10.1128/JB.180.17.4481-4486.1998; Harger M, 2013, ACS SYNTH BIOL, V2, P59, DOI 10.1021/sb300061x; Heath RJ, 1996, J BIOL CHEM, V271, P1833, DOI 10.1074/jbc.271.4.1833; Holland-Staley CA, 2000, J BACTERIOL, V182, P6049, DOI 10.1128/JB.182.21.6049-6054.2000; Howard TP, 2013, P NATL ACAD SCI USA, V110, P7636, DOI 10.1073/pnas.1215966110; Jing FY, 2011, BMC BIOCHEM, V12, DOI 10.1186/1471-2091-12-44; Lennen RM, 2010, BIOTECHNOL BIOENG, V106, P193, DOI 10.1002/bit.22660; Lo YC, 2005, BIOCHEMISTRY-US, V44, P1971, DOI 10.1021/bi048109x; MCNEVIN JP, 1993, GENOME, V36, P610, DOI 10.1139/g93-082; Na D, 2013, NAT BIOTECHNOL, V31, P170, DOI 10.1038/nbt.2461; NAGGERT J, 1991, J BIOL CHEM, V266, P11044; NUNN WD, 1983, J BACTERIOL, V154, P554, DOI 10.1128/JB.154.2.554-560.1983; Palmeros B, 2000, GENE, V247, P255, DOI 10.1016/S0378-1119(00)00075-5; Peralta-Yahya PP, 2012, NATURE, V488, P320, DOI 10.1038/nature11478; POLLARD MR, 1991, ARCH BIOCHEM BIOPHYS, V284, P306, DOI 10.1016/0003-9861(91)90300-8; Reiser S, 1997, J BACTERIOL, V179, P2969, DOI 10.1128/jb.179.9.2969-2975.1997; Sambrook J, 2001, MOL CLONING LAB MANU; Schirmer A, 2010, SCIENCE, V329, P559, DOI 10.1126/science.1187936; Steen EJ, 2010, NATURE, V463, P559, DOI 10.1038/nature08721; Torella JP, 2013, P NATL ACAD SCI USA, V110, P11290, DOI 10.1073/pnas.1307129110; TSAY JT, 1992, J BIOL CHEM, V267, P6807; Yuan LZ, 2006, METAB ENG, V8, P79, DOI 10.1016/j.ymben.2005.08.005; Zhang FZ, 2012, NAT BIOTECHNOL, V30, P354, DOI 10.1038/nbt.2149; Zhang HX, 2006, FEMS MICROBIOL LETT, V259, P249, DOI 10.1111/j.1574-6968.2006.00277.x; Zheng YN, 2012, BIOTECHNOL BIOFUELS, V5, DOI 10.1186/1754-6834-5-76	33	305	327	8	330	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 24	2013	502	7472					571	+		10.1038/nature12536	http://dx.doi.org/10.1038/nature12536			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	238YN	24077097				2022-12-24	WOS:000325988400059
J	Priebe, S; Yeeles, K; Bremner, S; Lauber, C; Eldridge, S; Ashby, D; David, AS; O'Connell, N; Forrest, A; Burns, T				Priebe, Stefan; Yeeles, Ksenija; Bremner, Stephen; Lauber, Christoph; Eldridge, Sandra; Ashby, Deborah; David, Anthony S.; O'Connell, Nicola; Forrest, Alexandra; Burns, Tom			Effectiveness of financial incentives to improve adherence to maintenance treatment with antipsychotics: cluster randomised controlled trial	BMJ-BRITISH MEDICAL JOURNAL			English	Article							SEVERE MENTAL-ILLNESS; REDUCE SUBSTANCE USE; MONETARY REINFORCEMENT; CONTINGENCY MANAGEMENT; MEDICATION ADHERENCE; HEALTH-CARE; SCHIZOPHRENIA; PEOPLE; INDIVIDUALS; ABSTINENCE	Objective To test whether offering financial incentives to patients with psychotic disorders is effective in improving adherence to maintenance treatment with antipsychotics. Design Cluster randomised controlled trial. Setting Community mental health teams in secondary psychiatric care in the United Kingdom. Participants Patients with a diagnosis of schizophrenia, schizoaffective disorder, or bipolar disorder, who were prescribed long acting antipsychotic (depot) injections but had received 75% or less of the prescribed injections. We randomly allocated 73 teams with a total of 141 patients. Primary outcome data were available for 35 intervention teams with 75 patients (96% of randomised) and for 31 control teams with 56 patients (89% of randomised). Interventions Participants in the intervention group were offered 15 pound ((sic)17; $22) for each depot injection over a 12 month period. Participants in the control condition received treatment as usual. Main outcome measure The primary outcome was the percentage of prescribed depot injections given during the 12 month intervention period. Results 73 teams with 141 consenting patients were randomised, and outcomes were assessed for 131 patients (93%).double down arrow Average baseline adherence was 69% in the intervention group and 67% in the control group. During the 12 month trial period adherence was 85% in the intervention group and 71% in the control group. The adjusted effect estimate was 11.5% (95% confidence interval 3.9% to 19.0%, P=0.003). A secondary outcome was an adherence of >= 95%, which was achieved in 28% of the intervention group and 5% of the control group (adjusted odds ratio 8.21, 95% confidence interval 2.00 to 33.67, P=0.003). Although differences in clinician rated clinical improvement between the groups failed to reach statistical significance, patients in the intervention group had more favourable subjective quality of life ratings (beta=0.71, 95% confidence interval 0.26 to 1.15, P=0.002). The number of admissions to hospital and adverse events were low in both groups and did not show substantial differences. Conclusion Offering modest financial incentives to patients with psychotic disorders is an effective method for improving adherence to maintenance treatment with antipsychotics.	[Priebe, Stefan; O'Connell, Nicola] Queen Mary Univ London, Unit Social & Community Psychiat, Newham Ctr Mental Hlth, London E13 8SP, England; [Yeeles, Ksenija; Burns, Tom] Univ Oxford, Warneford Hosp, Dept Psychiat, Oxford, England; [Bremner, Stephen; Eldridge, Sandra] Barts & London Queen Marys Sch Med & Dent, Blizard Inst, Ctr Primary Care & Publ Hlth, London, England; [Lauber, Christoph] Jura Bernois, Psychiat Serv, Bienne Seeland, Bellelay, Switzerland; [Ashby, Deborah] Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, London, England; [David, Anthony S.] Kings Coll London, Inst Psychiat, Dept Psychosis Studies, London, England	University of London; Queen Mary University London; University of Oxford; University of London; Queen Mary University London; Imperial College London; University of London; King's College London	Priebe, S (corresponding author), Queen Mary Univ London, Unit Social & Community Psychiat, Newham Ctr Mental Hlth, London E13 8SP, England.	s.priebe@qmul.ac.uk	David, Anthony/O-1750-2019; Bremner, Stephen/R-4038-2016; David, Anthony S/C-1315-2011	David, Anthony/0000-0003-0967-774X; Bremner, Stephen/0000-0003-0790-7070; David, Anthony S/0000-0003-0967-774X; Yeeles, Ksenija/0000-0002-7757-0154; O'Connell, Nicola/0000-0002-5143-1797; Priebe, Stefan/0000-0001-9864-3394; Eldridge, Sandra/0000-0001-5638-2317	National Institute for Health Research Health Technology Assessment (NIHR HTA) programme [07/60/43]; National Institute for Health Research [07/60/43] Funding Source: researchfish	National Institute for Health Research Health Technology Assessment (NIHR HTA) programme(National Institute for Health Research (NIHR)); National Institute for Health Research(National Institute for Health Research (NIHR))	This trial was funded by the National Institute for Health Research Health Technology Assessment (NIHR HTA) programme (project No 07/60/43) and will be published in full in Health Technology Assessment. The views and opinions expressed therein are those of the authors and do not necessarily reflect those of the HTA programme, NIHR, NHS, or the Department of Health. The trial is registered with ISRCTN (SRCTN77769281) and is adopted into the UKCRN and MHRN portfolios. The funder had no role in study design, data collection, data analysis, interpretation, writing of the report, or decision to submit for publication. All study researchers were independent from a funder. All authors had full access to all of the data (including statistical reports and tables) in the study and can take responsibility for the integrity of the data and the accuracy of the data analysis.	[Anonymous], 2009, STAT STAT 10 1 PROGR; Burns T, 2007, BRIT MED J, V335, P232, DOI 10.1136/bmj.39286.399514.BE; Burton A, 2010, EPIDEMIOL PSICHIAT S, V19, P233; CAREY KB, 1990, J BEHAV THER EXP PSY, V21, P205, DOI 10.1016/0005-7916(90)90008-9; Claassen D, 2007, PSYCHIATR BULL, V31, P4, DOI 10.1192/pb.31.1.4; Claassen D, 2007, J MED ETHICS, V33, P189, DOI 10.1136/jme.2006.016188; Conley RR, 2001, BIOL PSYCHIAT, V50, P898, DOI 10.1016/S0006-3223(01)01271-9; Cookson R., 2008, BMJ-BRIT MED J, V337, pa589, DOI DOI 10.1136/BMJ.A589; Drebing CE, 2005, J APPL BEHAV ANAL, V38, P359, DOI 10.1901/jaba.2005.100-03; Giuffrida A, 1997, BRIT MED J, V315, P703, DOI 10.1136/bmj.315.7110.703; Glover GR, 1999, BRIT J PSYCHIAT, V175, P544, DOI 10.1192/bjp.175.6.544; Gray R, 2006, BRIT J PSYCHIAT, V189, P508, DOI 10.1192/bjp.bp.105.019489; Guy W, 1976, ECDEU ASSESSMENT MAN, DOI DOI 10.1037/E591322011-001; Helmus TC, 2003, PSYCHOL ADDICT BEHAV, V17, P249, DOI 10.1037/0893-164X.17.3.249; Knapp M, 2004, BRIT J PSYCHIAT, V184, P509, DOI 10.1192/bjp.184.6.509; Marteau TM, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1415; McDonald HP, 2002, JAMA-J AM MED ASSOC, V288, P2868, DOI 10.1001/jama.288.22.2868; National Collaborating Centre for Mental Health, 2009, SCHIZ COR INT TREATM, P41; Nose M, 2003, BRIT J PSYCHIAT, V183, P197, DOI 10.1192/bjp.183.3.197; Novick D, 2010, PSYCHIAT RES, V176, P109, DOI 10.1016/j.psychres.2009.05.004; OLSON RP, 1972, J CONSULT CLIN PSYCH, V38, P376, DOI 10.1037/h0032910; Popay Jennie, 2008, BMJ, V337, pa594, DOI 10.1136/bmj.a594; Post EP, 2006, PSYCHIAT SERV, V57, P414, DOI 10.1176/appi.ps.57.3.414; Priebe S, 2007, BRIT J PSYCHIAT, V191, P420, DOI 10.1192/bjp.bp.107.036939; Priebe S, 2012, BMC PSYCHIATRY, V12, DOI 10.1186/1471-244X-12-113; Priebe S, 2010, J MED ETHICS, V36, P463, DOI 10.1136/jme.2009.035071; Promberger M, 2011, J MED ETHICS, V37, P682, DOI 10.1136/jme.2010.039347; Ries RK, 2004, PSYCHIAT SERV, V55, P445, DOI 10.1176/appi.ps.55.4.445; Roll JM, 1998, EXP CLIN PSYCHOPHARM, V6, P157, DOI 10.1037/1064-1297.6.2.157; Roll JM, 2004, PSYCHIAT RES, V125, P61, DOI 10.1016/j.psychres.2003.10.003; Ryan P, 1998, STATA TECHNICAL B, V41, P43; Shaner A, 1997, PSYCHIAT SERV, V48, P807; Shaw Joanne, 2007, BMJ, V335, P233, DOI 10.1136/bmj.39286.422639.BE; Sigmon SC, 2000, EXP CLIN PSYCHOPHARM, V8, P509, DOI 10.1037//1064-1297.8.4.509; Staring ABP, 2010, PSYCHOPHARMACOL BULL, V43, P5; Tidey JW, 2012, PREV MED, V55, pS54, DOI 10.1016/j.ypmed.2011.11.010; Tidey JW, 2002, EXP CLIN PSYCHOPHARM, V10, P241, DOI 10.1037//1064-1297.10.3.241; Tracy K, 2007, AM J DRUG ALCOHOL AB, V33, P253, DOI 10.1080/00952990601174931; Vieta E, 2005, J CLIN PSYCHIAT, V66, P24; WHO, 2012, ICD 10 CLASS MENT BE; Wise J., 2010, BMJ, V340, pc2747, DOI [10.1136/bmj.c2747, DOI 10.1136/BMJ.C2747]	41	76	76	0	11	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 7	2013	347								f5847	10.1136/bmj.f5847	http://dx.doi.org/10.1136/bmj.f5847			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	235OG	24100934	Green Published, Green Accepted, hybrid			2022-12-24	WOS:000325728300001
J	Dietrich, MO; Liu, ZW; Horvath, TL				Dietrich, Marcelo O.; Liu, Zhong-Wu; Horvath, Tamas L.			Mitochondrial Dynamics Controlled by Mitofusins Regulate Agrp Neuronal Activity and Diet-Induced Obesity	CELL			English	Article							NEUROPEPTIDE-Y; MELANOCORTIN SYSTEM; MAMMALIAN HOMOLOGS; ENERGY; PROTEIN; FUSION; CELL; AMPK; POMC; RESISTANCE	Mitochondria are key organelles in the maintenance of cellular energy metabolism and integrity. Here, we show that mitochondria number decrease but their size increase in orexigenic agouti-related protein (Agrp) neurons during the transition from fasted to fed to overfed state. These fusion-like dynamic changes were cell-type specific, as they occurred in the opposite direction in anorexigenic pro-opiomelanocortin (POMC) neurons. Interfering with mitochondrial fusion mechanisms in Agrp neurons by cell-selectively knocking down mitofusin 1 (Mfn1) or mitofusin 2 (Mfn2) resulted in altered mitochondria size and density in these cells. Deficiency in mitofusins impaired the electric activity of Agrp neurons during high-fat diet (HFD), an event reversed by cell-selective administration of ATP. Agrp-specific Mfn1 or Mfn2 knockout mice gained less weight when fed a HFD due to decreased fat mass. Overall, our data unmask an important role for mitochondrial dynamics governed by Mfn1 and Mfn2 in Agrp neurons in central regulation of whole-body energy metabolism.	[Dietrich, Marcelo O.; Liu, Zhong-Wu; Horvath, Tamas L.] Yale Univ, Sch Med, Comparat Med Sect, Program Integrat Cell Signaling & Neurobiol Metab, New Haven, CT 06520 USA; [Dietrich, Marcelo O.] Univ Fed Rio Grande do Sul, Dept Biochem, BR-90035 Porto Alegre, RS, Brazil	Yale University; Universidade Federal do Rio Grande do Sul	Dietrich, MO (corresponding author), Yale Univ, Sch Med, Comparat Med Sect, Program Integrat Cell Signaling & Neurobiol Metab, 333 Cedar St, New Haven, CT 06520 USA.	marcelo.dietrich@yale.edu; tamas.horvath@yale.edu	Dietrich, Marcelo/A-9928-2009	Dietrich, Marcelo/0000-0001-9781-2221	NIH [DP1 DK006850, R01AG040236, P01NS062686]; American Diabetes Association; Helmholtz Society (ICEMED); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, Brazil [401476/2012-0]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [DP1DK098058] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS062686] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG040236] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); Helmholtz Society (ICEMED); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank Catiele Antunes, Marcelo R. Zimmer, Antonio Giaimo, Melissa Taylor, Ester de La Fuente, Jeremy Bober, and Klara Szigeti for support in the experiments described here. This work was supported by NIH (DP1 DK006850, R01AG040236, and P01NS062686), the American Diabetes Association, the Helmholtz Society (ICEMED) and by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (401476/2012-0, Brazil).	Andrews ZB, 2008, NATURE, V454, P846, DOI 10.1038/nature07181; Aponte Y, 2011, NAT NEUROSCI, V14, P351, DOI 10.1038/nn.2739; Attwell D, 2001, J CEREBR BLOOD F MET, V21, P1133, DOI 10.1097/00004647-200110000-00001; Bach D, 2003, J BIOL CHEM, V278, P17190, DOI 10.1074/jbc.M212754200; Broberger C, 1998, P NATL ACAD SCI USA, V95, P15043, DOI 10.1073/pnas.95.25.15043; Cerveny KL, 2007, TRENDS CELL BIOL, V17, P563, DOI 10.1016/j.tcb.2007.08.006; Chen HC, 2007, CELL, V130, P548, DOI 10.1016/j.cell.2007.06.026; Chen HY, 2004, ENDOCRINOLOGY, V145, P2607, DOI 10.1210/en.2003-1596; Cipolat S, 2004, P NATL ACAD SCI USA, V101, P15927, DOI 10.1073/pnas.0407043101; Claret M, 2007, J CLIN INVEST, V117, P2325, DOI 10.1172/JCI31516; CLARK JT, 1984, ENDOCRINOLOGY, V115, P427, DOI 10.1210/endo-115-1-427; Cone RD, 2005, NAT NEUROSCI, V8, P571, DOI 10.1038/nn1455; Coppola A, 2007, CELL METAB, V5, P21, DOI 10.1016/j.cmet.2006.12.002; Diano S, 2011, NAT MED, V17, P1121, DOI 10.1038/nm.2421; Dietrich MO, 2010, J NEUROSCI, V30, P11815, DOI 10.1523/JNEUROSCI.2234-10.2010; Dietrich MO, 2009, EUR J NEUROSCI, V30, P1688, DOI 10.1111/j.1460-9568.2009.06963.x; Eura Y, 2003, J BIOCHEM, V134, P333, DOI 10.1093/jb/mvg150; Guillet V, 2011, FASEB J, V25, P1618, DOI 10.1096/fj.10-173609; Hahn TM, 1998, NAT NEUROSCI, V1, P271, DOI 10.1038/1082; Horvath TL, 2010, P NATL ACAD SCI USA, V107, P14875, DOI 10.1073/pnas.1004282107; Horvath TL, 1999, J NEUROSCI, V19, P10417; Horvath TL, 1997, BRAIN RES, V756, P283, DOI 10.1016/S0006-8993(97)00184-4; Ishihara N, 2004, J CELL SCI, V117, P6535, DOI 10.1242/jcs.01565; Jahani-Asl A, 2007, J BIOL CHEM, V282, P23788, DOI 10.1074/jbc.M703812200; Jheng HF, 2012, MOL CELL BIOL, V32, P309, DOI 10.1128/MCB.05603-11; Joly-Amado A, 2012, EMBO J, V31, P4276, DOI 10.1038/emboj.2012.250; Kohno D, 2008, BIOCHEM BIOPH RES CO, V366, P388, DOI 10.1016/j.bbrc.2007.11.166; Krashes MJ, 2011, J CLIN INVEST, V121, P1424, DOI 10.1172/JCI46229; Laughlin SB, 1998, NAT NEUROSCI, V1, P36, DOI 10.1038/236; Lee S, 2012, HUM MOL GENET, V21, P4827, DOI 10.1093/hmg/dds352; Lewis MR, 1914, SCIENCE, V39, P330, DOI 10.1126/science.39.1000.330; Liu ZW, 2011, J PHYSIOL-LONDON, V589, P4157, DOI 10.1113/jphysiol.2011.212514; Newton AJ, 2013, ENDOCRINOLOGY, V154, P172, DOI 10.1210/en.2012-1643; Ollmann MM, 1997, SCIENCE, V278, P135, DOI 10.1126/science.278.5335.135; Pham AH, 2012, HUM MOL GENET, V21, P4817, DOI 10.1093/hmg/dds311; Pich S, 2005, HUM MOL GENET, V14, P1405, DOI 10.1093/hmg/ddi149; Pinto S, 2004, SCIENCE, V304, P110, DOI 10.1126/science.1089459; POSAKONY JW, 1977, J CELL BIOL, V74, P468, DOI 10.1083/jcb.74.2.468; Reddy PH, 2011, BRAIN RES REV, V67, P103, DOI 10.1016/j.brainresrev.2010.11.004; Rodriguez-Navarro JA, 2010, NEUROBIOL DIS, V39, P423, DOI 10.1016/j.nbd.2010.05.014; Rojo M, 2002, J CELL SCI, V115, P1663; Santel A, 2003, J CELL SCI, V116, P2763, DOI 10.1242/jcs.00479; Santel A, 2001, J CELL SCI, V114, P867; Sanz E, 2009, P NATL ACAD SCI USA, V106, P13939, DOI 10.1073/pnas.0907143106; Schneeberger M, 2013, CELL, V155, P172, DOI 10.1016/j.cell.2013.09.003; Smirnova E, 1998, J CELL BIOL, V143, P351, DOI 10.1083/jcb.143.2.351; Song ZY, 2009, MOL BIOL CELL, V20, P3525, DOI 10.1091/mbc.E09-03-0252; Sternson SM, 2005, NAT NEUROSCI, V8, P1356, DOI 10.1038/nn1550; Takahashi KA, 2005, ENDOCRINOLOGY, V146, P1043, DOI 10.1210/en.2004-1397; Weibel E R, 1969, Int Rev Cytol, V26, P235, DOI 10.1016/S0074-7696(08)61637-X; WEIBEL ER, 1969, J CELL BIOL, V42, P68, DOI 10.1083/jcb.42.1.68; WEIBEL ER, 1966, J CELL BIOL, V30, P23, DOI 10.1083/jcb.30.1.23; Wicksell SD, 1925, BIOMETRIKA, V17, P84, DOI 10.1093/biomet/17.1-2.84; Wicksell SD, 1926, BIOMETRIKA, V18, P151, DOI 10.1093/biomet/18.1-2.151; Yang YL, 2011, CELL, V146, P991, DOI 10.1016/j.cell.2011.07.039; ZARJEVSKI N, 1993, ENDOCRINOLOGY, V133, P1753, DOI 10.1210/en.133.4.1753	56	208	215	2	34	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 26	2013	155	1					188	199		10.1016/j.cell.2013.09.004	http://dx.doi.org/10.1016/j.cell.2013.09.004			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	224UX	24074868	Bronze, Green Accepted			2022-12-24	WOS:000324916700019
J	Betses, M; Brennan, T				Betses, Mitch; Brennan, Troyen			Abusive Prescribing of Controlled Substances - A Pharmacy View	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							OPIOID PRESCRIPTION; GUIDELINES	Pharmacies have a role to play in the oversight of prescriptions for controlled substances, especially opioids. The pharmacy chain CVS recently used its aggregated information on all prescriptions filled at its stores to attempt to limit inappropriate prescribing. Public health advocates are increasingly focused on illness and deaths caused by inappropriate use of controlled substances in particular, opioid analgesics. Opioid prescriptions have increased dramatically, by more than 300% between 1999 and 2010.(1) This increase has led to substantial iatrogenic disease. Most strikingly, the number of deaths due to overdose in the United States increased from 4000 in 1999 to 16,600 in 2010.(2) Indeed, overdose is now the second-leading cause of accidental death in this country, where more than 2.4 million people were considered opioid abusers in 2010.(3) The causes of increases in prescriptions and the prevalence of ...	[Betses, Mitch; Brennan, Troyen] CVS Caremark, Woonsocket, RI USA		Betses, M (corresponding author), CVS Caremark, Woonsocket, RI USA.							Dowell D, 2013, JAMA-J AM MED ASSOC, V309, P2219, DOI 10.1001/jama.2013.5794; Drug Enforcement Administration, 2013, DEA SERV AN WALGR PH; Kunins HV, 2013, ANN INTERN MED, V158, P841, DOI 10.7326/0003-4819-158-11-201306040-00631; Lembke A, 2012, NEW ENGL J MED, V367, P1580, DOI 10.1056/NEJMp1208498; Rosenau AM, 2013, ANN INTERN MED, V158, P843, DOI 10.7326/0003-4819-158-11-201306040-00632	5	39	40	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 12	2013	369	11					989	991		10.1056/NEJMp1308222	http://dx.doi.org/10.1056/NEJMp1308222			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	216SK	23964897	Bronze			2022-12-24	WOS:000324304200004
J	Fields, RD				Fields, R. Douglas			Map the other brain	NATURE			English	Editorial Material									US Natl Inst Hlth, Nervous Syst Dev & Plast Sect, Bethesda, MD USA	National Institutes of Health (NIH) - USA	Fields, RD (corresponding author), US Natl Inst Hlth, Nervous Syst Dev & Plast Sect, Bethesda, MD USA.	fieldsd@mail.nih.gov			Intramural NIH HHS [Z01 HD000713-13] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD000713] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Alivisatos AP, 2013, SCIENCE, V339, P1284, DOI 10.1126/science.1236939; Alivisatos AP, 2012, NEURON, V74, P970, DOI 10.1016/j.neuron.2012.06.006; Fields R. D., NEUROSCIENT IN PRESS; FIELDS RD, 2009, OTHER BRAIN; Han XN, 2013, CELL STEM CELL, V12, P342, DOI 10.1016/j.stem.2012.12.015; Kettenmann H., 2013, NEUROGLIA; Schafer DP, 2012, NEURON, V74, P691, DOI 10.1016/j.neuron.2012.03.026; Wake H, 2011, SCIENCE, V333, P1647, DOI 10.1126/science.1206998; Zatorre RJ, 2012, NAT NEUROSCI, V15, P528, DOI 10.1038/nn.3045	9	21	22	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 5	2013	501	7465					25	27		10.1038/501025a	http://dx.doi.org/10.1038/501025a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	211ER	24010144	Bronze, Green Accepted			2022-12-24	WOS:000323888300012
J	Levy, BD				Levy, Bruce D.			Sphingolipids and Susceptibility to Asthma	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Levy, Bruce D.] Brigham & Womens Hosp, Dept Internal Med, Pulm & Crit Care Med Div, Boston, MA 02115 USA; [Levy, Bruce D.] Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Levy, BD (corresponding author), Brigham & Womens Hosp, Dept Internal Med, Pulm & Crit Care Med Div, 75 Francis St, Boston, MA 02115 USA.				NIGMS NIH HHS [P01 GM095467] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM095467] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Breslow DK, 2010, NATURE, V463, P1048, DOI 10.1038/nature08787; Miller M, 2012, P NATL ACAD SCI USA, V109, P16648, DOI 10.1073/pnas.1204151109; Moffatt MF, 2010, NEW ENGL J MED, V363, P1211, DOI 10.1056/NEJMoa0906312; Verlaan DJ, 2009, AM J HUM GENET, V85, P377, DOI 10.1016/j.ajhg.2009.08.007; Worgall TS, 2013, SCI TRANSL MED, V5	5	20	22	0	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 5	2013	369	10					976	978		10.1056/NEJMcibr1306864	http://dx.doi.org/10.1056/NEJMcibr1306864			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	211KV	24004126				2022-12-24	WOS:000323906900016
J	Briggs, JP; Killen, J				Briggs, Josephine P.; Killen, Jack			Perspectives on Complementary and Alternative Medicine Research	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Briggs, Josephine P.; Killen, Jack] NIH, Natl Ctr Complementary & Alternat Med, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Center for Complementary & Alternative Medicine	Briggs, JP (corresponding author), Natl Ctr Complementary & Alternat Med, 31 Ctr Dr,Bldg 31,Ste 2B11, Bethesda, MD 20814 USA.	briggsj@mail.nih.gov						[Anonymous], 2012, NBJS SUPPLEMENT BUSI; [Anonymous], SPOTLIGHTED RESEARCH; [Anonymous], 2010, PAIN MANAGEMENT TASK; Barnes PM, 2008, NATL HLTH STAT REPOR, V12, P1, DOI DOI 10.1037/E623942009-001; Chou R, 2007, ANN INTERN MED, V147, P478, DOI 10.7326/0003-4819-147-7-200710020-00006; Offit PA, 2012, JAMA-J AM MED ASSOC, V307, P1803, DOI 10.1001/jama.2012.518; Schultz AM, 2009, INTEGRATIVE MEDICINE	7	21	22	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 21	2013	310	7					691	692		10.1001/jama.2013.6540	http://dx.doi.org/10.1001/jama.2013.6540			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	202XP	23990064				2022-12-24	WOS:000323254500015
J	Goodman, DB; Church, GM; Kosuri, S				Goodman, Daniel B.; Church, George M.; Kosuri, Sriram			Causes and Effects of N-Terminal Codon Bias in Bacterial Genes	SCIENCE			English	Article							TRANSLATIONAL EFFICIENCY; USAGE; EXPRESSION; SELECTION; DESIGN	Most amino acids are encoded by multiple codons, and codon choice has strong effects on protein expression. Rare codons are enriched at the N terminus of genes in most organisms, although the causes and effects of this bias are unclear. Here, we measure expression from >14,000 synthetic reporters in Escherichia coli and show that using N-terminal rare codons instead of common ones increases expression by similar to 14-fold (median 4-fold). We quantify how individual N-terminal codons affect expression and show that these effects shape the sequence of natural genes. Finally, we demonstrate that reduced RNA structure and not codon rarity itself is responsible for expression increases. Our observations resolve controversies over the roles of N-terminal codon bias and suggest a straightforward method for optimizing heterologous gene expression in bacteria.	[Goodman, Daniel B.; Church, George M.; Kosuri, Sriram] Wyss Inst Biol Inspired Engn, Boston, MA 02115 USA; [Goodman, Daniel B.; Church, George M.] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Goodman, Daniel B.] Harvard MIT Hlth Sci & Technol, Cambridge, MA 02139 USA	Harvard University; Harvard Medical School; Harvard University	Church, GM (corresponding author), Wyss Inst Biol Inspired Engn, 3 Blackfan Circle, Boston, MA 02115 USA.	gchurch@genetics.med.harvard.edu; sri.kosuri@wyss.harvard.edu		Kosuri, Sriram/0000-0002-4661-0600; church, george/0000-0001-6232-9969; Goodman, Daniel/0000-0003-3759-6883	U.S. Department of Energy [DE-FG02-02ER63445]; NSF SynBERC [SA5283-11210]; Office of Naval Research [N000141010144]; Agilent Technologies; Wyss Institute; NSF	U.S. Department of Energy(United States Department of Energy (DOE)); NSF SynBERC(National Science Foundation (NSF)); Office of Naval Research(Office of Naval Research); Agilent Technologies; Wyss Institute; NSF(National Science Foundation (NSF))	We thank J. C. Way, E. R. Daugharthy, and R. T. Sauer for comments. The research was supported by the U.S. Department of Energy (DE-FG02-02ER63445 to G. M. C.), NSF SynBERC (SA5283-11210 to G. M. C.), Office of Naval Research (N000141010144 to G. M. C. and S. K.), Agilent Technologies, Wyss Institute, and an NSF Graduate Research Fellowship to D. B. G. Data can be accessed on the National Center for Biotechnology Information, NIH, Sequence Read Archive (SRA) (SRP029609). pGERC reporter can be obtained from AddGene (#47441). Accession numbers: The Project accession at the SRA is SRP029609. The sample accession is SRS477429. There are three experiments, one for DNA, one for RNA, one for FlowSeq: RNA, SRX346948; DNA, SRX346944; and FlowSeq, SRX346268.	Allert M, 2010, J MOL BIOL, V402, P905, DOI 10.1016/j.jmb.2010.08.010; Bentele K, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.32; Coleman JR, 2008, SCIENCE, V320, P1784, DOI 10.1126/science.1155761; DESMIT MH, 1990, P NATL ACAD SCI USA, V87, P7668, DOI 10.1073/pnas.87.19.7668; dos Reis M, 2004, NUCLEIC ACIDS RES, V32, P5036, DOI 10.1093/nar/gkh834; GOUY M, 1982, NUCLEIC ACIDS RES, V10, P7055, DOI 10.1093/nar/10.22.7055; Gu WJ, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000664; HARTL DL, 1994, GENETICS, V138, P227; Komar AA, 2009, TRENDS BIOCHEM SCI, V34, P16, DOI 10.1016/j.tibs.2008.10.002; Kosuri S, 2013, P NATL ACAD SCI USA, V110, P14024, DOI 10.1073/pnas.1301301110; Kudla G, 2009, SCIENCE, V324, P255, DOI 10.1126/science.1170160; LeProust EM, 2010, NUCLEIC ACIDS RES, V38, P2522, DOI 10.1093/nar/gkq163; Li GW, 2012, NATURE, V484, P538, DOI 10.1038/nature10965; Navon S, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-2-r12; Pechmann S, 2013, NAT STRUCT MOL BIOL, V20, P237, DOI 10.1038/nsmb.2466; Pedelacq JD, 2006, NAT BIOTECHNOL, V24, P79, DOI 10.1038/nbt1172; Plotkin JB, 2011, NAT REV GENET, V12, P32, DOI 10.1038/nrg2899; Shah P, 2013, CELL, V153, P1589, DOI 10.1016/j.cell.2013.05.049; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; SHARP PM, 1987, NUCLEIC ACIDS RES, V15, P1281, DOI 10.1093/nar/15.3.1281; Subramaniam AR, 2013, P NATL ACAD SCI USA, V110, P2419, DOI 10.1073/pnas.1211077110; Tuller T, 2010, CELL, V141, P344, DOI 10.1016/j.cell.2010.03.031; Tuller T, 2010, P NATL ACAD SCI USA, V107, P3645, DOI 10.1073/pnas.0909910107; Voges D, 2004, BIOCHEM BIOPH RES CO, V318, P601, DOI 10.1016/j.bbrc.2004.04.064; Welch M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007002; Yamazaki Yukiko, 2008, V416, P385, DOI 10.1007/978-1-59745-321-9_26; Zadeh JN, 2011, J COMPUT CHEM, V32, P170, DOI 10.1002/jcc.21596; Zhou M, 2013, NATURE, V495, P111, DOI 10.1038/nature11833	28	361	379	1	124	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 25	2013	342	6157					475	479		10.1126/science.1241934	http://dx.doi.org/10.1126/science.1241934			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239RH	24072823				2022-12-24	WOS:000326042600042
J	Ruff, CC; Ugazio, G; Fehr, E				Ruff, C. C.; Ugazio, G.; Fehr, E.			Changing Social Norm Compliance with Noninvasive Brain Stimulation	SCIENCE			English	Article							LATERAL PREFRONTAL CORTEX; NEURAL FOUNDATIONS; DECISION-MAKING; IMPULSE CONTROL; PUNISHMENT; FAIRNESS; COOPERATION	All known human societies have maintained social order by enforcing compliance with social norms. The biological mechanisms underlying norm compliance are, however, hardly understood. We show that the right lateral prefrontal cortex (rLPFC) is involved in both voluntary and sanction-induced norm compliance. Both types of compliance could be changed by varying the neural excitability of this brain region with transcranial direct current stimulation, but they were affected in opposite ways, suggesting that the stimulated region plays a fundamentally different role in voluntary and sanction-based compliance. Brain stimulation had a particularly strong effect on compliance in the context of socially constituted sanctions, whereas it left beliefs about what the norm prescribes and about subjectively expected sanctions unaffected. Our findings suggest that rLPFC activity is a key biological prerequisite for an evolutionarily and socially important aspect of human behavior.	[Ruff, C. C.; Ugazio, G.; Fehr, E.] Univ Zurich, Dept Econ, Lab Social & Neural Syst Res SNS Lab, Zurich, Switzerland; [Ugazio, G.] Univ Vienna, Social Cognit & Affect Neurosci Unit, Vienna, Austria	University of Zurich; University of Vienna	Ruff, CC (corresponding author), Univ Zurich, Dept Econ, Lab Social & Neural Syst Res SNS Lab, Zurich, Switzerland.	christian.ruff@econ.uzh.ch; ernst.fehr@econ.uzh.ch	Ruff, Christian C/N-9552-2016	Ruff, Christian C/0000-0002-3964-2364	European Research Council; Swiss National Science Foundation (SNSF) [CRSII3_141965, 51NF40_144609]; SNSF	European Research Council(European Research Council (ERC)European Commission); Swiss National Science Foundation (SNSF)(Swiss National Science Foundation (SNSF)); SNSF(Swiss National Science Foundation (SNSF))	C.C.R. and E. F. designed the research, C. C. R. and G. U. conducted the research, C. C. R. and G. U. analyzed data with input from E. F., and C. C. R. and E. F. wrote the paper with comments by G. U. We thank K. Treiber and A. Schlaepfer for their assistance with data collection. This study was supported by a European Research Council grant to E. F. (Foundations of Economic Preferences), Swiss National Science Foundation (SNSF) grants to C. C. R. and E. F. (CRSII3_141965 and 51NF40_144609), and the SNSF-funded Swiss National Center of Competence in Research Affective Sciences.	Aron AR, 2004, TRENDS COGN SCI, V8, P170, DOI 10.1016/j.tics.2004.02.010; Bechara A, 2005, CURR OPIN NEUROL, V18, P734, DOI 10.1097/01.wco.0000194141.56429.3c; Boyd R, 2003, P NATL ACAD SCI USA, V100, P3531, DOI 10.1073/pnas.0630443100; Buckholtz JW, 2012, NAT NEUROSCI, V15, P655, DOI 10.1038/nn.3087; Buckholtz JW, 2008, NEURON, V60, P930, DOI 10.1016/j.neuron.2008.10.016; Camerer C.F., 2003, BEHAV GAME THEORY EX, DOI 10.1257/jep.9.2.209; Crockett MJ, 2013, J NEUROSCI, V33, P3505, DOI 10.1523/JNEUROSCI.2761-12.2013; Croxson PL, 2005, J NEUROSCI, V25, P8854, DOI 10.1523/JNEUROSCI.1311-05.2005; de Quervain DJF, 2004, SCIENCE, V305, P1254, DOI 10.1126/science.1100735; Driver J, 2009, TRENDS COGN SCI, V13, P319, DOI 10.1016/j.tics.2009.04.007; Dunbar RIM, 2012, TRENDS COGN SCI, V16, P101, DOI 10.1016/j.tics.2011.11.013; Duncan J, 2010, TRENDS COGN SCI, V14, P172, DOI 10.1016/j.tics.2010.01.004; Fehr E, 2002, NATURE, V415, P137, DOI 10.1038/415137a; Fehr E, 2004, EVOL HUM BEHAV, V25, P63, DOI 10.1016/S1090-5138(04)00005-4; Figner B, 2010, NAT NEUROSCI, V13, P538, DOI 10.1038/nn.2516; Fischbacher U, 2001, ECON LETT, V71, P397, DOI 10.1016/S0165-1765(01)00394-9; FORSYTHE R, 1994, GAME ECON BEHAV, V6, P347, DOI 10.1006/game.1994.1021; Henrich J, 2001, AM ECON REV, V91, P73, DOI 10.1257/aer.91.2.73; King-Casas B, 2008, SCIENCE, V321, P806, DOI 10.1126/science.1156902; Knoch D, 2006, SCIENCE, V314, P829, DOI 10.1126/science.1129156; Loeber R, 2000, DEV PSYCHOPATHOL, V12, P737, DOI 10.1017/S0954579400004107; Mathew S, 2011, P NATL ACAD SCI USA, V108, P11375, DOI 10.1073/pnas.1105604108; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Montague PR, 2007, NEURON, V56, P14, DOI 10.1016/j.neuron.2007.09.020; Nitsche MA, 2000, J PHYSIOL-LONDON, V527, P633, DOI 10.1111/j.1469-7793.2000.t01-1-00633.x; Raine A, 2006, SOC COGN AFFECT NEUR, V1, P203, DOI 10.1093/scan/nsl033; Sanfey AG, 2003, SCIENCE, V300, P1755, DOI 10.1126/science.1082976; Sober E., 1998, OTHERS EVOLUTION PSY; Spitzer M, 2007, NEURON, V56, P185, DOI 10.1016/j.neuron.2007.09.011; Steinbeis N, 2012, NEURON, V73, P1040, DOI 10.1016/j.neuron.2011.12.027; Xue G, 2012, P NATL ACAD SCI USA, V109, P4401, DOI 10.1073/pnas.1111927109	31	179	184	2	87	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 25	2013	342	6157					482	484		10.1126/science.1241399	http://dx.doi.org/10.1126/science.1241399			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	239RH	24091703	Green Accepted			2022-12-24	WOS:000326042600044
J	Carraretto, L; Formentin, E; Teardo, E; Checchetto, V; Tomizioli, M; Morosinotto, T; Giacometti, GM; Finazzi, G; Szabo, I				Carraretto, Luca; Formentin, Elide; Teardo, Enrico; Checchetto, Vanessa; Tomizioli, Martino; Morosinotto, Tomas; Giacometti, Giorgio Mario; Finazzi, Giovanni; Szabo, Ildiko			A Thylakoid-Located Two-Pore K+ Channel Controls Photosynthetic Light Utilization in Plants	SCIENCE			English	Article							MEMBRANE; FLUORESCENCE; VOLTAGE; MEMBERS; ROLES; TPK1; PH	The size of the light-induced proton motive force (pmf) across the thylakoid membrane of chloroplasts is regulated in response to environmental stimuli. Here, we describe a component of the thylakoid membrane, the two-pore potassium (K+) channel TPK3, which modulates the composition of the pmf through ion counterbalancing. Recombinant TPK3 exhibited potassium-selective channel activity sensitive to Ca2+ and H+. In Arabidopsis plants, the channel is found in the thylakoid stromal lamellae. Arabidopsis plants silenced for the TPK3 gene display reduced growth and altered thylakoid membrane organization. This phenotype reflects an impaired capacity to generate a normal pmf, which results in reduced CO2 assimilation and deficient nonphotochemical dissipation of excess absorbed light. Thus, the TPK3 channel manages the pmf necessary to convert photochemical energy into physiological functions.	[Carraretto, Luca; Formentin, Elide; Teardo, Enrico; Checchetto, Vanessa; Morosinotto, Tomas; Giacometti, Giorgio Mario; Szabo, Ildiko] Univ Padua, Dept Biol, I-35121 Padua, Italy; [Checchetto, Vanessa; Tomizioli, Martino; Finazzi, Giovanni] CNRS, Lab Physiol Cellulaire & Vegetale, UMR 5168, F-38054 Grenoble, France; [Checchetto, Vanessa; Tomizioli, Martino; Finazzi, Giovanni] Commissariat Energie Atom & Energies Alternat, Inst Rech Technol & Sci Vivant, F-38054 Grenoble, France; [Checchetto, Vanessa; Tomizioli, Martino; Finazzi, Giovanni] Univ Grenoble Alpes, F-38041 Grenoble, France; [Checchetto, Vanessa; Tomizioli, Martino; Finazzi, Giovanni] INRA, USC 1359, F-38054 Grenoble, France	University of Padua; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; CEA; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); INRAE	Finazzi, G (corresponding author), CNRS, Lab Physiol Cellulaire & Vegetale, UMR 5168, F-38054 Grenoble, France.	giovanni.finazzi@cea.fr; ildi@civ.bio.unipd.it	Padova, Ildiko/K-5344-2016; Szabo, Ildiko/AAW-5972-2021; Morosinotto, Tomas/AAC-3188-2019; checchetto, vanessa/ABI-6145-2020	Szabo, Ildiko/0000-0002-3637-3947; Morosinotto, Tomas/0000-0002-0803-7591; checchetto, vanessa/0000-0001-8911-6146	Italy's PRIN (Research Projects of National Interest) [2010CSJX4F_005]; European Molecular Biology Organization Young Investigator Program; Aldo Gini Program; Italian Ministry of Education [L170]; French National Agency [ANR-2010-GENOM-BTV-002-01, ANR-NT09_567009]; Marie Curie Initial Training Network "AccliPhot" [316427]; Labex GRAL (Grenoble Alliance for Integrated Structural Cell Biology)	Italy's PRIN (Research Projects of National Interest); European Molecular Biology Organization Young Investigator Program(European Molecular Biology Organization (EMBO)); Aldo Gini Program; Italian Ministry of Education; French National Agency(French National Research Agency (ANR)); Marie Curie Initial Training Network "AccliPhot"; Labex GRAL (Grenoble Alliance for Integrated Structural Cell Biology)	The authors are grateful to M. Zoratti and N. La Rascio for useful discussion and to J. Barber, N. Uozumi, P. Joliot, and N. Rolland for critical reading of the manuscript. We thank A. Spena for the pBIN RolC plasmid, L. Leanza for help with antibody production, and M. Simonetti for help with artwork. We thank Italy's PRIN (Research Projects of National Interest) (2010CSJX4F_005 to I. S.) and European Molecular Biology Organization Young Investigator Program for financial support (to I. S.) and the Aldo Gini Program for a short-term grant to V. C. to work in the laboratory of G. F.; the Ph.D. fellowship for L. C. was provided by the Italian Ministry of Education (L170). M. T. was supported by the French National Agency (ANR-2010-GENOM-BTV-002-01 Chloro-Type). G. F. was funded by the French National Agency "Project PhytAdapt" (ANR-NT09_567009), the Marie Curie Initial Training Network "AccliPhot" (FP7-PEPOPLE-2012-ITN, grant agreement number 316427), and the Labex GRAL (Grenoble Alliance for Integrated Structural Cell Biology) grants. Author contributions: expression and purification of AtTPK3: L.C. and E. T.; electrophysiology: L. C., E. T., and I. S.; localization: L. C., E. F., and M. T.; silencing: L. C. and E. F.; pigment analysis: L. C. and T. M.; analysis of visible phenotype: L. C., T. M., I. S., and G. F.; electron microscopy and transmission electron microscopy service: L. C.; pmf measurements: M. T., V. C., and G. F. The study was designed by I. S., G. F., and G. M. G.; the paper was written by I. S. and G. F. This paper is dedicated to G. Franchin and E. Vaccher at Centro di Riferimento Oncologico (CRO), Aviano. Authors declare no conflict of interest. Additional data are in the supplementary materials.	Allen JF, 2002, CELL, V110, P273, DOI 10.1016/S0092-8674(02)00870-X; Avenson TJ, 2004, P NATL ACAD SCI USA, V101, P5530, DOI 10.1073/pnas.0401269101; Bailleul B, 2010, PHOTOSYNTH RES, V106, P179, DOI 10.1007/s11120-010-9579-z; Becker D, 2004, P NATL ACAD SCI USA, V101, P15621, DOI 10.1073/pnas.0401502101; BENDALL DS, 1982, BIOCHIM BIOPHYS ACTA, V683, P119, DOI 10.1016/0304-4173(82)90008-8; Bihler H, 2005, PLANT PHYSIOL, V139, P417, DOI 10.1104/pp.105.065599; Cruz JA, 2001, BIOCHEMISTRY-US, V40, P1226, DOI 10.1021/bi0018741; de Bianchi S, 2011, PLANT CELL, V23, P2659, DOI 10.1105/tpc.111.087320; Dunkel M, 2008, MOL PLANT, V1, P938, DOI 10.1093/mp/ssn064; Eberhard S, 2008, ANNU REV GENET, V42, P463, DOI 10.1146/annurev.genet.42.110807.091452; Enyedi P, 2010, PHYSIOL REV, V90, P559, DOI 10.1152/physrev.00029.2009; Gobert A, 2007, P NATL ACAD SCI USA, V104, P10726, DOI 10.1073/pnas.0702595104; Ioannidis NE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029864; Isayenkov S, 2013, PLANT SIGNAL BEHAV, V8, DOI 10.4161/psb.24665; Kramer DM, 2003, TRENDS PLANT SCI, V8, P27, DOI 10.1016/S1360-1385(02)00010-9; Li ZR, 2009, ANNU REV PLANT BIOL, V60, P239, DOI 10.1146/annurev.arplant.58.032806.103844; Marcel D, 2010, FEBS LETT, V584, P2433, DOI 10.1016/j.febslet.2010.04.038; Maxwell K, 2000, J EXP BOT, V51, P659, DOI 10.1093/jexbot/51.345.659; Paramonova NV, 2004, RUSS J PLANT PHYSL+, V51, P86, DOI 10.1023/B:RUPP.0000011307.95130.8f; Rintamaki E, 2000, P NATL ACAD SCI USA, V97, P11644, DOI 10.1073/pnas.180054297; SCHONKNECHT G, 1988, NATURE, V336, P589, DOI 10.1038/336589a0; Schonknecht G, 2002, FEBS LETT, V511, P28, DOI 10.1016/S0014-5793(01)03273-2; TESTER M, 1989, PLANT PHYSIOL, V91, P249, DOI 10.1104/pp.91.1.249; Voelker C, 2010, PLANT BIOLOGY, V12, P56, DOI 10.1111/j.1438-8677.2010.00353.x; Voelker C, 2006, PLANT J, V48, P296, DOI 10.1111/j.1365-313X.2006.02868.x; WITT HT, 1979, BIOCHIM BIOPHYS ACTA, V505, P355, DOI 10.1016/0304-4173(79)90008-9; WRAIGHT CA, 1970, EUR J BIOCHEM, V17, P319, DOI 10.1111/j.1432-1033.1970.tb01169.x; Zanetti M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010118	28	119	123	3	107	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 4	2013	342	6154					114	118		10.1126/science.1242113	http://dx.doi.org/10.1126/science.1242113			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	227PP	24009357				2022-12-24	WOS:000325126100058
J	Hunt, LP; Ben-Shlomo, Y; Clark, EM; Dieppe, P; Judge, A; MacGregor, AJ; Tobias, JH; Vernon, K; Blom, AW				Hunt, Linda P.; Ben-Shlomo, Yoav; Clark, Emma M.; Dieppe, Paul; Judge, Andrew; MacGregor, Alex J.; Tobias, Jon H.; Vernon, Kelly; Blom, Ashley W.		Natl Joint Registry England Wales	90-day mortality after 409 096 total hip replacements for osteoarthritis, from the National Joint Registry for England and Wales: a retrospective analysis	LANCET			English	Article							EARLY POSTOPERATIVE MORTALITY; RISK-FACTORS; ARTHROPLASTY; COMPLICATIONS; MORBIDITY; POSTERIOR; TRENDS; DEATH	Background Death within 90 days after total hip replacement is rare but might be avoidable dependent on patient and treatment factors. We assessed whether a secular decrease in death caused by hip replacement has occurred in England and Wales and whether modifi able perioperative factors exist that could reduce deaths. Methods We took data about hip replacements done in England and Wales between April, 2003, and December, 2011, from the National Joint Registry for England and Wales. Patient identifi ers were used to link these data to the national mortality database and the Hospital Episode Statistics database to obtain details of death, sociodemographics, and comorbidity. We assessed mortality within 90 days of operation by Kaplan-Meier analysis and assessed the role of patient and treatment factors by Cox proportional hazards model. Findings 409 096 primary hip replacements were done to treat osteoarthritis. 1743 patients died within 90 days of surgery during 8 years, with a substantial secular decrease in mortality, from 0.56% in 2003 to 0.29% in 2011, even after adjustment for age, sex, and comorbidity. Several modifi able clinical factors were associated with decreased mortality according to an adjusted model: posterior surgical approach (hazard ratio [HR] 0.82, 95% CI 0.73-0.92; p=0.001), mechanical thromboprophylaxis (0.85, 0.74-0.99; p=0.036), chemical thromboprophylaxis with heparin with or without aspirin (0.79, 0.66-0.93; p=0.005), and spinal versus general anaesthetic (0.85, 0.74-0.97; p=0.019). Type of prosthesis was unrelated to mortality. Being overweight was associated with lower mortality (0.76, 0.62-0.92; p=0.006). Interpretation Postoperative mortality after hip joint replacement has fallen substantially. Widespread adoption of four simple clinical management strategies (posterior surgical approach, mechanical and chemical prophylaxis, and spinal anaesthesia) could, if causally related, reduce mortality further.	[Hunt, Linda P.; Clark, Emma M.; Tobias, Jon H.; Vernon, Kelly; Blom, Ashley W.] Univ Bristol, Sch Clin Sci, Musculoskeletal Res Unit, Bristol, Avon, England; [Ben-Shlomo, Yoav] Univ Bristol, Sch Social & Community Med, Bristol, Avon, England; [Dieppe, Paul] Univ Exeter, Sch Med, Exeter, Devon, England; [Judge, Andrew] Univ Oxford, NIHR Musculoskeletal Biomed Res Unit, Oxford, England; [MacGregor, Alex J.] Norwich Med Sch, Norwich, Norfolk, England	University of Bristol; University of Bristol; University of Exeter; University of Oxford; University of East Anglia	Blom, AW (corresponding author), Univ Bristol, Sch Clin Sci, Musculoskeletal Res Unit, Bristol, Avon, England.	ashley.blom@nbt.nhs.uk	Ben-Shlomo, Yoav/ABD-2004-2021; Tobias, Jon/E-2832-2014	Ben-Shlomo, Yoav/0000-0001-6648-3007; Tobias, Jon/0000-0002-7475-3932; Judge, Andrew/0000-0003-3015-0432; Blom, Ashley/0000-0002-9940-1095; MacGregor, Alex/0000-0003-2163-2325	National Joint Registry for England and Wales	National Joint Registry for England and Wales	National Joint Registry for England and Wales.	Barrett J, 2005, J BONE JOINT SURG AM, V87A, P1965, DOI 10.2106/JBJS.D.02440; Blom A, 2006, ACTA ORTHOP, V77, P347, DOI 10.1080/17453670610046244; Bozic KJ, 2012, J BONE JOINT SURG AM, V94A, P794, DOI 10.2106/JBJS.K.00072; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Christensen K, 2009, LANCET, V374, P1196, DOI 10.1016/S0140-6736(09)61460-4; Hamer M, 2013, PREV MED, V57, P12, DOI 10.1016/j.ypmed.2013.02.012; Jimenez-Garcia R, 2011, BMC MUSCULOSKEL DIS, V12, DOI 10.1186/1471-2474-12-43; Jolles BM, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003828.pub3; Kirksey M, 2012, ANESTH ANALG, V115, P321, DOI 10.1213/ANE.0b013e31825b6824; Lie SA, 2002, ACTA ORTHOP SCAND, V73, P392, DOI 10.1080/00016470216312; Liu SS, 2009, INT ORTHOP, V33, P643, DOI 10.1007/s00264-008-0549-4; Memtsoudis SG, 2012, J ORTHOP RES, V30, P1811, DOI 10.1002/jor.22139; Memtsoudis SG, 2010, J ARTHROPLASTY, V25, P19, DOI 10.1016/j.arth.2008.11.010; National Joint Registry for England Wales Northern Ireland and the Isle of Man, 2012, 9 NAT JOINT REG ENGL; Parvizi J, 2001, J BONE JOINT SURG AM, V83A, P1524, DOI 10.2106/00004623-200110000-00010; Pedersen AB, 2011, J BONE JOINT SURG BR, V93B, P172, DOI 10.1302/0301-620X.93B2.25629; Pugely AJ, 2013, J BONE JOINT SURG AM, V95A, P193, DOI [10.2106/JBJS.K.01682, 10.2106/JBJS.L.01440]; Quan HD, 2005, MED CARE, V43, P1130, DOI 10.1097/01.mlr.0000182534.19832.83; Singh JA, 2012, J ARTHROPLASTY, V27, P1417, DOI 10.1016/j.arth.2012.03.008; Singh JA, 2011, J RHEUMATOL, V38, P1507, DOI 10.3899/jrheum.110280; Weale AE, 1996, J BONE JOINT SURG BR, V78B, P899, DOI 10.1302/0301-620X78B6.6603	21	204	212	0	27	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 28	2013	382	9898					1097	1104		10.1016/S0140-6736(13)61749-3	http://dx.doi.org/10.1016/S0140-6736(13)61749-3			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	228SG	24075049				2022-12-24	WOS:000325208100025
J	Sollenberger, JF; Holloway, RG				Sollenberger, Julia F.; Holloway, Robert G., Jr.			The Evolving Role and Value of Libraries and Librarians in Health Care	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							SERVICES		[Sollenberger, Julia F.] Univ Rochester, Edward G Miner Lib, Rochester, NY 14642 USA; [Holloway, Robert G., Jr.] Univ Rochester, Sch Med & Dent, Dept Neurol, Rochester, NY 14642 USA	University of Rochester; University of Rochester	Sollenberger, JF (corresponding author), Univ Rochester, Edward G Miner Lib, 601 Elmwood Ave, Rochester, NY 14642 USA.	julia_sollenberger@urmc.rochester.edu		Sollenberger, Julia/0000-0002-6993-953X				Aitken EM, 2011, ACAD MED, V86, P1508, DOI 10.1097/ACM.0b013e31823595cd; Association of Academic Health Sciences Libraries, 2010, ANN STAT MED SCH LIB; Association of Academic Health Sciences Libraries (AAHSL), 2013, ANN STAT MED SCH LIB; Banks DE, 2007, J MED LIBR ASSOC, V95, P381, DOI 10.3163/1536-5050.95.4.381; Brettle A, 2011, HEALTH INFO LIBR J, V28, P3, DOI 10.1111/j.1471-1842.2010.00925.x; Marshall JG, 2013, J MED LIBR ASSOC, V101, P38, DOI 10.3163/1536-5050.101.1.007; McGowan J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003785; Oliver KB, 2011, J MED LIBR ASSOC, V99, P237, DOI 10.3163/1536-5050.99.3.011; Sievert M, 2011, J HOSP LIBRARIANSHIP, V11, P140, DOI [10.1080/15323269.2011.558882, DOI 10.1080/15323269.2011.558882]	9	25	29	0	21	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 25	2013	310	12					1231	1232		10.1001/jama.2013.277050	http://dx.doi.org/10.1001/jama.2013.277050			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	222SO	24065006				2022-12-24	WOS:000324751800016
J	Beronja, S; Janki, P; Heller, E; Lien, WH; Keyes, BE; Oshimori, N; Fuchs, E				Beronja, Slobodan; Janki, Peter; Heller, Evan; Lien, Wen-Hui; Keyes, Brice E.; Oshimori, Naoki; Fuchs, Elaine			RNAi screens in mice identify physiological regulators of oncogenic growth	NATURE			English	Article							HAIR FOLLICLE MORPHOGENESIS; BETA-CATENIN; STEM-CELLS; EPIDERMAL DIFFERENTIATION; CANCER-CELLS; MOUSE SKIN; TGF-BETA; LEUKEMIA; HOMEOSTASIS; ACTIVATION	Tissue growth is the multifaceted outcome of a cell's intrinsic capabilities and its interactions with the surrounding environment. Decoding these complexities is essential for understanding human development and tumorigenesis. Here we tackle this problem by carrying out the first genome-wide RNA-interference-mediated screens in mice. Focusing on skin development and oncogenic (Hras(G12V)-induced) hyperplasia, our screens uncover previously unknown as well as anticipated regulators of embryonic epidermal growth. Among the top oncogenic screen hits are Mllt6 and the Wnt effector beta-catenin, which maintain Hras(G12V)-dependent hyperproliferation. We also expose beta-catenin as an unanticipated antagonist of normal epidermal growth, functioning through Wnt-independent intercellular adhesion. Finally, we validate functional significance in mouse and human cancers, thereby establishing the feasibility of in vivo mammalian genome-wide investigations to dissect tissue development and tumorigenesis. By documenting some oncogenic growth regulators, we pave the way for future investigations of other hits and raise promise for unearthing new targets for cancer therapies.	[Beronja, Slobodan; Janki, Peter; Heller, Evan; Lien, Wen-Hui; Keyes, Brice E.; Oshimori, Naoki; Fuchs, Elaine] Rockefeller Univ, Howard Hughes Med Inst, Lab Mammalian Cell Biol & Dev, New York, NY 10065 USA	Howard Hughes Medical Institute; Rockefeller University	Fuchs, E (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, Lab Mammalian Cell Biol & Dev, New York, NY 10065 USA.	fuchslb@rockefeller.edu	Fuchs, Elaine/G-1565-2016	Lien, Wen-Hui/0000-0002-2282-3169; Beronja, Slobodan/0000-0002-6769-9261	NIH [R37-AR27883, K99-AR061469]; Emerald Foundation; Human Frontiers Science Program Postdoctoral Fellowship; NATIONAL CANCER INSTITUTE [K99CA178197] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K99AR061469, R37AR027883] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Emerald Foundation; Human Frontiers Science Program Postdoctoral Fellowship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank J. Fagin for inducible oncogenic Hras mice; S. Williams, M. Schober, A. Rodriguez Folgueras, S. Dewell and D. Schramek for intellectual input; D. Oristian and N. Stokes as mouse specialists; Comparative Bioscience Center (AAALAC accredited) for care of mice in accordance with National Institutes of Health (NIH) guidelines; Genomics Resource Center (C. Zhao, Director) for sequencing; Bioimaging Center (A. North, Director) for advice; Flow Cytometry facility (S. Mazel, Director) for FACS sorting. E. F. is an Investigator of the Howard Hughes Medical Institute. This research was supported by grants from the NIH (R37-AR27883(E. F.) and K99-AR061469 (S. B.)), Emerald Foundation (E. F.) and Human Frontiers Science Program Postdoctoral Fellowship (S.B.).	Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Auer PL, 2010, GENETICS, V185, P405, DOI 10.1534/genetics.110.114983; Babij C, 2011, CANCER RES, V71, P5818, DOI 10.1158/0008-5472.CAN-11-0778; BALMAIN A, 1983, NATURE, V303, P72, DOI 10.1038/303072a0; Bernt KM, 2011, CANCER CELL, V20, P66, DOI 10.1016/j.ccr.2011.06.010; Beronja Slobodan, 2013, Methods Mol Biol, V961, P351, DOI 10.1007/978-1-62703-227-8_23; Beronja S, 2010, NAT MED, V16, P821, DOI 10.1038/nm.2167; Chan EF, 1999, NAT GENET, V21, P410, DOI 10.1038/7747; Chen X, 2009, P NATL ACAD SCI USA, V106, P7979, DOI 10.1073/pnas.0900343106; Clevers H, 2012, CELL, V149, P1192, DOI 10.1016/j.cell.2012.05.012; DasGupta R, 1999, DEVELOPMENT, V126, P4557; Davidson KC, 2012, P NATL ACAD SCI USA, V109, P4485, DOI 10.1073/pnas.1118777109; Donninger H, 2010, MOL CELL BIOL, V30, P2608, DOI 10.1128/MCB.00208-09; Ezratty EJ, 2011, CELL, V145, P1129, DOI 10.1016/j.cell.2011.05.030; Gat U, 1998, CELL, V95, P605, DOI 10.1016/S0092-8674(00)81631-1; Huang SMA, 2009, NATURE, V461, P614, DOI 10.1038/nature08356; Huelsken J, 2001, CELL, V105, P533, DOI 10.1016/S0092-8674(01)00336-1; Kandyba E, 2013, P NATL ACAD SCI USA, V110, P1351, DOI 10.1073/pnas.1121312110; Karnoub AE, 2008, NAT REV MOL CELL BIO, V9, P517, DOI 10.1038/nrm2438; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Linkert M, 2010, J CELL BIOL, V189, P777, DOI 10.1083/jcb.201004104; Malanchi I, 2008, NATURE, V452, P650, DOI 10.1038/nature06835; Miyata Y, 2010, STEM CELLS, V28, P308, DOI 10.1002/stem.270; Moffat J, 2006, CELL, V124, P1283, DOI 10.1016/j.cell.2006.01.040; Nguyen H, 2009, NAT GENET, V41, P1068, DOI 10.1038/ng.431; Nowak Jonathan A., 2009, V482, P215, DOI 10.1007/978-1-59745-060-7_14; Nusse R, 2008, CELL RES, V18, P523, DOI 10.1038/cr.2008.47; Oshimori N, 2012, CELL STEM CELL, V10, P63, DOI 10.1016/j.stem.2011.11.005; Posthaus H, 2002, J CELL SCI, V115, P4587, DOI 10.1242/jcs.00141; PRASAD R, 1994, P NATL ACAD SCI USA, V91, P8107, DOI 10.1073/pnas.91.17.8107; R Research Development Team, 2012, R LANG ENV STAT COMP; Schober M, 2011, P NATL ACAD SCI USA, V108, P10544, DOI 10.1073/pnas.1107807108; Scholl C, 2009, CELL, V137, P821, DOI 10.1016/j.cell.2009.03.017; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Suva ML, 2013, SCIENCE, V339, P1567, DOI 10.1126/science.1230184; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Vasioukhin V, 2000, CELL, V100, P209, DOI 10.1016/S0092-8674(00)81559-7; Vasioukhin V, 1999, P NATL ACAD SCI USA, V96, P8551, DOI 10.1073/pnas.96.15.8551; Wang YZ, 2010, SCIENCE, V327, P1650, DOI 10.1126/science.1186624; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Wiederschain D, 2009, CELL CYCLE, V8, P498, DOI 10.4161/cc.8.3.7701; Williams SE, 2011, NATURE, V470, P353, DOI 10.1038/nature09793; Zuber J, 2011, NATURE, V478, P524, DOI 10.1038/nature10334	44	114	115	1	64	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 12	2013	501	7466					185	+		10.1038/nature12464	http://dx.doi.org/10.1038/nature12464			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	215XR	23945586	Green Accepted			2022-12-24	WOS:000324244900033
J	Xu, Y; Wang, LM; He, J; Bi, YF; Li, M; Wang, TG; Wang, LH; Jiang, Y; Dai, M; Lu, JL; Xu, M; Li, YC; Hu, N; Li, JH; Mi, SQ; Chen, CS; Li, GW; Mu, YM; Zhao, JJ; Kong, LZ; Chen, JL; Lai, SH; Wang, WQ; Zhao, WH; Ning, G				Xu, Yu; Wang, Limin; He, Jiang; Bi, Yufang; Li, Mian; Wang, Tiange; Wang, Linhong; Jiang, Yong; Dai, Meng; Lu, Jieli; Xu, Min; Li, Yichong; Hu, Nan; Li, Jianhong; Mi, Shengquan; Chen, Chung-Shiuan; Li, Guangwei; Mu, Yiming; Zhao, Jiajun; Kong, Lingzhi; Chen, Jialun; Lai, Shenghan; Wang, Weiqing; Zhao, Wenhua; Ning, Guang		2010 China Noncommunicable Dis Sur	Prevalence and Control of Diabetes in Chinese Adults	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							IMPAIRED FASTING GLUCOSE; RISK-FACTORS; CANCER; MELLITUS; DISEASE; HEALTH; WOMEN; MEN	IMPORTANCE Noncommunicable chronic diseases have become the leading causes of mortality and disease burden worldwide. OBJECTIVE To investigate the prevalence of diabetes and glycemic control in the Chinese adult population. DESIGN, SETTING, AND PARTICIPANTS Using a complex, multistage, probability sampling design, we conducted a cross-sectional survey in a nationally representative sample of 98 658 Chinese adults in 2010. MAIN OUTCOMES AND MEASURES Plasma glucose and hemoglobin A(1c) levels were measured after at least a 10-hour overnight fast among all study participants, and a 2-hour oral glucose tolerance test was conducted among participants without a self-reported history of diagnosed diabetes. Diabetes and prediabetes were defined according to the 2010 American Diabetes Association criteria; whereas, a hemoglobin A1c level of <7.0% was considered adequate glycemic control. RESULTS The overall prevalence of diabetes was estimated to be 11.6% (95% CI, 11.3%-11.8%) in the Chinese adult population. The prevalence among men was 12.1% (95% CI, 11.7%-12.5%) and among women was 11.0% (95% CI, 10.7%-11.4%). The prevalence of previously diagnosed diabetes was estimated to be 3.5%(95% CI, 3.4%-3.6%) in the Chinese population: 3.6%(95% CI, 3.4%-3.8%) inmen and 3.4%(95% CI, 3.2%-3.5%) in women. The prevalence of undiagnosed diabetes was 8.1% (95% CI, 7.9%-8.3%) in the Chinese population: 8.5%(95% CI, 8.2%-8.8%) inmen and 7.7%(95% CI, 7.4%-8.0%) in women. In addition, the prevalence of prediabetes was estimated to be 50.1%(95% CI, 49.7%-50.6%) in Chinese adults: 52.1% (95% CI, 51.5%-52.7%) in men and 48.1%(95% CI, 47.6%-48.7%) in women. The prevalence of diabetes was higher in older age groups, in urban residents, and in persons living in economically developed regions. Among patients with diabetes, only 25.8% (95% CI, 24.9%-26.8%) received treatment for diabetes, and only 39.7%(95% CI, 37.6%-41.8%) of those treated had adequate glycemic control. CONCLUSIONS AND RELEVANCE The estimated prevalence of diabetes among a representative sample of Chinese adults was 11.6% and the prevalence of prediabetes was 50.1%. Projections based on sample weighting suggest this may represent up to 113.9 million Chinese adults with diabetes and 493.4 million with prediabetes. These findings indicate the importance of diabetes as a public health problem in China.	[Xu, Yu; Bi, Yufang; Li, Mian; Wang, Tiange; Dai, Meng; Lu, Jieli; Xu, Min; Chen, Jialun; Wang, Weiqing; Ning, Guang] Shanghai Jiao Tong Univ, Key Lab Endocrine & Metab Dis, State Key Lab Med Genom,E Inst Shanghai Univ, Rui Jin Hosp,Sch Med,Minist Hlth, Shanghai 200025, Peoples R China; [Xu, Yu; Bi, Yufang; Li, Mian; Wang, Tiange; Dai, Meng; Lu, Jieli; Xu, Min; Chen, Jialun; Wang, Weiqing; Ning, Guang] Shanghai Jiao Tong Univ, Shanghai Clin Ctr Endocrine & Metab Dis, Shanghai Inst Endocrine & Metab Dis, Dept Endocrine & Metab Dis,Rui Jin Hosp,Sch Med, Shanghai 200025, Peoples R China; [Wang, Limin; Wang, Linhong; Jiang, Yong; Li, Yichong; Hu, Nan; Li, Jianhong; Mi, Shengquan; Zhao, Wenhua] Chinese Ctr Dis Control & Prevent, Natl Ctr Chron & Noncommunicable Dis Control & Pr, Beijing, Peoples R China; [He, Jiang; Chen, Chung-Shiuan] Tulane Univ, Sch Publ Hlth & Trop Med, Dept Epidemiol, New Orleans, LA USA; [Li, Guangwei] Fuwai Hosp, Dept Endocrinol, Beijing, Peoples R China; [Mu, Yiming] Chinese Peoples Liberat Army Gen Hosp, Dept Endocrinol, Beijing, Peoples R China; [Zhao, Jiajun] Shandong Prov Hosp, Dept Endocrinol, Jinan, Shandong, Peoples R China; [Kong, Lingzhi] Minist Hlth, Dept Dis Control, Beijing, Peoples R China; [Lai, Shenghan] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA	Chinese Academy of Sciences; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Chinese Center for Disease Control & Prevention; National Center for Chronic & Noncommunicable Disease Control & Prevention, Chinese Center for Disease Control & Prevention; Tulane University; Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS; Chinese People's Liberation Army General Hospital; Shandong First Medical University & Shandong Academy of Medical Sciences; Johns Hopkins University	Ning, G (corresponding author), Shanghai Jiao Tong Univ, Key Lab Endocrine & Metab Dis, Dept Endocrine & Metab Dis, Rui Jin Hosp,Sch Med,Minist Hlth, 197 Rui Jin 2nd Rd, Shanghai 200025, Peoples R China.	wqingw@hotmail.com; whzhao@ilsichina.org; gning@sibs.ac.cn	mi, shengquan/GQI-0129-2022; wang, lin/GSE-3040-2022; Zhao, Jiajun/W-2963-2018; Li, Yichong/A-3559-2019; He, Jiang/AAF-5303-2020	mi, shengquan/0000-0003-3470-5458; Zhao, Jiajun/0000-0003-3267-9292; Li, Yichong/0000-0003-3842-475X; He, Jiang/0000-0002-8286-9652; Hong, Tianpei/0000-0002-5744-5129	Chinese Ministry of Finance from the Key Laboratory for Endocrine and Metabolic Diseases of Ministry of Health [1994DP131044]; Ministry of Health [201002002]; National Key New Drug Creation and Manufacturing Program of Ministry of Science and Technology [2012ZX09303006-001]; National High Technology Research and Development Program of China (863 Program) [2011AA020107]; National Natural Science Foundation of China [81030011, 81222008, 81130016]	Chinese Ministry of Finance from the Key Laboratory for Endocrine and Metabolic Diseases of Ministry of Health; Ministry of Health; National Key New Drug Creation and Manufacturing Program of Ministry of Science and Technology; National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work is supported by the Chinese Ministry of Finance grants 1994DP131044 from the Key Laboratory for Endocrine and Metabolic Diseases of Ministry of Health; 201002002 from the Sector Funds of Ministry of Health; 2012ZX09303006-001 from the National Key New Drug Creation and Manufacturing Program of Ministry of Science and Technology; 2011AA020107 from the National High Technology Research and Development Program of China (863 Program); and 81030011, 81222008, and 81130016 from the National Natural Science Foundation of China.	Alcorn T, 2012, LANCET, V379, P2227, DOI 10.1016/S0140-6736(12)60963-5; Ali MK, 2013, NEW ENGL J MED, V368, P1613, DOI 10.1056/NEJMsa1213829; Amer Diabet Assoc, 2010, DIABETES CARE, V33, pS62, DOI 10.2337/dc10-s062; [Anonymous], 1981, Zhonghua Nei Ke Za Zhi, V20, P678; [Anonymous], 2011, FACT SHEET; Armstrong T, 2006, J PUBLIC HEALTH-HEID, V14, P66, DOI 10.1007/s10389-006-0024-x; Chan JCN, 2009, JAMA-J AM MED ASSOC, V301, P2129, DOI 10.1001/jama.2009.726; Danaei G, 2006, LANCET, V368, P1651, DOI 10.1016/S0140-6736(06)69700-6; Flegal KM, 2012, JAMA-J AM MED ASSOC, V307, P491, DOI 10.1001/jama.2012.39; Friberg E, 2007, DIABETOLOGIA, V50, P1365, DOI 10.1007/s00125-007-0681-5; Gu D, 2003, DIABETOLOGIA, V46, P1190, DOI 10.1007/s00125-003-1167-8; He J, 2005, NEW ENGL J MED, V353, P1124, DOI 10.1056/NEJMsa050467; Hu FB, 2011, DIABETES CARE, V34, P1249, DOI 10.2337/dc11-0442; Huxley R, 2005, BRIT J CANCER, V92, P2076, DOI 10.1038/sj.bjc.6602619; International Diabetes Federation, DIABETES ATLAS, V9th; KISH L, 1949, J AM STAT ASSOC, V44, P380, DOI 10.2307/2280236; Larsson SC, 2005, JNCI-J NATL CANCER I, V97, P1679, DOI 10.1093/jnci/dji375; Larsson SC, 2007, INT J CANCER, V121, P856, DOI 10.1002/ijc.22717; Levey AS, 2012, LANCET, V379, P165, DOI 10.1016/S0140-6736(11)60178-5; Levitzky YS, 2008, J AM COLL CARDIOL, V51, P264, DOI 10.1016/j.jacc.2007.09.038; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Mohamed Q, 2007, JAMA-J AM MED ASSOC, V298, P902, DOI 10.1001/jama.298.8.902; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; Pan XR, 1997, DIABETES CARE, V20, P1664, DOI 10.2337/diacare.20.11.1664; Roglic G, 2010, DIABETES RES CLIN PR, V87, P15, DOI 10.1016/j.diabres.2009.10.006; Schmidt MI, 2005, DIABETES CARE, V28, P2013, DOI 10.2337/diacare.28.8.2013; VOSS EM, 1992, DIABETES CARE, V15, P700, DOI 10.2337/diacare.15.5.700; Wang LD, 2005, LANCET, V366, P1821, DOI 10.1016/S0140-6736(05)67344-8; World Health Organization, PREV DIAB MELL; World Health Organization, 1997, OB PREV MAN GLOB EP; World Health Organization Western Pacific Region International Association for the Study of Obesity International Obesity TaskForce, AS PAC PERSP RED OB; Yang Gonghuan, 2005, Popul Health Metr, V3, P3, DOI 10.1186/1478-7954-3-3; Yang WY, 2010, NEW ENGL J MED, V362, P1090, DOI 10.1056/NEJMoa0908292; Yau JWY, 2012, DIABETES CARE, V35, P556, DOI 10.2337/dc11-1909	34	2093	2948	22	549	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 4	2013	310	9					948	958		10.1001/jama.2013.168118	http://dx.doi.org/10.1001/jama.2013.168118			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	211DT	24002281	Bronze			2022-12-24	WOS:000323885700025
J	Tuck, AC; Tollervey, D				Tuck, Alex Charles; Tollervey, David			A Transcriptome-wide Atlas of RNP Composition Reveals Diverse Classes of mRNAs and lncRNAs	CELL			English	Article							POLY(A) TAIL LENGTH; BINDING PROTEIN; BIDIRECTIONAL PROMOTERS; STRUCTURAL BASIS; NUCLEAR EXOSOME; TERMINATION; DEGRADATION; EXPORT; GENE; SPECIFICITY	Eukaryotic genomes generate a heterogeneous ensemble of mRNAs and long noncoding RNAs (lncRNAs). LncRNAs and mRNAs are both transcribed by Pol II and acquire 5' caps and poly(A) tails, but only mRNAs are translated into proteins. To address how these classes are distinguished, we identified the transcriptome-wide targets of 13 RNA processing, export, and turnover factors in budding yeast. Comparing the maturation pathways of mRNAs and lncRNAs revealed that transcript fate is largely determined during 3' end formation. Most lncRNAs are targeted for nuclear RNA surveillance, but a subset with 3' cleavage and polyadenylation features resembling the mRNA consensus can be exported to the cytoplasm. The Hrp1 and Nab2 proteins act at this decision point, with dual roles in mRNA cleavage/polyadenylation and lncRNA surveillance. Our data also reveal the dynamic and heterogeneous nature of mRNA maturation, and highlight a subset of "lncRNA-like" mRNAs regulated by the nuclear surveillance machinery.	[Tuck, Alex Charles; Tollervey, David] Univ Edinburgh, Wellcome Trust Ctr Cell Biol, Edinburgh EH9 3JR, Midlothian, Scotland	University of Edinburgh	Tollervey, D (corresponding author), Univ Edinburgh, Wellcome Trust Ctr Cell Biol, Michael Swann Bldg,Kings Bldg, Edinburgh EH9 3JR, Midlothian, Scotland.	d.tollervey@ed.ac.uk	Tollervey, David/AAR-6662-2020	Tollervey, David/0000-0003-2894-2772; Tuck, Alex/0000-0003-0748-9913	Wellcome Trust [086587, 077248, 092076]; European Commission [201142]	Wellcome Trust(Wellcome TrustEuropean Commission); European Commission(European CommissionEuropean Commission Joint Research Centre)	We thank Sander Granneman and Grzegorz Kudla for help with analyses and Ola Helwak and Jai Tree for comments on the manuscript. This work was supported by Wellcome Trust grants (086587 and 077248) and European Commission 7th Framework Programme (UNICELLSYS, Grant No. 201142). Work in the Wellcome Trust Centre for Cell Biology is supported by Wellcome Trust core funding (092076). A. C. T. and D. T. designed the experiments; A. C. T. performed experiments and analyzed the data; A. C. T. and D. T. wrote the paper.	Batisse J, 2009, J BIOL CHEM, V284, P34911, DOI 10.1074/jbc.M109.062034; Bousquet-Antonelli C, 2000, CELL, V102, P765, DOI 10.1016/S0092-8674(00)00065-9; Brar GA, 2012, SCIENCE, V335, P552, DOI 10.1126/science.1215110; Brockmann C, 2012, STRUCTURE, V20, P1007, DOI 10.1016/j.str.2012.03.011; Camblong J, 2009, GENE DEV, V23, P1534, DOI 10.1101/gad.522509; Castelnuovo M, 2013, NAT STRUCT MOL BIOL, V20, P851, DOI 10.1038/nsmb.2598; Churchman LS, 2011, NATURE, V469, P368, DOI 10.1038/nature09652; Ciais D, 2008, NUCLEIC ACIDS RES, V36, P3075, DOI 10.1093/nar/gkn160; Creamer TJ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002329; David L, 2006, P NATL ACAD SCI USA, V103, P5320, DOI 10.1073/pnas.0601091103; Faza MB, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002915; Geisler S, 2012, MOL CELL, V45, P279, DOI 10.1016/j.molcel.2011.11.025; Gonzalez CI, 2000, MOL CELL, V5, P489, DOI 10.1016/S1097-2765(00)80443-8; Gonzalez-Aguilera C, 2011, MOL BIOL CELL, V22, P2729, DOI 10.1091/mbc.E11-01-0055; Gornemann J, 2005, MOL CELL, V19, P53, DOI 10.1016/j.molcel.2005.05.007; Granneman S, 2011, EMBO J, V30, P4006, DOI 10.1038/emboj.2011.256; Gudipati RK, 2012, MOL CELL, V48, P409, DOI 10.1016/j.molcel.2012.08.018; Gudipati RK, 2012, EMBO J, V31, P2427, DOI 10.1038/emboj.2012.81; Guisbert KK, 2005, RNA, V11, P383, DOI 10.1261/rna.7234205; Hasegawa Y, 2008, RNA, V14, P2333, DOI 10.1261/rna.1016508; Hieronymus H, 2003, NAT GENET, V33, P155, DOI 10.1038/ng1080; Hilleren PJ, 2003, MOL CELL, V12, P1453, DOI 10.1016/S1097-2765(03)00488-X; Hu WQ, 2009, NATURE, V461, P225, DOI 10.1038/nature08265; Iglesias N, 2010, GENE DEV, V24, P1927, DOI 10.1101/gad.583310; Ji XJ, 2011, EMBO J, V30, P2622, DOI 10.1038/emboj.2011.171; Kessler MM, 1997, GENE DEV, V11, P2545, DOI 10.1101/gad.11.19.2545; Kim M, 2004, EMBO J, V23, P354, DOI 10.1038/sj.emboj.7600053; Kim M, 2006, MOL CELL, V24, P723, DOI 10.1016/j.molcel.2006.11.011; Kuehner JN, 2008, MOL CELL, V31, P201, DOI 10.1016/j.molcel.2008.05.018; Larochelle M, 2012, NUCLEIC ACIDS RES, V40, P10240, DOI 10.1093/nar/gks838; Lund MK, 2005, MOL CELL, V20, P645, DOI 10.1016/j.molcel.2005.10.005; Mauchi N, 2010, CELL STRUCT FUNCT, V35, P95, DOI 10.1247/csf.10011; Mayer A, 2012, SCIENCE, V336, P1723, DOI 10.1126/science.1219651; Mayer A, 2010, NAT STRUCT MOL BIOL, V17, P1272, DOI 10.1038/nsmb.1903; Mitchell SF, 2013, NAT STRUCT MOL BIOL, V20, P127, DOI 10.1038/nsmb.2468; Neil H, 2009, NATURE, V457, P1038, DOI 10.1038/nature07747; Paquin N, 2008, TRENDS CELL BIOL, V18, P105, DOI 10.1016/j.tcb.2007.12.004; Parker R, 2012, GENETICS, V191, P671, DOI 10.1534/genetics.111.137265; Pelechano V, 2013, NATURE, V497, P127, DOI 10.1038/nature12121; Perez-Canadillas JM, 2006, EMBO J, V25, P3167, DOI 10.1038/sj.emboj.7601190; Porrua O, 2013, BBA-GENE REGUL MECH, V1829, P604, DOI 10.1016/j.bbagrm.2013.02.012; Reis CC, 2007, GENETICS, V175, P993, DOI 10.1534/genetics.106.065987; Rhee HS, 2012, NATURE, V483, P295, DOI 10.1038/nature10799; Rondon AG, 2010, BBA-GENE REGUL MECH, V1799, P533, DOI 10.1016/j.bbagrm.2010.06.002; Roth KM, 2009, RNA, V15, P1045, DOI 10.1261/rna.709609; Schmid M, 2012, MOL CELL, V47, P267, DOI 10.1016/j.molcel.2012.05.005; Schneider C, 2012, MOL CELL, V48, P422, DOI 10.1016/j.molcel.2012.08.013; Schwer B, 2011, NUCLEIC ACIDS RES, V39, P6715, DOI 10.1093/nar/gkr279; Thiebaut M, 2008, MOL CELL, V31, P671, DOI 10.1016/j.molcel.2008.08.010; Tollervey JR, 2011, NAT NEUROSCI, V14, P452, DOI 10.1038/nn.2778; Tran EJ, 2007, MOL CELL, V28, P850, DOI 10.1016/j.molcel.2007.09.019; van Dijk EL, 2011, NATURE, V475, P114, DOI 10.1038/nature10118; Vasiljeva L, 2006, MOL CELL, V21, P239, DOI 10.1016/j.molcel.2005.11.028; Viphakone N, 2008, NUCLEIC ACIDS RES, V36, P2418, DOI 10.1093/nar/gkn080; Vogel C, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.009217; Wagschal A, 2012, CELL, V150, P1147, DOI 10.1016/j.cell.2012.08.004; Wlotzka W, 2011, EMBO J, V30, P1790, DOI 10.1038/emboj.2011.97; Wolf JJ, 2010, GENETICS, V185, P513, DOI 10.1534/genetics.110.113944; Wong CM, 2007, MOL CELL BIOL, V27, P6520, DOI 10.1128/MCB.00733-07; Xu ZY, 2009, NATURE, V457, P1033, DOI 10.1038/nature07728	60	160	162	0	37	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 29	2013	154	5					996	1009		10.1016/j.cell.2013.07.047	http://dx.doi.org/10.1016/j.cell.2013.07.047			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	209OE	23993093	Green Published, hybrid			2022-12-24	WOS:000323767300014
J	Marijon, E; Bougouin, W; Perier, MC; Celermajer, DS; Jouven, X				Marijon, Eloi; Bougouin, Wulfran; Perier, Marie-Cecile; Celermajer, David S.; Jouven, Xavier			Incidence of Sports-Related Sudden Death in France by Specific Sports and Sex	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Marijon, Eloi] Univ Paris 05, Sorbonne Paris Cite, Paris, France; [Bougouin, Wulfran] AP HP, Paris, France; [Perier, Marie-Cecile] INSERM, Paris Cardiovasc Res Ctr, U970, Paris, France; [Celermajer, David S.] Univ Sydney, Sydney Med Sch, Sydney, NSW 2006, Australia; [Jouven, Xavier] Sudden Death Expertise Ctr, Paris, France	UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; University of Sydney	Marijon, E (corresponding author), Hop Europeen Georges Pompidou, Paris Cardiovasc Res Ctr, 56 Rue Leblanc, F-75737 Paris 15, France.	eloi_marijon@yahoo.fr	Bougouin, Wulfran/AAS-7565-2021	Celermajer, David/0000-0001-7640-0439				Albert CM, 1996, CIRCULATION, V93, P1170, DOI 10.1161/01.CIR.93.6.1170; Borjesson M, 2011, EUR J CARDIOV PREV R, V18, P446, DOI 10.1097/HJR.0b013e32833bo969; Drezner JA, 2008, CURR OPIN CARDIOL, V23, P494, DOI 10.1097/HCO.0b013e32830b3624; Marijon E, 2011, CIRCULATION, V124, P672, DOI 10.1161/CIRCULATIONAHA.110.008979; Ministere de la Jeunesse et des Sports; Institut National du Sport et de l'Education Physique, 2002, PRAT SPORT FRANC	5	30	30	1	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 14	2013	310	6					641	642		10.1001/jama.2013.8711	http://dx.doi.org/10.1001/jama.2013.8711			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	200HI	23942684	Bronze			2022-12-24	WOS:000323058400021
J	Silber, JH; Rosenbaum, PR; Clark, AS; Giantonio, BJ; Ross, RN; Teng, Y; Wang, M; Niknam, BA; Ludwig, JM; Wang, W; Even-Shoshan, O; Fox, KR				Silber, Jeffrey H.; Rosenbaum, Paul R.; Clark, Amy S.; Giantonio, Bruce J.; Ross, Richard N.; Teng, Yun; Wang, Min; Niknam, Bijan A.; Ludwig, Justin M.; Wang, Wei; Even-Shoshan, Orit; Fox, Kevin R.			Characteristics Associated With Differences in Survival Among Black and White Women With Breast Cancer	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ADJUVANT HORMONAL-THERAPY; SOCIOECONOMIC-STATUS; RACIAL DISPARITIES; ETHNIC-DIFFERENCES; COMORBIDITY INDEX; UNITED-STATES; FINE BALANCE; TUMOR SIZE; MEDICARE; STAGE	IMPORTANCE Difference in breast cancer survival by race is a recognized problem among Medicare beneficiaries. OBJECTIVE To determine if racial disparity in breast cancer survival is primarily attributable to differences in presentation characteristics at diagnosis or subsequent treatment. DESIGN, SETTING, AND PATIENTS Comparison of 7375 black women 65 years and older diagnosed between 1991 to 2005 and 3 sets of 7375 matched white control patients selected from 99 898 white potential controls, using data for 16 US Surveillance, Epidemiology and End Results (SEER) sites in the SEER-Medicare database. All patients received follow-up through December 31, 2009, and the black case patients were matched to 3 white control populations on demographics (age, year of diagnosis, and SEER site), presentation (demographics variables plus patient comorbid conditions and tumor characteristics such as stage, size, grade, and estrogen receptor status), and treatment (presentation variables plus details of surgery, radiation therapy, and chemotherapy). MAIN OUTCOMES AND MEASURES 5-Year survival. RESULTS The absolute difference in 5-year survival (blacks, 55.9%; whites, 68.8%) was 12.9% (95% CI, 11.5%-14.5%; P < .001) in the demographics match. This difference remained unchanged between 1991 and 2005. After matching on presentation characteristics, the absolute difference in 5-year survival was 4.4%(95% CI, 2.8%-5.8%; P < .001) and was 3.6% (95% CI, 2.3%-4.9%; P < .001) lower for blacks than for whites matched also on treatment. In the presentation match, fewer blacks received treatment (87.4% vs 91.8%; P < .001), time from diagnosis to treatment was longer (29.2 vs 22.8 days; P < .001), use of anthracyclines and taxols was lower (3.7% vs 5.0%; P < .001), and breast-conserving surgery without other treatment was more frequent (8.2% vs 7.3%; P = .04). Nevertheless, differences in survival associated with treatment differences accounted for only 0.81% of the 12.9% survival difference. CONCLUSIONS AND RELEVANCE In the SEER-Medicare database, differences in breast cancer survival between black and white women did not substantially change among women diagnosed between 1991 and 2005. These differences in survival appear primarily related to presentation characteristics at diagnosis rather than treatment differences.	[Silber, Jeffrey H.; Ross, Richard N.; Teng, Yun; Wang, Min; Niknam, Bijan A.; Ludwig, Justin M.; Wang, Wei; Even-Shoshan, Orit] Childrens Hosp Philadelphia, Ctr Outcomes Res, Philadelphia, PA 19104 USA; [Silber, Jeffrey H.; Clark, Amy S.; Giantonio, Bruce J.; Fox, Kevin R.] Univ Penn, Leonard & Madlyn Abramson Canc Ctr, Philadelphia, PA 19104 USA; [Silber, Jeffrey H.] Univ Penn, Dept Pediat, Perelman Sch Med, Philadelphia, PA 19104 USA; [Silber, Jeffrey H.] Childrens Hosp Philadelphia, Dept Pediat, Div Pediat Oncol, Philadelphia, PA 19104 USA; [Silber, Jeffrey H.] Univ Penn, Perelman Sch Med, Dept Anesthesiol & Crit Care, Philadelphia, PA 19104 USA; [Silber, Jeffrey H.] Univ Penn, Wharton Sch, Dept Hlth Care Management, Philadelphia, PA 19104 USA; [Silber, Jeffrey H.; Rosenbaum, Paul R.; Even-Shoshan, Orit] Univ Penn, Leonard Davis Inst Hlth Econ, Philadelphia, PA 19104 USA; [Rosenbaum, Paul R.] Univ Penn, Wharton Sch, Dept Stat, Philadelphia, PA 19104 USA; [Clark, Amy S.; Giantonio, Bruce J.; Fox, Kevin R.] Hosp Univ Penn, Div Med Oncol, Philadelphia, PA 19104 USA; [Clark, Amy S.; Giantonio, Bruce J.; Fox, Kevin R.] Univ Penn, Dept Med, Perelman Sch Med, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine	Silber, JH (corresponding author), Childrens Hosp Philadelphia, Ctr Outcomes Res, 3535 Market St,Ste 1029, Philadelphia, PA 19104 USA.	silber@email.chop.edu	Rosenbaum, Paul R/H-8687-2012		Agency for Healthcare Research and Quality (AHRQ); Department of Health and Human Services [R01 HS 018355]; US National Science Foundation [NSF SBS 1260782]; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [R01HS018355] Funding Source: NIH RePORTER	Agency for Healthcare Research and Quality (AHRQ)(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); Department of Health and Human Services; US National Science Foundation(National Science Foundation (NSF)); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	This research was funded through a grant from the Agency for Healthcare Research and Quality (AHRQ), Department of Health and Human Services (R01 HS 018355), and by the US National Science Foundation (NSF SBS 1260782). This study used the linked SEER-Medicare database.	Agency Healthcare Research and Quality, 2011, 2011 NAT HEALTHC QUA, V2011; [Anonymous], 2009, STAT AN SOFTW SYST U; Bach PB, 2004, NEW ENGL J MED, V351, P575, DOI 10.1056/NEJMsa040609; Bach PB, 2002, MED CARE, V40, P19; Bishop YMM, 1975, DISCRETE MULTIVARIAT, P281; Byers TE, 2008, CANCER-AM CANCER SOC, V113, P582, DOI 10.1002/cncr.23567; Carey LA, 2006, JAMA-J AM MED ASSOC, V295, P2492, DOI 10.1001/jama.295.21.2492; Chagpar AB, 2011, SURGERY, V150, P796, DOI 10.1016/j.surg.2011.07.066; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; COCHRAN WG, 1973, SANKHYA SER A, V35, P417; Cross CK, 2002, CANCER, V95, P1988, DOI 10.1002/cncr.10830; Curtis E, 2008, CANCER-AM CANCER SOC, V112, P171, DOI 10.1002/cncr.23131; Daniel SR, 2008, J COMPUT GRAPH STAT, V17, P914, DOI 10.1198/106186008X385806; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; Efron B, 1986, STAT SCI, V1, P54, DOI DOI 10.1214/SS/1177013815; Gorey KM, 2009, BREAST CANCER RES TR, V113, P595, DOI 10.1007/s10549-008-9960-1; Grann V, 2006, SOC SCI MED, V62, P337, DOI 10.1016/j.socscimed.2005.06.038; Haas JS, 2008, CANCER-AM CANCER SOC, V113, P2166, DOI 10.1002/cncr.23828; Heller R, 2010, AM STAT, V64, P299, DOI 10.1198/tast.2010.09210; Hershman D, 2005, J CLIN ONCOL, V23, P6639, DOI 10.1200/JCO.2005.12.633; Hershman DL, 2010, J CLIN ONCOL, V28, P4120, DOI 10.1200/JCO.2009.25.9655; Hollander M, 1973, NONPARAMETRIC STAT M; HOLT JD, 1974, BIOMETRIKA, V61, P17, DOI 10.1093/biomet/61.1.17; Joffe MM, 1999, AM J EPIDEMIOL, V150, P327; Kalbfleish J., 1980, STAT ANAL FAILURE TI; Kimmick G, 2009, J CLIN ONCOL, V27, P3445, DOI 10.1200/JCO.2008.19.2419; Klabunde CN, 2007, ANN EPIDEMIOL, V17, P584, DOI 10.1016/j.annepidem.2007.03.011; Klabunde CN, 2000, J CLIN EPIDEMIOL, V53, P1258, DOI 10.1016/S0895-4356(00)00256-0; McBride R, 2007, CANCER-AM CANCER SOC, V110, P1201, DOI 10.1002/cncr.22884; McCarthy EP, 1998, ANN INTERN MED, V128, P729, DOI 10.7326/0003-4819-128-9-199805010-00005; National Cancer Institute, SEER MED LINK DAT; OBRIEN PC, 1987, BIOMETRICS, V43, P169, DOI 10.2307/2531957; Ooi SL, 2011, BREAST CANCER RES TR, V127, P729, DOI 10.1007/s10549-010-1191-6; Owusu C, 2008, J CLIN ONCOL, V26, P549, DOI 10.1200/JCO.2006.10.1022; Pham HH, 2007, NEW ENGL J MED, V356, P1130, DOI 10.1056/NEJMsa063979; R Development Core Team, 2012, R LANG ENV STAT COMP; Rosenbaum PR, 2007, J AM STAT ASSOC, V102, P75, DOI 10.1198/016214506000001059; Rosenbaum PR, 2013, AM STAT, V67, P67, DOI 10.1080/00031305.2013.769914; Rosenbaum PR, 2010, SPRINGER SER STAT, P197, DOI 10.1007/978-1-4419-1213-8_10; Rosenbaum PR, 2005, J ROY STAT SOC B, V67, P515, DOI 10.1111/j.1467-9868.2005.00513.x; Rosenbaum PR, 2010, SPRINGER SER STAT, P1, DOI 10.1007/978-1-4419-1213-8; ROSENBAUM PR, 1983, BIOMETRIKA, V70, P41, DOI 10.1093/biomet/70.1.41; ROSENBAUM PR, 1985, AM STAT, V39, P33, DOI 10.2307/2683903; Rubin DB, 2001, HLTH SERV OUTCOME RE, V2, P169, DOI 10.1023/A:1020363010465; Rubin DB, 2008, ANN APPL STAT, V2, P808, DOI 10.1214/08-AOAS187; Rubin DB, 2007, STAT MED, V26, P20, DOI 10.1002/sim.2739; SAS Institute Inc, 1999, SAS OR US GUID MATH, P39; Gorin SS, 2006, ARCH INTERN MED, V166, P2244, DOI 10.1001/archinte.166.20.2244; Silber JH, 2012, ANN SURG, V256, P79, DOI 10.1097/SLA.0b013e31825375ef; Silber JH, 2001, MED CARE, V39, P1048, DOI 10.1097/00005650-200110000-00003; Smith-Bindman R, 2006, ANN INTERN MED, V144, P541, DOI 10.7326/0003-4819-144-8-200604180-00004; Tammemagi CM, 2005, JAMA-J AM MED ASSOC, V294, P1765, DOI 10.1001/jama.294.14.1765; Thu AM, 2008, AM J SURG, V196, P500, DOI 10.1016/j.amjsurg.2008.06.027; Volpp KG, 2007, JAMA-J AM MED ASSOC, V298, P984, DOI 10.1001/jama.298.9.984; Volpp KG, 2007, JAMA-J AM MED ASSOC, V298, P975, DOI 10.1001/jama.298.9.975; Ward E, 2004, CA-CANCER J CLIN, V54, P78, DOI 10.3322/canjclin.54.2.78; Warren JL, 2002, MED CARE, V40, P3; Yang D, 2012, BIOMETRICS, V68, P628, DOI 10.1111/j.1541-0420.2011.01691.x	58	215	216	0	36	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 24	2013	310	4					389	397		10.1001/jama.2013.8272	http://dx.doi.org/10.1001/jama.2013.8272			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	187LV	23917289	Bronze, Green Submitted			2022-12-24	WOS:000322121500016
J	Ho, BT; Basler, M; Mekalanos, JJ				Ho, Brian T.; Basler, Marek; Mekalanos, John J.			Type 6 Secretion System-Mediated Immunity to Type 4 Secretion System-Mediated Gene Transfer	SCIENCE			English	Article							PLASMID RP4; ESCHERICHIA-COLI; POLYMYXIN-B; HOST-RANGE; TRA2 CORE; PROTEINS; IDENTIFICATION; MOBILIZATION; RESISTANCE; EFFECTOR	Gram-negative bacteria use the type VI secretion system (T6SS) to translocate toxic effector proteins into adjacent cells. The Pseudomonas aeruginosa H1-locus T6SS assembles in response to exogenous T6SS attack by other bacteria. We found that this lethal T6SS counterattack also occurs in response to the mating pair formation (Mpf) system encoded by broad-host-range IncP alpha conjugative plasmid RP4 present in adjacent donor cells. This T6SS response was eliminated by disruption of Mpf structural genes but not components required only for DNA transfer. Because T6SS activity was also strongly induced by membrane-disrupting natural product polymyxin B, we conclude that RP4 induces "donor-directed T6SS attacks" at sites corresponding to Mpf-mediated membrane perturbations in recipient P. aeruginosa cells to potentially block acquisition of parasitic foreign DNA.	[Ho, Brian T.; Basler, Marek; Mekalanos, John J.] Harvard Univ, Sch Med, Dept Microbiol & Immunobiol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Mekalanos, JJ (corresponding author), Harvard Univ, Sch Med, Dept Microbiol & Immunobiol, 77 Ave Louis Pasteur, Boston, MA 02115 USA.	john_mekalanos@hms.harvard.edu	Ho, Brian/M-1976-2019; Basler, Marek/A-3559-2012	Ho, Brian/0000-0003-4979-780X; Basler, Marek/0000-0001-5414-2088	National Institute of Allergy and Infectious Diseases [AI-018045, AI-26289]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI026289, R37AI018045, R22AI018045, R01AI018045] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Supporting movies and table can be found in the supplementary materials. This work was supported by National Institute of Allergy and Infectious Diseases grants AI-018045 and AI-26289 to J.J.M.	Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Basler M, 2012, SCIENCE, V337, P815, DOI 10.1126/science.1222901; Basler M, 2012, NATURE, V483, P182, DOI 10.1038/nature10846; Basler M, 2013, CELL, V152, P884, DOI 10.1016/j.cell.2013.01.042; BAYER M, 1995, J BACTERIOL, V177, P4279, DOI 10.1128/jb.177.15.4279-4288.1995; Boyer F, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-104; Christie PJ, 2000, TRENDS MICROBIOL, V8, P354, DOI 10.1016/S0966-842X(00)01792-3; Dong TG, 2013, P NATL ACAD SCI USA, V110, P2623, DOI 10.1073/pnas.1222783110; Fernandez D, 1996, J BACTERIOL, V178, P3168, DOI 10.1128/jb.178.11.3168-3176.1996; Giebelhaus LA, 1996, J BACTERIOL, V178, P6378, DOI 10.1128/jb.178.21.6378-6381.1996; HAASE J, 1995, J BACTERIOL, V177, P4779, DOI 10.1128/jb.177.16.4779-4791.1995; Hankins JV, 2012, P NATL ACAD SCI USA, V109, P8722, DOI 10.1073/pnas.1201313109; Hibbing ME, 2010, NAT REV MICROBIOL, V8, P15, DOI 10.1038/nrmicro2259; Hood RD, 2010, CELL HOST MICROBE, V7, P25, DOI 10.1016/j.chom.2009.12.007; Horvath P, 2010, SCIENCE, V327, P167, DOI 10.1126/science.1179555; LANGER PJ, 1981, J BACTERIOL, V145, P1310, DOI 10.1128/JB.145.3.1310-1316.1981; Leiman PG, 2009, P NATL ACAD SCI USA, V106, P4154, DOI 10.1073/pnas.0813360106; Li ZY, 1997, J BIOL CHEM, V272, P19582, DOI 10.1074/jbc.272.31.19582; Luo ZQ, 2004, P NATL ACAD SCI USA, V101, P841, DOI 10.1073/pnas.0304916101; McPhee JB, 2003, MOL MICROBIOL, V50, P205, DOI 10.1046/j.1365-2958.2003.03673.x; MORRISON DC, 1976, IMMUNOCHEMISTRY, V13, P813, DOI 10.1016/0019-2791(76)90181-6; Mougous JD, 2006, SCIENCE, V312, P1526, DOI 10.1126/science.1128393; NAITO T, 1995, SCIENCE, V267, P897, DOI 10.1126/science.7846533; PANSEGRAU W, 1994, J MOL BIOL, V239, P623, DOI 10.1006/jmbi.1994.1404; Pukatzki S, 2006, P NATL ACAD SCI USA, V103, P1528, DOI 10.1073/pnas.0510322103; Rietsch A, 2005, P NATL ACAD SCI USA, V102, P8006, DOI 10.1073/pnas.0503005102; Schroder G, 2005, PLASMID, V54, P1, DOI 10.1016/j.plasmid.2005.02.001; SIMON R, 1983, BIO-TECHNOL, V1, P784, DOI 10.1038/nbt1183-784; Zhong ZP, 2005, PLASMID, V54, P48, DOI 10.1016/j.plasmid.2004.11.001	29	81	83	2	50	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 11	2013	342	6155					250	253		10.1126/science.1243745	http://dx.doi.org/10.1126/science.1243745			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232EV	24115441	Green Accepted			2022-12-24	WOS:000325475200046
J	Babaria, P				Babaria, Palav			Threatened Hope - PEPFAR and Health in Africa	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material								Mr. C. had been aged by his life circumstances. Like most of the South African clinic's patients, he was malnourished and frail but had a tenacity that had sustained him through his HIV diagnosis and his first bout of tuberculosis several years earlier. Cows, chickens, and patients lounged outside the clinic in the blistering heat of a waning South African summer. From the window, I watched them gravitate to the shade of a giant jacaranda tree. The electricity was out for the fourth time that morning, and beads of perspiration dotted our bodies as we waited. It would be hours before the x-ray machine, lights, and air conditioner returned to life. Doctor, you have another patient, the nurse announced, though I was neither a doctor nor supposed to be seeing patients. I was a fourth-year medical student posted to a rural district hospital ...	[Babaria, Palav] Univ Calif San Francisco, Dept Internal Med, San Francisco, CA 94143 USA; [Babaria, Palav] Highland Hosp, Dept Med, Oakland, CA USA	University of California System; University of California San Francisco	Babaria, P (corresponding author), Univ Calif San Francisco, Dept Internal Med, San Francisco, CA 94143 USA.								0	0	0	0	8	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 10	2013	369	15					1388	1389		10.1056/NEJMp1301649	http://dx.doi.org/10.1056/NEJMp1301649			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	231QE	24106931				2022-12-24	WOS:000325431500003
J	Colbert, JA; Jangi, S				Colbert, James A.; Jangi, Sushrut			Training Physicians to Manage Obesity - Back to the Drawing Board	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							INTERNAL-MEDICINE RESIDENTS	Just as obesity treatment should begin while patients are young and behaviors are relatively easy to change, educational programs should be developed for young physicians-in-training that will enable them to recognize, treat, and research obesity. According to the Centers for Disease Control and Prevention, nearly one third of U.S. children and about two thirds of U.S. adults are overweight or obese (see map) and therefore at increased risk for hypertension, diabetes, and musculoskeletal disease. If the trend continues unchecked, half the adults in the United States may be obese by 2030. Although a few clinics specializing in weight management have sprung up around the country, not everyone is lucky enough to be able to attend a multidisciplinary weight-management program. Thus, the front lines of the obesity epidemic often lie in a primary care doctor's office. ...	[Colbert, James A.] Brigham & Womens Hosp, Boston, MA 02115 USA; [Jangi, Sushrut] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA; [Colbert, James A.] Newton Wellesley Hosp, Newton, MA USA	Harvard University; Brigham & Women's Hospital; Harvard University; Beth Israel Deaconess Medical Center; Newton Wellesley Hospital	Colbert, JA (corresponding author), Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA.							Block JP, 2003, PREV MED, V36, P669, DOI 10.1016/S0091-7435(03)00055-0; Blue AV, 2007, J PUBLIC HEALTH MAN, V13, P539; Martino S, 2007, MED EDUC, V41, P160, DOI 10.1111/j.1365-2929.2006.02673.x; Ruser CB, 2005, J GEN INTERN MED, V20, P1139, DOI 10.1111/j.1525-1497.2005.0263.x	4	23	23	0	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 10	2013	369	15					1389	1391		10.1056/NEJMp1306460	http://dx.doi.org/10.1056/NEJMp1306460			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	231QE	24106932				2022-12-24	WOS:000325431500004
J	Rice, CM; Kemp, K; Wilkins, A; Scolding, NJ				Rice, Claire M.; Kemp, Kevin; Wilkins, Alastair; Scolding, Neil J.			Cell therapy for multiple sclerosis: an evolving concept with implications for other neurodegenerative diseases	LANCET			English	Article							MESENCHYMAL STEM-CELLS; MARROW STROMAL CELLS; RAT SPINAL-CORD; CENTRAL-NERVOUS-SYSTEM; BONE-MARROW; REGENERATIVE MEDICINE; HEMATOPOIETIC-CELLS; IFATS COLLECTION; PURKINJE NEURONS; REMYELINATION	Multiple sclerosis is a major cause of neurological disability, and particularly occurs in young adults. It is characterised by conspicuous patches of damage throughout the brain and spinal cord, with loss of myelin and myelinating cells (oligodendrocytes), and damage to neurons and axons. Multiple sclerosis is incurable, but stem-cell therapy might off er valuable therapeutic potential. Eff orts to develop stem-cell therapies for multiple sclerosis have been conventionally built on the principle of direct implantation of cells to replace oligodendrocytes, and therefore to regenerate myelin. Recent progress in understanding of disease processes in multiple sclerosis include observations that spontaneous myelin repair is far more widespread and successful than was previously believed, that loss of axons and neurons is more closely associated with progressive disability than is myelin loss, and that damage occurs diff usely throughout the CNS in grey and white matter, not just in discrete, isolated patches or lesions. These fi ndings have introduced new and serious challenges that stem-cell therapy needs to overcome; the practical challenges to achieve cell replacement alone are diffi cult enough, but, to be useful, cell therapy for multiple sclerosis must achieve substantially more than the replacement of lost oligodendrocytes. However, parallel advances in understanding of the reparative properties of stem cells-including their distinct immunomodulatory and neuroprotective properties, interactions with resident or tissue-based stem cells, cell fusion, and neurotrophin elaboration-off er renewed hope for development of cell-based therapies. Additionally, these advances suggest avenues for translation of this approach not only for multiple sclerosis, but also for other common neurological and neurodegenerative diseases.	[Rice, Claire M.; Kemp, Kevin; Wilkins, Alastair; Scolding, Neil J.] Univ Bristol, Inst Clin Neurosci, Burden MS Stem Cell Labs, Bristol BS16 1LE, Avon, England; [Rice, Claire M.; Kemp, Kevin; Wilkins, Alastair; Scolding, Neil J.] Frenchay Hosp, BrAMS Unit, Bristol BS16 1LE, Avon, England	University of Bristol	Scolding, NJ (corresponding author), Univ Bristol, Inst Clin Neurosci, Burden MS Stem Cell Labs, Bristol BS16 1LE, Avon, England.	n.j.scolding@bristol.ac.uk	Rice, Claire M/A-1673-2011; Kemp, Kevin/B-9755-2017	Rice, Claire M/0000-0002-9851-4426; Kemp, Kevin/0000-0003-1465-1309; Scolding, Neil/0000-0001-9177-1043	National Institute for Health; Medical Research Council; Silverman Family Foundation; MRC [MR/J012580/1, MR/K004166/1] Funding Source: UKRI; Medical Research Council [MR/K004166/1, MR/J012580/1] Funding Source: researchfish; National Institute for Health Research [CL-2010-25-003] Funding Source: researchfish; Rosetrees Trust [M180] Funding Source: researchfish	National Institute for Health; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Silverman Family Foundation; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); Rosetrees Trust(Rosetrees Trust)	CMR is supported by a National Institute for Health Research clinical lectureship. KK is supported by the Medical Research Council. The Burden Neurological Institute MS Stem Cell Therapy programme is supported by the Silverman Family Foundation.	Akiyama Y, 2002, GLIA, V39, P229, DOI 10.1002/glia.10102; Akiyama Y, 2002, J NEUROSCI, V22, P6623; Albert M, 2007, BRAIN PATHOL, V17, P129, DOI 10.1111/j.1750-3639.2006.00043.x; Alusi SH, 1999, J NEUROL NEUROSUR PS, V66, P131, DOI 10.1136/jnnp.66.2.131; Alves H, 2010, J CELL MOL MED, V14, P2729, DOI 10.1111/j.1582-4934.2009.00931.x; Back SA, 2005, NAT MED, V11, P966, DOI 10.1038/nm1279; Bai LH, 2009, GLIA, V57, P1192, DOI 10.1002/glia.20841; Barhum Y, 2010, J MOL NEUROSCI, V41, P129, DOI 10.1007/s12031-009-9302-8; Bennetto L, 2011, MULT SCLER J, V17, P1218, DOI 10.1177/1352458511407368; Bernardo ME, 2012, ANN NY ACAD SCI, V1266, P107, DOI 10.1111/j.1749-6632.2012.06667.x; BLAKEMORE WF, 1977, NATURE, V266, P68, DOI 10.1038/266068a0; Bonab MM, 2012, CURR STEM CELL RES T, V7, P407; Brex PA, 2002, NEW ENGL J MED, V346, P158, DOI 10.1056/NEJMoa011341; Chang A, 2008, BRAIN, V131, P2366, DOI 10.1093/brain/awn157; Chard D, 2009, CURR OPIN NEUROL, V22, P214, DOI 10.1097/WCO.0b013e32832b4c62; Charles P, 2002, BRAIN, V125, P1972, DOI 10.1093/brain/awf216; Chen JL, 2001, STROKE, V32, P1005, DOI 10.1161/01.STR.32.4.1005; Chen KA, 2011, MOL CELL NEUROSCI, V47, P61, DOI 10.1016/j.mcn.2011.03.003; Cogle CR, 2004, LANCET, V363, P1432, DOI 10.1016/S0140-6736(04)16102-3; Connick P, 2012, LANCET NEUROL, V11, P150, DOI 10.1016/S1474-4422(11)70305-2; Crisostomo PR, 2006, SHOCK, V26, P575, DOI 10.1097/01.shk.0000235087.45798.93; Daher SR, 2008, STEM CELLS, V26, P2664, DOI 10.1634/stemcells.2008-0927; Dahl JA, 2008, INT J DEV BIOL, V52, P1033, DOI 10.1387/ijdb.082663jd; De Feo D, 2012, CURR OPIN NEUROL, V25, P322, DOI 10.1097/WCO.0b013e328352ec45; Devine SM, 2003, BLOOD, V101, P2999, DOI 10.1182/blood-2002-06-1830; Duncan ID, 2008, J NEUROL SCI, V265, P89, DOI 10.1016/j.jns.2007.04.043; Duncan ID, 2005, J INHERIT METAB DIS, V28, P357, DOI 10.1007/s10545-005-7058-z; Evangelou N, 2005, BRAIN, V128, P29, DOI 10.1093/brain/awh323; Fancy SPJ, 2010, EXP NEUROL, V225, P18, DOI 10.1016/j.expneurol.2009.12.020; Franklin RJM, 2002, NAT REV NEUROSCI, V3, P705, DOI 10.1038/nrn917; Freedman MS, 2010, MULT SCLER J, V16, P503, DOI 10.1177/1352458509359727; Fu LJ, 2008, STEM CELLS DEV, V17, P1109, DOI 10.1089/scd.2008.0068; Fu XB, 2009, AGEING RES REV, V8, P244, DOI 10.1016/j.arr.2009.02.002; Gordon D, 2010, J NEUROPATH EXP NEUR, V69, P1087, DOI 10.1097/NEN.0b013e3181f97392; Gordon D, 2008, NEUROSCI LETT, V448, P71, DOI 10.1016/j.neulet.2008.10.040; Grigoriadis N, 2011, EXP NEUROL, V230, P78, DOI 10.1016/j.expneurol.2011.02.021; Hirst C, 2008, J NEUROL, V255, P280, DOI 10.1007/s00415-008-0743-8; Huang JK, 2011, NEUROCHEM INT, V59, P329, DOI 10.1016/j.neuint.2011.01.017; Irvine KA, 2008, BRAIN, V131, P1464, DOI 10.1093/brain/awn080; Johansson CB, 2008, NAT CELL BIOL, V10, P575, DOI 10.1038/ncb1720; Karussis D, 2010, ARCH NEUROL-CHICAGO, V67, P1187, DOI 10.1001/archneurol.2010.248; Kassis I, 2008, ARCH NEUROL-CHICAGO, V65, P753, DOI 10.1001/archneur.65.6.753; Kemp K, 2011, NEUROPATH APPL NEURO, V37, P166, DOI 10.1111/j.1365-2990.2010.01122.x; Kemp K, 2012, BRAIN, V135, P2962, DOI 10.1093/brain/aws226; Kemp K, 2010, STEM CELL REV REP, V6, P548, DOI 10.1007/s12015-010-9178-6; Kemp K, 2010, J NEUROCHEM, V114, P1569, DOI 10.1111/j.1471-4159.2009.06553.x; Korbling M, 2003, NEW ENGL J MED, V349, P570, DOI 10.1056/NEJMra022361; Kutzelnigg A, 2005, BRAIN, V128, P2705, DOI 10.1093/brain/awh641; Lalu MM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047559; Lang AE, 2012, ANN NEUROL, V71, P283, DOI 10.1002/ana.22676; Lee AS, 2013, NAT MED, V19, P998, DOI 10.1038/nm.3267; Lee JP, 2007, NAT MED, V13, P439, DOI 10.1038/nm1548; Lee JK, 2012, STEM CELLS, V30, P1544, DOI 10.1002/stem.1125; Lee PH, 2012, ANN NEUROL, V72, P32, DOI 10.1002/ana.23612; Lee RH, 2009, CELL STEM CELL, V5, P54, DOI 10.1016/j.stem.2009.05.003; Lescaudron L, 2012, CURR MED CHEM, V19, P6018; Maeda Y, 2001, ANN NEUROL, V49, P776, DOI 10.1002/ana.1015; Magrassi L, 2007, J NEUROSCI, V27, P9885, DOI 10.1523/JNEUROSCI.2539-07.2007; Morikawa S, 2009, BIOCHEM BIOPH RES CO, V379, P1114, DOI 10.1016/j.bbrc.2009.01.031; Muller. R., 1949, ACTA MED SCAND  S222, V133, P1; Munoz JR, 2005, P NATL ACAD SCI USA, V102, P18171, DOI 10.1073/pnas.0508945102; Nasef A, 2009, INT J LAB HEMATOL, V31, P9, DOI 10.1111/j.1751-553X.2007.00997.x; Nygren JM, 2008, NAT CELL BIOL, V10, P584, DOI 10.1038/ncb1721; Oh JY, 2012, MOL THER, V20, P2143, DOI 10.1038/mt.2012.165; Osaka M, 2010, BRAIN RES, V1343, P226, DOI 10.1016/j.brainres.2010.05.011; Patani R, 2007, NEUROPATH APPL NEURO, V33, P277, DOI 10.1111/j.1365-2990.2007.00805.x; Paty DW, 2002, NEW ENGL J MED, V346, P199, DOI 10.1056/NEJM200201173460311; PERIER O, 1965, BRAIN, V88, P937, DOI 10.1093/brain/88.5.937; Phinney DG, 2012, J CELL BIOCHEM, V113, P2806, DOI 10.1002/jcb.24166; Picard-Riera N, 2002, P NATL ACAD SCI USA, V99, P13211, DOI 10.1073/pnas.192314199; Pisati F, 2007, CELL TRANSPLANT, V16, P41, DOI 10.3727/000000007783464443; PRINEAS JW, 1979, ANN NEUROL, V5, P22, DOI 10.1002/ana.410050105; Prockop DJ, 2012, NAT MED, V18, P653, DOI 10.1038/nm.2769; Prockop DJ, 2012, MOL THER, V20, P14, DOI 10.1038/mt.2011.211; Prockop DJ, 2010, CYTOTHERAPY, V12, P576, DOI 10.3109/14653249.2010.507330; Rice CM, 2010, CLIN PHARMACOL THER, V87, P679, DOI 10.1038/clpt.2010.44; Rice CM, 2013, J NEUROL NEUROSUR PS, V84, P1100, DOI 10.1136/jnnp-2012-304140; Rice CM, 2010, CELL ADHES MIGR, V4, P235, DOI 10.4161/cam.4.2.11404; Rice CM, 2010, BRIT J HAEMATOL, V148, P441, DOI 10.1111/j.1365-2141.2009.07986.x; Rice CM, 2004, LANCET, V364, P193, DOI 10.1016/S0140-6736(04)16633-6; Riordan NH, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-29; Sasaki H, 2009, SPINE, V34, P249, DOI 10.1097/BRS.0b013e3181913cde; Sasaki M, 2001, GLIA, V35, P26, DOI 10.1002/glia.1067; Scalfari A, 2010, BRAIN, V133, P1914, DOI 10.1093/brain/awq118; Scolding N, 1998, BRAIN, V121, P2221, DOI 10.1093/brain/121.12.2221; Scolding N, 1998, LANCET, V352, P340, DOI 10.1016/S0140-6736(05)60463-1; Shen LH, 2011, STROKE, V42, P459, DOI 10.1161/STROKEAHA.110.593863; Snethen H, 2008, REGEN MED, V3, P835, DOI 10.2217/17460751.3.6.835; Stadelmann C, 2011, BBA-MOL BASIS DIS, V1812, P275, DOI 10.1016/j.bbadis.2010.07.007; Tateno K, 2006, CURR PHARM DESIGN, V12, P557, DOI 10.2174/138161206775474332; Uccelli A, 2007, TRENDS IMMUNOL, V28, P219, DOI 10.1016/j.it.2007.03.001; Wang DX, 2012, AQUAT ECOSYST HEALTH, V15, P4, DOI 10.1080/14634988.2012.663631; Wei X, 2009, STEM CELLS, V27, P478, DOI 10.1634/stemcells.2008-0333; Wilkins A, 2003, J NEUROSCI, V23, P4967, DOI 10.1523/jneurosci.23-12-04967.2003; Wilkins A, 2009, STEM CELL RES, V3, P63, DOI 10.1016/j.scr.2009.02.006; Wolswijk G, 1998, J NEUROSCI, V18, P601; Wright KT, 2011, STEM CELLS, V29, P169, DOI 10.1002/stem.570; Yamout B, 2010, J NEUROIMMUNOL, V227, P185, DOI 10.1016/j.jneuroim.2010.07.013; Yi L, 2005, GLIA, V49, P407, DOI 10.1002/glia.20126; Zappia E, 2005, BLOOD, V106, P1755, DOI 10.1182/blood-2005-04-1496; Zhang J, 2006, J NEUROSCI RES, V84, P587, DOI 10.1002/jnr.20962	101	45	45	0	34	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 5	2013	382	9899					1204	1213		10.1016/S0140-6736(13)61810-3	http://dx.doi.org/10.1016/S0140-6736(13)61810-3			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	228SL	24095194				2022-12-24	WOS:000325209100025
J	Black, ME				Black, Mary E.			How to get out of hospital	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												drmaryblack@gmail.com							0	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 25	2013	347								f5788	10.1136/bmj.f5788	http://dx.doi.org/10.1136/bmj.f5788			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	227CW	24068724				2022-12-24	WOS:000325087200021
J	Nakashima, A; Takeuchi, H; Imai, T; Saito, H; Kiyonari, H; Abe, T; Chen, M; Weinstein, LS; Yu, CR; Storm, DR; Nishizumi, H; Sakano, H				Nakashima, Ai; Takeuchi, Haruki; Imai, Takeshi; Saito, Harumi; Kiyonari, Hiroshi; Abe, Takaya; Chen, Min; Weinstein, Lee S.; Yu, C. Ron; Storm, Daniel R.; Nishizumi, Hirofumi; Sakano, Hitoshi			Agonist-Independent GPCR Activity Regulates Anterior-Posterior Targeting of Olfactory Sensory Neurons	CELL			English	Article							ODORANT RECEPTORS; BETA(2)-ADRENERGIC RECEPTOR; MAP; GENE; EXPRESSION; MUTAGENESIS; DISRUPTION; ACTIVATION; G(S)ALPHA; DOMAINS	G-protein-coupled receptors (GPCRs) are known to possess two different conformations, active and inactive, and they spontaneously alternate between the two in the absence of ligands. Here, we analyzed the agonist-independent GPCR activity for its possible role in receptor-instructed axonal projection. We generated transgenic mice expressing activity mutants of the beta 2-adrenergic receptor, a well-characterized GPCR with the highest homology to odorant receptors (ORs). We found that mutants with altered agonist-independent activity changed the transcription levels of axon-targeting molecules-e.g., Neuropilin-1 and Plexin-A1-but not of glomerular segregation molecules-e.g., Kirrel2 and Kirrel3-thus causing shifts in glomerular locations along the anterior-posterior (A-P) axis. Knockout and in vitro experiments demonstrated that G(s), but not G(olf), is responsible for mediating the agonist-independent GPCR activity. We conclude that the equilibrium of conformational transitions set by each OR is the major determinant of expression levels of A-P-targeting molecules.	[Nakashima, Ai; Takeuchi, Haruki; Imai, Takeshi; Saito, Harumi; Nishizumi, Hirofumi; Sakano, Hitoshi] Univ Tokyo, Grad Sch Sci, Dept Biophys & Biochem, Tokyo 1130032, Japan; [Nakashima, Ai; Takeuchi, Haruki; Sakano, Hitoshi] Univ Fukui, Sch Med Sci, Dept Brain Funct, Fukui 9101193, Japan; [Imai, Takeshi] RIKEN Ctr Dev Biol, Lab Sensory Circuit Format, Kobe, Hyogo 6500047, Japan; [Imai, Takeshi] Japan Sci & Technol Agcy, PRESTO, Kawaguchi, Saitama 3320012, Japan; [Kiyonari, Hiroshi; Abe, Takaya] RIKEN Ctr Dev Biol, Lab Anim Resources & Genet Engn, Kobe, Hyogo 6500047, Japan; [Chen, Min; Weinstein, Lee S.] NIDDK, Metab Dis Branch, NIH, Bethesda, MD 20892 USA; [Yu, C. Ron] Stowers Inst Med Res, Kansas City, MO 64110 USA; [Storm, Daniel R.] Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA	University of Tokyo; University of Fukui; RIKEN; Japan Science & Technology Agency (JST); RIKEN; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Stowers Institute for Medical Research; University of Washington; University of Washington Seattle	Sakano, H (corresponding author), Univ Tokyo, Grad Sch Sci, Dept Biophys & Biochem, Tokyo 1130032, Japan.	sakano@mail.ecc.u-tokyo.ac.jp	Imai, Takeshi/L-2201-2013; Kiyonari, Hiroshi/N-7936-2015; Weinstein, Lee S/I-5575-2015	Imai, Takeshi/0000-0002-8449-0080; Takeuchi, Haruki/0000-0003-4911-4060; Nakashima, Ai/0000-0002-2274-5009	PRESTO program of Japan Science and Technology Corporation; Toray Science Foundation; Sumitomo Foundation; Nakajima Foundation; Mitsubishi Foundation; Japan Foundation for Applied Enzymology; Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan; MEXT of Japan; Grants-in-Aid for Scientific Research [23680038, 24000014, 23300140] Funding Source: KAKEN; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK043313] Funding Source: NIH RePORTER	PRESTO program of Japan Science and Technology Corporation; Toray Science Foundation(Toray Industries, Inc.); Sumitomo Foundation; Nakajima Foundation; Mitsubishi Foundation; Japan Foundation for Applied Enzymology; Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); MEXT of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank R. Axel for G<INF>olf</INF>-KO mice; R. Kobayakawa and K. Kobayakawa for Omacs-cre mice; T. Hirata for antibodies against Nrp1; H. Ueno for antibodies against Kirrel3; F. Suto and Y. Hiromi for antibodies against PlxnA1; S. Suzuki and A. Miyajima for FACS analysis; A. Katsuyama for technical assistance; J.-P. Changeux, L. Luo, O. Nureki, and H. Kato for insightful discussion; and J. Ngai, L. Buck, and our laboratory members for valuable comments. This research was supported by the PRESTO program of Japan Science and Technology Corporation (T.I.), Toray Science Foundation (H.S.), Sumitomo Foundation (T.I.), Nakajima Foundation (T.I.), Mitsubishi Foundation (H.S. and T.I.), Japan Foundation for Applied Enzymology (T.I., H.T., H.N., and H.S.), grants in aid from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan (T.I., H.N., H.T., and H.S.), and a Specially Promoted Research Grant from MEXT of Japan (H.S.).	Ballesteros JA, 2001, J BIOL CHEM, V276, P29171, DOI 10.1074/jbc.M103747200; Belluscio L, 1998, NEURON, V20, P69, DOI 10.1016/S0896-6273(00)80435-3; Bond RA, 2006, TRENDS PHARMACOL SCI, V27, P92, DOI 10.1016/j.tips.2005.12.007; BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; Chen M, 2005, P NATL ACAD SCI USA, V102, P7386, DOI 10.1073/pnas.0408268102; Chen Y, 2006, CELL, V127, P881, DOI 10.1016/j.cell.2006.11.017; Chesler AT, 2007, P NATL ACAD SCI USA, V104, P1039, DOI 10.1073/pnas.0609215104; CHESS A, 1994, CELL, V78, P823, DOI 10.1016/S0092-8674(94)90562-2; Connelly T, 2013, J NEUROPHYSIOL, V110, P55, DOI 10.1152/jn.00910.2012; COPPOLA DM, 1989, NEUROSCI LETT, V106, P241, DOI 10.1016/0304-3940(89)90170-5; Dal Col JA, 2007, DEVELOPMENT, V134, P2481, DOI 10.1242/dev.006346; Feinstein P, 2004, CELL, V117, P833, DOI 10.1016/j.cell.2004.05.013; Feldheim DA, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001768; Feller MB, 2002, J NEUROBIOL, V53, P556, DOI 10.1002/neu.10140; Imai T, 2008, CURR OPIN NEUROBIOL, V18, P251, DOI 10.1016/j.conb.2008.07.009; Imai T, 2006, SCIENCE, V314, P657, DOI 10.1126/science.1131794; Imai T, 2009, SCIENCE, V325, P585, DOI 10.1126/science.1173596; Johns DC, 1999, J NEUROSCI, V19, P1691; Kato A, 2008, J NEUROCHEM, V107, P1261, DOI 10.1111/j.1471-4159.2008.05693.x; Kobayakawa K, 2007, NATURE, V450, P503, DOI 10.1038/nature06281; Kobilka BK, 2007, TRENDS PHARMACOL SCI, V28, P397, DOI 10.1016/j.tips.2007.06.003; Liu HY, 2001, J NEUROCHEM, V78, P325, DOI 10.1046/j.1471-4159.2001.00422.x; Luo LQ, 2007, NEURON, V56, P284, DOI 10.1016/j.neuron.2007.10.014; McLaughlin T, 2003, NEURON, V40, P1147, DOI 10.1016/S0896-6273(03)00790-6; Milligan G, 2000, TRENDS PHARMACOL SCI, V21, P24, DOI 10.1016/S0165-6147(99)01404-2; Miyamichi K, 2005, J NEUROSCI, V25, P3586, DOI 10.1523/JNEUROSCI.0324-05.2005; Mombaerts P, 1996, CELL, V87, P675, DOI 10.1016/S0092-8674(00)81387-2; Mori K, 2011, ANNU REV NEUROSCI, V34, P467, DOI 10.1146/annurev-neuro-112210-112917; Nakatani H, 2003, EUR J NEUROSCI, V18, P2425, DOI 10.1046/j.1460-9568.2003.02998.x; Nygaard R, 2013, CELL, V152, P532, DOI 10.1016/j.cell.2013.01.008; ODOWD BF, 1988, J BIOL CHEM, V263, P15985; Penn AA, 1998, SCIENCE, V279, P2108, DOI 10.1126/science.279.5359.2108; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Rasmussen SGF, 2011, NATURE, V469, P175, DOI 10.1038/nature09648; Reisert J, 2010, J GEN PHYSIOL, V136, P529, DOI 10.1085/jgp.201010528; RESSLER KJ, 1994, CELL, V79, P1245, DOI 10.1016/0092-8674(94)90015-9; Rosenbaum DM, 2009, NATURE, V459, P356, DOI 10.1038/nature08144; Saito H, 2004, CELL, V119, P679, DOI 10.1016/j.cell.2004.11.021; Saito H, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000016; Sakano H, 2010, NEURON, V67, P530, DOI 10.1016/j.neuron.2010.07.003; SAVARESE TM, 1992, BIOCHEM J, V283, P1; Seifert R, 1998, J BIOL CHEM, V273, P5109, DOI 10.1074/jbc.273.9.5109; Serizawa S, 2003, SCIENCE, V302, P2088, DOI 10.1126/science.1089122; Serizawa S, 2000, NAT NEUROSCI, V3, P687, DOI 10.1038/76641; Serizawa S, 2006, CELL, V127, P1057, DOI 10.1016/j.cell.2006.10.031; Takeuchi H, 2010, CELL, V141, P1056, DOI 10.1016/j.cell.2010.04.041; Tsuboi A, 2011, EUR J NEUROSCI, V33, P205, DOI 10.1111/j.1460-9568.2010.07495.x; VASSAR R, 1994, CELL, V79, P981, DOI 10.1016/0092-8674(94)90029-9; Vassart G, 2011, NAT REV ENDOCRINOL, V7, P362, DOI 10.1038/nrendo.2011.20; Wang F, 1998, CELL, V93, P47, DOI 10.1016/S0092-8674(00)81145-9; Wong ST, 2000, NEURON, V27, P487, DOI 10.1016/S0896-6273(00)00060-X; YAGI T, 1993, ANAL BIOCHEM, V214, P70, DOI 10.1006/abio.1993.1458; Yu CR, 2004, NEURON, V42, P553, DOI 10.1016/S0896-6273(04)00224-7; Yu SH, 1998, P NATL ACAD SCI USA, V95, P8715, DOI 10.1073/pnas.95.15.8715; Zhang XM, 2002, NAT NEUROSCI, V5, P124, DOI 10.1038/nn800; Zhang XM, 2004, P NATL ACAD SCI USA, V101, P14168, DOI 10.1073/pnas.0405350101; Zhuang H, 2008, NAT PROTOC, V3, P1402, DOI 10.1038/nprot.2008.120	57	92	93	0	30	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 12	2013	154	6					1314	1325		10.1016/j.cell.2013.08.033	http://dx.doi.org/10.1016/j.cell.2013.08.033			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	215VQ	24034253	Bronze, Green Accepted			2022-12-24	WOS:000324239300019
J	Tucker, BE				Tucker, Brian E.			Reducing Earthquake Risk	SCIENCE			English	Editorial Material									GeoHazards Int, Menlo Pk, CA 94025 USA		Tucker, BE (corresponding author), GeoHazards Int, 687 Bay Rd, Menlo Pk, CA 94025 USA.	tucker@geohaz.org						Bilham R., 2009, B EARTHQ ENG, V2009, P1; Bilham R, 2013, SCIENCE, V341, P618, DOI 10.1126/science.1238476; Di Mauro M, 2013, NAT HAZARDS, V68, P373, DOI 10.1007/s11069-013-0632-z; Earthquake Engineering Research Institute, 2011, LEARN EARTHQ JAP TOH; Erdik M, 2013, SCIENCE, V341, P724, DOI 10.1126/science.1238945; Gawande A., 2013, NEW YORKER, V29; Geohazards International, VULN COMM; Gilbert D, 2006, STUMBLING HAPPINESS; Global Humanitarian Assistance, GHA REP 2011; Holzer TL, 2013, EARTHQ SPECTRA, V29, P155, DOI 10.1193/1.4000106; LATROBE S, 2003, NATURAL DISASTER RIS; OECD, 2005, REC COUNC GUID EARTH; Stein RS, 2013, SCIENCE, V341, P850, DOI 10.1126/science.1238944; The United Nations Department of Economic and Social Affairs, WORLD URB PROSP 2011; TUCKER BE, 1994, NATO ADV SCI INST SE, V271, P1; United Nations Office for Disaster Reduction, HYOG FRAM ACT; USGS, EARTHQ HAZ PROGR PAG; USGS, SIGN EARTHQ WORLD; von Hillebrandt-Andrade C, 2013, SCIENCE, V341, P966, DOI 10.1126/science.1238943; Wyss M, 2005, NAT HAZARDS, V34, P305, DOI 10.1007/s11069-004-2073-1	20	17	20	0	29	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 6	2013	341	6150					1070	1072		10.1126/science.1239236	http://dx.doi.org/10.1126/science.1239236			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	211TG	24009380				2022-12-24	WOS:000323933100028
J	Gigerenzer, G				Gigerenzer, Gerd			THE ART OF RISK COMMUNICATION HIV screening: helping clinicians make sense of test results to patients	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Gigerenzer, Gerd] Max Planck Inst Human Dev, Harding Ctr Risk Literacy, Berlin, Germany; [Gigerenzer, Gerd] Max Planck Inst Human Dev, Ctr Adapt Behav & Cognit, Berlin, Germany	Max Planck Society; Max Planck Society	Gigerenzer, G (corresponding author), Max Planck Inst Human Dev, Harding Ctr Risk Literacy, Berlin, Germany.	gigerenzer@mpib-berlin.mpg.de	Gigerenzer, Gerd/A-6250-2012; Gigerenzer, Gerd/M-5595-2013	Gigerenzer, Gerd/0000-0002-6163-5419; 				Akl EA, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006776.pub2; Centers for Disease Control and Prevention, 2007, HIV PREV SEL POP LOW; GIGERENZER G, 1995, PSYCHOL REV, V102, P684, DOI 10.1037/0033-295X.102.4.684; Gigerenzer G, 1998, AIDS CARE, V10, P197, DOI 10.1080/09540129850124451; Gigerenzer G, 1999, PSYCHOL REV, V106, P425, DOI 10.1037/0033-295X.106.2.425; Gigerenzer G., 2002, RECKONING RISK; Gigerenzer G, RISK SAVVY IN PRESS; Kleinman S, 1998, JAMA-J AM MED ASSOC, V280, P1080, DOI 10.1001/jama.280.12.1080; Moyer VA, 2013, ANN INTERN MED, V159, P51, DOI 10.7326/0003-4819-159-1-201307020-00645; Piattelli-Palmarini M, 1991, BOSTONIA         MAR	10	9	9	0	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 21	2013	347								f5151	10.1136/bmj.f5151	http://dx.doi.org/10.1136/bmj.f5151			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	207SO	23965510	Green Published			2022-12-24	WOS:000323624300011
J	Bilham, R; Gaur, V				Bilham, Roger; Gaur, Vinod			Buildings as Weapons of Mass Destruction	SCIENCE			English	Editorial Material							INDIA; RISK		[Bilham, Roger] Univ Colorado, Cooperat Inst Res Environm Sci, Boulder, CO 80309 USA; [Bilham, Roger] Univ Colorado, Dept Geol Sci, Boulder, CO 80309 USA; [Gaur, Vinod] CSIR Ctr Math Modelling & Comp Simulat, Bangalore, Karnataka, India; [Gaur, Vinod] Indian Inst Astrophys, Bangalore 560034, Karnataka, India	University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; Council of Scientific & Industrial Research (CSIR) - India; CSIR - Fourth Paradigm Institute (CSIR 4PI); Department of Science & Technology (India); Indian Institute of Astrophysics (IIA)	Bilham, R (corresponding author), Univ Colorado, Cooperat Inst Res Environm Sci, Boulder, CO 80309 USA.	bilham@colorado.edu; vgaur@iiap.res.in		Bilham, Roger/0000-0002-5547-4102	Directorate For Geosciences [0739081] Funding Source: National Science Foundation	Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))		Avouac JP, 2003, ADV GEOPHYS, V46, P1, DOI 10.1016/S0065-2687(03)46001-9; Bagla P, 2012, SCIENCE, V338, P1275, DOI 10.1126/science.338.6112.1275; Bilham R, 2009, B EARTHQ ENG, V2009, P1; Bilham R, 2013, TECTONOPHYSICS, V584, P166, DOI 10.1016/j.tecto.2012.03.023; England P, 2011, NAT GEOSCI, V4, P348, DOI 10.1038/ngeo1168; Gaur VK, 2012, CURR SCI INDIA, V103, P1273; Iyengar R. N., 1999, INDIAN J HIST SCI, V34, P181; Jain SK, 2005, CURR SCI INDIA, V89, P1464; Jaiswal K, 2011, EARTHQ SPECTRA, V27, P775, DOI 10.1193/1.3606398; Kumar S, 2010, J GEOPHYS RES-SOL EA, V115, DOI 10.1029/2009JB006789; Rastogi B. K., 2011, CURR SCI, V103, P130; Roshan AD, 2010, NUCL ENG DES, V240, P3443, DOI 10.1016/j.nucengdes.2010.04.037; Sapkota SN, 2013, NAT GEOSCI, V6, P152, DOI 10.1038/NGEO1720; Talwani P, 1997, PURE APPL GEOPHYS, V150, P511, DOI 10.1007/s000240050091; Tiwari VM, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL039401; Walker R, 2004, TECTONICS, V23, DOI 10.1029/2003TC001529; WYSS M, 2004, DISASTERS SOC HAZARD, P165	17	14	14	0	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 9	2013	341	6146					618	619		10.1126/science.1238476	http://dx.doi.org/10.1126/science.1238476			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	197XC	23929970				2022-12-24	WOS:000322884800023
J	Nyblom, M; Poulsen, H; Gourdon, P; Reinhard, L; Andersson, M; Lindahl, E; Fedosova, N; Nissen, P				Nyblom, Maria; Poulsen, Hanne; Gourdon, Pontus; Reinhard, Linda; Andersson, Magnus; Lindahl, Erik; Fedosova, Natalya; Nissen, Poul			Crystal Structure of Na+, K+-ATPase in the Na+-Bound State	SCIENCE			English	Article							ONSET DYSTONIA-PARKINSONISM; SODIUM-POTASSIUM PUMP; DE-NOVO MUTATIONS; CALCIUM-PUMP; ALTERNATING HEMIPLEGIA; TERMINAL TYROSINES; ATP1A3; AFFINITY; BINDING; NA,K-ATPASE	The Na+, K+-adenosine triphosphatase (ATPase) maintains the electrochemical gradients of Na+ and K+ across the plasma membrane-a prerequisite for electrical excitability and secondary transport. Hitherto, structural information has been limited to K+-bound or ouabain-blocked forms. We present the crystal structure of a Na+-bound Na+, K+-ATPase as determined at 4.3 angstrom resolution. Compared with the K+-bound form, large conformational changes are observed in the a subunit whereas the beta and gamma subunit structures are maintained. The locations of the three Na+ sites are indicated with the unique site III at the recently suggested IIIb, as further supported by electrophysiological studies on leak currents. Extracellular release of the third Na+ from IIIb through IIIa, followed by exchange of Na+ for K+ at sites I and II, is suggested.	[Nyblom, Maria; Poulsen, Hanne; Gourdon, Pontus; Reinhard, Linda; Fedosova, Natalya; Nissen, Poul] Danish Natl Res Fdn, Ctr Membrane Pumps Cells & Dis PUMPkin, DK-8000 Aarhus, Denmark; [Nyblom, Maria; Poulsen, Hanne; Gourdon, Pontus; Reinhard, Linda; Nissen, Poul] Aarhus Univ, Dept Mol Biol & Genet, DK-8000 Aarhus, Denmark; [Poulsen, Hanne; Gourdon, Pontus; Nissen, Poul] Nord EMBL Partnership Mol Med, Danish Res Inst Translat Neurosci DANDRITE, Aarhus, Denmark; [Andersson, Magnus; Lindahl, Erik] KTH Royal Inst Technol, Swedish E Sci Res Ctr, Dept Theoret Phys, Sci Life Lab, SE-17121 Solna, Sweden; [Lindahl, Erik] Stockholm Univ, Dept Biochem & Biophys, Sci Life Lab, SE-10691 Stockholm, Sweden; [Fedosova, Natalya] Aarhus Univ, Dept Biomed, DK-8000 Aarhus, Denmark	Danmarks Grundforskningsfond; Aarhus University; Royal Institute of Technology; Stockholm University; Aarhus University	Poulsen, H (corresponding author), Danish Natl Res Fdn, Ctr Membrane Pumps Cells & Dis PUMPkin, DK-8000 Aarhus, Denmark.	hp@mb.au.dk; pn@mb.au.dk	Gourdon, Pontus/E-1076-2014; Gourdon, Pontus/HCI-8898-2022	Gourdon, Pontus/0000-0002-8631-3539; Nissen, Poul/0000-0003-0948-6628; Fedosova, Natalya U./0000-0002-1706-6108; Andersson, Magnus/0000-0002-3364-6647; Gourdon, Maria/0000-0001-8801-1756	Danscatt program of the Danish Natural Science Research Council; Swedish Research Council; Danish Council for Independent Research in Medical Sciences; European Research Council [209825, 250322]; Lundbeck Foundation; Carlsberg Foundation; L'Oreal/United Nations Educational, Scientific, and Cultural Organization; Lundbeck Foundation [R139-2012-12689] Funding Source: researchfish	Danscatt program of the Danish Natural Science Research Council; Swedish Research Council(Swedish Research CouncilEuropean Commission); Danish Council for Independent Research in Medical Sciences; European Research Council(European Research Council (ERC)European Commission); Lundbeck Foundation(Lundbeckfonden); Carlsberg Foundation(Carlsberg Foundation); L'Oreal/United Nations Educational, Scientific, and Cultural Organization; Lundbeck Foundation(Lundbeckfonden)	B. Vilsen and J. Petersen, Department of Biomedicine, Aarhus University, Denmark, are thanked for preparing enzyme for crystallization. We thank C. Schulze-Briese, T. Tomizaki, and V. Olieric (Swiss Light Source) for assistance with synchrotron data collection; B. Bjerring Jensen, A. M. Nielsen, and J. L. Karlsen for technical assistance; and J. P. Morth, L. Yatime, M. Laursen, H. Khandelia, and M. J. Clausen for valuable discussions. Support was provided by the Danscatt program of the Danish Natural Science Research Council. M.N. was supported by the Swedish Research Council, L. R. by the Danish Council for Independent Research in Medical Sciences, E. L. by a European Research Council starting grant (contract 209825), and P.N. by a European Research Council advanced grant (contract 250322). H. P. was supported by the Lundbeck Foundation, the Carlsberg Foundation, and L'Oreal/United Nations Educational, Scientific, and Cultural Organization. The authors made the following contributions: H. P. and P.N. performed study design. M.N. crystallized the protein, collected and processed x-ray data, and determined and refined the structure, assisted by L. R. and P. G. The structural analysis was carried out by M. N., L. R., and P. G., assisted by P.N., whereas M. A. and E. L. performed the MD simulations, assisted by P. G. H. P. designed and performed the electrophysiological studies. N. F. designed and performed the deocclusion experiments. M. N., L. R., P. G., H. P., and P.N. wrote the paper. All authors discussed the results and commented on the manuscript. Coordinates and structure factors have been deposited in the Protein Data Bank (PDB) with accession no. 4hqj.	Aguiar PD, 2004, NEURON, V43, P169, DOI 10.1016/j.neuron.2004.06.028; Anselm IA, 2009, NEUROLOGY, V73, P400, DOI 10.1212/WNL.0b013e3181b04acd; Azizan EAB, 2013, NAT GENET, V45, P1055, DOI 10.1038/ng.2716; Blanco G, 1998, AM J PHYSIOL-RENAL, V275, pF633, DOI 10.1152/ajprenal.1998.275.5.F633; Blanco-Arias P, 2009, HUM MOL GENET, V18, P2370, DOI 10.1093/hmg/ddp170; De Fusco M, 2003, NAT GENET, V33, P192, DOI 10.1038/ng1081; Dempski RE, 2006, J BIOL CHEM, V281, P36338, DOI 10.1074/jbc.M604788200; Einholm AP, 2010, J BIOL CHEM, V285, P26245, DOI 10.1074/jbc.M110.123976; ESMANN M, 1985, BIOCHEM BIOPH RES CO, V127, P857, DOI 10.1016/S0006-291X(85)80022-X; Heinzen EL, 2012, NAT GENET, V44, P1030, DOI 10.1038/ng.2358; Holmgren M, 2000, NATURE, V403, P898, DOI 10.1038/35002599; Imagawa T, 2005, J BIOL CHEM, V280, P18736, DOI 10.1074/jbc.M500137200; JEWELLMOTZ EA, 1993, BIOCHEMISTRY-US, V32, P13523, DOI 10.1021/bi00212a018; Laursen M, 2013, P NATL ACAD SCI USA, V110, P10958, DOI 10.1073/pnas.1222308110; Li CM, 2006, J MEMBRANE BIOL, V213, P1, DOI 10.1007/s00232-006-0035-0; Meier S, 2010, J GEN PHYSIOL, V135, P115, DOI 10.1085/jgp.200910301; Morth JP, 2007, NATURE, V450, P1043, DOI 10.1038/nature06419; Ogawa H, 2002, P NATL ACAD SCI USA, V99, P15977, DOI 10.1073/pnas.202622299; Ogawa H, 2009, P NATL ACAD SCI USA, V106, P13742, DOI 10.1073/pnas.0907054106; Olesen C, 2007, NATURE, V450, P1036, DOI 10.1038/nature06418; Poulsen H, 2010, NATURE, V467, P99, DOI 10.1038/nature09309; Rosewich H, 2012, LANCET NEUROL, V11, P764, DOI 10.1016/S1474-4422(12)70182-5; Shinoda T, 2009, NATURE, V459, P446, DOI 10.1038/nature07939; Sorensen TLM, 2004, SCIENCE, V304, P1672, DOI 10.1126/science.1099366; Toustrup-Jensen MS, 2009, J BIOL CHEM, V284, P18715, DOI 10.1074/jbc.M109.015099; Toyoshima C, 2004, NATURE, V430, P529, DOI 10.1038/nature02680; Toyoshima C, 2013, NATURE, V495, P260, DOI 10.1038/nature11899; Vasilyev A, 2004, J MEMBRANE BIOL, V198, P65, DOI 10.1007/s00232-004-0660-4; Vedovato N, 2010, J GEN PHYSIOL, V136, P63, DOI 10.1085/jgp.201010407; Winther AML, 2013, NATURE, V495, P265, DOI 10.1038/nature11900; Yatime L, 2011, J STRUCT BIOL, V174, P296, DOI 10.1016/j.jsb.2010.12.004; Zanotti-Fregonara P, 2008, J NEUROL SCI, V273, P148, DOI 10.1016/j.jns.2008.06.033	32	138	139	3	84	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 4	2013	342	6154					123	127		10.1126/science.1243352	http://dx.doi.org/10.1126/science.1243352			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	227PP	24051246				2022-12-24	WOS:000325126100060
J	Eyre, DW; Cule, ML; Wilson, DJ; Griffiths, D; Vaughan, A; O'Connor, L; Ip, CLC; Golubchik, T; Batty, EM; Finney, JM; Wyllie, DH; Didelot, X; Piazza, P; Bowden, R; Dingle, KE; Harding, RM; Crook, DW; Wilcox, MH; Peto, TEA; Walker, AS				Eyre, David W.; Cule, Madeleine L.; Wilson, Daniel J.; Griffiths, David; Vaughan, Alison; O'Connor, Lily; Ip, Camilla L. C.; Golubchik, Tanya; Batty, Elizabeth M.; Finney, John M.; Wyllie, David H.; Didelot, Xavier; Piazza, Paolo; Bowden, Rory; Dingle, Kate E.; Harding, Rosalind M.; Crook, Derrick W.; Wilcox, Mark H.; Peto, Tim E. A.; Walker, A. Sarah			Diverse Sources of C. difficile Infection Identified on Whole-Genome Sequencing	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ACQUIRED CLOSTRIDIUM-DIFFICILE; CARE FACILITY RESIDENTS; COLONIZATION; DISEASE; EPIDEMIOLOGY; TRANSMISSION; ACQUISITION; RISK; GUIDELINES; ADMISSIONS	BackgroundIt has been thought that Clostridium difficile infection is transmitted predominantly within health care settings. However, endemic spread has hampered identification of precise sources of infection and the assessment of the efficacy of interventions. MethodsFrom September 2007 through March 2011, we performed whole-genome sequencing on isolates obtained from all symptomatic patients with C. difficile infection identified in health care settings or in the community in Oxfordshire, United Kingdom. We compared single-nucleotide variants (SNVs) between the isolates, using C. difficile evolution rates estimated on the basis of the first and last samples obtained from each of 145 patients, with 0 to 2 SNVs expected between transmitted isolates obtained less than 124 days apart, on the basis of a 95% prediction interval. We then identified plausible epidemiologic links among genetically related cases from data on hospital admissions and community location. ResultsOf 1250 C. difficile cases that were evaluated, 1223 (98%) were successfully sequenced. In a comparison of 957 samples obtained from April 2008 through March 2011 with those obtained from September 2007 onward, a total of 333 isolates (35%) had no more than 2 SNVs from at least 1 earlier case, and 428 isolates (45%) had more than 10 SNVs from all previous cases. Reductions in incidence over time were similar in the two groups, a finding that suggests an effect of interventions targeting the transition from exposure to disease. Of the 333 patients with no more than 2 SNVs (consistent with transmission), 126 patients (38%) had close hospital contact with another patient, and 120 patients (36%) had no hospital or community contact with another patient. Distinct subtypes of infection continued to be identified throughout the study, which suggests a considerable reservoir of C. difficile. ConclusionsOver a 3-year period, 45% of C. difficile cases in Oxfordshire were genetically distinct from all previous cases. Genetically diverse sources, in addition to symptomatic patients, play a major part in C. difficile transmission. (Funded by the U.K. Clinical Research Collaboration Translational Infection Research Initiative and others.) Where does Clostridium difficile come from? In this report from the United Kingdom, of 1223 C. difficile isolates that were evaluated on whole-genome sequencing over a 3-year period, more than 45% were genetically distinct from all previous isolates. Most episodes of Clostridium difficile infection are believed to result from recent acquisition within a health care setting. Prevention efforts have therefore focused on symptomatic patients, their immediate environment, and judicious use of antimicrobial drugs.(1),(2) Person-to-person transmission of C. difficile infection and surrounding contamination have been well documented.(2)-(5) However, there are multiple other potential sources, including patients with asymptomatic colonization(6),(7) and sources in the wider environment, such as water, farm animals or pets, and food.(8) The contribution of cases acquired from these sources to the overall burden of disease is unclear, particularly with increasing reports of community-associated ...	[Eyre, David W.; Wilson, Daniel J.; Griffiths, David; Vaughan, Alison; O'Connor, Lily; Finney, John M.; Wyllie, David H.; Dingle, Kate E.; Crook, Derrick W.; Peto, Tim E. A.; Walker, A. Sarah] Univ Oxford, Nuffield Dept Clin Med, Oxford, England; [Cule, Madeleine L.; Ip, Camilla L. C.; Golubchik, Tanya; Didelot, Xavier; Bowden, Rory] Univ Oxford, Dept Stat, Oxford OX1 3TG, England; [Harding, Rosalind M.] Univ Oxford, Dept Zool, Oxford OX1 3PS, England; [Eyre, David W.; Cule, Madeleine L.; Griffiths, David; Vaughan, Alison; Ip, Camilla L. C.; Golubchik, Tanya; Batty, Elizabeth M.; Finney, John M.; Wyllie, David H.; Didelot, Xavier; Bowden, Rory; Dingle, Kate E.; Harding, Rosalind M.; Crook, Derrick W.; Peto, Tim E. A.; Walker, A. Sarah] John Radcliffe Hosp, NIHR Oxford Biomed Res Ctr, Oxford OX3 9DU, England; [Wilson, Daniel J.; Batty, Elizabeth M.; Piazza, Paolo; Bowden, Rory] Wellcome Trust Ctr Human Genet, Oxford, England; [O'Connor, Lily; Crook, Derrick W.; Peto, Tim E. A.] Oxford Univ Hosp Natl Hlth Serv Trust, Oxford, England; [Wilcox, Mark H.] Leeds Teaching Hosp, Leeds, W Yorkshire, England; [Wilcox, Mark H.] Univ Leeds, Dept Microbiol, Leeds Gen Infirm, Leeds LS2 9JT, W Yorkshire, England; [Walker, A. Sarah] MRC, Clin Trials Unit, London, England	University of Oxford; University of Oxford; University of Oxford; University of Oxford; University of Oxford; Wellcome Centre for Human Genetics; Oxford University Hospitals NHS Foundation Trust; University of Leeds; Leeds General Infirmary; University of Leeds; Medical Research Council Clinical Trials Unit	Eyre, DW (corresponding author), John Radcliffe Hosp, NIHR Oxford Biomed Res Ctr, Oxford OX3 9DU, England.	david.eyre@ndm.ox.ac.uk	Wilson, Daniel J/AAE-8975-2019; Didelot, Xavier/P-4282-2019; Walker, Sarah/HDM-8717-2022; Eyre, David W/P-6887-2016; Golubchik, Tanya/B-4226-2018	Wilson, Daniel J/0000-0002-0940-3311; Didelot, Xavier/0000-0003-1885-500X; Eyre, David W/0000-0001-5095-6367; Golubchik, Tanya/0000-0003-2765-9828; peto, tim/0000-0003-3477-8307; Dingle, Kate/0000-0002-2303-5957; Batty, Liz/0000-0001-8559-452X; Piazza, Paolo/0000-0002-3736-1841	NIHR under its Oxford Biomedical Research Centre Infection Theme; United Kingdom Clinical Research Collaboration (UKCRC) Modernising Medical Microbiology Consortium; Medical Research Council under the UKCRC Translational Infection Research Initiative; Biotechnology and Biological Sciences Research Council under the UKCRC Translational Infection Research Initiative; NIHR on behalf of the Department of Health [G0800778]; Wellcome Trust [087646/Z/08/Z]; MRC [G0600719, G0800778, MR/K010174/1] Funding Source: UKRI; Medical Research Council [G0800778, MR/K010174/1B, G0600719, G0600719B, MR/K010174/1] Funding Source: researchfish; National Institute for Health Research [NF-SI-0512-10047, NF-SI-0508-10279, DRF-2010-03-40] Funding Source: researchfish	NIHR under its Oxford Biomedical Research Centre Infection Theme; United Kingdom Clinical Research Collaboration (UKCRC) Modernising Medical Microbiology Consortium; Medical Research Council under the UKCRC Translational Infection Research Initiative(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council under the UKCRC Translational Infection Research Initiative(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NIHR on behalf of the Department of Health; Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	Supported by the NIHR under its Oxford Biomedical Research Centre Infection Theme and the United Kingdom Clinical Research Collaboration (UKCRC) Modernising Medical Microbiology Consortium, the latter funded under the UKCRC Translational Infection Research Initiative through grants from the Medical Research Council, the Biotechnology and Biological Sciences Research Council, and the NIHR on behalf of the Department of Health (G0800778) and the Wellcome Trust (087646/Z/08/Z). Profs. Crook and Peto are NIHR Senior Investigators. Dr. Eyre is an NIHR Doctoral Research Fellow.	[Anonymous], 2011, ANN REP CHIEF MED OF; Bartsch SM, 2012, EUR J CLIN MICROBIOL, V31, P3163, DOI 10.1007/s10096-012-1681-z; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; CLABOTS CR, 1992, J INFECT DIS, V166, P561, DOI 10.1093/infdis/166.3.561; Cohen SH, 2010, INFECT CONT HOSP EP, V31, P431, DOI 10.1086/651706; Dancer SJ, 2013, INT J ANTIMICROB AG, V41, P137, DOI 10.1016/j.ijantimicag.2012.10.013; Department of Health, 2012, UPD GUID DIAGN REP C; Didelot X, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-12-r118; Dubberke ER, 2007, ARCH INTERN MED, V167, P1092, DOI 10.1001/archinte.167.10.1092; Enoch DA, 2011, J INFECTION, V63, P105, DOI 10.1016/j.jinf.2011.05.016; Eyre DW, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003059; Eyre DW, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001124; Eyre DW, 2012, J CLIN MICROBIOL, V50, P142, DOI 10.1128/JCM.05177-11; Griffiths D, 2010, J CLIN MICROBIOL, V48, P770, DOI 10.1128/JCM.01796-09; Harbarth S, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001171; He M, 2013, NAT GENET, V45, P109, DOI 10.1038/ng.2478; He M, 2010, P NATL ACAD SCI USA, V107, P7527, DOI 10.1073/pnas.0914322107; Health Protection Agency, 2012, RES MAND CLOSTR DIFF; Health Protection Agency, Q EP COMM MAND MRSA; Hensgens MPM, 2012, CLIN MICROBIOL INFEC, V18, P635, DOI 10.1111/j.1469-0691.2012.03853.x; Jinno S, 2012, INFECT CONT HOSP EP, V33, P638, DOI 10.1086/665712; JOHNSON S, 1990, LANCET, V336, P97, DOI 10.1016/0140-6736(90)91605-A; Loo VG, 2011, NEW ENGL J MED, V365, P1693, DOI 10.1056/NEJMoa1012413; MCFARLAND LV, 1989, NEW ENGL J MED, V320, P204, DOI 10.1056/NEJM198901263200402; Miyajima F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022804; Muto CA, 2007, CLIN INFECT DIS, V45, P999, DOI 10.1086/521855; Noren T, 2004, J CLIN MICROBIOL, V42, P3635, DOI [10.1128/JCM.42.8.3635-3643.2004, 10.1128/jcm.42.8.3635-3643.2004]; Ozaki E, 2004, J MED MICROBIOL, V53, P167, DOI 10.1099/jmm.0.05376-0; Riggs MM, 2007, CLIN INFECT DIS, V45, P992, DOI 10.1086/521854; Rodrigo AG, 1999, EVOLUTION OF HIV, P233; SAMORE MH, 1994, CLIN INFECT DIS, V18, P181, DOI 10.1093/clinids/18.2.181; Sethi AK, 2010, INFECT CONT HOSP EP, V31, P21, DOI 10.1086/649016; Shim JK, 1998, LANCET, V351, P633, DOI 10.1016/S0140-6736(97)08062-8; Stabler RA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031559; Stabler RA, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-9-r102; Starr JM, 2009, J HOSP INFECT, V71, P49, DOI 10.1016/j.jhin.2008.09.013; Stoesser NE, 2013, CLIN INFECT DIS, V56, P1680, DOI 10.1093/cid/cit089; Surawicz CM, 2013, AM J GASTROENTEROL, V108, P478, DOI 10.1038/ajg.2013.4; Vonberg RP, 2008, CLIN MICROBIOL INFEC, V14, P2, DOI 10.1111/j.1469-0691.2008.01992.x; Walker AS, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001172; Wilcox MH, 2012, CLIN INFECT DIS, V55, P1056, DOI 10.1093/cid/cis614; Wilcox MH, 2011, SUMMARY RES UNDERPIN; Wyllie DH, 2011, BMJ OPEN, V1, DOI 10.1136/bmjopen-2011-000160	43	442	460	0	54	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 26	2013	369	13					1195	1205		10.1056/NEJMoa1216064	http://dx.doi.org/10.1056/NEJMoa1216064			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	224LT	24066741	Green Accepted, Green Published			2022-12-24	WOS:000324888200006
J	Galloway, KE; Franco, E; Smolke, CD				Galloway, Kate E.; Franco, Elisa; Smolke, Christina D.			Dynamically Reshaping Signaling Networks to Program Cell Fate via Genetic Controllers	SCIENCE			English	Article							MAP KINASE; DIFFERENTIAL REGULATION; CANCER-CELLS; SCAFFOLD; PHOSPHATASE; ROBUSTNESS; YEAST; SPECIFICITY; HOMEOSTASIS; EXPRESSION	Engineering of cell fate through synthetic gene circuits requires methods to precisely implement control around native decision-making pathways and offers the potential to direct cell processes. We demonstrate a class of genetic control systems, molecular network diverters, that interface with a native signaling pathway to route cells to divergent fates in response to environmental signals without modification of native genetic material. A method for identifying control points within natural networks is described that enables the construction of synthetic control systems that activate or attenuate native pathways to direct cell fate. We integrate opposing genetic programs by developing network architectures for reduced antagonism and demonstrate rational tuning of performance. Extension of these control strategies to mammalian systems should facilitate the engineering of complex cellular signaling systems.	[Galloway, Kate E.] CALTECH, Div Chem & Chem Engn, Pasadena, CA 91125 USA; [Franco, Elisa] Univ Calif Riverside, Dept Mech Engn, Riverside, CA 92521 USA; [Smolke, Christina D.] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA	California Institute of Technology; University of California System; University of California Riverside; Stanford University	Smolke, CD (corresponding author), Stanford Univ, Dept Bioengn, 473 Via Ortega,MC 4201, Stanford, CA 94305 USA.	christina.smolke@stanford.edu		Galloway, Kate E/0000-0001-7416-3193	NIH; NSF; Defense Advanced Research Projects Agency; Bill and Melinda Gates Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086663] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); Defense Advanced Research Projects Agency(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank D. Endy, J. Michener, A. Chang, and Y.-H. Wang for comments on the manuscript; J. Liang for technical guidance with RNA transducers; and R. Yu and S. Chapman for discussions on mating assays. This work was supported by funds from the NIH (grant to C.D.S.), NSF (grant to C.D.S.), Defense Advanced Research Projects Agency (grant to C.D.S.), and the Bill and Melinda Gates Foundation (grant to C.D.S.). K.E.G. and C.D.S. designed the study and experiments; K.E.G. performed experiments; E.F. and K.E.G. designed and constructed the model; and C.D.S. and K.E.G. analyzed and discussed all results and wrote the manuscript.	Anderson JC, 2006, J MOL BIOL, V355, P619, DOI 10.1016/j.jmb.2005.10.076; Andersson J, 2004, EMBO J, V23, P2564, DOI 10.1038/sj.emboj.7600250; Angeli D, 2004, P NATL ACAD SCI USA, V101, P1822, DOI 10.1073/pnas.0308265100; Banerjee C, 2001, ENDOCRINOLOGY, V142, P4026, DOI 10.1210/en.142.9.4026; Bashor CJ, 2008, SCIENCE, V319, P1539, DOI 10.1126/science.1151153; Becskei A, 2000, NATURE, V405, P590, DOI 10.1038/35014651; Beisel CL, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000363; Bhalla US, 2002, SCIENCE, V297, P1018, DOI 10.1126/science.1068873; Callura JM, 2010, P NATL ACAD SCI USA, V107, P15898, DOI 10.1073/pnas.1009747107; Chapman SA, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.73; Chen YY, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-2-240; Chen YY, 2010, P NATL ACAD SCI USA, V107, P8531, DOI 10.1073/pnas.1001721107; Culler SJ, 2010, SCIENCE, V330, P1251, DOI 10.1126/science.1192128; Deans TL, 2007, CELL, V130, P363, DOI 10.1016/j.cell.2007.05.045; Dohlman HG, 2001, ANNU REV BIOCHEM, V70, P703, DOI 10.1146/annurev.biochem.70.1.703; Eldar A, 2002, NATURE, V419, P304, DOI 10.1038/nature01061; Elion EA, 2000, CURR OPIN MICROBIOL, V3, P573, DOI 10.1016/S1369-5274(00)00143-0; Franco E, 2013, J MATH BIOL, V67, P1633, DOI 10.1007/s00285-012-0606-x; Fraser HB, 2004, PLOS BIOL, V2, P834, DOI 10.1371/journal.pbio.0020137; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Huang CYF, 1996, P NATL ACAD SCI USA, V93, P10078, DOI 10.1073/pnas.93.19.10078; Ingolia NT, 2007, CURR BIOL, V17, P668, DOI 10.1016/j.cub.2007.03.016; Kemmer C, 2010, NAT BIOTECHNOL, V28, P355, DOI 10.1038/nbt.1617; Kobayashi H, 2004, P NATL ACAD SCI USA, V101, P8414, DOI 10.1073/pnas.0402940101; Kofahl B, 2004, YEAST, V21, P831, DOI 10.1002/yea.1122; Kolch W, 2005, FEBS LETT, V579, P1891, DOI 10.1016/j.febslet.2005.02.002; Liang JC, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks636; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; McCormick F, 1999, TRENDS BIOCHEM SCI, V24, pM53, DOI 10.1016/S0968-0004(99)01480-2; Negro A, 2004, RECENT PROG HORM RES, V59, P1, DOI 10.1210/rp.59.1.1; O'Shaughnessy EC, 2011, CELL, V144, P119, DOI 10.1016/j.cell.2010.12.014; Osterberg M, 2006, P NATL ACAD SCI USA, V103, P11148, DOI 10.1073/pnas.0604078103; Palpant Rebecca G, 2006, Prev Chronic Dis, V3, pA62; Park SH, 2003, SCIENCE, V299, P1061, DOI 10.1126/science.1076979; Pierce KL, 2002, NAT REV MOL CELL BIO, V3, P639, DOI 10.1038/nrm908; Santos SDM, 2007, NAT CELL BIOL, V9, P324, DOI 10.1038/ncb1543; SEGER R, 1995, FASEB J, V9, P726, DOI 10.1096/fasebj.9.9.7601337; SPRAGUE G F JR, 1991, P77; Srikanth S, 1999, MOL CELL BIOCHEM, V199, P169, DOI 10.1023/A:1006980326855; Stelling J, 2004, P NATL ACAD SCI USA, V101, P13210, DOI 10.1073/pnas.0401463101; Stelling J, 2004, CELL, V118, P675, DOI 10.1016/j.cell.2004.09.008; Stoll G, 2010, BIOSYSTEMS, V102, P3, DOI 10.1016/j.biosystems.2010.07.014; Thomson TM, 2011, P NATL ACAD SCI USA, V108, P20265, DOI 10.1073/pnas.1004042108; Wang JY, 2006, J NEUROCHEM, V98, P89, DOI 10.1111/j.1471-4159.2006.03852.x; Weber W, 2007, P NATL ACAD SCI USA, V104, P10435, DOI 10.1073/pnas.0701382104; Win MN, 2007, P NATL ACAD SCI USA, V104, P14283, DOI 10.1073/pnas.0703961104; Wu W, 2005, J BIOL CHEM, V280, P4117, DOI 10.1074/jbc.M411200200; Wu W, 2004, CANCER RES, V64, P1757, DOI 10.1158/0008-5472.CAN-03-2546; Xie Z, 2011, SCIENCE, V333, P1307, DOI 10.1126/science.1205527; Ye HF, 2011, SCIENCE, V332, P1565, DOI 10.1126/science.1203535; Yuan YA, 2009, P NATL ACAD SCI USA, V106, P22020, DOI 10.1073/pnas.0906869106; Zhan XL, 1997, GENE DEV, V11, P1690, DOI 10.1101/gad.11.13.1690	52	48	49	0	53	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 20	2013	341	6152					1358	+	1235005	10.1126/science.1235005	http://dx.doi.org/10.1126/science.1235005			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	220PK	23950497	Green Accepted			2022-12-24	WOS:000324597200036
J	Stergachis, AB; Neph, S; Reynolds, A; Humbert, R; Miller, B; Paige, SL; Vernot, B; Cheng, JB; Thurman, RE; Sandstrom, R; Haugen, E; Heimfeld, S; Murry, CE; Akey, JM; Stamatoyannopoulos, JA				Stergachis, Andrew B.; Neph, Shane; Reynolds, Alex; Humbert, Richard; Miller, Brady; Paige, Sharon L.; Vernot, Benjamin; Cheng, Jeffrey B.; Thurman, Robert E.; Sandstrom, Richard; Haugen, Eric; Heimfeld, Shelly; Murry, Charles E.; Akey, Joshua M.; Stamatoyannopoulos, John A.			Developmental Fate and Cellular Maturity Encoded in Human Regulatory DNA Landscapes	CELL			English	Article							EMBRYONIC STEM-CELLS; TRANSCRIPTION FACTORS; HYPERSENSITIVE SITES; EPIGENETIC MEMORY; IN-VIVO; CHROMATIN; TRANSITIONS; PATTERNS; LINEAGE; CANCER	Cellular-state information between generations of developing cells may be propagated via regulatory regions. We report consistent patterns of gain and loss of DNase I-hypersensitive sites (DHSs) as cells progress from embryonic stem cells (ESCs) to terminal fates. DHS patterns alone convey rich information about cell fate and lineage relationships distinct from information conveyed by gene expression. Developing cells share a proportion of their DHS landscapes with ESCs; that proportion decreases continuously in each cell type as differentiation progresses, providing a quantitative benchmark of developmental maturity. Developmentally stable DHSs densely encode binding sites for transcription factors involved in autoregulatory feedback circuits. In contrast to normal cells, cancer cells extensively reactivate silenced ESC DHSs and those from developmental programs external to the cell lineage from which the malignancy derives. Our results point to changes in regulatory DNA landscapes as quantitative indicators of cell-fate transitions, lineage relationships, and dysfunction.	[Stergachis, Andrew B.; Neph, Shane; Reynolds, Alex; Humbert, Richard; Miller, Brady; Vernot, Benjamin; Thurman, Robert E.; Sandstrom, Richard; Haugen, Eric; Akey, Joshua M.; Stamatoyannopoulos, John A.] Univ Washington, Dept Genome Sci, Seattle, WA 98109 USA; [Paige, Sharon L.; Murry, Charles E.] Univ Washington, Dept Pathol, Seattle, WA 98109 USA; [Paige, Sharon L.; Murry, Charles E.] Univ Washington, Inst Stem Cell & Regenerat Med, Seattle, WA 98109 USA; [Murry, Charles E.] Univ Washington, Dept Bioengn, Seattle, WA 98109 USA; [Miller, Brady] Univ Washington, Dept Med, Div Hematol, Seattle, WA 98195 USA; [Murry, Charles E.] Univ Washington, Dept Med, Div Cardiol, Seattle, WA 98195 USA; [Stamatoyannopoulos, John A.] Univ Washington, Dept Med, Div Oncol, Seattle, WA 98195 USA; [Heimfeld, Shelly] Fred Hutchinson Canc Res Ctr, Div Clin Res, Seattle, WA 98109 USA; [Cheng, Jeffrey B.] Univ Calif San Francisco, Dept Dermatol, San Francisco, CA 94143 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center; University of California System; University of California San Francisco	Stamatoyannopoulos, JA (corresponding author), Univ Washington, Dept Genome Sci, Seattle, WA 98109 USA.	jstam@uw.edu	Vernot, Benjamin/ABH-1495-2021	Vernot, Benjamin/0000-0002-6820-2181; Haugen, Eric/0000-0001-7444-8981; Sandstrom, Richard/0000-0002-3356-1547; Akey, Joshua/0000-0002-4411-1330	NIH [U54HG004592, U54HG007010, U01ES017156, P30DK056465, P01GM081719, U01HL100405, P01HL094374, R01HL084642]; NIDDK [FDK095678A]; NHLBI [F30HL095343]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL084642, U01HL100405, P01HL094374, F30HL095343] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG007010, U54HG004592] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056465, F30DK095678] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [U01ES017156] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007266, P01GM081619] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH grants U54HG004592, U54HG007010, and U01ES017156 to J.A.S.; NIH grant P30DK056465 to S. H.; and NIH grants P01GM081719, U01HL100405, P01HL094374, and R01HL084642 to C. E. M. We thank many colleagues, particularly Joseph Costello (UCSF), for contributing cells for DNase I mapping and expression profiling. A. B. S. was supported by grant FDK095678A from NIDDK. S. L. P. was supported by NHLBI grant F30HL095343. We thank Rae Senarighi (UW) for expert assistance with graphic design. All data from this study are available through the ENCODE data repository at UCSC (http://www.encodeproject.org) and the Roadmap Epigenomics data repository at NCBI (http://www.ncbi.nlm.nih.gov/epigenomics). All data from this study are free to use and are not subject to consortium embargo dates.	Akhtar-Zaidi B, 2012, SCIENCE, V336, P736, DOI 10.1126/science.1217277; Alon U., 2006, INTRO SYSTEMS BIOL D; Baer v., 1828, ENTWICKLUNGSGESCHICH; Bard J, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-2-r21; Beard J, 1902, LANCET, V1, P1758; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Carroll JS, 2005, CELL, V122, P33, DOI 10.1016/j.cell.2005.05.008; Cavalli G, 1998, CELL, V93, P505, DOI 10.1016/S0092-8674(00)81181-2; Cohen J., 1963, LIVING EMBRYOS INTRO; Domazet-Loso T, 2010, NATURE, V468, P815, DOI 10.1038/nature09632; DUBOULE D, 1994, DEVELOPMENT, P135; Egli D, 2008, NAT REV MOL CELL BIO, V9, P505, DOI 10.1038/nrm2439; Gascoyne DM, 2009, NAT IMMUNOL, V10, P1118, DOI 10.1038/ni.1787; GLEASON DF, 1974, J UROLOGY, V111, P58, DOI 10.1016/S0022-5347(17)59889-4; GROSS DS, 1988, ANNU REV BIOCHEM, V57, P159, DOI 10.1146/annurev.bi.57.070188.001111; GROUDINE M, 1982, CELL, V30, P131, DOI 10.1016/0092-8674(82)90019-8; Harvey W, 1651, EXERCITATIONES GENER; Hathaway NA, 2012, CELL, V149, P1447, DOI 10.1016/j.cell.2012.03.052; Hawkins RD, 2010, CELL STEM CELL, V6, P479, DOI 10.1016/j.stem.2010.03.018; Hesselberth JR, 2009, NAT METHODS, V6, P283, DOI [10.1038/NMETH.1313, 10.1038/nmeth.1313]; Hirszfeld L., 1932, Z IMMUNITATSFORSCH, V75, P209; John S, 2011, NAT GENET, V43, P264, DOI 10.1038/ng.759; Kalinka AT, 2010, NATURE, V468, P811, DOI 10.1038/nature09634; Kim K, 2010, NATURE, V467, P285, DOI 10.1038/nature09342; Liao WP, 2009, GENESIS, V47, P476, DOI 10.1002/dvg.20520; LYONS I, 1995, GENE DEV, V9, P1654, DOI 10.1101/gad.9.13.1654; Morgan TH, 1901, AM NAT, V35, P949, DOI 10.1086/278049; Neph S, 2012, CELL, V150, P1274, DOI 10.1016/j.cell.2012.04.040; Neph S, 2012, NATURE, V489, P83, DOI 10.1038/nature11212; Neph S, 2012, BIOINFORMATICS, V28, P1919, DOI 10.1093/bioinformatics/bts277; ORKIN SH, 1995, J BIOL CHEM, V270, P4955, DOI 10.1074/jbc.270.10.4955; Paige SL, 2012, CELL, V151, P221, DOI 10.1016/j.cell.2012.08.027; Passeron T, 2009, J CLIN INVEST, V119, P954, DOI 10.1172/JCI34015; Patten B. M., 1920, EARLY EMBRYOLOGY CHI; Pennacchio LA, 2006, NATURE, V444, P499, DOI 10.1038/nature05295; PERSSON H, 1984, SCIENCE, V225, P718, DOI 10.1126/science.6463648; PTASHNE M, 1980, CELL, V19, P1, DOI 10.1016/0092-8674(80)90383-9; Ptashne M, 2007, CURR BIOL, V17, pR233, DOI 10.1016/j.cub.2007.02.030; Pujadas E, 2012, CELL, V148, P1123, DOI 10.1016/j.cell.2012.02.045; Raff R. A., 1996, SHAPE LIFE GENES DEV; Samstein RM, 2012, CELL, V151, P153, DOI 10.1016/j.cell.2012.06.053; Tanaka M, 2001, MOL CELL BIOL, V21, P4391, DOI 10.1128/MCB.21.13.4391-4398.2001; TATARINOV Iu S, 1964, Vopr Med Khim, V10, P90; Thurman RE, 2012, NATURE, V489, P75, DOI 10.1038/nature11232; Turing AM, 1937, P LOND MATH SOC, V42, P230, DOI 10.1112/plms/s2-42.1.230; Vernot B, 2012, GENOME RES, V22, P1689, DOI 10.1101/gr.134890.111; Waddington C.H., 1940, ORG GENES; Waddington C H, 1957, STRATEGY GENES DISCU; Waddington C. H., 1939, INTRO MODERN GENETIC; Waddington CH, 1935, NATURE, V135, P606, DOI 10.1038/135606a0; Wamstad JA, 2012, CELL, V151, P206, DOI 10.1016/j.cell.2012.07.035; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Yang L, 2008, NATURE, V453, P524, DOI 10.1038/nature06894; Zhu J, 2013, CELL, V152, P642, DOI 10.1016/j.cell.2012.12.033	55	231	240	0	27	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 15	2013	154	4					888	903		10.1016/j.cell.2013.07.020	http://dx.doi.org/10.1016/j.cell.2013.07.020			16	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	202GQ	23953118	Green Accepted, Bronze			2022-12-24	WOS:000323202500018
J	Thedieck, K; Holzwarth, B; Prentzell, MT; Boehlke, C; Klasener, K; Ruf, S; Sonntag, AG; Maerz, L; Grellscheid, SN; Kremmer, E; Nitschke, R; Kuehn, EW; Jonker, JW; Groen, AK; Reth, M; Hall, MN; Baumeister, R				Thedieck, Kathrin; Holzwarth, Birgit; Prentzell, Mirja Tamara; Boehlke, Christopher; Klaesener, Kathrin; Ruf, Stefanie; Sonntag, Annika Gwendolin; Maerz, Lars; Grellscheid, Sushma-Nagaraja; Kremmer, Elisabeth; Nitschke, Roland; Kuehn, E. Wolfgang; Jonker, Johan W.; Groen, Albert K.; Reth, Michael; Hall, Michael N.; Baumeister, Ralf			Inhibition of mTORC1 by Astrin and Stress Granules Prevents Apoptosis in Cancer Cells	CELL			English	Article							MESSENGER-RNA TRANSLATION; MAMMALIAN TARGET; HYDROGEN-PEROXIDE; COMPLEX 1; SIGNALING PATHWAY; RAPAMYCIN; PROTEIN; ACTIVATION; INITIATION; KINASE	Mammalian target of rapamycin complex 1 (mTORC1) controls growth and survival in response to metabolic cues. Oxidative stress affects mTORC1 via inhibitory and stimulatory inputs. Whereas downregulation of TSC1-TSC2 activates mTORC1 upon oxidative stress, the molecular mechanism of mTORC1 inhibition remains unknown. Here, we identify astrin as an essential negative mTORC1 regulator in the cellular stress response. Upon stress, astrin inhibits mTORC1 association and recruits the mTORC1 component raptor to stress granules (SGs), thereby preventing mTORC1-hyperactivation-induced apoptosis. In turn, balanced mTORC1 activity enables expression of stress factors. By identifying astrin as a direct molecular link between mTORC1, SG assembly, and the stress response, we establish a unifying model of mTORC1 inhibition and activation upon stress. Importantly, we show that in cancer cells, apoptosis suppression during stress depends on astrin. Being frequently upregulated in tumors, astrin is a potential clinically relevant target to sensitize tumors to apoptosis.	[Thedieck, Kathrin; Holzwarth, Birgit; Prentzell, Mirja Tamara; Klaesener, Kathrin; Ruf, Stefanie; Sonntag, Annika Gwendolin; Maerz, Lars; Nitschke, Roland; Reth, Michael; Baumeister, Ralf] Univ Freiburg, Fac Biol, D-79104 Freiburg, Germany; [Thedieck, Kathrin; Klaesener, Kathrin; Ruf, Stefanie; Nitschke, Roland; Kuehn, E. Wolfgang; Reth, Michael; Baumeister, Ralf] Univ Freiburg, BIOSS Ctr Biol Signalling Studies, D-79104 Freiburg, Germany; [Thedieck, Kathrin; Nitschke, Roland; Baumeister, Ralf] Univ Freiburg, Ctr Syst Biol ZBSA, D-79104 Freiburg, Germany; [Prentzell, Mirja Tamara] Univ Freiburg, Spemann Grad Sch Biol & Med SGBM, D-79104 Freiburg, Germany; [Ruf, Stefanie] Univ Freiburg, Res Training Grp RTG 1104, D-79104 Freiburg, Germany; [Baumeister, Ralf] Univ Freiburg, Fac Med, ZBMZ Ctr Biochem & Mol Cell Res, D-79104 Freiburg, Germany; [Thedieck, Kathrin; Boehlke, Christopher; Kuehn, E. Wolfgang] Univ Hosp Freiburg, Div Renal, D-79106 Freiburg, Germany; [Klaesener, Kathrin; Reth, Michael] Max Planck Inst Immunobiol & Epigenet, D-79108 Freiburg, Germany; [Grellscheid, Sushma-Nagaraja] Univ Durham, Sch Biol & Biomed Sci, Durham DH1 3LE, England; [Kremmer, Elisabeth] Inst Mol Immunol, Helmholtz Zentrum Munchen, D-81377 Munich, Germany; [Hall, Michael N.] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland; [Jonker, Johan W.; Groen, Albert K.] Univ Groningen, Univ Med Ctr Groningen, Dept Pediat, Ctr Liver Digest & Metab Dis, NL-9713 GZ Groningen, Netherlands	University of Freiburg; University of Freiburg; University of Freiburg; University of Freiburg; University of Freiburg; University of Freiburg; University of Freiburg; Max Planck Society; Durham University; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Basel; University of Groningen	Thedieck, K (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Pediat, Ctr Liver Digest & Metab Dis, Hanzepl 1, NL-9713 GZ Groningen, Netherlands.	k.thedieck@umcg.nl	Nitschke, Roland/F-9525-2010; Jonker, Johan W./ABE-6853-2020; Boehlke, Christopher/AAZ-6627-2021	Nitschke, Roland/0000-0002-9397-8475; Jonker, Johan W./0000-0002-3919-5437; Boehlke, Christopher/0000-0002-6985-0201; Thedieck, Kathrin/0000-0002-9069-2930; Klasener, Kathrin/0000-0002-5969-2553; Prentzell, Mirja Tamara/0000-0002-9659-9825; Hall, Michael N/0000-0002-2998-0757	EC 6th FP NoE LifeSpan [LSHG-CT-2007-036894]; Schlieben-Lange-Programm; Excellence Initiative of the German Research Foundation [EXC 294, GSC-4]; Excellence Initiative of the German Research Foundation (Spemann Graduate School); DFG Research Training Group RTG [1104]; DFG [KU 1504, CRC746, CRC850]; BMBF Gerontosys II-NephAge [031 5896A]; Freiburg Institute for Advanced Studies, FRIAS; Peter und Traudl Engelhorn Stiftung zur Forderung der Biotechnologie und Gentechnik; Addison Wheeler Fellowship; European Research Council [IRG-277169]; Human Frontier Science Program [CDA00013/2011-C]; Netherlands Organization for Scientific Research (VIDI) [016.126.338]; Dutch Digestive Foundation [WO 11-67]; Dutch Diabetes Foundation [2012.00.1537]	EC 6th FP NoE LifeSpan; Schlieben-Lange-Programm; Excellence Initiative of the German Research Foundation(German Research Foundation (DFG)); Excellence Initiative of the German Research Foundation (Spemann Graduate School); DFG Research Training Group RTG(German Research Foundation (DFG)); DFG(German Research Foundation (DFG)); BMBF Gerontosys II-NephAge(Federal Ministry of Education & Research (BMBF)); Freiburg Institute for Advanced Studies, FRIAS(Fonds de la Recherche Scientifique - FNRS); Peter und Traudl Engelhorn Stiftung zur Forderung der Biotechnologie und Gentechnik; Addison Wheeler Fellowship; European Research Council(European Research Council (ERC)European Commission); Human Frontier Science Program(Human Frontier Science Program); Netherlands Organization for Scientific Research (VIDI)(Netherlands Organization for Scientific Research (NWO)); Dutch Digestive Foundation; Dutch Diabetes Foundation	We thank Daryl P. Shanley (Newcastle University, UK) and Anna Johann for helpful discussions and critical reading of the manuscript. We thank Jerry Pelletier, McGill University, Montreal, Quebec, Canada for kindly providing hippuristanol. We thank our reviewers for excellent feedback and helpful experimental suggestions. Special thanks go to the staff of the Life Imaging Center (LIC) in the Center for Systems Biology, Albert-Ludwigs-University Freiburg for excellent confocal and widefield microscopy resources and the support in image analysis. This study was supported in part by the EC 6th FP NoE LifeSpan (LSHG-CT-2007-036894, to K. T. and R. B.), the Schlieben-Lange-Programm (K. T.), the Excellence Initiative of the German Research Foundation (EXC 294 to K. T., R. B., M. R., E. W. K., and R.N.; GSC-4, Spemann Graduate School to M. T. P.), the DFG Research Training Group RTG 1104 (S. R.), DFG grant KU 1504 (E. W. K.), BMBF Gerontosys II-NephAge (031 5896A) (K. T. and R. B.), the DFG grants CRC746 (M. R. and R. B.) and CRC850 (R. B.), the Freiburg Institute for Advanced Studies, FRIAS (K. T.), and the Peter und Traudl Engelhorn Stiftung zur Forderung der Biotechnologie und Gentechnik (K. T.). SNG is supported by an Addison Wheeler Fellowship. J.W.J. is supported by grants from the European Research Council (IRG-277169), Human Frontier Science Program (CDA00013/2011-C), the Netherlands Organization for Scientific Research (VIDI grant 016.126.338), the Dutch Digestive Foundation (grant WO 11-67), and the Dutch Diabetes Foundation (grant 2012.00.1537). A part of this work is the basis for a pending European patent application, filed on January 11, 2013 (Application no. EP13151022.4).	Alexander A, 2010, P NATL ACAD SCI USA, V107, P4153, DOI 10.1073/pnas.0913860107; Anderson P, 2008, TRENDS BIOCHEM SCI, V33, P141, DOI 10.1016/j.tibs.2007.12.003; Anderson P, 2009, NAT REV MOL CELL BIO, V10, P430, DOI 10.1038/nrm2694; Appenzeller-Herzog C, 2012, TRENDS CELL BIOL, V22, P274, DOI 10.1016/j.tcb.2012.02.006; Arimoto K, 2008, NAT CELL BIOL, V10, P1324, DOI 10.1038/ncb1791; Bae GU, 1999, J BIOL CHEM, V274, P32596, DOI 10.1074/jbc.274.46.32596; Benjamin D, 2011, NAT REV DRUG DISCOV, V10, P868, DOI 10.1038/nrd3531; Bordeleau ME, 2006, NAT CHEM BIOL, V2, P213, DOI 10.1038/nchembio776; Buchan JR, 2009, MOL CELL, V36, P932, DOI 10.1016/j.molcel.2009.11.020; Buechler S, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-243; Chang MS, 2001, BIOCHEM BIOPH RES CO, V287, P116, DOI 10.1006/bbrc.2001.5554; Chou SD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039679; Dai N, 2011, GENE DEV, V25, P1159, DOI 10.1101/gad.2042311; Dennis MD, 2013, J BIOL CHEM, V288, P10, DOI 10.1074/jbc.M112.402461; Emara MM, 2012, BIOCHEM BIOPH RES CO, V423, P763, DOI 10.1016/j.bbrc.2012.06.033; Farny NG, 2009, RNA, V15, P1814, DOI 10.1261/rna.1684009; Fournier MJ, 2013, MOL CELL BIOL, V33, P2285, DOI 10.1128/MCB.01517-12; Fruehauf JP, 2007, CLIN CANCER RES, V13, P789, DOI 10.1158/1078-0432.CCR-06-2082; Thomas MG, 2011, CELL SIGNAL, V23, P324, DOI 10.1016/j.cellsig.2010.08.011; Gruber J, 2002, J CELL SCI, V115, P4053, DOI 10.1242/jcs.00088; Grzmil M, 2012, CANCER RES, V72, P3891, DOI 10.1158/0008-5472.CAN-12-0026; Gwinn DM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009197; Halim VA, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003664; Holcik M, 2005, NAT REV MOL CELL BIO, V6, P318, DOI 10.1038/nrm1618; Hsieh AC, 2012, NATURE, V485, P55, DOI 10.1038/nature10912; Huang CS, 2002, CANCER RES, V62, P5689; Huo YL, 2012, BIOCHEM J, V444, P141, DOI 10.1042/BJ20112107; Kedersha N, 2000, J CELL BIOL, V151, P1257, DOI 10.1083/jcb.151.6.1257; Kedersha N, 2007, METHOD ENZYMOL, V431, P61, DOI 10.1016/S0076-6879(07)31005-7; Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Lee CH, 2007, EMBO J, V26, P4812, DOI 10.1038/sj.emboj.7601900; Li M, 2010, CELL SIGNAL, V22, P1469, DOI 10.1016/j.cellsig.2010.05.015; Luo XA, 2011, RNA BIOL, V8, P14, DOI 10.4161/rna.8.1.13483; Mack GJ, 2001, P NATL ACAD SCI USA, V98, P14434, DOI 10.1073/pnas.261371298; Manning AL, 2010, EMBO J, V29, P3531, DOI 10.1038/emboj.2010.230; Mihaylova MM, 2011, NAT CELL BIOL, V13, P1016, DOI 10.1038/ncb2329; Nakashima A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002223; Pezze PD, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002469; Polak P, 2009, CURR OPIN CELL BIOL, V21, P209, DOI 10.1016/j.ceb.2009.01.024; Pour NK, 2011, BIOCHEMISTRY-US, V50, P6942, DOI 10.1021/bi200711v; Ramirez-Valle F, 2008, J CELL BIOL, V181, P293, DOI 10.1083/jcb.200710215; Ramirez-Valle F, 2010, MOL CELL BIOL, V30, P3151, DOI 10.1128/MCB.00322-09; Rapley J, 2011, J BIOL CHEM, V286, P38043, DOI 10.1074/jbc.M111.245449; Rubsamen D, 2012, RNA, V18, P1910, DOI 10.1261/rna.033019.112; Sancak Y, 2010, CELL, V141, P290, DOI 10.1016/j.cell.2010.02.024; Sarbassov DD, 2006, MOL CELL, V22, P159, DOI 10.1016/j.molcel.2006.03.029; Sarbassov DD, 2005, J BIOL CHEM, V280, P39505, DOI 10.1074/jbc.M506096200; Shah OJ, 2004, CURR BIOL, V14, P1650, DOI 10.1016/j.cub.2004.08.026; Shao XP, 2001, MOL REPROD DEV, V59, P410, DOI 10.1002/mrd.1047; Soderberg O, 2008, METHODS, V45, P227, DOI 10.1016/j.ymeth.2008.06.014; Sonntag AG, 2012, FEBS J, V279, P3314, DOI 10.1111/j.1742-4658.2012.08582.x; Sosa V, 2013, AGEING RES REV, V12, P376, DOI 10.1016/j.arr.2012.10.004; Takahara T, 2012, MOL CELL, V47, P242, DOI 10.1016/j.molcel.2012.05.019; Talarek N, 2010, MOL CELL, V38, P345, DOI 10.1016/j.molcel.2010.02.039; Thedieck K, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001217; Thein KH, 2007, J CELL BIOL, V178, P345, DOI 10.1083/jcb.200701163; Thoreen CC, 2012, NATURE, V485, P109, DOI 10.1038/nature11083; Tourriere H, 2003, J CELL BIOL, V160, P823, DOI 10.1083/jcb.200212128; Valk K, 2010, ONCOLOGY-BASEL, V79, P283, DOI 10.1159/000322116; Vattem KM, 2004, P NATL ACAD SCI USA, V101, P11269, DOI 10.1073/pnas.0400541101; Wang XM, 1997, BIOCHEM BIOPH RES CO, V238, P207, DOI 10.1006/bbrc.1997.7273; Wickman G, 2012, CELL DEATH DIFFER, V19, P735, DOI 10.1038/cdd.2012.25; Wippich F, 2013, CELL, V152, P791, DOI 10.1016/j.cell.2013.01.033; Yamasaki S, 2008, CURR OPIN CELL BIOL, V20, P222, DOI 10.1016/j.ceb.2008.01.013; Yoshida S, 2011, J BIOL CHEM, V286, P32651, DOI 10.1074/jbc.M111.238014	66	180	189	0	52	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 15	2013	154	4					859	874		10.1016/j.cell.2013.07.031	http://dx.doi.org/10.1016/j.cell.2013.07.031			16	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	202GQ	23953116	Bronze			2022-12-24	WOS:000323202500016
J	Maisak, MS; Haag, J; Ammer, G; Serbe, E; Meier, M; Leonhardt, A; Schilling, T; Bahl, A; Rubin, GM; Nern, A; Dickson, BJ; Reiff, DF; Hopp, E; Borst, A				Maisak, Matthew S.; Haag, Juergen; Ammer, Georg; Serbe, Etienne; Meier, Matthias; Leonhardt, Aljoscha; Schilling, Tabea; Bahl, Armin; Rubin, Gerald M.; Nern, Aljoscha; Dickson, Barry J.; Reiff, Dierk F.; Hopp, Elisabeth; Borst, Alexander			A directional tuning map of Drosophila elementary motion detectors	NATURE			English	Article							VISUAL INTERNEURONS; OPTIC LOBE; DETECTION CIRCUITS; LOBULA PLATE; FLY; MELANOGASTER; PATHWAYS; MEDULLA; VISION; SELECTIVITY	The extraction of directional motion information from changing retinal images is one of the earliest and most important processing steps in any visual system. In the fly optic lobe, two parallel processing streams have been anatomically described, leading from two first-order interneurons, L1 and L2, via T4 and T5 cells onto large, wide-field motion-sensitive interneurons of the lobula plate(1). Therefore, T4 and T5 cells are thought to have a pivotal role in motion processing; however, owing to their small size, it is difficult to obtain electrical recordings of T4 and T5 cells, leaving their visual response properties largely unknown. We circumvent this problem by means of optical recording from these cells in Drosophila, using the genetically encoded calcium indicator GCaMP5 (ref. 2). Here we find that specific subpopulations of T4 and T5 cells are directionally tuned to one of the four cardinal directions; that is, front-to-back, back-to-front, upwards and downwards. Depending on their preferred direction, T4 and T5 cells terminate in specific sublayers of the lobula plate. T4 and T5 functionally segregate with respect to contrast polarity: whereas T4 cells selectively respond to moving brightness increments (ON edges), T5 cells only respond to moving brightness decrements (OFF edges). When the output from T4 or T5 cells is blocked, the responses of postsynaptic lobula plate neurons to moving ON (T4 block) or OFF edges (T5 block) are selectively compromised. The same effects are seen in turning responses of tethered walking flies. Thus, starting with L1 and L2, the visual input is split into separate ON and OFF pathways, and motion along all four cardinal directions is computed separately within each pathway. The output of these eight different motion detectors is then sorted such that ON (T4) and OFF (T5) motion detectors with the same directional tuning converge in the same layer of the lobula plate, jointly providing the input to downstream circuits and motion-driven behaviours.	[Maisak, Matthew S.; Haag, Juergen; Ammer, Georg; Serbe, Etienne; Meier, Matthias; Leonhardt, Aljoscha; Schilling, Tabea; Bahl, Armin; Reiff, Dierk F.; Hopp, Elisabeth; Borst, Alexander] Max Planck Inst Neurobiol, D-82152 Martinsried, Germany; [Rubin, Gerald M.; Nern, Aljoscha] Janelia Farm Res Campus, Ashburn, VA 20147 USA; [Dickson, Barry J.] Inst Mol Pathol, A-1030 Vienna, Austria	Max Planck Society; Howard Hughes Medical Institute; Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP)	Borst, A (corresponding author), Max Planck Inst Neurobiol, D-82152 Martinsried, Germany.	borst@neuro.mpg.de	Dickson, Barry/AAE-7632-2019	Dickson, Barry/0000-0003-0715-892X; Rubin, Gerald/0000-0001-8762-8703; Meier, Matthias/0000-0003-3608-4384; Serbe-Kamp, Etienne/0000-0002-7097-6274; Bahl, Armin/0000-0001-7591-5860	Deutsche Forschungsgemeinschaft [SFB 870]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	We thank L. Looger, J. Simpson, V. Jayaraman and the Janelia GECI team for making and providing us with the GCaMP5 flies before publication; J. Plett for designing and engineering the LED arena; C. Theile, W. Essbauer and M. Sauter for fly work; and A. Mauss, F. Gabbiani and T. Bonhoeffer for critically reading the manuscript. This work was in part supported by the Deutsche Forschungsgemeinschaft (SFB 870). M. S. M., G. A., E. S., M. M., A. L., A. Ba and A. Bo are members of the Graduate School of Systemic Neurosciences.	Akerboom J, 2012, J NEUROSCI, V32, P13819, DOI 10.1523/JNEUROSCI.2601-12.2012; BAUSENWEIN B, 1992, CELL TISSUE RES, V267, P17, DOI 10.1007/BF00318687; BORST A, 1990, P NATL ACAD SCI USA, V87, P9363, DOI 10.1073/pnas.87.23.9363; Borst A, 2010, ANNU REV NEUROSCI, V33, P49, DOI 10.1146/annurev-neuro-060909-153155; BUCHNER E, 1984, J COMP PHYSIOL, V155, P471, DOI 10.1007/BF00611912; Clark DA, 2011, NEURON, V70, P1165, DOI 10.1016/j.neuron.2011.05.023; DENK W, 1990, SCIENCE, V248, P73, DOI 10.1126/science.2321027; Douglass JK, 1996, J NEUROSCI, V16, P4551; EGELHAAF M, 1995, J NEUROPHYSIOL, V73, P2540, DOI 10.1152/jn.1995.73.6.2540; EGELHAAF M, 1992, VISUAL NEUROSCI, V8, P151, DOI 10.1017/S0952523800009317; Eichner H, 2011, NEURON, V70, P1155, DOI 10.1016/j.neuron.2011.03.028; Euler T, 2002, NATURE, V418, P845, DOI 10.1038/nature00931; Euler T, 2009, PFLUG ARCH EUR J PHY, V457, P1393, DOI 10.1007/s00424-008-0603-5; FISCHBACH KF, 1989, CELL TISSUE RES, V258, P441, DOI 10.1007/BF00218858; Franceschini N., 1989, P360; Jenett A, 2012, CELL REP, V2, P991, DOI 10.1016/j.celrep.2012.09.011; Joesch M, 2008, CURR BIOL, V18, P368, DOI 10.1016/j.cub.2008.02.022; Joesch M, 2013, J NEUROSCI, V33, P902, DOI 10.1523/JNEUROSCI.3374-12.2013; Joesch M, 2010, NATURE, V468, P300, DOI 10.1038/nature09545; OYSTER CW, 1967, SCIENCE, V155, P841, DOI 10.1126/science.155.3764.841; Pfeiffer BD, 2008, P NATL ACAD SCI USA, V105, P9715, DOI 10.1073/pnas.0803697105; Pologruto TA, 2003, BIOMED ENG ONLINE, V2, DOI 10.1186/1475-925X-2-13; Reichardt W, 1961, SENS COMMUN, P303; Reiff DF, 2010, NAT NEUROSCI, V13, P973, DOI 10.1038/nn.2595; Reiser MB, 2008, J NEUROSCI METH, V167, P127, DOI 10.1016/j.jneumeth.2007.07.019; Sanchez D, 1915, CONTRIBUCION CONOCIM; Schnell B, 2010, J NEUROPHYSIOL, V103, P1646, DOI 10.1152/jn.00950.2009; Schnell B, 2012, J COMP PHYSIOL A, V198, P389, DOI 10.1007/s00359-012-0716-3; Seelig JD, 2010, NAT METHODS, V7, P535, DOI [10.1038/NMETH.1468, 10.1038/nmeth.1468]; Single S, 1997, J NEUROSCI, V17, P6023; STRAUSFELD NJ, 1991, VISUAL NEUROSCI, V7, P13, DOI 10.1017/S0952523800010919; Strausfeld NJ., 1976, ATLAS INSECT BRAIN, DOI 10.1007/978-3-642-66179-2; SWEENEY ST, 1995, NEURON, V14, P341, DOI 10.1016/0896-6273(95)90290-2; Takemura SY, 2008, J COMP NEUROL, V509, P493, DOI 10.1002/cne.21757	34	206	206	1	92	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 8	2013	500	7461					212	+		10.1038/nature12320	http://dx.doi.org/10.1038/nature12320			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	197CH	23925246				2022-12-24	WOS:000322825500036
J	Sun, YD; Li, L; Macho, AP; Han, ZF; Hu, ZH; Zipfel, C; Zhou, JM; Chai, JJ				Sun, Yadong; Li, Lei; Macho, Alberto P.; Han, Zhifu; Hu, Zehan; Zipfel, Cyril; Zhou, Jian-Min; Chai, Jijie			Structural Basis for flg22-Induced Activation of the Arabidopsis FLS2-BAK1 Immune Complex	SCIENCE			English	Article							BACTERIAL ELICITOR FLAGELLIN; INNATE IMMUNITY; MOLECULAR-PATTERNS; RECEPTOR; PERCEPTION; KINASE; FLS2; RECOGNITION; BAK1; BRI1	Flagellin perception in Arabidopsis is through recognition of its highly conserved N-terminal epitope (flg22) by flagellin-sensitive 2 (FLS2). Flg22 binding induces FLS2 heteromerization with BRASSINOSTEROID INSENSITIVE 1-associated kinase 1 (BAK1) and their reciprocal activation followed by plant immunity. Here, we report the crystal structure of FLS2 and BAK1 ectodomains complexed with flg22 at 3.06 angstroms. A conserved and a nonconserved site from the inner surface of the FLS2 solenoid recognize the C-and N-terminal segment of flg22, respectively, without oligomerization or conformational changes in the FLS2 ectodomain. Besides directly interacting with FLS2, BAK1 acts as a co-receptor by recognizing the C terminus of the FLS2-bound flg22. Our data reveal the molecular mechanisms underlying FLS2-BAK1 complex recognition of flg22 and provide insight into the immune receptor complex activation.	[Sun, Yadong; Han, Zhifu; Hu, Zehan; Chai, Jijie] Tsinghua Univ, Sch Life Sci, Beijing 100084, Peoples R China; [Sun, Yadong; Han, Zhifu; Hu, Zehan; Chai, Jijie] Tsinghua Peking Ctr Life Sci, Beijing 100084, Peoples R China; [Li, Lei; Zhou, Jian-Min] Chinese Acad Sci, Inst Genet & Dev Biol, State Key Lab Plant Genom, Beijing 100101, Peoples R China; [Li, Lei; Zhou, Jian-Min] Chinese Acad Sci, Inst Genet & Dev Biol, Natl Ctr Plant Gene Res, Beijing 100101, Peoples R China; [Macho, Alberto P.; Zipfel, Cyril] Sainsbury Lab, Norwich NR4 7UH, Norfolk, England	Tsinghua University; Tsinghua University; Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS; Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center	Han, ZF (corresponding author), Tsinghua Univ, Sch Life Sci, Beijing 100084, Peoples R China.	hanzhifu@mail.tsinghua.edu.cn; jmzhou@genetics.ac.cn; chaijj@mail.tsinghua.edu.cn	poinssot, benoit/B-2569-2009; ZIPFEL, CYRIL/ABD-5076-2021; Macho, Alberto/L-1393-2014; ZIPFEL, CYRIL B/D-7103-2011; Hu, Zehan/AAU-4752-2021; Zhou, Jian-Min/A-3140-2013; Hu, Zehan/AAH-7139-2020	poinssot, benoit/0000-0001-5890-4318; ZIPFEL, CYRIL/0000-0003-4935-8583; ZIPFEL, CYRIL B/0000-0003-4935-8583; Hu, Zehan/0000-0002-4648-5301; Zhou, Jian-Min/0000-0002-9943-2975; Macho, Alberto P/0000-0001-9935-8026; Sun, Yadong/0000-0003-4470-6630; Chai, Jijie/0000-0001-7591-3873; Li, LEI/0000-0001-5376-6462	State Key Program of National Natural Science of China [31130063]; National Outstanding Young Scholar Science Foundation of China [31025008]; Chinese Natural Science Foundation [31230007]; Chinese Ministry of Science and Technology [2011CB100700]; Gatsby Charitable Foundation; European Research Council; Federation of European Biochemical Societies	State Key Program of National Natural Science of China(National Natural Science Foundation of China (NSFC)); National Outstanding Young Scholar Science Foundation of China; Chinese Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Chinese Ministry of Science and Technology(Ministry of Science and Technology, China); Gatsby Charitable Foundation; European Research Council(European Research Council (ERC)European Commission); Federation of European Biochemical Societies	We thank S. Huang and J. He at Shanghai Synchrotron Radiation Facility (SSRF) for assistance with data collection. This research was funded by State Key Program of National Natural Science of China (31130063) and the National Outstanding Young Scholar Science Foundation of China (31025008) to J. C.; Chinese Natural Science Foundation (31230007) and Chinese Ministry of Science and Technology (2011CB100700) to J.-M.Z.; and the Gatsby Charitable Foundation and the European Research Council to C.Z. A. P. M. is supported by a postdoctoral fellowship from the Federation of European Biochemical Societies. The coordinates and structural factors for FLS2LRR-flg22-BAK1LRR and FLS2 Delta LRR2-6 have been deposited in Protein Data Bank with accession codes 4MN8 and 4MNA, respectively.	Bauer Z, 2001, J BIOL CHEM, V276, P45669, DOI 10.1074/jbc.M102390200; Boller T, 2009, ANNU REV PLANT BIOL, V60, P379, DOI 10.1146/annurev.arplant.57.032905.105346; Chinchilla D, 2006, PLANT CELL, V18, P465, DOI 10.1105/tpc.105.036574; Chinchilla D, 2007, NATURE, V448, P497, DOI 10.1038/nature05999; Dunning FM, 2007, PLANT CELL, V19, P3297, DOI 10.1105/tpc.106.048801; Felix G, 1999, PLANT J, V18, P265, DOI 10.1046/j.1365-313X.1999.00265.x; Feng F, 2012, NATURE, V485, P114, DOI 10.1038/nature10962; Gomez-Gomez L, 2000, MOL CELL, V5, P1003, DOI 10.1016/S1097-2765(00)80265-8; Hecht V, 2001, PLANT PHYSIOL, V127, P803, DOI 10.1104/pp.010324; Heese A, 2007, P NATL ACAD SCI USA, V104, P12217, DOI 10.1073/pnas.0705306104; Hothorn M, 2011, NATURE, V474, P467, DOI 10.1038/nature10153; Li J, 2002, CELL, V110, P213, DOI 10.1016/S0092-8674(02)00812-7; Liu TT, 2012, SCIENCE, V336, P1160, DOI 10.1126/science.1218867; Lu DP, 2010, P NATL ACAD SCI USA, V107, P496, DOI 10.1073/pnas.0909705107; Meindl T, 2000, PLANT CELL, V12, P1783, DOI 10.1105/tpc.12.9.1783; Mueller K, 2012, PLANT CELL, V24, P2213, DOI 10.1105/tpc.112.096073; Mythreye K, 2009, CELL SIGNAL, V21, P1548, DOI 10.1016/j.cellsig.2009.05.001; Nam KH, 2002, CELL, V110, P203, DOI 10.1016/S0092-8674(02)00814-0; Park BS, 2009, NATURE, V458, P1191, DOI 10.1038/nature07830; Roux M, 2011, PLANT CELL, V23, P2440, DOI 10.1105/tpc.111.084301; Santiago J, 2013, SCIENCE, V341, P889, DOI 10.1126/science.1242468; Schulze B, 2010, J BIOL CHEM, V285, P9444, DOI 10.1074/jbc.M109.096842; Schwessinger B, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002046; She J, 2011, NATURE, V474, P472, DOI 10.1038/nature10178; Song DH, 2012, IMMUNOL REV, V250, P216, DOI 10.1111/j.1600-065X.2012.01167.x; Sun WX, 2012, PLANT CELL, V24, P1096, DOI 10.1105/tpc.112.095919; Tan X, 2007, NATURE, V446, P640, DOI 10.1038/nature05731; Yoon SI, 2012, SCIENCE, V335, P859, DOI 10.1126/science.1215584; Zhang J, 2010, CELL HOST MICROBE, V7, P290, DOI 10.1016/j.chom.2010.03.007; Zipfel C, 2004, NATURE, V428, P764, DOI 10.1038/nature02485	30	435	475	45	363	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 1	2013	342	6158					624	628		10.1126/science.1243825	http://dx.doi.org/10.1126/science.1243825			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243RJ	24114786				2022-12-24	WOS:000326334300050
J	Bauer, DE; Kamran, SC; Lessard, S; Xu, J; Fujiwara, Y; Lin, C; Shao, Z; Canver, MC; Smith, EC; Pinello, L; Sabo, PJ; Vierstra, J; Voit, RA; Yuan, GC; Porteus, MH; Stamatoyannopoulos, JA; Lettre, G; Orkin, SH				Bauer, Daniel E.; Kamran, Sophia C.; Lessard, Samuel; Xu, Jian; Fujiwara, Yuko; Lin, Carrie; Shao, Zhen; Canver, Matthew C.; Smith, Elenoe C.; Pinello, Luca; Sabo, Peter J.; Vierstra, Jeff; Voit, Richard A.; Yuan, Guo-Cheng; Porteus, Matthew H.; Stamatoyannopoulos, John A.; Lettre, Guillaume; Orkin, Stuart H.			An Erythroid Enhancer of BCL11A Subject to Genetic Variation Determines Fetal Hemoglobin Level	SCIENCE			English	Article							GENOME-WIDE ASSOCIATION; SICKLE-CELL-DISEASE; HAPLOTYPE FUSION PCR; LYMPHOID DEVELOPMENT; COMMON DISEASE; GLOBIN; DNA; DISSECTION; EXPRESSION; DYNAMICS	Genome-wide association studies (GWASs) have ascertained numerous trait-associated common genetic variants, frequently localized to regulatory DNA. We found that common genetic variation at BCL11A associated with fetal hemoglobin (HbF) level lies in noncoding sequences decorated by an erythroid enhancer chromatin signature. Fine-mapping uncovers a motif-disrupting common variant associated with reduced transcription factor (TF) binding, modestly diminished BCL11A expression, and elevated HbF. The surrounding sequences function in vivo as a developmental stage-specific, lineage-restricted enhancer. Genome engineering reveals the enhancer is required in erythroid but not B-lymphoid cells for BCL11A expression. These findings illustrate how GWASs may expose functional variants of modest impact within causal elements essential for appropriate gene expression. We propose the GWAS-marked BCL11A enhancer represents an attractive target for therapeutic genome engineering for the beta-hemoglobinopathies.	[Bauer, Daniel E.; Xu, Jian; Fujiwara, Yuko; Lin, Carrie; Shao, Zhen; Smith, Elenoe C.; Orkin, Stuart H.] Boston Childrens Hosp, Div Hematol Oncol, Boston, MA 02115 USA; [Bauer, Daniel E.; Orkin, Stuart H.] Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA; [Bauer, Daniel E.; Kamran, Sophia C.; Xu, Jian; Canver, Matthew C.; Orkin, Stuart H.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Kamran, Sophia C.; Orkin, Stuart H.] Howard Hughes Med Inst, Boston, MA 02115 USA; [Lessard, Samuel; Lettre, Guillaume] Montreal Heart Inst, Montreal, PQ H1T 1C8, Canada; [Lessard, Samuel; Lettre, Guillaume] Univ Montreal, Montreal, PQ H1T 1C8, Canada; [Pinello, Luca; Yuan, Guo-Cheng] Dana Farber Canc Inst, Dept Biostat & Computat Biol, Boston, MA 02115 USA; [Sabo, Peter J.; Vierstra, Jeff; Stamatoyannopoulos, John A.] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Sabo, Peter J.; Vierstra, Jeff; Stamatoyannopoulos, John A.] Univ Washington, Dept Med, Seattle, WA 98195 USA; [Voit, Richard A.; Porteus, Matthew H.] Stanford Univ, Dept Pediat, Palo Alto, CA 94304 USA; [Yuan, Guo-Cheng] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Universite de Montreal; Universite de Montreal; Harvard University; Dana-Farber Cancer Institute; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Stanford University; Harvard University; Harvard T.H. Chan School of Public Health	Orkin, SH (corresponding author), Boston Childrens Hosp, Div Hematol Oncol, Boston, MA 02115 USA.	stuart_orkin@dfci.harvard.edu	Kamran, Sophia C./AAB-2976-2019	Kamran, Sophia C./0000-0001-9283-6515; Canver, Matthew/0000-0002-8146-3992; Pinello, Luca/0000-0003-1109-3823; Vierstra, Jeff/0000-0001-6406-8563; Shao, Zhen/0000-0002-4934-4360	Doris Duke Charitable Foundation [2009089]; Canadian Institute of Health Research [123382]; Amon Carter Foundation; Hyundai Hope on Wheels; NIH [U54HG004594, U54HG007010, R01HL032259, P01HL032262, P30DK049216]; Lucille Packard Foundation; National Institute of Diabetes and Digestive and Kidney Diseases Career Development [K08DK093705]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL032259, P01HL032262] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG005085, U54HG007010] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK049216, K08DK093705] Funding Source: NIH RePORTER	Doris Duke Charitable Foundation(Doris Duke Charitable Foundation (DDCF)); Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); Amon Carter Foundation; Hyundai Hope on Wheels; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Lucille Packard Foundation; National Institute of Diabetes and Digestive and Kidney Diseases Career Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank A. Woo, A. Cantor, M. Kowalczyk, S. Burns, J. Wright, J. Snow, J. Trowbridge, and members of the Orkin laboratory-particularly C. Peng, P. Das, G. Guo, M. Kerenyi, and E. Baena-for discussions. C. Guo and F. Alt provided the pre-B cell line; A. He and W. Pu provided the pWHERE lacZ reporter construct; C. Currie and M. Nguyen provided technical assistance; D. Bates and T. Kutyavin provided expertise with sequence analysis; R. Sandstrom provided help with data management; G. Losyev and J. Daley provided aid with flow cytometry; and J. Desimini provided graphical assistance. L. Yan at EpigenDx (Hopkinton, Massachusetts) conducted the custom pyrosequencing reactions. This work was funded by grants from the Doris Duke Charitable Foundation (2009089) and Canadian Institute of Health Research (123382) to G. L.; Amon Carter Foundation, Hyundai Hope on Wheels, NIH, Lucille Packard Foundation to M. H. P.; NIH grants U54HG004594 and U54HG007010 to J. A. S.; and NIH R01HL032259, P01HL032262, and P30DK049216 (Center of Excellence in Molecular Hematology) to S. H. O. D. E. B. is supported by National Institute of Diabetes and Digestive and Kidney Diseases Career Development Award K08DK093705. D. E. B., J. X., and S. H. O. are inventors on a patent application related to this work, filed by Boston Children's Hospital. The CSSCD samples with DNA and associated phenotype information are available from the National Heart, Lung, and Blood Institute to researchers that have appropriate institutional review board approval to use the materials.	Bauer DE, 2012, BLOOD, V120, P2945, DOI 10.1182/blood-2012-06-292078; Bhatnagar P, 2011, J HUM GENET, V56, P316, DOI 10.1038/jhg.2011.12; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Ernst J, 2011, NATURE, V473, P43, DOI 10.1038/nature09906; Esteghamat F, 2013, BLOOD, V121, P2553, DOI 10.1182/blood-2012-06-434530; FARBER MD, 1985, J CHRON DIS, V38, P495, DOI 10.1016/0021-9681(85)90033-5; Frazer KA, 2009, NAT REV GENET, V10, P241, DOI 10.1038/nrg2554; Fugger L, 2012, NEW ENGL J MED, V367, P2370, DOI 10.1056/NEJMp1212285; John A, 2012, DEVELOPMENT, V139, P1831, DOI 10.1242/dev.072850; Joung JK, 2013, NAT REV MOL CELL BIO, V14, P49, DOI 10.1038/nrm3486; Kassouf MT, 2010, GENOME RES, V20, P1064, DOI 10.1101/gr.104935.110; Koehler AN, 2010, CURR OPIN CHEM BIOL, V14, P331, DOI 10.1016/j.cbpa.2010.03.022; Kowalczyk MS, 2012, MOL CELL, V45, P447, DOI 10.1016/j.molcel.2011.12.021; Lee HJ, 2010, GENOME RES, V20, P81, DOI 10.1101/gr.099747.109; Leid M, 2004, GENE EXPR PATTERNS, V4, P733, DOI 10.1016/j.modgep.2004.03.009; Lettre G, 2008, P NATL ACAD SCI USA, V105, P11869, DOI 10.1073/pnas.0804799105; Liu PT, 2003, NAT IMMUNOL, V4, P525, DOI 10.1038/ni925; Maurano MT, 2012, SCIENCE, V337, P1190, DOI 10.1126/science.1222794; Melnikov A, 2012, NAT BIOTECHNOL, V30, P271, DOI 10.1038/nbt.2137; Menzel S, 2007, NAT GENET, V39, P1197, DOI 10.1038/ng2108; Nuinoon M, 2010, HUM GENET, V127, P303, DOI 10.1007/s00439-009-0770-2; Patwardhan RP, 2012, NAT BIOTECHNOL, V30, P265, DOI 10.1038/nbt.2136; Paul DS, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002139; Sankaran VG, 2009, NATURE, V460, P1093, DOI 10.1038/nature08243; Sankaran VG, 2008, SCIENCE, V322, P1839, DOI 10.1126/science.1165409; Soler E, 2010, GENE DEV, V24, P277, DOI 10.1101/gad.551810; Solovieff N, 2010, BLOOD, V115, P1815, DOI 10.1182/blood-2009-08-239517; Turner DJ, 2009, NAT PROTOC, V4, P1771, DOI 10.1038/nprot.2009.184; Tyson J, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-693; Uda M, 2008, P NATL ACAD SCI USA, V105, P1620, DOI 10.1073/pnas.0711566105; Urnov FD, 2010, NAT REV GENET, V11, P636, DOI 10.1038/nrg2842; van der Harst P, 2012, NATURE, V492, P369, DOI 10.1038/nature11677; van der Oost J, 2013, SCIENCE, V339, P768, DOI 10.1126/science.1234726; Xu J, 2013, P NATL ACAD SCI USA, V110, P6518, DOI 10.1073/pnas.1303976110; Xu J, 2011, SCIENCE, V334, P993, DOI 10.1126/science.1211053; Xu J, 2010, GENE DEV, V24, P783, DOI 10.1101/gad.1897310; Yu Y, 2012, J EXP MED, V209, P2467, DOI 10.1084/jem.20121846	37	395	440	0	70	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 11	2013	342	6155					253	257		10.1126/science.1242088	http://dx.doi.org/10.1126/science.1242088			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232EV	24115442	Green Accepted			2022-12-24	WOS:000325475200047
J	Jennings, JH; Rizzi, G; Stamatakis, AM; Ung, RL; Stuber, GD				Jennings, Joshua H.; Rizzi, Giorgio; Stamatakis, Alice M.; Ung, Randall L.; Stuber, Garret D.			The Inhibitory Circuit Architecture of the Lateral Hypothalamus Orchestrates Feeding	SCIENCE			English	Article							MELANIN-CONCENTRATING HORMONE; EXTENDED AMYGDALA; SELF-STIMULATION; NEURONS; OREXIN; RATS; AREA; REINFORCEMENT; RECEPTORS; DISTINCT	The growing prevalence of overeating disorders is a key contributor to the worldwide obesity epidemic. Dysfunction of particular neural circuits may trigger deviations from adaptive feeding behaviors. The lateral hypothalamus (LH) is a crucial neural substrate for motivated behavior, including feeding, but the precise functional neurocircuitry that controls LH neuronal activity to engage feeding has not been defined. We observed that inhibitory synaptic inputs from the extended amygdala preferentially innervate and suppress the activity of LH glutamatergic neurons to control food intake. These findings help explain how dysregulated activity at a number of unique nodes can result in a cascading failure within a defined brain network to produce maladaptive feeding.	[Jennings, Joshua H.; Rizzi, Giorgio; Stamatakis, Alice M.; Ung, Randall L.; Stuber, Garret D.] Univ N Carolina, Dept Psychiat, Chapel Hill, NC 27599 USA; [Jennings, Joshua H.; Stamatakis, Alice M.; Stuber, Garret D.] Univ N Carolina, Neurobiol Curriculum, Chapel Hill, NC 27599 USA; [Rizzi, Giorgio] Univ Med Ctr Utrecht, Dept Neurosci & Pharmacol, Brain Ctr Rudolf Magnus, Master Program Neurosci & Cognit, NL-3584 CX Utrecht, Netherlands; [Stuber, Garret D.] Univ N Carolina, Bowles Ctr Alcohol Studies, Chapel Hill, NC 27599 USA; [Stuber, Garret D.] Univ N Carolina, Ctr Neurosci, Chapel Hill, NC 27599 USA; [Stuber, Garret D.] Univ N Carolina, Dept Cell Biol & Physiol, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Utrecht University; Utrecht University Medical Center; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Stuber, GD (corresponding author), Univ N Carolina, Dept Psychiat, Chapel Hill, NC 27599 USA.	gstuber@med.unc.edu	, UNC Neuroscience Microscopy Core/AAE-8305-2022; Core, Vector/CAF-4832-2022; Stuber, Garret/E-1160-2011	Stuber, Garret/0000-0003-1730-4855; Ung, Randall/0000-0002-5303-3741	Klarman Family Foundation; Brain and Behavior Research Foundation; Foundation of Hope; National Institute on Drug Abuse [DA032750]; National Institute on Alcohol Abuse and Alcoholism [AA022234, AA011605];  [NS007431];  [DA034472]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS045892, T32NS007431] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [P50AA011605, P60AA011605, R01AA022234] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R37DA032750, F31DA034472, R01DA032750] Funding Source: NIH RePORTER	Klarman Family Foundation; Brain and Behavior Research Foundation; Foundation of Hope; National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); National Institute on Alcohol Abuse and Alcoholism(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); ; ; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank the Stuber laboratory and C. Bulik for discussion. We thank K. Deisseroth and E. Boyden for viral constructs and the University of North Carolina (UNC) Vector Core for viral packaging, North Carolina (UNC) Vector Core for viral packaging, B. Lowell and L. Vong for mice, and the UNC Neuroscience Center Microscopy Core (P30 NS045892). This study was supported by the Klarman Family Foundation, the Brain and Behavior Research Foundation, the Foundation of Hope, and the National Institute on Drug Abuse (DA032750) and the National Institute on Alcohol Abuse and Alcoholism (AA022234 and AA011605). A. M. S. was supported by NS007431 and DA034472.	Angeles-Castellanos M, 2007, NEUROSCIENCE, V144, P344, DOI 10.1016/j.neuroscience.2006.08.064; Atasoy D, 2012, NATURE, V488, P172, DOI 10.1038/nature11270; Berthoud HR, 2011, PHYSIOL BEHAV, V104, P29, DOI 10.1016/j.physbeh.2011.04.051; Chow BY, 2010, NATURE, V463, P98, DOI 10.1038/nature08652; de Olmos JS, 1999, ANN NY ACAD SCI, V877, P1; DELGADO JMR, 1953, AM J PHYSIOL, V172, P162, DOI 10.1152/ajplegacy.1952.172.1.162; Hahn JD, 2012, J COMP NEUROL, V520, P1831, DOI 10.1002/cne.23064; HOEBEL BG, 1962, SCIENCE, V135, P375, DOI 10.1126/science.135.3501.375; Jennings JH, 2013, NATURE, V496, P224, DOI 10.1038/nature12041; Johnson PM, 2010, NAT NEUROSCI, V13, P635, DOI 10.1038/nn.2519; Karnani MM, 2013, J PHYSIOL-LONDON, V591, P933, DOI 10.1113/jphysiol.2012.243493; Kim SY, 2013, NATURE, V496, P219, DOI 10.1038/nature12018; Knight ZA, 2012, CELL, V151, P1126, DOI 10.1016/j.cell.2012.10.039; Kudo T, 2012, J NEUROSCI, V32, P18035, DOI 10.1523/JNEUROSCI.4057-12.2012; Leinninger GM, 2011, CELL METAB, V14, P313, DOI 10.1016/j.cmet.2011.06.016; Mattis J, 2012, NAT METHODS, V9, P159, DOI [10.1038/nmeth.1808, 10.1038/NMETH.1808]; OLDS J, 1954, J COMP PHYSIOL PSYCH, V47, P419, DOI 10.1037/h0058775; Sakurai T, 1998, CELL, V92, P573, DOI 10.1016/S0092-8674(00)80949-6; Sharf R, 2010, BIOL PSYCHIAT, V67, P753, DOI 10.1016/j.biopsych.2009.12.035; STANLEY BG, 1993, BRAIN RES, V613, P88; Swanson LW, 2005, NEUROSCI LETT, V387, P80, DOI 10.1016/j.neulet.2005.06.066; Turenius CI, 2009, BRAIN RES, V1262, P16, DOI 10.1016/j.brainres.2009.01.016; Watabe-Uchida M, 2012, NEURON, V74, P858, DOI 10.1016/j.neuron.2012.03.017; Wickersham IR, 2007, NAT METHODS, V4, P47, DOI 10.1038/NMETH999; WISE RA, 1968, SCIENCE, V162, P377, DOI 10.1126/science.162.3851.377	25	290	295	2	65	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 27	2013	341	6153					1517	1521		10.1126/science.1241812	http://dx.doi.org/10.1126/science.1241812			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	224NS	24072922	Green Submitted, Green Accepted			2022-12-24	WOS:000324894600052
J	Li, PP; Spann, NJ; Kaikkonen, MU; Lu, M; Oh, DY; Fox, JN; Bandyopadhyay, G; Talukdar, S; Xu, JF; Lagakos, WS; Patsouris, D; Armando, A; Quehenberger, O; Dennis, EA; Watkins, SM; Auwerx, J; Glass, CK; Olefsky, JM				Li, Pingping; Spann, Nathanael J.; Kaikkonen, Minna U.; Lu, Min; Oh, Da Young; Fox, Jesse N.; Bandyopadhyay, Gautam; Talukdar, Saswata; Xu, Jianfeng; Lagakos, William S.; Patsouris, David; Armando, Aaron; Quehenberger, Oswald; Dennis, Edward A.; Watkins, Steven M.; Auwerx, Johan; Glass, Christopher K.; Olefsky, Jerrold M.			NCoR Repression of LXRs Restricts Macrophage Biosynthesis of Insulin-Sensitizing Omega 3 Fatty Acids	CELL			English	Article							PPAR-GAMMA; ADIPOSE-TISSUE; INFLAMMATION; OBESITY; ACTIVATION; RESISTANCE; ROLES; TRANSREPRESSION; COREPRESSORS; STIMULATION	Macrophage-mediated inflammation is a major contributor to obesity-associated insulin resistance. The corepressor NCoR interacts with inflammatory pathway genes in macrophages, suggesting that its removal would result in increased activity of inflammatory responses. Surprisingly, we find that macrophage-specific deletion of NCoR instead results in an anti-inflammatory phenotype along with robust systemic insulin sensitization in obese mice. We present evidence that derepression of LXRs contributes to this paradoxical anti-inflammatory phenotype by causing increased expression of genes that direct biosynthesis of palmitoleic acid and omega 3 fatty acids. Remarkably, the increased omega 3 fatty acid levels primarily inhibit NF-kappa B-dependent inflammatory responses by uncoupling NF-kappa B binding and enhancer/promoter histone acetylation from subsequent steps required for proinflammatory gene activation. This provides a mechanism for the in vivo anti-inflammatory insulin-sensitive phenotype observed in mice with macrophage-specific deletion of NCoR. Therapeutic methods to harness this mechanism could lead to a new approach to insulin-sensitizing therapies.	[Li, Pingping; Lu, Min; Oh, Da Young; Bandyopadhyay, Gautam; Talukdar, Saswata; Xu, Jianfeng; Lagakos, William S.; Patsouris, David; Quehenberger, Oswald; Glass, Christopher K.; Olefsky, Jerrold M.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Spann, Nathanael J.; Kaikkonen, Minna U.; Fox, Jesse N.; Glass, Christopher K.] Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Armando, Aaron; Quehenberger, Oswald; Dennis, Edward A.] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA; [Dennis, Edward A.] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA; [Kaikkonen, Minna U.] Univ Eastern Finland, Dept Biotechnol & Mol Med, AI Virtanen Inst, Kuopio 70211, Finland; [Watkins, Steven M.] Lip Technol Inc, West Sacramento, CA 95691 USA; [Auwerx, Johan] Ecole Polytech Fed Lausanne, Lab Integrat & Syst Physiol, CH-1015 Lausanne, Switzerland	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of Eastern Finland; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Glass, CK (corresponding author), Univ Calif San Diego, Dept Med, 9500 Gilman Dr, La Jolla, CA 92093 USA.	cglass@ucsd.edu; jolefsky@ucsd.edu	Kaikkonen, Minna U/AAK-3612-2020; Dennis, Edward A./M-5554-2019; Auwerx, Johan/ABE-9307-2021; Li, Pingping/F-1109-2019; Glass, Christopher/AAI-3933-2021	Kaikkonen, Minna U/0000-0001-6294-0979; Dennis, Edward A./0000-0003-3738-3140; Li, Pingping/0000-0003-0679-270X; Glass, Christopher/0000-0003-4344-3592; Talukdar, Saswata/0000-0003-3042-0025; Auwerx, Johan/0000-0002-5065-5393	Ecole Polytechnique Federale de Lausanne; Swiss National Science Foundation; EU Ideas program [ERC-AdG-23118]; Eunice Kennedy Shriver NICHD/NIH through a Cooperative Centers Program in Reproduction and Infertility Research;  [DK033651];  [DK074868];  [DK-063491];  [DK-09062];  [GM069338];  [DK091183]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P50HD012303] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA023100] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F32DK009062, R37DK033651, R01DK091183, R01DK033651, P30DK063491, P01DK074868] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM069338] Funding Source: NIH RePORTER	Ecole Polytechnique Federale de Lausanne; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); EU Ideas program; Eunice Kennedy Shriver NICHD/NIH through a Cooperative Centers Program in Reproduction and Infertility Research; ; ; ; ; ; ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the Flow Cytometry Resource (Dennis Young) for FACS analysis at the Rebecca and John Moores Cancer Center and thank Jachelle M. Ofrecio for genotyping at UCSD. This study was funded in part by grants to J.M.O. (DK033651, DK074868, DK-063491, and DK-09062), C.K.G. (DK074868, GM069338, and DK091183), and J.A. (the Ecole Polytechnique Federale de Lausanne, the Swiss National Science Foundation, and the EU Ideas program [ERC-AdG-23118]). This study was also funded by the Eunice Kennedy Shriver NICHD/NIH through a Cooperative Centers Program in Reproduction and Infertility Research to J.M.O.	Barish GD, 2012, CELL METAB, V15, P554, DOI 10.1016/j.cmet.2012.02.012; Bouhlel MA, 2007, CELL METAB, V6, P137, DOI 10.1016/j.cmet.2007.06.010; Brown HA, 2007, METHOD ENZYMOL, V434, P49, DOI 10.1016/S0076-6879(07)34004-4; Cao HM, 2008, CELL, V134, P933, DOI 10.1016/j.cell.2008.07.048; CHEN JD, 1995, NATURE, V377, P454, DOI 10.1038/377454a0; Clausen BE, 1999, TRANSGENIC RES, V8, P265, DOI 10.1023/A:1008942828960; Codina A, 2005, P NATL ACAD SCI USA, V102, P6009, DOI 10.1073/pnas.0500299102; Escoubet-Lozach L, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002401; FOLCH J, 1957, J BIOL CHEM, V226, P497; Ghisletti S, 2009, GENE DEV, V23, P681, DOI 10.1101/gad.1773109; Glass CK, 2010, NAT REV IMMUNOL, V10, P365, DOI 10.1038/nri2748; Glass CK, 2006, NAT REV IMMUNOL, V6, P44, DOI 10.1038/nri1748; Haffner S, 2003, CIRCULATION, V108, P1541, DOI 10.1161/01.CIR.0000088845.17586.EC; Hargreaves DC, 2009, CELL, V138, P129, DOI 10.1016/j.cell.2009.05.047; He HSHS, 2010, NAT GENET, V42, P343, DOI 10.1038/ng.545; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Hevener AL, 2007, J CLIN INVEST, V117, P1658, DOI 10.1172/JCI31561; HORLEIN AJ, 1995, NATURE, V377, P397, DOI 10.1038/377397a0; Hu X, 2003, MOL ENDOCRINOL, V17, P1019, DOI 10.1210/me.2002-0399; Jager J, 2007, ENDOCRINOLOGY, V148, P241, DOI 10.1210/en.2006-0692; Kintscher U, 2008, ARTERIOSCL THROM VAS, V28, P1304, DOI 10.1161/ATVBAHA.108.165100; Lai F, 2013, NATURE, V494, P497, DOI 10.1038/nature11884; Lanthier N, 2010, AM J PHYSIOL-GASTR L, V298, pG107, DOI 10.1152/ajpgi.00391.2009; Li PP, 2011, CELL, V147, P815, DOI 10.1016/j.cell.2011.09.050; Medzhitov R, 2009, NAT REV IMMUNOL, V9, P692, DOI 10.1038/nri2634; Mori Trevor A, 2004, Curr Atheroscler Rep, V6, P461, DOI 10.1007/s11883-004-0087-5; Mottis A, 2013, GENE DEV, V27, P819, DOI 10.1101/gad.214023.113; Mullican SE, 2011, GENE DEV, V25, P2480, DOI 10.1101/gad.175950.111; Ng HH, 2003, MOL CELL, V11, P709, DOI 10.1016/S1097-2765(03)00092-3; Odegaard JI, 2007, NATURE, V447, P1116, DOI 10.1038/nature05894; Oh DY, 2010, CELL, V142, P687, DOI 10.1016/j.cell.2010.07.041; Olefsky JM, 2010, ANNU REV PHYSIOL, V72, P219, DOI 10.1146/annurev-physiol-021909-135846; Ostuni R, 2013, CELL, V152, P157, DOI 10.1016/j.cell.2012.12.018; Pascual G, 2005, NATURE, V437, P759, DOI 10.1038/nature03988; Reaven GM, 2005, ANNU REV NUTR, V25, P391, DOI 10.1146/annurev.nutr.24.012003.132155; Rosenfeld MG, 2006, GENE DEV, V20, P1405, DOI 10.1101/gad.1424806; Rotter V, 2003, J BIOL CHEM, V278, P45777, DOI 10.1074/jbc.M301977200; Shoelson SE, 2007, GASTROENTEROLOGY, V132, P2169, DOI 10.1053/j.gastro.2007.03.059; Spann NJ, 2012, CELL, V151, P138, DOI 10.1016/j.cell.2012.06.054; Wagner BL, 2003, MOL CELL BIOL, V23, P5780, DOI 10.1128/MCB.23.16.5780-5789.2003; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Yamamoto H, 2011, CELL, V147, P827, DOI 10.1016/j.cell.2011.10.017; Yang HW, 2010, J IMMUNOL, V185, P1836, DOI 10.4049/jimmunol.1000021; Yang ZY, 2005, MOL CELL, V19, P535, DOI 10.1016/j.molcel.2005.06.029	44	112	115	0	35	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 26	2013	155	1					200	214		10.1016/j.cell.2013.08.054	http://dx.doi.org/10.1016/j.cell.2013.08.054			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	224UX	24074869	Bronze, Green Accepted, Green Published			2022-12-24	WOS:000324916700020
J	Bedard, PL; Hansen, AR; Ratain, MJ; Siu, LL				Bedard, Philippe L.; Hansen, Aaron R.; Ratain, Mark J.; Siu, Lillian L.			Tumour heterogeneity in the clinic	NATURE			English	Review							FACTOR RECEPTOR 2; METASTATIC BREAST-CANCER; HER2 GENE AMPLIFICATION; ANTI-EGFR THERAPY; CELL LUNG CANCERS; ACQUIRED-RESISTANCE; COLORECTAL-CANCER; INTRATUMOR HETEROGENEITY; IN-SITU; MUTATIONAL EVOLUTION	Recent therapeutic advances in oncology have been driven by the identification of tumour genotype variations between patients, called interpatient heterogeneity, that predict the response of patients to targeted treatments. Subpopulations of cancer cells with unique genomes in the same patient may exist across different geographical regions of a tumour or evolve over time, called intratumour heterogeneity. Sequencing technologies can be used to characterize intratumour heterogeneity at diagnosis, monitor clonal dynamics during treatment and identify the emergence of clinical resistance during disease progression. Genetic interpatient and intratumour heterogeneity can pose challenges for the design of clinical trials that use these data.	[Bedard, Philippe L.; Hansen, Aaron R.; Siu, Lillian L.] Univ Hlth Network, Div Med Oncol & Hematol, Princess Margaret Canc Ctr, Toronto, ON, Canada; [Bedard, Philippe L.; Hansen, Aaron R.; Siu, Lillian L.] Univ Toronto, Dept Med, Toronto, ON, Canada; [Ratain, Mark J.] Univ Chicago, Dept Med, Chicago, IL 60637 USA	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto; University of Chicago	Siu, LL (corresponding author), Univ Hlth Network, Div Med Oncol & Hematol, Princess Margaret Canc Ctr, Toronto, ON, Canada.	lillian.siu@uhn.ca	wang, edwin/G-5372-2010	Hansen, Aaron/0000-0002-2363-8707; Bedard, Philippe/0000-0002-6771-2999	Cancer Care Ontario Applied Cancer Research Units Grant; US National Institute of Health [U01 GM61393]; NATIONAL CANCER INSTITUTE [UM1CA186644] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM061393] Funding Source: NIH RePORTER	Cancer Care Ontario Applied Cancer Research Units Grant; US National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Supported in part by the Cancer Care Ontario Applied Cancer Research Units Grant (P. L. B, L. L. S) and by the US National Institute of Health Grant U01 GM61393 (M.J.R).	Albiges L., 2012, CANCER RES, V72, pS1746; Amir E, 2012, J CLIN ONCOL, V30, P587, DOI 10.1200/JCO.2010.33.5232; [Anonymous], 1992, Fed Regist, V57, P7002; Antonescu CR, 2005, CLIN CANCER RES, V11, P4182, DOI 10.1158/1078-0432.CCR-04-2245; Aparicio S, 2013, NEW ENGL J MED, V368, P842, DOI 10.1056/NEJMra1204892; Artale S, 2008, J CLIN ONCOL, V26, P4217, DOI 10.1200/JCO.2008.18.7286; Bai H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054170; Bang YJ, 2010, LANCET, V376, P1302; Barker AD, 2009, CLIN PHARMACOL THER, V86, P97, DOI 10.1038/clpt.2009.68; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Baselga J, 2012, NEW ENGL J MED, V366, P520, DOI 10.1056/NEJMoa1109653; Bedard P, 2013, J CLIN ONCOL, V31, P11002; Begley CG, 2012, NATURE, V483, P531, DOI 10.1038/483531a; Beltran H, 2013, EUR UROL, V63, P920, DOI 10.1016/j.eururo.2012.08.053; Berry DA, 2012, CLIN CANCER RES, V18, P638, DOI 10.1158/1078-0432.CCR-11-2018; Bozzetti C, 2011, BRIT J CANCER, V104, P1372, DOI 10.1038/bjc.2011.121; Buttitta F, 2013, CLIN CANCER RES, V19, P691, DOI 10.1158/1078-0432.CCR-12-1958; Callaway E., 2012, NATURE          0202; Campbell PJ, 2010, NATURE, V467, P1109, DOI 10.1038/nature09460; Chan KCA, 2013, CLIN CHEM, V59, P211, DOI 10.1373/clinchem.2012.196014; Chang HJ, 2011, JPN J CLIN ONCOL, V41, P593, DOI 10.1093/jjco/hyr020; Chapman PB, 2011, NEW ENGL J MED, V364, P2507, DOI 10.1056/NEJMoa1103782; Colombino M, 2012, J CLIN ONCOL, V30, P2522, DOI 10.1200/JCO.2011.41.2452; COONS SW, 1995, CANCER RES, V55, P1569; Cristofanilli M, 2004, NEW ENGL J MED, V351, P781, DOI 10.1056/NEJMoa040766; Dancey JE, 2012, CELL, V148, P409, DOI 10.1016/j.cell.2012.01.014; Davies C, 2011, LANCET, V378, P771, DOI 10.1016/S0140-6736(11)60993-8; Dawson SJ, 2013, NEW ENGL J MED, V368, P1199, DOI 10.1056/NEJMoa1213261; De Roock W, 2008, ANN ONCOL, V19, P508, DOI 10.1093/annonc/mdm496; Diaz LA, 2012, NATURE, V486, P537, DOI 10.1038/nature11219; Dienstmann R, 2012, MOL CANCER THER, V11, P2062, DOI 10.1158/1535-7163.MCT-12-0290; Ding L, 2010, NATURE, V464, P999, DOI 10.1038/nature08989; Elisei R, 2008, J CLIN ENDOCR METAB, V93, P682, DOI 10.1210/jc.2007-1714; FIDLER IJ, 1982, SCIENCE, V217, P998, DOI 10.1126/science.7112116; Forshew T, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003726; Gabler NB, 2011, MED CARE, V49, P761, DOI 10.1097/MLR.0b013e318215d90d; Gargis AS, 2012, NAT BIOTECHNOL, V30, P1033, DOI 10.1038/nbt.2403; Garnett MJ, 2012, NATURE, V483, P570, DOI 10.1038/nature11005; Garraway L. A., 2013, GENOMICS DRIVEN CLIN; Gasch C, 2013, CLIN CHEM, V59, P252, DOI 10.1373/clinchem.2012.188557; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Getz M., 2012, BREAST CANC GENOME G; Gong Y, 2011, CANCER-AM CANCER SOC, V117, P705, DOI 10.1002/cncr.25506; Heinrich MC, 2006, J CLIN ONCOL, V24, P4764, DOI 10.1200/JCO.2006.06.2265; Heselmeyer-Haddad K, 2012, AM J PATHOL, V181, P1807, DOI 10.1016/j.ajpath.2012.07.012; Hollebecque A, 2013, ASCO M, V31, P2512; Hou Y, 2012, CELL, V148, P873, DOI 10.1016/j.cell.2012.02.028; Jang MH, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3239; Janjigian YY, 2012, ANN ONCOL, V23, P2656, DOI 10.1093/annonc/mds104; Johnson CE, 2012, BREAST CANCER RES TR, V133, P889, DOI 10.1007/s10549-011-1835-1; Kalikaki A, 2008, BRIT J CANCER, V99, P923, DOI 10.1038/sj.bjc.6604629; Kaplan R., 2013, MRC FOCUS 4 NEW TRIA; Karapetis CS, 2008, NEW ENGL J MED, V359, P1757, DOI 10.1056/NEJMoa0804385; Kim ES, 2011, CANCER DISCOV, V1, P44, DOI 10.1158/2159-8274.CD-10-0010; Kim H, 2013, HISTOPATHOLOGY, V62, P305, DOI 10.1111/j.1365-2559.2012.04356.x; Kim H, 2011, J THORAC ONCOL, V6, P1359, DOI 10.1097/JTO.0b013e31821cfc73; Kim MA, 2011, HISTOPATHOLOGY, V59, P822, DOI 10.1111/j.1365-2559.2011.04012.x; Kinde I, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3004952; Knijn N, 2011, BRIT J CANCER, V104, P1020, DOI 10.1038/bjc.2011.26; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Kopetz S, 2010, J CLIN ONCOL, V28, DOI 10.1200/jco.2010.28.15_suppl.3534; Kummar S., 2012, CHALLENGES INCORPORA; Kurzrock R., 2012, WINTHER WIN THERAPEU; Leary RJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004742; Liedtke C, 2009, ANN ONCOL, V20, P1953, DOI 10.1093/annonc/mdp263; Lillie EO, 2011, PERS MED, V8, P161, DOI 10.2217/PME.11.7; Lindstrom LS, 2012, J CLIN ONCOL, V30, P2601, DOI 10.1200/JCO.2011.37.2482; Lipson D, 2012, NAT MED, V18, P382, DOI 10.1038/nm.2673; Maheswaran S, 2008, NEW ENGL J MED, V359, P366, DOI 10.1056/NEJMoa0800668; MD Anderson Cancer Center, 2012, SHEIK KHAL BIN ZAYED; Melcher C., 2012, CANCER RES, V72; Mendelsohn J, 2013, J CLIN ONCOL, V31, P1904, DOI 10.1200/JCO.2012.45.3605; Mick R, 2000, CONTROL CLIN TRIALS, V21, P343, DOI 10.1016/S0197-2456(00)00058-1; Miller V.A., 2013, J CLIN ONCOL, V31, P11020, DOI [10.1200/jco.2013.31.15_suppl.11020, DOI 10.1200/JCO.2013.31.15_SUPPL.11020]; Misale S, 2012, NATURE, V486, P532, DOI 10.1038/nature11156; Mok TS, 2009, NEW ENGL J MED, V361, P947, DOI 10.1056/NEJMoa0810699; Murtaza M, 2013, NATURE, V497, P108, DOI 10.1038/nature12065; Navin N, 2011, NATURE, V472, P90, DOI 10.1038/nature09807; Newburger DE, 2013, GENOME RES, V23, P1097, DOI 10.1101/gr.151670.112; Niikura N, 2012, J CLIN ONCOL, V30, P593, DOI 10.1200/JCO.2010.33.8889; NOWELL PC, 1976, SCIENCE, V194, P23, DOI 10.1126/science.959840; Papillon-Cavanagh S, 2013, J AM MED INFORM ASSN, V20, P597, DOI 10.1136/amiajnl-2012-001442; Park S, 2009, J THORAC ONCOL, V4, P809, DOI 10.1097/JTO.0b013e3181a94af4; Perez K, 2013, EXP MOL PATHOL, V95, P74, DOI 10.1016/j.yexmp.2013.01.004; Rodon J, 2012, NAT REV CLIN ONCOL, V9, P359, DOI 10.1038/nrclinonc.2012.48; Rollins B., 2013, J CLIN ONCOL, V31, P1531; Rye IH, 2012, CANCER RES, V72, DOI 10.1158/0008-5472.SABCS12-P3-05-04; Sakurada A, 2008, J THORAC ONCOL, V3, P527, DOI 10.1097/JTO.0b013e318168be93; Schmid K, 2009, CLIN CANCER RES, V15, P4554, DOI 10.1158/1078-0432.CCR-09-0089; Schwarzenbach H, 2011, NAT REV CANCER, V11, P426, DOI 10.1038/nrc3066; Sequist LV, 2011, ANN ONCOL, V22, P2616, DOI 10.1093/annonc/mdr489; Shah SP, 2012, NATURE, V486, P395, DOI 10.1038/nature10933; Shah SP, 2009, NATURE, V461, P809, DOI 10.1038/nature08489; Slamon DJ, 2001, NEW ENGL J MED, V344, P783, DOI 10.1056/NEJM200103153441101; Sleijfer S, 2013, J CLIN ONCOL, V31, P1834, DOI 10.1200/JCO.2012.45.3639; Starczynski J, 2012, AM J CLIN PATHOL, V137, P595, DOI 10.1309/AJCPATBZ2JFN1QQC; Swanton C, 2012, CANCER RES, V72, P4875, DOI 10.1158/0008-5472.CAN-12-2217; Taniguchi K, 2008, CANCER SCI, V99, P929, DOI 10.1111/j.1349-7006.2008.00782.x; Tao Y, 2011, P NATL ACAD SCI USA, V108, P12042, DOI 10.1073/pnas.1108715108; Tapia C, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1676; Thompson AM, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2771; Tolmachev V, 2010, LANCET ONCOL, V11, P992, DOI 10.1016/S1470-2045(10)70088-7; Tougeron D, 2013, ANN ONCOL, V24, P1267, DOI 10.1093/annonc/mds620; Tran B, 2013, INT J CANCER, V132, P1547, DOI 10.1002/ijc.27817; Tran B, 2012, J CLIN ONCOL, V30, P647, DOI 10.1200/JCO.2011.39.2316; Tsimberidou AM, 2012, CLIN CANCER RES, V18, P6373, DOI 10.1158/1078-0432.CCR-12-1627; Turner NC, 2012, LANCET ONCOL, V13, pE178, DOI 10.1016/S1470-2045(11)70335-7; Vakiani E, 2012, J CLIN ONCOL, V30, P2956, DOI 10.1200/JCO.2011.38.2994; Vanderbilt-Ingram Cancer Center, 2011, PERS CANC THER VAND; Voest E., 2012, DELIVERING STRATIFIE; Wagle N, 2012, CANCER DISCOV, V2, P82, DOI 10.1158/2159-8290.CD-11-0184; Walker I, 2013, J CLIN ONCOL, V31; Walter MJ, 2012, NEW ENGL J MED, V366, P1090, DOI 10.1056/NEJMoa1106968; Weller M, 2010, NAT REV NEUROL, V6, P39, DOI 10.1038/nrneurol.2009.197; Williams P., 2013, REQUEST INFORM RFI E; Wilmott JS, 2012, MOL CANCER THER, V11, P2704, DOI 10.1158/1535-7163.MCT-12-0530; Wu X, 2012, NATURE, V482, P529, DOI 10.1038/nature10825; Xu X, 2012, CELL, V148, P886, DOI 10.1016/j.cell.2012.02.025; Xu XH, 2012, J CLIN ONCOL, V30; Yachida S, 2010, NATURE, V467, P1114, DOI 10.1038/nature09515; Yancovitz M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029336; Yoon HH, 2012, J CLIN ONCOL, V30, P3932, DOI 10.1200/JCO.2012.43.1890	122	781	804	12	265	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 19	2013	501	7467					355	364		10.1038/nature12627	http://dx.doi.org/10.1038/nature12627			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219XT	24048068	Green Accepted			2022-12-24	WOS:000324545700034
J	Hsiang, SM; Burke, M; Miguel, E				Hsiang, Solomon M.; Burke, Marshall; Miguel, Edward			Quantifying the Influence of Climate on Human Conflict	SCIENCE			English	Article							ECONOMIC-GROWTH; CIVIL CONFLICT; SOCIAL-CONFLICT; TEMPERATURE; WEATHER; VIOLENCE; SHOCKS; ENVIRONMENT; VARIABILITY; COLLAPSE	A rapidly growing body of research examines whether human conflict can be affected by climatic changes. Drawing from archaeology, criminology, economics, geography, history, political science, and psychology, we assemble and analyze the 60 most rigorous quantitative studies and document, for the first time, a striking convergence of results. We find strong causal evidence linking climatic events to human conflict across a range of spatial and temporal scales and across all major regions of the world. The magnitude of climate's influence is substantial: for each one standard deviation (1 sigma) change in climate toward warmer temperatures or more extreme rainfall, median estimates indicate that the frequency of interpersonal violence rises 4% and the frequency of intergroup conflict rises 14%. Because locations throughout the inhabited world are expected to warm 2 sigma to 4 sigma by 2050, amplified rates of human conflict could represent a large and critical impact of anthropogenic climate change.	[Hsiang, Solomon M.] Princeton Univ, Woodrow Wilson Sch Publ & Int Affairs, Program Sci Technol & Environm Policy, Princeton, NJ 08544 USA; [Hsiang, Solomon M.; Miguel, Edward] Natl Bur Econ Res, Cambridge, MA 02138 USA; [Burke, Marshall] Univ Calif Berkeley, Dept Agr & Resource Econ, Berkeley, CA 94720 USA; [Miguel, Edward] Univ Calif Berkeley, Dept Econ, Berkeley, CA 94720 USA	Princeton University; National Bureau of Economic Research; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Hsiang, SM (corresponding author), Univ Calif Berkeley, Goldman Sch Publ Policy, Berkeley, CA 94720 USA.	shsiang@berkeley.edu		Miguel, Edward/0000-0001-6927-709X; Burke, Marshall/0000-0003-4288-5858	Postdoctoral Fellowship in Science, Technology and Environmental Policy at Princeton University; NSF; Oxfam Faculty Chair in Environmental and Resource Economics at UC Berkeley	Postdoctoral Fellowship in Science, Technology and Environmental Policy at Princeton University; NSF(National Science Foundation (NSF)); Oxfam Faculty Chair in Environmental and Resource Economics at UC Berkeley	We thank C. Almer, D. Blakeslee, D. Card, P. Burke, H. Buhaug, P. deMenocal, N. P. Gleditsch, M. Harari, G. Haug, R. Larrick, H. Lee, L. Lefgren, M. Levy, S. Naidu, J. O'Loughlin, M. Ranson, O. M. Theisen, and N. von Uexkull for providing results and data. We also thank three anonymous reviewers, I. Bannon, D. Card, M. Cane, M. Kremer, D. Lobell, K. Meng, S. Mullainathan, M. Oppenheimer, M. Roberts, I. Salehyan, W. Schlenker, J. Shapiro, R. Singh, D. Stahle, L. Thompson, D. Zhang, and seminar participants at Columbia University, Harvard University, the International Studies Association Annual Meeting, Oxford University, the Pacific Development Conference, Princeton University, University of California (UC) Berkeley, UC San Diego, and the World Bank for comments, suggestions, and references. We thank C. Baysan and F. Gonzalez for excellent research assistance. S.M.H. was funded by a Postdoctoral Fellowship in Science, Technology and Environmental Policy at Princeton University. M.B. was funded by a Graduate Research Fellowship from the NSF. E.M. was funded by the Oxfam Faculty Chair in Environmental and Resource Economics at UC Berkeley. S.M.H. served as consultant for Scitor, a company that has been analyzing security risks that emerge from climatic changes. Data and replication code for all results in this paper are available for download at: http://cega.berkeley.edu/assets/miscellaneous_files/HsiangBurkeMiguel-2013-data.zip. Author contributions: S.M.H. and M.B. conceived of and designed the study; S.M.H. and M.B. collected and analyzed data; S.M.H., M.B., and E.M. interpreted the findings and wrote the paper.	Achen C. H., 2004, BLIND RETROSPE UNPUB; Almer C., 2012, DP1203; Anderson CA, 1997, J PERS SOC PSYCHOL, V73, P1213, DOI 10.1037/0022-3514.73.6.1213; Anderson CA, 2000, ADV EXP SOC PSYCHOL, V32, P63, DOI 10.1016/S0065-2601(00)80004-0; Anderson RW., 2013, PERSECUTING PROTECTV; Angrist JD, 2009, MOSTLY HARMLESS ECONOMETRICS: AN EMPIRICISTS COMPANION, P1; Angrist JD, 2008, REV ECON STAT, V90, P191, DOI 10.1162/rest.90.2.191; Angrist JD, 2010, J ECON PERSPECT, V24, P3, DOI 10.1257/jep.24.2.3; [Anonymous], RAINFALL SHOCKS PROP; [Anonymous], 2012, MAN RISKS EXTR EV DI; Anttila-Hughes J. K., 2012, WORKING PAPER; Arezki R, 2011, 1162 IMF; Auffhammer M, 2013, REV ENV ECON POLICY, V7, P181, DOI 10.1093/reep/ret016; AULICIEMS A, 1995, INT J BIOMETEOROL, V39, P34, DOI 10.1007/BF01320891; Bai Y, 2011, REV ECON STAT, V93, P970, DOI 10.1162/REST_a_00106; Barrett C. B., 2013, FOOD CONSEQUENCES FO; Barrios S, 2006, J URBAN ECON, V60, P357, DOI 10.1016/j.jue.2006.04.005; Barrios S, 2010, REV ECON STAT, V92, P350, DOI 10.1162/rest.2010.11212; Bergholt D, 2012, J PEACE RES, V49, P147, DOI 10.1177/0022343311426167; Berman E, 2011, J POLIT ECON, V119, P766, DOI 10.1086/661983; Bernauer T, 2012, ENVIRON RES LETT, V7, DOI 10.1088/1748-9326/7/1/015601; Blattman C, 2010, J ECON LIT, V48, P3, DOI 10.1257/jel.48.1.3; Bohlken AT, 2010, J PEACE RES, V47, P589, DOI 10.1177/0022343310373032; Bruckner M, 2011, ECONOMETRICA, V79, P923, DOI 10.3982/ECTA8183; Buckley BM, 2010, P NATL ACAD SCI USA, V107, P6748, DOI 10.1073/pnas.0910827107; Buntgen U, 2011, SCIENCE, V331, P578, DOI 10.1126/science.1197175; Buhaug H., 2010, SENSITIVITY ANAL CLI; Buhaug H, 2010, P NATL ACAD SCI USA, V107, pE186, DOI 10.1073/pnas.1015796108; Buhaug H, 2010, P NATL ACAD SCI USA, V107, P16477, DOI 10.1073/pnas.1005739107; Burke M, 2013, ADAPTATION CLIMATE C; Burke M, 2010, 16440 NBER; Burke MB, 2010, P NATL ACAD SCI USA, V107, pE185, DOI 10.1073/pnas.1014879107; Burke MB, 2010, P NATL ACAD SCI USA, V107, pE103, DOI 10.1073/pnas.1005748107; Burke MB, 2009, P NATL ACAD SCI USA, V106, P20670, DOI 10.1073/pnas.0907998106; Burke PJ, 2012, BE J MACROECON, V12, DOI 10.1515/1935-1690.2398; Burke PJ, 2010, AM ECON J-MACROECON, V2, P124, DOI 10.1257/mac.2.4.124; Bushman BJ, 2005, J PERS SOC PSYCHOL, V89, P74, DOI 10.1037/0022-3514.89.1.74; Butler CK, 2012, J PEACE RES, V49, P23, DOI 10.1177/0022343311426166; Butzer KW, 2012, P NATL ACAD SCI USA, V109, P3632, DOI 10.1073/pnas.1114845109; CARD D, 1995, AM ECON REV, V85, P238; Card D, 2011, Q J ECON, V126, P103, DOI 10.1093/qje/qjr001; Carter B., 2012, PUBLIC POLICY PRICE; Cervellati M., 2011, IZA Discussion Papers - Forschungsinstitut zur Zukunft der Arbeit; Chaney E., ECONOMETRIC IN PRESS; Chassang S, 2009, Q J POLIT SCI, V4, P211, DOI 10.1561/100.00008072; Ciccone A, 2011, AM ECON J-APPL ECON, V3, P215, DOI 10.1257/app.3.4.215; Cohn EG, 1997, J PERS SOC PSYCHOL, V72, P1322; Couttenier M., 2013, ECON J, V124, P201, DOI DOI 10.1111/ECOJ.12042; Cullen HM, 2000, GEOLOGY, V28, P379, DOI 10.1130/0091-7613(2000)28<379:CCATCO>2.0.CO;2; D'Anjou RM, 2012, P NATL ACAD SCI USA, V109, P20332, DOI 10.1073/pnas.1212730109; Dal Bo E, 2011, J EUR ECON ASSOC, V9, P646, DOI 10.1111/j.1542-4774.2011.01025.x; Deligiannis T, 2012, GLOBAL ENVIRON POLIT, V12, P78, DOI 10.1162/GLEP_a_00098; Dell M, 2012, AM ECON J-MACROECON, V4, P66, DOI 10.1257/mac.4.3.66; Deschenes O, 2011, AM ECON J-APPL ECON, V3, P152, DOI 10.1257/app.3.4.152; Dube O, 2013, REV ECON STUD, V80, P1384, DOI 10.1093/restud/rdt009; Fearon JD, 2003, AM POLIT SCI REV, V97, P75, DOI 10.1017/S0003055403000534; Feng S, 2012, W17734 NAT BUR EC RE, DOI DOI 10.3386/W17734; Fjelde H, 2012, POLIT GEOGR, V31, P444, DOI 10.1016/j.polgeo.2012.08.004; FREEDMAN DA, 1991, SOCIOL METHODOL, V21, P291, DOI 10.2307/270939; Gelman A., 2004, BAYESIAN DATA ANAL; Gelman A., 2007, ANAL METHODS SOCIAL, DOI 10.1017/CBO9780511790942; Gleditsch NP, 2012, J PEACE RES, V49, P3, DOI 10.1177/0022343311431288; Gleditsch NP, 1998, J PEACE RES, V35, P381, DOI 10.1177/0022343398035003007; Greene W., 2003, ECONOMETRIC ANAL; Grove RH, 2007, MEDIEV HIST J, V10, P75, DOI 10.1177/097194580701000203; Harari M, 2013, CONFLICT CLIMATE CEL; Haug GH, 2003, SCIENCE, V299, P1731, DOI 10.1126/science.1080444; Healy AJ, 2010, P NATL ACAD SCI USA, V107, P12804, DOI 10.1073/pnas.1007420107; Hedges L. V., 1985, STAT METHOD METAANAL; Hendrix CS, 2012, J PEACE RES, V49, P35, DOI 10.1177/0022343311426165; Hidalgo FD, 2010, REV ECON STAT, V92, P505, DOI 10.1162/REST_a_00007; HOLLAND PW, 1986, J AM STAT ASSOC, V81, P945, DOI 10.2307/2289064; Homer-Dixon T.F., 1999, ENV SCARCITY VIOLENC; Hornbeck R, 2012, AM ECON REV, V102, P1477, DOI 10.1257/aer.102.4.1477; Hsiang SM, 2012, CLIM CHANG ECON, V3, DOI 10.1142/S201000781250011X; Hsiang SM, 2014, CLIMATIC CHANGE, V123, P39, DOI 10.1007/s10584-013-0868-3; Hsiang SM, 2011, NATURE, V476, P438, DOI 10.1038/nature10311; Hsiang SM, 2010, P NATL ACAD SCI USA, V107, P15367, DOI 10.1073/pnas.1009510107; Huntington E, 1917, Q J ECON, V31, P173, DOI 10.2307/1883908; Jacob B, 2007, J HUM RESOUR, V42, P489, DOI 10.3368/jhr.XLII.3.489; Jensen PS, 2009, DEFENCE PEACE ECON, V20, P359, DOI 10.1080/10242690902868277; Jia R., 2013, ECON J, DOI [10.1111/ecoj.12037, DOI 10.1111/EC0J.12037]; Jones BF, 2010, AM ECON REV, V100, P454, DOI 10.1257/aer.100.2.454; Kelly RL, 2013, P NATL ACAD SCI USA, V110, P443, DOI 10.1073/pnas.1201341110; Kennett DJ, 2012, SCIENCE, V338, P788, DOI 10.1126/science.1226299; KENRICK DT, 1986, ENVIRON BEHAV, V18, P179, DOI 10.1177/0013916586182002; Kung J. K., 2012, WORKING PAPER; Kuper R, 2006, SCIENCE, V313, P803, DOI 10.1126/science.1130989; Lagi M., 2011, ARXIV11082455; Larrick RP, 2011, PSYCHOL SCI, V22, P423, DOI 10.1177/0956797611399292; Lee HF, 2013, CLIM RES, V56, P1, DOI 10.3354/cr01129; LEGATES DR, 1990, THEOR APPL CLIMATOL, V41, P11, DOI 10.1007/BF00866198; Lei Y., 2011, DO GIANT OILFIELD DI; LEVY MA, 1995, INT SECURITY, V20, P35, DOI 10.2307/2539228; Levy MA, 2005, INT WORKSH HUM SEC C; Libecap G.D., 2011, EC CLIMATE CHANGE AD; Lobell D, 2010, ADV GLOB CHANGE RES, V37, P1; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Manacorda M, 2011, AM ECON J-APPL ECON, V3, P1, DOI 10.1257/app.3.3.1; Mares D, 2013, J URBAN HEALTH, V90, P768, DOI 10.1007/s11524-013-9791-1; Mathers C, 2008, GLOBAL BURDEN OF DISEASE: 2004 UPDATE, P1; Maystadt J. F., 2013, IFPRI - Discussion Papers; Meehl GA, 2007, B AM METEOROL SOC, V88, P1383, DOI 10.1175/BAMS-88-9-1383; Meehl GA, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P747; Mehlum H, 2006, J URBAN ECON, V59, P370, DOI 10.1016/j.jue.2005.09.007; Miguel E, 2005, REV ECON STUD, V72, P1153, DOI 10.1111/0034-6527.00365; Miguel E, 2004, J POLIT ECON, V112, P725, DOI 10.1086/421174; Miguel E, 2011, AM ECON J-APPL ECON, V3, P228, DOI 10.1257/app.3.4.228; Nadaraya E. A., 1964, THEOR PROBAB APPL, V9, P141, DOI [DOI 10.1137/1109020, 10.1137/1110024]; Neidell M., J LABOR EC IN PRESS; O'Loughlin J, 2012, P NATL ACAD SCI USA, V109, P18344, DOI 10.1073/pnas.1205130109; ORTLOFF CR, 1993, J ARCHAEOL SCI, V20, P195, DOI 10.1006/jasc.1993.1014; Patterson WP, 2010, P NATL ACAD SCI USA, V107, P5306, DOI 10.1073/pnas.0902522107; Ranson M., J ENV EC MA IN PRESS; Rotton J, 2000, J PERS SOC PSYCHOL, V78, P1074, DOI 10.1037//0022-3514.78.6.1074; Salehyan I, 2012, ANN CONV INT STUD AS; Sarsons H., 2011, RAINFALL CONFLICT; SCHEFFRAN J, 2012, CLIMATE CHANGE HUMAN, V8; Scheffran J, 2012, SCIENCE, V336, P869, DOI 10.1126/science.1221339; Schlenker W, 2006, REV AGR ECON, V28, P391, DOI 10.1111/j.1467-9353.2006.00304.x; Schlenker W, 2010, ENVIRON RES LETT, V5, DOI 10.1088/1748-9326/5/1/014010; Schlenker W, 2009, P NATL ACAD SCI USA, V106, P15594, DOI 10.1073/pnas.0906865106; Sekhri S., 2012, WORKING PAPER; Solomon Hsiang, 2013, VISUALLY WEIGHTED RE, DOI 10.2139/ssrn.2265501; Stahle DW, 1998, SCIENCE, V280, P564, DOI 10.1126/science.280.5363.564; Sutton AE, 2010, P NATL ACAD SCI USA, V107, pE102, DOI 10.1073/pnas.1005278107; Theisen OM, 2012, J PEACE RES, V49, P81, DOI 10.1177/0022343311425842; Theisen OM, 2011, INT SECURITY, V36, P79; Tol RSJ, 2010, CLIMATIC CHANGE, V99, P65, DOI 10.1007/s10584-009-9659-2; VRIJ A, 1994, J COMMUNITY APPL SOC, V4, P365, DOI 10.1002/casp.2450040505; Watson G., 1964, SANKHYA A, V26, P359, DOI DOI 10.2307/25049340; Witschi H, 2001, TOXICOL SCI, V64, P4, DOI 10.1093/toxsci/64.1.4; Wittman Donald A., 2006, OXFORD HDB POLITICAL, P565; Wooldridge J., 2002, ECONOMETRIC ANAL CRO; Yancheva G, 2007, NATURE, V445, P74, DOI 10.1038/nature05431; Zhang DD, 2007, P NATL ACAD SCI USA, V104, P19214, DOI 10.1073/pnas.0703073104; Zhang DD, 2006, CLIMATIC CHANGE, V76, P459, DOI 10.1007/s10584-005-9024-z; Zhang DD, 2011, P NATL ACAD SCI USA, V108, P17296, DOI 10.1073/pnas.1104268108	139	787	802	34	534	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 13	2013	341	6151					1212	+		10.1126/science.1235367	http://dx.doi.org/10.1126/science.1235367			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	215ZA	24031020				2022-12-24	WOS:000324248800034
J	Wesemann, DR; Portuguese, AJ; Meyers, RM; Gallagher, MP; Cluff-Jones, K; Magee, JM; Panchakshari, RA; Rodig, SJ; Kepler, TB; Alt, FW				Wesemann, Duane R.; Portuguese, Andrew J.; Meyers, Robin M.; Gallagher, Michael P.; Cluff-Jones, Kendra; Magee, Jennifer M.; Panchakshari, Rohit A.; Rodig, Scott J.; Kepler, Thomas B.; Alt, Frederick W.			Microbial colonization influences early B-lineage development in the gut lamina propria	NATURE			English	Article							ANTIBODY REPERTOIRE DEVELOPMENT; CELL DEVELOPMENT; RAG EXPRESSION; RECOMBINATION; IMMUNIZATION; TOLERANCE; GENES; MOUSE; FETAL; MICE	The RAG1/RAG2 endonuclease (RAG) initiates the V(D)J recombination reaction that assembles immunoglobulin heavy (IgH) and light (IgL) chain variable region exons from germline gene segments to generate primary antibody repertoires(1). IgH V(D)J assembly occurs in progenitor (pro-) B cells followed by that of IgL in precursor (pre-) B cells. Expression of IgH mu and IgL (Ig kappa or Ig lambda) chains generates IgM, which is expressed on immature B cells as the B-cell antigen-binding receptor (BCR). Rag expression can continue in immature B cells(2), allowing continued Ig kappa V(D)J recombination that replaces the initial V kappa J kappa exon with one that generates a new specificity(3-5). This 'receptor editing' process, which can also lead to Ig lambda V(D)J recombination and expression(3,6,7), provides a mechanism whereby antigen encounter at the Rag-expressing immature B-cell stage helps shape pre-immune BCR repertoires. As the major site of postnatal B-cell development, the bone marrow is the principal location of primary immunoglobulin repertoire diversification in mice. Here we report that early B-cell development also occurs within the mouse intestinal lamina propria (LP), where the associated V(D)J recombination/receptor editing processes modulate primary LP immunoglobulin repertoires. At weanling age in normally housed mice, the LP contains a population of Rag-expressing B-lineage cells that harbour intermediates indicative of ongoing V(D)J recombination and which contain cells with pro-B, pre-B and editing phenotypes. Consistent with LP-specific receptor editing, Rag-expressing LP B-lineage cells have similar V-H repertoires, but significantly different V kappa repertoires, compared to those of Rag2-expressing bone marrow counterparts. Moreover, colonization of germ-free mice leads to an increased ratio of Ig lambda-expressing versus Ig kappa-expressing B cells specifically in the LP. We conclude that B-cell development occurs in the intestinal mucosa, where it is regulated by extracellular signals from commensal microbes that influence gut immunoglobulin repertoires.	[Wesemann, Duane R.; Portuguese, Andrew J.; Meyers, Robin M.; Gallagher, Michael P.; Cluff-Jones, Kendra; Magee, Jennifer M.; Panchakshari, Rohit A.; Alt, Frederick W.] Childrens Hosp Boston, Program Cellular & Mol Med, Boston, MA 02115 USA; [Wesemann, Duane R.; Portuguese, Andrew J.; Meyers, Robin M.; Gallagher, Michael P.; Cluff-Jones, Kendra; Magee, Jennifer M.; Panchakshari, Rohit A.; Alt, Frederick W.] Childrens Hosp Boston, Dept Med, Boston, MA 02115 USA; [Wesemann, Duane R.; Portuguese, Andrew J.; Meyers, Robin M.; Gallagher, Michael P.; Cluff-Jones, Kendra; Magee, Jennifer M.; Panchakshari, Rohit A.; Alt, Frederick W.] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Wesemann, Duane R.; Portuguese, Andrew J.; Meyers, Robin M.; Gallagher, Michael P.; Cluff-Jones, Kendra; Magee, Jennifer M.; Panchakshari, Rohit A.; Alt, Frederick W.] Howard Hughes Med Inst, Boston, MA 02115 USA; [Wesemann, Duane R.] Brigham & Womens Hosp, Dept Med, Div Rheumatol Immunol & Allergy, Boston, MA 02115 USA; [Rodig, Scott J.] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; [Kepler, Thomas B.] Boston Univ, Sch Med, Dept Microbiol, Boston, MA 02215 USA	Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Boston University	Alt, FW (corresponding author), Childrens Hosp Boston, Program Cellular & Mol Med, Boston, MA 02115 USA.	dwesemann@research.bwh.harvard.edu; alt@enders.tch.harvard.edu	Rodig, Scott/Y-3889-2019; Portuguese, Andrew Jay/AAX-4103-2020	Portuguese, Andrew Jay/0000-0003-1010-4578; Meyers, Robin/0000-0002-1802-7231; Wesemann, Duane/0000-0002-6690-944X	National Institutes of Health [AI020047, AI89972, HHSN272201000053C]; Lymphoma and Leukemia SCOR [7009-12]; American Academy of Allergy Asthma and Immunology; CSL-Behring; Career Award for Medical Scientists from the Burroughs Wellcome Fund; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI020047, K08AI089972, R37AI020047] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Lymphoma and Leukemia SCOR; American Academy of Allergy Asthma and Immunology; CSL-Behring; Career Award for Medical Scientists from the Burroughs Wellcome Fund(Burroughs Wellcome Fund); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health grants AI020047 (to F. W. A.) and AI89972 (to D. R. W.), Lymphoma and Leukemia SCOR 7009-12 (to F. W. A.), and National Institutes of Health research contract HHSN272201000053C (to T. B. K.). D. R. W. was also supported by an award from the American Academy of Allergy Asthma and Immunology and CSL-Behring and holds a Career Award for Medical Scientists from the Burroughs Wellcome Fund. F. W. A. is an Investigator of the Howard Hughes Medical Institute.	Butler JE, 2002, J IMMUNOL, V169, P6822, DOI 10.4049/jimmunol.169.12.6822; DESIDERIO SV, 1984, NATURE, V311, P752, DOI 10.1038/311752a0; Gartner F, 2000, J EXP MED, V192, P1745, DOI 10.1084/jem.192.12.1745; GAY D, 1993, J EXP MED, V177, P999, DOI 10.1084/jem.177.4.999; Golby S, 2002, J LEUKOCYTE BIOL, V72, P279; Hertz M, 1997, IMMUNITY, V6, P429, DOI 10.1016/S1074-7613(00)80286-1; Hooper LV, 2012, SCIENCE, V336, P1268, DOI 10.1126/science.1223490; Jankovic M, 2004, ANNU REV IMMUNOL, V22, P485, DOI 10.1146/annurev.immunol.22.012703.104707; Jenne CN, 2006, DEV COMP IMMUNOL, V30, P165, DOI 10.1016/j.dci.2005.06.009; Jung D, 2006, ANNU REV IMMUNOL, V24, P541, DOI 10.1146/annurev.immunol.23.021704.115830; Kepler Thomas B, 2013, F1000Res, V2, P103, DOI 10.12688/f1000research.2-103.v1; Lanning D, 2000, IMMUNOL REV, V175, P214, DOI 10.1034/j.1600-065X.2000.017516.x; Lanning DK, 2005, TRENDS IMMUNOL, V26, P419, DOI 10.1016/j.it.2005.06.001; Lefrancois L, 2001, Curr Protoc Immunol, VChapter 3, DOI 10.1002/0471142735.im0319s17; Mackie RI, 1999, AM J CLIN NUTR, V69, p1035S, DOI 10.1093/ajcn/69.5.1035s; Monroe RJ, 1999, IMMUNITY, V11, P201, DOI 10.1016/S1074-7613(00)80095-3; Nagaoka H, 2000, J EXP MED, V191, P2113, DOI 10.1084/jem.191.12.2113; Nagaoka H, 2000, CURR OPIN IMMUNOL, V12, P187, DOI 10.1016/S0952-7915(99)00070-9; Pelanda R, 1997, IMMUNITY, V7, P765, DOI 10.1016/S1074-7613(00)80395-7; RAFF MC, 1976, NATURE, V259, P224, DOI 10.1038/259224a0; Ratcliffe MJH, 2006, DEV COMP IMMUNOL, V30, P101, DOI 10.1016/j.dci.2005.06.018; Reich M, 2006, NAT GENET, V38, P500, DOI 10.1038/ng0506-500; Retter MW, 1998, J EXP MED, V188, P1231, DOI 10.1084/jem.188.7.1231; TIEGS SL, 1993, J EXP MED, V177, P1009, DOI 10.1084/jem.177.4.1009; Ueda Y, 2004, J EXP MED, V199, P47, DOI 10.1084/jem.20031104; Ueda Y, 2007, J IMMUNOL, V178, P3593, DOI 10.4049/jimmunol.178.6.3593; Wang JH, 2009, NATURE, V460, P231, DOI 10.1038/nature08159; Wang JH, 2008, J EXP MED, V205, P3079, DOI 10.1084/jem.20082271; Warren RL, 2011, GENOME RES, V21, P790, DOI 10.1101/gr.115428.110; Yu W, 1999, NATURE, V400, P682, DOI 10.1038/23287	30	175	205	2	37	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 5	2013	501	7465								10.1038/nature12496	http://dx.doi.org/10.1038/nature12496			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8YC	23965619	Green Accepted, Green Submitted			2022-12-24	WOS:000339424700001
J	Basu, A; Bodycombe, NE; Cheah, JH; Price, EV; Liu, K; Schaefer, GI; Ebright, RY; Stewart, ML; Ito, D; Wang, S; Bracha, AL; Liefeld, T; Wawer, M; Gilbert, JC; Wilson, AJ; Stransky, N; Kryukov, GV; Dancik, V; Barretina, J; Garraway, LA; Hon, CSY; Munoz, B; Bittker, JA; Stockwell, BR; Khabele, D; Stern, AM; Clemons, PA; Shamji, AF; Schreiber, SL				Basu, Amrita; Bodycombe, Nicole E.; Cheah, Jaime H.; Price, Edmund V.; Liu, Ke; Schaefer, Giannina I.; Ebright, Richard Y.; Stewart, Michelle L.; Ito, Daisuke; Wang, Stephanie; Bracha, Abigail L.; Liefeld, Ted; Wawer, Mathias; Gilbert, Joshua C.; Wilson, Andrew J.; Stransky, Nicolas; Kryukov, Gregory V.; Dancik, Vlado; Barretina, Jordi; Garraway, Levi A.; Hon, C. Suk-Yee; Munoz, Benito; Bittker, Joshua A.; Stockwell, Brent R.; Khabele, Dineo; Stern, Andrew M.; Clemons, Paul A.; Shamji, Alykhan F.; Schreiber, Stuart L.			An Interactive Resource to Identify Cancer Genetic and Lineage Dependencies Targeted by Small Molecules	CELL			English	Article							INHIBITION; IDENTIFICATION; SENSITIVITY; RESISTANCE; THERAPIES; SURVIVAL; PATHWAY; KINASE; CELLS; BCL-2	The high rate of clinical response to protein-kinase-targeting drugs matched to cancer patients with specific genomic alterations has prompted efforts to use cancer cell line (CCL) profiling to identify additional biomarkers of small-molecule sensitivities. We have quantitatively measured the sensitivity of 242 genomically characterized CCLs to an Informer Set of 354 small molecules that target many nodes in cell circuitry, uncovering protein dependencies that: (1) associate with specific cancer-genomic alterations and (2) can be targeted by small molecules. We have created the Cancer Therapeutics Response Portal (http://www.broadinstitute.org/ctrp) to enable users to correlate genetic features to sensitivity in individual lineages and control for confounding factors of CCL profiling. We report a candidate dependency, associating activating mutations in the oncogene beta-catenin with sensitivity to the Bcl-2 family antagonist, navitoclax. The resource can be used to develop novel therapeutic hypotheses and to accelerate discovery of drugs matched to patients by their cancer genotype and lineage.	[Basu, Amrita; Bodycombe, Nicole E.; Cheah, Jaime H.; Price, Edmund V.; Liu, Ke; Schaefer, Giannina I.; Ebright, Richard Y.; Stewart, Michelle L.; Ito, Daisuke; Wang, Stephanie; Bracha, Abigail L.; Liefeld, Ted; Wawer, Mathias; Gilbert, Joshua C.; Stransky, Nicolas; Kryukov, Gregory V.; Dancik, Vlado; Barretina, Jordi; Garraway, Levi A.; Hon, C. Suk-Yee; Munoz, Benito; Bittker, Joshua A.; Stern, Andrew M.; Clemons, Paul A.; Shamji, Alykhan F.; Schreiber, Stuart L.] Broad Inst Harvard & MIT, Cambridge, MA 02142 USA; [Wilson, Andrew J.; Khabele, Dineo] Vanderbilt Univ, Sch Med, Nashville, TN 37232 USA; [Stockwell, Brent R.] Columbia Univ, New York, NY 10027 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Vanderbilt University; Columbia University	Clemons, PA (corresponding author), Broad Inst Harvard & MIT, Cambridge, MA 02142 USA.	pclemons@broadinstitute.org; ashamji@broadinstitute.org; stuart_schreiber@harvard.edu	Kryukov, Gregory V/A-9592-2008; Stockwell, Brent R/AAE-7200-2019; Barretina, Jordi/A-7192-2013	Stockwell, Brent R/0000-0002-3532-3868; Stern, Andrew/0000-0002-8437-2957; Price, Edmund/0000-0001-6495-4725; Barretina, Jordi/0000-0002-3478-4080; Kryukov, Gregory/0000-0002-6131-9483	NCI's Cancer Target Discovery and Development Network [RC2-CA148399]; Novartis; NATIONAL CANCER INSTITUTE [R01CA097061, R01CA161061, RC2CA148399, K08CA148887] Funding Source: NIH RePORTER	NCI's Cancer Target Discovery and Development Network; Novartis(Novartis); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the NCI's Cancer Target Discovery and Development Network (RC2-CA148399, awarded to S. L. S.). We acknowledge the following colleagues for contributing compounds and for valuable critique: Drs. D. Adams, A. Beeler, J. Bradner, P. Brown, S. Chattopadhyay, C. Chen, A. Choudhury, J. Clardy, E. J. Corey, M. Dai, K. Hartwell, E. Holson, C. Johannessen, A. Koehler, T. Luo, A. G. Myers, J. Paulk, J. Porco, G. Ramachandran, A. Ramanathan, S. Schaus, K. P. Seiler, M. D. Shair, B. Wagner, Q. Wang, and PharmaMar. We thank J. McGrath, G. Wendel, and the Broad Compound Management team for handling the Informer Set; D.-K. Jang, A. Li, and M. Reich for supporting web portal development; and the Biological Samples Platform for providing CCLs. The project was enabled by the Broad Institute Chemical Biology Program and Platform. L. A. G. is a consultant for and equity holder in Foundation Medicine, Inc. and received sponsored research from Novartis. The authors are grateful for the leadership of the CTD<SUP>2</SUP> Network by Daniela Gerhard (Director, Office of Cancer Genomics, NCI). S. L. S. is an Investigator at the Howard Hughes Medical Institute.	Acosta JC, 2008, CELL, V133, P1006, DOI 10.1016/j.cell.2008.03.038; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bennett CN, 2002, J BIOL CHEM, V277, P30998, DOI 10.1074/jbc.M204527200; BROWN EJ, 1995, NATURE, V377, P441, DOI 10.1038/377441a0; Chen Z, 2012, NATURE, V483, P613, DOI 10.1038/nature10937; Cheung HW, 2011, P NATL ACAD SCI USA, V108, P12372, DOI 10.1073/pnas.1109363108; Corcoran RB, 2013, CANCER CELL, V23, P121, DOI 10.1016/j.ccr.2012.11.007; Corcoran RB, 2011, ONCOTARGET, V2, P336; Cormen T, 2000, THEOR COMPUT SYST, V33, P335, DOI 10.1007/s002240010016; de Castro DG, 2013, CLIN PHARMACOL THER, V93, P252, DOI 10.1038/clpt.2012.237; Dixon SJ, 2012, CELL, V149, P1060, DOI 10.1016/j.cell.2012.03.042; Gandhi L, 2011, J CLIN ONCOL, V29, P909, DOI 10.1200/JCO.2010.31.6208; Garnett MJ, 2012, NATURE, V483, P570, DOI 10.1038/nature11005; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Heiser LM, 2012, P NATL ACAD SCI USA, V109, P2724, DOI 10.1073/pnas.1018854108; Jho EH, 2002, MOL CELL BIOL, V22, P1172, DOI 10.1128/MCB.22.4.1172-1183.2002; Jimenez-Marin Angeles, 2009, BMC Proc, V3 Suppl 4, pS6, DOI 10.1186/1753-6561-3-S4-S6; Ju J, 2005, CANCER RES, V65, P10623, DOI 10.1158/0008-5472.CAN-05-1949; Kaga S, 2006, J MOL CELL CARDIOL, V40, P138, DOI 10.1016/j.yjmcc.2005.09.009; Larsen JE, 2011, CANCER J, V17, P512, DOI 10.1097/PPO.0b013e31823e701a; Lefebvre C, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.31; Liberzon A, 2011, BIOINFORMATICS, V27, P1739, DOI 10.1093/bioinformatics/btr260; LIU J, 1991, CELL, V66, P807, DOI 10.1016/0092-8674(91)90124-H; Luo J, 2009, CELL, V137, P835, DOI 10.1016/j.cell.2009.05.006; McDermott U, 2007, P NATL ACAD SCI USA, V104, P19936, DOI 10.1073/pnas.0707498104; Pan HL, 2012, ANTI-CANCER AGENT ME, V12, P247, DOI 10.2174/187152012800228814; Prahallad A, 2012, NATURE, V483, P100, DOI 10.1038/nature10868; Ran ZH, 2005, CHINESE MED J-PEKING, V118, P1330; Rosenbluh J, 2012, CELL, V151, P1457, DOI 10.1016/j.cell.2012.11.026; Sartore-Bianchi A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007287; Sharma SV, 2010, NAT REV CANCER, V10, P241, DOI 10.1038/nrc2820; Shoemaker RH, 2006, NAT REV CANCER, V6, P813, DOI 10.1038/nrc1951; SKEHAN P, 1990, J NATL CANCER I, V82, P1107, DOI 10.1093/jnci/82.13.1107; Smalley KSM, 2010, CURR OPIN INVEST DR, V11, P699; Sparks AB, 1998, CANCER RES, V58, P1130; Straussman R, 2012, NATURE, V487, P500, DOI 10.1038/nature11183; Sun S, 2007, J CLIN INVEST, V117, P2740, DOI 10.1172/JCI31809; Tahir SK, 2010, MOL CANCER THER, V9, P545, DOI 10.1158/1535-7163.MCT-09-0651; Tse C, 2008, CANCER RES, V68, P3421, DOI 10.1158/0008-5472.CAN-07-5836; Vervoorts J, 2006, J BIOL CHEM, V281, P34725, DOI 10.1074/jbc.R600017200; Wang ZY, 2009, J AM SOC NEPHROL, V20, P1919, DOI 10.1681/ASN.2009030253; Weiwer M, 2012, BIOORG MED CHEM LETT, V22, P1822, DOI 10.1016/j.bmcl.2011.09.047; Yoon J, 2011, CANCER RES, V71, P445, DOI 10.1158/0008-5472.CAN-10-3058; Zhu J, 2004, BIOSTATISTICS, V5, P427, DOI 10.1093/biostatistics/kxg046	45	408	411	2	50	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 29	2013	154	5					1151	1161		10.1016/j.cell.2013.08.003	http://dx.doi.org/10.1016/j.cell.2013.08.003			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	209OE	23993102	Bronze, Green Submitted, Green Accepted			2022-12-24	WOS:000323767300026
J	Akhtar, W; de Jong, J; Pindyurin, AV; Pagie, L; Meuleman, W; de Ridder, J; Berns, A; Wessels, LFA; van Lohuizen, M; van Steensel, B				Akhtar, Waseem; de Jong, Johann; Pindyurin, Alexey V.; Pagie, Ludo; Meuleman, Wouter; de Ridder, Jeroen; Berns, Anton; Wessels, Lodewyk F. A.; van Lohuizen, Maarten; van Steensel, Bas			Chromatin Position Effects Assayed by Thousands of Reporters Integrated in Parallel	CELL			English	Article							NUCLEAR LAMINA INTERACTIONS; GENE-EXPRESSION; DOMAIN ORGANIZATION; ENHANCER TRAP; GENOME; CELL; PIGGYBAC; STATE; ARCHITECTURE; PLURIPOTENT	Reporter genes integrated into the genome are a powerful tool to reveal effects of regulatory elements and local chromatin context on gene expression. However, so far such reporter assays have been of low throughput. Here, we describe a multiplexing approach for the parallel monitoring of transcriptional activity of thousands of randomly integrated reporters. More than 27,000 distinct reporter integrations in mouse embryonic stem cells, obtained with two differentpromoters, show similar to 1,000-fold variation in expression levels. Data analysis indicates that lamina-associated domains act as attenuators of transcription, likely by reducing access of transcription factors to binding sites. Furthermore, chromatin compaction is predictive of reporter activity. We also found evidence for crosstalk between neighboring genes and estimate that enhancers can influence gene expression on average over similar to 20 kb. The multiplexed reporter assay is highly flexible in design and can be modified to query a wide range of aspects of gene regulation.	[Akhtar, Waseem; Berns, Anton; van Lohuizen, Maarten] Netherlands Canc Inst, Div Mol Genet, NL-1066 CX Amsterdam, Netherlands; [Akhtar, Waseem; Pindyurin, Alexey V.; Pagie, Ludo; Meuleman, Wouter; van Steensel, Bas] Netherlands Canc Inst, Div Gene Regulat, NL-1066 CX Amsterdam, Netherlands; [de Jong, Johann; Wessels, Lodewyk F. A.] Netherlands Canc Inst, Div Mol Carcinogenesis, NL-1066 CX Amsterdam, Netherlands; [Meuleman, Wouter; de Ridder, Jeroen; Wessels, Lodewyk F. A.] Delft Univ Technol, Delft Bioinformat Lab, NL-2628 CD Delft, Netherlands	Netherlands Cancer Institute; Netherlands Cancer Institute; Netherlands Cancer Institute; Delft University of Technology	Wessels, LFA (corresponding author), Netherlands Canc Inst, Div Mol Carcinogenesis, Plesmanlaan 121, NL-1066 CX Amsterdam, Netherlands.	l.wessels@nki.nl; m.v.lohuizen@nki.nl; b.v.steensel@nki.nl	Pindyurin, Alexey/G-4167-2014	Pindyurin, Alexey/0000-0001-6959-0641; de Jong, Johann/0000-0002-2097-0915; Meuleman, Wouter/0000-0002-1196-5401; de Ridder, Jeroen/0000-0002-0828-3477	Netherlands Consortium for Systems Biology; EURYI; NWO-ALW VICI; ERC [293662]	Netherlands Consortium for Systems Biology; EURYI(European Science Foundation (ESF)); NWO-ALW VICI(Netherlands Organization for Scientific Research (NWO)); ERC(European Research Council (ERC)European Commission)	We thank the NKI Genomics Core Facility for sequencing support, Guillaume Filion for insightful suggestions, Mario Amendola for providing the reference plasmid for IR copy number quantification, and members of our laboratories for helpful discussions and critical reading of the manuscript. This work was supported by the Netherlands Consortium for Systems Biology (L. F. A. W., M. v. L., B. v. S.) and EURYI, NWO-ALW VICI and ERC Advanced grant 293662 (B.v.S.).	Babenko VN, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-318; Bickmore WA, 2013, CELL, V152, P1270, DOI 10.1016/j.cell.2013.02.001; Cadinanos J, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm446; Chen M, 2013, CELL REP, V3, P128, DOI 10.1016/j.celrep.2012.12.003; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; De S, 2009, GENOME RES, V19, P785, DOI 10.1101/gr.086165.108; Dixon JR, 2012, NATURE, V485, P376, DOI 10.1038/nature11082; Dobzhansky T, 1936, BIOL REV CAMB PHILOS, V11, P364, DOI 10.1111/j.1469-185X.1936.tb00911.x; Ebisuya M, 2008, NAT CELL BIOL, V10, P1106, DOI 10.1038/ncb1771; Ernst J, 2011, NATURE, V473, P43, DOI 10.1038/nature09906; Foat BC, 2006, BIOINFORMATICS, V22, pE141, DOI 10.1093/bioinformatics/btl223; Furey TS, 2012, NAT REV GENET, V13, P840, DOI 10.1038/nrg3306; Gerlach C, 2010, J EXP MED, V207, P1235, DOI 10.1084/jem.20091175; Gerrits A, 2010, BLOOD, V115, P2610, DOI 10.1182/blood-2009-06-229757; Gierman HJ, 2007, GENOME RES, V17, P1286, DOI 10.1101/gr.6276007; Girton JR, 2008, ADV GENET, V61, P1, DOI 10.1016/S0065-2660(07)00001-6; GOSSEN M, 1995, SCIENCE, V268, P1766, DOI 10.1126/science.7792603; Grewal SIS, 2007, NAT REV GENET, V8, P35, DOI 10.1038/nrg2008; Guelen L, 2008, NATURE, V453, P948, DOI 10.1038/nature06947; Handoko L, 2011, NAT GENET, V43, P630, DOI 10.1038/ng.857; Hawkins RD, 2010, NAT REV GENET, V11, P476, DOI 10.1038/nrg2795; Heintzman ND, 2009, NATURE, V459, P108, DOI 10.1038/nature07829; Hezroni H, 2011, J BIOL CHEM, V286, P35977, DOI 10.1074/jbc.M111.266254; Hiratani I, 2008, PLOS BIOL, V6, P2220, DOI 10.1371/journal.pbio.0060245; Huang X, 2010, MOL THER, V18, P1803, DOI 10.1038/mt.2010.141; Hurst LD, 2004, NAT REV GENET, V5, P299, DOI 10.1038/nrg1319; Kind J, 2010, CURR OPIN CELL BIOL, V22, P320, DOI 10.1016/j.ceb.2010.04.002; Korzh V, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-S1-S8; Li GH, 2011, CURR OPIN GENET DEV, V21, P175, DOI 10.1016/j.gde.2011.01.022; Li MM, 2012, MOL CELL, V46, P30, DOI 10.1016/j.molcel.2012.01.020; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Lienert F, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002090; Marson A, 2008, CELL, V134, P521, DOI 10.1016/j.cell.2008.07.020; Masui S, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni043; MCBURNEY MW, 1991, NUCLEIC ACIDS RES, V19, P5755, DOI 10.1093/nar/19.20.5755; Meir YJJ, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-28; Michalak P, 2008, GENOMICS, V91, P243, DOI 10.1016/j.ygeno.2007.11.002; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Mohn Fabio, 2009, V507, P55, DOI 10.1007/978-1-59745-522-0_5; Montavon T, 2012, TRENDS CELL BIOL, V22, P347, DOI 10.1016/j.tcb.2012.04.003; Nora EP, 2012, NATURE, V485, P381, DOI 10.1038/nature11049; OCHMAN H, 1988, GENETICS, V120, P621; Peric-Hupkes D, 2010, MOL CELL, V38, P603, DOI 10.1016/j.molcel.2010.03.016; Ruf S, 2011, NAT GENET, V43, P379, DOI 10.1038/ng.790; Sexton T, 2012, CELL, V148, P458, DOI 10.1016/j.cell.2012.01.010; Southall Tony D., 2007, Briefings in Functional Genomics & Proteomics, V6, P133, DOI 10.1093/bfgp/elm013; Stadler MB, 2011, NATURE, V480, P490, DOI 10.1038/nature10716; SUNDARESAN V, 1995, GENE DEV, V9, P1797, DOI 10.1101/gad.9.14.1797; Sutherland H, 2009, NAT REV GENET, V10, P457, DOI 10.1038/nrg2592; Vogel MJ, 2007, NAT PROTOC, V2, P1467, DOI 10.1038/nprot.2007.148; WEBER F, 1984, CELL, V36, P983, DOI 10.1016/0092-8674(84)90048-5; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968	53	200	210	2	33	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 15	2013	154	4					914	927		10.1016/j.cell.2013.07.018	http://dx.doi.org/10.1016/j.cell.2013.07.018			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	202GQ	23953119	Bronze			2022-12-24	WOS:000323202500020
J	Di Ruscio, A; Ebralidze, AK; Benoukraf, T; Amabile, G; Goff, LA; Terragni, J; Figueroa, ME; Pontes, LLD; Alberich-Jorda, M; Zhang, P; Wu, MC; D'Alo, F; Melnick, A; Leone, G; Ebralidze, KK; Pradhan, S; Rinn, JL; Tenen, DG				Di Ruscio, Annalisa; Ebralidze, Alexander K.; Benoukraf, Touati; Amabile, Giovanni; Goff, Loyal A.; Terragni, Jolyon; Figueroa, Maria Eugenia; Pontes, Lorena Lobo De Figueiredo; Alberich-Jorda, Meritxell; Zhang, Pu; Wu, Mengchu; D'Alo, Francesco; Melnick, Ari; Leone, Giuseppe; Ebralidze, Konstantin K.; Pradhan, Sriharsa; Rinn, John L.; Tenen, Daniel G.			DNMT1-interacting RNAs block gene-specific DNA methylation	NATURE			English	Article							GENOME-WIDE IDENTIFICATION; TRANSCRIPTION FACTORS; EXPRESSION; MAINTENANCE; POLYMERASE; METHYLTRANSFERASE; CHROMATIN; REVEALS; CANCER; SITES	DNA methylation was first described almost a century ago; however, the rules governing its establishment and maintenance remain elusive. Here we present data demonstrating that active transcription regulates levels of genomic methylation. We identify a novel RNA arising from the CEBPA gene locus that is critical in regulating the local DNA methylation profile. This RNA binds to DNMT1 and prevents CEBPA gene locus methylation. Deep sequencing of transcripts associated with DNMT1 combined with genome-scale methylation and expression profiling extend the generality of this finding to numerous gene loci. Collectively, these results delineate the nature of DNMT1-RNA interactions and suggest strategies for gene-selective demethylation of therapeutic targets in human diseases.	[Di Ruscio, Annalisa; Ebralidze, Alexander K.; Amabile, Giovanni; Pontes, Lorena Lobo De Figueiredo; Alberich-Jorda, Meritxell; Zhang, Pu; Rinn, John L.; Tenen, Daniel G.] Harvard Univ, Sch Med, Harvard Stem Cell Inst, Boston, MA 02115 USA; [Di Ruscio, Annalisa; Ebralidze, Alexander K.; Amabile, Giovanni; Pontes, Lorena Lobo De Figueiredo; Alberich-Jorda, Meritxell; Ebralidze, Konstantin K.; Rinn, John L.] Beth Israel Deaconess Med Ctr, Boston, MA 02115 USA; [D'Alo, Francesco; Leone, Giuseppe] Univ Cattolica Sacro Cuore, Inst Hematol, I-00168 Rome, Italy; [Benoukraf, Touati; Wu, Mengchu; Tenen, Daniel G.] Natl Univ Singapore, Canc Sci Inst, Singapore 117599, Singapore; [Goff, Loyal A.; Rinn, John L.] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [Goff, Loyal A.; Rinn, John L.] Broad Inst MIT & Harvard, Cambridge Ctr 7, Cambridge, MA 02142 USA; [Goff, Loyal A.] MIT, Comp Sci & Artificial Intelligence Lab, Cambridge, MA 02139 USA; [Terragni, Jolyon; Pradhan, Sriharsa] New England Biolabs Inc, Ipswich, MA 01938 USA; [Figueroa, Maria Eugenia] Univ Michigan, Dept Pathol, Ann Arbor, MI 48109 USA; [Alberich-Jorda, Meritxell] Acad Sci Czech Republ, Inst Mol Genet, CR-14220 Prague, Czech Republic; [Melnick, Ari] C620 Weill Cornell Med Coll, Dept Med, New York, NY 10021 USA	Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; National University of Singapore; Harvard University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT); New England Biolabs; University of Michigan System; University of Michigan; Czech Academy of Sciences; Institute of Molecular Genetics of the Czech Academy of Sciences	Tenen, DG (corresponding author), Harvard Univ, Sch Med, Harvard Stem Cell Inst, Boston, MA 02115 USA.	daniel.tenen@nus.edu.sg	de Figueiredo Pontes, Lorena Lobo/GPC-6003-2022; Figueiredo-Pontes, Lorena L/K-6520-2013; Melnick, Ari/AAA-5763-2020; Figueroa, Maria/AAE-8662-2019; Benoukraf, Touati/K-9978-2019; Jorda, Meritxell Alberich/G-3137-2014; Giuseppe Leone, Full Professor/I-9166-2019	de Figueiredo Pontes, Lorena Lobo/0000-0002-2139-5756; Figueiredo-Pontes, Lorena L/0000-0002-2139-5756; Benoukraf, Touati/0000-0002-4789-8028; Jorda, Meritxell Alberich/0000-0002-8093-641X; Giuseppe Leone, Full Professor/0000-0002-7812-5300; Tenen, Daniel/0000-0002-6423-3888; Goff, Loyal/0000-0003-2875-451X; Di Ruscio, Annalisa/0000-0002-9705-4245; Figueroa, Maria Eugenia/0000-0003-4887-4981; Rinn, John/0000-0002-7231-7539	National Institutes of Health (NIH) [CA118316, CA66996, HL56745, T32 HL007917-11A1]; Italian Foundation for Cancer Research (FIRC); Societa Italiana di Ematologia Sperimentale (SIES); FAMRI CIA [103063]; Fondazione Roma; American Italian Cancer Foundation Fellowship (AICF); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2011/11822-6]; National Research Foundation; Singapore Ministry of Education under its Centres of Excellence initiative; MSMT Navrat grant [LK21307]; New England Biolabs; Singapore Ministry of Health's National Medical Research Council under its Singapore Translational Research (STaR) Investigator Award; NATIONAL CANCER INSTITUTE [P01CA066996, R01CA118316] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL056745, R01HL112719, T32HL007917] Funding Source: NIH RePORTER; Associazione Italiana per la Ricerca sul Cancro Funding Source: Custom	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Italian Foundation for Cancer Research (FIRC)(Fondazione AIRC per la ricerca sul cancro); Societa Italiana di Ematologia Sperimentale (SIES); FAMRI CIA; Fondazione Roma(Fondazione RomaEuropean Commission); American Italian Cancer Foundation Fellowship (AICF); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); National Research Foundation; Singapore Ministry of Education under its Centres of Excellence initiative(Ministry of Education, Singapore); MSMT Navrat grant; New England Biolabs; Singapore Ministry of Health's National Medical Research Council under its Singapore Translational Research (STaR) Investigator Award(Ministry of Health-SingaporeNational Medical Research Council, Singapore); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro)	This work was supported by grants CA118316, CA66996 and HL56745 from the National Institutes of Health (NIH) to D.G.T., the Italian Foundation for Cancer Research (FIRC) 'Leonino Fontana e Maria Lionello' fellowship, the NIH T32 HL007917-11A1 and the Societa Italiana di Ematologia Sperimentale (SIES) 'Dr. Tito Bastianello' fellowship to A.D.R.; FAMRI CIA (103063) grant to A.K.E.; Fondazione Roma 'Progetto cellule staminali' to G.L. and F.D'A.; the American Italian Cancer Foundation Fellowship (AICF) to G.A.; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)-grant no. 2011/11822-6-to L.L.D.F.P.; the National Research Foundation and the Singapore Ministry of Education under its Centres of Excellence initiative to M.W. and T.B.; the MSMT Navrat grant LK21307 to M.A.-J. S.P. and J.T. were supported by New England Biolabs. We thank R. White, D. Johnson, M. Frank-Kamenetskii, S. M. Mirkin, D. Gautheret, B. Tazon-Vega, C. Bonifer, C. Bock, M. T. Voso, J. J. Dunn (deceased) and R. A. M. Fouchier for helpful advice and reagents; I. Rigoutsos for providing the latest released pyknons database; all the members of the Tenen Laboratory; P. Tan and T. S. Ting from the Genome Institute of Singapore; R. Soong from the Cancer Science Institute Translational Interface; J. LaVecchio and G. Buruzula from the Harvard Stem Cell Institute/Joslin Diabetes Center flow cytometry facility; and F. Hyde from Epicentre-Illumina. This research is supported by the Singapore Ministry of Health's National Medical Research Council under its Singapore Translational Research (STaR) Investigator Award (D.G.T.).	Akalin A, 2012, GENOME BIOL, V13, DOI [10.1186/gb-2012-13-10-R87, 10.1186/gb-2012-13-10-r87]; Benoukraf T, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks1281; BLOBEL G, 1966, SCIENCE, V154, P1662, DOI 10.1126/science.154.3757.1662; Bock C, 2005, BIOINFORMATICS, V21, P4067, DOI 10.1093/bioinformatics/bti652; Bock C, 2010, NAT BIOTECHNOL, V28, P1106, DOI 10.1038/nbt.1681; BOLDEN A, 1984, J BIOL CHEM, V259, P2437; BOLDEN AH, 1986, MOL CELL BIOL, V6, P1135, DOI 10.1128/MCB.6.4.1135; Christman JK, 2002, ONCOGENE, V21, P5483, DOI 10.1038/sj.onc.1205699; Dieci G, 2007, TRENDS GENET, V23, P614, DOI 10.1016/j.tig.2007.09.001; DUNN JJ, 1988, GENE, V68, P259, DOI 10.1016/0378-1119(88)90028-5; Ebisuya M, 2008, NAT CELL BIOL, V10, P1106, DOI 10.1038/ncb1771; Ebralidze A, 2004, SCIENCE, V303, P383, DOI 10.1126/science.1088679; Ebralidze AK, 2008, GENE DEV, V22, P2085, DOI 10.1101/gad.1654808; Esteve PO, 2006, GENE DEV, V20, P3089, DOI 10.1101/gad.1463706; Figueroa ME, 2010, CANCER CELL, V17, P13, DOI 10.1016/j.ccr.2009.11.020; FRANKKAMENETSKII MD, 1995, ANNU REV BIOCHEM, V64, P65, DOI 10.1146/annurev.bi.64.070195.000433; FROMMER M, 1992, P NATL ACAD SCI USA, V89, P1827, DOI 10.1073/pnas.89.5.1827; FUERST TR, 1986, P NATL ACAD SCI USA, V83, P8122, DOI 10.1073/pnas.83.21.8122; GILL G, 1988, NATURE, V334, P721, DOI 10.1038/334721a0; Gupta RA, 2010, NATURE, V464, P1071, DOI 10.1038/nature08975; Guttman M, 2012, NATURE, V482, P339, DOI 10.1038/nature10887; Hackanson B, 2008, CANCER RES, V68, P3142, DOI 10.1158/0008-5472.CAN-08-0483; Harrow J, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-s1-s4; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Hofacker IL, 2003, NUCLEIC ACIDS RES, V31, P3429, DOI 10.1093/nar/gkg599; Huarte M, 2010, CELL, V142, P409, DOI 10.1016/j.cell.2010.06.040; Illingworth RS, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001134; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jones PA, 2002, NAT REV GENET, V3, P415, DOI 10.1038/nrg816; Jothi R, 2008, NUCLEIC ACIDS RES, V36, P5221, DOI 10.1093/nar/gkn488; Karreth FA, 2011, CELL, V147, P382, DOI 10.1016/j.cell.2011.09.032; Keene JD, 2007, NAT REV GENET, V8, P533, DOI 10.1038/nrg2111; LEONHARDT H, 1992, CELL, V71, P865, DOI 10.1016/0092-8674(92)90561-P; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Listerman I, 2007, PLOS GENET, V3, P2268, DOI 10.1371/journal.pgen.0030212; Maniatis T., 1982, MOL CLONING LAB MANU; Meissner A, 2005, NUCLEIC ACIDS RES, V33, P5868, DOI 10.1093/nar/gki901; Mitchell JA, 2008, GENE DEV, V22, P20, DOI 10.1101/gad.454008; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nagano T, 2008, SCIENCE, V322, P1717, DOI 10.1126/science.1163802; Oler AJ, 2010, NAT STRUCT MOL BIOL, V17, P620, DOI 10.1038/nsmb.1801; Pagano A, 2007, PLOS GENET, V3, P174, DOI 10.1371/journal.pgen.0030001; Poliseno L, 2010, NATURE, V465, P1033, DOI 10.1038/nature09144; Pradhan S, 2003, BIOCHEMISTRY-US, V42, P5321, DOI 10.1021/bi034160+; Preker P, 2008, SCIENCE, V322, P1851, DOI 10.1126/science.1164096; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Raha D, 2010, P NATL ACAD SCI USA, V107, P3639, DOI 10.1073/pnas.0911315106; Rinn JL, 2007, CELL, V129, P1311, DOI 10.1016/j.cell.2007.05.022; Robertson KD, 2001, ONCOGENE, V20, P3139, DOI 10.1038/sj.onc.1204341; Sambrook J, 2001, MOL CLONING LAB MANU; Saxonov S, 2006, P NATL ACAD SCI USA, V103, P1412, DOI 10.1073/pnas.0510310103; Shin HJ, 2009, BIOINFORMATICS, V25, P2605, DOI 10.1093/bioinformatics/btp479; Smith ZD, 2009, METHODS, V48, P226, DOI 10.1016/j.ymeth.2009.05.003; Song JK, 2011, SCIENCE, V331, P1036, DOI 10.1126/science.1195380; Stewart SA, 2003, RNA, V9, P493, DOI 10.1261/rna.2192803; Svedruzic ZM, 2008, CURR MED CHEM, V15, P92, DOI 10.2174/092986708783330700; Tada T, 2006, JNCI-J NATL CANCER I, V98, P396, DOI 10.1093/jnci/djj093; Tay Y, 2011, CELL, V147, P344, DOI 10.1016/j.cell.2011.09.029; Tenen DG, 2003, NAT REV CANCER, V3, P89, DOI 10.1038/nrc989; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Tsirigos A, 2008, NUCLEIC ACIDS RES, V36, P3484, DOI 10.1093/nar/gkn155; Wouters BJ, 2007, BLOOD, V110, P3706, DOI 10.1182/blood-2007-02-073486; Xi YP, 2009, BMC BIOINFORMATICS, V10, DOI [10.1186/1471-2105-10-S1-S58, 10.1186/1471-2105-10-232]; Zhao J, 2010, MOL CELL, V40, P939, DOI 10.1016/j.molcel.2010.12.011	66	355	370	4	110	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 21	2013	503	7476					371	+		10.1038/nature12598	http://dx.doi.org/10.1038/nature12598			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254KG	24107992	Green Accepted, Green Submitted			2022-12-24	WOS:000327163200035
J	Hnisz, D; Abraham, BJ; Lee, TI; Lau, A; Saint-Andre, V; Sigova, AA; Hoke, HA; Young, RA				Hnisz, Denes; Abraham, Brian J.; Lee, Tong Ihn; Lau, Ashley; Saint-Andre, Violaine; Sigova, Alla A.; Hoke, Heather A.; Young, Richard A.			Super-Enhancers in the Control of Cell Identity and Disease	CELL			English	Article							CHROMATIN REMODELING COMPLEX; MASTER TRANSCRIPTION FACTORS; GENE-EXPRESSION; GLOBIN GENE; PLURIPOTENCY; COMPONENT; MEDIATOR; CANCER; LOCI; RNAS	Super-enhancers are large clusters of transcriptional enhancers that drive expression of genes that define cell identity. Improved understanding of the roles that super-enhancers play in biology would be afforded by knowing the constellation of factors that constitute these domains and by identifying super-enhancers across the spectrum of human cell types. We describe here the population of transcription factors, cofactors, chromatin regulators, and transcription apparatus occupying super-enhancers in embryonic stem cells and evidence that super-enhancers are highly transcribed. We produce a catalog of super-enhancers in a broad range of human cell types and find that super-enhancers associate with genes that control and define the biology of these cells. Interestingly, disease-associated variation is especially enriched in the super-enhancers of disease-relevant cell types. Furthermore, we find that cancer cells generate super-enhancers at oncogenes and other genes important in tumor pathogenesis. Thus, super-enhancers play key roles in human cell identity in health and in disease.	[Hnisz, Denes; Abraham, Brian J.; Lee, Tong Ihn; Lau, Ashley; Saint-Andre, Violaine; Sigova, Alla A.; Hoke, Heather A.; Young, Richard A.] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Lau, Ashley; Hoke, Heather A.; Young, Richard A.] MIT, Dept Biol, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT)	Young, RA (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	young@wi.mit.edu	Saint-André, Violaine/AAQ-8488-2020; Young, Richard A/F-6495-2012; Hnisz, Denes/AAE-9592-2019; Abraham, Brian/C-2230-2019	Young, Richard A/0000-0001-8855-8647; Hnisz, Denes/0000-0002-6256-1693; Abraham, Brian/0000-0001-8085-3027	National Institutes of Health [HG002668, CA109901, CA146445];  [P30AG10161];  [R01AG17917];  [R01AG36042];  [RC2AG36547]; NATIONAL CANCER INSTITUTE [R01CA146445, P01CA109901] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG002668] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [RC2AG036547, R01AG036042, P30AG010161, R01AG017917] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; ; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank David Orlando and Charles Lin for bioinformatics support; Lee Lawton, Jamie Newman, Peter Rahl, and Warren Whyte for sharing data; Nancy Hannett for assistance with data acquisition; Tom Volkert, Jennifer Love, Sumeet Gupta, and Jeong-Ah Kwon at the Whitehead Genome Technologies Core for Solexa sequencing; and members of the Young lab for helpful discussions. We acknowledge the Genome Centers at the Broad Institute and the University of California and San Diego for ChIP-seq data sets produced in the framework of the ENCODE and NIH Roadmap Epigenome Projects and the Rush Alzheimer's Disease Center at Rush University Medical Center, Chicago (supported by P30AG10161, R01AG17917, R01AG36042, and RC2AG36547). This work was supported by the National Institutes of Health grants HG002668 (R.A.Y.), CA109901 (R.A.Y.) and CA146445 (R.A.Y. and T. I. L.). R.A.Y. is a founder of Syros Pharmaceuticals.	Ahmadiyeh N, 2010, P NATL ACAD SCI USA, V107, P9742, DOI 10.1073/pnas.0910668107; Bertram L, 2008, NAT REV NEUROSCI, V9, P768, DOI 10.1038/nrn2494; BISHOP JM, 1987, SCIENCE, V235, P305, DOI 10.1126/science.3541204; Bonifer C, 2000, TRENDS GENET, V16, P310, DOI 10.1016/S0168-9525(00)02029-1; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Bulger M, 2011, CELL, V144, P327, DOI 10.1016/j.cell.2011.01.024; Calo E, 2013, MOL CELL, V49, P825, DOI 10.1016/j.molcel.2013.01.038; Carey M, 1998, CELL, V92, P5, DOI 10.1016/S0092-8674(00)80893-4; Chapuis J, 2013, MOL PSYCHIATR, V18, P1225, DOI 10.1038/mp.2013.1; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Cherry ABC, 2012, CELL, V148, P1110, DOI 10.1016/j.cell.2012.02.031; Costa-Reis P, 2013, CURR RHEUMATOL REP, V15, DOI 10.1007/s11926-013-0369-4; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; Deng Y, 2010, NAT REV RHEUMATOL, V6, P683, DOI 10.1038/nrrheum.2010.176; Denslow SA, 2007, ONCOGENE, V26, P5433, DOI 10.1038/sj.onc.1210611; Dowen JM, 2013, STEM CELL REP, V1, P371, DOI 10.1016/j.stemcr.2013.09.002; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; Forbes SA, 2010, NUCLEIC ACIDS RES, V38, pD652, DOI 10.1093/nar/gkp995; FORRESTER WC, 1990, GENE DEV, V4, P1637, DOI 10.1101/gad.4.10.1637; Foster CT, 2010, MOL CELL BIOL, V30, P4851, DOI 10.1128/MCB.00521-10; Garraway LA, 2013, CELL, V153, P17, DOI 10.1016/j.cell.2013.03.002; Graf T, 2009, NATURE, V462, P587, DOI 10.1038/nature08533; Grossman SR, 2013, CELL, V152, P703, DOI 10.1016/j.cell.2013.01.035; GROSVELD F, 1987, CELL, V51, P975, DOI 10.1016/0092-8674(87)90584-8; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Heintzman ND, 2009, NATURE, V459, P108, DOI 10.1038/nature07829; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Ho L, 2009, P NATL ACAD SCI USA, V106, P5181, DOI 10.1073/pnas.0812889106; Ho LN, 2009, P NATL ACAD SCI USA, V106, P5187, DOI 10.1073/pnas.0812888106; Iwakawa R, 2013, GENE CHROMOSOME CANC, V52, P802, DOI 10.1002/gcc.22076; Jang MK, 2005, MOL CELL, V19, P523, DOI 10.1016/j.molcel.2005.06.027; Jiang YW, 1998, P NATL ACAD SCI USA, V95, P8538, DOI 10.1073/pnas.95.15.8538; Kagey MH, 2010, NATURE, V467, P430, DOI 10.1038/nature09380; Kaji K, 2006, NAT CELL BIOL, V8, P285, DOI 10.1038/ncb1372; Kaji K, 2007, DEVELOPMENT, V134, P1123, DOI 10.1242/dev.02802; Kim TK, 2010, NATURE, V465, P182, DOI 10.1038/nature09033; Lai F, 2013, NATURE, V494, P497, DOI 10.1038/nature11884; Lam MTY, 2013, NATURE, V498, P511, DOI 10.1038/nature12209; Lee TI, 2013, CELL, V152, P1237, DOI 10.1016/j.cell.2013.02.014; Lelli KM, 2012, ANNU REV GENET, V46, P43, DOI 10.1146/annurev-genet-110711-155437; Levine M, 2003, NATURE, V424, P147, DOI 10.1038/nature01763; Li WB, 2013, NATURE, V498, P516, DOI 10.1038/nature12210; Ling JH, 2004, J BIOL CHEM, V279, P51704, DOI 10.1074/jbc.M404039200; Loven J, 2013, CELL, V153, P320, DOI 10.1016/j.cell.2013.03.036; Maston GA, 2006, ANNU REV GENOM HUM G, V7, P29, DOI 10.1146/annurev.genom.7.080505.115623; Merika M, 1998, MOL CELL, V1, P277, DOI 10.1016/S1097-2765(00)80028-3; Mousavi K, 2013, MOL CELL, V51, P606, DOI 10.1016/j.molcel.2013.07.022; Mullen AC, 2011, CELL, V147, P565, DOI 10.1016/j.cell.2011.08.050; Natoli G, 2012, ANNU REV GENET, V46, P1, DOI 10.1146/annurev-genet-110711-155459; Neph S, 2012, NATURE, V489, P83, DOI 10.1038/nature11212; Ng HH, 2011, NAT CELL BIOL, V13, P490, DOI 10.1038/ncb0511-490; Noble JA, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a007732; Ong CT, 2011, NAT REV GENET, V12, P283, DOI 10.1038/nrg2957; Orom UA, 2010, CELL, V143, P46, DOI 10.1016/j.cell.2010.09.001; Panne D, 2008, CURR OPIN STRUC BIOL, V18, P236, DOI 10.1016/j.sbi.2007.12.002; Rada-Iglesias A, 2011, NATURE, V470, P279, DOI 10.1038/nature09692; Reynolds N, 2012, CELL STEM CELL, V10, P583, DOI 10.1016/j.stem.2012.02.020; Reynolds N, 2012, EMBO J, V31, P593, DOI 10.1038/emboj.2011.431; Schnetz MP, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001023; Shen Y, 2012, NATURE, V488, P116, DOI 10.1038/nature11243; Shi YJ, 2004, CELL, V119, P941, DOI 10.1016/j.cell.2004.12.012; Sigova AA, 2013, P NATL ACAD SCI USA, V110, P2876, DOI 10.1073/pnas.1221904110; Spitz F, 2012, NAT REV GENET, V13, P613, DOI 10.1038/nrg3207; Tanzi Rudolph E, 2012, Cold Spring Harb Perspect Med, V2, DOI 10.1101/cshperspect.a006296; Thurman RE, 2012, NATURE, V489, P75, DOI 10.1038/nature11232; TUAN D, 1985, P NATL ACAD SCI USA, V82, P6384, DOI 10.1073/pnas.82.19.6384; Vernot B, 2012, GENOME RES, V22, P1689, DOI 10.1101/gr.134890.111; Visel A, 2009, NATURE, V457, P854, DOI 10.1038/nature07730; Vogelstein B, 2013, SCIENCE, V339, P1546, DOI 10.1126/science.1235122; Whyte WA, 2013, CELL, V153, P307, DOI 10.1016/j.cell.2013.03.035; Whyte WA, 2012, NATURE, V482, P221, DOI 10.1038/nature10805; Xie W, 2013, SCIENCE, V341, P245, DOI 10.1126/science.1236254; Young RA, 2011, CELL, V144, P940, DOI 10.1016/j.cell.2011.01.032; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhou Q, 2008, NATURE, V455, P627, DOI 10.1038/nature07314	77	2020	2074	12	229	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 7	2013	155	4					934	947		10.1016/j.cell.2013.09.053	http://dx.doi.org/10.1016/j.cell.2013.09.053			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	251MW	24119843	Green Published, Bronze, Green Accepted			2022-12-24	WOS:000326934300021
J	Paulson, T				Paulson, Tom			A MORTAL FOE	NATURE			English	Editorial Material																			0	92	94	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 10	2013	502	7470					S2	S3		10.1038/502S2a	http://dx.doi.org/10.1038/502S2a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231RU	24108078	Bronze			2022-12-24	WOS:000325436100002
J	Cogliati, S; Frezza, C; Soriano, ME; Varanita, T; Quintana-Cabrera, R; Corrado, M; Cipolat, S; Costa, V; Casarin, A; Gomes, LC; Perales-Clemente, E; Salviati, L; Fernandez-Silva, P; Enriquez, JA; Scorrano, L				Cogliati, Sara; Frezza, Christian; Soriano, Maria Eugenia; Varanita, Tatiana; Quintana-Cabrera, Ruben; Corrado, Mauro; Cipolat, Sara; Costa, Veronica; Casarin, Alberto; Gomes, Ligia C.; Perales-Clemente, Ester; Salviati, Leonardo; Fernandez-Silva, Patricio; Enriquez, Jose A.; Scorrano, Luca			Mitochondrial Cristae Shape Determines Respiratory Chain Supercomplexes Assembly and Respiratory Efficiency	CELL			English	Article							DOMINANT OPTIC ATROPHY; ATP SYNTHASE; CYTOCHROME-C; OXIDATIVE-PHOSPHORYLATION; ENDOPLASMIC-RETICULUM; MAMMALIAN-CELLS; INNER MEMBRANE; COMPLEX-I; APOPTOSIS; PROTEIN	Respiratory chain complexes assemble into functional quaternary structures called supercomplexes (RCS) within the folds of the inner mitochondrial membrane, or cristae. Here, we investigate the relationship between respiratory function and mitochondrial ultrastructure and provide evidence that cristae shape determines the assembly and stability of RCS and hence mitochondrial respiratory efficiency. Genetic and apoptotic manipulations of cristae structure affect assembly and activity of RCS in vitro and in vivo, independently of changes to mitochondrial protein synthesis or apoptotic outer mitochondrial membrane permeabilization. We demonstrate that, accordingly, the efficiency of mitochondria-dependent cell growth depends on cristae shape. Thus, RCS assembly emerges as a link between membrane morphology and function.	[Cogliati, Sara; Frezza, Christian; Soriano, Maria Eugenia; Varanita, Tatiana; Quintana-Cabrera, Ruben; Corrado, Mauro; Cipolat, Sara; Costa, Veronica; Gomes, Ligia C.; Scorrano, Luca] Venetian Inst Mol Med, Dulbecco Telethon Inst, I-35129 Padua, Italy; [Cogliati, Sara; Soriano, Maria Eugenia; Varanita, Tatiana; Quintana-Cabrera, Ruben; Scorrano, Luca] Univ Padua, Dept Biol, I-35121 Padua, Italy; [Corrado, Mauro; Scorrano, Luca] IRCCS Fdn Santa Lucia, I-00143 Rome, Italy; [Casarin, Alberto; Salviati, Leonardo] Univ Padua, Dept Woman & Child Hlth, Clin Genet Unit, I-35128 Padua, Italy; [Perales-Clemente, Ester; Enriquez, Jose A.] Ctr Nacl Invest Cardiovasc Carlos III, Madrid 28029, Spain; [Fernandez-Silva, Patricio] Univ Zaragoza, Fac Ciencias, Dept Bioquim & Biol Mol & Celular, E-50009 Zaragoza, Spain	Fondazione Telethon; Dulbecco Telethon Institute (DTI); Veneto Institute Molecular Medicine; University of Padua; IRCCS Santa Lucia; University of Padua; Centro Nacional de Investigaciones Cardiovasculares (CNIC); University of Zaragoza	Enriquez, JA (corresponding author), Ctr Nacl Invest Cardiovasc Carlos III, Melchor Fernandez Almagro 3, Madrid 28029, Spain.	jaenriquez@cnic.es; luca.scorrano@unipd.it	Cogliati, Sara/H-6156-2015; Frezza, Christian/G-2174-2010; Scorrano, Luca/A-6652-2008; Scorrano, Luca/K-3967-2019; Quintana-Cabrera, Ruben/A-4937-2019; Cogliati, Sara/GLR-0692-2022; Enríquez, J.A./M-8468-2016; Silva, Patricio Fernandez/U-2256-2017; Cogliati, Sara/ABC-2688-2020; Salviati, Leonardo/L-1007-2016	Cogliati, Sara/0000-0002-0374-3489; Frezza, Christian/0000-0002-3293-7397; Scorrano, Luca/0000-0002-8515-8928; Scorrano, Luca/0000-0002-8515-8928; Quintana-Cabrera, Ruben/0000-0002-0601-349X; Cogliati, Sara/0000-0002-0374-3489; Enríquez, J.A./0000-0002-3671-2961; Silva, Patricio Fernandez/0000-0001-8971-7355; Salviati, Leonardo/0000-0001-5642-9963; Soriano, Maria Eugenia/0000-0002-7971-2961; Perales-Clemente, Ester/0000-0002-6333-4070; Varanita, Tatiana/0000-0002-4952-6148	Telethon Italy [GGP12162, GPP10005B, TCR02016]; AIRC Italy, MOH Italy [GR 09.021]; Swiss National Foundation [31-118171]; MINECO [SAF2012-32776, CSD2007-00020]; DGA [B55, PIPAMER O905]; CAM [S2011/BMD-2402]; Journal of Cell Science Travelling Fellowship; AIRC Biennial Fellowship; Instituto de Salud Carlos III-MICINN; Pro-CNIC Foundation; MRC [MC_UU_12022/6] Funding Source: UKRI	Telethon Italy(Fondazione Telethon); AIRC Italy, MOH Italy(Fondazione AIRC per la ricerca sul cancro); Swiss National Foundation(Swiss National Science Foundation (SNSF)); MINECO(Spanish Government); DGA; CAM; Journal of Cell Science Travelling Fellowship; AIRC Biennial Fellowship(Fondazione AIRC per la ricerca sul cancro); Instituto de Salud Carlos III-MICINN(Instituto de Salud Carlos IIIMinistry of Science and Innovation, Spain (MICINN)Spanish Government); Pro-CNIC Foundation; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank A. Gross (Weizmann Institute) for anti-BID antibody, A. Latorre-Pellicer (CNIC) for mtDNA RT-PCR, and M. Albiero (VIMM) for tail vein injections. L.S. is a senior scientist of the Dulbecco-Telethon Institute. This work is supported by Telethon Italy (GGP12162, GPP10005B, and TCR02016), AIRC Italy, MOH Italy (GR 09.021), and Swiss National Foundation (31-118171). J.A.E. is supported by MINECO (SAF2012-32776 and CSD2007-00020), DGA (B55, PIPAMER O905), and CAM (S2011/BMD-2402). S. C. was supported by a Journal of Cell Science Travelling Fellowship. C. F. was supported by an AIRC Biennial Fellowship. The CNIC is funded by the Instituto de Salud Carlos III-MICINN and the Pro-CNIC Foundation.	Acin-Perez R, 2004, MOL CELL, V13, P805, DOI 10.1016/S1097-2765(04)00124-8; Acin-Perez R, 2008, MOL CELL, V32, P529, DOI 10.1016/j.molcel.2008.10.021; Alexander C, 2000, NAT GENET, V26, P211, DOI 10.1038/79944; Campanella M, 2008, CELL METAB, V8, P13, DOI 10.1016/j.cmet.2008.06.001; Cereghetti GM, 2008, P NATL ACAD SCI USA, V105, P15803, DOI 10.1073/pnas.0808249105; Chen HC, 2003, J CELL BIOL, V160, P189, DOI 10.1083/jcb.200211046; Chen HC, 2010, CELL, V141, P280, DOI 10.1016/j.cell.2010.02.026; Chen YC, 2012, CELL METAB, V15, P348, DOI 10.1016/j.cmet.2012.02.006; Cheng EHYA, 2001, MOL CELL, V8, P705, DOI 10.1016/S1097-2765(01)00320-3; Cipolat S, 2004, P NATL ACAD SCI USA, V101, P15927, DOI 10.1073/pnas.0407043101; Cipolat S, 2006, CELL, V126, P163, DOI 10.1016/j.cell.2006.06.021; Costa V, 2010, EMBO MOL MED, V2, P490, DOI 10.1002/emmm.201000102; Danial NN, 2004, CELL, V116, P205, DOI 10.1016/S0092-8674(04)00046-7; Davies KM, 2011, P NATL ACAD SCI USA, V108, P14121, DOI 10.1073/pnas.1103621108; de Brito OM, 2008, NATURE, V456, P605, DOI 10.1038/nature07534; Dimmer KS, 2006, PHYSIOLOGY, V21, P233, DOI 10.1152/physiol.00010.2006; Duvezin-Caubet S, 2006, J BIOL CHEM, V281, P37972, DOI 10.1074/jbc.M606059200; Frey TG, 2000, TRENDS BIOCHEM SCI, V25, P319, DOI 10.1016/S0968-0004(00)01609-1; Frezza C, 2006, CELL, V126, P177, DOI 10.1016/j.cell.2006.06.025; Germain M, 2005, EMBO J, V24, P1546, DOI 10.1038/sj.emboj.7600592; Gomes LC, 2011, NAT CELL BIOL, V13, P589, DOI 10.1038/ncb2220; Green DR, 2004, SCIENCE, V305, P626, DOI 10.1126/science.1099320; Griparic L, 2001, TRAFFIC, V2, P235, DOI 10.1034/j.1600-0854.2001.1r008.x; HACKENBROCK CR, 1966, J CELL BIOL, V30, P269, DOI 10.1083/jcb.30.2.269; Landes T, 2010, EMBO REP, V11, P459, DOI 10.1038/embor.2010.50; Lapuente-Brun E, 2013, SCIENCE, V340, P1567, DOI 10.1126/science.1230381; Legros F, 2002, MOL BIOL CELL, V13, P4343, DOI 10.1091/mbc.E02-06-0330; Lodi R, 2004, ANN NEUROL, V56, P719, DOI 10.1002/ana.20278; Merkwirth C, 2008, GENE DEV, V22, P476, DOI 10.1101/gad.460708; Minauro-Sanmiguel F, 2005, P NATL ACAD SCI USA, V102, P12356, DOI 10.1073/pnas.0503893102; Paumard P, 2002, EMBO J, V21, P221, DOI 10.1093/emboj/21.3.221; PFEIFFER DR, 1995, J BIOL CHEM, V270, P4923, DOI 10.1074/jbc.270.9.4923; Santel A, 2003, J CELL SCI, V116, P2763, DOI 10.1242/jcs.00479; Santel A, 2001, J CELL SCI, V114, P867; Schagger H, 1995, METHOD ENZYMOL, V260, P190, DOI 10.1016/0076-6879(95)60137-6; Scorrano L, 2002, DEV CELL, V2, P55, DOI 10.1016/S1534-5807(01)00116-2; Smirnova E, 2001, MOL BIOL CELL, V12, P2245, DOI 10.1091/mbc.12.8.2245; Strauss M, 2008, EMBO J, V27, P1154, DOI 10.1038/emboj.2008.35; Strogolova V, 2012, MOL CELL BIOL, V32, P1363, DOI 10.1128/MCB.06369-11; Sun MG, 2007, NAT CELL BIOL, V9, P1057, DOI 10.1038/ncb1630; Vogel F, 2006, J CELL BIOL, V175, P237, DOI 10.1083/jcb.200605138; Vukotic M, 2012, CELL METAB, V15, P336, DOI 10.1016/j.cmet.2012.01.016; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; Wei MC, 2000, GENE DEV, V14, P2060; Yamaguchi R, 2008, MOL CELL, V31, P557, DOI 10.1016/j.molcel.2008.07.010; Yoon Y, 2001, MOL BIOL CELL, V12, P2894, DOI 10.1091/mbc.12.9.2894; Zanna C, 2008, BRAIN, V131, P352, DOI 10.1093/brain/awm335	47	696	716	15	100	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	SEP 26	2013	155	1					160	171		10.1016/j.cell.2013.08.032	http://dx.doi.org/10.1016/j.cell.2013.08.032			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	224UX	24055366	Green Published, Green Submitted, hybrid			2022-12-24	WOS:000324916700017
J	Manzanillo, PS; Ayres, JS; Watson, RO; Collins, AC; Souza, G; Rae, CS; Schneider, DS; Nakamura, K; Shiloh, MU; Cox, JS				Manzanillo, Paolo S.; Ayres, Janelle S.; Watson, Robert O.; Collins, Angela C.; Souza, Gianne; Rae, Chris S.; Schneider, David S.; Nakamura, Ken; Shiloh, Michael U.; Cox, Jeffery S.			The ubiquitin ligase parkin mediates resistance to intracellular pathogens	NATURE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; DEFICIENT MICE; BODY FORMATION; AUTOPHAGY; DROSOPHILA; P62/SQSTM1; MITOPHAGY; DISEASE; SUSCEPTIBILITY; ASSOCIATIONS	Ubiquitin-mediated targeting of intracellular bacteria to the autophagy pathway is a key innate defence mechanism against invading microbes, including the important human pathogen Mycobacterium tuberculosis. However, the ubiquitin ligases responsible for catalysing ubiquitin chains that surround intracellular bacteria are poorly understood. The parkin protein is a ubiquitin ligase with a well-established role in mitophagy, and mutations in the parkin gene (PARK2) lead to increased susceptibility to Parkinson's disease. Surprisingly, genetic polymorphisms in the PARK2 regulatory region are also associated with increased susceptibility to intracellular bacterial pathogens in humans, including Mycobacterium leprae and Salmonella enterica serovar Typhi, but the function of parkin in immunity has remained unexplored. Here we show that parkin has a role in ubiquitin-mediated autophagy of M. tuberculosis. Both parkin-deficient mice and flies are sensitive to various intracellular bacterial infections, indicating parkin has a conserved role in metazoan innate defence. Moreover, our work reveals an unexpected functional link between mitophagy and infectious disease.	[Manzanillo, Paolo S.; Watson, Robert O.; Souza, Gianne; Cox, Jeffery S.] Univ Calif San Francisco, Dept Microbiol & Immunol, Program Microbial Pathogenesis & Host Def, San Francisco, CA 94158 USA; [Ayres, Janelle S.] Salk Inst Biol Studies, Immunobiol & Microbial Pathogenesis Lab, La Jolla, CA 92037 USA; [Collins, Angela C.; Shiloh, Michael U.] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA; [Rae, Chris S.] Univ Calif Berkeley, Dept Mol & Cellular Biol, Div Immunol & Pathogenesis, Berkeley, CA 94720 USA; [Schneider, David S.] Stanford Univ, Dept Microbiol & Immunol, Stanford, CA 94305 USA; [Nakamura, Ken] Univ Calif San Francisco, Gladstone Inst Neurol Dis, San Francisco, CA 94158 USA; [Nakamura, Ken] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94158 USA; [Nakamura, Ken] Univ Calif San Francisco, Grad Program Neurosci, San Francisco, CA 94158 USA; [Nakamura, Ken] Univ Calif San Francisco, Grad Program Biomed Sci, San Francisco, CA 94158 USA	University of California System; University of California San Francisco; Salk Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of California System; University of California Berkeley; Stanford University; University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Cox, JS (corresponding author), Univ Calif San Francisco, Dept Microbiol & Immunol, Program Microbial Pathogenesis & Host Def, San Francisco, CA 94158 USA.	jeffery.cox@ucsf.edu	Shiloh, Michael/AAS-8883-2020	Shiloh, Michael/0000-0003-4329-2253; Collins, Angela/0000-0001-6392-7151; Nakamura, Ken/0000-0002-9192-182X	National Institutes of Health [R01 AI081727, P01 AI063302, R01 AI099439]; NINDS [P30NS069496]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI060537, P01AI063302, R01AI099439, R01AI081727] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS069496] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank N. Mizushima, S. Cherry, and K. Huynh for mice and reagents. We are grateful to S. Johnson for use of his microscope, members of the Schneider laboratory for assistance with fly work and D. Portnoy, R. Vance and S. Virgin for helpful discussions. This work was supported by National Institutes of Health grants R01 AI081727, P01 AI063302 and R01 AI099439, and NINDS P30NS069496 to K.N.	Ali S, 2006, CLIN EXP IMMUNOL, V144, P425, DOI 10.1111/j.1365-2249.2006.03087.x; Alonso S, 2007, P NATL ACAD SCI USA, V104, P6031, DOI 10.1073/pnas.0700036104; Anderson CA, 2011, NAT GENET, V43, P246, DOI 10.1038/ng.764; Ayres JS, 2008, PLOS BIOL, V6, P2764, DOI 10.1371/journal.pbio.0060305; Chen D, 2010, J BIOL CHEM, V285, P38214, DOI 10.1074/jbc.M110.101469; Chopra R, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003578; Collins CA, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000430; de Leseleuc L, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002015; Deretic V, 2009, CELL HOST MICROBE, V5, P527, DOI 10.1016/j.chom.2009.05.016; Geisler S, 2010, NAT CELL BIOL, V12, P119, DOI 10.1038/ncb2012; Goldberg MS, 2003, J BIOL CHEM, V278, P43628, DOI 10.1074/jbc.M308947200; Houben D, 2012, CELL MICROBIOL, V14, P1287, DOI 10.1111/j.1462-5822.2012.01799.x; Huett A, 2012, CELL HOST MICROBE, V12, P778, DOI 10.1016/j.chom.2012.10.019; Johnson BN, 2012, P NATL ACAD SCI USA, V109, P6283, DOI 10.1073/pnas.1113248109; Jostins L, 2012, NATURE, V491, P119, DOI 10.1038/nature11582; Kim KY, 2011, J CLIN INVEST, V121, P3701, DOI 10.1172/JCI44736; Kitada T, 1998, NATURE, V392, P605, DOI 10.1038/33416; Komatsu M, 2007, CELL, V131, P1149, DOI 10.1016/j.cell.2007.10.035; Lim KL, 2005, J NEUROSCI, V25, P2002, DOI 10.1523/JNEUROSCI.4474-04.2005; Marin I, 2002, MOL BIOL EVOL, V19, P2039, DOI 10.1093/oxfordjournals.molbev.a004029; Martin I, 2011, ANNU REV GENOM HUM G, V12, P301, DOI 10.1146/annurev-genom-082410-101440; Mira MT, 2004, NATURE, V427, P636, DOI 10.1038/nature02326; Moy RH, 2013, J INNATE IMMUN, V5, P444, DOI 10.1159/000350326; Nakahira K, 2011, NAT IMMUNOL, V12, P222, DOI 10.1038/ni.1980; Narendra DP, 2010, AUTOPHAGY, V6, P1090, DOI 10.4161/auto.6.8.13426; Newton K, 2008, CELL, V134, P668, DOI 10.1016/j.cell.2008.07.039; Ohol YM, 2010, CELL HOST MICROBE, V7, P210, DOI 10.1016/j.chom.2010.02.006; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Ponpuak M, 2010, IMMUNITY, V32, P329, DOI 10.1016/j.immuni.2010.02.009; Romagnoli A, 2012, AUTOPHAGY, V8, P1357, DOI 10.4161/auto.20881; Stavru F, 2011, P NATL ACAD SCI USA, V108, P3612, DOI 10.1073/pnas.1100126108; Thibault ST, 2004, NAT GENET, V36, P283, DOI 10.1038/ng1314; Voronin D, 2012, P NATL ACAD SCI USA, V109, pE1638, DOI 10.1073/pnas.1203519109; Watson RO, 2012, CELL, V150, P803, DOI 10.1016/j.cell.2012.06.040; Wild P, 2011, SCIENCE, V333, P228, DOI 10.1126/science.1205405; Yano T, 2008, NAT IMMUNOL, V9, P908, DOI 10.1038/ni.1634; Youle RJ, 2011, NAT REV MOL CELL BIO, V12, P9, DOI 10.1038/nrm3028; Zhao ZJ, 2008, CELL HOST MICROBE, V4, P458, DOI 10.1016/j.chom.2008.10.003; Zhou RB, 2011, NATURE, V469, P221, DOI 10.1038/nature09663	39	363	375	4	91	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 26	2013	501	7468					512	+		10.1038/nature12566	http://dx.doi.org/10.1038/nature12566			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	223RP	24005326	Green Accepted, Green Submitted			2022-12-24	WOS:000324826300050
J	Yen, KY; Vinayachandran, V; Pugh, BF				Yen, Kuangyu; Vinayachandran, Vinesh; Pugh, B. Franklin			SWR-C and INO80 Chromatin Remodelers Recognize Nucleosome-free Regions Near+1 Nucleosomes	CELL			English	Article							ACTIN-RELATED PROTEINS; VARIANT HISTONE H2A.Z; CRYSTAL-STRUCTURE; BUDDING YEAST; COMPLEX; GENOME; TRANSCRIPTION; PROMOTERS; GENES; DNA	SWR-C/SWR1 and INO80 are multisubunit complexes that catalyze the deposition and removal, respectively, of histone variant H2A.Z from the first nucleosome at the start of genes. How they target and engage these +1 nucleosomes is unclear. Using ChIP-exo, we identified the subnucleosomal placement of 20 of their subunits across the yeast genome. The Swc2 subunit of SWR-C bound a narrowly defined region in the adjacent nucleosome-free region (NFR), where it positioned the Swr1 subunit over one of two sites of H2A.Z deposition at +1. The genomic binding maps suggest that many subunits have a rather plastic organization that allows subunits to exchange between the two complexes. One outcome of promoting H2A/H2A.Z exchange was an enhanced turnover of entire nucleosomes, thereby creating dynamic chromatin at the start of genes. Our findings provide unifying concepts on how these two opposing chromatin remodeling complexes function selectively at the +1 nucleosome of nearly all genes.	[Yen, Kuangyu; Vinayachandran, Vinesh; Pugh, B. Franklin] Penn State Univ, Dept Biochem & Mol Biol, Ctr Eukaryot Gene Regulat, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Pugh, BF (corresponding author), Penn State Univ, Dept Biochem & Mol Biol, Ctr Eukaryot Gene Regulat, University Pk, PA 16802 USA.	bfp2@psu.edu	Vinayachandran, Vinesh/ABD-6386-2020	Vinayachandran, Vinesh/0000-0002-2045-6086	NIH [5R01HG4160]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG004160] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We thank Matt Rossi for valuable suggestions on the figures, Anna Chan-Salis for sequencing, and Yunfei Li for bioinformatics support. This work was funded by NIH grant 5R01HG4160.	Albert I, 2008, BIOINFORMATICS, V24, P1305, DOI 10.1093/bioinformatics/btn119; Albert I, 2007, NATURE, V446, P572, DOI 10.1038/nature05632; Badis G, 2008, MOL CELL, V32, P878, DOI 10.1016/j.molcel.2008.11.020; Chen L, 2011, J BIOL CHEM, V286, P11283, DOI 10.1074/jbc.M111.222505; Cheung KLY, 2010, J MOL BIOL, V404, P478, DOI 10.1016/j.jmb.2010.10.003; Conaway RC, 2009, TRENDS BIOCHEM SCI, V34, P71, DOI 10.1016/j.tibs.2008.10.010; Dang WW, 2006, MOL CELL BIOL, V26, P7388, DOI 10.1128/MCB.01159-06; Dion MF, 2007, SCIENCE, V315, P1405, DOI 10.1126/science.1134053; Durr H, 2005, CELL, V121, P363, DOI 10.1016/j.cell.2005.03.026; Ebbert R, 1999, MOL MICROBIOL, V32, P741, DOI 10.1046/j.1365-2958.1999.01390.x; Eisen A, 2001, J BIOL CHEM, V276, P3484, DOI 10.1074/jbc.M008159200; Galarneau L, 2000, MOL CELL, V5, P927, DOI 10.1016/S1097-2765(00)80258-0; Ganapathi M, 2011, NUCLEIC ACIDS RES, V39, P2032, DOI 10.1093/nar/gkq1161; Gerhold CB, 2012, NUCLEIC ACIDS RES, V40, P11036, DOI 10.1093/nar/gks842; Ginsburg DS, 2009, MOL CELL BIOL, V29, P6473, DOI 10.1128/MCB.01033-09; Gribun A, 2008, J MOL BIOL, V376, P1320, DOI 10.1016/j.jmb.2007.12.049; Grigoletto A, 2011, BBA-REV CANCER, V1815, P147, DOI 10.1016/j.bbcan.2010.11.002; Guillemette B, 2005, PLOS BIOL, V3, P2100, DOI 10.1371/journal.pbio.0030384; Halley JE, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000401; Hartley PD, 2009, CELL, V137, P445, DOI 10.1016/j.cell.2009.02.043; Huber O, 2008, CANCER RES, V68, P6873, DOI 10.1158/0008-5472.CAN-08-0547; Huen J, 2010, BIOCHEM CELL BIOL, V88, P29, DOI [10.1139/o09-122, 10.1139/O09-122]; Jha S, 2009, MOL CELL, V34, P521, DOI 10.1016/j.molcel.2009.05.016; Jiang CZ, 2009, NAT REV GENET, V10, P161, DOI 10.1038/nrg2522; Jin CY, 2007, GENE DEV, V21, P1519, DOI 10.1101/gad.1547707; Jin JY, 2005, J BIOL CHEM, V280, P41207, DOI 10.1074/jbc.M509128200; Jonsson ZO, 2001, J BIOL CHEM, V276, P16279, DOI 10.1074/jbc.M011523200; Kobor MS, 2004, PLOS BIOL, V2, P587, DOI 10.1371/journal.pbio.0020131; Krogan NJ, 2003, MOL CELL, V12, P1565, DOI 10.1016/S1097-2765(03)00497-0; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Li B, 2005, P NATL ACAD SCI USA, V102, P18385, DOI 10.1073/pnas.0507975102; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Luk E, 2010, CELL, V143, P725, DOI 10.1016/j.cell.2010.10.019; Matias PM, 2006, J BIOL CHEM, V281, P38918, DOI 10.1074/jbc.M605625200; Meneghini MD, 2003, CELL, V112, P725, DOI 10.1016/S0092-8674(03)00123-5; Millar CB, 2006, GENE DEV, V20, P711, DOI 10.1101/gad.1395506; Mizuguchi G, 2004, SCIENCE, V303, P343, DOI 10.1126/science.1090701; Morillo-Huesca M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012143; Morrison AJ, 2009, NAT REV MOL CELL BIO, V10, P373, DOI 10.1038/nrm2693; Papamichos-Chronakis M, 2011, CELL, V144, P200, DOI 10.1016/j.cell.2010.12.021; Puri T, 2007, J MOL BIOL, V366, P179, DOI 10.1016/j.jmb.2006.11.030; Raisner RM, 2005, CELL, V123, P233, DOI 10.1016/j.cell.2005.10.002; Rhee HS, 2012, NATURE, V483, P295, DOI 10.1038/nature10799; Rhee HS, 2011, CELL, V147, P1408, DOI 10.1016/j.cell.2011.11.013; Schermer UJ, 2005, MOL CELL, V19, P279, DOI 10.1016/j.molcel.2005.05.028; Shen XT, 2003, MOL CELL, V12, P147, DOI 10.1016/S1097-2765(03)00264-8; Suto RK, 2000, NAT STRUCT BIOL, V7, P1121; Szerlong H, 2008, NAT STRUCT MOL BIOL, V15, P469, DOI 10.1038/nsmb.1403; Torreira E, 2008, STRUCTURE, V16, P1511, DOI 10.1016/j.str.2008.08.009; Udugama M, 2011, MOL CELL BIOL, V31, P662, DOI 10.1128/MCB.01035-10; Watanabe S, 2013, SCIENCE, V340, P195, DOI 10.1126/science.1229758; Wu WH, 2009, J BIOL CHEM, V284, P6200, DOI 10.1074/jbc.M808830200; Yen KY, 2012, CELL, V149, P1461, DOI 10.1016/j.cell.2012.04.036; Zhang HY, 2005, CELL, V123, P219, DOI 10.1016/j.cell.2005.08.036; Zhang LY, 2011, GENOME RES, V21, P875, DOI 10.1101/gr.117465.110	55	128	128	0	55	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	SEP 12	2013	154	6					1246	1256		10.1016/j.cell.2013.08.043	http://dx.doi.org/10.1016/j.cell.2013.08.043			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	215VQ	24034248	Bronze, Green Accepted			2022-12-24	WOS:000324239300014
J	Bogorad, IW; Lin, TS; Liao, JC				Bogorad, Igor W.; Lin, Tzu-Shyang; Liao, James C.			Synthetic non-oxidative glycolysis enables complete carbon conservation	NATURE			English	Article							ESCHERICHIA-COLI; PATHWAY; FLUX; ASSIMILATION; METABOLISM; CATABOLISM; EXPRESSION; CONVERSION; PRODUCTS; GLUCOSE	Glycolysis, or its variations, is a fundamental metabolic pathway in life that functions in almost all organisms to decompose external or intracellular sugars. The pathway involves the partial oxidation and splitting of sugars to pyruvate, which in turn is decarboxylated to produce acetyl-coenzyme A (CoA) for various biosynthetic purposes. The decarboxylation of pyruvate loses a carbon equivalent, and limits the theoretical carbon yield to only two moles of two-carbon (C2) metabolites per mole of hexose. This native route is a major source of carbon loss in biorefining and microbial carbon metabolism. Here we design and construct a non-oxidative, cyclic pathway that allows the production of stoichiometric amounts of C2 metabolites from hexose, pentose and triose phosphates without carbon loss. We tested this pathway, termed non-oxidative glycolysis (NOG), in vitro and in vivo in Escherichia coli. NOG enables complete carbon conservation in sugar catabolism to acetyl-CoA, and can be used in conjunction with CO2 fixation(1) and other one-carbon (C1) assimilation pathways(2) to achieve a 100% carbon yield to desirable fuels and chemicals.	[Bogorad, Igor W.; Lin, Tzu-Shyang; Liao, James C.] Univ Calif Los Angeles, Dept Chem & Biomol Engn, Los Angeles, CA 90095 USA; [Bogorad, Igor W.] Univ Calif Los Angeles, Dept Bioengn, Los Angeles, CA 90095 USA; [Liao, James C.] Univ Calif Los Angeles, Inst Genom & Prote, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Liao, JC (corresponding author), Univ Calif Los Angeles, Dept Chem & Biomol Engn, 420 Westwood Plaza, Los Angeles, CA 90095 USA.	liaoj@ucla.edu		Liao, James/0000-0002-4580-7276; Bogorad, Igor/0000-0002-7023-2494	National Science Foundation (NSF) [MCB-1139318]; Department of Energy (DOE) [DE0-SC0006698]; NSF Integrative Graduate Education and Research Traineeship (IGERT) [0903720]	National Science Foundation (NSF)(National Science Foundation (NSF)); Department of Energy (DOE)(United States Department of Energy (DOE)); NSF Integrative Graduate Education and Research Traineeship (IGERT)(National Science Foundation (NSF))	This work was partially supported by National Science Foundation (NSF) grant MCB-1139318 and Department of Energy (DOE) grant DE0-SC0006698. I. W. B. was supported by NSF Integrative Graduate Education and Research Traineeship (IGERT) grant no. 0903720.	ASLANIDIS C, 1990, NUCLEIC ACIDS RES, V18, P6069, DOI 10.1093/nar/18.20.6069; Atsumi S, 2008, METAB ENG, V10, P305, DOI 10.1016/j.ymben.2007.08.003; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; BASSHAM JA, 1954, J AM CHEM SOC, V76, P1760, DOI 10.1021/ja01636a012; Berg IA, 2007, SCIENCE, V318, P1782, DOI 10.1126/science.1149976; Causey TB, 2003, P NATL ACAD SCI USA, V100, P825, DOI 10.1073/pnas.0337684100; DALDAL F, 1983, J BACTERIOL, V153, P390, DOI 10.1128/JB.153.1.390-394.1983; Drake HL, 2004, RES MICROBIOL, V155, P868, DOI 10.1016/j.resmic.2004.10.001; Dugar D, 2011, NAT BIOTECHNOL, V29, P1074, DOI 10.1038/nbt.2055; Gonzalez R, 2002, BIOTECHNOL PROGR, V18, P6, DOI 10.1021/bp010121i; Gronenberg LS, 2013, CURR OPIN CHEM BIOL, V17, P462, DOI 10.1016/j.cbpa.2013.03.037; Guterl JK, 2012, CHEMSUSCHEM, V5, P2165, DOI 10.1002/cssc.201200365; Lan EI, 2012, P NATL ACAD SCI USA, V109, P6018, DOI 10.1073/pnas.1200074109; Li H, 2012, SCIENCE, V335, P1596, DOI 10.1126/science.1217643; Liao JC, 1996, BIOTECHNOL BIOENG, V52, P129, DOI 10.1002/(SICI)1097-0290(19961005)52:1<129::AID-BIT13>3.0.CO;2-J; Liu LX, 2012, J BACTERIOL, V194, P5413, DOI 10.1128/JB.00713-12; Liu XY, 2011, P NATL ACAD SCI USA, V108, P6899, DOI 10.1073/pnas.1103014108; Lutz R, 1997, NUCLEIC ACIDS RES, V25, P1203, DOI 10.1093/nar/25.6.1203; MELENDEZHEVIA E, 1985, J THEOR BIOL, V117, P251, DOI 10.1016/S0022-5193(85)80220-4; Nelson D., 2005, LEHNINGER PRINCIPLES; PATNAIK R, 1992, J BACTERIOL, V174, P7527, DOI 10.1128/JB.174.23.7527-7532.1992; Peekhaus N, 1998, J BACTERIOL, V180, P3495, DOI 10.1128/JB.180.14.3495-3502.1998; Ragsdale SW, 2006, CHEM REV, V106, P3317, DOI 10.1021/cr0503153; Ragsdale SW, 2008, BBA-PROTEINS PROTEOM, V1784, P1873, DOI 10.1016/j.bbapap.2008.08.012; ROSEMAN S, 1990, J BIOL CHEM, V265, P2993; SCHUSTER R, 1993, COMPUT APPL BIOSCI, V9, P79; Tao H, 2001, J BACTERIOL, V183, P2979, DOI 10.1128/JB.183.10.2979-2988.2001; Tcherkez GGB, 2006, P NATL ACAD SCI USA, V103, P7246, DOI 10.1073/pnas.0600605103; Ye XT, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-120; Yin XH, 2005, FEMS MICROBIOL LETT, V246, P251, DOI 10.1016/j.femsle.2005.04.013; Yurimoto H, 2005, CHEM REC, V5, P367, DOI 10.1002/tcr.20056	31	220	243	17	211	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 31	2013	502	7473					693	+		10.1038/nature12575	http://dx.doi.org/10.1038/nature12575			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243CC	24077099				2022-12-24	WOS:000326293200050
J	Shneider, MM; Buth, SA; Ho, BT; Basler, M; Mekalanos, JJ; Leiman, PG				Shneider, Mikhail M.; Buth, Sergey A.; Ho, Brian T.; Basler, Marek; Mekalanos, John J.; Leiman, Petr G.			PAAR-repeat proteins sharpen and diversify the type VI secretion system spike	NATURE			English	Article							BACTERIOPHAGE-T4 BASEPLATE; 3-DIMENSIONAL STRUCTURE; VIBRIO-CHOLERAE; IDENTIFICATION; COMPETITION; EXPRESSION; APPARATUS; SOFTWARE; HOMOLOGY; SERVER	The bacterial type VI secretion system (T6SS) is a large multicomponent, dynamic macromolecular machine that has an important role in the ecology of many Gram-negative bacteria. T6SS is responsible for translocation of a wide range of toxic effector molecules, allowing predatory cells to kill both prokaryotic as well as eukaryotic prey cells(1-5). The T6SS organelle is functionally analogous to contractile tails of bacteriophages and is thought to attack cells by initially penetrating them with a trimeric protein complex called the VgrG spike(6,7). Neither the exact protein composition of the T6SS organelle nor the mechanisms of effector selection and delivery are known. Here we report that proteins from the PAAR (proline-alanine-alanine-arginine) repeat superfamily form a sharp conical extension on the VgrG spike, which is further involved in attaching effector domains to the spike. The crystal structures of two PAAR-repeat proteins bound to VgrG-like partners show that these proteins sharpen the tip of the T6SS spike complex. We demonstrate that PAAR proteins are essential for T6SS-mediated secretion and target cell killing by Vibrio cholerae and Acinetobacter baylyi. Our results indicate a new model of the T6SS organelle in which the VgrG-PAAR spike complex is decorated with multiple effectors that are delivered simultaneously into target cells in a single contraction-driven translocation event.	[Shneider, Mikhail M.; Buth, Sergey A.; Leiman, Petr G.] Ecole Polytech Fed Lausanne, CH-1015 Lausanne, Switzerland; [Shneider, Mikhail M.] Shemyakin Ovchinnikov Inst Bioorgan Chem, Lab Mol Bioengn, Moscow 117997, Russia; [Ho, Brian T.; Basler, Marek; Mekalanos, John J.] Harvard Univ, Sch Med, Dept Microbiol & Immunobiol, Boston, MA 02115 USA	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences; Institute of Bioorganic Chemistry of the Russian Academy of Sciences; Harvard University; Harvard Medical School	Leiman, PG (corresponding author), Ecole Polytech Fed Lausanne, BSP 415, CH-1015 Lausanne, Switzerland.	john_mekalanos@hms.harvard.edu; petr.leiman@epfl.ch	Shneider, Mikhail/AAL-6817-2020; Basler, Marek/A-3559-2012; Leiman, Petr G/E-5120-2010; Buth, Sergey A./F-9794-2017; Buth, Sergey/P-1690-2019; Ho, Brian/M-1976-2019	Shneider, Mikhail/0000-0002-3768-3541; Basler, Marek/0000-0001-5414-2088; Leiman, Petr G/0000-0002-9091-0918; Buth, Sergey A./0000-0003-1922-0866; Buth, Sergey/0000-0003-1922-0866; Ho, Brian/0000-0003-4979-780X	Swiss National Science Foundation [31003A_127092]; EPFL; NIAID [AI-026289, AI-01845]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI026289, K08AI001845, R01AI018045, R37AI018045] Funding Source: NIH RePORTER	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); EPFL; NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank the entire staff of the Swiss Light Source PX beamlines and V. Olieric in particular for support related to crystallographic data collection. The project was made possible by the Swiss National Science Foundation (grant 31003A_127092) and EPFL funding to P. G. L., and grants AI-026289 and AI-01845 from the NIAID to J.J.M.	Adams PD, 2011, METHODS, V55, P94, DOI 10.1016/j.ymeth.2011.07.005; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Basler M, 2012, NATURE, V483, P182, DOI 10.1038/nature10846; Basler M, 2013, CELL, V152, P884, DOI 10.1016/j.cell.2013.01.042; BEARDEN JA, 1967, REV MOD PHYS, V39, P78, DOI 10.1103/RevModPhys.39.78; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Dong TG, 2013, P NATL ACAD SCI USA, V110, P2623, DOI 10.1073/pnas.1222783110; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Felisberto-Rodrigues C, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002386; Finn RD, 2011, NUCLEIC ACIDS RES, V39, pW29, DOI 10.1093/nar/gkr367; Finn RD, 2010, NUCLEIC ACIDS RES, V38, pD211, DOI 10.1093/nar/gkp985; FURSTE JP, 1986, GENE, V48, P119, DOI 10.1016/0378-1119(86)90358-6; Geer LY, 2002, GENOME RES, V12, P1619, DOI 10.1101/gr.278202; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; Hachani A, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.193045; Hamburger ZA, 1999, SCIENCE, V286, P291, DOI 10.1126/science.286.5438.291; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kanamaru S, 2002, NATURE, V415, P553, DOI 10.1038/415553a; Kapitein N, 2013, CURR OPIN MICROBIOL, V16, P52, DOI 10.1016/j.mib.2012.11.009; KIKUCHI Y, 1975, J MOL BIOL, V99, P673, DOI 10.1016/S0022-2836(75)80179-3; Koskiniemi S, 2013, P NATL ACAD SCI USA, V110, P7032, DOI 10.1073/pnas.1300627110; Kostyuchenko VA, 2003, NAT STRUCT BIOL, V10, P688, DOI 10.1038/nsb970; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Leiman PG, 2009, P NATL ACAD SCI USA, V106, P4154, DOI 10.1073/pnas.0813360106; Marchler-Bauer A, 2013, NUCLEIC ACIDS RES, V41, pD348, DOI 10.1093/nar/gks1243; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mougous JD, 2006, SCIENCE, V312, P1526, DOI 10.1126/science.1128393; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pukatzki S, 2006, P NATL ACAD SCI USA, V103, P1528, DOI 10.1073/pnas.0510322103; Pukatzki S, 2007, P NATL ACAD SCI USA, V104, P15508, DOI 10.1073/pnas.0706532104; ROSSMANN MG, 1962, ACTA CRYSTALLOGR, V15, P24, DOI 10.1107/S0365110X62000067; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408	36	312	324	4	107	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 15	2013	500	7462					350	+		10.1038/nature12453	http://dx.doi.org/10.1038/nature12453			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201AF	23925114	Green Accepted, Green Submitted			2022-12-24	WOS:000323112400036
J	Smith, R; Rabadan-Diehl, C; Wu, YF; Niessen, L; Prabhakaran, D; Xavier, D; Ghannem, H; Kimaiyo, S; Levitt, N; Denman, CA; Ramirez-Zea, M; Miranda, J; Rubenstein, A				Smith, Richard; Rabadan-Diehl, Christina; Wu, Yangfeng; Niessen, Louis; Prabhakaran, Dorajai; Xavier, Denis; Ghannem, Hassen; Kimaiyo, Sylvester; Levitt, Naomi; Denman, Catalina A.; Ramirez-Zea, Manuel; Miranda, Jaime; Rubenstein, Adolfo		UnitedHlth Grp Natl Heart Lung	A global research network for non-communicable diseases	LANCET			English	Editorial Material							FRAMINGHAM		[Smith, Richard; Rabadan-Diehl, Christina; Wu, Yangfeng; Niessen, Louis; Prabhakaran, Dorajai; Xavier, Denis; Ghannem, Hassen; Kimaiyo, Sylvester; Levitt, Naomi; Denman, Catalina A.; Ramirez-Zea, Manuel; Miranda, Jaime; Rubenstein, Adolfo; UnitedHlth Grp Natl Heart Lung] Inst Ctr Excellence, London SW4 0LD, England		Smith, R (corresponding author), Inst Ctr Excellence, London SW4 0LD, England.	richardswsmith@yahoo.co.uk	Prabhakaran, Dorairaj/B-4147-2011; Niessen, Louis/F-6254-2015	Prabhakaran, Dorairaj/0000-0002-3172-834X; Niessen, Louis/0000-0002-8639-5191				Greenberg H, 2010, PROG CARDIOVASC DIS, V53, P1, DOI 10.1016/j.pcad.2010.05.003; Institute of Medicine, 2010, PROMOTING CARDIOVASC; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; Nabel EG, 2009, LANCET, V373, P2004, DOI 10.1016/S0140-6736(09)61074-6; Nugent RA, 2010, 228 CTR GLOB DEV; Puska P, 2010, PROG CARDIOVASC DIS, V53, P15, DOI 10.1016/j.pcad.2010.01.003; Quam L, 2006, LANCET, V368, P1221, DOI 10.1016/s0140-6736(06)69422-1; Stevens D, 2007, LANCET, V370, P1901, DOI 10.1016/S0140-6736(07)61802-9; United Nations, 2011, REPORT SPECIAL RAPPO; UnitedHealth National Heart Lung and Blood Centres of Excellence, 2011, BMJ-BRIT MED J, V342, P76; World Health Organization, 2013, GLOB ACT PLAN PREV C	11	16	16	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 26	2014	383	9927					1446	1447		10.1016/S0140-6736(13)61808-5	http://dx.doi.org/10.1016/S0140-6736(13)61808-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AG3NI	24094840				2022-12-24	WOS:000335325800008
J	Cotten, M; Watson, SJ; Kellam, P; Al-Rabeeah, AA; Makhdoom, HQ; Assiri, A; Al-Tawfiq, JA; Alhakeem, RF; Madani, H; AlRabiah, FA; Al Hajjar, S; Al-Nassir, WN; Albarrak, A; Flemban, H; Balkhy, HH; Alsubaie, S; Palser, AL; Gall, A; Bashford-Rogers, R; Rambaut, A; Zumla, AI; Memish, ZA				Cotten, Matthew; Watson, Simon J.; Kellam, Paul; Al-Rabeeah, Abdullah A.; Makhdoom, Hatem Q.; Assiri, Abdullah; Al-Tawfiq, Jaffar A.; Alhakeem, Rafat F.; Madani, Hossam; AlRabiah, Fahad A.; Al Hajjar, Sami; Al-Nassir, Wafa N.; Albarrak, Ali; Flemban, Hesham; Balkhy, Hanan H.; Alsubaie, Sarah; Palser, Anne L.; Gall, Astrid; Bashford-Rogers, Rachael; Rambaut, Andrew; Zumla, Alimuddin I.; Memish, Ziad A.			Transmission and evolution of the Middle East respiratory syndrome coronavirus in Saudi Arabia: a descriptive genomic study	LANCET			English	Article							PHYLOGENETIC ANALYSIS; SPIKE PROTEIN; ACTIVATION; RECEPTOR; INFERENCE; CLEAVAGE	Background Since June, 2012, Middle East respiratory syndrome coronavirus (MERS-CoV) has, worldwide, caused 104 infections in people including 49 deaths, with 82 cases and 41 deaths reported from Saudi Arabia. In addition to confirming diagnosis, we generated the MERS-CoV genomic sequences obtained directly from patient samples to provide important information on MERS-CoV transmission, evolution, and origin. Methods Full genome deep sequencing was done on nucleic acid extracted directly from PCR-confirmed clinical samples. Viral genomes were obtained from 21 MERS cases of which 13 had 100%, four 85-95%, and four 30-50% genome coverage. Phylogenetic analysis of the 21 sequences, combined with nine published MERS-CoV genomes, was done. Findings Three distinct MERS-CoV genotypes were identified in Riyadh. Phylogeographic analyses suggest the MERS-CoV zoonotic reservoir is geographically disperse. Selection analysis of the MERS-CoV genomes reveals the expected accumulation of genetic diversity including changes in the S protein. The genetic diversity in the Al-Hasa cluster suggests that the hospital outbreak might have had more than one virus introduction. Interpretation We present the largest number of MERS-CoV genomes (21) described so far. MERS-CoV full genome sequences provide greater detail in tracking transmission. Multiple introductions of MERS-CoV are identified and suggest lower R 0 values. Transmission within Saudi Arabia is consistent with either movement of an animal reservoir, animal products, or movement of infected people. Further definition of the exposures responsible for the sporadic introductions of MERS-CoV into human populations is urgently needed.	[Al-Rabeeah, Abdullah A.; Assiri, Abdullah; Alhakeem, Rafat F.; Zumla, Alimuddin I.; Memish, Ziad A.] Minist Hlth, Global Ctr Mass Gatherings Med, Riyadh 11176, Saudi Arabia; [Cotten, Matthew; Watson, Simon J.; Kellam, Paul; Palser, Anne L.; Gall, Astrid; Bashford-Rogers, Rachael] Wellcome Trust Sanger Inst, Hinxton, England; [Makhdoom, Hatem Q.; Madani, Hossam] Minist Hlth, Jeddah Reg Lab, Jeddah, Saudi Arabia; [Al-Tawfiq, Jaffar A.] Saudi Aramco Med Serv Org, Dhahran, Saudi Arabia; [Rambaut, Andrew] Ashworth Labs, Inst Evolutionary Biol, Edinburgh, Midlothian, Scotland; [Rambaut, Andrew] NIH, Fogarty Int Ctr, Bethesda, MD 20892 USA; [AlRabiah, Fahad A.; Al Hajjar, Sami] King Faisal Specialist Hosp & Res Ctr, Riyadh, Saudi Arabia; [Al-Nassir, Wafa N.] Natl Guard Hlth Affairs Dammam, Imam Abdulrahman Bin Mohamed Hosp, Dammam, Saudi Arabia; [Albarrak, Ali] Prince Sultan Mil Med City, Riyadh, Saudi Arabia; [Flemban, Hesham] Alhada Mil Hosp, Riyadh, Saudi Arabia; [Balkhy, Hanan H.] King Abdul Aziz Med City, Riyadh, Saudi Arabia; [Alsubaie, Sarah] King Saud Univ, Riyadh 11451, Saudi Arabia; [Kellam, Paul; Zumla, Alimuddin I.] UCL, Div Infect & Immun, London, England; [Zumla, Alimuddin I.] UCL Hosp NHS Fdn Trust, London, England	Wellcome Trust Sanger Institute; Ministry of Health - Saudi Arabia; Saudi Aramco; University of Edinburgh; National Institutes of Health (NIH) - USA; NIH Fogarty International Center (FIC); King Faisal Specialist Hospital & Research Center; Prince Sultan Military Medical City; King Saud University; University of London; University College London; University of London; University College London	Memish, ZA (corresponding author), Minist Hlth, Global Ctr Mass Gatherings Med, Riyadh 11176, Saudi Arabia.	zmemish@yahoo.com	Memish, Ziad Ahmed/AEJ-9424-2022; assiri, abdullah/AAF-5665-2021; Rambaut, Andrew/B-2481-2009; Assiri, Abdullah M./GQP-2239-2022; ZUMLA, Alimuddin/ABA-8208-2020	Memish, Ziad Ahmed/0000-0002-5099-0714; assiri, abdullah/0000-0002-5605-2876; Rambaut, Andrew/0000-0003-4337-3707; ZUMLA, Alimuddin/0000-0002-5111-5735; Rambaut FRSE, Professor Andrew/0000-0002-1278-598X; Cotten, Matthew/0000-0002-3361-3351; Kellam, Paul/0000-0003-3166-4734; Gall, Astrid/0000-0001-6452-5816; Bashford-Rogers, Rachael/0000-0002-6838-0711; Alsubaie, Sarah/0000-0002-3128-5921	Saudi Arabian Ministry of Health; Wellcome Trust; European Community; National Institute of Health Research University College London Hospitals Biomedical Research Centre	Saudi Arabian Ministry of Health; Wellcome Trust(Wellcome TrustEuropean Commission); European Community(European Commission); National Institute of Health Research University College London Hospitals Biomedical Research Centre	Funding Saudi Arabian Ministry of Health, Wellcome Trust, European Community, and National Institute of Health Research University College London Hospitals Biomedical Research Centre.	AlBarrak AM, 2012, SAUDI MED J, V33, P1265; [Anonymous], 2013, MIDDL E RESP SYNDR C; Assiri A, 2013, NEW ENGL J MED, V369, P407, DOI 10.1056/NEJMoa1306742; Bankevich A, 2012, J COMPUT BIOL, V19, P455, DOI 10.1089/cmb.2012.0021; Belouzard S, 2009, P NATL ACAD SCI USA, V106, P5871, DOI 10.1073/pnas.0809524106; Bottcher E, 2006, J VIROL, V80, P9896, DOI 10.1128/JVI.01118-06; Breban R, 2013, LANCET, V382, P694, DOI 10.1016/S0140-6736(13)61492-0; Corman VM, 2012, EUROSURVEILLANCE, V17, P2; Corman VM, 2012, EUROSURVEILLANCE, V17, P3; Cotten M, 2013, EMERG INFECT DIS, V19, P736, DOI 10.3201/eid1905.130057; Delport W, 2010, BIOINFORMATICS, V26, P2455, DOI 10.1093/bioinformatics/btq429; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Duckert P, 2004, PROTEIN ENG DES SEL, V17, P107, DOI 10.1093/protein/gzh013; Guan Y, 2004, LANCET, V363, P99, DOI 10.1016/S0140-6736(03)15259-2; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Ithete NL, 2013, EMERG INFECT DIS, V19, P1697, DOI 10.3201/eid1910.130946; Li WH, 2005, EMBO J, V24, P1634, DOI 10.1038/sj.emboj.7600640; Lu GW, 2013, NATURE, V500, P227, DOI 10.1038/nature12328; Matsuyama S, 2010, J VIROL, V84, P12658, DOI 10.1128/JVI.01542-10; Memish ZA, 2013, EMERG INFECT DIS, V19, P1819, DOI 10.3201/eid1911.131172; Memish ZA, 2013, NEW ENGL J MED, V368, P2487, DOI 10.1056/NEJMoa1303729; Minin VN, 2008, MOL BIOL EVOL, V25, P1459, DOI 10.1093/molbev/msn090; Pond SLK, 2005, BIOINFORMATICS, V21, P676, DOI 10.1093/bioinformatics/bti079; Raj VS, 2013, NATURE, V495, P251, DOI 10.1038/nature12005; Rambaut A., NOVEL HUMAN BETACORO; Reusken CBEM, 2013, LANCET INFECT DIS, V13, P859, DOI 10.1016/S1473-3099(13)70164-6; Sheahan T, 2008, J VIROL, V82, P2274, DOI 10.1128/JVI.02041-07; Song HD, 2005, P NATL ACAD SCI USA, V102, P2430, DOI 10.1073/pnas.0409608102; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; van Boheemen S, 2012, MBIO, V3, DOI 10.1128/mBio.00473-12; Zaki AM, 2012, NEW ENGL J MED, V367, P1814, DOI 10.1056/NEJMoa1211721	32	220	243	1	61	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 14	2013	382	9909					1993	2002		10.1016/S0140-6736(13)61887-5	http://dx.doi.org/10.1016/S0140-6736(13)61887-5			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	269EI	24055451	Green Published, hybrid, Green Accepted			2022-12-24	WOS:000328223700026
J	Ring, AM; Manglik, A; Kruse, AC; Enos, MD; Weis, WI; Garcia, KC; Kobilka, BK				Ring, Aaron M.; Manglik, Aashish; Kruse, Andrew C.; Enos, Michael D.; Weis, William I.; Garcia, K. Christopher; Kobilka, Brian K.			Adrenaline-activated structure of beta(2)-adrenoceptor stabilized by an engineered nanobody	NATURE			English	Article							PROTEIN-COUPLED RECEPTOR; ADRENERGIC-RECEPTOR; LIGAND-BINDING; AGONIST; ADRENOCEPTOR; RHODOPSIN; COMPLEX; DISPLAY; SERINE; STATE	G-protein-coupled receptors (GPCRs) are integral membrane proteins that have an essential role in human physiology, yet the molecular processes through which they bind to their endogenous agonists and activate effector proteins remain poorly understood. So far, it has not been possible to capture an active-state GPCR bound to its native neurotransmitter. Crystal structures of agonist-bound GPCRs have relied on the use of either exceptionally high-affinity agonists(1,2) or receptor stabilization by mutagenesis(3-5). Many natural agonists such as adrenaline, which activates the beta(2)-adrenoceptor (beta(2)AR), bind with relatively low affinity, and they are often chemically unstable. Using directed evolution, we engineered a high-affinity camelid antibody fragment that stabilizes the active state of the beta(2)AR, and used this to obtain crystal structures of the activated receptor bound to multiple ligands. Here we present structures of the active-state human beta(2)AR bound to three chemically distinct agonists: the ultrahigh-affinity agonist BI167107, the high-affinity catecholamine agonist hydroxybenzyl isoproterenol, and the low-affinity endogenous agonist adrenaline. The crystal structures reveal a highly conserved overall ligand recognition and activation mode despite diverse ligand chemical structures and affinities that range from 100 nM to similar to 80 pM. Overall, the adrenaline-bound receptor structure is similar to the others, but it has substantial rearrangements in extracellular loop three and the extracellular tip of transmembrane helix 6. These structures also reveal a water-mediated hydrogen bond between two conserved tyrosines, which appears to stabilize the active state of the beta(2)AR and related GPCRs.	[Ring, Aaron M.; Manglik, Aashish; Kruse, Andrew C.; Enos, Michael D.; Weis, William I.; Garcia, K. Christopher; Kobilka, Brian K.] Stanford Univ, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA; [Ring, Aaron M.; Enos, Michael D.; Weis, William I.; Garcia, K. Christopher] Stanford Univ, Dept Biol Struct, Stanford, CA 94305 USA; [Garcia, K. Christopher] Stanford Univ, Sch Med, Howard Hughes Med Inst, Stanford, CA 94305 USA	Stanford University; Stanford University; Howard Hughes Medical Institute; Stanford University	Garcia, KC (corresponding author), Stanford Univ, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA.	kcgarcia@stanford.edu; kobilka@stanford.edu	Weis, William I/G-1437-2011	Weis, William I/0000-0002-5583-6150; Enos, Michael/0000-0003-3208-7043; Ring, Aaron/0000-0003-3699-2446; Kobilka, Brian/0000-0001-5958-3990	Stanford Medical Scientist Training Program; American Heart Association; National Science Foundation; Ruth L. Kirschstein National Research Service Award; National Institutes of Health [NS02847123, GM08311806]; Mathers Foundation; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083118, T32GM008294] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS028471, R01NS028471] Funding Source: NIH RePORTER	Stanford Medical Scientist Training Program; American Heart Association(American Heart Association); National Science Foundation(National Science Foundation (NSF)); Ruth L. Kirschstein National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mathers Foundation; Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank D. Hilger for critical reading of the manuscript. We acknowledge support from the Stanford Medical Scientist Training Program (A.M. and A.M.R.), the American Heart Association (A.M.), the National Science Foundation (A.C.K.), the Ruth L. Kirschstein National Research Service Award (A.M.R.), National Institutes of Health grants NS02847123 and GM08311806 (B.K.K.), from the Mathers Foundation (B.K.K., W.I.W. and K.C.G.), and from the Howard Hughes Medical Institute (K.C.G.).	Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Caffrey M, 2009, NAT PROTOC, V4, P706, DOI 10.1038/nprot.2009.31; Chao G, 2006, NAT PROTOC, V1, P755, DOI 10.1038/nprot.2006.94; Deupi X, 2012, P NATL ACAD SCI USA, V109, P119, DOI 10.1073/pnas.1114089108; Elgeti M, 2011, J AM CHEM SOC, V133, P7159, DOI 10.1021/ja200545n; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Goncalves JA, 2010, P NATL ACAD SCI USA, V107, P19861, DOI 10.1073/pnas.1009405107; KOBILKA BK, 1995, ANAL BIOCHEM, V231, P269, DOI 10.1006/abio.1995.1533; Lebon G, 2011, NATURE, V474, P521, DOI 10.1038/nature10136; Liapakis G, 2000, J BIOL CHEM, V275, P37779, DOI 10.1074/jbc.M002092200; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Nygaard R, 2013, CELL, V152, P532, DOI 10.1016/j.cell.2013.01.008; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Rasmussen SGF, 2011, NATURE, V469, P175, DOI 10.1038/nature09648; Rosenbaum DM, 2011, NATURE, V469, P236, DOI 10.1038/nature09665; Schneider EH, 2010, J PHARMACOL EXP THER, V333, P382, DOI 10.1124/jpet.109.163220; Serrano-Vega MJ, 2008, P NATL ACAD SCI USA, V105, P877, DOI 10.1073/pnas.0711253105; STRADER CD, 1989, J BIOL CHEM, V264, P13572; Venkatakrishnan AJ, 2013, NATURE, V494, P185, DOI 10.1038/nature11896; Wang Z, 2005, PROTEIN ENG DES SEL, V18, P337, DOI 10.1093/protein/gzi036; Warne T, 2008, NATURE, V454, P486, DOI 10.1038/nature07101; Warne T, 2011, NATURE, V469, P241, DOI 10.1038/nature09746; White JF, 2012, NATURE, V490, P508, DOI 10.1038/nature11558; Whorton MR, 2007, P NATL ACAD SCI USA, V104, P7682, DOI 10.1073/pnas.0611448104; Xu F, 2011, SCIENCE, V332, P322, DOI 10.1126/science.1202793; Zou YZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046039	27	341	347	9	178	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 24	2013	502	7472					575	+		10.1038/nature12572	http://dx.doi.org/10.1038/nature12572			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	238YN	24056936	Green Submitted, Green Accepted			2022-12-24	WOS:000325988400060
J	Erickson, JR; Pereira, L; Wang, LG; Han, GH; Ferguson, A; Dao, K; Copeland, RJ; Despa, F; Hart, GW; Ripplinger, CM; Bers, DM				Erickson, Jeffrey R.; Pereira, Laetitia; Wang, Lianguo; Han, Guanghui; Ferguson, Amanda; Dao, Khanha; Copeland, Ronald J.; Despa, Florin; Hart, Gerald W.; Ripplinger, Crystal M.; Bers, Donald M.			Diabetic hyperglycaemia activates CaMKII and arrhythmias by O-linked glycosylation	NATURE			English	Article							CA2+/CALMODULIN-DEPENDENT PROTEIN-KINASE; HEART-FAILURE; CARDIAC-HYPERTROPHY; N-ACETYLGLUCOSAMINE; CYTOSOLIC PROTEINS; CARDIOMYOCYTES; MYOCYTES; MELLITUS; RECEPTOR; INSIGHT	Ca2+/calmodulin-dependent protein kinase II (CaMKII) is an enzyme with important regulatory functions in the heart and brain, and its chronic activation can be pathological. CaMKII activation is seen in heart failure, and can directly induce pathological changes in ion channels, Ca2+ handling and gene transcription(1). Here, in human, rat and mouse, we identify a novel mechanism linking CaMKII and hyperglycaemic signalling in diabetes mellitus, which is a key risk factor for heart(2) and neurodegenerative diseases(3,4). Acute hyperglycaemia causes covalent modification of CaMKII by O-linked N-acetylglucosamine (O-GlcNAc). O-GlcNAc modification of CaMKII at Ser 279 activates CaMKII autonomously, creating molecular memory even after Ca2+ concentration declines. O-GlcNAc-modified CaMKII is increased in the heart and brain of diabetic humans and rats. In cardiomyocytes, increased glucose concentration significantly enhances CaMKII-dependent activation of spontaneous sarcoplasmic reticulum Ca2+ release events that can contribute to cardiac mechanical dysfunction and arrhythmias(1). These effects were prevented by pharmacological inhibition of O-GlcNAc signalling or genetic ablation of CaMKII delta. In intact perfused hearts, arrhythmias were aggravated by increased glucose concentration through O-GlcNAc- and CaMKII-dependent pathways. In diabetic animals, acute blockade of O-GlcNAc inhibited arrhythmogenesis. Thus, O-GlcNAc modification of CaMKII is a novel signalling event in pathways that may contribute critically to cardiac and neuronal pathophysiology in diabetes and other diseases.	[Erickson, Jeffrey R.; Pereira, Laetitia; Wang, Lianguo; Ferguson, Amanda; Dao, Khanha; Despa, Florin; Ripplinger, Crystal M.; Bers, Donald M.] Univ Calif Davis, Dept Pharmacol, Davis, CA 95616 USA; [Erickson, Jeffrey R.] Univ Otago, Dept Physiol, Dunedin 9054, New Zealand; [Han, Guanghui; Copeland, Ronald J.; Hart, Gerald W.] Johns Hopkins Univ, Sch Med, Dept Biol Chem, Baltimore, MD 21205 USA; [Despa, Florin] Univ Kentucky, Dept Mol & Biomed Pharmacol, Lexington, KY 40536 USA	University of California System; University of California Davis; University of Otago; Johns Hopkins University; University of Kentucky	Bers, DM (corresponding author), Univ Calif Davis, Dept Pharmacol, 451 Hlth Sci Dr, Davis, CA 95616 USA.	dmbers@ucdavis.edu	Wang, Lianguo/B-5644-2012; Han, Guanghui/N-8573-2013	Wang, Lianguo/0000-0002-4747-0419; Han, Guanghui/0000-0002-9893-9168; Pereira, Laetitia/0000-0002-0080-3546; Ripplinger, Crystal/0000-0002-9908-4106; Hart, Gerald/0000-0001-7812-4351; Bers, Donald/0000-0002-2237-9483	American Heart Association [13SDG14680072]; National Institutes of Health (NIH) [T32HL86350, 1R01HL118474-01A1, R01DK61671, P01HL107153, R01HL111600, P01HL080101, R37HL30077]; NSF CBET [1133339]; ADA [1-13-IN-70]; AHA [13GRNT16470034]; Fondation Leducq Transatlantic CaMKII Alliance; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL107153, R01HL118474, P01HL080101, R01HL105242, R01HL030077, T32HL086350, R01HL111600, R37HL030077] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK061671, P30DK079637] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG010129] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF CBET(National Science Foundation (NSF)); ADA(American Diabetes Association); AHA(American Heart Association); Fondation Leducq Transatlantic CaMKII Alliance(Leducq Foundation); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank Y. Hayashi for providing initial Camui samples, H. Schulman for helpful discussions, K. Margulies for human heart samples, L.-W. Jin, M. Melara and the University of California, Davis Alzheimer's Disease Center (NIH-P30AG010129) for human brain samples, and J. H. Brown for providing CaMKII delta-knockout mice. We thank Pfizer, Inc. for the gift of a breeding pair of HIP rats to F.D. This work was supported by American Heart Association 13SDG14680072 and National Institutes of Health (NIH) T32HL86350 (J.R.E.); NIH 1R01HL118474-01A1, NSF CBET 1133339, ADA 1-13-IN-70 and AHA 13GRNT16470034 (F.D.); NIH R01DK61671 and P01HL107153 (G.W.H.); NIH R01HL111600 (C.M.R.); NIH P01HL080101, R37HL30077 and Fondation Leducq Transatlantic CaMKII Alliance (D.M.B.). G.W.H. receives a share of royalty on sales of the CTD 110.6 antibody, which are managed by Johns Hopkins University.	Anderson ME, 2011, J MOL CELL CARDIOL, V51, P468, DOI 10.1016/j.yjmcc.2011.01.012; Ashpole NM, 2011, MOL CELL NEUROSCI, V46, P720, DOI 10.1016/j.mcn.2011.02.003; Biessels GJ, 2006, LANCET NEUROL, V5, P64, DOI 10.1016/S1474-4422(05)70284-2; Bimboese P, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.206482; Butler AE, 2004, DIABETES, V53, P1509, DOI 10.2337/diabetes.53.6.1509; Chatham JC, 2010, BBA-GEN SUBJECTS, V1800, P57, DOI 10.1016/j.bbagen.2009.07.004; CURTIS MJ, 1988, CARDIOVASC RES, V22, P656, DOI 10.1093/cvr/22.9.656; Del Gobbo LC, 2012, CARDIOVASC DIABETOL, V11, DOI 10.1186/1475-2840-11-23; Despa S, 2012, CIRC RES, V110, P598, DOI [10.1161/CIRCRESAHA.111.258285, 10.1161/circresaha.111.258285]; Dias WB, 2009, J BIOL CHEM, V284, P21327, DOI 10.1074/jbc.M109.007310; Erickson JR, 2008, CELL, V133, P462, DOI 10.1016/j.cell.2008.02.048; Erickson JR, 2011, CIRC RES, V109, P729, DOI 10.1161/CIRCRESAHA.111.247148; Gao Y, 2001, J BIOL CHEM, V276, P9838, DOI 10.1074/jbc.M010420200; Guo T, 2006, CIRC RES, V99, P398, DOI 10.1161/01.RES.0000236756.06252.13; Haan MN, 2006, NAT CLIN PRACT NEURO, V2, P159, DOI 10.1038/ncpneuro0124; Hart GW, 2007, NATURE, V446, P1017, DOI 10.1038/nature05815; Hoch B, 1999, CIRC RES, V84, P713, DOI 10.1161/01.RES.84.6.713; Hudmon A, 2002, BIOCHEM J, V364, P593, DOI 10.1042/BJ20020228; Kohlhaas M, 2006, CIRC RES, V98, P235, DOI 10.1161/01.RES.0000200739.90811.9f; Kreppel LK, 1997, J BIOL CHEM, V272, P9308; Ling HY, 2009, J CLIN INVEST, V119, P1230, DOI 10.1172/JCI38022; Luo M, 2013, J CLIN INVEST, V123, P1262, DOI 10.1172/JCI65268; Rengifo J, 2007, J NEUROSCI, V27, P13813, DOI 10.1523/JNEUROSCI.2069-07.2007; Roger VL, 2011, CIRCULATION, V123, pE18, DOI 10.1161/CIR.0b013e3182009701; Rosenberg OS, 2005, CELL, V123, P849, DOI 10.1016/j.cell.2005.10.029; Takao K, 2005, J NEUROSCI, V25, P3107, DOI 10.1523/JNEUROSCI.0085-05.2005; van Oort RJ, 2010, CIRCULATION, V122, P2669, DOI 10.1161/CIRCULATIONAHA.110.982298; Zhang T, 2003, CIRC RES, V92, P912, DOI 10.1161/01.RES.0000069686.31472.C5; Zhao ZH, 2011, J MOL CELL CARDIOL, V50, P128, DOI 10.1016/j.yjmcc.2010.11.001; Zhu-Mauldin X, 2012, J BIOL CHEM, V287, P39094, DOI 10.1074/jbc.M112.383778	30	385	398	7	144	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 17	2013	502	7471					372	+		10.1038/nature12537	http://dx.doi.org/10.1038/nature12537			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	235GY	24077098	Green Accepted			2022-12-24	WOS:000325706300053
J	Shyer, AE; Tallinen, T; Nerurkar, NL; Wei, ZY; Gil, ES; Kaplan, DL; Tabin, CJ; Mahadevan, L				Shyer, Amy E.; Tallinen, Tuomas; Nerurkar, Nandan L.; Wei, Zhiyan; Gil, Eun Seok; Kaplan, David L.; Tabin, Clifford J.; Mahadevan, L.			Villification: How the Gut Gets Its Villi	SCIENCE			English	Article							SMOOTH-MUSCLE-CELLS; INTESTINAL VILLI; MORPHOGENESIS; GROWTH; DIFFERENTIATION	The villi of the human and chick gut are formed in similar stepwise progressions, wherein the mesenchyme and attached epithelium first fold into longitudinal ridges, then a zigzag pattern, and lastly individual villi. We find that these steps of villification depend on the sequential differentiation of the distinct smooth muscle layers of the gut, which restrict the expansion of the growing endoderm and mesenchyme, generating compressive stresses that lead to their buckling and folding. A quantitative computational model, incorporating measured properties of the developing gut, recapitulates the morphological patterns seen during villification in a variety of species. These results provide a mechanistic understanding of the formation of these elaborations of the lining of the gut, essential for providing sufficient surface area for nutrient absorption.	[Shyer, Amy E.; Nerurkar, Nandan L.; Tabin, Clifford J.] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Tallinen, Tuomas; Wei, Zhiyan; Mahadevan, L.] Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA; [Tallinen, Tuomas] Univ Jyvaskyla, Dept Phys, FI-40014 Jyvaskyla, Finland; [Tallinen, Tuomas] Univ Jyvaskyla, Nanosci Ctr, FI-40014 Jyvaskyla, Finland; [Gil, Eun Seok; Kaplan, David L.] Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA; [Mahadevan, L.] Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA; [Mahadevan, L.] Harvard Univ, Dept Phys, Cambridge, MA 02138 USA; [Mahadevan, L.] Harvard Univ, Wyss Inst Biol Inspired Engn, Cambridge, MA 02138 USA; [Mahadevan, L.] Harvard Univ, Kavli Inst Nanobio Sci & Technol, Cambridge, MA 02138 USA	Harvard University; Harvard Medical School; Harvard University; University of Jyvaskyla; University of Jyvaskyla; Tufts University; Harvard University; Harvard University; Harvard University; Harvard University	Tabin, CJ (corresponding author), Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA.	tabin@genetics.med.harvard.edu; lm@seas.harvard.edu	Wei, Zhiyan/P-7447-2016; Tallinen, Tuomas/J-7065-2013		Academy of Finland; NIH [RO1 HD047360]; MacArthur Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD047360] Funding Source: NIH RePORTER	Academy of Finland(Academy of Finland); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MacArthur Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	We thank M. Kirschner for providing Xenopus tadpoles and O. Pourquie for providing snake embryos. D. L. K. and Tufts University hold a series of patents that cover the processing of silk into material structures, including those used in the research reported here. T. T. acknowledges the Academy of Finland for support. Computations were run at CSC-IT Center for Science, Finland. C.J.T. acknowledges the support of a grant from NIH RO1 HD047360. L. M. acknowledges the support of the MacArthur Foundation.	Audoly B, 2008, J MECH PHYS SOLIDS, V56, P2444, DOI 10.1016/j.jmps.2008.03.001; BELL L, 1982, ANAT EMBRYOL, V165, P437, DOI 10.1007/BF00305579; BELLWARE FT, 1970, J EMBRYOL EXP MORPH, V24, P335; Ben Amar M, 2013, P NATL ACAD SCI USA, V110, P10525, DOI 10.1073/pnas.1217391110; Benabdallah H, 2008, PHARMACOL RES, V57, P132, DOI 10.1016/j.phrs.2008.01.002; Bowden N, 1998, NATURE, V393, P146, DOI 10.1038/30193; BURGESS DR, 1975, J EMBRYOL EXP MORPH, V34, P723; DAUCA M, 1990, International Journal of Developmental Biology, V34, P205; FERRI S, 1976, J ANAT, V121, P291; Fukuda K, 1998, DEVELOPMENT, V125, P3535; Hannezo E, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.078104; HARADA N, 1992, LIFE SCI, V51, P1381, DOI 10.1016/0024-3205(92)90638-6; His W., 1880, ANATOMIE MENSCHLICHE; Krause WJ, 2011, ANAT HISTOL EMBRYOL, V40, P352, DOI 10.1111/j.1439-0264.2011.01092.x; Kurahashi M, 2008, NEUROGASTROENT MOTIL, V20, P521, DOI 10.1111/j.1365-2982.2007.01055.x; Lovett ML, 2008, BIOMATERIALS, V29, P4650, DOI 10.1016/j.biomaterials.2008.08.025; Mahadevan L, 2005, SCIENCE, V307, P1740, DOI 10.1126/science.1105169; MCAVOY JW, 1978, J ANAT, V125, P155; Mclin VA, 2009, GASTROENTEROLOGY, V136, P2074, DOI 10.1053/j.gastro.2009.03.001; Moulton DE, 2011, J MECH PHYS SOLIDS, V59, P525, DOI 10.1016/j.jmps.2011.01.005; Noah TK, 2011, EXP CELL RES, V317, P2702, DOI 10.1016/j.yexcr.2011.09.006; Ramalho-Santos M, 2000, DEVELOPMENT, V127, P2763; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Savin T, 2011, NATURE, V476, P57, DOI 10.1038/nature10277; SBARBATI R, 1982, J ANAT, V135, P477; Stahlberg C. A., 1984, VIRCHOWS ARCH B, V47, P27; Sukegawa A, 2000, DEVELOPMENT, V127, P1971; Tallinen T, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.024302; Uni Z, 2003, POULTRY SCI, V82, P320, DOI 10.1093/ps/82.2.320; Walton KD, 2012, P NATL ACAD SCI USA, V109, P15817, DOI 10.1073/pnas.1205669109	30	311	317	3	114	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 11	2013	342	6155					212	218		10.1126/science.1238842	http://dx.doi.org/10.1126/science.1238842			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232EV	23989955	Green Accepted			2022-12-24	WOS:000325475200036
J	Mora, C; Frazier, AG; Longman, RJ; Dacks, RS; Walton, MM; Tong, EJ; Sanchez, JJ; Kaiser, LR; Stender, YO; Anderson, JM; Ambrosino, CM; Fernandez-Silva, I; Giuseffi, LM; Giambelluca, TW				Mora, Camilo; Frazier, Abby G.; Longman, Ryan J.; Dacks, Rachel S.; Walton, Maya M.; Tong, Eric J.; Sanchez, Joseph J.; Kaiser, Lauren R.; Stender, Yuko O.; Anderson, James M.; Ambrosino, Christine M.; Fernandez-Silva, Iria; Giuseffi, Louise M.; Giambelluca, Thomas W.			The projected timing of climate departure from recent variability	NATURE			English	Article							GLOBAL PATTERNS; CHANGE IMPACTS; SPECIES RICHNESS; RANGE SHIFTS; BIODIVERSITY; EXTINCTION; DISEASE; EVENTS; FUTURE; FACE	Ecological and societal disruptions by modern climate change are critically determined by the time frame over which climates shift beyond historical analogues. Here we present a new index of the year when the projected mean climate of a given location moves to a state continuously outside the bounds of historical variability under alternative greenhouse gas emissions scenarios. Using 1860 to 2005 as the historical period, this index has a global mean of 2069 (+/- 18 years s.d.) for near-surface air temperature under an emissions stabilization scenario and 2047 (+/- 14 years s.d.) under a 'business-as-usual' scenario. Unprecedented climates will occur earliest in the tropics and among low-income countries, highlighting the vulnerability of global biodiversity and the limited governmental capacity to respond to the impacts of climate change. Our findings shed light on the urgency of mitigating greenhouse gas emissions if climates potentially harmful to biodiversity and society are to be prevented.	[Mora, Camilo; Frazier, Abby G.; Longman, Ryan J.; Sanchez, Joseph J.; Kaiser, Lauren R.; Stender, Yuko O.; Giuseffi, Louise M.; Giambelluca, Thomas W.] Univ Hawaii Manoa, Dept Geog, Honolulu, HI 96822 USA; [Dacks, Rachel S.; Walton, Maya M.; Anderson, James M.; Ambrosino, Christine M.] Univ Hawaii Manoa, Dept Biol, Honolulu, HI 96822 USA; [Walton, Maya M.; Tong, Eric J.; Stender, Yuko O.; Anderson, James M.; Ambrosino, Christine M.; Fernandez-Silva, Iria] Univ Hawaii Manoa, Hawaii Inst Marine Biol, Kaneohe, HI 96744 USA; [Tong, Eric J.] Univ Hawaii Manoa, Dept Oceanog, Honolulu, HI 96822 USA; [Fernandez-Silva, Iria] Univ Ryukyus, TRO SIS, Nishihara, Okinawa 9030213, Japan	University of Hawaii System; University of Hawaii Manoa; University of Hawaii System; University of Hawaii Manoa; University of Hawaii System; University of Hawaii Manoa; University of Hawaii System; University of Hawaii Manoa; University of the Ryukyus	Mora, C (corresponding author), Univ Hawaii Manoa, Dept Geog, Honolulu, HI 96822 USA.	cmora@hawaii.edu	Fernandez-Silva, Iria/AAA-8996-2020; Frazier, Abby/P-5511-2017	Frazier, Abby/0000-0003-4076-4577; Anderson, James/0000-0002-4900-5916; Giambelluca, Thomas/0000-0002-6798-3780	Pacific Islands Climate Change Cooperative (PICCC) [F10AC00077]; National Science Foundation Hawai'i EPSCoR [EPS-0903833]; Pacific Islands Climate Science Center; PICCC [F10A00079]; National Science Foundation; Japanese Society for the Promotion of Science; EPSCoR [0903833] Funding Source: National Science Foundation	Pacific Islands Climate Change Cooperative (PICCC); National Science Foundation Hawai'i EPSCoR; Pacific Islands Climate Science Center; PICCC; National Science Foundation(National Science Foundation (NSF)); Japanese Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); EPSCoR(National Science Foundation (NSF)NSF - Office of the Director (OD))	We thank D. Beilman for commenting on the paper; E. Wingert for help on the figures; D. Olsen for technical support; H. Kreft and the International Union for Conservation of Nature, BirdLife International, the Food and Agriculture Organization of the United Nations, the World Bank Database, the National Centers for Environmental Prediction, the World Database of Protected Areas, and the Gridded Human Population of the World Database for making their data openly available. We acknowledge the World Climate Research Programme's Working Group on Coupled Modelling, which is responsible for CMIP5, and we thank the climate modelling groups (listed in Extended Data Table 1) for producing and making available their model outputs. This work was made possible by funding from the University of Hawai'i Sea Grant to C. M. The paper was developed as part of the graduate course on 'Methods for Large Scale Analyses' in the Department of Geography, University of Hawai'i at Manoa. A.G.F. and T.W.G were supported by Pacific Islands Climate Change Cooperative (PICCC) award F10AC00077 and National Science Foundation Hawai'i EPSCoR grant no. EPS-0903833. R.J.L. was supported by the Pacific Islands Climate Science Center and PICCC award F10A00079. R. S. D. and E.J.T. were supported by National Science Foundation Graduate Fellowships, and I.F.-S. by a postdoctoral fellowship from the Japanese Society for the Promotion of Science.	Allen CD, 2010, FOREST ECOL MANAG, V259, P660, DOI 10.1016/j.foreco.2009.09.001; Alley RB, 2003, SCIENCE, V299, P2005, DOI 10.1126/science.1081056; Angert AL, 2011, ECOL LETT, V14, P677, DOI 10.1111/j.1461-0248.2011.01620.x; [Anonymous], 2011, ECOLOGICAL NICHES GE; Baird A, 2008, SCIENCE, V320, P315, DOI 10.1126/science.320.5874.315; Baker AC, 2008, ESTUAR COAST SHELF S, V80, P435, DOI 10.1016/j.ecss.2008.09.003; Berg MP, 2010, GLOBAL CHANGE BIOL, V16, P587, DOI 10.1111/j.1365-2486.2009.02014.x; Berry HL, 2010, INT J PUBLIC HEALTH, V55, P123, DOI 10.1007/s00038-009-0112-0; Carey C, 2003, DIVERS DISTRIB, V9, P111, DOI 10.1046/j.1472-4642.2003.00011.x; Chen IC, 2011, SCIENCE, V333, P1024, DOI 10.1126/science.1206432; Chown SL, 1998, ECOGRAPHY, V21, P342, DOI 10.1111/j.1600-0587.1998.tb00399.x; Colwell RK, 2008, SCIENCE, V322, P258, DOI 10.1126/science.1162547; CROWLEY TJ, 1988, SCIENCE, V240, P996, DOI 10.1126/science.240.4855.996; Deutsch CA, 2008, P NATL ACAD SCI USA, V105, P6668, DOI 10.1073/pnas.0709472105; Devictor V, 2012, NAT CLIM CHANGE, V2, P121, DOI 10.1038/NCLIMATE1347; Diaz S, 2006, PLOS BIOL, V4, P1300, DOI 10.1371/journal.pbio.0040277; Doney SC, 2012, ANNU REV MAR SCI, V4, P11, DOI 10.1146/annurev-marine-041911-111611; Epstein PR, 2002, EPIDEMIOLOGY, V13, P373, DOI 10.1097/00001648-200207000-00001; Gaston KJ, 2000, NATURE, V405, P220, DOI 10.1038/35012228; Hoegh-Guldberg O, 1999, MAR FRESHWATER RES, V50, P839, DOI 10.1071/MF99078; Khasnis AA, 2005, ARCH MED RES, V36, P689, DOI 10.1016/j.arcmed.2005.03.041; Kier G, 2009, P NATL ACAD SCI USA, V106, P9322, DOI 10.1073/pnas.0810306106; Kloor K., 2009, NATURE REP CLIM CHAN, V3, P145, DOI DOI 10.1038/CLIMATE.2009.120; La Sorte FA, 2012, J ANIM ECOL, V81, P914, DOI 10.1111/j.1365-2656.2012.01958.x; Lobell DB, 2012, PLANT PHYSIOL, V160, P1686, DOI 10.1104/pp.112.208298; McKechnie AE, 2010, BIOL LETTERS, V6, P253, DOI 10.1098/rsbl.2009.0702; Meinshausen M, 2011, CLIMATIC CHANGE, V109, P213, DOI 10.1007/s10584-011-0156-z; Mora Camilo, 2013, P239; Mora C, 2011, MAR ECOL PROG SER, V434, P251, DOI 10.3354/meps09214; Pandolfi JM, 2011, SCIENCE, V333, P418, DOI 10.1126/science.1204794; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Patz JA, 2006, ANN TROP MED PARASIT, V100, P535, DOI 10.1179/136485906X97426; Raven J, 2005, OCEAN ACIDIFICATION; Reilly J., 2000, IRREVERSIBILITY UNCE; Rockstrom J, 2009, NATURE, V461, P472, DOI 10.1038/461472a; Sherwood SC, 2010, P NATL ACAD SCI USA, V107, P9552, DOI 10.1073/pnas.0913352107; Solomon S., 2007, CLIMATE CHANGE PHYS; Sorte CJB, 2013, OIKOS, V122, P161, DOI 10.1111/j.1600-0706.2012.00066.x; Taylor KE, 2012, B AM METEOROL SOC, V93, P485, DOI 10.1175/BAMS-D-11-00094.1; Taylor RG, 2013, NAT CLIM CHANGE, V3, P322, DOI [10.1038/nclimate1744, 10.1038/NCLIMATE1744]; Thomas CD, 2006, TRENDS ECOL EVOL, V21, P415, DOI 10.1016/j.tree.2006.05.012; Tittensor DP, 2010, NATURE, V466, P1098, DOI 10.1038/nature09329; Tol RSJ, 2002, ENVIRON RESOUR ECON, V21, P47, DOI 10.1023/A:1014500930521; van Vliet J, 2009, ENERG ECON, V31, pS152, DOI 10.1016/j.eneco.2009.06.010; van Vuuren DP, 2011, CLIMATIC CHANGE, V109, P5, DOI [10.1007/s10584-011-0148-z, 10.1007/s10584-011-0157-y]; Williams JW, 2007, FRONT ECOL ENVIRON, V5, P475, DOI 10.1890/070037; Williams JW, 2007, P NATL ACAD SCI USA, V104, P5738, DOI 10.1073/pnas.0606292104; Zeebe RE, 2008, SCIENCE, V321, P51, DOI 10.1126/science.1159124; Zhang X, 2013, GEOPHYS RES LETT, V40, P1111, DOI 10.1002/grl.50279; Zhu K, 2012, GLOBAL CHANGE BIOL, V18, P1042, DOI 10.1111/j.1365-2486.2011.02571.x	51	421	430	8	259	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 10	2013	502	7470					183	+		10.1038/nature12540	http://dx.doi.org/10.1038/nature12540			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231RU	24108050				2022-12-24	WOS:000325436100040
J	Chakravarti, A; Clark, AG; Mootha, VK				Chakravarti, Aravinda; Clark, Andrew G.; Mootha, Vamsi K.			Distilling Pathophysiology from Complex Disease Genetics	CELL			English	Article							ENVIRONMENT INTERACTION; MUTATIONS; TRAITS; COMMON	Technologies for genome-wide sequence interrogation have dramatically improved our ability to identify loci associated with complex human disease. However, a chasm remains between correlations and causality that stems, in part, from a limiting theoretical framework derived from Mendelian genetics and an incomplete understanding of disease physiology. Here we propose a set of criteria, akin to Koch's postulates for infectious disease, for assigning causality between genetic variants and human disease phenotypes.	[Chakravarti, Aravinda] Johns Hopkins Univ, Sch Med, Baltimore, MD 21205 USA; [Clark, Andrew G.] Cornell Univ, Ithaca, NY 14850 USA; [Mootha, Vamsi K.] Massachusetts Gen Hosp, Boston, MA 02114 USA	Johns Hopkins University; Cornell University; Harvard University; Massachusetts General Hospital	Chakravarti, A (corresponding author), Johns Hopkins Univ, Sch Med, Baltimore, MD 21205 USA.	aravinda@jhmi.edu		Clark, Andrew/0000-0001-7159-8511	NHLBI NIH HHS [R01 HL072904] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL072904] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Alberts B., 2010, MOL BIOL CELL; Altenburg E, 1920, GENETICS, V5, P1; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Brooke BS, 2008, NEW ENGL J MED, V358, P2787, DOI 10.1056/NEJMoa0706585; BROWN MS, 1992, CELL, V71, P187, DOI 10.1016/0092-8674(92)90346-E; Chakravarti A, 2001, NATURE, V409, P822, DOI 10.1038/35057281; Chin BL, 2012, GENETICS, V192, P1523, DOI 10.1534/genetics.112.145573; Dutkowski J, 2013, NAT BIOTECHNOL, V31, P38, DOI 10.1038/nbt.2463; Emison ES, 2010, AM J HUM GENET, V87, P60, DOI 10.1016/j.ajhg.2010.06.007; FALKOW S, 1988, REV INFECT DIS, V10, pS274; Falkow S, 2004, NAT REV MICROBIOL, V2, P67, DOI 10.1038/nrmicro799; Farago AF, 2012, CELL, V149, P246, DOI 10.1016/j.cell.2012.03.015; Graham DB, 2013, TRENDS IMMUNOL, V34, P371, DOI 10.1016/j.it.2013.04.001; Groop L, 2013, MOL CELL ENDOCRINOL; GUYTON AC, 1972, ANNU REV PHYSIOL, V34, P13, DOI 10.1146/annurev.ph.34.030172.000305; Hartman JL, 2001, SCIENCE, V291, P1001, DOI 10.1126/science.291.5506.1001; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Ilsley GR, 2013, ELIFE, V2, DOI 10.7554/eLife.00522; Jostins L, 2012, NATURE, V491, P119, DOI 10.1038/nature11582; Kohane IS, 2006, JAMA-J AM MED ASSOC, V296, P212, DOI 10.1001/jama.296.2.212; Ludolph AC, 2012, CURR OPIN NEUROL, V25, P530, DOI 10.1097/WCO.0b013e328356d328; MacArthur DG, 2012, SCIENCE, V335, P823, DOI 10.1126/science.1215040; McCallion AS, 2003, COLD SPRING HARB SYM, V68, P373, DOI 10.1101/sqb.2003.68.373; Moon RT, 2004, NAT REV GENET, V5, P689, DOI 10.1038/nrg1427; Musunuru K, 2010, NATURE, V466, P714, DOI 10.1038/nature09266; PLUMP AS, 1992, CELL, V71, P343, DOI 10.1016/0092-8674(92)90362-G; Provine, 1971, ORIGINS THEORETICAL; Raj A, 2010, NATURE, V463, P913, DOI 10.1038/nature08781; Sparrow DB, 2012, CELL, V149, P295, DOI 10.1016/j.cell.2012.02.054; Vogelstein B, 2013, SCIENCE, V339, P1546, DOI 10.1126/science.1235122; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Watson JD, 2007, MOL BIOL GENE; Yang J, 2011, NAT GENET, V43, P519, DOI 10.1038/ng.823; Yosef N, 2013, NATURE, V496, P461, DOI 10.1038/nature11981; Zerba KE, 1996, GENETICS, V143, P463	35	58	60	1	21	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 26	2013	155	1					21	26		10.1016/j.cell.2013.09.001	http://dx.doi.org/10.1016/j.cell.2013.09.001			6	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	224UX	24074858	Green Accepted, Bronze			2022-12-24	WOS:000324916700006
J	Chanda, B; Ditadi, A; Iscove, NN; Keller, G				Chanda, Bhaskar; Ditadi, Andrea; Iscove, Norman N.; Keller, Gordon			Retinoic Acid Signaling Is Essential for Embryonic Hematopoietic Stem Cell Development	CELL			English	Article							ALDEHYDE DEHYDROGENASE; DEFINITIVE HEMATOPOIESIS; RECEPTOR-ALPHA; GENERATION; SPECIFICATION; PROGENITORS; ENDOTHELIUM; EXPRESSION; GAMMA; REQUIREMENT	Hematopoietic stem cells (HSCs) develop from a specialized subpopulation of endothelial cells known as hemogenic endothelium (HE). Although the HE origin of HSCs is now well established in different species, the signaling pathways that control this transition remain poorly understood. Here, we show that activation of retinoic acid (RA) signaling in aorta-gonad-mesonephros-derived HE ex vivo dramatically enhanced its HSC potential, whereas conditional inactivation of the RA metabolizing enzyme retinal dehydrogenase 2 in VE-cadherin expressing endothelial cells in vivo abrogated HSC development. Wnt signaling completely blocked the HSC inductive effects of RA modulators, whereas inhibition of the pathway promoted the development of HSCs in the absence of RA signaling. Collectively, these findings position RA and Wnt signaling as key regulators of HSC development and in doing so provide molecular insights that will aid in developing strategies for their generation from pluripotent stem cells.	[Chanda, Bhaskar; Ditadi, Andrea; Iscove, Norman N.; Keller, Gordon] Univ Toronto, McEwen Ctr Regenerat Med, Toronto, ON M5G 1L7, Canada; [Chanda, Bhaskar; Iscove, Norman N.; Keller, Gordon] Univ Toronto, Dept Med Biophys, Toronto, ON M5G 1L7, Canada; [Iscove, Norman N.; Keller, Gordon] Univ Toronto, Univ Hlth Network, Princess Margaret Canc Ctr, Toronto, ON M5G 1L7, Canada	University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre	Keller, G (corresponding author), Univ Toronto, McEwen Ctr Regenerat Med, Toronto, ON M5G 1L7, Canada.	gkeller@uhnresearch.ca	Ditadi, Andrea/K-3461-2016	Ditadi, Andrea/0000-0003-3283-8943; Keller, Gordon/0000-0001-9309-9297	Banting and Best Canada Graduate PhD Scholarship from CIHR [FRN-72038762, MOP-93569]; Magna-Golftown Postdoctoral Fellowship; NIH [UO1 HL100405]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL100405] Funding Source: NIH RePORTER	Banting and Best Canada Graduate PhD Scholarship from CIHR; Magna-Golftown Postdoctoral Fellowship; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank Dr. Shanthini Socknathan at John Hopkins University, Dr. Nancy Speck at the University of Pennsylvania, and Dr. Kenneth Murphy at Washington University for providing Raldh2<SUP>f/f</SUP> mice, VEC-Cre mice, and TOP and FOP Flash A2lox mouse ESC lines, respectively. We also thank the following people for their assistance in different experiments: Arian Khandani and Tharsan Theruvillapurium for cell sorting, Robert Banh for western blot analyses, Alexander Mikryukov and David Tsui for immunohistochemistry, and Wilfred Ip for luciferase assay. In addition, we thank the Keller laboratory members for their feedback on the manuscript. B.C. is supported by a Banting and Best Canada Graduate PhD Scholarship from CIHR (FRN-72038762), and A.D. by Magna-Golftown Postdoctoral Fellowship. This research is funded by operating grants from CIHR (MOP-93569) and NIH (UO1 HL100405).	Antonchuk J, 2002, CELL, V109, P39, DOI 10.1016/S0092-8674(02)00697-9; APFEL C, 1992, P NATL ACAD SCI USA, V89, P7129, DOI 10.1073/pnas.89.15.7129; Armstrong L, 2004, STEM CELLS, V22, P1142, DOI 10.1634/stemcells.2004-0170; Balmer JE, 2005, J STEROID BIOCHEM, V96, P347, DOI 10.1016/j.jsbmb.2005.05.005; Balmer JE, 2002, J LIPID RES, V43, P1773, DOI 10.1194/jlr.R100015-JLR200; Bertrand JY, 2010, NATURE, V464, P108, DOI 10.1038/nature08738; Bertrand JY, 2005, P NATL ACAD SCI USA, V102, P134, DOI 10.1073/pnas.0402270102; Boisset JC, 2010, NATURE, V464, P116, DOI 10.1038/nature08764; Chen BZ, 2009, NAT CHEM BIOL, V5, P100, DOI 10.1038/nchembio.137; Chen MJ, 2011, CELL STEM CELL, V9, P541, DOI 10.1016/j.stem.2011.10.003; Chen MJ, 2009, NATURE, V457, P887, DOI 10.1038/nature07619; Clarke RL, 2013, NAT CELL BIOL, V15, P502, DOI 10.1038/ncb2724; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; de Jong JLO, 2010, BLOOD, V116, P201, DOI 10.1182/blood-2009-10-249557; DELESCLUSE C, 1991, MOL PHARMACOL, V40, P556; Duester G, 1999, ADV EXP MED BIOL, V463, P311; Duester G, 2008, CELL, V134, P921, DOI 10.1016/j.cell.2008.09.002; Easwaran V, 1999, CURR BIOL, V9, P1415, DOI 10.1016/S0960-9822(00)80088-3; Eilken HM, 2009, NATURE, V457, P896, DOI 10.1038/nature07760; Fitch SR, 2012, CELL STEM CELL, V11, P554, DOI 10.1016/j.stem.2012.07.002; GIANNI M, 1993, BIOCHEM BIOPH RES CO, V196, P252, DOI 10.1006/bbrc.1993.2242; Goessling W, 2009, CELL, V136, P1136, DOI 10.1016/j.cell.2009.01.015; Goldie LC, 2008, BLOOD, V112, P3194, DOI 10.1182/blood-2008-02-139055; Gonsalves FC, 2011, P NATL ACAD SCI USA, V108, P5954, DOI 10.1073/pnas.1017496108; Hadland BK, 2004, BLOOD, V104, P3097, DOI 10.1182/blood-2004-03-1224; Hess DA, 2004, BLOOD, V104, P1648, DOI 10.1182/blood-2004-02-0448; Irion S, 2010, DEVELOPMENT, V137, P2829, DOI 10.1242/dev.042119; JONES RJ, 1995, BLOOD, V85, P2742, DOI 10.1182/blood.V85.10.2742.bloodjournal85102742; Kaimakis P, 2013, BBA-GEN SUBJECTS, V1830, P2395, DOI 10.1016/j.bbagen.2012.10.004; Kumano K, 2003, IMMUNITY, V18, P699, DOI 10.1016/S1074-7613(03)00117-1; Kumar S, 2012, BBA-MOL CELL BIOL L, V1821, P198, DOI 10.1016/j.bbalip.2011.04.004; Lancrin C, 2009, NATURE, V457, P892, DOI 10.1038/nature07679; Lindsley RC, 2006, DEVELOPMENT, V133, P3787, DOI 10.1242/dev.02551; Lund BW, 2005, J MED CHEM, V48, P7517, DOI 10.1021/jm050891r; Mark M., 2009, NUCL RECEPT SIGNAL, V7, pe002; Medvinsky A, 1996, CELL, V86, P897, DOI 10.1016/S0092-8674(00)80165-8; Mikkola HKA, 2003, NATURE, V421, P547, DOI 10.1038/nature01345; Mukouyama Y, 2000, DEV BIOL, V220, P27, DOI 10.1006/dbio.2000.9617; Niederreither K, 1999, NAT GENET, V21, P444, DOI 10.1038/7788; Purton LE, 2006, J EXP MED, V203, P1283, DOI 10.1084/jem.20052105; Ren X, 2010, BLOOD, V115, P5338, DOI 10.1182/blood-2009-09-244640; Rhinn M, 2012, DEVELOPMENT, V139, P843, DOI 10.1242/dev.065938; Ruiz-Herguido C, 2012, J EXP MED, V209, P1457, DOI 10.1084/jem.20120225; Rybtsov S, 2011, J EXP MED, V208, P1305, DOI 10.1084/jem.20102419; Sato N, 2004, NAT MED, V10, P55, DOI 10.1038/nm979; Schlaeger TM, 2005, BLOOD, V105, P3871, DOI 10.1182/blood-2004-11-4467; Taoudi S, 2005, DEVELOPMENT, V132, P4179, DOI 10.1242/dev.01974; Taoudi S, 2008, CELL STEM CELL, V3, P99, DOI 10.1016/j.stem.2008.06.004; TSAI FY, 1994, NATURE, V371, P221, DOI 10.1038/371221a0; Walkley CR, 2007, CELL, V129, P1097, DOI 10.1016/j.cell.2007.05.014; Wang Q, 1996, CELL, V87, P697, DOI 10.1016/S0092-8674(00)81389-6; Xiao JH, 2003, J BIOL CHEM, V278, P29954, DOI 10.1074/jbc.M304761200; Yokomizo T, 2001, GENES CELLS, V6, P13, DOI 10.1046/j.1365-2443.2001.00393.x; Yoshimoto M, 2009, NATURE, V457, P801, DOI 10.1038/457801a; Yu C, 2010, BLOOD, V116, P4786, DOI 10.1182/blood-2010-01-263335; Zon LI, 2008, NATURE, V453, P306, DOI 10.1038/nature07038	56	127	137	2	34	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 26	2013	155	1					215	227		10.1016/j.cell.2013.08.055	http://dx.doi.org/10.1016/j.cell.2013.08.055			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	224UX	24074870	Bronze			2022-12-24	WOS:000324916700021
J	Stuart-Smith, RD; Bates, AE; Lefcheck, JS; Duffy, JE; Baker, SC; Thomson, RJ; Stuart-Smith, JF; Hill, NA; Kininmonth, SJ; Airoldi, L; Becerro, MA; Campbell, SJ; Dawson, TP; Navarrete, SA; Soler, GA; Strain, EMA; Willis, TJ; Edgar, GJ				Stuart-Smith, Rick D.; Bates, Amanda E.; Lefcheck, Jonathan S.; Duffy, J. Emmett; Baker, Susan C.; Thomson, Russell J.; Stuart-Smith, Jemina F.; Hill, Nicole A.; Kininmonth, Stuart J.; Airoldi, Laura; Becerro, Mikel A.; Campbell, Stuart J.; Dawson, Terence P.; Navarrete, Sergio A.; Soler, German A.; Strain, Elisabeth M. A.; Willis, Trevor J.; Edgar, Graham J.			Integrating abundance and functional traits reveals new global hotspots of fish diversity	NATURE			English	Article							MARINE BIODIVERSITY; PATTERNS; BIOGEOGRAPHY; COMMUNITIES; CONSUMERS; EVENNESS; GRADIENT; ENTROPY; FORESTS	Species richness has dominated our view of global biodiversity patterns for centuries(1,2). The dominance of this paradigm is reflected in the focus by ecologists and conservation managers on richness and associated occurrence-based measures for understanding drivers of broad-scale diversity patterns and as a biological basis for management(3,4). However, this is changing rapidly, as it is now recognized that not only the number of species but the species present, their phenotypes and the number of individuals of each species are critical in determining the nature and strength of the relationships between species diversity and a range of ecological functions (such as biomass production and nutrient cycling)(5). Integrating these measures should provide a more relevant representation of global biodiversity patterns in terms of ecological functions than that provided by simple species counts. Here we provide comparisons of a traditional global biodiversity distribution measure based on richness with metrics that incorporate species abundances and functional traits. We use data from standardized quantitative surveys of 2,473 marine reef fish species at 1,844 sites, spanning 133 degrees of latitude from all ocean basins, to identify new diversity hotspots in some temperate regions and the tropical eastern Pacific Ocean. These relate to high diversity of functional traits amongst individuals in the community (calculated using Rao's Q(6)), and differ from previously reported patterns in functional diversity and richness for terrestrial animals, which emphasize species-rich tropical regions only(7,8). There is a global trend for greater evenness in the number of individuals of each species, across the reef fish species observed at sites ('community evenness'), at higher latitudes. This contributes to the distribution of functional diversity hotspots and contrasts with well-known latitudinal gradients in richness(2,4). Our findings suggest that the contribution of species diversity to a range of ecosystem functions varies over large scales, and imply that in tropical regions, which have higher numbers of species, each species contributes proportionally less to community-level ecological processes on average than species in temperate regions. Metrics of ecological function usefully complement metrics of species diversity in conservation management, including when identifying planning priorities and when tracking changes to biodiversity values.	[Stuart-Smith, Rick D.; Bates, Amanda E.; Thomson, Russell J.; Stuart-Smith, Jemina F.; Hill, Nicole A.; Soler, German A.; Edgar, Graham J.] Univ Tasmania, Inst Marine & Antarctic Studies, Hobart, Tas 7001, Australia; [Lefcheck, Jonathan S.; Duffy, J. Emmett] Virginia Inst Marine Sci, Dept Biol Sci, Gloucester Point, VA 23062 USA; [Baker, Susan C.] Univ Tasmania, Sch Plant Sci, Hobart, Tas 7001, Australia; [Kininmonth, Stuart J.] Stockholm Univ, Stockholm Resilience Ctr, SE-11419 Stockholm, Sweden; [Airoldi, Laura; Strain, Elisabeth M. A.] Univ Bologna, Dipartimento Sci Biol Geol & Ambientali, I-48123 Ravenna, Italy; [Airoldi, Laura] Stanford Univ, Hopkins Marine Stn, Pacific Grove, CA 93950 USA; [Becerro, Mikel A.] IPNA CSIC, Nat Prod & Agrobiol Inst, Tenerife 38206, Spain; [Campbell, Stuart J.] Wildlife Conservat Soc, Indonesia Marine Program, Bogor 16151, Jawa Barat, Indonesia; [Dawson, Terence P.] Univ Dundee, Sch Environm, Dundee DD1 4HN, Scotland; [Navarrete, Sergio A.] Pontificia Univ Catolica Chile, Estn Costera Invest Marinas, Santiago, Chile; [Navarrete, Sergio A.] Pontificia Univ Catolica Chile, Ctr Marine Conservat, Santiago, Chile; [Willis, Trevor J.] Univ Portsmouth, Inst Marine Sci, Sch Biol Sci, Portsmouth PO4 9LY, Hants, England	University of Tasmania; William & Mary; Virginia Institute of Marine Science; University of Tasmania; Stockholm University; University of Bologna; Stanford University; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Productos Naturales y Agrobiologia (IPNA); Wildlife Conservation Society - Indonesia; University of Dundee; Pontificia Universidad Catolica de Chile; Pontificia Universidad Catolica de Chile; University of Portsmouth	Stuart-Smith, RD (corresponding author), Univ Tasmania, Inst Marine & Antarctic Studies, Private Bag 49, Hobart, Tas 7001, Australia.	rstuarts@utas.edu.au	Thomson, Russell J/H-5653-2012; Willis, Trevor/F-5337-2012; Strain, Elisabeth/U-3520-2017; Baker, Susan C/F-9307-2011; Lefcheck, Jonathan/H-8768-2019; Hill, Nicole/AAI-7323-2021; Kininmonth, Stuart/N-9299-2013; Airoldi, Laura/I-3553-2019; Duffy, J. Emmett/ABF-9200-2020; Hill, Nicole A/J-7856-2014; Edgar, Graham/C-8341-2013; Dawson, Terence Peter/E-4724-2011; Bates, Amanda E./ABD-6874-2021; Stuart-Smith, Rick D/M-1829-2013; Becerro, Mikel/ABC-9478-2021; Baker, Susan/O-8482-2019; Stuart-Smith, Rick/I-5214-2019; Edgar, Graham/AAY-3797-2020	Thomson, Russell J/0000-0003-4949-4120; Willis, Trevor/0000-0002-0357-1189; Strain, Elisabeth/0000-0003-2165-9544; Baker, Susan C/0000-0002-7593-0267; Lefcheck, Jonathan/0000-0002-8787-1786; Hill, Nicole/0000-0001-9329-6717; Kininmonth, Stuart/0000-0001-9198-3396; Airoldi, Laura/0000-0001-5046-0871; Duffy, J. Emmett/0000-0001-8595-6391; Hill, Nicole A/0000-0001-9329-6717; Edgar, Graham/0000-0003-0833-9001; Dawson, Terence Peter/0000-0002-4314-1378; Bates, Amanda E./0000-0002-0198-4537; Stuart-Smith, Rick D/0000-0002-8874-0083; Becerro, Mikel/0000-0002-6047-350X; Baker, Susan/0000-0002-7593-0267; Stuart-Smith, Rick/0000-0002-8874-0083; Edgar, Graham/0000-0003-0833-9001; Campbell, Stuart/0000-0002-1158-3200	Australian Government's National Environmental Research Program; National Geographic Society; Conservation International; Wildlife Conservation Society Indonesia; Winston Churchill Memorial Trust; ASSEMBLE Marine	Australian Government's National Environmental Research Program(Australian Government); National Geographic Society(National Geographic Society); Conservation International; Wildlife Conservation Society Indonesia; Winston Churchill Memorial Trust; ASSEMBLE Marine	We thank the many Reef Life Survey (RLS) divers who participated in data collection and provide ongoing expertize and commitment to the program, University of Tasmania staff including T. Cooper, M. Davey, N. Barrett, J. Berkhout and E. Oh, and T. Bird for assistance running models and checking code. Development of the RLS data set was supported by the former Commonwealth Environment Research Facilities Program, and analyses were supported by the Australian Research Council, Institute for Marine and Antarctic Studies, and the Marine Biodiversity Hub, a collaborative partnership supported through the Australian Government's National Environmental Research Program. Additional funding and support for field surveys was provided by grants from the National Geographic Society, Conservation International, Wildlife Conservation Society Indonesia, The Winston Churchill Memorial Trust, and ASSEMBLE Marine.	Allen GR, 2008, AQUAT CONSERV, V18, P541, DOI 10.1002/aqc.880; Botta-Dukat Z, 2005, J VEG SCI, V16, P533, DOI 10.1111/j.1654-1103.2005.tb02393.x; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Cadotte MW, 2011, J APPL ECOL, V48, P1067, DOI 10.1111/j.1365-2664.2011.02056.x; Devictor V, 2010, ECOL LETT, V13, P1030, DOI 10.1111/j.1461-0248.2010.01493.x; Duffy JE, 2013, BIOSCIENCE, V63, P350, DOI 10.1525/bio.2013.63.5.8; Duffy JE, 2009, FRONT ECOL ENVIRON, V7, P437, DOI 10.1890/070195; Edgar GJ, 2004, J EXP MAR BIOL ECOL, V308, P269, DOI 10.1016/j.jembe.2004.03.004; Edgar GJ, 2004, J BIOGEOGR, V31, P1107, DOI 10.1111/j.1365-2699.2004.01055.x; Edgar GJ, 2009, ECOL APPL, V19, P1967, DOI 10.1890/09-0610.1; Edgar GJ, 2009, MAR ECOL PROG SER, V388, P51, DOI 10.3354/meps08149; Ellis N, 2012, ECOLOGY, V93, P156, DOI 10.1890/11-0252.1; Fonseca CR, 2001, J ECOL, V89, P118, DOI 10.1046/j.1365-2745.2001.00528.x; Gamfeldt L, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2328; Gaston KJ, 2000, NATURE, V405, P220, DOI 10.1038/35012228; Grime JP, 1998, J ECOL, V86, P902, DOI 10.1046/j.1365-2745.1998.00306.x; Hillebrand H, 2004, AM NAT, V163, P192, DOI 10.1086/381004; Jones JPG, 2011, CONSERV BIOL, V25, P450, DOI 10.1111/j.1523-1739.2010.01605.x; Jost L, 2006, OIKOS, V113, P363, DOI 10.1111/j.2006.0030-1299.14714.x; Karpievitch YV, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007087; Laliberte E., 2011, FD MEASURING FUNCTIO; Laliberte E, 2010, ECOLOGY, V91, P299, DOI 10.1890/08-2244.1; Luck GW, 2009, BIOSCIENCE, V59, P223, DOI 10.1525/bio.2009.59.3.7; Margules CR, 2000, NATURE, V405, P243, DOI 10.1038/35012251; Mora C, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000606; MORAN PAP, 1950, BIOMETRIKA, V37, P17, DOI 10.2307/2332142; Mouillot D, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001569; Mouillot D, 2013, TRENDS ECOL EVOL, V28, P167, DOI 10.1016/j.tree.2012.10.004; Pala C, 2013, SCIENCE, V339, P640, DOI 10.1126/science.339.6120.640; Roberts CM, 2002, SCIENCE, V295, P1280, DOI 10.1126/science.1067728; Rodrigues ASL, 2004, NATURE, V428, P640, DOI 10.1038/nature02422; Safi K, 2011, PHILOS T R SOC B, V366, P2536, DOI 10.1098/rstb.2011.0024; Silverman BW, 1986, DENSITY ESTIMATION S, DOI 10.1201/9781315140919; Spalding MD, 2007, BIOSCIENCE, V57, P573, DOI 10.1641/B570707; Stevens RD, 2003, ECOL LETT, V6, P1099, DOI 10.1046/j.1461-0248.2003.00541.x; Strobl C, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-307; Tittensor DP, 2010, NATURE, V466, P1098, DOI 10.1038/nature09329; Tuomisto H, 2012, OIKOS, V121, P1203, DOI 10.1111/j.1600-0706.2011.19897.x; Tyberghein L, 2012, GLOBAL ECOL BIOGEOGR, V21, P272, DOI 10.1111/j.1466-8238.2011.00656.x; Wiens JJ, 2004, TRENDS ECOL EVOL, V19, P639, DOI 10.1016/j.tree.2004.09.011; Wittebolle L, 2009, NATURE, V458, P623, DOI 10.1038/nature07840; Wood LJ, 2008, ORYX, V42, P340, DOI 10.1017/S003060530800046X	42	354	364	30	479	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 26	2013	501	7468					539	+		10.1038/nature12529	http://dx.doi.org/10.1038/nature12529			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	223RP	24067714	Green Submitted			2022-12-24	WOS:000324826300056
J	Chung, BC; Zhao, JS; Gillespie, RA; Kwon, DY; Guan, ZQ; Hong, JY; Zhou, P; Lee, SY				Chung, Ben C.; Zhao, Jinshi; Gillespie, Robert A.; Kwon, Do-Yeon; Guan, Ziqiang; Hong, Jiyong; Zhou, Pei; Lee, Seok-Yong			Crystal Structure of MraY, an Essential Membrane Enzyme for Bacterial Cell Wall Synthesis	SCIENCE			English	Article							LYSIS PROTEIN-E; PENTAPEPTIDE TRANSLOCASE; STEP; INHIBITORS; PHOSPHATE; DOMAIN	MraY (phospho-MurNAc-pentapeptide translocase) is an integral membrane enzyme that catalyzes an essential step of bacterial cell wall biosynthesis: the transfer of the peptidoglycan precursor phospho-MurNAc-pentapeptide to the lipid carrier undecaprenyl phosphate. MraY has long been considered a promising target for the development of antibiotics, but the lack of a structure has hindered mechanistic understanding of this critical enzyme and the enzyme superfamily in general. The superfamily includes enzymes involved in bacterial lipopolysaccharide/teichoic acid formation and eukaryotic N-linked glycosylation, modifications that are central in many biological processes. We present the crystal structure of MraY from Aquifex aeolicus (MraY(AA)) at 3.3 angstrom resolution, which allows us to visualize the overall architecture, locate Mg2+ within the active site, and provide a structural basis of catalysis for this class of enzyme.	[Chung, Ben C.; Zhao, Jinshi; Gillespie, Robert A.; Guan, Ziqiang; Zhou, Pei; Lee, Seok-Yong] Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA; [Kwon, Do-Yeon; Hong, Jiyong; Zhou, Pei] Duke Univ, Dept Chem, Durham, NC 27708 USA; [Hong, Jiyong] Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA	Duke University; Duke University; Duke University	Lee, SY (corresponding author), Duke Univ, Med Ctr, Dept Biochem, 2 Genome Ct, Durham, NC 27710 USA.	sylee@biochem.duke.edu	Guan, Ziqiang/AAE-5110-2019; Zhou, Pei/O-6704-2019	Zhou, Pei/0000-0002-7823-3416	Duke University Medical Center; Duke University; National Institutes of Health (NIH) [GM-51310, AI-55588, GM-069338]; NIH; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI055588] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM100984, R01GM051310, U54GM069338] Funding Source: NIH RePORTER	Duke University Medical Center; Duke University; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Data for this study were collected at beamlines NE-CAT ID 24-C and SER-CAT BM22/ID22 at the Advanced Photon Source. We thank C. Pemble and N. Nicely from the Duke x-ray crystallography facility for help with remote data collection; F. Murphy for help with data collection at ID 24-C; and Z. Johnson for critical reading of the manuscript. This work was supported by start-up funds from the Duke University Medical Center (S.-Y.L.), Duke University (J.H.), and the National Institutes of Health (NIH) (grants GM-51310 and AI-55588 to P. Z. and Lipid Maps glue grant GM-069338 to Z. G.). S.-Y.L. is a McKnight Scholar, Klingenstein fellow, Alfred P. Sloan Research fellow, Mallinckrodt Scholar, Whitehead Scholar, Basil O'Connor Starter Scholar, and NIH Director's New Innovator awardee. The authors declare no conflict of interest. The coordinates and structure factors are deposited in the Protein Data Bank (4J72). B. C. C. expressed, purified, and crystallized MraY<INF>AA</INF>. B. C. C. and S.-Y. L. collected the crystallographic data, solved the structure, and refined the model. B. C. C. performed the cross-linking studies and prepared all the protein for functional assays. J. Z. and R. A. G. performed the translocase assays (J. Z. performed all the mutational studies, and R. A. G. performed capuramycin and divalent metal experiments) under the guidance of P. Z. D.-Y.K. synthesized capuramycin under the guidance of J.H. Z.G. performed mass spectrometry characterization. B. C. C. and S.-Y.L. wrote the paper.	Al-Dabbagh B, 2008, BIOCHEMISTRY-US, V47, P8919, DOI 10.1021/bi8006274; Amer AO, 2001, MICROBIOL-SGM, V147, P3015, DOI 10.1099/00221287-147-11-3015; Anderson MS, 2000, FEMS MICROBIOL LETT, V191, P169, DOI 10.1111/j.1574-6968.2000.tb09335.x; Auberger N, 2011, ORG BIOMOL CHEM, V9, P8301, DOI 10.1039/c1ob06124k; Bouhss A, 2004, J BIOL CHEM, V279, P29974, DOI 10.1074/jbc.M314165200; Bouhss A, 1999, MOL MICROBIOL, V34, P576, DOI 10.1046/j.1365-2958.1999.01623.x; Bouhss A, 2008, FEMS MICROBIOL REV, V32, P208, DOI 10.1111/j.1574-6976.2007.00089.x; Boyle DS, 1998, J BACTERIOL, V180, P6429; Bugg TDH, 2011, TRENDS BIOTECHNOL, V29, P167, DOI 10.1016/j.tibtech.2010.12.006; Bugg Timothy D. H., 2006, Infectious Disorders - Drug Targets, V6, P85, DOI 10.2174/187152606784112128; Dini C, 2005, CURR TOP MED CHEM, V5, P1221, DOI 10.2174/156802605774463042; Koga T, 2004, J ANTIMICROB CHEMOTH, V54, P755, DOI 10.1093/jac/dkh417; LEHRMAN MA, 1994, GLYCOBIOLOGY, V4, P768, DOI 10.1093/glycob/4.6.768; Lloyd AJ, 2004, J BACTERIOL, V186, P1747, DOI 10.1128/JB.186.6.1747-1757.2004; Mendel S, 2006, MICROBIOL-SGM, V152, P2959, DOI 10.1099/mic.0.28776-0; Shapiro AB, 2012, J BIOMOL SCREEN, V17, P662, DOI 10.1177/1087057112436885; Tanaka S, 2012, MOL MICROBIOL, V85, P975, DOI 10.1111/j.1365-2958.2012.08153.x; White CL, 2010, MOL MICROBIOL, V76, P616, DOI 10.1111/j.1365-2958.2010.07108.x; Winn M, 2010, NAT PROD REP, V27, P279, DOI 10.1039/b816215h	19	135	138	1	66	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 30	2013	341	6149					1012	1016		10.1126/science.1236501	http://dx.doi.org/10.1126/science.1236501			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	208BZ	23990562	Green Accepted			2022-12-24	WOS:000323652300046
J	Rodriguez-Lado, L; Sun, GF; Berg, M; Zhang, Q; Xue, HB; Zheng, QM; Johnson, CA				Rodriguez-Lado, Luis; Sun, Guifan; Berg, Michael; Zhang, Qiang; Xue, Hanbin; Zheng, Quanmei; Johnson, C. Annette			Groundwater Arsenic Contamination Throughout China	SCIENCE			English	Article							DRINKING-WATER; DATONG BASIN; AQUIFERS; MOBILIZATION; HISTORY; PLAIN; COAL	Arsenic-contaminated groundwater used for drinking in China is a health threat that was first recognized in the 1960s. However, because of the sheer size of the country, millions of groundwater wells remain to be tested in order to determine the magnitude of the problem. We developed a statistical risk model that classifies safe and unsafe areas with respect to geogenic arsenic contamination in China, using the threshold of 10 micrograms per liter, the World Health Organization guideline and current Chinese standard for drinking water. We estimate that 19.6 million people are at risk of being affected by the consumption of arsenic-contaminated groundwater. Although the results must be confirmed with additional field measurements, our risk model identifies numerous arsenic-affected areas and highlights the potential magnitude of this health threat in China.	[Rodriguez-Lado, Luis; Berg, Michael; Xue, Hanbin; Johnson, C. Annette] Eawag, Swiss Fed Inst Aquat Sci & Technol, CH-8600 Dubendorf, Switzerland; [Sun, Guifan; Zhang, Qiang; Zheng, Quanmei] China Med Univ, Sch Publ Hlth, Dept Occupat & Environm Hlth, Shenyang 110001, Peoples R China	Swiss Federal Institutes of Technology Domain; Swiss Federal Institute of Aquatic Science & Technology (EAWAG); China Medical University	Johnson, CA (corresponding author), Eawag, Swiss Fed Inst Aquat Sci & Technol, CH-8600 Dubendorf, Switzerland.	annette.johnson@eawag.ch	Berg, Michael/C-3738-2012; Rodríguez-Lado, Luis/O-8563-2016	Berg, Michael/0000-0002-7342-4061; Rodríguez-Lado, Luis/0000-0002-0090-2405	Swiss State Secretariat for Education and Research [IZLCZ2 123971]; National Science and Technology Pillar Program of China [2006BAI06B04]; Chinese Academy of Sciences; Xunta de Galicia (Spain)	Swiss State Secretariat for Education and Research; National Science and Technology Pillar Program of China; Chinese Academy of Sciences(Chinese Academy of Sciences); Xunta de Galicia (Spain)(Xunta de Galicia)	Supported by the Sino-Swiss Science and Technology Cooperation Program of the Swiss State Secretariat for Education and Research (project IZLCZ2 123971), the National Science and Technology Pillar Program of China during the 11th Five-Year Plan Period (contract grant no. 2006BAI06B04), and the External Cooperation Program of the Chinese Academy of Sciences. We thank G.-B. Jiang and J. Shi of the Research Center for Eco-Environmental Sciences, Beijing, for support and data collection in the initial phase of the project. L.R.-L. also acknowledges the Isidro Parga Pondal research program from the Xunta de Galicia (Spain) for current financial support. Additional data are available at www.eawag.ch/repository/remarc.	Amini M, 2008, ENVIRON SCI TECHNOL, V42, P3669, DOI 10.1021/es702859e; Bian JM, 2012, J GEOCHEM EXPLOR, V112, P347, DOI 10.1016/j.gexplo.2011.10.003; Currell M, 2011, APPL GEOCHEM, V26, P540, DOI 10.1016/j.apgeochem.2011.01.012; Deng YM, 2009, APPL GEOCHEM, V24, P587, DOI 10.1016/j.apgeochem.2008.12.018; Dochartaigh B. E. O., 2006, GROUNDWATER DEGRADAT; Edmunds WM, 2006, APPL GEOCHEM, V21, P2148, DOI 10.1016/j.apgeochem.2006.07.016; Guo HM, 2005, J GEOCHEM EXPLOR, V87, P109, DOI 10.1016/j.gexplo.2005.08.002; Guo HM, 2010, CHEM GEOL, V270, P117, DOI 10.1016/j.chemgeo.2009.11.010; Guo JX, 2007, J ENVIRON SCI HEAL A, V42, P1853, DOI 10.1080/10934520701566918; Hagiwara H, 2011, APPL GEOCHEM, V26, P380, DOI 10.1016/j.apgeochem.2010.12.011; Han SB, 2010, GEOCHIM COSMOCHIM AC, V74, pA378; Jin Yinlong, 2003, Wei Sheng Yan Jiu, V32, P519; Lado LR, 2008, APPL GEOCHEM, V23, P3010, DOI 10.1016/j.apgeochem.2008.06.028; Lee JJ, 2009, ENVIRON SCI TECHNOL, V43, P6662, DOI 10.1021/es900540s; Li SH, 2012, SCI TOTAL ENVIRON, V421, P31, DOI 10.1016/j.scitotenv.2011.02.040; Liu J, 2002, ENVIRON HEALTH PERSP, V110, P119, DOI 10.1289/ehp.02110119; Mead MN, 2005, ENVIRON HEALTH PERSP, V113, pA378, DOI 10.1289/ehp.113-a378; Qiu J, 2011, SCIENCE, V334, P745, DOI 10.1126/science.334.6057.745; Smedley PL, 2003, APPL GEOCHEM, V18, P1453, DOI 10.1016/S0883-2927(03)00062-3; Smedley PL, 2002, APPL GEOCHEM, V17, P517, DOI 10.1016/S0883-2927(02)00018-5; Sun GF, 2004, TOXICOL APPL PHARM, V198, P268, DOI 10.1016/j.taap.2003.10.017; Sun GF, 2001, ARSENIC EXPOSURE AND HEALTH EFFECTS IV, P79; Sun GF, 2011, KAOHSIUNG J MED SCI, V27, P377, DOI 10.1016/j.kjms.2011.05.004; TSENG WP, 1968, J NATL CANCER I, V40, P453; Winkel L, 2008, NAT GEOSCI, V1, P536, DOI 10.1038/ngeo254; Winkel LHE, 2011, P NATL ACAD SCI USA, V108, P1246, DOI 10.1073/pnas.1011915108; Xia YJ, 2004, TOXICOLOGY, V198, P25, DOI 10.1016/j.tox.2004.01.016; Xie XJ, 2013, CHEMOSPHERE, V90, P1878, DOI 10.1016/j.chemosphere.2012.10.012; Yu GQ, 2007, ENVIRON HEALTH PERSP, V115, P636, DOI 10.1289/ehp.9268; Zhang LH, 2007, PROC MONOGR ENG WATE, P1299	30	600	677	131	1224	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 23	2013	341	6148					866	868		10.1126/science.1237484	http://dx.doi.org/10.1126/science.1237484			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204MY	23970694	Green Accepted			2022-12-24	WOS:000323370600036
J	Kwon, Y; Vinayagam, A; Sun, XY; Dephoure, N; Gygi, SP; Hong, PY; Perrimon, N				Kwon, Young; Vinayagam, Arunachalam; Sun, Xiaoyun; Dephoure, Noah; Gygi, Steven P.; Hong, Pengyu; Perrimon, Norbert			The Hippo Signaling Pathway Interactome	SCIENCE			English	Article							TUMOR-SUPPRESSOR PATHWAY; AFFINITY PURIFICATION; DROSOPHILA; COMPLEXES; GROWTH; CANCER	The Hippo pathway controls metazoan organ growth by regulating cell proliferation and apoptosis. Many components have been identified, but our knowledge of the composition and structure of this pathway is still incomplete. Using existing pathway components as baits, we generated by mass spectrometry a high-confidence Drosophila Hippo protein-protein interaction network (Hippo-PPIN) consisting of 153 proteins and 204 interactions. Depletion of 67% of the proteins by RNA interference regulated the transcriptional coactivator Yorkie (Yki) either positively or negatively. We selected for further characterization a new member of the alpha-arrestin family, Leash, and show that it promotes degradation of Yki through the lysosomal pathway. Given the importance of the Hippo pathway in tumor development, the Hippo-PPIN will contribute to our understanding of this network in both normal growth and cancer.	[Kwon, Young; Vinayagam, Arunachalam; Perrimon, Norbert] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Perrimon, Norbert] Harvard Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02115 USA; [Sun, Xiaoyun; Hong, Pengyu] Brandeis Univ, Dept Comp Sci, Volen Ctr Complex Syst, Waltham, MA 02454 USA; [Dephoure, Noah; Gygi, Steven P.] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Brandeis University; Harvard University; Harvard Medical School	Perrimon, N (corresponding author), Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA.	perrimon@receptor.med.harvard.edu	Hong, Pengyu/AAE-6736-2020; Kwon, Young/AHC-8026-2022; Dephoure, Noah/N-7818-2014	Dephoure, Noah/0000-0001-5802-2657; arunachalam, vinayagam/0000-0003-0091-4497; Hong, Pengyu/0000-0002-3177-2754; Kwon, Young/0000-0002-8937-3182; Perrimon, Norbert/0000-0001-7542-472X	Damon Runyon Cancer Research Foundation;  [R01-DK088718];  [P01-CA120964]; NATIONAL CANCER INSTITUTE [P01CA120964] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK088718] Funding Source: NIH RePORTER	Damon Runyon Cancer Research Foundation; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank the Transgenic RNAi Project, Drosophila RNAi Screening Center, and Bloomington Stock Center for fly stocks and reagents; C. Villata, E. Heffern, and R. Binari for technical support; L. Sansores-Garcia and G. Halder for help with the Yki-reporter assay; S. Blair and K. Irvine for reagents; and P. Karpowicz and R. Sopko for comments. Y.K. was supported by the Damon Runyon Cancer Research Foundation. This work was supported by R01-DK088718 and P01-CA120964 to N.P. N.P. is an Investigator of the Howard Hughes Medical Institute. AP/MS data are presented in the supplementary materials. RNAi screen data are available at Drosophila RNAi Screening Center.	Cho E, 2006, NAT GENET, V38, P1142, DOI 10.1038/ng1887; Choi H, 2011, NAT METHODS, V8, P70, DOI 10.1038/NMETH.1541; Draheim KM, 2010, ONCOGENE, V29, P5032, DOI 10.1038/onc.2010.250; Friedman AA, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002029; Halder G, 2012, NAT REV MOL CELL BIO, V13, P591, DOI 10.1038/nrm3416; Halder G, 2011, DEVELOPMENT, V138, P9, DOI 10.1242/dev.045500; Karpowicz P, 2010, DEVELOPMENT, V137, P4135, DOI 10.1242/dev.060483; Kyriakakis P, 2008, FLY, V2, P229, DOI 10.4161/fly.6669; Mao YL, 2011, GENE DEV, V25, P131, DOI 10.1101/gad.610511; Oh H, 2013, CELL REP, V3, P309, DOI 10.1016/j.celrep.2013.01.008; Pan DJ, 2010, DEV CELL, V19, P491, DOI 10.1016/j.devcel.2010.09.011; Ren FF, 2010, P NATL ACAD SCI USA, V107, P21064, DOI 10.1073/pnas.1012759107; Ribeiro PS, 2010, MOL CELL, V39, P521, DOI 10.1016/j.molcel.2010.08.002; Rock JM, 2013, SCIENCE, V340, P871, DOI 10.1126/science.1235822; Sansores-Garcia L, 2011, EMBO J, V30, P2325, DOI 10.1038/emboj.2011.157; Staley BK, 2012, DEV DYNAM, V241, P3, DOI 10.1002/dvdy.22723; Tofaris GK, 2011, P NATL ACAD SCI USA, V108, P17004, DOI 10.1073/pnas.1109356108; Vinayagam A, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003629; Wehr MC, 2013, NAT CELL BIOL, V15, P61, DOI 10.1038/ncb2658; Yu FX, 2013, GENE DEV, V27, P355, DOI 10.1101/gad.210773.112	20	123	125	2	55	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 8	2013	342	6159					737	740		10.1126/science.1243971	http://dx.doi.org/10.1126/science.1243971			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247UK	24114784	Green Accepted			2022-12-24	WOS:000326647600043
J	Busby, JN; Panjikar, S; Landsberg, MJ; Hurst, MRH; Lott, JS				Busby, Jason N.; Panjikar, Santosh; Landsberg, Michael J.; Hurst, Mark R. H.; Lott, J. Shaun			The BC component of ABC toxins is an RHS-repeat-containing protein encapsulation device	NATURE			English	Article							BIOLOGICAL MACROMOLECULES; SOLUTION SCATTERING; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; FAMILY; SYSTEM; ACQUISITION; TENEURINS; ELEMENTS; COMPLEX	The ABC toxin complexes produced by certain bacteria are of interest owing to their potent insecticidal activity(1,2) and potential role in human disease(3). These complexes comprise at least three proteins (A, B and C), which must assemble to be fully toxic(4). The carboxyterminal region of the C protein is the main cytotoxic component(5), and is poorly conserved between different toxin complexes. A general model of action has been proposed, in which the toxin complex binds to the cell surface via the A protein, is endocytosed, and subsequently forms a pH-triggered channel, allowing the translocation of C into the cytoplasm, where it can cause cytoskeletal disruption in both insect and mammalian cells(5). Toxin complexes have been visualized using single-particle electron microscopy(6,7), but no high-resolution structures of the components are available, and the role of the B protein in the mechanism of toxicity remains unknown. Here we report the three-dimensional structure of the complex formed between the B and C proteins, determined to 2.5 angstrom by X-ray crystallography. These proteins assemble to form an unprecedented, large hollow structure that encapsulates and sequesters the cytotoxic, C-terminal region of the C protein like the shell of an egg. The shell is decorated on one end by a beta-propeller domain, which mediates attachment of the B-C heterodimer to the A protein in the native complex. The structure reveals how C auto-proteolyses when folded in complex with B. The C protein is the first example, to our knowledge, of a structure that contains rearrangement hotspot (RHS) repeats(8), and illustrates a marked structural architecture that is probably conserved across both this widely distributed bacterial protein family and the related eukaryotic tyrosine-aspartate (YD)-repeat-containing protein family, which includes the teneurins(9). The structure provides the first clues about the function of these protein repeat families, and suggests a generic mechanism for protein encapsulation and delivery.	[Busby, Jason N.; Lott, J. Shaun] Univ Auckland, Sch Biol Sci, AgRes Struct Biol Lab, Auckland 1142, New Zealand; [Panjikar, Santosh] Australian Synchrotron, Clayton, Vic 3168, Australia; [Panjikar, Santosh] Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic 3800, Australia; [Landsberg, Michael J.] Univ Queensland, Inst Mol Biosci, St Lucia, Qld 4072, Australia; [Hurst, Mark R. H.] AgResearch, Lincoln Res Ctr, Innovat Farming Syst, Christchurch 8140, New Zealand	University of Auckland; Monash University; University of Queensland; AgResearch - New Zealand	Lott, JS (corresponding author), Univ Auckland, Sch Biol Sci, AgRes Struct Biol Lab, Auckland 1142, New Zealand.	mark.hurst@agresearch.co.nz; s.lott@auckland.ac.nz	Panjikar, Santosh/D-2709-2012; Hurst, Mark/J-7309-2013; Landsberg, Michael/A-3363-2011; Busby, Jason/D-9607-2013	Panjikar, Santosh/0000-0001-7429-3879; Landsberg, Michael/0000-0002-2464-990X; Busby, Jason/0000-0002-9805-9224; Lott, Shaun/0000-0003-3660-452X; Hurst, Mark/0000-0001-5826-5253	New Zealand Foundation for Research, Science and Technology [C10X0804]	New Zealand Foundation for Research, Science and Technology(New Zealand Foundation for Research, Science and Technology)	We are grateful to M. Sullivan, R. Kingston, T. Baker and many other members of the Structural Biology section at the University of Auckland for discussions, to V. Arcus for initial enthusiasm, and to B. Hankamer for provision of laboratory space at the University of Queensland and for mentorship. This work was supported by the New Zealand Foundation for Research, Science and Technology contract C10X0804, awarded to M. R. H. H. We would like to thank all beamline staff at the MX1, MX2 and SAXS/WAXS beamlines at the Australian Synchrotron for their support, and to the New Zealand Synchrotron Group Ltd for synchrotron access arrangements.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bowen D, 1998, SCIENCE, V280, P2129, DOI 10.1126/science.280.5372.2129; Buetow L, 2001, NAT STRUCT BIOL, V8, P584, DOI 10.1038/89610; Busby JN, 2012, J MOL BIOL, V415, P359, DOI 10.1016/j.jmb.2011.11.018; Chand D, 2013, MOL CELL NEUROSCI, V52, P38, DOI 10.1016/j.mcn.2012.09.006; Feng K, 2002, J BIOL CHEM, V277, P26128, DOI 10.1074/jbc.M203722200; ffrench-Constant RH, 2006, NAT BIOTECHNOL, V24, P660, DOI 10.1038/nbt0606-660; Franke D, 2009, J APPL CRYSTALLOGR, V42, P342, DOI 10.1107/S0021889809000338; Gatsogiannis C, 2013, NATURE, V495, P520, DOI 10.1038/nature11987; HILL CW, 1994, MOL MICROBIOL, V12, P865, DOI 10.1111/j.1365-2958.1994.tb01074.x; Hong WZ, 2012, NATURE, V484, P201, DOI 10.1038/nature10926; Hurst MRH, 2011, J BACTERIOL, V193, P1966, DOI 10.1128/JB.01044-10; Iyer LM, 2011, NUCLEIC ACIDS RES, V39, P9473, DOI 10.1093/nar/gkr691; Jackson AP, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-584; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Landsberg MJ, 2011, P NATL ACAD SCI USA, V108, P20544, DOI 10.1073/pnas.1111155108; Lang AE, 2010, SCIENCE, V327, P1139, DOI 10.1126/science.1184557; McPhillips TM, 2002, J SYNCHROTRON RADIAT, V9, P401, DOI 10.1107/S0909049502015170; Minet AD, 1999, J CELL SCI, V112, P2019; Mosca TJ, 2012, NATURE, V484, P237, DOI 10.1038/nature10923; Orthaber D, 2000, J APPL CRYSTALLOGR, V33, P218, DOI 10.1107/S0021889899015216; Panjikar S, 2005, ACTA CRYSTALLOGR D, V61, P449, DOI 10.1107/S0907444905001307; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pinheiro VB, 2007, CELL MICROBIOL, V9, P2372, DOI 10.1111/j.1462-5822.2007.00966.x; Scheres SHW, 2008, NAT PROTOC, V3, P977, DOI 10.1038/nprot.2008.62; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6; Tucker RP, 2006, DEV BIOL, V290, P237, DOI 10.1016/j.ydbio.2005.11.038; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Wang YD, 1998, J BACTERIOL, V180, P4102, DOI 10.1128/JB.180.16.4102-4110.1998; Waterfield N, 2005, CELL MICROBIOL, V7, P373, DOI 10.1111/j.1462-5822.2004.00467.x; Xu ZH, 1997, NATURE, V388, P741, DOI 10.1038/41944; Zhang DP, 2012, BIOL DIRECT, V7, DOI 10.1186/1745-6150-7-18	35	95	104	1	53	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 26	2013	501	7468					547	+		10.1038/nature12465	http://dx.doi.org/10.1038/nature12465			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	223RP	23913273				2022-12-24	WOS:000324826300058
J	Loupy, A; Lefaucheur, C; Vernerey, D; Prugger, C; van Huyen, JPD; Mooney, N; Suberbielle, C; Fremeaux-Bacchi, V; Mejean, A; Desgrandchamps, F; Anglicheau, D; Nochy, D; Charron, D; Empana, JP; Delahousse, M; Legendre, C; Glotz, D; Hill, GS; Zeevi, A; Jouven, X				Loupy, Alexandre; Lefaucheur, Carmen; Vernerey, Dewi; Prugger, Christof; van Huyen, Jean-Paul Duong; Mooney, Nuala; Suberbielle, Caroline; Fremeaux-Bacchi, Veronique; Mejean, Arnaud; Desgrandchamps, Francois; Anglicheau, Dany; Nochy, Dominique; Charron, Dominique; Empana, Jean-Philippe; Delahousse, Michel; Legendre, Christophe; Glotz, Denis; Hill, Gary S.; Zeevi, Adriana; Jouven, Xavier			Complement-Binding Anti-HLA Antibodies and Kidney-Allograft Survival	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							HUMAN-LEUKOCYTE ANTIGEN; MEDIATED REJECTION; C1Q ASSAY; CLASSIFICATION; DEPOSITION; DIAGNOSIS; FAILURE; MARKER	BackgroundAnti-HLA antibodies hamper successful transplantation, and activation of the complement cascade is involved in antibody-mediated rejection. We investigated whether the complement-binding capacity of anti-HLA antibodies plays a role in kidney-allograft failure. MethodsWe enrolled patients who received kidney allografts at two transplantation centers in Paris between January 1, 2005, and January 1, 2011, in a population-based study. Patients were screened for the presence of circulating donor-specific anti-HLA antibodies and their complement-binding capacity. Graft injury phenotype and the time to kidney-allograft loss were assessed. ResultsThe primary analysis included 1016 patients. Patients with complement-binding donor-specific anti-HLA antibodies after transplantation had the lowest 5-year rate of graft survival (54%), as compared with patients with non-complement-binding donor-specific anti-HLA antibodies (93%) and patients without donor-specific anti-HLA antibodies (94%) (P<0.001 for both comparisons). The presence of complement-binding donor-specific anti-HLA antibodies after transplantation was associated with a risk of graft loss that was more than quadrupled (hazard ratio, 4.78; 95% confidence interval [CI], 2.69 to 8.49) when adjusted for clinical, functional, histologic, and immunologic factors. These antibodies were also associated with an increased rate of antibody-mediated rejection, a more severe graft injury phenotype with more extensive microvascular inflammation, and increased deposition of complement fraction C4d within graft capillaries. Adding complement-binding donor-specific anti-HLA antibodies to a traditional risk model improved the stratification of patients at risk for graft failure (continuous net reclassification improvement, 0.75; 95% CI, 0.54 to 0.97). ConclusionsAssessment of the complement-binding capacity of donor-specific anti-HLA antibodies appears to be useful in identifying patients at high risk for kidney-allograft loss. This study showed that assessment of the complement-binding capacity of donor-specific anti-HLA antibodies may help identify patients at high risk for kidney-allograft loss and may improve risk stratification to guide treatment. Despite considerable advances in transplantation, the induced alloimmune response remains a major determinant of late kidney-allograft loss.(1)-(3) In the United States and Europe, thousands of kidney transplants fail each year, and kidney-allograft failure is a major cause of end-stage renal disease, leading to increased morbidity, mortality, and costs.(4),(5) One of the most important advances in transplantation medicine has been the recognition that anti-HLA antibodies are destructive.(6)-(10) Various studies over the past decade have indicated that the alloimmune response, mediated by anti-HLA antibodies, plays a key role in the failure of kidney allografts; this concept has been extended ...	[Loupy, Alexandre; Lefaucheur, Carmen; van Huyen, Jean-Paul Duong; Fremeaux-Bacchi, Veronique; Delahousse, Michel; Legendre, Christophe; Glotz, Denis; Jouven, Xavier] Paris Translat Res Ctr Organ Transplantat, Paris, France; [Loupy, Alexandre; Lefaucheur, Carmen; Vernerey, Dewi; Prugger, Christof; van Huyen, Jean-Paul Duong; Empana, Jean-Philippe; Jouven, Xavier] INSERM, U970, Paris, France; [Loupy, Alexandre; Anglicheau, Dany; Legendre, Christophe] Univ Paris 05, Hop Necker, Dept Kidney Transplantat, Paris, France; [Loupy, Alexandre; Anglicheau, Dany; Legendre, Christophe] AP HP, Paris, France; [Lefaucheur, Carmen; Glotz, Denis] Paris Diderot Univ, Hop St Louis, AP HP, Dept Nephrol & Kidney Transplantat, Paris, France; [Suberbielle, Caroline; Charron, Dominique] Paris Diderot Univ, Hop St Louis, AP HP, Dept Immunol & Histocompatibil, Paris, France; [Desgrandchamps, Francois] Paris Diderot Univ, Hop St Louis, AP HP, Dept Urol, Paris, France; [van Huyen, Jean-Paul Duong; Nochy, Dominique; Hill, Gary S.] Georges Pompidou European Hosp, Dept Pathol, Paris, France; [Fremeaux-Bacchi, Veronique] Georges Pompidou European Hosp, Dept Immunol, Paris, France; [Mejean, Arnaud] Georges Pompidou European Hosp, Dept Urol, Paris, France; [Mooney, Nuala; Glotz, Denis] INSERM, U940, Paris, France; [Delahousse, Michel] Foch Hosp, Dept Nephrol & Kidney Transplantat, Suresnes, France; [Zeevi, Adriana] Univ Pittsburgh, Med Ctr, Dept Transplantat Pathol, Pittsburgh, PA USA	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); Hospital Foch; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Loupy, A (corresponding author), Paris Translat Res Ctr Organ Transplantat, Paris, France.	alexandreloupy@gmail.com	lefaucheur, carmen/AAS-7494-2020; Empana, Jean-Philippe/AAF-6923-2021; Loupy, Alexandre/K-8512-2019	Empana, Jean-Philippe/0000-0002-1469-7772; Glotz, Denis/0000-0001-5258-4237; Mooney, Nuala/0000-0002-3516-6882; Prugger, Christof/0000-0003-1845-0950				[Anonymous], 2012, AM J TRANSPLANT, V12, P1, DOI 10.1111/j.1600-6143.2011.03886.x; Bohmig GA, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V1341091; Chen G, 2011, HUM IMMUNOL, V72, P849, DOI 10.1016/j.humimm.2011.07.001; Chin C, 2011, J HEART LUNG TRANSPL, V30, P158, DOI 10.1016/j.healun.2010.08.020; Collins AB, 1999, J AM SOC NEPHROL, V10, P2208; Colvin RB, 2005, NAT REV IMMUNOL, V5, P807, DOI 10.1038/nri1702; Colvin RB, 2007, J AM SOC NEPHROL, V18, P1046, DOI 10.1681/ASN.2007010073; Eknoyan G, 2002, AM J KIDNEY DIS, V39, pS14, DOI 10.1053/ajkd.2002.30939; FEUCHT HE, 1991, CLIN EXP IMMUNOL, V86, P464; Freitas MCS, 2013, TRANSPLANTATION, V95, P1113, DOI 10.1097/TP.0b013e3182888db6; Gaston RS, 2010, TRANSPLANTATION, V90, P68, DOI 10.1097/TP.0b013e3181e065de; Hourmant M, 2005, J AM SOC NEPHROL, V16, P2804, DOI 10.1681/ASN.2004121130; Lachmann N, 2013, TRANSPLANTATION, V95, P694, DOI 10.1097/TP.0b013e31827b3dc3; Lachmann N, 2009, TRANSPLANTATION, V87, P1505, DOI 10.1097/TP.0b013e3181a44206; Lamb KE, 2011, AM J TRANSPLANT, V11, P450, DOI 10.1111/j.1600-6143.2010.03283.x; Lefaucheur C, 2009, AM J TRANSPLANT, V9, P1099, DOI 10.1111/j.1600-6143.2009.02591.x; Lefaucheur C, 2010, J AM SOC NEPHROL, V21, P1398, DOI 10.1681/ASN.2009101065; Loupy A, 2011, AM J TRANSPLANT, V11, P56, DOI 10.1111/j.1600-6143.2010.03364.x; Loupy A, 2010, TRANSPLANTATION, V89, P1403, DOI 10.1097/TP.0b013e3181da1cc3; Nankivell BJ, 2011, LANCET, V378, P1428, DOI 10.1016/S0140-6736(11)60699-5; Nankivell BJ, 2010, NEW ENGL J MED, V363, P1451, DOI 10.1056/NEJMra0902927; Otten HG, 2012, AM J TRANSPLANT, V12, P1618, DOI 10.1111/j.1600-6143.2011.03985.x; PATEL R, 1969, NEW ENGL J MED, V280, P735, DOI 10.1056/NEJM196904032801401; Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929; Pencina MJ, 2004, STAT MED, V23, P2109, DOI 10.1002/sim.1802; Racusen LC, 2003, AM J TRANSPLANT, V3, P708, DOI 10.1034/j.1600-6143.2003.00072.x; Racusen LC, 2006, CLIN J AM SOC NEPHRO, V1, P415, DOI 10.2215/CJN.01881105; Sellares J, 2012, AM J TRANSPLANT, V12, P388, DOI 10.1111/j.1600-6143.2011.03840.x; Sis B, 2009, AM J TRANSPLANT, V9, P2312, DOI 10.1111/j.1600-6143.2009.02761.x; Solez K, 2008, AM J TRANSPLANT, V8, P753, DOI 10.1111/j.1600-6143.2008.02159.x; Stegall MD, 2011, AM J TRANSPLANT, V11, P2405, DOI 10.1111/j.1600-6143.2011.03757.x; Sutherland SM, 2012, PEDIATR TRANSPLANT, V16, P12, DOI 10.1111/j.1399-3046.2011.01599.x; Terasaki PI, 2004, AM J TRANSPLANT, V4, P438, DOI 10.1111/j.1600-6143.2004.00360.x; Yabu JM, 2011, TRANSPLANTATION, V91, P342, DOI 10.1097/TP.0b013e318203fd26; Zeevi A, 2012, HUM IMMUNOL, V73, P48, DOI 10.1016/j.humimm.2011.10.011	35	604	622	0	36	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 26	2013	369	13					1215	1226		10.1056/NEJMoa1302506	http://dx.doi.org/10.1056/NEJMoa1302506			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	224LT	24066742				2022-12-24	WOS:000324888200008
J	McCann, KL; Baserga, SJ				McCann, Kathleen L.; Baserga, Susan J.			Mysterious Ribosomopathies	SCIENCE			English	Editorial Material							TRANSLATION; P53		[McCann, Kathleen L.; Baserga, Susan J.] Yale Univ, Sch Med, Dept Genet, New Haven, CT 06520 USA; [Baserga, Susan J.] Yale Univ, Sch Med, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA; [Baserga, Susan J.] Yale Univ, Sch Med, Dept Therapeut Radiol, New Haven, CT 06520 USA	Yale University; Yale University; Yale University	McCann, KL (corresponding author), Yale Univ, Sch Med, Dept Genet, 333 Cedar St, New Haven, CT 06520 USA.	susan.baserga@yale.edu		McCann, Kathleen/0000-0002-7144-4851	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R29GM052581, R01GM052581] Funding Source: NIH RePORTER; NIGMS NIH HHS [R29 GM052581, GM 52581, R01 GM052581] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bolze A, 2013, SCIENCE, V340, P976, DOI 10.1126/science.1234864; Boultwood Jacqueline, 2012, Adv Biol Regul, V52, P196; Burwick N, 2011, SEMIN HEMATOL, V48, P136, DOI 10.1053/j.seminhematol.2011.01.002; Freed EF, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002892; Freed EF, 2010, MOL BIOSYST, V6, P481, DOI 10.1039/b919670f; Horos R, 2012, BLOOD, V119, P262, DOI 10.1182/blood-2011-06-358200; Jones NC, 2008, NAT MED, V14, P125, DOI 10.1038/nm1725; Kondrashov N, 2011, CELL, V145, P383, DOI 10.1016/j.cell.2011.03.028; Lee ASY, 2013, P NATL ACAD SCI USA, V110, P324, DOI 10.1073/pnas.1216454109; McGowan KA, 2008, NAT GENET, V40, P963, DOI 10.1038/ng.188; Provost E, 2012, DEVELOPMENT, V139, P3232, DOI 10.1242/dev.077107; Raiser D. M., 2013, LEUKEMIA LYMPHOMA, V1; Rubbi CP, 2003, EMBO J, V22, P6068, DOI 10.1093/emboj/cdg579	13	84	85	1	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 23	2013	341	6148					849	850		10.1126/science.1244156	http://dx.doi.org/10.1126/science.1244156			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204MY	23970686	Green Accepted			2022-12-24	WOS:000323370600026
J	Tellez, LA; Medina, S; Han, WF; Ferreira, JG; Licona-Limon, P; Ren, XY; Lam, TT; Schwartz, GJ; de Araujo, IE				Tellez, Luis A.; Medina, Sara; Han, Wenfei; Ferreira, Jozelia G.; Licona-Limon, Paula; Ren, Xueying; Lam, TuKiet T.; Schwartz, Gary J.; de Araujo, Ivan E.			A Gut Lipid Messenger Links Excess Dietary Fat to Dopamine Deficiency	SCIENCE			English	Article							BRAIN DOPAMINE; DRUG-ADDICTION; FOOD REWARD; OBESITY; MECHANISMS; RAT; ANANDAMIDE; RELEASE; SEEKING; ABSENCE	Excessive intake of dietary fats leads to diminished brain dopaminergic function. It has been proposed that dopamine deficiency exacerbates obesity by provoking compensatory overfeeding as one way to restore reward sensitivity. However, the physiological mechanisms linking prolonged high-fat intake to dopamine deficiency remain elusive. We show that administering oleoylethanolamine, a gastrointestinal lipid messenger whose synthesis is suppressed after prolonged high-fat exposure, is sufficient to restore gut-stimulated dopamine release in high-fat-fed mice. Administering oleoylethanolamine to high-fat-fed mice also eliminated motivation deficits during flavorless intragastric feeding and increased oral intake of low-fat emulsions. Our findings suggest that high-fat-induced gastrointestinal dysfunctions play a key role in dopamine deficiency and that restoring gut-generated lipid signaling may increase the reward value of less palatable, yet healthier, foods.	[Tellez, Luis A.; Medina, Sara; Han, Wenfei; Ferreira, Jozelia G.; Ren, Xueying; de Araujo, Ivan E.] John B Pierce Lab, New Haven, CT 06519 USA; [Tellez, Luis A.; Han, Wenfei; Ferreira, Jozelia G.; Ren, Xueying; de Araujo, Ivan E.] Yale Univ, Sch Med, Dept Psychiat, New Haven, CT 06511 USA; [Han, Wenfei] Tongji Univ, Sch Stomatol, Shanghai 200072, Peoples R China; [Licona-Limon, Paula] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06520 USA; [Lam, TuKiet T.] Yale Univ, WM Keck Fdn Biotechnol Resource Lab, New Haven, CT 06511 USA; [Schwartz, Gary J.] Yeshiva Univ, Albert Einstein Coll Med, Bronx, NY 10461 USA	Yale University; The John B Pierce Laboratory, Inc; Yale University; Tongji University; Yale University; Yale University; Yeshiva University; Albert Einstein College of Medicine	de Araujo, IE (corresponding author), John B Pierce Lab, New Haven, CT 06519 USA.	iaraujo@jbpierce.org	Ren, Xueying/AAA-9464-2020; Ferreira, Jozelia/C-5724-2015; Ren, Xueying/ABF-8967-2021	Ferreira, Jozelia/0000-0003-0097-3104; Ren, Xueying/0000-0002-6503-0425; Tellez, Luis A/0000-0002-3101-5817; De Araujo, Ivan/0000-0003-3081-3339	Yale Clinical and Translational Science Award [UL1RR024139]; NIH [DC009997, DK085579, DK020541, DK026687]; Ajinomoto USA; Instituto de Ciencia y Tecnologia del Distrito Federal (Mexico) [BI10-164]; China Scholarship Council (CSC) [201206260072]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024139] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK026687, P60DK020541, R01DK085579, P30DK020541] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC009997] Funding Source: NIH RePORTER	Yale Clinical and Translational Science Award; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ajinomoto USA; Instituto de Ciencia y Tecnologia del Distrito Federal (Mexico); China Scholarship Council (CSC)(China Scholarship Council); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We thank M. Freire, M. LoPresti, and T. Abbott for surgical procedures, gut sample preparation, and MS data analysis respectively; Yale Clinical and Translational Science Award (UL1RR024139) for the 4000 QTRAP (AB Sciex) liquid chromatography (LC)-tandem mass spectrometry; and PerkinElmer for the Flexar ultra-high performance LC. I.E.d.A. is funded by NIH grants DC009997 and DK085579 and Ajinomoto USA. G.J.S. is funded by NIH grants DK020541 and DK026687. L. A. T. was supported by Instituto de Ciencia y Tecnologia del Distrito Federal (Mexico) BI10-164. W. H. was supported by China Scholarship Council (CSC) 201206260072.	Artmann A, 2008, BBA-MOL CELL BIOL L, V1781, P200, DOI 10.1016/j.bbalip.2008.01.006; Berridge KC, 1996, NEUROSCI BIOBEHAV R, V20, P1, DOI 10.1016/0149-7634(95)00033-B; Berthoud HR, 2012, P NUTR SOC, V71, P478, DOI 10.1017/S0029665112000602; Davis JF, 2008, BEHAV NEUROSCI, V122, P1257, DOI 10.1037/a0013111; de Araujo IE, 2012, PHYSIOL BEHAV, V106, P394, DOI 10.1016/j.physbeh.2012.02.026; de Fonseca FR, 2001, NATURE, V414, P209, DOI 10.1038/35102582; Di Marzo V, 2004, BIOORGAN MED CHEM, V12, P5161, DOI 10.1016/j.bmc.2004.07.026; Diep TA, 2011, FASEB J, V25, P765, DOI 10.1096/fj.10-166595; Everitt BJ, 2008, PHILOS T R SOC B, V363, P3125, DOI 10.1098/rstb.2008.0089; Ferreira JG, 2012, J PHYSIOL-LONDON, V590, P953, DOI 10.1113/jphysiol.2011.218289; Fu J, 2003, NATURE, V425, P90, DOI 10.1038/nature01921; Hajnal A, 2004, AM J PHYSIOL-REG I, V286, pR31, DOI 10.1152/ajpregu.00282.2003; Hansen HS, 2009, BIOCHEM PHARMACOL, V78, P553, DOI 10.1016/j.bcp.2009.04.024; Johnson PM, 2010, NAT NEUROSCI, V13, P635, DOI 10.1038/nn.2519; Kenny PJ, 2011, NAT REV NEUROSCI, V12, P638, DOI 10.1038/nrn3105; McCutcheon JE, 2012, SYNAPSE, V66, P346, DOI 10.1002/syn.21519; Murray JE, 2012, NEUROPSYCHOPHARMACOL, V37, P2456, DOI 10.1038/npp.2012.104; Proulx K, 2005, AM J PHYSIOL-REG I, V289, pR729, DOI 10.1152/ajpregu.00029.2005; REED DR, 1990, APPETITE, V14, P219, DOI 10.1016/0195-6663(90)90089-Q; Ren XY, 2010, J NEUROSCI, V30, P8012, DOI 10.1523/JNEUROSCI.5749-09.2010; Schwartz GJ, 2008, CELL METAB, V8, P281, DOI 10.1016/j.cmet.2008.08.005; Small DM, 2003, NEUROIMAGE, V19, P1709, DOI 10.1016/S1053-8119(03)00253-2; Sotak BN, 2005, BRAIN RES, V1061, P88, DOI 10.1016/j.brainres.2005.08.053; Stice E, 2008, SCIENCE, V322, P449, DOI 10.1126/science.1161550; Volkow ND, 2011, TRENDS COGN SCI, V15, P37, DOI 10.1016/j.tics.2010.11.001; Wang GJ, 2004, J ADDICT DIS, V23, P39, DOI 10.1300/J069v23n03_04; Wang GJ, 2001, LANCET, V357, P354, DOI 10.1016/S0140-6736(00)03643-6; Wise RA, 2006, PHILOS T R SOC B, V361, P1149, DOI 10.1098/rstb.2006.1854; Zheng H, 2009, INT J OBESITY, V33, pS8, DOI 10.1038/ijo.2009.65	29	189	192	3	72	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 16	2013	341	6147					800	802		10.1126/science.1239275	http://dx.doi.org/10.1126/science.1239275			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201DZ	23950538				2022-12-24	WOS:000323122200052
J	Muchnik, L; Aral, S; Taylor, SJ				Muchnik, Lev; Aral, Sinan; Taylor, Sean J.			Social Influence Bias: A Randomized Experiment	SCIENCE			English	Article							WORD-OF-MOUTH; NETWORKS; CONTAGION; EMERGENCE; REVIEWS	Our society is increasingly relying on the digitized, aggregated opinions of others to make decisions. We therefore designed and analyzed a large-scale randomized experiment on a social news aggregation Web site to investigate whether knowledge of such aggregates distorts decision-making. Prior ratings created significant bias in individual rating behavior, and positive and negative social influences created asymmetric herding effects. Whereas negative social influence inspired users to correct manipulated ratings, positive social influence increased the likelihood of positive ratings by 32% and created accumulating positive herding that increased final ratings by 25% on average. This positive herding was topic-dependent and affected by whether individuals were viewing the opinions of friends or enemies. A mixture of changing opinion and greater turnout under both manipulations together with a natural tendency to up-vote on the site combined to create the herding effects. Such findings will help interpret collective judgment accurately and avoid social influence bias in collective intelligence in the future.	[Muchnik, Lev] Hebrew Univ Jerusalem, Sch Business Adm, IL-91905 Jerusalem, Israel; [Aral, Sinan] MIT, Alfred P Sloan Sch Management, Cambridge, MA 02142 USA; [Taylor, Sean J.] NYU, Stern Sch Business, New York, NY 10012 USA	Hebrew University of Jerusalem; Massachusetts Institute of Technology (MIT); New York University	Aral, S (corresponding author), MIT, Alfred P Sloan Sch Management, 100 Main St, Cambridge, MA 02142 USA.	sinana@mit.edu		Aral, Sinan/0000-0002-2762-058X; Muchnik, Lev/0000-0002-5011-8336	Microsoft Research faculty fellowship; NSF Career Award [0953832]	Microsoft Research faculty fellowship(Microsoft); NSF Career Award(National Science Foundation (NSF)NSF - Office of the Director (OD))	We thank D. Eckles and D. Watts for invaluable discussions. This work was supported by a Microsoft Research faculty fellowship (S. A.) and by NSF Career Award 0953832 (S. A.). The research was approved by the New York University institutional review board. There are legal obstacles to making the data available and revealing the name of the Web site, but code is available upon request. All of the user data that we analyzed is publically available, except the treatment assignment and the random identifier that links a deidentified user to a vote, and therefore does not contain any other information that cannot be obtained by crawling the Web site. The randomized testing that the Web site performed is covered by the Web site's terms of service. Opt-in permissions were granted by the users when they registered for the Web site. No data on nonregistered users was collected.	Apicella CL, 2012, NATURE, V481, P497, DOI 10.1038/nature10736; Aral S, 2012, SCIENCE, V337, P337, DOI 10.1126/science.1215842; Aral S, 2011, IEEE INTELL SYST, V26, P91, DOI 10.1109/MIS.2011.89; Aral S, 2011, MANAGE SCI, V57, P1623, DOI 10.1287/mnsc.1110.1421; Aral S, 2011, MARKET SCI, V30, P217, DOI 10.1287/mksc.1100.0596; Aral S, 2009, P NATL ACAD SCI USA, V106, P21544, DOI 10.1073/pnas.0908800106; Archak N, 2011, MANAGE SCI, V57, P1485, DOI 10.1287/mnsc.1110.1370; Bakshy E, 2009, 10TH ACM CONFERENCE ON ELECTRONIC COMMERCE - EC 2009, P325; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; BIKHCHANDANI S, 1992, J POLIT ECON, V100, P992, DOI 10.1086/261849; Cabral L., 2004, W10363 NAT BUR EC RE; Centola D, 2005, AM J SOCIOL, V110, P1009, DOI 10.1086/427321; Chevalier JA, 2006, J MARKETING RES, V43, P345, DOI 10.1509/jmkr.43.3.345; Danescu-Niculescu-Mizil C., 2009, WWW, P141, DOI [10.1145/1526709.1526729, DOI 10.1145/1526709.1526729]; Dellarocas C, 2003, MANAGE SCI, V49, P1407, DOI 10.1287/mnsc.49.10.1407.17308; Hidalgo CA, 2006, NEW J PHYS, V8, DOI 10.1088/1367-2630/8/4/052; Hirshleifer D., 1995, NEW EC HUMAN BEHAV, P188; Janis I. L., 1982, GROUPTHINK PSYCHOL S; Leskovec J, 2006, LECT NOTES ARTIF INT, V3918, P380; Lorenz J, 2011, P NATL ACAD SCI USA, V108, P9020, DOI 10.1073/pnas.1008636108; MANSKI CF, 1993, REV ECON STUD, V60, P531, DOI 10.2307/2298123; Merton R. K., 1957, SOCIAL THEORY SOCIAL; Onnela JP, 2010, P NATL ACAD SCI USA, V107, P18375, DOI 10.1073/pnas.0914572107; Pope DG, 2009, J HEALTH ECON, V28, P1154, DOI 10.1016/j.jhealeco.2009.08.006; Salganik MJ, 2006, SCIENCE, V311, P854, DOI 10.1126/science.1121066; Shalizi CR, 2011, SOCIOL METHOD RES, V40, P211, DOI 10.1177/0049124111404820; SIMON HA, 1955, BIOMETRIKA, V42, P425; Woolley AW, 2010, SCIENCE, V330, P686, DOI 10.1126/science.1193147; Wu F, 2008, LECT NOTES COMPUT SC, V5385, P334	29	424	438	21	287	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 9	2013	341	6146					647	651		10.1126/science.1240466	http://dx.doi.org/10.1126/science.1240466			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	197XC	23929980				2022-12-24	WOS:000322884800036
J	Lee, MT; Bonneau, AR; Takacs, CM; Bazzini, AA; DiVito, KR; Fleming, ES; Giraldez, AJ				Lee, Miler T.; Bonneau, Ashley R.; Takacs, Carter M.; Bazzini, Ariel A.; DiVito, Kate R.; Fleming, Elizabeth S.; Giraldez, Antonio J.			Nanog, Pou5f1 and SoxB1 activate zygotic gene expression during the maternal-to-zygotic transition	NATURE			English	Article							ENDODERM FORMATION; HUMAN FIBROBLASTS; PLURIPOTENCY; GENOME; OCT4; NETWORK; IDENTIFICATION; TRANSLATION; DYNAMICS; PROTEIN	After fertilization, maternal factors direct development and trigger zygotic genome activation (ZGA) at the maternal-to-zygotic transition (MZT). In zebrafish, ZGA is required for gastrulation and clearance of maternal messenger RNAs, which is in part regulated by the conserved microRNA miR-430. However, the factors that activate the zygotic program in vertebrates are unknown. Here we show that Nanog, Pou5f1 (also called Oct4) and SoxB1 regulate zygotic gene activation in zebrafish. We identified several hundred genes directly activated by maternal factors, constituting the first wave of zygotic transcription. Ribosome profiling revealed that nanog, sox19b and pou5f1 are the most highly translated transcription factors pre-MZT. Combined loss of these factors resulted in developmental arrest before gastrulation and a failure to activate >75% of zygotic genes, including miR-430. Our results demonstrate that maternal Nanog, Pou5f1 and SoxB1 are required to initiate the zygotic developmental program and induce clearance of the maternal program by activating miR-430 expression.	[Lee, Miler T.; Bonneau, Ashley R.; Takacs, Carter M.; Bazzini, Ariel A.; DiVito, Kate R.; Fleming, Elizabeth S.; Giraldez, Antonio J.] Yale Univ, Sch Med, Dept Genet, New Haven, CT 06510 USA; [Giraldez, Antonio J.] Yale Univ, Sch Med, Yale Stem Cell Ctr, New Haven, CT 06520 USA	Yale University; Yale University	Giraldez, AJ (corresponding author), Yale Univ, Sch Med, Dept Genet, New Haven, CT 06510 USA.	antonio.giraldez@yale.edu		Giraldez, Antonio/0000-0002-6823-137X	NIH [F32HD071697-02, T32GM007499, F32HD061194-03]; Pew Fellows Program in Biomedical Sciences; Pew Scholars Program in the Biomedical Sciences; Yale Scholars Program;  [R01GM081602-06];  [R01GM103789-01];  [R01HD074078-02]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [F32HD071697, R01HD074078, F32HD061194] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081602, R01GM103789, T32GM007499] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pew Fellows Program in Biomedical Sciences; Pew Scholars Program in the Biomedical Sciences; Yale Scholars Program; ; ; ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Y. Kamachi, W. Driever, A. F. Schier, N. Ivanova and I.-H. Park for reagents and fish lines; S. Mane and J. Overton for outstanding sequencing support; E. Zdobnov for hosting genomics data; A. Hubaud, N. Darricarrere and M. Koziol for contribution in the early stages of this project; and all the members of the Giraldez laboratory for discussions. This work was supported by NIH grants F32HD071697-02 (M.T.L.), T32GM007499 (A.R.B), F32HD061194-03 (C.M.T.), Pew Fellows Program in Biomedical Sciences (A.A.B), R01GM081602-06, R01GM103789-01, R01HD074078-02, the Pew Scholars Program in the Biomedical Sciences and the Yale Scholars Program (A.J.G.).	Aanes H, 2011, GENOME RES, V21, P1328, DOI 10.1101/gr.116012.110; Amsterdam A, 2004, P NATL ACAD SCI USA, V101, P12792, DOI 10.1073/pnas.0403929101; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Andersen IS, 2013, CURR TOP DEV BIOL, V104, P85, DOI 10.1016/B978-0-12-416027-9.00003-6; Bazzini AA, 2012, SCIENCE, V336, P233, DOI 10.1126/science.1215704; Belting HG, 2011, DEV BIOL, V356, P323, DOI 10.1016/j.ydbio.2011.05.660; Berg MG, 2012, CELL, V150, P53, DOI 10.1016/j.cell.2012.05.029; Chambers I, 2007, NATURE, V450, P1230, DOI 10.1038/nature06403; Chambers I, 2009, DEVELOPMENT, V136, P2311, DOI 10.1242/dev.024398; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Collins JE, 2012, GENOME RES, V22, P2067, DOI 10.1101/gr.137901.112; Foygel K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004109; Frum T, 2013, DEV CELL, V25, P610, DOI 10.1016/j.devcel.2013.05.004; Giraldez AJ, 2006, SCIENCE, V312, P75, DOI 10.1126/science.1122689; Giraldez AJ, 2005, SCIENCE, V308, P833, DOI 10.1126/science.1109020; Giraldez AJ, 2010, CURR OPIN GENET DEV, V20, P369, DOI 10.1016/j.gde.2010.04.003; Gurdon JB, 2008, SCIENCE, V322, P1811, DOI 10.1126/science.1160810; GURDON JB, 1958, NATURE, V182, P64, DOI 10.1038/182064a0; Hamatani T, 2004, DEV CELL, V6, P117, DOI 10.1016/S1534-5807(03)00373-3; Harvey SA, 2013, DEVELOPMENT, V140, P2703, DOI 10.1242/dev.095091; Hauptmann G, 2002, DEVELOPMENT, V129, P1645; Ingolia NT, 2009, SCIENCE, V324, P218, DOI 10.1126/science.1168978; Iwafuchi-Doi M, 2011, DEV BIOL, V352, P354, DOI 10.1016/j.ydbio.2010.12.027; Jiang L, 2013, CELL, V153, P773, DOI 10.1016/j.cell.2013.04.041; Judson RL, 2009, NAT BIOTECHNOL, V27, P459, DOI 10.1038/nbt.1535; Kaida D, 2010, NATURE, V468, P664, DOI 10.1038/nature09479; KANE DA, 1993, DEVELOPMENT, V119, P447; Keramari M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013952; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Liang HL, 2008, NATURE, V456, P400, DOI 10.1038/nature07388; Lindeman LC, 2011, DEV CELL, V21, P993, DOI 10.1016/j.devcel.2011.10.008; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; Lund E, 2009, RNA, V15, P2351, DOI 10.1261/rna.1882009; Lunde K, 2004, CURR BIOL, V14, P48, DOI 10.1016/j.cub.2003.11.022; Marson A, 2008, CELL, V134, P521, DOI 10.1016/j.cell.2008.07.020; Masui S, 2007, NAT CELL BIOL, V9, P625, DOI 10.1038/ncb1589; Matter N, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni041; Messerschmidt DM, 2010, DEV BIOL, V344, P129, DOI 10.1016/j.ydbio.2010.04.020; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Okuda Y, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000936; Onichtchouk D, 2012, GENESIS, V50, P75, DOI 10.1002/dvg.20800; Onichtchouk D, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.9; Potok ME, 2013, CELL, V153, P759, DOI 10.1016/j.cell.2013.04.030; Rosel TD, 2011, EMBO J, V30, P1965, DOI 10.1038/emboj.2011.106; Soufi A, 2012, CELL, V151, P994, DOI 10.1016/j.cell.2012.09.045; Subramanyam D, 2011, NAT BIOTECHNOL, V29, P443, DOI 10.1038/nbt.1862; Tadros W, 2009, DEVELOPMENT, V136, P3033, DOI 10.1242/dev.033183; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tan MH, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2012.65; ten Bosch JR, 2006, DEVELOPMENT, V133, P1967, DOI 10.1242/dev.02373; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Vastenhouw NL, 2010, NATURE, V464, P922, DOI 10.1038/nature08866; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Xu C, 2012, DEV CELL, V22, P625, DOI 10.1016/j.devcel.2012.01.003; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526	59	273	285	2	80	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 21	2013	503	7476					360	+		10.1038/nature12632	http://dx.doi.org/10.1038/nature12632			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254KG	24056933	Green Accepted			2022-12-24	WOS:000327163200033
J	Parker, J; Tsagkogeorga, G; Cotton, JA; Liu, Y; Provero, P; Stupka, E; Rossiter, SJ				Parker, Joe; Tsagkogeorga, Georgia; Cotton, James A.; Liu, Yuan; Provero, Paolo; Stupka, Elia; Rossiter, Stephen J.			Genome-wide signatures of convergent evolution in echolocating mammals	NATURE			English	Article							PARALLEL EVOLUTION; SEQUENCE EVOLUTION; GENES; ADAPTATION; THOUSANDS; SELECTION; ALIGNMENT; ACCURACY; FLIGHT; SPACE	Evolution is typically thought to proceed through divergence of genes, proteins and ultimately phenotypes(1-3). However, similar traits might also evolve convergently in unrelated taxa owing to similar selection pressures(4,5). Adaptive phenotypic convergence is widespread in nature, and recent results from several genes have suggested that this phenomenon is powerful enough to also drive recurrent evolution at the sequence level(6-9). Where homoplasious substitutions do occur these have long been considered the result of neutral processes. However, recent studies have demonstrated that adaptive convergent sequence evolution can be detected in vertebrates using statistical methods that model parallel evolution(9,10), although the extent to which sequence convergence between genera occurs across genomes is unknown. Here we analyse genomic sequence data in mammals that have independently evolved echolocation and show that convergence is not a rare process restricted to several loci but is instead widespread, continuously distributed and commonly driven by natural selection acting on a small number of sites per locus. Systematic analyses of convergent sequence evolution in 805,053 amino acids within 2,326 orthologous coding gene sequences compared across 22 mammals (including four newly sequenced bat genomes) revealed signatures consistent with convergence in nearly 200 loci. Strong and significant support for convergence among bats and the bottlenose dolphin was seen in numerous genes linked to hearing or deafness, consistent with an involvement in echolocation. Unexpectedly, we also found convergence in many genes linked to vision: the convergent signal of many sensory genes was robustly correlated with the strength of natural selection. This first attempt to detect genome-wide convergent sequence evolution across divergent taxa reveals the phenomenon to be much more pervasive than previously recognized.	[Parker, Joe; Tsagkogeorga, Georgia; Cotton, James A.; Rossiter, Stephen J.] Univ London, Sch Biol & Chem Sci, London E1 4NS, England; [Liu, Yuan] BGI Europe, DK-2200 Copenhagen N, Denmark; [Provero, Paolo; Stupka, Elia] Ist Sci San Raffaele, Ctr Translat Genom & Bioinformat, I-20132 Milan, Italy; [Provero, Paolo] Univ Turin, Dept Mol Biotechnol & Hlth Sci, I-10126 Turin, Italy	University of London; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; University of Turin	Parker, J (corresponding author), Univ London, Sch Biol & Chem Sci, London E1 4NS, England.	j.d.parker@qmul.ac.uk; s.j.rossiter@qmul.ac.uk	Provero, Paolo/AAC-1930-2019; Cotton, James A/B-8806-2008	Cotton, James A/0000-0001-5475-3583; Parker, Joe/0000-0003-3777-2269; Rossiter, Stephen/0000-0002-3881-4515; Stupka, Elia/0000-0003-3154-4011	Biotechnology and Biological Sciences Research [BB/H017178/1]; BBSRC [BB/H017178/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/H017178/1] Funding Source: researchfish	Biotechnology and Biological Sciences Research(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We are grateful to K. Baker, L. Davalos, D. Hayman, E. Koilmani, Y. Liu, A. Peel, R. Ransome and A. Rodriguez for providing material for sequencing. We thank C. Walker (Queen Mary GridPP High Throughput Cluster) and A. Terry and C. Mein (Barts and the London Genome Centre) for providing access to computing facilities, and for assistance with running analyses. We are also grateful to S. Dodsworth, R. Buggs, K. Davies, J. Kirkpatrick, R. Nichols, Y. Wurm and S. Young for comments on the manuscript. This work was funded by Biotechnology and Biological Sciences Research grant BB/H017178/1 awarded to S.J.R., E.S. and J.A.C.	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Au WWL, 2007, PHYS TODAY, V60, P40, DOI 10.1063/1.2784683; Becker KG, 2004, NAT GENET, V36, P431, DOI 10.1038/ng0504-431; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bielawski JP, 2004, J MOL EVOL, V59, P121, DOI 10.1007/s00239-004-2597-8; Bininda-Emonds ORP, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-156; Castoe TA, 2009, P NATL ACAD SCI USA, V106, P8986, DOI 10.1073/pnas.0900233106; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Clark AG, 2007, NATURE, V450, P203, DOI 10.1038/nature06341; Davies KTJ, 2012, HEREDITY, V108, P480, DOI 10.1038/hdy.2011.119; Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Fasick JI, 2000, VISUAL NEUROSCI, V17, P781, DOI 10.1017/S095252380017511X; FITCH WM, 1967, SCIENCE, V155, P279, DOI 10.1126/science.155.3760.279; Grant PR, 2004, EVOLUTION, V58, P1588; Hancock AM, 2010, P NATL ACAD SCI USA, V107, P8924, DOI 10.1073/pnas.0914625107; Hoy RR, 2012, SCIENCE, V338, P894, DOI 10.1126/science.1231169; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Hughes JF, 2010, NATURE, V463, P536, DOI 10.1038/nature08700; Jones G, 2006, TRENDS ECOL EVOL, V21, P149, DOI 10.1016/j.tree.2006.01.001; Jones G, 2007, P R SOC B, V274, P905, DOI 10.1098/rspb.2006.0200; Junier T, 2010, BIOINFORMATICS, V26, P1669, DOI 10.1093/bioinformatics/btq243; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; Kim EB, 2011, NATURE, V479, P223, DOI 10.1038/nature10533; Kriener K, 2000, IMMUNOGENETICS, V51, P169, DOI 10.1007/s002510050028; Lartillot N, 2009, BIOINFORMATICS, V25, P2286, DOI 10.1093/bioinformatics/btp368; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li G, 2008, P NATL ACAD SCI USA, V105, P13959, DOI 10.1073/pnas.0802097105; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Lindblad-Toh K, 2011, NATURE, V478, P476, DOI 10.1038/nature10530; Liu Y, 2012, MOL BIOL EVOL, V29, P1441, DOI 10.1093/molbev/msr310; Liu Y, 2010, CURR BIOL, V20, P1834, DOI 10.1016/j.cub.2010.09.008; Liu Y, 2010, CURR BIOL, V20, pR53, DOI 10.1016/j.cub.2009.11.058; Murphy WJ, 2007, GENOME RES, V17, P413, DOI 10.1101/gr.5918807; Parra G, 2007, BIOINFORMATICS, V23, P1061, DOI 10.1093/bioinformatics/btm071; Parra G, 2009, NUCLEIC ACIDS RES, V37, P289, DOI 10.1093/nar/gkn916; Prasad TSK, 2009, NUCLEIC ACIDS RES, V37, pD767, DOI 10.1093/nar/gkn892; Ranwez V, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-241; Ryan AF, 2003, CURR TOP DEV BIOL, V57, P449, DOI 10.1016/S0070-2153(03)57014-4; Schneider A, 2009, GENOME BIOL EVOL, V1, P114, DOI 10.1093/gbe/evp012; She R, 2011, BIOINFORMATICS, V27, P2141, DOI 10.1093/bioinformatics/btr342; Shen YY, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002788; Soskine M, 2010, NAT REV GENET, V11, P572, DOI 10.1038/nrg2808; Stamatakis A, 2006, P 20 IEEE INT PAR DI, DOI DOI 10.1109/IPDPS.2006.1639535; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Sun YB, 2013, GENOME BIOL EVOL, V5, P130, DOI 10.1093/gbe/evs123; Teeling EC, 2000, NATURE, V403, P188, DOI 10.1038/35003188; Teeling EC, 2002, P NATL ACAD SCI USA, V99, P1431, DOI 10.1073/pnas.022477199; Terrinoni A, 2013, P NATL ACAD SCI USA, V110, P7300, DOI 10.1073/pnas.1214498110; Vater M, 2004, ECHOLOCATION BATS DO, P89; Wong WSW, 2004, GENETICS, V168, P1041, DOI 10.1534/genetics.104.031153; Yang ZH, 2000, GENETICS, V155, P431; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Zhang GJ, 2013, SCIENCE, V339, P456, DOI 10.1126/science.1230835; Zhang JZ, 1997, MOL BIOL EVOL, V14, P527, DOI 10.1093/oxfordjournals.molbev.a025789; Zhao HB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008326; Zhao HB, 2009, P NATL ACAD SCI USA, V106, P8980, DOI 10.1073/pnas.0813201106; Zhou XM, 2012, SYST BIOL, V61, P150, DOI 10.1093/sysbio/syr089	59	225	234	7	282	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 10	2013	502	7470					228	+		10.1038/nature12511	http://dx.doi.org/10.1038/nature12511			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231RU	24005325	Green Published, Green Accepted, hybrid			2022-12-24	WOS:000325436100049
J	Tinberg, CE; Khare, SD; Dou, JY; Doyle, L; Nelson, JW; Schena, A; Jankowski, W; Kalodimos, CG; Johnsson, K; Stoddard, BL; Baker, D				Tinberg, Christine E.; Khare, Sagar D.; Dou, Jiayi; Doyle, Lindsey; Nelson, Jorgen W.; Schena, Alberto; Jankowski, Wojciech; Kalodimos, Charalampos G.; Johnsson, Kai; Stoddard, Barry L.; Baker, David			Computational design of ligand-binding proteins with high affinity and selectivity	NATURE			English	Article							ANTIBODIES; OPTIMIZATION; SPECIFICITY; REVEAL	The ability to design proteins with high affinity and selectivity for any given small molecule is a rigorous test of our understanding of the physiochemical principles that govern molecular recognition. Attempts to rationally design ligand-binding proteins have met with little success, however, and the computational design of protein-small-molecule interfaces remains an unsolved problem(1). Current approaches for designing ligand-binding proteins for medical(2) and biotechnological uses rely on raising antibodies against a target antigen in immunized animals(3,4) and/or performing laboratory-directed evolution of proteins with an existing low affinity for the desired ligand(5-7), neither of which allows complete control over the interactions involved in binding. Here we describe a general computational method for designing pre-organized and shape complementary small-molecule-binding sites, and use it to generate protein binders to the steroid digoxigenin (DIG). Of seventeen experimentally characterized designs, two bind DIG; the model of the higher affinity binder has the most energetically favourable and pre-organized interface in the design set. A comprehensive binding-fitness landscape of this design, generated by library selections and deep sequencing, was used to optimize its binding affinity to a picomolar level, and X-ray co-crystal structures of two variants show atomic-level agreement with the corresponding computational models. The optimized binder is selective for DIG over the related steroids digitoxigenin, progesterone and beta-oestradiol, and this steroid binding preference can be reprogrammed by manipulation of explicitly designed hydrogen-bonding interactions. The computational design method presented here should enable the development of a new generation of biosensors, therapeutics and diagnostics.	[Tinberg, Christine E.; Khare, Sagar D.; Baker, David] Univ Washington, Dept Biochem, Seattle, WA 98195 USA; [Dou, Jiayi] Univ Washington, Dept Bioengn, Seattle, WA 98195 USA; [Dou, Jiayi] Univ Washington, Grad Program Biol Phys Struct & Design, Seattle, WA 98195 USA; [Doyle, Lindsey; Stoddard, Barry L.] Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98109 USA; [Nelson, Jorgen W.] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Schena, Alberto; Johnsson, Kai] Ecole Polytech Fed Lausanne, Inst Chem Sci & Engn, Inst Bioengn, Natl Ctr Competence Res NCCR Chem Biol, CH-1015 Lausanne, Switzerland; [Jankowski, Wojciech; Kalodimos, Charalampos G.] Rutgers State Univ, Ctr Integrat Prote Res, Dept Chem & Chem Biol, Piscataway, NJ 08854 USA; [Baker, David] Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Rutgers State University New Brunswick; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle	Baker, D (corresponding author), Univ Washington, Dept Biochem, Seattle, WA 98195 USA.	dabaker@u.washington.edu	Kalodimos, Charalampos/Q-9846-2018; johnsson, kai/P-4222-2014; Baker, David/K-8941-2012	Kalodimos, Charalampos/0000-0001-6354-2796; johnsson, kai/0000-0002-8002-1981; Baker, David/0000-0001-7896-6217; Doyle, Lindsey/0000-0002-0008-473X; Nelson, Jorgen/0000-0002-0202-2460	Washington State Life Sciences Discovery Fund; Center for the Intracellular Delivery of Biologics; National Human Genome Research Institute under the Interdisciplinary Training in Genome Sciences program [T32 HG00035]; DTRA; DARPA; Swiss National Science Foundation; National Science Foundation [MCB1121896]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [T32HG000035] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103533, R01GM049857] Funding Source: NIH RePORTER	Washington State Life Sciences Discovery Fund; Center for the Intracellular Delivery of Biologics; National Human Genome Research Institute under the Interdisciplinary Training in Genome Sciences program; DTRA(United States Department of DefenseDefense Threat Reduction Agency); DARPA(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); National Science Foundation(National Science Foundation (NSF)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank E.-M. Strauch and P.-S. Huang for providing the ZZ/pETCON and S2/pETCON plasmids, respectively, and B. Shen for assistance with data processing, modelling and refinement of the X-ray crystal structures. We thank J. P. Sumida for assistance with analytical ultracentrifugation data collection, processing, and analysis. Analytical ultracentrifugation experiments were performed at the University of Washington Analytical Biopharmacy Core, which is supported by the Washington State Life Sciences Discovery Fund and the Center for the Intracellular Delivery of Biologics. We thank S. Fleishman, O. Khersonsky and P.-S. Huang for comments on the manuscript. J.W.N. acknowledges a pre-doctoral fellowship from the National Human Genome Research Institute under the Interdisciplinary Training in Genome Sciences program (T32 HG00035). This work was supported by grants from DTRA and DARPA to D. B., a grant from the Swiss National Science Foundation to K. J., and National Science Foundation grant MCB1121896 to C.G.K.	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Baker D, 2010, PROTEIN SCI, V19, P1817, DOI 10.1002/pro.481; Benatuil L, 2010, PROTEIN ENG DES SEL, V23, P155, DOI 10.1093/protein/gzq002; Boehr DD, 2009, NAT CHEM BIOL, V5, P789, DOI 10.1038/nchembio.232; Bradbury ARM, 2011, NAT BIOTECHNOL, V29, P245, DOI 10.1038/nbt.1791; Brustad EM, 2011, CURR OPIN CHEM BIOL, V15, P201, DOI 10.1016/j.cbpa.2010.11.020; Chao G, 2006, NAT PROTOC, V1, P755, DOI 10.1038/nprot.2006.94; Chen G, 2001, NAT BIOTECHNOL, V19, P537, DOI 10.1038/89281; Cooper S, 2010, NATURE, V466, P756, DOI 10.1038/nature09304; De Wolf FA, 2000, PHARMACOL REV, V52, P207; Eisel D., 2008, DIG APPL MANUAL NONR; FERSHT AR, 1985, NATURE, V314, P235, DOI 10.1038/314235a0; Flanagan RJ, 2004, DRUG SAFETY, V27, P1115, DOI 10.2165/00002018-200427140-00004; Fleishman SJ, 2012, CELL, V149, P262, DOI 10.1016/j.cell.2012.03.016; Fleishman SJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020161; Fleishman SJ, 2011, PROTEIN SCI, V20, P753, DOI 10.1002/pro.604; Fowler DM, 2011, BIOINFORMATICS, V27, P3430, DOI 10.1093/bioinformatics/btr577; Fowler DM, 2010, NAT METHODS, V7, P741, DOI 10.1038/nmeth.1492; Frederick KK, 2007, NATURE, V448, P325, DOI 10.1038/nature05959; HUNTER MM, 1982, J IMMUNOL, V129, P1165; Jiang L, 2008, SCIENCE, V319, P1387, DOI 10.1126/science.1152692; Kellogg EH, 2011, PROTEINS, V79, P830, DOI 10.1002/prot.22921; Khare SD, 2013, FEBS LETT, V587, P1147, DOI 10.1016/j.febslet.2012.12.009; Khersonsky O, 2012, P NATL ACAD SCI USA, V109, P10358, DOI 10.1073/pnas.1121063109; Kuhlman B, 2000, P NATL ACAD SCI USA, V97, P10383, DOI 10.1073/pnas.97.19.10383; LAWRENCE MC, 1993, J MOL BIOL, V234, P946, DOI 10.1006/jmbi.1993.1648; McLaughlin RN, 2012, NATURE, V491, P138, DOI 10.1038/nature11500; Perry G, 1997, NEW ENGL J MED, V336, P525; Richter F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019230; Rossi AM, 2011, NAT PROTOC, V6, DOI 10.1038/nprot.2011.305; Rothlisberger D, 2008, NATURE, V453, P190, DOI 10.1038/nature06879; Schreier B, 2009, P NATL ACAD SCI USA, V106, P18491, DOI 10.1073/pnas.0907950106; Shen XY, 2012, CLIN PHARMACOL THER, V91, P60, DOI 10.1038/clpt.2011.281; Siegel JB, 2010, SCIENCE, V329, P309, DOI 10.1126/science.1190239; Telmer PG, 2005, J MOL BIOL, V354, P829, DOI 10.1016/j.jmb.2005.10.016; Wang L, 2012, J MOL BIOL, V415, P615, DOI 10.1016/j.jmb.2011.10.043; Whitehead TA, 2012, NAT BIOTECHNOL, V30, P543, DOI 10.1038/nbt.2214; Zanghellini A, 2006, PROTEIN SCI, V15, P2785, DOI 10.1110/ps.062353106	38	282	291	12	304	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 12	2013	501	7466					212	+		10.1038/nature12443	http://dx.doi.org/10.1038/nature12443			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	215XR	24005320	Green Accepted			2022-12-24	WOS:000324244900039
J	Vanholme, R; Cesarino, I; Rataj, K; Xiao, YG; Sundin, L; Goeminne, G; Kim, H; Cross, J; Morreel, K; Araujo, P; Welsh, L; Haustraete, J; McClellan, C; Vanholme, B; Ralph, J; Simpson, GG; Halpin, C; Boerjan, W				Vanholme, Ruben; Cesarino, Igor; Rataj, Katarzyna; Xiao, Yuguo; Sundin, Lisa; Goeminne, Geert; Kim, Hoon; Cross, Joanna; Morreel, Kris; Araujo, Pedro; Welsh, Lydia; Haustraete, Jurgen; McClellan, Christopher; Vanholme, Bartel; Ralph, John; Simpson, Gordon G.; Halpin, Claire; Boerjan, Wout			Caffeoyl Shikimate Esterase (CSE) Is an Enzyme in the Lignin Biosynthetic Pathway in Arabidopsis	SCIENCE			English	Article							SECONDARY CELL-WALL; PHENYLPROPANOID METABOLISM; MONOLIGNOL BIOSYNTHESIS; TRANSCRIPTION FACTORS; DEPOSITION; THALIANA; 3'-HYDROXYLASE; PHENOTYPE; GROWTH; ACID	Lignin is a major component of plant secondary cell walls. Here we describe caffeoyl shikimate esterase (CSE) as an enzyme central to the lignin biosynthetic pathway. Arabidopsis thaliana cse mutants deposit less lignin than do wild-type plants, and the remaining lignin is enriched in p-hydroxyphenyl units. Phenolic metabolite profiling identified accumulation of the lignin pathway intermediate caffeoyl shikimate in cse mutants as compared to caffeoyl shikimate levels in the wild type, suggesting caffeoyl shikimate as a substrate for CSE. Accordingly, recombinant CSE hydrolyzed caffeoyl shikimate into caffeate. Associated with the changes in lignin, the conversion of cellulose to glucose in cse mutants increased up to fourfold as compared to that in the wild type upon saccharification without pretreatment. Collectively, these data necessitate the revision of currently accepted models of the lignin biosynthetic pathway.	[Vanholme, Ruben; Cesarino, Igor; Sundin, Lisa; Goeminne, Geert; Cross, Joanna; Morreel, Kris; Araujo, Pedro; Vanholme, Bartel; Boerjan, Wout] VIB Flanders Inst Biotechnol, Dept Plant Syst Biol, B-9052 Ghent, Belgium; [Vanholme, Ruben; Cesarino, Igor; Sundin, Lisa; Goeminne, Geert; Cross, Joanna; Morreel, Kris; Araujo, Pedro; Vanholme, Bartel; Boerjan, Wout] Univ Ghent, Dept Plant Biotechnol & Bioinformat, B-9052 Ghent, Belgium; [Rataj, Katarzyna; Xiao, Yuguo; Welsh, Lydia; McClellan, Christopher; Simpson, Gordon G.; Halpin, Claire] James Hutton Inst, Univ Dundee, Coll Life Sci, Div Plant Sci, Dundee DD2 5DA, Scotland; [Kim, Hoon; Ralph, John] Univ Wisconsin, Dept Biochem, Madison, WI 53726 USA; [Kim, Hoon; Ralph, John] Univ Wisconsin, Dept Biol Syst Engn, Madison, WI 53726 USA; [Kim, Hoon; Ralph, John] Univ Wisconsin, Dept Energy, Great Lakes Bioenergy Res Ctr, Wisconsin Energy Inst, Madison, WI 53726 USA; [Haustraete, Jurgen] Univ Ghent, VIB, Dept Mol Biomed Res, Prot Serv Facil, B-9052 Ghent, Belgium; [Simpson, Gordon G.] James Hutton Inst, Dundee DD2 5DA, Scotland	Flanders Institute for Biotechnology (VIB); Ghent University; James Hutton Institute; University of Dundee; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; United States Department of Energy (DOE); University of Wisconsin System; University of Wisconsin Madison; Flanders Institute for Biotechnology (VIB); Ghent University; James Hutton Institute	Halpin, C (corresponding author), James Hutton Inst, Univ Dundee, Coll Life Sci, Div Plant Sci, Dundee DD2 5DA, Scotland.	c.halpin@dundee.ac.uk; wout.boerjan@psb.vib-ugent.be	Boerjan, Wout/Y-4158-2019; Araujo, Pedro/P-9688-2016; Kim, Hoon/E-8245-2013; Ralph, John/C-3161-2009; Vanholme, Ruben/AAA-7996-2022; Cesarino, Igor/N-5887-2014; Xiao, Yuguo/ABD-8421-2020	Boerjan, Wout/0000-0003-1495-510X; Araujo, Pedro/0000-0002-3205-5749; Kim, Hoon/0000-0001-7425-7464; Ralph, John/0000-0002-6093-4521; Cesarino, Igor/0000-0002-6789-2432; Xiao, Yuguo/0000-0002-0747-5856; Welsh, Lydia/0000-0003-1606-0852; McClellan, Christopher/0000-0002-4393-4079; Halpin, Claire/0000-0002-1808-8130	European Commission [211982, 270089]; Stanford University's Global Climate and Energy Project; Hercules program of Ghent University for the Synapt Q-Tof [AUGE/014]; Bijzonder Onderzoeksfonds-Zware Apparatuur of Ghent University [174PZA05]; Ghent University [01MRB510W]; Research Foundation-Flanders; Agency for Innovation by Science and Technology (IWT); CAPES-Brazil [201660/2010-5]; CNPq-Brazil [201998/2011-4]; U.S. Department of Energy's Great Lakes Bioenergy Research Center (DOE Office of Science) [BER DE-FC02-07ER64494]; Scottish Government; Science Advisory Board of the NSF [DBI-0922391]; BBSRC [BB/G016232/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/G016232/1] Funding Source: researchfish	European Commission(European CommissionEuropean Commission Joint Research Centre); Stanford University's Global Climate and Energy Project; Hercules program of Ghent University for the Synapt Q-Tof; Bijzonder Onderzoeksfonds-Zware Apparatuur of Ghent University; Ghent University(Ghent University); Research Foundation-Flanders(FWO); Agency for Innovation by Science and Technology (IWT)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)); CAPES-Brazil(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CNPq-Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); U.S. Department of Energy's Great Lakes Bioenergy Research Center (DOE Office of Science)(United States Department of Energy (DOE)); Scottish Government; Science Advisory Board of the NSF; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The authors thank A. Bleys for help in preparing the manuscript and K. Graham for technical support. We gratefully acknowledge funding through the European Commission's Directorate-General for Research within the 7th Framework Program (FP7/2007-2013) under grant agreements 211982 (RENEWALL) and 270089 (MULTIBIOPRO); Stanford University's Global Climate and Energy Project (Towards New Degradable Lignin Types, Novel Mutants Optimized for Lignin, Growth and Biofuel Production via Re-Mutagenesis, and Efficient Biomass Conversion: Delineating the Best Lignin Monomer-Substitutes); the Hercules program of Ghent University for the Synapt Q-Tof (grant AUGE/014); the Bijzonder Onderzoeksfonds-Zware Apparatuur of Ghent University for the Fourier transform ion cyclotron resonance mass spectrometer (174PZA05); and the Multidisciplinary Research Partnership Biotechnology for a Sustainable Economy (01MRB510W) of Ghent University. R. V. is indebted to the Research Foundation-Flanders for a postdoctoral fellowship and L. S., I. C., and P. A. to the Agency for Innovation by Science and Technology (IWT), CAPES-Brazil (grant 201660/2010-5), and the CNPq-Brazil sandwich Ph.D. (grant 201998/2011-4), respectively, for predoctoral fellowships. J.R. and H. K. were funded in part by the U.S. Department of Energy's Great Lakes Bioenergy Research Center (DOE Office of Science BER DE-FC02-07ER64494). G. G. S. was partially funded by the Scottish Government. W. B. is on the Science Advisory Board of the NSF-funded project Regulation and Modeling of Lignin Biosynthesis, DBI-0922391. A patent application, "Modified plants" PCT/GB2013/051206, on the modification of CSE expression to improve processes that require carbohydrate extraction, has been filed jointly by the University of Dundee and the Flanders Institute for Biotechnology (VIB).	Besseau S, 2007, PLANT CELL, V19, P148, DOI 10.1105/tpc.106.044495; Boerjan W, 2003, ANNU REV PLANT BIOL, V54, P519, DOI 10.1146/annurev.arplant.54.031902.134938; Bonawitz ND, 2010, ANNU REV GENET, V44, P337, DOI 10.1146/annurev-genet-102209-163508; Chen F, 2007, NAT BIOTECHNOL, V25, P759, DOI 10.1038/nbt1316; Chen F, 2006, PLANT J, V48, P113, DOI 10.1111/j.1365-313X.2006.02857.x; Chen HC, 2011, P NATL ACAD SCI USA, V108, P21253, DOI 10.1073/pnas.1116416109; Coleman HD, 2008, P NATL ACAD SCI USA, V105, P4501, DOI 10.1073/pnas.0706537105; Ehlting J, 1999, PLANT J, V19, P9, DOI 10.1046/j.1365-313X.1999.00491.x; Franke R, 2002, PLANT J, V30, P33, DOI 10.1046/j.1365-313X.2002.01266.x; Franke R, 2002, PLANT J, V30, P47, DOI 10.1046/j.1365-313X.2002.01267.x; Freudenberg K., 1968, MOL BIOL BIOCH BIOPH, V2, P1; Gao W, 2010, PLANT J, V62, P989, DOI 10.1111/j.1365-313X.2010.04209.x; Hoffmann L, 2003, J BIOL CHEM, V278, P95, DOI 10.1074/jbc.M209362200; Humphreys JM, 2002, CURR OPIN PLANT BIOL, V5, P224, DOI 10.1016/S1369-5266(02)00257-1; Li X, 2010, PLANT CELL, V22, P1620, DOI 10.1105/tpc.110.074161; Mitsuda N, 2007, PLANT CELL, V19, P270, DOI 10.1105/tpc.106.047043; Nilsson R, 2010, MOL CELL PROTEOMICS, V9, P368, DOI 10.1074/mcp.M900289-MCP200; Raes J, 2003, PLANT PHYSIOL, V133, P1051, DOI 10.1104/pp.103.026484; Ralph John, 2004, Phytochemistry Reviews, V3, P29, DOI 10.1023/B:PHYT.0000047809.65444.a4; Schoch G, 2001, J BIOL CHEM, V276, P36566, DOI 10.1074/jbc.M104047200; Turner SR, 1997, PLANT CELL, V9, P689, DOI 10.1105/tpc.9.5.689; Van Acker R., 2013, BIOTECHNOLOGY BIOFUE; Vanholme R, 2012, NEW PHYTOL, V196, P978, DOI 10.1111/j.1469-8137.2012.04337.x; Vanholme R, 2012, PLANT CELL, V24, P3506, DOI 10.1105/tpc.112.102574; Weng JK, 2010, NEW PHYTOL, V187, P273, DOI 10.1111/j.1469-8137.2010.03327.x; Yang F, 2013, PLANT BIOTECHNOL J, V11, P325, DOI 10.1111/pbi.12016; Zhong RQ, 2007, PLANTA, V225, P1603, DOI 10.1007/s00425-007-0498-y	27	309	321	14	324	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 6	2013	341	6150					1103	1106		10.1126/science.1241602	http://dx.doi.org/10.1126/science.1241602			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	211TG	23950498	Green Published			2022-12-24	WOS:000323933100042
J	Swift, J; Ivanovska, IL; Buxboim, A; Harada, T; Dingal, PCDP; Pinter, J; Pajerowski, JD; Spinler, KR; Shin, JW; Tewari, M; Rehfeldt, F; Speicher, DW; Discher, DE				Swift, Joe; Ivanovska, Irena L.; Buxboim, Amnon; Harada, Takamasa; Dingal, P. C. Dave P.; Pinter, Joel; Pajerowski, J. David; Spinler, Kyle R.; Shin, Jae-Won; Tewari, Manorama; Rehfeldt, Florian; Speicher, David W.; Discher, Dennis E.			Nuclear Lamin-A Scales with Tissue Stiffness and Enhances Matrix-Directed Differentiation	SCIENCE			English	Article							SERUM RESPONSE FACTOR; STEM-CELL FATE; B-TYPE LAMINS; RETINOIC ACID; EXTRACELLULAR-MATRIX; STEREOLOGICAL ANALYSIS; SKELETAL-MUSCLE; GENE-EXPRESSION; HIPPO PATHWAY; ACTIN	Tissues can be soft like fat, which bears little stress, or stiff like bone, which sustains high stress, but whether there is a systematic relationship between tissue mechanics and differentiation is unknown. Here, proteomics analyses revealed that levels of the nucleoskeletal protein lamin-A scaled with tissue elasticity, E, as did levels of collagens in the extracellular matrix that determine E. Stem cell differentiation into fat on soft matrix was enhanced by low lamin-A levels, whereas differentiation into bone on stiff matrix was enhanced by high lamin-A levels. Matrix stiffness directly influenced lamin-A protein levels, and, although lamin-A transcription was regulated by the vitamin A/retinoic acid (RA) pathway with broad roles in development, nuclear entry of RA receptors was modulated by lamin-A protein. Tissue stiffness and stress thus increase lamin-A levels, which stabilize the nucleus while also contributing to lineage determination.	[Swift, Joe; Ivanovska, Irena L.; Buxboim, Amnon; Harada, Takamasa; Dingal, P. C. Dave P.; Pinter, Joel; Pajerowski, J. David; Spinler, Kyle R.; Shin, Jae-Won; Tewari, Manorama; Rehfeldt, Florian; Discher, Dennis E.] Univ Penn, Mol & Cell Biophys Lab, Philadelphia, PA 19104 USA; [Speicher, David W.; Discher, Dennis E.] Wistar Inst Anat & Biol, Ctr Syst & Computat Biol, Philadelphia, PA 19104 USA	University of Pennsylvania; The Wistar Institute	Discher, DE (corresponding author), Univ Penn, Mol & Cell Biophys Lab, Philadelphia, PA 19104 USA.	discher@seas.upenn.edu	Swift, Joe/A-5149-2014; Rehfeldt, Florian/A-1078-2007	Swift, Joe/0000-0002-5039-9094; Rehfeldt, Florian/0000-0001-9086-3835; Buxboim, Amnon/0000-0003-2412-9792; discher, dennis/0000-0001-6163-2229	U.S. National Institutes of Health [NIH R01HL062352, P01DK032094, R01EB007049, NCATS-8UL1TR000003]; U.S. National Science Foundation [1200834]; Human Frontier Science Program; Stem Cell Xenograft Core; Microarray Cores [P30-DK090969]; U.S. NIH [HL038794, CA010815]; NATIONAL CANCER INSTITUTE [P30CA010815] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000003] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL062352, R01HL038794] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB007049] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK032094, P30DK090969] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. National Science Foundation(National Science Foundation (NSF)); Human Frontier Science Program(Human Frontier Science Program); Stem Cell Xenograft Core; Microarray Cores; U.S. NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We greatly appreciate support from the U.S. National Institutes of Health (NIH R01HL062352, P01DK032094, R01EB007049, and NCATS-8UL1TR000003), the U.S. National Science Foundation (grant 1200834, the University of Pennsylvania's Materials Research Science and Engineering Center, and Nano Science and Engineering Center, Nano/Bio Interface Center), the Human Frontier Science Program (to I. L. I. and D. E. D.), and the Stem Cell Xenograft Core (to A. Secreto, J. Glover, and G. Danet-Desnoyers) and Microarray Cores (P30-DK090969). We thank the Wistar Institute Proteomics Core for assistance with MS and standard data analyses. This work was also supported in part by U.S. NIH grants HL038794 (to D. W. S.) and CA010815 (National Cancer Institute core grant to the Wistar Institute). We thank D. Gilbert (Florida State University, Department of Biological Science), H. Herrmann (Heidelberg, DKFZ), and H. Worman (Columbia University, Department of Medicine), respectively, for GFP-lamin-A, recombinant lamins, and SUN2 plasmids.	Agarwal C, 1996, J BIOL CHEM, V271, P12209, DOI 10.1074/jbc.271.21.12209; Akter R, 2009, J BONE MINER RES, V24, P283, DOI 10.1359/JBMR.081010; Alves RDAM, 2011, J PROTEOME RES, V10, P4725, DOI 10.1021/pr200522n; Ayala-Sumuano JT, 2011, SCI REP-UK, V1, DOI 10.1038/srep00178; Baarlink C, 2013, SCIENCE, V340, P864, DOI 10.1126/science.1235038; Barnes H.A, 2000, HDB ELEMENTARY RHEOL; Beck K, 1998, J STRUCT BIOL, V122, P17, DOI 10.1006/jsbi.1998.3965; Bertacchini J, 2013, FASEB J, V27, P2145, DOI 10.1096/fj.12-218214; Broers JLV, 1997, HISTOCHEM CELL BIOL, V107, P505, DOI 10.1007/s004180050138; Chamberlain JS, 2007, FASEB J, V21, P2195, DOI 10.1096/fj.06-7353com; Chen BPC, 2001, PHYSIOL GENOMICS, V7, P55, DOI 10.1152/physiolgenomics.2001.7.1.55; Chen JF, 2012, J BONE MINER RES, V27, P1659, DOI 10.1002/jbmr.1607; Connelly JT, 2010, NAT CELL BIOL, V12, P711, DOI 10.1038/ncb2074; De Vos WH, 2011, HUM MOL GENET, V20, P4175, DOI 10.1093/hmg/ddr344; Dechat T, 2008, GENE DEV, V22, P832, DOI 10.1101/gad.1652708; Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995; Dupont S, 2011, NATURE, V474, P179, DOI 10.1038/nature10137; EISENBERG BR, 1975, J ULTRA MOL STRUCT R, V51, P176, DOI 10.1016/S0022-5320(75)80146-8; Engler AJ, 2008, J CELL SCI, V121, P3794, DOI 10.1242/jcs.029678; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Engler AJ, 2004, J CELL BIOL, V166, P877, DOI 10.1083/jcb.200405004; Flynn BP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012337; Franz C, 2007, EMBO REP, V8, P165, DOI 10.1038/sj.embor.7400889; FROST HM, 1987, ANAT RECORD, V219, P1, DOI 10.1002/ar.1092190104; Gardel ML, 2004, SCIENCE, V304, P1301, DOI 10.1126/science.1095087; Georges PC, 2006, BIOPHYS J, V90, P3012, DOI 10.1529/biophysj.105.073114; Gilbert PM, 2010, SCIENCE, V329, P1078, DOI 10.1126/science.1191035; Goldman RD, 2002, GENE DEV, V16, P533, DOI 10.1101/gad.960502; Haque F, 2010, J BIOL CHEM, V285, P3487, DOI 10.1074/jbc.M109.071910; Hayashi YK, 2009, J CLIN INVEST, V119, P2623, DOI 10.1172/JCI38660; HEALD R, 1990, CELL, V61, P579, DOI 10.1016/0092-8674(90)90470-Y; Heo Y, 2005, J RHEOL, V49, P1117, DOI 10.1122/1.1993595; Herrmann H, 2009, J CLIN INVEST, V119, P1772, DOI 10.1172/JCI38214; Ho CY, 2013, NATURE, V497, P507, DOI 10.1038/nature12105; Hong JH, 2005, SCIENCE, V309, P1074, DOI 10.1126/science.1110955; HOPE J, 1970, J ULTRA MOL STRUCT R, V33, P292, DOI 10.1016/S0022-5320(70)90023-7; Huebsch N, 2010, NAT MATER, V9, P518, DOI [10.1038/NMAT2732, 10.1038/nmat2732]; Jahn D, 2012, NUCLEUS-AUSTIN, V3, P463, DOI 10.4161/nucl.21676; Johnson CP, 2007, SCIENCE, V317, P663, DOI 10.1126/science.1139857; Khetan S, 2013, NAT MATER, V12, P458, DOI [10.1038/NMAT3586, 10.1038/nmat3586]; Kim HJ, 2011, P NATL ACAD SCI USA, V108, P2010, DOI 10.1073/pnas.1018974108; Kim T, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000439; Kim Y, 2011, SCIENCE, V334, P1706, DOI 10.1126/science.1211222; Kong HJ, 2005, P NATL ACAD SCI USA, V102, P4300, DOI 10.1073/pnas.0405873102; Krimm I, 2002, STRUCTURE, V10, P811, DOI 10.1016/S0969-2126(02)00777-3; Kubben N, 2011, NUCLEUS-PHILA, V2, P195, DOI 10.4161/nucl.2.3.15731; Kubben N, 2010, NUCLEUS-PHILA, V1, P513, DOI 10.4161/nucl.1.6.13512; Lammerding J, 2006, J BIOL CHEM, V281, P25768, DOI 10.1074/jbc.M513511200; Lamond A. I., 2009, NUCL ISOLATION PROTO; Lloyd DJ, 2002, HUM MOL GENET, V11, P769, DOI 10.1093/hmg/11.7.769; Lu PPY, 2011, J NEUROSCI, V31, P16651, DOI 10.1523/JNEUROSCI.3015-11.2011; Ma X, 2010, MOL BIOL REP, V37, P4003, DOI 10.1007/s11033-010-0059-5; Mahaney BL, 2009, BIOCHEM J, V417, P639, DOI 10.1042/BJ20080413; Mattout A, 2011, J MOL CELL BIOL, V3, P341, DOI 10.1093/jmcb/mjr028; Meuleman W, 2013, GENOME RES, V23, P270, DOI 10.1101/gr.141028.112; Moore KA, 2006, SCIENCE, V311, P1880, DOI 10.1126/science.1110542; Murakami M, 2005, P NATL ACAD SCI USA, V102, P18034, DOI 10.1073/pnas.0509109102; Okumura K, 2004, BIOCHEM BIOPH RES CO, V320, P487, DOI 10.1016/j.bbrc.2004.05.191; Olins AL, 2001, EXP CELL RES, V268, P115, DOI 10.1006/excr.2001.5269; Olson EN, 2010, NAT REV MOL CELL BIO, V11, P353, DOI 10.1038/nrm2890; Pajerowski JD, 2007, P NATL ACAD SCI USA, V104, P15619, DOI 10.1073/pnas.0702576104; Pelham RJ, 1997, P NATL ACAD SCI USA, V94, P13661, DOI 10.1073/pnas.94.25.13661; Raab M, 2012, J CELL BIOL, V199, P669, DOI 10.1083/jcb.201205056; Rubinstein M, 2003, POLYM PHYS; Sawada Y, 2006, CELL, V127, P1015, DOI 10.1016/j.cell.2006.09.044; Scaffidi P, 2008, NAT CELL BIOL, V10, P452, DOI 10.1038/ncb1708; Shimi T, 2008, GENE DEV, V22, P3409, DOI 10.1101/gad.1735208; Shimono K, 2011, NAT MED, V17, P454, DOI 10.1038/nm.2334; Shin JW, 2013, DIFFERENTIATION, V86, P77, DOI 10.1016/j.diff.2013.05.001; Shin JW, 2011, P NATL ACAD SCI USA, V108, P11458, DOI 10.1073/pnas.1017474108; Shivashankar GV, 2011, ANNU REV BIOPHYS, V40, P361, DOI 10.1146/annurev-biophys-042910-155319; Shumaker DK, 2005, P NATL ACAD SCI USA, V102, P15494, DOI 10.1073/pnas.0507612102; Simon DN, 2011, NAT REV MOL CELL BIO, V12, P695, DOI 10.1038/nrm3207; Simon DN, 2010, NUCLEUS-PHILA, V1, P264, DOI 10.4161/nucl.1.3.11799; Storm C, 2005, NATURE, V435, P191, DOI 10.1038/nature03521; Strobl G., 2007, PHYS POLYM CONCEPTS; Su D, 2008, BIOCHEM PHARMACOL, V75, P1129, DOI 10.1016/j.bcp.2007.11.006; Sullivan T, 1999, J CELL BIOL, V147, P913, DOI 10.1083/jcb.147.5.913; Trappmann B, 2012, NAT MATER, V11, P642, DOI [10.1038/NMAT3339, 10.1038/nmat3339]; Tunnah D, 2005, J MOL HISTOL, V36, P337, DOI 10.1007/s10735-005-9004-7; Ulrich TA, 2009, CANCER RES, V69, P4167, DOI 10.1158/0008-5472.CAN-08-4859; Vogel V, 2006, NAT REV MOL CELL BIO, V7, P265, DOI 10.1038/nrm1890; Wang N, 2009, NAT REV MOL CELL BIO, V10, P75, DOI 10.1038/nrm2594; Welch ID, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2604; Worman HJ, 2012, J PATHOL, V226, P316, DOI 10.1002/path.2999; Yang YL, 2009, BIOPHYS J, V97, P2051, DOI 10.1016/j.bpj.2009.07.035; Yu SL, 2012, J BIOL CHEM, V287, P42195, DOI 10.1074/jbc.M112.410381; Zaidi SK, 2004, EMBO J, V23, P790, DOI 10.1038/sj.emboj.7600073; Zhang H, 2004, J MOL MED, V82, P488, DOI 10.1007/s00109-004-0549-9; Zhang W, 2010, BRAIN RES, V1359, P256, DOI 10.1016/j.brainres.2010.08.072; Zhao B, 2008, GENE DEV, V22, P1962, DOI 10.1101/gad.1664408; Zhao B, 2007, GENE DEV, V21, P2747, DOI 10.1101/gad.1602907; Zhao B, 2011, NAT CELL BIOL, V13, P877, DOI 10.1038/ncb2303; Zullo JM, 2012, CELL, V149, P1474, DOI 10.1016/j.cell.2012.04.035	94	1145	1178	20	323	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 30	2013	341	6149							1240104	10.1126/science.1240104	http://dx.doi.org/10.1126/science.1240104			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	208BZ	23990565	Green Accepted			2022-12-24	WOS:000323652300034
J	Le Chatelier, E; Nielsen, T; Qin, JJ; Prifti, E; Hildebrand, F; Falony, G; Almeida, M; Arumugam, M; Batto, JM; Kennedy, S; Leonard, P; Li, JH; Burgdorf, K; Grarup, N; Jorgensen, T; Brandslund, I; Nielsen, HB; Juncker, AS; Bertalan, M; Levenez, F; Pons, N; Rasmussen, S; Sunagawa, S; Tap, J; Tims, S; Zoetendal, EG; Brunak, S; Clement, K; Dore, J; Kleerebezem, M; Kristiansen, K; Renault, P; Sicheritz-Ponten, T; de Vos, WM; Zucker, JD; Raes, J; Hansen, T; Bork, P; Wang, J; Ehrlich, SD; Pedersen, O				Le Chatelier, Emmanuelle; Nielsen, Trine; Qin, Junjie; Prifti, Edi; Hildebrand, Falk; Falony, Gwen; Almeida, Mathieu; Arumugam, Manimozhiyan; Batto, Jean-Michel; Kennedy, Sean; Leonard, Pierre; Li, Junhua; Burgdorf, Kristoffer; Grarup, Niels; Jorgensen, Torben; Brandslund, Ivan; Nielsen, Henrik Bjorn; Juncker, Agnieszka S.; Bertalan, Marcelo; Levenez, Florence; Pons, Nicolas; Rasmussen, Simon; Sunagawa, Shinichi; Tap, Julien; Tims, Sebastian; Zoetendal, Erwin G.; Brunak, Soren; Clement, Karine; Dore, Joel; Kleerebezem, Michiel; Kristiansen, Karsten; Renault, Pierre; Sicheritz-Ponten, Thomas; de Vos, Willem M.; Zucker, Jean-Daniel; Raes, Jeroen; Hansen, Torben; Bork, Peer; Wang, Jun; Ehrlich, S. Dusko; Pedersen, Oluf		MetaHIT Consortium	Richness of human gut microbiome correlates with metabolic markers	NATURE			English	Article							BODY-MASS INDEX; DIET-INDUCED OBESITY; WIDE ASSOCIATION; WEIGHT; INFLAMMATION; LOCI; RESISTANCE; CHILDHOOD; VARIANTS; BACTERIA	We are facing a global metabolic health crisis provoked by an obesity epidemic. Here we report the human gut microbial composition in a population sample of 123 non-obese and 169 obese Danish individuals. We find two groups of individuals that differ by the number of gut microbial genes and thus gut bacterial richness. They contain known and previously unknown bacterial species at different proportions; individuals with a low bacterial richness (23% of the population) are characterized by more marked overall adiposity, insulin resistance and dyslipidaemia and a more pronounced inflammatory phenotype when compared with high bacterial richness individuals. The obese individuals among the lower bacterial richness group also gain more weight over time. Only a few bacterial species are sufficient to distinguish between individuals with high and low bacterial richness, and even between lean and obese participants. Our classifications based on variation in the gut microbiome identify subsets of individuals in the general white adult population who may be at increased risk of progressing to adiposity-associated co-morbidities.	[Le Chatelier, Emmanuelle; Prifti, Edi; Almeida, Mathieu; Batto, Jean-Michel; Kennedy, Sean; Leonard, Pierre; Levenez, Florence; Pons, Nicolas; Tap, Julien; Dore, Joel] INRA, Metagenopolis US1367, F-78350 Jouy En Josas, France; [Nielsen, Trine; Arumugam, Manimozhiyan; Burgdorf, Kristoffer; Grarup, Niels; Hansen, Torben; Pedersen, Oluf] Univ Copenhagen, Fac Hlth & Med Sci, Novo Nordisk Fdn, Ctr Basic Metab Res, DK-2200 Copenhagen, Denmark; [Qin, Junjie; Arumugam, Manimozhiyan; Li, Junhua] BGI Shenzhen, Shenzhen 518083, Peoples R China; [Hildebrand, Falk; Falony, Gwen; Raes, Jeroen] VIB, Dept Biol Struct, B-1050 Brussels, Belgium; [Hildebrand, Falk; Falony, Gwen; Raes, Jeroen] Vrije Univ Brussel, Dept Biosci Engn, B-1050 Brussels, Belgium; [Arumugam, Manimozhiyan; Sunagawa, Shinichi; Tap, Julien; Bork, Peer] European Mol Biol Lab, D-69117 Heidelberg, Germany; [Li, Junhua] S China Univ Technol, Sch Biosci & Biotechnol, Guangzhou 510006, Guangdong, Peoples R China; [Jorgensen, Torben] Glostrup Univ Hosp, Res Ctr Prevent & Hlth, DK-2900 Glostrup, Denmark; [Jorgensen, Torben] Univ Copenhagen, Fac Hlth & Med Sci, DK-2200 Copenhagen, Denmark; [Jorgensen, Torben] Aalborg Univ, Fac Med, Inst Publ Hlth, DK-9100 Aalborg, Denmark; [Brandslund, Ivan] Vejle Hosp, Dept Clin Biochem, DK-7100 Vejle, Denmark; [Brandslund, Ivan] Univ Southern Denmark, Inst Reg Hlth Res, DK-8200 Odense, Denmark; [Nielsen, Henrik Bjorn; Juncker, Agnieszka S.; Bertalan, Marcelo; Rasmussen, Simon; Brunak, Soren; Sicheritz-Ponten, Thomas] Tech Univ Denmark, Ctr Biol Sequence Anal, DK-2800 Lyngby, Denmark; [Nielsen, Henrik Bjorn; Juncker, Agnieszka S.; Bertalan, Marcelo; Rasmussen, Simon; Brunak, Soren; Sicheritz-Ponten, Thomas] Tech Univ Denmark, Novo Nordisk Fdn, Ctr Biosustainabil, DK-2800 Lyngby, Denmark; [Tims, Sebastian; Zoetendal, Erwin G.; Kleerebezem, Michiel; de Vos, Willem M.] Wageningen Univ, Lab Microbiol, NL-6710 BA Ede, Netherlands; [Clement, Karine] Ctr Rech Cordeliers, Inst Natl Sante & Rech Med, U872, Equipe 7, F-75006 Paris, France; [Clement, Karine; Zucker, Jean-Daniel] Univ Paris 06, F-75006 Paris, France; [Clement, Karine] CRNH Ile France, Inst Cardiometab & Nutr, AP HP, F-75013 Paris, France; [Dore, Joel; Renault, Pierre] INRA, MICALIS, UMR14121, F-78350 Jouy En Josas, France; [Kristiansen, Karsten] Univ Copenhagen, Dept Biol, DK-2200 Copenhagen, Denmark; [de Vos, Willem M.] Univ Helsinki, Dept Bacteriol & Immunol, FIN-00014 Helsinki, Finland; [Zucker, Jean-Daniel] Inst Rech Dev, UMI 209, Unite Modelisat Math & Informat Syst Complexes, F-93143 Bondy, France; [Hansen, Torben] Univ Southern Denmark, Fac Hlth Sci, DK-8200 Odense, Denmark; [Wang, Jun] King Abdulaziz Univ, Jeddah 21589, Saudi Arabia; [Wang, Jun] Univ Copenhagen, Novo Nordisk Fdn, Ctr Basic Metab Res, DK-2200 Copenhagen, Denmark; [Wang, Jun] Aarhus Univ, Ctr Sequencing, DK-8000 Aarhus C, Denmark; [Pedersen, Oluf] Hagedorn Res Inst, DK-2820 Gentofte, Denmark; [Pedersen, Oluf] Univ Copenhagen, Fac Hlth & Med Sci, Inst Biomed Sci, DK-2200 Copenhagen, Denmark; [Pedersen, Oluf] Aarhus Univ, Fac Hlth, DK-8000 Aarhus, Denmark	INRAE; UDICE-French Research Universities; Universite Paris Saclay; Novo Nordisk Foundation; University of Copenhagen; Beijing Genomics Institute (BGI); Flanders Institute for Biotechnology (VIB); Vrije Universiteit Brussel; European Molecular Biology Laboratory (EMBL); South China University of Technology; University of Copenhagen; University of Copenhagen; Aalborg University; University of Southern Denmark; Lillebaelt Hospital; University of Southern Denmark; Technical University of Denmark; Novo Nordisk Foundation; Technical University of Denmark; Wageningen University & Research; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); UDICE-French Research Universities; Sorbonne Universite; AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay; University of Copenhagen; University of Helsinki; Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Sorbonne Universite; University of Southern Denmark; King Abdulaziz University; Novo Nordisk Foundation; University of Copenhagen; Aarhus University; Novo Nordisk; Hagedorn Research Institute; University of Copenhagen; Aarhus University	Bork, P (corresponding author), European Mol Biol Lab, Meyerhofstr 1, D-69117 Heidelberg, Germany.	bork@embl.de; wangj@genomics.org.cn; dusko.ehrlich@jouy.inra.fr; oluf@sund.ku.dk	ZUCKER, Jean-Daniel/K-3008-2016; Arumugam, Manimozhiyan/AAJ-2394-2020; Rasmussen, Simon/AAA-2308-2020; Grarup, Niels/K-2807-2015; Falony, Gwen/AAN-5011-2020; Nielsen, Henrik/B-8961-2019; raes, jeroen/D-7835-2018; Pedersen, Oluf/AAG-8015-2020; Guedon, Eric/S-5635-2016; Knol, Jan/AAL-6487-2020; Kleerebezem, Michiel/AAT-2078-2021; Bork, Peer/F-1813-2013; Prifti, Edi/F-3967-2019; Rescigno, Maria/J-9704-2012; Pedersen, Oluf/Z-1731-2019; Knol, Jan/A-2178-2010; Li, Junhua/AAG-3919-2019; GUEDON, Eric/N-8624-2019; Veiga, Patrick/A-9862-2011; LE CHATELIER, Emmanuelle/O-1243-2017; Dore, Joel/ABA-8921-2020; Hildebrand, Falk/K-1914-2014; Kristiansen, Karsten/J-5148-2014; Leclerc, Marion/AAZ-3950-2021; Wang, Jun/A-7261-2013; Guarner, Francisco/ABF-1192-2020; Ehrlich, S./Y-2423-2019; Tap, Julien/E-5760-2010; Borruel, Natalia/AFO-6891-2022; Jørgensen, Torben/Z-1335-2018; BLOTTIERE, Hervé M/C-6120-2011; Clément, karine/R-1120-2017; Sunagawa, Shinichi/Q-5950-2019; van Hylckama Vlieg, Johan/F-7887-2014; Guédon, Eric/AAP-4143-2021; Rasmussen, Simon/G-6258-2016; Arumugam, Manimozhiyan/E-1211-2011; Brunak, Soren/O-6621-2016; Sicheritz-Ponten, Thomas/A-4325-2017; Wang, Jun/B-9503-2016; Wang, Jun/C-8434-2016	ZUCKER, Jean-Daniel/0000-0002-5597-7922; Arumugam, Manimozhiyan/0000-0002-0886-9101; Rasmussen, Simon/0000-0001-6323-9041; Grarup, Niels/0000-0001-5526-1070; Falony, Gwen/0000-0003-2450-0782; Nielsen, Henrik/0000-0003-2281-5713; raes, jeroen/0000-0002-1337-041X; Guedon, Eric/0000-0002-0901-4447; Knol, Jan/0000-0002-2103-5961; Bork, Peer/0000-0002-2627-833X; Prifti, Edi/0000-0001-8861-1305; Rescigno, Maria/0000-0002-6464-509X; Pedersen, Oluf/0000-0002-3321-3972; Knol, Jan/0000-0002-2103-5961; Li, Junhua/0000-0001-6784-1873; GUEDON, Eric/0000-0002-0901-4447; Veiga, Patrick/0000-0001-6318-8547; LE CHATELIER, Emmanuelle/0000-0002-2724-0536; Hildebrand, Falk/0000-0002-0078-8948; Kristiansen, Karsten/0000-0002-6024-0917; Leclerc, Marion/0000-0001-8684-2847; Guarner, Francisco/0000-0002-4051-0836; Ehrlich, S./0000-0002-7563-4046; Tap, Julien/0000-0001-8998-5413; Borruel, Natalia/0000-0002-4449-2292; BLOTTIERE, Hervé M/0000-0002-8390-0607; Sunagawa, Shinichi/0000-0003-3065-0314; van Hylckama Vlieg, Johan/0000-0001-6656-8668; Rasmussen, Simon/0000-0001-6323-9041; Arumugam, Manimozhiyan/0000-0002-0886-9101; Derrien, Muriel/0000-0001-8841-9153; Delorme, Christine/0000-0002-5208-7238; Hansen, Torben/0000-0001-8748-3831; Pelletier, Eric/0000-0003-4228-1712; Chaysavanh, Manichanh/0000-0002-2287-4003; TORREJON, ANTONIO/0000-0002-3126-1532; Brunak, Soren/0000-0003-0316-5866; Kleerebezem, Michiel/0000-0001-8552-2235; Sicheritz-Ponten, Thomas/0000-0001-6615-1141; Nielsen, Trine/0000-0002-2066-7895; Brandslund, Ivan/0000-0002-4203-5442; Wang, Jun/0000-0002-2113-5874; Varela Castro, Encarna/0000-0001-6334-9320; Jorgensen, Torben/0000-0001-9453-2830; Kennedy, Sean/0000-0002-3932-8922; Burgdorf, Kristoffer/0000-0001-5814-6844; Wang, Jun/0000-0002-8540-8931	European Community [HEALTH-F4-2007-201052]; Lundbeck Foundation Centre for Applied Medical Genomics in Personalized Disease Prediction, Prevention and Care (LuCamp); ANR MicroObes, the Metagenopolis grant [ANR-11-DPBS-0001]; Region Ile de France (CODDIM); Fondacoeur; Novo Nordisk Foundation; Novo Nordisk Fonden [NNF10CC1016517] Funding Source: researchfish	European Community(European Commission); Lundbeck Foundation Centre for Applied Medical Genomics in Personalized Disease Prediction, Prevention and Care (LuCamp); ANR MicroObes, the Metagenopolis grant(French National Research Agency (ANR)); Region Ile de France (CODDIM)(Region Ile-de-France); Fondacoeur; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Novo Nordisk Fonden(Novo Nordisk Foundation)	The authors wish to thank A. Forman, T. Lorentzen, B. Andreasen, G. J. Klavsen and M. M. Andersen for technical assistance; A. L. Nielsen, G. Lademann and M. M. H. Kristensen for management assistance, K. Kiil for discussions and assistance, and A. Walker for comments on the manuscript. This research has received funding from European Community's Seventh Framework Program (FP7/2007-2013): MetaHIT, grant agreement HEALTH-F4-2007-201052. Additional funding came from The Lundbeck Foundation Centre for Applied Medical Genomics in Personalized Disease Prediction, Prevention and Care (LuCamp, http://www.lucamp.org), ANR MicroObes, the Metagenopolis grant ANR-11-DPBS-0001, Region Ile de France (CODDIM) and Fondacoeur. The Novo Nordisk Foundation Center for Basic Metabolic Research is an independent Research Center at the University of Copenhagen partially funded by an unrestricted donation from the Novo Nordisk Foundation (http://www.metabol.ku.dk).	Ajslev TA, 2011, INT J OBESITY, V35, P522, DOI 10.1038/ijo.2011.27; Allison DB, 1996, INT J OBESITY, V20, P501; Arumugam M, 2011, NATURE, V473, P174, DOI 10.1038/nature09944; Backhed F, 2004, P NATL ACAD SCI USA, V101, P15718, DOI 10.1073/pnas.0407076101; Backhed F, 2005, SCIENCE, V307, P1915, DOI 10.1126/science.1104816; Backhed F, 2007, P NATL ACAD SCI USA, V104, P979, DOI 10.1073/pnas.0605374104; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Cai ZJ, 1999, WHO TECH REP SER, V887, P1; Chevaleyre Y., 2013, P 30 INT C MACH LEAR, V28, P651; Cho I, 2012, NATURE, V488, P621, DOI 10.1038/nature11400; Claesson MJ, 2012, NATURE, V488, P178, DOI 10.1038/nature11319; Costello EK, 2009, SCIENCE, V326, P1694, DOI 10.1126/science.1177486; Devillard E, 2007, J BACTERIOL, V189, P2566, DOI 10.1128/JB.01359-06; Duncan SH, 2008, INT J OBESITY, V32, P1720, DOI 10.1038/ijo.2008.155; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Furet JP, 2010, DIABETES, V59, P3049, DOI 10.2337/db10-0253; Heid IM, 2010, NAT GENET, V42, P949, DOI 10.1038/ng.685; Jensen LJ, 2008, NUCLEIC ACIDS RES, V36, pD250, DOI 10.1093/nar/gkm796; Joossens M, 2011, GUT, V60, P631, DOI 10.1136/gut.2010.223263; Jorgensen Torben, 2003, Eur J Cardiovasc Prev Rehabil, V10, P377; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Kelly T, 2008, INT J OBESITY, V32, P1431, DOI 10.1038/ijo.2008.102; Lepage P, 2011, GASTROENTEROLOGY, V141, P227, DOI 10.1053/j.gastro.2011.04.011; Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Lindgren CM, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000508; Loos RJF, 2008, NAT GENET, V40, P768, DOI 10.1038/ng.140; Maes HHM, 1997, BEHAV GENET, V27, P325, DOI 10.1023/A:1025635913927; Mandard S, 2006, J BIOL CHEM, V281, P934, DOI 10.1074/jbc.M506519200; Manichanh C, 2006, GUT, V55, P205, DOI 10.1136/gut.2005.073817; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Membrez M, 2008, FASEB J, V22, P2416, DOI 10.1096/fj.07-102723; Obesity and Overweight, 2006, OB OV FACT SHEET 311; Ouchi N, 2011, NAT REV IMMUNOL, V11, P85, DOI 10.1038/nri2921; Png CW, 2010, AM J GASTROENTEROL, V105, P2420, DOI 10.1038/ajg.2010.281; Qin JJ, 2012, NATURE, V490, P55, DOI 10.1038/nature11450; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Rajilic-Stojanovic M, 2009, ENVIRON MICROBIOL, V11, P1736, DOI 10.1111/j.1462-2920.2009.01900.x; Schwiertz A, 2010, OBESITY, V18, P190, DOI 10.1038/oby.2009.167; Shoelson SE, 2006, J CLIN INVEST, V116, P1793, DOI 10.1172/JCI29069; Sokol H, 2008, P NATL ACAD SCI USA, V105, P16731, DOI 10.1073/pnas.0804812105; Speliotes EK, 2010, NAT GENET, V42, P937, DOI 10.1038/ng.686; STUNKARD AJ, 1990, NEW ENGL J MED, V322, P1483, DOI 10.1056/NEJM199005243222102; Sun YJ, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq872; Swidsinski A, 2005, J CLIN MICROBIOL, V43, P3380, DOI 10.1128/JCM.43.7.3380-3389.2005; Thorleifsson G, 2009, NAT GENET, V41, P18, DOI 10.1038/ng.274; TREUTH MS, 1995, AM J CLIN NUTR, V62, P527, DOI 10.1093/ajcn/62.3.527; Turnbaugh PJ, 2008, CELL HOST MICROBE, V3, P213, DOI 10.1016/j.chom.2008.02.015; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Vijay-Kumar M, 2010, SCIENCE, V328, P228, DOI 10.1126/science.1179721; Willer CJ, 2009, NAT GENET, V41, P25, DOI 10.1038/ng.287; Wu GD, 2011, SCIENCE, V334, P105, DOI 10.1126/science.1208344; Yang B, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S2-S5; Yatsunenko T, 2012, NATURE, V486, P222, DOI 10.1038/nature11053	56	2573	2652	30	967	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 29	2013	500	7464					541	+		10.1038/nature12506	http://dx.doi.org/10.1038/nature12506			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	207TD	23985870				2022-12-24	WOS:000323625900026
J	Yoshida-Moriguchi, T; Willer, T; Anderson, ME; Venzke, D; Whyte, T; Muntoni, F; Lee, H; Nelson, SF; Yu, LP; Campbell, KP				Yoshida-Moriguchi, Takako; Willer, Tobias; Anderson, Mary E.; Venzke, David; Whyte, Tamieka; Muntoni, Francesco; Lee, Hane; Nelson, Stanley F.; Yu, Liping; Campbell, Kevin P.			SGK196 Is a Glycosylation-Specific O-Mannose Kinase Required for Dystroglycan Function	SCIENCE			English	Article							CONGENITAL MUSCULAR-DYSTROPHY; WALKER-WARBURG SYNDROME; ALPHA-DYSTROGLYCAN; LAMININ-BINDING; MUTATIONS; ISPD	Phosphorylated O-mannosyl trisaccharide [N-acetylgalactosamine-beta 3-N-acetylglucosamine-beta 4-(phosphate-6-)mannose] is required for dystroglycan to bind laminin-G domain-containing extracellular proteins with high affinity in muscle and brain. However, the enzymes that produce this structure have not been fully elucidated. We found that glycosyltransferase-like domain-containing 2 (GTDC2) is a protein O-linked mannose beta 1,4-N-acetylglucosaminyltransferase whose product could be extended by beta 1,3-N-acetylgalactosaminyltransferase2 (B3GALNT2) to form the O-mannosyl trisaccharide. Furthermore, we identified SGK196 as an atypical kinase that phosphorylated the 6-position of O-mannose, specifically after the mannose had been modified by both GTDC2 and B3GALNT2. These findings suggest how mutations in GTDC2, B3GALNT2, and SGK196 disrupt dystroglycan receptor function and lead to congenital muscular dystrophy.	[Yoshida-Moriguchi, Takako; Willer, Tobias; Anderson, Mary E.; Venzke, David; Campbell, Kevin P.] Univ Iowa, Roy J & Lucille A Carver Coll Med, Howard Hughes Med Inst,Dept Neurol, Dept Mol Physiol & Biophys,Dept Internal Med, Iowa City, IA 52242 USA; [Whyte, Tamieka; Muntoni, Francesco] Inst Child Hlth, Div Neurosci, Dubowitz Neuromuscular Ctr, London, England; [Whyte, Tamieka; Muntoni, Francesco] Great Ormond St Hosp Sick Children, London WC1N 3JH, England; [Lee, Hane; Nelson, Stanley F.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Human Genet, Los Angeles, CA 90095 USA; [Yu, Liping] Univ Iowa, Roy J & Lucille A Carver Coll Med, Med Nucl Magnet Resonance Facil, Iowa City, IA 52242 USA	Howard Hughes Medical Institute; University of Iowa; University of London; University College London; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Iowa	Campbell, KP (corresponding author), Univ Iowa, Roy J & Lucille A Carver Coll Med, Howard Hughes Med Inst,Dept Neurol, Dept Mol Physiol & Biophys,Dept Internal Med, 4283 Carver Biomed Res Bldg,285 Newton Rd, Iowa City, IA 52242 USA.	kevin-campbell@uiowa.edu	Nelson, Stanley F/D-4771-2009	Nelson, Stanley F/0000-0002-2082-3114; Yu, Liping/0000-0003-3536-6427; Campbell, Kevin/0000-0003-2066-5889; Venzke, David/0000-0001-8180-9562	Paul D. Wellstone Muscular Dystrophy Cooperative Research Center [1U54NS053672]; Muscular Dystrophy Campaign; Great Ormond Street Hospital Children Charity; MRC [MR/K000608/1] Funding Source: UKRI; Medical Research Council [MR/K000608/1] Funding Source: researchfish; Rosetrees Trust [M145] Funding Source: researchfish; Muscular Dystrophy UK [RA4/924, RA4/0924] Funding Source: researchfish; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL079031] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR057230] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U54NS053672] Funding Source: NIH RePORTER	Paul D. Wellstone Muscular Dystrophy Cooperative Research Center; Muscular Dystrophy Campaign(Muscular Dystrophy AssociationEuropean Commission); Great Ormond Street Hospital Children Charity; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Rosetrees Trust(Rosetrees Trust); Muscular Dystrophy UK; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank all members of the Campbell laboratory, C. M. Brenner, and C. M. Blaumueller for fruitful discussions; Y. Hara for making an adenovirus vector; H. van Bokhoven for providing patient cells; J. R. Levy for helping imaging studies; H. Nguyen for graphical arts; and the University of Iowa Proteomics Facility and Gene Transfer Vector Core for their services. This work was supported in part by a Paul D. Wellstone Muscular Dystrophy Cooperative Research Center grant (1U54NS053672, K.P.C.), the Muscular Dystrophy Campaign, and the Great Ormond Street Hospital Children Charity (F.M.). K.P.C. is an Investigator of the Howard Hughes Medical Institute. The data are included in the paper and the supplementary materials.	Barresi R, 2006, J CELL SCI, V119, P199, DOI 10.1242/jcs.02814; Buysse K, 2013, HUM MOL GENET, V22, P1746, DOI 10.1093/hmg/ddt021; Chiba A, 1997, J BIOL CHEM, V272, P2156; Hara Y, 2011, P NATL ACAD SCI USA, V108, P17426, DOI 10.1073/pnas.1114836108; Hiruma T, 2004, J BIOL CHEM, V279, P14087, DOI 10.1074/jbc.M310614200; Inamori K, 2012, SCIENCE, V335, P93, DOI 10.1126/science.1214115; Jae LT, 2013, SCIENCE, V340, P479, DOI 10.1126/science.1233675; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Manya H, 2004, P NATL ACAD SCI USA, V101, P500, DOI 10.1073/pnas.0307228101; Manzini MC, 2012, AM J HUM GENET, V91, P541, DOI 10.1016/j.ajhg.2012.07.009; Michele DE, 2002, NATURE, V418, P417, DOI 10.1038/nature00837; Stalnaker SH, 2011, J BIOL CHEM, V286, P21180, DOI 10.1074/jbc.M110.203281; Stevens E, 2013, AM J HUM GENET, V92, P354, DOI 10.1016/j.ajhg.2013.01.016; Vuillaumier-Barrot S, 2012, AM J HUM GENET, V91, P1135, DOI 10.1016/j.ajhg.2012.10.009; Willer T, 2012, NAT GENET, V44, P575, DOI 10.1038/ng.2252; Yoshida-Moriguchi T, 2010, SCIENCE, V327, P88, DOI 10.1126/science.1180512	16	144	152	0	43	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 23	2013	341	6148					896	899		10.1126/science.1239951	http://dx.doi.org/10.1126/science.1239951			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204MY	23929950	Green Accepted			2022-12-24	WOS:000323370600045
J	Millien, VO; Lu, W; Shaw, J; Yuan, XY; Mak, G; Roberts, L; Song, LZ; Knight, JM; Creighton, CJ; Luong, A; Kheradmand, F; Corry, DB				Millien, Valentine Ongeri; Lu, Wen; Shaw, Joanne; Yuan, Xiaoyi; Mak, Garbo; Roberts, Luz; Song, Li-Zhen; Knight, J. Morgan; Creighton, Chad J.; Luong, Amber; Kheradmand, Farrah; Corry, David B.			Cleavage of Fibrinogen by Proteinases Elicits Allergic Responses Through Toll-Like Receptor 4	SCIENCE			English	Article							CELLS; ANTIGEN; INTERLEUKIN-4; ACTIVATION; DEFENSE; ASTHMA; FUNGI; IL-4	Proteinases and the innate immune receptor Toll-like receptor 4 (TLR4) are essential for expression of allergic inflammation and diseases such as asthma. A mechanism that links these inflammatory mediators is essential for explaining the fundamental basis of allergic disease but has been elusive. Here, we demonstrate that TLR4 is activated by airway proteinase activity to initiate both allergic airway disease and antifungal immunity. These outcomes were induced by proteinase cleavage of the clotting protein fibrinogen, yielding fibrinogen cleavage products that acted as TLR4 ligands on airway epithelial cells and macrophages. Thus, allergic airway inflammation represents an antifungal defensive strategy that is driven by fibrinogen cleavage and TLR4 activation. These findings clarify the molecular basis of allergic disease and suggest new therapeutic strategies.	[Millien, Valentine Ongeri; Kheradmand, Farrah; Corry, David B.] Baylor Coll Med, Translat Biol & Mol Med Program, Houston, TX 77030 USA; [Lu, Wen; Yuan, Xiaoyi; Knight, J. Morgan; Kheradmand, Farrah; Corry, David B.] Baylor Coll Med, Dept Pathol & Immunol, Houston, TX 77030 USA; [Shaw, Joanne; Mak, Garbo; Roberts, Luz; Song, Li-Zhen; Kheradmand, Farrah; Corry, David B.] Baylor Coll Med, Dept Med, Houston, TX 77030 USA; [Creighton, Chad J.] Baylor Coll Med, Dan L Duncan Canc Ctr, Houston, TX 77030 USA; [Luong, Amber] Univ Texas Hlth Sci Ctr Houston, Dept Otorhinolaryngol Head & Neck Surg, Houston, TX 77030 USA; [Kheradmand, Farrah; Corry, David B.] Baylor Coll Med, Biol Inflammat Ctr, Houston, TX 77030 USA; [Kheradmand, Farrah; Corry, David B.] Michael E DeBakey VA Med Ctr, Houston, TX USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; University of Texas System; University of Texas Health Science Center Houston; Baylor College of Medicine; Baylor College of Medicine	Kheradmand, F (corresponding author), Baylor Coll Med, Translat Biol & Mol Med Program, Houston, TX 77030 USA.	farrahk@bcm.edu; dcorry@bcm.edu	Lu, Wen/C-6543-2019		NIH [HL75243, AI057696, AI070973, CA125123, T32GM088129, R25GM56929]; C.N. and Mary V. Papadopoulos Charitable Fund from the Biology of Inflammation Center; NATIONAL CANCER INSTITUTE [P30CA125123] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K02HL075243, R01HL095382, R01HL117181] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI057696, U19AI070973] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM088129, R25GM056929] Funding Source: NIH RePORTER; Veterans Affairs [I01BX002221] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); C.N. and Mary V. Papadopoulos Charitable Fund from the Biology of Inflammation Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Veterans Affairs(US Department of Veterans Affairs)	The data presented in this paper are tabulated in the main paper and in the supplementary materials. Microarray data are available through the National Center for Biotechnology Information Gene Expression Omnibus, accession number GSE48609. We thank Y. Qian, T. Bird, and Y. Zhang for excellent technical assistance. Funding was provided by NIH grants HL75243, AI057696, and AI070973 (to D. B. C.); CA125123 (to C.J.C.); and T32GM088129 and R25GM56929 (to V.O.M.) and the C.N. and Mary V. Papadopoulos Charitable Fund from the Biology of Inflammation Center.	Casanova JL, 2011, ANNU REV IMMUNOL, V29, P447, DOI 10.1146/annurev-immunol-030409-101335; Clarke AH, 1999, INT ARCH ALLERGY IMM, V120, P126, DOI 10.1159/000024230; Dabbagh K, 2002, J IMMUNOL, V168, P4524, DOI 10.4049/jimmunol.168.9.4524; Eisenbarth SC, 2002, J EXP MED, V196, P1645, DOI 10.1084/jem.20021340; FINKELMAN FD, 1988, J IMMUNOL, V141, P2335; GAY NJ, 1992, BIOCHIM BIOPHYS ACTA, V1132, P290, DOI 10.1016/0167-4781(92)90163-T; Halim TYF, 2012, IMMUNITY, V36, P451, DOI 10.1016/j.immuni.2011.12.020; Hammad H, 2009, NAT MED, V15, P410, DOI 10.1038/nm.1946; Hodgkinson CR, 2008, THROMB HAEMOSTASIS, V100, P301, DOI 10.1160/TH08-03-0179; Jozefowski S, 2012, INFLAMM RES, V61, P113, DOI 10.1007/s00011-011-0395-5; Kelada SNP, 2011, AM J RESP CELL MOL, V45, P817, DOI 10.1165/rcmb.2010-0315OC; Kheradmand F, 2002, J IMMUNOL, V169, P5904, DOI 10.4049/jimmunol.169.10.5904; Lamhamedi-Cherradi SE, 2008, J IMMUNOL, V180, P6000, DOI 10.4049/jimmunol.180.9.6000; Lim KC, 1999, AM J TROP MED HYG, V60, P487, DOI 10.4269/ajtmh.1999.60.487; Mills CD, 2001, CRIT REV IMMUNOL, V21, P399, DOI 10.1615/critrevimmunol.v21.i5.10; Munitz A, 2008, P NATL ACAD SCI USA, V105, P7240, DOI 10.1073/pnas.0802465105; Okamura Y, 2001, J BIOL CHEM, V276, P10229, DOI 10.1074/jbc.M100099200; PENE J, 1988, P NATL ACAD SCI USA, V85, P6880, DOI 10.1073/pnas.85.18.6880; Piggott DA, 2005, J CLIN INVEST, V115, P459, DOI 10.1172/JCI200522462; Porter P, 2009, MUCOSAL IMMUNOL, V2, P504, DOI 10.1038/mi.2009.102; Singh M, 2010, J ALLERGY CLIN IMMUN, V125, P1369, DOI 10.1016/j.jaci.2010.02.035; SNAPPER CM, 1988, J EXP MED, V167, P183, DOI 10.1084/jem.167.1.183; STEVENS TL, 1988, NATURE, V334, P255, DOI 10.1038/334255a0; Tomee JFC, 1997, J INFECT DIS, V176, P740, DOI 10.1086/514098; Trompette A, 2009, NATURE, V457, P585, DOI 10.1038/nature07548; Woods CM, 2011, AM J RHINOL ALLERGY, V25, P236, DOI 10.2500/ajra.2011.25.3631	26	154	161	1	40	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 16	2013	341	6147					792	796		10.1126/science.1240342	http://dx.doi.org/10.1126/science.1240342			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201DZ	23950537	Green Accepted			2022-12-24	WOS:000323122200050
J	Nussbaum, JC; Van Dyken, SJ; von Moltke, J; Cheng, LE; Mohapatra, A; Molofsky, AB; Thornton, EE; Krummel, MF; Chawla, A; Liang, HE; Locksley, RM				Nussbaum, Jesse C.; Van Dyken, Steven J.; von Moltke, Jakob; Cheng, Laurence E.; Mohapatra, Alexander; Molofsky, Ari B.; Thornton, Emily E.; Krummel, Matthew F.; Chawla, Ajay; Liang, Hong-Erh; Locksley, Richard M.			Type 2 innate lymphoid cells control eosinophil homeostasis	NATURE			English	Article							VASOACTIVE-INTESTINAL-PEPTIDE; VPAC(2) RECEPTOR; DEFICIENT MICE; IMMUNITY; LUNG; SIGNALS; MOUSE	Eosinophils are specialized myeloid cells associated with allergy and helminth infections. Blood eosinophils demonstrate circadian cycling, as described over 80 years ago(1), and are abundant in the healthy gastrointestinal tract. Although a cytokine, interleukin (IL)-5, and chemokines such as eotaxins mediate eosinophil development and survival(2), and tissue recruitment(3), respectively, the processes underlying the basal regulation of these signals remain unknown. Here we show that serum IL-5 levels are maintained by long-lived type 2 innate lymphoid cells (ILC2) resident in peripheral tissues. ILC2 cells secrete IL-5 constitutively and are induced to co-express IL-13 during type 2 inflammation, resulting in localized eotaxin production and eosinophil accumulation. In the small intestine where eosinophils and eotaxin are constitutive(4), ILC2 cells co-express IL-5 and IL-13; this co-expression is enhanced after caloric intake. The circadian synchronizer vasoactive intestinal peptide also stimulates ILC2 cells through the VPAC2 receptor to release IL-5, linking eosinophil levels with metabolic cycling. Tissue ILC2 cells regulate basal eosinophilopoiesis and tissue eosinophil accumulation through constitutive and stimulated cytokine expression, and this dissociated regulation can be tuned by nutrient intake and central circadian rhythms.	[Nussbaum, Jesse C.; Van Dyken, Steven J.; von Moltke, Jakob; Chawla, Ajay; Liang, Hong-Erh; Locksley, Richard M.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Cheng, Laurence E.] Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94143 USA; [Mohapatra, Alexander; Locksley, Richard M.] Univ Calif San Francisco, Dept Microbiol, San Francisco, CA 94143 USA; [Mohapatra, Alexander; Locksley, Richard M.] Univ Calif San Francisco, Dept Immunol, San Francisco, CA 94143 USA; [Molofsky, Ari B.] Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA; [Thornton, Emily E.; Krummel, Matthew F.] Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94143 USA; [Chawla, Ajay] Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94143 USA; [Chawla, Ajay] Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94143 USA; [Locksley, Richard M.] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco	Locksley, RM (corresponding author), Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA.	locksley@medicine.ucsf.edu		Molofsky, Ari/0000-0003-0764-3175; Thornton, Emily/0000-0002-0068-2502; Van Dyken, Steven/0000-0002-9787-0883	NIH [AI026918, AI030663, AI078869, HL107202, AI007641, AI007334]; Diabetes Endocrinology Research Center [DK063720]; Howard Hughes Medical Institute; Sandler Asthma Basic Research Center at the University of California San Francisco; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD044331] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL024136, P01HL107202] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI077439, T32AI007641, R37AI026918, P01AI078869, R01AI030663, R01AI026918, T32AI007334] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [DP1AR064158] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK063720] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007618] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Diabetes Endocrinology Research Center; Howard Hughes Medical Institute(Howard Hughes Medical Institute); Sandler Asthma Basic Research Center at the University of California San Francisco; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the NIH Tetramer Core Facility for reagents, B. Sullivan, N. Flores, M. Consengco and Z. Wang for technical expertise, and M. Anderson, C. Lowell and M. McCune for comments on the manuscript. Supported by NIH (AI026918, AI030663, AI078869, HL107202), the Diabetes Endocrinology Research Center grant (DK063720), the Howard Hughes Medical Institute and the Sandler Asthma Basic Research Center at the University of California San Francisco. J.C.N. is supported by NIH training grants (AI007641 and AI007334).	Carlens J, 2009, J IMMUNOL, V183, P5600, DOI 10.4049/jimmunol.0801581; Colwell CS, 2003, AM J PHYSIOL-REG I, V285, pR939, DOI 10.1152/ajpregu.00200.2003; Dickson L, 2009, PHARMACOL THERAPEUT, V121, P294, DOI 10.1016/j.pharmthera.2008.11.006; Domarus Av, 1931, DTSCH ARCH KLIN MED, V171, P333; HALBERG F, 1953, AM J PHYSIOL, V174, P109, DOI 10.1152/ajplegacy.1953.174.1.109; Harmar AJ, 2002, CELL, V109, P497, DOI 10.1016/S0092-8674(02)00736-5; Ikutani M, 2012, J IMMUNOL, V188, P703, DOI 10.4049/jimmunol.1101270; Kopf M, 1996, IMMUNITY, V4, P15, DOI 10.1016/S1074-7613(00)80294-0; Lelievre V, 2007, PEPTIDES, V28, P1688, DOI 10.1016/j.peptides.2007.05.006; Liang HE, 2012, NAT IMMUNOL, V13, P58, DOI 10.1038/ni.2182; Maywood ES, 2013, P NATL ACAD SCI USA, V110, P9547, DOI 10.1073/pnas.1220894110; Mishra A, 1999, J CLIN INVEST, V103, P1719, DOI 10.1172/JCI6560; Mjosberg JM, 2011, NAT IMMUNOL, V12, P1055, DOI 10.1038/ni.2104; Molofsky AB, 2013, J EXP MED, V210, P535, DOI 10.1084/jem.20121964; Moro K, 2010, NATURE, V463, P540, DOI 10.1038/nature08636; Neill DR, 2010, NATURE, V464, P1367, DOI 10.1038/nature08900; PAULY JE, 1975, ACTA ANAT, V93, P60; Pope SM, 2001, J ALLERGY CLIN IMMUN, V108, P594, DOI 10.1067/mai.2001.118600; Price AE, 2010, P NATL ACAD SCI USA, V107, P11489, DOI 10.1073/pnas.1003988107; Rothenberg ME, 2006, ANNU REV IMMUNOL, V24, P147, DOI 10.1146/annurev.immunol.24.021605.090720; Samarasinghe AE, 2010, PEPTIDES, V31, P1068, DOI 10.1016/j.peptides.2010.03.001; Sheward WJ, 2007, J NEUROSCI, V27, P4351, DOI 10.1523/JNEUROSCI.4843-06.2007; Spits H, 2012, ANNU REV IMMUNOL, V30, P647, DOI 10.1146/annurev-immunol-020711-075053; Sullivan BM, 2011, NAT IMMUNOL, V12, P527, DOI 10.1038/ni.2036; Takatsu K, 2008, CURR OPIN IMMUNOL, V20, P288, DOI 10.1016/j.coi.2008.04.001; Thornton EE, 2012, J EXP MED, V209, P1183, DOI 10.1084/jem.20112667; Tsutsumi M, 2002, DIABETES, V51, P1453, DOI 10.2337/diabetes.51.5.1453; Voice J, 2004, J IMMUNOL, V172, P7289, DOI 10.4049/jimmunol.172.12.7289; Vomhof-DeKrey EE, 2011, PEPTIDES, V32, P2058, DOI 10.1016/j.peptides.2011.08.014; Yoshida T, 1996, IMMUNITY, V4, P483, DOI 10.1016/S1074-7613(00)80414-8	30	662	686	3	103	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 10	2013	502	7470					245	+		10.1038/nature12526	http://dx.doi.org/10.1038/nature12526			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231RU	24037376	Green Accepted, Green Submitted			2022-12-24	WOS:000325436100053
J	Pauklin, S; Vallier, L				Pauklin, Siim; Vallier, Ludovic			The Cell-Cycle State of Stem Cells Determines Cell Fate Propensity	CELL			English	Article							DEPENDENT KINASE; G1 PHASE; RETINOBLASTOMA PROTEIN; DIFFERENTIATION; EXPRESSION; EPIBLAST; PLURIPOTENCY; INHIBITION; FGF; PHOSPHORYLATION	Self-renewal and differentiation of stem cells are fundamentally associated with cell-cycle progression to enable tissue specification, organ homeostasis, and potentially tumorigenesis. However, technical challenges have impaired the study of the molecular interactions coordinating cell fate choice and cell-cycle progression. Here, we bypass these limitations by using the FUCCI reporter system in human pluripotent stem cells and show that their capacity of differentiation varies during the progression of their cell cycle. These mechanisms are governed by the cell-cycle regulators cyclin D1-3 that control differentiation signals such as the TGF-beta-Smad2/3 pathway. Conversely, cell-cycle manipulation using a small molecule directs differentiation of hPSCs and provides an approach to generate cell types with a clinical interest. Our results demonstrate that cell fate decisions are tightly associated with the cell-cycle machinery and reveal insights in the mechanisms synchronizing differentiation and proliferation in developing tissues.	[Pauklin, Siim; Vallier, Ludovic] Univ Cambridge, Anne McLaren Lab Regenerat Med, Wellcome Trust Med Res Council Cambridge Stem Cel, Cambridge CB2 0SZ, England; [Pauklin, Siim; Vallier, Ludovic] Univ Cambridge, Dept Surg, Cambridge CB2 0SZ, England; [Vallier, Ludovic] Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England	University of Cambridge; University of Cambridge; Wellcome Trust Sanger Institute	Pauklin, S (corresponding author), Univ Cambridge, Anne McLaren Lab Regenerat Med, Wellcome Trust Med Res Council Cambridge Stem Cel, Cambridge CB2 0SZ, England.	sp579@cam.ac.uk; lv225@cam.ac.uk	vallier, ludovic/C-6368-2011	Vallier, Ludovic/0000-0002-3848-2602	MRC Senior nonclinical fellowship; Cambridge Hospitals National Institute for Health Research Biomedical Research Center; FEBS long-term fellowship; Medical Research Council [G0701448] Funding Source: researchfish; MRC [G0701448] Funding Source: UKRI	MRC Senior nonclinical fellowship(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cambridge Hospitals National Institute for Health Research Biomedical Research Center; FEBS long-term fellowship; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank Anne Ferguson-Smith and Michael Stratton for discussions and proofreading and Nigel Miller for help with cell sorting experiments. This work was supported by the MRC Senior nonclinical fellowship and the Cambridge Hospitals National Institute for Health Research Biomedical Research Center (L.V.). S.P. was funded by FEBS long-term fellowship. S.P. and L.V. conceived the research and wrote the manuscript.	Brons IGM, 2007, NATURE, V448, P191, DOI 10.1038/nature05950; Brown S, 2011, STEM CELLS, V29, P1176, DOI 10.1002/stem.666; Calder A, 2013, STEM CELLS DEV, V22, P279, DOI 10.1089/scd.2012.0168; Chambers SM, 2009, NAT BIOTECHNOL, V27, P275, DOI 10.1038/nbt.1529; Chng ZZ, 2010, CELL STEM CELL, V6, P59, DOI 10.1016/j.stem.2009.11.015; Cho CHH, 2012, DIABETOLOGIA, V55, P3284, DOI 10.1007/s00125-012-2687-x; Coronado D, 2013, STEM CELL RES, V10, P118, DOI 10.1016/j.scr.2012.10.004; D'Amour KA, 2005, NAT BIOTECHNOL, V23, P1534, DOI 10.1038/nbt1163; Diehl JA, 1997, MOL CELL BIOL, V17, P7362, DOI 10.1128/MCB.17.12.7362; Fry DW, 2004, MOL CANCER THER, V3, P1427; Fuchs E, 2009, CELL, V137, P811, DOI 10.1016/j.cell.2009.05.002; Kozar K, 2004, CELL, V118, P477, DOI 10.1016/j.cell.2004.07.025; Kretzschmar M, 1999, GENE DEV, V13, P804, DOI 10.1101/gad.13.7.804; Kuijk EW, 2012, DEVELOPMENT, V139, P871, DOI 10.1242/dev.071688; Lange C, 2010, CELL CYCLE, V9, P1893, DOI 10.4161/cc.9.10.11598; Lange C, 2009, CELL STEM CELL, V5, P320, DOI 10.1016/j.stem.2009.05.026; Li LH, 2010, SCIENCE, V327, P542, DOI 10.1126/science.1180794; Lo RS, 1999, NAT CELL BIOL, V1, P472, DOI 10.1038/70258; Matsuura I, 2004, NATURE, V430, P226, DOI 10.1038/nature02650; Mullen AC, 2011, CELL, V147, P565, DOI 10.1016/j.cell.2011.08.050; Neganova I, 2009, ONCOGENE, V28, P20, DOI 10.1038/onc.2008.358; Neganova I, 2011, STEM CELLS, V29, P651, DOI 10.1002/stem.620; Roccio M, 2013, DEVELOPMENT, V140, P459, DOI 10.1242/dev.086215; Roode M, 2012, DEV BIOL, V361, P358, DOI 10.1016/j.ydbio.2011.10.030; Sakaue-Sawano A, 2008, CELL, V132, P487, DOI 10.1016/j.cell.2007.12.033; Savatier P, 1996, ONCOGENE, V12, P309; SAVATIER P, 1994, ONCOGENE, V9, P809; Sela Y, 2012, STEM CELLS, V30, P1097, DOI 10.1002/stem.1078; Tesar PJ, 2007, NATURE, V448, P196, DOI 10.1038/nature05972; Vallier L, 2004, STEM CELLS, V22, P2, DOI 10.1634/stemcells.22-1-2; Vallier L, 2005, J CELL SCI, V118, P4495, DOI 10.1242/jcs.02553; Vallier L, 2009, STEM CELLS, V27, P2655, DOI 10.1002/stem.199; Vallier L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006082; Vallier L, 2009, DEVELOPMENT, V136, P1339, DOI 10.1242/dev.033951; Wianny F, 1998, DEV DYNAM, V212, P49, DOI 10.1002/(SICI)1097-0177(199805)212:1<49::AID-AJA5>3.0.CO;2-2; Xu RH, 2008, CELL STEM CELL, V3, P196, DOI 10.1016/j.stem.2008.07.001	36	376	382	5	75	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	SEP 26	2013	155	1					135	147		10.1016/j.cell.2013.08.031	http://dx.doi.org/10.1016/j.cell.2013.08.031			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	224UX	24074866	Green Published, hybrid			2022-12-24	WOS:000324916700015
J	Iwamoto, H; Yagi, N				Iwamoto, H.; Yagi, N.			The Molecular Trigger for High-Speed Wing Beats in a Bee	SCIENCE			English	Article							X-RAY-DIFFRACTION; STRETCH-ACTIVATION; FLIGHT-MUSCLE; MYOSIN-FILAMENTS; CROSS-BRIDGES; INSECT; ACTIN; DROSOPHILA; SKELETAL; EXTENSIBILITY	The high-frequency wing beat of higher-order insects is driven by self-sustained oscillations of constantly activated flight muscles. However, whether its underlying mechanism is based on flight muscle-specific features or on preexisting contractile functions is unknown. Here, we recorded X-ray diffraction movies, at a rate of 5000 frames/second, simultaneously from the two antagonistic flight muscles of bumblebees during wing beat. Signals that occurred at the right timing for triggering each wing-beat stroke were resolved in both muscles. The signals likely reflect stretch-induced myosin deformation, which would also enhance force in vertebrate muscles. The results suggest that insects use a refined preexisting force-enhancing mechanism for high-frequency wing beat, rather than developing a novel mechanism.	[Iwamoto, H.; Yagi, N.] Japan Synchrotron Radiat Res Inst JASRI, SPring 8, Res & Utilizat Div, Sayo, Hyogo 6795198, Japan	Japan Synchrotron Radiation Research Institute	Iwamoto, H (corresponding author), Japan Synchrotron Radiat Res Inst JASRI, SPring 8, Res & Utilizat Div, 1-1-1 Kouto, Sayo, Hyogo 6795198, Japan.	iwamoto@spring8.or.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan [23612009]; CREST, Japan Science and Technology Agency, Japan	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); CREST, Japan Science and Technology Agency, Japan(Japan Science & Technology Agency (JST))	We thank Photron, Inc., for the use of the demonstration model of the CMOS camera. Performed under approval of SPring-8 (Proposal 2012A1839). Supported by a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan, 23612009 (H.I.) and partly by CREST, Japan Science and Technology Agency, Japan (N.Y.). H.I. and N.Y. planned and performed experiments, analyzed data, and wrote the paper. Data have been deposited in the Dryad Repository (accession: doi: 10.5061/dryad.bt51g).	ABBOTT RH, 1977, J PHYSIOL-LONDON, V266, P13, DOI 10.1113/jphysiol.1977.sp011754; Agianian B, 2004, EMBO J, V23, P772, DOI 10.1038/sj.emboj.7600097; Bekyarova TI, 2008, P NATL ACAD SCI USA, V105, P10372, DOI 10.1073/pnas.0709877105; Bullard B, 2011, J MUSCLE RES CELL M, V32, P303, DOI 10.1007/s10974-011-9278-1; Dickinson M, 2005, NATURE, V433, P330, DOI 10.1038/nature03230; HILL AV, 1949, PROC R SOC SER B-BIO, V136, P399, DOI 10.1098/rspb.1949.0033; HUXLEY HE, 1994, BIOPHYS J, V67, P2411, DOI 10.1016/S0006-3495(94)80728-3; Irving TC, 2000, BIOPHYS J, V78, P2511, DOI 10.1016/S0006-3495(00)76796-8; Iwamoto H, 2003, BIOPHYS J, V85, P2492, DOI 10.1016/S0006-3495(03)74672-4; IWAMOTO H, 1995, BIOPHYS J, V68, P243, DOI 10.1016/S0006-3495(95)80180-3; Iwamoto H, 2007, P R SOC B, V274, P2297, DOI 10.1098/rspb.2007.0607; Iwamoto H, 2011, BIOPHYS J, V100, P11; Iwamoto H, 2010, BIOPHYS J, V99, P184, DOI 10.1016/j.bpj.2010.04.009; Iwamoto H, 2009, J MOL BIOL, V390, P99, DOI 10.1016/j.jmb.2009.05.002; Josephson RK, 2000, J EXP BIOL, V203, P2713; Linari M, 2004, BIOPHYS J, V87, P1101, DOI 10.1529/biophysj.103.037374; Perz-Edwards RJ, 2011, P NATL ACAD SCI USA, V108, P120, DOI 10.1073/pnas.1014599107; PRINGLE JWS, 1978, PROC R SOC SER B-BIO, V201, P107, DOI 10.1098/rspb.1978.0035; Stelzer JE, 2006, J GEN PHYSIOL, V128, P461, DOI 10.1085/jgp.200609634; Swank DM, 2012, METHODS, V56, P69, DOI 10.1016/j.ymeth.2011.10.015; THORSON J, 1983, J PHYSIOL-LONDON, V343, P59, DOI 10.1113/jphysiol.1983.sp014881; Tregear RT, 1998, BIOPHYS J, V74, P1439, DOI 10.1016/S0006-3495(98)77856-7; WAKABAYASHI K, 1994, BIOPHYS J, V67, P2422, DOI 10.1016/S0006-3495(94)80729-5; Wu SP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039422; Wu SP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012643	25	19	19	2	59	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 13	2013	341	6151					1243	1246		10.1126/science.1237266	http://dx.doi.org/10.1126/science.1237266			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	215ZA	23970560				2022-12-24	WOS:000324248800044
J	Yang, H; Wang, HY; Shivalila, CS; Cheng, AW; Shi, LY; Jaenisch, R				Yang, Hui; Wang, Haoyi; Shivalila, Chikdu S.; Cheng, Albert W.; Shi, Linyu; Jaenisch, Rudolf			One-Step Generation of Mice Carrying Reporter and Conditional Alleles by CRISPR/Cas-Mediated Genome Engineering	CELL			English	Article							EMBRYO MICROINJECTION; KNOCKOUT RATS; EXPRESSION; BACTERIA	The type II bacterial CRISPR/Cas system is a novel genome-engineering technology with the ease of multiplexed gene targeting. Here, we created reporter and conditional mutant mice by coinjection of zygotes with Cas9 mRNA and different guide RNAs (sgRNAs) as well as DNA vectors of different sizes. Using this one-step procedure we generated mice carrying a tag or a fluorescent reporter construct in the Nanog, the Sox2, and the Oct4 gene as well as Mecp2 conditional mutant mice. In addition, using sgRNAs targeting two separate sites in the Mecp2 gene, we produced mice harboring the predicted deletions of about 700 bps. Finally, we analyzed potential off-targets of five sgRNAs in gene-modified mice and ESC lines and identified off-target mutations in only rare instances.	[Yang, Hui; Wang, Haoyi; Shivalila, Chikdu S.; Cheng, Albert W.; Shi, Linyu; Jaenisch, Rudolf] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Shivalila, Chikdu S.] MIT, Dept Biol, Cambridge, MA 02142 USA; [Cheng, Albert W.; Jaenisch, Rudolf] MIT, Computat & Syst Biol Program, Cambridge, MA 02142 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Jaenisch, R (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	jaenisch@wi.mit.edu		yang, hui/0000-0003-3590-722X; Cheng, Albert/0000-0003-2653-5743	Croucher scholarship; NIH [HD 045022, R37CA084198]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R37HD045022] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD045022] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R37CA084198] Funding Source: NIH RePORTER	Croucher scholarship; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Ruth Flannery and Kibibi Ganz for support with animal care and experiments. We thank Jaenisch lab members for helpful discussions on the manuscript. We are also grateful to Dina A. Faddah for help with editing the manuscript. A.W.C. is supported by a Croucher scholarship. R.J. is an adviser to Stemgent and a cofounder of Fate Therapeutics. This work was supported by NIH grants HD 045022 and R37CA084198 to R.J.	Brown AJ, 2013, NAT METHODS, V10, P638, DOI 10.1038/nmeth.2516; Capecchi MR, 2005, NAT REV GENET, V6, P507, DOI 10.1038/nrg1619; Chen RZ, 2001, NAT GENET, V27, P327, DOI 10.1038/85906; Cho SW, 2013, NAT BIOTECHNOL, V31, P230, DOI 10.1038/nbt.2507; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Cui XX, 2011, NAT BIOTECHNOL, V29, P64, DOI 10.1038/nbt.1731; Faddah DA, 2013, CELL STEM CELL, V13, P23, DOI 10.1016/j.stem.2013.04.019; Fu YF, 2013, NAT BIOTECHNOL, V31, P822, DOI 10.1038/nbt.2623; Geurts AM, 2009, SCIENCE, V325, P433, DOI 10.1126/science.1172447; Gilbert LA, 2013, CELL, V154, P442, DOI 10.1016/j.cell.2013.06.044; Guschin DY, 2010, METHODS MOL BIOL, V649, P247, DOI 10.1007/978-1-60761-753-2_15; Horvath P, 2010, SCIENCE, V327, P167, DOI 10.1126/science.1179555; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Hwang WY, 2013, NAT BIOTECHNOL, V31, P227, DOI 10.1038/nbt.2501; Jiang WY, 2013, NAT BIOTECHNOL, V31, P233, DOI 10.1038/nbt.2508; Jinek M, 2013, ELIFE, V2, DOI 10.7554/eLife.00471; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Lengner CJ, 2007, CELL STEM CELL, V1, P403, DOI 10.1016/j.stem.2007.07.020; Mali P, 2013, NAT BIOTECHNOL, V31, P833, DOI 10.1038/nbt.2675; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Meyer M, 2010, P NATL ACAD SCI USA, V107, P15022, DOI 10.1073/pnas.1009424107; Qi LS, 2013, CELL, V152, P1173, DOI 10.1016/j.cell.2013.02.022; Shen B, 2013, CELL RES, V23, P720, DOI 10.1038/cr.2013.46; Sung YH, 2013, NAT BIOTECHNOL, V31, P23, DOI 10.1038/nbt.2477; Tesson L, 2011, NAT BIOTECHNOL, V29, P695, DOI 10.1038/nbt.1940; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Wefers B, 2013, P NATL ACAD SCI USA, V110, P3782, DOI 10.1073/pnas.1218721110; Wiedenheft B, 2012, NATURE, V482, P331, DOI 10.1038/nature10886	28	1108	1290	10	354	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 12	2013	154	6					1370	1379		10.1016/j.cell.2013.08.022	http://dx.doi.org/10.1016/j.cell.2013.08.022			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	215VQ	23992847	Green Published, Green Accepted, Bronze			2022-12-24	WOS:000324239300023
J	Yan, J; Enge, M; Whitington, T; Dave, K; Liu, JP; Sur, I; Schmierer, B; Jolma, A; Kivioja, T; Taipale, M; Taipale, J				Yan, Jian; Enge, Martin; Whitington, Thomas; Dave, Kashyap; Liu, Jianping; Sur, Inderpreet; Schmierer, Bernhard; Jolma, Arttu; Kivioja, Teemu; Taipale, Minna; Taipale, Jussi			Transcription Factor Binding in Human Cells Occurs in Dense Clusters Formed around Cohesin Anchor Sites	CELL			English	Article							GENE-EXPRESSION; HUMAN GENOME; NUCLEOSOME ORGANIZATION; HISTONE ACETYLATION; CHROMATIN-STRUCTURE; MITOTIC CHROMATIN; COLORECTAL-CANCER; EUKARYOTIC GENOME; DNA-REPLICATION; SNP RS6983267	During cell division, transcription factors (TFs) are removed from chromatin twice, during DNA synthesis and during condensation of chromosomes. How TFs can efficiently find their sites following these stages has been unclear. Here, we have analyzed the binding pattern of expressed TFs in human colorectal cancer cells. We find that binding of TFs is highly clustered and that the clusters are enriched in binding motifs for several major TF classes. Strikingly, almost all clusters are formed around cohesin, and loss of cohesin decreases both DNA accessibility and binding of TFs to clusters. We show that cohesin remains bound in S phase, holding the nascent sister chromatids together at the TF cluster sites. Furthermore, cohesin remains bound to the cluster sites when TFs are evicted in early M phase. These results suggest that cohesin-binding functions as a cellular memory that promotes re-establishment of TF clusters after DNA replication and chromatin condensation.	[Yan, Jian; Enge, Martin; Whitington, Thomas; Dave, Kashyap; Liu, Jianping; Sur, Inderpreet; Schmierer, Bernhard; Jolma, Arttu; Kivioja, Teemu; Taipale, Minna; Taipale, Jussi] Karolinska Inst, Dept Biosci & Nutr, Sci Life Lab, S-14183 Stockholm, Sweden; [Kivioja, Teemu] Univ Helsinki, Dept Comp Sci, Helsinki 00014, Finland; [Kivioja, Teemu; Taipale, Minna; Taipale, Jussi] Univ Helsinki, Genome Scale Biol Program, FIN-00014 Helsinki, Finland	Karolinska Institutet; University of Helsinki; University of Helsinki	Taipale, J (corresponding author), Karolinska Inst, Dept Biosci & Nutr, Sci Life Lab, S-14183 Stockholm, Sweden.	jussi.taipale@ki.se	Dave, Kashyap/D-3290-2014; Jolma, Arttu/AAK-9649-2021; Yan, Jian/B-2631-2018; Schmierer, Bernhard/P-4208-2019; Enge, Martin/GYQ-5073-2022	Dave, Kashyap/0000-0003-0332-8362; Yan, Jian/0000-0002-1267-2870; Schmierer, Bernhard/0000-0002-9082-7022; Jolma, Arttu/0000-0002-2543-7490; Taipale, Minna/0000-0002-1905-2551; Enge, Martin/0000-0001-8748-8931; Sur, Inderpreet Kaur/0000-0001-5787-1040; Liu, Jianping/0000-0002-7336-3895	EU FP7 project SYSCOL; Goran Gustafssons stiftelse; Knut and Alice Wallenberg Foundation; Vetenskapsradet; Cancerfonden; Center for Biosciences; Academy of Finland Center of Excellence in Cancer Genetics	EU FP7 project SYSCOL; Goran Gustafssons stiftelse; Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Vetenskapsradet(Swedish Research Council); Cancerfonden(Swedish Cancer Society); Center for Biosciences; Academy of Finland Center of Excellence in Cancer Genetics	We thank R. Nurmi, S. Miettinen, S. Augsten, L. Hu, and A. Zetterlund for technical assistance. This work was supported by the EU FP7 project SYSCOL, Goran Gustafssons stiftelse, Knut and Alice Wallenberg Foundation, Vetenskapsradet, Cancerfonden, the Center for Biosciences and the Academy of Finland Center of Excellence in Cancer Genetics.	Badis G, 2009, SCIENCE, V324, P1720, DOI 10.1126/science.1162327; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; BODE J, 1980, EUR J BIOCHEM, V110, P143, DOI 10.1111/j.1432-1033.1980.tb04849.x; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Burke LJ, 2005, EMBO J, V24, P3291, DOI 10.1038/sj.emboj.7600793; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; Faure AJ, 2012, GENOME RES, V22, P2163, DOI 10.1101/gr.136507.111; Garber M, 2012, MOL CELL, V47, P810, DOI 10.1016/j.molcel.2012.07.030; Gerstein MB, 2012, NATURE, V489, P91, DOI 10.1038/nature11245; Giresi PG, 2007, GENOME RES, V17, P877, DOI 10.1101/gr.5533506; Guillou E, 2010, GENE DEV, V24, P2812, DOI 10.1101/gad.608210; Hammar P, 2012, SCIENCE, V336, P1595, DOI 10.1126/science.1221648; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Jin CY, 2009, NAT GENET, V41, P941, DOI 10.1038/ng.409; Jolma A, 2013, CELL, V152, P327, DOI 10.1016/j.cell.2012.12.009; Kagey MH, 2010, NATURE, V467, P430, DOI 10.1038/nature09380; Kaplan N, 2009, NATURE, V458, P362, DOI 10.1038/nature07667; LEE DY, 1993, CELL, V72, P73, DOI 10.1016/0092-8674(93)90051-Q; Levine M, 2010, CURR BIOL, V20, pR754, DOI 10.1016/j.cub.2010.06.070; Lynch M, 2007, P NATL ACAD SCI USA, V104, P8597, DOI 10.1073/pnas.0702207104; MARTINEZBALBAS MA, 1995, CELL, V83, P29, DOI 10.1016/0092-8674(95)90231-7; Moorman C, 2006, P NATL ACAD SCI USA, V103, P12027, DOI 10.1073/pnas.0605003103; Nasmyth K, 2011, NAT CELL BIOL, V13, P1170, DOI 10.1038/ncb2349; OLIVA R, 1987, J BIOL CHEM, V262, P17016; Ong CT, 2011, NAT REV GENET, V12, P283, DOI 10.1038/nrg2957; Pique-Regi R, 2011, GENOME RES, V21, P447, DOI 10.1101/gr.112623.110; Pomerantz MM, 2009, NAT GENET, V41, P882, DOI 10.1038/ng.403; Radman-Livaja M, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001075; Rollins RA, 1999, GENETICS, V152, P577; Roy S, 2010, SCIENCE, V330, P1787, DOI 10.1126/science.1198374; Schuldiner O, 2008, DEV CELL, V14, P227, DOI 10.1016/j.devcel.2007.11.001; Sherwood R, 2010, GENE DEV, V24, P2723, DOI 10.1101/gad.1976710; STANOJEVIC D, 1991, SCIENCE, V254, P1385, DOI 10.1126/science.1683715; Sur IK, 2012, SCIENCE, V338, P1360, DOI 10.1126/science.1228606; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Thurman RE, 2012, NATURE, V489, P75, DOI 10.1038/nature11232; Tuupanen S, 2009, NAT GENET, V41, P885, DOI 10.1038/ng.406; Vaquerizas JM, 2009, NAT REV GENET, V10, P252, DOI 10.1038/nrg2538; Visel A, 2009, NATURE, V457, P854, DOI 10.1038/nature07730; Whitington T, 2009, NUCLEIC ACIDS RES, V37, P14, DOI 10.1093/nar/gkn866; Zaidi SK, 2010, NAT REV GENET, V11, P583, DOI 10.1038/nrg2827; Zaret KS, 2011, GENE DEV, V25, P2227, DOI 10.1101/gad.176826.111; Zhang ZH, 2011, SCIENCE, V332, P977, DOI 10.1126/science.1200508	44	235	239	0	58	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	AUG 15	2013	154	4					801	813		10.1016/j.cell.2013.07.034	http://dx.doi.org/10.1016/j.cell.2013.07.034			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	202GQ	23953112	Bronze			2022-12-24	WOS:000323202500012
J	Seelig, JD; Jayaraman, V				Seelig, Johannes D.; Jayaraman, Vivek			Feature detection and orientation tuning in the Drosophila central complex	NATURE			English	Article							MOUSE VISUAL-CORTEX; RECEPTIVE-FIELDS; ELLIPSOID BODY; LOCUST BRAIN; NEURONS; PATTERN; ORGANIZATION; BEHAVIOR; INSECT; MEMORY	Many animals, including insects, are known to use visual landmarks to orient in their environment. In Drosophila melanogaster, behavioural genetics studies have identified a higher brain structure called the central complex as being required for the fly's innate responses to vertical visual features(1) and its short-and long-term memory for visual patterns(2-4). But whether and how neurons of the fly central complex represent visual features are unknown. Here we use two-photon calcium imaging in head-fixed walking and flying flies to probe visuomotor responses of ring neurons-a class of central complex neurons that have been implicated in landmark-driven spatial memory in walking flies(2,3) and memory for visual patterns in tethered flying flies(5). We show that dendrites of ring neurons are visually responsive and arranged retinotopically. Ring neuron receptive fields comprise both excitatory and inhibitory subfields, resembling those of simple cells in the mammalian primary visual cortex. Ring neurons show strong and, in some cases, direction-selective orientation tuning, with a notable preference for vertically oriented features similar to those that evoke innate responses in flies(1,2). Visual responses were diminished during flight, but, in contrast with the hypothesized role of the central complex in the control of locomotion(6), not modulated during walking. Taken together, these results indicate that ring neurons represent behaviourally relevant visual features in the fly's environment, enabling downstream central complex circuits to produce appropriate motor commands(6). More broadly, this study opens the door to mechanistic investigations of circuit computations underlying visually guided action selection in the Drosophila central complex.	[Seelig, Johannes D.; Jayaraman, Vivek] Howard Hughes Med Inst, Ashburn, VA 20147 USA	Howard Hughes Medical Institute	Jayaraman, V (corresponding author), Howard Hughes Med Inst, Janelia Farm Res Campus,19700 Helix Dr, Ashburn, VA 20147 USA.	vivek@janelia.hhmi.org			Howard Hughes Medical Institute	Howard Hughes Medical Institute(Howard Hughes Medical Institute)	We thank A. Nern for sharing flies and technical advice; B. Pfeiffer and G. Rubin for providing pJFRC64, pJFRC118, and pJFRC119 flies; and R. Harris for building fly lines, sharing preliminary results, and providing critical feedback on the use of fly reagents. We thank K. Hibbard, D. Hall, J. Kao and the Janelia Fly Core for fly crosses and support; E. Chiappe for initial anatomy experiments; M. Reiser and J. Truman for sharing equipment; J. Liu for technical support; V. Iyer for ScanImage support; T. Adelman for helpful suggestions; and L. Looger and the Janelia GENIE team for GCaMP5 and GCaMP6. We are grateful to A. Leonardo, M. Reiser, E. Chiappe, J. Freeman, A. Karpova, S. Huston and members of Vivek's laboratory for useful discussions and comments on the manuscript. This work was supported by the Howard Hughes Medical Institute.	Bahl A, 2013, NAT NEUROSCI, V16, P730, DOI 10.1038/nn.3386; BAUSENWEIN B, 1994, J COMP NEUROL, V340, P255, DOI 10.1002/cne.903400210; Bonin V, 2011, J NEUROSCI, V31, P18506, DOI 10.1523/JNEUROSCI.2974-11.2011; Chiappe ME, 2010, CURR BIOL, V20, P1470, DOI 10.1016/j.cub.2010.06.072; Chichilnisky EJ, 2001, NETWORK-COMP NEURAL, V12, P199, DOI 10.1088/0954-898X/12/2/306; COLLETT T, 1971, NATURE, V232, P127, DOI 10.1038/232127a0; EGELHAAF M, 1993, J NEUROSCI, V13, P4563; Freifeld L, 2013, NEURON, V78, P1075, DOI 10.1016/j.neuron.2013.04.024; Guo PY, 2013, J EXP BIOL, V216, P992, DOI 10.1242/jeb.080473; HANESCH U, 1989, CELL TISSUE RES, V257, P343, DOI 10.1007/BF00261838; Heinze S, 2007, SCIENCE, V315, P995, DOI 10.1126/science.1135531; Heinze S, 2011, NEURON, V69, P345, DOI 10.1016/j.neuron.2010.12.025; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; Jenett A, 2012, CELL REP, V2, P991, DOI 10.1016/j.celrep.2012.09.011; Liu G, 2006, NATURE, V439, P551, DOI 10.1038/nature04381; Maimon G, 2010, NAT NEUROSCI, V13, P393, DOI 10.1038/nn.2492; Mu LY, 2012, J NEUROSCI, V32, P6061, DOI 10.1523/JNEUROSCI.0221-12.2012; Neuser K, 2008, NATURE, V453, P1244, DOI 10.1038/nature07003; Nicolai LJJ, 2010, P NATL ACAD SCI USA, V107, P20553, DOI 10.1073/pnas.1010198107; Niell CM, 2008, J NEUROSCI, V28, P7520, DOI 10.1523/JNEUROSCI.0623-08.2008; OCARROLL D, 1993, NATURE, V362, P541, DOI 10.1038/362541a0; Ofstad TA, 2011, NATURE, V474, P204, DOI 10.1038/nature10131; Pan YF, 2009, LEARN MEMORY, V16, P289, DOI 10.1101/lm.1331809; Peng HC, 2011, NAT METHODS, V8, P493, DOI [10.1038/NMETH.1602, 10.1038/nmeth.1602]; Pfeiffer BD, 2012, P NATL ACAD SCI USA, V109, P6626, DOI 10.1073/pnas.1204520109; Pfeiffer BD, 2010, GENETICS, V186, P735, DOI 10.1534/genetics.110.119917; Pfeiffer K, 2005, J NEUROPHYSIOL, V94, P3903, DOI 10.1152/jn.00276.2005; POGGIO T, 1973, KYBERNETIK, V12, P185, DOI 10.1007/BF00270572; Pologruto TA, 2003, BIOMED ENG ONLINE, V2, DOI 10.1186/1475-925X-2-13; Priebe NJ, 2012, NEURON, V75, P194, DOI 10.1016/j.neuron.2012.06.011; Reiser MB, 2008, J NEUROSCI METH, V167, P127, DOI 10.1016/j.jneumeth.2007.07.019; Renn SCP, 1999, J NEUROBIOL, V41, P189; Rosner R, 2013, J NEUROSCI, V33, P8122, DOI 10.1523/JNEUROSCI.5390-12.2013; Seelig JD, 2010, NAT METHODS, V7, P535, DOI [10.1038/NMETH.1468, 10.1038/nmeth.1468]; Strauss R, 2002, CURR OPIN NEUROBIOL, V12, P633, DOI 10.1016/S0959-4388(02)00385-9; STRUHL G, 1993, CELL, V72, P527, DOI 10.1016/0092-8674(93)90072-X; Suver MP, 2012, CURR BIOL, V22, P2294, DOI 10.1016/j.cub.2012.10.034; Swindale NV, 1998, BIOL CYBERN, V78, P45, DOI 10.1007/s004220050411; Swindale NV, 2003, CEREB CORTEX, V13, P225, DOI 10.1093/cercor/13.3.225; Trager U, 2008, J COMP NEUROL, V506, P288, DOI 10.1002/cne.21512; Wang J, 2002, NEURON, V33, P559, DOI 10.1016/S0896-6273(02)00570-6; Weber F, 2010, NEURON, V67, P629, DOI 10.1016/j.neuron.2010.07.017; Young JM, 2010, J COMP NEUROL, V518, P1500, DOI 10.1002/cne.22284; Zhang YQ, 2002, GENESIS, V34, P142, DOI 10.1002/gene.10144	44	177	177	0	77	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 14	2013	503	7475					262	+		10.1038/nature12601	http://dx.doi.org/10.1038/nature12601			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	250YX	24107996	Green Accepted			2022-12-24	WOS:000326894200051
J	Birkmeyer, JD; Finks, JF; O'Reilly, A; Oerline, M; Carlin, AM; Nunn, AR; Dimick, J; Banerjee, M; Birkmeyer, NJO				Birkmeyer, John D.; Finks, Jonathan F.; O'Reilly, Amanda; Oerline, Mary; Carlin, Arthur M.; Nunn, Andre R.; Dimick, Justin; Banerjee, Mousumi; Birkmeyer, Nancy J. O.		Michigan Bariatric Surg Collaborat	Surgical Skill and Complication Rates after Bariatric Surgery	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							SITE INFECTION PREVENTION; MEDICAL-EDUCATION; DURATION; RISK; MORTALITY; QUALITY; BYPASS; PERFORMANCE	BackgroundClinical outcomes after many complex surgical procedures vary widely across hospitals and surgeons. Although it has been assumed that the proficiency of the operating surgeon is an important factor underlying such variation, empirical data are lacking on the relationships between technical skill and postoperative outcomes. MethodsWe conducted a study involving 20 bariatric surgeons in Michigan who participated in a statewide collaborative improvement program. Each surgeon submitted a single representative videotape of himself or herself performing a laparoscopic gastric bypass. Each videotape was rated in various domains of technical skill on a scale of 1 to 5 (with higher scores indicating more advanced skill) by at least 10 peer surgeons who were unaware of the identity of the operating surgeon. We then assessed relationships between these skill ratings and risk-adjusted complication rates, using data from a prospective, externally audited, clinical-outcomes registry involving 10,343 patients. ResultsMean summary ratings of technical skill ranged from 2.6 to 4.8 across the 20 surgeons. The bottom quartile of surgical skill, as compared with the top quartile, was associated with higher complication rates (14.5% vs. 5.2%, P<0.001) and higher mortality (0.26% vs. 0.05%, P=0.01). The lowest quartile of skill was also associated with longer operations (137 minutes vs. 98 minutes, P<0.001) and higher rates of reoperation (3.4% vs. 1.6%, P=0.01) and readmission (6.3% vs. 2.7%) (P<0.001). ConclusionsThe technical skill of practicing bariatric surgeons varied widely, and greater skill was associated with fewer postoperative complications and lower rates of reoperation, readmission, and visits to the emergency department. Although these findings are preliminary, they suggest that peer rating of operative skill may be an effective strategy for assessing a surgeon's proficiency. In this preliminary study, videos of gastric bypass operations submitted by 20 bariatric surgeons were rated by peer surgeons. Surgical-skill ratings were highly correlated with complication rates (14.5% for surgeons in the bottom quartile vs. 5.2% in the top quartile). A considerable body of research suggests that some surgeons have better results than others. Early studies of coronary-artery bypass surgery showed wide variation in risk-adjusted patient mortality across surgeons; studies of other procedures and other outcomes have shown similar variation among surgeons.(1)-(3) Efforts to reduce such variation have focused primarily on improving perioperative care. For example, the Surgical Care Improvement Project and related pay-for-performance programs have provided financial incentives to increase surgeons' compliance with evidence-based practices related to prophylaxis against surgical-site infection and venous thromboembolism. As of this writing, however, there is little evidence that such initiatives have improved ...	[Birkmeyer, John D.; Finks, Jonathan F.; O'Reilly, Amanda; Oerline, Mary; Dimick, Justin; Banerjee, Mousumi; Birkmeyer, Nancy J. O.] Univ Michigan, Ctr Healthcare Outcomes & Policy, Ann Arbor, MI 48109 USA; [Birkmeyer, John D.; Finks, Jonathan F.; O'Reilly, Amanda; Oerline, Mary; Dimick, Justin; Banerjee, Mousumi; Birkmeyer, Nancy J. O.] Univ Michigan, Dept Surg, Ann Arbor, MI 48109 USA; [Carlin, Arthur M.] Henry Ford Hlth Syst, Dept Surg, Detroit, MI USA; [Nunn, Andre R.] Forest Hlth Med Ctr, Ypsilanti, MI USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Henry Ford Health System; Henry Ford Hospital	Birkmeyer, JD (corresponding author), Univ Michigan, Ctr Healthcare Outcomes & Policy, N Campus Res Complex,2800 Plymouth Rd,Bldg 16-136, Ann Arbor, MI 48109 USA.	jbirkmey@umich.edu	Page, Piers/G-4917-2012; Codina-Cazador, Antonio/H-9987-2017; Callahan, Charles D/L-1641-2013; Bergkvist, David Julià/H-8886-2017	Page, Piers/0000-0003-1071-1036; Codina-Cazador, Antonio/0000-0003-3040-2716; Bergkvist, David Julià/0000-0001-7184-9405	Blue Cross Blue Shield of Michigan; Blue Care Network	Blue Cross Blue Shield of Michigan; Blue Care Network	Supported by Blue Cross Blue Shield of Michigan and Blue Care Network.	Birkmeyer JD, 2003, NEW ENGL J MED, V349, P2117, DOI 10.1056/NEJMsa035205; Birkmeyer NJO, 2010, JAMA-J AM MED ASSOC, V304, P435, DOI 10.1001/jama.2010.1034; Birkmeyer NJO, 2005, SURGERY, V138, P815, DOI 10.1016/j.surg.2005.06.037; Campbell DA, 2008, J AM COLL SURGEONS, V207, P810, DOI 10.1016/j.jamcollsurg.2008.08.018; Carty MJ, 2009, PLAST RECONSTR SURG, V124, P706, DOI 10.1097/PRS.0b013e3181b17a13; Chan MM, 2013, SURG OBES RELAT DIS, V9, P88, DOI 10.1016/j.soard.2011.09.019; Davis D, 1999, JAMA-J AM MED ASSOC, V282, P867, DOI 10.1001/jama.282.9.867; Finks JF, 2011, ANN SURG, V254, P633, DOI 10.1097/SLA.0b013e318230058c; Gawande A., 2011, NEW YORKER, P44; Gofton WT, 2012, ACAD MED, V87, P1401, DOI 10.1097/ACM.0b013e3182677805; Hall BL, 2004, Q REV EC FINANCE, V44, P410; HANNAN EL, 1990, JAMA-J AM MED ASSOC, V264, P2768, DOI 10.1001/jama.264.21.2768; Hawn MT, 2011, ANN SURG, V254, P494, DOI 10.1097/SLA.0b013e31822c6929; Hu YY, 2012, J AM COLL SURGEONS, V214, P115, DOI 10.1016/j.jamcollsurg.2011.10.009; Kessler Stefan, 2003, Acta Orthop Belg, V69, P328; Leong G, 2006, J HOSP INFECT, V63, P255, DOI 10.1016/j.jhin.2006.02.007; Livingston EH, 2010, SURG OBES RELAT DIS, V6, P587, DOI 10.1016/j.soard.2010.05.023; Martin JA, 1997, BRIT J SURG, V84, P273, DOI 10.1046/j.1365-2168.1997.02502.x; Nicholas LH, 2010, ARCH SURG-CHICAGO, V145, P999, DOI 10.1001/archsurg.2010.191; OCONNOR GT, 1991, JAMA-J AM MED ASSOC, V266, P803, DOI 10.1001/jama.266.6.803; Procter LD, 2010, J AM COLL SURGEONS, V210, P60, DOI 10.1016/j.jamcollsurg.2009.09.034; Reznick RK, 2006, NEW ENGL J MED, V355, P2664, DOI 10.1056/NEJMra054785; Share DA, 2011, HEALTH AFFAIR, V30, P636, DOI 10.1377/hlthaff.2010.0526; Stulberg JJ, 2010, JAMA-J AM MED ASSOC, V303, P2479, DOI 10.1001/jama.2010.841; Tan TW, 2012, J AM COLL SURGEONS, V215, P512, DOI 10.1016/j.jamcollsurg.2012.06.007; van Hove PD, 2010, BRIT J SURG, V97, P972, DOI 10.1002/bjs.7115; Vassiliou MC, 2007, SURG INNOV, V14, P211, DOI 10.1177/1553350607308466; Zevin B, 2013, J AM COLL SURGEONS, V216, P955, DOI 10.1016/j.jamcollsurg.2013.01.003	28	839	847	1	50	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 10	2013	369	15					1434	1442		10.1056/NEJMsa1300625	http://dx.doi.org/10.1056/NEJMsa1300625			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	231QE	24106936				2022-12-24	WOS:000325431500011
J	Zahm, JA; Padrick, SB; Chen, ZC; Pak, CW; Yunus, AA; Henry, L; Tomchick, DR; Chen, Z; Rosen, MK				Zahm, Jacob A.; Padrick, Shae B.; Chen, Zhucheng; Pak, Chi W.; Yunus, Ali A.; Henry, Lisa; Tomchick, Diana R.; Chen, Zhe; Rosen, Michael K.			The Bacterial Effector VopL Organizes Actin into Filament-like Structures	CELL			English	Article							ARP2/3 COMPLEX; MONOMERIC ACTIN; F-ACTIN; NUCLEATION; MECHANISM; PROTEINS; SPIRE; ELONGATION; PROFILIN; DOMAINS	VopL is an effector protein from Vibrio parahaemolyticus that nucleates actin filaments. VopL consists of a VopL C-terminal domain (VCD) and an array of three WASP homology 2 (WH2) motifs. Here, we report the crystal structure of the VCD dimer bound to actin. The VCD organizes three actin monomers in a spatial arrangement close to that found in the canonical actin filament. In this arrangement, WH2 motifs can be modeled into the binding site of each actin without steric clashes. The data suggest a mechanism of nucleation wherein VopL creates filament-like structures, organized by the VCD with monomers delivered by the WH2 array, that can template addition of new subunits. Similarities with Arp2/3 complex and formin proteins suggest that organization of monomers into filament-like structures is a general and central feature of actin nucleation.	[Zahm, Jacob A.; Padrick, Shae B.; Chen, Zhucheng; Pak, Chi W.; Yunus, Ali A.; Henry, Lisa; Tomchick, Diana R.; Chen, Zhe; Rosen, Michael K.] Univ Texas SW Med Ctr Dallas, Dept Biophys, Dallas, TX 75390 USA; [Zahm, Jacob A.; Padrick, Shae B.; Chen, Zhucheng; Pak, Chi W.; Yunus, Ali A.; Henry, Lisa; Rosen, Michael K.] Univ Texas SW Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas	Rosen, MK (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Biophys, Dallas, TX 75390 USA.	michael.rosen@utsouthwestern.edu	Tomchick, Diana/HGV-2018-2022; Zahm, Jacob/AFN-8950-2022	Tomchick, Diana/0000-0002-7529-4643; Padrick, Shae/0000-0002-6916-6194; Chen, Zhe/0000-0002-1668-4051	Howard Hughes Medical Institute; NIH [R01-GM56322]; Welch Foundation [I-1544]; U.S. Department of Energy Office of Biological and Environmental Research [DE-AC02-06CH11357]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056322, T32GM008297] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Welch Foundation(The Welch Foundation); U.S. Department of Energy Office of Biological and Environmental Research(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Dr. Luke Rice for discussion and assistance with crystallographic model building and refinement, Dr. Dominika Borek for assistance with crystallographic data processing, and Lynda Doolittle for assistance with actin assembly assays. Work was supported by the Howard Hughes Medical Institute and grants from the NIH (R01-GM56322) and Welch Foundation (I-1544). Results shown in this report are derived from work performed at the Argonne National Laboratory, Structural Biology Center at the Advanced Photon Source. Argonne is operated by UChicago Argonne for the U.S. Department of Energy Office of Biological and Environmental Research under contract DE-AC02-06CH11357.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Alto NM, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a006114; Campellone KG, 2010, NAT REV MOL CELL BIO, V11, P237, DOI 10.1038/nrm2867; Carlier MF, 2011, INT REV CEL MOL BIO, V290, P55, DOI 10.1016/B978-0-12-386037-8.00005-3; Chhabra ES, 2009, J CELL SCI, V122, P1430, DOI 10.1242/jcs.040691; Dominguez R, 2009, CRIT REV BIOCHEM MOL, V44, P351, DOI 10.3109/10409230903277340; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fujii T, 2010, NATURE, V467, P724, DOI 10.1038/nature09372; Goode BL, 2007, ANNU REV BIOCHEM, V76, P593, DOI 10.1146/annurev.biochem.75.103004.142647; Gould CJ, 2011, CURR BIOL, V21, P384, DOI 10.1016/j.cub.2011.01.047; Haglund CM, 2011, J CELL BIOL, V195, P7, DOI 10.1083/jcb.201103148; Heimsath EG, 2012, J BIOL CHEM, V287, P3087, DOI 10.1074/jbc.M111.312207; HOLMES KC, 1990, NATURE, V347, P44, DOI 10.1038/347044a0; Hung RJ, 2011, SCIENCE, V334, P1710, DOI 10.1126/science.1211956; Kaiser DA, 1999, J CELL SCI, V112, P3779; KELLEHER JF, 1995, J CELL BIOL, V131, P385, DOI 10.1083/jcb.131.2.385; Leung DW, 2006, METHOD ENZYMOL, V406, P281, DOI 10.1016/S0076-6879(06)06021-6; Liverman ADB, 2007, P NATL ACAD SCI USA, V104, P17117, DOI 10.1073/pnas.0703196104; MACHESKY LM, 1994, J CELL BIOL, V127, P107, DOI 10.1083/jcb.127.1.107; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mullins RD, 1997, J CELL BIOL, V136, P331, DOI 10.1083/jcb.136.2.331; Nair UB, 2008, J MOL BIOL, V384, P848, DOI 10.1016/j.jmb.2008.09.082; Namgoong S, 2011, NAT STRUCT MOL BIOL, V18, P1060, DOI 10.1038/nsmb.2109; Nolen BJ, 2007, MOL CELL, V26, P449, DOI 10.1016/j.molcel.2007.04.017; Oda T, 2009, NATURE, V457, P441, DOI 10.1038/nature07685; Okada K, 2010, J CELL BIOL, V189, P1087, DOI 10.1083/jcb.201001016; OSHEA EK, 1993, CURR BIOL, V3, P658, DOI 10.1016/0960-9822(93)90063-T; Otomo T, 2005, NATURE, V433, P488, DOI 10.1038/nature03251; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Padrick SB, 2008, MOL CELL, V32, P426, DOI 10.1016/j.molcel.2008.10.012; Padrick SB, 2011, P NATL ACAD SCI USA, V108, pE472, DOI 10.1073/pnas.1100236108; Padrick SB, 2010, ANNU REV BIOCHEM, V79, P707, DOI 10.1146/annurev.biochem.77.060407.135452; Paul AS, 2009, CELL MOTIL CYTOSKEL, V66, P606, DOI 10.1002/cm.20379; POLLARD TD, 1986, ANNU REV BIOCHEM, V55, P987, DOI 10.1146/annurev.bi.55.070186.005011; Pollard TD, 2007, ANNU REV BIOPH BIOM, V36, P451, DOI 10.1146/annurev.biophys.35.040405.101936; Pollard TD, 2009, SCIENCE, V326, P1208, DOI 10.1126/science.1175862; Potterton E, 2002, ACTA CRYSTALLOGR D, V58, P1955, DOI 10.1107/S0907444902015391; Qualmann B, 2009, TRENDS CELL BIOL, V19, P276, DOI 10.1016/j.tcb.2009.03.004; Quinlan ME, 2007, J CELL BIOL, V179, P117, DOI 10.1083/jcb.200706196; Rebowski G, 2010, J MOL BIOL, V403, P11, DOI 10.1016/j.jmb.2010.08.040; Robinson RC, 2001, SCIENCE, V294, P1679, DOI 10.1126/science.1066333; Rodal AA, 2005, NAT STRUCT MOL BIOL, V12, P26, DOI 10.1038/nsmb870; Rouiller I, 2008, J CELL BIOL, V180, P887, DOI 10.1083/jcb.200709092; Sano KI, 2002, FEBS LETT, V532, P143, DOI 10.1016/S0014-5793(02)03659-1; Schmid MF, 2004, NATURE, V431, P104, DOI 10.1038/nature02881; Sept D, 2001, BIOPHYS J, V81, P667, DOI 10.1016/S0006-3495(01)75731-1; Thompson ME, 2013, NAT STRUCT MOL BIOL, V20, P111, DOI 10.1038/nsmb.2462; Ti SC, 2011, P NATL ACAD SCI USA, V108, pE463, DOI 10.1073/pnas.1100125108; Vizcarra CL, 2011, P NATL ACAD SCI USA, V108, P11884, DOI 10.1073/pnas.1105703108; Xu XP, 2012, EMBO J, V31, P236, DOI 10.1038/emboj.2011.343; Yeung P S Marie, 2004, Foodborne Pathog Dis, V1, P74, DOI 10.1089/153531404323143594; Yu BK, 2011, NAT STRUCT MOL BIOL, V18, P1068, DOI 10.1038/nsmb.2110	52	34	35	0	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 10	2013	155	2					423	434		10.1016/j.cell.2013.09.019	http://dx.doi.org/10.1016/j.cell.2013.09.019			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	235LH	24120140	Green Accepted, Bronze			2022-12-24	WOS:000325719800018
J	Nguyen, KD; Fentress, SJ; Qiu, YF; Yun, KR; Cox, JS; Chawla, A				Nguyen, Khoa D.; Fentress, Sarah J.; Qiu, Yifu; Yun, Karen; Cox, Jeffery S.; Chawla, Ajay			Circadian Gene Bmal1 Regulates Diurnal Oscillations of Ly6C(hi) Inflammatory Monocytes	SCIENCE			English	Article							IMMUNE DEFENSE; INNATE; CLOCK; RECRUITMENT; RHYTHMS; ROLES; MACROPHAGES; METABOLISM; INFECTION; SUBSETS	Circadian clocks have evolved to regulate physiologic and behavioral rhythms in anticipation of changes in the environment. Although the molecular clock is present in innate immune cells, its role in monocyte homeostasis remains unknown. Here, we report that Ly6C(hi) inflammatory monocytes exhibit diurnal variation, which controls their trafficking to sites of inflammation. This cyclic pattern of trafficking confers protection against Listeria monocytogenes and is regulated by the repressive activity of the circadian gene Bmal1. Accordingly, myeloid cell-specific deletion of Bmal1 induces expression of monocyte-attracting chemokines and disrupts rhythmic cycling of Ly6C(hi) monocytes, predisposing mice to development of pathologies associated with acute and chronic inflammation. These findings have unveiled a critical role for BMAL1 in controlling the diurnal rhythms in Ly6C(hi) monocyte numbers.	[Nguyen, Khoa D.; Qiu, Yifu; Yun, Karen; Chawla, Ajay] Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94158 USA; [Nguyen, Khoa D.] Stanford Univ, Program Immunol, Stanford, CA 94305 USA; [Fentress, Sarah J.; Cox, Jeffery S.] Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94158 USA; [Chawla, Ajay] Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94158 USA; [Chawla, Ajay] Univ Calif San Francisco, Dept Med, San Francisco, CA 94158 USA	University of California System; University of California San Francisco; Stanford University; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Chawla, A (corresponding author), Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94158 USA.	ajay.chawla@ucsf.edu		Nguyen, Khoa/0000-0002-6720-2470; Qiu, Yifu/0000-0001-5645-3189	NIH [HL076746, DK094641, DP1AR064158, PO1AI063302, T32AI007334]; Larry L. Hillblom Foundation Network; Diabetes Family Fund [University of California, San Francisco (UCSF)]; Stanford Graduate fellowship; American Heart Association (AHA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL076746] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI063302, T32AI007334] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [DP1AR064158] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK094641] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Larry L. Hillblom Foundation Network; Diabetes Family Fund [University of California, San Francisco (UCSF)]; Stanford Graduate fellowship(Stanford University); American Heart Association (AHA)(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank members of the Chawla laboratory and A. Loh for comments on the manuscript. The data presented in this paper are tabulated in the main paper and in the supplementary materials. The authors' work was supported by NIH grants HL076746 and DK094641, a Larry L. Hillblom Foundation Network grant, the Diabetes Family Fund [University of California, San Francisco (UCSF)], and an NIH Director's Pioneer Award (DP1AR064158) to A.C. and NIH grant PO1AI063302 to J.S.C. K.D.N. was supported by Stanford Graduate and American Heart Association (AHA) Predoctoral fellowships, Y.Q. by an AHA Postdoctoral Fellowship, and S.J.F. by an NIH Training Grant (T32AI007334). All animal care and procedures were performed in accordance with Stanford University's Administrative Panel on Laboratory Animal Care and UCSF's Institutional Animal Care and Use Committee guidelines. The authors declare that they have no competing financial interests.	Asher G, 2011, CELL METAB, V13, P125, DOI 10.1016/j.cmet.2011.01.006; Auffray C, 2007, SCIENCE, V317, P666, DOI 10.1126/science.1142883; Bass J, 2010, SCIENCE, V330, P1349, DOI 10.1126/science.1195027; Boring L, 1997, J CLIN INVEST, V100, P2552, DOI 10.1172/JCI119798; Cornish CJ, 1996, J CELL PHYSIOL, V166, P427, DOI 10.1002/(SICI)1097-4652(199602)166:2<427::AID-JCP21>3.0.CO;2-6; Damiola F, 2000, GENE DEV, V14, P2950, DOI 10.1101/gad.183500; Etchegaray JP, 2006, J BIOL CHEM, V281, P21209, DOI 10.1074/jbc.M603722200; Feng D, 2012, MOL CELL, V47, P158, DOI 10.1016/j.molcel.2012.06.026; Geissmann F, 2003, IMMUNITY, V19, P71, DOI 10.1016/S1074-7613(03)00174-2; Geissmann F, 2010, SCIENCE, V327, P656, DOI 10.1126/science.1178331; Gibbs JE, 2012, P NATL ACAD SCI USA, V109, P582, DOI 10.1073/pnas.1106750109; Haus E, 1999, CHRONOBIOL INT, V16, P581, DOI 10.3109/07420529908998730; Hayashi F, 2001, NATURE, V410, P1099, DOI 10.1038/35074106; Hayashi M, 2007, BIOL PHARM BULL, V30, P621, DOI 10.1248/bpb.30.621; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Keller M, 2009, P NATL ACAD SCI USA, V106, P21407, DOI 10.1073/pnas.0906361106; Lamia KA, 2008, P NATL ACAD SCI USA, V105, P15172, DOI 10.1073/pnas.0806717105; MARTIN RJ, 1993, AM REV RESPIR DIS, V147, pS25, DOI 10.1164/ajrccm/147.6_Pt_2.S25; Medzhitov R, 2008, NATURE, V454, P428, DOI 10.1038/nature07201; MULLER JE, 1985, NEW ENGL J MED, V313, P1315, DOI 10.1056/NEJM198511213132103; Odegaard JI, 2013, SCIENCE, V339, P172, DOI 10.1126/science.1230721; Robbins CS, 2010, CELL MOL LIFE SCI, V67, P2685, DOI 10.1007/s00018-010-0375-x; Sahar Saurabh, 2013, Handb Exp Pharmacol, P29, DOI 10.1007/978-3-642-25950-0_2; Saini C, 2011, COLD SH Q B, V76, P39, DOI 10.1101/sqb.2011.76.010918; Scheiermann C, 2013, NAT REV IMMUNOL, V13, P190, DOI 10.1038/nri3386; Scheiermann C, 2012, IMMUNITY, V37, P290, DOI 10.1016/j.immuni.2012.05.021; Serbina NV, 2012, ADV IMMUNOL, V113, P119, DOI 10.1016/B978-0-12-394590-7.00003-8; Serbina NV, 2003, IMMUNITY, V19, P59, DOI 10.1016/S1074-7613(03)00171-7; SHACKELFORD PG, 1973, SCIENCE, V182, P285, DOI 10.1126/science.182.4109.285; Shi C, 2011, J IMMUNOL, V187, P5293, DOI 10.4049/jimmunol.1101721; Shi C, 2011, NAT REV IMMUNOL, V11, P762, DOI 10.1038/nri3070; Silver AC, 2012, IMMUNITY, V36, P251, DOI 10.1016/j.immuni.2011.12.017; Straub RH, 2007, ARTHRITIS RHEUM, V56, P399, DOI 10.1002/art.22368; Torres D, 2004, INFECT IMMUN, V72, P2131, DOI 10.1128/IAI.72.4.2131-2139.2004; Tsou CL, 2007, J CLIN INVEST, V117, P902, DOI 10.1172/JCI29919; Yoo SH, 2004, P NATL ACAD SCI USA, V101, P5339, DOI 10.1073/pnas.0308709101	36	388	401	1	52	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 27	2013	341	6153					1483	1488		10.1126/science.1240636	http://dx.doi.org/10.1126/science.1240636			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	224NS	23970558	Green Accepted			2022-12-24	WOS:000324894600042
J	Harvey, BM; Klein, BP; Petridou, N; Dumoulin, SO				Harvey, B. M.; Klein, B. P.; Petridou, N.; Dumoulin, S. O.			Topographic Representation of Numerosity in the Human Parietal Cortex	SCIENCE			English	Article							NUMERICAL INFORMATION; NUMBER; MAGNITUDE; QUANTITY; TIME	Numerosity, the set size of a group of items, is processed by the association cortex, but certain aspects mirror the properties of primary senses. Sensory cortices contain topographic maps reflecting the structure of sensory organs. Are the cortical representation and processing of numerosity organized topographically, even though no sensory organ has a numerical structure? Using high-field functional magnetic resonance imaging (at a field strength of 7 teslas), we described neural populations tuned to small numerosities in the human parietal cortex. They are organized topographically, forming a numerosity map that is robust to changes in low-level stimulus features. The cortical surface area devoted to specific numerosities decreases with increasing numerosity, and the tuning width increases with preferred numerosity. These organizational properties extend topographic principles to the representation of higher-order abstract features in the association cortex.	[Harvey, B. M.; Klein, B. P.; Dumoulin, S. O.] Univ Utrecht, Dept Expt Psychol, Helmholtz Inst, NL-3584 CS Utrecht, Netherlands; [Petridou, N.] Univ Med Ctr Utrecht, Rudolf Magnus Inst Neurosci, Dept Radiol, NL-3584 CX Utrecht, Netherlands	Utrecht University; Utrecht University; Utrecht University Medical Center	Harvey, BM (corresponding author), Univ Utrecht, Dept Expt Psychol, Helmholtz Inst, NL-3584 CS Utrecht, Netherlands.	b.m.harvey@uu.nl	Dumoulin, Serge O/A-3603-2012	Dumoulin, Serge O/0000-0001-7474-7711; , Natalia/0000-0002-0783-0387; Harvey, Benjamin/0000-0003-2694-618X	Nederlandse Organisatie voor Wetenschappelijk Onderzoek Vidi [452.08.008]	Nederlandse Organisatie voor Wetenschappelijk Onderzoek Vidi(Netherlands Organization for Scientific Research (NWO))	Processed data reported in the paper are presented in full in the supplementary materials. Raw data and custom analysis code are available on request from the authors. This work was supported by Nederlandse Organisatie voor Wetenschappelijk Onderzoek Vidi grant 452.08.008. We thank J. W. Brascamp for critical comments on the manuscript.	Bongard S, 2010, P NATL ACAD SCI USA, V107, P2277, DOI 10.1073/pnas.0909180107; Brannon EM, 1998, SCIENCE, V282, P746, DOI 10.1126/science.282.5389.746; Burr D, 2008, CURR BIOL, V18, P425, DOI 10.1016/j.cub.2008.02.052; Cajal SRY, 1999, TEXTURE OF THE NERVOUS SYSTEM OF MAN AND THE VERTEBRATES, VOL I, P1; Cantlon JF, 2007, PLOS BIOL, V5, P2912, DOI 10.1371/journal.pbio.0050328; Cantlon JF, 2009, J COGNITIVE NEUROSCI, V21, P2217, DOI 10.1162/jocn.2008.21159; Chen BL, 2006, P NATL ACAD SCI USA, V103, P4723, DOI 10.1073/pnas.0506806103; COLLINS DL, 1994, J COMPUT ASSIST TOMO, V18, P192, DOI 10.1097/00004728-199403000-00005; Dakin SC, 2011, P NATL ACAD SCI USA, V108, P19552, DOI 10.1073/pnas.1113195108; DEHAENE S, 1991, NEUROPSYCHOLOGIA, V29, P1045, DOI 10.1016/0028-3932(91)90076-K; Dehaene S, 1999, SCIENCE, V284, P970, DOI 10.1126/science.284.5416.970; DEHAENE S, 1993, J COGNITIVE NEUROSCI, V5, P390, DOI 10.1162/jocn.1993.5.4.390; Dehaene S., 2011, NUMBER SENSE MIND CR; Dehaene S, 2008, SCIENCE, V320, P1217, DOI 10.1126/science.1156540; Dumoulin SO, 2008, NEUROIMAGE, V39, P647, DOI 10.1016/j.neuroimage.2007.09.034; Eger E, 2009, CURR BIOL, V19, P1608, DOI 10.1016/j.cub.2009.08.047; Halberda J, 2008, NATURE, V455, P665, DOI 10.1038/nature07246; Nieder A, 2004, P NATL ACAD SCI USA, V101, P7457, DOI 10.1073/pnas.0402239101; Nieder A, 2003, NEURON, V37, P149, DOI 10.1016/S0896-6273(02)01144-3; Nieder A, 2002, SCIENCE, V297, P1708, DOI 10.1126/science.1072493; Piazza M, 2004, NEURON, V44, P547, DOI 10.1016/j.neuron.2004.10.014; Pinel P, 1999, NEUROREPORT, V10, P1473, DOI 10.1097/00001756-199905140-00015; Saltzman IJ, 1948, J PSYCHOL, V25, P227, DOI 10.1080/00223980.1948.9917373; STARKEY P, 1992, COGNITION, V43, P93, DOI 10.1016/0010-0277(92)90034-F; Swisher JD, 2007, J NEUROSCI, V27, P5326, DOI 10.1523/JNEUROSCI.0991-07.2007; Tokita M, 2010, ATTEN PERCEPT PSYCHO, V72, P1839, DOI 10.3758/APP.72.7.1839; Tudusciuc O, 2007, P NATL ACAD SCI USA, V104, P14513, DOI 10.1073/pnas.0705495104; Walsh V, 2003, TRENDS COGN SCI, V7, P483, DOI 10.1016/j.tics.2003.09.002; Whalen J, 1999, PSYCHOL SCI, V10, P130, DOI 10.1111/1467-9280.00120; Winawer J, 2010, J VISION, V10, DOI 10.1167/10.5.1	30	272	273	4	80	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 6	2013	341	6150					1123	1126		10.1126/science.1239052	http://dx.doi.org/10.1126/science.1239052			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	211TG	24009396	Green Submitted			2022-12-24	WOS:000323933100048
J	Menees, DS; Peterson, ED; Wang, Y; Curtis, JP; Messenger, JC; Rumsfeld, JS; Gurm, HS				Menees, Daniel S.; Peterson, Eric D.; Wang, Yongfei; Curtis, Jeptha P.; Messenger, John C.; Rumsfeld, John S.; Gurm, Hitinder S.			Door-to-Balloon Time and Mortality among Patients Undergoing Primary PCI	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ACUTE-MYOCARDIAL-INFARCTION; PERCUTANEOUS CORONARY INTERVENTION; CARDIOVASCULAR DATA REGISTRY; PRIMARY ANGIOPLASTY; REPERFUSION; STRATEGIES; OUTCOMES; QUALITY; TRENDS; ASSOCIATION	BACKGROUND Current guidelines for the treatment of ST-segment elevation myocardial infarction recommend a door-to-balloon time of 90 minutes or less for patients undergoing primary percutaneous coronary intervention (PCI). Door-to-balloon time has become a performance measure and is the focus of regional and national quality-improvement initiatives. However, it is not known whether national improvements in door-to-balloon times have been accompanied by a decline in mortality. METHODS We analyzed annual trends in door-to-balloon times and in-hospital mortality using data from 96,738 admissions for patients undergoing primary PCI for ST-segment elevation myocardial infarction from July 2005 through June 2009 at 515 hospitals participating in the CathPCI Registry. In a subgroup analysis using a linked Medicare data set, we assessed 30-day mortality. RESULTS Median door-to-balloon times declined significantly, from 83 minutes in the 12 months from July 2005 through June 2006 to 67 minutes in the 12 months from July 2008 through June 2009 (P<0.001). Similarly, the percentage of patients for whom the door-to-balloon time was 90 minutes or less increased from 59.7% in the first year to 83.1% in the last year (P<0.001). Despite improvements in door-to-balloon times, there was no significant overall change in unadjusted in-hospital mortality (4.8% in 2005-2006 and 4.7% in 2008-2009, P=0.43 for trend) or in risk-adjusted in-hospital mortality (5.0% in 2005-2006 and 4.7% in 2008-2009, P=0.34), nor was a significant difference observed in unadjusted 30-day mortality (P=0.64). CONCLUSIONS Although national door-to-balloon times have improved significantly for patients undergoing primary PCI for ST-segment elevation myocardial infarction, in-hospital mortality has remained virtually unchanged. These data suggest that additional strategies are needed to reduce in-hospital mortality in this population.	[Menees, Daniel S.; Gurm, Hitinder S.] Univ Michigan, Ann Arbor, MI 48109 USA; [Menees, Daniel S.; Gurm, Hitinder S.] Vet Affairs VA Ann Arbor Hlth Care Syst, Ann Arbor, MI USA; [Peterson, Eric D.] Duke Univ, Durham, NC USA; [Wang, Yongfei; Curtis, Jeptha P.] Yale Univ, New Haven, CT USA; [Messenger, John C.; Rumsfeld, John S.] Univ Colorado, Sch Med, Aurora, CO USA; [Rumsfeld, John S.] Denver VA Med Ctr, Denver, CO USA	University of Michigan System; University of Michigan; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Ann Arbor Healthcare System; Duke University; Yale University; University of Colorado System; University of Colorado Anschutz Medical Campus; US Department of Veterans Affairs; Veterans Health Administration (VHA); Veterans Affairs Medical Center - Denver	Menees, DS (corresponding author), Univ Michigan, Dept Internal Med, Div Cardiovasc Med, 1500 East Med Ctr Dr,2A396, Ann Arbor, MI 48109 USA.	dmenees@umich.edu	Peterson, Eric David/ABF-5033-2021	Gurm, Hitinder/0000-0002-1646-0218	National Cardiovascular Data Registry of the American College of Cardiology Foundation	National Cardiovascular Data Registry of the American College of Cardiology Foundation	Funded by the National Cardiovascular Data Registry of the American College of Cardiology Foundation.	Adams RJ, 2004, CIRCULATION, V110, P2512, DOI 10.1161/01.CIR.0000134791.68010.FA; BERGER PB, 1994, AM J CARDIOL, V73, P231, DOI 10.1016/0002-9149(94)90225-9; Berger PB, 1999, CIRCULATION, V100, P14, DOI 10.1161/01.CIR.100.1.14; Brodie BR, 1998, J AM COLL CARDIOL, V32, P1312, DOI 10.1016/S0735-1097(98)00395-7; Brodie BR, 2001, AM J CARDIOL, V88, P1085, DOI 10.1016/S0002-9149(01)02039-2; De Luca G, 2004, CIRCULATION, V109, P1223, DOI 10.1161/01.CIR.0000121424.76486.20; De Luca G, 2003, J AM COLL CARDIOL, V42, P991, DOI 10.1016/S0735-1097(03)00919-7; Flynn A, 2010, ARCH INTERN MED, V170, P1842, DOI 10.1001/archinternmed.2010.381; GARCIADORADO D, 1987, CARDIOVASC RES, V21, P537, DOI 10.1093/cvr/21.7.537; Gibson CM, 2008, AM HEART J, V156, P1035, DOI 10.1016/j.ahj.2008.07.029; Hammill BG, 2009, AM HEART J, V157, P995, DOI 10.1016/j.ahj.2009.04.002; Jacobs AK, 2006, CIRCULATION, V113, P2152, DOI 10.1161/CIRCULATIONAHA.106.174477; Krumholz HM, 2008, JACC-CARDIOVASC INTE, V1, P97, DOI 10.1016/j.jcin.2007.10.006; Krumholz HM, 2011, CIRCULATION, V124, P1038, DOI 10.1161/CIRCULATIONAHA.111.044107; Kumbhani DJ, 2009, JAMA-J AM MED ASSOC, V302, P2207, DOI 10.1001/jama.2009.1715; McNamara RL, 2006, J AM COLL CARDIOL, V47, P2180, DOI 10.1016/j.jacc.2005.12.072; Messenger JC, 2012, J AM COLL CARDIOL, V60, P1484, DOI 10.1016/j.jacc.2012.07.020; Peterson ED, 2010, J AM COLL CARDIOL, V55, P1923, DOI 10.1016/j.jacc.2010.02.005; *QUALITYNET, SPEC MAN NAT HOSP QU; REIMER KA, 1977, CIRCULATION, V56, P786, DOI 10.1161/01.CIR.56.5.786; Roe MT, 2010, J AM COLL CARDIOL, V56, P254, DOI 10.1016/j.jacc.2010.05.008; Thiemann DR, 1999, NEW ENGL J MED, V340, P1640, DOI 10.1056/NEJM199905273402106; van't Hof AWJ, 2002, EUR HEART J, V23, P510	23	486	505	1	16	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 5	2013	369	10					901	909		10.1056/NEJMoa1208200	http://dx.doi.org/10.1056/NEJMoa1208200			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	211KV	24004117	Bronze			2022-12-24	WOS:000323906900007
J	Farihi, J; Gansicke, BT; Koester, D				Farihi, J.; Gaensicke, B. T.; Koester, D.			Evidence for Water in the Rocky Debris of a Disrupted Extrasolar Minor Planet	SCIENCE			English	Article							WHITE-DWARFS; ACCRETION; DUST; DIFFERENTIATION; DIFFUSION; METALS; DISKS	The existence of water in extrasolar planetary systems is of great interest because it constrains the potential for habitable planets and life. We have identified a circumstellar disk that resulted from the destruction of a water-rich and rocky extrasolar minor planet. The parent body formed and evolved around a star somewhat more massive than the Sun, and the debris now closely orbits the white dwarf remnant of the star. The stellar atmosphere is polluted with metals accreted from the disk, including oxygen in excess of that expected for oxide minerals, indicating that the parent body was originally composed of 26% water by mass. This finding demonstrates that water-bearing planetesimals exist around A- and F-type stars that end their lives as white dwarfs.	[Farihi, J.] Univ Cambridge, Inst Astron, Cambridge CB3 0HA, England; [Gaensicke, B. T.] Univ Warwick, Dept Phys, Coventry CV5 7AL, W Midlands, England; [Koester, D.] Univ Kiel, Inst Theoret Phys & Astrophys, D-24098 Kiel, Germany	University of Cambridge; University of Warwick; University of Kiel	Farihi, J (corresponding author), Univ Cambridge, Inst Astron, Madingley Rd, Cambridge CB3 0HA, England.	jfarihi@ast.cam.ac.uk	Gaensicke, Boris T/A-9421-2012	Gaensicke, Boris T/0000-0002-2761-3005; Farihi, Jay/0000-0003-1748-602X	NASA [NAS 5-26555]; W. M. Keck Foundation; UK Science and Technology Facilities Council [ST/J003344/1, ST/I001719/1]; European Research Council under the European Union [267697]; NOAO through the Telescope System Instrumentation Program [2011B-0554]; NSF;  [12169];  [12474]; STFC [ST/J003344/2, ST/K003453/1, ST/J003344/1, ST/K003453/2, ST/J003344/3, ST/I001719/1] Funding Source: UKRI; Science and Technology Facilities Council [ST/I001719/1, ST/J003344/2, ST/K003453/1, ST/K003453/2, ST/J003344/1, ST/J003344/3] Funding Source: researchfish	NASA(National Aeronautics & Space Administration (NASA)); W. M. Keck Foundation(W.M. Keck Foundation); UK Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); European Research Council under the European Union(European Research Council (ERC)); NOAO through the Telescope System Instrumentation Program; NSF(National Science Foundation (NSF)); ; ; STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))	This work is based on observations made with the Hubble Space Telescope, which is operated by the Association of Universities for Research in Astronomy under NASA contract NAS 5-26555. These observations are associated with program programs 12169 and 12474. Some of the data presented herein were obtained at the W. M. Keck Observatory, which is operated as a scientific partnership among the California Institute of Technology, the University of California, and NASA. The Observatory was made possible by the generous financial support of the W. M. Keck Foundation. J.F. acknowledges support from the UK Science and Technology Facilities Council in the form of an Ernest Rutherford Fellowship (ST/J003344/1). The research leading to these results has received funding from the European Research Council under the European Union's Seventh Framework Programme (FP/2007-2013)/ERC Grant Agreement no. 267697 (WDTracer). B. T. G. was supported in part by the UK Science and Technology Facilities Council (ST/I001719/1). Keck telescope time for program 2011B-0554 was granted by NOAO through the Telescope System Instrumentation Program, funded by NSF.	Batalha NM, 2011, ASTROPHYS J, V729, DOI 10.1088/0004-637X/729/1/27; Debes JH, 2012, ASTROPHYS J, V747, DOI 10.1088/0004-637X/747/2/148; Desharnais S, 2008, ASTROPHYS J, V672, P540, DOI 10.1086/523699; Farihi J, 2008, ASTROPHYS J, V674, P431, DOI 10.1086/521715; Farihi J, 2012, MON NOT R ASTRON SOC, V421, P1635, DOI 10.1111/j.1365-2966.2012.20421.x; Farihi J, 2011, ASTROPHYS J LETT, V728, DOI 10.1088/2041-8205/728/1/L8; Farihi J, 2010, MON NOT R ASTRON SOC, V404, P2123, DOI 10.1111/j.1365-2966.2010.16426.x; Farihi J, 2010, ASTROPHYS J, V714, P1386, DOI 10.1088/0004-637X/714/2/1386; Farihi J, 2009, ASTROPHYS J, V694, P805, DOI 10.1088/0004-637X/694/2/805; Fressin F, 2012, NATURE, V482, P195, DOI 10.1038/nature10780; Gansicke BT, 2012, MON NOT R ASTRON SOC, V424, P333, DOI 10.1111/j.1365-2966.2012.21201.x; Gansicke BT, 2006, SCIENCE, V314, P1908, DOI 10.1126/science.1135033; Girven J, 2012, ASTROPHYS J, V749, DOI 10.1088/0004-637X/749/2/154; Jura M, 2008, ASTRON J, V135, P1785, DOI 10.1088/0004-6256/135/5/1785; Jura M, 2007, ASTROPHYS J, V663, P1285, DOI 10.1086/518767; Jura M, 2003, ASTROPHYS J, V584, pL91, DOI 10.1086/374036; Jura M, 2010, ASTRON J, V140, P1129, DOI 10.1088/0004-6256/140/5/1129; Jura M, 2009, ASTROPHYS J, V699, P1473, DOI 10.1088/0004-637X/699/2/1473; Jura M, 2009, ASTRON J, V137, P3191, DOI 10.1088/0004-6256/137/2/3191; Klein B, 2010, ASTROPHYS J, V709, P950, DOI 10.1088/0004-637X/709/2/950; Koester D, 2005, ASTRON ASTROPHYS, V439, P317, DOI 10.1051/0004-6361:20053058; Koester D, 2006, ASTRON ASTROPHYS, V453, P1051, DOI 10.1051/0004-6361:20064843; Koester D, 2009, ASTRON ASTROPHYS, V498, P517, DOI 10.1051/0004-6361/200811468; Lisse CM, 2012, ASTROPHYS J, V747, DOI 10.1088/0004-637X/747/2/93; Reach WT, 2005, ASTROPHYS J, V635, pL161, DOI 10.1086/499561; Rivkin A.S., 2002, ASTEROIDS, VIII, P235, DOI DOI 10.1038/NATURE09028; Russell CT, 2012, SCIENCE, V336, P684, DOI 10.1126/science.1219381; Sing DK, 2011, MON NOT R ASTRON SOC, V416, P1443, DOI 10.1111/j.1365-2966.2011.19142.x; Thomas PC, 2005, NATURE, V437, P224, DOI 10.1038/nature03938; Tremblay PE, 2008, ASTROPHYS J, V672, P1144, DOI 10.1086/524134; Visscher C, 2013, ASTROPHYS J LETT, V767, DOI 10.1088/2041-8205/767/1/L12; Xu S, 2012, ASTROPHYS J, V745, DOI 10.1088/0004-637X/745/1/88; Zuckerman B, 2007, ASTROPHYS J, V671, P872, DOI 10.1086/522223; Zuckerman B, 2003, ASTROPHYS J, V596, P477, DOI 10.1086/377492	34	114	114	3	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 11	2013	342	6155					218	220		10.1126/science.1239447	http://dx.doi.org/10.1126/science.1239447			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232EV	24115434	Green Accepted, Green Submitted			2022-12-24	WOS:000325475200037
J	Zeron-Medina, J; Wang, XT; Repapi, E; Campbell, MR; Su, D; Castro-Giner, F; Davies, B; Peterse, EFP; Sacilotto, N; Walker, GJ; Terzian, T; Tomlinson, IP; Box, NF; Meinshausen, N; De Val, S; Bell, DA; Bond, GL				Zeron-Medina, Jorge; Wang, Xuting; Repapi, Emmanouela; Campbell, Michelle R.; Su, Dan; Castro-Giner, Francesc; Davies, Benjamin; Peterse, Elisabeth F. P.; Sacilotto, Natalia; Walker, Graeme J.; Terzian, Tamara; Tomlinson, Ian P.; Box, Neil F.; Meinshausen, Nicolai; De Val, Sarah; Bell, Douglas A.; Bond, Gareth L.			A Polymorphic p53 Response Element in KIT Ligand Influences Cancer Risk and Has Undergone Natural Selection	CELL			English	Article							GERM-CELL CANCER; SINGLE-NUCLEOTIDE POLYMORPHISMS; TUMOR-SUPPRESSOR PATHWAY; FACTOR-BINDING-SITES; TESTICULAR CANCER; HUMAN GENOME; DNA-DAMAGE; TRANSCRIPTIONAL ACTIVATION; HAPLOTYPE STRUCTURE; GENETIC-VARIANTS	The ability of p53 to regulate transcription is crucial for tumor suppression and implies that inherited polymorphisms in functional p53-binding sites could influence cancer. Here, we identify a polymorphic p53 responsive element and demonstrate its influence on cancer risk using genome-wide data sets of cancer susceptibility loci, genetic variation, p53 occupancy, and p53-binding sites. We uncover a single-nucleotide polymorphism (SNP) in a functional p53-binding site and establish its influence on the ability of p53 to bind to and regulate transcription of the KITLG gene. The SNP resides in KITLG and associates with one of the largest risks identified among cancer genome-wide association studies. We establish that the SNP has undergone positive selection throughout evolution, signifying a selective benefit, but go on to show that similar SNPs are rare in the genome due to negative selection, indicating that polymorphisms in p53-binding sites are primarily detrimental to humans.	[Zeron-Medina, Jorge; Repapi, Emmanouela; Peterse, Elisabeth F. P.; Sacilotto, Natalia; De Val, Sarah; Bond, Gareth L.] Univ Oxford, Nuffield Dept Clin Med, Ludwig Inst Canc Res, Oxford OX3 7DQ, England; [Wang, Xuting; Campbell, Michelle R.; Su, Dan; Bell, Douglas A.] NIEHS, Environm Genom Grp, Mol Genet Lab, NIH, Res Triangle Pk, NC 27709 USA; [Castro-Giner, Francesc; Tomlinson, Ian P.] Univ Oxford, Wellcome Trust Ctr Human Genet, Mol & Populat Genet Lab, Oxford OX3 7BN, England; [Davies, Benjamin] Univ Oxford, Wellcome Trust Ctr Human Genet, Transgen Technol Res Grp, Oxford OX3 7BN, England; [Walker, Graeme J.] Queensland Inst Med Res, Skin Carcinogenesis Lab, Herston, Qld 4006, Australia; [Terzian, Tamara; Box, Neil F.] Univ Colorado Denver, Dept Dermatol, Aurora, CO 80045 USA; [Terzian, Tamara; Box, Neil F.] Univ Colorado Denver, Charles C Gates Ctr Regenerat Med & Stem Cell Bio, Aurora, CO 80045 USA; [Meinshausen, Nicolai] Univ Oxford, Dept Stat, Oxford OX1 3TG, England	Ludwig Institute for Cancer Research; University of Oxford; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); University of Oxford; Wellcome Centre for Human Genetics; University of Oxford; Wellcome Centre for Human Genetics; QIMR Berghofer Medical Research Institute; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Oxford	Bell, DA (corresponding author), NIEHS, Environm Genom Grp, Mol Genet Lab, NIH, POB 12233, Res Triangle Pk, NC 27709 USA.	bell1@niehs.nih.gov; gareth.bond@ndm.ox.ac.uk	Bell, Douglas A/C-7687-2019; su, dan/GYJ-1940-2022; Davies, Ben/GYD-9163-2022; Castro-Giner, Francesc/D-7992-2014; Box, Neil/F-3591-2010; Zeron-Medina, Jorge/E-2480-2013	Bell, Douglas A/0000-0001-7700-0840; Davies, Ben/0000-0003-3405-507X; Castro-Giner, Francesc/0000-0001-6111-0754; Box, Neil/0000-0002-3486-0346; Zeron-Medina, Jorge/0000-0001-5030-3219; Davies, Benjamin/0000-0003-3623-600X; /0000-0001-8085-0731; Wang, Xuting/0000-0001-6781-8008	Ludwig Institute for Cancer Research; Development Fund-Oxford Cancer Research Centre-University of Oxford; Nuffield Department of Medicine; Clarendon Fund; Wellcome Trust [090532/Z/09/Z]; Oxford NIHR Comprehensive Biomedical Research Centre; Intramural Research Program of the National Institute of Environmental Health Sciences-National Institutes of Health [Z01ES100475, Z01ES046008]; Australian NHMRC; NIAMS [1P30AR057212, 5K01AR063203]; Cancer Council of Queensland; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR057212, K01AR063203] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [Z01ES046008, Z01ES100475, ZIAES100475, Z01ES065079, ZIAES046008] Funding Source: NIH RePORTER; British Heart Foundation [PG/10/83/28610] Funding Source: researchfish; Medical Research Council [MR/J007765/1] Funding Source: researchfish; MRC [MR/J007765/1] Funding Source: UKRI	Ludwig Institute for Cancer Research; Development Fund-Oxford Cancer Research Centre-University of Oxford; Nuffield Department of Medicine; Clarendon Fund; Wellcome Trust(Wellcome TrustEuropean Commission); Oxford NIHR Comprehensive Biomedical Research Centre; Intramural Research Program of the National Institute of Environmental Health Sciences-National Institutes of Health; Australian NHMRC(National Health and Medical Research Council (NHMRC) of Australia); NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Cancer Council of Queensland(Cancer Council Queensland); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was funded in part by the Ludwig Institute for Cancer Research, the Development Fund-Oxford Cancer Research Centre-University of Oxford, the Nuffield Department of Medicine, the Clarendon Fund, the Wellcome Trust (090532/Z/09/Z), the Oxford NIHR Comprehensive Biomedical Research Centre, the Intramural Research Program of the National Institute of Environmental Health Sciences-National Institutes of Health (projects: Z01ES100475 and Z01ES046008), the Australian NHMRC, Cancer Council of Queensland and the NIAMS (projects: 1P30AR057212 and 5K01AR063203). The authors would like to acknowledge Daniel Biggs and Nicole Hortin for assistance with ES cell culture; Shuangshuang Dai for Linux computing support; Colin Goding and Will Fairbrother for helpful discussions; and Suzanne Christen, Claire Beveridge, Elisabeth Bond, and Mark Shipman for help with the preparation of this manuscript.	Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Amigo J, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-428; Atwal GS, 2007, P NATL ACAD SCI USA, V104, P4524, DOI 10.1073/pnas.0610998104; Atwal GS, 2009, P NATL ACAD SCI USA, V106, P10236, DOI 10.1073/pnas.0901298106; Bandele OJ, 2011, NUCLEIC ACIDS RES, V39, P178, DOI 10.1093/nar/gkq764; Beckerman R, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000935; BECKMAN G, 1994, HUM HERED, V44, P266, DOI 10.1159/000154228; Belyi VA, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001198; Bieging KT, 2012, TRENDS CELL BIOL, V22, P97, DOI 10.1016/j.tcb.2011.10.006; Bond GL, 2004, CELL, V119, P591, DOI 10.1016/j.cell.2004.11.022; Bosl GJ, 1997, NEW ENGL J MED, V337, P242, DOI 10.1056/NEJM199707243370406; Botcheva K, 2011, CELL CYCLE, V10, P4237, DOI 10.4161/cc.10.24.18383; Chanock S, 2009, NAT GENET, V41, P765, DOI 10.1038/ng0709-765; Chao C, 2000, EMBO J, V19, P4967, DOI 10.1093/emboj/19.18.4967; Chen CM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023376; Chia VM, 2010, CANCER EPIDEM BIOMAR, V19, P1151, DOI 10.1158/1055-9965.EPI-10-0031; Chresta CM, 1996, CANCER RES, V56, P1834; CROOK T, 1994, CELL, V79, P817, DOI 10.1016/0092-8674(94)90071-X; Czene K, 2002, INT J CANCER, V99, P260, DOI 10.1002/ijc.10332; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Freed-Pastor WA, 2012, GENE DEV, V26, P1268, DOI 10.1101/gad.190678.112; Garner MJ, 2005, INT J CANCER, V116, P331, DOI 10.1002/ijc.21032; Gautier M, 2012, BIOINFORMATICS, V28, P1176, DOI 10.1093/bioinformatics/bts115; Gilbert D, 2011, NAT REV CANCER, V11, P278, DOI 10.1038/nrc3021; Gutekunst M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019198; Hitz C, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm475; Holmes L, 2008, PUBLIC HEALTH, V122, P862, DOI 10.1016/j.puhe.2007.10.010; Houldsworth J, 1998, ONCOGENE, V16, P2345, DOI 10.1038/sj.onc.1201770; JACKS T, 1994, CURR BIOL, V4, P1, DOI 10.1016/S0960-9822(00)00002-6; Jolma A, 2013, CELL, V152, P327, DOI 10.1016/j.cell.2012.12.009; Junttila MR, 2009, NAT REV CANCER, V9, P821, DOI 10.1038/nrc2728; Kanetsky PA, 2009, NAT GENET, V41, P811, DOI 10.1038/ng.393; KOTHARY R, 1988, NATURE, V335, P435, DOI 10.1038/335435a0; Lane D, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000893; Lao O, 2007, ANN HUM GENET, V71, P354, DOI 10.1111/j.1469-1809.2006.00341.x; Lennartsson J, 2012, PHYSIOL REV, V92, P1619, DOI 10.1152/physrev.00046.2011; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; Lu WJ, 2009, NAT REV CANCER, V9, P758, DOI 10.1038/nrc2732; Lu X, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000984; Lutzker SG, 1998, APMIS, V106, P85, DOI 10.1111/j.1699-0463.1998.tb01323.x; Lutzker SG, 1996, NAT MED, V2, P804, DOI 10.1038/nm0796-804; MALKIN D, 1990, SCIENCE, V250, P1233, DOI 10.1126/science.1978757; Masters JRW, 2003, NAT REV CANCER, V3, P517, DOI 10.1038/nrc1120; McGowan KA, 2008, NAT GENET, V40, P963, DOI 10.1038/ng.188; MOUL JW, 1994, CANCER, V73, P388, DOI 10.1002/1097-0142(19940115)73:2<388::AID-CNCR2820730225>3.0.CO;2-Q; Murase D, 2009, J BIOL CHEM, V284, P4343, DOI 10.1074/jbc.M805570200; Nikulenkov F, 2012, CELL DEATH DIFFER, V19, P1992, DOI 10.1038/cdd.2012.89; Noureddine MA, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000462; PENG HQ, 1993, CANCER RES, V53, P3574; PIETENPOL JA, 1994, P NATL ACAD SCI USA, V91, P1998, DOI 10.1073/pnas.91.6.1998; Post SM, 2010, CANCER CELL, V18, P220, DOI 10.1016/j.ccr.2010.07.010; Rapley EA, 2009, NAT GENET, V41, P807, DOI 10.1038/ng.394; ROSS RK, 1979, BRIT J CANCER, V39, P284, DOI 10.1038/bjc.1979.53; Schodel J, 2012, NAT GENET, V44, P420, DOI 10.1038/ng.2204; Shi H, 2009, AM J HUM GENET, V84, P534, DOI 10.1016/j.ajhg.2009.03.009; Smeenk L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017574; Sperka T, 2012, NAT REV MOL CELL BIO, V13, P579, DOI 10.1038/nrm3420; Sur IK, 2012, SCIENCE, V338, P1360, DOI 10.1126/science.1228606; Terzian T, 2010, PIGM CELL MELANOMA R, V23, P781, DOI 10.1111/j.1755-148X.2010.00773.x; Turnbull C, 2010, NAT GENET, V42, P604, DOI 10.1038/ng.607; Valouev A, 2008, NAT METHODS, V5, P829, DOI 10.1038/NMETH.1246; Voight BF, 2006, PLOS BIOL, V4, P446, DOI 10.1371/journal.pbio.0040072; Walker GJ, 2009, J INVEST DERMATOL, V129, P184, DOI 10.1038/jid.2008.210; Wang XT, 2007, HUM MOL GENET, V16, P1188, DOI 10.1093/hmg/ddm066; Wei CL, 2006, CELL, V124, P207, DOI 10.1016/j.cell.2005.10.043	65	97	99	0	31	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 10	2013	155	2					410	422		10.1016/j.cell.2013.09.017	http://dx.doi.org/10.1016/j.cell.2013.09.017			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	235LH	24120139	Bronze, Green Accepted			2022-12-24	WOS:000325719800017
J	de Goeij, JM; van Oevelen, D; Vermeij, MJA; Osinga, R; Middelburg, JJ; de Goeij, AFPM; Admiraal, W				de Goeij, Jasper M.; van Oevelen, Dick; Vermeij, Mark J. A.; Osinga, Ronald; Middelburg, Jack J.; de Goeij, Anton F. P. M.; Admiraal, Wim			Surviving in a Marine Desert: The Sponge Loop Retains Resources Within Coral Reefs	SCIENCE			English	Article							ORGANIC-CARBON; HALISARCA-CAERULEA; POPULATIONS; COMMUNITY; REMOVAL; PRODUCTIVITY; MICROBES; BACTERIA; MATTER; DOC	Ever since Darwin's early descriptions of coral reefs, scientists have debated how one of the world's most productive and diverse ecosystems can thrive in the marine equivalent of a desert. It is an enigma how the flux of dissolved organic matter (DOM), the largest resource produced on reefs, is transferred to higher trophic levels. Here we show that sponges make DOM available to fauna by rapidly expelling filter cells as detritus that is subsequently consumed by reef fauna. This "sponge loop" was confirmed in aquarium and in situ food web experiments, using C-13- and N-15-enriched DOM. The DOM-sponge-fauna pathway explains why biological hot spots such as coral reefs persist in oligotrophic seas-the reef's paradox-and has implications for reef ecosystem functioning and conservation strategies.	[de Goeij, Jasper M.; Admiraal, Wim] Univ Amsterdam, Inst Biodivers & Ecosyst Dynam, Dept Aquat Ecol & Ecotoxicol, POB 94248, NL-1090 GE Amsterdam, Netherlands; [van Oevelen, Dick] NIOZ Royal Netherlands Inst Sea Res, Dept Ecosyst Studies, NL-4400 AC Yerseke, Netherlands; [Vermeij, Mark J. A.] Univ Amsterdam, Inst Biodivers & Ecosyst Dynam, Dept Aquat Microbiol, Willemstad, Curacao, Netherlands; [Osinga, Ronald] Wageningen Univ, Dept Aquaculture & Fisheries, NL-6700 AH Wageningen, Netherlands; [Middelburg, Jack J.] Univ Utrecht, Fac Geosci, NL-3584 CD Utrecht, Netherlands; [de Goeij, Anton F. P. M.] Maastricht Univ, Fac Hlth Med & Life Sci, NL-6200 MD Maastricht, Netherlands	University of Amsterdam; Utrecht University; Royal Netherlands Institute for Sea Research (NIOZ); University of Amsterdam; Wageningen University & Research; Utrecht University; Maastricht University	de Goeij, JM (corresponding author), Univ Amsterdam, Inst Biodivers & Ecosyst Dynam, Dept Aquat Ecol & Ecotoxicol, POB 94248, NL-1090 GE Amsterdam, Netherlands.	j.m.degoeij@uva.nl	Middelburg, Jack/B-4951-2011; Vermeij, Mark/AAR-6757-2020; Vermeij, Mark/B-2752-2013; de Goeij, Jasper/L-6992-2017	Middelburg, Jack/0000-0003-3601-9072; Vermeij, Mark/0000-0001-9612-9527; Vermeij, Mark/0000-0001-9612-9527; de Goeij, Jasper/0000-0002-3411-3084	Innovational Research Incentives Scheme of the Netherlands Organization for Scientific Research (NWO-VENI) [863.10.009]; Schure-Beijerinck-Popping fund	Innovational Research Incentives Scheme of the Netherlands Organization for Scientific Research (NWO-VENI); Schure-Beijerinck-Popping fund	J.M.d.G. and D.v.O. contributed equally to this work. We thank D. M. de Bakker, C. G. W. Whalen, and B. E. Alexander for their technical assistance in the field and lab; C. E. Mueller, and P. van Rijswijk for preparation of the DOM substrate, lab assistance, and isotope analysis; and E. R. Hunting for discussion. This work was supported financially by the Innovational Research Incentives Scheme of the Netherlands Organization for Scientific Research (NWO-VENI; 863.10.009, granted to J.M.d.G.) and the Schure-Beijerinck-Popping fund. J.M.d.G. and R.O. are also affiliated with Porifarma BV Poelbos 3, 6718 HT Ede, Netherlands. The authors declare no conflicts of interest. A detailed description of all materials and methods and additional data are available as supplementary materials. All authors discussed the experimental data and jointly wrote the manuscript. The data are deposited in DRYAD, accession no. http://doi.org/10.5061/dryad.4gb17.	Atkinson M.J., 2003, BIOGEOCHEMISTRY MARI, P40; AZAM F, 1983, MAR ECOL PROG SER, V10, P257, DOI 10.3354/meps010257; Bowen BW, 2013, TRENDS ECOL EVOL, V28, P359, DOI 10.1016/j.tree.2013.01.018; CROSSLAND CJ, 1991, CORAL REEFS, V10, P55, DOI 10.1007/BF00571824; De Goeij JM, 2009, J EXP BIOL, V212, P3892, DOI 10.1242/jeb.034561; de Goeij JM, 2008, MAR ECOL PROG SER, V357, P139, DOI 10.3354/meps07403; de Goeij JM, 2008, LIMNOL OCEANOGR, V53, P1376, DOI 10.4319/lo.2008.53.4.1376; de Goeij JM, 2007, LIMNOL OCEANOGR, V52, P2608, DOI 10.4319/lo.2007.52.6.2608; Dubinsky Z, 2001, AQUAT SCI, V63, P4, DOI 10.1007/PL00001343; Gonzalez-Rivero M, 2011, ECOL MODEL, V222, P1847, DOI 10.1016/j.ecolmodel.2011.03.020; Haas AF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027973; Haas AF, 2010, J EXP MAR BIOL ECOL, V389, P53, DOI 10.1016/j.jembe.2010.03.018; HATCHER BG, 1990, TRENDS ECOL EVOL, V5, P149, DOI 10.1016/0169-5347(90)90221-X; Hughes TP, 2007, CURR BIOL, V17, P360, DOI 10.1016/j.cub.2006.12.049; McMurray SE, 2010, ECOLOGY, V91, P560, DOI 10.1890/08-2060.1; Nelson CE, 2011, ISME J, V5, P1374, DOI 10.1038/ismej.2011.12; Norstrom AV, 2009, MAR ECOL PROG SER, V376, P295, DOI 10.3354/meps07815; ODUM HT, 1955, ECOL MONOGR, V25, P291, DOI 10.2307/1943285; REISWIG HM, 1971, BIOL BULL, V141, P568, DOI 10.2307/1540270; Ribes M, 2012, ENVIRON MICROBIOL, V14, P1224, DOI 10.1111/j.1462-2920.2012.02701.x; Richter C, 2001, NATURE, V413, P726, DOI 10.1038/35099547; Sandin SA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001548; Scheffers SR, 2004, CORAL REEFS, V23, P413, DOI 10.1007/s00338-004-0400-3; Slattery M, 2013, MAR ECOL PROG SER, V476, P71, DOI 10.3354/meps10139; Southwell MW, 2008, LIMNOL OCEANOGR, V53, P986, DOI 10.4319/lo.2008.53.3.0986; Tanaka Y, 2008, B MAR SCI, V82, P237; van Oevelen D, 2009, LIMNOL OCEANOGR, V54, P1829, DOI 10.4319/lo.2009.54.6.1829; Wild C, 2004, NATURE, V428, P66, DOI 10.1038/nature02344; Witte U, 1997, MAR ECOL PROG SER, V154, P241, DOI 10.3354/meps154241; Yahel G, 2003, LIMNOL OCEANOGR, V48, P141, DOI 10.4319/lo.2003.48.1.0141	30	411	415	16	287	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 4	2013	342	6154					108	110		10.1126/science.1241981	http://dx.doi.org/10.1126/science.1241981			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	227PP	24092742				2022-12-24	WOS:000325126100056
J	Gibson, L; Lynam, AJ; Bradshaw, CJA; He, FL; Bickford, DP; Woodruff, DS; Bumrungsri, S; Laurance, WF				Gibson, Luke; Lynam, Antony J.; Bradshaw, Corey J. A.; He, Fangliang; Bickford, David P.; Woodruff, David S.; Bumrungsri, Sara; Laurance, William F.			Near-Complete Extinction of Native Small Mammal Fauna 25 Years After Forest Fragmentation	SCIENCE			English	Article							SPECIES LOSS; DEFORESTATION; BIODIVERSITY; RATES; AREA	Tropical forests continue to be felled and fragmented around the world. A key question is how rapidly species disappear from forest fragments and how quickly humans must restore forest connectivity to minimize extinctions. We surveyed small mammals on forest islands in Chiew Larn Reservoir in Thailand 5 to 7 and 25 to 26 years after isolation and observed the near-total loss of native small mammals within 5 years from <10-hectare (ha) fragments and within 25 years from 10- to 56-ha fragments. Based on our results, we developed an island biogeographic model and estimated mean extinction half-life (50% of resident species disappearing) to be 13.9 years. These catastrophic extinctions were probably partly driven by an invasive rat species; such biotic invasions are becoming increasingly common in human-modified landscapes. Our results are thus particularly relevant to other fragmented forest landscapes and suggest that small fragments are potentially even more vulnerable to biodiversity loss than previously thought.	[Gibson, Luke; Bickford, David P.] Natl Univ Singapore, Dept Biol Sci, Singapore 117543, Singapore; [Lynam, Antony J.] Wildlife Conservat Soc, Global Conservat Programs, Bronx, NY 10460 USA; [Bradshaw, Corey J. A.] Univ Adelaide, Inst Environm, Adelaide, SA 5005, Australia; [Bradshaw, Corey J. A.] Univ Adelaide, Sch Earth & Environm Sci, Adelaide, SA 5005, Australia; [He, Fangliang] Sun Yat Sen Univ, State Key Lab Biocontrol, SYSU Alberta Joint Lab Biodivers Conservat, Guangzhou 510275, Guangdong, Peoples R China; [He, Fangliang] Sun Yat Sen Univ, Sch Life Sci, Guangzhou 510275, Guangdong, Peoples R China; [He, Fangliang] Univ Alberta, Dept Renewable Resources, Edmonton, AB T6G 2H1, Canada; [Woodruff, David S.] Univ Calif San Diego, Div Biol Sci, Ecol Behav & Evolut Sect, La Jolla, CA 92093 USA; [Bumrungsri, Sara] Prince Songkla Univ, Fac Sci, Dept Biol, Hat Yai, Songkhla, Thailand; [Laurance, William F.] James Cook Univ, Ctr Trop Environm & Sustainable Sci, Cairns, Qld 4878, Australia; [Laurance, William F.] James Cook Univ, Sch Marine & Trop Biol, Cairns, Qld 4878, Australia	National University of Singapore; Wildlife Conservation Society; University of Adelaide; University of Adelaide; Sun Yat Sen University; Sun Yat Sen University; University of Alberta; University of California System; University of California San Diego; Prince of Songkla University; James Cook University; James Cook University	Gibson, L (corresponding author), Natl Univ Singapore, Dept Biol Sci, 14 Sci Dr 4, Singapore 117543, Singapore.	lggibson@nus.edu.sg; fhe@mail.sysu.edu.cn; dbsbdp@nus.edu.sg	Lynam, Antony/H-3036-2015; Bradshaw, Corey J.A./A-1311-2008; Laurance, William F/B-2709-2012; Bickford, David P/A-5306-2011; /Y-6615-2018	Lynam, Antony/0000-0002-8395-7902; Bradshaw, Corey J.A./0000-0002-5328-7741; Laurance, William F/0000-0003-4430-9408; Bickford, David P/0000-0003-1478-3387; /0000-0002-7706-3355	NSF [BSR-9000486, BSR-9300182]; National University of Singapore [R-154-000-479-112]; Ah Meng Memorial Conservation Fund [R-154-000-521-720]; Singapore International Graduate Award; Australian Research Council (ARC); National Sciences and Engineering Research Council of Canada; Sun Yat-sen University; ARC Australian Laureate Fellowship	NSF(National Science Foundation (NSF)); National University of Singapore(National University of Singapore); Ah Meng Memorial Conservation Fund; Singapore International Graduate Award; Australian Research Council (ARC)(Australian Research Council); National Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Sun Yat-sen University; ARC Australian Laureate Fellowship(Australian Research Council)	We thank our Thai field assistants for their invaluable efforts; the National Research Council of Thailand and the Department of National Parks, Wildlife and Plant Conservation for granting access and collection permission; and the superintendents and staff of Khlong Saeng Wildlife Sanctuary and Khao Sok National Park for access to Chiew Larn reservoir. We thank J.-F. Cosson for genetically confirming the identity of Rattus tiomanicus. Finally, we are indebted to N. Sodhi for providing this research opportunity on extinction debt. Field research in 1992-1994 was funded by grants BSR-9000486 and BSR-9300182 from NSF to D.S.W. Field research in 2012-2013 was funded by grant R-154-000-479-112 from the National University of Singapore and grant R-154-000-521-720 from the Ah Meng Memorial Conservation Fund. L.G. was supported by a Singapore International Graduate Award, C.J.A.B. by an Australian Research Council (ARC) Future Fellowship, F.H. by the National Sciences and Engineering Research Council of Canada and Sun Yat-sen University, and W.F.L. by an ARC Australian Laureate Fellowship. This study was approved by the Institutional Animal Care and Use Committee of the National University of Singapore.	Achard F, 2002, SCIENCE, V297, P999, DOI 10.1126/science.1070656; Asner GP, 2009, CONSERV BIOL, V23, P1386, DOI 10.1111/j.1523-1739.2009.01333.x; Blackburn TM, 2004, SCIENCE, V305, P1955, DOI 10.1126/science.1101617; Broadbent EN, 2008, BIOL CONSERV, V141, P1745, DOI 10.1016/j.biocon.2008.04.024; Brooks TM, 1999, CONSERV BIOL, V13, P1140, DOI 10.1046/j.1523-1739.1999.98341.x; Canale GR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041671; Diamond J, 2001, SCIENCE, V294, P1847, DOI 10.1126/science.1067012; DIAMOND JM, 1972, P NATL ACAD SCI USA, V69, P3199, DOI 10.1073/pnas.69.11.3199; Dirzo R, 2003, ANNU REV ENV RESOUR, V28, P137, DOI 10.1146/annurev.energy.28.050302.105532; Ellis EC, 2010, GLOBAL ECOL BIOGEOGR, V19, P589, DOI 10.1111/j.1466-8238.2010.00540.x; European Commission, 2020, GUID GEOGR IND GIS S; Feeley KJ, 2008, ANIM CONSERV, V11, P366, DOI 10.1111/j.1469-1795.2008.00207.x; Ferraz G, 2003, P NATL ACAD SCI USA, V100, P14069, DOI 10.1073/pnas.2336195100; Gibson L, 2011, NATURE, V478, P378, DOI 10.1038/nature10425; Halley JM, 2011, P NATL ACAD SCI USA, V108, P2316, DOI 10.1073/pnas.1011217108; Hanski I, 2013, P NATL ACAD SCI USA, V110, P12715, DOI 10.1073/pnas.1311491110; Harris DB, 2007, ECOLOGY, V88, P2330, DOI 10.1890/06-1701.1; Harris DB, 2009, BIOL INVASIONS, V11, P1611, DOI 10.1007/s10530-008-9393-0; Jones H, 2008, POETRY WALES, V43, P22; Laurance WF, 2012, NATURE, V489, P290, DOI 10.1038/nature11318; Laurance WF, 2011, BIOL CONSERV, V144, P56, DOI 10.1016/j.biocon.2010.09.021; Laurance WF, 2009, TRENDS ECOL EVOL, V24, P659, DOI 10.1016/j.tree.2009.06.009; Lynam AJ, 1999, BIOL CONSERV, V91, P191, DOI 10.1016/S0006-3207(99)00082-8; NAKHASATHIEN S, 1989, Oryx, V23, P146; Prugh LR, 2008, P NATL ACAD SCI USA, V105, P20770, DOI 10.1073/pnas.0806080105; Terborgh J, 2001, SCIENCE, V294, P1923, DOI 10.1126/science.1064397; TILMAN D, 1994, NATURE, V371, P65, DOI 10.1038/371065a0; Turner IM, 1996, TRENDS ECOL EVOL, V11, P330, DOI 10.1016/0169-5347(96)10046-X	28	225	237	8	276	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 27	2013	341	6153					1508	1510		10.1126/science.1240495	http://dx.doi.org/10.1126/science.1240495			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	224NS	24072921				2022-12-24	WOS:000324894600049
J	Banaszynski, LA; Wen, DC; Dewell, S; Whitcomb, SJ; Lin, MY; Diaz, N; Elsasser, SJ; Chapgier, A; Goldberg, AD; Canaani, E; Rafii, S; Zheng, DY; Allis, CD				Banaszynski, Laura A.; Wen, Duancheng; Dewell, Scott; Whitcomb, Sarah J.; Lin, Mingyan; Diaz, Nichole; Elsaesser, Simon J.; Chapgier, Ariane; Goldberg, Aaron D.; Canaani, Eli; Rafii, Shahin; Zheng, Deyou; Allis, C. David			Hira-Dependent Histone H3.3 Deposition Facilitates PRC2 Recruitment at Developmental Loci in ES Cells	CELL			English	Article							EMBRYONIC STEM-CELLS; REGULATING GENE-EXPRESSION; RNA-POLYMERASE-II; GENOME-WIDE; CHROMATIN; PLURIPOTENT; ACETYLATION; COMPLEX; TRANSCRIPTION; GASTRULATION	Polycomb repressive complex 2 (PRC2) regulates gene expression during lineage specification through trimethylation of lysine 27 on histone H3 (H3K27me3). In Drosophila, polycomb binding sites are dynamic chromatin regions enriched with the histone variant H3.3. Here, we show that, in mouse embryonic stem cells (ESCs), H3.3 is required for proper establishment of H3K27me3 at the promoters of developmentally regulated genes. Upon H3.3 depletion, these promoters show reduced nucleosome turnover measured by deposition of de novo synthesized histones and reduced PRC2 occupancy. Further, we show H3.3-dependent interaction of PRC2 with the histone chaperone, Hira, and that Hira localization to chromatin requires H3.3. Our data demonstrate the importance of H3.3 in maintaining a chromatin landscape in ESCs that is important for proper gene regulation during differentiation. Moreover, our findings support the emerging notion that H3.3 has multiple functions in distinct genomic locations that are not always correlated with an "active'' chromatin state.	[Banaszynski, Laura A.; Whitcomb, Sarah J.; Diaz, Nichole; Elsaesser, Simon J.; Goldberg, Aaron D.; Allis, C. David] Rockefeller Univ, Lab Chromatin Biol & Epigenet, New York, NY 10065 USA; [Wen, Duancheng; Rafii, Shahin] Weill Cornell Med Coll, Ansary Stem Cell Inst, Howard Hughes Med Inst, New York, NY 10065 USA; [Wen, Duancheng; Rafii, Shahin] Weill Cornell Med Coll, Dept Med Genet, New York, NY 10065 USA; [Dewell, Scott] Rockefeller Univ, Genom Resource Ctr, New York, NY 10065 USA; [Lin, Mingyan; Zheng, Deyou] Albert Einstein Coll Med, Dept Genet, Bronx, NY 10461 USA; [Chapgier, Ariane] Inst Child Hlth, Mol Med Unit, London WC1N 1EH, England; [Canaani, Eli] Weizmann Inst Sci, Dept Mol Cell Biol, IL-76100 Rehovot, Israel; [Zheng, Deyou] Albert Einstein Coll Med, Dept Neurol, Bronx, NY 10461 USA; [Zheng, Deyou] Albert Einstein Coll Med, Dept Neurosci, Bronx, NY 10461 USA	Rockefeller University; Cornell University; Howard Hughes Medical Institute; Cornell University; Rockefeller University; Yeshiva University; Albert Einstein College of Medicine; University of London; University College London; Weizmann Institute of Science; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Allis, CD (corresponding author), Rockefeller Univ, Lab Chromatin Biol & Epigenet, New York, NY 10065 USA.	alliscd@rockefeller.edu	Elsässer, Simon/B-8911-2014; Elsässer, Simon/AAM-3986-2020; lin, mingyan/HDL-9420-2022	Elsässer, Simon/0000-0001-8724-4849; Elsässer, Simon/0000-0001-8724-4849; Wen, Duancheng/0000-0002-3160-6289; Chapgier, Ariane/0000-0002-1734-0744; Zheng, Deyou/0000-0003-4354-5337; Whitcomb, Sarah/0000-0002-1392-1496; Goldberg, Aaron/0000-0002-2892-2643	Rockefeller University Fund; Tri-Institutional Stem Cell Initiative; US National Institute of Mental Health [MH087840, MH073164]; Damon Runyon Cancer Research Foundation; Rockefeller University Women & Science Initiative; NICHD; British Heart Foundation [FS/10/31/28395] Funding Source: researchfish; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007739] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH073164, R33MH087840, R21MH087840] Funding Source: NIH RePORTER	Rockefeller University Fund; Tri-Institutional Stem Cell Initiative; US National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Damon Runyon Cancer Research Foundation; Rockefeller University Women & Science Initiative; NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); British Heart Foundation(British Heart Foundation); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by The Rockefeller University Fund (to C. D. A.), Tri-Institutional Stem Cell Initiative (to C. D. A. and S. R.), US National Institute of Mental Health (MH087840 and MH073164 to D.Z.), Damon Runyon Cancer Research Foundation (L. A. B.), and The Rockefeller University Women & Science Initiative (L. A. B.). We thank I. Falciatori for help with the teratoma assay, Y. Zhang for purified recombinant PRC2 complex, and S. Chen and Y. Shi for the Jmjd3 antibody. The Troma-I hybridoma developed by P. Brulet and R. Kemler was obtained from the Developmental Studies Hybridoma Bank developed under the auspices of the NICHD and maintained by the Department of Biology at The University of Iowa. We thank L. Baker, E. Korb, E. Duncan, and C. Lu for critical reading of this manuscript and J. Wysocka and members of the Allis lab for helpful discussions.	Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Brookes E, 2012, CELL STEM CELL, V10, P157, DOI 10.1016/j.stem.2011.12.017; Brookes E, 2009, EMBO REP, V10, P1213, DOI 10.1038/embor.2009.221; Bush KM, 2013, EPIGENET CHROMATIN, V6, DOI 10.1186/1756-8935-6-7; Couldrey C, 1999, HUM MOL GENET, V8, P2489, DOI 10.1093/hmg/8.13.2489; Cox SG, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002938; Cui BW, 2006, MOL CELL BIOL, V26, P7719, DOI 10.1128/MCB.01139-06; Deal RB, 2010, SCIENCE, V328, P1161, DOI 10.1126/science.1186777; Dunleavy EM, 2011, NUCLEUS-PHILA, V2, P146, DOI 10.4161/nucl.2.2.15211; Filipescu D, 2013, TRENDS GENET, V29, P630, DOI 10.1016/j.tig.2013.06.002; Gaspar-Maia A, 2011, NAT REV MOL CELL BIO, V12, P36, DOI 10.1038/nrm3036; Goldberg AD, 2010, CELL, V140, P678, DOI 10.1016/j.cell.2010.01.003; Hodl M, 2009, CURR BIOL, V19, P1221, DOI 10.1016/j.cub.2009.05.048; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Hudson QJ, 2010, HEREDITY, V105, P45, DOI 10.1038/hdy.2010.23; Koh KP, 2011, CELL STEM CELL, V8, P200, DOI 10.1016/j.stem.2011.01.008; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lau PNI, 2011, P NATL ACAD SCI USA, V108, P2801, DOI 10.1073/pnas.1012798108; Li G, 2010, GENE DEV, V24, P368, DOI 10.1101/gad.1886410; Loyola A, 2006, MOL CELL, V24, P309, DOI 10.1016/j.molcel.2006.08.019; Lu CW, 2008, NAT GENET, V40, P921, DOI 10.1038/ng.173; Margueron R, 2011, NATURE, V469, P343, DOI 10.1038/nature09784; McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630; Meshorer E, 2006, DEV CELL, V10, P105, DOI 10.1016/j.devcel.2005.10.017; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Mito Y, 2007, SCIENCE, V315, P1408, DOI 10.1126/science.1134004; Morasso MI, 1999, P NATL ACAD SCI USA, V96, P162, DOI 10.1073/pnas.96.1.162; Pasini D, 2010, NUCLEIC ACIDS RES, V38, P4958, DOI 10.1093/nar/gkq244; Pchelintsev NA, 2013, CELL REP, V3, P1012, DOI 10.1016/j.celrep.2013.03.026; Peng JC, 2009, CELL, V139, P1290, DOI 10.1016/j.cell.2009.12.002; Ray-Gallet D, 2011, MOL CELL, V44, P928, DOI 10.1016/j.molcel.2011.12.006; Reynolds N, 2012, EMBO J, V31, P593, DOI 10.1038/emboj.2011.431; Roberts C, 2002, MOL CELL BIOL, V22, P2318, DOI 10.1128/MCB.22.7.2318-2328.2002; Rossant J, 2008, CELL, V132, P527, DOI 10.1016/j.cell.2008.01.039; Sakai A, 2009, CURR BIOL, V19, P1816, DOI 10.1016/j.cub.2009.09.021; Schwartzentruber J, 2012, NATURE, V482, P226, DOI [10.1038/nature10833, 10.1007/s13311-012-0137-6]; Surface LE, 2010, CELL STEM CELL, V7, P288, DOI 10.1016/j.stem.2010.08.004; Szenker E, 2012, CELL REP, V1, P730, DOI 10.1016/j.celrep.2012.05.006; Tagami H, 2004, CELL, V116, P51, DOI 10.1016/S0092-8674(03)01064-X; Tie F, 2009, DEVELOPMENT, V136, P3131, DOI 10.1242/dev.037127; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Weake VM, 2010, NAT REV GENET, V11, P426, DOI 10.1038/nrg2781; WELLMAN SE, 1987, GENE, V59, P29, DOI 10.1016/0378-1119(87)90263-0; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	45	173	179	0	29	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 26	2013	155	1					107	120		10.1016/j.cell.2013.08.061	http://dx.doi.org/10.1016/j.cell.2013.08.061			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	224UX	24074864	Green Accepted, Bronze			2022-12-24	WOS:000324916700013
J	Haitin, Y; Carlson, AE; Zagotta, WN				Haitin, Yoni; Carlson, Anne E.; Zagotta, William N.			The structural mechanism of KCNH-channel regulation by the eag domain	NATURE			English	Article							LONG-QT SYNDROME; HERG POTASSIUM CHANNELS; AMINO-TERMINAL DOMAIN; HUMAN-ETHER; MUTATIONS; DROSOPHILA; DEACTIVATION; PHYSIOLOGY; BINDING; REGION	The KCNH voltage-dependent potassium channels (ether-a-go-go, EAG; EAG-related gene, ERG; EAG-like channels, ELK) are important regulators of cellular excitability(1-3) and have key roles in diseases such as cardiac long QT syndrome type 2 (LQT2)(4), epilepsy(5), schizophrenia(6) and cancer(7). The intracellular domains of KCNH channels are structurally distinct from other voltage-gated channels. The amino-terminal region contains an eag domain, which is composed of a Per-Arnt-Sim (PAS) domain and aPAS-cap domain(8), whereas the carboxy-terminal region contains a cyclic nucleotide-binding homology domain (CNBHD), which is connected to the pore through a C-linker domain. Many disease-causing mutations localize to these specialized intracellular domains, which underlie the unique gating and regulation of KCNH channels(9). It has been suggested that the eag domain may regulate the channel by interacting with either the S4-S5 linker or the CNBHD8,10. Here we present a 2 angstrom resolution crystal structure of the eag domain-CNBHD complex of themouse EAG1 (also known as KCNH1) channel. It displays extensive interactions between the eag domain and the CNBHD, indicating that the regulatory mechanism of the eag domain primarily involves the CNBHD. Notably, the structure reveals that a number of LQT2 mutations at homologous positions in human ERG, in addition to cancer-associated mutations in EAG channels, localize to the eag domain-CNBHD interface. Furthermore, mutations at the interface produced marked effects on channel gating, demonstrating the important physiological role of the eag domain-CNBHD interaction. Our structure of the eag domain-CNBHD complex of mouse EAG1 provides unique insights into the physiological and pathophysiological mechanisms of KCNH channels.	[Haitin, Yoni; Carlson, Anne E.; Zagotta, William N.] Univ Washington, Sch Med, Dept Physiol & Biophys, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Zagotta, WN (corresponding author), Univ Washington, Sch Med, Dept Physiol & Biophys, Seattle, WA 98195 USA.	zagotta@uw.edu	Haitin, Yoni/AAQ-4571-2021; Carlson, Anne/I-9495-2019	Haitin, Yoni/0000-0002-1648-6792; Carlson, Anne/0000-0003-2724-1325	National Institutes of Health (NIH) [R01 EY010329]; International Human Frontier Science Program Organization (HFSPO) [LT-001025/2011]; NIH [F32 HL095241]; National Institutes of Health, National Institute of General Medical Sciences; Howard Hughes Medical Institute; Office of Science, Office of Basic Energy Sciences of the US Department of Energy [DE-AC02-05CH11231]; NATIONAL EYE INSTITUTE [R01EY010329] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F32HL095241] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); International Human Frontier Science Program Organization (HFSPO)(Human Frontier Science Program); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health, National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Office of Science, Office of Basic Energy Sciences of the US Department of Energy(United States Department of Energy (DOE)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank S. Cunnington and S. Camp for technical assistance. We thank the beamline staff at the Advanced Light Source (ALS). We also thank G. Flynn, J. Bankston, M. Puljung and S. Gordon for helpful discussions and critical reading of the manuscript. This work was supported by the National Institutes of Health (NIH) grant R01 EY010329 (W.N.Z.), The International Human Frontier Science Program Organization (HFSPO) long-term postdoctoral fellowship LT-001025/2011 (Y.H.), and NIH grant F32 HL095241 (A.E.C.). The Berkeley Center for Structural Biology is supported in part by the National Institutes of Health, National Institute of General Medical Sciences, and the Howard Hughes Medical Institute. The Advanced Light Source is supported by the Director, Office of Science, Office of Basic Energy Sciences, of the US Department of Energy under Contract No. DE-AC02-05CH11231.	Adaixo R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059265; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bamford S, 2004, BRIT J CANCER, V91, P355, DOI 10.1038/sj.bjc.6601894; Bauer CK, 2001, J MEMBRANE BIOL, V182, P1; Brelidze TI, 2013, P NATL ACAD SCI USA, V110, P11648, DOI 10.1073/pnas.1306887110; Brelidze TI, 2012, NATURE, V481, P530, DOI 10.1038/nature10735; Brelidze TI, 2009, J BIOL CHEM, V284, P27989, DOI 10.1074/jbc.M109.016337; Cabral JHM, 1998, CELL, V95, P649, DOI 10.1016/S0092-8674(00)81635-9; Camacho J, 2006, CANCER LETT, V233, P1, DOI 10.1016/j.canlet.2005.02.016; Chen J, 1999, J BIOL CHEM, V274, P10113, DOI 10.1074/jbc.274.15.10113; Cherubini A, 2005, MOL BIOL CELL, V16, P2972, DOI 10.1091/mbc.E04-10-0940; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ganetzky B, 1999, ANN NY ACAD SCI, V868, P356, DOI 10.1111/j.1749-6632.1999.tb11297.x; Gustina AS, 2012, CELL SIGNAL, V24, P1592, DOI 10.1016/j.cellsig.2012.04.004; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; Huffaker SJ, 2009, NAT MED, V15, P509, DOI 10.1038/nm.1962; Kawate T, 2006, STRUCTURE, V14, P673, DOI 10.1016/j.str.2006.01.013; Li QX, 2010, BIOCHEM BIOPH RES CO, V403, P126, DOI 10.1016/j.bbrc.2010.10.132; Marques-Carvalho MJ, 2012, J MOL BIOL, V423, P34, DOI 10.1016/j.jmb.2012.06.025; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; Muskett FW, 2011, J BIOL CHEM, V286, P6184, DOI 10.1074/jbc.M110.199364; Napolitano C, 2005, JAMA-J AM MED ASSOC, V294, P2975, DOI 10.1001/jama.294.23.2975; Ng CA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016191; Rossi AM, 2011, NAT PROTOC, V6, DOI 10.1038/nprot.2011.305; Sanguinetti MC, 2006, NATURE, V440, P463, DOI 10.1038/nature04710; Splawski I, 2000, CIRCULATION, V102, P1178, DOI 10.1161/01.CIR.102.10.1178; Stevens L, 2009, EUR BIOPHYS J BIOPHY, V38, P523, DOI 10.1007/s00249-009-0402-8; Sun XX, 2004, J BIOL CHEM, V279, P10206, DOI 10.1074/jbc.M310728200; Taraska JW, 2009, NAT METHODS, V6, P532, DOI 10.1038/nmeth.1341; Tester DJ, 2005, HEART RHYTHM, V2, P507, DOI 10.1016/j.hrthm.2005.01.020; Wang JL, 1998, J GEN PHYSIOL, V112, P637, DOI 10.1085/jgp.112.5.637; Wang JL, 2000, J GEN PHYSIOL, V115, P749, DOI 10.1085/jgp.115.6.749; WARMKE J, 1991, SCIENCE, V252, P1560, DOI 10.1126/science.1840699; Zagotta WN, 2003, NATURE, V425, P200, DOI 10.1038/nature01922; ZAGOTTA WN, 1989, P NATL ACAD SCI USA, V86, P7243, DOI 10.1073/pnas.86.18.7243; Zhang XF, 2010, NAT NEUROSCI, V13, P1056, DOI 10.1038/nn.2610; Ziechner U, 2006, FEBS J, V273, P1074, DOI 10.1111/j.1742-4658.2006.05134.x	38	80	83	2	33	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 19	2013	501	7467					444	+		10.1038/nature12487	http://dx.doi.org/10.1038/nature12487			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219XT	23975098	Green Accepted			2022-12-24	WOS:000324545700051
J	Klein, CA				Klein, Christoph A.			Selection and adaptation during metastatic cancer progression	NATURE			English	Article							DISSEMINATED TUMOR-CELLS; PRIMARY COLORECTAL CANCERS; BREAST-CANCER; BONE-MARROW; CLONAL EVOLUTION; IN-SITU; ADHESION MOLECULE; GENOMIC ANALYSIS; GENETIC-ANALYSIS; DIVERSITY	Cancer is often regarded as a process of asexual evolution driven by genomic and genetic instability. Mutation, selection and adaptation are by convention thought to occur primarily within, and to a lesser degree outside, the primary tumour. However, disseminated cancer cells that remain after 'curative' surgery exhibit extreme genomic heterogeneity before the manifestation of metastasis. This heterogeneity is later reduced by selected clonal expansion, suggesting that the disseminated cells had yet to acquire key traits of fully malignant cells. Abrogation of the cells' progression outside the primary tumour implies new challenges and opportunities for diagnosis and adjuvant therapies.	[Klein, Christoph A.] Univ Regensburg, D-93053 Regensburg, Germany; [Klein, Christoph A.] Fraunhofer Inst Toxicol & Expt Med, Personalized Tumor Therapy Project Grp, Regensburg, Germany	University of Regensburg; Fraunhofer Gesellschaft	Klein, CA (corresponding author), Univ Regensburg, D-93053 Regensburg, Germany.	christoph.klein@ukr.de		Klein, Christoph A./0000-0001-7128-1725				AARONSON SA, 1968, SCIENCE, V162, P1024, DOI 10.1126/science.162.3857.1024; Alberts SR, 2012, JAMA-J AM MED ASSOC, V307, P1383, DOI 10.1001/jama.2012.385; Allred DC, 2008, CLIN CANCER RES, V14, P370, DOI 10.1158/1078-0432.CCR-07-1127; Banys M, 2012, BREAST CANCER RES TR, V131, P801, DOI 10.1007/s10549-011-1478-2; Bardi G, 1997, BRIT J CANCER, V76, P765, DOI 10.1038/bjc.1997.459; Baudis M, 2001, BIOINFORMATICS, V17, P1228, DOI 10.1093/bioinformatics/17.12.1228; BERENBLUM I, 1947, BRIT J CANCER, V1, P379, DOI 10.1038/bjc.1947.35; Bettington M, 2013, HISTOPATHOLOGY, V62, P367, DOI 10.1111/his.12055; Boecker W, 2001, J PATHOL, V195, P415, DOI 10.1002/path.982; Bos PD, 2009, NATURE, V459, P1005, DOI 10.1038/nature08021; Brabletz T, 2001, P NATL ACAD SCI USA, V98, P10356, DOI 10.1073/pnas.171610498; Braun S, 2005, NEW ENGL J MED, V353, P793, DOI 10.1056/NEJMoa050434; CAIRNS J, 1975, NATURE, V255, P197, DOI 10.1038/255197a0; Campbell PJ, 2010, NATURE, V467, P1109, DOI 10.1038/nature09460; Carr NJ, 2009, J CLIN PATHOL, V62, P516, DOI 10.1136/jcp.2008.061960; Castellarin M, 2013, J PATHOL, V229, P515, DOI 10.1002/path.4105; Cauffman G, 2009, HUM REPROD, V24, P63, DOI 10.1093/humrep/den351; Chin K, 2004, NAT GENET, V36, P984, DOI 10.1038/ng1409; Ding L, 2010, NATURE, V464, P999, DOI 10.1038/nature08989; Douillard JY, 2010, J CLIN ONCOL, V28, P4697, DOI 10.1200/JCO.2009.27.4860; Engel J, 2003, EUR J CANCER, V39, P1794, DOI 10.1016/S0959-8049(03)00422-2; Engel J, 2012, CANCER METAST REV, V31, P235, DOI 10.1007/s10555-011-9343-7; Fisher B, 2002, NEW ENGL J MED, V347, P1233, DOI 10.1056/NEJMoa022152; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Ghajar CM, 2013, NAT CELL BIOL, V15, P807, DOI 10.1038/ncb2767; Gires O, 2009, NAT REV CANCER, V9, P143, DOI 10.1038/nrc2499-c1; Goss GD, 2010, J CLIN ONCOL, V28, DOI 10.1200/jco.2010.28.18_suppl.lba7005; GOTTLINGER H, 1986, HYBRIDOMA, V5, pS29; Greaves M, 2012, NATURE, V481, P306, DOI 10.1038/nature10762; Gudjonsson T, 2002, GENE DEV, V16, P693, DOI 10.1101/gad.952602; Hafner C, 2007, P NATL ACAD SCI USA, V104, P13450, DOI 10.1073/pnas.0705218104; Hafner C, 2010, P NATL ACAD SCI USA, V107, P20780, DOI 10.1073/pnas.1008365107; Heitzer E, 2013, CANCER RES, V73, P2965, DOI 10.1158/0008-5472.CAN-12-4140; Heng HHO, 2011, ADV CANCER RES, V112, P217, DOI 10.1016/B978-0-12-387688-1.00008-9; Hiratsuka S, 2008, NAT CELL BIOL, V10, P1349, DOI 10.1038/ncb1794; Holzel D, 2010, CANCER METAST REV, V29, P737, DOI 10.1007/s10555-010-9260-1; Husemann Y, 2008, CANCER CELL, V13, P58, DOI 10.1016/j.ccr.2007.12.003; Johnston LA, 2009, SCIENCE, V324, P1679, DOI 10.1126/science.1163862; Kang YB, 2003, CANCER CELL, V3, P537, DOI 10.1016/S1535-6108(03)00132-6; Kang YB, 2013, CANCER CELL, V23, P573, DOI 10.1016/j.ccr.2013.04.017; Kaplan RN, 2005, NATURE, V438, P820, DOI 10.1038/nature04186; Kennecke H, 2010, J CLIN ONCOL, V28, P3271, DOI 10.1200/JCO.2009.25.9820; Kitchener H, 2009, LANCET, V373, P125, DOI 10.1016/S0140-6736(08)61766-3; Klein CA, 2002, LANCET, V360, P683, DOI 10.1016/S0140-6736(02)09838-0; Klein CA, 2006, CELL CYCLE, V5, P1788, DOI 10.4161/cc.5.16.3097; Klein CA, 2011, CURR OPIN GENET DEV, V21, P42, DOI 10.1016/j.gde.2010.10.011; Klein CA, 2009, CANCER RES, V69, P5285, DOI 10.1158/0008-5472.CAN-08-4586; Klein CA, 2009, NAT REV CANCER, V9, P302, DOI 10.1038/nrc2627; Kloosterman WP, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-10-r103; LEE LW, 1989, AM J PATHOL, V135, P63; Levayer R, 2013, J CELL BIOL, V200, P689, DOI 10.1083/jcb.201301051; Lu TY, 2010, J BIOL CHEM, V285, P8719, DOI 10.1074/jbc.M109.077081; Magbanua MJM, 2013, CANCER RES, V73, P30, DOI 10.1158/0008-5472.CAN-11-3017; Magbanua MJM, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-78; Maley CC, 2006, NAT GENET, V38, P468, DOI 10.1038/ng1768; McAllister SS, 2008, CELL, V133, P994, DOI 10.1016/j.cell.2008.04.045; Minn AJ, 2005, NATURE, V436, P518, DOI 10.1038/nature03799; Miranda E, 2013, CANCER-AM CANCER SOC, V119, P266, DOI 10.1002/cncr.27722; Mitelman F, 2013, MITELMAN DATABASE CH; Mok TS, 2009, NEW ENGL J MED, V361, P947, DOI 10.1056/NEJMoa0810699; MOLL R, 1982, CELL, V31, P11, DOI 10.1016/0092-8674(82)90400-7; Moreno E, 2008, NAT REV CANCER, V8, P141, DOI 10.1038/nrc2252; Mueller MM, 2006, EUR J CANCER, V42, P735, DOI 10.1016/j.ejca.2006.01.014; Naski MC, 1996, NAT GENET, V13, P233, DOI 10.1038/ng0696-233; Neuville A, 2011, HUM PATHOL, V42, P244, DOI 10.1016/j.humpath.2010.07.003; Ng VY, 2010, STEM CELLS, V28, P29, DOI 10.1002/stem.221; Nguyen DX, 2009, NAT REV CANCER, V9, P274, DOI 10.1038/nrc2622; NOWELL PC, 1976, SCIENCE, V194, P23, DOI 10.1126/science.959840; OREILLY MS, 1994, CELL, V79, P315, DOI 10.1016/0092-8674(94)90200-3; Park SY, 2010, J CLIN INVEST, V120, P636, DOI 10.1172/JCI40724; Peinado H, 2012, NAT MED, V18, P883, DOI 10.1038/nm.2753; Polzer B, 2013, NAT MED, V19, P274, DOI 10.1038/nm.3121; Rasnick D, 2002, CANCER GENET CYTOGEN, V136, P66, DOI 10.1016/S0165-4608(01)00665-3; Riethdorf S, 2008, INT J CANCER, V123, P1991, DOI 10.1002/ijc.23825; Rubin H, 2008, P NATL ACAD SCI USA, V105, P6215, DOI 10.1073/pnas.0800747105; Rudenstam CM, 2006, J CLIN ONCOL, V24, P337, DOI 10.1200/JCO.2005.01.5784; Ruggiero RA, 2011, CANCER RES, V71, P7113, DOI 10.1158/0008-5472.CAN-11-0581; Sanger N, 2011, INT J CANCER, V129, P2522, DOI 10.1002/ijc.25895; Schardt JA, 2005, CANCER CELL, V8, P227, DOI 10.1016/j.ccr.2005.08.003; SCHLIMOK G, 1987, P NATL ACAD SCI USA, V84, P8672, DOI 10.1073/pnas.84.23.8672; Schmidt-Kittler O, 2003, P NATL ACAD SCI USA, V100, P7737, DOI 10.1073/pnas.1331931100; Shah SP, 2009, NATURE, V461, P809, DOI 10.1038/nature08489; Shiozawa Y, 2011, J CLIN INVEST, V121, P1298, DOI 10.1172/JCI43414; Slamon DJ, 2001, NEW ENGL J MED, V344, P783, DOI 10.1056/NEJM200103153441101; Sosman JA, 2012, NEW ENGL J MED, V366, P707, DOI 10.1056/NEJMoa1112302; Steeg PS, 2012, NATURE, V485, pS58, DOI 10.1038/485S58a; Stephens PJ, 2011, CELL, V144, P27, DOI 10.1016/j.cell.2010.11.055; Stoecklein NH, 2008, CANCER CELL, V13, P441, DOI 10.1016/j.ccr.2008.04.005; Stoecklein NH, 2010, INT J CANCER, V126, P589, DOI 10.1002/ijc.24916; Tang YC, 2013, CELL, V152, P394, DOI 10.1016/j.cell.2012.11.043; Tang YC, 2011, CELL, V144, P499, DOI 10.1016/j.cell.2011.01.017; Teixeira MR, 2011, ADV CANCER RES, V112, P127, DOI 10.1016/B978-0-12-387688-1.00005-3; Theissen G, 2009, THEOR BIOSCI, V128, P43, DOI 10.1007/s12064-009-0058-z; Toyota M, 1999, P NATL ACAD SCI USA, V96, P8681, DOI 10.1073/pnas.96.15.8681; Valastyan S, 2011, CELL, V147, P275, DOI 10.1016/j.cell.2011.09.024; VANDUUREN BL, 1975, CANCER RES, V35, P502; Vermaat JS, 2012, CLIN CANCER RES, V18, P688, DOI 10.1158/1078-0432.CCR-11-1965; Veronesi U, 1999, EUR J CANCER, V35, P1320, DOI 10.1016/S0959-8049(99)00133-1; Visvader JE, 2008, NAT REV CANCER, V8, P755, DOI 10.1038/nrc2499; VOGELSTEIN B, 1988, NEW ENGL J MED, V319, P525, DOI 10.1056/NEJM198809013190901; Weckermann D, 2009, J CLIN ONCOL, V27, P1549, DOI 10.1200/JCO.2008.17.0563; Weedon-Fekjaer H, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2092; Winawer SJ, 2006, GASTROENTEROLOGY, V130, P1872, DOI 10.1053/j.gastro.2006.03.012; Yachida S, 2010, NATURE, V467, P1114, DOI 10.1038/nature09515	104	196	200	0	80	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 19	2013	501	7467					365	372		10.1038/nature12628	http://dx.doi.org/10.1038/nature12628			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219XT	24048069				2022-12-24	WOS:000324545700035
J	Yin, F; Yu, JZ; Zheng, YG; Chen, Q; Zhang, NL; Pan, DJ				Yin, Feng; Yu, Jianzhong; Zheng, Yonggang; Chen, Qian; Zhang, Nailing; Pan, Duojia			Spatial Organization of Hippo Signaling at the Plasma Membrane Mediated by the Tumor Suppressor Merlin/NF2	CELL			English	Article							CELL-PROLIFERATION; PROTEIN-KINASE; TISSUE-GROWTH; NF2 GENE; F-ACTIN; PATHWAY; PHOSPHORYLATION; CONJUNCTION; RESTRICTS; SALVADOR	Although Merlin/NF2 was discovered two decades ago as a tumor suppressor underlying Neurofibromatosis type II, its precise molecular mechanism remains poorly understood. Recent studies in Drosophila revealed a potential link between Merlin and the Hippo pathway by placing Merlin genetically upstream of the kinase Hpo/Mst. In contrast to the commonly depicted linear model of Merlin functioning through Hpo/Mst, here we show that in both Drosophila and mammals, Merlin promotes downstream Hippo signaling without activating the intrinsic kinase activity of Hpo/Mst. Instead, Merlin directly binds and recruits the effector kinase Wts/Lats to the plasma membrane. Membrane recruitment, in turn, promotes Wts phosphorylation by the Hpo-Sav kinase complex. We further show that disruption of the actin cytoskeleton promotes Merlin-Wts interactions, which implicates Merlin in actin-mediated regulation of Hippo signaling. Our findings elucidate an important molecular function of Merlin and highlight the plasma membrane as a critical subcellular compartment for Hippo signal transduction.	[Yin, Feng; Yu, Jianzhong; Zheng, Yonggang; Chen, Qian; Zhang, Nailing; Pan, Duojia] Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Dept Mol Biol & Genet, Baltimore, MD 21205 USA	Howard Hughes Medical Institute; Johns Hopkins University	Pan, DJ (corresponding author), Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Dept Mol Biol & Genet, Baltimore, MD 21205 USA.	djpan@jhmi.edu	YIN, FENG/AAM-3823-2020	YIN, FENG/0000-0002-8444-1123	National Institutes of Health [EY015708]; Department of Defense [NF093145]; NATIONAL EYE INSTITUTE [R01EY015708] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We thank Dr. Rick Fehon for the gift of anti-Mer antibody, Dr. Marco Giovannini for providing FC-912 and FH-912 Schwann cells, and Dr. Vijaya Ramesh for advice on GST-NF2 purification. This study was supported in part by grants from the National Institutes of Health (EY015708) and Department of Defense (NF093145). D.P. is an investigator of the Howard Hughes Medical Institute.	Ahronowitz I, 2007, HUM MUTAT, V28, P1, DOI 10.1002/humu.20393; Bischof J, 2007, P NATL ACAD SCI USA, V104, P3312, DOI 10.1073/pnas.0611511104; Bossuyt W, 2014, ONCOGENE, V33, P1218, DOI 10.1038/onc.2013.82; Bretscher A, 2002, NAT REV MOL CELL BIO, V3, P586, DOI 10.1038/nrm882; Cai J, 2010, GENE DEV, V24, P2383, DOI 10.1101/gad.1978810; Dupont S, 2011, NATURE, V474, P179, DOI 10.1038/nature10137; Fernandez BG, 2011, DEVELOPMENT, V138, P2337, DOI 10.1242/dev.063545; Genevet A, 2010, DEV CELL, V18, P300, DOI 10.1016/j.devcel.2009.12.011; Giovannini M, 2000, GENE DEV, V14, P1617; Good MC, 2011, SCIENCE, V332, P680, DOI 10.1126/science.1198701; Groves JT, 2010, NAT STRUCT MOL BIOL, V17, P659, DOI 10.1038/nsmb.1844; Halder G, 2011, DEVELOPMENT, V138, P9, DOI 10.1242/dev.045500; Hamaratoglu F, 2006, NAT CELL BIOL, V8, P27, DOI 10.1038/ncb1339; Harvey K, 2007, NAT REV CANCER, V7, P182, DOI 10.1038/nrc2070; Hergovich A, 2005, MOL CELL BIOL, V25, P8259, DOI 10.1128/MCB.25.18.8259-8272.2005; Ho LL, 2010, DEV BIOL, V337, P274, DOI 10.1016/j.ydbio.2009.10.042; Jin HC, 2006, NATURE, V442, P576, DOI 10.1038/nature04856; Kang BS, 2002, ACTA CRYSTALLOGR D, V58, P381, DOI 10.1107/S0907444901021175; Kango-Singh M, 2002, DEVELOPMENT, V129, P5719, DOI 10.1242/dev.00168; LaJeunesse DR, 1998, J CELL BIOL, V141, P1589, DOI 10.1083/jcb.141.7.1589; Li W, 2012, EMBO REP, V13, P204, DOI 10.1038/embor.2012.11; Li W, 2010, CELL, V140, P477, DOI 10.1016/j.cell.2010.01.029; Lu L, 2010, P NATL ACAD SCI USA, V107, P1437, DOI 10.1073/pnas.0911427107; Metpally RPR, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-106; Nguyen R, 2001, J BIOL CHEM, V276, P7621, DOI 10.1074/jbc.M006708200; Pan DJ, 2010, DEV CELL, V19, P491, DOI 10.1016/j.devcel.2010.09.011; Roeder T, 2005, ANNU REV ENTOMOL, V50, P447, DOI 10.1146/annurev.ento.50.071803.130404; ROULEAU GA, 1993, NATURE, V363, P515, DOI 10.1038/363515a0; Sansores-Garcia L, 2011, EMBO J, V30, P2325, DOI 10.1038/emboj.2011.157; Scheel H, 2003, CURR BIOL, V13, pR899, DOI 10.1016/j.cub.2003.11.007; Shaw RJ, 2001, DEV CELL, V1, P63, DOI 10.1016/S1534-5807(01)00009-0; Sher I, 2012, DEV CELL, V22, P703, DOI 10.1016/j.devcel.2012.03.008; Struhl G, 1998, CELL, V93, P649, DOI 10.1016/S0092-8674(00)81193-9; Surace EI, 2004, ONCOGENE, V23, P580, DOI 10.1038/sj.onc.1207142; TROFATTER JA, 1993, CELL, V72, P791, DOI 10.1016/0092-8674(93)90406-G; Wada KI, 2011, DEVELOPMENT, V138, P3907, DOI 10.1242/dev.070987; Wu S, 2003, CELL, V114, P445, DOI 10.1016/S0092-8674(03)00549-X; Xiao L, 2011, J BIOL CHEM, V286, P7788, DOI 10.1074/jbc.M110.173468; Yu FX, 2013, GENE DEV, V27, P1223, DOI 10.1101/gad.219402.113; Yu FX, 2012, CELL, V150, P780, DOI 10.1016/j.cell.2012.06.037; Yu JZ, 2010, DEV CELL, V18, P288, DOI 10.1016/j.devcel.2009.12.012; Zhang NL, 2010, DEV CELL, V19, P27, DOI 10.1016/j.devcel.2010.06.015; Zhao B, 2012, GENE DEV, V26, P54, DOI 10.1101/gad.173435.111; Zhou DW, 2009, CANCER CELL, V16, P425, DOI 10.1016/j.ccr.2009.09.026	44	344	355	4	58	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 12	2013	154	6					1342	1355		10.1016/j.cell.2013.08.025	http://dx.doi.org/10.1016/j.cell.2013.08.025			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	215VQ	24012335	Green Accepted, Bronze			2022-12-24	WOS:000324239300021
J	Yamanaka, N; Romero, NM; Martin, FA; Rewitz, KF; Sun, M; O'Connor, MB; Leopold, P				Yamanaka, Naoki; Romero, Nuria M.; Martin, Francisco A.; Rewitz, Kim F.; Sun, Mu; O'Connor, Michael B.; Leopold, Pierre			Neuroendocrine Control of Drosophila Larval Light Preference	SCIENCE			English	Article							GENE ACTIVITY; MELANOGASTER; NEURONS; PHOTOBEHAVIOR; BEHAVIOR; HORMONE	Animal development is coupled with innate behaviors that maximize chances of survival. Here, we show that the prothoracicotropic hormone (PTTH), a neuropeptide that controls the developmental transition from juvenile stage to sexual maturation, also regulates light avoidance in Drosophila melanogaster larvae. PTTH, through its receptor Torso, acts on two light sensors-the Bolwig's organ and the peripheral class IV dendritic arborization neurons-to regulate light avoidance. We found that PTTH concomitantly promotes steroidogenesis and light avoidance at the end of larval stage, driving animals toward a darker environment to initiate the immobile maturation phase. Thus, PTTH controls the decisions of when and where animals undergo metamorphosis, optimizing conditions for adult development.	[Yamanaka, Naoki; O'Connor, Michael B.] Univ Minnesota, Dept Genet Cell Biol & Dev, Minneapolis, MN 55455 USA; [Romero, Nuria M.; Martin, Francisco A.; Leopold, Pierre] Univ Nice Sophia Antipolis, CNRS, INSERM, Inst Biol Valrose, F-06108 Nice, France; [Rewitz, Kim F.] Univ Copenhagen, Dept Biol Cell & Neurobiol, DK-2200 Copenhagen, Denmark; [Sun, Mu] GlaxoSmithKline Res & Dev Ltd, Neurodegenerat Discovery Performance Unit, Shanghai 201203, Peoples R China	University of Minnesota System; University of Minnesota Twin Cities; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur; University of Copenhagen; GlaxoSmithKline	O'Connor, MB (corresponding author), Univ Minnesota, Dept Genet Cell Biol & Dev, Minneapolis, MN 55455 USA.	moconnor@umn.edu; leopold@unice.fr	Martin, Francisco A/K-2785-2014; Romero, Nuria/AAG-8686-2021; Rewitz, Kim F/M-6012-2014; Yamanaka, Naoki/F-1358-2010; Sun, Mu/A-6772-2008; O'Connor, Michael B/C-9977-2014	Martin, Francisco A/0000-0002-1916-1934; Rewitz, Kim F/0000-0002-4409-9941; Yamanaka, Naoki/0000-0002-6244-2686; Sun, Mu/0000-0001-8261-3705; O'Connor, Michael B/0000-0002-3067-5506; ROMERO, NURIA/0000-0001-6235-1330	CNRS; INSERM; Agence Nationale de la Recherche; Fondation pour la Recherche Medicale; European Research Council [268813]; NIH [K99 HD073239, R01 GM093301]; Danish Council for Independent Research, Natural Sciences [11-105446]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K99HD073239] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM093301] Funding Source: NIH RePORTER	CNRS(Centre National de la Recherche Scientifique (CNRS)); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Agence Nationale de la Recherche(French National Research Agency (ANR)); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); European Research Council(European Research Council (ERC)European Commission); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Danish Council for Independent Research, Natural Sciences(Det Frie Forskningsrad (DFF)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank G. Jarretou and B. Polo for technical assistance; F. Casares, J. Bessa, M. Bate, W. Johnson, C. Desplan, F. Pichaud, Y. N. Jan, and stock centers in Kyoto, Bloomington, and Vienna for fly stocks; B. Prud'homme and N. Gompel for wild D. melanogaster isolates; L. Vollborn for antibody to PTTH; P. Baroni for light-emitting diode spectrum analysis; and F. Rouyer, J. Simon, S. Sprecher, and laboratory members from O'Connor and Leopold groups for comments on the manuscript. This work was supported by the CNRS, INSERM, Agence Nationale de la Recherche, Fondation pour la Recherche Medicale, European Research Council (grant 268813) to N. M. R., F. A. M., and P. L.; NIH grant K99 HD073239 to N.Y.; Danish Council for Independent Research, Natural Sciences grant 11-105446 to K. F. R.; and NIH grant R01 GM093301 to M.B.O. Materials are available from CNRS under a material transfer agreement.	Bodenstein D., 1950, BIOL DROSOPHILA, P275; DOMINICK OS, 1985, J EXP BIOL, V117, P45; Gong ZF, 2010, SCIENCE, V330, P499, DOI 10.1126/science.1195993; Grueber WB, 2002, DEVELOPMENT, V129, P2867; Hassan J, 2005, J COMP NEUROL, V481, P266, DOI 10.1002/cne.20383; Keene AC, 2012, TRENDS NEUROSCI, V35, P104, DOI 10.1016/j.tins.2011.11.003; MARKOW TA, 1981, BEHAV NEURAL BIOL, V31, P348, DOI 10.1016/S0163-1047(81)91409-6; Mazzoni EO, 2005, NEURON, V45, P293, DOI 10.1016/j.neuron.2004.12.038; McBrayer Z, 2007, DEV CELL, V13, P857, DOI 10.1016/j.devcel.2007.11.003; Montell C, 2012, TRENDS NEUROSCI, V35, P356, DOI 10.1016/j.tins.2012.03.004; Rewitz KF, 2009, SCIENCE, V326, P1403, DOI 10.1126/science.1176450; Sanyal S, 2009, GENE EXPR PATTERNS, V9, P371, DOI 10.1016/j.gep.2009.01.002; SawinMcCormack EP, 1995, J NEUROGENET, V10, P119, DOI 10.3109/01677069509083459; SCHMUCKER D, 1992, NEURON, V9, P1025, DOI 10.1016/0896-6273(92)90063-J; Siegmund T, 2001, J COMP NEUROL, V431, P481, DOI 10.1002/1096-9861(20010319)431:4<481::AID-CNE1084>3.0.CO;2-7; Warren JT, 2006, DEV DYNAM, V235, P315, DOI 10.1002/dvdy.20626; Xiang Y, 2010, NATURE, V468, P921, DOI 10.1038/nature09576; Yamanaka N, 2013, ANNU REV ENTOMOL, V58, P497, DOI 10.1146/annurev-ento-120811-153608	18	76	77	2	53	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 6	2013	341	6150					1113	1116		10.1126/science.1241210	http://dx.doi.org/10.1126/science.1241210			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	211TG	24009394	Green Accepted			2022-12-24	WOS:000323933100045
J	Howe, MW; Tierney, PL; Sandberg, SG; Phillips, PEM; Graybiel, AM				Howe, Mark W.; Tierney, Patrick L.; Sandberg, Stefan G.; Phillips, Paul E. M.; Graybiel, Ann M.			Prolonged dopamine signalling in striatum signals proximity and value of distant rewards	NATURE			English	Article							NUCLEUS-ACCUMBENS DOPAMINE; NEURONS; PREDICTION; NAVIGATION; DEPLETION	Predictions about future rewarding events have a powerful influence on behaviour. The phasic spike activity of dopamine-containing neurons, and corresponding dopamine transients in the striatum, are thought to underlie these predictions, encoding positive and negative reward prediction errors(1-5). However, many behaviours are directed towards distant goals, for which transient signals may fail to provide sustained drive. Here we report an extended mode of reward-predictive dopamine signalling in the striatum that emerged as rats moved towards distant goals. These dopamine signals, which were detected with fast-scan cyclic voltammetry (FSCV), gradually increased or-in rare instances-decreased as the animals navigated mazes to reach remote rewards, rather than having phasic or steady tonic profiles. These dopamine increases (ramps) scaled flexibly with both the distance and size of the rewards. During learning, these dopamine signals showed spatial preferences for goals in different locations and readily changed in magnitude to reflect changing values of the distant rewards. Such prolonged dopamine signalling could provide sustained motivational drive, a control mechanism that may be important for normal behaviour and that can be impaired in a range of neurologic and neuropsychiatric disorders.	[Howe, Mark W.; Tierney, Patrick L.; Graybiel, Ann M.] MIT, McGovern Inst Brain Res, Cambridge, MA 02139 USA; [Howe, Mark W.; Tierney, Patrick L.; Graybiel, Ann M.] MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA; [Sandberg, Stefan G.; Phillips, Paul E. M.] Univ Washington, Dept Psychiat & Behav Sci, Seattle, WA 98195 USA; [Sandberg, Stefan G.; Phillips, Paul E. M.] Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Graybiel, AM (corresponding author), MIT, McGovern Inst Brain Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	graybiel@mit.edu	Phillips, Paul/E-7813-2013; Phillips, Paul E. M./A-4463-2008	Phillips, Paul/0000-0002-8749-7026; Phillips, Paul E. M./0000-0002-8749-7026; Graybiel, Ann/0000-0002-4326-7720	US National Institutes of Health (NIH) [R01 MH060379]; National Parkinson Foundation; CHDI Foundation [A-5552]; Stanley H. and Sheila G. Sydney Fund; Mark Gorenberg fellowship; NIH [R01 DA027858, R01 MH079292]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH079292, R01MH060379] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG044839] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA027858] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Parkinson Foundation; CHDI Foundation; Stanley H. and Sheila G. Sydney Fund; Mark Gorenberg fellowship; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank G. Telian, L. Li, T. Lechina, S. Ng-Evans and N. Hollon for help, and M. J. Kim, K. S. Smith, T. J. Sejnowski, L. G. Gibb and Y. Kubota for their comments. This work was supported by US National Institutes of Health (NIH) grant R01 MH060379 (A. M. G.), National Parkinson Foundation (A. M. G.), CHDI Foundation grant A-5552, the Stanley H. and Sheila G. Sydney Fund (A. M. G.), a Mark Gorenberg fellowship (M. W. H.), and NIH grants R01 DA027858 and R01 MH079292 (P.E.M.P.).	Barnes TD, 2005, NATURE, V437, P1158, DOI 10.1038/nature04053; Bayer HM, 2005, NEURON, V47, P129, DOI 10.1016/j.neuron.2005.05.020; Berridge KC, 2007, PSYCHOPHARMACOLOGY, V191, P391, DOI 10.1007/s00213-006-0578-x; Braun AA, 2012, NEUROBIOL LEARN MEM, V97, P402, DOI 10.1016/j.nlm.2012.03.004; Clark JJ, 2010, NAT METHODS, V7, P126, DOI [10.1038/NMETH.1412, 10.1038/nmeth.1412]; Cohen JY, 2012, NATURE, V482, P85, DOI 10.1038/nature10754; Day JJ, 2007, NAT NEUROSCI, V10, P1020, DOI 10.1038/nn1923; Day JJ, 2010, BIOL PSYCHIAT, V68, P306, DOI 10.1016/j.biopsych.2010.03.026; Derdikman D, 2010, TRENDS COGN SCI, V14, P561, DOI 10.1016/j.tics.2010.09.004; Fiorillo CD, 2003, SCIENCE, V299, P1898, DOI 10.1126/science.1077349; Flagel SB, 2011, NATURE, V469, P53, DOI 10.1038/nature09588; Gan JO, 2010, NAT NEUROSCI, V13, P25, DOI 10.1038/nn.2460; HIKOSAKA O, 1989, J NEUROPHYSIOL, V61, P814, DOI 10.1152/jn.1989.61.4.814; Keithley RB, 2009, TRAC-TREND ANAL CHEM, V28, P1127, DOI 10.1016/j.trac.2009.07.002; Matsumoto M, 2009, NATURE, V459, P837, DOI 10.1038/nature08028; Niv Y, 2005, BEHAV BRAIN FUNCT, V1, DOI 10.1186/1744-9081-1-6; Niv Y, 2007, PSYCHOPHARMACOLOGY, V191, P507, DOI 10.1007/s00213-006-0502-4; Phillips PEM, 2003, NATURE, V422, P614, DOI 10.1038/nature01566; Redgrave P, 2006, NAT REV NEUROSCI, V7, P967, DOI 10.1038/nrn2022; Salamone JD, 2007, PSYCHOPHARMACOLOGY, V191, P389, DOI 10.1007/s00213-006-0623-9; Salamone JD, 2012, NEURON, V76, P470, DOI 10.1016/j.neuron.2012.10.021; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Schultz W, 2002, NEURON, V36, P241, DOI 10.1016/S0896-6273(02)00967-4; Tobler PN, 2005, SCIENCE, V307, P1642, DOI 10.1126/science.1105370; Waelti P, 2001, NATURE, V412, P43, DOI 10.1038/35083500; Wang LP, 2011, NEURON, V72, P1055, DOI 10.1016/j.neuron.2011.10.019; WHISHAW IQ, 1985, BEHAV BRAIN RES, V18, P11, DOI 10.1016/0166-4328(85)90165-2; Zweifel LS, 2009, P NATL ACAD SCI USA, V106, P7281, DOI 10.1073/pnas.0813415106	28	295	296	5	91	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 29	2013	500	7464					575	+		10.1038/nature12475	http://dx.doi.org/10.1038/nature12475			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	207TD	23913271	Green Accepted, Green Submitted			2022-12-24	WOS:000323625900034
J	Zhang, XHF; Jin, X; Malladi, S; Zou, YL; Wen, YH; Brogi, E; Smid, M; Foekens, JA; Massague, J				Zhang, Xiang H. -F.; Jin, Xin; Malladi, Srinivas; Zou, Yilong; Wen, Yong H.; Brogi, Edi; Smid, Marcel; Foekens, John A.; Massague, Joan			Selection of Bone Metastasis Seeds by Mesenchymal Signals in the Primary Tumor Stroma	CELL			English	Article							BREAST-CANCER METASTASIS; MOLECULAR CHARACTERIZATION; STEM-CELLS; GROWTH; INSIGHTS; PROGRAM; SRC	How organ-specific metastatic traits arise in primary tumors remains unknown. Here, we show a role of the breast tumor stroma in selecting cancer cells that are primed for metastasis in bone. Cancer-associated fibroblasts (CAFs) in triple-negative (TN) breast tumors skew heterogeneous cancer cell populations toward a predominance of clones that thrive on the CAF-derived factors CXCL12 and IGF1. Limiting concentrations of these factors select for cancer cells with high Src activity, a known clinical predictor of bone relapse and an enhancer of PI3K-Akt pathway activation by CXCL12 and IGF1. Carcinoma clones selected in this manner are primed for metastasis in the CXCL12-rich microenvironment of the bone marrow. The evidence suggests that stromal signals resembling those of a distant organ select for cancer cells that are primed for metastasis in that organ, thus illuminating the evolution of metastatic traits in a primary tumor and its distant metastases.	[Zhang, Xiang H. -F.; Jin, Xin; Malladi, Srinivas; Zou, Yilong; Massague, Joan] Mem Sloan Kettering Canc Ctr, Canc Biol & Genet Program, New York, NY 10065 USA; [Wen, Yong H.; Brogi, Edi] Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10065 USA; [Smid, Marcel; Foekens, John A.] Erasmus Univ, Med Ctr, Erasmus MC Canc Inst, Dept Med Oncol, NL-3015 CE Rotterdam, Netherlands; [Massague, Joan] Howard Hughes Med Inst, Chevy Chase, MD 21205 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Erasmus University Rotterdam; Erasmus MC; Erasmus MC Cancer Institute; Howard Hughes Medical Institute	Massague, J (corresponding author), Mem Sloan Kettering Canc Ctr, Canc Biol & Genet Program, New York, NY 10065 USA.	j-massague@ski.mskcc.org		Zou, Yilong/0000-0001-8198-6067; Zhang, Xiang/0000-0002-5674-8670; Smid, Marcel/0000-0003-0605-1901; Massague, Joan/0000-0001-9324-8408	NIH [CA151293, CA94060]; Breast Cancer Research Foundation; NATIONAL CANCER INSTITUTE [P30CA008748, R00CA151293, P01CA094060, K99CA151293] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Breast Cancer Research Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We would like to thank E. Holland, N.X. Rosen, A. Ventura, and S. Vanharanta for helpful input, A. Viale and N. Socci for support with RNA-seq analysis, N. Fan and M. Turkekul for advice on immunohistochemistry, and R. Somwar for reagents. This work was supported by NIH grants CA151293 (to X.H.-F.Z.) and CA94060 (to J.M.). X.H.-F.Z. is a McNair Scholar and is the recipient of a grant from Breast Cancer Research Foundation. S. M. is an American Cancer Society postdoctoral fellow. J.M. is an investigator of the Howard Hughes Medical Institute.	Acharyya S, 2012, CELL, V150, P165, DOI 10.1016/j.cell.2012.04.042; Allinen M, 2004, CANCER CELL, V6, P17, DOI 10.1016/j.ccr.2004.06.010; Calon A, 2012, CANCER CELL, V22, P571, DOI 10.1016/j.ccr.2012.08.013; Carboni JM, 2009, MOL CANCER THER, V8, P3341, DOI 10.1158/1535-7163.MCT-09-0499; Chambers AF, 2002, NAT REV CANCER, V2, P563, DOI 10.1038/nrc865; Chang HY, 2005, P NATL ACAD SCI USA, V102, P3738, DOI 10.1073/pnas.0409462102; Chung AS, 2010, NAT REV CANCER, V10, P505, DOI 10.1038/nrc2868; Collins P, 1999, NAT MED, V5, P1130, DOI 10.1038/13453; DeNardo DG, 2011, CANCER DISCOV, V1, P54, DOI 10.1158/2159-8274.CD-10-0028; Dent R, 2009, BREAST CANCER RES TR, V115, P423, DOI 10.1007/s10549-008-0086-2; FIDLER IJ, 1973, NATURE-NEW BIOL, V242, P148, DOI 10.1038/newbio242148a0; Fidler IJ, 2003, NAT REV CANCER, V3, P453, DOI 10.1038/nrc1098; Gocheva V, 2010, GENE DEV, V24, P241, DOI 10.1101/gad.1874010; Gupta GP, 2006, CELL, V127, P679, DOI 10.1016/j.cell.2006.11.001; Hanahan D, 2012, CANCER CELL, V21, P309, DOI 10.1016/j.ccr.2012.02.022; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hatse S, 2002, FEBS LETT, V527, P255, DOI 10.1016/S0014-5793(02)03143-5; Heiman M, 2008, CELL, V135, P738, DOI 10.1016/j.cell.2008.10.028; Ishizawar RC, 2007, ONCOGENE, V26, P3503, DOI 10.1038/sj.onc.1210138; Joyce JA, 2009, NAT REV CANCER, V9, P239, DOI 10.1038/nrc2618; Kang YB, 2005, P NATL ACAD SCI USA, V102, P13909, DOI 10.1073/pnas.0506517102; Kang YB, 2003, CANCER CELL, V3, P537, DOI 10.1016/S1535-6108(03)00132-6; Kaplan RN, 2005, NATURE, V438, P820, DOI 10.1038/nature04186; Karnoub AE, 2007, NATURE, V449, P557, DOI 10.1038/nature06188; Kim MY, 2009, CELL, V139, P1315, DOI 10.1016/j.cell.2009.11.025; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Lu X, 2009, GENE DEV, V23, P1882, DOI 10.1101/gad.1824809; Mendez-Ferrer S, 2010, NATURE, V466, P829, DOI 10.1038/nature09262; Minn AJ, 2005, NATURE, V436, P518, DOI 10.1038/nature03799; Mishra PJ, 2008, CANCER RES, V68, P4331, DOI 10.1158/0008-5472.CAN-08-0943; NOWELL PC, 1976, SCIENCE, V194, P23, DOI 10.1126/science.959840; Orimo A, 2005, CELL, V121, P335, DOI 10.1016/j.cell.2005.02.034; Qian BZ, 2011, NATURE, V475, P222, DOI 10.1038/nature10138; Quante M, 2011, CANCER CELL, V19, P257, DOI 10.1016/j.ccr.2011.01.020; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Valastyan S, 2011, CELL, V147, P275, DOI 10.1016/j.cell.2011.09.024; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Weigelt B, 2003, P NATL ACAD SCI USA, V100, P15901, DOI 10.1073/pnas.2634067100; Zhang SY, 2011, NAT MED, V17, P461, DOI 10.1038/nm.2309	40	284	300	0	55	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 29	2013	154	5					1060	1073		10.1016/j.cell.2013.07.036	http://dx.doi.org/10.1016/j.cell.2013.07.036			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	209OE	23993096	Green Accepted, Bronze			2022-12-24	WOS:000323767300019
J	Harjutsalo, V; Sund, R; Knip, M; Groop, PH				Harjutsalo, Valma; Sund, Reijo; Knip, Mikael; Groop, Per-Henrik			Incidence of Type 1 Diabetes in Finland	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Harjutsalo, Valma] Natl Inst Hlth & Welf, Diabet Prevent Unit, Helsinki, Finland; [Sund, Reijo] Natl Inst Hlth & Welf, Serv Syst Res Unit, Helsinki, Finland; [Knip, Mikael] Univ Helsinki, Childrens Hosp, Helsinki, Finland; [Groop, Per-Henrik] Folkhalsan Inst Genet, Biomedicum Helsinki, FIN-00014 Helsinki, Finland	Finland National Institute for Health & Welfare; Finland National Institute for Health & Welfare; University of Helsinki	Harjutsalo, V (corresponding author), Folkhalsan Inst Genet, Haartmaninkatu 8,POB 63, FIN-00014 Helsinki, Finland.	valma.harjutsalo@helsinki.fi	Knip, Mikael/AAL-3773-2020; Harjutsalo, Valma/AAL-6588-2021; Sund, Reijo/N-5471-2016	Harjutsalo, Valma/0000-0003-3568-9779; Sund, Reijo/0000-0002-6268-8117; Knip, Mikael/0000-0003-0474-0033				Berhan Y, 2011, DIABETES, V60, P577, DOI 10.2337/db10-0813; Forlenza GP, 2011, CURR OPIN ENDOCRINOL, V18, P248, DOI 10.1097/MED.0b013e32834872ce; Harjutsalo V, 2008, LANCET, V371, P1777, DOI 10.1016/S0140-6736(08)60765-5; HULKKO T, 2010, INFECT DIS FINLAND; Kaikkonen R., 2012, HLTH WELL BEING INEQ; Knip M, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a007690	6	165	170	0	14	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 24	2013	310	4					427	428		10.1001/jama.2013.8399	http://dx.doi.org/10.1001/jama.2013.8399			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	187LV	23917294	Bronze			2022-12-24	WOS:000322121500021
J	Peek, CB; Nati, AHA; Ramsey, KM; Kuo, HY; Yu, W; Sena, LA; Ilkayeva, O; Marcheva, B; Kobayashi, Y; Omura, C; Levine, DC; Bacsik, DJ; Gius, D; Newgard, CB; Goetzman, E; Chandel, NS; Denu, JM; Mrksich, M; Bass, J				Peek, Clara Bien; Nati, Alison H. Affi; Ramsey, Kathryn Moynihan; Kuo, Hsin-Yu; Yu, Wei; Sena, Laura A.; Ilkayeva, Olga; Marcheva, Biliana; Kobayashi, Yumiko; Omura, Chiaki; Levine, Daniel C.; Bacsik, David J.; Gius, David; Newgard, Christopher B.; Goetzman, Eric; Chandel, Navdeep S.; Denu, John M.; Mrksich, Milan; Bass, Joseph			Circadian Clock NAD(+) Cycle Drives Mitochondrial Oxidative Metabolism in Mice	SCIENCE			English	Article							FATTY-ACID OXIDATION; GENE-EXPRESSION; NICOTINAMIDE; PATHWAYS; TISSUE; ACETYLATION; PROMOTES; GLUCOSE; MOUSE; CELLS	Circadian clocks are self-sustained cellular oscillators that synchronize oxidative and reductive cycles in anticipation of the solar cycle. We found that the clock transcription feedback loop produces cycles of nicotinamide adenine dinucleotide (NAD(+)) biosynthesis, adenosine triphosphate production, and mitochondrial respiration through modulation of mitochondrial protein acetylation to synchronize oxidative metabolic pathways with the 24-hour fasting and feeding cycle. Circadian control of the activity of the NAD(+)-dependent deacetylase sirtuin 3 (SIRT3) generated rhythms in the acetylation and activity of oxidative enzymes and respiration in isolated mitochondria, and NAD(+) supplementation restored protein deacetylation and enhanced oxygen consumption in circadian mutant mice. Thus, circadian control of NAD(+) bioavailability modulates mitochondrial oxidative function and organismal metabolism across the daily cycles of fasting and feeding.	[Peek, Clara Bien; Nati, Alison H. Affi; Ramsey, Kathryn Moynihan; Marcheva, Biliana; Kobayashi, Yumiko; Omura, Chiaki; Levine, Daniel C.; Bacsik, David J.; Bass, Joseph] Northwestern Univ, Feinberg Sch Med, Dept Med, Div Endocrinol Metab & Mol Med, Chicago, IL 60611 USA; [Peek, Clara Bien; Nati, Alison H. Affi; Ramsey, Kathryn Moynihan; Marcheva, Biliana; Kobayashi, Yumiko; Omura, Chiaki; Levine, Daniel C.; Bacsik, David J.; Bass, Joseph] Northwestern Univ, Dept Neurobiol, Evanston, IL 60208 USA; [Kuo, Hsin-Yu; Mrksich, Milan] Northwestern Univ, Dept Chem, Evanston, IL 60208 USA; [Kuo, Hsin-Yu; Mrksich, Milan] Northwestern Univ, Howard Hughes Med Inst, Evanston, IL 60208 USA; [Yu, Wei; Denu, John M.] Univ Wisconsin, Dept Biomol Chem, Madison, WI 53715 USA; [Yu, Wei; Denu, John M.] Univ Wisconsin, Wisconsin Inst Discovery, Madison, WI 53715 USA; [Sena, Laura A.; Chandel, Navdeep S.] Northwestern Univ, Feinberg Sch Med, Dept Med, Div Pulm & Crit Care Med, Chicago, IL 60611 USA; [Sena, Laura A.; Chandel, Navdeep S.] Northwestern Univ, Feinberg Sch Med, Dept Cell & Mol Biol, Chicago, IL 60611 USA; [Ilkayeva, Olga; Newgard, Christopher B.] Duke Univ, Med Ctr, Sarah W Stedman Nutr & Metab Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27705 USA; [Ilkayeva, Olga; Newgard, Christopher B.] Duke Univ, Med Ctr, Sarah W Stedman Nutr & Metab Ctr, Dept Med, Durham, NC 27705 USA; [Gius, David] Northwestern Univ, Feinberg Sch Med, Dept Radiat Oncol, Chicago, IL 60611 USA; [Goetzman, Eric] Univ Pittsburgh, Sch Med, Childrens Hosp Pittsburgh, Dept Pediat, Pittsburgh, PA 15224 USA	Northwestern University; Feinberg School of Medicine; Northwestern University; Northwestern University; Howard Hughes Medical Institute; Northwestern University; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Duke University; Duke University; Northwestern University; Feinberg School of Medicine; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Bass, J (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Med, Div Endocrinol Metab & Mol Med, Chicago, IL 60611 USA.	j-bass@northwestern.edu	Mrksich, Milan/G-2469-2011	Marcheva, Biliana/0000-0001-8697-2625; YU, WEI/0000-0001-9898-4607; Levine, Daniel/0000-0002-3453-951X; Affinati, Alison/0000-0002-4967-9240; Mrksich, Milan/0000-0002-4964-796X	NIH/NIAMS [5P30AR057216-05]; National Institute of Diabetes and Digestive and Kidney Diseases [F32 DK092034, F30 DK085936, T32 DK007169]; Endocrine Society; NIH [R01DK090242-03, P01DK58398, R01 AG038679, R01 CA152601-01, R01 CA152799-01A1, R01 CA168292-01A1, R01 CA16383801A1, 5P01HL071643-10, P01AG011412-16, R01HL097817-01, R01DK090625-01A1]; Merck; Janssen Pharmaceuticals; Vanda Pharmaceuticals; Matsutani America; Sirtris, a GSK company; Reset Therapeutics; NATIONAL CANCER INSTITUTE [R01CA152601, R01CA152799, P30CA014520, R01CA168292, P30CA060553] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007909, P01HL071643, R01HL097817] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR057216] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F30DK085936, R01DK090625, F32DK092034, T32DK007169, P01DK058398, R01DK090242] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [F30ES019815] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM059785, R01GM065386] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG038679, P01AG011412] Funding Source: NIH RePORTER	NIH/NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Endocrine Society; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Merck(Merck & Company); Janssen Pharmaceuticals(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Vanda Pharmaceuticals; Matsutani America; Sirtris, a GSK company; Reset Therapeutics; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank P. Schumacker, R. Allada, S. Imai, G. Barish, members of the Bass lab for discussion and comments on the manuscript; K. Lamia and P. Schumacker for Cry1<SUP>-/-</SUP>;Cry2<SUP>-/-</SUP> MEFs and Sirt3<SUP>-/-</SUP> mice, respectively; the Washington University Metabolomics Facility for nicotinamide measurements; the Northwestern University Skin Disease Research Center (NIH/NIAMS grant 5P30AR057216-05), and W. Song for technical assistance. Supported by National Institute of Diabetes and Digestive and Kidney Diseases grants F32 DK092034 (C. B. P.), F30 DK085936 (A. H. A.), and T32 DK007169 (B. M.); the Endocrine Society (D.J.B.); and NIH grants R01DK090242-03 (E. G.); P01DK58398 (C.B.N.); R01 AG038679 (J.M.D.); R01 CA152601-01, R01 CA152799-01A1, R01 CA168292-01A1, and R01 CA16383801A1 (D. G.); 5P01HL071643-10 (N.S.C.); and P01AG011412-16, R01HL097817-01, and R01DK090625-01A1 (J.B.). J.B. has financial interest in and serves as advisor to Reset Therapeutics, and has been a paid consultant for Merck, Janssen Pharmaceuticals, Vanda Pharmaceuticals, Gerson Lehrman Group, and Matsutani America. J.D. is a paid consultant for Sirtris, a GSK company. A provisional patent has been applied for by Northwestern University related to the role of the clock-NAD pathway in the mitochondrial control of cell growth, inflammation, and metabolism.	Alenghat T, 2008, NATURE, V456, P997, DOI 10.1038/nature07541; Balsalobre A, 1998, CELL, V93, P929, DOI 10.1016/S0092-8674(00)81199-X; Belenky P, 2007, CELL, V129, P473, DOI 10.1016/j.cell.2007.03.024; Bitterman KJ, 2002, J BIOL CHEM, V277, P45099, DOI 10.1074/jbc.M205670200; Canto C, 2012, CELL METAB, V15, P838, DOI 10.1016/j.cmet.2012.04.022; DAVIES SP, 1992, EUR J BIOCHEM, V203, P615, DOI 10.1111/j.1432-1033.1992.tb16591.x; Dodd AN, 2005, SCIENCE, V309, P630, DOI 10.1126/science.1115581; Feng D, 2012, MOL CELL, V47, P158, DOI 10.1016/j.molcel.2012.06.026; Goetzman ES, 2009, OBESITY, V17, P196, DOI 10.1038/oby.2008.467; Gurard-Levin ZA, 2010, ACS CHEM BIOL, V5, P863, DOI 10.1021/cb100088g; Hallows WC, 2011, MOL CELL, V41, P139, DOI 10.1016/j.molcel.2011.01.002; Hirschey MD, 2011, COLD SH Q B, V76, P267, DOI 10.1101/sqb.2011.76.010850; Hirschey MD, 2010, NATURE, V464, P121, DOI 10.1038/nature08778; Imai SI, 2010, PHARMACOL RES, V62, P42, DOI 10.1016/j.phrs.2010.01.006; Kim SC, 2006, MOL CELL, V23, P607, DOI 10.1016/j.molcel.2006.06.026; Lamia KA, 2008, P NATL ACAD SCI USA, V105, P15172, DOI 10.1073/pnas.0806717105; Liu AC, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000023; Marcheva B, 2010, NATURE, V466, P627, DOI 10.1038/nature09253; Marroquin LD, 2007, TOXICOL SCI, V97, P539, DOI 10.1093/toxsci/kfm052; McCarthy JJ, 2007, PHYSIOL GENOMICS, V31, P86, DOI 10.1152/physiolgenomics.00066.2007; Nakahata Y, 2009, SCIENCE, V324, P654, DOI 10.1126/science.1170803; Nicholls David G, 2010, J Vis Exp, DOI 10.3791/2511; Nikiforov A, 2011, J BIOL CHEM, V286, P21767, DOI 10.1074/jbc.M110.213298; O'Neill JS, 2011, NATURE, V469, P498, DOI 10.1038/nature09702; PAIK WK, 1970, BIOCHIM BIOPHYS ACTA, V213, P513, DOI 10.1016/0005-2787(70)90058-4; Panda S, 2002, CELL, V109, P307, DOI 10.1016/S0092-8674(02)00722-5; Pizarro A, 2013, NUCLEIC ACIDS RES, V41, pD1009, DOI 10.1093/nar/gks1161; Ramsey KM, 2009, SCIENCE, V324, P651, DOI 10.1126/science.1171641; Rogers GW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021746; Rudic RD, 2004, PLOS BIOL, V2, P1893, DOI 10.1371/journal.pbio.0020377; Rutter J, 2001, SCIENCE, V293, P510, DOI 10.1126/science.1060698; Shimazu T, 2010, CELL METAB, V12, P654, DOI 10.1016/j.cmet.2010.11.003; Someya S, 2010, CELL, V143, P802, DOI 10.1016/j.cell.2010.10.002; Storch KF, 2002, NATURE, V417, P78, DOI 10.1038/nature744; Tao RD, 2010, MOL CELL, V40, P893, DOI 10.1016/j.molcel.2010.12.013; Turek FW, 2005, SCIENCE, V308, P1043, DOI 10.1126/science.1108750; Wu JY, 2004, J CLIN INVEST, V113, P434, DOI 10.1172/JCI200419574; Yan OY, 1998, P NATL ACAD SCI USA, V95, P8660, DOI 10.1073/pnas.95.15.8660; Yang XY, 2006, CELL, V126, P801, DOI 10.1016/j.cell.2006.06.050; Yoshino J, 2011, CELL METAB, V14, P528, DOI 10.1016/j.cmet.2011.08.014; Yu W, 2012, J BIOL CHEM, V287, P14078, DOI 10.1074/jbc.M112.355206; Zhang XP, 2012, NUCLEIC ACIDS RES, V40, P3419, DOI 10.1093/nar/gkr1297	42	403	420	3	59	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 1	2013	342	6158					591	+		10.1126/science.1243417	http://dx.doi.org/10.1126/science.1243417			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243RJ	24051248	Green Accepted			2022-12-24	WOS:000326334300040
J	Clark, RI; Tan, SWS; Pean, CB; Roostalu, U; Vivancos, V; Bronda, K; Pilatova, M; Fu, JQ; Walker, DW; Berdeaux, R; Geissmann, F; Dionne, MS				Clark, Rebecca I.; Tan, Sharon W. S.; Pean, Claire B.; Roostalu, Urmas; Vivancos, Valerie; Bronda, Kevin; Pilatova, Martina; Fu, Jingqi; Walker, David W.; Berdeaux, Rebecca; Geissmann, Frederic; Dionne, Marc S.			MEF2 Is an In Vivo Immune-Metabolic Switch	CELL			English	Article							MYOCYTE-ENHANCER FACTOR-2; TRANSCRIPTION FACTOR MEF2C; GENE-EXPRESSION; DROSOPHILA-MELANOGASTER; T-LYMPHOCYTES; HOST-DEFENSE; KINASE; ACTIVATION; PATHWAY; P38	Infections disturb metabolic homeostasis in many contexts, but the underlying connections are not completely understood. To address this, we use paired genetic and computational screens in Drosophila to identify transcriptional regulators of immunity and pathology and their associated target genes and physiologies. We show that Mef2 is required in the fat body for anabolic function and the immune response. Using genetic and biochemical approaches, we find that MEF2 is phosphorylated at a conserved site in healthy flies and promotes expression of lipogenic and glycogenic enzymes. Upon infection, this phosphorylation is lost, and the activity of MEF2 changes-MEF2 now associates with the TATA binding protein to bind a distinct TATA box sequence and promote antimicrobial peptide expression. The loss of phosphorylated MEF2 contributes to loss of anabolic enzyme expression in Gram-negative bacterial infection. MEF2 is thus a critical transcriptional switch in the adult fat body between metabolism and immunity.	[Clark, Rebecca I.; Tan, Sharon W. S.; Pean, Claire B.; Roostalu, Urmas; Vivancos, Valerie; Bronda, Kevin; Pilatova, Martina; Geissmann, Frederic; Dionne, Marc S.] Kings Coll London, Sch Med, Ctr Mol & Cellular Biol Inflammat, London SE1 1UL, England; [Clark, Rebecca I.; Tan, Sharon W. S.; Pean, Claire B.; Roostalu, Urmas; Vivancos, Valerie; Bronda, Kevin; Pilatova, Martina; Geissmann, Frederic; Dionne, Marc S.] Kings Coll London, Sch Med, Peter Gorer Dept Immunobiol, London SE1 1UL, England; [Fu, Jingqi; Berdeaux, Rebecca] Univ Texas Hlth Sci Ctr Houston, Dept Integrat Biol & Pharmacol, Houston, TX 77030 USA; [Berdeaux, Rebecca] Univ Texas Hlth Sci Ctr Houston, Grad Sch Biomed Sci, Houston, TX 77030 USA; [Clark, Rebecca I.; Walker, David W.] Univ Calif Los Angeles, Dept Integrat Biol & Physiol, Los Angeles, CA 90095 USA; [Walker, David W.] Univ Calif Los Angeles, Mol Biol Inst, Los Angeles, CA 90095 USA	University of London; King's College London; University of London; King's College London; University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Dionne, MS (corresponding author), Kings Coll London, Sch Med, Ctr Mol & Cellular Biol Inflammat, London SE1 1UL, England.	marc.dionne@kcl.ac.uk	Clark, Rebecca/J-9135-2015	Clark, Rebecca/0000-0002-1194-5048; Roostalu, Urmas/0000-0002-7849-2055; Fu, Jingqi/0000-0003-3871-428X; Berdeaux, Rebecca/0000-0002-9929-1711; Dionne, Marc/0000-0002-8283-1750; geissmann, frederic/0000-0001-5029-2468	NIDDK [R01DK092590]; NIAMS [R01AR059847]; NIA [R01AG040288, R01AG037514]; Ellison Medical Foundation [AG-NS-0470-08]; BBSRC [BB/E02128X/1]; Wellcome Trust [WT085119MA]; MRC [G0900867] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/E02128X/1] Funding Source: researchfish; Medical Research Council [G0900867] Funding Source: researchfish; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR059847] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK092590] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG037514, R01AG040288] Funding Source: NIH RePORTER	NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Ellison Medical Foundation(Lawrence Ellison Foundation); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank the Vienna Drosophila RNAi Center, the Bloomington Drosophila Stock Center, Michael Taylor, Nazif Alic, Petros Ligoxygakis, Hanh Nguyen, and Richard Cripps for flies; Eileen Furlong and Bruce Paterson for antibodies; and Neal Silverman for peptidoglycan. Karen Liu, Vince Dionne, Brian Stramer, Thiago Carvalho, QueeLim Ch'ng, Joe Bateman, Rich Freiman, Mimi Shirasu-Hiza, David Schneider, and members of the Dionne, Stramer, and Geissmann laboratories provided essential discussion and comments. We would like to acknowledge funding from NIDDK (R01DK092590 to R.B.), NIAMS (R01AR059847 to R.B.), NIA (R01AG040288 and R01AG037514 to D.W.W.), and Ellison Medical Foundation (AG-NS-0470-08 to D.W.W.). Work in the Dionne lab was supported by grants from the BBSRC (BB/E02128X/1) and the Wellcome Trust (WT085119MA).	Alessi DR, 1996, FEBS LETT, V399, P333, DOI 10.1016/S0014-5793(96)01370-1; Berdeaux R, 2007, NAT MED, V13, P597, DOI 10.1038/nm1573; Blanchard FJ, 2010, J NEUROSCI, V30, P5855, DOI 10.1523/JNEUROSCI.2688-09.2010; BOUR BA, 1995, GENE DEV, V9, P730, DOI 10.1101/gad.9.6.730; Chen JM, 2010, P NATL ACAD SCI USA, V107, P20774, DOI 10.1073/pnas.1009223107; Chen W, 2002, J BIOL CHEM, V277, P49105, DOI 10.1074/jbc.M204934200; Chintapalli VR, 2007, NAT GENET, V39, P715, DOI 10.1038/ng2049; Clark RI, 2011, CURR BIOL, V21, P1672, DOI 10.1016/j.cub.2011.08.048; De Gregorio E, 2001, P NATL ACAD SCI USA, V98, P12590, DOI 10.1073/pnas.221458698; De Gregorio E, 2002, EMBO J, V21, P2568, DOI 10.1093/emboj/21.11.2568; Delaney JR, 2006, EMBO J, V25, P3068, DOI 10.1038/sj.emboj.7601182; DiAngelo JR, 2009, P NATL ACAD SCI USA, V106, P20853, DOI 10.1073/pnas.0906749106; Dijkers PF, 2007, CURR BIOL, V17, P2087, DOI 10.1016/j.cub.2007.11.001; Dionne MS, 2006, CURR BIOL, V16, P1977, DOI 10.1016/j.cub.2006.08.052; Dionne MS, 2003, INFECT IMMUN, V71, P3540, DOI 10.1128/IAI.71.6.3540-3550.2003; Frith MC, 2004, NUCLEIC ACIDS RES, V32, P1372, DOI 10.1093/nar/gkh299; Futschik Matthias E., 2005, Journal of Bioinformatics and Computational Biology, V3, P965, DOI 10.1142/S0219720005001375; Gottar M, 2006, CELL, V127, P1425, DOI 10.1016/j.cell.2006.10.046; Han J, 1997, NATURE, V386, P296, DOI 10.1038/386296a0; Handschin C, 2003, P NATL ACAD SCI USA, V100, P7111, DOI 10.1073/pnas.1232352100; Hedengren M, 1999, MOL CELL, V4, P827, DOI 10.1016/S1097-2765(00)80392-5; Hirosumi J, 2002, NATURE, V420, P333, DOI 10.1038/nature01137; Hoskins RA, 2011, GENOME RES, V21, P182, DOI 10.1101/gr.112466.110; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Hrdlicka L, 2002, GENESIS, V34, P51, DOI 10.1002/gene.10125; Kaneko T, 2004, IMMUNITY, V20, P637, DOI 10.1016/S1074-7613(04)00104-9; Khiem D, 2008, P NATL ACAD SCI USA, V105, P17067, DOI 10.1073/pnas.0804868105; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Lemaitre B, 2007, ANNU REV IMMUNOL, V25, P697, DOI 10.1146/annurev.immunol.25.022106.141615; LILLY B, 1995, SCIENCE, V267, P688, DOI 10.1126/science.7839146; Liopeta K, 2009, MOL IMMUNOL, V46, P345, DOI 10.1016/j.molimm.2008.10.025; Molkentin JD, 1995, CELL, V83, P1125, DOI 10.1016/0092-8674(95)90139-6; Moritz A, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000998; Ni T, 2010, NAT METHODS, V7, P521, DOI [10.1038/nmeth.1464, 10.1038/NMETH.1464]; Pan F, 2004, J BIOL CHEM, V279, P14477, DOI 10.1074/jbc.C300487200; POLLOCK R, 1991, GENE DEV, V5, P2327, DOI 10.1101/gad.5.12a.2327; Reed DE, 2008, P NATL ACAD SCI USA, V105, P8351, DOI 10.1073/pnas.0802921105; Rynes J, 2012, MOL CELL BIOL, V32, P3949, DOI 10.1128/MCB.00429-12; Schmid CD, 2006, NUCLEIC ACIDS RES, V34, pD82, DOI 10.1093/nar/gkj146; Schneider DS, 2008, NAT REV IMMUNOL, V8, P889, DOI 10.1038/nri2432; Schwenk A, 2000, Curr Opin Clin Nutr Metab Care, V3, P285, DOI 10.1097/00075197-200007000-00008; Senger K, 2004, MOL CELL, V13, P19, DOI 10.1016/S1097-2765(03)00500-8; Shalizi A, 2006, SCIENCE, V311, P1012, DOI 10.1126/science.1122513; Tappy L, 2007, CRIT CARE MED, V35, pS531, DOI 10.1097/01.CCM.0000278062.28122.A4; Thai MV, 1998, J BIOL CHEM, V273, P14285, DOI 10.1074/jbc.273.23.14285; TRACEY KJ, 1994, ANNU REV MED, V45, P491, DOI 10.1146/annurev.med.45.1.491; Vallerie SN, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001007; Van den Berghe G, 2002, CRIT CARE CLIN, V18, P509, DOI 10.1016/S0749-0704(02)00007-6; Wang XM, 2005, J BIOL CHEM, V280, P16705, DOI 10.1074/jbc.M501819200; Wilker PR, 2008, NAT IMMUNOL, V9, P603, DOI 10.1038/ni.1609; Wu H, 2001, EMBO J, V20, P6414, DOI 10.1093/emboj/20.22.6414; Zhang CL, 2002, CELL, V110, P479, DOI 10.1016/S0092-8674(02)00861-9	52	100	102	4	35	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 10	2013	155	2					435	447		10.1016/j.cell.2013.09.007	http://dx.doi.org/10.1016/j.cell.2013.09.007			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	235LH	24075010	hybrid, Green Published, Green Accepted			2022-12-24	WOS:000325719800019
J	Paridaen, JTML; Wilsch-Brauninger, M; Huttner, WB				Paridaen, Judith T. M. L.; Wilsch-Braeuninger, Michaela; Huttner, Wieland B.			Asymmetric Inheritance of Centrosome-Associated Primary Cilium Membrane Directs Ciliogenesis after Cell Division	CELL			English	Article							NEURAL PROGENITORS; NEUROGENESIS; LOCALIZATION; NEOCORTEX; ZONE	Primary cilia are key sensory organelles that are thought to be disassembled prior to mitosis. Inheritance of the mother centriole, which nucleates the primary cilium, in relation to asymmetric daughter cell behavior has previously been studied. However, the fate of the ciliary membrane upon cell division is unknown. Here, we followed the ciliary membrane in dividing embryonic neocortical stem cells and cultured cells. Ciliary membrane attached to the mother centriole was endocytosed at mitosis onset, persisted through mitosis at one spindle pole, and was asymmetrically inherited by one daughter cell, which retained stem cell character. This daughter re-established a primary cilium harboring an activated signal transducer earlier than the noninheriting daughter. Centrosomal association of ciliary membrane in dividing neural stem cells decreased at late neurogenesis when these cells differentiate. Our data imply that centrosome-associated ciliary membrane acts as a determinant for the temporal-spatial control of ciliogenesis.	[Paridaen, Judith T. M. L.; Wilsch-Braeuninger, Michaela; Huttner, Wieland B.] Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany	Max Planck Society	Huttner, WB (corresponding author), Max Planck Inst Mol Cell Biol & Genet, Pfotenhauerstr 108, D-01307 Dresden, Germany.	huttner@mpi-cbg.de	Paridaen, Judith/O-1159-2015; Huttner, Wieland B./P-4080-2018	Paridaen, Judith/0000-0003-3253-6646; 	EMBO long-term fellowship; DFG [SFB 655, A2, TRR 83, Tp6]; ERC [250197]; Fonds der Chemischen Industrie; DFG	EMBO long-term fellowship(European Molecular Biology Organization (EMBO)); DFG(German Research Foundation (DFG)); ERC(European Research Council (ERC)European Commission); Fonds der Chemischen Industrie(Fonds der Chemischen IndustrieEuropean Commission); DFG(German Research Foundation (DFG))	We are indebted to Jussi Helppi and team of the Animal Facility, Jan Peychl and team of the Light Microscopy Facility, and various other services and facilities of the Max Planck Institute of Molecular Cell Biology and Genetics for outstanding support. We thank Miguel Turrero Garcia for advice on organo-typic slice culture, Jula Peters for excellent technical assistance, and Stephan Saalfeld for help with the TrakEM plugin. We acknowledge Michel Bornens, Tamara Caspary, Fumio Matsuzaki, Kirk Mykytyn, and Caren Norden for their kind gift of reagents and thank Alex Sykes and Marnix Wieffer for critical reading of the manuscript. J.T.M.L.P. was supported by an EMBO long-term fellowship. W.B.H. was supported by grants from the DFG (SFB 655, A2; TRR 83, Tp6) and the ERC (250197), by the DFG-funded Center for Regenerative Therapies Dresden, and by the Fonds der Chemischen Industrie.	Aaku-Saraste E, 1997, MECH DEVELOP, V69, P71, DOI 10.1016/S0925-4773(97)00156-1; Anderson CT, 2009, CURR BIOL, V19, P1498, DOI 10.1016/j.cub.2009.07.034; Berbari NF, 2008, MOL BIOL CELL, V19, P1540, DOI 10.1091/mbc.E07-09-0942; Cevik S, 2010, J CELL BIOL, V188, P953, DOI 10.1083/jcb.200908133; Chen JK, 2002, P NATL ACAD SCI USA, V99, P14071, DOI 10.1073/pnas.182542899; Duldulao NA, 2009, DEVELOPMENT, V136, P4033, DOI 10.1242/dev.036350; Frank-Kamenetsky Maria, 2002, J Biol, V1, P10, DOI 10.1186/1475-4924-1-10; Garcia-Gonzalo FR, 2012, J CELL BIOL, V197, P697, DOI 10.1083/jcb.201111146; Goetz SC, 2010, NAT REV GENET, V11, P331, DOI 10.1038/nrg2774; Gotz M, 2005, NAT REV MOL CELL BIO, V6, P777, DOI 10.1038/nrm1739; Graser S, 2007, J CELL BIOL, V179, P321, DOI 10.1083/jcb.200707181; Horner VL, 2011, DEV BIOL, V355, P43, DOI 10.1016/j.ydbio.2011.04.019; Kim S, 2013, CURR OPIN CELL BIOL, V25, P506, DOI 10.1016/j.ceb.2013.04.011; Kim S, 2011, CELL CYCLE, V10, P2683, DOI 10.4161/cc.10.16.17009; Konno D, 2008, NAT CELL BIOL, V10, P93, DOI 10.1038/ncb1673; Kriegstein A, 2009, ANNU REV NEUROSCI, V32, P149, DOI 10.1146/annurev.neuro.051508.135600; Lancaster MA, 2012, CURR OPIN NEUROBIOL, V22, P737, DOI 10.1016/j.conb.2012.04.003; Lehtinen MK, 2011, ANNU REV CELL DEV BI, V27, P653, DOI 10.1146/annurev-cellbio-092910-154026; Louvi A, 2011, NEURON, V69, P1046, DOI 10.1016/j.neuron.2011.03.002; Mogensen MM, 2000, J CELL SCI, V113, P3013; Nachury MV, 2010, ANNU REV CELL DEV BI, V26, P59, DOI 10.1146/annurev.cellbio.042308.113337; Nigg EA, 2011, NAT CELL BIOL, V13, P1154, DOI 10.1038/ncb2345; Pelletier L, 2012, CURR OPIN CELL BIOL, V24, P541, DOI 10.1016/j.ceb.2012.05.005; Piotrowska-Nitsche Karolina, 2012, Cilia, V1, DOI 10.1186/2046-2530-1-6; Reiter JF, 2012, EMBO REP, V13, P608, DOI 10.1038/embor.2012.73; Riparbelli MG, 2012, DEV CELL, V23, P425, DOI 10.1016/j.devcel.2012.05.024; Robbins DJ, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002906; Rohatgi R, 2007, SCIENCE, V317, P372, DOI 10.1126/science.1139740; Seeley ES, 2010, J CELL SCI, V123, P511, DOI 10.1242/jcs.061093; Shitamukai A, 2011, J NEUROSCI, V31, P3683, DOI 10.1523/JNEUROSCI.4773-10.2011; Sillibourne JE, 2011, CYTOSKELETON, V68, P619, DOI 10.1002/cm.20536; SOROKIN S, 1962, J CELL BIOL, V15, P363, DOI 10.1083/jcb.15.2.363; SOROKIN SP, 1968, J CELL SCI, V3, P207; Tsunekawa Y, 2012, EMBO J, V31, P1879, DOI 10.1038/emboj.2012.43; Wang XQ, 2009, NATURE, V461, P947, DOI 10.1038/nature08435; Wilsch-Brauninger M, 2012, DEVELOPMENT, V139, P95, DOI 10.1242/dev.069294; Yamashita YM, 2007, SCIENCE, V315, P518, DOI 10.1126/science.1134910	37	187	191	2	62	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 10	2013	155	2					333	344		10.1016/j.cell.2013.08.060	http://dx.doi.org/10.1016/j.cell.2013.08.060			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	235LH	24120134	Bronze			2022-12-24	WOS:000325719800011
J	Ran, FA; Hsu, PD; Lin, CY; Gootenberg, JS; Konermann, S; Trevino, AE; Scott, DA; Inoue, A; Matoba, S; Zhang, Y; Zhang, F				Ran, F. Ann; Hsu, Patrick D.; Lin, Chie-Yu; Gootenberg, Jonathan S.; Konermann, Silvana; Trevino, Alexandro E.; Scott, David A.; Inoue, Azusa; Matoba, Shogo; Zhang, Yi; Zhang, Feng			Double Nicking by RNA-Guided CRISPR Cas9 for Enhanced Genome Editing Specificity	CELL			English	Article							NUCLEASE; SYSTEM; CELLS; GENERATION; KNOCKOUT; BACTERIA	Targeted genome editing technologies have enabled a broad range of research and medical applications. The Cas9 nuclease from the microbial CRISPR-Cas system is targeted to specific genomic loci by a 20 nt guide sequence, which can tolerate certain mismatches to the DNA target and thereby promote undesired off-target mutagenesis. Here, we describe an approach that combines a Cas9 nickase mutant with paired guide RNAs to introduce targeted double-strand breaks. Because individual nicks in the genome are repaired with high fidelity, simultaneous nicking via appropriately offset guide RNAs is required for double-stranded breaks and extends the number of specifically recognized bases for target cleavage. We demonstrate that using paired nicking can reduce off-target activity by 50- to 1,500-fold in cell lines and to facilitate gene knockout in mouse zygotes without sacrificing on-target cleavage efficiency. This versatile strategy enables a wide variety of genome editing applications that require high specificity.	[Ran, F. Ann; Hsu, Patrick D.; Lin, Chie-Yu; Gootenberg, Jonathan S.; Konermann, Silvana; Trevino, Alexandro E.; Scott, David A.; Zhang, Feng] Broad Inst MIT & Harvard, Cambridge Ctr 7, Cambridge, MA 02142 USA; [Ran, F. Ann; Hsu, Patrick D.; Lin, Chie-Yu; Gootenberg, Jonathan S.; Konermann, Silvana; Scott, David A.; Zhang, Feng] MIT, McGovern Inst Brain Res, Cambridge, MA 02139 USA; [Ran, F. Ann; Hsu, Patrick D.; Lin, Chie-Yu; Gootenberg, Jonathan S.; Konermann, Silvana; Scott, David A.; Zhang, Feng] MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA; [Ran, F. Ann; Hsu, Patrick D.; Lin, Chie-Yu; Gootenberg, Jonathan S.; Konermann, Silvana; Scott, David A.; Zhang, Feng] MIT, Dept Biol Engn, Cambridge, MA 02139 USA; [Ran, F. Ann; Hsu, Patrick D.] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; [Lin, Chie-Yu] Harvard Univ, Sch Med, Harvard MIT Div Hlth Sci & Technol, Boston, MA 02115 USA; [Inoue, Azusa; Matoba, Shogo; Zhang, Yi] Harvard Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02115 USA; [Inoue, Azusa; Matoba, Shogo; Zhang, Yi] Harvard Univ, Sch Med, Program Cellular & Mol Med, Boston, MA 02115 USA; [Inoue, Azusa; Matoba, Shogo; Zhang, Yi] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Inoue, Azusa; Matoba, Shogo; Zhang, Yi] Harvard Univ, Sch Med, Harvard Stem Cell Inst, Boston, MA 02115 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Harvard University; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Zhang, F (corresponding author), Broad Inst MIT & Harvard, Cambridge Ctr 7, Cambridge, MA 02142 USA.	zhang@broadinstitute.org	Gootenberg, Jonathan/AAY-8174-2021; Hsu, Patrick/ABD-5749-2021; Macrae, Rhiannon/AAX-1536-2020; MATOBA, Shogo/D-9995-2016	Gootenberg, Jonathan/0000-0003-2757-2175; MATOBA, Shogo/0000-0003-0474-232X; Hsu, Patrick/0000-0002-9380-2648; Zhang, Yi/0000-0002-2789-0811	National Institute of General Medical Sciences [T32GM007753]; NIH [GM68804, U01DK089565, 1DP1-MH100706, 1R01-DK097768]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK089565, R01DK097768] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007753, R01GM068804] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [DP1MH100706] Funding Source: NIH RePORTER	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank Joshua Weinstein and Yinqing Li for statistical consultation, Xuebing Wu and Phillip Sharp for assistance with northern blotting experiments, Su Vora for help with the manuscript, and the entire Zhang lab for their support and advice. P.D.H. is a James Mills Pierce Fellow. C.-Y.L. is supported by T32GM007753 from the National Institute of General Medical Sciences. D.A.S. is an NSF predoctoral fellow. A.I. and S.M. are research fellows for Research Abroad of the Japan Society for the Promotion of Science. Y.Z. is supported by NIH grants GM68804 and U01DK089565 and is an Investigator of the Howard Hughes Medical Institute. F.Z. is supported by an NIH Director's Pioneer Award (1DP1-MH100706), a NIH Transformative R01 grant (1R01-DK097768), the Keck, McKnight, Damon Runyon, Searle Scholars, Klingen-stein, Vallee, and Simons Foundations, Bob Metcalfe, and Jane Pauley.	Boch J, 2009, SCIENCE, V326, P1509, DOI 10.1126/science.1178811; Carlson DF, 2012, P NATL ACAD SCI USA, V109, P17382, DOI 10.1073/pnas.1211446109; Chang NN, 2013, CELL RES, V23, P465, DOI 10.1038/cr.2013.45; Cho SW, 2013, NAT BIOTECHNOL, V31, P230, DOI 10.1038/nbt.2507; Christian M, 2010, GENETICS, V186, P757, DOI 10.1534/genetics.110.120717; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Deltcheva E, 2011, NATURE, V471, P602, DOI 10.1038/nature09886; Deveau H, 2010, ANNU REV MICROBIOL, V64, P475, DOI 10.1146/annurev.micro.112408.134123; Dianov GL, 2013, NUCLEIC ACIDS RES, V41, P3483, DOI 10.1093/nar/gkt076; Ding QR, 2013, CELL STEM CELL, V12, P238, DOI 10.1016/j.stem.2012.11.011; Friedland AE, 2013, NAT METHODS, V10, P741, DOI 10.1038/nmeth.2532; Fu YF, 2013, NAT BIOTECHNOL, V31, P822, DOI 10.1038/nbt.2623; Gasiunas G, 2012, P NATL ACAD SCI USA, V109, pE2579, DOI 10.1073/pnas.1208507109; Geurts AM, 2009, SCIENCE, V325, P433, DOI 10.1126/science.1172447; Gratz SJ, 2013, GENETICS, V194, P1029, DOI 10.1534/genetics.113.152710; Horvath P, 2010, SCIENCE, V327, P167, DOI 10.1126/science.1179555; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Hsu PD, 2012, ACS CHEM NEUROSCI, V3, P603, DOI 10.1021/cn300089k; Jiang WY, 2013, NAT BIOTECHNOL, V31, P233, DOI 10.1038/nbt.2508; Jinek M, 2013, ELIFE, V2, DOI 10.7554/eLife.00471; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Mali P, 2013, NAT BIOTECHNOL, V31, P833, DOI 10.1038/nbt.2675; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Maresca M, 2013, GENOME RES, V23, P539, DOI 10.1101/gr.145441.112; Miller JC, 2007, NAT BIOTECHNOL, V25, P778, DOI 10.1038/nbt1319; Miller JC, 2011, NAT BIOTECHNOL, V29, P143, DOI 10.1038/nbt.1755; Moscou MJ, 2009, SCIENCE, V326, P1501, DOI 10.1126/science.1178817; Pattanayak V, 2013, NAT BIOTECHNOL, V31, P839, DOI 10.1038/nbt.2673; Perez EE, 2008, NAT BIOTECHNOL, V26, P808, DOI 10.1038/nbt1410; Porteus MH, 2003, SCIENCE, V300, P763, DOI 10.1126/science.1078395; Reyon D, 2012, NAT BIOTECHNOL, V30, P460, DOI 10.1038/nbt.2170; Sander JD, 2011, NAT METHODS, V8, P67, DOI 10.1038/NMETH.1542; Sanjana NE, 2012, NAT PROTOC, V7, P171, DOI 10.1038/nprot.2011.431; Shirogane Y, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2252; Soldner F, 2011, CELL, V146, P318, DOI 10.1016/j.cell.2011.06.019; Takasu Y, 2010, INSECT BIOCHEM MOLEC, V40, P759, DOI 10.1016/j.ibmb.2010.07.012; Urnov FD, 2010, NAT REV GENET, V11, P636, DOI 10.1038/nrg2842; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Wood AJ, 2011, SCIENCE, V333, P307, DOI 10.1126/science.1207773; Zhang F, 2011, NAT BIOTECHNOL, V29, P149, DOI 10.1038/nbt.1775	40	2178	2639	31	1213	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 12	2013	154	6					1380	1389		10.1016/j.cell.2013.08.021	http://dx.doi.org/10.1016/j.cell.2013.08.021			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	215VQ	23992846	Bronze, Green Accepted, Green Published			2022-12-24	WOS:000324239300024
J	Mueller, T; O'Hara, RB; Converse, SJ; Urbanek, RP; Fagan, WF				Mueller, Thomas; O'Hara, Robert B.; Converse, Sarah J.; Urbanek, Richard P.; Fagan, William F.			Social Learning of Migratory Performance	SCIENCE			English	Article							DECISION-MAKING; ORIENTATION; MOVE; INFORMATION; EVOLUTION; GENETICS; MODELS; BIRDS	Successful bird migration can depend on individual learning, social learning, and innate navigation programs. Using 8 years of data on migrating whooping cranes, we were able to partition genetic and socially learned aspects of migration. Specifically, we analyzed data from a reintroduced population wherein all birds were captive bred and artificially trained by ultralight aircraft on their first lifetime migration. For subsequent migrations, in which birds fly individually or in groups but without ultralight escort, we found evidence of long-term social learning, but no effect of genetic relatedness on migratory performance. Social learning from older birds reduced deviations from a straight-line path, with 7 years of experience yielding a 38% improvement in migratory accuracy.	[Mueller, Thomas; Fagan, William F.] Univ Maryland, Dept Biol, College Pk, MD 20742 USA; [Mueller, Thomas; O'Hara, Robert B.] Senckenberg Gesell Nat Forsch, Biodivers & Climate Res Ctr BiK F, D-60325 Frankfurt, Main, Germany; [Mueller, Thomas; O'Hara, Robert B.] Goethe Univ Frankfurt, D-60325 Frankfurt, Main, Germany; [Mueller, Thomas] Smithsonian Conservat Biol Inst, Front Royal, VA 22630 USA; [Converse, Sarah J.] US Geol Survey, Patuxent Wildlife Res Ctr, Laurel, MD 20708 USA; [Urbanek, Richard P.] US Fish & Wildlife Serv, Necedah Natl Wildlife Refuge, Necedah, WI 54646 USA	University System of Maryland; University of Maryland College Park; Senckenberg Biodiversitat & Klima- Forschungszentrum (BiK-F); Senckenberg Gesellschaft fur Naturforschung (SGN); Goethe University Frankfurt; Smithsonian Institution; Smithsonian National Zoological Park & Conservation Biology Institute; United States Department of the Interior; United States Geological Survey; United States Department of the Interior; US Fish & Wildlife Service	Mueller, T (corresponding author), Univ Maryland, Dept Biol, College Pk, MD 20742 USA.	muellert@gmail.com	O'Hara, Bob/A-7499-2008; Mueller, Thomas/A-1740-2014	O'Hara, Bob/0000-0001-9737-3724; Mueller, Thomas/0000-0001-9305-7716; Converse, Sarah J/0000-0002-3719-5441	NSF [1062411]; Landes-Offensive zur Entwicklung Wissenschaftlich-okonomischer Exzellenz programme (Hesse, Germany); Robert Bosch Foundation	NSF(National Science Foundation (NSF)); Landes-Offensive zur Entwicklung Wissenschaftlich-okonomischer Exzellenz programme (Hesse, Germany); Robert Bosch Foundation	T.M. and W.F.F. were supported by NSF Advances in Biological Informatics award 1062411, T. M. and R.B.O. were supported by the Landes-Offensive zur Entwicklung Wissenschaftlich-okonomischer Exzellenz programme (Hesse, Germany), and T. M. was supported by the Robert Bosch Foundation. Data were provided by the Whooping Crane Eastern Partnership and K. Jones and are deposited in the Dryad Repository: http://doi.org/10.5061/dryad.1r0f7. We thank F. Hailer, S. Servanty, E. Grant, J. Calabrese, R. Reynolds, S. Via, E. L. Neuschulz, C. Rushing, D. Bennu, and three anonymous reviewers for helpful comments and discussions.	Akesson S, 2007, BIOSCIENCE, V57, P123, DOI 10.1641/B570207; Alerstam T, 1996, J EXP BIOL, V199, P9; Alerstam T, 2003, OIKOS, V103, P247, DOI 10.1034/j.1600-0706.2003.12559.x; Alerstam T, 2006, SCIENCE, V313, P791, DOI 10.1126/science.1129048; Chapman JW, 2011, CURR BIOL, V21, pR861, DOI 10.1016/j.cub.2011.08.014; Chernetsov N, 2004, J EXP BIOL, V207, P937, DOI 10.1242/jeb.00853; Conradt L, 2005, TRENDS ECOL EVOL, V20, P449, DOI 10.1016/j.tree.2005.05.008; Converse SJ, 2012, J ORNITHOL, V152, pS561, DOI 10.1007/s10336-011-0695-0; Couzin ID, 2005, NATURE, V433, P513, DOI 10.1038/nature03236; Damgaard LH, 2007, J ANIM SCI, V85, P1363, DOI 10.2527/jas.2006-543; Flack A, 2012, ANIM BEHAV, V83, P703, DOI 10.1016/j.anbehav.2011.12.018; Fransson T, 2001, NATURE, V414, P35, DOI 10.1038/35102115; Guttal V, 2010, P NATL ACAD SCI USA, V107, P16172, DOI 10.1073/pnas.1006874107; Jones KL, 2002, CONSERV BIOL, V16, P789, DOI 10.1046/j.1523-1739.2002.00001.x; Kuyt E., 1992, 74 CAN WILDL SERV, P1; Liedvogel M, 2011, TRENDS ECOL EVOL, V26, P561, DOI 10.1016/j.tree.2011.07.009; Mettke-Hofmann C, 2003, P NATL ACAD SCI USA, V100, P5863, DOI 10.1073/pnas.1037505100; Mouritsen H, 1998, J EXP BIOL, V201, P2927; Newton I, 2006, J ORNITHOL, V147, P146, DOI 10.1007/s10336-006-0058-4; O'Hara RB, 2008, J EVOLUTION BIOL, V21, P949, DOI 10.1111/j.1420-9101.2008.01529.x; O'Hara RB, 2009, ANN ZOOL FENN, V46, P124, DOI 10.5735/086.046.0205; Palacin C, 2011, J AVIAN BIOL, V42, P301, DOI 10.1111/j.1600-048X.2011.05395.x; Schuz E., 1950, VOGELWARTE, V1, P239; Schuz E., 1949, VOGELWARTE, V2, P63; Thorup K, 2003, P ROY SOC B-BIOL SCI, V270, pS8, DOI 10.1098/rsbl.2003.0014; Thorup K, 2007, P NATL ACAD SCI USA, V104, P18115, DOI 10.1073/pnas.0704734104; Urbanek R.P., 2005, N AM CRANE WORK P, V9, P213; Urbanek RP, 2010, BIRD CONSERV INT, V20, P43, DOI 10.1017/S0959270909990153; Waldmann P, 2009, EVOLUTION, V63, P1640, DOI 10.1111/j.1558-5646.2009.00645.x; Wikelski M, 2003, NATURE, V423, P704, DOI 10.1038/423704a; Wilson AJ, 2010, J ANIM ECOL, V79, P13, DOI 10.1111/j.1365-2656.2009.01639.x	31	202	205	9	258	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 30	2013	341	6149					999	1002		10.1126/science.1237139	http://dx.doi.org/10.1126/science.1237139			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	208BZ	23990559				2022-12-24	WOS:000323652300042
J	Yamamoto, R; Morita, Y; Ooehara, J; Hamanaka, S; Onodera, M; Rudolph, KL; Ema, H; Nakauchi, H				Yamamoto, Ryo; Morita, Yohei; Ooehara, Jun; Hamanaka, Sanae; Onodera, Masafumi; Rudolph, Karl Lenhard; Ema, Hideo; Nakauchi, Hiromitsu			Clonal Analysis Unveils Self-Renewing Lineage-Restricted Progenitors Generated Directly from Hematopoietic Stem Cells	CELL			English	Article							MOUSE BONE-MARROW; LONG-TERM; MULTIPOTENT PROGENITORS; DIFFERENTIATION; COMMITMENT; RECONSTITUTION; IDENTIFICATION; HETEROGENEITY; PROGRAMS; NOTCH	Consensus holds that hematopoietic stem cells (HSCs) give rise to multipotent progenitors (MPPs) of reduced self-renewal potential and that MPPs eventually produce lineage-committed progenitor cells in a stepwise manner. Using a single-cell transplantation system and marker mice, we unexpectedly found myeloid-restricted progenitors with long-term repopulating activity (MyRPs), which are lineage-committed to megakaryocytes, megakaryocyte-erythroid cells, or common myeloid cells (MkRPs, MERPs, or CMRPs, respectively) in the phenotypically defined HSC compartment together with HSCs. Paired daughter cell assays combined with transplantation revealed that HSCs can give rise to HSCs via symmetric division or directly differentiate into MyRPs via asymmetric division (yielding HSC-MkRP or HSC-CMRP pairs). These myeloid bypass pathways could be essential for fast responses to ablation stress. Our results show that loss of self-renewal and stepwise progression through specific differentiation stages are not essential for lineage commitment of HSCs and suggest a revised model of hematopoietic differentiation.	[Yamamoto, Ryo; Morita, Yohei; Ooehara, Jun; Hamanaka, Sanae; Ema, Hideo; Nakauchi, Hiromitsu] Univ Tokyo, Inst Med Sci, Ctr Stem Cell Biol & Regenerat Med, Div Stem Cell Therapy,Minato Ku, Tokyo 1088639, Japan; [Morita, Yohei; Rudolph, Karl Lenhard] Fritz Lipmann Inst, Leibniz Inst Age Res, D-07745 Jena, Germany; [Hamanaka, Sanae; Nakauchi, Hiromitsu] Japan Sci & Technol Agcy, ERATO, Nakauchi Stem Cell & Organ Regenerat Project, Minato Ku, Tokyo 1088639, Japan; [Onodera, Masafumi] Natl Res Inst Child Hlth & Dev, Dept Human Genet, Setagaya Ku, Tokyo 1578535, Japan	University of Tokyo; Leibniz Institut fur Alternsforschung - Fritz-Lipmann-Institut (FLI); Japan Science & Technology Agency (JST); National Center for Child Health & Development - Japan	Nakauchi, H (corresponding author), Univ Tokyo, Inst Med Sci, Ctr Stem Cell Biol & Regenerat Med, Div Stem Cell Therapy,Minato Ku, 4-6-1 Shirokanedai, Tokyo 1088639, Japan.	nakauchi@ims.u-tokyo.ac.jp	Yamamoto, Ryo/Y-9464-2018; Yamamoto, Ryo/V-9312-2019; Morita, Yohei/N-1260-2014	Yamamoto, Ryo/0000-0001-5504-6004; Morita, Yohei/0000-0003-4163-5080; Rudolph, Karl Lenhard/0000-0002-4839-2862	Ministry of Education, Culture, Sports, and Technology, Japan; Grants-in-Aid for Scientific Research [23500490] Funding Source: KAKEN	Ministry of Education, Culture, Sports, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank S. Yamazaki, H. Nishikii, and K. Ito for discussions; S. Yamazaki, B. Dykstra, J. Seita, M. Kasai, A. Ieyasu, and A. S. Knisely for critical reading of the manuscript; Y. Yamazaki and Y. Ishii for help with FACS operation, and C. Pronk and D. Bryder for advice on colony assays. This work was supported in part by a Grant-in-Aid for Scientific Research on Innovative Areas from the Ministry of Education, Culture, Sports, and Technology, Japan. R. Y. and Y. M. contributed equally to the study. R. Y. designed the study, performed all experiments, analyzed all data, and wrote the manuscript. Y. M. designed the study, performed single-cell transplantations, analyzed related data, and wrote the manuscript. J.O. helped to perform paired daughter cell assays. S. H. and M.O. established the KuO mouse line. K. L. R. edited the manuscript. H. E., and H.N. edited the manuscript and supervised the study. H.N. is a founder, a member of scientific advisory board and shareholder of ReproCELL. H.N. is a scientific advisor of Megakaryon, iCELL and Shionogi & Co.	Adolfsson J, 2005, CELL, V121, P295, DOI 10.1016/j.cell.2005.02.013; Akashi K, 2000, NATURE, V404, P193, DOI 10.1038/35004599; Akashi K, 2003, BLOOD, V101, P383, DOI 10.1182/blood-2002-06-1780; Benveniste P, 2010, CELL STEM CELL, V6, P48, DOI 10.1016/j.stem.2009.11.014; Benz C, 2012, CELL STEM CELL, V10, P273, DOI 10.1016/j.stem.2012.02.007; Boyer SW, 2011, CELL STEM CELL, V9, P64, DOI 10.1016/j.stem.2011.04.021; Christensen JL, 2001, P NATL ACAD SCI USA, V98, P14541, DOI 10.1073/pnas.261562798; Cornejo MG, 2011, BLOOD, V118, P1264, DOI 10.1182/blood-2011-01-328567; Cumano A, 2001, CURR OPIN IMMUNOL, V13, P166, DOI 10.1016/S0952-7915(00)00200-4; Dykstra B, 2007, CELL STEM CELL, V1, P218, DOI 10.1016/j.stem.2007.05.015; Forsberg EC, 2006, CELL, V126, P415, DOI 10.1016/j.cell.2006.06.037; Hamanaka S, 2013, BIOCHEM BIOPH RES CO, V435, P586, DOI 10.1016/j.bbrc.2013.05.017; Hansen JD, 1998, IMMUNOL REV, V166, P199, DOI 10.1111/j.1600-065X.1998.tb01264.x; Huang H, 2009, J CELL BIOCHEM, V107, P857, DOI 10.1002/jcb.22184; Kawamoto H, 2010, IMMUNOL REV, V238, P23, DOI 10.1111/j.1600-065X.2010.00959.x; Kent DG, 2009, BLOOD, V113, P6342, DOI 10.1182/blood-2008-12-192054; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Kondo M, 1997, CELL, V91, P661, DOI 10.1016/S0092-8674(00)80453-5; Lai AY, 2006, J EXP MED, V203, P1867, DOI 10.1084/jem.20060697; Lai AY, 2005, J IMMUNOL, V175, P5016, DOI 10.4049/jimmunol.175.8.5016; Mansson R, 2007, IMMUNITY, V26, P407, DOI 10.1016/j.immuni.2007.02.013; Mercher T, 2008, CELL STEM CELL, V3, P314, DOI 10.1016/j.stem.2008.07.010; Miyamoto T, 2002, DEV CELL, V3, P137, DOI 10.1016/S1534-5807(02)00201-0; Morita Y, 2010, J EXP MED, V207, P1173, DOI 10.1084/jem.20091318; MORRISON SJ, 1994, IMMUNITY, V1, P661, DOI 10.1016/1074-7613(94)90037-X; Muller-Sieburg CE, 2002, BLOOD, V100, P1302, DOI 10.1182/blood.V100.4.1302.h81602001302_1302_1309; Nakorn TN, 2003, P NATL ACAD SCI USA, V100, P205, DOI 10.1073/pnas.262655099; Nutt SL, 2005, J EXP MED, V201, P221, DOI 10.1084/jem.20041535; Osawa M, 1996, SCIENCE, V273, P242, DOI 10.1126/science.273.5272.242; Seita J, 2007, P NATL ACAD SCI USA, V104, P2349, DOI 10.1073/pnas.0606238104; SUDA J, 1984, BLOOD, V64, P393; Takano H, 2004, J EXP MED, V199, P295, DOI 10.1084/jem.20030929; Vellenga E, 2001, BRIT J HAEMATOL, V114, P319, DOI 10.1046/j.1365-2141.2001.02926.x; Ye M, 2003, IMMUNITY, V19, P689, DOI 10.1016/S1074-7613(03)00299-1; Yoshida T, 2006, NAT IMMUNOL, V7, P382, DOI 10.1038/ni1314	35	435	452	0	37	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	AUG 29	2013	154	5					1112	1126		10.1016/j.cell.2013.08.007	http://dx.doi.org/10.1016/j.cell.2013.08.007			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	209OE	23993099	Bronze			2022-12-24	WOS:000323767300023
J	You, CH; Okano, H; Hui, S; Zhang, ZG; Kim, M; Gunderson, CW; Wang, YP; Lenz, P; Yan, DL; Hwa, T				You, Conghui; Okano, Hiroyuki; Hui, Sheng; Zhang, Zhongge; Kim, Minsu; Gunderson, Carl W.; Wang, Yi-Ping; Lenz, Peter; Yan, Dalai; Hwa, Terence			Coordination of bacterial proteome with metabolism by cyclic AMP signalling	NATURE			English	Article							LAC OPERON EXPRESSION; ESCHERICHIA-COLI; CATABOLITE REPRESSION; ADENYLATE-CYCLASE; PHOSPHOTRANSFERASE SYSTEM; TRANSIENT REPRESSION; BETA-GALACTOSIDASE; GENE-EXPRESSION; GROWTH; GLUCOSE	The cyclic AMP (cAMP)-dependent catabolite repression effect in Escherichia coli is among the most intensely studied regulatory processes in biology. However, the physiological function(s) of cAMP signalling and its molecular triggers remain elusive. Here we use a quantitative physiological approach to show that cAMP signalling tightly coordinates the expression of catabolic proteins with biosynthetic and ribosomal proteins, in accordance with the cellular metabolic needs during exponential growth. The expression of carbon catabolic genes increased linearly with decreasing growth rates upon limitation of carbon influx, but decreased linearly with decreasing growth rate upon limitation of nitrogen or sulphur influx. In contrast, the expression of biosynthetic genes showed the opposite linear growth-rate dependence as the catabolic genes. A coarse-grained mathematical model provides a quantitative framework for understanding and predicting gene expression responses to catabolic and anabolic limitations. A scheme of integral feedback control featuring the inhibition of cAMP signalling by metabolic precursors is proposed and validated. These results reveal a key physiological role of cAMP-dependent catabolite repression: to ensure that proteomic resources are spent on distinct metabolic sectors as needed in different nutrient environments. Our findings underscore the power of quantitative physiology in unravelling the underlying functions of complex molecular signalling networks.	[You, Conghui; Okano, Hiroyuki; Hui, Sheng; Kim, Minsu; Hwa, Terence] Univ Calif San Diego, Dept Phys, La Jolla, CA 92093 USA; [You, Conghui; Okano, Hiroyuki; Zhang, Zhongge; Gunderson, Carl W.; Hwa, Terence] Univ Calif San Diego, Div Biol Sci, Sect Mol Biol, La Jolla, CA 92093 USA; [Hui, Sheng; Hwa, Terence] Univ Calif San Diego, Ctr Theoret Biol Phys, La Jolla, CA 92093 USA; [Wang, Yi-Ping] Peking Univ, Coll Life Sci, State Key Lab Prot & Plant Gene Res, Beijing 100871, Peoples R China; [Lenz, Peter] Univ Marburg, Dept Phys, D-35032 Marburg, Germany; [Lenz, Peter] Univ Marburg, Ctr Synthet Microbiol, D-35032 Marburg, Germany; [Yan, Dalai] Indiana Univ Sch Med, Dept Microbiol & Immunol, Indianapolis, IN 46202 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; Peking University; Philipps University Marburg; Philipps University Marburg; Indiana University System; Indiana University Bloomington	Hwa, T (corresponding author), Univ Calif San Diego, Dept Phys, La Jolla, CA 92093 USA.	hwa@ucsd.edu	Hwa, Terence/J-4012-2013; Hwa, Terry/GOJ-9904-2022; Lenz, Peter/L-5980-2013	Hwa, Terence/0000-0003-1837-6842; Hui, Sheng/0000-0002-4226-6806; Lenz, Peter/0000-0001-7705-3950; Wang, Yiping/0000-0002-1995-8521	Human Frontiers in Science Program [RGP0022]; NSF [PHY1058793]; NSF through the Center for Theoretical Biological Physics [PHY0822283]; Direct For Mathematical & Physical Scien [1058793] Funding Source: National Science Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM095903] Funding Source: NIH RePORTER	Human Frontiers in Science Program(Human Frontier Science Program); NSF(National Science Foundation (NSF)); NSF through the Center for Theoretical Biological Physics(National Science Foundation (NSF)); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to R. Bender, A. Danchin, P. Geiduschek, J. Ingraham, S. Kustu, W. F. Loomis, A. Narang, J. Rabinowitz, M. H. Saier and members of the Hwa laboratory for valuable comments. This work was supported by the Human Frontiers in Science Program (RGP0022), and by the NSF to T.H. (PHY1058793) and through the Center for Theoretical Biological Physics (PHY0822283).	BENDER RA, 1977, J BACTERIOL, V132, P100, DOI 10.1128/JB.132.1.100-105.1977; Bettenbrock K, 2007, J BACTERIOL, V189, P6891, DOI 10.1128/JB.00819-07; Brent R, 2009, FEBS LETT, V583, P4019, DOI 10.1016/j.febslet.2009.11.029; CLARK DJ, 1964, BIOCHIM BIOPHYS ACTA, V92, P85, DOI 10.1016/0926-6569(64)90272-X; Deutscher J, 2006, MICROBIOL MOL BIOL R, V70, P939, DOI 10.1128/MMBR.00024-06; Doucette CD, 2011, NAT CHEM BIOL, V7, P894, DOI [10.1038/NCHEMBIO.685, 10.1038/nchembio.685]; Epps HMR, 1942, BIOCHEM J, V36, P619, DOI 10.1042/bj0360619; EPSTEIN W, 1975, P NATL ACAD SCI USA, V72, P2300, DOI 10.1073/pnas.72.6.2300; Goyal S, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000802; Hao N, 2013, SCIENCE, V339, P460, DOI 10.1126/science.1227299; HARWOOD JP, 1975, J BIOL CHEM, V250, P4656; Hengge R, 2009, NAT REV MICROBIOL, V7, P263, DOI 10.1038/nrmicro2109; Hogema BM, 1997, MOL MICROBIOL, V24, P857, DOI 10.1046/j.1365-2958.1997.3991761.x; Inada T, 1996, GENES CELLS, V1, P293, DOI 10.1046/j.1365-2443.1996.24025.x; Kim M, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.46; Klumpp S, 2009, CELL, V139, P1366, DOI 10.1016/j.cell.2009.12.001; KOLB A, 1993, ANNU REV BIOCHEM, V62, P749, DOI 10.1146/annurev.bi.62.070193.003533; Kuhlman T, 2007, P NATL ACAD SCI USA, V104, P6043, DOI 10.1073/pnas.0606717104; Kuo JT, 2003, FEBS LETT, V553, P397, DOI 10.1016/S0014-5793(03)01071-8; Laub MT, 2007, ANNU REV GENET, V41, P121, DOI 10.1146/annurev.genet.41.042007.170548; Leigh J.R., 2004, CONTROL THEORY; M_uller-Hill B., 1996, LAC OPERON SHORT HIS; Maaloe O., 1979, BIOL REGUL DEV, P487; MAGASANIK B, 1961, COLD SPRING HARB SYM, V26, P249, DOI 10.1101/SQB.1961.026.01.031; MAKMAN RS, 1965, J BIOL CHEM, V240, P1309; MANDELSTAM J, 1962, BIOCHEM J, V82, P489, DOI 10.1042/bj0820489; MCFALL E, 1962, BIOCHIM BIOPHYS ACTA, V55, P900; MONOD J, 1947, GROWTH, V11, P223; Narang A, 2007, J THEOR BIOL, V244, P326, DOI 10.1016/j.jtbi.2006.08.007; NEIDHARDT FC, 1957, J BACTERIOL, V73, P260, DOI 10.1128/JB.73.2.260-263.1957; OKADA T, 1981, J BACTERIOL, V146, P1030, DOI 10.1128/JB.146.3.1030-1037.1981; PERLMAN RL, 1969, NATURE, V223, P810, DOI 10.1038/223810a0; PETERKOFSKY A, 1979, P NATL ACAD SCI USA, V76, P1099, DOI 10.1073/pnas.76.3.1099; Porter SL, 2011, NAT REV MICROBIOL, V9, P153, DOI 10.1038/nrmicro2505; Potrykus K, 2008, ANNU REV MICROBIOL, V62, P35, DOI 10.1146/annurev.micro.62.081307.162903; Purvis JE, 2012, SCIENCE, V336, P1440, DOI 10.1126/science.1218351; Reitzer L, 2003, ANNU REV MICROBIOL, V57, P155, DOI 10.1146/annurev.micro.57.030502.090820; SAIER MH, 1976, J BIOL CHEM, V251, P883; SCHAECHTER M, 1958, J GEN MICROBIOL, V19, P592, DOI 10.1099/00221287-19-3-592; Schuetz R, 2012, SCIENCE, V336, P601, DOI 10.1126/science.1216882; Scott M, 2011, CURR OPIN BIOTECH, V22, P559, DOI 10.1016/j.copbio.2011.04.014; Scott M, 2010, SCIENCE, V330, P1099, DOI 10.1126/science.1192588; SILVERSTONE AE, 1970, P NATL ACAD SCI USA, V66, P773, DOI 10.1073/pnas.66.3.773; TYLER B, 1970, J BACTERIOL, V102, P411, DOI 10.1128/JB.102.2.411-422.1970; ULLMANN A, 1976, P NATL ACAD SCI USA, V73, P3476, DOI 10.1073/pnas.73.10.3476; WANNER BL, 1978, J BACTERIOL, V136, P947, DOI 10.1128/JB.136.3.947-954.1978; Yan DL, 2011, APPL ENVIRON MICROB, V77, P6763, DOI 10.1128/AEM.05257-11; Young JW, 2013, P NATL ACAD SCI USA, V110, P4140, DOI 10.1073/pnas.1213060110	48	237	244	12	225	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 15	2013	500	7462					301	306		10.1038/nature12446	http://dx.doi.org/10.1038/nature12446			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201AF	23925119	Green Accepted			2022-12-24	WOS:000323112400025
J	Takemura, S; Bharioke, A; Lu, ZY; Nern, A; Vitaladevuni, S; Rivlin, PK; Katz, WT; Olbris, DJ; Plaza, SM; Winston, P; Zhao, T; Horne, JA; Fetter, RD; Takemura, S; Blazek, K; Chang, LA; Ogundeyi, O; Saunders, MA; Shapiro, V; Sigmund, C; Rubin, GM; Scheffer, LK; Meinertzhagen, IA; Chklovskii, DB				Takemura, Shin-ya; Bharioke, Arjun; Lu, Zhiyuan; Nern, Aljoscha; Vitaladevuni, Shiv; Rivlin, Patricia K.; Katz, William T.; Olbris, Donald J.; Plaza, Stephen M.; Winston, Philip; Zhao, Ting; Horne, Jane Anne; Fetter, Richard D.; Takemura, Satoko; Blazek, Katerina; Chang, Lei-Ann; Ogundeyi, Omotara; Saunders, Mathew A.; Shapiro, Victor; Sigmund, Christopher; Rubin, Gerald M.; Scheffer, Louis K.; Meinertzhagen, Ian A.; Chklovskii, Dmitri B.			A visual motion detection circuit suggested by Drosophila connectomics	NATURE			English	Article							OPTIC LOBE; SENSITIVE PATHWAYS; SELECTIVE UNITS; MOVEMENT; FLY; MELANOGASTER; CELLS; INTERNEURONS; MEDULLA; SIGNALS	Animal behaviour arises from computations in neuronal circuits, but our understanding of these computations has been frustrated by the lack of detailed synaptic connection maps, or connectomes. For example, despite intensive investigations over half a century, the neuronal implementation of local motion detection in the insect visual system remains elusive. Here we develop a semi-automated pipeline using electron microscopy to reconstruct a connectome, containing 379 neurons and 8,637 chemical synaptic contacts, within the Drosophila optic medulla. By matching reconstructed neurons to examples from light microscopy, we assigned neurons to cell types and assembled a connectome of the repeating module of the medulla. Within this module, we identified cell types constituting a motion detection circuit, and showed that the connections onto individual motion-sensitive neurons in this circuit were consistent with their direction selectivity. Our results identify cellular targets for future functional investigations, and demonstrate that connectomes can provide key insights into neuronal computations.	[Takemura, Shin-ya; Bharioke, Arjun; Lu, Zhiyuan; Nern, Aljoscha; Vitaladevuni, Shiv; Rivlin, Patricia K.; Katz, William T.; Olbris, Donald J.; Plaza, Stephen M.; Winston, Philip; Zhao, Ting; Fetter, Richard D.; Takemura, Satoko; Blazek, Katerina; Chang, Lei-Ann; Ogundeyi, Omotara; Saunders, Mathew A.; Shapiro, Victor; Sigmund, Christopher; Rubin, Gerald M.; Scheffer, Louis K.; Meinertzhagen, Ian A.; Chklovskii, Dmitri B.] HHMI, Ashburn, VA 20147 USA; [Lu, Zhiyuan; Horne, Jane Anne; Meinertzhagen, Ian A.] Dalhousie Univ, Dept Psychol & Neurosci, Halifax, NS B3H 4R2, Canada	Howard Hughes Medical Institute; Dalhousie University	Chklovskii, DB (corresponding author), HHMI, Janelia Farm Res Campus, Ashburn, VA 20147 USA.	iam@dal.ca; mitya@janelia.hhmi.org	Bharioke, Arjun/AAL-3302-2021; Zhao, Ting/C-9500-2014	Bharioke, Arjun/0000-0003-3012-1412; Rubin, Gerald/0000-0001-8762-8703; Meinertzhagen, Ian/0000-0002-6578-4526; Katz, William/0000-0002-9417-6212; Takemura, Shin-ya/0000-0003-2400-6426	Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		ASHMORE JF, 1980, NATURE, V288, P84, DOI 10.1038/288084a0; BARLOW HB, 1965, J PHYSIOL-LONDON, V178, P477, DOI 10.1113/jphysiol.1965.sp007638; BAUSENWEIN B, 1992, CELL TISSUE RES, V270, P25, DOI 10.1007/BF00381876; BAUSENWEIN B, 1992, CELL TISSUE RES, V267, P17, DOI 10.1007/BF00318687; Blondel VD, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/10/P10008; Borst A, 2010, ANNU REV NEUROSCI, V33, P49, DOI 10.1146/annurev-neuro-060909-153155; Briggman KL, 2011, NATURE, V471, P183, DOI 10.1038/nature09818; BUCHNER E, 1984, J COMP PHYSIOL, V155, P471, DOI 10.1007/BF00611912; Campos-Ortega J. A., 1972, INFORMATION PROCESSI, V1972, P31, DOI 10.1007/978-3-642-65477-0_5; CANNY J, 1986, IEEE T PATTERN ANAL, V8, P679, DOI 10.1109/TPAMI.1986.4767851; Cardona A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038011; Chklovskii DB, 2010, CURR OPIN NEUROBIOL, V20, P667, DOI 10.1016/j.conb.2010.08.002; Clark DA, 2011, NEURON, V70, P1165, DOI 10.1016/j.neuron.2011.05.023; Dollar P., 2006, P IEEE COMP SOC C CO, V2, P1964, DOI DOI 10.1109/CVPR.2006.298; Douglass JK, 1996, J NEUROSCI, V16, P4551; Douglass JK, 2003, MICROSC RES TECHNIQ, V62, P132, DOI 10.1002/jemt.10367; Euler T, 2002, NATURE, V418, P845, DOI 10.1038/nature00931; FISCHBACH KF, 1989, CELL TISSUE RES, V258, P441, DOI 10.1007/BF00218858; FRANCESCHINI N, 1981, SCIENCE, V213, P1264, DOI 10.1126/science.7268434; Gouwens NW, 2009, J NEUROSCI, V29, P6239, DOI 10.1523/JNEUROSCI.0764-09.2009; Haag J, 2001, J NEUROSCI, V21, P5685, DOI 10.1523/JNEUROSCI.21-15-05685.2001; HASSENSTEIN B, 1956, Z NATURFORSCH PT B, V11, P513; Heisenberg M., 1984, VISION DROSOPHILA GE; Helmstaedter M, 2008, CURR OPIN NEUROBIOL, V18, P633, DOI 10.1016/j.conb.2009.03.005; Joesch M, 2008, CURR BIOL, V18, P368, DOI 10.1016/j.cub.2008.02.022; Joesch M, 2010, NATURE, V468, P300, DOI 10.1038/nature09545; Kasai H, 2003, TRENDS NEUROSCI, V26, P360, DOI 10.1016/S0166-2236(03)00162-0; Kim IJ, 2008, NATURE, V452, P478, DOI 10.1038/nature06739; Kirschfeld K., 1972, INFORM PROCESSING VI, P61; Krapp HG, 1996, NATURE, V384, P463, DOI 10.1038/384463a0; LAUGHLIN SB, 1994, PROG RETIN EYE RES, V13, P165, DOI 10.1016/1350-9462(94)90009-4; Maisak MS, 2013, NATURE, V500, P212, DOI 10.1038/nature12320; Martin DR, 2004, IEEE T PATTERN ANAL, V26, P530, DOI 10.1109/TPAMI.2004.1273918; Meinertzhagen I A, 2001, Prog Brain Res, V131, P53; Meinertzhagen Ian A., 1993, P1363; MIZUNAMI M, 1990, BIOL CYBERN, V64, P1, DOI 10.1007/BF00203624; Mohanta PP, 2002, INT C PATT RECOG, P664, DOI 10.1109/ICPR.2002.1044838; OYSTER CW, 1967, SCIENCE, V155, P841, DOI 10.1126/science.155.3764.841; Reichardt W, 1961, SENS COMMUN, P303; RIEHLE A, 1984, EXP BRAIN RES, V54, P390; Rister J, 2007, NEURON, V56, P155, DOI 10.1016/j.neuron.2007.09.014; Rivera-Alba M, 2011, CURR BIOL, V21, P2000, DOI 10.1016/j.cub.2011.10.022; Sato M., 2000, 8 PAC C COMP GRAPH A; Scheffer L. K., 2013, PREPRINT; Schnell B, 2012, J COMP PHYSIOL A, V198, P389, DOI 10.1007/s00359-012-0716-3; SCHULING FH, 1989, J COMP PHYSIOL A, V165, P179, DOI 10.1007/BF00619192; Soille P., 2003, MORPHOLOGICAL IMAGE, P316; Song S, 2005, PLOS BIOL, V3, P507, DOI 10.1371/journal.pbio.0030068; SRINIVASAN MV, 1980, J COMP PHYSIOL, V140, P1, DOI 10.1007/BF00613743; Strausfeld N. J., 1981, HDB SENSORY PHYSL, VVII, P1; STRAUSFELD NJ, 1991, VISUAL NEUROSCI, V7, P13, DOI 10.1017/S0952523800010919; Takemura SY, 2008, J COMP NEUROL, V509, P493, DOI 10.1002/cne.21757; Tuthill JC, 2013, NEURON, V79, P128, DOI 10.1016/j.neuron.2013.05.024; Van Eck NJ, 2007, STUD CLASS DATA ANAL, P299; Varshney LR, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001066; VINCENT L, 1991, IEEE T PATTERN ANAL, V13, P583, DOI 10.1109/34.87344; Vitaladevuni S., 2008, WORKSH MICR IM APPL; VITALADEVUNI SN, 2010, IEEE COMP SOC C COMP; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056	59	413	416	5	159	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 8	2013	500	7461					175	+		10.1038/nature12450	http://dx.doi.org/10.1038/nature12450			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	197CH	23925240	Green Accepted			2022-12-24	WOS:000322825500028
J	Brennan, CW; Verhaak, RGW; McKenna, A; Campos, B; Noushmehr, H; Salama, SR; Zheng, SY; Chakravarty, D; Sanborn, JZ; Berman, SH; Beroukhim, R; Bernard, B; Wu, CJ; Genovese, G; Shmulevich, I; Barnholtz-Sloan, J; Zou, LH; Vegesna, R; Shukla, SA; Ciriello, G; Yung, WK; Zhang, W; Sougnez, C; Mikkelsen, T; Aldape, K; Bigner, DD; Van Meir, EG; Prados, M; Sloan, A; Black, KL; Eschbacher, J; Finocchiaro, G; Friedman, W; Andrews, DW; Guha, A; Iacocca, M; O'Neill, BP; Foltz, G; Myers, J; Weisenberger, DJ; Penny, R; Kucherlapati, R; Perou, CM; Hayes, DN; Gibbs, R; Marra, M; Mills, GB; Lander, E; Spellman, P; Wilson, R; Sander, C; Weinstein, J; Meyerson, M; Gabriel, S; Laird, PW; Haussler, D; Getz, G; Chin, L				Brennan, Cameron W.; Verhaak, Roel G. W.; McKenna, Aaron; Campos, Benito; Noushmehr, Houtan; Salama, Sofie R.; Zheng, Siyuan; Chakravarty, Debyani; Sanborn, J. Zachary; Berman, Samuel H.; Beroukhim, Rameen; Bernard, Brady; Wu, Chang-Jiun; Genovese, Giannicola; Shmulevich, Ilya; Barnholtz-Sloan, Jill; Zou, Lihua; Vegesna, Rahulsimham; Shukla, Sachet A.; Ciriello, Giovanni; Yung, W. K.; Zhang, Wei; Sougnez, Carrie; Mikkelsen, Tom; Aldape, Kenneth; Bigner, Darell D.; Van Meir, Erwin G.; Prados, Michael; Sloan, Andrew; Black, Keith L.; Eschbacher, Jennifer; Finocchiaro, Gaetano; Friedman, William; Andrews, David W.; Guha, Abhijit; Iacocca, Mary; O'Neill, Brian P.; Foltz, Greg; Myers, Jerome; Weisenberger, Daniel J.; Penny, Robert; Kucherlapati, Raju; Perou, Charles M.; Hayes, D. Neil; Gibbs, Richard; Marra, Marco; Mills, Gordon B.; Lander, Eric; Spellman, Paul; Wilson, Richard; Sander, Chris; Weinstein, John; Meyerson, Matthew; Gabriel, Stacey; Laird, Peter W.; Haussler, David; Getz, Gad; Chin, Lynda		TCGA Res Network	The Somatic Genomic Landscape of Glioblastoma	CELL			English	Article							COPY-NUMBER ALTERATION; DRIVER MUTATIONS; EGFR; EXPRESSION; PATHWAYS; GLIOMAS; KINASE; PDGFRA; GENES; GRADE	We describe the landscape of somatic genomic alterations based on multidimensional and comprehensive characterization of more than 500 glioblastoma tumors (GBMs). We identify several novel mutated genes as well as complex rearrangements of signature receptors, including EGFR and PDGFRA. TERT promoter mutations are shown to correlate with elevated mRNA expression, supporting a role in telomerase reactivation. Correlative analyses confirm that the survival advantage of the proneural subtype is conferred by the G-CIMP phenotype, and MGMT DNA methylation may be a predictive biomarker for treatment response only in classical subtype GBM. Integrative analysis of genomic and proteomic profiles challenges the notion of therapeutic inhibition of a pathway as an alternative to inhibition of the target itself. These data will facilitate the discovery of therapeutic and diagnostic target candidates, the validation of research and clinical observations and the generation of unanticipated hypotheses that can advance our molecular understanding of this lethal cancer.	[Brennan, Cameron W.; Chakravarty, Debyani; Berman, Samuel H.] Mem Sloan Kettering Canc Ctr, Brain Tumor Ctr, Human Oncol & Pathogenesis Program, New York, NY 10065 USA; [Brennan, Cameron W.] Weill Cornell Med Ctr, Dept Neurol Surg, Mem Sloan Kettering Canc Ctr, Dept Neurosurg, New York, NY 10065 USA; [Verhaak, Roel G. W.; Zheng, Siyuan; Vegesna, Rahulsimham; Weinstein, John] Univ Texas MD Anderson Canc Ctr, Dept Bioinformat & Computat Biol, Houston, TX 77030 USA; [McKenna, Aaron; Beroukhim, Rameen; Zou, Lihua; Sougnez, Carrie; Lander, Eric; Meyerson, Matthew; Gabriel, Stacey; Getz, Gad; Chin, Lynda] Broad Inst Harvard & MIT, Canc Program, Cambridge, MA 02142 USA; [Campos, Benito; Beroukhim, Rameen; Shukla, Sachet A.; Meyerson, Matthew] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Campos, Benito] Univ Heidelberg Hosp, Dept Neurosurg, Div Expt Neurosurg, D-69120 Heidelberg, Germany; [Noushmehr, Houtan; Weisenberger, Daniel J.; Laird, Peter W.] Univ So Calif, Keck Sch Med, Univ Southern Calif Epigenome Ctr, Los Angeles, CA 90033 USA; [Noushmehr, Houtan] Univ Sao Paulo, Fac Med Ribeirao Preto, Ctr Integrat Syst Biol, Dept Genet, BR-14049900 Sao Paulo, Brazil; [Salama, Sofie R.; Sanborn, J. Zachary; Haussler, David] Univ Calif Santa Cruz, Dept Biomol Engn, Santa Cruz, CA 95064 USA; [Salama, Sofie R.; Sanborn, J. Zachary; Haussler, David] Univ Calif Santa Cruz, Ctr Biomol Sci & Engn, Santa Cruz, CA 95064 USA; [Bernard, Brady; Shmulevich, Ilya] Inst Syst Biol, Seattle, WA 98109 USA; [Verhaak, Roel G. W.; Wu, Chang-Jiun; Genovese, Giannicola; Chin, Lynda] Univ Texas MD Anderson Canc Ctr, Dept Genom Med, Houston, TX 77030 USA; [Barnholtz-Sloan, Jill] Case Western Reserve Univ, Sch Med, Case Comprehens Canc Ctr, Cleveland, OH 44106 USA; [Ciriello, Giovanni; Sander, Chris] Mem Sloan Kettering Canc Ctr, Computat Biol Ctr, New York, NY 10065 USA; [Yung, W. K.] Univ Texas MD Anderson Canc Ctr, Dept Neurooncol, Houston, TX 77030 USA; [Zhang, Wei; Aldape, Kenneth] Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA; [Mikkelsen, Tom] Henry Ford Hosp, Dept Neurol, Detroit, MI 48202 USA; [Mikkelsen, Tom] Henry Ford Hosp, Dept Neurosurg, Detroit, MI 48202 USA; [Bigner, Darell D.] Duke Univ, Med Ctr, Dept Pathol, Durham, NC 27710 USA; [Van Meir, Erwin G.] Emory Univ, Winship Canc Inst, Dept Neurosurg, Atlanta, GA 30322 USA; [Van Meir, Erwin G.] Emory Univ, Winship Canc Inst, Dept Hematol & Med Oncol, Atlanta, GA 30322 USA; [Van Meir, Erwin G.] Emory Univ, Sch Med, Atlanta, GA 30322 USA; [Prados, Michael] Univ Calif San Francisco, Dept Neurosurg, San Francisco, CA 94143 USA; [Sloan, Andrew] Univ Hosp Case Med Ctr, Seidman Canc Ctr, Dept Neurosurg, Cleveland, OH 44106 USA; [Black, Keith L.] Cedars Sinai Med Ctr, Dept Neurosurg, Los Angeles, CA 90048 USA; [Eschbacher, Jennifer] St Josephs Hosp, Dept Pathol, Phoenix, AZ 85013 USA; [Finocchiaro, Gaetano] Ist Neurol Besta, Dept Neurooncol, I-20133 Milan, Italy; [Friedman, William] Univ Florida, Dept Neurosurg, Gainesville, FL 32610 USA; [Andrews, David W.] Thomas Jefferson Univ, Dept Neurol Surg, Philadelphia, PA 19107 USA; [Guha, Abhijit] Toronto Western Hosp, Dept Neurosurg, Toronto, ON M5T 2S8, Canada; [Iacocca, Mary] Helen F Graham Canc Ctr, Christiana Care, Dept Pathol, Newark, DE 19713 USA; [O'Neill, Brian P.] Mayo Clin, Dept Neurol, Rochester, MN 55905 USA; [O'Neill, Brian P.] Mayo Clin, Ctr Canc, Rochester, MN 55905 USA; [Foltz, Greg] Swedish Neurosci Inst, Ivy Brain Tumor Ctr, Seattle, WA 98122 USA; [Myers, Jerome] Penrose St Francis Hlth Serv, Dept Pathol, Colorado Springs, CO 80907 USA; [Penny, Robert] Int Genom Consortium, Phoenix, AZ 85004 USA; [Kucherlapati, Raju] Brigham & Womens Hosp, Boston, MA 02215 USA; [Kucherlapati, Raju] Harvard Univ, Sch Med, Boston, MA 02215 USA; [Perou, Charles M.; Hayes, D. Neil] Univ N Carolina, Dept Genet, Chapel Hill, NC 27599 USA; [Gibbs, Richard] Baylor Coll Med, Human Genome Sequencing Ctr, Houston, TX 77030 USA; [Marra, Marco] BC Canc Agcy, Canadas Michael Smith Genome Sci Ctr, Vancouver, BC V5Z 4S6, Canada; [Mills, Gordon B.] Univ Texas MD Anderson Canc Ctr, Dept Syst Biol, Houston, TX 77030 USA; [Spellman, Paul] Oregon Hlth & Sci Univ, Dept Mol & Med Genet, Portland, OR 97239 USA; [Wilson, Richard] Washington Univ, Genome Inst, St Louis, MO 63110 USA; [Haussler, David] Univ Calif Santa Cruz, Howard Hughes Med Inst, Santa Cruz, CA 95064 USA	Memorial Sloan Kettering Cancer Center; Cornell University; Memorial Sloan Kettering Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Dana-Farber Cancer Institute; Ruprecht Karls University Heidelberg; University of Southern California; Universidade de Sao Paulo; University of California System; University of California Santa Cruz; University of California System; University of California Santa Cruz; Institute for Systems Biology (ISB); University of Texas System; UTMD Anderson Cancer Center; Case Western Reserve University; Memorial Sloan Kettering Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Henry Ford Health System; Henry Ford Hospital; Henry Ford Health System; Henry Ford Hospital; Duke University; Emory University; Emory University; Emory University; University of California System; University of California San Francisco; Case Western Reserve University; Case Western Reserve University Hospital; Cedars Sinai Medical Center; St. Joseph's Hospital and Medical Center; IRCCS Istituto Neurologico Besta; State University System of Florida; University of Florida; Jefferson University; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Christiana Care Health System; Helen F. Graham Cancer Center & Research Institute; Mayo Clinic; Mayo Clinic; Swedish Medical Center; International Genomics Consortium; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; University of North Carolina; University of North Carolina Chapel Hill; Baylor College of Medicine; British Columbia Cancer Agency; University of Texas System; UTMD Anderson Cancer Center; Oregon Health & Science University; Washington University (WUSTL); Howard Hughes Medical Institute; University of California System; University of California Santa Cruz	Brennan, CW (corresponding author), Mem Sloan Kettering Canc Ctr, Brain Tumor Ctr, Human Oncol & Pathogenesis Program, New York, NY 10065 USA.	cbrennan@mskcc.org; lchin@mdanderson.org	Friedman, William/GLR-1220-2022; Wilson, Richard K./AAF-4139-2019; Zheng, sy/GRS-3136-2022; Kucherlapati, Raju/ABC-8807-2021; Finocchiaro, Gaetano/AAG-6791-2020; Pollo, Bianca/K-5347-2018; Schumacher, Steven/E-9821-2013; Brennan, Cameron/R-7082-2019; Van Den Berg, David J/G-8598-2017; Laird, Peter W/G-8683-2012; Lee, Semin/S-2629-2016; Chen, Ken/AAU-1432-2021; Gao, JianJiong/B-5673-2016; Ostrom, Quinn/F-1820-2018; Sloan, Andrew/AAE-9842-2020; Salama, Sofie/K-6412-2019; N, Houtan/C-9692-2013; Perou, Charles M/H-9934-2014; Weisenberger, Daniel/AAA-8314-2020; Prados, Michael/N-5220-2019; Miller, Ryan/B-9365-2008; Marra, Marco A/B-5987-2008; Verhaak, Roel/ABE-7058-2020; Barnholtz-Sloan, Jill/A-4817-2011; Skanderup, Anders Jacobsen/K-1081-2013; Eoli, Marica/K-7748-2016; maderna, emanuela/F-1420-2019; DiMeco, Francesco/Q-3785-2016	Wilson, Richard K./0000-0002-1992-1358; Pollo, Bianca/0000-0002-5523-4256; Schumacher, Steven/0000-0002-6819-5647; Brennan, Cameron/0000-0003-4064-8891; Van Den Berg, David J/0000-0002-5404-5218; Laird, Peter W/0000-0001-9117-3641; Lee, Semin/0000-0002-9015-6046; Chen, Ken/0000-0003-4013-5279; Gao, JianJiong/0000-0002-5739-1781; Ostrom, Quinn/0000-0003-3469-7558; N, Houtan/0000-0003-4051-8114; Perou, Charles M/0000-0001-9827-2247; Weisenberger, Daniel/0000-0001-8303-2603; Miller, Ryan/0000-0002-0096-8762; Marra, Marco A/0000-0001-7146-7175; Barnholtz-Sloan, Jill/0000-0001-6190-9304; Skanderup, Anders Jacobsen/0000-0001-6847-4980; Bootwalla, Moiz/0000-0001-6158-7114; Heiman, David/0000-0001-7895-4259; Tarnuzzer, Roy/0000-0002-3725-4173; Meyerson, Matthew/0000-0002-9133-8108; Eoli, Marica/0000-0003-4744-9377; Bogler, Oliver/0000-0002-3700-0480; Lash, Alex/0000-0003-3787-1590; maderna, emanuela/0000-0002-5736-3166; Yachnis, Anthony/0000-0002-6971-0698; Auman, James/0000-0002-9328-8829; Stuart, Joshua/0000-0002-2171-565X; Ciriello, Giovanni/0000-0003-2021-8683; Jensen, Mark/0000-0001-5215-101X; Gehlenborg, Nils/0000-0003-0327-8297; Weinstein, John/0000-0001-9401-6908; Lipp, Eric/0000-0002-4372-5533; DiMeco, Francesco/0000-0001-6213-5793; Park, Peter/0000-0001-9378-960X; Cibulskis, Kristian/0000-0003-1343-1582; Harshyne, Larry/0000-0002-8699-3028; Triche, Tim/0000-0001-5665-946X; Genovese, Giannicola/0000-0003-1392-9954; Zheng, Siyuan/0000-0002-1031-9424; Pot, David/0000-0002-1480-9826; Fuller, Gregory/0000-0001-9447-2647; Hoadley, Katherine/0000-0002-1216-477X; Salama, Sofie/0000-0001-6999-7193; Black, Keith/0000-0002-0546-4934; Van Meir, Erwin G./0000-0003-2444-7707; Chakravarty, Debyani/0000-0001-8629-5732; Gutmann, David/0000-0002-3127-5045; Finocchiaro, Gaetano/0000-0003-3583-4040; Berens, Michael/0000-0002-3382-6787; Raghunathan, Aditya/0000-0001-6198-7441; Chen, Peng-Chieh ( Jessica )/0000-0002-2060-1765	USA National Institutes of Health [U24CA143883, U24CA143858, U24C A143840, U24CA143799, U24CA143835, U24CA143845, U24CA143882, U24 CA143867, U24CA143866];  [U24CA143848];  [U24CA144025];  [U24CA143843];  [U54HG003067];  [U54HG003079];  [U54HG003273];  [U24CA126543];  [U24CA12 6544];  [U24CA126546];  [U24CA126551];  [U24CA126554];  [U24CA126561];  [U24CA 126563];  [U24CA143731]; NATIONAL CANCER INSTITUTE [P50CA108961, U24CA126544, U24CA126543, P30CA015083, U24CA143858, P30CA008748, U24CA143835, U24CA143799, U24CA143866, U24CA143843, R01CA163722, U24CA143867, U24CA126563, U24CA126551, U24CA126546, P30CA016672, U24CA126561, U24CA126554, U24CA144025, U24CA143840, U24CA143845, U24CA143848, U24CA143883, P50CA098258, U24CA143882] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003067, U54HG003273, U54HG003079] Funding Source: NIH RePORTER	USA National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; ; ; ; ; ; ; ; ; ; ; ; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	The TCGA research network contributed collectively to this study. Biospecimens were provided by the Tissue Source Sites and processed by the Biospecimen Core Resource. Data generation and analyses were performed by the Genome Sequencing Centers, Cancer Genome Characterization Centers, and Genome Data Analysis Centers. All data were released through the Data Coordinating Center. Project activities were coordinated by NCI and NHGRI Project Teams. This work was supported by the following grants from the USA National Institutes of Health: U24CA143883, U24CA143858, U24C A143840, U24CA143799, U24CA143835, U24CA143845, U24CA143882, U24 CA143867, U24CA143866, U24CA143848, U24CA144025, U24CA143843, U54HG003067, U54HG003079, U54HG003273, U24CA126543, U24CA12 6544, U24CA126546, U24CA126551, U24CA126554, U24CA126561, U24CA 126563, and U24CA143731.	Bady P, 2012, ACTA NEUROPATHOL, V124, P547, DOI 10.1007/s00401-012-1016-2; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; Berger MF, 2012, NATURE, V485, P502, DOI 10.1038/nature11071; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Brennan C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007752; CALLAGHAN T, 1993, ONCOGENE, V8, P2939; Chapman PB, 2011, NEW ENGL J MED, V364, P2507, DOI 10.1056/NEJMoa1103782; Chen AJ, 2012, GENE DEV, V26, P1459, DOI 10.1101/gad.189001.112; Cho J, 2011, CANCER RES, V71, P7587, DOI 10.1158/0008-5472.CAN-11-0821; Ciriello G, 2012, GENOME RES, V22, P398, DOI 10.1101/gr.125567.111; Dolecek TA, 2012, NEURO-ONCOLOGY, V14, pv1, DOI 10.1093/neuonc/nos218; Dunn GP, 2012, GENE DEV, V26, P756, DOI 10.1101/gad.187922.112; Hammerman PS, 2012, NATURE, V489, P519, DOI 10.1038/nature11404; Hegi ME, 2005, NEW ENGL J MED, V352, P997, DOI 10.1056/NEJMoa043331; Hodis E, 2012, CELL, V150, P251, DOI 10.1016/j.cell.2012.06.024; Holmes KM, 2012, P NATL ACAD SCI USA, V109, P3475, DOI 10.1073/pnas.1120375109; Ichimura K, 2009, NEURO-ONCOLOGY, V11, P341, DOI 10.1215/15228517-2009-025; Imielinski M, 2012, CELL, V150, P1107, DOI 10.1016/j.cell.2012.08.029; Inda MD, 2010, GENE DEV, V24, P1731, DOI 10.1101/gad.1890510; Kannan K, 2012, ONCOTARGET, V3, P1194; Killela PJ, 2013, P NATL ACAD SCI USA, V110, P6021, DOI 10.1073/pnas.1303607110; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Krol J, 2010, NAT REV GENET, V11, P597, DOI 10.1038/nrg2843; KURAHASHI H, 1995, HUM MOL GENET, V4, P541, DOI 10.1093/hmg/4.4.541; Kuttler F, 2007, SEMIN CANCER BIOL, V17, P56, DOI 10.1016/j.semcancer.2006.10.007; Liu XY, 2012, ACTA NEUROPATHOL, V124, P615, DOI 10.1007/s00401-012-1031-3; Lovejoy CA, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002772; Mermel CH, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-4-r41; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Noushmehr H, 2010, CANCER CELL, V17, P510, DOI 10.1016/j.ccr.2010.03.017; Ohgaki H, 2007, AM J PATHOL, V170, P1445, DOI 10.2353/ajpath.2007.070011; Ozawa T, 2010, GENE DEV, V24, P2205, DOI 10.1101/gad.1972310; Park SY, 2009, NAT STRUCT MOL BIOL, V16, P23, DOI 10.1038/nsmb.1533; Phillips HS, 2006, CANCER CELL, V9, P157, DOI 10.1016/j.ccr.2006.02.019; Schittenhelm J, 2009, MODERN PATHOL, V22, P1600, DOI 10.1038/modpathol.2009.132; Schwartzentruber J, 2012, NATURE, V482, P226, DOI [10.1038/nature10833, 10.1007/s13311-012-0137-6]; Shono T, 2001, CANCER RES, V61, P4375; Singh D, 2012, SCIENCE, V337, P1231, DOI 10.1126/science.1220834; Snuderl M, 2011, CANCER CELL, V20, P810, DOI 10.1016/j.ccr.2011.11.005; Sturm D, 2012, CANCER CELL, V22, P425, DOI 10.1016/j.ccr.2012.08.024; Sumazin P, 2011, CELL, V147, P370, DOI 10.1016/j.cell.2011.09.041; Szerlip NJ, 2012, P NATL ACAD SCI USA, V109, P3041, DOI 10.1073/pnas.1114033109; Tay Y, 2011, CELL, V147, P344, DOI 10.1016/j.cell.2011.09.029; Varela I, 2011, NATURE, V469, P539, DOI 10.1038/nature09639; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Vivanco I, 2012, CANCER DISCOV, V2, P458, DOI 10.1158/2159-8290.CD-11-0284; Wiegand KC, 2010, NEW ENGL J MED, V363, P1532, DOI 10.1056/NEJMoa1008433; Zheng SC, 2011, NEURO-ONCOLOGY, V13, P280, DOI 10.1093/neuonc/noq190; Zheng SY, 2013, GENE DEV, V27, P1462, DOI 10.1101/gad.213686.113	50	2895	2941	12	306	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 10	2013	155	2					462	477		10.1016/j.cell.2013.09.034	http://dx.doi.org/10.1016/j.cell.2013.09.034			16	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	235LH	24120142	Bronze, Green Published, Green Accepted, Green Submitted			2022-12-24	WOS:000325719800021
J	Dong, XT; Liu, OW; Howell, AS; Shen, K				Dong, Xintong; Liu, Oliver W.; Howell, Audrey S.; Shen, Kang			An Extracellular Adhesion Molecule Complex Patterns Dendritic Branching and Morphogenesis	CELL			English	Article							DROSOPHILA SENSORY NEURONS; SELF-AVOIDANCE; CAENORHABDITIS-ELEGANS; C-ELEGANS; DSCAM; L1; ORGANIZATION; HOMOLOG; SPECIFICITY; RETINA	Robust dendrite morphogenesis is a critical step in the development of reproducible neural circuits. However, little is known about the extracellular cues that pattern complex dendrite morphologies. In the model nematode Caenorhabditis elegans, the sensory neuron PVD establishes stereotypical, highly branched dendrite morphology. Here, we report the identification of a tripartite ligand-receptor complex of membrane adhesion molecules that is both necessary and sufficient to instruct spatially restricted growth and branching of PVD dendrites. The ligand complex SAX-7/L1CAM and MNR-1 function at defined locations in the surrounding hypodermal tissue, whereas DMA-1 acts as the cognate receptor on PVD. Mutations in this complex lead to dramatic defects in the formation, stabilization, and organization of the dendritic arbor. Ectopic expression of SAX-7 and MNR-1 generates a predictable, unnaturally patterned dendritic tree in a DMA-1-dependent manner. Both in vivo and in vitro experiments indicate that all three molecules are needed for interaction.	[Dong, Xintong; Liu, Oliver W.; Howell, Audrey S.; Shen, Kang] Stanford Univ, Dept Biol, Howard Hughes Med Inst, Stanford, CA 94305 USA	Howard Hughes Medical Institute; Stanford University	Shen, K (corresponding author), Stanford Univ, Dept Biol, Howard Hughes Med Inst, 385 Serra Mall, Stanford, CA 94305 USA.	kangshen@stanford.edu		Dong, Xintong/0000-0002-6887-8712	Howard Hughes Medical Institute; NIH [1R01NS082208]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS082208] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank the Caenorhabditis Genetics Center for the sax-7(nj48) strain, and the laboratory of H. Beulow for sharing unpublished information. We also thank C. Yu for helping in forward genetic screens, C. Gao and the laboratories of L. Luo, E. Ozkan, and K.C. Garcia for technical assistance, and G. Maro, C.A. Taylor, and V. Ericson for thoughtful comments on the manuscript. This work was supported by the Howard Hughes Medical Institute and the NIH (1R01NS082208).	Aguirre-Chen C, 2011, DEVELOPMENT, V138, P507, DOI 10.1242/dev.060939; BRENNER S, 1974, GENETICS, V77, P71; Brummendorf T, 1998, CURR OPIN NEUROBIOL, V8, P87, DOI 10.1016/S0959-4388(98)80012-3; Hall DH, 2011, TRENDS NEUROSCI, V34, P443, DOI 10.1016/j.tins.2011.07.004; Han C, 2012, NEURON, V73, P64, DOI 10.1016/j.neuron.2011.10.036; Hong WZ, 2009, NAT NEUROSCI, V12, P1542, DOI 10.1038/nn.2442; Jan YN, 2010, NAT REV NEUROSCI, V11, P316, DOI 10.1038/nrn2836; Kim ME, 2012, NEURON, V73, P79, DOI 10.1016/j.neuron.2011.10.033; Lefebvre JL, 2012, NATURE, V488, P517, DOI 10.1038/nature11305; Li LS, 2011, CELL, V147, P1615, DOI 10.1016/j.cell.2011.11.027; Liu OW, 2012, NAT NEUROSCI, V15, P57, DOI 10.1038/nn.2978; Matthews BJ, 2007, CELL, V129, P593, DOI 10.1016/j.cell.2007.04.013; McCarter J, 1999, DEV BIOL, V205, P111, DOI 10.1006/dbio.1998.9109; Mumm JS, 2006, NEURON, V52, P609, DOI 10.1016/j.neuron.2006.10.004; Oren-Suissa M, 2010, SCIENCE, V328, P1285, DOI 10.1126/science.1189095; Pocock R, 2008, MOL CELL NEUROSCI, V37, P56, DOI 10.1016/j.mcn.2007.08.014; Polleux F, 2000, NATURE, V404, P567, DOI 10.1038/35007001; Salzberg Y, 2013, CELL, V155, P308, DOI 10.1016/j.cell.2013.08.058; Sanes JR, 2010, NEURON, V66, P15, DOI 10.1016/j.neuron.2010.01.018; Sanes JR, 2009, ANNU REV CELL DEV BI, V25, P161, DOI 10.1146/annurev.cellbio.24.110707.175402; Sasakura H, 2005, EMBO J, V24, P1477, DOI 10.1038/sj.emboj.7600621; Schurmann G, 2001, MOL BIOL CELL, V12, P1765, DOI 10.1091/mbc.12.6.1765; Smith CJ, 2013, NEURON, V79, P266, DOI 10.1016/j.neuron.2013.05.009; Smith CJ, 2012, NAT NEUROSCI, V15, P731, DOI 10.1038/nn.3065; Smith CJ, 2010, DEV BIOL, V345, P18, DOI 10.1016/j.ydbio.2010.05.502; Soba P, 2007, NEURON, V54, P403, DOI 10.1016/j.neuron.2007.03.029; SULSTON JE, 1977, DEV BIOL, V56, P110, DOI 10.1016/0012-1606(77)90158-0; Tursun B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004625; VanCamp G, 1996, HUM MUTAT, V8, P391, DOI 10.1002/(SICI)1098-1004(1996)8:4<391::AID-HUMU19>3.0.CO;2-Y; VITS L, 1994, NAT GENET, V7, P408, DOI 10.1038/ng0794-408; Wojtowicz WM, 2004, CELL, V118, P619, DOI 10.1016/j.cell.2004.08.021; Yamagata M, 2008, NATURE, V451, P465, DOI 10.1038/nature06469; Yamagata M, 2012, J NEUROSCI, V32, P14402, DOI 10.1523/JNEUROSCI.3193-12.2012; Yasunaga K, 2010, DEV CELL, V18, P621, DOI 10.1016/j.devcel.2010.02.010; Zallen JA, 1999, DEVELOPMENT, V126, P3679; ZORIO DAR, 1994, NATURE, V372, P270, DOI 10.1038/372270a0	36	103	106	1	30	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 10	2013	155	2					296	307		10.1016/j.cell.2013.08.059	http://dx.doi.org/10.1016/j.cell.2013.08.059			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	235LH	24120131	Green Accepted, Bronze			2022-12-24	WOS:000325719800008
J	Hawn, MT; Graham, LA; Richman, JS; Itani, KMF; Henderson, WG; Maddox, TM				Hawn, Mary T.; Graham, Laura A.; Richman, Joshua S.; Itani, Kamal M. F.; Henderson, William G.; Maddox, Thomas M.			Risk of Major Adverse Cardiac Events Following Noncardiac Surgery in Patients With Coronary Stents	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							DRUG-ELUTING STENTS; LATE THROMBOSIS; BARE-METAL; DISCONTINUATION; INTERVENTION; IMPLANTATION; MANAGEMENT; CARE	IMPORTANCE Guidelines recommend delaying noncardiac surgery in patients after coronary stent procedures for 1 year after drug-eluting stents (DES) and for 6 weeks after bare metal stents (BMS). The evidence underlying these recommendations is limited and conflicting. OBJECTIVE To determine risk factors for adverse cardiac events in patients undergoing noncardiac surgery following coronary stent implantation. DESIGN, SETTING, AND PARTICIPANTS A national, retrospective cohort study of 41 989 Veterans Affairs (VA) and non-VA operations occurring in the 24 months after a coronary stent implantation between 2000 and 2010. Nonlinear generalized additive models examined the association between timing of surgery and stent type with major adverse cardiac events (MACE) adjusting for patient, surgery, and cardiac risk factors. A nested case-control study assessed the association between perioperative antiplatelet cessation and MACE. MAIN OUTCOMES AND MEASURES A composite 30-day MACE rate of all-cause mortality, myocardial infarction, and cardiac revascularization. RESULTS Within 24 months of 124 844 coronary stent implantations (47.6% DES, 52.4% BMS), 28 029 patients (22.5%; 95% CI, 22.2%-22.7%) underwent noncardiac operations resulting in 1980 MACE (4.7%; 95% CI, 4.5%-4.9%). Time between stent and surgery was associated with MACE (<6 weeks, 11.6%; 6 weeks to <6 months, 6.4%; 6-12 months, 4.2%; >12-24 months, 3.5%; P<.001). MACE rate by stent type was 5.1% for BMS and 4.3% for DES (P<.001). After adjustment, the 3 factors most strongly associated with MACE were nonelective surgical admission (adjusted odds ratio [AOR], 4.77; 95% CI, 4.07-5.59), history of myocardial infarction in the 6 months preceding surgery (AOR, 2.63; 95% CI, 2.32-2.98), and revised cardiac risk index greater than 2 (AOR, 2.13; 95% CI, 1.85-2.44). Of the 12 variables in the model, timing of surgery ranked fifth in explanatory importance measured by partial effects analysis. Stent type ranked last, and DES was not significantly associated with MACE (AOR, 0.91; 95% CI, 0.83-1.01). After both BMS and DES placement, the risk of MACE was stable at 6 months. A case-control analysis of 284 matched pairs found no association between antiplatelet cessation and MACE (OR, 0.86; 95% CI, 0.57-1.29). CONCLUSIONS AND RELEVANCE Among patients undergoing noncardiac surgery within 2 years of coronary stent placement, MACE were associated with emergency surgery and advanced cardiac disease but not stent type or timing of surgery beyond 6 months after stent implantation. Guideline emphasis on stent type and surgical timing for both DES and BMS should be reevaluated.	[Hawn, Mary T.; Graham, Laura A.; Richman, Joshua S.] Birmingham Vet Adm Hosp, Ctr Surg Med Acute Care Res & Transit C SMART, Birmingham, AL USA; [Hawn, Mary T.; Richman, Joshua S.] Univ Alabama Birmingham, Dept Surg, Sect Gastrointestinal Surg, Birmingham, AL 35294 USA; [Itani, Kamal M. F.] Boston Univ, Dept Surg, VA Boston Hlth Care Syst, Boston, MA 02215 USA; [Itani, Kamal M. F.] Harvard Univ, Sch Med, Boston, MA USA; [Henderson, William G.] Univ Colorado, Hlth Outcomes Program, Aurora, CO USA; [Henderson, William G.] Colorado Sch Publ Hlth, Dept Biostat & Informat, Aurora, CO USA; [Maddox, Thomas M.] VA Eastern Colorado Hlth Care Syst, Denver, CO USA; [Maddox, Thomas M.] Univ Colorado, Denver, CO 80202 USA	University of Alabama System; University of Alabama Birmingham; Boston University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System; Harvard University; Harvard Medical School; University of Colorado System; University of Colorado Anschutz Medical Campus; Colorado School of Public Health; University of Colorado System; University of Colorado Denver	Hawn, MT (corresponding author), Univ Alabama Birmingham, Dept Surg, Sect Gastrointestinal Surg, 1922 7th Ave S,KB 428, Birmingham, AL 35294 USA.	mhawn@uab.edu	Graham, Laura/T-8484-2017	Graham, Laura/0000-0002-7327-3793	VA Health Services Research & Development grant [IIR 09-347]; VA Career Development Awards	VA Health Services Research & Development grant; VA Career Development Awards	This study is supported by a VA Health Services Research & Development grant (No. IIR 09-347). In addition, Drs Maddox and Richman are supported by VA Career Development Awards.	Assali A, 2009, CATHETER CARDIO INTE, V74, P837, DOI 10.1002/ccd.22158; Bavry AA, 2006, AM J MED, V119, P1056, DOI 10.1016/j.amjmed.2006.01.023; Berger PB, 2010, JACC-CARDIOVASC INTE, V3, P920, DOI 10.1016/j.jcin.2010.03.021; Brilakis ES, 2013, JAMA-J AM MED ASSOC, V310, P189, DOI 10.1001/jama.2013.7086; Dehmer GJ, 2012, J AM COLL CARDIOL, V60, P2017, DOI 10.1016/j.jacc.2012.08.966; Finn AV, 2007, CIRCULATION, V115, P2435, DOI 10.1161/CIRCULATIONAHA.107.693739; Fleisher LA, 2007, J AM COLL CARDIOL, V50, P1707, DOI 10.1016/j.jacc.2007.09.001; Gandhi NK, 2011, CATHETER CARDIO INTE, V77, P972, DOI 10.1002/ccd.22744; Grines CL, 2007, CIRCULATION, V115, P813, DOI 10.1161/CIRCULATIONAHA.106.180944; Harrell FE, 2001, REGRESSION MODELING; Hawn MT, 2012, J AM COLL SURGEONS, V214, P658, DOI 10.1016/j.jamcollsurg.2011.12.011; Joner M, 2006, J AM COLL CARDIOL, V48, P193, DOI 10.1016/j.jacc.2006.03.042; Lee TH, 1999, CIRCULATION, V100, P1043, DOI 10.1161/01.CIR.100.10.1043; Malenka DJ, 2008, JAMA-J AM MED ASSOC, V299, P2868, DOI 10.1001/jama.299.24.2868; Mauri L, 2007, NEW ENGL J MED, V356, P1020, DOI 10.1056/NEJMoa067731; McFadden EP, 2004, LANCET, V364, P1519, DOI 10.1016/S0140-6736(04)17275-9; Murphy JT, 2005, ANESTH ANALG, V101, P971, DOI 10.1213/01.ANE.0000175821.42010.9F; Nasser M, 2005, CATHETER CARDIO INTE, V65, P516, DOI 10.1002/ccd.20391; Rabbitts JA, 2008, ANESTHESIOLOGY, V109, P596, DOI 10.1097/ALN.0b013e318186de1c; STOKES ME, 1991, CATEGORICAL DATA ANA; Stukel TA, 2007, JAMA-J AM MED ASSOC, V297, P278, DOI 10.1001/jama.297.3.278; To ACY, 2009, CIRC-CARDIOVASC INTE, V2, P213, DOI 10.1161/CIRCINTERVENTIONS.108.830158; Tokushige A, 2012, CIRC-CARDIOVASC INTE, V5, P237, DOI 10.1161/CIRCINTERVENTIONS.111.963728; van Kuijk JP, 2009, AM J CARDIOL, V104, P1229, DOI 10.1016/j.amjcard.2009.06.038; Vicenzi MN, 2006, BRIT J ANAESTH, V96, P686, DOI 10.1093/bja/ael083; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Wijeysundera DN, 2012, CIRCULATION, V126, P1355, DOI 10.1161/CIRCULATIONAHA.112.102715; Wood S, 2017, GEN ADDITIVE MODELS, DOI 10.1201/9781315370279	28	227	238	2	17	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 9	2013	310	14					1462	1472		10.1001/jama.2013.278787	http://dx.doi.org/10.1001/jama.2013.278787			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	230PK	24101118	Bronze			2022-12-24	WOS:000325354100022
J	Weiberg, A; Wang, M; Lin, FM; Zhao, HW; Zhang, ZH; Kaloshian, I; Huang, HD; Jin, HL				Weiberg, Arne; Wang, Ming; Lin, Feng-Mao; Zhao, Hongwei; Zhang, Zhihong; Kaloshian, Isgouhi; Huang, Hsien-Da; Jin, Hailing			Fungal Small RNAs Suppress Plant Immunity by Hijacking Host RNA Interference Pathways	SCIENCE			English	Article							PATHOGENIC FUNGUS; GENE; EFFECTORS; MICRORNAS; DIVERSE; ROLES; CELLS	Botrytis cinerea, the causative agent of gray mold disease, is an aggressive fungal pathogen that infects more than 200 plant species. Here, we show that some B. cinerea small RNAs (Bc-sRNAs) can silence Arabidopsis and tomato genes involved in immunity. These Bc-sRNAs hijack the host RNA interference (RNAi) machinery by binding to Arabidopsis Argonaute 1 (AGO1) and selectively silencing host immunity genes. The Arabidopsis ago1 mutant exhibits reduced susceptibility to B. cinerea, and the B. cinerea dcl1 dcl2 double mutant that can no longer produce these Bc-sRNAs displays reduced pathogenicity on Arabidopsis and tomato. Thus, this fungal pathogen transfers "virulent" sRNA effectors into host plant cells to suppress host immunity and achieve infection, which demonstrates a naturally occurring cross-kingdom RNAi as an advanced virulence mechanism.	[Weiberg, Arne; Wang, Ming; Zhao, Hongwei; Zhang, Zhihong; Jin, Hailing] Univ Calif Riverside, Dept Plant Pathol & Microbiol, Riverside, CA 92521 USA; [Weiberg, Arne; Wang, Ming; Zhao, Hongwei; Zhang, Zhihong; Kaloshian, Isgouhi; Jin, Hailing] Univ Calif Riverside, Ctr Plant Cell Biol, Riverside, CA 92521 USA; [Weiberg, Arne; Wang, Ming; Zhao, Hongwei; Zhang, Zhihong; Kaloshian, Isgouhi; Jin, Hailing] Univ Calif Riverside, Inst Integrat Genome Biol, Riverside, CA 92521 USA; [Lin, Feng-Mao; Huang, Hsien-Da] Natl Chiao Tung Univ, Dept Biol Sci & Technol, Hsinchu 300, Taiwan; [Zhang, Zhihong] Shenyang Agr Univ, Coll Hort, Shenyang 110866, Liaoning, Peoples R China; [Kaloshian, Isgouhi] Univ Calif Riverside, Dept Nematol, Riverside, CA 92521 USA; [Huang, Hsien-Da] Natl Chiao Tung Univ, Inst Bioinformat & Syst Biol, Hsinchu 300, Taiwan	University of California System; University of California Riverside; University of California System; University of California Riverside; University of California System; University of California Riverside; National Yang Ming Chiao Tung University; Shenyang Agricultural University; University of California System; University of California Riverside; National Yang Ming Chiao Tung University	Jin, HL (corresponding author), Univ Calif Riverside, Dept Plant Pathol & Microbiol, Riverside, CA 92521 USA.	hailingj@ucr.edu	Jin, Hailing/Z-1168-2019; Huang, Hsien-Da/AAA-7376-2019; Zhang, Zhihong/W-1011-2017; Wang, Ming/C-5276-2017; Weiberg, Arne/L-1105-2015	Jin, Hailing/0000-0001-5778-5193; Zhang, Zhihong/0000-0001-5935-1567; Wang, Ming/0000-0002-1223-3421; Weiberg, Arne/0000-0003-4300-4864	NIH [R01 GM093008]; NSF [MCB-0642843, IOS-1257576]; AES-CE award [PPA-7517H]; National Science Council of the Republic of China [NSC 101-2311-B-009-003-MY3, NSC 100-2627-B-009-002]; UST-UCSD I-RiCE Program [NSC 101-2911-I-009-101]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM093008] Funding Source: NIH RePORTER; Division Of Integrative Organismal Systems [1257576] Funding Source: National Science Foundation	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); AES-CE award; National Science Council of the Republic of China(Ministry of Science and Technology, Taiwan); UST-UCSD I-RiCE Program; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	We thank Y. Qi for AGO1 antibody; J. Carrington for the AGO1 and AGO2 tagged lines; H. Vaucheret for ago1-27 mutant; M. J. Marcote for mpk1 mpk2 seeds; and P. Karlovsky for pPK2 binary vector and A. tumefaciens strain AGL1 for B. cinerea transformation and gene knockout. This work was supported by an NIH grant (R01 GM093008), an NSF Career Award (MCB-0642843), an NSF award (IOS-1257576), and an AES-CE award (PPA-7517H) to H.J.; National Science Council of the Republic of China (NSC 101-2311-B-009-003-MY3 and NSC 100-2627-B-009-002) and UST-UCSD I-RiCE Program (NSC 101-2911-I-009-101) grants to H.-D.H.	Amselem J, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002230; Ashida H, 2011, CURR OPIN MICROBIOL, V14, P16, DOI 10.1016/j.mib.2010.08.014; Bozkurt TO, 2012, CURR OPIN PLANT BIOL, V15, P483, DOI 10.1016/j.pbi.2012.03.008; Ellendorff U, 2009, J EXP BOT, V60, P591, DOI 10.1093/jxb/ern306; Hilbi H, 2012, TRAFFIC, V13, P1187, DOI 10.1111/j.1600-0854.2012.01344.x; Jiang N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052734; Kale SD, 2010, CELL, V142, P284, DOI 10.1016/j.cell.2010.06.008; Katiyar-Agarwal S, 2010, ANNU REV PHYTOPATHOL, V48, P225, DOI 10.1146/annurev-phyto-073009-114457; Lee HC, 2010, MOL CELL, V38, P803, DOI 10.1016/j.molcel.2010.04.005; Liu YL, 2002, PLANT J, V31, P777, DOI 10.1046/j.1365-313X.2002.01394.x; Mi SJ, 2008, CELL, V133, P116, DOI 10.1016/j.cell.2008.02.034; Montgomery TA, 2008, CELL, V133, P128, DOI 10.1016/j.cell.2008.02.033; Morel JB, 2002, PLANT CELL, V14, P629, DOI 10.1105/tpc.010358; Nunes CC, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-288; Ortiz-Masia D, 2007, FEBS LETT, V581, P1834, DOI 10.1016/j.febslet.2007.03.075; Qutob D, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2354; Rafiqi M, 2012, CURR OPIN PLANT BIOL, V15, P477, DOI 10.1016/j.pbi.2012.05.003; Rafiqi M, 2010, PLANT CELL, V22, P2017, DOI 10.1105/tpc.109.072983; Raman V, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-326; Ruiz-Ferrer V, 2009, ANNU REV PLANT BIOL, V60, P485, DOI 10.1146/annurev.arplant.043008.092111; Schornack S, 2010, P NATL ACAD SCI USA, V107, P17421, DOI 10.1073/pnas.1008491107; Schwab R, 2006, PLANT CELL, V18, P1121, DOI 10.1105/tpc.105.039834; Veronese P, 2006, PLANT CELL, V18, P257, DOI 10.1105/tpc.105.035576; Wawra S, 2012, CURR OPIN MICROBIOL, V15, P685, DOI 10.1016/j.mib.2012.10.008; Wawra S, 2012, P NATL ACAD SCI USA, V109, P2096, DOI 10.1073/pnas.1113775109; Wessner B, 2010, EXERC IMMUNOL REV, V16, P22; Zhang XM, 2011, MOL CELL, V42, P356, DOI 10.1016/j.molcel.2011.04.010; Zhou JH, 2012, MOL GENET GENOMICS, V287, P275, DOI 10.1007/s00438-012-0678-8	28	662	704	43	678	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 4	2013	342	6154					118	123		10.1126/science.1239705	http://dx.doi.org/10.1126/science.1239705			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	227PP	24092744	Green Accepted			2022-12-24	WOS:000325126100059
J	Stanton, TP; Shaw, WJ; Truffer, M; Corr, HFJ; Peters, LE; Riverman, KL; Bindschadler, R; Holland, DM; Anandakrishnan, S				Stanton, T. P.; Shaw, W. J.; Truffer, M.; Corr, H. F. J.; Peters, L. E.; Riverman, K. L.; Bindschadler, R.; Holland, D. M.; Anandakrishnan, S.			Channelized Ice Melting in the Ocean Boundary Layer Beneath Pine Island Glacier, Antarctica	SCIENCE			English	Article							WEST ANTARCTICA; SHELF; SHEET	Ice shelves play a key role in the mass balance of the Antarctic ice sheets by buttressing their seaward-flowing outlet glaciers; however, they are exposed to the underlying ocean and may weaken if ocean thermal forcing increases. An expedition to the ice shelf of the remote Pine Island Glacier, a major outlet of the West Antarctic Ice Sheet that has rapidly thinned and accelerated in recent decades, has been completed. Observations from geophysical surveys and long-term oceanographic instruments deployed down bore holes into the ocean cavity reveal a buoyancy-driven boundary layer within a basal channel that melts the channel apex by 0.06 meter per day, with near-zero melt rates along the flanks of the channel. A complex pattern of such channels is visible throughout the Pine Island Glacier shelf.	[Stanton, T. P.; Shaw, W. J.] Naval Postgrad Sch, Dept Oceanog, Monterey, CA 93943 USA; [Truffer, M.] Univ Alaska, Inst Geophys, Fairbanks, AK 99775 USA; [Corr, H. F. J.] British Antarctic Survey, Cambridge CB3 OET, England; [Peters, L. E.; Riverman, K. L.; Anandakrishnan, S.] Penn State Univ, Dept Geosci, University Pk, PA 16802 USA; [Peters, L. E.; Riverman, K. L.; Anandakrishnan, S.] Penn State Univ, Earth & Environm Syst Inst, University Pk, PA 16802 USA; [Bindschadler, R.] NASA, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA; [Holland, D. M.] NYU, Dept Math, New York, NY 10012 USA	United States Department of Defense; United States Navy; Naval Postgraduate School; University of Alaska System; University of Alaska Fairbanks; UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); NERC British Antarctic Survey; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; New York University	Stanton, TP (corresponding author), Naval Postgrad Sch, Dept Oceanog, Monterey, CA 93943 USA.	stanton@nps.edu			NSF's Office of Polar Programs under NSF [ANT-0732926]; NASA's Cryospheric Sciences Program; New York University Abhu Dabi grant [1204]; Natural Environment Research Council-British Antarctic Survey Polar Science for Planet Earth Program; Natural Environment Research Council [bas0100027] Funding Source: researchfish	NSF's Office of Polar Programs under NSF; NASA's Cryospheric Sciences Program(National Aeronautics & Space Administration (NASA)); New York University Abhu Dabi grant; Natural Environment Research Council-British Antarctic Survey Polar Science for Planet Earth Program; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	Data presented here are archived with the supplementary materials and also as a MATLAB data structure at www.oc.nps.edu/similar to stanton/pig/data/data.html/PIGSITE1_first35days. The authors acknowledge the contributions of J. Stockel in software development and deployment of the ocean instruments, D. Pomraning in designing and manning the hot-water drill equipment, and M. Shortt for making the British Antarctic Survey pRES field measurements. Outstanding logistic and safety support was provided by K. Gibbon, D. Einerson, E. Steinarsson, F. Mcarthy, S. Consalvi, the PIG support camp personnel, and the NSF Antarctic support team. This research project was supported by NSF's Office of Polar Programs under NSF grants including ANT-0732926, funding from NASA's Cryospheric Sciences Program, New York University Abhu Dabi grant 1204, and the Natural Environment Research Council-British Antarctic Survey Polar Science for Planet Earth Program.	Bamber JL, 2009, SCIENCE, V324, P901, DOI 10.1126/science.1169335; Bindschadler R, 2011, CRYOSPHERE, V5, P569, DOI 10.5194/tc-5-569-2011; Bindschadler R, 2011, J GLACIOL, V57, P581, DOI 10.3189/002214311797409802; Dutrieux P., 2013, CRYOSPHERE DISCUSS, V7, P1591; Gladish CV, 2012, J GLACIOL, V58, P1227, DOI 10.3189/2012JoG12J003; Haran T., 2005, MODERATE RESOLUTION; Jacobs SS, 1996, GEOPHYS RES LETT, V23, P957, DOI 10.1029/96GL00723; Jacobs SS, 2011, NAT GEOSCI, V4, P519, DOI [10.1038/NGEO1188, 10.1038/ngeo1188]; Jenkins A, 2010, NAT GEOSCI, V3, P468, DOI 10.1038/NGEO890; Payne AJ, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL021284; Pritchard HD, 2009, NATURE, V461, P971, DOI 10.1038/nature08471; Rignot E, 2011, SCIENCE, V333, P1427, DOI 10.1126/science.1208336; Rignot E, 2008, NAT GEOSCI, V1, P106, DOI 10.1038/ngeo102; Shepherd A, 2001, SCIENCE, V291, P862, DOI 10.1126/science.291.5505.862; Trowbridge JH, 1998, J PHYS OCEANOGR, V28, P2075, DOI 10.1175/1520-0485(1998)028<2075:DOTBBL>2.0.CO;2; Vaughan DG, 2012, J GEOPHYS RES-EARTH, V117, DOI 10.1029/2012JF002360; Wingham DJ, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL039126	17	72	73	1	50	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 13	2013	341	6151					1236	1239		10.1126/science.1239373	http://dx.doi.org/10.1126/science.1239373			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	215ZA	24031016				2022-12-24	WOS:000324248800042
J	Magny, EG; Pueyo, JI; Pearl, FMG; Cespedes, MA; Niven, JE; Bishop, SA; Couso, JP				Magny, Emile G.; Pueyo, Jose Ignacio; Pearl, Frances M. G.; Cespedes, Miguel Angel; Niven, Jeremy E.; Bishop, Sarah A.; Couso, Juan Pablo			Conserved Regulation of Cardiac Calcium Uptake by Peptides Encoded in Small Open Reading Frames	SCIENCE			English	Article							SARCOPLASMIC-RETICULUM; SARCOLIPIN; PHOSPHOLAMBAN; DROSOPHILA; TRANSPORT; CONTRACTILITY; SHAVENBABY; REVEALS; SERCA	Small open reading frames (smORFs) are short DNA sequences that are able to encode small peptides of less than 100 amino acids. Study of these elements has been neglected despite thousands existing in our genomes. We and others previously showed that peptides as short as 11 amino acids are translated and provide essential functions during insect development. Here, we describe two peptides of less than 30 amino acids regulating calcium transport, and hence influencing regular muscle contraction, in the Drosophila heart. These peptides seem conserved for more than 550 million years in a range of species from flies to humans, in which they have been implicated in cardiac pathologies. Such conservation suggests that the mechanisms for heart regulation are ancient and that smORFs may be a fundamental genome component that should be studied systematically.	[Magny, Emile G.; Pueyo, Jose Ignacio; Pearl, Frances M. G.; Cespedes, Miguel Angel; Niven, Jeremy E.; Bishop, Sarah A.; Couso, Juan Pablo] Univ Sussex, Sch Life Sci, Brighton BN1 9QG, E Sussex, England; [Pearl, Frances M. G.] Inst Canc Res, Div Canc Therapeut, Sutton SM2 5NG, Surrey, England	University of Sussex; University of London; Institute of Cancer Research - UK	Couso, JP (corresponding author), Univ Sussex, Sch Life Sci, Brighton BN1 9QG, E Sussex, England.	j.p.couso@sussex.ac.uk	Couso, Juan Pablo/ABH-5860-2020	Pearl, Frances/0000-0002-8210-4393; Pueyo, Jose Ignacio/0000-0002-4255-1850; Magny, Emile/0000-0001-7553-7097	Conacyt; Daphne Jackson Fellowship; UK Medical Research Council; Royal Society University Fellowship; Wellcome Trust Fellowship [087516]	Conacyt(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Daphne Jackson Fellowship; UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Royal Society University Fellowship(Royal Society of London); Wellcome Trust Fellowship(Wellcome Trust)	We thank Rose Phillips, Roger Phillips, and J. Thorpe for technical support; M. Ramaswami for the antibody to Ca-P60A; and F. Casares, M. Baylies, I. Galindo, C. Alonso, and laboratory members for manuscript comments. E. M. was supported by Conacyt, F. P. was supported by a Daphne Jackson Fellowship and the UK Medical Research Council, and J.N. was supported by a Royal Society University Fellowship. Otherwise, this work was funded by a Wellcome Trust Fellowship (ref 087516) awarded to J. P. C. The GenBank accession number for Drosophila Scl sequences is NR_001662.	Asahi M, 2003, P NATL ACAD SCI USA, V100, P5040, DOI 10.1073/pnas.0330962100; Babu GJ, 2006, J BIOL CHEM, V281, P3972, DOI 10.1074/jbc.M508998200; Babu GJ, 2007, P NATL ACAD SCI USA, V104, P17867, DOI 10.1073/pnas.0707722104; Basrai MA, 1997, GENOME RES, V7, P768, DOI 10.1101/gr.7.8.768; Bhupathy P, 2007, J MOL CELL CARDIOL, V42, P903, DOI 10.1016/j.yjmcc.2007.03.738; Galindo MI, 2007, PLOS BIOL, V5, P1052, DOI 10.1371/journal.pbio.0050106; Ingolia NT, 2011, CELL, V147, P789, DOI 10.1016/j.cell.2011.10.002; Kondo T, 2010, SCIENCE, V329, P336, DOI 10.1126/science.1188158; Ladoukakis E, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-11-r118; Nekrutenko A, 2002, GENOME RES, V12, P198, DOI 10.1101/gr.200901; Oxenoid K, 2005, P NATL ACAD SCI USA, V102, P10870, DOI 10.1073/pnas.0504920102; Periasamy M, 2007, MUSCLE NERVE, V35, P430, DOI 10.1002/mus.20745; Pueyo JI, 2011, DEV BIOL, V355, P183, DOI 10.1016/j.ydbio.2011.03.033; Razzaq R. I., 2001, GENE DEV, V15, P22; Savard J, 2006, CELL, V126, P559, DOI 10.1016/j.cell.2006.05.053; Shanmugam M, 2011, BIOCHEM BIOPH RES CO, V410, P97, DOI 10.1016/j.bbrc.2011.05.113; Tupy JL, 2005, P NATL ACAD SCI USA, V102, P5495, DOI 10.1073/pnas.0501422102; WAWRZYNOW A, 1992, ARCH BIOCHEM BIOPHYS, V298, P620, DOI 10.1016/0003-9861(92)90457-8	18	226	246	2	66	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 6	2013	341	6150					1116	1120		10.1126/science.1238802	http://dx.doi.org/10.1126/science.1238802			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	211TG	23970561				2022-12-24	WOS:000323933100046
J	Abe-Ouchi, A; Saito, F; Kawamura, K; Raymo, ME; Okuno, J; Takahashi, K; Blatter, H				Abe-Ouchi, Ayako; Saito, Fuyuki; Kawamura, Kenji; Raymo, Maureen E.; Okuno, Jun'ichi; Takahashi, Kunio; Blatter, Heinz			Insolation-driven 100,000-year glacial cycles and hysteresis of ice-sheet volume	NATURE			English	Article							CARBON-DIOXIDE; CLIMATE; MODEL; SYSTEM; SIMULATIONS; TEMPERATURE; GROWTH; PHASE	The growth and reduction of Northern Hemisphere ice sheets over the past million years is dominated by an approximately 100,000-year periodicity and a sawtooth pattern(1,2) (gradual growth and fast termination). Milankovitch theory proposes that summer insolation at high northern latitudes drives the glacial cycles(3), and statistical tests have demonstrated that the glacial cycles are indeed linked to eccentricity, obliquity and precession cycles(4,5). Yet insolation alone cannot explain the strong 100,000-year cycle, suggesting that internal climatic feedbacks may also be at work(4-7). Earlier conceptual models, for example, showed that glacial terminations are associated with the build-up of Northern Hemisphere 'excess ice'(5,8-10), but the physical mechanisms underpinning the 100,000-year cycle remain unclear. Here we show, using comprehensive climate and ice-sheet models, that insolation and internal feedbacks between the climate, the ice sheets and the lithosphere-asthenosphere system explain the 100,000-year periodicity. The responses of equilibrium states of ice sheets to summer insolation show hysteresis(11-13), with the shape and position of the hysteresis loop playing a key part in determining the periodicities of glacial cycles. The hysteresis loop of the North American ice sheet is such that after inception of the ice sheet, its mass balance remains mostly positive through several precession cycles, whose amplitudes decrease towards an eccentricity minimum. The larger the ice sheet grows and extends towards lower latitudes, the smaller is the insolation required to make the mass balance negative. Therefore, once a large ice sheet is established, a moderate increase in insolation is sufficient to trigger a negative mass balance, leading to an almost complete retreat of the ice sheet within several thousand years. This fast retreat is governed mainly by rapid ablation due to the lowered surface elevation resulting from delayed isostatic rebound(14-16), which is the lithosphere-asthenosphere response. Carbon dioxide is involved, but is not determinative, in the evolution of the 100,000-year glacial cycles.	[Abe-Ouchi, Ayako; Okuno, Jun'ichi; Blatter, Heinz] Univ Tokyo, Atmosphere & Ocean Res Inst, Kashiwa, Chiba 2778568, Japan; [Abe-Ouchi, Ayako; Saito, Fuyuki; Okuno, Jun'ichi; Takahashi, Kunio] Japan Agcy Marine Earth Sci & Technol, Res Inst Global Change, Yokohama, Kanagawa 2360001, Japan; [Abe-Ouchi, Ayako; Kawamura, Kenji; Okuno, Jun'ichi] Natl Inst Polar Res, Tachikawa, Tokyo 1908518, Japan; [Kawamura, Kenji] Japan Agcy Marine Earth Sci & Technol, Inst Biogeosci, Yokosuka, Kanagawa 2370061, Japan; [Raymo, Maureen E.] Columbia Univ, Lamont Doherty Earth Observ, Palisades, NY 10964 USA; [Blatter, Heinz] ETH, Inst Atmospher & Climate Sci, CH-8092 Zurich, Switzerland	University of Tokyo; Japan Agency for Marine-Earth Science & Technology (JAMSTEC); Research Organization of Information & Systems (ROIS); National Institute of Polar Research (NIPR) - Japan; Japan Agency for Marine-Earth Science & Technology (JAMSTEC); Columbia University; Swiss Federal Institutes of Technology Domain; ETH Zurich	Abe-Ouchi, A (corresponding author), Univ Tokyo, Atmosphere & Ocean Res Inst, Kashiwa, Chiba 2778568, Japan.	abeouchi@aori.u-tokyo.ac.jp	Abe-Ouchi, Ayako/M-6359-2013; SAITO, Fuyuki/B-8776-2013; Raymo, Maureen E/A-1270-2012; Kawamura, Kenji/C-7660-2011	Abe-Ouchi, Ayako/0000-0003-1745-5952; SAITO, Fuyuki/0000-0001-5935-9614; Kawamura, Kenji/0000-0003-1163-700X	JSPS KAKENHI [25241005, 22101005, 21671001]; MEXT, Japan; Ministry of the Environment, Japan [S-10]; Grants-in-Aid for Scientific Research [22101005, 22221002, 21671001] Funding Source: KAKEN	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); MEXT, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of the Environment, Japan(Ministry of the Environment, Japan); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	Discussions with numerous people including M. Kimoto, J. Hargreaves, M. Yoshimori, J. Annan, F.-F. Jin and W.-L. Chan contributed to this work. M. Ichino and T. Segawa provided technical support. We thank the MIROC group for continuous development and support of the MIROC GCM. The numerical experiments were carried out on the NIES supercomputer system (NEC SX-8R/128M16) and the JAMSTEC Earth Simulator. This research was supported by JSPS KAKENHI grants 25241005, 22101005 and 21671001, the Global COE Program grant "From the Earth to 'Earths'", MEXT, Japan, and the Environment Research and Technology Development Fund (S-10) of the Ministry of the Environment, Japan.	Abe-Ouchi A, 2007, CLIM PAST, V3, P423, DOI 10.5194/cp-3-423-2007; ABE-OUCHI A, 1993, ANN GLACIOL-SER, V18, P203, DOI 10.1017/S0260305500011514; Berger A, 1998, CLIM DYNAM, V14, P615, DOI 10.1007/s003820050245; BERGER AL, 1978, J ATMOS SCI, V35, P2362, DOI [10.1175/1520-0469(1978)035<2362:LTVODI>2.0.CO;2, 10.1016/0033-5894(78)90064-9]; Braconnot P, 2012, NAT CLIM CHANGE, V2, P417, DOI 10.1038/NCLIMATE1456; Calov R, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL024518; Calov R, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2002GL016078; Clark PU, 2009, SCIENCE, V325, P710, DOI 10.1126/science.1172873; Claussen M, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL026111; Crucifix M, 2001, EARTH PLANET SC LETT, V184, P623, DOI 10.1016/S0012-821X(00)00361-7; Deblonde G, 1992, PALAEOGEOGR PALAEOCL, V98, P37, DOI 10.1016/0031-0182(92)90255-4; Ganopolski A, 2011, CLIM PAST, V7, P1415, DOI 10.5194/cp-7-1415-2011; Ganopolski A, 2009, QUATERNARY SCI REV, V28, P3361, DOI 10.1016/j.quascirev.2009.09.019; Gregoire LJ, 2012, NATURE, V487, P219, DOI 10.1038/nature11257; HAYS JD, 1976, SCIENCE, V194, P1121, DOI 10.1126/science.194.4270.1121; He F, 2013, NATURE, V494, P81, DOI 10.1038/nature11822; Huybers P, 2011, NATURE, V480, P229, DOI 10.1038/nature10626; Kawamura K, 2007, NATURE, V448, P912, DOI 10.1038/nature06015; Kurahashi-Nakamura T, 2010, CLIM DYNAM, V35, P713, DOI 10.1007/s00382-009-0609-5; Laske G., 1997, EOS T AM GEOPHYSICAL, V78, pF483; LISIECKI LE, 2005, PALEOCEANOGRAPHY, V0020; Lisiecki LE, 2010, NAT GEOSCI, V3, P349, DOI 10.1038/NGEO828; Marshall SJ, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2002GL015192; Milankovitch M., 1941, KANON ERDBESTRAHLUNG; OERLEMANS J, 1980, NATURE, V287, P430, DOI 10.1038/287430a0; Okada Y., 2008, THESIS U TOKYO; Okuno J, 2001, EARTH PLANETS SPACE, V53, P1121, DOI 10.1186/BF03352408; Paillard D, 1998, NATURE, V391, P378, DOI 10.1038/34891; Paillard D, 2004, EARTH PLANET SC LETT, V227, P263, DOI 10.1016/j.epsl.2004.08.023; Parrenin F, 2003, EARTH PLANET SC LETT, V214, P243, DOI 10.1016/S0012-821X(03)00363-7; PELTIER WR, 1995, J GEOPHYS RES-ATMOS, V100, P14269, DOI 10.1029/95JD00015; Petit JR, 1999, NATURE, V399, P429, DOI 10.1038/20859; Pollard D, 2005, GLOBAL PLANET CHANGE, V45, P9, DOI 10.1016/j.gloplacha.2004.09.011; POLLARD D, 1982, NATURE, V296, P334, DOI 10.1038/296334a0; POLLARD D., 1984, MILANKOVITCH CLIMA 2, P541; Pollard D, 2010, CLIMATIC CHANGE, V100, P173, DOI 10.1007/s10584-010-9830-9; Pollard D, 2009, NATURE, V458, P329, DOI 10.1038/nature07809; Raymo ME, 1997, PALEOCEANOGRAPHY, V12, P577, DOI 10.1029/97PA01169; REEH N, 1991, POLARFORSCHUNG, V0059; SALTZMAN B, 1984, J ATMOS SCI, V41, P3380, DOI 10.1175/1520-0469(1984)041<3380:TLQGAT>2.0.CO;2; Shackleton NJ, 2000, SCIENCE, V289, P1897, DOI 10.1126/science.289.5486.1897; Tziperman E, 2006, PALEOCEANOGRAPHY, V21, DOI 10.1029/2005PA001241	42	227	234	3	194	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 8	2013	500	7461					190	+		10.1038/nature12374	http://dx.doi.org/10.1038/nature12374			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	197CH	23925242	Green Published			2022-12-24	WOS:000322825500031
J	Rompolas, P; Mesa, KR; Greco, V				Rompolas, Panteleimon; Mesa, Kailin R.; Greco, Valentina			Spatial organization within a niche as a determinant of stem-cell fate	NATURE			English	Article							HAIR FOLLICLE BULGE; LABEL-RETAINING CELLS; SELF-RENEWAL; WOUND REPAIR; IN-VIVO; HOMEOSTASIS; DISTINCT; SKIN; LGR5; IDENTIFICATION	Stem-cell niches in mammalian tissues are often heterogeneous and compartmentalized; however, whether distinct niche locations determine different stem-cell fates remains unclear. To test this hypothesis, here we use the mouse hair follicle niche and combine intravital microscopy with genetic lineage tracing to re-visit the same stem-cell lineages, from their exact place of origin, throughout regeneration in live mice. Using this method, we show directly that the position of a stem cell within the hair follicle niche can predict whether it is likely to remain uncommitted, generate precursors or commit to a differentiated fate. Furthermore, using laser ablation we demonstrate that hair follicle stem cells are dispensable for regeneration, and that epithelial cells, which do not normally participate in hair growth, re-populate the lost stem-cell compartment and sustain hair regeneration. This study provides a general model for niche-induced fate determination in adult tissues.	[Rompolas, Panteleimon; Mesa, Kailin R.; Greco, Valentina] Yale Univ, Sch Med, Dept Genet, Dept Dermatol,Yale Stem Cell Ctr,Yale Canc Ctr, New Haven, CT 06510 USA	Yale University	Greco, V (corresponding author), Yale Univ, Sch Med, Dept Genet, Dept Dermatol,Yale Stem Cell Ctr,Yale Canc Ctr, New Haven, CT 06510 USA.	valentina.greco@yale.edu		Rompolas, Panteleimon/0000-0001-9135-7651; Mesa, Kailin/0000-0003-4452-9048	New York Stem Cell Foundation; American Cancer Society [RGS-12-059-01-DCC]; National Institute of Arthritis and Musculoskeletal and Skin Diseases [1RO1AR063663-01]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR063663] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007223] Funding Source: NIH RePORTER	New York Stem Cell Foundation; American Cancer Society(American Cancer Society); National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to S. King, S. Guo and A. Horwich for critical feedback on the manuscript. We thank E. Fuchs for the K14-H2BGFP, Lef1-RFP and pTRE-H2BGFP mice, A. Glick for the K5-tTA mice and G. Gu for the K19-CreER mice. We thank D. Gonzalez and A. Haberman for technical support with intravital microscopy. P. R. is a New York Stem Cell Foundation-Druckenmiller Fellow. This work was supported by The New York Stem Cell Foundation and by grants to V. G. from the American Cancer Society (RGS-12-059-01-DCC) and the National Institute of Arthritis and Musculoskeletal and Skin Diseases (1RO1AR063663-01).	Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Barroca V, 2009, NAT CELL BIOL, V11, P190, DOI 10.1038/ncb1826; Blanpain C, 2004, CELL, V118, P635, DOI 10.1016/j.cell.2004.08.012; Buczacki SJA, 2013, NATURE, V495, P65, DOI 10.1038/nature11965; Chi W, 2013, DEVELOPMENT, V140, P1676, DOI 10.1242/dev.090662; Claudinot S, 2005, P NATL ACAD SCI USA, V102, P14677, DOI 10.1073/pnas.0507250102; Copley MR, 2012, CELL STEM CELL, V10, P690, DOI 10.1016/j.stem.2012.05.006; COTSARELIS G, 1990, CELL, V61, P1329, DOI 10.1016/0092-8674(90)90696-C; Diamond I, 2000, J INVEST DERMATOL, V115, P788, DOI 10.1046/j.1523-1747.2000.00144.x; Ding L, 2013, NATURE, V495, P231, DOI 10.1038/nature11885; Fuchs E, 2009, CELL, V137, P811, DOI 10.1016/j.cell.2009.05.002; Greco V, 2010, DEVELOPMENT, V137, P1585, DOI 10.1242/dev.041103; Greco V, 2009, CELL STEM CELL, V4, P155, DOI 10.1016/j.stem.2008.12.009; Greenbaum A, 2013, NATURE, V495, P227, DOI 10.1038/nature11926; Hsu YC, 2011, CELL, V144, P92, DOI 10.1016/j.cell.2010.11.049; Ito M, 2005, NAT MED, V11, P1351, DOI 10.1038/nm1328; Ito M, 2004, DIFFERENTIATION, V72, P548, DOI 10.1111/j.1432-0436.2004.07209008.x; JAHODA CAB, 1984, NATURE, V311, P560, DOI 10.1038/311560a0; Jaks V, 2008, NAT GENET, V40, P1291, DOI 10.1038/ng.239; Kaufman CK, 2003, GENE DEV, V17, P2108, DOI 10.1101/gad.1115203; Kopp HG, 2005, PHYSIOLOGY, V20, P349, DOI 10.1152/physiol.00025.2005; Legue E, 2005, DEVELOPMENT, V132, P4143, DOI 10.1242/dev.01975; Li LH, 2010, SCIENCE, V327, P542, DOI 10.1126/science.1180794; Liu YP, 2003, J INVEST DERMATOL, V121, P963, DOI 10.1046/j.1523-1747.2003.12600.x; Lo Celso C, 2009, NATURE, V457, P92, DOI 10.1038/nature07434; Lopez-Garcia C, 2010, SCIENCE, V330, P822, DOI 10.1126/science.1196236; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Means AL, 2008, GENESIS, V46, P318, DOI 10.1002/dvg.20397; Morris RJ, 2004, NAT BIOTECHNOL, V22, P411, DOI 10.1038/nbt950; Muller-Rover S, 2001, J INVEST DERMATOL, V117, P3, DOI 10.1046/j.0022-202x.2001.01377.x; Nystul T, 2007, CELL STEM CELL, V1, P277, DOI 10.1016/j.stem.2007.07.009; Plikus MV, 2012, SEMIN CELL DEV BIOL, V23, P946, DOI 10.1016/j.semcdb.2012.10.001; Rendl M, 2005, PLOS BIOL, V3, P1910, DOI 10.1371/journal.pbio.0030331; Rompolas P, 2012, NATURE, V487, P496, DOI 10.1038/nature11218; Sangiorgi E, 2008, NAT GENET, V40, P915, DOI 10.1038/ng.165; Sato T, 2009, NAT MED, V15, P696, DOI 10.1038/nm.1973; Scadden DT, 2006, NATURE, V441, P1075, DOI 10.1038/nature04957; Sequeira I, 2012, DEVELOPMENT, V139, P3741, DOI 10.1242/dev.081091; Snippert HJ, 2010, CELL, V143, P134, DOI 10.1016/j.cell.2010.09.016; Spradling AC, 2008, COLD SH Q B, V73, P49, DOI 10.1101/sqb.2008.73.023; Takeda N, 2011, SCIENCE, V334, P1420, DOI 10.1126/science.1213214; Trempus CS, 2003, J INVEST DERMATOL, V120, P501, DOI 10.1046/j.1523-1747.2003.12088.x; Tumbar T, 2004, SCIENCE, V303, P359, DOI 10.1126/science.1092436; Van Keymeulen A, 2012, J CELL BIOL, V197, P575, DOI 10.1083/jcb.201201041; Vasioukhin V, 1999, P NATL ACAD SCI USA, V96, P8551, DOI 10.1073/pnas.96.15.8551; Wilson A, 2008, CELL, V135, P1118, DOI 10.1016/j.cell.2008.10.048; Xie YC, 2009, NATURE, V457, P97, DOI 10.1038/nature07639; Youssef KK, 2010, NAT CELL BIOL, V12, P299, DOI 10.1038/ncb2031; Zhang YV, 2009, CELL STEM CELL, V5, P267, DOI 10.1016/j.stem.2009.06.004	49	269	272	1	65	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 24	2013	502	7472					513	+		10.1038/nature12602	http://dx.doi.org/10.1038/nature12602			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	238YN	24097351	Green Published, Green Accepted			2022-12-24	WOS:000325988400046
J	Deshmukh, VA; Tardif, V; Lyssiotis, CA; Green, CC; Kerman, B; Kim, HJ; Padmanabhan, K; Swoboda, JG; Ahmad, I; Kondo, T; Gage, FH; Theofilopoulos, AN; Lawson, BR; Schultz, PG; Lairson, LL				Deshmukh, Vishal A.; Tardif, Virginie; Lyssiotis, Costas A.; Green, Chelsea C.; Kerman, Bilal; Kim, Hyung Joon; Padmanabhan, Krishnan; Swoboda, Jonathan G.; Ahmad, Insha; Kondo, Toru; Gage, Fred H.; Theofilopoulos, Argyrios N.; Lawson, Brian R.; Schultz, Peter G.; Lairson, Luke L.			A regenerative approach to the treatment of multiple sclerosis	NATURE			English	Article							EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; MUSCARINIC RECEPTOR SUBTYPES; CENTRAL-NERVOUS-SYSTEM; EMBRYONIC STEM-CELLS; OLIGODENDROCYTE DIFFERENTIATION; PROGENITOR CELLS; THYROID-HORMONE; PRECURSOR CELLS; MYELIN REPAIR; SPINAL-CORD	Progressive phases of multiple sclerosis are associated with inhibited differentiation of the progenitor cell population that generates the mature oligodendrocytes required for remyelination and disease remission. To identify selective inducers of oligodendrocyte differentiation, we performed an image-based screen for myelin basic protein (MBP) expression using primary rat optic-nerve-derived progenitor cells. Here we show that among the most effective compounds identifed was benztropine, which significantly decreases clinical severity in the experimental autoimmune encephalomyelitis (EAE) model of relapsing-remitting multiple sclerosis when administered alone or in combination with approved immunosuppressive treatments for multiple sclerosis. Evidence from a cuprizone-inducedmodel of demyelination, in vitro and in vivo T-cell assays and EAE adoptive transfer experiments indicated that the observed efficacy of this drug results directly from an enhancement of remyelination rather than immune suppression. Pharmacological studies indicate that benztropine functions by a mechanism that involves direct antagonism of M1 and/or M3 muscarinic receptors. These studies should facilitate the development of effective new therapies for the treatment of multiple sclerosis that complement established immunosuppressive approaches.	[Deshmukh, Vishal A.; Lyssiotis, Costas A.; Green, Chelsea C.; Swoboda, Jonathan G.; Ahmad, Insha; Schultz, Peter G.; Lairson, Luke L.] Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA; [Tardif, Virginie; Theofilopoulos, Argyrios N.; Lawson, Brian R.] Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA; [Kerman, Bilal; Kim, Hyung Joon; Padmanabhan, Krishnan; Gage, Fred H.] Salk Inst Biol Sci, Lab Genet, La Jolla, CA 92037 USA; [Kondo, Toru] Hokkaido Univ, Inst Med Genet, Div Stem Cell Biol, Kita Ku, Sapporo, Hokkaido 0600815, Japan; [Schultz, Peter G.; Lairson, Luke L.] Calif Inst Biomed Res, La Jolla, CA 92037 USA	Scripps Research Institute; Scripps Research Institute; Salk Institute; Hokkaido University	Lawson, BR (corresponding author), Scripps Res Inst, Dept Immunol & Microbial Sci, 10550 North Torrey Pines Rd, La Jolla, CA 92037 USA.	blawson@scripps.edu; schultz@scripps.edu; llairson@scripps.edu	Lyssiotis, Costas A/AAI-1923-2019; TARDIF, Virginie/U-4383-2019; Tardif, Virginie/M-9665-2019; Kerman, Bilal Ersen/W-7237-2019	Lyssiotis, Costas A/0000-0001-9309-6141; TARDIF, Virginie/0000-0001-5604-6524; Kerman, Bilal Ersen/0000-0003-1106-3288; Lairson, Luke/0000-0001-6701-996X	Skaggs Institute for Chemical Biology; California Institute for Regenerative Medicine [TR3-05617, TG2-01165]; National Science Foundation; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R21AR065384, R01AR053228, R37AR039555] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R00MH101634, K99MH101634] Funding Source: NIH RePORTER	Skaggs Institute for Chemical Biology; California Institute for Regenerative Medicine(California Institute for Regenerative Medicine); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by the Skaggs Institute for Chemical Biology and the California Institute for Regenerative Medicine grant TR3-05617 (to P. G. S), the California Institute for Regenerative Medicine (TG2-01165) and National Science Foundation pre-doctoral fellowships (to V. A. D and C. A. L, respectively). We are grateful to T. Hasnat, M. Chadwell, W. Kiosses and M. Wood for technical support. This is manuscript number 21786 of The Scripps Research Institute.	Agoston GE, 1997, J MED CHEM, V40, P4329, DOI 10.1021/jm970525a; Aharoni R, 2011, J AUTOIMMUN, V37, P228, DOI 10.1016/j.jaut.2011.06.003; Baer AS, 2009, BRAIN, V132, P465, DOI 10.1093/brain/awn334; BARRES BA, 1992, CELL, V70, P31, DOI 10.1016/0092-8674(92)90531-G; BARRES BA, 1994, DEVELOPMENT, V120, P1097; Belachew S, 2003, J CELL BIOL, V161, P169, DOI 10.1083/jcb.200210110; Billon N, 2001, DEV BIOL, V235, P110, DOI 10.1006/dbio.2001.0293; Brinkmann V, 2002, J BIOL CHEM, V277, P21453, DOI 10.1074/jbc.C200176200; Buckley CE, 2010, NEUROPHARMACOLOGY, V59, P149, DOI 10.1016/j.neuropharm.2010.04.014; Calza L, 2010, J MOL ENDOCRINOL, V44, P13, DOI 10.1677/JME-09-0067; Chang A, 2002, NEW ENGL J MED, V346, P165, DOI 10.1056/NEJMoa010994; Chari DM, 2003, J NEUROSCI RES, V73, P787, DOI 10.1002/jnr.10700; De Angelis F, 2012, DEV NEUROBIOL, V72, P713, DOI 10.1002/dneu.20976; Durelli L, 2002, LANCET, V359, P1453, DOI 10.1016/S0140-6736(02)08430-1; ESHLEMAN AJ, 1994, MOL PHARMACOL, V45, P312; FELDER CC, 1995, FASEB J, V9, P619, DOI 10.1096/fasebj.9.8.7768353; Fernandez M, 2004, P NATL ACAD SCI USA, V101, P16363, DOI 10.1073/pnas.0407262101; Franklin RJM, 2002, NAT REV NEUROSCI, V3, P705, DOI 10.1038/nrn917; Franklin RJM, 2008, NAT REV NEUROSCI, V9, P839, DOI 10.1038/nrn2480; GARD AL, 1990, NEURON, V5, P615, DOI 10.1016/0896-6273(90)90216-3; Gaspard N, 2009, NAT PROTOC, V4, P1454, DOI 10.1038/nprot.2009.157; Gensert JM, 1997, NEURON, V19, P197, DOI 10.1016/S0896-6273(00)80359-1; HART IK, 1989, J CELL BIOL, V109, P3411, DOI 10.1083/jcb.109.6.3411; Horner PJ, 2000, J NEUROSCI, V20, P2218; Huang JK, 2011, NAT NEUROSCI, V14, P45, DOI 10.1038/nn.2702; Ibanez C, 2003, PROG NEUROBIOL, V71, P49, DOI 10.1016/j.pneurobio.2003.09.002; Izrael M, 2007, MOL CELL NEUROSCI, V34, P310, DOI 10.1016/j.mcn.2006.11.008; Joubert L, 2010, J NEUROSCI RES, V88, P2546, DOI 10.1002/jnr.22434; Kappos L, 2006, NEW ENGL J MED, V355, P1124, DOI 10.1056/NEJMoa052643; Kawashima K, 2008, J PHARMACOL SCI, V106, P167, DOI 10.1254/jphs.FM0070073; Kondo T, 2000, EMBO J, V19, P1998, DOI 10.1093/emboj/19.9.1998; Kremer D, 2011, ANN NEUROL, V69, P602, DOI 10.1002/ana.22415; Kuhlmann T, 2008, BRAIN, V131, P1749, DOI 10.1093/brain/awn096; Lawson BR, 2007, J IMMUNOL, V178, P5366, DOI 10.4049/jimmunol.178.8.5366; Liu LP, 2010, J NEUROSCI, V30, P9074, DOI 10.1523/JNEUROSCI.1238-10.2010; Matsushima GK, 2001, BRAIN PATHOL, V11, P107; MCKEARNEY JW, 1982, PSYCHOPHARMACOLOGY, V77, P156, DOI 10.1007/BF00431939; Mi S, 2007, NAT MED, V13, P1228, DOI 10.1038/nm1664; Mix E, 2008, J NEUROL, V255, P7, DOI 10.1007/s00415-008-6003-0; NORONHA A, 1993, J NEUROIMMUNOL, V46, P145, DOI 10.1016/0165-5728(93)90244-S; Nunes MC, 2003, NAT MED, V9, P439, DOI 10.1038/nm837; OWENS T, 1995, NEUROL CLIN, V13, P51, DOI 10.1016/S0733-8619(18)30061-6; Pang Y, 2012, BRAIN BEHAV, V2, P53, DOI 10.1002/brb3.33; Patel JR, 2011, FEBS LETT, V585, P3730, DOI 10.1016/j.febslet.2011.04.037; Pfeiffer Steve E., 1993, Trends in Cell Biology, V3, P191, DOI 10.1016/0962-8924(93)90213-K; Ragheb F, 2001, J NEUROCHEM, V77, P1396, DOI 10.1046/j.1471-4159.2001.00356.x; Steelman AJ, 2012, NEUROSCI RES, V72, P32, DOI 10.1016/j.neures.2011.10.002; Steinman L, 2005, TRENDS IMMUNOL, V26, P565, DOI 10.1016/j.it.2005.08.014; Stern JNH, 2010, P NATL ACAD SCI USA, V107, P17280, DOI 10.1073/pnas.1010263107; Stidworthy MF, 2004, BRAIN, V127, P1928, DOI 10.1093/brain/awh217; Taveggia C, 2010, NAT REV NEUROL, V6, P276, DOI 10.1038/nrneurol.2010.37; Tokumoto YM, 2001, EMBO J, V20, P5261, DOI 10.1093/emboj/20.18.5261; Wang SL, 2001, NEURON, V29, P603, DOI 10.1016/S0896-6273(01)00237-9; Wolswijk G, 1998, J NEUROSCI, V18, P601	54	336	351	6	162	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 17	2013	502	7471					327	+		10.1038/nature12647	http://dx.doi.org/10.1038/nature12647			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	235GY	24107995	Green Accepted			2022-12-24	WOS:000325706300044
J	Saini, N; Ramakrishnan, S; Elango, R; Ayyar, S; Zhang, Y; Deem, A; Ira, G; Haber, JE; Lobachev, KS; Malkova, A				Saini, Natalie; Ramakrishnan, Sreejith; Elango, Rajula; Ayyar, Sandeep; Zhang, Yu; Deem, Angela; Ira, Grzegorz; Haber, James E.; Lobachev, Kirill S.; Malkova, Anna			Migrating bubble during break-induced replication drives conservative DNA synthesis	NATURE			English	Article							DOUBLE-STRAND BREAKS; SACCHAROMYCES-CEREVISIAE; HALF-CROSSOVERS; REPAIR; RECOMBINATION; YEAST; BACTERIOPHAGE-T4; TELOMERASE; MUTATIONS; RAD51	The repair of chromosomal double strand breaks (DSBs) is crucial for the maintenance of genomic integrity. However, the repair of DSBs can also destabilize the genome by causing mutations and chromosomal rearrangements, the driving forces for carcinogenesis and hereditary diseases. Break-induced replication (BIR) is one of the DSB repair pathways that is highly prone to genetic instability(1-3). BIR proceeds by invasion of one broken end into a homologous DNA sequence followed by replication that can copy hundreds of kilobases of DNA from a donor molecule all the way through its telomere(4,5). The resulting repaired chromosome comes at a great cost to the cell, as BIR promotes mutagenesis, loss of heterozygosity, translocations, and copy number variations, all hallmarks of carcinogenesis(4-9). BIR uses most known replication proteins to copy large portions of DNA, similar to S-phase replication(10,11). It has therefore been suggested that BIR proceeds by semiconservative replication; however, the model of a bona fide, stable replication fork contradicts the known instabilities associated with BIR such as a 1,000-fold increase in mutation rate compared to normal replication(9). Here we demonstrate that in budding yeast the mechanism of replication during BIR is significantly different from S-phase replication, as it proceeds via an unusual bubble-like replication fork that results in conservative inheritance of the new genetic material. We provide evidence that this atypical mode of DNA replication, dependent on Pif1 helicase, is responsible for the marked increase in BIR-associated mutations. We propose that the BIR mode of synthesis presents a powerful mechanism that can initiate bursts of genetic instability in eukaryotes, including humans.	[Saini, Natalie; Zhang, Yu; Lobachev, Kirill S.] Georgia Inst Technol, Sch Biol, Atlanta, GA 30332 USA; [Saini, Natalie; Zhang, Yu; Lobachev, Kirill S.] Georgia Inst Technol, Inst Bioengn & Biosci, Atlanta, GA 30332 USA; [Ramakrishnan, Sreejith; Elango, Rajula; Ayyar, Sandeep; Deem, Angela; Malkova, Anna] IUPUI, Dept Biol, Indianapolis, IN 46202 USA; [Ira, Grzegorz] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Haber, James E.] Dept Biol, Waltham, MA 02454 USA; [Haber, James E.] Rosenstiel Basic Med Sci Res Ctr, Waltham, MA 02454 USA; [Malkova, Anna] Univ Iowa, Dept Biol, Coll Liberal Arts & Sci, Iowa City, IA 52242 USA	University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology; Indiana University System; Indiana University-Purdue University Indianapolis; Baylor College of Medicine; University of Iowa	Malkova, A (corresponding author), IUPUI, Dept Biol, Indianapolis, IN 46202 USA.	kirill.lobachev@biology.gatech.edu; amalkova@iupui.edu	Saini, Natalie/J-4044-2019	Saini, Natalie/0000-0002-1668-5417; Elango, Rajula/0000-0001-7282-623X; Zhang, Yu/0000-0002-1126-770X; /0000-0003-1178-6806; RAMAKRISHNAN, SREEJITH/0000-0002-0514-9694	US National Institutes of Health; National Science Foundation; NSF [MCB-0818122]; NIH [R01GM084242, R01GM082950, R03ES016434, GM76020, GM080600]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R03ES016434] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM076020, R01GM082950, R37GM020056, R01GM080600, R01GM084242] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank O. Aparicio for the gift of BrdU cassette plasmid. We thank Y. Pavlov for providing ura3-29 cassette plasmid and P. Chastain and A. Hangaard Andersen for providing us with reagents. We are thankful to D. Gordenin and all members of A.M., K.S.L., G.I. and J.E.H. laboratories for discussions throughout the work. This work was funded by grants from the US National Institutes of Health and National Science Foundation (MCB-0818122 from NSF to K.S.L., and NIH grants R01GM084242 to A.M., R01GM082950 to K.S.L., R03ES016434 to A.M. and K.S.L., GM76020 to J.E.H., and GM080600 to G.I.).	Bosco G, 1998, GENETICS, V150, P1037; Chung WH, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000948; Conti C., 2001, CURR PROTOC CYTOM; Davis AP, 2004, MOL CELL BIOL, V24, P2344, DOI 10.1128/MCB.24.6.2344-2351.2004; Deem A, 2008, GENETICS, V179, P1845, DOI 10.1534/genetics.108.087940; Deem A, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000594; FANGMAN WL, 1991, ANNU REV CELL BIOL, V7, P375, DOI 10.1146/annurev.cb.07.110191.002111; Ferguson DO, 1996, P NATL ACAD SCI USA, V93, P5419, DOI 10.1073/pnas.93.11.5419; FORMOSA T, 1986, CELL, V47, P793, DOI 10.1016/0092-8674(86)90522-2; Friedman KL, 1995, METHOD ENZYMOL, V262, P613; Goldstein AL, 1999, YEAST, V15, P1541, DOI 10.1002/(SICI)1097-0061(199910)15:14<1541::AID-YEA476>3.3.CO;2-B; Guthrie C, 1991, GUIDE YEAST GENETICS; Halazonetis TD, 2008, SCIENCE, V319, P1352, DOI 10.1126/science.1140735; Hashimoto Y, 2011, METHODS MOL BIOL, V745, P437, DOI 10.1007/978-1-61779-129-1_25; Hastings PJ, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000327; KREUZER KN, 1995, J BACTERIOL, V177, P6844, DOI 10.1128/jb.177.23.6844-6853.1995; KUZMINOV A, 1995, MOL MICROBIOL, V16, P373, DOI 10.1111/j.1365-2958.1995.tb02403.x; Le S, 1999, GENETICS, V152, P143; Llorente B, 2008, CELL CYCLE, V7, P859, DOI 10.4161/cc.7.7.5613; Lydeard JR, 2007, NATURE, V448, P820, DOI 10.1038/nature06047; Lydeard JR, 2010, GENE DEV, V24, P1133, DOI 10.1101/gad.1922610; Malkova A, 2005, MOL CELL BIOL, V25, P933, DOI 10.1128/MCB.25.3.933-944.2005; Malkova A., 2013, CURR OPIN GENET DEV; Malkova A, 2012, ANNU REV GENET, V46, P455, DOI 10.1146/annurev-genet-110711-155547; MANN HB, 1947, ANN MATH STAT, V18, P50, DOI 10.1214/aoms/1177730491; Oh SD, 2009, METHODS MOL BIOL, V557, P209, DOI 10.1007/978-1-59745-527-5_14; Payen C, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000175; Pohjoismaki JLO, 2011, BIOESSAYS, V33, P290, DOI 10.1002/bies.201000137; Roberts SA, 2012, MOL CELL, V46, P424, DOI 10.1016/j.molcel.2012.03.030; Shcherbakova PV, 1996, GENETICS, V142, P717; Smith CE, 2007, NATURE, V447, P102, DOI 10.1038/nature05723; Smith CE, 2009, MOL CELL BIOL, V29, P1432, DOI 10.1128/MCB.01469-08; VanHulle K, 2007, MOL CELL BIOL, V27, P2601, DOI 10.1128/MCB.01740-06; Viggiani CJ, 2006, YEAST, V23, P1045, DOI 10.1002/yea.1406; WACH A, 1994, YEAST, V10, P1793, DOI 10.1002/yea.320101310; Yang Y, 2010, DNA REPAIR, V9, P914, DOI 10.1016/j.dnarep.2010.06.005; Yang Y, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000264	37	228	229	1	69	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 17	2013	502	7471					389	+		10.1038/nature12584	http://dx.doi.org/10.1038/nature12584			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	235GY	24025772	Green Accepted			2022-12-24	WOS:000325706300057
J	van Dijk, FS; Zillikens, MC; Micha, D; Riessland, M; Marcelis, CLM; de Die-Smulders, CE; Milbradt, J; Franken, AA; Harsevoort, AJ; Lichtenbelt, KD; Pruijs, HE; Rubio-Gozalbo, ME; Zwertbroek, R; Moutaouakil, Y; Egthuijsen, J; Hammerschmidt, M; Bijman, R; Semeins, CM; Bakker, AD; Everts, V; Klein-Nulend, J; Campos-Obando, N; Hofman, A; te Meerman, GJ; Verkerk, AJMH; Uitterlinden, AG; Maugeri, A; Sistermans, EA; Waisfisz, Q; Meijers-Heijboer, H; Wirth, B; Simon, MEH; Pals, G				van Dijk, Fleur S.; Zillikens, M. Carola; Micha, Dimitra; Riessland, Markus; Marcelis, Carlo L. M.; de Die-Smulders, Christine E.; Milbradt, Janine; Franken, Anton A.; Harsevoort, Arjan J.; Lichtenbelt, Klaske D.; Pruijs, Hans E.; Rubio-Gozalbo, M. Estela; Zwertbroek, Rolf; Moutaouakil, Youssef; Egthuijsen, Jaqueline; Hammerschmidt, Matthias; Bijman, Renate; Semeins, Cor M.; Bakker, Astrid D.; Everts, Vincent; Klein-Nulend, Jenneke; Campos-Obando, Natalia; Hofman, Albert; te Meerman, Gerard J.; Verkerk, Annemieke J. M. H.; Uitterlinden, Andre G.; Maugeri, Alessandra; Sistermans, Erik A.; Waisfisz, Quinten; Meijers-Heijboer, Hanne; Wirth, Brunhilde; Simon, Marleen E. H.; Pals, Gerard			PLS3 Mutations in X-Linked Osteoporosis with Fractures	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ACTIN; PLASTIN	Plastin 3 (PLS3), a protein involved in the formation of filamentous actin (F-actin) bundles, appears to be important in human bone health, on the basis of pathogenic variants in PLS3 in five families with X-linked osteoporosis and osteoporotic fractures that we report here. The bone-regulatory properties of PLS3 were supported by in vivo analyses in zebrafish. Furthermore, in an additional five families (described in less detail) referred for diagnosis or ruling out of osteogenesis imperfecta type I, a rare variant (rs140121121) in PLS3 was found. This variant was also associated with a risk of fracture among elderly heterozygous women that was two times as high as that among noncarriers, which indicates that genetic variation in PLS3 is a novel etiologic factor involved in common, multi-factorial osteoporosis.	[van Dijk, Fleur S.; Micha, Dimitra; Moutaouakil, Youssef; Egthuijsen, Jaqueline; Bijman, Renate; Maugeri, Alessandra; Sistermans, Erik A.; Waisfisz, Quinten; Meijers-Heijboer, Hanne; Pals, Gerard] Vrije Univ Amsterdam, Med Ctr, Dept Clin Genet, Ctr Connect Tissue Res, NL-1007 MB Amsterdam, Netherlands; [Zillikens, M. Carola; Campos-Obando, Natalia; Verkerk, Annemieke J. M. H.; Uitterlinden, Andre G.] Erasmus MC, Dept Internal Med, Rotterdam, Netherlands; [Hofman, Albert; Uitterlinden, Andre G.] Erasmus MC, Dept Epidemiol, Rotterdam, Netherlands; [Simon, Marleen E. H.] Erasmus MC, Dept Clin Genet, Rotterdam, Netherlands; [Marcelis, Carlo L. M.] Radboud Univ Nijmegen, Med Ctr, Dept Genet, NL-6525 ED Nijmegen, Netherlands; [de Die-Smulders, Christine E.] Maastricht Univ, Med Ctr, Dept Clin Genet, Maastricht, Netherlands; [Rubio-Gozalbo, M. Estela] Maastricht Univ, Med Ctr, Dept Pediat, Maastricht, Netherlands; [Rubio-Gozalbo, M. Estela] Maastricht Univ, Med Ctr, Dept Pediat & Lab Genet Metab Dis, Maastricht, Netherlands; [Franken, Anton A.] Isala Clin Zwolle, Dept Internal Med, Zwolle, Netherlands; [Harsevoort, Arjan J.] Isala Clin Zwolle, Dept Orthoped, Zwolle, Netherlands; [Lichtenbelt, Klaske D.] Univ Med Ctr Utrecht, Dept Med Genet, Utrecht, Netherlands; [Pruijs, Hans E.] Wilhelmina Childrens Hosp, Univ Med Ctr Utrecht, Dept Pediat Orthoped, Utrecht, Netherlands; [Zwertbroek, Rolf] Westfries Gasthuis, Dept Internal Med, Hoorn, Netherlands; [Semeins, Cor M.; Bakker, Astrid D.; Everts, Vincent; Klein-Nulend, Jenneke] Univ Amsterdam, Acad Ctr Dent Amsterdam, Dept Oral Cell Biol, Amsterdam, Netherlands; [Semeins, Cor M.; Bakker, Astrid D.; Everts, Vincent; Klein-Nulend, Jenneke] Vrije Univ Amsterdam, MOVE Res Inst Amsterdam, Amsterdam, Netherlands; [te Meerman, Gerard J.] Univ Groningen, Univ Med Ctr Groningen, Dept Genet, NL-9700 AB Groningen, Netherlands; [Riessland, Markus; Milbradt, Janine; Wirth, Brunhilde] Univ Cologne, Inst Genet, Inst Human Genet, Cologne, Germany; [Riessland, Markus; Milbradt, Janine; Wirth, Brunhilde] Univ Cologne, Ctr Mol Med Cologne, D-50931 Cologne, Germany; [Hammerschmidt, Matthias] Univ Cologne, Dept Dev Biol, D-50931 Cologne, Germany	Vrije Universiteit Amsterdam; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Radboud University Nijmegen; Maastricht University; Maastricht University; Maastricht University; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Wilhelmina Kinderziekenhuis; Academic Center for Dentistry Amsterdam; University of Amsterdam; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; University of Groningen; University of Cologne; University of Cologne; University of Cologne	Pals, G (corresponding author), Vrije Univ Amsterdam, Med Ctr, Dept Clin Genet, Ctr Connect Tissue Res, POB 7057, NL-1007 MB Amsterdam, Netherlands.	g.pals@vumc.nl; g.pals@vumc.nl	Bakker, Astrid Diana/AAD-1286-2019; Wirth, Brunhilde/H-3192-2019; Sistermans, Erik/B-1109-2009; Marcelis, C.L.M./L-4504-2015; Riessland, Markus/AAM-6708-2021; Micha, Dimitra/U-4979-2019; Rubio-Gozalbo, M Estela/H-1833-2011	Sistermans, Erik/0000-0001-7187-4563; Marcelis, C.L.M./0000-0001-7095-4641; Micha, Dimitra/0000-0001-7890-4411; Waisfisz, Quinten/0000-0002-7384-9182; Wirth, Brunhilde/0000-0003-4051-5191; Pals, Gerard/0000-0003-4091-7115; Verkerk, Annemieke JMH/0000-0002-7523-3656; Riessland, Markus/0000-0003-2592-5045	Erasmus Medical Center; Erasmus University, Rotterdam; Netherlands Organization of Scientific Research (NWO) [175.010.2005.011, 911-03-012]; Research Institute for Diseases in the Elderly [014-93-015, RIDE2]; Ministry of Education, Culture, and Science; Ministry for Health, Welfare, and Sports; Directorate-General XII of the European Commission; NWO [050-060-810]; Netherlands Consortium of Healthy Aging; Municipality of Rotterdam; European Union [2012-305121]; Deutsche Forschungsgemeinschaft [Wi945-14/1]	Erasmus Medical Center; Erasmus University, Rotterdam; Netherlands Organization of Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Research Institute for Diseases in the Elderly; Ministry of Education, Culture, and Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry for Health, Welfare, and Sports; Directorate-General XII of the European Commission; NWO(Netherlands Organization for Scientific Research (NWO)); Netherlands Consortium of Healthy Aging; Municipality of Rotterdam; European Union(European Commission); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	Supported by grants to the Rotterdam Study from Erasmus Medical Center and Erasmus University, Rotterdam; the Netherlands Organization of Scientific Research (NWO) Investments (175.010.2005.011 and 911-03-012); the Research Institute for Diseases in the Elderly (014-93-015 and RIDE2); the Ministry of Education, Culture, and Science; the Ministry for Health, Welfare, and Sports; Directorate-General XII of the European Commission; the Netherlands Genomics Initiative and NWO Project (050-060-810); the Netherlands Consortium of Healthy Aging; and the Municipality of Rotterdam. The zebrafish studies were supported by grants from the European Union Program FP7 Program (2012-305121), Deutsche Forschungsgemeinschaft (Wi945-14/1, to Dr. Wirth), and SMA-Europe (to Dr. Riessland). The col1a1:eGFP transgenic line was a gift from Dr. Shannon Fisher to Dr. Hammerschmidt's laboratory.	Ackermann B, 2013, HUM MOL GENET, V22, P1328, DOI 10.1093/hmg/dds540; Ameziane N, 2012, ANEMIA, V2012, DOI 10.1155/2012/132856; Bacabac RG, 2006, FASEB J, V20, P858, DOI 10.1096/fj.05-4966.com; Bonewald LF, 2011, J BONE MINER RES, V26, P229, DOI 10.1002/jbmr.320; Clarke L, 2012, NAT METHODS, V9, P1, DOI [10.1038/NMETH.1974, 10.1038/nmeth.1974]; Clayton D, 2008, BIOSTATISTICS, V9, P593, DOI 10.1093/biostatistics/kxn007; DEARRUDA MV, 1990, J CELL BIOL, V111, P1069, DOI 10.1083/jcb.111.3.1069; Delanote V, 2005, ACTA PHARMACOL SIN, V26, P769, DOI 10.1111/j.1745-7254.2005.00145.x; Estrada K, 2012, NAT GENET, V44, P491, DOI 10.1038/ng.2249; Hartikka H, 2005, J BONE MINER RES, V20, P783, DOI 10.1359/JBMR.050101; Hofman A, 2011, EUR J EPIDEMIOL, V26, P657, DOI 10.1007/s10654-011-9610-5; Kague E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047394; Kamioka H, 2004, J BONE MINER RES, V19, P471, DOI 10.1359/JBMR.040128; KANIS JA, 1994, J BONE MINER RES, V9, P1137, DOI 10.1002/jbmr.5650090802; Keupp K, 2013, AM J HUM GENET, V92, P565, DOI 10.1016/j.ajhg.2013.02.010; Laine CM, 2013, NEW ENGL J MED, V368, P1809, DOI 10.1056/NEJMoa1215458; Laine CM, 2012, AM J MED GENET A, V158A, P1252, DOI 10.1002/ajmg.a.35278; Mulvihill BM, 2010, CLIN BIOMECH, V25, P491, DOI 10.1016/j.clinbiomech.2010.01.006; Oprea GE, 2008, SCIENCE, V320, P524, DOI 10.1126/science.1155085; Shwartz Y, 2012, DEV BIOL, V370, P154, DOI 10.1016/j.ydbio.2012.07.026; Sillence DO, 1980, BONE DYSPLASIA GENET; Tanaka-Kamioka K, 1998, J BONE MINER RES, V13, P1555, DOI 10.1359/jbmr.1998.13.10.1555; van der Pauw MTM, 2000, J PERIODONTAL RES, V35, P335, DOI 10.1034/j.1600-0765.2000.035006335.x; van Dijk FS, 2013, EUR J HUM GENET, V21, DOI 10.1038/ejhg.2012.210; Weinbaum S, 2011, CELL MOL BIOENG, V4, P510, DOI 10.1007/s12195-011-0179-6	25	131	134	0	25	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 17	2013	369	16					1529	1536		10.1056/NEJMoa1308223	http://dx.doi.org/10.1056/NEJMoa1308223			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	267MJ	24088043	Green Published			2022-12-24	WOS:000328101700010
J	Ranjan, A; Mizuguchi, G; FitzGerald, PC; Wei, D; Wang, F; Huang, YZ; Luk, E; Woodcock, CL; Wu, C				Ranjan, Anand; Mizuguchi, Gaku; FitzGerald, Peter C.; Wei, Debbie; Wang, Feng; Huang, Yingzi; Luk, Ed; Woodcock, Christopher L.; Wu, Carl			Nucleosome-free Region Dominates Histone Acetylation in Targeting SWR1 to Promoters for H2A.Z Replacement	CELL			English	Article							CHROMATIN REMODELING COMPLEX; SACCHAROMYCES-CEREVISIAE GENOME; HEAT-SHOCK GENES; VARIANT HTZ1; BIDIRECTIONAL PROMOTERS; CRYSTAL-STRUCTURE; CORE PARTICLE; CELL-CYCLE; YEAST; TRANSCRIPTION	The histone variant H2A.Z is a genome-wide signature of nucleosomes proximal to eukaryotic regulatory DNA. Whereas the multisubunit chromatin remodeler SWR1 is known to catalyze ATP-dependent deposition of H2A.Z, the mechanism of SWR1 recruitment to S. cerevisiae promoters has been unclear. A sensitive assay for competitive binding of dinucleosome substrates revealed that SWR1 preferentially binds long nucleosome-free DNA and the adjoining nucleosome core particle, allowing discrimination of gene promoters over gene bodies. Analysis of mutants indicates that the conserved Swc2/YL1 subunit and the adenosine triphosphatase domain of Swr1 are mainly responsible for binding to substrate. SWR1 binding is enhanced on nucleosomes acetylated by the NuA4 histone acetyltransferase, but recognition of nucleosome-free and nucleosomal DNA is dominant over interaction with acetylated histones. Such hierarchical cooperation between DNA and histone signals expands the dynamic range of genetic switches, unifying classical gene regulation by DNA-binding factors with ATP-dependent nucleosome remodeling and posttranslational histone modifications.	[Ranjan, Anand; Wei, Debbie; Wang, Feng; Huang, Yingzi; Wu, Carl] NCI, Lab Biochem & Mol Biol, NIH, Bethesda, MD 20892 USA; [FitzGerald, Peter C.] NCI, Genome Anal Unit, NIH, Bethesda, MD 20892 USA; [Mizuguchi, Gaku; Wu, Carl] Howard Hughes Med Inst, Janelia Farm Res Campus, Ashburn, VA 20147 USA; [Luk, Ed] SUNY Stony Brook, Dept Biochem & Cell Biol, Stony Brook, NY 11794 USA; [Woodcock, Christopher L.] Univ Massachusetts, Dept Biol, Amherst, MA 01003 USA; [Woodcock, Christopher L.] Univ Massachusetts, Program Mol & Cellular Biol, Amherst, MA 01003 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Howard Hughes Medical Institute; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; University of Massachusetts System; University of Massachusetts Amherst; University of Massachusetts System; University of Massachusetts Amherst	Ranjan, A (corresponding author), NCI, Lab Biochem & Mol Biol, NIH, Bethesda, MD 20892 USA.	ranjana@mail.nih.gov; wuc@janelia.hhmi.org		Luk, Ed/0000-0002-6619-2258	Leukemia and Lymphoma Society fellowship; Janelia Farm Research Campus, Howard Hughes Medical Institute; Center for Cancer Research, National Cancer Institute	Leukemia and Lymphoma Society fellowship(Leukemia and Lymphoma Society); Janelia Farm Research Campus, Howard Hughes Medical Institute; Center for Cancer Research, National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Dr. Joseph Wall, STEM facility, Biology Department, Brookhaven Laboratories, Upton, NY, and his staff for conducting STEM mass measurements; Karolin Luger's laboratory for sharing unpublished data on Swc2; Wei-Hua Wu for the kind gift of yeast strains; Sameet Mehta for bioinformatics; and Michael Lichten, Sean Eddy, Claude Klee, Joseph Landry, members of our laboratory and reviewers for helpful comments. This work was supported by a Leukemia and Lymphoma Society fellowship (to A.R.), by the Janelia Farm Research Campus, Howard Hughes Medical Institute (to C.W. and G.M.), and by the Center for Cancer Research, National Cancer Institute.	Albert I, 2007, NATURE, V446, P572, DOI 10.1038/nature05632; Alkhatib SG, 2011, FEBS LETT, V585, P3197, DOI 10.1016/j.febslet.2011.09.003; Altaf M, 2010, J BIOL CHEM, V285, P15966, DOI 10.1074/jbc.M110.117069; Angus-Hill ML, 2001, MOL CELL, V7, P741, DOI 10.1016/S1097-2765(01)00219-2; ARENTS G, 1991, P NATL ACAD SCI USA, V88, P10148, DOI 10.1073/pnas.88.22.10148; Badis G, 2008, MOL CELL, V32, P878, DOI 10.1016/j.molcel.2008.11.020; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bernstein BE, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-9-r62; Brown CE, 2001, SCIENCE, V292, P2333, DOI 10.1126/science.1060214; Cai Y, 2005, J BIOL CHEM, V280, P13665, DOI 10.1074/jbc.M500001200; Cairns BR, 1999, MOL CELL, V4, P715, DOI 10.1016/S1097-2765(00)80382-2; Cole HA, 2011, P NATL ACAD SCI USA, V108, P12687, DOI 10.1073/pnas.1104978108; Da GP, 2006, P NATL ACAD SCI USA, V103, P2057, DOI 10.1073/pnas.0510949103; Dhillon N, 2006, MOL CELL BIOL, V26, P489, DOI 10.1128/MCB.26.2.489-501.2006; Durant M, 2007, MOL CELL BIOL, V27, P5327, DOI 10.1128/MCB.00468-07; Fan JY, 2002, NAT STRUCT BIOL, V9, P172, DOI 10.1038/nsb767; Fan XC, 2010, P NATL ACAD SCI USA, V107, P17945, DOI 10.1073/pnas.1012674107; Gallant-Behm CL, 2012, GENE DEV, V26, P2325, DOI 10.1101/gad.198069.112; Gavin AC, 2006, NATURE, V440, P631, DOI 10.1038/nature04532; Halley JE, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000401; Hartley PD, 2009, CELL, V137, P445, DOI 10.1016/j.cell.2009.02.043; Holstege FCP, 1998, CELL, V95, P717, DOI 10.1016/S0092-8674(00)81641-4; HORIKAWA I, 1995, BIOCHEM BIOPH RES CO, V208, P999, DOI 10.1006/bbrc.1995.1433; Jiang CZ, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-10-r109; Jin CY, 2007, GENE DEV, V21, P1519, DOI 10.1101/gad.1547707; Kalocsay M, 2009, MOL CELL, V33, P335, DOI 10.1016/j.molcel.2009.01.016; Keogh MC, 2006, GENE DEV, V20, P660, DOI 10.1101/gad.1388106; Kobor MS, 2004, PLOS BIOL, V2, P587, DOI 10.1371/journal.pbio.0020131; Krogan NJ, 2004, P NATL ACAD SCI USA, V101, P13513, DOI 10.1073/pnas.0405753101; Krogan NJ, 2003, MOL CELL, V12, P1565, DOI 10.1016/S1097-2765(03)00497-0; Kusch T, 2004, SCIENCE, V306, P2084, DOI 10.1126/science.1103455; Kwon SY, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000574; Ladurner AG, 2003, MOL CELL, V11, P365, DOI 10.1016/S1097-2765(03)00035-2; Landry JW, 2011, GENE DEV, V25, P275, DOI 10.1101/gad.2007311; Li B, 2007, SCIENCE, V316, P1050, DOI 10.1126/science.1139004; Lowary PT, 1998, J MOL BIOL, V276, P19, DOI 10.1006/jmbi.1997.1494; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Luk E, 2010, CELL, V143, P725, DOI 10.1016/j.cell.2010.10.019; Matangkasombut O, 2003, MOL CELL, V11, P353, DOI 10.1016/S1097-2765(03)00033-9; Mavrich TN, 2008, NATURE, V453, P358, DOI 10.1038/nature06929; Meneghini MD, 2003, CELL, V112, P725, DOI 10.1016/S0092-8674(03)00123-5; Millar CB, 2006, NAT REV MOL CELL BIO, V7, P657, DOI 10.1038/nrm1986; Mizuguchi G, 2004, SCIENCE, V303, P343, DOI 10.1126/science.1090701; Morillo-Huesca M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012143; Neil H, 2009, NATURE, V457, P1038, DOI 10.1038/nature07747; Neph S, 2012, NATURE, V489, P83, DOI 10.1038/nature11212; Ptashne M, 2013, P NATL ACAD SCI USA, V110, P7101, DOI 10.1073/pnas.1305399110; Radman-Livaja M, 2010, DEV BIOL, V339, P258, DOI 10.1016/j.ydbio.2009.06.012; Raisner RM, 2005, CELL, V123, P233, DOI 10.1016/j.cell.2005.10.002; Rangasamy D, 2004, NAT STRUCT MOL BIOL, V11, P650, DOI 10.1038/nsmb786; Ruthenburg AJ, 2011, CELL, V145, P692, DOI 10.1016/j.cell.2011.03.053; Santisteban MS, 2000, CELL, V103, P411, DOI 10.1016/S0092-8674(00)00133-1; Schones DE, 2008, CELL, V132, P887, DOI 10.1016/j.cell.2008.02.022; Suto RK, 2000, NAT STRUCT BIOL, V7, P1121; Thurman RE, 2012, NATURE, V489, P75, DOI 10.1038/nature11232; Tirosh I, 2008, GENOME RES, V18, P1084, DOI 10.1101/gr.076059.108; Venters BJ, 2009, GENOME RES, V19, P360, DOI 10.1101/gr.084970.108; Weake VM, 2012, TRENDS CELL BIOL, V22, P177, DOI 10.1016/j.tcb.2011.11.005; Weiner A, 2010, GENOME RES, V20, P90, DOI 10.1101/gr.098509.109; WU C, 1984, NATURE, V309, P229, DOI 10.1038/309229a0; WU C, 1980, NATURE, V286, P854, DOI 10.1038/286854a0; Wu WH, 2009, J BIOL CHEM, V284, P6200, DOI 10.1074/jbc.M808830200; Wu WH, 2005, NAT STRUCT MOL BIOL, V12, P1064, DOI 10.1038/nsmb1023; Wysocka J, 2006, NATURE, V442, P86, DOI 10.1038/nature04815; Xi YX, 2011, GENOME RES, V21, P718, DOI 10.1101/gr.117101.110; Xiao H, 2001, MOL CELL, V8, P531, DOI 10.1016/S1097-2765(01)00345-8; Xu ZY, 2009, NATURE, V457, P1033, DOI 10.1038/nature07728; Yuan GC, 2005, SCIENCE, V309, P626, DOI 10.1126/science.1112178; Zhang HY, 2005, CELL, V123, P219, DOI 10.1016/j.cell.2005.08.036	69	121	122	1	52	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	SEP 12	2013	154	6					1232	1245		10.1016/j.cell.2013.08.005	http://dx.doi.org/10.1016/j.cell.2013.08.005			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	215VQ	24034247	Bronze, Green Accepted			2022-12-24	WOS:000324239300013
J	Walker, MC; Thuronyi, BW; Charkoudian, LK; Lowry, B; Khosla, C; Chang, MCY				Walker, Mark C.; Thuronyi, Benjamin W.; Charkoudian, Louise K.; Lowry, Brian; Khosla, Chaitan; Chang, Michelle C. Y.			Expanding the Fluorine Chemistry of Living Systems Using Engineered Polyketide Synthase Pathways	SCIENCE			English	Article							ACTIVE-SITE OCCUPANCY; ESCHERICHIA-COLI; NATURAL-PRODUCTS; EXTENDER UNITS; BIOSYNTHESIS; ENZYME; PHARMACEUTICALS; MUTASYNTHESIS; RECOGNITION; CONVERSION	Organofluorines represent a rapidly expanding proportion of molecules that are used in pharmaceuticals, diagnostics, agrochemicals, and materials. Despite the prevalence of fluorine in synthetic compounds, the known biological scope is limited to a single pathway that produces fluoroacetate. Here, we demonstrate that this pathway can be exploited as a source of fluorinated building blocks for introduction of fluorine into natural-product scaffolds. Specifically, we have constructed pathways involving two polyketide synthase systems, and we show that fluoroacetate can be used to incorporate fluorine into the polyketide backbone in vitro. We further show that fluorine can be inserted site-selectively and introduced into polyketide products in vivo. These results highlight the prospects for the production of complex fluorinated natural products using synthetic biology.	[Walker, Mark C.; Chang, Michelle C. Y.] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Thuronyi, Benjamin W.; Chang, Michelle C. Y.] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Charkoudian, Louise K.; Khosla, Chaitan] Stanford Univ, Dept Chem, Stanford, CA 94305 USA; [Lowry, Brian; Khosla, Chaitan] Stanford Univ, Dept Chem Engn, Stanford, CA 94305 USA; [Khosla, Chaitan] Stanford Univ, Dept Biochem, Stanford, CA 94305 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; Stanford University; Stanford University; Stanford University	Chang, MCY (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.	mcchang@berkeley.edu		Walker, Mark/0000-0003-3942-003X; Khosla, Chaitan/0000-0001-6529-495X; Thuronyi, Benjamin/0000-0003-0821-3791	NIH [1S10RR023679-01, S10 RR16634-01, 1 T32 GMO66698, 1 DP2 OD008696, R01 GM087934]; Gerald K. Branch Predoctoral Fellowship; UC Cancer Research Council Committee Predoctoral Fellowship; National Cancer Institute [F32 CA137994]; UC Berkeley; NATIONAL CANCER INSTITUTE [F32CA137994] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR023679, S10RR016634] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM066698, R01GM087934] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD008696] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Gerald K. Branch Predoctoral Fellowship; UC Cancer Research Council Committee Predoctoral Fellowship; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); UC Berkeley; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank B. Bond-Watts and I. Aanei for assembly and cloning of the synthetic nphT7 gene, X. Yu for providing plasmids for the E. coli ACCase, C. Harvey for synthetic chemistry assistance, F. T. Wong for helpful discussions, and A. Lingel (Novartis) for QCI-F CryoProbe use. The College of Chemistry NMR Facility at the University of California, Berkeley (UC Berkeley) is supported in part by the NIH (grants 1S10RR023679-01 and S10 RR16634-01). M. C. W. and B. W. T acknowledge the support of a NIH National Research Service Award Training Grant (1 T32 GMO66698) and the Gerald K. Branch Predoctoral Fellowship and UC Cancer Research Council Committee Predoctoral Fellowship (to B. W. T). L. K. C. acknowledges support from the National Cancer Institute (grant F32 CA137994). This work was funded by generous support from UC Berkeley and the NIH (grant 1 DP2 OD008696 to M.C.Y.C. and grant R01 GM087934 to C.K.).	Atsumi S, 2008, NATURE, V451, P86, DOI 10.1038/nature06450; Ball ND, 2009, J AM CHEM SOC, V131, P3796, DOI 10.1021/ja8054595; Begue JP, 2006, J FLUORINE CHEM, V127, P992, DOI 10.1016/j.jfluchem.2006.05.006; Bennett BD, 2009, NAT CHEM BIOL, V5, P593, DOI 10.1038/nchembio.186; Bonnett SA, 2011, CHEM BIOL, V18, P1075, DOI 10.1016/j.chembiol.2011.07.016; BROWN TDK, 1977, J GEN MICROBIOL, V102, P327, DOI 10.1099/00221287-102-2-327; Cane DE, 1998, SCIENCE, V282, P63, DOI 10.1126/science.282.5386.63; Chan YA, 2009, NAT PROD REP, V26, P90, DOI 10.1039/b801658p; Croteau R., 2000, BIOCH MOL BIOL PLANT, P1250, DOI DOI 10.1201/B11003-3; Dong CJ, 2004, NATURE, V427, P561, DOI 10.1038/nature02280; Eustaquio AS, 2010, J NAT PROD, V73, P378, DOI 10.1021/np900719u; Furuya T, 2011, NATURE, V473, P470, DOI 10.1038/nature10108; Gokhale RS, 1999, SCIENCE, V284, P482, DOI 10.1126/science.284.5413.482; Goss RJM, 2010, CHEMBIOCHEM, V11, P698, DOI 10.1002/cbic.200900723; Haller T, 2000, BIOCHEMISTRY-US, V39, P4622, DOI 10.1021/bi992888d; Hughes AJ, 2011, CHEM BIOL, V18, P165, DOI 10.1016/j.chembiol.2010.12.014; Izumikawa M, 2003, J IND MICROBIOL BIOT, V30, P510, DOI 10.1007/s10295-003-0075-8; Khosla C, 2007, ANNU REV BIOCHEM, V76, P195, DOI 10.1146/annurev.biochem.76.053105.093515; Koryakina I, 2013, ORG BIOMOL CHEM, V11, P4449, DOI 10.1039/c3ob40633d; Kumar P, 2003, J AM CHEM SOC, V125, P14307, DOI 10.1021/ja037429l; Lee E, 2011, SCIENCE, V334, P639, DOI 10.1126/science.1212625; Liou GF, 2003, BIOCHEMISTRY-US, V42, P200, DOI 10.1021/bi0268100; Llano-Sotelo B, 2010, ANTIMICROB AGENTS CH, V54, P4961, DOI 10.1128/AAC.00860-10; McDaniel R, 1999, P NATL ACAD SCI USA, V96, P1846, DOI 10.1073/pnas.96.5.1846; Mo S, 2011, J AM CHEM SOC, V133, P976, DOI 10.1021/ja108399b; Muller K, 2007, SCIENCE, V317, P1881, DOI 10.1126/science.1131943; O'Hagan D, 2008, CHEM SOC REV, V37, P308, DOI 10.1039/b711844a; O'Hagan D, 2006, J FLUORINE CHEM, V127, P1479, DOI 10.1016/j.jfluchem.2006.09.006; Okamura E, 2010, P NATL ACAD SCI USA, V107, P11265, DOI 10.1073/pnas.1000532107; Pfeifer BA, 2001, SCIENCE, V291, P1790, DOI 10.1126/science.1058092; Powers JC, 2002, CHEM REV, V102, P4639, DOI 10.1021/cr010182v; Rauniyar V, 2011, SCIENCE, V334, P1681, DOI 10.1126/science.1213918; Rivkin A, 2002, ORG LETT, V4, P4081, DOI 10.1021/ol0268283; Ro DK, 2006, NATURE, V440, P940, DOI 10.1038/nature04640; Runguphan W, 2009, P NATL ACAD SCI USA, V106, P13673, DOI 10.1073/pnas.0903393106; Siskos AP, 2005, CHEM BIOL, V12, P1145, DOI 10.1016/j.chembiol.2005.08.017; Staunton J, 2001, NAT PROD REP, V18, P380, DOI 10.1039/a909079g; Sundermann U, 2013, ACS CHEM BIOL, V8, P443, DOI 10.1021/cb300505w; Tsuji SY, 2001, BIOCHEMISTRY-US, V40, P2326, DOI 10.1021/bi002463n; Walker MC, 2012, ACS CHEM BIOL, V7, P1576, DOI 10.1021/cb3002057; Watson DA, 2009, SCIENCE, V325, P1661, DOI 10.1126/science.1178239; Weeks AM, 2011, BIOCHEMISTRY-US, V50, P5404, DOI 10.1021/bi200416g; Wong FT, 2011, BIOCHEMISTRY-US, V50, P6539, DOI 10.1021/bi200632j; Wong FT, 2010, BIOCHEMISTRY-US, V49, P95, DOI 10.1021/bi901826g; Wu N, 2000, J AM CHEM SOC, V122, P4847, DOI 10.1021/ja000023d	45	124	130	3	136	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 6	2013	341	6150					1089	1094		10.1126/science.1242345	http://dx.doi.org/10.1126/science.1242345			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	211TG	24009388	Green Accepted			2022-12-24	WOS:000323933100038
J	Thompson, IM; Goodman, PJ; Tangen, CM; Parnes, HL; Minasian, LM; Godley, PA; Lucia, MS; Ford, LG				Thompson, Ian M., Jr.; Goodman, Phyllis J.; Tangen, Catherine M.; Parnes, Howard L.; Minasian, Lori M.; Godley, Paul A.; Lucia, M. Scott; Ford, Leslie G.			Long-Term Survival of Participants in the Prostate Cancer Prevention Trial	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							5-ALPHA-REDUCTASE INHIBITORS; FOLLOW-UP; FINASTERIDE; SENSITIVITY	BackgroundIn the Prostate Cancer Prevention Trial (PCPT), finasteride significantly reduced the risk of prostate cancer but was associated with an increased risk of high-grade disease. With up to 18 years of follow-up, we analyzed rates of survival among all study participants and among those with prostate cancer. MethodsWe collected data on the incidence of prostate cancer among PCPT participants for an additional year after our first report was published in 2003 and searched the Social Security Death Index to assess survival status through October 31, 2011. ResultsAmong 18,880 eligible men who underwent randomization, prostate cancer was diagnosed in 989 of 9423 (10.5%) in the finasteride group and 1412 of 9457 (14.9%) in the placebo group (relative risk in the finasteride group, 0.70; 95% confidence interval [CI], 0.65 to 0.76; P<0.001). Of the men who were evaluated, 333 (3.5%) in the finasteride group and 286 (3.0%) in the placebo group had high-grade cancer (Gleason score, 7 to 10) (relative risk, 1.17; 95% CI, 1.00 to 1.37; P=0.05). Of the men who died, 2538 were in the finasteride group and 2496 were in the placebo group, for 15-year survival rates of 78.0% and 78.2%, respectively. The unadjusted hazard ratio for death in the finasteride group was 1.02 (95% CI, 0.97 to 1.08; P=0.46). Ten-year survival rates were 83.0% in the finasteride group and 80.9% in the placebo group for men with low-grade prostate cancer and 73.0% and 73.6%, respectively, for those with high-grade prostate cancer. ConclusionsFinasteride reduced the risk of prostate cancer by about one third. High-grade prostate cancer was more common in the finasteride group than in the placebo group, but after 18 years of follow-up, there was no significant between-group difference in the rates of overall survival or survival after the diagnosis of prostate cancer. (Funded by the National Cancer Institute.) The use of finasteride to prevent prostate cancer reduced the risk of low-grade tumors by 43%, as compared with placebo. High-grade tumors were more common in the finasteride group, but long-term follow-up did not show a significant between-group difference in survival. With the advent of prostate-specific antigen (PSA) testing in the late 1980s, the rate of diagnosis of prostate cancer rose dramatically. Currently, a man in the United States has a 16.5% lifetime risk of receiving a diagnosis of prostate cancer.(1) The timing and magnitude of the 44% reduction in prostate-cancer mortality after the widespread adoption of PSA testing suggest that both screening and treatment improvements have contributed to this decline.(2) Unfortunately, treatments for prostate cancer (radiation and surgery) are associated with a substantial risk of side effects, including sexual, urinary, and bowel complications, that can dramatically affect quality of life. ...	[Thompson, Ian M., Jr.] Univ Texas Hlth Sci Ctr San Antonio, Canc Therapy & Res Ctr, San Antonio, TX 78229 USA; [Goodman, Phyllis J.; Tangen, Catherine M.] SW Oncol Grp, Ctr Stat, Seattle, WA USA; [Goodman, Phyllis J.; Tangen, Catherine M.] Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA; [Parnes, Howard L.; Minasian, Lori M.; Ford, Leslie G.] NCI, Canc Prevent Div, Bethesda, MD 20892 USA; [Godley, Paul A.] Univ N Carolina, Sch Med, Div Hematol Oncol, Sch Publ Hlth, Chapel Hill, NC USA; [Godley, Paul A.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Lucia, M. Scott] Univ Colorado, Denver Sch Med, Dept Pathol, Denver, CO 80202 USA	Cancer Therapy & Research Center; University of Texas System; University of Texas Health San Antonio; Southwest Oncology Group; Fred Hutchinson Cancer Center; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver	Thompson, IM (corresponding author), Canc Therapy & Res Ctr S Texas, Suite U627,7979 Wurzbach Rd, San Antonio, TX 78229 USA.	thompsoni@uthscsa.edu			Public Health Service grant from Division of Cancer Prevention, National Cancer Institute [CA37429]; Ferring; Amgen; Eli Lilly; NATIONAL CANCER INSTITUTE [UM1CA182883, U10CA037429, U01CA086402, P30CA054174] Funding Source: NIH RePORTER	Public Health Service grant from Division of Cancer Prevention, National Cancer Institute; Ferring(Ferring Pharmaceuticals); Amgen(Amgen); Eli Lilly(Eli Lilly); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Supported by a Public Health Service grant (CA37429) from the Division of Cancer Prevention, National Cancer Institute. Dr. Thompson reports receiving consulting fees from Ferring and being a named inventor on patent applications filed by his institution for a penile-prosthesis design for the management of erectile dysfunction and for a lab-on-a-chip procedure for point-of-service identification of biomarkers for prostate-cancer detection; and Dr. Tangen, receiving consulting fees from Amgen and Eli Lilly. No other potential conflict of interest relevant to this article was reported.	[Anonymous], 2012, NY TIMES; Cuzick J, 2010, CANCER PREV RES, V3, P689, DOI 10.1158/1940-6207.CAPR-10-0096; Etzioni R, 2012, CANCER-AM CANCER SOC, V118, P5955, DOI 10.1002/cncr.27594; FDA, 2011, FDA DRUG SAF COMM 5; Hamilton RJ, 2010, CANCER EPIDEM BIOMAR, V19, P2164, DOI 10.1158/1055-9965.EPI-10-0082; Kramer BS, 2009, J CLIN ONCOL, V27, P1502, DOI 10.1200/JCO.2008.16.9599; Lucia MS, 2007, JNCI-J NATL CANCER I, V99, P1375, DOI 10.1093/jnci/djm117; Manecksha RP, 2012, SCI WORLD J, DOI 10.1100/2012/650858; Moyer VA, 2012, ANN INTERN MED, V157, P120, DOI 10.7326/0003-4819-157-2-201207170-00459; OLLENDORF D, 2009, MANAGEMENT OPTIONS L; Quinn J, 2008, WEST J EMERG MED, V9, P6; Redman MW, 2008, CANCER PREV RES, V1, P174, DOI 10.1158/1940-6207.CAPR-08-0092; Sanda MG, 2008, NEW ENGL J MED, V358, P1250, DOI 10.1056/NEJMoa074311; Schroder FH, 2012, NEW ENGL J MED, V366, P2137; Schroder FH, 2012, NEW ENGL J MED, V366, P981, DOI 10.1056/NEJMoa1113135; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Theoret MR, 2011, NEW ENGL J MED, V365, P97, DOI 10.1056/NEJMp1106783; Thompson IM, 2007, J UROLOGY, V177, P1749, DOI 10.1016/j.juro.2007.01.071; Thompson IM, 2006, J NATL CANCER I, V98, P1128, DOI 10.1093/jnci/djj307; Thompson IM, 2003, NEW ENGL J MED, V349, P215, DOI 10.1056/NEJMoa030660; Winn D., COULD REC CHANG AV D	21	183	187	0	10	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 15	2013	369	7					603	610		10.1056/NEJMoa1215932	http://dx.doi.org/10.1056/NEJMoa1215932			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	243YO	23944298	Green Published, Green Accepted			2022-12-24	WOS:000326354500006
J	Bauch, CT; Galvani, AP				Bauch, Chris T.; Galvani, Alison P.			Social Factors in Epidemiology	SCIENCE			English	Editorial Material							SPREAD; IMPACT		[Bauch, Chris T.; Galvani, Alison P.] Univ Waterloo, Dept Appl Math, Waterloo, ON N2L 3G1, Canada; [Galvani, Alison P.] Yale Univ, Sch Publ Hlth, New Haven, CT 06520 USA	University of Waterloo; Yale University	Bauch, CT (corresponding author), Univ Waterloo, Dept Appl Math, Waterloo, ON N2L 3G1, Canada.	alison.galvani@yale.edu			CIHR Funding Source: Medline; NIGMS NIH HHS [U01 GM15627, U01 GM105627, U01 GM087719] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM087719, U01GM105627] Funding Source: NIH RePORTER	CIHR(Canadian Institutes of Health Research (CIHR)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Basu S, 2008, P NATL ACAD SCI USA, V105, P19018, DOI 10.1073/pnas.0808114105; Bauch CT, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002452; Christakis NA, 2007, NEW ENGL J MED, V357, P370, DOI 10.1056/NEJMsa066082; Crepaz N, 2004, JAMA-J AM MED ASSOC, V292, P224, DOI 10.1001/jama.292.2.224; d'Onofrio A, 2011, J THEOR BIOL, V273, P63, DOI 10.1016/j.jtbi.2010.12.029; Funk S, 2009, P NATL ACAD SCI USA, V106, P6872, DOI 10.1073/pnas.0810762106; Kahan DM, 2013, SCIENCE, V342, P53, DOI 10.1126/science.1245724; Liu JZ, 2012, J R SOC INTERFACE, V9, P68, DOI 10.1098/rsif.2011.0001; May RM, 2008, NATURE, V451, P893, DOI 10.1038/451893a; O'Farrell John, 2007, UTTERLY IMPARTIAL HI; Reluga TC, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000793; Salathe M, 2013, NEW ENGL J MED, V369, P401, DOI 10.1056/NEJMp1307752; WHO, 2013, EP CURV SEV AC RESP; Williams WW, 2013, MMWR-MORBID MORTAL W, V62, P66	14	141	147	4	54	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 4	2013	342	6154					47	49		10.1126/science.1244492	http://dx.doi.org/10.1126/science.1244492			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	227PP	24092718	Green Accepted			2022-12-24	WOS:000325126100036
J	Tedeschi, A; Wutz, G; Huet, S; Jaritz, M; Wuensche, A; Schirghuber, E; Davidson, IF; Tang, W; Cisneros, DA; Bhaskara, V; Nishiyama, T; Vaziri, A; Wutz, A; Ellenberg, J; Peters, JM				Tedeschi, Antonio; Wutz, Gordana; Huet, Sebastien; Jaritz, Markus; Wuensche, Annelie; Schirghuber, Erika; Davidson, Iain Finley; Tang, Wen; Cisneros, David A.; Bhaskara, Venugopal; Nishiyama, Tomoko; Vaziri, Alipasha; Wutz, Anton; Ellenberg, Jan; Peters, Jan-Michael			Wapl is an essential regulator of chromatin structure and chromosome segregation	NATURE			English	Article							BUDDING YEAST; IN-VIVO; COHESIN; PROTEIN; SEPARASE; ANAPHASE; ORGANIZATION; INTERPHASE; EXPRESSION; PROPHASE	Mammalian genomes contain several billion base pairs of DNA that are packaged in chromatin fibres. At selected gene loci, cohesin complexes have been proposed to arrange these fibres into higher-order structures(1-7), but how important this function is for determining overall chromosome architecture and how the process is regulated are not well understood. Using conditional mutagenesis in the mouse, here we show that depletion of the cohesin-associated protein Wapl(8,9) stably locks cohesin on DNA, leads to clustering of cohesin in axial structures, and causes chromatin condensation in interphase chromosomes. These findings reveal that the stability of cohesin-DNA interactions is an important determinant of chromatin structure, and indicate that cohesin has an architectural role in interphase chromosome territories. Furthermore, we show that regulation of cohesin-DNA interactions by Wapl is important for embryonic development, expression of genes such as c-myc (also known as Myc), and cell cycle progression. In mitosis, Wapl-mediated release of cohesin from DNA is essential for proper chromosome segregation and protects cohesin from cleavage by the protease separase, thus enabling mitotic exit in the presence of functional cohesin complexes.	[Tedeschi, Antonio; Wutz, Gordana; Jaritz, Markus; Schirghuber, Erika; Davidson, Iain Finley; Tang, Wen; Cisneros, David A.; Bhaskara, Venugopal; Nishiyama, Tomoko; Vaziri, Alipasha; Wutz, Anton; Peters, Jan-Michael] Res Inst Mol Pathol IMP, A-1030 Vienna, Austria; [Huet, Sebastien; Wuensche, Annelie; Ellenberg, Jan] European Mol Biol Lab, Cell Biol & Biophys Unit, D-69117 Heidelberg, Germany; [Huet, Sebastien] Inst Genet & Dev Rennes, CNRS, UMR 6290, F-35043 Rennes, France; [Huet, Sebastien] Univ Europeenne Bretagne, Univ Rennes 1, Struct Federat Rech Biosit, Fac Med, F-35043 Rennes, France; [Cisneros, David A.; Vaziri, Alipasha] Univ Vienna, Max F Perutz Labs, A-1030 Vienna, Austria; [Cisneros, David A.; Vaziri, Alipasha] Univ Vienna, Res Platform Quantum Phenomena& Nanoscale Biol Sy, A-1030 Vienna, Austria	Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP); European Molecular Biology Laboratory (EMBL); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Bretagne Occidentale; Universite de Rennes; Medical University of Vienna; University of Vienna; Vienna Biocenter (VBC); Max F. Perutz Laboratories (MFPL); University of Vienna	Peters, JM (corresponding author), Res Inst Mol Pathol IMP, Dr Bohr Gasse 7, A-1030 Vienna, Austria.	jan-michael.peters@imp.ac.at	Cisneros, David A./B-1141-2012; Ellenberg, Jan/I-4688-2014	Cisneros, David A./0000-0001-9919-0075; Ellenberg, Jan/0000-0001-5909-701X; Tedeschi, Antonio/0000-0001-7276-4550; Bhaskara, Venugopal/0000-0002-8807-3292; Jaritz, Markus/0000-0002-9326-2047	European Molecular Biology Organization (EMBO); Japanese Society for the Promotion of Science (JSPS); Agence National de la Recherche [JCJC-SVSE2-2011]; European Union [FP7-PEOPLE-2011-CIG]; MFPL VIPS Program (BMWF); MFPL VIPS Program (City of Vienna); Vienna Science and Technology Fund (WWTF) [VRG10-11]; Research Platform Quantum Phenomena and Nanoscale Biological Systems (QuNaBioS); Boehringer Ingelheim; Austrian Science Fund (FWF) [SFB F34, Z196-B20]; Austrian Research Promotion Agency (FFG, Laura Bassi Center for Optimized Structural Studies); Vienna Science and Technology Fund [WWTF LS09-13]; European Community [241548 (MitoSys)]; Grants-in-Aid for Scientific Research [25711002] Funding Source: KAKEN	European Molecular Biology Organization (EMBO)(European Molecular Biology Organization (EMBO)); Japanese Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Agence National de la Recherche(French National Research Agency (ANR)); European Union(European Commission); MFPL VIPS Program (BMWF); MFPL VIPS Program (City of Vienna); Vienna Science and Technology Fund (WWTF); Research Platform Quantum Phenomena and Nanoscale Biological Systems (QuNaBioS); Boehringer Ingelheim(Boehringer Ingelheim); Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Austrian Research Promotion Agency (FFG, Laura Bassi Center for Optimized Structural Studies); Vienna Science and Technology Fund; European Community(European Commission); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We dedicate this paper to the memory of B. Peters, who performed the first experiments on Wapl in our laboratory. We are grateful to K. Aumayr, O. F.-Capetillo, T. Hoffmann, M. E. Idarraga-Amado, S. Kueng, T. Kulcsar, M. Leeb, P. Pasierbek, D. Santamaria, G. Schmauss, A. Souabni, H. Tkadletz, K. Wendt and members of the Peters laboratory for discussions and assistance, J. Hutchins for suggesting the term vermicelli, K. Nasmyth for the separase mouse model, and M. Barbacid, T. Cremer, T. Hirano, T. Jenuwein, M. Malumbres and J. Zuber for reagents. T.N. was supported by the European Molecular Biology Organization (EMBO) and the Japanese Society for the Promotion of Science (JSPS). S. H. was supported by funds from the Agence National de la Recherche (JCJC-SVSE2-2011, ChromaTranscript project) and the European Union (FP7-PEOPLE-2011-CIG, ChromaTranscript project). D. A. C. was supported by MFPL VIPS Program (BMWF and City of Vienna). A. V. acknowledges financial support by the Vienna Science and Technology Fund (WWTF) project VRG10-11, the Research Platform Quantum Phenomena and Nanoscale Biological Systems (QuNaBioS) and by Boehringer Ingelheim. Research in the laboratory of J.-M.P. is supported by Boehringer Ingelheim, the Austrian Science Fund (FWF special research program SFB F34 'Chromosome Dynamics', and Wittgenstein award Z196-B20), the Austrian Research Promotion Agency (FFG, Laura Bassi Center for Optimized Structural Studies), the Vienna Science and Technology Fund (WWTF LS09-13), and the European Community's Seventh Framework Programme (FP7/2007-2013) under grant agreement no. 241548 (MitoSys).	Bugler B, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-29; Buheitel J, 2013, EMBO J, V32, P666, DOI 10.1038/emboj.2013.7; Cerqueira A, 2009, J CELL BIOL, V187, P773, DOI 10.1083/jcb.200903033; Chan KL, 2011, SEMIN CELL DEV BIOL, V22, P906, DOI 10.1016/j.semcdb.2011.07.001; Chan KL, 2012, CELL, V150, P961, DOI 10.1016/j.cell.2012.07.028; DeMare L. E., 2013, GENOME RES; Farcas AM, 2011, MOL CELL, V44, P97, DOI 10.1016/j.molcel.2011.07.034; Gandhi R, 2006, CURR BIOL, V16, P2406, DOI 10.1016/j.cub.2006.10.061; Gerlich D, 2006, CURR BIOL, V16, P1571, DOI 10.1016/j.cub.2006.06.068; Guacci V, 2012, MOL BIOL CELL, V23, P729, DOI 10.1091/mbc.E11-08-0696; Hadjantonakis AK, 2004, BMC BIOTECHNOL, V4, DOI 10.1186/1472-6750-4-33; Hadjur S, 2009, NATURE, V460, P410, DOI 10.1038/nature08079; Haering CH, 2008, NATURE, V454, P297, DOI 10.1038/nature07098; Hauf S, 2003, J CELL BIOL, V161, P281, DOI 10.1083/jcb.200208092; Hauf S, 2001, SCIENCE, V293, P1320, DOI 10.1126/science.1061376; Kagey MH, 2010, NATURE, V467, P430, DOI 10.1038/nature09380; Kueng S, 2006, CELL, V127, P955, DOI 10.1016/j.cell.2006.09.040; Kumada K, 2006, J CELL BIOL, V172, P835, DOI 10.1083/jcb.200511126; Lopez-Serra L, 2013, CURR BIOL, V23, P64, DOI 10.1016/j.cub.2012.11.030; Mishiro T, 2009, EMBO J, V28, P1234, DOI 10.1038/emboj.2009.81; Nativio R, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000739; Nishiyama T, 2010, CELL, V143, P737, DOI 10.1016/j.cell.2010.10.031; Ono T, 2003, CELL, V115, P109, DOI 10.1016/S0092-8674(03)00724-4; Peters JM, 2008, GENE DEV, V22, P3089, DOI 10.1101/gad.1724308; Pezzi N, 2000, FASEB J, V14, P581, DOI 10.1096/fasebj.14.3.581; Phillips-Cremins JE, 2013, CELL, V153, P1281, DOI 10.1016/j.cell.2013.04.053; Poser I, 2008, NAT METHODS, V5, P409, DOI 10.1038/NMETH.1199; Rodriguez CI, 2000, NAT GENET, V25, P139, DOI 10.1038/75973; Schermelleh L, 2001, CHROMOSOME RES, V9, P77, DOI 10.1023/A:1026799818566; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Seibler J, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng012; Seitan VC, 2012, CURR OPIN GENET DEV, V22, P93, DOI 10.1016/j.gde.2011.11.003; Seitan VC, 2011, NATURE, V476, P467, DOI 10.1038/nature10312; Stedman W, 2008, EMBO J, V27, P654, DOI 10.1038/emboj.2008.1; Sun YX, 2009, CELL, V137, P123, DOI 10.1016/j.cell.2009.01.040; Tallquist MD, 2000, GENESIS, V26, P113, DOI 10.1002/(SICI)1526-968X(200002)26:2<113::AID-GENE3>3.0.CO;2-2; Uhlmann F, 1999, NATURE, V400, P37, DOI 10.1038/21831; Verni F, 2000, GENETICS, V154, P1693; Wang LHC, 2010, J CELL SCI, V123, P806, DOI 10.1242/jcs.058255; Wendt KS, 2008, NATURE, V451, P796, DOI 10.1038/nature06634; Wirth KG, 2006, J CELL BIOL, V172, P847, DOI 10.1083/jcb.200506119; Zink D, 1998, HUM GENET, V102, P241, DOI 10.1007/s004390050686; Zuber J, 2011, NATURE, V478, P524, DOI 10.1038/nature10334	45	190	191	0	49	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 26	2013	501	7468					564	+		10.1038/nature12471	http://dx.doi.org/10.1038/nature12471			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	223RP	23975099	Green Accepted			2022-12-24	WOS:000324826300062
J	Lee, SM; Donaldson, GP; Mikulski, Z; Boyajian, S; Ley, K; Mazmanian, SK				Lee, S. Melanie; Donaldson, Gregory P.; Mikulski, Zbigniew; Boyajian, Silva; Ley, Klaus; Mazmanian, Sarkis K.			Bacterial colonization factors control specificity and stability of the gut microbiota	NATURE			English	Article							BACTEROIDES-THETAIOTAOMICRON; INTESTINAL MICROBIOTA; COMMENSAL; DIVERSITY; DISEASE; SYMBIOSIS; SYSTEM; MODEL; FLORA	Mammals harbour a complex gut microbiome, comprising bacteria that confer immunological, metabolic and neurological benefits(1). Despite advances in sequence-based microbial profiling and myriad studies defining microbiome composition during health and disease, little is known about the molecular processes used by symbiotic bacteria to stably colonize the gastrointestinal tract. We sought to define how mammals assemble and maintain the Bacteroides, one of the most numerically prominent genera of the human microbiome. Here we find that, whereas the gut normally contains hundreds of bacterial species(2,3), germ-free mice mono-associated with a single Bacteroides species are resistant to colonization by the same, but not different, species. To identify bacterial mechanisms for species-specific saturable colonization, we devised an in vivo genetic screen and discovered a unique class of polysaccharide utilization loci that is conserved among intestinal Bacteroides. We named this genetic locus the commensal colonization factors (ccf). Deletion of the ccf genes in the model symbiont, Bacteroides fragilis, results in colonization defects in mice and reduced horizontal transmission. The ccf genes of B. fragilis are upregulated during gut colonization, preferentially at the colonic surface. When we visualize microbial biogeography within the colon, B. fragilis penetrates the colonic mucus and resides deep within crypt channels, whereas ccf mutants are defective in crypt association. Notably, the CCF system is required for B. fragilis colonization following microbiome disruption with Citrobacter rodentium infection or antibiotic treatment, suggesting that the niche within colonic crypts represents a reservoir for bacteria to maintain long-term colonization. These findings reveal that intestinal Bacteroides have evolved species-specific physical interactions with the host that mediate stable and resilient gut colonization, and the CCF system represents a novel molecular mechanism for symbiosis.	[Lee, S. Melanie; Donaldson, Gregory P.; Boyajian, Silva; Mazmanian, Sarkis K.] CALTECH, Div Biol & Biol Engn, Pasadena, CA 91125 USA; [Mikulski, Zbigniew; Ley, Klaus] La Jolla Inst Allergy & Immunol, Div Inflammat Biol, La Jolla, CA 92037 USA	California Institute of Technology; La Jolla Institute for Immunology	Mazmanian, SK (corresponding author), CALTECH, Div Biol & Biol Engn, Pasadena, CA 91125 USA.	sarkis@caltech.edu	Mazmanian, Sarkis/ABD-7729-2021; Mikulski, Zbigniew/AAB-4447-2020	Mazmanian, Sarkis/0000-0003-2713-1513; Mikulski, Zbigniew/0000-0002-1918-9216; Donaldson, Gregory/0000-0002-8551-374X	National Institutes of Health [GM099535, DK078938]; Crohn's and Colitis Foundation of America;  [GM007616]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK078938, P01DK091222, R56DK078938, R21DK083633] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM099535, T32GM007616] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Crohn's and Colitis Foundation of America; ; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank T. Thron and S. McBride for the maintenance of germ-free animals, J. Selicha for assisting with the experimental procedures and G. Chodaczek for help with confocal and two-photon microscopy. We are grateful to E. C. Martens and members of the Mazmanian laboratory for critical review of the manuscript. S. M. L. and G. P. D. were supported by a pre-doctoral training grant (GM007616). This work was supported by grants from the National Institutes of Health (GM099535 and DK078938) and the Crohn's and Colitis Foundation of America to S.K.M.	Bloom SM, 2011, CELL HOST MICROBE, V9, P390, DOI 10.1016/j.chom.2011.04.009; Bry L, 1996, SCIENCE, V273, P1380, DOI 10.1126/science.273.5280.1380; Dethlefsen L, 2008, PLOS BIOL, V6, P2383, DOI 10.1371/journal.pbio.0060280; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; FRETER R, 1983, INFECT IMMUN, V39, P676, DOI 10.1128/IAI.39.2.676-685.1983; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Kawada M, 2008, LAB INVEST, V88, P883, DOI 10.1038/labinvest.2008.47; Koropatkin NM, 2012, NAT REV MICROBIOL, V10, P323, DOI 10.1038/nrmicro2746; Ley RE, 2006, CELL, V124, P837, DOI 10.1016/j.cell.2006.02.017; Martens EC, 2008, CELL HOST MICROBE, V4, P447, DOI 10.1016/j.chom.2008.09.007; Martens EC, 2009, J BIOL CHEM, V284, P24673, DOI 10.1074/jbc.R109.022848; Mazmanian SK, 2008, NATURE, V453, P620, DOI 10.1038/nature07008; Mazmanian SK, 2005, CELL, V122, P107, DOI 10.1016/j.cell.2005.05.007; McFall-Ngai M, 2013, P NATL ACAD SCI USA, V110, P3229, DOI 10.1073/pnas.1218525110; Mundy R, 2005, CELL MICROBIOL, V7, P1697, DOI 10.1111/j.1462-5822.2005.00625.x; Ochoa-Reparaz J, 2010, J IMMUNOL, V185, P4101, DOI 10.4049/jimmunol.1001443; Palmer C, 2007, PLOS BIOL, V5, P1556, DOI 10.1371/journal.pbio.0050177; Pedron T, 2012, MBIO, V3, DOI 10.1128/mBio.00116-12; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Round JL, 2011, SCIENCE, V332, P974, DOI 10.1126/science.1206095; Round JL, 2010, P NATL ACAD SCI USA, V107, P12204, DOI 10.1073/pnas.0909122107; Schauer K, 2008, TRENDS BIOCHEM SCI, V33, P330, DOI 10.1016/j.tibs.2008.04.012; Shipman JA, 2000, J BACTERIOL, V182, P5365, DOI 10.1128/JB.182.19.5365-5372.2000; Sonnenburg JL, 2005, SCIENCE, V307, P1955, DOI 10.1126/science.1109051; Wurch T, 1998, BIOTECHNOL TECH, V12, P653, DOI 10.1023/A:1008848517221; Xu J, 2003, SCIENCE, V299, P2074, DOI 10.1126/science.1080029; Yatsunenko T, 2012, NATURE, V486, P222, DOI 10.1038/nature11053	27	348	358	6	304	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 19	2013	501	7467					426	+		10.1038/nature12447	http://dx.doi.org/10.1038/nature12447			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219XT	23955152	Green Accepted			2022-12-24	WOS:000324545700047
J	Delgoffe, GM; Woo, SR; Turnis, ME; Gravano, DM; Guy, C; Overacre, AE; Bettini, ML; Vogel, P; Finkelstein, D; Bonnevier, J; Workman, CJ; Vignali, DAA				Delgoffe, Greg M.; Woo, Seng-Ryong; Turnis, Meghan E.; Gravano, David M.; Guy, Cliff; Overacre, Abigail E.; Bettini, Matthew L.; Vogel, Peter; Finkelstein, David; Bonnevier, Jody; Workman, Creg J.; Vignali, Dario A. A.			Stability and function of regulatory T cells is maintained by a neuropilin-1-semaphorin-4a axis	NATURE			English	Article							PLASMACYTOID DENDRITIC CELLS; TRANSCRIPTION FACTOR FOXP3; BREAST-CANCER CELLS; IN-VIVO; NEUROPILIN-1; EXPRESSION; AKT; DIFFERENTIATION; ACTIVATION; MARKER	Regulatory T cells (T-reg cells) have a crucial role in the immune system by preventing autoimmunity, limiting immunopathology, and maintaining immune homeostasis(1). However, they also represent a major barrier to effective anti-tumour immunity and sterilizing immunity to chronic viral infections(1). The transcription factor Foxp3 has a major role in the development and programming of T-reg cells(2,3). The relative stability of T-reg cells at inflammatory disease sites has been a highly contentious subject(4-6). There is considerable interest in identifying pathways that control the stability of T-reg cells as many immune-mediated diseases are characterized by either exacerbated or limited T-reg-cell function. Here we show that the immune-cell-expressed ligand semaphorin-4a (Sema4a) and the T-reg-cell-expressed receptor neuropilin-1 (Nrp1) interact both in vitro, to potentiate T-reg-cell function and survival, and in vivo, at inflammatory sites. Using mice with a T-reg-cell-restricted deletion of Nrp1, we show that Nrp1 is dispensable for suppression of autoimmunity and maintenance of immune homeostasis, but is required by T-reg cells to limit anti-tumour immune responses and to cure established inflammatory colitis. Sema4a ligation of Nrp1 restrained Akt phosphorylation cellularly and at the immunologic synapse by phosphatase and tensin homologue (PTEN), which increased nuclear localization of the transcription factor Foxo3a. The Nrp1-induced transcriptome promoted T-reg-cell stability by enhancing quiescence and survival factors while inhibiting programs that promote differentiation. Importantly, this Nrp1-dependent molecular program is evident in intra-tumoral T-reg cells. Our data support a model in which T-reg-cell stability can be subverted in certain inflammatory sites, but is maintained by a Sema4a-Nrp1 axis, highlighting this pathway as a potential therapeutic target that could limit T-reg-cell-mediated tumour-induced tolerance without inducing autoimmunity.	[Delgoffe, Greg M.; Woo, Seng-Ryong; Turnis, Meghan E.; Gravano, David M.; Guy, Cliff; Overacre, Abigail E.; Bettini, Matthew L.; Workman, Creg J.; Vignali, Dario A. A.] St Jude Childrens Res Hosp, Dept Immunol, Memphis, TN 38105 USA; [Overacre, Abigail E.] Univ Tennessee, Hlth Sci Ctr, Integrated Biomed Sci Program, Memphis, TN 38163 USA; [Vogel, Peter] St Jude Childrens Res Hosp, Dept Pathol, Memphis, TN 38105 USA; [Finkelstein, David] St Jude Childrens Res Hosp, Memphis, TN 38105 USA; [Bonnevier, Jody] R&D Syst Inc, Minneapolis, MN 55413 USA	St Jude Children's Research Hospital; University of Tennessee System; University of Tennessee Health Science Center; St Jude Children's Research Hospital; St Jude Children's Research Hospital	Vignali, DAA (corresponding author), St Jude Childrens Res Hosp, Dept Immunol, 332 N Lauderdale St, Memphis, TN 38105 USA.	vignali.lab@stjude.org	Vogel, Peter/N-2490-2018; Delgoffe, Greg M./HCH-2805-2022	Vogel, Peter/0000-0002-7535-0545; Delgoffe, Greg M./0000-0002-2957-8135; Overacre, Abigail/0000-0003-4027-3487	National Institutes of Health [R01 AI091977, AI039480, F32 AI098383]; NCI Comprehensive Cancer Center Support CORE grant [CA21765]; ALSAC; NATIONAL CANCER INSTITUTE [P30CA021765] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [F32AI098383, T32AI007610, R29AI039480, R01AI039480, R01AI091977] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI Comprehensive Cancer Center Support CORE grant; ALSAC(American Lebanese Syrian Associated Charities (ALSAC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The authors would like to thank E. J. Wherry and H. Chi for advice; A. Rudensky, D. Cheresh, K. Yang, T. Geiger and H. Chi for mice; D. R. Green for plasmids; and B. Triplett, M. Howard and M. McKenna at St Louis Cord Blood Bank for cord blood samples. The authors also thank K. Forbes and A. McKenna for maintenance, breeding and genotyping of mouse colonies; A. Castellaw for preparation of human cord blood samples; K. M. Vignali for assistance with cloning; A. Herrada for generating Nrp1-IgG1; A. L. Szymczak-Workman for assistance with histological analysis; S. Morgan, G. Lennon and R. Cross of the St Jude Immunology Flow Lab for cell sorting; the staff of the Shared Animal Resource Center at St Jude Children's Research Hospital for the animal husbandry; the Hartwell Center for Biotechnology and Bioinformatics at St Jude Children's Research Hospital for Affymetrix microarray analysis; the Veterinary Pathology Core for histological preparation; and the Immunology Department at St Jude Children's Research Hospital for helpful discussions. This work was supported by the National Institutes of Health (R01 AI091977 and AI039480 to D. A. A. V.; F32 AI098383 to G. M. D.), NCI Comprehensive Cancer Center Support CORE grant (CA21765, to D. A. A. V.) and ALSAC (to D.A.A.V.).	Bruder D, 2004, EUR J IMMUNOL, V34, P623, DOI 10.1002/eji.200324799; Castro-Rivera E, 2008, CANCER RES, V68, P8295, DOI 10.1158/0008-5472.CAN-07-6601; Collison LW, 2009, J IMMUNOL, V182, P6121, DOI 10.4049/jimmunol.0803646; Crellin NK, 2007, BLOOD, V109, P2014, DOI 10.1182/blood-2006-07-035279; Demoulin S, 2013, J LEUKOCYTE BIOL, V93, P343, DOI 10.1189/jlb.0812397; Fontenot JD, 2017, J IMMUNOL, V198, P986, DOI 10.1038/ni904; FRANKE TF, 1995, CELL, V81, P727, DOI 10.1016/0092-8674(95)90534-0; Guy CS, 2013, NAT IMMUNOL, V14, P262, DOI 10.1038/ni.2538; Haxhinasto S, 2008, J EXP MED, V205, P565, DOI 10.1084/jem.20071477; Heng TSP, 2008, NAT IMMUNOL, V9, P1091, DOI 10.1038/ni1008-1091; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Kerdiles YM, 2011, IMMUNITY, V34, P135, DOI 10.1016/j.immuni.2011.01.008; Kim JM, 2007, NAT IMMUNOL, V8, P191, DOI 10.1038/ni1428; Kolodkin AL, 1997, CELL, V90, P753, DOI 10.1016/S0092-8674(00)80535-8; Kumanogoh A, 2002, NATURE, V419, P629, DOI 10.1038/nature01037; Merkenschlager M, 2010, J EXP MED, V207, P1347, DOI 10.1084/jem.20101156; Milpied P, 2009, EUR J IMMUNOL, V39, P1466, DOI 10.1002/eji.200839040; Miyao T, 2012, IMMUNITY, V36, P262, DOI 10.1016/j.immuni.2011.12.012; Nishikawa H, 2010, INT J CANCER, V127, P759, DOI 10.1002/ijc.25429; Ouyang W, 2010, NAT IMMUNOL, V11, P618, DOI 10.1038/ni.1884; Pellet-Many C, 2008, BIOCHEM J, V411, P211, DOI 10.1042/BJ20071639; Piechnik A., 2013, INT J CANC; Qiao M, 2007, IMMUNOLOGY, V121, P146, DOI 10.1111/j.1365-2567.2007.02625.x; Rubtsov YP, 2010, SCIENCE, V329, P1667, DOI 10.1126/science.1191996; Sawant A, 2012, J IMMUNOL, V189, P4258, DOI 10.4049/jimmunol.1101855; Stambolic V, 1998, CELL, V95, P29, DOI 10.1016/S0092-8674(00)81780-8; Vignali DAA, 2008, NAT REV IMMUNOL, V8, P523, DOI 10.1038/nri2343; Weiss JM, 2012, J EXP MED, V209, P1723, DOI 10.1084/jem.20120914; Wilde S, 2012, J IMMUNOL, V189, P598, DOI 10.4049/jimmunol.1102165; Yadav M, 2012, J EXP MED, V209, P1713, DOI 10.1084/jem.20120822; Zhou XY, 2009, NAT IMMUNOL, V10, P1000, DOI 10.1038/ni.1774	31	365	390	6	70	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 12	2013	501	7466					252	+		10.1038/nature12428	http://dx.doi.org/10.1038/nature12428			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	215XR	23913274	Green Accepted			2022-12-24	WOS:000324244900047
J	Alexandrov, LB; Nik-Zainal, S; Wedge, DC; Aparicio, SAJR; Behjati, S; Biankin, AV; Bignell, GR; Bolli, N; Borg, A; Borresen-Dale, AL; Boyault, S; Burkhardt, B; Butler, AP; Caldas, C; Davies, HR; Desmedt, C; Eils, R; Eyfjord, JE; Foekens, JA; Greaves, M; Hosoda, F; Hutter, B; Ilicic, T; Imbeaud, S; Imielinsk, M; Jager, N; Jones, DTW; Jones, D; Knappskog, S; Kool, M; Lakhani, SR; Lopez-Otin, C; Martin, S; Munshi, NC; Nakamura, H; Northcott, PA; Pajic, M; Papaemmanuil, E; Paradiso, A; Pearson, JV; Puente, XS; Raine, K; Ramakrishna, M; Richardson, AL; Richter, J; Rosenstiel, P; Schlesner, M; Schumacher, TN; Span, PN; Teague, JW; Totoki, Y; Tutt, ANJ; Valdes-Mas, R; van Buuren, MM; van 't Veer, L; Vincent-Salomon, A; Waddell, N; Yates, LR; Zucman-Rossi, J; Futreal, PA; McDermott, U; Lichter, P; Meyerson, M; Grimmond, SM; Siebert, R; Campo, E; Shibata, T; Pfister, SM; Campbell, PJ; Stratton, MR				Alexandrov, Ludmil B.; Nik-Zainal, Serena; Wedge, David C.; Aparicio, Samuel A. J. R.; Behjati, Sam; Biankin, Andrew V.; Bignell, Graham R.; Bolli, Niccolo; Borg, Ake; Borresen-Dale, Anne-Lise; Boyault, Sandrine; Burkhardt, Birgit; Butler, Adam P.; Caldas, Carlos; Davies, Helen R.; Desmedt, Christine; Eils, Roland; Eyfjord, Jorunn Erla; Foekens, John A.; Greaves, Mel; Hosoda, Fumie; Hutter, Barbara; Ilicic, Tomislav; Imbeaud, Sandrine; Imielinsk, Marcin; Jaeger, Natalie; Jones, David T. W.; Jones, David; Knappskog, Stian; Kool, Marcel; Lakhani, Sunil R.; Lopez-Otin, Carlos; Martin, Sancha; Munshi, Nikhil C.; Nakamura, Hiromi; Northcott, Paul A.; Pajic, Marina; Papaemmanuil, Elli; Paradiso, Angelo; Pearson, John V.; Puente, Xose S.; Raine, Keiran; Ramakrishna, Manasa; Richardson, Andrea L.; Richter, Julia; Rosenstiel, Philip; Schlesner, Matthias; Schumacher, Ton N.; Span, Paul N.; Teague, Jon W.; Totoki, Yasushi; Tutt, Andrew N. J.; Valdes-Mas, Rafael; van Buuren, Marit M.; van 't Veer, Laura; Vincent-Salomon, Anne; Waddell, Nicola; Yates, Lucy R.; Zucman-Rossi, Jessica; Futreal, P. Andrew; McDermott, Ultan; Lichter, Peter; Meyerson, Matthew; Grimmond, Sean M.; Siebert, Reiner; Campo, Elias; Shibata, Tatsuhiro; Pfister, Stefan M.; Campbell, Peter J.; Stratton, Michael R.		Australian Pancreatic Canc Genome; ICGC Breast Canc Consortium; ICGC MMML-Seq Consortium; ICGC PedBrain	Signatures of mutational processes in human cancer	NATURE			English	Article							RECURRENT MUTATIONS; SOMATIC MUTATIONS; GENETIC LANDSCAPE; FREQUENT MUTATION; DRIVER MUTATIONS; MISMATCH REPAIR; EXOME; REVEALS; ADENOCARCINOMA; INSTABILITY	All cancers are caused by somatic mutations; however, understanding of the biological processes generating these mutations is limited. The catalogue of somatic mutations from a cancer genome bears the signatures of the mutational processes that have been operative. Here we analysed 4,938,362 mutations from 7,042 cancers and extracted more than 20 distinct mutational signatures. Some are present in many cancer types, notably a signature attributed to the APOBEC family of cytidine deaminases, whereas others are confined to a single cancer class. Certain signatures are associated with age of the patient at cancer diagnosis, known mutagenic exposures or defects in DNA maintenance, but many are of cryptic origin. In addition to these genome-wide mutational signatures, hypermutation localized to small genomic regions, 'kataegis', is found in many cancer types. The results reveal the diversity of mutational processes underlying the development of cancer, with potential implications for understanding of cancer aetiology, prevention and therapy.	[Alexandrov, Ludmil B.; Nik-Zainal, Serena; Wedge, David C.; Behjati, Sam; Bignell, Graham R.; Bolli, Niccolo; Butler, Adam P.; Davies, Helen R.; Ilicic, Tomislav; Jones, David; Martin, Sancha; Papaemmanuil, Elli; Raine, Keiran; Ramakrishna, Manasa; Teague, Jon W.; Yates, Lucy R.; Futreal, P. Andrew; McDermott, Ultan; Campbell, Peter J.; Stratton, Michael R.] Wellcome Trust Sanger Inst, Canc Genome Project, Hinxton CB10 1SA, Cambs, England; [Nik-Zainal, Serena] Addenbrookes Hosp NHS Trust, Dept Med Genet, Cambridge CB2 0QQ, England; [Aparicio, Samuel A. J. R.] BC Canc Agcy, Michael Smith Genome Sci Ctr, Vancouver, BC V5Z 1L3, Canada; [Aparicio, Samuel A. J. R.] BC Canc Agcy, Michael Smith Genome Sci Ctr, Ctr Translat & Appl Genom, Vancouver, BC V5Z 1L3, Canada; [Aparicio, Samuel A. J. R.] Univ British Columbia, Dept Pathol, Vancouver, BC V6T 2B5, Canada; [Behjati, Sam] Univ Cambridge, Dept Paediat, Cambridge CB2 2XY, England; [Biankin, Andrew V.; Pajic, Marina] Univ Glasgow, Wolfson Wohl Canc Res Ctr, Inst Canc Sci, Glasgow G61 1BD, Lanark, Scotland; [Biankin, Andrew V.] Glasgow Royal Infirm, West Scotland Pancreat Unit, Glasgow G4 0SF, Lanark, Scotland; [Biankin, Andrew V.] Kinghorn Canc Ctr, Darlinghurst, NSW, Australia; [Biankin, Andrew V.] Garvan Inst Med Res, Canc Res Program, Darlinghurst, NSW 2010, Australia; [Biankin, Andrew V.] Bankstown Hosp, Dept Surg, Sydney, NSW 2200, Australia; [Biankin, Andrew V.] Univ New S Wales, South Western Sydney Clin Sch, Fac Med, Liverpool, NSW 2170, Australia; [Bolli, Niccolo; Campbell, Peter J.] Addenbrookes Hosp, Dept Haematol, Cambridge CB2 0QQ, England; [Bolli, Niccolo; Campbell, Peter J.] Univ Cambridge, Dept Haematol, Cambridge CB2 2XY, England; [Borg, Ake] Lund Univ, Dept Oncol, SE-22185 Lund, Sweden; [Borresen-Dale, Anne-Lise] Norwegian Radium Hosp, Oslo Univ Hosp, Dept Genet, Inst Canc Res, N-0310 Oslo, Norway; [Borresen-Dale, Anne-Lise] Univ Oslo, Fac Med, Inst Clin Med, KG Jebsen Ctr Breast Canc Res, N-0310 Oslo, Norway; [Boyault, Sandrine] Ctr Leon Berard, Plateforme Bioinformat Synergie Lyon Canc, F-69373 Lyon 08, France; [Burkhardt, Birgit] Univ Childrens Hosp, NHL BFM Study Ctr, D-48149 Munster, Germany; [Burkhardt, Birgit] Univ Childrens Hosp, Dept Pediat Hematol & Oncol, D-48149 Munster, Germany; [Burkhardt, Birgit] Univ Childrens Hosp, NHL BFM Study Ctr, D-35392 Giessen, Germany; [Burkhardt, Birgit] Univ Childrens Hosp, Dept Pediat Hematol & Oncol, D-35392 Giessen, Germany; [Caldas, Carlos] Univ Cambridge, Li Ka Shing Ctr, Canc Res UK Cambridge Inst, Cambridge CB2 0RE, England; [Desmedt, Christine] Univ Libre Bruxelles, Inst Jules Bordet, Breast Canc Translat Res Lab BCTL, B-1000 Brussels, Belgium; [Eils, Roland; Hutter, Barbara; Jaeger, Natalie; Schlesner, Matthias] German Canc Res Ctr, Dept Theoret Bioinformat B080, D-69120 Heidelberg, Germany; [Eyfjord, Jorunn Erla] Univ Iceland, Canc Res Lab, Fac Med, Biomed Ctr, IS-101 Reykjavik, Iceland; [Foekens, John A.] Erasmus MC Canc Inst, Dept Med Oncol, NL-3015 CE Rotterdam, Netherlands; [Greaves, Mel] Inst Canc Res, Dept Haematooncol, Sutton SM2 5NG, Surrey, England; [Hosoda, Fumie; Nakamura, Hiromi; Totoki, Yasushi; Shibata, Tatsuhiro] Natl Canc Ctr, Res Inst, Div Canc Genom, Chuo Ku, Tokyo 1040045, Japan; [Imbeaud, Sandrine; Zucman-Rossi, Jessica] IUH, INSERM, UMR 674, F-75475 Paris, France; [Imbeaud, Sandrine; Zucman-Rossi, Jessica] Univ Paris 05, Sorbonne Paris Cite, Fac Med, F-75006 Paris, France; [Imielinsk, Marcin; Meyerson, Matthew] Broad Inst MIT & Harvard, Cambridge, MA 02141 USA; [Jones, David T. W.; Kool, Marcel; Northcott, Paul A.; Pfister, Stefan M.] German Canc Res Ctr, Div Pediat Neurooncol, D-69120 Heidelberg, Germany; [Knappskog, Stian] Univ Bergen, Dept Clin Sci, Sect Oncol, N-5020 Bergen, Norway; [Knappskog, Stian] Haukeland Hosp, Dept Oncol, N-5021 Bergen, Norway; [Lakhani, Sunil R.] Univ Queensland, Royal Brisbane & Womens Hosp, Clin Res Ctr, Sch Med & Pathol Queensland, Brisbane, Qld 4029, Australia; [Lopez-Otin, Carlos; Puente, Xose S.; Valdes-Mas, Rafael] Univ Oviedo, IUOPA, Dept Bioquim & Biol Mol, E-33006 Oviedo, Spain; [Munshi, Nikhil C.] Harvard Univ, Sch Med, Jerome Lipper Multiple Myeloma Dis Ctr, Dana Farber Canc Inst, Boston, MA 02215 USA; [Munshi, Nikhil C.] Boston Vet Adm Healthcare Syst, West Roxbury, MA 02132 USA; [Paradiso, Angelo] Natl Canc Inst, Clin Expt Oncol Lab, I-70126 Bari, Italy; [Pearson, John V.; Waddell, Nicola; Grimmond, Sean M.] Univ Queensland, Queensland Ctr Med Genom, Inst Mol Biosci, Brisbane, Qld 4072, Australia; [Richardson, Andrea L.; Meyerson, Matthew] Dana Farber Canc Inst, Boston, MA 02215 USA; [Richardson, Andrea L.; Meyerson, Matthew] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Richardson, Andrea L.] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; [Richter, Julia; Siebert, Reiner] Univ Kiel, Inst Human Genet, D-24118 Kiel, Germany; [Rosenstiel, Philip] Univ Kiel, Inst Clin Mol Biol, D-24118 Kiel, Germany; [Schumacher, Ton N.; van Buuren, Marit M.] Netherlands Canc Inst, Div Immunol, NL-1066 CX Amsterdam, Netherlands; [Span, Paul N.] Radboud Univ Nijmegen, Med Ctr, Dept Radiat Oncol, NL-6500 HB Nijmegen, Netherlands; [Span, Paul N.] Radboud Univ Nijmegen, Med Ctr, Dept Lab Med, NL-6500 HB Nijmegen, Netherlands; [Tutt, Andrew N. J.] Kings Coll London, Sch Med, Breakthrough Breast Canc Res Unit, London SW3 6JB, England; [van 't Veer, Laura] Netherlands Canc Inst, NL-1066 CX Amsterdam, Netherlands; [Vincent-Salomon, Anne] INSERM, U830, Dept Pathol, Inst Curie, F-75248 Paris 05, France; [Lichter, Peter] German Canc Res Ctr, Div Mol Genet, D-69120 Heidelberg, Germany; [Campo, Elias] Univ Barcelona, Unidad Hematopatol, Serv Anat Patol, Hosp Clin,IDIBAPS, E-08036 Barcelona, Spain; [Pfister, Stefan M.] Dept Pediat Hematol & Oncol, D-69120 Heidelberg, Germany	Wellcome Trust Sanger Institute; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; British Columbia Cancer Agency; British Columbia Cancer Agency; University of British Columbia; University of Cambridge; University of Glasgow; University of Glasgow; Garvan Institute of Medical Research; University of New South Wales Sydney; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Cambridge; Lund University; University of Oslo; University of Oslo; UNICANCER; Centre Leon Berard; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Munster; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Munster; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; Cancer Research UK; CRUK Cambridge Institute; University of Cambridge; Institut Jules Bordet; Universite Libre de Bruxelles; Helmholtz Association; German Cancer Research Center (DKFZ); University of Iceland; Erasmus University Rotterdam; Erasmus MC; Erasmus MC Cancer Institute; University of London; Institute of Cancer Research - UK; National Cancer Center - Japan; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Helmholtz Association; German Cancer Research Center (DKFZ); University of Bergen; University of Bergen; Haukeland University Hospital; Royal Brisbane & Women's Hospital; University of Queensland; University of Oviedo; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; IRCCS Istituto Tumori Bari Giovanni Paolo II; University of Queensland; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; University of Kiel; University of Kiel; Netherlands Cancer Institute; Radboud University Nijmegen; Radboud University Nijmegen; University of London; King's College London; Netherlands Cancer Institute; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm); Helmholtz Association; German Cancer Research Center (DKFZ); University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS	Alexandrov, LB (corresponding author), Wellcome Trust Sanger Inst, Canc Genome Project, Wellcome Trust Genome Campus, Hinxton CB10 1SA, Cambs, England.	mrs@sanger.ac.uk	Caldas, Carlos/U-7250-2019; Wedge, David/AAC-4977-2021; paradiso, angelo V/J-9457-2018; Shibata, Tatsuhiro/ABA-8234-2020; Grimmond, Sean/K-3246-2019; Valdés-Mas, Rafael/AAC-2879-2021; Nik-Zainal, Serena/ABD-4437-2020; Burkhardt, Birgit/AAS-9678-2021; Schumacher, Ton/Y-2432-2019; Bolli, Niccolo/D-4057-2011; Hoffmann, Steve/E-1438-2013; Langenberger, David/AAF-3313-2020; Rosenstiel, Philip/A-5137-2009; Kool, Marcel/H-2541-2013; Campo, Elias/AAC-5593-2019; Stadler, Peter F. F/L-7857-2015; j, zucman-rossi/AAV-3594-2021; Pearson, John V/F-2249-2011; Waddell, Nicola/H-4929-2015; Klapper, Wolfram/S-6314-2016; Grimmond, Sean M/J-5304-2016; Ammerpohl, Ole/G-2691-2010; Pearson, John/AAT-4211-2020; zucman-rossi, Jessica/B-5098-2009; Pfister, Stefan M/F-6860-2013; Schlesner, Matthias/I-4030-2013; Siebert, Reiner/A-8049-2010; Span, Paul/G-4710-2012; Lakhani, Sunil R/I-1970-2018; Munshi, Nikhil/ABE-2338-2021; Puente, Xosé S./ADB-0672-2022; Desmedt, Christine/P-7438-2017; Eils, Roland/B-6121-2009; Shibata, Tatsuhiro/AAO-1278-2021; Jones, David TW/G-9588-2013; Hoell, Jessica/J-8136-2016; Northcott, Paul A/N-4022-2018; Alexandrov, Ludmil/AAS-1454-2021; Bult, Peter/L-4236-2015; Gill, Anthony/D-4215-2015; López-Otín, Carlos/AAB-2106-2020; Sweep, C.G.J./H-8096-2014; Jones, David T. W./Z-1963-2019; Imbeaud, Sandrine/P-8780-2017; Radlwimmer, Bernhard/I-3229-2013; Langenberger, David/D-4155-2013	Caldas, Carlos/0000-0003-3547-1489; Grimmond, Sean/0000-0002-8102-7998; Valdés-Mas, Rafael/0000-0002-0737-5425; Burkhardt, Birgit/0000-0002-1151-829X; Schumacher, Ton/0000-0003-0517-8804; Bolli, Niccolo/0000-0002-1018-5139; Rosenstiel, Philip/0000-0002-9692-8828; Campo, Elias/0000-0001-9850-9793; Stadler, Peter F. F/0000-0002-5016-5191; j, zucman-rossi/0000-0002-5687-0334; Pearson, John V/0000-0003-0904-4598; Waddell, Nicola/0000-0002-3950-2476; Grimmond, Sean M/0000-0002-8102-7998; zucman-rossi, Jessica/0000-0002-5687-0334; Pfister, Stefan M/0000-0002-5447-5322; Schlesner, Matthias/0000-0002-5896-4086; Span, Paul/0000-0002-1930-6638; Lakhani, Sunil R/0000-0003-4067-2760; Puente, Xosé S./0000-0001-9525-1483; Desmedt, Christine/0000-0002-5223-5579; Eils, Roland/0000-0002-0034-4036; Jones, David TW/0000-0002-2036-5141; Hoell, Jessica/0000-0002-5532-9845; Northcott, Paul A/0000-0002-1220-5252; Alexandrov, Ludmil/0000-0003-3596-4515; Bult, Peter/0000-0001-6427-9889; Gill, Anthony/0000-0002-9447-1967; López-Otín, Carlos/0000-0001-6964-1904; Sweep, C.G.J./0000-0003-1103-3070; Pajic, Marina/0000-0002-3871-3829; , Stephan/0000-0002-5928-9449; Aparicio, Samuel/0000-0002-0487-9599; Nik-Zainal, Serena/0000-0001-5054-1727; Wedge, David/0000-0002-7572-3196; Tutt, Andrew/0000-0001-8715-2901; Imbeaud, Sandrine/0000-0001-8439-6732; Kuppers, Ralf/0000-0002-6691-7191; Yates, Lucy/0000-0003-4519-7794; Hutter, Barbara/0000-0002-9034-0329; Knappskog, Stian/0000-0002-4153-1655; Jaeger, Natalie/0000-0002-9589-7580; Martin, Sancha/0000-0001-6213-5259; Claviez, Alexander/0000-0002-1561-5185; McDermott, Ultan/0000-0001-9032-4700; Biankin, Andrew/0000-0002-0362-5597; Raine, Keiran/0000-0002-5634-1539; Radlwimmer, Bernhard/0000-0002-4553-7800; Kreuz, Markus/0000-0002-0520-8391; Langenberger, David/0000-0001-9424-9701; Meyerson, Matthew/0000-0002-9133-8108	Wellcome Trust [098051]; Breast Cancer Now [KCL-Q1] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [T32CA009216] Funding Source: NIH RePORTER	Wellcome Trust(Wellcome TrustEuropean Commission); Breast Cancer Now; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We would like to thank the Wellcome Trust for support (grant reference 098051) together with many other funding bodies and individuals (Supplementary Note 1).	Agrawal N, 2011, SCIENCE, V333, P1154, DOI 10.1126/science.1206923; Alexandrov LB, 2013, CELL REP, V3, P246, DOI 10.1016/j.celrep.2012.12.008; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Barbieri CE, 2012, NAT GENET, V44, P685, DOI 10.1038/ng.2279; Baumbusch LO, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-379; Berger MF, 2012, NATURE, V485, P502, DOI 10.1038/nature11071; Berger MF, 2011, NATURE, V470, P214, DOI 10.1038/nature09744; Boland CR, 2010, GASTROENTEROLOGY, V138, P2073, DOI [10.1053/j.gastro.2009.12.064, 10.1053/j.gastro.2010.04.024]; Burns MB, 2013, NATURE, V494, P366, DOI 10.1038/nature11881; De Keersmaecker K, 2013, NAT GENET, V45, P186, DOI 10.1038/ng.2508; Di Nola JM, 2007, ANNU REV BIOCHEM, V76, P1, DOI 10.1146/annurev.biochem.76.061705.090740; Ding L, 2008, NATURE, V455, P1069, DOI 10.1038/nature07423; Ding L, 2012, NATURE, V481, P506, DOI 10.1038/nature10738; Dulak AM, 2013, NAT GENET, V45, P478, DOI 10.1038/ng.2591; Fu WQ, 2013, NATURE, V493, P216, DOI 10.1038/nature11690; Getz G, 2013, NATURE, V497, P67, DOI 10.1038/nature12113; Grasso CS, 2012, NATURE, V487, P239, DOI 10.1038/nature11125; Guo GW, 2012, NAT GENET, V44, P17, DOI 10.1038/ng.1014; Hanawalt PC, 2008, NAT REV MOL CELL BIO, V9, P958, DOI 10.1038/nrm2549; Harris RS, 2002, MOL CELL, V10, P1247, DOI 10.1016/S1097-2765(02)00742-6; Hodis E, 2012, CELL, V150, P251, DOI 10.1016/j.cell.2012.06.024; Holmfeldt L, 2013, NAT GENET, V45, P242, DOI 10.1038/ng.2532; Hudson TJ, 2010, NATURE, V464, P993, DOI 10.1038/nature08987; Hunter C, 2006, CANCER RES, V66, P3987, DOI 10.1158/0008-5472.CAN-06-0127; Imielinski M, 2012, CELL, V150, P1107, DOI 10.1016/j.cell.2012.08.029; Jiao YC, 2011, SCIENCE, V331, P1199, DOI 10.1126/science.1200609; Jones S, 2010, SCIENCE, V330, P228, DOI 10.1126/science.1196333; Koito A, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00028; Lawrence MS, 2013, NATURE, V499, P214, DOI 10.1038/nature12213; Love C, 2012, NAT GENET, V44, P1321, DOI 10.1038/ng.2468; Morin RD, 2011, NATURE, V476, P298, DOI 10.1038/nature10351; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Nik-Zainal S, 2012, CELL, V149, DOI 10.1016/j.cell.2012.04.023; Nik-Zainal S, 2012, CELL, V149, P979, DOI 10.1016/j.cell.2012.04.024; Olivier M, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001008; Peifer M, 2012, NAT GENET, V44, P1104, DOI 10.1038/ng.2396; Pena-Diaz J, 2012, MOL CELL, V47, P669, DOI 10.1016/j.molcel.2012.07.006; Pena-LlopiS S, 2012, NAT GENET, V44, P751, DOI 10.1038/ng.2323; Pfeifer GP, 2010, GENOME MED, V2, DOI 10.1186/gm175; Pfeifer GP, 2006, CURR TOP MICROBIOL, V301, P259; Pfeifer GP, 2005, MUTAT RES-FUND MOL M, V571, P19, DOI 10.1016/j.mrfmmm.2004.06.057; Pfeifer GP, 2002, ONCOGENE, V21, P7435, DOI 10.1038/sj.onc.1205803; Pickrell JK, 2011, BIOINFORMATICS, V27, P2144, DOI 10.1093/bioinformatics/btr354; Puente XS, 2011, NATURE, V475, P101, DOI 10.1038/nature10113; Pugh TJ, 2013, NAT GENET, V45, P279, DOI 10.1038/ng.2529; Quesada V, 2012, NAT GENET, V44, P47, DOI 10.1038/ng.1032; Rudin CM, 2012, NAT GENET, V44, P1111, DOI 10.1038/ng.2405; Sausen M, 2013, NAT GENET, V45, P12, DOI 10.1038/ng.2493; Seo JS, 2012, GENOME RES, V22, P2109, DOI 10.1101/gr.145144.112; Seshagiri S, 2012, NATURE, V488, P660, DOI 10.1038/nature11282; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Stark MS, 2012, NAT GENET, V44, P165, DOI 10.1038/ng.1041; Stephens PJ, 2012, NATURE, V486, P400, DOI 10.1038/nature11017; Stransky N, 2011, SCIENCE, V333, P1157, DOI 10.1126/science.1208130; Stratton MR, 2009, NATURE, V458, P719, DOI 10.1038/nature07943; Taylor BJM, 2013, ELIFE, V2, DOI 10.7554/eLife.00534; Thompson LH, 2012, MUTAT RES-REV MUTAT, V751, P158, DOI 10.1016/j.mrrev.2012.06.002; Tomita-Mitchell A, 2000, MUTAT RES-FUND MOL M, V450, P125, DOI 10.1016/S0027-5107(00)00020-8; Wang K, 2011, NAT GENET, V43, P1219, DOI 10.1038/ng.982; Welch JS, 2012, CELL, V150, P264, DOI 10.1016/j.cell.2012.06.023; Wu J, 2011, P NATL ACAD SCI USA, V108, P21188, DOI 10.1073/pnas.1118046108; Zang ZJ, 2012, NAT GENET, V44, P570, DOI 10.1038/ng.2246; Zhang JH, 2013, NAT GENET, V45, P602, DOI 10.1038/ng.2611; Zhang JH, 2012, NATURE, V481, P157, DOI 10.1038/nature10725	64	5885	6020	28	660	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 22	2013	500	7463					415	+		10.1038/nature12477	http://dx.doi.org/10.1038/nature12477			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	203TJ	23945592	Green Accepted, Bronze, Green Submitted			2022-12-24	WOS:000323316100026
J	Adolph, TE; Tomczak, MF; Niederreiter, L; Ko, HJ; Bock, J; Martinez-Naves, E; Glickman, JN; Tschurtschenthaler, M; Hartwig, J; Hosomi, S; Flak, MB; Cusick, JL; Kohno, K; Iwawaki, T; Billmann-Born, S; Raine, T; Bharti, R; Lucius, R; Kweon, MN; Marciniak, SJ; Choi, A; Hagen, SJ; Schreiber, S; Rosenstiel, P; Kaser, A; Blumberg, RS				Adolph, Timon E.; Tomczak, Michal F.; Niederreiter, Lukas; Ko, Hyun-Jeong; Boeck, Janne; Martinez-Naves, Eduardo; Glickman, Jonathan N.; Tschurtschenthaler, Markus; Hartwig, John; Hosomi, Shuhei; Flak, Magdalena B.; Cusick, Jennifer L.; Kohno, Kenji; Iwawaki, Takao; Billmann-Born, Susanne; Raine, Tim; Bharti, Richa; Lucius, Ralph; Kweon, Mi-Na; Marciniak, Stefan J.; Choi, Augustine; Hagen, Susan J.; Schreiber, Stefan; Rosenstiel, Philip; Kaser, Arthur; Blumberg, Richard S.			Paneth cells as a site of origin for intestinal inflammation	NATURE			English	Article							ENDOPLASMIC-RETICULUM STRESS; GENOME-WIDE ASSOCIATION; FACTOR-KAPPA-B; ER STRESS; SUSCEPTIBILITY LOCI; EPITHELIAL-CELLS; CROHN-DISEASE; GENE ATG16L1; AUTOPHAGY; ACTIVATION	The recognition of autophagy related 16-like 1 (ATG16L1) as a genetic risk factor has exposed the critical role of autophagy in Crohn's disease(1). Homozygosity for the highly prevalent ATG16L1 risk allele, or murine hypomorphic (HM) activity, causes Paneth cell dysfunction(2,3). As Atg16l1(HM) mice do not develop spontaneous intestinal inflammation, the mechanism(s) by which ATG16L1 contributes to disease remains obscure. Deletion of the unfolded protein response (UPR) transcription factor X-box binding protein-1 (Xbp1) in intestinal epithelial cells, the human orthologue of which harbours rare inflammatory bowel disease risk variants, results in endoplasmic reticulum (ER) stress, Paneth cell impairment and spontaneous enteritis4. Unresolved ER stress is a common feature of inflammatory bowel disease epithelium(4,5), and several genetic risk factors of Crohn's disease affect Paneth cells(2,4,6-9). Here we show that impairment in either UPR (Xbp1(Delta IEC)) or autophagy function (Atg16l1(Delta IEC) or Atg7(Delta IEC)) in intestinal epithelial cells results in each other's compensatory engagement, and severe spontaneous Crohn's-disease-like transmural ileitis if both mechanisms are compromised. Xbp1DIEC mice show autophagosome formation in hypomorphic Paneth cells, which is linked to ER stress via protein kinase RNA-like endoplasmic reticulum kinase (PERK), elongation initiation factor 2 alpha (eIF2 alpha) and activating transcription factor 4 (ATF4). Ileitis is dependent on commensal microbiota and derives from increased intestinal epithelial cell death, inositol requiring enzyme 1 alpha (IRE1 alpha)-regulated NF-kappa B activation and tumour-necrosis factor signalling, which are synergistically increased when autophagy is deficient. ATG16L1 restrains IRE1a activity, and augmentation of autophagy in intestinal epithelial cells ameliorates ER stress-induced intestinal inflammation and eases NF-kappa B overactivation and intestinal epithelial cell death. ER stress, autophagy induction and spontaneous ileitis emerge from Paneth-cell-specific deletion of Xbp1. Genetically and environmentally controlled UPR function within Paneth cells may therefore set the threshold for the development of intestinal inflammation upon hypomorphic ATG16L1 function and implicate ileal Crohn's disease as a specific disorder of Paneth cells.	[Adolph, Timon E.; Niederreiter, Lukas; Tschurtschenthaler, Markus; Raine, Tim; Kaser, Arthur] Univ Cambridge, Addenbrookes Hosp, Dept Med, Div Gastroenterol & Hepatol, Cambridge CB2 0QQ, England; [Tomczak, Michal F.; Ko, Hyun-Jeong; Hosomi, Shuhei; Flak, Magdalena B.; Cusick, Jennifer L.; Blumberg, Richard S.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Gastroenterol,Dept Med, Boston, MA 02115 USA; [Boeck, Janne; Billmann-Born, Susanne; Bharti, Richa; Schreiber, Stefan; Rosenstiel, Philip] Univ Kiel, Inst Clin Mol Biol, D-24105 Kiel, Germany; [Martinez-Naves, Eduardo] Univ Complutense Madrid, Fac Med, Dept Microbiol & Immunol, E-28040 Madrid, Spain; [Glickman, Jonathan N.] Miraca Life Sci, GI Pathol Div, Newton, MA 02464 USA; [Tschurtschenthaler, Markus] Med Univ Innsbruck, Dept Med, A-6020 Innsbruck, Austria; [Hartwig, John] Harvard Univ, Brigham & Womens Hosp, Sch Med, Translat Med Div,Dept Med, Boston, MA 02115 USA; [Kohno, Kenji] Nara Inst Sci & Technol NAIST, Grad Sch Biol Sci, Lab Mol & Cell Genet, Nara 6300192, Japan; [Iwawaki, Takao] Gunma Univ, Adv Sci Res Leaders Dev Unit, Maebashi, Gunma 3718511, Japan; [Iwawaki, Takao] RIKEN, Adv Sci Inst, Iwawaki Initiat Res Unit, Wako, Saitama 3510198, Japan; [Lucius, Ralph] Univ Kiel, Anat Inst, D-24098 Kiel, Germany; [Kweon, Mi-Na] Int Vaccine Inst, Div Sci Lab, Mucosal Immunol Sect, Seoul 151818, South Korea; [Marciniak, Stefan J.] Univ Cambridge, Dept Med, Cambridge Inst Med Res CIMR, Cambridge CB2 0XY, England; [Choi, Augustine] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Pulm & Crit Care Med,Dept Med, Boston, MA 02115 USA; [Hagen, Susan J.] Beth Israel Deaconess Med Ctr, Dept Surg, Boston, MA 02215 USA	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of Kiel; Complutense University of Madrid; Medical University of Innsbruck; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Nara Institute of Science & Technology; Gunma University; RIKEN; University of Kiel; International Vaccine Institute; University of Cambridge; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center	Blumberg, RS (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Gastroenterol,Dept Med, 75 Francis St, Boston, MA 02115 USA.	ak729@cam.ac.uk; rblumberg@partners.org	Rosenstiel, Philip/A-5137-2009; Flak, Magdalena B/M-7106-2016; Lucius, Ralph/B-1614-2010; Tschurtschenthaler, Markus/O-8931-2019; Flak, Magdalena/AAG-5272-2020; MARTINEZ-NAVES, EDUARDO/Y-6177-2019; Parry, Lee/A-9623-2011; Kohno, Kenji/AAZ-6573-2020	Rosenstiel, Philip/0000-0002-9692-8828; Flak, Magdalena B/0000-0002-8238-9835; Tschurtschenthaler, Markus/0000-0002-0060-4790; Flak, Magdalena/0000-0002-8238-9835; Parry, Lee/0000-0002-4467-9196; Kohno, Kenji/0000-0002-3503-6551; Iwawaki, Takao/0000-0001-8753-1979; Marciniak, Stefan/0000-0001-8472-7183; Glickman, Jonathan/0000-0003-0910-2655; MARTINEZ-NAVES, EDUARDO/0000-0001-8136-9042; Raine, Tim/0000-0002-5855-9873	NIH [DK044319, DK051362, DK053056, DK088199]; Harvard Digestive Diseases Center (HDDC) [DK0034854]; European Research Council under the European Community/ERC [260961]; National Institute for Health Research Cambridge Biomedical Research Centre; Austrian Science Fund; Ministry of Science [P21530-B18, START Y446-B18]; Addenbrooke's Charitable Trust; BMBF NGFN Animal Model grant; DFG Cluster of Excellence Inflammation at Interfaces; EU; Hans-Dietrich Bruhn Memorial Foundation; DFG [RO2994/5-1, SFB 877]; Inflammatory Bowel Disease Working Group; Crohn's and Colitis Foundation of America; European Crohn's and Colitis Organization; Crohn's in Childhood Research Association; National Research Foundation of Korea; Korean government [KRF-2008-357-E00022, 2011-0009018]; Grants-in-Aid for Scientific Research [24390049] Funding Source: KAKEN; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK044319, R01DK044319, R01DK051362, R01DK053056, R56DK053056, P30DK034854, R01DK088199] Funding Source: NIH RePORTER; MRC [G1002610, G0601840] Funding Source: UKRI; Austrian Science Fund (FWF) [P 21530] Funding Source: researchfish; Medical Research Council [G1002610, G0601840] Funding Source: researchfish	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Harvard Digestive Diseases Center (HDDC); European Research Council under the European Community/ERC(European Research Council (ERC)); National Institute for Health Research Cambridge Biomedical Research Centre(National Institute for Health Research (NIHR)); Austrian Science Fund(Austrian Science Fund (FWF)); Ministry of Science(Ministry of Science, ICT & Future Planning, Republic of Korea); Addenbrooke's Charitable Trust; BMBF NGFN Animal Model grant(Federal Ministry of Education & Research (BMBF)); DFG Cluster of Excellence Inflammation at Interfaces(German Research Foundation (DFG)); EU(European Commission); Hans-Dietrich Bruhn Memorial Foundation; DFG(German Research Foundation (DFG)); Inflammatory Bowel Disease Working Group; Crohn's and Colitis Foundation of America; European Crohn's and Colitis Organization; Crohn's in Childhood Research Association; National Research Foundation of Korea(National Research Foundation of Korea); Korean government(Korean Government); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank L. Glimcher, A. Goldberg, J. Yuan, M. Parkes, A. Franke, H. Tilg, M. Pasparakis, K. Vlantis, A.-H. Lee and C. L. Bevins for discussion of the project, are grateful to J. Gordon, L. Hooper and K. Rajewsky for providing critical reagents, and thank O. Will for initial handling of the Atg16l1 colony and help with DSS colitis. A. Kaser began work for this study at the Department of Internal Medicine II, Innsbruck Medical University, A-6020 Innsbruck, Austria. This work was supported by NIH grants DK044319, DK051362, DK053056, DK088199, the Harvard Digestive Diseases Center (HDDC) (DK0034854) (R. S. B.); the European Research Council under the European Community's Seventh Framework Programme (FP7/2007-2013)/ERC Grant agreement no. 260961 (A. K.); the National Institute for Health Research Cambridge Biomedical Research Centre (A. K.); the Austrian Science Fund and Ministry of Science P21530-B18 and START Y446-B18 (A. K.); the Addenbrooke's Charitable Trust (A. K. and L.N.); BMBF NGFN Animal Model grant (P. R.), the DFG Cluster of Excellence Inflammation at Interfaces (S. S. and P. R.); EU SysmedIBD grant (P. R), the Hans-Dietrich Bruhn Memorial Foundation (R. B.); DFG grants RO2994/5-1 (P. R.) and SFB 877 project B9 (P. R. and S. S.); fellowships from Inflammatory Bowel Disease Working Group (M. F. T.), Crohn's and Colitis Foundation of America (M. B. F.), European Crohn's and Colitis Organization (T. E. A.), Crohn's in Childhood Research Association (A. K. and L.N.), National Research Foundation of Korea funded by the Korean government KRF-2008-357-E00022 no. 2011-0009018 (H. -J.K.).	Baert L, 2008, APPL ENVIRON MICROB, V74, P543, DOI 10.1128/AEM.01039-07; Barrett JC, 2008, NAT GENET, V40, P955, DOI 10.1038/ng.175; Bertolotti A, 2001, J CLIN INVEST, V107, P585, DOI 10.1172/JCI11476; Boyce M, 2005, SCIENCE, V307, P935, DOI 10.1126/science.1101902; BRY L, 1994, P NATL ACAD SCI USA, V91, P10335, DOI 10.1073/pnas.91.22.10335; Cadwell K, 2008, NATURE, V456, P259, DOI 10.1038/nature07416; Cadwell K, 2010, CELL, V141, P1135, DOI 10.1016/j.cell.2010.05.009; Cao SS, 2013, GASTROENTEROLOGY, V144, P989, DOI 10.1053/j.gastro.2013.01.023; Carchman EH, 2011, HEPATOLOGY, V53, P2053, DOI 10.1002/hep.24324; Cleynen I., 2012, GUT; Deuring J. J., 2013, GUT; Fujita N, 2008, MOL BIOL CELL, V19, P2092, DOI 10.1091/mbc.E07-12-1257; Fujita N, 2009, J BIOL CHEM, V284, P32602, DOI 10.1074/jbc.M109.037671; Garabedian EM, 1997, J BIOL CHEM, V272, P23729, DOI 10.1074/jbc.272.38.23729; Hampe J, 2007, NAT GENET, V39, P207, DOI 10.1038/ng1954; Hempel SL, 1999, FREE RADICAL BIO MED, V27, P146, DOI 10.1016/S0891-5849(99)00061-1; Hu P, 2006, MOL CELL BIOL, V26, P3071, DOI 10.1128/MCB.26.8.3071-3084.2006; Iwawaki T, 2009, P NATL ACAD SCI USA, V106, P16657, DOI 10.1073/pnas.0903775106; Jostins L, 2012, NATURE, V491, P119, DOI 10.1038/nature11582; Kaneko M, 2003, BIOL PHARM BULL, V26, P931, DOI 10.1248/bpb.26.931; Kaser A, 2008, CELL, V134, P743, DOI 10.1016/j.cell.2008.07.021; Kaser A, 2010, ANNU REV IMMUNOL, V28, P573, DOI 10.1146/annurev-immunol-030409-101225; Kobayashi KS, 2005, SCIENCE, V307, P731, DOI 10.1126/science.1104911; Komatsu M, 2005, J CELL BIOL, V169, P425, DOI 10.1083/jcb.200412022; Kuballa P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003391; Levine B, 2011, NATURE, V469, P323, DOI 10.1038/nature09782; Madison BB, 2002, J BIOL CHEM, V277, P33275, DOI 10.1074/jbc.M204935200; Maloy KJ, 2011, NATURE, V474, P298, DOI 10.1038/nature10208; Mizushima N, 2004, MOL BIOL CELL, V15, P1101, DOI 10.1091/mbc.E03-09-0704; Mizushima N, 2003, J CELL SCI, V116, P1679, DOI 10.1242/jcs.00381; Novoa I, 2003, EMBO J, V22, P1180, DOI 10.1093/emboj/cdg112; Parkes M, 2007, NAT GENET, V39, P830, DOI 10.1038/ng2061; Pierce JW, 1997, J BIOL CHEM, V272, P21096, DOI 10.1074/jbc.272.34.21096; Rioux JD, 2007, NAT GENET, V39, P596, DOI 10.1038/ng2032; Rogler G, 1998, GASTROENTEROLOGY, V115, P357, DOI 10.1016/S0016-5085(98)70202-1; Rouschop KMA, 2010, J CLIN INVEST, V120, P127, DOI 10.1172/JCI40027; Sarkar S, 2009, METHOD ENZYMOL, V453, P83, DOI 10.1016/S0076-6879(08)04005-6; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; SATOH Y, 1990, J ELECTRON MICR TECH, V16, P69, DOI 10.1002/jemt.1060160109; Shimshek DR, 2002, GENESIS, V32, P19, DOI 10.1002/gene.10023; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Tashiro E, 2007, J ANTIBIOT, V60, P547, DOI 10.1038/ja.2007.69; Treton X, 2011, GASTROENTEROLOGY, V141, P1024, DOI 10.1053/j.gastro.2011.05.033; Urano F, 2000, SCIENCE, V287, P664, DOI 10.1126/science.287.5453.664; Vaishnava S, 2008, P NATL ACAD SCI USA, V105, P20858, DOI 10.1073/pnas.0808723105; VIDAL K, 1993, J IMMUNOL METHODS, V166, P63, DOI 10.1016/0022-1759(93)90329-6; Wehkamp J, 2005, P NATL ACAD SCI USA, V102, P18129, DOI 10.1073/pnas.0505256102; Wei YJ, 2008, AUTOPHAGY, V4, P949, DOI 10.4161/auto.6788; Yang L, 2010, CELL METAB, V11, P467, DOI 10.1016/j.cmet.2010.04.005; Zhao F, 2010, DEV BIOL, V338, P268, DOI 10.1016/j.ydbio.2009.12.008	50	465	487	7	129	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 14	2013	503	7475					272	+		10.1038/nature12599	http://dx.doi.org/10.1038/nature12599			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	250YX	24089213	Green Accepted, Green Submitted			2022-12-24	WOS:000326894200053
J	Puthucheary, ZA; Rawal, J; McPhail, M; Connolly, B; Ratnayake, G; Chan, P; Hopkinson, NS; Padhke, R; Dew, T; Sidhu, PS; Velloso, C; Seymour, J; Agley, CC; Selby, A; Limb, M; Edwards, LM; Smith, K; Rowlerson, A; Rennie, MJ; Moxham, J; Harridge, SDR; Hart, N; Montgomery, HE				Puthucheary, Zudin A.; Rawal, Jaikitry; McPhail, Mark; Connolly, Bronwen; Ratnayake, Gamunu; Chan, Pearl; Hopkinson, Nicholas S.; Padhke, Rahul; Dew, Tracy; Sidhu, Paul S.; Velloso, Cristiana; Seymour, John; Agley, Chibeza C.; Selby, Anna; Limb, Marie; Edwards, Lindsay M.; Smith, Kenneth; Rowlerson, Anthea; Rennie, Michael John; Moxham, John; Harridge, Stephen D. R.; Hart, Nicholas; Montgomery, Hugh E.			Acute Skeletal Muscle Wasting in Critical Illness	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							INTENSIVE-CARE-UNIT; ACUTE LUNG INJURY; EDEN RANDOMIZED-TRIAL; ILL PATIENTS; PROTEIN-SYNTHESIS; FUNCTIONAL DISABILITY; PARENTERAL-NUTRITION; FOLLOW-UP; DISEASE; TURNOVER	IMPORTANCE Survivors of critical illness demonstrate skeletal muscle wasting with associated functional impairment. OBJECTIVE To perform a comprehensive prospective characterization of skeletal muscle wasting, defining the pathogenic roles of altered protein synthesis and breakdown. DESIGN, SETTING, AND PARTICIPANTS Sixty-three critically ill patients (59% male; mean age: 54.7 years [95% CI, 50.0-59.6 years]) with an Acute Physiology and Chronic Health Evaluation II score of 23.5 (95% CI, 21.9-25.2) were prospectively recruited within 24 hours following intensive care unit (ICU) admission from August 2009 to April 2011 at a university teaching and a community hospital in England. Patients were recruited if older than 18 years and were anticipated to be intubated for longer than 48 hours, to spend more than 7 days in critical care, and to survive ICU stay. MAIN OUTCOMES AND MEASURES Muscle loss was determined through serial ultrasound measurement of the rectus femoris cross-sectional area (CSA) on days 1, 3, 7, and 10. In a subset of patients, the fiber CSA area was quantified along with the ratio of protein to DNA on days 1 and 7. Histopathological analysis was performed. In addition, muscle protein synthesis, breakdown rates, and respective signaling pathways were characterized. RESULTS There were significant reductions in the rectus femoris CSA observed at day 10 (-17.7%[95% CI, -25.9% to 8.1%]; P < .001). In the 28 patients assessed by all 3 measurement methods on days 1 and 7, the rectus femoris CSA decreased by 10.3%(95% CI, 6.1% to 14.5%), the fiber CSA by 17.5%(95% CI, 5.8% to 29.3%), and the ratio of protein to DNA by 29.5%(95% CI, 13.4% to 45.6%). Decrease in the rectus femoris CSA was greater in patients who experienced multiorgan failure by day 7 (-15.7%; 95% CI, -27.7% to 11.4%) compared with single organ failure (-3.0%; 95% CI, -5.3% to 2.1%) (P < .001), even by day 3 (-8.7%[95% CI, -59.3% to 50.6%] vs -1.8%[95% CI, -12.3% to 10.5%], respectively; P = .03). Myofiber necrosis occurred in 20 of 37 patients (54.1%). Protein synthesis measured by the muscle protein fractional synthetic rate was depressed in patients on day 1 (0.035%/hour; 95% CI, 0.023% to 0.047%/hour) compared with rates observed in fasted healthy controls (0.039%/hour; 95% CI, 0.029% to 0.048%/hour) (P = .57) and increased by day 7 (0.076%[95% CI, 0.032%-0.120%/hour]; P = .03) to rates associated with fed controls (0.065%/hour [95% CI, 0.049% to 0.080%/hour]; P = .30), independent of nutritional load. Leg protein breakdown remained elevated throughout the study (8.5 [95% CI, 4.7 to 12.3] to 10.6 [95% CI, 6.8 to 14.4] mu mol of phenylalanine/min/ideal body weight x 100; P = .40). The pattern of intracellular signaling supported increased breakdown (n = 9, r = -0.83, P = .005) and decreased synthesis (n = 9, r = -0.69, P = .04). CONCLUSIONS AND RELEVANCE Among these critically ill patients, muscle wasting occurred early and rapidly during the first week of critical illness and was more severe among those with multiorgan failure compared with single organ failure. These findings may provide insights into skeletal muscle wasting in critical illness.	[Puthucheary, Zudin A.; Rawal, Jaikitry; Chan, Pearl; Montgomery, Hugh E.] UCL, Inst Hlth & Human Performance, London WC1E 6AU, England; [McPhail, Mark] Imperial Coll London St Marys Hosp NHS Trust, London, England; [Puthucheary, Zudin A.; Connolly, Bronwen; Ratnayake, Gamunu; Hart, Nicholas] Guys & St Thomas NHS Fdn Trust, Comprehens Biomed Res Ctr, London, England; [Puthucheary, Zudin A.; Connolly, Bronwen; Ratnayake, Gamunu; Hart, Nicholas] Kings Coll London, London, England; [Puthucheary, Zudin A.; Ratnayake, Gamunu; Velloso, Cristiana; Agley, Chibeza C.; Edwards, Lindsay M.; Rowlerson, Anthea; Harridge, Stephen D. R.] Kings Coll London, Ctr Human & Aerosp Physiol Sci, London, England; [Hopkinson, Nicholas S.] Univ London Imperial Coll Sci Technol & Med, Royal Brompton Hosp, London, England; [Padhke, Rahul] UCL, Dept Neurol, Natl Hosp Neurol & Neurosurg, London WC1E 6AU, England; [Puthucheary, Zudin A.; McPhail, Mark; Dew, Tracy; Sidhu, Paul S.; Seymour, John; Moxham, John] Kings Coll Hosp NHS Trust, London, England; [Selby, Anna; Limb, Marie; Smith, Kenneth; Rennie, Michael John] Univ Nottingham, Dept Clin Physiol, Nottingham NG7 2RD, England; [Puthucheary, Zudin A.; Connolly, Bronwen; Ratnayake, Gamunu; Hart, Nicholas] Guys & St Thomas NHS Fdn Trust, St Thomas Hosp, Lane Fox Clin Resp Physiol Res Unit, London, England; [Puthucheary, Zudin A.; Connolly, Bronwen; Ratnayake, Gamunu; Moxham, John; Hart, Nicholas] Kings Coll London, Div Asthma Allergy & Lung Biol, London, England	University of London; University College London; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; University of London; King's College London; Imperial College London; Royal Brompton Hospital; University of London; University College London; UCL Medical School; University College London Hospitals NHS Foundation Trust; King's College Hospital NHS Foundation Trust; King's College Hospital; University of Nottingham; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London	Puthucheary, ZA (corresponding author), UCL, 74 Huntley St,Room 443, London WC1E 6AU, England.	zudin.puthucheary.09@ucl.ac.uk	Hart, Nicholas/O-7076-2015; Montgomery, Hugh/L-1229-2019; Chan, Pearl/HGU-0471-2022; Montgomery, Hugh/C-2592-2008	Hart, Nicholas/0000-0002-6863-585X; Montgomery, Hugh/0000-0001-8797-5019; Hopkinson, Nicholas/0000-0003-3235-0454; Selby, Anna/0000-0003-1098-5782; Smith, Ken/0000-0001-8971-6635; Harridge, Stephen/0000-0002-8203-0769; Puthucheary, Zudin/0000-0003-4267-1892; Sidhu, Paul/0000-0003-1928-4077	National Institute of Health Research (NIHR); Wellcome Trust UK; European Society of Intensive Care Medicine; NIHR Clinical Research Facility at Guy's and St Thomas' NHS Foundation Trust; NIHR Biomedical Research Centre at Guy's and St Thomas' NHS Foundation Trust; King's College London; Whittington Hospital NHS Trust; MRC [MR/K00414X/1] Funding Source: UKRI; Medical Research Council [MR/K00414X/1] Funding Source: researchfish; National Institute for Health Research [DRF-2010-03-114, ACF-2010-17-001] Funding Source: researchfish	National Institute of Health Research (NIHR)(National Institute for Health Research (NIHR)); Wellcome Trust UK(Wellcome Trust); European Society of Intensive Care Medicine; NIHR Clinical Research Facility at Guy's and St Thomas' NHS Foundation Trust; NIHR Biomedical Research Centre at Guy's and St Thomas' NHS Foundation Trust; King's College London; Whittington Hospital NHS Trust; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	Dr Puthucheary is funded by a doctorate fellowship from the National Institute of Health Research (NIHR). Dr McPhail received funding from Wellcome Trust UK as part of a postdoctoral training fellowship. Additional funding was received from the European Society of Intensive Care Medicine, the NIHR Clinical Research Facility at Guy's and St Thomas' NHS Foundation Trust and NIHR Biomedical Research Centre based at Guy's and St Thomas' NHS Foundation Trust and King's College London, and the Whittington Hospital NHS Trust.	Biolo G, 2002, J CLIN ENDOCR METAB, V87, P3378, DOI 10.1210/jc.87.7.3378; Bohe J, 2001, J PHYSIOL-LONDON, V532, P575, DOI 10.1111/j.1469-7793.2001.0575f.x; Casaer MP, 2011, NEW ENGL J MED, V365, P506, DOI 10.1056/NEJMoa1102662; Constantin D, 2011, J PHYSIOL-LONDON, V589, P3883, DOI 10.1113/jphysiol.2011.206193; deGodoy I, 1996, AM J RESP CRIT CARE, V153, P633, DOI 10.1164/ajrccm.153.2.8564110; DEVINE BJ, 1974, DRUG INTEL CLIN PHAR, V8, P650, DOI 10.1177/106002807400801104; DIETRICHSON P, 1987, J NEUROL NEUROSUR PS, V50, P1461, DOI 10.1136/jnnp.50.11.1461; Essen P, 1998, CRIT CARE MED, V26, P92, DOI 10.1097/00003246-199801000-00022; Gosker HR, 2003, EUR RESPIR J, V22, P280, DOI 10.1183/09031936.03.00012803; Hart N, 2013, AM J RESP CRIT CARE, V188, P523, DOI 10.1164/rccm.201306-1162ED; HAUPTMANN S, 1994, VIRCHOWS ARCH, V424, P653, DOI 10.1007/BF01069747; Heidegger CP, 2013, LANCET, V381, P385, DOI 10.1016/S0140-6736(12)61351-8; HELLIWELL TR, 1991, J PATHOL, V164, P307, DOI 10.1002/path.1711640406; Herridge MS, 2011, NEW ENGL J MED, V364, P1293, DOI 10.1056/NEJMoa1011802; Iwashyna TJ, 2010, JAMA-J AM MED ASSOC, V304, P1787, DOI 10.1001/jama.2010.1553; Klaude M, 2012, CLIN SCI, V122, P133, DOI 10.1042/CS20110233; Latronico N, 1996, LANCET, V347, P1579, DOI 10.1016/S0140-6736(96)91074-0; Lone NI, 2012, AM J RESP CRIT CARE, V186, P640, DOI 10.1164/rccm.201201-0059OC; National Institute for Health and Care Excellence, 2009, CRIT ILLN REH CG83; Needham DM, 2013, AM J RESP CRIT CARE, V188, P567, DOI 10.1164/rccm.201304-0651OC; Needham DM, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1532; Ochala J, 2011, J PHYSIOL-LONDON, V589, P2007, DOI 10.1113/jphysiol.2010.202044; Paddon-Jones D, 2006, J CLIN ENDOCR METAB, V91, P4836, DOI 10.1210/jc.2006-0651; Preedy VR, 2001, EUR J NEUROL, V8, P677, DOI 10.1046/j.1468-1331.2001.00303.x; Puthucheary Z, 2012, AM J RESP CRIT CARE, V185, P911, DOI 10.1164/rccm.201107-1320OE; RENNIE MJ, 1985, BRIT MED BULL, V41, P257, DOI 10.1093/oxfordjournals.bmb.a072060; Rice TW, 2012, JAMA-J AM MED ASSOC, V307, P795, DOI 10.1001/jama.2012.137; Sandri M, 2008, PHYSIOLOGY, V23, P160, DOI 10.1152/physiol.00041.2007; Seymour JM, 2010, EUR RESPIR J, V36, P81, DOI 10.1183/09031936.00104909; Seymour JM, 2009, THORAX, V64, P418, DOI 10.1136/thx.2008.103986; Stein A, 1997, KIDNEY INT, V52, P1089, DOI 10.1038/ki.1997.433; Vesali RF, 2010, CLIN SCI, V118, P421, DOI 10.1042/CS20090332; Vescovo G, 1996, HEART, V76, P337, DOI 10.1136/hrt.76.4.337; Vincent JL, 1996, INTENS CARE MED, V22, P707, DOI 10.1007/BF01709751; Weiss G, 2005, NEW ENGL J MED, V352, P1011, DOI 10.1056/NEJMra041809; Wilkes EA, 2009, AM J CLIN NUTR, V90, P1343, DOI 10.3945/ajcn.2009.27543; Williams JP, 2012, AM J CLIN NUTR, V96, P1064, DOI 10.3945/ajcn.112.045708	37	966	1028	2	49	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 16	2013	310	15					1591	1600		10.1001/jama.2013.278481	http://dx.doi.org/10.1001/jama.2013.278481			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	234EP	24108501	Green Submitted, Bronze			2022-12-24	WOS:000325624800022
J	Finlay, JC; Small, GE; Sterner, RW				Finlay, Jacques C.; Small, Gaston E.; Sterner, Robert W.			Human Influences on Nitrogen Removal in Lakes	SCIENCE			English	Article							CYCLE; DENITRIFICATION; EUTROPHICATION; TRANSFORMATION; ECOSYSTEMS; RETENTION; WATERS	Human activities have increased the availability of reactive nitrogen in many ecosystems, leading to negative impacts on human health, biodiversity, and water quality. Freshwater ecosystems, including lakes, streams, and wetlands, are a large global sink for reactive nitrogen, but factors that determine the efficacy of freshwater nitrogen removal rates are poorly known. Using a global lake data set, we show that the availability of phosphorus, a limiting nutrient, affects both annual nitrogen removal rate and efficiency. This result indicates that increased phosphorus inputs from human activities have stimulated nitrogen removal processes in many lakes. Recent management-driven reductions in phosphorus availability promote water column accumulation and export of nitrogen from large lakes, an unintended consequence of single-element management that argues for greater control of nitrogen as well as phosphorus sources.	[Finlay, Jacques C.; Small, Gaston E.; Sterner, Robert W.] Univ Minnesota, Dept Ecol Evolut & Behav, St Paul, MN 55108 USA	University of Minnesota System; University of Minnesota Twin Cities	Finlay, JC (corresponding author), Univ Minnesota, Dept Ecol Evolut & Behav, St Paul, MN 55108 USA.	jfinlay@umn.edu	Finlay, Jacques/B-6081-2011	Finlay, Jacques/0000-0002-7968-7030; Sterner, Robert/0000-0003-2292-6122	NSF [OCE-0927512]; Directorate For Geosciences [0927512] Funding Source: National Science Foundation; Div Of Chem, Bioeng, Env, & Transp Sys [1209402] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO)); Div Of Chem, Bioeng, Env, & Transp Sys(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG))	Data used in the analyses on nitrogen removal and the sources of these data are described in the supplementary materials (table S3). This research was supported by NSF under grant OCE-0927512.	Baron JS, 2013, BIOGEOCHEMISTRY, V114, P71, DOI 10.1007/s10533-012-9788-y; Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; Carpenter SR, 1998, ECOL APPL, V8, P559, DOI 10.1890/1051-0761(1998)008[0559:NPOSWW]2.0.CO;2; Cole JJ, 2007, ECOSYSTEMS, V10, P171, DOI 10.1007/s10021-006-9013-8; DAVISON W, 1995, NATURE, V377, P504, DOI 10.1038/377504a0; Elser JJ, 2009, SCIENCE, V326, P835, DOI 10.1126/science.1176199; Galloway JN, 2008, SCIENCE, V320, P889, DOI 10.1126/science.1136674; Gerdeaux D, 2006, ACTA OECOL, V30, P161, DOI 10.1016/j.actao.2006.02.007; Harrison JA, 2009, BIOGEOCHEMISTRY, V93, P143, DOI 10.1007/s10533-008-9272-x; HOHENER P, 1993, AQUAT SCI, V55, P112, DOI 10.1007/BF00877440; Howarth R, 2011, FRONT ECOL ENVIRON, V9, P18, DOI 10.1890/100008; Jeppesen E, 2005, FRESHWATER BIOL, V50, P1747, DOI 10.1111/j.1365-2427.2005.01415.x; Kaste O, 2005, CAN J FISH AQUAT SCI, V62, P312, DOI 10.1139/F04-233; PETERSON BJ, 1985, SCIENCE, V229, P1383, DOI 10.1126/science.229.4720.1383; Saunders DL, 2001, HYDROBIOLOGIA, V443, P205, DOI 10.1023/A:1017506914063; Schindler DW, 2006, LIMNOL OCEANOGR, V51, P356, DOI 10.4319/lo.2006.51.1_part_2.0356; Schindler DW, 2012, P ROY SOC B-BIOL SCI, V279, P4322, DOI 10.1098/rspb.2012.1032; Schlesinger WH, 2009, P NATL ACAD SCI USA, V106, P203, DOI 10.1073/pnas.0810193105; Seitzinger S, 2006, ECOL APPL, V16, P2064, DOI 10.1890/1051-0761(2006)016[2064:DALAWA]2.0.CO;2; SEITZINGER SP, 1988, LIMNOL OCEANOGR, V33, P702, DOI 10.4319/lo.1988.33.4_part_2.0702; Small GE, 2014, HYDROBIOLOGIA, V731, P95, DOI 10.1007/s10750-013-1569-7; Suddick EC, 2013, BIOGEOCHEMISTRY, V114, P1, DOI 10.1007/s10533-012-9795-z; Tartari G, 1997, WATER AIR SOIL POLL, V99, P523, DOI 10.1023/A:1018360010991; Taylor PG, 2010, NATURE, V464, P1178, DOI 10.1038/nature08985; Vitousek PM, 2009, SCIENCE, V324, P1519, DOI 10.1126/science.1170261; Vitousek PM, 1997, ECOL APPL, V7, P737, DOI 10.2307/2269431; Weyhenmeyer GA, 2007, LIMNOL OCEANOGR, V52, P1346, DOI 10.4319/lo.2007.52.4.1346	27	234	252	21	554	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 11	2013	342	6155					247	250		10.1126/science.1242575	http://dx.doi.org/10.1126/science.1242575			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232EV	24115440				2022-12-24	WOS:000325475200045
J	Lee, JC; Espeli, M; Anderson, CA; Linterman, MA; Pocock, JM; Williams, NJ; Roberts, R; Viatte, S; Fu, B; Peshu, N; Hien, TT; Phu, NH; Wesley, E; Edwards, C; Ahmad, T; Mansfield, JC; Gearry, R; Dunstan, S; Williams, TN; Barton, A; Vinuesa, CG; Parkes, M; Lyons, PA; Smith, KGC				Lee, James C.; Espeli, Marion; Anderson, Carl A.; Linterman, Michelle A.; Pocock, Joanna M.; Williams, Naomi J.; Roberts, Rebecca; Viatte, Sebastien; Fu, Bo; Peshu, Norbert; Tran Tinh Hien; Nguyen Hoan Phu; Wesley, Emma; Edwards, Cathryn; Ahmad, Tariq; Mansfield, John C.; Gearry, Richard; Dunstan, Sarah; Williams, Thomas N.; Barton, Anne; Vinuesa, Carola G.; Parkes, Miles; Lyons, Paul A.; Smith, Kenneth G. C.		UK IBD Genetics Consortium	Human SNP Links Differential Outcomes in Inflammatory and Infectious Disease to a FOXO3-Regulated Pathway	CELL			English	Article							FOXO TRANSCRIPTION FACTORS; RHEUMATOID-ARTHRITIS; PREDICTS PROGNOSIS; CELLS; MACROPHAGES; EXPRESSION; MONOCYTES; BETA; HETEROGENEITY; ESTABLISHMENT	The clinical course and eventual outcome, or prognosis, of complex diseases varies enormously between affected individuals. This variability critically determines the impact a disease has on a patient's life but is very poorly understood. Here, we exploit existing genome-wide association study data to gain insight into the role of genetics in prognosis. We identify a noncoding polymorphism in FOXO3A (rs12212067: T > G) at which the minor (G) allele, despite not being associated with disease susceptibility, is associated with a milder course of Crohn's disease and rheumatoid arthritis and with increased risk of severe malaria. Minor allele carriage is shown to limit inflammatory responses in monocytes via a FOXO3-driven pathway, which through TGF beta 1 reduces production of proinflammatory cytokines, including TNF alpha, and increases production of anti-inflammatory cytokines, including IL-10. Thus, we uncover a shared genetic contribution to prognosis in distinct diseases that operates via a FOXO3-driven pathway modulating inflammatory responses.	[Lee, James C.; Espeli, Marion; Linterman, Michelle A.; Pocock, Joanna M.; Lyons, Paul A.; Smith, Kenneth G. C.] Univ Cambridge, Cambridge Inst Med Res, Cambridge CB2 0XY, England; [Lee, James C.; Espeli, Marion; Linterman, Michelle A.; Pocock, Joanna M.; Parkes, Miles; Lyons, Paul A.; Smith, Kenneth G. C.] Univ Cambridge, Sch Clin Med, Addenbrookes Hosp, Dept Med, Cambridge CB2 0QQ, England; [Anderson, Carl A.] Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England; [Williams, Naomi J.; Vinuesa, Carola G.] Australian Natl Univ, John Curtin Sch Med Res, Dept Pathogens & Immun, Canberra, ACT 2601, Australia; [Roberts, Rebecca; Gearry, Richard] Univ Otago, Dept Med, Christchurch 8011, New Zealand; [Viatte, Sebastien; Fu, Bo; Barton, Anne] Univ Manchester, Manchester Acad Hlth Sci Ctr, Arthrit Res UK Epidemiol Unit, Manchester M13 9PT, Lancs, England; [Fu, Bo] Univ Manchester, Inst Populat Hlth, Ctr Biostat, Manchester M13 9PL, Lancs, England; [Peshu, Norbert; Williams, Thomas N.] Kenya Govt Med Res Ctr, Wellcome Trust Res Program, Ctr Geog Med Res, Kilifi, Kenya; [Tran Tinh Hien; Dunstan, Sarah] Univ Oxford, Clin Res Unit, Wellcome Trust Major Overseas Program, Hosp Trop Dis, Ho Chi Minh City, Vietnam; [Nguyen Hoan Phu] Hosp Trop Dis, Ho Chi Minh City, Vietnam; [Wesley, Emma; Ahmad, Tariq] Univ Exeter, Peninsula Coll Med & Dent, Exeter EX2 5DW, Devon, England; [Edwards, Cathryn] Torbay Hosp, Dept Gastroenterol, Torquay TQ2 7AA, England; [Mansfield, John C.] Newcastle Univ, Inst Med Genet, Newcastle Upon Tyne NE1 3BZ, Tyne & Wear, England; [Dunstan, Sarah] Univ Oxford, Nuffield Dept Clin Med, Ctr Trop Med, Oxford OX3 7LJ, England; [Williams, Thomas N.] Univ London Imperial Coll Sci Technol & Med, Dept Med, London SW7 2AZ, England	University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Wellcome Trust Sanger Institute; Australian National University; John Curtin School of Medical Research; University of Otago; University of Manchester; University of Manchester; Kenya Medical Research Institute; University of Oxford; University of Exeter; University of Plymouth; Newcastle University - UK; University of Oxford; Imperial College London	Smith, KGC (corresponding author), Univ Cambridge, Cambridge Inst Med Res, Cambridge Biomed Campus, Cambridge CB2 0XY, England.	kgcs2@cam.ac.uk	Kennedy, Nicholas Alexander/AET-5648-2022; Linterman, Michelle/AAN-4210-2021; Espeli, Marion/AAH-4483-2021; Gearry, Richard B/H-3959-2019; Lee, James/ABD-5920-2020; Dunstan, Sarah/AAO-9597-2020; Viatte, Sebastien/B-4253-2015; Vinuesa, Carola G/B-1108-2010; Barclay, Murray Lindsay/D-9000-2012; Barton, Anne/N-2053-2014	Kennedy, Nicholas Alexander/0000-0003-4368-1961; Linterman, Michelle/0000-0001-6047-1996; Espeli, Marion/0000-0001-5005-1664; Gearry, Richard B/0000-0002-2298-5141; Lee, James/0000-0001-5711-9385; Viatte, Sebastien/0000-0001-6471-3358; Vinuesa, Carola G/0000-0001-9799-0298; Barclay, Murray Lindsay/0000-0003-2944-8338; Barrett, Jeffrey/0000-0002-1152-370X; Edwards, Cathryn/0000-0002-5550-9184; Parkes, Miles/0000-0002-6467-0631; Henderson, Paul/0000-0003-3634-6428; Smith, Kenneth/0000-0003-3829-4326; Dunstan, Sarah/0000-0001-7873-933X; Newman, William/0000-0002-6382-4678; Lees, Charlie/0000-0002-0732-8215; Anderson, Carl/0000-0003-1719-7009; Barton, Anne/0000-0003-3316-2527; Simmons, Alison/0000-0003-3454-0710	NIHR Biomedical Research centers in Cambridge and Manchester; Wellcome Trust [083650/Z/07/Z, 087007/Z/08/Z, 098051, 091758/Z/10/Z]; Arthritis Research UK; Swiss Foundation for Medical Science [PASMP3_134380]; Wellcome Trust Strategic Award [079895]; MRC [G0400929, MC_UU_12010/7, G0800759, G0600329, G0800675] Funding Source: UKRI; Academy of Medical Sciences (AMS) [AMS-SGCL9-Lee] Funding Source: researchfish; Medical Research Council [G0800675, G0600329, G0400929, MC_UU_12010/7, G0800759] Funding Source: researchfish; National Institute for Health Research [NIHR-RP-R3-12-026] Funding Source: researchfish; Crohn&quot;s and Colitis UK [M11-1] Funding Source: researchfish; Chief Scientist Office [CZB/4/540, ETM/75, ETM/137] Funding Source: researchfish	NIHR Biomedical Research centers in Cambridge and Manchester; Wellcome Trust(Wellcome TrustEuropean Commission); Arthritis Research UK(Versus Arthritis); Swiss Foundation for Medical Science; Wellcome Trust Strategic Award(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Academy of Medical Sciences (AMS)(Academy of Medical Sciences (AMS)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); Crohn&quot;s and Colitis UK; Chief Scientist Office	We gratefully thank the following: Cambridge BioResource (CBR) volunteers, the CBR staff for coordinating volunteer recruitment, and the CBR SAB for support; Emma Whitelaw (QIMR) for providing Foxo3a<SUP>MommeR1</SUP> mice; Prof Adam Young (PI-NOAR) and Prof Deborah Symons (PI-ERAS) for collaboration; Alex W. Macharia, Sophie Uyoga, Carolyne Ndila, Emily Nyatichi, Metrine Tendwa, Johnstone Mkale, Adan Mohamed, Prophet Ingosi, and Mary Njoroge for DNA extraction at the KEMRI-Wellcome Trust Programme; and Gideon Nyutu, Kenneth Magua, and Ruth Mwarabu for database support. This work is published with permission from the director of KEMRI, supported by NIHR Biomedical Research centers in Cambridge and Manchester, and funded by the Wellcome Trust (program grant 083650/Z/07/Z, grants to J.C.L. 087007/Z/08/Z, C.A.A. 098051 and T.N.W. 091758/Z/10/Z), Arthritis Research UK and the Swiss Foundation for Medical Science (grant to S.V. PASMP3_134380). The Cambridge Institute for Medical Research is in receipt of Wellcome Trust Strategic Award (079895).	Accili D, 2004, CELL, V117, P421, DOI 10.1016/S0092-8674(04)00452-0; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Auffray C, 2009, ANNU REV IMMUNOL, V27, P669, DOI 10.1146/annurev.immunol.021908.132557; Bain CC, 2013, MUCOSAL IMMUNOL, V6, P498, DOI 10.1038/mi.2012.89; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Burgering BMT, 2002, TRENDS BIOCHEM SCI, V27, P352, DOI 10.1016/S0968-0004(02)02113-8; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Davignon JL, 2013, RHEUMATOLOGY, V52, P590, DOI 10.1093/rheumatology/kes304; Dejean AS, 2009, NAT IMMUNOL, V10, P504, DOI 10.1038/ni.1729; Dieleman LA, 1998, CLIN EXP IMMUNOL, V114, P385; Eijkelenboom A, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2012.74; Fadok VA, 1998, J CLIN INVEST, V101, P890, DOI 10.1172/JCI1112; Feldmann M, 2008, IMMUNOL REV, V223, P7, DOI 10.1111/j.1600-065X.2008.00626.x; Geissmann F, 2010, SCIENCE, V327, P656, DOI 10.1126/science.1178331; Gomis RR, 2006, P NATL ACAD SCI USA, V103, P12747, DOI 10.1073/pnas.0605333103; Harada Y, 2010, J EXP MED, V207, P1381, DOI 10.1084/jem.20100004; Hedrick SM, 2009, NAT IMMUNOL, V10, P1057, DOI 10.1038/ni.1784; Hehlio T, 2003, GUT, V52, P558, DOI 10.1136/gut.52.4.558; Hien TT, 1996, NEW ENGL J MED, V335, P76, DOI 10.1056/NEJM199607113350202; Hindorff L., 2013, CATALOG PUBLISHED GE; Hugosson E, 2004, PARASITE IMMUNOL, V26, P111, DOI 10.1111/j.0141-9838.2004.00678.x; James D, 2004, RHEUMATOLOGY, V43, P369, DOI 10.1093/rheumatology/keh059; Jostins L, 2012, NATURE, V491, P119, DOI 10.1038/nature11582; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kenyon CJ, 2010, NATURE, V464, P504, DOI 10.1038/nature08980; Kerdiles YM, 2010, IMMUNITY, V33, P890, DOI 10.1016/j.immuni.2010.12.002; Khor B, 2011, NATURE, V474, P307, DOI 10.1038/nature10209; Krygier Darin S, 2009, Expert Rev Gastroenterol Hepatol, V3, P407, DOI 10.1586/egh.09.25; Lee JC, 2011, J CLIN INVEST, V121, P4170, DOI 10.1172/JCI59255; Licastro Federico, 2005, Immun Ageing, V2, P8; Litvak V, 2012, NATURE, V490, P421, DOI 10.1038/nature11428; Lundberg AM, 2007, BLOOD, V110, P3245, DOI 10.1182/blood-2007-02-072934; Malaguarnera L, 2002, LANCET INFECT DIS, V2, P472, DOI 10.1016/S1473-3099(02)00344-4; McClellan J, 2010, CELL, V141, P210, DOI 10.1016/j.cell.2010.03.032; McKinney EF, 2010, NAT MED, V16, P586, DOI 10.1038/nm.2130; Modur V, 2002, J BIOL CHEM, V277, P47928, DOI 10.1074/jbc.M207509200; Mulherin D, 1996, ARTHRITIS RHEUM, V39, P115, DOI 10.1002/art.1780390116; MUSSO T, 1990, BLOOD, V76, P2466; Nakae J, 2008, FEBS LETT, V582, P54, DOI 10.1016/j.febslet.2007.11.025; Ouyang W, 2010, NAT IMMUNOL, V11, P618, DOI 10.1038/ni.1884; Pritchard JK, 2000, GENETICS, V155, P945; Rainbow DB, 2008, BIOCHEM SOC T, V36, P312, DOI 10.1042/BST0360312; Rennick DM, 1997, J LEUKOCYTE BIOL, V61, P389, DOI 10.1002/jlb.61.4.389; Rivollier A, 2012, J EXP MED, V209, P139, DOI 10.1084/jem.20101387; Seoane J, 2004, CELL, V117, P211, DOI 10.1016/S0092-8674(04)00298-3; SUNDSTROM C, 1976, INT J CANCER, V17, P565, DOI 10.1002/ijc.2910170504; Symmons DPM, 2003, CLIN EXP RHEUMATOL, V21, pS94; Watkins SK, 2011, J CLIN INVEST, V121, P1361, DOI 10.1172/JCI44325; Wildey GM, 2009, J BIOL CHEM, V284, P20227, DOI 10.1074/jbc.M109.027201; Williams TN, 2005, BLOOD, V106, P368, DOI 10.1182/blood-2005-01-0313; Yang JY, 2008, NAT CELL BIOL, V10, P138, DOI 10.1038/ncb1676; Youngson NA, 2011, MAMM GENOME, V22, P235, DOI 10.1007/s00335-011-9317-7; ZIEGLERHEITBROCK HWL, 1988, INT J CANCER, V41, P456, DOI 10.1002/ijc.2910410324	53	166	172	0	25	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 26	2013	155	1					57	69		10.1016/j.cell.2013.08.034	http://dx.doi.org/10.1016/j.cell.2013.08.034			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	224UX	24035192	Green Published, hybrid, Green Submitted			2022-12-24	WOS:000324916700009
J	Neri, F; Krepelova, A; Incarnato, D; Maldotti, M; Parlato, C; Galvagni, F; Matarese, F; Stunnenberg, HG; Oliviero, S				Neri, Francesco; Krepelova, Anna; Incarnato, Danny; Maldotti, Mara; Parlato, Caterina; Galvagni, Federico; Matarese, Filomena; Stunnenberg, Hendrik G.; Oliviero, Salvatore			Dnmt3L Antagonizes DNA Methylation at Bivalent Promoters and Favors DNA Methylation at Gene Bodies in ESCs	CELL			English	Article							DE-NOVO METHYLATION; HISTONE H3; DYNAMIC REGULATION; POLYCOMB; CHROMATIN; METHYLTRANSFERASE; PLURIPOTENT; PROTEIN; 5-HYDROXYMETHYLCYTOSINE; BINDING	The de novo DNA methyltransferase 3-like (Dnmt3L) is a catalytically inactive DNA methyltransferase that cooperates with Dnmt3a and Dnmt3b to methylate DNA. Dnmt3L is highly expressed in mouse embryonic stem cells (ESCs), but its function in these cells is unknown. Through genome-wide analysis of Dnmt3L knockdown in ESCs, we found that Dnmt3L is a positive regulator of methylation at the gene bodies of housekeeping genes and, more surprisingly, is also a negative regulator of methylation at promoters of bivalent genes. Dnmt3L is required for the differentiation of ESCs into primordial germ cells (PGCs) through the activation of the homeotic gene Rhox5. We demonstrate that Dnmt3L interacts with the Polycomb PRC2 complex in competition with the DNA methyltransferases Dnmt3a and Dnmt3b to maintain low methylation levels at the H3K27me3 regions. Thus, in ESCs, Dnmt3L counteracts the activity of de novo DNA methylases to maintain hypomethylation at promoters of bivalent developmental genes.	[Neri, Francesco; Krepelova, Anna; Incarnato, Danny; Maldotti, Mara; Parlato, Caterina; Oliviero, Salvatore] Human Genet Fdn HuGeF, I-10126 Turin, Italy; [Krepelova, Anna; Incarnato, Danny; Galvagni, Federico; Oliviero, Salvatore] Univ Siena, Dipartimento Biotecnol Chim & Farm, I-53100 Siena, Italy; [Matarese, Filomena; Stunnenberg, Hendrik G.] Nijmegen Ctr Mol Life Sci, Dept Mol Biol, NL-6500 HB Nijmegen, Netherlands	University of Siena; Radboud University Nijmegen	Oliviero, S (corresponding author), Human Genet Fdn HuGeF, Via Nizza 52, I-10126 Turin, Italy.	salvatore.oliviero@hugef-torino.org	Stunnenberg, Hendrik G./D-6875-2012; oliviero, salvatore/R-6657-2019; Galvagni, Federico/F-9186-2013; Neri, Francesco/A-3321-2014	Stunnenberg, Hendrik G./0000-0002-0066-1576; oliviero, salvatore/0000-0002-3405-765X; Neri, Francesco/0000-0003-3903-1974; Maldotti, Mara/0000-0002-3299-9053; PARLATO, CATERINA/0000-0001-5304-3117; Krepelova, Anna/0000-0002-2775-1336	Associazione Italiana Ricerca sul Cancro (AIRC); Regione Toscana programma salute	Associazione Italiana Ricerca sul Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro); Regione Toscana programma salute(Regione Toscana)	This work was supported by the Associazione Italiana Ricerca sul Cancro (AIRC) and Regione Toscana programma salute. We thank Dr. S. Yamanaka (Kyoto University, Japan) for providing the anti-Dnmt3L antibody, Dr. En Li (Novartis, China) for providing the Dnmt3a<SUP>-/-</SUP>Dnmt3b<SUP>-/-</SUP>ESCs and Dr. Dies Meijer for providing the Avi-tag plasmid and BirA ESCs.	Bartke T, 2010, CELL, V143, P470, DOI 10.1016/j.cell.2010.10.012; Bestor TH, 2000, HUM MOL GENET, V9, P2395, DOI 10.1093/hmg/9.16.2395; Boch J, 2009, SCIENCE, V326, P1509, DOI 10.1126/science.1178811; Borgel J, 2010, NAT GENET, V42, P1093, DOI 10.1038/ng.708; Bourc'his D, 2001, SCIENCE, V294, P2536, DOI 10.1126/science.1065848; Bourc'his D, 2004, NATURE, V431, P96, DOI 10.1038/nature02886; Brinkman AB, 2012, GENOME RES, V22, P1128, DOI 10.1101/gr.133728.111; Chedin F, 2002, P NATL ACAD SCI USA, V99, P16916, DOI 10.1073/pnas.262443999; Chen ZX, 2005, J CELL BIOCHEM, V95, P902, DOI 10.1002/jcb.20447; Driegen S, 2005, TRANSGENIC RES, V14, P477, DOI 10.1007/s11248-005-7220-2; Ficz G, 2011, NATURE, V473, P398, DOI 10.1038/nature10008; Fouse SD, 2008, CELL STEM CELL, V2, P160, DOI 10.1016/j.stem.2007.12.011; Galvagni F, 2001, J MOL BIOL, V306, P985, DOI 10.1006/jmbi.2000.4335; Gowher H, 2005, J BIOL CHEM, V280, P13341, DOI 10.1074/jbc.M413412200; Hata K, 2002, DEVELOPMENT, V129, P1983; Hawkins RD, 2010, CELL STEM CELL, V6, P479, DOI 10.1016/j.stem.2010.03.018; Hayashi K, 2011, CELL, V146, P519, DOI 10.1016/j.cell.2011.06.052; Jia D, 2007, NATURE, V449, P248, DOI 10.1038/nature06146; Jurkowska RZ, 2011, J BIOL CHEM, V286, P24200, DOI 10.1074/jbc.M111.254987; Jurkowska RZ, 2011, CHEMBIOCHEM, V12, P206, DOI 10.1002/cbic.201000195; Kaneda M, 2004, NATURE, V429, P900, DOI 10.1038/nature02633; Kareta MS, 2006, J BIOL CHEM, V281, P25893, DOI 10.1074/jbc.M603140200; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Li E, 2002, NAT REV GENET, V3, P662, DOI 10.1038/nrg887; Li Q, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-63; Lienert F, 2011, NAT GENET, V43, P1091, DOI 10.1038/ng.946; Lindroth AM, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000145; MacLean JA, 2011, MOL CELL BIOL, V31, P1275, DOI 10.1128/MCB.00734-10; MacLean JA, 2010, REPRODUCTION, V140, P195, DOI 10.1530/REP-10-0100; Margueron R, 2011, NATURE, V469, P343, DOI 10.1038/nature09784; Matarese F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.95; Meissner A, 2008, NATURE, V454, P766, DOI 10.1038/nature07107; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Mohn F, 2008, MOL CELL, V30, P755, DOI 10.1016/j.molcel.2008.05.007; Moscou MJ, 2009, SCIENCE, V326, P1501, DOI 10.1126/science.1178817; Neri F, 2012, MOL CELL BIOL, V32, P840, DOI 10.1128/MCB.06148-11; Ohm JE, 2007, NAT GENET, V39, P237, DOI 10.1038/ng1972; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Ooi SKT, 2007, NATURE, V448, P714, DOI 10.1038/nature05987; Pasini D, 2007, MOL CELL BIOL, V27, P3769, DOI 10.1128/MCB.01432-06; Pastor WA, 2011, NATURE, V473, P394, DOI 10.1038/nature10102; Pontier DB, 2011, HUM GENET, V130, P223, DOI 10.1007/s00439-011-1008-7; Rush Margaret, 2009, Epigenetics, V4, P404; Schlesinger Y, 2007, NAT GENET, V39, P232, DOI 10.1038/ng1950; Schuettengruber B, 2009, DEVELOPMENT, V136, P3531, DOI 10.1242/dev.033902; Shen XH, 2008, MOL CELL, V32, P491, DOI 10.1016/j.molcel.2008.10.016; Simmer F, 2012, EPIGENETICS-US, V7, P1355, DOI 10.4161/epi.22562; Stadler MB, 2011, NATURE, V480, P490, DOI 10.1038/nature10716; Suetake I, 2004, J BIOL CHEM, V279, P27816, DOI 10.1074/jbc.M400181200; Turbendian HK, 2013, DEVELOPMENT, V140, P1639, DOI 10.1242/dev.093260; Vire E, 2006, NATURE, V439, P871, DOI 10.1038/nature04431; West JA, 2009, NATURE, V460, P909, DOI 10.1038/nature08210; Widschwendter M, 2007, NAT GENET, V39, P157, DOI 10.1038/ng1941; Wu H, 2010, SCIENCE, V329, P444, DOI 10.1126/science.1190485; Zhang Y, 2010, NUCLEIC ACIDS RES, V38, P4246, DOI 10.1093/nar/gkq147	55	120	122	0	32	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 26	2013	155	1					121	134		10.1016/j.cell.2013.08.056	http://dx.doi.org/10.1016/j.cell.2013.08.056			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	224UX	24074865	Bronze, Green Submitted			2022-12-24	WOS:000324916700014
J	Adorno, M; Sikandar, S; Mitra, SS; Kuo, A; Di Robilant, BN; Haro-Acosta, V; Ouadah, Y; Quarta, M; Rodriguez, J; Qian, DL; Reddy, VM; Cheshier, S; Garner, CC; Clarke, MF				Adorno, Maddalena; Sikandar, Shaheen; Mitra, Siddhartha S.; Kuo, Angera; Di Robilant, Benedetta Nicolis; Haro-Acosta, Veronica; Ouadah, Youcef; Quarta, Marco; Rodriguez, Jacqueline; Qian, Dalong; Reddy, Vadiyala M.; Cheshier, Samuel; Garner, Craig C.; Clarke, Michael F.			Usp16 contributes to somatic stem-cell defects in Down's syndrome	NATURE			English	Article							MOUSE MODEL; HEMATOPOIETIC STEM; ALZHEIMERS-DISEASE; SELF-RENEWAL; PROLIFERATION; PURIFICATION; EXPRESSION; BMI-1; DISSECTION; BIOMARKER	Down's syndrome results from full or partial trisomy of chromosome 21. However, the consequences of the underlying gene-dosage imbalance on adult tissues remain poorly understood. Here we show that in Ts65Dn mice, which are trisomic for 132 genes homologous to genes on human chromosome 21, triplication of Usp16 reduces the self-renewal of haematopoietic stem cells and the expansion of mammary epithelial cells, neural progenitors and fibroblasts. In addition, Usp16 is associated with decreased ubiquitination of Cdkn2a and accelerated senescence in Ts65Dn fibroblasts. Usp16 can remove ubiquitin from histone H2A on lysine 119, a critical mark for the maintenance of multiple somatic tissues. Downregulation of Usp16, either by mutation of a single normal Usp16 allele or by short interfering RNAs, largely rescues all of these defects. Furthermore, in human tissues overexpression of USP16 reduces the expansion of normal fibroblasts and postnatal neural progenitors, whereas downregulation of USP16 partially rescues the proliferation defects of Down's syndrome fibroblasts. Taken together, these results suggest that USP16 has an important role in antagonizing the self-renewal and/or senescence pathways in Down's syndrome and could serve as an attractive target to ameliorate some of the associated pathologies.	[Adorno, Maddalena; Sikandar, Shaheen; Mitra, Siddhartha S.; Kuo, Angera; Di Robilant, Benedetta Nicolis; Haro-Acosta, Veronica; Ouadah, Youcef; Qian, Dalong; Cheshier, Samuel; Clarke, Michael F.] Stanford Univ, Sch Med, Inst Stem Cell Biol & Regenerat Med, Stanford, CA 94305 USA; [Di Robilant, Benedetta Nicolis] San Raffaele Univ, Int PhD Sch Mol Med, Milan, Italy; [Ouadah, Youcef] Stanford Univ, Sch Med, Program Canc Biol, Stanford, CA 94305 USA; [Quarta, Marco] Stanford Univ, Sch Med, Dept Neurol, Stanford, CA 94305 USA; [Rodriguez, Jacqueline; Garner, Craig C.] Stanford Univ, Sch Med, Dept Psychiat & Behav Sci, Stanford, CA 94305 USA; [Reddy, Vadiyala M.] Stanford Univ, Sch Med, Dept Pediat, Div Pediat Cardiol, Stanford, CA 94305 USA; [Cheshier, Samuel] Stanford Univ, Sch Med, Dept Neurosurg, Div Pediat Neurosurg, Stanford, CA 94305 USA	Stanford University; Vita-Salute San Raffaele University; Stanford University; Stanford University; Stanford University; Stanford University; Stanford University	Clarke, MF (corresponding author), Stanford Univ, Sch Med, Inst Stem Cell Biol & Regenerat Med, Stanford, CA 94305 USA.	mfclarke@stanford.edu		Garner, Craig/0000-0003-1970-5417	California Institute for Regenerative Medicine (CIRM) basic biology award III; National Institutes of Health [CA100225, CA154209]; CIRM bridges fellowship; Fondazione Umberto Veronesi; Breast Cancer Research Program; Department of Defense; The Breast Cancer Research Foundation (BCRF); Stanford Graduate Fellowship; Down Syndrome Research and Treatment Foundation; Fidelity Foundation; NATIONAL CANCER INSTITUTE [T32CA009302, R01CA100225, R01CA104987, U01CA154209] Funding Source: NIH RePORTER	California Institute for Regenerative Medicine (CIRM) basic biology award III; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CIRM bridges fellowship; Fondazione Umberto Veronesi(Fondazione Umberto Veronesi); Breast Cancer Research Program; Department of Defense(United States Department of Defense); The Breast Cancer Research Foundation (BCRF); Stanford Graduate Fellowship(Stanford University); Down Syndrome Research and Treatment Foundation; Fidelity Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank S. Marro for help in establishing MEF and TTF lines; I. L. Weissman for sharing C57BL/6 CD45.1 mice; the animal core facility of SIM1, in particular A. Valledifiera and M. Alvarez. This study was supported in part by a California Institute for Regenerative Medicine (CIRM) basic biology award III, National Institutes of Health grant numbers CA100225 and CA154209, CIRM bridges fellowship (V. H.-A.), Fondazione Umberto Veronesi (B.N.d.R.), Breast Cancer Research Program sponsored by Department of Defense (S. S.), The Breast Cancer Research Foundation (BCRF), Stanford Graduate Fellowship (Y.O.) and the Down Syndrome Research and Treatment Foundation and the Fidelity Foundation (C.C.G.).	Akala OO, 2008, NATURE, V453, P228, DOI 10.1038/nature06869; Antonarakis SE, 2004, NAT REV GENET, V5, P725, DOI 10.1038/nrg1448; Arron JR, 2006, NATURE, V441, P595, DOI 10.1038/nature04678; Cao GL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032015; CARMELIET G, 1991, MUTAT RES, V256, P221, DOI 10.1016/0921-8734(91)90013-2; Chao MP, 2008, COLD SH Q B, V73, P439, DOI 10.1101/sqb.2008.73.031; Dalerba P, 2011, NAT BIOTECHNOL, V29, P1120, DOI 10.1038/nbt.2038; Ellis P, 2004, DEV NEUROSCI-BASEL, V26, P148, DOI 10.1159/000082134; Fischer J, 2011, NAT PROTOC, V6, P1981, DOI 10.1038/nprot.2011.412; Hu YF, 2009, J IMMUNOL METHODS, V347, P70, DOI 10.1016/j.jim.2009.06.008; Jacobs JJL, 1999, NATURE, V397, P164, DOI 10.1038/16476; Janzen V, 2006, NATURE, V443, P421, DOI 10.1038/nature05159; Joo HY, 2007, NATURE, V449, P1068, DOI 10.1038/nature06256; Kimura M, 2005, FREE RADICAL BIO MED, V39, P374, DOI 10.1016/j.freeradbiomed.2005.03.023; Krishnamurthty J, 2004, J CLIN INVEST, V114, P1299, DOI 10.1172/JCI200422475; Liu L, 2011, J CELL BIOL, V193, P257, DOI 10.1083/jcb.201010131; Liu Y, 2009, AGING CELL, V8, P439, DOI 10.1111/j.1474-9726.2009.00489.x; Lorenzi HA, 2006, BRAIN RES, V1104, P153, DOI 10.1016/j.brainres.2006.05.022; Lorenzo LPE, 2011, ANTIOXID REDOX SIGN, V15, P2083, DOI 10.1089/ars.2010.3798; Majeti R, 2007, CELL STEM CELL, V1, P635, DOI 10.1016/j.stem.2007.10.001; Molofsky AV, 2003, NATURE, V425, P962, DOI 10.1038/nature02060; Negishi M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012373; Park IK, 2003, NATURE, V423, P302, DOI 10.1038/nature01587; Pastrana E, 2009, P NATL ACAD SCI USA, V106, P6387, DOI 10.1073/pnas.0810407106; Pietersen AM, 2008, CURR BIOL, V18, P1094, DOI 10.1016/j.cub.2008.06.070; REEVES RH, 1995, NAT GENET, V11, P177, DOI 10.1038/ng1095-177; Reinholdt LG, 2011, MAMM GENOME, V22, P685, DOI 10.1007/s00335-011-9357-z; Roth GM, 1996, AM J NEURORADIOL, V17, P1283; Roy A, 2012, P NATL ACAD SCI USA, V109, P17579, DOI 10.1073/pnas.1211405109; Sago H, 2000, PEDIATR RES, V48, P606, DOI 10.1203/00006450-200011000-00009; Sago H, 1998, P NATL ACAD SCI USA, V95, P6256, DOI 10.1073/pnas.95.11.6256; Shackleton M, 2006, NATURE, V439, P84, DOI 10.1038/nature04372; Shimono Y, 2009, CELL, V138, P592, DOI 10.1016/j.cell.2009.07.011; Stingl J, 2006, NATURE, V439, P993, DOI 10.1038/nature04496; Tiscornia G, 2006, NAT PROTOC, V1, P241, DOI 10.1038/nprot.2006.37; Ventura A, 2004, P NATL ACAD SCI USA, V101, P10380, DOI 10.1073/pnas.0403954101; Yang QH, 2002, LANCET, V359, P1019, DOI 10.1016/S0140-6736(02)08092-3; Zeng YA, 2010, CELL STEM CELL, V6, P568, DOI 10.1016/j.stem.2010.03.020; Zigman WB, 2007, MENT RETARD DEV D R, V13, P237, DOI 10.1002/mrdd.20163	39	84	92	0	32	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 19	2013	501	7467					380	+		10.1038/nature12530	http://dx.doi.org/10.1038/nature12530			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219XT	24025767	Green Accepted, Green Submitted			2022-12-24	WOS:000324545700037
J	Noinaj, N; Kuszak, AJ; Gumbart, JC; Lukacik, P; Chang, HS; Easley, NC; Lithgow, T; Buchanan, SK				Noinaj, Nicholas; Kuszak, Adam J.; Gumbart, James C.; Lukacik, Petra; Chang, Hoshing; Easley, Nicole C.; Lithgow, Trevor; Buchanan, Susan K.			Structural insight into the biogenesis of beta-barrel membrane proteins	NATURE			English	Article							OUTER-MEMBRANE; CRYSTAL-STRUCTURE; MOLECULAR-DYNAMICS; ESSENTIAL COMPONENT; ASSEMBLY MACHINERY; BAMA; BACTERIA; FLEXIBILITY; EVOLUTION; INSERTION	beta-barrel membrane proteins are essential for nutrient import, signalling, motility and survival. InGram-negative bacteria, the beta-barrel assembly machinery (BAM) complex is responsible for the biogenesis of beta-barrel membrane proteins, with homologous complexes found in mitochondria and chloroplasts. Here we describe the structure of BamA, the central and essential component of the BAM complex, from two species of bacteria: Neisseria gonorrhoeae and Haemophilus ducreyi. BamA consists of a large periplasmic domain attached to a 16-strand transmembrane beta-barrel domain. Three structural features shed light on the mechanism by which BamA catalyses beta-barrel assembly. First, the interior cavity is accessible in one BamA structure and conformationally closed in the other. Second, an exterior rim of the beta-barrel has a distinctly narrowed hydrophobic surface, locally destabilizing the outer membrane. And third, the beta-barrel can undergo lateral opening, suggesting a route from the interior cavity in BamA into the outer membrane.	[Noinaj, Nicholas; Kuszak, Adam J.; Chang, Hoshing; Easley, Nicole C.; Buchanan, Susan K.] NIDDK, NIH, Bethesda, MD 20892 USA; [Gumbart, James C.] Georgia Inst Technol, Sch Phys, Atlanta, GA 30332 USA; [Lukacik, Petra] Diamond Light Source Ltd, Oxford OX11 0DE, England; [Lithgow, Trevor] Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic 3800, Australia	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); University System of Georgia; Georgia Institute of Technology; Diamond Light Source; Monash University	Buchanan, SK (corresponding author), NIDDK, NIH, Bethesda, MD 20892 USA.	skbuchan@helix.nih.gov	Lukacik, Petra/AAY-3775-2021; Lithgow, Trevor/H-5925-2017	Lukacik, Petra/0000-0002-3179-7273; Kuszak, Adam/0000-0001-8719-145X; Lithgow, Trevor/0000-0002-0102-7884	National Institutes of Health (NIH), National Institute of Diabetes and Digestive and Kidney Diseases; NIH [K22-AI100927, R01-GM67887]; Diamond Light Source; ARC Discovery Project [DP120101878]; ARC Linkage International Grant [LX0776170]; US Department of Energy, Office of Science, Office of Basic Energy Sciences [W-31-109-Eng-38]; US Department of Energy, Basic Energy Sciences, Office of Science [DE-AC02-06CH11357]; Pittsburgh Supercomputing Center [RC2GM093307]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K22AI100927] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK036139] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [RC2GM093307, R01GM067887] Funding Source: NIH RePORTER	National Institutes of Health (NIH), National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Diamond Light Source; ARC Discovery Project(Australian Research Council); ARC Linkage International Grant(Australian Research Council); US Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); US Department of Energy, Basic Energy Sciences, Office of Science(United States Department of Energy (DOE)); Pittsburgh Supercomputing Center; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank H. Bernstein and R. Ieva for providing JCM-166 cells, J. Beckwith and R. Misra for providing antibodies, and A. M. Stanley and T. Barnard for discussions and comments on the manuscript. N. N., A. J. K., N. C. E., H. C. and S. K. B. are supported by the Intramural Research Program of the National Institutes of Health (NIH), National Institute of Diabetes and Digestive and Kidney Diseases. J. C. G. acknowledges support from the NIH under grants K22-AI100927 and R01-GM67887. P. L. is supported by a postdoctoral fellowship through the Diamond Light Source. T. L. is an Australian Research Council (ARC) Federation Fellow and acknowledges support from ARC Discovery Project (DP120101878) and ARC Linkage International Grant (LX0776170). We thank the respective staffs at the Southeast Regional Collaborative Access Team (SER-CAT) and General Medicine and Cancer Institute's Collaborative Access Team (GM/CA-CAT) beamlines at the Advanced Photon Source, Argonne National Laboratory and the Diamond Light Source for their assistance during data collection. Use of the Advanced Photon Source was supported by the US Department of Energy, Office of Science, Office of Basic Energy Sciences, under contract no. W-31-109-Eng-38 (SER-CAT), and by the US Department of Energy, Basic Energy Sciences, Office of Science, under contract no. DE-AC02-06CH11357 (GM/CA-CAT). Anton computer time was provided by the National Resource for Biomedical Supercomputing and the Pittsburgh Supercomputing Center through Grant RC2GM093307 from the NIH, using a machine donated by DE Shaw Research.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Agah Sayeh, 2012, Methods Mol Biol, V914, P3, DOI 10.1007/978-1-62703-023-6_1; Albrecht R, 2011, J BIOL CHEM, V286, P27792, DOI 10.1074/jbc.M111.238931; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Barnard TJ, 2012, J MOL BIOL, V415, P128, DOI 10.1016/j.jmb.2011.10.049; Chacinska A, 2009, CELL, V138, P628, DOI 10.1016/j.cell.2009.08.005; Clantin B, 2007, SCIENCE, V317, P957, DOI 10.1126/science.1143860; Cuesta-Seijo JA, 2010, STRUCTURE, V18, P1210, DOI 10.1016/j.str.2010.06.014; Dalbey RE, 2011, ANNU REV BIOCHEM, V80, P161, DOI 10.1146/annurev-biochem-060409-092524; Dong C, 2012, ACTA CRYSTALLOGR D, V68, P95, DOI 10.1107/S0907444911051031; Du Plessis DJF, 2011, BBA-BIOMEMBRANES, V1808, P851, DOI 10.1016/j.bbamem.2010.08.016; Elbing Karen, 2002, Curr Protoc Mol Biol, VChapter 1, DOI 10.1002/0471142727.mb0101s59; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fairman JW, 2012, STRUCTURE, V20, P1233, DOI 10.1016/j.str.2012.04.011; Fan E, 2012, J BIOL CHEM, V287, P2591, DOI 10.1074/jbc.M111.293068; Gatzeva-Topalova PZ, 2008, STRUCTURE, V16, P1873, DOI 10.1016/j.str.2008.09.014; Gatzeva-Topalova PZ, 2010, STRUCTURE, V18, P1492, DOI 10.1016/j.str.2010.08.012; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Gumbart J, 2009, J MOL BIOL, V393, P1129, DOI 10.1016/j.jmb.2009.09.004; Hagan CL, 2011, ANNU REV BIOCHEM, V80, P189, DOI 10.1146/annurev-biochem-061408-144611; Hagan CL, 2010, SCIENCE, V328, P890, DOI 10.1126/science.1188919; Hearn EM, 2009, NATURE, V458, P367, DOI 10.1038/nature07678; Heuck A, 2011, J MOL BIOL, V406, P659, DOI 10.1016/j.jmb.2011.01.002; Hong HD, 2006, J BIOL CHEM, V281, P7568, DOI 10.1074/jbc.M512365200; Jiang JH, 2012, INT J MOL SCI, V13, P8038, DOI 10.3390/ijms13078038; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kim KH, 2011, J BIOL CHEM, V286, P39116, DOI 10.1074/jbc.M111.298166; Kim S, 2007, SCIENCE, V317, P961, DOI 10.1126/science.1143993; Klauda JB, 2010, J PHYS CHEM B, V114, P7830, DOI 10.1021/jp101759q; Knowles TJ, 2008, MOL MICROBIOL, V68, P1216, DOI 10.1111/j.1365-2958.2008.06225.x; Knowles TJ, 2011, EMBO REP, V12, P123, DOI 10.1038/embor.2010.202; Knowles TJ, 2009, NAT REV MICROBIOL, V7, P206, DOI 10.1038/nrmicro2069; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Leonard-Rivera M, 2012, J BACTERIOL, V194, P4662, DOI 10.1128/JB.00825-12; Mackerell AD, 2004, J COMPUT CHEM, V25, P1400, DOI 10.1002/jcc.20065; Noinaj N, 2011, J MOL BIOL, V407, P248, DOI 10.1016/j.jmb.2011.01.042; Osborne AR, 2005, ANNU REV CELL DEV BI, V21, P529, DOI 10.1146/annurev.cellbio.21.012704.133214; Paschen SA, 2005, TRENDS BIOCHEM SCI, V30, P575, DOI 10.1016/j.tibs.2005.08.009; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; PUGSLEY AP, 1993, MICROBIOL REV, V57, P50, DOI 10.1128/MMBR.57.1.50-108.1993; Ramachandran S, 2011, PROTEINS, V79, P261, DOI 10.1002/prot.22879; Ricci DP, 2012, BBA-BIOMEMBRANES, V1818, P1067, DOI 10.1016/j.bbamem.2011.08.020; Rigel NW, 2013, P NATL ACAD SCI USA, V110, P5151, DOI 10.1073/pnas.1302662110; Rigel NW, 2012, CURR OPIN MICROBIOL, V15, P189, DOI 10.1016/j.mib.2011.12.007; Robert V, 2006, PLOS BIOL, V4, P1984, DOI 10.1371/journal.pbio.0040377; Sandoval CM, 2011, J MOL BIOL, V409, P348, DOI 10.1016/j.jmb.2011.03.035; Shaw DE, 2008, COMMUN ACM, V51, P91, DOI 10.1145/1364782.1364802; Stein N, 2008, J APPL CRYSTALLOGR, V41, P641, DOI 10.1107/S0021889808006985; Tamm LK, 2004, BBA-BIOMEMBRANES, V1666, P250, DOI 10.1016/j.bbamem.2004.06.011; Tamm LK, 2001, J BIOL CHEM, V276, P32399, DOI 10.1074/jbc.R100021200; Tommassen J, 2010, MICROBIOL-SGM, V156, P2587, DOI 10.1099/mic.0.042689-0; Ujwal R, 2011, METHODS, V55, P337, DOI 10.1016/j.ymeth.2011.09.020; Ulmschneider JP, 2011, J AM CHEM SOC, V133, P15487, DOI 10.1021/ja204042f; Walther DM, 2009, CELL MOL LIFE SCI, V66, P2789, DOI 10.1007/s00018-009-0029-z; Webb CT, 2012, TRENDS MICROBIOL, V20, P612, DOI 10.1016/j.tim.2012.08.006; White SH, 2008, ANNU REV BIOPHYS, V37, P23, DOI 10.1146/annurev.biophys.37.032807.125904; Wu T, 2005, CELL, V121, P235, DOI 10.1016/j.cell.2005.02.015; Zhang H, 2011, ACTA CRYSTALLOGR F, V67, P734, DOI 10.1107/S1744309111014254	60	299	303	6	138	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 19	2013	501	7467					385	+		10.1038/nature12521	http://dx.doi.org/10.1038/nature12521			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219XT	23995689	Green Accepted			2022-12-24	WOS:000324545700038
J	Farkas, RH; Unger, EF; Temple, R				Farkas, Ronald H.; Unger, Ellis F.; Temple, Robert			Zolpidem and Driving Impairment - Identifying Persons at Risk	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Farkas, Ronald H.; Unger, Ellis F.; Temple, Robert] US FDA, Ctr Drug Evaluat & Res, Silver Spring, MD USA	US Food & Drug Administration (FDA)	Farkas, RH (corresponding author), US FDA, Ctr Drug Evaluat & Res, Silver Spring, MD USA.							[Anonymous], FDA REQUIRES LOWER R; Colten HR, 2006, SLEEP DISORDERS SLEE	2	78	78	0	9	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 22	2013	369	8					689	691		10.1056/NEJMp1307972	http://dx.doi.org/10.1056/NEJMp1307972			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	204FA	23923991				2022-12-24	WOS:000323349300002
J	Mousavi, SAR; Chauvin, A; Pascaud, F; Kellenberger, S; Farmer, EE				Mousavi, Seyed A. R.; Chauvin, Adeline; Pascaud, Francois; Kellenberger, Stephan; Farmer, Edward E.			GLUTAMATE RECEPTOR-LIKE genes mediate leaf-to-leaf wound signalling	NATURE			English	Article							JASMONIC ACID; ATPASE ACTIVITY; ARABIDOPSIS; DEFENSE; PLANTS; ACCUMULATION; POTENTIALS; EXPRESSION; INDUCTION; RESPONSES	Wounded leaves communicate their damage status to one another through a poorly understood process of long-distance signalling. This stimulates the distal production of jasmonates, potent regulators of defence responses. Using non-invasive electrodes we mapped surface potential changes in Arabidopsis thaliana after wounding leaf eight and found that membrane depolarizations correlated with jasmonate signalling domains in undamaged leaves. Furthermore, current injection elicited jasmonoyl-isoleucine accumulation, resulting in a transcriptome enriched in RNAs encoding key jasmonate signalling regulators. From among 34 screened membrane protein mutant lines, mutations in several clade 3 GLUTAMATE RECEPTOR-LIKE genes (GLRs 3.2, 3.3 and 3.6) attenuated wound-induced surface potential changes. Jasmonate-response gene expression in leaves distal to wounds was reduced in a glr3.3 glr3.6 double mutant. This work provides a genetic basis for investigating mechanisms of long-distance wound signalling in plants and indicates that plant genes related to those important for synaptic activity in animals function in organ-to-organ wound signalling.	[Mousavi, Seyed A. R.; Farmer, Edward E.] Univ Lausanne, Dept Plant Mol Biol, CH-1015 Lausanne, Switzerland; [Chauvin, Adeline] Univ Geneva, Sch Pharmaceut Sci, CH-1211 Geneva 4, Switzerland; [Pascaud, Francois; Kellenberger, Stephan] Univ Lausanne, Dept Pharmacol & Toxicol, CH-1005 Lausanne, Switzerland	University of Lausanne; University of Geneva; University of Lausanne	Farmer, EE (corresponding author), Univ Lausanne, Dept Plant Mol Biol, CH-1015 Lausanne, Switzerland.	edward.farmer@unil.ch	Farmer, Edward E/H-1635-2011; mousavi, seyyed amin ayatollahi/Q-8504-2016	mousavi, seyyed amin ayatollahi/0000-0002-5367-483X; Mousavi, Seyed Ali Reza/0000-0002-2948-1771; Kellenberger, Stephan/0000-0003-1755-6198	Faculty of Biology and Medicine Interdisciplinary grant; Swiss NSF [3100A0-122441, 31003A-138235]	Faculty of Biology and Medicine Interdisciplinary grant; Swiss NSF(Swiss National Science Foundation (SNSF))	Supported by a Faculty of Biology and Medicine Interdisciplinary grant (to S.K. and E.E.F.) and Swiss NSF grants 3100A0-122441 and 31003A-138235 (to E.E.F.). We thank I. Acosta, D. Gasperini, S. Stolz and A. Chetelat and other Farmer lab members for critical comments and/or technical help, M. Blanchard for help with electrophysiology, and the Lausanne Genomic Technologies Facility and M. Shakhsi-Niaei for help with transcriptome analyses. We thank Y. Lee and F. Mauch for rbohD seeds, P. Schweizer and P. Reymond for insect larvae, J.-L. Wolfender for analytics support, and R. Benton, C. Fankhauser, N. Geldner, C. Hardtke and Y. Poirier for valuable comments.	BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berberich T., 2008, HDB PLANT FUNCTIONAL, P113; Boller T, 2009, ANNU REV PLANT BIOL, V60, P379, DOI 10.1146/annurev.arplant.57.032905.105346; Bonaventure G, 2007, PLANT J, V49, P889, DOI 10.1111/j.1365-313X.2006.03002.x; Browse J, 2009, ANNU REV PLANT BIOL, V60, P183, DOI 10.1146/annurev.arplant.043008.092007; Brux A, 2008, PLANT CELL, V20, P1088, DOI 10.1105/tpc.108.058362; Card G, 2008, CURR BIOL, V18, P1300, DOI 10.1016/j.cub.2008.07.094; Carpaneto A, 2007, PLANT PHYSIOL, V143, P487, DOI 10.1104/pp.106.090928; Chauvin A, 2013, NEW PHYTOL, V197, P566, DOI 10.1111/nph.12029; Chiu JC, 2002, MOL BIOL EVOL, V19, P1066, DOI 10.1093/oxfordjournals.molbev.a004165; Czechowski T, 2005, PLANT PHYSIOL, V139, P5, DOI 10.1104/pp.105.063743; Dengler NG, 2006, CAN J BOT, V84, P1660, DOI 10.1139/B06-126; Escalante-Perez M, 2011, P NATL ACAD SCI USA, V108, P15492, DOI 10.1073/pnas.1112535108; Favre P, 2007, PHYSIOL PLANTARUM, V131, P263, DOI 10.1111/j.1399-3054.2007.00954.x; Fisahn J, 2004, PLANT CELL PHYSIOL, V45, P456, DOI 10.1093/pcp/pch054; Fonseca S, 2009, NAT CHEM BIOL, V5, P344, DOI 10.1038/nchembio.161; Fromm J, 2007, PLANT CELL ENVIRON, V30, P249, DOI 10.1111/j.1365-3040.2006.01614.x; Glauser G, 2008, J BIOL CHEM, V283, P16400, DOI 10.1074/jbc.M801760200; Glauser G, 2009, J BIOL CHEM, V284, P34506, DOI 10.1074/jbc.M109.061432; Herde O, 1996, PLANT PHYSIOL, V112, P853, DOI 10.1104/pp.112.2.853; Howe GA, 2008, ANNU REV PLANT BIOL, V59, P41, DOI 10.1146/annurev.arplant.59.032607.092825; JEFFERSON RA, 1987, EMBO J, V6, P3901; Kang S, 2006, MOL CELLS, V21, P418; Kilian J, 2007, PLANT J, V50, P347, DOI 10.1111/j.1365-313X.2007.03052.x; Koo AJK, 2009, PHYTOCHEMISTRY, V70, P1571, DOI 10.1016/j.phytochem.2009.07.018; Koo AJK, 2009, PLANT J, V59, P974, DOI 10.1111/j.1365-313X.2009.03924.x; Kramell R, 1997, CHROMATOGRAPHIA, V45, P104, DOI 10.1007/BF02505545; Krol E, 2010, J BIOL CHEM, V285, P13471, DOI 10.1074/jbc.M109.097394; Kwaaitaal M, 2011, BIOCHEM J, V440, P355, DOI 10.1042/BJ20111112; Liu YL, 2005, PLANT PHYSIOL, V139, P1545, DOI 10.1104/pp.105.066837; Maffei M, 2004, PLANT PHYSIOL, V134, P1752, DOI 10.1104/pp.103.034165; Michard E, 2011, SCIENCE, V332, P434, DOI 10.1126/science.1201101; Miller G, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000448; MINORSKY PV, 1989, PLANT CELL ENVIRON, V12, P119, DOI 10.1111/j.1365-3040.1989.tb01924.x; Mueller MJ, 2006, PLANT J, V45, P472, DOI 10.1111/j.1365-313X.2005.02614.x; Onate-Sanchez Luis, 2008, BMC Res Notes, V1, P93, DOI 10.1186/1756-0500-1-93; Qi Z, 2006, PLANT PHYSIOL, V142, P963, DOI 10.1104/pp.106.088989; Reymond P, 2004, PLANT CELL, V16, P3132, DOI 10.1105/tpc.104.026120; Schaller A, 1999, PLANT CELL, V11, P263, DOI 10.1105/tpc.11.2.263; Schaller A, 2001, PLANTA, V212, P431, DOI 10.1007/s004250000413; Shimada TL, 2010, PLANT J, V61, P519, DOI 10.1111/j.1365-313X.2009.04060.x; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Stahlberg R, 2006, COMMUNICATION IN PLANTS: NEURONAL ASPECTS OF PLANT LIFE, P291; STAHLBERG R, 1994, PLANT CELL ENVIRON, V17, P1143, DOI 10.1111/j.1365-3040.1994.tb02012.x; Stephens NR, 2008, PLANT PHYSIOL, V146, P529, DOI 10.1104/pp.107.108134; Torres MA, 2002, P NATL ACAD SCI USA, V99, P517, DOI 10.1073/pnas.012452499; Traynelis SF, 2010, PHARMACOL REV, V62, P405, DOI 10.1124/pr.109.002451; vanWees S, 2008, COLD SPRING HARB PRO; Walley JW, 2007, PLOS GENET, V3, P1800, DOI 10.1371/journal.pgen.0030172; Walters D. R., 2011, PLANT DEFENSE; WILDON DC, 1992, NATURE, V360, P62, DOI 10.1038/360062a0; Xie DX, 1998, SCIENCE, V280, P1091, DOI 10.1126/science.280.5366.1091; Yan YX, 2007, PLANT CELL, V19, P2470, DOI 10.1105/tpc.107.050708; Zimmermann MR, 2009, PLANT PHYSIOL, V149, P1593, DOI 10.1104/pp.108.133884	54	441	459	17	346	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 22	2013	500	7463					422	+		10.1038/nature12478	http://dx.doi.org/10.1038/nature12478			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	203TJ	23969459	Green Accepted, Green Submitted			2022-12-24	WOS:000323316100027
J	Palmsten, K; Hernandez-Diaz, S; Huybrechts, KF; Williams, PL; Michels, KB; Achtyes, ED; Mogun, H; Setoguchi, S				Palmsten, Kristin; Hernandez-Diaz, Sonia; Huybrechts, Krista F.; Williams, Paige L.; Michels, Karin B.; Achtyes, Eric D.; Mogun, Helen; Setoguchi, Soko			Use of antidepressants near delivery and risk of postpartum hemorrhage: cohort study of low income women in the United States	BMJ-BRITISH MEDICAL JOURNAL			English	Article							SEROTONIN REUPTAKE INHIBITORS; MATERNAL OBESITY; OUTCOMES; DEPRESSION; PREGNANCY; PROFILE; ASSOCIATION; DULOXETINE; MORTALITY; SELECTION	Objective To determine whether use of serotonin or non-serotonin reuptake inhibitors near to delivery is associated with postpartum hemorrhage. Design Cohort study. Setting 2000-07 nationwide Medicaid data (Medicaid Analytic eXtract). Population 106 000 pregnant women aged 12-55 with a diagnosis of mood or anxiety disorder. Women were categorized into four mutually exclusive exposure groups according to pharmacy dispensing data: current (delivery date), recent (1-30 days before delivery date), past (1-5 months before delivery date), and no exposure (reference group). Main outcome measures Risk of postpartum hemorrhage by timing of exposure and by serotonin or non-serotonin reuptake inhibitors, classes of antidepressant, and antidepressant types. Relative risks and 95% confidence intervals adjusted for delivery year, risk factors for postpartum hemorrhage, indicators of severity of mood/anxiety disorder, other indications for antidepressants, and other drugs. High dimensional propensity score (hdPS) methods were used to empirically identify and adjust for additional factors. Results 12 710 (12%) women had current exposure to serotonin reuptake inhibitor monotherapy, and 1495 (1.4%) women had current exposure to non-serotonin reuptake inhibitor monotherapy. The risk of postpartum hemorrhage was 2.8% among women with mood/anxiety disorders but no exposure to antidepressants, 4.0% in the current users of serotonin reuptake inhibitors, 3.8% in the current users of non-serotonin reuptake inhibitors, 3.2% in the recent users of serotonin reuptake inhibitors, 3.1% in the recent users of non-serotonin reuptake inhibitors, 2.5% in the past users of serotonin reuptake inhibitors, and 3.4% in the past users of non-serotonin reuptake inhibitors. Compared with no exposure, women with current exposure to serotonin reuptake inhibitors had a 1.47-fold increased risk of postpartum hemorrhage (95% confidence interval 1.33 to 1.62) and women with current non-serotonin reuptake inhibitor exposure had a 1.39-fold increased risk (1.07 to 1.81). Results were similar with hdPS adjustment. Women with current exposure to serotonin reuptake inhibitors had an adjusted excess risk of 1.26% (0.90% to 1.62%), with a number needed to harm of 80, and for women with current exposure to non-serotonin reuptake inhibitors the excess risk was 1.03% (0.07% to 1.99%), with a number needed to harm of 97. For exposure to serotonin reuptake inhibitors the relative risk was 1.19 (1.03 to 1.38) for recent exposure and 0.93 (0.82 to 1.06) for past exposure; for non-serotonin reuptake inhibitors the figures were 1.17 (0.80 to 1.70) and 1.26 (1.00 to 1.59), respectively. Current exposure to selective serotonin reuptake inhibitor monotherapy was also associated with postpartum hemorrhage (1.42, 1.27 to 1.57), as was current serotonin norepinephrine (noradrenaline) reuptake inhibitor (1.90, 1.37 to 2.63) and tricyclic monotherapy (1.77, 0.90 to 3.47). All types of selective serotonin reuptake inhibitors available for analysis and venlafaxine, a serotonin norepinephrine reuptake inhibitor, were significantly associated with postpartum hemorrhage. Conclusions Exposure to serotonin and non-serotonin reuptake inhibitors, including selective serotonin reuptake inhibitors, serotonin-norepinephrine reuptake inhibitors, and tricyclics, close to the time of delivery was associated with a 1.4 to 1.9-fold increased risk for postpartum hemorrhage. While potential confounding by unmeasured factors cannot be ruled out, these findings suggest that patients treated with antidepressants during late pregnancy are more likely to experience postpartum hemorrhage.	[Palmsten, Kristin; Hernandez-Diaz, Sonia; Michels, Karin B.; Setoguchi, Soko] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Huybrechts, Krista F.; Mogun, Helen] Brigham & Womens Hosp, Dept Med, Div Pharmacoepidemiol & Pharmacoecon, Boston, MA 02120 USA; [Huybrechts, Krista F.; Mogun, Helen] Harvard Univ, Sch Med, Boston, MA 02120 USA; [Williams, Paige L.] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; [Michels, Karin B.] Harvard Univ, Brigham & Womens Hosp, Dept Obstet Gynecol & Reprod Biol, Sch Med,Obstet & Gynecol Epidemiol Ctr, Boston, MA 02115 USA; [Michels, Karin B.] Univ Freiburg, Med Ctr, Inst Prevent & Canc Epidemiol, Freiburg, Germany; [Achtyes, Eric D.] Michigan State Univ, Coll Human Med, Div Psychiat & Behav Med, Grand Rapids, MI 49503 USA; [Setoguchi, Soko] Duke Univ, Sch Med, Duke Clin Res Inst, Durham, NC 27705 USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of Freiburg; Michigan State University; Michigan State University College of Human Medicine; Duke University	Palmsten, K (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Epidemiol, 677 Huntington Ave, Boston, MA 02115 USA.	kkp762@mail.harvard.edu	Achtyes, Eric/M-6024-2016; Achtyes, Eric/AAA-6372-2020	Achtyes, Eric/0000-0001-8939-1535; 	Agency for Healthcare Research and Quality (AHRQ) [R01HS018533]; Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health [T32HD060454]; AHRQ [K02-HS017731]; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [K02HS017731, R01HS018533] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD060454] Funding Source: NIH RePORTER	Agency for Healthcare Research and Quality (AHRQ)(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); AHRQ(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by the Agency for Healthcare Research and Quality (AHRQ) (grant R01HS018533 to SH-D). KP was supported by training grant T32HD060454 in reproductive, perinatal, and pediatric epidemiology from the Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health. SS was supported by a mid-career development award grant K02-HS017731 from the AHRQ. The AHRQ had no role in the study design and the collection, analysis, and interpretation of data and writing of the article and the decision to submit it for publication. Research was conducted independently of the sponsor and funders.	American College of Obstetricians and Gynecologists, 2006, Obstet Gynecol, V108, P1039; Ananth CV, 2011, AM J EPIDEMIOL, V174, P99, DOI 10.1093/aje/kwr045; Andersen J, 2009, CHEM COMMUN, P3677, DOI 10.1039/b903035m; Andrade SE, 2008, AM J OBSTET GYNECOL, V198, DOI 10.1016/j.ajog.2007.07.036; Baskett T F, 2005, J Obstet Gynaecol, V25, P7, DOI 10.1080/01674820400023408; Berg CJ, 2010, OBSTET GYNECOL, V116, P1302, DOI 10.1097/AOG.0b013e3181fdfb11; Blomberg M, 2011, OBSTET GYNECOL, V118, P561, DOI 10.1097/AOG.0b013e31822a6c59; Callaghan WM, 2010, AM J OBSTET GYNECOL, V202, DOI 10.1016/j.ajog.2010.01.011; Castro VM, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2011-000544; Clark SM, 2011, OBSTET GYN CLIN N AM, V38, P297, DOI 10.1016/j.ogc.2011.02.017; Cooper WO, 2007, AM J OBSTET GYNECOL, V196, P544, DOI 10.1016/j.ajog.2007.01.033; Cordeaux Y, 2009, J PHARMACOL EXP THER, V328, P682, DOI 10.1124/jpet.108.143040; Coupland C, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4551; de Abajo FJ, 1999, BRIT MED J, V319, P1106, DOI 10.1136/bmj.319.7217.1106; de Abajo FJ, 2006, BASIC CLIN PHARMACOL, V98, P304, DOI 10.1111/j.1742-7843.2006.pto_303.x; de Abajo FJ, 2011, DRUG AGING, V28, P345, DOI 10.2165/11589340-000000000-00000; Ford JB, 2007, INT J GYNECOL OBSTET, V98, P237, DOI 10.1016/j.ijgo.2007.03.011; Fyfe EM, 2012, BMC PREGNANCY CHILDB, V12, DOI 10.1186/1471-2393-12-112; Garcia G, MATERNAL CHILD HLTH; Gilbert TT, 2003, OBSTET GYNECOL, V102, P897, DOI 10.1016/S0029-7844(03)00767-1; Guirgis R. R., 1997, Journal of Obstetrics and Gynaecology (Abingdon), V17, P149; Hernan MA, 2002, AM J EPIDEMIOL, V155, P176, DOI 10.1093/aje/155.2.176; Hernan MA, 2004, EPIDEMIOLOGY, V15, P615, DOI 10.1097/01.ede.0000135174.63482.43; Huybrechts KF, 2013, GEN HOSP PSYCHIAT, V35, P265, DOI 10.1016/j.genhosppsych.2012.12.010; Joseph KS, 2007, BJOG-INT J OBSTET GY, V114, P751, DOI 10.1111/j.1471-0528.2007.01316.x; Knight M, 2009, BMC PREGNANCY CHILDB, V9, DOI 10.1186/1471-2393-9-55; Kramer MS, 2011, J OBSTET GYNAECOL CA, V33, P810, DOI 10.1016/S1701-2163(16)34984-2; Kuo F, 2004, BIOORG MED CHEM LETT, V14, P3481, DOI 10.1016/j.bmcl.2004.04.066; Lee YC, 2012, J CLIN PSYCHOPHARM, V32, P518, DOI 10.1097/JCP.0b013e31825ccd5a; Magann EF, 2005, SOUTH MED J, V98, P419, DOI 10.1097/01.SMJ.0000152760.34443.86; Marchant S, 2006, PAEDIATR PERINAT EP, V20, P392, DOI 10.1111/j.1365-3016.2006.00743.x; Martin Joyce A, 2012, Natl Vital Stat Rep, V61, P1; Meijer WEE, 2004, ARCH INTERN MED, V164, P2367, DOI 10.1001/archinte.164.21.2367; Mitchell AA, 2011, AM J OBSTET GYNECOL, V205, DOI 10.1016/j.ajog.2011.02.029; Nonacs R, 2003, PSYCHIAT CLIN N AM, V26, P547, DOI 10.1016/S0193-953X(03)00046-7; O'Donnell JF., 2011, GOODMAN GILMANS PHAR; Owens MJ, 2001, BIOL PSYCHIAT, V50, P345, DOI 10.1016/S0006-3223(01)01145-3; Oyelese Y, 2010, CLIN OBSTET GYNECOL, V53, P147, DOI 10.1097/GRF.0b013e3181cc406d; Palmsten K, 2013, EPIDEMIOLOGY, V24, P682, DOI 10.1097/EDE.0b013e31829e0aaa; Palmsten K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067405; Rassen JA, 2012, PHARMACOEPIDEMIOLOGY; Rassen JA, 2011, AM J EPIDEMIOL, V173, P1404, DOI 10.1093/aje/kwr001; Reis M, 2010, PSYCHOL MED, V40, P1723, DOI 10.1017/S0033291709992194; Romano PS, 2005, OBSTET GYNECOL, V106, P717, DOI 10.1097/01.AOG.0000179552.36108.6d; Salkeld E, 2008, J CLIN PSYCHOPHARM, V28, P230, DOI 10.1097/JCP.0b013e318166c52e; Schneeweiss S, 2001, AM J EPIDEMIOL, V154, P854, DOI 10.1093/aje/154.9.854; Schneeweiss S, 2006, PHARMACOEPIDEM DR S, V15, P291, DOI 10.1002/pds.1200; Spiegelman D, 2005, AM J EPIDEMIOL, V162, P199, DOI 10.1093/aje/kwi188; Stephansson Olof, 2011, Clin Epidemiol, V3, P43, DOI 10.2147/CLEP.S16305; Stewart DE, 2011, NEW ENGL J MED, V365, P1605, DOI 10.1056/NEJMcp1102730; Tatsumi M, 1997, EUR J PHARMACOL, V340, P249, DOI 10.1016/S0014-2999(97)01393-9; Thase ME, 2005, J CLIN PSYCHOPHARM, V25, P132, DOI 10.1097/01.jcp.0000155815.44338.95; Thase ME, 1998, J CLIN PSYCHIAT, V59, P502, DOI 10.4088/JCP.v59n1002; The National Health and Nutrition Examination Survey (NHANES), 2005, AN REP GUID; Valeri L, 2013, PSYCHOL METHODS, V18, P137, DOI 10.1037/a0031034; van Walraven C, 2001, BMJ-BRIT MED J, V323, P655, DOI 10.1136/bmj.323.7314.655; Walker AM, 1991, EPIDEMIOLOGY RESOURC; Werler MM, 2005, AM J OBSTET GYNECOL, V193, P771, DOI 10.1016/j.ajog.2005.02.100; West SL, 2000, J CLIN EPIDEMIOL, V53, P823, DOI 10.1016/S0895-4356(99)00237-1; Zou GY, 2011, STAT METHODS MED RES	60	65	68	0	15	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 21	2013	347								f4877	10.1136/bmj.f4877	http://dx.doi.org/10.1136/bmj.f4877			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	207SO	23965506	Green Published, hybrid			2022-12-24	WOS:000323624300004
J	Adey, A; Burton, JN; Kitzman, JO; Hiatt, JB; Lewis, AP; Martin, BK; Qiu, RL; Lee, C; Shendure, J				Adey, Andrew; Burton, Joshua N.; Kitzman, Jacob O.; Hiatt, Joseph B.; Lewis, Alexandra P.; Martin, Beth K.; Qiu, Ruolan; Lee, Choli; Shendure, Jay			The haplotype-resolved genome and epigenome of the aneuploid HeLa cancer cell line	NATURE			English	Article							SEQUENCE; DNA; CONTAMINATION; INTEGRATION; FRAMEWORK; BREAST	The HeLa cell line was established in 1951 from cervical cancer cells taken from a patient, Henrietta Lacks. This was the first successful attempt to immortalize human-derived cells in vitro(1). The robust growth and unrestricted distribution of HeLa cells resulted in its broad adoption-both intentionally and through widespread cross-contamination(2)-and for the past 60 years it has served a role analogous to that of a model organism(3). The cumulative impact of the HeLa cell line on research is demonstrated by its occurrence in more than 74,000 PubMed abstracts (approximately 0.3%). The genomic architecture of HeLa remains largely unexplored beyond its karyotype(4), partly because like many cancers, its extensive aneuploidy renders such analyses challenging. We carried out haplotype-resolved whole-genome sequencing(5) of the HeLa CCL-2 strain, examined point-and indel-mutation variations, mapped copy-number variations and loss of heterozygosity regions, and phased variants across full chromosome arms. We also investigated variation and copy-number profiles for HeLa S3 and eight additional strains. We find that HeLa is relatively stable in terms of point variation, with few new mutations accumulating after early passaging. Haplotype resolution facilitated reconstruction of an amplified, highly rearranged region of chromosome 8q24.21 at which integration of the human papilloma virus type 18 (HPV-18) genome occurred and that is likely to be the event that initiated tumorigenesis. We combined these maps with RNA-seq(6) and ENCODE Project(7) data sets to phase the HeLa epigenome. This revealed strong, haplotype-specific activation of the proto-oncogene MYC by the integrated HPV-18 genome approximately 500 kilobases upstream, and enabled global analyses of the relationship between gene dosage and expression. These data provide an extensively phased, high-quality reference genome for past and future experiments relying on HeLa, and demonstrate the value of haplotype resolution for characterizing cancer genomes and epigenomes.	[Adey, Andrew; Burton, Joshua N.; Kitzman, Jacob O.; Hiatt, Joseph B.; Lewis, Alexandra P.; Martin, Beth K.; Qiu, Ruolan; Lee, Choli; Shendure, Jay] Univ Washington, Dept Genome Sci, Seattle, WA 98115 USA	University of Washington; University of Washington Seattle	Shendure, J (corresponding author), Univ Washington, Dept Genome Sci, Seattle, WA 98115 USA.	acadey@uw.edu; shendure@uw.edu	Shendure, Jay/AAU-3684-2021	Kitzman, Jacob/0000-0002-6145-882X; Burton, Joshua/0000-0003-2817-7353; Martin, Beth/0000-0002-9661-014X; Shendure, Jay/0000-0002-1516-1865	National Genome Research Institute (NHGRI) [HG006283]; National Cancer Institute [CA160080]; National Science Foundation [DGE-0718124]; NHGRI [T32HG000035]; National Institute of Aging [AG039173]; NATIONAL CANCER INSTITUTE [R21CA160080] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [T32HG000035, R01HG006283] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007266] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [F30AG039173] Funding Source: NIH RePORTER	National Genome Research Institute (NHGRI); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Science Foundation(National Science Foundation (NSF)); NHGRI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Institute of Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The genome sequence described in this paper was derived from a HeLa cell line. Henrietta Lacks, and the HeLa cell line that was established from her tumour cells in 1951, have made significant contributions to scientific progress and advances in human health. We are grateful to Henrietta Lacks, now deceased, and to her surviving family members for their contributions to biomedical research. We also thank M. Kircher, M. Snyder, A. Kumar and R. Patwardhan as well as other members of the Shendure laboratory for advice and suggestions. We thank the Stamatoyannopoulos and Malik laboratories for cell aliquots. Our work was supported by a gift from the Washington Research Foundation; grant HG006283 from the National Genome Research Institute (NHGRI, to J.S.); grant CA160080 from the National Cancer Institute (to J.S.); a graduate research fellowship DGE-0718124 from the National Science Foundation (to A. A. and J.K.); grant T32HG000035 from the NHGRI (to J.N.B.); and grant AG039173 from the National Institute of Aging (to J.B.H.). J.S. is the Lowell Milken Prostate Cancer Foundation Young Investigator. J.S. is a member of the scientific advisory board or serves as a consultant for Ariosa Diagnostics, Stratos Genomics, Good Start Genetics, and Adaptive Biotechnologies.	Adey A, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-12-r119; Ahmadiyeh N, 2010, P NATL ACAD SCI USA, V107, P9742, DOI 10.1073/pnas.0910668107; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; [Anonymous], 2013, CANC GEN PROJ; Bouallaga I, 2000, EMBO REP, V1, P422, DOI 10.1093/embo-reports/kvd091; Corver WE, 2008, CANCER RES, V68, P10333, DOI 10.1158/0008-5472.CAN-08-2665; Duitama J, 2012, NUCLEIC ACIDS RES, V40, P2041, DOI 10.1093/nar/gkr1042; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Fan HC, 2011, NAT BIOTECHNOL, V29, P51, DOI 10.1038/nbt.1739; GARTLER SM, 1968, NATURE, V217, P750, DOI 10.1038/217750a0; GEY GO, 1952, CANCER RES, V12, P264; Gnerre S, 2011, P NATL ACAD SCI USA, V108, P1513, DOI 10.1073/pnas.1017351108; Goodwin EC, 2000, P NATL ACAD SCI USA, V97, P10978, DOI 10.1073/pnas.97.20.10978; Gymrek M, 2012, GENOME RES, V22, P1154, DOI 10.1101/gr.135780.111; Hach F, 2010, NAT METHODS, V7, P576, DOI 10.1038/nmeth0810-576; Hammerman PS, 2012, NATURE, V489, P519, DOI 10.1038/nature11404; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Kitzman JO, 2011, NAT BIOTECHNOL, V29, P59, DOI 10.1038/nbt.1740; LAZO PA, 1989, CANCER RES, V49, P4305; Li GL, 2012, CELL, V148, P84, DOI 10.1016/j.cell.2011.12.014; Li H, 2011, BIOINFORMATICS, V27, P2987, DOI 10.1093/bioinformatics/btr509; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Macville M, 1999, CANCER RES, V59, P141; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Meyer M, 2012, SCIENCE, V338, P222, DOI 10.1126/science.1224344; Morin RD, 2008, BIOTECHNIQUES, V45, P81, DOI 10.2144/000112900; Nagaraj N, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.81; NELSONREES WA, 1981, SCIENCE, V212, P446, DOI 10.1126/science.6451928; Nik-Zainal S, 2012, CELL, V149, DOI 10.1016/j.cell.2012.04.023; Peter M, 2006, ONCOGENE, V25, P5985, DOI 10.1038/sj.onc.1209625; PUCK TT, 1955, P NATL ACAD SCI USA, V41, P432, DOI 10.1073/pnas.41.7.432; Roberts A, 2011, BIOINFORMATICS, V27, P2325, DOI 10.1093/bioinformatics/btr355; Rosty C, 2005, MOL CANCER, V4, DOI 10.1186/1476-4598-4-15; Skloot R, 2011, IMMORTAL LIFE HENRIE; Sudmant PH, 2010, SCIENCE, V330, P641, DOI 10.1126/science.1197005; Talkowski ME, 2011, AM J HUM GENET, V88, P469, DOI 10.1016/j.ajhg.2011.03.013; Talora C, 2002, GENE DEV, V16, P2252, DOI 10.1101/gad.988902; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Wentzensen N, 2004, CANCER RES, V64, P3878, DOI 10.1158/0008-5472.CAN-04-0009; White EA, 2012, J VIROL, V86, P13174, DOI 10.1128/JVI.02172-12; Wingo SN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005137; Wistuba II, 1997, CANCER RES, V57, P3154	42	230	245	5	118	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 8	2013	500	7461					207	+		10.1038/nature12064	http://dx.doi.org/10.1038/nature12064			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	197CH	23925245	Green Accepted			2022-12-24	WOS:000322825500035
J	Pampliega, O; Orhon, I; Patel, B; Sridhar, S; Diaz-Carretero, A; Beau, I; Codogno, P; Satir, BH; Satir, P; Cuervo, AM				Pampliega, Olatz; Orhon, Idil; Patel, Bindi; Sridhar, Sunandini; Diaz-Carretero, Antonio; Beau, Isabelle; Codogno, Patrice; Satir, Birgit H.; Satir, Peter; Cuervo, Ana Maria			Functional interaction between autophagy and ciliogenesis	NATURE			English	Article							PRIMARY CILIUM; COMPLEX; FIBROBLASTS; DISEASE; LEVEL; CELLS	Nutrient deprivation is a stimulus shared by both autophagy and the formation of primary cilia. The recently discovered role of primary cilia in nutrient sensing and signalling motivated us to explore the possible functional interactions between this signalling hub and autophagy. Here we show that part of the molecular machinery involved in ciliogenesis also participates in the early steps of the autophagic process. Signalling from the cilia, such as that from the Hedgehog pathway, induces autophagy by acting directly on essential autophagy-related proteins strategically located in the base of the cilium by ciliary trafficking proteins. Whereas abrogation of ciliogenesis partially inhibits autophagy, blockage of autophagy enhances primary cilia growth and cilia-associated signalling during normal nutritional conditions. We propose that basal autophagy regulates ciliary growth through the degradation of proteins required for intraflagellar transport. Compromised ability to activate the autophagic response may underlie some common ciliopathies.	[Pampliega, Olatz; Patel, Bindi; Sridhar, Sunandini; Diaz-Carretero, Antonio; Cuervo, Ana Maria] Albert Einstein Coll Med, Dept Dev & Mol Biol, Bronx, NY 10461 USA; [Orhon, Idil; Codogno, Patrice] INSERM, U845, F-75014 Paris, France; [Orhon, Idil; Codogno, Patrice] Paris Descartes Univ, F-75014 Paris, France; [Orhon, Idil; Beau, Isabelle; Codogno, Patrice] INSERM, U984, F-92296 Chatenay Malabry, France; [Orhon, Idil; Beau, Isabelle; Codogno, Patrice] Univ Paris Sud, F-92296 Chatenay Malabry, France; [Satir, Birgit H.; Satir, Peter; Cuervo, Ana Maria] Albert Einstein Coll Med, Dept Anat & Struct Biol, Bronx, NY 10461 USA; [Cuervo, Ana Maria] Albert Einstein Coll Med, Inst Aging Studies, Bronx, NY 10461 USA	Yeshiva University; Albert Einstein College of Medicine; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Cuervo, AM (corresponding author), Albert Einstein Coll Med, Dept Dev & Mol Biol, Bronx, NY 10461 USA.	peter.satir@einstein.yu.edu; ana-maria.cuervo@einstein.yu.edu	Pampliega, Olatz/A-9204-2015; Beau, Isabelle/M-4423-2017; Pampliega, Olatz/K-9037-2019; orhon, idil/AAB-1940-2020	Pampliega, Olatz/0000-0002-7924-6374; Beau, Isabelle/0000-0002-3352-6813; Pampliega, Olatz/0000-0002-7924-6374; orhon, idil/0000-0002-0779-8719; Cuervo, Ana Maria/0000-0002-0771-700X	National Institute of Health National Institute on Aging [AG031782, AG038072]; National Institute of Diabetes and Digestive and Kidney Diseases [DK098408]; Institut National de la Sante et de la Recherche Medicale; Institut National du Cancer and L'Agence Nationale de la Recherche; Basque Government; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK098408] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R37AG021904, P30AG038072, P01AG031782] Funding Source: NIH RePORTER	National Institute of Health National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Institut National de la Sante et de la Recherche Medicale(Institut National de la Sante et de la Recherche Medicale (Inserm)); Institut National du Cancer and L'Agence Nationale de la Recherche(French National Research Agency (ANR)); Basque Government(Basque Government); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank N. Mizushima and G. Pazour for providing MEFs and I. R. Veland and S. T. Christensen for providing the plasmid for expression of GFP-inversin. We also thank the personnel at the Analytical Imaging Facility for their technical assistance with TEM, J. Kraut and N. Rodriguez for their early assistance in cilia staining optimization and S. Kaushik for critically reviewing this manuscript. This work was supported by grants from the National Institute of Health National Institute on Aging AG031782 and AG038072, National Institute of Diabetes and Digestive and Kidney Diseases DK098408 (to A. M. C.), Institut National de la Sante et de la Recherche Medicale (to P. C. and I. B.), Institut National du Cancer and L'Agence Nationale de la Recherche (to P. C.), and the generous support of Robert and Renee Belfer (to A. M. C.). O.P. was supported by a Basque Government Postdoctoral Fellowship.	AUTERI JS, 1983, J CELL PHYSIOL, V115, P167, DOI 10.1002/jcp.1041150210; Boehlke C, 2010, NAT CELL BIOL, V12, P1115, DOI 10.1038/ncb2117; Finetti F, 2009, NAT CELL BIOL, V11, P1332, DOI 10.1038/ncb1977; Follit JA, 2009, CELL MOTIL CYTOSKEL, V66, P457, DOI 10.1002/cm.20346; Hamasaki M, 2013, CURR OPIN CELL BIOL, V25, P455, DOI 10.1016/j.ceb.2013.03.004; Huang BQ, 2006, AM J PHYSIOL-GASTR L, V291, pG500, DOI 10.1152/ajpgi.00064.2006; Jimenez-Sanchez M, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2212; Kiprilov EN, 2008, J CELL BIOL, V180, P897, DOI 10.1083/jcb.200706028; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; Li HJ, 2012, AM J PHYSIOL-HEART C, V303, pH1319, DOI 10.1152/ajpheart.00160.2012; Liem KF, 2012, J CELL BIOL, V197, P789, DOI 10.1083/jcb.201110049; MARZELLA L, 1982, J CELL BIOL, V93, P144, DOI 10.1083/jcb.93.1.144; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Onodera J, 2005, J BIOL CHEM, V280, P31582, DOI 10.1074/jbc.M506736200; Pazour GJ, 2002, CURR BIOL, V12, pR378, DOI 10.1016/S0960-9822(02)00877-1; Petralia RS, 2013, BIOL OPEN, V2, P499, DOI 10.1242/bio.20134275; Ravikumar B, 2010, NAT CELL BIOL, V12, P747, DOI 10.1038/ncb2078; Richey EA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043118; Rohatgi R, 2007, SCIENCE, V317, P372, DOI 10.1126/science.1139740; Satir P, 2012, DEV DYNAM, V241, P426, DOI 10.1002/dvdy.23713; Satir P, 2010, J CELL SCI, V123, P499, DOI 10.1242/jcs.050377; Schneider L, 2005, CURR BIOL, V15, P1861, DOI 10.1016/j.cub.2005.09.012; Singh R, 2009, NATURE, V458, P1131, DOI 10.1038/nature07976; Sridhar S, 2013, EMBO J, V32, P324, DOI 10.1038/emboj.2012.341; Tanida I, 2005, AUTOPHAGY, V1, P84, DOI 10.4161/auto.1.2.1697; Taschner M, 2012, DIFFERENTIATION, V83, pS12, DOI 10.1016/j.diff.2011.11.001; Veland IR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060193; WADA K, 1986, CHEM PHARM BULL, V34, P1688; Wang Y, 2013, HEPATOLOGY, V58, P995, DOI 10.1002/hep.26394; Yang ZF, 2010, CURR OPIN CELL BIOL, V22, P124, DOI 10.1016/j.ceb.2009.11.014	30	286	308	2	78	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 10	2013	502	7470					194	+		10.1038/nature12639	http://dx.doi.org/10.1038/nature12639			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231RU	24089209	Green Accepted			2022-12-24	WOS:000325436100042
J	Johnston, SE; Gratten, J; Berenos, C; Pilkington, JG; Clutton-Brock, TH; Pemberton, JM; Slate, J				Johnston, Susan E.; Gratten, Jacob; Berenos, Camillo; Pilkington, Jill G.; Clutton-Brock, Tim H.; Pemberton, Josephine M.; Slate, Jon			Life history trade-offs at a single locus maintain sexually selected genetic variation	NATURE			English	Article							ANTAGONISTIC SELECTION; POPULATION; WEAPONRY; FITNESS; POLYMORPHISM; ASSOCIATION; RESISTANCE; REVEALS; CAPTURE	Sexual selection, through intra-male competition or female choice, is assumed to be a source of strong and sustained directional selection in the wild(1,2). In the presence of such strong directional selection, alleles enhancing a particular trait are predicted to become fixed within a population, leading to a decrease in the underlying genetic variation(3). However, there is often considerable genetic variation underlying sexually selected traits in wild populations, and consequently, this phenomenon has become a long-discussed issue in the field of evolutionary biology(1,4,5). In wild Soay sheep, large horns confer an advantage in strong intra-sexual competition, yet males show an inherited polymorphism for horn type and have substantial genetic variation in their horn size(6). Here we show that most genetic variation in this trait is maintained by a trade-off between natural and sexual selection at a single gene, relaxin-like receptor 2 (RXFP2). We found that an allele conferring larger horns, Ho+, is associated with higher reproductive success, whereas a smaller horn allele, Ho-P, confers increased survival, resulting in a net effect of overdominance (that is, heterozygote advantage) for fitness at RXFP2. The nature of this trade-off is simple relative to commonly proposed explanations for the maintenance of sexually selected traits, such as genic capture(7,8) ('good genes') and sexually antagonistic selection(5,9). Our results demonstrate that by identifying the genetic architecture of trait variation, we can determine the principal mechanisms maintaining genetic variation in traits under strong selection and explain apparently counter-evolutionary observations.	[Johnston, Susan E.; Gratten, Jacob; Slate, Jon] Univ Sheffield, Dept Anim & Plant Sci, Sheffield S10 2TN, S Yorkshire, England; [Johnston, Susan E.; Berenos, Camillo; Pilkington, Jill G.; Pemberton, Josephine M.] Univ Edinburgh, Inst Evolutionary Biol, Edinburgh EH9 3JT, Midlothian, Scotland; [Gratten, Jacob] Univ Queensland, Queensland Brain Inst, Brisbane, Qld 4072, Australia; [Clutton-Brock, Tim H.] Univ Cambridge, Dept Zool, Cambridge CB2 3EJ, England	University of Sheffield; University of Edinburgh; University of Queensland; University of Cambridge	Johnston, SE (corresponding author), Univ Edinburgh, Inst Evolutionary Biol, Edinburgh EH9 3JT, Midlothian, Scotland.	Susan.Johnston@ed.ac.uk; j.slate@shef.ac.uk	Slate, Jon/D-2925-2012; Pemberton, Josephine M/F-3100-2010; Gratten, Jacob/G-1485-2011	Slate, Jon/0000-0003-3356-5123; Gratten, Jacob/0000-0003-1293-409X; Johnston, Susan/0000-0002-5623-8902	Natural Environment Research Council (NERC); NERC; European Research Council (ERC); Biotechnology and Biological Sciences Research Council CASE studentship; Natural Environment Research Council [NE/B504314/1, NE/G004854/1] Funding Source: researchfish; NERC [NE/G004854/1] Funding Source: UKRI	Natural Environment Research Council (NERC)(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); European Research Council (ERC)(European Research Council (ERC)European Commission); Biotechnology and Biological Sciences Research Council CASE studentship(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	We thank the numerous Soay sheep project members and volunteers for collection of data and samples; M. Robinson, J. Hadfield, D. Childs and D. Nussey for statistical advice and discussions; J. McEwan, N. Pickering and J. Kijas for SNP information; D. Beraldi, E. Brown and P. Ellis for laboratory assistance; L. Evenden, J. Gibson and L. Murphy at the Wellcome Trust Clinical Research Facility Genetics Core for genome-wide SNP genotypes; I. Stevenson for database development; G. Prior and A. Ozgul for images; National Trust for Scotland and Scottish Natural Heritage for permission to work on St Kilda; and QinetiQ and Eurest for logistical support. The Soay sheep project is funded by the Natural Environment Research Council (NERC). SNP genotyping was funded by NERC and the European Research Council (ERC). S. E. J. was funded by a Biotechnology and Biological Sciences Research Council CASE studentship.	ALLISON AC, 1954, BRIT MED J, V1, P290, DOI 10.1136/bmj.1.4857.290; Andersson Malte, 1994; Bonduriansky R, 2009, TRENDS ECOL EVOL, V24, P280, DOI 10.1016/j.tree.2008.12.005; Chenoweth SF, 2010, ANNU REV ECOL EVOL S, V41, P81, DOI 10.1146/annurev-ecolsys-102209-144657; Chessa B, 2009, SCIENCE, V324, P532, DOI 10.1126/science.1170587; Chippindale AK, 2001, P NATL ACAD SCI USA, V98, P1671, DOI 10.1073/pnas.041378098; Connallon T, 2012, GENETICS, V190, P1477, DOI 10.1534/genetics.111.137117; Dominik S, 2012, ANIM GENET, V43, P468, DOI 10.1111/j.1365-2052.2011.02271.x; Ellegren H, 2008, NATURE, V452, P169, DOI 10.1038/nature06737; Falconer D. S, 1996, INTRO QUANTITATIVE G; Gemmell NJ, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000125; Gratten J, 2012, MOL ECOL, V21, P2977, DOI 10.1111/j.1365-294X.2012.05536.x; GREAVES JH, 1977, GENET RES, V30, P257, DOI 10.1017/S0016672300017663; Grubb P., 1974, P195; Hadfield JD, 2006, MOL ECOL, V15, P3715, DOI 10.1111/j.1365-294X.2006.03050.x; Hadfield JD, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i02; Hayward AD, 2011, J EVOLUTION BIOL, V24, P1664, DOI 10.1111/j.1420-9101.2011.02300.x; Hedrick P. W., 2011, GENETICS POPULATIONS; Johnston SE, 2011, MOL ECOL, V20, P2555, DOI 10.1111/j.1365-294X.2011.05076.x; Kenta T, 2008, MOL ECOL RESOUR, V8, P1230, DOI 10.1111/j.1755-0998.2008.02190.x; Kijas JW, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001258; Kijas JW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004668; Kingsolver JG, 2001, AM NAT, V157, P245, DOI 10.1086/319193; Kruuk LEB, 2008, ANNU REV ECOL EVOL S, V39, P525, DOI 10.1146/annurev.ecolsys.39.110707.173542; POMIANKOWSKI A, 1995, P ROY SOC B-BIOL SCI, V260, P21, DOI 10.1098/rspb.1995.0054; Preston BT, 2003, P ROY SOC B-BIOL SCI, V270, P633, DOI 10.1098/rspb.2002.2268; PROMISLOW DEL, 1992, P ROY SOC B-BIOL SCI, V247, P203, DOI 10.1098/rspb.1992.0030; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Robinson MR, 2006, EVOLUTION, V60, P2168, DOI 10.1111/j.0014-3820.2006.tb01854.x; Rowe L, 1996, P ROY SOC B-BIOL SCI, V263, P1415, DOI 10.1098/rspb.1996.0207; Slate J, 2010, TRENDS GENET, V26, P275, DOI 10.1016/j.tig.2010.03.005; Stapley J, 2010, TRENDS ECOL EVOL, V25, P705, DOI 10.1016/j.tree.2010.09.002; Stevenson IR, 2004, SOAY SHEEP: DYNAMICS AND SELECTION IN AN ISLAND POPULATION, P243; Tomkins JL, 2004, TRENDS ECOL EVOL, V19, P323, DOI 10.1016/j.tree.2004.03.029	34	190	198	4	281	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 3	2013	502	7469					93	+		10.1038/nature12489	http://dx.doi.org/10.1038/nature12489			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	227IM	23965625				2022-12-24	WOS:000325106000037
J	Chiu, IM; Heesters, BA; Ghasemlou, N; Von Hehn, CA; Zhao, F; Tran, J; Wainger, B; Strominger, A; Muralidharan, S; Horswill, AR; Wardenburg, JB; Hwang, SW; Carroll, MC; Woolf, CJ				Chiu, Isaac M.; Heesters, Balthasar A.; Ghasemlou, Nader; Von Hehn, Christian A.; Zhao, Fan; Tran, Johnathan; Wainger, Brian; Strominger, Amanda; Muralidharan, Sriya; Horswill, Alexander R.; Wardenburg, Juliane Bubeck; Hwang, Sun Wook; Carroll, Michael C.; Woolf, Clifford J.			Bacteria activate sensory neurons that modulate pain and inflammation	NATURE			English	Article							FORMYL-PEPTIDE RECEPTORS; STAPHYLOCOCCUS-AUREUS; ALPHA-HEMOLYSIN; T-CELLS; IMMUNITY; USA300; MICE; IDENTIFICATION; PATHOGENESIS; NOCICEPTORS	Nociceptor sensory neurons are specialized to detect potentially damaging stimuli, protecting the organism by initiating the sensation of pain and eliciting defensive behaviours. Bacterial infections produce pain by unknown molecular mechanisms, although they are presumed to be secondary to immune activation. Here we demonstrate that bacteria directly activate nociceptors, and that the immune response mediated through TLR2, MyD88, T cells, B cells, and neutrophils and monocytes is not necessary for Staphylococcus aureus-induced pain in mice. Mechanical and thermal hyperalgesia in mice is correlated with live bacterial load rather than tissue swelling or immune activation. Bacteria induce calcium flux and action potentials in nociceptor neurons, in part via bacterial N-formylated peptides and the pore-forming toxin alpha-haemolysin, through distinct mechanisms. Specific ablation of Nav1.8-lineage neurons, which include nociceptors, abrogated pain during bacterial infection, but concurrently increased local immune infiltration and lymphadenopathy of the draining lymph node. Thus, bacterial pathogens produce pain by directly activating sensory neurons that modulate inflammation, an unsuspected role for the nervous systemin host-pathogen interactions.	[Chiu, Isaac M.; Ghasemlou, Nader; Von Hehn, Christian A.; Tran, Johnathan; Wainger, Brian; Strominger, Amanda; Muralidharan, Sriya; Hwang, Sun Wook; Woolf, Clifford J.] Boston Childrens Hosp, Kirby Neurobiol Ctr, Boston, MA 02115 USA; [Chiu, Isaac M.; Ghasemlou, Nader; Von Hehn, Christian A.; Tran, Johnathan; Wainger, Brian; Strominger, Amanda; Muralidharan, Sriya; Hwang, Sun Wook; Woolf, Clifford J.] Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA; [Heesters, Balthasar A.; Carroll, Michael C.] Boston Childrens Hosp, Program Cellular & Mol Med, Boston, MA 02115 USA; [Heesters, Balthasar A.; Carroll, Michael C.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Heesters, Balthasar A.] Univ Med Ctr, NL-3584 CX Utrecht, Netherlands; [Zhao, Fan] Brandeis Univ, Dept Chem, Quantitat Biol Program, Waltham, MA 02454 USA; [Horswill, Alexander R.] Univ Iowa, Dept Microbiol, Roy J & Lucille A Carver Coll Med, Iowa City, IA 52242 USA; [Wardenburg, Juliane Bubeck] Univ Chicago, Dept Pediat, Chicago, IL 60637 USA; [Wardenburg, Juliane Bubeck] Univ Chicago, Dept Microbiol, Chicago, IL 60637 USA; [Hwang, Sun Wook] Korea Univ, Grad Sch Med, Seoul 136705, South Korea	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard University; Harvard Medical School; Utrecht University; Utrecht University Medical Center; Brandeis University; University of Iowa; University of Chicago; University of Chicago; Korea University; Korea University Medicine (KU Medicine)	Woolf, CJ (corresponding author), Boston Childrens Hosp, Kirby Neurobiol Ctr, Boston, MA 02115 USA.	clifford.woolf@childrens.harvard.edu	Ghasemlou, Nader/AAB-5673-2022; Heesters, Balthasar/ABA-7594-2021; Wainger, Brian/L-7553-2017; Woolf, Clifford/A-9784-2010; Zhao, Fan/A-3686-2012; Chiu, Isaac/R-3803-2016	Ghasemlou, Nader/0000-0002-1696-7342; Heesters, Balthasar/0000-0002-2909-8481; Zhao, Fan/0000-0002-6103-5608; Chiu, Isaac/0000-0002-0723-4841; Hwang, Sun Wook/0000-0001-8460-7480	NIH [PO1AI078897, 5RO1AI039246, R37NS039518, 5P01NS072040, 5F32NS076297]; FACS; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD018655] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI039246, P01AI078897] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS072040, F32NS076297, R37NS039518, R01NS039518] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); FACS; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank L. Barrett, V. Wang, N. Andrews, C. Melin, Y. Wang, K. Duong, E. Cobos del Moral, O. Babanyi and G. Bryman for technical help. We thank Y.-C. Cheng and R. Becker for technical advice; J. Sprague and A. Yekkirala for developing whole-well imaging; I. Inoshima for recombinant alpha HL; R. Malley, J. Steen and Q. Ma for discussions; J. Chiu for moral support; S. Liberles, B. Xu and V. Kuchroo for mentoring. This work was supported by NIH PO1AI078897, 5RO1AI039246 (M. C. C.), R37NS039518, 5P01NS072040 (C. J. W.), 5F32NS076297 (I. M. C.), FACS, and microarrays at Boston Children's Hospital IDDRC facilities (NIH-P30-HD018655).	Abrahamsen B, 2008, SCIENCE, V321, P702, DOI 10.1126/science.1156916; Agarwal N, 2004, GENESIS, V38, P122, DOI 10.1002/gene.20010; Andersson U, 2012, ANNU REV IMMUNOL, V30, P313, DOI 10.1146/annurev-immunol-020711-075015; Binshtok AM, 2008, J NEUROSCI, V28, P14062, DOI 10.1523/JNEUROSCI.3795-08.2008; Boxio R, 2004, J LEUKOCYTE BIOL, V75, P604, DOI 10.1189/jlb.0703340; Chiu IM, 2012, NAT NEUROSCI, V15, P1063, DOI 10.1038/nn.3144; Diep BA, 2006, LANCET, V367, P731, DOI 10.1016/S0140-6736(06)68231-7; Dinges MM, 2000, CLIN MICROBIOL REV, V13, P16, DOI 10.1128/CMR.13.1.16-34.2000; Diogenes A, 2011, J DENT RES, V90, P759, DOI 10.1177/0022034511400225; Durr MC, 2006, CELL MICROBIOL, V8, P207, DOI 10.1111/j.1462-5822.2005.00610.x; Fernandes ES, 2012, J IMMUNOL, V188, P5741, DOI 10.4049/jimmunol.1102147; Gautier EL, 2012, NAT IMMUNOL, V13, P1118, DOI 10.1038/ni.2419; Gomes RN, 2005, SHOCK, V24, P590, DOI 10.1097/01.shk.0000183395.29014.7c; Gordon RJ, 2008, CLIN INFECT DIS, V46, pS350, DOI 10.1086/533591; Harzenetter MD, 2007, J IMMUNOL, V179, P607, DOI 10.4049/jimmunol.179.1.607; Hill DR, 2002, ORG LETT, V4, P111, DOI 10.1021/ol016976d; Holzmann B, 2013, AMINO ACIDS, V45, P1, DOI 10.1007/s00726-011-1161-2; Inoshima I, 2011, NAT MED, V17, P1310, DOI 10.1038/nm.2451; Kennedy AD, 2010, J INFECT DIS, V202, P1050, DOI 10.1086/656043; Kim HK, 2012, CURR OPIN MICROBIOL, V15, P92, DOI 10.1016/j.mib.2011.10.012; Lang R, 2011, NEUROPEPTIDES, V45, P1, DOI 10.1016/j.npep.2010.10.005; Le YY, 2002, TRENDS IMMUNOL, V23, P541, DOI 10.1016/S1471-4906(02)02316-5; Lennertz RC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043597; Liberles SD, 2009, P NATL ACAD SCI USA, V106, P9842, DOI 10.1073/pnas.0904464106; Liu T, 2012, NEUROSCI BULL, V28, P131, DOI 10.1007/s12264-012-1219-5; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; McLachlan JB, 2003, NAT IMMUNOL, V4, P1199, DOI 10.1038/ni1005; Medzhitov R, 2008, NATURE, V454, P428, DOI 10.1038/nature07201; Miller LS, 2011, NAT REV IMMUNOL, V11, P505, DOI 10.1038/nri3010; Miller LS, 2006, IMMUNITY, V24, P79, DOI 10.1016/j.immuni.2005.11.011; MOMBAERTS P, 1992, CELL, V68, P869, DOI 10.1016/0092-8674(92)90030-G; Morgan M, 2011, INJURY, V42, pS11, DOI 10.1016/S0020-1383(11)70127-9; Muller-Anstett MA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013153; Pang YY, 2010, J INNATE IMMUN, V2, P546, DOI 10.1159/000319855; Pinter E, 2006, PHARMACOL THERAPEUT, V112, P440, DOI 10.1016/j.pharmthera.2006.04.010; Ren K, 2010, NAT MED, V16, P1267, DOI 10.1038/nm.2234; Rigby KM, 2012, SEMIN IMMUNOPATHOL, V34, P237, DOI 10.1007/s00281-011-0295-3; Rittner HL, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000362; Riviere S, 2009, NATURE, V459, P574, DOI 10.1038/nature08029; Rosas-Ballina M, 2011, SCIENCE, V334, P98, DOI 10.1126/science.1209985; Sai JQ, 2008, J BIOL CHEM, V283, P26538, DOI 10.1074/jbc.M805611200; SCHENK S, 1992, FEMS MICROBIOL LETT, V94, P133; Shultz LD, 2005, J IMMUNOL, V174, P6477, DOI 10.4049/jimmunol.174.10.6477; Southgate EL, 2008, J IMMUNOL, V181, P1429, DOI 10.4049/jimmunol.181.2.1429; Sun JR, 2011, SCIENCE, V332, P729, DOI 10.1126/science.1203411; Voehringer D, 2008, J IMMUNOL, V180, P4742, DOI 10.4049/jimmunol.180.7.4742; Wang R, 2007, NAT MED, V13, P1510, DOI 10.1038/nm1656; Wardenburg JB, 2007, INFECT IMMUN, V75, P1040, DOI 10.1128/IAI.01313-06; WEIHE E, 1991, INT J NEUROSCI, V59, P1; White R J, 2009, J Wound Care, V18, P245; Wilke GA, 2010, P NATL ACAD SCI USA, V107, P13473, DOI 10.1073/pnas.1001815107; Wong CHY, 2011, SCIENCE, V334, P101, DOI 10.1126/science.1210301; Zhang XC, 2011, PAIN, V152, P140, DOI 10.1016/j.pain.2010.10.002	53	488	498	9	180	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 5	2013	501	7465					52	+		10.1038/nature12479	http://dx.doi.org/10.1038/nature12479			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	211ER	23965627	Green Accepted, Green Published, Green Submitted			2022-12-24	WOS:000323888300030
J	Owen, SF; Tuncdemir, SN; Bader, PL; Tirko, NN; Fishell, G; Tsien, RW				Owen, Scott F.; Tuncdemir, Sebnem N.; Bader, Patrick L.; Tirko, Natasha N.; Fishell, Gord; Tsien, Richard W.			Oxytocin enhances hippocampal spike transmission by modulating fast-spiking interneurons	NATURE			English	Article							RAT HIPPOCAMPUS; FEEDFORWARD INHIBITION; PYRAMIDAL NEURONS; SYNAPTIC DEPRESSION; AUTISM; NOREPINEPHRINE; MOTHERHOOD; ACTIVATION; EXCITATION; FREQUENCY	Neuromodulatory control by oxytocin is essential to a wide range of social(1,2), parental(3) and stress-related behaviours(4). Autism spectrum disorders (ASD) are associated with deficiencies in oxytocin levels(5) and with genetic alterations of the oxytocin receptor (OXTR)(6). Thirty years ago, Muhlethaler et al.(7) found that oxytocin increases the firing of inhibitory hippocampal neurons, but it remains unclear how elevated inhibition could account for the ability of oxytocin to improve information processing in the brain. Here we describe in mammalian hippocampus a simple yet powerful mechanism by which oxytocin enhances cortical information transfer while simultaneously lowering background activity, thus greatly improving the signal-to-noise ratio. Increased fast-spiking interneuron activity not only suppresses spontaneous pyramidal cell firing, but also enhances the fidelity of spike transmission and sharpens spike timing. Use-dependent depression at the fast-spiking interneuron-pyramidal cell synapse is both necessary and sufficient for the enhanced spike throughput. We show the generality of this novel circuit mechanism by activation of fast-spiking interneurons with cholecystokinin or channelrhodopsin-2. This provides insight into how a diffusely delivered neuromodulator can improve the performance of neural circuitry that requires synapse specificity and millisecond precision.	[Owen, Scott F.; Bader, Patrick L.; Tsien, Richard W.] Stanford Univ, Sch Med, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA; [Tuncdemir, Sebnem N.; Bader, Patrick L.; Tirko, Natasha N.; Fishell, Gord; Tsien, Richard W.] NYU, Inst Neurosci, New York, NY 10016 USA	Stanford University; New York University	Tsien, RW (corresponding author), Stanford Univ, Sch Med, Dept Mol & Cellular Physiol, 279 Campus Dr, Stanford, CA 94305 USA.	richard.tsien@nyumc.org		Owen, Scott/0000-0001-6294-7513; Fishell, Gordon/0000-0002-9640-9278; Tuncdemir, Sebnem/0000-0003-0573-0179	Burnett Family Fund; Mosbacher Fund; Mathers Foundation; National Institute of Mental Health [MH064070, MH071739]; National Institute of Neurological Disorders and Stroke [NS024067]; Simons Foundation [95395]; NDSEG fellowship; NIMH-NRSA fellowship [F31MH084430]; SNSF; SFGBM fellowship [PASMP3_140063/1]; NATIONAL INSTITUTE OF MENTAL HEALTH [R37MH071739, R56MH064070, R01MH064070, F31MH084430, R01MH071739] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS024067, R01NS074785] Funding Source: NIH RePORTER	Burnett Family Fund; Mosbacher Fund; Mathers Foundation; National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Simons Foundation; NDSEG fellowship; NIMH-NRSA fellowship; SNSF(Swiss National Science Foundation (SNSF)); SFGBM fellowship; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank C. Foldy for generous assistance with techniques for interneuron recording and classification, and thank Y. Li, M. Tadross, A. Mitra, D. Poburko, L. Prolo, J. Huguenard, S. Hestrin, D. Madison, L. Luo, K. Pelkey and K. Deisseroth for discussion and comments. This work was supported by the Burnett Family Fund, the Mosbacher Fund, and the Mathers Foundation, as well as grants from the National Institute of Mental Health (MH064070, MH071739), the National Institute of Neurological Disorders and Stroke (NS024067) and the Simons Foundation (95395). S.F.O. is supported by an NDSEG fellowship and by an NIMH-NRSA fellowship (F31MH084430). P.L.B. is supported by an SNSF and SFGBM fellowship (PASMP3_140063/1).	Alberi S, 1997, EUR J NEUROSCI, V9, P2605, DOI 10.1111/j.1460-9568.1997.tb01690.x; Anagnostou E, 2012, MOL AUTISM, V3, DOI 10.1186/2040-2392-3-16; Ascoli GA, 2010, J NEUROSCI, V30, P6434, DOI 10.1523/JNEUROSCI.4066-09.2010; Atallah BV, 2009, NEURON, V62, P566, DOI 10.1016/j.neuron.2009.04.027; Bergles DE, 1996, J NEUROSCI, V16, P572; BUZSAKI G, 1981, BRAIN RES, V230, P346, DOI 10.1016/0006-8993(81)90413-3; Dinstein I, 2012, NEURON, V75, P981, DOI 10.1016/j.neuron.2012.07.026; Domes G, 2007, BIOL PSYCHIAT, V61, P731, DOI 10.1016/j.biopsych.2006.07.015; DOZE VA, 1991, NEURON, V6, P889, DOI 10.1016/0896-6273(91)90229-S; Ferguson JN, 2001, J NEUROSCI, V21, P8278; Foldy C, 2007, NAT NEUROSCI, V10, P1128, DOI 10.1038/nn1952; Freund TF, 1996, HIPPOCAMPUS, V6, P347, DOI 10.1002/(SICI)1098-1063(1996)6:4<347::AID-HIPO1>3.0.CO;2-I; Galarreta M, 1998, NAT NEUROSCI, V1, P587, DOI 10.1038/2822; Glickfeld LL, 2006, NAT NEUROSCI, V9, P807, DOI 10.1038/nn1688; Gogolla N, 2009, J NEURODEV DISORD, V1, P172, DOI 10.1007/s11689-009-9023-x; Guastella AJ, 2010, BIOL PSYCHIAT, V67, P692, DOI 10.1016/j.biopsych.2009.09.020; Hao J, 2009, P NATL ACAD SCI USA, V106, P21906, DOI 10.1073/pnas.0912022106; Hippenmeyer S, 2005, PLOS BIOL, V3, P878, DOI 10.1371/journal.pbio.0030159; Kinsley CH, 1999, NATURE, V402, P137, DOI 10.1038/45957; Knobloch HS, 2012, NEURON, V73, P553, DOI 10.1016/j.neuron.2011.11.030; Kraushaar U, 2000, J NEUROSCI, V20, P5594, DOI 10.1523/JNEUROSCI.20-15-05594.2000; Kuo SP, 2011, NEURON, V71, P306, DOI 10.1016/j.neuron.2011.05.039; Lee SH, 2012, NATURE, V488, P379, DOI 10.1038/nature11312; MADISON DV, 1986, J PHYSIOL-LONDON, V372, P221, DOI 10.1113/jphysiol.1986.sp016006; Modahl C, 1998, BIOL PSYCHIAT, V43, P270, DOI 10.1016/S0006-3223(97)00439-3; MUHLETHALER M, 1984, BRAIN RES, V308, P97, DOI 10.1016/0006-8993(84)90921-1; Persico AM, 2006, TRENDS NEUROSCI, V29, P349, DOI 10.1016/j.tins.2006.05.010; Pouille F, 2001, SCIENCE, V293, P1159, DOI 10.1126/science.1060342; SEGAL M, 1976, BRAIN RES, V107, P513, DOI 10.1016/0006-8993(76)90141-4; Shu YS, 2006, NATURE, V441, P761, DOI 10.1038/nature04720; Tomizawa K, 2003, NAT NEUROSCI, V6, P384, DOI 10.1038/nn1023; Verret L, 2012, CELL, V149, P708, DOI 10.1016/j.cell.2012.02.046; Wilson RI, 2001, NEURON, V31, P453, DOI 10.1016/S0896-6273(01)00372-5; Wu SP, 2005, BIOL PSYCHIAT, V58, P74, DOI 10.1016/j.biopsych.2005.03.013; Yoshida M, 2009, J NEUROSCI, V29, P2259, DOI 10.1523/JNEUROSCI.5593-08.2009; Zaninetti M, 2000, EUR J NEUROSCI, V12, P3975, DOI 10.1046/j.1460-9568.2000.00290.x	36	226	230	1	61	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 22	2013	500	7463					458	+		10.1038/nature12330	http://dx.doi.org/10.1038/nature12330			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	203TJ	23913275	Green Accepted			2022-12-24	WOS:000323316100035
J	Dai, W; Fu, C; Raytcheva, D; Flanagan, J; Khant, HA; Liu, XG; Rochat, RH; Haase-Pettingell, C; Piret, J; Ludtke, SJ; Nagayama, K; Schmid, MF; King, JA; Chiu, W				Dai, Wei; Fu, Caroline; Raytcheva, Desislava; Flanagan, John; Khant, Htet A.; Liu, Xiangan; Rochat, Ryan H.; Haase-Pettingell, Cameron; Piret, Jacqueline; Ludtke, Steve J.; Nagayama, Kuniaki; Schmid, Michael F.; King, Jonathan A.; Chiu, Wah			Visualizing virus assembly intermediates inside marine cyanobacteria	NATURE			English	Article							ELECTRON CRYOTOMOGRAPHY; CRYOELECTRON MICROSCOPY; BACTERIOPHAGE EPSILON15; RESOLUTION; PROCHLOROCOCCUS; CARBOXYSOMES; ORGANIZATION; ARCHITECTURE; TOMOGRAPHY; REVEAL	Cyanobacteria are photosynthetic organisms responsible for similar to 25% of organic carbon fixation on the Earth. These bacteria began to convert solar energy and carbon dioxide into bioenergy and oxygen more than two billion years ago. Cyanophages, which infect these bacteria, have an important role in regulating the marine ecosystem by controlling cyanobacteria community organization and mediating lateral gene transfer. Here we visualize the maturation process of cyanophage Syn5 inside its host cell, Synechococcus, using Zernike phase contrast electron cryo-tomography (cryoET)(1,2). This imaging modality yields dramatic enhancement of image contrast over conventional cryoET and thus facilitates the direct identification of subcellular components, including thylakoid membranes, carboxysomes and polyribosomes, as well as phages, inside the congested cytosol of the infected cell. By correlating the structural features and relative abundance of viral progeny within cells at different stages of infection, we identify distinct Syn5 assembly intermediates. Our results indicate that the procapsid releases scaffolding proteins and expands its volume at an early stage of genome packaging. Later in the assembly process, we detected full particles with a tail either with or without an additional horn. The morphogenetic pathway we describe here is highly conserved and was probably established long before that of double-stranded DNA viruses infecting more complex organisms.	[Dai, Wei; Fu, Caroline; Flanagan, John; Khant, Htet A.; Liu, Xiangan; Rochat, Ryan H.; Ludtke, Steve J.; Schmid, Michael F.; Chiu, Wah] Baylor Coll Med, Verna & Marrs Mclean Dept Biochem & Mol Biol, Natl Ctr Macromol Imaging, Houston, TX 77030 USA; [Raytcheva, Desislava; Haase-Pettingell, Cameron; King, Jonathan A.] MIT, Dept Biol, Cambridge, MA 02139 USA; [Raytcheva, Desislava; Piret, Jacqueline] Northeastern Univ, Dept Biol, Boston, MA 02115 USA; [Rochat, Ryan H.; Ludtke, Steve J.; Schmid, Michael F.; Chiu, Wah] Baylor Coll Med, Program Struct & Computat Biol & Mol Biophys, Houston, TX 77030 USA; [Nagayama, Kuniaki] Natl Inst Nat Sci, Natl Inst Physiol Sci, Okazaki, Aichi 4448787, Japan	Baylor College of Medicine; Massachusetts Institute of Technology (MIT); Northeastern University; Baylor College of Medicine; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS)	Chiu, W (corresponding author), Baylor Coll Med, Verna & Marrs Mclean Dept Biochem & Mol Biol, Natl Ctr Macromol Imaging, Houston, TX 77030 USA.	wah@bcm.edu	Nagayama, Kuniaki/O-2522-2018; Ludtke, Steven/A-4478-2008	/0000-0003-3905-8085; Schmid, Michael/0000-0003-1077-5750; Ludtke, Steven/0000-0002-1903-1574	Robert Welch Foundation [Q1242]; National Institutes of Health [P41GM123832, AI0175208, PN2EY016525, GM080139]; National Institutes of Health through the Gulf Coast Consortia [T15LM007093]; National Institutes of Health through the MSTP [T32GM007330]; NATIONAL EYE INSTITUTE [PN2EY016525] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI075208] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080139, P41GM103832, T32GM007330] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [T15LM007093] Funding Source: NIH RePORTER	Robert Welch Foundation(The Welch Foundation); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health through the Gulf Coast Consortia; National Institutes of Health through the MSTP; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	This research was supported by grants from the Robert Welch Foundation (Q1242) and National Institutes of Health (P41GM123832 to W.C.; AI0175208 and PN2EY016525 to W.C. and J.A.K.; GM080139 to S.J.L.; T15LM007093 through the Gulf Coast Consortia to W.D. and R.H.R.; T32GM007330 through the MSTP to R.H.R.). We thank J. G. Galaz-Montoya and R. N. Irobalieva for editing of the manuscript.	Aksyuk AA, 2011, VIRUSES-BASEL, V3, P172, DOI 10.3390/v3030172; Baker ML, 2013, P NATL ACAD SCI USA, V110, P12301, DOI 10.1073/pnas.1309947110; Chang JT, 2010, J MOL BIOL, V402, P731, DOI 10.1016/j.jmb.2010.07.058; Chen DH, 2011, P NATL ACAD SCI USA, V108, P1355, DOI 10.1073/pnas.1015739108; Danev R, 2010, METHOD ENZYMOL, V481, P343, DOI 10.1016/S0076-6879(10)81014-6; Danev R, 2009, ULTRAMICROSCOPY, V109, P312, DOI 10.1016/j.ultramic.2008.12.006; Fuller DN, 2007, J MOL BIOL, V373, P1113, DOI 10.1016/j.jmb.2007.09.011; Fuller NJ, 2003, APPL ENVIRON MICROB, V69, P2430, DOI 10.1128/AEM.69.5.2430-2443.2003; Hegde S, 2012, J VIROL, V86, P4046, DOI 10.1128/JVI.07197-11; Henderson R, 2012, STRUCTURE, V20, P205, DOI 10.1016/j.str.2011.12.014; HENDRIX RW, 1979, NATURE, V277, P172, DOI 10.1038/277172a0; Hu B, 2013, SCIENCE, V339, P576, DOI 10.1126/science.1231887; Iancu CV, 2010, J MOL BIOL, V396, P105, DOI 10.1016/j.jmb.2009.11.019; Kremer JR, 1996, J STRUCT BIOL, V116, P71, DOI 10.1006/jsbi.1996.0013; Liberton M, 2011, PLANT PHYSIOL, V155, P1656, DOI 10.1104/pp.110.165332; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Machado IMP, 2012, J BIOTECHNOL, V162, P50, DOI 10.1016/j.jbiotec.2012.03.005; Marko M, 2011, J STRUCT BIOL, V174, P400, DOI 10.1016/j.jsb.2011.01.005; Murata K, 2010, STRUCTURE, V18, P903, DOI 10.1016/j.str.2010.06.006; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pope WH, 2007, J MOL BIOL, V368, P966, DOI 10.1016/j.jmb.2007.02.046; PREVELIGE PE, 1988, J MOL BIOL, V202, P743, DOI 10.1016/0022-2836(88)90555-4; Raytcheva DA, 2011, J VIROL, V85, P2406, DOI 10.1128/JVI.01601-10; Rocap G, 2002, APPL ENVIRON MICROB, V68, P1180, DOI 10.1128/AEM.68.3.1180-1191.2002; Rochat RH, 2011, J VIROL, V85, P1871, DOI 10.1128/JVI.01663-10; Rosenthal PB, 2003, J MOL BIOL, V333, P721, DOI 10.1016/j.jmb.2003.07.013; Schmid MF, 2008, J STRUCT BIOL, V161, P243, DOI 10.1016/j.jsb.2007.09.018; Schmid MF, 2006, J MOL BIOL, V364, P526, DOI 10.1016/j.jmb.2006.09.024; Schmid MF, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002961; Schmid MF, 2011, ADV PROTEIN CHEM STR, V82, P37, DOI 10.1016/B978-0-12-386507-6.00002-6; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; Taylor KA, 2008, J STRUCT BIOL, V163, P214, DOI 10.1016/j.jsb.2008.06.004; Ting CS, 2007, J BACTERIOL, V189, P4485, DOI 10.1128/JB.01948-06	33	81	87	1	117	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 31	2013	502	7473					707	+		10.1038/nature12604	http://dx.doi.org/10.1038/nature12604			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243CC	24107993	Green Accepted			2022-12-24	WOS:000326293200053
J	Montagnac, G; Meas-Yedid, V; Irondelle, M; Castro-Castro, A; Franco, M; Shida, T; Nachury, MV; Benmerah, A; Olivo-Marin, JC; Chavrier, P				Montagnac, Guillaume; Meas-Yedid, Vannary; Irondelle, Marie; Castro-Castro, Antonio; Franco, Michel; Shida, Toshinobu; Nachury, Maxence V.; Benmerah, Alexandre; Olivo-Marin, Jean-Christophe; Chavrier, Philippe			alpha TAT1 catalyses microtubule acetylation at clathrin-coated pits	NATURE			English	Article							POSTTRANSLATIONAL MODIFICATIONS; TUBULIN; HDAC6; ACETYLTRANSFERASE; STABILIZATION; TRAFFICKING; ENDOCYTOSIS; MIGRATION; PROTEINS; INTEGRIN	In most eukaryotic cells microtubules undergo post-translational modifications such as acetylation of alpha-tubulin on lysine 40, a wide-spread modification restricted to a subset of microtubules that turns over slowly(1). This subset of stable microtubules accumulates in cell protrusions(2) and regulates cell polarization(3), migration and invasion(4-7). However, mechanisms restricting acetylation to these microtubules are unknown. Here we report that clathrin-coated pits (CCPs) control microtubule acetylation through a direct interaction of the alpha-tubulin acetyltransferase alpha TAT1 (refs 8, 9) with the clathrin adaptor AP2. We observe that about one-third of growing microtubule ends contact and pause at CCPs and that loss of CCPs decreases lysine 40 acetylation levels. We show that alpha TAT1 localizes to CCPs through a direct interaction with AP2 that is required for microtubule acetylation. In migrating cells, the polarized orientation of acetylated microtubules correlates with CCP accumulation at the leading edge(10), and interaction of alpha TAT1 with AP2 is required for directional migration. We conclude that microtubules contacting CCPs become acetylated by alpha TAT1. In migrating cells, this mechanism ensures the acetylation of microtubules oriented towards the leading edge, thus promoting directional cell locomotion and chemotaxis.	[Montagnac, Guillaume; Irondelle, Marie; Castro-Castro, Antonio; Chavrier, Philippe] Inst Curie, Res Ctr, F-75005 Paris, France; [Montagnac, Guillaume; Irondelle, Marie; Castro-Castro, Antonio; Chavrier, Philippe] CNRS, UMR 144, F-75005 Paris, France; [Meas-Yedid, Vannary; Olivo-Marin, Jean-Christophe] Inst Pasteur, CNRS, URA 2582, Unite Anal Images Quantitat, F-75015 Paris, France; [Franco, Michel] Univ Nice Sophia Antipolis, CNRS, UMR 6097, Inst Pharmacol Mol & Cellulaire, F-06560 Valbonne, France; [Shida, Toshinobu; Nachury, Maxence V.] Stanford Univ, Sch Med, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA; [Benmerah, Alexandre] Hop Necker Enfants Malad, INSERM, U983, F-75015 Paris, France; [Benmerah, Alexandre] Univ Paris 05, Sorbonne Paris Cite, Inst Imagine, F-75015 Paris, France	UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur; Stanford University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Montagnac, G (corresponding author), Inst Curie, Res Ctr, F-75005 Paris, France.	guillaume.montagnac@curie.fr; philippe.chavrier@curie.fr	CHAVRIER, Philippe/AAG-2645-2020; Franco, Michel/ABH-4993-2020; Nachury, Maxence/A-8759-2008; Nachury, Maxence/H-3695-2019; benmerah, alexandre/H-3742-2017; FRANCO, michel/AAA-9735-2021; Olivo-Marin, Jean-Christophe/K-4428-2015; CHAVRIER, Philippe/B-4707-2010	CHAVRIER, Philippe/0000-0002-7351-733X; Franco, Michel/0000-0003-1853-8661; Nachury, Maxence/0000-0003-4918-1562; Nachury, Maxence/0000-0003-4918-1562; benmerah, alexandre/0000-0003-0188-8016; Olivo-Marin, Jean-Christophe/0000-0001-6796-0696; CHAVRIER, Philippe/0000-0002-7351-733X	Institut Curie; CNRS; Fondation ARC pour la Recherche contre le Cancer [SL220100601356]; Institut National du Cancer [2009-1-PL BIO-12-IC-1]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM089933] Funding Source: NIH RePORTER	Institut Curie; CNRS(Centre National de la Recherche Scientifique (CNRS)); Fondation ARC pour la Recherche contre le Cancer; Institut National du Cancer(Institut National du Cancer (INCA) France); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors wish to thank P. Tran and C. Janke for comments on the manuscript and S. Linder for the suggestion of the three-dimensional collagen I EGF-chemotaxis assay. We thank E. Macia for purification of recombinant AP2 complex and S. Lemeer for generation of alpha-adaptin mutants. We thank the Cell and Tissue Imaging Facility and Nikon Imaging Center@Institut Curie & Centre National de la Recherche Scientifique (CNRS) for help with image acquisition. Core funding for this work was provided by the Institut Curie and the CNRS and additional support was provided by grants from Fondation ARC pour la Recherche contre le Cancer (SL220100601356) and Institut National du Cancer (2009-1-PL BIO-12-IC-1) to P.C.	Akella JS, 2010, NATURE, V467, P218, DOI 10.1038/nature09324; BULINSKI JC, 1988, J CELL BIOL, V106, P1213, DOI 10.1083/jcb.106.4.1213; CAMPBELL CH, 1983, J BIOL CHEM, V258, P2628; Castro-Castro A, 2012, EUR J CELL BIOL, V91, P950, DOI 10.1016/j.ejcb.2012.07.001; Caswell PT, 2007, DEV CELL, V13, P496, DOI 10.1016/j.devcel.2007.08.012; Chabin-Brion K, 2001, MOL BIOL CELL, V12, P2047, DOI 10.1091/mbc.12.7.2047; Collins BM, 2002, CELL, V109, P523, DOI 10.1016/S0092-8674(02)00735-3; Condeelis J, 2006, CELL, V124, P263, DOI 10.1016/j.cell.2006.01.007; de Chaumont F, 2012, NAT METHODS, V9, P690, DOI [10.1038/NMETH.2075, 10.1038/nmeth.2075]; de Chaumont F, 2011, I S BIOMED IMAGING, P234, DOI 10.1109/ISBI.2011.5872395; Efimov A, 2007, DEV CELL, V12, P917, DOI 10.1016/j.devcel.2007.04.002; ELSDALE T, 1972, J CELL BIOL, V54, P626, DOI 10.1083/jcb.54.3.626; Ezratty EJ, 2009, J CELL BIOL, V187, P733, DOI 10.1083/jcb.200904054; Ferguson S, 2009, DEV CELL, V17, P811, DOI 10.1016/j.devcel.2009.11.005; Fuller D, 2010, P NATL ACAD SCI USA, V107, P9656, DOI 10.1073/pnas.0911178107; GUNDERSEN GG, 1988, P NATL ACAD SCI USA, V85, P5946, DOI 10.1073/pnas.85.16.5946; Gundersen GG, 2002, CURR BIOL, V12, pR645, DOI 10.1016/S0960-9822(02)01156-9; Hinrichsen L, 2003, J BIOL CHEM, V278, P45160, DOI 10.1074/jbc.M307290200; Howes MT, 2010, J CELL BIOL, V190, P675, DOI 10.1083/jcb.201002119; Hubbert C, 2002, NATURE, V417, P455, DOI 10.1038/417455a; Kaplan OI, 2010, J CELL SCI, V123, P3966, DOI 10.1242/jcs.073908; Kelm JM, 2003, BIOTECHNOL BIOENG, V83, P173, DOI 10.1002/bit.10655; Montagnac G, 2011, CURR BIOL, V21, P574, DOI 10.1016/j.cub.2011.02.034; Perdiz D, 2011, CELL SIGNAL, V23, P763, DOI 10.1016/j.cellsig.2010.10.014; Rappoport JZ, 2003, TRAFFIC, V4, P460, DOI 10.1034/j.1600-0854.2003.00100.x; Rappoport JZ, 2003, J CELL SCI, V116, P847, DOI 10.1242/jcs.00289; Rey M, 2011, EUR J CELL BIOL, V90, P128, DOI 10.1016/j.ejcb.2010.09.004; Rowe RG, 2008, TRENDS CELL BIOL, V18, P560, DOI 10.1016/j.tcb.2008.08.007; Shida T, 2010, P NATL ACAD SCI USA, V107, P21517, DOI 10.1073/pnas.1013728107; Tanabe K, 2009, J CELL BIOL, V185, P939, DOI 10.1083/jcb.200803153; Tran ADA, 2007, J CELL SCI, V120, P1469, DOI 10.1242/jcs.03431; Watanabe T, 2005, TRENDS CELL BIOL, V15, P76, DOI 10.1016/j.tcb.2004.12.006; Witte H, 2008, J CELL BIOL, V180, P619, DOI 10.1083/jcb.200707042; Wloga D, 2010, J CELL SCI, V123, P3447, DOI 10.1242/jcs.063727	34	67	73	2	34	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 24	2013	502	7472					567	+		10.1038/nature12571	http://dx.doi.org/10.1038/nature12571			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	238YN	24097348	Green Accepted			2022-12-24	WOS:000325988400058
J	Rais, Y; Zviran, A; Geula, S; Gafni, O; Chomsky, E; Viukov, S; Mansour, AA; Caspi, I; Krupalnik, V; Zerbib, M; Maza, I; Mor, N; Baran, D; Weinberger, L; Jaitin, DA; Lara-Astiaso, D; Blecher-Gonen, R; Shipony, Z; Mukamel, Z; Hagai, T; Gilad, S; Amann-Zalcenstein, D; Tanay, A; Amit, I; Novershtern, N; Hanna, JH				Rais, Yoach; Zviran, Asaf; Geula, Shay; Gafni, Ohad; Chomsky, Elad; Viukov, Sergey; Mansour, Abed AlFatah; Caspi, Inbal; Krupalnik, Vladislav; Zerbib, Mirie; Maza, Itay; Mor, Nofar; Baran, Dror; Weinberger, Leehee; Jaitin, Diego A.; Lara-Astiaso, David; Blecher-Gonen, Ronnie; Shipony, Zohar; Mukamel, Zohar; Hagai, Tzachi; Gilad, Shlomit; Amann-Zalcenstein, Daniela; Tanay, Amos; Amit, Ido; Novershtern, Noa; Hanna, Jacob H.			Deterministic direct reprogramming of somatic cells to pluripotency	NATURE			English	Article							DNA METHYLATION; NURD; COMPONENT; NETWORK; COMPLEX; NANOG; MBD3	Somatic cells can be inefficiently and stochastically reprogrammed into induced pluripotent stem(iPS) cells by exogenous expression of Oct4 (also called Pou5f1), Sox2, Klf4 and Myc (hereafter referred to as OSKM). The nature of the predominant rate-limiting barrier(s) preventing the majority of cells to successfully and synchronously reprogram remains to be defined. Here we show that depleting Mbd3, a core member of the Mbd3/NuRD (nucleosome remodelling and deacetylation) repressor complex, together with OSKM transduction and reprogramming in naive pluripotency promoting conditions, result in deterministic and synchronized iPS cell reprogramming (near 100% efficiency within seven days from mouse and human cells). Our findings uncover a dichotomous molecular function for the reprogramming factors, serving to reactivate endogenous pluripotency networks while simultaneously directly recruiting the Mbd3/NuRD repressor complex that potently restrains the reactivation of OSKM downstream target genes. Subsequently, the latter interactions, which are largely depleted during early pre-implantation development in vivo, lead to a stochastic and protracted reprogramming trajectory towards pluripotency in vitro. The deterministic reprogramming approach devised here offers a novel platform for the dissection of molecular dynamics leading to establishing pluripotency at unprecedented flexibility and resolution.	[Rais, Yoach; Zviran, Asaf; Geula, Shay; Gafni, Ohad; Chomsky, Elad; Viukov, Sergey; Mansour, Abed AlFatah; Caspi, Inbal; Krupalnik, Vladislav; Zerbib, Mirie; Maza, Itay; Mor, Nofar; Baran, Dror; Weinberger, Leehee; Novershtern, Noa; Hanna, Jacob H.] Weizmann Inst Sci, Dept Mol Genet, IL-76100 Rehovot, Israel; [Jaitin, Diego A.; Lara-Astiaso, David; Blecher-Gonen, Ronnie; Amit, Ido] Weizmann Inst Sci, Dept Immunol, IL-76100 Rehovot, Israel; [Shipony, Zohar; Mukamel, Zohar; Tanay, Amos] Weizmann Inst Sci, Dept Regulat Biol, IL-76100 Rehovot, Israel; [Shipony, Zohar; Mukamel, Zohar; Tanay, Amos] Weizmann Inst Sci, Dept Comp Sci, IL-76100 Rehovot, Israel; [Hagai, Tzachi] Weizmann Inst Sci, Dept Biol Struct, IL-76100 Rehovot, Israel; [Gilad, Shlomit; Amann-Zalcenstein, Daniela] Weizmann Inst Sci, Israel Natl Ctr Personalized Med, IL-76100 Rehovot, Israel	Weizmann Institute of Science; Weizmann Institute of Science; Weizmann Institute of Science; Weizmann Institute of Science; Weizmann Institute of Science; Weizmann Institute of Science	Hanna, JH (corresponding author), Weizmann Inst Sci, Dept Mol Genet, IL-76100 Rehovot, Israel.	noa.novershtern@weizmann.ac.il; jacob.hanna@weizmann.ac.il	Hanna, Jacob/K-1339-2012; Geula, Shay Yosef/Z-3789-2019; mansour, abed/GWC-2134-2022; Hagai, Tzachi/AAL-8758-2021	Hanna, Jacob/0000-0003-2042-9974; Geula, Shay Yosef/0000-0001-8111-4410; Blecher, Ronnie/0000-0003-2847-1149; Mansour, Abed AlFatah/0000-0001-9025-6998; Novershtern, Noa/0000-0002-2244-6877; Mor, Nofar/0000-0001-5826-4533; Tzachi, Hagai/0000-0002-4575-6624	Leona M. and Harry B. Helmsley Charitable Trust; ERC [StG-281906, StG-309788]; BIRAX initiative; Israel Science Foundation; ICRF; Fritz Thyssen Stiftung; The Benoziyo Endowment fund; Alon Scholar Program; HFSP Career Development Award, an ISF-Bikura; Weizmann Dean fellowship; Weizmann Institute management	Leona M. and Harry B. Helmsley Charitable Trust; ERC(European Research Council (ERC)European Commission); BIRAX initiative; Israel Science Foundation(Israel Science Foundation); ICRF; Fritz Thyssen Stiftung; The Benoziyo Endowment fund; Alon Scholar Program; HFSP Career Development Award, an ISF-Bikura; Weizmann Dean fellowship; Weizmann Institute management	J.H.H. is supported by a generous gift from I. and P. Mantoux; and grants from the Leona M. and Harry B. Helmsley Charitable Trust, ERC (StG-281906) grant, BIRAX initiative, Israel Science Foundation (BIKURA, ICORE and Regular programs), ICRF, Fritz Thyssen Stiftung, The Benoziyo Endowment fund, Alon Scholar Program, and the Clore research prize. I. A is supported by the HFSP Career Development Award, an ISF-Bikura and the ERC (StG-309788). A. A. M. is supported by a Weizmann Dean fellowship. We thank N. Barkai and her group, K. Saha, B. Hendrich, J. Nichols and A. Surani, for reagents and advice. We thank the Weizmann Institute management for providing critical financial and infrastructural support.	Ang YS, 2011, CELL, V145, P183, DOI 10.1016/j.cell.2011.03.003; Arce G. R., 2005, NONLINEAR SIGNAL PRO; Bedell VM, 2012, NATURE, V491, P114, DOI 10.1038/nature11537; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Blecher-Gonen R, 2013, NAT PROTOC, V8, P539, DOI 10.1038/nprot.2013.023; Bolch G., 2006, QUEUEING NETWORKS MA; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Duffy KR, 2012, SCIENCE, V335, P338, DOI 10.1126/science.1213230; Fisher S. R. A, 1970, STAT METHODS RES WOR, V14th; Hanna J, 2008, CELL, V133, P250, DOI 10.1016/j.cell.2008.03.028; Hanna J, 2009, NATURE, V462, P595, DOI 10.1038/nature08592; Hanna J, 2009, CELL STEM CELL, V4, P513, DOI 10.1016/j.stem.2009.04.015; Hanna JH, 2010, CELL, V143, P508, DOI 10.1016/j.cell.2010.10.008; Hockemeyer D, 2008, CELL STEM CELL, V3, P346, DOI 10.1016/j.stem.2008.08.014; Hockemeyer D, 2011, NAT BIOTECHNOL, V29, P731, DOI 10.1038/nbt.1927; Hu G, 2012, CELL STEM CELL, V10, P497, DOI 10.1016/j.stem.2012.04.011; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Kaji K, 2006, NAT CELL BIOL, V8, P285, DOI 10.1038/ncb1372; Kaji K, 2007, DEVELOPMENT, V134, P1123, DOI 10.1242/dev.02802; Kim JW, 2008, CELL, V132, P1049, DOI 10.1016/j.cell.2008.02.039; Le Guezennec X, 2006, MOL CELL BIOL, V26, P843, DOI 10.1128/MCB.26.3.843-851.2006; Leitch HG, 2010, DEVELOPMENT, V137, P2279, DOI 10.1242/dev.050427; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; Luo M, 2013, STEM CELLS, V31, P1278, DOI 10.1002/stem.1374; Mansour AA, 2012, NATURE, V488, P409, DOI 10.1038/nature11272; Mikkelsen TS, 2008, NATURE, V454, P49, DOI 10.1038/nature07056; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Onder TT, 2012, NATURE, V483, P598, DOI 10.1038/nature10953; Pawlak M, 2011, GENE DEV, V25, P1035, DOI 10.1101/gad.2039011; Reynolds N, 2012, CELL STEM CELL, V10, P583, DOI 10.1016/j.stem.2012.02.020; Reynolds N, 2012, EMBO J, V31, P593, DOI 10.1038/emboj.2011.431; Silva J, 2009, CELL, V138, P722, DOI 10.1016/j.cell.2009.07.039; Smith ZD, 2012, NATURE, V484, P339, DOI 10.1038/nature10960; Smith ZD, 2010, NAT BIOTECHNOL, V28, P521, DOI 10.1038/nbt.1632; Sommer CA, 2009, STEM CELLS, V27, P543, DOI 10.1634/stemcells.2008-1075; Soufi A, 2012, CELL, V151, P994, DOI 10.1016/j.cell.2012.09.045; Sridharan R, 2009, CELL, V136, P364, DOI 10.1016/j.cell.2009.01.001; Stadtfeld M, 2010, NATURE, V465, P175, DOI 10.1038/nature09017; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Warren L, 2010, CELL STEM CELL, V7, P618, DOI 10.1016/j.stem.2010.08.012	40	387	408	1	237	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 3	2013	502	7469					65	+		10.1038/nature12587	http://dx.doi.org/10.1038/nature12587			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	227IM	24048479				2022-12-24	WOS:000325106000031
J	Blair, DR; Lyttle, CS; Mortensen, JM; Bearden, CF; Jensen, AB; Khiabanian, H; Melamed, R; Rabadan, R; Bernstam, EV; Brunak, S; Jensen, LJ; Nicolae, D; Shah, NH; Grossman, RL; Cox, NJ; White, KP; Rzhetsky, A				Blair, David R.; Lyttle, Christopher S.; Mortensen, Jonathan M.; Bearden, Charles F.; Jensen, Anders Boeck; Khiabanian, Hossein; Melamed, Rachel; Rabadan, Raul; Bernstam, Elmer V.; Brunak, Soren; Jensen, Lars Juhl; Nicolae, Dan; Shah, Nigam H.; Grossman, Robert L.; Cox, Nancy J.; White, Kevin P.; Rzhetsky, Andrey			A Nondegenerate Code of Deleterious Variants in Mendelian Loci Contributes to Complex Disease Risk	CELL			English	Article							TERT PROMOTER MUTATIONS; MODIFIER GENES; DISORDERS; INHERITANCE; DELETION; CELLS	Although countless highly penetrant variants have been associated with Mendelian disorders, the genetic etiologies underlying complex diseases remain largely unresolved. By mining the medical records of over 110 million patients, we examine the extent to which Mendelian variation contributes to complex disease risk. We detect thousands of associations between Mendelian and complex diseases, revealing a nondegenerate, phenotypic code that links each complex disorder to a unique collection of Mendelian loci. Using genome-wide association results, we demonstrate that common variants associated with complex diseases are enriched in the genes indicated by this "Mendelian code.'' Finally, we detect hundreds of comorbidity associations among Mendelian disorders, and we use probabilistic genetic modeling to demonstrate that Mendelian variants likely contribute nonadditively to the risk for a subset of complex diseases. Overall, this study illustrates a complementary approach for mapping complex disease loci and provides unique predictions concerning the etiologies of specific diseases.	[Blair, David R.] Univ Chicago, Comm Genet Genom & Syst Biol, Chicago, IL 60637 USA; [Lyttle, Christopher S.] Univ Chicago, Ctr Hlth & Social Sci, Chicago, IL 60637 USA; [Nicolae, Dan] Univ Chicago, Dept Stat, Chicago, IL 60637 USA; [Nicolae, Dan; Grossman, Robert L.; Cox, Nancy J.; White, Kevin P.; Rzhetsky, Andrey] Univ Chicago, Dept Med, Chicago, IL 60637 USA; [Nicolae, Dan; Cox, Nancy J.; White, Kevin P.; Rzhetsky, Andrey] Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; [Grossman, Robert L.; White, Kevin P.; Rzhetsky, Andrey] Univ Chicago, Inst Genom & Syst Biol, Computat Inst, Chicago, IL 60637 USA; [Mortensen, Jonathan M.; Shah, Nigam H.] Stanford Ctr Biomed Informat Res, Stanford, CA 94305 USA; [Bearden, Charles F.; Bernstam, Elmer V.] Univ Texas Hlth Sci Ctr Houston, Dept Internal Med, Sch Biomed Informat, Houston, TX 77030 USA; [Jensen, Anders Boeck; Brunak, Soren; Jensen, Lars Juhl] Tech Univ Denmark, Ctr Biol Sequence Anal, DK-2800 Copenhagen, Denmark; [Khiabanian, Hossein; Melamed, Rachel; Rabadan, Raul] Columbia Univ, Ctr Computat Biol & Bioinformat, Dept Biomed Informat, New York, NY 10032 USA; [Brunak, Soren; Jensen, Lars Juhl] Univ Copenhagen, Novo Nordisk Fdn Ctr Prot Res, DK-2200 Copenhagen, Denmark	University of Chicago; University of Chicago; University of Chicago; University of Chicago; University of Chicago; University of Chicago; University of Texas System; University of Texas Health Science Center Houston; Technical University of Denmark; Columbia University; University of Copenhagen	White, KP (corresponding author), Univ Chicago, Dept Med, 5841 S Maryland Ave, Chicago, IL 60637 USA.	kpwhite@uchicago.edu; arzhetsky@uchicago.edu	Jensen, Lars Juhl/C-6492-2008; Khiabanian, Hossein/N-7207-2019; rzhetsky, andrey/B-6118-2012; Rabadan, Raul/AAZ-7367-2020; Brunak, Soren/O-6621-2016; Blair, David/G-6052-2011; Grossman, Robert/B-1865-2009	Jensen, Lars Juhl/0000-0001-7885-715X; Khiabanian, Hossein/0000-0003-1446-4394; rzhetsky, andrey/0000-0001-6959-7405; Melamed, Rachel/0000-0003-3089-9806; Brunak, Soren/0000-0003-0316-5866; Blair, David/0000-0002-4658-3251; Jensen, Anders Boeck/0000-0002-5784-308X; Grossman, Robert/0000-0003-3741-5739; Rabadan, Raul/0000-0001-7946-9255; Nicolae, Dan/0000-0002-0918-4630; Blair, David/0000-0002-7455-6488	National Institutes of Health [1P50MH094267, NHLBI MAPGen U01HL108634-01, P50GM081892-01A1, 2T32GM007281-39]; Chicago Biomedical Consortium; Div Of Information & Intelligent Systems [0964613] Funding Source: National Science Foundation; Novo Nordisk Foundation Center for Protein Research [PI Lars Juhl Jensen, PI S�ren Brunak] Funding Source: researchfish; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL108634] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG004028] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM081892, T32GM007281] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH094267] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [T15LM007033] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Chicago Biomedical Consortium; Div Of Information & Intelligent Systems(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE)); Novo Nordisk Foundation Center for Protein Research; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	We are grateful to Steven Bagley, Richard R. Hudson, Ivan Iossifov, Ravinesh Kumar, Simon Lovestone, Fabiola Rivas, Gregory Gibson, Jason Pitt, Rita Rzhetsky, Michael Wigler, and anonymous reviewers for helpful comments on earlier versions of the manuscript. GeneXplain, GmbH, provided help with annotation of Mendelian disorders. This work was supported by grants (1P50MH094267, NHLBI MAPGen U01HL108634-01, P50GM081892-01A1, and 2T32GM007281-39) from the National Institutes of Health and by a Lever Award from the Chicago Biomedical Consortium.	Ashwood P, 2010, BRAIN BEHAV IMMUN, V24, P898, DOI 10.1016/j.bbi.2010.01.008; Badano JL, 2006, NATURE, V439, P326, DOI 10.1038/nature04370; Badano JL, 2002, NAT REV GENET, V3, P779, DOI 10.1038/nrg910; Bassett AS, 2008, HUM MOL GENET, V17, P4045, DOI 10.1093/hmg/ddn307; Blondel VD, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/10/P10008; Calderhead B, 2009, COMPUT STAT DATA AN, V53, P4028, DOI 10.1016/j.csda.2009.07.025; Cutting GR, 2010, ANN NY ACAD SCI, V1214, P57, DOI 10.1111/j.1749-6632.2010.05879.x; DEBOULLE K, 1993, NAT GENET, V3, P31, DOI 10.1038/ng0193-31; DeHert M, 1996, AM J MED GENET, V67, P212; DESANCTIS V, 1988, ARCH DIS CHILD, V63, P58, DOI 10.1136/adc.63.1.58; Dickson SP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000294; Gamazon ER, 2010, BIOINFORMATICS, V26, P259, DOI 10.1093/bioinformatics/btp644; Hidalgo CA, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000353; Horn S, 2013, SCIENCE, V339, P959, DOI 10.1126/science.1230062; Huang FW, 2013, SCIENCE, V339, P957, DOI 10.1126/science.1229259; Iossifov I, 2012, NEURON, V74, P285, DOI 10.1016/j.neuron.2012.04.009; KAJIWARA K, 1994, SCIENCE, V264, P1604, DOI 10.1126/science.8202715; Katsanis N, 2001, SCIENCE, V293, P2256, DOI 10.1126/science.1063525; Killela PJ, 2013, P NATL ACAD SCI USA, V110, P6021, DOI 10.1073/pnas.1303607110; Kirwan M, 2009, BBA-MOL BASIS DIS, V1792, P371, DOI 10.1016/j.bbadis.2009.01.010; Kumar RA, 2008, HUM MOL GENET, V17, P628, DOI 10.1093/hmg/ddm376; Lee DS, 2008, P NATL ACAD SCI USA, V105, P9880, DOI 10.1073/pnas.0802208105; Lee I, 2011, GENOME RES, V21, P1109, DOI 10.1101/gr.118992.110; Lemmers RJLF, 2012, NAT GENET, V44, P1370, DOI 10.1038/ng.2454; Lupski JR, 2011, CELL, V147, P32, DOI 10.1016/j.cell.2011.09.008; Lyles RH, 2002, AM J EPIDEMIOL, V155, P274, DOI 10.1093/aje/155.3.274; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Min WW, 2009, NEUROPHARMACOLOGY, V56, P463, DOI 10.1016/j.neuropharm.2008.09.017; O'Roak BJ, 2011, NAT GENET, V43, P585, DOI 10.1038/ng.835; Parmeggiani F, 2011, CURR GENOMICS, V12, P236, DOI 10.2174/138920211795860080; PODOLSKY S, 1972, LANCET, V1, P1356; RISCH N, 1990, AM J HUM GENET, V46, P222; Ristow M, 2004, J MOL MED, V82, P510, DOI 10.1007/s00109-004-0552-1; Rzhetsky A, 2007, P NATL ACAD SCI USA, V104, P11694, DOI 10.1073/pnas.0704820104; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sellers TA, 1997, J NUTR, V127, pS929, DOI 10.1093/jn/127.5.929S; Shinawi M, 2010, J MED GENET, V47, P332, DOI 10.1136/jmg.2009.073015; Sinibaldi Lorenzo, 2004, Hum Mutat, V24, P534, DOI 10.1002/humu.9292; Smoller JW, 2013, LANCET, V381, P1371, DOI 10.1016/S0140-6736(12)62129-1; Strong A, 2012, CURR ATHEROSCLER REP, V14, P211, DOI 10.1007/s11883-012-0248-x; Tabet AC, 2012, EUR J HUM GENET, V20, P540, DOI 10.1038/ejhg.2011.244; van Walraven C, 2012, J CLIN EPIDEMIOL, V65, P126, DOI 10.1016/j.jclinepi.2011.08.002; Visscher PM, 2012, AM J HUM GENET, V90, P7, DOI 10.1016/j.ajhg.2011.11.029; Vissers LELM, 2010, NAT GENET, V42, P1109, DOI 10.1038/ng.712; Wallace AS, 2011, WORLD J GASTROENTERO, V17, P4937, DOI 10.3748/wjg.v17.i45.4937; Yu TW, 2013, NEURON, V77, P259, DOI 10.1016/j.neuron.2012.11.002; Zaghloul NA, 2010, P NATL ACAD SCI USA, V107, P10602, DOI 10.1073/pnas.1000219107; Zang JB, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000758; Zhao JH, 2010, DIABETES, V59, P751, DOI 10.2337/db09-0972	49	149	151	0	30	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 26	2013	155	1					70	80		10.1016/j.cell.2013.08.030	http://dx.doi.org/10.1016/j.cell.2013.08.030			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	224UX	24074861	Green Accepted, Bronze			2022-12-24	WOS:000324916700010
J	Hu, LC; Kim, TM; Son, MY; Kim, SA; Holland, CL; Tateishi, S; Kim, DH; Yew, PR; Montagna, C; Dumitrache, LC; Hasty, P				Hu, Lingchuan; Kim, Tae Moon; Son, Mi Young; Kim, Sung-A; Holland, Cory L.; Tateishi, Satoshi; Kim, Dong Hyun; Yew, P. Renee; Montagna, Cristina; Dumitrache, Lavinia C.; Hasty, Paul			Two replication fork maintenance pathways fuse inverted repeats to rearrange chromosomes	NATURE			English	Article							GENOMIC INSTABILITY; HPRT MINIGENE; DNA; GENE; BRCA2; RECOMBINATION; AMPLIFICATION; REPAIR; HLTF; POLYUBIQUITINATION	Replication fork maintenance pathways preserve chromosomes, but their faulty application at nonallelic repeats could generate rearrangements causing cancer, genomic disorders and speciation(1-3). Potential causal mechanisms are homologous recombination and error-free postreplication repair (EF-PRR). Homologous recombination repairs damage-induced DNA double-strand breaks (DSBs) and single-ended DSBs within replication. To facilitate homologous recombination, the recombinase RAD51 and mediator BRCA2 forma filament on the 3' DNA strand at a break to enable annealing to the complementary sister chromatid(4) while the RecQ helicase, BLM (Bloom syndrome mutated) suppresses crossing over to prevent recombination(5). Homologous recombination also stabilizes(6,7) and restarts(8,9) replication forks without a DSB10,11. EF-PRR bypasses DNA incongruities that impede replication by ubiquitinating PCNA (proliferating cell nuclear antigen) using the RAD6-RAD18 and UBC13-MMS2-RAD5 ubiquitin ligase complexes(12). Some components are common to both homologous recombination and EF-PRR such as RAD51 and RAD18(13,14). Here we delineate two pathways that spontaneously fuse inverted repeats to generate unstable chromosomal rearrangements in wild-type mouse embryonic stem (ES) cells. Gamma-radiation induced a BLM-regulated pathway that selectively fused identical, but not mismatched, repeats. By contrast, ultraviolet light induced a RAD18-dependent pathway that efficiently fused mismatched repeats. Furthermore, TREX2 (a 3'-> 5' exonuclease) suppressed identical repeat fusion but enhanced mismatched repeat fusion, clearly separating these pathways. TREX2 associated with UBC13 and enhanced PCNA ubiquitination in response to ultraviolet light, consistent with it being a novel member of EF-PRR. RAD18 and TREX2 also suppressed replication fork stalling in response to nucleotide depletion. Interestingly, replication fork stalling induced fusion for identical and mismatched repeats, implicating faulty replication as a causal mechanism for both pathways.	[Hu, Lingchuan; Kim, Tae Moon; Son, Mi Young; Kim, Sung-A; Holland, Cory L.; Kim, Dong Hyun; Yew, P. Renee; Dumitrache, Lavinia C.; Hasty, Paul] Univ Texas Hlth Sci Ctr San Antonio, Barshop Inst Longev & Aging Studies, Inst Biotechnol, Dept Mol Med, San Antonio, TX 78245 USA; [Tateishi, Satoshi] Kumamoto Univ, IMEG, Kumamoto 8600811, Japan; [Montagna, Cristina] Yeshiva Univ Albert Einstein Coll Med, Dept Genet, Bronx, NY 10461 USA	University of Texas System; University of Texas Health San Antonio; Kumamoto University; Yeshiva University; Albert Einstein College of Medicine	Hasty, P (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Barshop Inst Longev & Aging Studies, Inst Biotechnol, Dept Mol Med, 15355 Lambda Dr, San Antonio, TX 78245 USA.	hastye@uthscsa.edu		Kim, Dong Hyun/0000-0002-8762-1496; Hasty, Paul/0000-0003-3046-0131; Kim, Tae Moon/0000-0001-9715-9568	National Institutes of Health [1 RO1 CA123203-01A1, 2P01AG017242-12, P30CA013330]; Cancer Therapy & Research Center at The University of Texas at San Antonio (CTRC) [P30 CA054174]; NATIONAL CANCER INSTITUTE [P30CA054174, P30CA013330, R01CA123203] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG017242] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Therapy & Research Center at The University of Texas at San Antonio (CTRC); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank C. Williams and S. Dodds for technical assistance and the Molecular Cytogenetic Core at Albert Einstein College of Medicine for help with the execution of spectral karyotyping and two-colour FISH. This work was supported by the National Institutes of Health (1 RO1 CA123203-01A1 to P. H., 2P01AG017242-12 to P. H. and C. M. P30CA013330 to C. M.) and with support from the Cancer Therapy & Research Center at The University of Texas at San Antonio (CTRC) (P30 CA054174).	ADRA CN, 1987, GENE, V60, P65, DOI 10.1016/0378-1119(87)90214-9; Araki K, 1997, NUCLEIC ACIDS RES, V25, P868, DOI 10.1093/nar/25.4.868; Blastyak A, 2010, MOL CELL BIOL, V30, P684, DOI 10.1128/MCB.00863-09; Carr A. M., 2013, J MOL BIOL; Carr AM, 2011, SEMIN CELL DEV BIOL, V22, P866, DOI 10.1016/j.semcdb.2011.10.008; Cavalli G, 2013, NAT STRUCT MOL BIOL, V20, P290, DOI 10.1038/nsmb.2474; Chen MJ, 2007, CANCER RES, V67, P9077, DOI 10.1158/0008-5472.CAN-07-1146; Chen MJ, 2007, NUCLEIC ACIDS RES, V35, P2682, DOI 10.1093/nar/gkm151; DAVISSON MT, 1994, GENE, V147, P157, DOI 10.1016/0378-1119(94)90060-4; Donoho G, 2003, GENE CHROMOSOME CANC, V36, P317, DOI 10.1002/gcc.10148; Dumitrache LC, 2011, GENETICS, V188, P787, DOI 10.1534/genetics.111.129833; Dumitrache LC, 2009, MUTAT RES-FUND MOL M, V662, P84, DOI 10.1016/j.mrfmmm.2008.11.012; Dutra BE, 2006, J MOL BIOL, V356, P300, DOI 10.1016/j.jmb.2005.11.071; Falbo KB, 2009, NAT STRUCT MOL BIOL, V16, P1167, DOI 10.1038/nsmb.1686; Filippo JS, 2008, ANNU REV BIOCHEM, V77, P229, DOI 10.1146/annurev.biochem.77.061306.125255; FRIEDRICH G, 1991, GENE DEV, V5, P1513, DOI 10.1101/gad.5.9.1513; Goldfless SJ, 2006, MOL CELL, V21, P595, DOI 10.1016/j.molcel.2006.01.025; Guenatri M, 2004, J CELL BIOL, V166, P493, DOI 10.1083/jcb.200403109; Harada S, 2011, NUCLEIC ACIDS RES, V39, P958, DOI 10.1093/nar/gkq882; Hastings PJ, 2009, NAT REV GENET, V10, P551, DOI 10.1038/nrg2593; Holcomb VB, 2007, GENESIS, V45, P275, DOI 10.1002/dvg.20300; Horvath JE, 2003, MOL BIOL EVOL, V20, P1463, DOI 10.1093/molbev/msg158; Huang J, 2009, NAT CELL BIOL, V11, P592, DOI 10.1038/ncb1865; Kim DH, 2010, MOL CELL BIOL, V30, P4120, DOI 10.1128/MCB.01135-09; Kim TM, 2012, MOL CELL BIOL, V32, P3663, DOI 10.1128/MCB.00406-12; Kim TM, 2008, GENESIS, V46, P732, DOI 10.1002/dvg.20439; Krijger PHL, 2011, DNA REPAIR, V10, P438, DOI 10.1016/j.dnarep.2010.12.008; Lee JA, 2007, CELL, V131, P1235, DOI 10.1016/j.cell.2007.11.037; Luo GB, 2000, NAT GENET, V26, P424, DOI 10.1038/82548; Mizuno K, 2013, NATURE, V493, P246, DOI 10.1038/nature11676; Mizuno K, 2009, GENE DEV, V23, P2876, DOI 10.1101/gad.1863009; Montagna C, 2002, ONCOGENE, V21, P890, DOI 10.1038/sj.onc.1205146; Morimatsu M, 1998, CANCER RES, V58, P3441; Motegi A, 2008, P NATL ACAD SCI USA, V105, P12411, DOI 10.1073/pnas.0805685105; Moynahan ME, 2001, MOL CELL, V7, P263, DOI 10.1016/S1097-2765(01)00174-5; Petermann E, 2010, MOL CELL, V37, P492, DOI 10.1016/j.molcel.2010.01.021; RAMIREZSOLIS R, 1992, ANAL BIOCHEM, V201, P331, DOI 10.1016/0003-2697(92)90347-A; REID LH, 1990, P NATL ACAD SCI USA, V87, P4299, DOI 10.1073/pnas.87.11.4299; Schlacher K, 2012, CANCER CELL, V22, P106, DOI 10.1016/j.ccr.2012.05.015; Schlacher K, 2011, CELL, V145, P529, DOI 10.1016/j.cell.2011.03.041; Shimizu N, 2005, EXP CELL RES, V302, P233, DOI 10.1016/j.yexcr.2004.09.001; Sirbu BM, 2011, GENE DEV, V25, P1320, DOI 10.1101/gad.2053211; SORIANO P, 1991, CELL, V64, P693, DOI 10.1016/0092-8674(91)90499-O; Tateishi S, 2003, MOL CELL BIOL, V23, P474, DOI 10.1128/MCB.23.2.474-481.2003; Terai K, 2010, MOL CELL, V37, P143, DOI 10.1016/j.molcel.2009.12.018; Ulrich HD, 2009, DNA REPAIR, V8, P461, DOI 10.1016/j.dnarep.2009.01.006; Wu L, 2003, NATURE, V426, P870, DOI 10.1038/nature02253	47	34	35	0	29	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 26	2013	501	7468					569	+		10.1038/nature12500	http://dx.doi.org/10.1038/nature12500			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	223RP	24013173	Green Accepted			2022-12-24	WOS:000324826300063
J	Ross, JM; Stewart, JB; Hagstrom, E; Brene, S; Mourier, A; Coppotelli, G; Freyer, C; Lagouge, M; Hoffer, BJ; Olson, L; Larsson, NG				Ross, Jaime M.; Stewart, James B.; Hagstrom, Erik; Brene, Stefan; Mourier, Arnaud; Coppotelli, Giuseppe; Freyer, Christoph; Lagouge, Marie; Hoffer, Barry J.; Olson, Lars; Larsson, Nils-Goran			Germline mitochondrial DNA mutations aggravate ageing and can impair brain development	NATURE			English	Article							PURIFYING SELECTION; MTDNA; HETEROPLASMY; FREQUENCY; DELETIONS; REVEALS; TISSUES	Ageing is due to an accumulation of various types of damage(1,2), and mitochondrial dysfunction has long been considered to be important in this process(3-8). There is substantial sequence variation in mammalian mitochondrial DNA (mtDNA)(9), and the high mutation rate is counteracted by different mechanisms that decrease maternal transmission of mutated mtDNA(10-13). Despite these protective mechanisms(14), it is becoming increasingly clear that lowlevel mtDNA heteroplasmy is quite common and often inherited in humans(15,16). We designed a series of mouse mutants to investigate the extent to which inherited mtDNA mutations can contribute to ageing. Here we report that maternally transmitted mtDNA mutations can induce mild ageing phenotypes in mice with a wild-type nuclear genome. Furthermore, maternally transmittedmtDNAmutations lead to anticipation of reduced fertility in mice that are heterozygous for themtDNAmutator allele (PolgAwt/mut) and aggravate premature ageing phenotypes inmtDNAmutatormice (PolgAmut/mut). Unexpectedly, a combination of maternally transmitted and somatic mtDNA mutations also leads to stochastic brain malformations. Our findings show that a pre-existing mutation load will not only allow somatic mutagenesis to create a critically high total mtDNA mutation load sooner but will also increase clonal expansionofmtDNA mutations(17) to enhance the normally occurring mosaic respiratory chain deficiency in ageing tissues(18,19). Our findings suggest that maternally transmitted mtDNA mutations may have a similar role in aggravating aspects of normal human ageing.	[Ross, Jaime M.; Coppotelli, Giuseppe; Olson, Lars] Karolinska Inst, Dept Neurosci, S-17177 Stockholm, Sweden; [Stewart, James B.; Mourier, Arnaud; Freyer, Christoph; Lagouge, Marie] Max Planck Inst Biol Ageing, D-50931 Cologne, Germany; [Hagstrom, Erik; Freyer, Christoph; Larsson, Nils-Goran] Karolinska Inst, Dept Lab Med, S-17177 Stockholm, Sweden; [Brene, Stefan] Karolinska Inst, KERIC, Dept Neurobiol Care Sci & Soc, S-17176 Stockholm, Sweden; [Hoffer, Barry J.] Univ Hosp, Case Western Reserve Med Ctr, Dept Neurosurg, Cleveland, OH 44106 USA	Karolinska Institutet; Max Planck Society; Karolinska Institutet; Karolinska Institutet; Case Western Reserve University; Case Western Reserve University Hospital; University Hospitals of Cleveland	Olson, L (corresponding author), Karolinska Inst, Dept Neurosci, Retzius Vag 8, S-17177 Stockholm, Sweden.	lars.olson@ki.se; larsson@age.mpg.de	Larsson, Nils-Göran/GVS-5578-2022; MOURIER, Arnaud/F-9657-2019; Stewart, James B/C-9633-2011; MOURIER, Arnaud/I-8117-2012	Larsson, Nils-Göran/0000-0001-5100-996X; MOURIER, Arnaud/0000-0002-5413-611X; Stewart, James B/0000-0002-2902-4968; MOURIER, Arnaud/0000-0002-5413-611X; Freyer, Christoph/0000-0003-0418-1673	ERC [268897, 322744]; Swedish Research Council [K2011-62X-21870-01-6, K2012-62X-03185-42-4]; Swedish Brain Foundation; Swedish Brain Power; Swedish Parkinson Foundation; Karolinska Distinguished Professor Award; Swedish Alzheimer Foundation; National Institutes of Health [AG04418, NS070825]; National Institute on Drug Abuse; National Institutes of Health/Karolinska Institutet Graduate Partnerships Program; Swedish Society for Medical Research; United Mitochondrial Disease Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS070825] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG004418] Funding Source: NIH RePORTER	ERC(European Research Council (ERC)European Commission); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Brain Foundation; Swedish Brain Power; Swedish Parkinson Foundation; Karolinska Distinguished Professor Award; Swedish Alzheimer Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); National Institutes of Health/Karolinska Institutet Graduate Partnerships Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swedish Society for Medical Research; United Mitochondrial Disease Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The study was supported by ERC Advanced Investigator grants (268897 to N.-G. L. and 322744 to L.O.), the Swedish Research Council (K2011-62X-21870-01-6 to N.-G. L. and K2012-62X-03185-42-4 to L.O.), the Swedish Brain Foundation (N.-G. L. and J.M.R.), Swedish Brain Power (L.O. and J.M.R.), the Swedish Parkinson Foundation (N.-G. L.), the Karolinska Distinguished Professor Award (L.O.), the Swedish Alzheimer Foundation (L.O.) the National Institutes of Health (AG04418 to L.O. and NS070825 to B.J.H.), the National Institute on Drug Abuse (J.M.R.), the National Institutes of Health/Karolinska Institutet Graduate Partnerships Program (J.M.R.) and the Swedish Society for Medical Research (G. C.). J.B.S. acknowledges support from the United Mitochondrial Disease Foundation.	Ahlqvist KJ, 2012, CELL METAB, V15, P100, DOI 10.1016/j.cmet.2011.11.012; Ameur A, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002028; Chen ML, 2009, BLOOD, V114, P4045, DOI 10.1182/blood-2008-08-169474; CORRALDEBRINSKI M, 1992, NAT GENET, V2, P324, DOI 10.1038/ng1292-324; CORTOPASSI GA, 1990, NUCLEIC ACIDS RES, V18, P6927, DOI 10.1093/nar/18.23.6927; ERNSTER L, 1955, EXP CELL RES, V9, P348, DOI 10.1016/0014-4827(55)90108-7; Fan WW, 2008, SCIENCE, V319, P958, DOI 10.1126/science.1147786; Freyer C, 2012, NAT GENET, V44, P1282, DOI 10.1038/ng.2427; Greaves LC, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003082; Greaves LC, 2009, BBA-GEN SUBJECTS, V1790, P1015, DOI 10.1016/j.bbagen.2009.04.018; Greaves LC, 2009, AGING CELL, V8, P566, DOI 10.1111/j.1474-9726.2009.00505.x; Hance N, 2005, HUM MOL GENET, V14, P1775, DOI 10.1093/hmg/ddi184; Hancock DK, 2005, GENOMICS, V86, P446, DOI 10.1016/j.ygeno.2005.06.006; Kirkwood TBL, 2005, CELL, V120, P437, DOI 10.1016/j.cell.2005.01.027; Krakauer DC, 1999, NATURE, V400, P125, DOI 10.1038/22026; Kraytsberg Y, 2005, EXPERT REV MOL DIAGN, V5, P809, DOI 10.1586/14737159.5.5.809; Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125; Larsson NG, 2010, ANNU REV BIOCHEM, V79, P683, DOI 10.1146/annurev-biochem-060408-093701; Li MK, 2010, AM J HUM GENET, V87, P237, DOI 10.1016/j.ajhg.2010.07.014; MIQUEL J, 1980, EXP GERONTOL, V15, P575, DOI 10.1016/0531-5565(80)90010-8; MULLERHOCKER J, 1989, AM J PATHOL, V134, P1167; Norddahl GL, 2011, CELL STEM CELL, V8, P499, DOI 10.1016/j.stem.2011.03.009; Pakendorf B, 2005, ANNU REV GENOM HUM G, V6, P165, DOI 10.1146/annurev.genom.6.080604.162249; Payne BAI, 2013, HUM MOL GENET, V22, P384, DOI 10.1093/hmg/dds435; Payne BAI, 2011, NAT GENET, V43, P806, DOI 10.1038/ng.863; PIKO L, 1988, MECH AGEING DEV, V43, P279, DOI 10.1016/0047-6374(88)90037-1; Ross JM, 2010, P NATL ACAD SCI USA, V107, P20087, DOI 10.1073/pnas.1008189107; Stewart JB, 2008, NAT REV GENET, V9, P657, DOI 10.1038/nrg2396; Stewart JB, 2008, PLOS BIOL, V6, P63, DOI 10.1371/journal.pbio.0060010; SZILARD L, 1959, P NATL ACAD SCI USA, V45, P30, DOI 10.1073/pnas.45.1.30; Taylor RW, 2003, J CLIN INVEST, V112, P1351, DOI 10.1172/JCI200319435; Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517; Wanrooij S, 2012, EMBO REP, V13, P1130, DOI 10.1038/embor.2012.161	33	187	191	2	61	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 19	2013	501	7467					412	+		10.1038/nature12474	http://dx.doi.org/10.1038/nature12474			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219XT	23965628	Green Accepted			2022-12-24	WOS:000324545700044
J	Lu, JX; Qiang, W; Yau, WM; Schwieters, CD; Meredith, SC; Tycko, R				Lu, Jun-Xia; Qiang, Wei; Yau, Wai-Ming; Schwieters, Charles D.; Meredith, Stephen C.; Tycko, Robert			Molecular Structure of beta-Amyloid Fibrils in Alzheimer's Disease Brain Tissue	CELL			English	Article							PROTEIN A-BETA; DISTANCE MEASUREMENTS; SENILE PLAQUES; IN-VIVO; SHEET; OLIGOMERS; POLYMORPHISM; DEPOSITION; A-BETA-40; PEPTIDE	In vitro, beta-amyloid (A beta) peptides form polymorphic fibrils, with molecular structures that depend on growth conditions, plus various oligomeric and protofibrillar aggregates. Here, we investigate structures of human brain-derived A beta fibrils, using seeded fibril growth from brain extract and data from solid-state nuclear magnetic resonance and electron microscopy. Experiments on tissue from two Alzheimer's disease (AD) patients with distinct clinical histories showed a single predominant 40 residue A beta (A beta 40) fibril structure in each patient; however, the structures were different from one another. A molecular structural model developed for A beta 40 fibrils from one patient reveals features that distinguish in-vivo-from in-vitro-produced fibrils. The data suggest that fibrils in the brain may spread from a single nucleation site, that structural variations may correlate with variations in AD, and that structure-specific amyloid imaging agents may be an important future goal.	[Lu, Jun-Xia; Qiang, Wei; Yau, Wai-Ming; Tycko, Robert] NIDDKD, Lab Chem Phys, NIH, Bethesda, MD 20892 USA; [Schwieters, Charles D.] NIH, Div Computat Biosci, Ctr Informat Technol, Bethesda, MD 20892 USA; [Meredith, Stephen C.] Univ Chicago, Dept Pathol, Chicago, IL 60637 USA; [Meredith, Stephen C.] Univ Chicago, Dept Biochem & Mol Biol, Chicago, IL 60637 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH Center for Information Technology (CIT); University of Chicago; University of Chicago	Tycko, R (corresponding author), NIDDKD, Lab Chem Phys, NIH, Bethesda, MD 20892 USA.	robertty@mail.nih.gov			National Institute of Diabetes and Digestive and Kidney Diseases; Center for Information Technology of the National Institutes of Health; N.I.H. [R01 NS042852]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK029061] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS042852] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Center for Information Technology of the National Institutes of Health; N.I.H.(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Supported by the Intramural Research Programs of the National Institute of Diabetes and Digestive and Kidney Diseases and the Center for Information Technology of the National Institutes of Health, and by N.I.H. grant R01 NS042852 (to S.C.M.). We thank Dr. Reed Wickner for assistance with gene sequencing and Dr. Peter Pytel for assistance with histopathology. Calculations were performed on the Biowulf Linux cluster at the N.I.H.	Ahmed M, 2010, NAT STRUCT MOL BIOL, V17, P561, DOI 10.1038/nsmb.1799; Aizenstein HJ, 2008, ARCH NEUROL-CHICAGO, V65, P1509, DOI 10.1001/archneur.65.11.1509; Bayro MJ, 2009, ANGEW CHEM INT EDIT, V48, P5708, DOI 10.1002/anie.200901520; Benzinger TLS, 1998, P NATL ACAD SCI USA, V95, P13407, DOI 10.1073/pnas.95.23.13407; Bertini I, 2011, J AM CHEM SOC, V133, P16013, DOI 10.1021/ja2035859; BESSEN RA, 1994, J VIROL, V68, P7859, DOI 10.1128/JVI.68.12.7859-7868.1994; Bitan G, 2003, P NATL ACAD SCI USA, V100, P330, DOI 10.1073/pnas.222681699; Cameron B, 2010, NEUROBIOL DIS, V37, P503, DOI 10.1016/j.nbd.2009.10.006; Chen B, 2009, P NATL ACAD SCI USA, V106, P14339, DOI 10.1073/pnas.0907821106; Chimon S, 2007, NAT STRUCT MOL BIOL, V14, P1157, DOI 10.1038/nsmb1345; Clark CM, 2011, JAMA-J AM MED ASSOC, V305, P275, DOI 10.1001/jama.2010.2008; Colletier JP, 2011, P NATL ACAD SCI USA, V108, P16938, DOI 10.1073/pnas.1112600108; Collinge J, 2001, ANNU REV NEUROSCI, V24, P519, DOI 10.1146/annurev.neuro.24.1.519; Cummings BJ, 1996, NEUROBIOL AGING, V17, P921, DOI 10.1016/S0197-4580(96)00170-4; De Paepe G, 2008, J CHEM PHYS, V129, DOI 10.1063/1.3036928; Giannakopoulos P, 1997, BRAIN RES REV, V25, P217, DOI 10.1016/S0165-0173(97)00023-4; Glass CK, 2010, CELL, V140, P918, DOI 10.1016/j.cell.2010.02.016; Goldsbury C, 2005, J MOL BIOL, V352, P282, DOI 10.1016/j.jmb.2005.07.029; Gordon DJ, 2001, BIOCHEMISTRY-US, V40, P8237, DOI 10.1021/bi002416v; GRAVINA SA, 1995, J BIOL CHEM, V270, P7013, DOI 10.1074/jbc.270.13.7013; Hu KN, 2012, J MAGN RESON, V218, P115, DOI 10.1016/j.jmr.2012.03.001; Ishii Y, 2001, J CHEM PHYS, V114, P8473, DOI 10.1063/1.1359445; IWATSUBO T, 1994, NEURON, V13, P45, DOI 10.1016/0896-6273(94)90458-8; Jan A, 2011, J BIOL CHEM, V286, P8585, DOI 10.1074/jbc.M110.172411; Jaroniec CP, 2001, J AM CHEM SOC, V123, P3507, DOI 10.1021/ja003266e; Jaroniec CP, 2002, J AM CHEM SOC, V124, P10728, DOI 10.1021/ja026385y; JARRETT JT, 1993, BIOCHEMISTRY-US, V32, P4693, DOI 10.1021/bi00069a001; Kheterpal I, 2001, BIOCHEMISTRY-US, V40, P11757, DOI 10.1021/bi010805z; Klunk WE, 2004, ANN NEUROL, V55, P306, DOI 10.1002/ana.20009; Kodali R, 2010, J MOL BIOL, V401, P503, DOI 10.1016/j.jmb.2010.06.023; Krafft GA, 2010, NEUROPHARMACOLOGY, V59, P230, DOI 10.1016/j.neuropharm.2010.07.012; Kuo YM, 1996, J BIOL CHEM, V271, P4077; Langer F, 2011, J NEUROSCI, V31, P14488, DOI 10.1523/JNEUROSCI.3088-11.2011; LANSBURY PT, 1995, NAT STRUCT BIOL, V2, P990, DOI 10.1038/nsb1195-990; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; Lopez del Amo JM, 2012, J MOL BIOL, V421, P517, DOI 10.1016/j.jmb.2012.01.013; Luhrs T, 2005, P NATL ACAD SCI USA, V102, P17342, DOI 10.1073/pnas.0506723102; Majumdar A, 2008, NEUROBIOL AGING, V29, P707, DOI 10.1016/j.neurobiolaging.2006.12.001; Mathis CA, 2003, J MED CHEM, V46, P2740, DOI 10.1021/jm030026b; Meinhardt J, 2009, J MOL BIOL, V386, P869, DOI 10.1016/j.jmb.2008.11.005; Meyer-Luehmann M, 2006, SCIENCE, V313, P1781, DOI 10.1126/science.1131864; Morcombe CR, 2004, J AM CHEM SOC, V126, P7196, DOI 10.1021/ja047919t; Noguchi A, 2009, J BIOL CHEM, V284, P32895, DOI 10.1074/jbc.M109.000208; Olofsson A, 2007, BIOCHEM J, V404, P63, DOI 10.1042/BJ20061561; Paravastu AK, 2009, P NATL ACAD SCI USA, V106, P7443, DOI 10.1073/pnas.0812033106; Paravastu AK, 2008, P NATL ACAD SCI USA, V105, P18349, DOI 10.1073/pnas.0806270105; Petkova AT, 2005, SCIENCE, V307, P262, DOI 10.1126/science.1105850; Petkova AT, 2006, BIOCHEMISTRY-US, V45, P498, DOI 10.1021/bi051952q; Qiang W, 2013, J AM CHEM SOC, V135, P6860, DOI 10.1021/ja311963f; Qiang W, 2012, P NATL ACAD SCI USA, V109, P4443, DOI 10.1073/pnas.1111305109; Qiang W, 2011, J AM CHEM SOC, V133, P4018, DOI 10.1021/ja109679q; Safar J, 1998, NAT MED, V4, P1157, DOI 10.1038/2654; Scheidt HA, 2011, ANGEW CHEM INT EDIT, V50, P2837, DOI 10.1002/anie.201007265; Scheuner D, 1996, NAT MED, V2, P864, DOI 10.1038/nm0896-864; Schwieters CD, 2006, PROG NUCL MAG RES SP, V48, P47, DOI 10.1016/j.pnmrs.2005.10.001; Selkoe DJ, 2008, BEHAV BRAIN RES, V192, P106, DOI 10.1016/j.bbr.2008.02.016; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Stohr J, 2012, P NATL ACAD SCI USA, V109, P11025, DOI 10.1073/pnas.1206555109; Sultana R, 2009, ACTA NEUROPATHOL, V118, P131, DOI 10.1007/s00401-009-0517-0; Tanzi RE, 2005, CELL, V120, P545, DOI 10.1016/j.cell.2005.02.008; Tomic JL, 2009, NEUROBIOL DIS, V35, P352, DOI 10.1016/j.nbd.2009.05.024; Torok M, 2002, J BIOL CHEM, V277, P40810, DOI 10.1074/jbc.M205659200; Tougu V, 2011, METALLOMICS, V3, P250, DOI 10.1039/c0mt00073f; Toyama BH, 2011, ANNU REV BIOCHEM, V80, P557, DOI 10.1146/annurev-biochem-090908-120656; Tycko R, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2437194; Villemagne VL, 2011, ANN NEUROL, V69, P181, DOI 10.1002/ana.22248; Walsh DM, 1999, J BIOL CHEM, V274, P25945, DOI 10.1074/jbc.274.36.25945; Yang FS, 2005, J BIOL CHEM, V280, P5892, DOI 10.1074/jbc.M404751200; Yankner BA, 2009, J BIOL CHEM, V284, P4754, DOI 10.1074/jbc.R800018200; Zhang R, 2009, P NATL ACAD SCI USA, V106, P4653, DOI 10.1073/pnas.0901085106	70	795	805	11	412	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 12	2013	154	6					1257	1268		10.1016/j.cell.2013.08.035	http://dx.doi.org/10.1016/j.cell.2013.08.035			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	215VQ	24034249	Green Accepted, Bronze			2022-12-24	WOS:000324239300015
J	Yang, YP; Muzny, DM; Reid, JG; Bainbridge, MN; Willis, A; Ward, PA; Braxton, A; Beuten, J; Xia, F; Niu, ZY; Hardison, M; Person, R; Bekheirnia, MR; Leduc, MS; Kirby, A; Pham, P; Scull, J; Wang, M; Ding, Y; Plon, SE; Lupski, JR; Beaudet, AL; Gibbs, RA; Eng, CM				Yang, Yaping; Muzny, Donna M.; Reid, Jeffrey G.; Bainbridge, Matthew N.; Willis, Alecia; Ward, Patricia A.; Braxton, Alicia; Beuten, Joke; Xia, Fan; Niu, Zhiyv; Hardison, Matthew; Person, Richard; Bekheirnia, Mir Reza; Leduc, Magalie S.; Kirby, Amelia; Peter Pham; Scull, Jennifer; Wang, Min; Ding, Yan; Plon, Sharon E.; Lupski, James R.; Beaudet, Arthur L.; Gibbs, Richard A.; Eng, Christine M.			Clinical Whole-Exome Sequencing for the Diagnosis of Mendelian Disorders	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CHROMATIN-REMODELING COMPLEX; ACMG RECOMMENDATIONS; DEVELOPMENTAL DELAY; HUMAN GENOME; MUTATIONS; MICROARRAY; STANDARDS; DATABASE; HEALTH; ARID1B	BackgroundWhole-exome sequencing is a diagnostic approach for the identification of molecular defects in patients with suspected genetic disorders. MethodsWe developed technical, bioinformatic, interpretive, and validation pipelines for whole-exome sequencing in a certified clinical laboratory to identify sequence variants underlying disease phenotypes in patients. ResultsWe present data on the first 250 probands for whom referring physicians ordered whole-exome sequencing. Patients presented with a range of phenotypes suggesting potential genetic causes. Approximately 80% were children with neurologic phenotypes. Insurance coverage was similar to that for established genetic tests. We identified 86 mutated alleles that were highly likely to be causative in 62 of the 250 patients, achieving a 25% molecular diagnostic rate (95% confidence interval, 20 to 31). Among the 62 patients, 33 had autosomal dominant disease, 16 had autosomal recessive disease, and 9 had X-linked disease. A total of 4 probands received two nonoverlapping molecular diagnoses, which potentially challenged the clinical diagnosis that had been made on the basis of history and physical examination. A total of 83% of the autosomal dominant mutant alleles and 40% of the X-linked mutant alleles occurred de novo. Recurrent clinical phenotypes occurred in patients with mutations that were highly likely to be causative in the same genes and in different genes responsible for genetically heterogeneous disorders. ConclusionsWhole-exome sequencing identified the underlying genetic defect in 25% of consecutive patients referred for evaluation of a possible genetic condition. (Funded by the National Human Genome Research Institute.)	[Yang, Yaping; Willis, Alecia; Ward, Patricia A.; Braxton, Alicia; Beuten, Joke; Xia, Fan; Niu, Zhiyv; Hardison, Matthew; Person, Richard; Bekheirnia, Mir Reza; Leduc, Magalie S.; Kirby, Amelia; Scull, Jennifer; Plon, Sharon E.; Lupski, James R.; Beaudet, Arthur L.; Eng, Christine M.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Plon, Sharon E.; Lupski, James R.] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; [Muzny, Donna M.; Reid, Jeffrey G.; Bainbridge, Matthew N.; Peter Pham; Wang, Min; Ding, Yan; Lupski, James R.; Gibbs, Richard A.] Baylor Coll Med, Human Genome Sequencing Ctr, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	Eng, CM (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, NAB 2015, Houston, TX 77030 USA.	ceng@bcm.edu	niu, zhiyv/A-6558-2009; Leduc, Magalie/R-9884-2019; Pinheiro, Maísa/E-7424-2012		National Human Genome Research Institute; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003273, U01HG006485] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K12DK083014] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007526] Funding Source: NIH RePORTER	National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funded by the National Human Genome Research Institute.	Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Bainbridge MN, 2013, GENOME MED, V5, DOI 10.1186/gm415; Bainbridge MN, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-7-r68; Bainbridge MN, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002243; BAIRD PA, 1988, AM J HUM GENET, V42, P677; Boone PM, 2010, HUM MUTAT, V31, P1326, DOI 10.1002/humu.21360; Cheung SW, 2005, GENET MED, V7, P422, DOI 10.1097/01.GIM.0000170992.63691.32; de Ligt J, 2012, NEW ENGL J MED, V367, P1921, DOI 10.1056/NEJMoa1206524; Deardorff MA, 2012, NATURE, V489, P313, DOI 10.1038/nature11316; Gahl WA, 2012, GENET MED, V14, P51, DOI 10.1038/gim.0b013e318232a005; Gonzaga-Jauregui C, 2012, ANNU REV MED, V63, P35, DOI 10.1146/annurev-med-051010-162644; Green RC, 2013, GENET MED, V15, P565, DOI 10.1038/gim.2013.73; Hamdan FF, 2009, NEW ENGL J MED, V360, P599, DOI 10.1056/NEJMoa0805392; Hoyer J, 2012, AM J HUM GENET, V90, P565, DOI 10.1016/j.ajhg.2012.02.007; Kohane IS, 2012, GENET MED, V14, P399, DOI 10.1038/gim.2011.68; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liu XM, 2011, HUM MUTAT, V32, P894, DOI 10.1002/humu.21517; Lupski JR, 2013, GENOME MED, V5, DOI 10.1186/gm461; Lupski JR, 2010, NEW ENGL J MED, V362, P1181, DOI 10.1056/NEJMoa0908094; March of Dimes Birth Defects Foundation, 2006, GLOB REP BIRTH DEF H; Miller DT, 2010, AM J HUM GENET, V86, P749, DOI 10.1016/j.ajhg.2010.04.006; Ng SB, 2009, NATURE, V461, P272, DOI 10.1038/nature08250; Pletcher BA, 2008, GENET MED, V10, P33, DOI [10.1097/GIM.0b013e31815f6eac, 10.1097/GIM.0b013e31815f247c]; Rauch A, 2012, LANCET, V380, P1674, DOI 10.1016/S0140-6736(12)61480-9; Richards CS, 2008, GENET MED, V10, P294, DOI 10.1097/GIM.0b013e31816b5cae; Santen GWE, 2012, NAT GENET, V44, P379, DOI 10.1038/ng.2217; Shaffer LG, 2005, GENET MED, V7, P650, DOI 10.1097/01.gim.0000186545.83160.1e; Shen YF, 2010, GENOME RES, V20, P273, DOI 10.1101/gr.096388.109; Shevell M, 2003, NEUROLOGY, V60, P367, DOI 10.1212/01.WNL.0000031431.81555.16; Stankiewicz P, 2010, ANNU REV MED, V61, P437, DOI 10.1146/annurev-med-100708-204735; Stenson PD, 2009, GENOME MED, V1, DOI 10.1186/gm13; Tarpey PS, 2009, NAT GENET, V41, P535, DOI 10.1038/ng.367; Tidyman WE, 2009, CURR OPIN GENET DEV, V19, P230, DOI 10.1016/j.gde.2009.04.001; Tsurusaki Y, 2012, NAT GENET, V44, P376, DOI 10.1038/ng.2219; Vissers LELM, 2010, NAT GENET, V42, P1109, DOI 10.1038/ng.712	35	1306	1368	5	143	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 17	2013	369	16					1502	1511		10.1056/NEJMoa1306555	http://dx.doi.org/10.1056/NEJMoa1306555			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	267MJ	24088041	Green Accepted, Bronze			2022-12-24	WOS:000328101700007
J	He, GB; Dhar, D; Nakagawa, H; Font-Burgada, J; Ogata, H; Jiang, YH; Shalapour, S; Seki, E; Yost, SE; Jepsen, K; Frazer, KA; Harismendy, O; Hatziapostolou, M; Iliopoulos, D; Suetsugu, A; Hoffman, RM; Tateishi, R; Koike, K; Karin, M				He, Guobin; Dhar, Debanjan; Nakagawa, Hayato; Font-Burgada, Joan; Ogata, Hisanobu; Jiang, Yuhong; Shalapour, Shabnam; Seki, Ekihiro; Yost, Shawn E.; Jepsen, Kristen; Frazer, Kelly A.; Harismendy, Olivier; Hatziapostolou, Maria; Iliopoulos, Dimitrios; Suetsugu, Atsushi; Hoffman, Robert M.; Tateishi, Ryosuke; Koike, Kazuhiko; Karin, Michael			Identification of Liver Cancer Progenitors Whose Malignant Progression Depends on Autocrine IL-6 Signaling	CELL			English	Article							DISEASED MOUSE-LIVER; HEPATOCELLULAR-CARCINOMA; STEM-CELLS; MET RECEPTOR; INTERLEUKIN-6; HEPATOCYTES; EXPRESSION; HEPATOCARCINOGENESIS; TRANSPLANTATION; CIRRHOSIS	Hepatocellular carcinoma (HCC) is a slowly developing malignancy postulated to evolve from premalignant lesions in chronically damaged livers. However, it was never established that premalignant lesions actually contain tumor progenitors that give rise to cancer. Here, we describe isolation and characterization of HCC progenitor cells (HcPCs) from different mouse HCC models. Unlike fully malignant HCC, HcPCs give rise to cancer only when introduced into a liver undergoing chronic damage and compensatory proliferation. Although HcPCs exhibit a similar transcriptomic profile to bipotential hepatobiliary progenitors, the latter do not give rise to tumors. Cells resembling HcPCs reside within dysplastic lesions that appear several months before HCC nodules. Unlike early hepatocarcinogenesis, which depends on paracrine IL-6 production by inflammatory cells, due to upregulation of LIN28 expression, HcPCs had acquired autocrine IL-6 signaling that stimulates their in vivo growth and malignant progression. This may be a general mechanism that drives other IL-6-producing malignancies.	[He, Guobin; Dhar, Debanjan; Nakagawa, Hayato; Font-Burgada, Joan; Ogata, Hisanobu; Jiang, Yuhong; Shalapour, Shabnam; Karin, Michael] Univ Calif San Diego, Sch Med, Dept Pharmacol, Lab Gene Regulat & Signal Transduct, San Diego, CA 92093 USA; [He, Guobin; Dhar, Debanjan; Nakagawa, Hayato; Font-Burgada, Joan; Ogata, Hisanobu; Jiang, Yuhong; Shalapour, Shabnam; Karin, Michael] Univ Calif San Diego, Sch Med, Dept Pathol, Lab Gene Regulat & Signal Transduct, San Diego, CA 92093 USA; [Seki, Ekihiro] Univ Calif San Diego, Sch Med, Dept Med, San Diego, CA 92093 USA; [Suetsugu, Atsushi; Hoffman, Robert M.] Univ Calif San Diego, Sch Med, Dept Surg, San Diego, CA 92093 USA; [Yost, Shawn E.] Univ Calif San Diego, Sch Med, Bioinformat Grad Program, San Diego, CA 92093 USA; [Yost, Shawn E.; Jepsen, Kristen; Frazer, Kelly A.; Harismendy, Olivier] Univ Calif San Diego, Sch Med, Radys Childrens Hosp, San Diego, CA 92093 USA; [Yost, Shawn E.; Jepsen, Kristen; Frazer, Kelly A.; Harismendy, Olivier] Univ Calif San Diego, Sch Med, Dept Pediat, San Diego, CA 92093 USA; [Frazer, Kelly A.; Harismendy, Olivier; Karin, Michael] Univ Calif San Diego, Sch Med, Moores UCSD Canc Ctr, San Diego, CA 92093 USA; [Frazer, Kelly A.; Harismendy, Olivier] Univ Calif San Diego, Sch Med, Clin & Translat Res Inst, San Diego, CA 92093 USA; [Frazer, Kelly A.] Univ Calif San Diego, Sch Med, Inst Genom Med, San Diego, CA 92093 USA; [Hatziapostolou, Maria; Iliopoulos, Dimitrios] Univ Calif Los Angeles, Ctr Syst Biomed, Div Digest Dis, Los Angeles, CA 90095 USA; [Hatziapostolou, Maria; Iliopoulos, Dimitrios] Univ Calif Los Angeles, David Geffen Sch Med, Inst Mol Med, Los Angeles, CA 90095 USA; [Suetsugu, Atsushi; Hoffman, Robert M.] AntiCancer Inc, San Diego, CA 92111 USA; [Nakagawa, Hayato; Tateishi, Ryosuke; Koike, Kazuhiko] Univ Tokyo, Dept Gastroenterol, Tokyo 1138655, Japan; [Ogata, Hisanobu] Kyushu Univ, Grad Sch Med Sci, Dept Med & Clin Sci, Fukuoka 8128582, Japan	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Anti Cancer Inc; University of Tokyo; Kyushu University	Karin, M (corresponding author), Univ Calif San Diego, Sch Med, Dept Pharmacol, Lab Gene Regulat & Signal Transduct, 9500 Gilman Dr, San Diego, CA 92093 USA.	karinoffice@ucsd.edu	Iliopoulos, Dimitrios/AAE-9106-2019; Hatziapostolou, Maria/N-1820-2015; Dhar, Debanjan/P-3072-2015; Tateishi, Ryosuke/G-7758-2014; Seki, Ekihiro/K-2481-2016; Nakagawa, Hayato/I-2837-2012; Harismendy, Olivier/AAM-2072-2021	Hatziapostolou, Maria/0000-0003-2493-7028; Tateishi, Ryosuke/0000-0003-3021-2517; Seki, Ekihiro/0000-0002-9472-6085; Nakagawa, Hayato/0000-0002-6973-5094; Harismendy, Olivier/0000-0002-8098-9888; Frazer, Kelly/0000-0002-6060-8902; Yost, Shawn/0000-0001-6653-1056	Superfund Basic Research Program [P42ES010337]; NIH [CA118165, CA155120]; Wellcome Trust [WT086755]; American Diabetes Association [7-08-MN-29]; Center for Translational Science [UL1RR031980, UL1TR000100]; National Center for Research Resources IMAT program [N12R1CA155615]; Damon Runyon Cancer Research Foundation; American Liver Foundation; Daiichi Sankyo Foundation of Life Science; California Institute for Regenerative Medicine Stem Cell Training Grant II [TG2-01154]; Kanzawa Medical Research Foundation; German Research Foundation (DFG) [SH721/1-1]; National Childhood Cancer Foundation; Ben and Wanda Hildyard Chair for Mitochondrial and Metabolic Diseases; NATIONAL CANCER INSTITUTE [R01CA118165, P30CA023100, R21CA155615, R01CA155120] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000100] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR031980] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P42ES010337] Funding Source: NIH RePORTER	Superfund Basic Research Program; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wellcome Trust(Wellcome TrustEuropean Commission); American Diabetes Association(American Diabetes Association); Center for Translational Science; National Center for Research Resources IMAT program; Damon Runyon Cancer Research Foundation; American Liver Foundation; Daiichi Sankyo Foundation of Life Science; California Institute for Regenerative Medicine Stem Cell Training Grant II; Kanzawa Medical Research Foundation(Kanzawa Medical Research Foundation); German Research Foundation (DFG)(German Research Foundation (DFG)); National Childhood Cancer Foundation; Ben and Wanda Hildyard Chair for Mitochondrial and Metabolic Diseases; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	We acknowledge the Biogem facility at UCSD for their assistance with transcriptome analysis and A. Arian, K. Iwaisako, Y. Hiroshima, and H. Matsui for technical assistance. We thank Dr. J. Hidalgo (Universitat Autonoma de Barcelona, Spain) for the Il6<SUP>F/F</SUP> mice. Research was supported by the Superfund Basic Research Program (P42ES010337), NIH (CA118165 and CA155120), Wellcome Trust (WT086755), American Diabetes Association (7-08-MN-29), the Center for Translational Science (UL1RR031980 and UL1TR000100), the National Center for Research Resources IMAT program (N12R1CA155615), and postdoctoral research fellowships from the Damon Runyon Cancer Research Foundation (G.H.), American Liver Foundation (D.D.), Daiichi Sankyo Foundation of Life Science (H.N.), California Institute for Regenerative Medicine Stem Cell Training Grant II (TG2-01154) fellowship (J.F.-B.), Kanzawa Medical Research Foundation (H.O.), the German Research Foundation (DFG, SH721/1-1 to S.S.), and a Young Investigator Award from the National Childhood Cancer Foundation, "CureSearch" (D.D.). M.K. is an ACS Research Professor and is a recipient of the Ben and Wanda Hildyard Chair for Mitochondrial and Metabolic Diseases.	BANNASCH P, 1984, J CANCER RES CLIN, V108, P11, DOI 10.1007/BF00390968; BLADT F, 1995, NATURE, V376, P768, DOI 10.1038/376768a0; DEVIERE J, 1989, CLIN EXP IMMUNOL, V77, P221; Dorrell C, 2011, GENE DEV, V25, P1193, DOI 10.1101/gad.2029411; Duncan AW, 2009, GASTROENTEROLOGY, V137, P466, DOI 10.1053/j.gastro.2009.05.044; Eferl R, 2003, CELL, V112, P181, DOI 10.1016/S0092-8674(03)00042-4; El-Serag HB, 2011, NEW ENGL J MED, V365, P1118, DOI 10.1056/NEJMra1001683; Grivennikov S, 2008, CANCER CELL, V13, P7, DOI 10.1016/j.ccr.2007.12.020; Gu DQ, 2002, TRANSPLANTATION, V73, P1818, DOI 10.1097/00007890-200206150-00020; Guichard C, 2012, NAT GENET, V44, P694, DOI 10.1038/ng.2256; Guo XD, 2012, DIAGN PATHOL, V7, DOI 10.1186/1746-1596-7-44; Haridass D, 2009, AM J PATHOL, V175, P1483, DOI 10.2353/ajpath.2009.090117; Hatziapostolou M, 2011, CELL, V147, P1233, DOI 10.1016/j.cell.2011.10.043; He GB, 2010, CANCER CELL, V17, P286, DOI 10.1016/j.ccr.2009.12.048; Hruban RH, 2007, GASTROENTEROL CLIN N, V36, P831, DOI 10.1016/j.gtc.2007.08.012; Hydroglou P, 2007, GASTROENTEROL CLIN N, V36, P867, DOI 10.1016/j.gtc.2007.08.010; Ichinohe N, 2012, CELL TRANSPLANT, V21, P11, DOI 10.3727/096368911X580626; Iliopoulos D, 2009, CELL, V139, P693, DOI 10.1016/j.cell.2009.10.014; Inokuchi S, 2010, P NATL ACAD SCI USA, V107, P844, DOI 10.1073/pnas.0909781107; Ji JF, 2009, NEW ENGL J MED, V361, P1437, DOI 10.1056/NEJMoa0901282; KAKUMU S, 1993, GASTROENTEROL JPN, V28, P18; Kang JS, 2007, CANCER RES, V67, P11141, DOI 10.1158/0008-5472.CAN-07-1369; Laconi E, 1998, AM J PATHOL, V153, P319, DOI 10.1016/S0002-9440(10)65574-5; Maeda S, 2005, CELL, V121, P977, DOI 10.1016/j.cell.2005.04.014; Marquardt JU, 2010, SEMIN LIVER DIS, V30, P26, DOI 10.1055/s-0030-1247130; Meyer K, 2003, CARCINOGENESIS, V24, P975, DOI 10.1093/carcin/bgg040; Mikhail S, 2011, INT J HEPATOL, V2011, DOI 10.4061/2011/486954; Naugler WE, 2007, SCIENCE, V317, P121, DOI 10.1126/science.1140485; Nguyen LV, 2012, NAT REV CANCER, V12, P133, DOI 10.1038/nrc3184; NOWELL PC, 1976, SCIENCE, V194, P23, DOI 10.1126/science.959840; Park EJ, 2010, CELL, V140, P197, DOI 10.1016/j.cell.2009.12.052; PITOT HC, 1990, ANNU REV PHARMACOL, V30, P465; Porta C, 2008, ANN ONCOL, V19, P353, DOI 10.1093/annonc/mdm448; Quintana A, 2013, BRAIN BEHAV IMMUN, V27, P162, DOI 10.1016/j.bbi.2012.10.011; RHIM JA, 1994, SCIENCE, V263, P1149, DOI 10.1126/science.8108734; Sansone P, 2007, J CLIN INVEST, V117, P3988, DOI 10.1172/JCI32533; Seki S, 2000, CLIN CANCER RES, V6, P3469; Sell S, 2008, J CLIN ONCOL, V26, P2800, DOI 10.1200/JCO.2007.15.5945; Shin S, 2011, GENE DEV, V25, P1185, DOI 10.1101/gad.2027811; Soresi M, 2006, WORLD J GASTROENTERO, V12, P2563, DOI 10.3748/wjg.v12.i16.2563; Su Q, 1997, VIRCHOWS ARCH, V431, P391, DOI 10.1007/s004280050116; SU Y, 1990, BIOCHEM BIOPH RES CO, V170, P892, DOI 10.1016/0006-291X(90)92175-Y; TAKAYAMA T, 1990, LANCET, V336, P1150, DOI 10.1016/0140-6736(90)92768-D; Terris B, 2010, J HEPATOL, V52, P280, DOI 10.1016/j.jhep.2009.10.026; TSUTSUMI M, 1989, HEPATOLOGY, V10, P437, DOI 10.1002/hep.1840100407; Verna L, 1996, PHARMACOL THERAPEUT, V71, P57, DOI 10.1016/0163-7258(96)00062-9; Viswanathan SR, 2010, CELL, V140, P445, DOI 10.1016/j.cell.2010.02.007; Wang R, 2001, J CELL BIOL, V153, P1023, DOI 10.1083/jcb.153.5.1023; Weglarz TC, 2000, AM J PATHOL, V157, P1963, DOI 10.1016/S0002-9440(10)64835-3; Wood LD, 2007, SCIENCE, V318, P1108, DOI 10.1126/science.1145720; Yamashita T, 2008, CANCER RES, V68, P1451, DOI 10.1158/0008-5472.CAN-07-6013; Yang ZF, 2008, CANCER CELL, V13, P153, DOI 10.1016/j.ccr.2008.01.013; Zheng TS, 2011, CANCER LETT, V302, P91, DOI 10.1016/j.canlet.2010.12.008; Zhu Z, 2010, INT J CANCER, V126, P2067, DOI 10.1002/ijc.24868; Zoller M, 2009, NAT REV CANCER, V9, P40, DOI 10.1038/nrc2543	55	318	344	1	76	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 10	2013	155	2					384	396		10.1016/j.cell.2013.09.031	http://dx.doi.org/10.1016/j.cell.2013.09.031			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	235LH	24120137	Green Accepted, Bronze			2022-12-24	WOS:000325719800015
J	Richard, M; Schrauwen, EJA; de Graaf, M; Bestebroer, TM; Spronken, MIJ; van Boheemen, S; de Meulder, D; Lexmond, P; Linster, M; Herfst, S; Smith, DJ; van den Brand, JM; Burke, DF; Kuiken, T; Rimmelzwaan, GF; Osterhaus, ADME; Fouchier, RAM				Richard, Mathilde; Schrauwen, Eefje J. A.; de Graaf, Miranda; Bestebroer, Theo M.; Spronken, Monique I. J.; van Boheemen, Sander; de Meulder, Dennis; Lexmond, Pascal; Linster, Martin; Herfst, Sander; Smith, Derek J.; van den Brand, Judith M.; Burke, David F.; Kuiken, Thijs; Rimmelzwaan, Guus F.; Osterhaus, Albert D. M. E.; Fouchier, Ron A. M.			Limited airborne transmission of H7N9 influenza A virus between ferrets	NATURE			English	Article							SINGLE AMINO-ACID; HUMAN INFECTIONS; POULTRY; ORIGIN; HEMAGGLUTININ; REPLICATION; ADAPTATION; GENERATION; DIVERSITY	Wild waterfowl form the main reservoir of influenza A viruses, from which transmission occurs directly or indirectly to various secondary hosts, including humans(1). Direct avian-to-human transmission has been observed for viruses of subtypes A(H5N1), A(H7N2), A(H7N3), A(H7N7), A(H9N2) and A(H10N7) upon human exposure to poultry(2-7), but a lack of sustained human-to-human transmission has prevented these viruses from causing new pandemics. Recently, avian A(H7N9) viruses were transmitted to humans, causing severe respiratory disease and deaths in China(8). Because transmission via respiratory droplets and aerosols (hereafter referred to as airborne transmission) is the main route for efficient transmission between humans, it is important to gain an insight into airborne transmission of the A(H7N9) virus. Here we show that although the A/Anhui/1/2013 A(H7N9) virus harbours determinants associated with human adaptation and transmissibility between mammals, its airborne transmissibility in ferrets is limited, and it is intermediate between that of typical human and avian influenza viruses. Multiple A(H7N9) virus genetic variants were transmitted. Upon ferret passage, variants with higher avian receptor binding, higher pH of fusion, and lower thermostability were selected, potentially resulting in reduced transmissibility. This A(H7N9) virus outbreak highlights the need for increased understanding of the determinants of efficient airborne transmission of avian influenza viruses between mammals.	[Richard, Mathilde; Schrauwen, Eefje J. A.; de Graaf, Miranda; Bestebroer, Theo M.; Spronken, Monique I. J.; van Boheemen, Sander; de Meulder, Dennis; Lexmond, Pascal; Linster, Martin; Herfst, Sander; van den Brand, Judith M.; Kuiken, Thijs; Rimmelzwaan, Guus F.; Osterhaus, Albert D. M. E.; Fouchier, Ron A. M.] Erasmus MC, Dept Virosci, NL-3015 GE Rotterdam, Netherlands; [Smith, Derek J.; Burke, David F.] Univ Cambridge, Dept Zool, Cambridge CB2 3EJ, England	Erasmus University Rotterdam; Erasmus MC; University of Cambridge	Fouchier, RAM (corresponding author), Erasmus MC, Dept Virosci, NL-3015 GE Rotterdam, Netherlands.	r.fouchier@erasmusmc.nl	de Graaf, Miranda/K-1262-2018; Smith, Derek/Z-3075-2019; Fouchier, Ron A/A-1911-2014; Linster, Martin/AAY-9088-2020; de Graaf, Miranda/AFM-6878-2022; Richard, Mathilde/F-5461-2017; Burke, David F/C-2091-2013	de Graaf, Miranda/0000-0002-7831-0098; Smith, Derek/0000-0002-2393-1890; Fouchier, Ron A/0000-0001-8095-2869; de Graaf, Miranda/0000-0002-7831-0098; Richard, Mathilde/0000-0003-0240-9312; Burke, David F/0000-0001-8830-3951; Kuiken, Thijs/0000-0001-5501-9049; Linster, Martin/0000-0003-2636-2512; Herfst, Sander/0000-0001-9866-8903; Osterhaus, Albert/0000-0002-6074-1172	NIAID-NIH [HHSN266200700010C]; EU program EMPERIE; EU program ANTIGONE	NIAID-NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); EU program EMPERIE; EU program ANTIGONE	We thank P. van Run, S. van der Vliet and A. Reiners for technical assistance. We thank the Chinese CDC for providing the A/Anhui/1/2013 isolate and R. Webby for the synthetic construct of HA. This work was financed through NIAID-NIH contract HHSN266200700010C and EU FP7 programs EMPERIE and ANTIGONE.	[Anonymous], 2013, HUM INF INFL A H7N9; Arzey GG, 2012, EMERG INFECT DIS, V18, P814, DOI 10.3201/eid1805.111852; Beigel H, 2005, NEW ENGL J MED, V353, P1374, DOI 10.1056/NEJMra052211; CALLEJA M, 2004, P UK E SCI ALL HANDS; Chen Y, 2013, LANCET, V381, P1916, DOI 10.1016/S0140-6736(13)60903-4; Chutinimitkul S, 2010, J VIROL, V84, P6825, DOI 10.1128/JVI.02737-09; Cowling BJ, 2013, LANCET, V382, P129, DOI 10.1016/S0140-6736(13)61171-X; de Wit E, 2004, VIRUS RES, V103, P155, DOI 10.1016/j.virusres.2004.02.028; de Wit E, 2010, J VIROL, V84, P1597, DOI 10.1128/JVI.01783-09; Fouchier RAM, 2004, P NATL ACAD SCI USA, V101, P1356, DOI 10.1073/pnas.0308352100; Galloway SE, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003151; Gao RB, 2013, NEW ENGL J MED, V368, P1888, DOI 10.1056/NEJMoa1304459; Herfst S, 2012, SCIENCE, V336, P1534, DOI 10.1126/science.1213362; Hirst GK, 1943, J EXP MED, V78, p4O7, DOI 10.1084/jem.78.5.407; Hirst M, 2004, EMERG INFECT DIS, V10, P2192, DOI 10.3201/eid1012.040743; Hoffmann E, 2000, P NATL ACAD SCI USA, V97, P6108, DOI 10.1073/pnas.100133697; Hoffmann E, 2001, ARCH VIROL, V146, P2275, DOI 10.1007/s007050170002; Imai M, 2012, NATURE, V486, P420, DOI 10.1038/nature10831; Jonges M, 2011, J VIROL, V85, P10598, DOI 10.1128/JVI.05369-11; Liu D, 2013, LANCET, V381, P1926, DOI 10.1016/S0140-6736(13)60938-1; Munster VJ, 2009, SCIENCE, V325, P481, DOI 10.1126/science.1177127; Nishiura H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055358; Nobusawa E, 2000, VIROLOGY, V278, P587, DOI 10.1006/viro.2000.0679; Ostrowsky B, 2012, EMERG INFECT DIS, V18, P1128, DOI 10.3201/eid1807.111913; REED L. J., 1938, AMER JOUR HYG, V27, P493; RUIGROK RWH, 1986, VIROLOGY, V155, P484, DOI 10.1016/0042-6822(86)90210-2; Russell CA, 2012, SCIENCE, V336, P1541, DOI 10.1126/science.1222526; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Smith RE, 2007, BIOINFORMATICS, V23, P1099, DOI 10.1093/bioinformatics/btm073; Steel J, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000252; SUBBARAO EK, 1993, J VIROL, V67, P1761, DOI 10.1128/JVI.67.4.1761-1764.1993; van Riel D, 2010, AM J PATHOL, V177, P2185, DOI 10.2353/ajpath.2010.100401; WEBSTER RG, 1992, MICROBIOL REV, V56, P152, DOI 10.1128/MMBR.56.1.152-179.1992; WHO, 2013, AV INFL A H7N9 VIR; Wu H, 2013, N ENGL J MED; Xiong X., 2013, NATURE; Zhu H, 2013, SCIENCE, V341, P183, DOI 10.1126/science.1239844	37	156	165	0	74	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 26	2013	501	7468					560	+		10.1038/nature12476	http://dx.doi.org/10.1038/nature12476			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	223RP	23925116	Green Accepted, Green Submitted			2022-12-24	WOS:000324826300061
J	Dorr, JR; Yu, Y; Milanovic, M; Beuster, G; Zasada, C; Dabritz, JHM; Lisec, J; Lenze, D; Gerhardt, A; Schleicher, K; Kratzat, S; Purfurst, B; Walenta, S; Mueller-Klieser, W; Graler, M; Hummel, M; Keller, U; Buck, AK; Dorken, B; Willmitzer, L; Reimann, M; Kempa, S; Lee, S; Schmitt, CA				Doerr, Jan R.; Yu, Yong; Milanovic, Maja; Beuster, Gregor; Zasada, Christin; Daebritz, J. Henry M.; Lisec, Jan; Lenze, Dido; Gerhardt, Anne; Schleicher, Katharina; Kratzat, Susanne; Purfuerst, Bettina; Walenta, Stefan; Mueller-Klieser, Wolfgang; Graeler, Markus; Hummel, Michael; Keller, Ulrich; Buck, Andreas K.; Doerken, Bernd; Willmitzer, Lothar; Reimann, Maurice; Kempa, Stefan; Lee, Soyoung; Schmitt, Clemens A.			Synthetic lethal metabolic targeting of cellular senescence in cancer therapy	NATURE			English	Article							ONCOGENE-INDUCED SENESCENCE; P53 TUMOR-SUPPRESSOR; NF-KAPPA-B; IN-VIVO; ENDOPLASMIC-RETICULUM; MASS-SPECTROMETRY; HUMAN-CELLS; AUTOPHAGY; HETEROCHROMATIN; LYMPHOMAGENESIS	Activated oncogenes and anticancer chemotherapy induce cellular senescence, a terminal growth arrest of viable cells characterized by S-phase entry-blocking histone 3 lysine 9 trimethylation (H3K9me3)(1,2). Although therapy-induced senescence (TIS) improves long-term outcomes(3), potentially harmful properties of senescent tumour cells make their quantitative elimination a therapeutic priority. Here we use the Em-myc transgenic mouse lymphoma model in which TIS depends on the H3K9 histone methyltransferase Suv39h1 to show the mechanism and therapeutic exploitation of senescence-related metabolic reprogramming in vitro and in vivo. After senescence-inducing chemotherapy, TIS-competent lymphomas but not TIS-incompetent Suv39h1(-) lymphomas show increased glucose utilization and much higher ATP production. We demonstrate that this is linked to massive proteotoxic stress, which is a consequence of the senescence-associated secretory phenotype (SASP) described previously(4-6). SASP-producing TIS cells exhibited endoplasmic reticulum stress, an unfolded protein response (UPR), and increased ubiquitination, thereby targeting toxic proteins for autophagy in an acutely energy-consuming fashion. Accordingly, TIS lymphomas, unlike senescence models that lack a strong SASP response, were more sensitive to blocking glucose utilization or autophagy, which led to their selective elimination through caspase-12-and caspase-3-mediated endoplasmic-reticulum-related apoptosis. Consequently, pharmacological targeting of these metabolic demands on TIS induction in vivo prompted tumour regression and improved treatment outcomes further. These findings unveil the hypercatabolic nature of TIS that is therapeutically exploitable by synthetic lethal metabolic targeting.	[Doerr, Jan R.; Milanovic, Maja; Daebritz, J. Henry M.; Lisec, Jan; Gerhardt, Anne; Schleicher, Katharina; Doerken, Bernd; Reimann, Maurice; Lee, Soyoung; Schmitt, Clemens A.] Charite, Mol Krebsforschungszentrum MKFZ, D-13353 Berlin, Germany; [Yu, Yong; Beuster, Gregor; Purfuerst, Bettina; Doerken, Bernd; Lee, Soyoung; Schmitt, Clemens A.] Max Delbruck Ctr Mol Med MDC, D-13125 Berlin, Germany; [Zasada, Christin; Kempa, Stefan] Max Delbruck Ctr Mol Med, Berlin Inst Med Syst Biol, D-13125 Berlin, Germany; [Lisec, Jan] Deutsch Krebsforschungzentrum DKFZ, German Canc Consortium, D-69120 Heidelberg, Germany; [Lenze, Dido; Hummel, Michael] Charite, Dept Pathol, D-10117 Berlin, Germany; [Kratzat, Susanne; Keller, Ulrich] Tech Univ Munich, Dept Med 3, D-81675 Munich, Germany; [Walenta, Stefan; Mueller-Klieser, Wolfgang] Johannes Gutenberg Univ Mainz, Univ Med, Inst Physiol & Pathophysiol, D-55128 Mainz, Germany; [Graeler, Markus] Univ Klinikum Jena, Dept Anesthesiol & Intens Care Med, D-07747 Jena, Germany; [Graeler, Markus] Univ Klinikum Jena, Ctr Sepsis Control & Care CSCC, D-07747 Jena, Germany; [Buck, Andreas K.] Univ Klinikum Wurzburg, Dept Nucl Med, D-97080 Wurzburg, Germany; [Willmitzer, Lothar] Max Planck Inst Mol Plant Physiol, D-14476 Potsdam, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Helmholtz Association; German Cancer Research Center (DKFZ); Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Technical University of Munich; Johannes Gutenberg University of Mainz; Friedrich Schiller University of Jena; Friedrich Schiller University of Jena; University of Wurzburg; Max Planck Society	Schmitt, CA (corresponding author), Charite, Mol Krebsforschungszentrum MKFZ, Augustenburger Pl 1, D-13353 Berlin, Germany.	clemens.schmitt@charite.de	kempa, stefan/C-5213-2008; Lee, Soyoung/AHC-5032-2022; Gräler, Markus/ABH-1905-2021; Lee, Soyoung/T-6669-2019; 高, 雨莉/HGU-8187-2022; Schmitt, Clemens A/S-9479-2017	kempa, stefan/0000-0002-0696-9299; Lee, Soyoung/0000-0002-4614-2931; Gräler, Markus/0000-0001-6650-7849; Schmitt, Clemens A/0000-0002-4731-2226; Zasada, Christin/0000-0003-1547-8317; Dabritz, Jan Henry Matthias/0000-0002-7184-9656; Schleicher, Katharina/0000-0002-8819-7287; Hummel, Michael/0000-0001-6717-605X; Milanovic, Maja/0000-0003-1860-6003; Buck, Andreas/0000-0002-6447-0613; Lisec, Jan/0000-0003-1220-2286; Yu, Yong/0000-0003-1928-2514; Dorr, Jan Rafael/0000-0002-4927-6548	Boehringer Ingelheim Foundation; Deutsche Forschungsgemeinschaft [MK576/15-1, SFB 824, SFB/TRR 54]; Helmholtz Association (Helmholtz Alliance 'Preclinical Comprehensive Cancer Center') [HA-305]; Deutsche Krebshilfe [108789]; Excellence Initiative; German Cancer Consortium (GCC)	Boehringer Ingelheim Foundation(Boehringer Ingelheim); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Helmholtz Association (Helmholtz Alliance 'Preclinical Comprehensive Cancer Center'); Deutsche Krebshilfe(Deutsche Krebshilfe); Excellence Initiative; German Cancer Consortium (GCC)	We thank the late A. Harris, T. Jacks, T. Jenuwein, P. A. Khavari, N. Mizushima, D. Peeper, and M. Vander Heiden for mice, cells and materials; the flow cytometry facility at the Berlin-Brandenburg Center for Regenerative Therapies; N. Burbach, J. Drager, A. Herrmann, K. Kirste, S. Masswig, B. Teichmann and S. Spiesicke-Wegener for technical assistance; and members of the Schmitt laboratory for discussions and editorial advice. This work was supported by a Ph.D. fellowship to J. R. D. from the Boehringer Ingelheim Foundation, and grants from the Deutsche Forschungsgemeinschaft to W.M.-K. (MK576/15-1), to U. K. and A. K. B. (SFB 824), to U. K., B. D., S. L. and C. A. S. (SFB/TRR 54), and to C. A. S. from the Helmholtz Association (Helmholtz Alliance 'Preclinical Comprehensive Cancer Center'; grant no. HA-305) and the Deutsche Krebshilfe (grant no. 108789). This interdisciplinary work was made possible by the structural framework of the inter-institutional cooperation between Charite and MDC (now represented by the Berlin Institute of Health (BIH)), the Berlin School of Integrative Oncology (BSIO) graduate program funded within the Excellence Initiative, and the German Cancer Consortium (GCC).	Acosta JC, 2008, CELL, V133, P1006, DOI 10.1016/j.cell.2008.03.038; ADAMS JM, 1985, NATURE, V318, P533, DOI 10.1038/318533a0; Berns K, 2004, NATURE, V428, P431, DOI 10.1038/nature02371; Bode Constantin, 2012, Methods Mol Biol, V874, P33, DOI 10.1007/978-1-61779-800-9_3; Braig M, 2005, NATURE, V436, P660, DOI 10.1038/nature03841; Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233; Castro F, 2013, INT J CANCER, V132, P308, DOI 10.1002/ijc.27675; Chien YC, 2011, GENE DEV, V25, P2125, DOI 10.1101/gad.17276711; Collado M, 2010, NAT REV CANCER, V10, P51, DOI 10.1038/nrc2772; Coppe JP, 2008, PLOS BIOL, V6, P2853, DOI 10.1371/journal.pbio.0060301; Cuadros-Inostroza A, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-428; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Giavalisco P, 2008, ANAL CHEM, V80, P9417, DOI 10.1021/ac8014627; Heiden MGV, 2010, SCIENCE, V329, P1492, DOI 10.1126/science.1188015; Jing H, 2011, GENE DEV, V25, P2137, DOI 10.1101/gad.17620611; Jones RG, 2005, MOL CELL, V18, P283, DOI 10.1016/j.molcel.2005.03.027; Kaelin WG, 2005, NAT REV CANCER, V5, P689, DOI 10.1038/nrc1691; Kang TW, 2011, NATURE, V479, P547, DOI 10.1038/nature10599; Kempa S, 2009, J BASIC MICROB, V49, P82, DOI 10.1002/jobm.200800337; Kroemer G, 2010, MOL CELL, V40, P280, DOI 10.1016/j.molcel.2010.09.023; Kuilman T, 2008, CELL, V133, P1019, DOI 10.1016/j.cell.2008.03.039; Kuilman T, 2010, GENE DEV, V24, P2463, DOI 10.1101/gad.1971610; Lisec J, 2006, NAT PROTOC, V1, P387, DOI 10.1038/nprot.2006.59; Lisec J, 2011, PLANT J, V68, P326, DOI 10.1111/j.1365-313X.2011.04689.x; Liu LD, 2012, NATURE, V483, P608, DOI 10.1038/nature10927; Marciniak SJ, 2004, GENE DEV, V18, P3066, DOI 10.1101/gad.1250704; Moskowitz CH, 2010, J CLIN ONCOL, V28, P1896, DOI 10.1200/JCO.2009.26.5942; Nakagawa T, 2000, NATURE, V403, P98, DOI 10.1038/47513; Nardella C, 2011, NAT REV CANCER, V11, P503, DOI 10.1038/nrc3057; Narita M, 2003, CELL, V113, P703, DOI 10.1016/S0092-8674(03)00401-X; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Peters AHFM, 2001, CELL, V107, P323, DOI 10.1016/S0092-8674(01)00542-6; Reimann M, 2007, BLOOD, V110, P2996, DOI 10.1182/blood-2007-02-075614; Reimann M, 2010, CANCER CELL, V17, P262, DOI 10.1016/j.ccr.2009.12.043; Reimer TA, 2005, BMC CANCER, V5, DOI 10.1186/1471-2407-5-47; Schmitt CA, 1999, GENE DEV, V13, P2670, DOI 10.1101/gad.13.20.2670; Schmitt CA, 2002, CANCER CELL, V1, P289, DOI 10.1016/S1535-6108(02)00047-8; Schmitt CA, 2002, CELL, V109, P335, DOI 10.1016/S0092-8674(02)00734-1; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Shields AF, 1998, NAT MED, V4, P1334, DOI 10.1038/3337; Stacklies W, 2007, BIOINFORMATICS, V23, P1164, DOI 10.1093/bioinformatics/btm069; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Walenta S, 2000, CANCER RES, V60, P916; Warburg O., 1925, KLIN WOCHENSCHR, V4, P534, DOI DOI 10.1007/BF01726151; Xue W, 2007, NATURE, V445, P656, DOI 10.1038/nature05529; Young ARJ, 2009, GENE DEV, V23, P798, DOI 10.1101/gad.519709	46	333	353	4	242	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 19	2013	501	7467					421	+		10.1038/nature12437	http://dx.doi.org/10.1038/nature12437			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219XT	23945590				2022-12-24	WOS:000324545700046
J	Joppa, LN; Visconti, P; Jenkins, CN; Pimm, SL				Joppa, L. N.; Visconti, P.; Jenkins, C. N.; Pimm, S. L.			Achieving the Convention on Biological Diversity's Goals for Plant Conservation	SCIENCE			English	Article							BIODIVERSITY HOTSPOTS; EXTINCTION; FUTURE	Identifying which areas capture how many species is the first question in conservation planning. The Convention on Biological Diversity (CBD) aspires to formal protection of at least 17% of the terrestrial world and, through the Global Strategy for Plant Conservation, 60% of plant species. Are these targets of protecting area and species compatible? We show that 67% of plant species live entirely within regions that comprise 17% of the land surface. Moreover, these regions include most terrestrial vertebrates with small geographical ranges. However, the connections between the CBD targets of protecting area and species are complex. Achieving both targets will be difficult because regions with the most plant species have only slightly more land protected than do those with fewer.	[Joppa, L. N.; Visconti, P.] Microsoft Res, Cambridge CB1 2FB, England; [Jenkins, C. N.] N Carolina State Univ, Dept Biol Sci, Raleigh, NC 27606 USA; [Pimm, S. L.] Duke Univ, Nicholas Sch Environm, Durham, NC 27708 USA	Microsoft; University of North Carolina; North Carolina State University; Duke University	Joppa, LN (corresponding author), Microsoft Res, 21 Stn Rd, Cambridge CB1 2FB, England.	stuartpimm@me.com	Jenkins, Clinton/D-6134-2011; Visconti, Piero/A-3253-2009; pimm, stuart/ABF-1082-2020	Jenkins, Clinton/0000-0003-2198-0637; Visconti, Piero/0000-0001-6823-2826; 				Adeney JM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005014; Andam KS, 2008, P NATL ACAD SCI USA, V105, P16089, DOI 10.1073/pnas.0800437105; BirdLife International, 2011, BIRD SPEC DISTR MAPS, V2013; Brummitt Neil, 2008, Endangered Species Research, V6, P127, DOI 10.3354/esr00135; Cantu-Salazar L, 2013, BIODIVERS CONSERV, V22, P1033, DOI 10.1007/s10531-013-0467-7; Geldmann J, 2013, BIOL CONSERV, V161, P230, DOI 10.1016/j.biocon.2013.02.018; International Union for Conservation of Nature, 2013, IUCN RED LIST THREAT; Jenkins CN, 2013, P NATL ACAD SCI USA, V110, pE2602, DOI 10.1073/pnas.1302251110; Jenkins CN, 2011, DIVERS DISTRIB, V17, P652, DOI 10.1111/j.1472-4642.2011.00770.x; Jenkins CN, 2009, BIOL CONSERV, V142, P2166, DOI 10.1016/j.biocon.2009.04.016; Joppa LN, 2008, P NATL ACAD SCI USA, V105, P6673, DOI 10.1073/pnas.0802471105; Joppa LN, 2011, P NATL ACAD SCI USA, V108, P13171, DOI 10.1073/pnas.1109389108; Joppa LN, 2011, P ROY SOC B-BIOL SCI, V278, P1633, DOI 10.1098/rspb.2010.1713; Joppa LN, 2011, P ROY SOC B-BIOL SCI, V278, P554, DOI 10.1098/rspb.2010.1004; Joppa LN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008273; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Nelson A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022722; Olson DM, 2001, BIOSCIENCE, V51, P933, DOI 10.1641/0006-3568(2001)051[0933:TEOTWA]2.0.CO;2; Paton A, 2011, BOT J LINN SOC, V166, P250, DOI 10.1111/j.1095-8339.2011.01155.x; PIMM SL, 1995, SCIENCE, V269, P347, DOI 10.1126/science.269.5222.347; Pimm SL, 1998, SCIENCE, V279, P2068, DOI 10.1126/science.279.5359.2068; Rosenzweig Michael L., 1995, DOI 10.1017/CBO9780511623387.002; Sax DF, 2008, P NATL ACAD SCI USA, V105, P11490, DOI 10.1073/pnas.0802290105; Scheffers BR, 2012, TRENDS ECOL EVOL, V27, P501, DOI 10.1016/j.tree.2012.05.008; Schnell JK, 2013, CONSERV BIOL, V27, P520, DOI 10.1111/cobi.12047; Strong D.R., 1984, INSECTS PLANTS COMMU; WCSP, 2008, WCSP 2008 WORLD CHEC	27	84	92	6	133	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 6	2013	341	6150					1100	1103		10.1126/science.1241706	http://dx.doi.org/10.1126/science.1241706			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	211TG	24009391				2022-12-24	WOS:000323933100041
J	Li, K; Zhou, T; Liao, LJ; Yang, ZF; Wong, C; Henn, F; Malinow, R; Yates, JR; Hu, HL				Li, Kun; Zhou, Tao; Liao, Lujian; Yang, Zhongfei; Wong, Catherine; Henn, Fritz; Malinow, Roberto; Yates, John R., III; Hu, Hailan			beta CaMKII in Lateral Habenula Mediates Core Symptoms of Depression	SCIENCE			English	Article							DEPENDENT-PROTEIN-KINASE; VENTRAL TEGMENTAL AREA; MAJOR DEPRESSION; BASAL GANGLIA; STRESS; NEURONS; MODEL; NEUROTOXICITY; HIPPOCAMPUS; ACTIVATION	The lateral habenula (LHb) has recently emerged as a key brain region in the pathophysiology of depression. However, the molecular mechanism by which LHb becomes hyperactive in depression remains unknown. Through a quantitative proteomic screen, we found that expression of the beta form of calcium/calmodulin-dependent protein kinase type II (beta CaMKII) was significantly up-regulated in the LHb of animal models of depression and down-regulated by antidepressants. Increasing beta-, but not alpha-, CaMKII in the LHb strongly enhanced the synaptic efficacy and spike output of LHb neurons and was sufficient to produce profound depressive symptoms, including anhedonia and behavioral despair. Down-regulation of beta CaMKII levels, blocking its activity or its target molecule the glutamate receptor GluR1 reversed the depressive symptoms. These results identify beta CaMKII as a powerful regulator of LHb neuron function and a key molecular determinant of depression.	[Li, Kun; Zhou, Tao; Yang, Zhongfei; Hu, Hailan] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Neurosci, Shanghai 200031, Peoples R China; [Li, Kun; Zhou, Tao; Yang, Zhongfei; Hu, Hailan] Chinese Acad Sci, Shanghai Inst Biol Sci, State Key Lab Neurosci, Shanghai 200031, Peoples R China; [Li, Kun; Zhou, Tao] Univ Chinese Acad Sci, Chinese Acad Sci, Grad Sch, Shanghai 200031, Peoples R China; [Liao, Lujian; Wong, Catherine; Yates, John R., III] Scripps Res Inst, Dept Mol & Cellular Neurobiol, La Jolla, CA 92037 USA; [Henn, Fritz] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; [Malinow, Roberto] Univ Calif San Diego, La Jolla, CA 92093 USA	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Scripps Research Institute; Cold Spring Harbor Laboratory; University of California System; University of California San Diego	Hu, HL (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Neurosci, Shanghai 200031, Peoples R China.	hailan@ion.ac.cn	zhou, tao/AAH-9986-2020	Hu, Hailan/0000-0002-0425-5057; Wong, Catherine CL/0000-0001-7270-980X	Chinese 973 Program [2011CBA00400]; Strategic Priority Research Program (B) of the Chinese Academy of Sciences [XDB02030004]; Hundreds of Talents Program; Outstanding Youth Grant; Shanghai Pujiang Talent Program; NIH [P41 GM103533, R01 MH067880]; Simon's Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103533] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH067880, R01MH091119] Funding Source: NIH RePORTER	Chinese 973 Program(National Basic Research Program of China); Strategic Priority Research Program (B) of the Chinese Academy of Sciences(Chinese Academy of Sciences); Hundreds of Talents Program(Chinese Academy of Sciences); Outstanding Youth Grant; Shanghai Pujiang Talent Program; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Simon's Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank D. Schulz for communication on cLH rats; D. Xu and J. Xiu for advice on AAV virus packaging; L. Monteggia for gift of the AAV-GFP-Cre plasmid; B. Li for communicating unpublished results; and X. Pan, C. Wang, P. Shen, D. Tong, Y. Zhang, and X. Zhang for technical help. Patent applied for CN2013103479386. The work was supported by Chinese 973 Program (2011CBA00400), the Strategic Priority Research Program (B) of the Chinese Academy of Sciences (XDB02030004), the Hundreds of Talents Program, the Outstanding Youth Grant and the Shanghai Pujiang Talent Program (to H. H.), the NIH P41 GM103533 and R01 MH067880 (to J. R. Y.), the Simon's Foundation (to F.H.).	Aizawa H, 2012, J COMP NEUROL, V520, P4051, DOI 10.1002/cne.23167; BRAUN AP, 1995, ANNU REV PHYSIOL, V57, P417, DOI 10.1146/annurev.ph.57.030195.002221; Brocke L, 1999, J BIOL CHEM, V274, P22713, DOI 10.1074/jbc.274.32.22713; CALDECOTTHAZARD S, 1988, J NEUROSCI, V8, P1951; CHARNEY D, 2005, NEUROBIOLOGY MENTAL; Du J, 2004, INT J NEUROPSYCHOPH, V7, P243, DOI 10.1017/S1461145704004432; ERONDU NE, 1985, J NEUROSCI, V5, P3270; Groth RD, 2011, P NATL ACAD SCI USA, V108, P828, DOI 10.1073/pnas.1018022108; Henn FA, 2005, NEUROSCI BIOBEHAV R, V29, P799, DOI 10.1016/j.neubiorev.2005.03.019; Hikosaka O, 2008, J NEUROSCI, V28, P11825, DOI 10.1523/JNEUROSCI.3463-08.2008; Lammel S, 2012, NATURE, V491, P212, DOI 10.1038/nature11527; Li B, 2011, NATURE, V470, P535, DOI 10.1038/nature09742; Liao LJ, 2008, P NATL ACAD SCI USA, V105, P15281, DOI 10.1073/pnas.0804678105; Lim BK, 2012, NATURE, V487, P183, DOI 10.1038/nature11160; Maier S. F., 1984, BIOL PSYCHIAT, V8, P435, DOI DOI 10.1016/S0278-5846(84)80032-9; Matsumoto M, 2007, NATURE, V447, P1111, DOI 10.1038/nature05860; Mayberg HS, 2003, BRIT MED BULL, V65, P193, DOI 10.1093/bmb/65.1.193; Morris JS, 1999, NEUROIMAGE, V10, P163, DOI 10.1006/nimg.1999.0455; Novak G, 2006, SYNAPSE, V59, P61, DOI 10.1002/syn.20211; Okamoto KI, 2007, P NATL ACAD SCI USA, V104, P6418, DOI 10.1073/pnas.0701656104; Popoli M, 2002, BIPOLAR DISORD, V4, P166, DOI 10.1034/j.1399-5618.2002.01159.x; PORSOLT RD, 1977, NATURE, V266, P730, DOI 10.1038/266730a0; Rumpel S, 2005, SCIENCE, V308, P83, DOI 10.1126/science.1103944; Sapolsky RM, 2000, BIOL PSYCHIAT, V48, P755, DOI 10.1016/S0006-3223(00)00971-9; Sartorius A, 2010, BIOL PSYCHIAT, V67, pE9, DOI 10.1016/j.biopsych.2009.08.027; Shabel SJ, 2012, NEURON, V74, P475, DOI 10.1016/j.neuron.2012.02.037; Sheline YI, 1996, MOL PSYCHIATR, V1, P298; Shen K, 1998, NEURON, V21, P593, DOI 10.1016/S0896-6273(00)80569-3; Shi SH, 1999, SCIENCE, V284, P1811, DOI 10.1126/science.284.5421.1811; Shumake J, 2003, BRAIN RES, V963, P274, DOI 10.1016/S0006-8993(02)04048-9; Stamatakis AM, 2012, NAT NEUROSCI, V15, P1105, DOI 10.1038/nn.3145; Suenaga T, 2004, INT J NEUROPSYCHOPH, V7, P299, DOI 10.1017/S1461145704004304; Thiagarajan TC, 2002, NEURON, V36, P1103, DOI 10.1016/S0896-6273(02)01049-8; Vaidya VA, 2001, BRIT MED BULL, V57, P61, DOI 10.1093/bmb/57.1.61; Wayman GA, 2011, CELL CALCIUM, V50, P1, DOI 10.1016/j.ceca.2011.02.007; Wheeler DG, 2008, J CELL BIOL, V183, P849, DOI 10.1083/jcb.200805048; Willner P, 1997, PSYCHOPHARMACOLOGY, V134, P319, DOI 10.1007/s002130050456; WIRTSHAFTER D, 1994, BRAIN RES, V633, P21, DOI 10.1016/0006-8993(94)91517-2; Xing GQ, 2002, NEUROREPORT, V13, P501, DOI 10.1097/00001756-200203250-00029	39	254	291	3	131	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 30	2013	341	6149					1016	1020		10.1126/science.1240729	http://dx.doi.org/10.1126/science.1240729			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	208BZ	23990563	Green Accepted			2022-12-24	WOS:000323652300047
J	Kuhlman, SJ; Olivas, ND; Tring, E; Ikrar, T; Xu, XM; Trachtenberg, JT				Kuhlman, Sandra J.; Olivas, Nicholas D.; Tring, Elaine; Ikrar, Taruna; Xu, Xiangmin; Trachtenberg, Joshua T.			A disinhibitory microcircuit initiates critical-period plasticity in the visual cortex	NATURE			English	Article							EXPERIENCE-DEPENDENT PLASTICITY; REMOTE-CONTROL; RESPONSES; ORGANIZATION; INHIBITION; MECHANISMS; RESOLUTION; AMBLYOPIA; NEOCORTEX; NETWORK	Early sensory experience instructs the maturation of neural circuitry in the cortex(1,2). This has been studied extensively in the primary visual cortex, in which loss of vision to one eye permanently degrades cortical responsiveness to that eye(3,4), a phenomenon known as ocular dominance plasticity (ODP). Cortical inhibition mediates this process(4-6), but the precise role of specific classes of inhibitory neurons in ODP is controversial. Here we report that evoked firing rates of binocular excitatory neurons in the primary visual cortex immediately drop by half when vision is restricted to one eye, but gradually return to normal over the following twenty-four hours, despite the fact that vision remains restricted to one eye. This restoration of binocular-like excitatory firing rates after monocular deprivation results from a rapid, although transient, reduction in the firing rates of fast-spiking, parvalbumin-positive (PV) interneurons, which in turn can be attributed to a decrease in local excitatory circuit input onto PV interneurons. This reduction in PV-cell-evoked responses after monocular lid suture is restricted to the critical period for ODP and appears to be necessary for subsequent shifts in excitatory ODP. Pharmacologically enhancing inhibition at the time of sight deprivation blocks ODP and, conversely, pharmacogenetic reduction of PV cell firing rates can extend the critical period for ODP. These findings define the microcircuit changes initiating competitive plasticity during critical periods of cortical development. Moreover, they show that the restoration of evoked firing rates of layer 2/3 pyramidal neurons by PV-specific disinhibition is a key step in the progression of ODP.	[Kuhlman, Sandra J.; Tring, Elaine; Trachtenberg, Joshua T.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurobiol, Los Angeles, CA 90048 USA; [Olivas, Nicholas D.; Ikrar, Taruna; Xu, Xiangmin] Univ Calif Irvine, Dept Anat & Neurobiol, Irvine, CA 92697 USA; [Xu, Xiangmin] Univ Calif Irvine, Dept Biomed Engn, Irvine, CA 92697 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Irvine; University of California System; University of California Irvine	Xu, XM (corresponding author), Univ Calif Irvine, Dept Anat & Neurobiol, Irvine, CA 92697 USA.	xiangmix@uci.edu; joshua.trachtenberg@gmail.com	Core, Vector/CAF-4832-2022; Ikrar, Taruna/I-3357-2014; Kuhlman, Sandra/Q-1211-2015	Kuhlman, Sandra/0000-0003-0450-7282	US National Eye Institute [EY016052]; US National Institute of Neurological Disorders and Stroke [NS078434]; NARSAD; NATIONAL EYE INSTITUTE [R01EY023871, R01EY016052] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS078434] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R00DA023700] Funding Source: NIH RePORTER	US National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); US National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NARSAD(NARSAD); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank S. Smith, W. Thompson, K. Miller and M. P. Stryker for comments on earlier versions of this manuscript, Y. Shi for help with software, Z. Nenadic for analytical suggestions, D. Ringach for help with GCaMP6 analysis and Z. J. Huang for useful discussions. This work was funded by grants from the US National Eye Institute (EY016052) to J. T. T., and the US National Institute of Neurological Disorders and Stroke (NS078434) and a NARSAD Young Investigator Grant to X.X.	Alexander GM, 2009, NEURON, V63, P27, DOI 10.1016/j.neuron.2009.06.014; Antonini A, 1999, J NEUROSCI, V19, P4388; Armbruster BN, 2007, P NATL ACAD SCI USA, V104, P5163, DOI 10.1073/pnas.0700293104; Chen TW, 2013, NATURE, V499, P295, DOI 10.1038/nature12354; de Villers-Sidani E, 2011, PROG BRAIN RES, V191, P119, DOI 10.1016/B978-0-444-53752-2.00009-6; Dombeck DA, 2007, NEURON, V56, P43, DOI 10.1016/j.neuron.2007.08.003; Dong SY, 2010, MOL BIOSYST, V6, P1376, DOI 10.1039/c002568m; Ferguson SM, 2011, NAT NEUROSCI, V14, P22, DOI 10.1038/nn.2703; Froemke RC, 2007, NATURE, V450, P425, DOI 10.1038/nature06289; Fu M, 2011, TRENDS NEUROSCI, V34, P177, DOI 10.1016/j.tins.2011.02.001; Gandhi SP, 2008, P NATL ACAD SCI USA, V105, P16797, DOI 10.1073/pnas.0806159105; Gdalyahu A, 2012, NEURON, V75, P121, DOI 10.1016/j.neuron.2012.04.035; Gordon JA, 1996, J NEUROSCI, V16, P3274; Harauzov A, 2010, J NEUROSCI, V30, P361, DOI 10.1523/JNEUROSCI.2233-09.2010; Hensch TK, 2005, NAT REV NEUROSCI, V6, P877, DOI 10.1038/nrn1787; Holmes JM, 2011, ARCH OPHTHALMOL-CHIC, V129, P1451, DOI 10.1001/archophthalmol.2011.179; Holtmaat A, 2009, NAT REV NEUROSCI, V10, P647, DOI 10.1038/nrn2699; Holtmaat A, 2009, NAT PROTOC, V4, P1128, DOI 10.1038/nprot.2009.89; Hooks BM, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000572; Jiang B, 2005, BRAIN RES REV, V50, P126, DOI 10.1016/j.brainresrev.2005.05.007; Kameyama K, 2010, J NEUROSCI, V30, P1551, DOI 10.1523/JNEUROSCI.5025-09.2010; Kanonidou Evgenia, 2011, International Ophthalmology, V31, P249, DOI 10.1007/s10792-011-9434-z; Ko H, 2013, NATURE, V496, P96, DOI 10.1038/nature12015; Kuhlman SJ, 2011, NAT NEUROSCI, V14, P1121, DOI 10.1038/nn.2890; Lambo ME, 2013, J NEUROSCI, V33, P8810, DOI 10.1523/JNEUROSCI.4502-12.2013; Letzkus JJ, 2011, NATURE, V480, P331, DOI 10.1038/nature10674; Levelt CN, 2012, ANNU REV NEUROSCI, V35, P309, DOI 10.1146/annurev-neuro-061010-113813; Li HH, 2013, NAT NEUROSCI, V16, P332, DOI 10.1038/nn.3322; Mrsic-Flogel TD, 2007, NEURON, V54, P961, DOI 10.1016/j.neuron.2007.05.028; Nimmerjahn A, 2004, NAT METHODS, V1, P31, DOI 10.1038/nmeth706; Pologruto TA, 2003, BIOMED ENG ONLINE, V2, DOI 10.1186/1475-925X-2-13; Rogan SC, 2011, PHARMACOL REV, V63, P291, DOI 10.1124/pr.110.003020; Shepherd GMG, 2005, J NEUROSCI, V25, P5670, DOI 10.1523/JNEUROSCI.1173-05.2005; Shepherd GMG, 2003, NEURON, V38, P277, DOI 10.1016/S0896-6273(03)00152-1; Shi YL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015517; Shih F., 2009, IMAGE PROCESSING MAT; Stosiek C, 2003, P NATL ACAD SCI USA, V100, P7319, DOI 10.1073/pnas.1232232100; Suter BA, 2010, FRONT NEURAL CIRCUIT, V4, P100, DOI DOI 10.3389/FNCIR.2010.00100; Webber Ann L, 2005, Clin Exp Optom, V88, P365; Weiler N, 2008, NAT NEUROSCI, V11, P360, DOI 10.1038/nn2049; White LE, 2007, NEURON, V56, P327, DOI 10.1016/j.neuron.2007.10.011; WIESEL TN, 1963, J NEUROPHYSIOL, V26, P1003, DOI 10.1152/jn.1963.26.6.1003; Xu CY, 1998, IEEE T IMAGE PROCESS, V7, P359, DOI 10.1109/83.661186; Xu XM, 2010, J NEUROPHYSIOL, V103, P2301, DOI 10.1152/jn.00992.2009; Yazaki-Sugiyama Y, 2009, NATURE, V462, P218, DOI 10.1038/nature08485; Yoshimura Y, 2005, NAT NEUROSCI, V8, P1552, DOI 10.1038/nn1565	46	250	252	3	86	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 26	2013	501	7468					543	+		10.1038/nature12485	http://dx.doi.org/10.1038/nature12485			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	223RP	23975100	Green Accepted, Green Submitted			2022-12-24	WOS:000324826300057
J	Lancaster, MA; Renner, M; Martin, CA; Wenzel, D; Bicknell, LS; Hurles, ME; Homfray, T; Penninger, JM; Jackson, AP; Knoblich, JA				Lancaster, Madeline A.; Renner, Magdalena; Martin, Carol-Anne; Wenzel, Daniel; Bicknell, Louise S.; Hurles, Matthew E.; Homfray, Tessa; Penninger, Josef M.; Jackson, Andrew P.; Knoblich, Juergen A.			Cerebral organoids model human brain development and microcephaly	NATURE			English	Article							EMBRYONIC STEM-CELLS; OUTER SUBVENTRICULAR ZONE; SPINDLE ORIENTATION; HUMAN NEOCORTEX; IN-VITRO; MAMMALIAN NEUROGENESIS; 3-DIMENSIONAL CULTURE; EXTRINSIC SIGNALS; MOUSE NEOCORTEX; SELF-FORMATION	The complexity of the human brain has made it difficult to study many brain disorders in model organisms, highlighting the need for an in vitro model of human brain development. Here we have developed a human pluripotent stem cell-derived three-dimensional organoid culture system, termed cerebral organoids, that develop various discrete, although interdependent, brain regions. These include a cerebral cortex containing progenitor populations that organize and produce mature cortical neuron subtypes. Furthermore, cerebral organoids are shown to recapitulate features of human cortical development, namely characteristic progenitor zone organization with abundant outer radial glial stem cells. Finally, we use RNA interference and patient-specific induced pluripotent stem cells to model microcephaly, a disorder that has been difficult to recapitulate in mice. We demonstrate premature neuronal differentiation in patient organoids, a defect that could help to explain the disease phenotype. Together, these data show that three-dimensional organoids can recapitulate development and disease even in this most complex human tissue.	[Lancaster, Madeline A.; Renner, Magdalena; Wenzel, Daniel; Penninger, Josef M.; Knoblich, Juergen A.] Austrian Acad Sci IMBA, Inst Mol Biotechnol, A-1030 Vienna, Austria; [Martin, Carol-Anne; Bicknell, Louise S.; Jackson, Andrew P.] Univ Edinburgh, Inst Genet & Mol Med, MRC Human Genet Unit, Edinburgh EH4 2XU, Midlothian, Scotland; [Hurles, Matthew E.] Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England; [Homfray, Tessa] St Georges Univ, Dept Clin Genet, London SW17 0RE, England	Austrian Academy of Sciences; Vienna Biocenter (VBC); Institute of Molecular Biotechnology (IMBA); University of Edinburgh; Wellcome Trust Sanger Institute; St Georges University London	Knoblich, JA (corresponding author), Austrian Acad Sci IMBA, Inst Mol Biotechnol, A-1030 Vienna, Austria.	juergen.knoblich@imba.oeaw.ac.at	Knoblich, Juergen A/C-2974-2015; Bicknell, Louise/AAL-8003-2020; Bicknell, Louise/GLR-4215-2022; Penninger, Josef M/I-6860-2013; Jackson, Andrew/D-3442-2009	Knoblich, Juergen A/0000-0002-6751-3404; Bicknell, Louise/0000-0001-6899-9322; Penninger, Josef M/0000-0002-8194-3777; Lancaster, Madeline/0000-0003-2324-8853; Jackson, Andrew/0000-0002-8739-2646; Martin, Carol-Anne/0000-0001-5914-2757	Wellcome Trust [WT098051]; Austrian Academy of Sciences; Austrian Science Fund (FWF) [Z153-B09, I552-B19]; ERC; EMBO; Helen Hay Whitney; Medical Research Council; European Research Council (ERC); Lister Institute for Preventative Medicine; Austrian Science Fund (FWF) [Z 153] Funding Source: researchfish; Medical Research Council [MC_PC_U127580972] Funding Source: researchfish; MRC [MC_PC_U127580972] Funding Source: UKRI	Wellcome Trust(Wellcome Trust); Austrian Academy of Sciences; Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); ERC(European Research Council (ERC)European Commission); EMBO(European Molecular Biology Organization (EMBO)); Helen Hay Whitney; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Research Council (ERC)(European Research Council (ERC)European Commission); Lister Institute for Preventative Medicine; Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We are grateful to members of the Knoblich laboratory for technical expertise and feedback, A. Peer, P. Moeseneder and N. Corsini for experimental support and M. Repic for help with establishing organoid electroporations. We also thank the Stem Cell and BioOptics core facilities of IMBA/IMP for technical support. We would especially like to thank the patients and their families for participating in this study. We would also like to thank S. McGurk for providing control MRI images. M. A. L. received funding from an EMBO post-doctoral fellowship and a Helen Hay Whitney post-doctoral fellowship. Work in A.P.J.'s laboratory is supported by the Medical Research Council, a starter grant from the European Research Council (ERC) and the Lister Institute for Preventative Medicine. This research was also supported in part by Wellcome Trust grant WT098051. Work in J.A.K.'s laboratory is supported by the Austrian Academy of Sciences, the Austrian Science Fund (FWF) (projects Z153-B09 and I552-B19) and an advanced grant from ERC.	Barrera JA, 2010, DEV CELL, V18, P913, DOI 10.1016/j.devcel.2010.05.017; Bedogni F, 2010, P NATL ACAD SCI USA, V107, P13129, DOI 10.1073/pnas.1002285107; Bond J, 2005, NAT GENET, V37, P353, DOI 10.1038/ng1539; Chedotal A, 2011, CURR OPIN NEUROBIOL, V21, P68, DOI 10.1016/j.conb.2010.07.008; CHENN A, 1995, CELL, V82, P631, DOI 10.1016/0092-8674(95)90035-7; Cox J, 2006, TRENDS MOL MED, V12, P358, DOI 10.1016/j.molmed.2006.06.006; Danjo T, 2011, J NEUROSCI, V31, P1919, DOI 10.1523/JNEUROSCI.5128-10.2011; DECARLOS JA, 1992, J NEUROSCI, V12, P1194; Eiraku M, 2008, CELL STEM CELL, V3, P519, DOI 10.1016/j.stem.2008.09.002; Eiraku M, 2012, CURR OPIN NEUROBIOL, V22, P768, DOI 10.1016/j.conb.2012.02.005; Eiraku M, 2011, NATURE, V472, P51, DOI 10.1038/nature09941; Fietz SA, 2011, CURR OPIN NEUROBIOL, V21, P23, DOI 10.1016/j.conb.2010.10.002; Fietz SA, 2010, NAT NEUROSCI, V13, P690, DOI 10.1038/nn.2553; Frotscher M, 1998, CURR OPIN NEUROBIOL, V8, P570, DOI 10.1016/S0959-4388(98)80082-2; Gaspard N, 2008, NATURE, V455, P351, DOI 10.1038/nature07287; Gotz M, 2005, NAT REV MOL CELL BIO, V6, P777, DOI 10.1038/nrm1739; Gruber R, 2011, NAT CELL BIOL, V13, P1325, DOI 10.1038/ncb2342; Hansen DV, 2010, NATURE, V464, P554, DOI 10.1038/nature08845; Hevner RF, 2001, NEURON, V29, P353, DOI 10.1016/S0896-6273(01)00211-2; Hu BY, 2010, METHODS MOL BIOL, V636, P123, DOI 10.1007/978-1-60761-691-7_8; Konno D, 2008, NAT CELL BIOL, V10, P93, DOI 10.1038/ncb1673; LaMonica BE, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2647; Lessard J, 2007, NEURON, V55, P201, DOI 10.1016/j.neuron.2007.06.019; Lizarraga SB, 2010, DEVELOPMENT, V137, P1907, DOI 10.1242/dev.040410; Lui JH, 2011, CELL, V146, P18, DOI 10.1016/j.cell.2011.06.030; Mariani J, 2012, P NATL ACAD SCI USA, V109, P12770, DOI 10.1073/pnas.1202944109; Matsuda T, 2004, P NATL ACAD SCI USA, V101, P16, DOI 10.1073/pnas.2235688100; Megraw TL, 2011, TRENDS CELL BIOL, V21, P470, DOI 10.1016/j.tcb.2011.04.007; Muguruma K, 2010, NAT NEUROSCI, V13, P1171, DOI 10.1038/nn.2638; Nakano T, 2012, CELL STEM CELL, V10, P771, DOI 10.1016/j.stem.2012.05.009; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Pagnamenta AT, 2012, AM J MED GENET A, V158A, P2577, DOI 10.1002/ajmg.a.35558; Postiglione MP, 2011, NEURON, V72, P269, DOI 10.1016/j.neuron.2011.09.022; Pulvers JN, 2010, P NATL ACAD SCI USA, V107, P16595, DOI 10.1073/pnas.1010494107; Sato TR, 2007, PLOS BIOL, V5, P1440, DOI 10.1371/journal.pbio.0050189; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Shafit-Zagardo B, 1998, MOL NEUROBIOL, V16, P149, DOI 10.1007/BF02740642; Shitamukai A, 2011, J NEUROSCI, V31, P3683, DOI 10.1523/JNEUROSCI.4773-10.2011; Siegenthaler JA, 2009, CELL, V139, P597, DOI 10.1016/j.cell.2009.10.004; SMART IHM, 1973, J ANAT, V116, P67; Smart IHM, 2002, CEREB CORTEX, V12, P37, DOI 10.1093/cercor/12.1.37; Suga H, 2011, NATURE, V480, P57, DOI 10.1038/nature10637; SWANSON LW, 1995, TRENDS NEUROSCI, V18, P471, DOI 10.1016/0166-2236(95)92766-J; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tremml G., 2008, CURR PROTOC STEM CEL, V1; Tsai LH, 2005, NEURON, V46, P383, DOI 10.1016/j.neuron.2005.04.013; Watanabe K, 2007, NAT BIOTECHNOL, V25, P681, DOI 10.1038/nbt1310; Willardsen MI, 2011, DEV DYNAM, V240, P1865, DOI 10.1002/dvdy.22684; Xia Xiaofeng, 2009, V549, P51, DOI 10.1007/978-1-60327-931-4_4; Yingling J, 2008, CELL, V132, P474, DOI 10.1016/j.cell.2008.01.026; Yoo AS, 2011, NATURE, V476, P228, DOI 10.1038/nature10323; ZAMENHOF S, 1987, DEV BRAIN RES, V31, P143, DOI 10.1016/0165-3806(87)90094-0; Zecevic N, 2005, J COMP NEUROL, V491, P109, DOI 10.1002/cne.20714	53	2485	2583	65	855	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 19	2013	501	7467					373	+		10.1038/nature12517	http://dx.doi.org/10.1038/nature12517			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219XT	23995685	Green Accepted			2022-12-24	WOS:000324545700036
J	Ni, LN; Bronk, P; Chang, EC; Lowell, AM; Flam, JO; Panzano, VC; Theobald, DL; Griffith, LC; Garrity, PA				Ni, Lina; Bronk, Peter; Chang, Elaine C.; Lowell, April M.; Flam, Juliette O.; Panzano, Vincent C.; Theobald, Douglas L.; Griffith, Leslie C.; Garrity, Paul A.			A gustatory receptor paralogue controls rapid warmth avoidance in Drosophila	NATURE			English	Article							NEURAL CIRCUITS; HEAT-SENSOR; TEMPERATURE; CHANNEL; TRPA1; NEURONS; MELANOGASTER; EXPRESSION; TASTE; ARCHITECTURE	Behavioural responses to temperature are critical for survival, and animals from insects to humans show strong preferences for specific temperatures(1,2). Preferred temperature selection promotes avoidance of adverse thermal environments in the short term and maintenance of optimal body temperatures over the long term(1,2), but its molecular and cellular basis is largely unknown. Recent studies have generated conflicting views of thermal preference in Drosophila, attributing importance to either internal(3) or peripheral(4) warmth sensors. Here we reconcile these views by showing that thermal preference is not a singular response, but involves multiple systems relevant in different contexts. We found previously that the transient receptor potential channel TRPA1 acts internally to control the slowly developing preference response of flies exposed to a shallow thermal gradient(3). We now find that the rapid response of flies exposed to a steep warmth gradient does not require TRPA1; rather, the gustatory receptor GR28B(D) drives this behaviour through peripheral thermosensors. Gustatory receptors are a large gene family, widely studied in insect gustation and olfaction, and are implicated in host-seeking by insect disease vectors(5-7), but have not previously been implicated in thermosensation. At the molecular level, GR28B(D) misexpression confers thermosensitivity upon diverse cell types, suggesting that it is a warmth sensor. These data reveal a new type of thermosensory molecule and uncover a functional distinction between peripheral and internal warmth sensors in this tiny ectotherm reminiscent of thermoregulatory systems in larger, endothermic animals(2). The use of multiple, distinct molecules to respond to a given temperature, as observed here, may facilitate independent tuning of an animal's distinct thermosensory responses.	[Ni, Lina; Bronk, Peter; Chang, Elaine C.; Lowell, April M.; Flam, Juliette O.; Panzano, Vincent C.; Griffith, Leslie C.; Garrity, Paul A.] Brandeis Univ, Natl Ctr Behav Genom, Waltham, MA 02454 USA; [Ni, Lina; Bronk, Peter; Chang, Elaine C.; Lowell, April M.; Flam, Juliette O.; Panzano, Vincent C.; Griffith, Leslie C.; Garrity, Paul A.] Brandeis Univ, Dept Biol, Volen Ctr Complex Syst, Waltham, MA 02454 USA; [Theobald, Douglas L.] Brandeis Univ, Dept Biochem, Waltham, MA 02454 USA	Brandeis University; Brandeis University; Brandeis University	Garrity, PA (corresponding author), Brandeis Univ, Natl Ctr Behav Genom, Waltham, MA 02454 USA.	pgarrity@brandeis.edu	Theobald, Douglas L/F-3514-2013	Theobald, Douglas L/0000-0002-2695-8343; Garrity, Paul/0000-0002-8274-6564; Griffith, Leslie/0000-0003-3164-9876	National Institute of Mental Health (NIMH) [EUREKA R01 MH094721]; National Institute of Neurological Disorders and Stroke (NINDS) [PO1 NS044232]; National Science Foundation [IOS-1025307]; National Institute of General Medical Sciences (NIGMS) [R01 GM054408]; NIMH [R01 MH067284]; NIGMS [R01 GM094468]; NINDS National Research Service Award; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM094468, R01GM096053, P01GM103770, T32GM007122, R01GM054408] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH067284, R01MH094721] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS044232] Funding Source: NIH RePORTER	National Institute of Mental Health (NIMH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute of Neurological Disorders and Stroke (NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Science Foundation(National Science Foundation (NSF)); National Institute of General Medical Sciences (NIGMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank the Garrity laboratory, C. B. Chien, L. Huang, R. Huey, E. Marder and G. Turrigiano for comments, H. Amrein, Y. Jan, C. Montell, C. Zuker and Bloomington Stock Center for strains, N. Donelson, M. Klein, A. Samuel, T. Lauer, P. Taneja, S. Nelson, Y. Yu, H. Bell, P. Sengupta, F. Baier and L. Vosshall for assistance. Supported by grants from National Institute of Mental Health (NIMH) (EUREKA R01 MH094721), National Institute of Neurological Disorders and Stroke (NINDS) (PO1 NS044232) and National Science Foundation (IOS-1025307) to P. A. G., National Institute of General Medical Sciences (NIGMS) (R01 GM054408) and NIMH (R01 MH067284) to L. C. G., NIGMS (R01 GM094468) to D. L. T. and NINDS National Research Service Award to V.C.P.	Bernstein JG, 2012, CURR OPIN NEUROBIOL, V22, P61, DOI 10.1016/j.conb.2011.10.023; Cho H, 2012, NAT NEUROSCI, V15, P1015, DOI 10.1038/nn.3111; Flouris AD, 2011, EUR J APPL PHYSIOL, V111, P1, DOI 10.1007/s00421-010-1602-8; FOELIX RF, 1989, CELL TISSUE RES, V258, P277, DOI 10.1007/BF00239448; Gallio M, 2011, CELL, V144, P614, DOI 10.1016/j.cell.2011.01.028; Garrity PA, 2010, GENE DEV, V24, P2365, DOI 10.1101/gad.1953710; Gingl E, 2005, J NEUROPHYSIOL, V94, P176, DOI 10.1152/jn.01164.2004; Hamada FN, 2008, NATURE, V454, P217, DOI 10.1038/nature07001; Kang KJ, 2012, NATURE, V481, P76, DOI 10.1038/nature10715; Kang K, 2010, NATURE, V464, P597, DOI 10.1038/nature08848; Kim SH, 2010, P NATL ACAD SCI USA, V107, P8440, DOI 10.1073/pnas.1001425107; Le SQ, 2008, MOL BIOL EVOL, V25, P1307, DOI 10.1093/molbev/msn067; Liu J, 2010, NAT NEUROSCI, V13, P715, DOI 10.1038/nn.2540; Pulver SR, 2009, J NEUROPHYSIOL, V101, P3075, DOI 10.1152/jn.00071.2009; Redelings BD, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-40; Robertson HM, 2003, P NATL ACAD SCI USA, V100, P14537, DOI 10.1073/pnas.2335847100; Sato K, 2011, P NATL ACAD SCI USA, V108, P11680, DOI 10.1073/pnas.1019622108; Sayeed O, 1996, P NATL ACAD SCI USA, V93, P6079, DOI 10.1073/pnas.93.12.6079; Silbering AF, 2010, EMBO REP, V11, P173, DOI 10.1038/embor.2010.8; Suchard MA, 2006, BIOINFORMATICS, V22, P2047, DOI 10.1093/bioinformatics/btl175; SWEENEY ST, 1995, NEURON, V14, P341, DOI 10.1016/0896-6273(95)90290-2; Thorne N, 2004, CURR BIOL, V14, P1065, DOI 10.1016/j.cub.2004.05.019; Thorne N, 2008, J COMP NEUROL, V506, P548, DOI 10.1002/cne.21547; Viswanath V, 2003, NATURE, V423, P822, DOI 10.1038/423822a; Vosshall LB, 2007, ANNU REV NEUROSCI, V30, P505, DOI 10.1146/annurev.neuro.30.051606.094306; Vyklicky L, 1999, J PHYSIOL-LONDON, V517, P181, DOI 10.1111/j.1469-7793.1999.0181z.x; Wang GR, 2009, EUR J NEUROSCI, V30, P967, DOI 10.1111/j.1460-9568.2009.06901.x; Xiang Y, 2010, NATURE, V468, P921, DOI 10.1038/nature09576; Xiao BL, 2011, NAT CHEM BIOL, V7, P351, DOI [10.1038/NCHEMBIO.558, 10.1038/nchembio.558]; Zars T, 2001, J COMP PHYSIOL A, V187, P235, DOI 10.1007/s003590100194; Zhong LX, 2012, CELL REP, V1, P43, DOI 10.1016/j.celrep.2011.11.002	31	135	139	1	92	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 29	2013	500	7464					580	+		10.1038/nature12390	http://dx.doi.org/10.1038/nature12390			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	207TD	23925112	Green Accepted			2022-12-24	WOS:000323625900035
J	Roukos, V; Voss, TC; Schmidt, CK; Lee, S; Wangsa, D; Misteli, T				Roukos, Vassilis; Voss, Ty C.; Schmidt, Christine K.; Lee, Seungtaek; Wangsa, Darawalee; Misteli, Tom			Spatial Dynamics of Chromosome Translocations in Living Cells	SCIENCE			English	Article							DOUBLE-STRAND BREAKS; DNA-PKCS; MOBILITY; RECOMBINATION; REPAIR	Chromosome translocations are a hallmark of cancer cells. We have developed an experimental system to visualize the formation of translocations in living cells and apply it to characterize the spatial and dynamic properties of translocation formation. We demonstrate that translocations form within hours of the occurrence of double-strand breaks (DSBs) and that their formation is cell cycle-independent. Translocations form preferentially between prepositioned genome elements, and perturbation of key factors of the DNA repair machinery uncouples DSB pairing from translocation formation. These observations generate a spatiotemporal framework for the formation of translocations in living cells.	[Roukos, Vassilis; Schmidt, Christine K.; Misteli, Tom] NCI, Bethesda, MD 20892 USA; [Voss, Ty C.] NCI, High Throughput Imaging Facil, Bethesda, MD 20892 USA; [Lee, Seungtaek] PerkinElmer Hlth Sci Inc, Waltham, MA 02451 USA; [Wangsa, Darawalee] NCI, Genet Branch, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Misteli, T (corresponding author), NCI, Bethesda, MD 20892 USA.	mistelit@mail.nih.gov	Roukos, Vassilis/K-6248-2012; Roukos, Vassilis/AAC-4827-2020; Schmidt, Christine/AAF-2625-2021	Schmidt, Christine/0000-0002-8363-7933; Roukos, Vassilis/0000-0002-5065-3937	National Institutes of Health (NIH), NCI, Center for Cancer Research; EMBO; NATIONAL CANCER INSTITUTE [ZIABC010309] Funding Source: NIH RePORTER	National Institutes of Health (NIH), NCI, Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); EMBO(European Molecular Biology Organization (EMBO)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank T. Tsukamoto, M. Jasin, E. Heard, D. Jullien, and M. Dundr for reagents; B. J. Taylor, S. Banerjee, J. Simone, and K. McKinnon for help with FACS experiments; T. Karpova (NCI Fluorescence Imaging Microscopy Facility) for help with microscopy; and T. Ried and K. Meaburn for expertise with SKY analysis and FISH. This research was supported by the Intramural Research Program of the National Institutes of Health (NIH), NCI, Center for Cancer Research, and by an EMBO long-term fellowship (C. K. S.). We dedicate this work to the memory of Dr. Michael Potter, NCI, a giant in the field of chromosome translocations.	Aten JA, 2004, SCIENCE, V303, P92, DOI 10.1126/science.1088845; Callen E, 2009, MOL CELL, V34, P285, DOI 10.1016/j.molcel.2009.04.025; Dion V, 2012, NAT CELL BIOL, V14, P502, DOI 10.1038/ncb2465; Dupre A, 2008, NAT CHEM BIOL, V4, P119, DOI 10.1038/nchembio.63; Jakob B, 2009, P NATL ACAD SCI USA, V106, P3172, DOI 10.1073/pnas.0810987106; Kruhlak MJ, 2006, J CELL BIOL, V172, P823, DOI 10.1083/jcb.200510015; Meaburn KJ, 2007, SEMIN CANCER BIOL, V17, P80, DOI 10.1016/j.semcancer.2006.10.008; Mine-Hattab J, 2012, NAT CELL BIOL, V14, P510, DOI 10.1038/ncb2472; Misteli T, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000794; Mitelman F, 2007, NAT REV CANCER, V7, P233, DOI 10.1038/nrc2091; Neal JA, 2011, MUTAT RES-FUND MOL M, V711, P73, DOI 10.1016/j.mrfmmm.2011.02.010; Nelms BE, 1998, SCIENCE, V280, P590, DOI 10.1126/science.280.5363.590; Niu Y, 2008, J MOL BIOL, V382, P188, DOI 10.1016/j.jmb.2008.07.010; Soutoglou E, 2007, NAT CELL BIOL, V9, P675, DOI 10.1038/ncb1591; Uematsu N, 2007, J CELL BIOL, V177, P219, DOI 10.1083/jcb.200608077; Weinstock David M, 2007, Nat Cell Biol, V9, P978	16	195	201	0	53	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 9	2013	341	6146					660	664		10.1126/science.1237150	http://dx.doi.org/10.1126/science.1237150			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	197XC	23929981	Green Accepted			2022-12-24	WOS:000322884800040
J	Bhatt, AS; Freeman, SS; Herrera, AF; Pedamallu, CS; Gevers, D; Duke, F; Jung, J; Michaud, M; Walker, BJ; Young, S; Earl, AM; Kostic, AD; Ojesina, AI; Hasserjian, R; Ballen, KK; Chen, YB; Hobbs, G; Antin, JH; Soiffer, RJ; Baden, LR; Garrett, WS; Hornick, JL; Marty, FM; Meyerson, M				Bhatt, Ami S.; Freeman, Samuel S.; Herrera, Alex F.; Pedamallu, Chandra Sekhar; Gevers, Dirk; Duke, Fujiko; Jung, Joonil; Michaud, Monia; Walker, Bruce J.; Young, Sarah; Earl, Ashlee M.; Kostic, Aleksander D.; Ojesina, Akinyemi I.; Hasserjian, Robert; Ballen, Karen K.; Chen, Yi-Bin; Hobbs, Gabriela; Antin, Joseph H.; Soiffer, Robert J.; Baden, Lindsey R.; Garrett, Wendy S.; Hornick, Jason L.; Marty, Francisco M.; Meyerson, Matthew			Sequence-Based Discovery of Bradyrhizobium enterica in Cord Colitis Syndrome	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							IN-SITU HYBRIDIZATION; BONE-MARROW; HEPATIC COMPLICATIONS; CELL; BLOOD; IDENTIFICATION; NITROIMIDAZOLES; METRONIDAZOLE; SEARCH; ADULTS	BACKGROUND Immunosuppression is associated with a variety of idiopathic clinical syndromes that may have infectious causes. It has been hypothesized that the cord colitis syndrome, a complication of umbilical-cord hematopoietic stem-cell transplantation, is infectious in origin. METHODS We performed shotgun DNA sequencing on four archived, paraffin-embedded endoscopic colon-biopsy specimens obtained from two patients with cord colitis. Computational subtraction of human and known microbial sequences and assembly of residual sequences into a bacterial draft genome were performed. We used polymerase-chain-reaction (PCR) assays and fluorescence in situ hybridization to determine whether the corresponding bacterium was present in additional patients and controls. RESULTS DNA sequencing of the biopsy specimens revealed more than 2.5 million sequencing reads that did not match known organisms. These sequences were computationally assembled into a 7.65-Mb draft genome showing a high degree of homology with genomes of bacteria in the bradyrhizobium genus. The corresponding newly discovered bacterium was provisionally named Bradyrhizobium enterica. PCR identified B. enterica nucleotide sequences in biopsy specimens from all three additional patients with cord colitis whose samples were tested, whereas B. enterica sequences were absent in samples obtained from healthy controls and patients with colon cancer or graft-versus-host disease. CONCLUSIONS We assembled a novel bacterial draft genome from the direct sequencing of tissue specimens from patients with cord colitis. Association of these sequences with cord colitis suggests that B. enterica may be an opportunistic human pathogen.	[Bhatt, Ami S.; Herrera, Alex F.; Pedamallu, Chandra Sekhar; Duke, Fujiko; Kostic, Aleksander D.; Ojesina, Akinyemi I.; Antin, Joseph H.; Soiffer, Robert J.; Baden, Lindsey R.; Garrett, Wendy S.; Marty, Francisco M.; Meyerson, Matthew] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Michaud, Monia; Garrett, Wendy S.] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; [Hasserjian, Robert; Ballen, Karen K.; Chen, Yi-Bin] Massachusetts Gen Hosp, Boston, MA 02114 USA; [Baden, Lindsey R.; Marty, Francisco M.] Brigham & Womens Hosp, Dept Internal Med, Div Infect Dis, Boston, MA 02115 USA; [Hornick, Jason L.] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; [Bhatt, Ami S.; Freeman, Samuel S.; Pedamallu, Chandra Sekhar; Gevers, Dirk; Duke, Fujiko; Jung, Joonil; Walker, Bruce J.; Young, Sarah; Earl, Ashlee M.; Kostic, Aleksander D.; Ojesina, Akinyemi I.; Garrett, Wendy S.; Meyerson, Matthew] Broad Inst, Cambridge, MA USA; [Hobbs, Gabriela] Mem Sloan Kettering Canc Ctr, Dept Med Oncol, New York, NY 10021 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Massachusetts General Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Memorial Sloan Kettering Cancer Center	Meyerson, M (corresponding author), 450 Brookline Ave, Boston, MA 02215 USA.	matthew_meyerson@dfci.harvard.edu	Gevers, Dirk/C-1451-2009; Marty, Francisco M./H-7088-2019; Pedamallu, Chandra Sekhar/AAV-6745-2020; Pedamallu, Chandra Sekhar/AAV-6723-2020	Marty, Francisco M./0000-0002-3708-8734; Bhatt, Ami/0000-0001-8099-2975; Earl, Ashlee/0000-0001-7857-9145; Garrett, Wendy/0000-0002-5092-0150; Kostic, Aleksandar/0000-0002-0837-4360; Hobbs, Gabriela/0000-0002-0199-9333; Freeman, Samuel/0000-0001-8285-0057; Meyerson, Matthew/0000-0002-9133-8108; Hornick, Jason/0000-0001-6475-8345; Ojesina, Akinyemi/0000-0003-0755-3639	National Cancer Institute; American Association for Cancer Research; American Society for Blood and Marrow Transplantation; Bladder Cancer Advocacy Network; Starr Cancer Consortium; National Cancer Institute [RC2CA148317]; NATIONAL CANCER INSTITUTE [RC2CA148317, R01CA183559, T32CA009172, R01CA154426] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); American Association for Cancer Research; American Society for Blood and Marrow Transplantation; Bladder Cancer Advocacy Network; Starr Cancer Consortium; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funded by the National Cancer Institute and others.; Supported by grants from the American Association for Cancer Research, the American Society for Blood and Marrow Transplantation, and the Bladder Cancer Advocacy Network (all to Dr. Bhatt); and by grants from the Starr Cancer Consortium and National Cancer Institute (RC2CA148317) (both to Dr. Meyerson).	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Butler J, 2008, GENOME RES, V18, P810, DOI 10.1101/gr.7337908; Castellarin M, 2012, GENOME RES, V22, P299, DOI 10.1101/gr.126516.111; Cid J, 2011, NEW ENGL J MED, V365, P2336, DOI 10.1056/NEJMc1111264; Copelan EA, 2006, NEW ENGL J MED, V354, P1813, DOI 10.1056/NEJMra052638; EDWARDS DI, 1986, BIOCHEM PHARMACOL, V35, P53, DOI 10.1016/0006-2952(86)90554-X; Feng HC, 2008, SCIENCE, V319, P1096, DOI 10.1126/science.1152586; Fredricks DN, 1996, CLIN MICROBIOL REV, V9, P18, DOI 10.1128/CMR.9.1.18; GOBER JW, 1989, APPL ENVIRON MICROB, V55, P1420, DOI 10.1128/AEM.55.6.1420-1425.1989; Herrera AF, 2011, NEW ENGL J MED, V365, P815, DOI 10.1056/NEJMoa1104959; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Hyatt D, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-119; Jjemba PK, 2002, CHEMOSPHERE, V46, P1019, DOI 10.1016/S0045-6535(01)00139-4; Kaneko T, 2002, DNA RES, V9, P225, DOI 10.1093/dnares/9.6.225; KELLEY BC, 1981, ARCH MICROBIOL, V129, P344, DOI 10.1007/BF00406459; Klein AK, 2001, BIOL BLOOD MARROW TR, V7, P454, DOI 10.1016/S1083-8791(01)80013-6; Kostic AD, 2012, GENOME RES, V22, P292, DOI 10.1101/gr.126573.111; Kostic AD, 2011, NAT BIOTECHNOL, V29, P393, DOI 10.1038/nbt.1868; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; MCDONALD GB, 1986, GASTROENTEROLOGY, V90, P770, DOI 10.1016/0016-5085(86)91137-6; MCDONALD GB, 1986, GASTROENTEROLOGY, V90, P460, DOI 10.1016/0016-5085(86)90949-2; MULLER M, 1986, BIOCHEM PHARMACOL, V35, P37, DOI 10.1016/0006-2952(86)90552-6; NEEDLEMAN SB, 1970, J MOL BIOL, V48, P443, DOI 10.1016/0022-2836(70)90057-4; Pop M, 2009, BRIEF BIOINFORM, V10, P354, DOI 10.1093/bib/bbp026; RELMAN DA, 1992, NEW ENGL J MED, V327, P293, DOI 10.1056/NEJM199207303270501; RELMAN DA, 1989, P NATL ACAD SCI USA, V86, P2637, DOI 10.1073/pnas.86.8.2637; Relman DA, 2011, NEW ENGL J MED, V365, P347, DOI 10.1056/NEJMra1003071; Rocha V, 2004, NEW ENGL J MED, V351, P2276, DOI 10.1056/NEJMoa041469; Schulenburg A, 2004, ANN HEMATOL, V83, P101, DOI 10.1007/s00277-003-0756-4; Swidsinski A, 2006, INFLAMM BOWEL DIS, V12, P824, DOI 10.1097/00054725-200608000-00018; Swidsinski A, 2005, WORLD J GASTROENTERO, V11, P1131, DOI 10.3748/wjg.v11.i8.1131; Tanaka Y, 2001, J INFECT DIS, V183, P359, DOI 10.1086/318091; Taur Y, 2012, CLIN INFECT DIS, V55, P905, DOI 10.1093/cid/cis580; van Kraaij MGJ, 2000, BONE MARROW TRANSPL, V26, P299, DOI 10.1038/sj.bmt.1702484; Virgin HW, 2011, CELL, V147, P44, DOI 10.1016/j.cell.2011.09.009; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	36	86	91	0	15	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 8	2013	369	6					517	528		10.1056/NEJMoa1211115	http://dx.doi.org/10.1056/NEJMoa1211115			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	197HX	23924002	Green Accepted, Green Published, Bronze			2022-12-24	WOS:000322842000008
J	Wilson, SR; The, L; Batia, LM; Beattie, K; Katibah, GE; McClain, SP; Pellegrino, M; Estandian, DM; Bautista, DM				Wilson, Sarah R.; The, Lydia; Batia, Lyn M.; Beattie, Katherine; Katibah, George E.; McClain, Shannan P.; Pellegrino, Maurizio; Estandian, Daniel M.; Bautista, Diana M.			The Epithelial Cell-Derived Atopic Dermatitis Cytokine TSLP Activates Neurons to Induce Itch	CELL			English	Article							THYMIC STROMAL LYMPHOPOIETIN; OPERATED CA2+ ENTRY; CRAC CHANNEL; HUMAN KERATINOCYTES; NETHERTON SYNDROME; DISEASE SEVERITY; TRP CHANNELS; HUMAN SKIN; RECEPTOR; MICE	Atopic dermatitis (AD) is a chronic itch and inflammatory disorder of the skin that affects one in ten people. Patients suffering from severe AD eventually progress to develop asthma and allergic rhinitis, in a process known as the "atopic march." Signaling between epithelial cells and innate immune cells via the cytokine thymic stromal lymphopoietin (TSLP) is thought to drive AD and the atopic march. Here, we report that epithelial cells directly communicate to cutaneous sensory neurons via TSLP to promote itch. We identify the ORAI1/NFAT calcium signaling pathway as an essential regulator of TSLP release from keratinocytes, the primary epithelial cells of the skin. TSLP then acts directly on a subset of TRPA1-positive sensory neurons to trigger robust itch behaviors. Our results support a model whereby calcium-dependent TSLP release by keratinocytes activates both primary afferent neurons and immune cells to promote inflammatory responses in the skin and airways.	[Wilson, Sarah R.; The, Lydia; Batia, Lyn M.; Beattie, Katherine; Katibah, George E.; McClain, Shannan P.; Pellegrino, Maurizio; Estandian, Daniel M.; Bautista, Diana M.] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Wilson, Sarah R.; Bautista, Diana M.] Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley	Bautista, DM (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.	dbautista@berkeley.edu			National Institutes of Health [AR059385, DOD007123A]; National Science Foundation; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR059385] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD007123] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We are grateful to Drs. Hariharan and Heald and lab members for critical comments on the manuscript. We thank K. Gerhold, J. Meeuwsen, T. Morita, M. Newton and M. Tsunozaki for behavior data analyses. This work was supported by National Institutes of Health grants AR059385 and DOD007123A (D.M.B.) and National Science Foundation Fellowships (S.R.W., L.T.). We thank the Neurobiology course at the Marine Biological Laboratory for pilot experiments.	Al-Daraji WI, 2002, J INVEST DERMATOL, V118, P779, DOI 10.1046/j.1523-1747.2002.01709.x; ALMERS W, 1985, FEBS LETT, V192, P13, DOI 10.1016/0014-5793(85)80033-8; Andoh T, 2001, J INVEST DERMATOL, V117, P1621, DOI 10.1046/j.0022-202x.2001.01585.x; Basbaum AI, 2009, CELL, V139, P267, DOI 10.1016/j.cell.2009.09.028; Bautista DM, 2013, ANNU REV PHYSIOL, V75, P181, DOI 10.1146/annurev-physiol-030212-183811; Bogiatzi SI, 2012, J ALLERGY CLIN IMMUN, V130, P233, DOI 10.1016/j.jaci.2012.04.038; Briot A, 2010, J INVEST DERMATOL, V130, P2736, DOI 10.1038/jid.2010.233; Briot A, 2009, J EXP MED, V206, P1135, DOI 10.1084/jem.20082242; Cahalan MD, 2009, NAT CELL BIOL, V11, P669, DOI 10.1038/ncb0609-669; Cevikbas F, 2007, CURR OPIN ALLERGY CL, V7, P365, DOI 10.1097/ACI.0b013e3282a644d2; Chang WC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029387; Dai Y, 2007, J CLIN INVEST, V117, P1979, DOI 10.1172/JCI30951; DeHaven WI, 2008, J BIOL CHEM, V283, P19265, DOI 10.1074/jbc.M801535200; Feske S, 2006, NATURE, V441, P179, DOI 10.1038/nature04702; Feske S, 2010, PFLUG ARCH EUR J PHY, V460, P417, DOI 10.1007/s00424-009-0777-5; Fitzsimons C, 2001, INFLAMM RES, V50, pS100; Fogg MI, 2003, J ALLERGY CLIN IMMUN, V112, P796, DOI 10.1016/S0091-6749(03)01715-9; Gerhold KA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055001; Gusarova GA, 2011, MOL CELL BIOL, V31, P3546, DOI 10.1128/MCB.05114-11; Gwack Y, 2007, CELL CALCIUM, V42, P145, DOI 10.1016/j.ceca.2007.03.007; Halfter UM, 2005, BIOCHEM J, V388, P17, DOI 10.1042/BJ20041236; He R, 2010, ANN NY ACAD SCI, V1183, P13, DOI 10.1111/j.1749-6632.2009.05128.x; Holgate ST, 2007, TRENDS IMMUNOL, V28, P248, DOI 10.1016/j.it.2007.04.007; Hovnanian A, 2013, CELL TISSUE RES, V351, P289, DOI 10.1007/s00441-013-1558-1; Ikoma A, 2003, ARCH DERMATOL, V139, P1455, DOI 10.1001/archderm.139.11.1455; Ikoma A, 2006, NAT REV NEUROSCI, V7, P535, DOI 10.1038/nrn1950; Imamachi N, 2009, P NATL ACAD SCI USA, V106, P11330, DOI 10.1073/pnas.0905605106; Jariwala SP, 2011, CLIN EXP ALLERGY, V41, P1515, DOI 10.1111/j.1365-2222.2011.03797.x; Jessup HK, 2008, J IMMUNOL, V181, P4311, DOI 10.4049/jimmunol.181.6.4311; Kanda N, 2005, J PHARMACOL EXP THER, V315, P796, DOI 10.1124/jpet.105.091645; Kouzaki H, 2009, J IMMUNOL, V183, P1427, DOI 10.4049/jimmunol.0900904; Lee CH, 2011, CURR PROBL DERMATOL, V41, P136, DOI 10.1159/000323307; Li M, 2005, P NATL ACAD SCI USA, V102, P14795, DOI 10.1073/pnas.0507385102; Lis A, 2007, CURR BIOL, V17, P794, DOI 10.1016/j.cub.2007.03.065; Liu BY, 2013, FASEB J, V27, P3549, DOI 10.1096/fj.13-229948; Liu Q, 2009, CELL, V139, P1353, DOI 10.1016/j.cell.2009.11.034; Locksley RM, 2010, CELL, V140, P777, DOI 10.1016/j.cell.2010.03.004; McCoy ES, 2013, NEURON, V78, P138, DOI 10.1016/j.neuron.2013.01.030; McCoy ES, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036355; Moniaga CS, 2013, AM J PATHOL, V182, P841, DOI 10.1016/j.ajpath.2012.11.039; Owsianik G, 2006, ANNU REV PHYSIOL, V68, P685, DOI 10.1146/annurev.physiol.68.040204.101406; Pandey A, 2000, NAT IMMUNOL, V1, P59, DOI 10.1038/76923; Prakriya M, 2006, NATURE, V443, P230, DOI 10.1038/nature05122; RAE J, 1991, J NEUROSCI METH, V37, P15, DOI 10.1016/0165-0270(91)90017-T; Ramsey IS, 2006, ANNU REV PHYSIOL, V68, P619, DOI 10.1146/annurev.physiol.68.040204.100431; Rao A, 1997, ANNU REV IMMUNOL, V15, P707, DOI 10.1146/annurev.immunol.15.1.707; Ross SE, 2011, CURR OPIN NEUROBIOL, V21, P880, DOI 10.1016/j.conb.2011.10.012; Schechter NM, 1998, J CELL PHYSIOL, V176, P365, DOI 10.1002/(SICI)1097-4652(199808)176:2<365::AID-JCP15>3.0.CO;2-2; Steinhoff M, 2003, J NEUROSCI, V23, P6176; TOBIN D, 1992, J ALLERGY CLIN IMMUN, V90, P613, DOI 10.1016/0091-6749(92)90134-N; Tominaga M, 2009, J DERMATOL SCI, V55, P40, DOI 10.1016/j.jdermsci.2009.03.007; Ui H, 2006, EUR J PHARMACOL, V530, P172, DOI 10.1016/j.ejphar.2005.11.021; Wilson SR, 2013, J NEUROSCI, V33, P9283, DOI 10.1523/JNEUROSCI.5318-12.2013; Wilson SR, 2011, NAT NEUROSCI, V14, P595, DOI 10.1038/nn.2789; Yeromin AV, 2006, NATURE, V443, P226, DOI 10.1038/nature05108; Ying S, 2005, J IMMUNOL, V174, P8183, DOI 10.4049/jimmunol.174.12.8183; Yoo J, 2005, J EXP MED, V202, P541, DOI 10.1084/jem.20041503; Zhang SYL, 2008, J BIOL CHEM, V283, P17662, DOI 10.1074/jbc.M801536200; Zhu Y, 2009, INT IMMUNOPHARMACOL, V9, P1332, DOI 10.1016/j.intimp.2009.08.006; Ziegler SF, 2013, ADV PHARMACOL, V66, P129, DOI 10.1016/B978-0-12-404717-4.00004-4	60	578	609	8	99	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 10	2013	155	2					285	295		10.1016/j.cell.2013.08.057	http://dx.doi.org/10.1016/j.cell.2013.08.057			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	235LH	24094650	Green Accepted, Bronze			2022-12-24	WOS:000325719800007
J	Lee, C; Kang, HJ; von Ballmoos, C; Newstead, S; Uzdavinys, P; Dotson, DL; Iwata, S; Beckstein, O; Cameron, AD; Drew, D				Lee, Chiara; Kang, Hae Joo; von Ballmoos, Christoph; Newstead, Simon; Uzdavinys, Povilas; Dotson, David L.; Iwata, So; Beckstein, Oliver; Cameron, Alexander D.; Drew, David			A two-domain elevator mechanism for sodium/proton antiport	NATURE			English	Article							MEMBRANE-PROTEIN OVEREXPRESSION; NHAA NA+/H+ ANTIPORTER; ESCHERICHIA-COLI; PH; PURIFICATION; TRANSPORT; DYNAMICS; PROTON; SYSTEM; MODEL	Sodium/proton (Na+/H+) antiporters, located at the plasma membrane in every cell, are vital for cell homeostasis1. In humans, their dysfunction has been linked to diseases, such as hypertension, heart failure and epilepsy, and they are well-established drug targets(2). The best understood model system for Na+/H+ antiport is NhaA from Escherichia coli(1,3), for which both electron microscopy and crystal structures are available(4-6). NhaA is made up of two distinct domains: a core domain and a dimerization domain. In the NhaA crystal structure a cavity is located between the two domains, providing access to the ion-binding site from the inward-facing surface of the protein(1,4). Likemany Na+/H+ antiporters, the activity of NhaA is regulated by pH, only becoming active above pH 6.5, at which point a conformational change is thought to occur(7). The only reported NhaA crystal structure so far is of the low pH inactivated form(4). Here we describe the active-state structure of a Na+/H+ antiporter, NapA from Thermus thermophilus, at 3 angstrom resolution, solved from crystals grown at pH7.8. In the NapA structure, the core and dimerization domains are in different positions to those seen in NhaA, and a negatively charged cavity has now opened to the outside. The extracellular cavity allows access to a strictly conserved aspartate residue thought to coordinate ion binding(1,8,9) directly, a role supported hereby molecular dynamics simulations. To alternate access to this ion-binding site, however, requires a surprisingly large rotation of the core domain, some 20 degrees against the dimerization interface. We conclude that despite their fast transport rates of up to 1,500 ions per second(3), Na+/H+ antiporters operate by a two-domain rocking bundle model, revealing themes relevant to secondary-active transporters in general.	[Lee, Chiara; Kang, Hae Joo; Newstead, Simon; Iwata, So; Cameron, Alexander D.; Drew, David] Univ London Imperial Coll Sci Technol & Med, Div Mol Biosci, London SW7 2AZ, England; [von Ballmoos, Christoph; Uzdavinys, Povilas; Drew, David] Stockholm Univ, Dept Biochem & Biophys, Ctr Biomembrane Res, SE-10691 Stockholm, Sweden; [Dotson, David L.; Beckstein, Oliver] Arizona State Univ, Dept Phys, Ctr Biol Phys, Tempe, AZ 85287 USA; [Iwata, So; Cameron, Alexander D.] Membrane Prot Lab, Diamond Light Source, Chilton OX11 0DE, Oxon, England; [Iwata, So; Cameron, Alexander D.] Rutherford Appleton Lab, Didcot OX11 0FA, Oxon, England; [Cameron, Alexander D.] Univ Warwick, Sch Life Sci, Coventry CV4 7AL, W Midlands, England	Imperial College London; Stockholm University; Arizona State University; Arizona State University-Tempe; Diamond Light Source; UK Research & Innovation (UKRI); Science & Technology Facilities Council (STFC); STFC Rutherford Appleton Laboratory; University of Warwick	Cameron, AD (corresponding author), Univ London Imperial Coll Sci Technol & Med, Div Mol Biosci, London SW7 2AZ, England.	a.cameron@warwick.ac.uk; d.drew@imperial.ac.uk	Beckstein, Oliver/C-9095-2009; Drew, David/D-3243-2018; Drew, David/AAY-3455-2020; Dotson, David/L-7155-2013; Cameron, Alexander/L-7288-2013	Beckstein, Oliver/0000-0003-1340-0831; Dotson, David/0000-0001-5879-2942; Uzdavinys, Povilas/0000-0001-8222-7660; Drew, David/0000-0001-8866-6349; Cameron, Alexander/0000-0001-8776-3518; Newstead, Simon/0000-0001-7432-2270; von Ballmoos, Christoph/0000-0002-4642-6088	Medical Research Council (MRC) [G0900990]; Swedish Research Council; BBSRC [BB/G02325/1]; Wellcome Trust at the Diamond Light Source Limited [062164/Z/00/Z]; Centre for Biomembrane Research (CBR); Swedish Foundation for Strategic Research; XSEDE [TG-MCB120151]; Human Frontiers Science Program (HFSP); Royal Society through the University Research Fellow (URF) scheme; BBSRC [BB/G023425/1] Funding Source: UKRI; MRC [G0900399, G0900990] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/G023425/1] Funding Source: researchfish; Medical Research Council [G0900399, G0900990] Funding Source: researchfish	Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Swedish Research Council(Swedish Research CouncilEuropean Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust at the Diamond Light Source Limited(Wellcome Trust); Centre for Biomembrane Research (CBR); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); XSEDE; Human Frontiers Science Program (HFSP)(Human Frontier Science Program); Royal Society through the University Research Fellow (URF) scheme; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We are grateful to D. Slotboom for critical reading of the manuscript and N.-J. Hu for assistance in data collection. Data were collected at the European Synchrotron Radiation Facility and Diamond Light Source, with excellent assistance from beamline scientists. This work was funded by grants from the Medical Research Council (MRC grant G0900990 to A. D. C. and D. D.), the Swedish Research Council (to C. v. B. and D. D.) and the BBSRC (BB/G02325/1 to S. I.). The authors are grateful for the use of the Membrane Protein Laboratory funded by the Wellcome Trust (grant 062164/Z/00/Z) at the Diamond Light Source Limited and The Centre for Biomembrane Research (CBR), supported by the Swedish Foundation for Strategic Research. Computer simulations were partially run on XSEDE resources (grant TG-MCB120151 to O.B.). C. L. was a recipient of a BBSRC-funded PhD scholarship, H.J.K. a Human Frontiers Science Program (HFSP) postdoctoral fellowship, and D. D. acknowledges the support from The Royal Society through the University Research Fellow (URF) scheme.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Appel M, 2009, J MOL BIOL, V388, P659, DOI 10.1016/j.jmb.2009.03.010; Arkin IT, 2007, SCIENCE, V317, P799, DOI 10.1126/science.1142824; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bond PJ, 2008, BIOCHEMISTRY-US, V47, P11321, DOI 10.1021/bi800642m; Brett CL, 2005, AM J PHYSIOL-CELL PH, V288, pC223, DOI 10.1152/ajpcell.00360.2004; Bricogne G, 2003, ACTA CRYSTALLOGR D, V59, P2023, DOI 10.1107/S0907444903017694; Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420; Cowtan K., 1994, JOINT CCP4 ESF EACBM, V31, P34; Dahl ACE, 2012, BIOINFORMATICS, V28, P2193, DOI 10.1093/bioinformatics/bts357; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Drew D, 2006, NAT METHODS, V3, P303, DOI 10.1038/nmeth0406-303; Drew D, 2008, NAT PROTOC, V3, P784, DOI 10.1038/nprot.2008.44; Drew DE, 2001, FEBS LETT, V507, P220, DOI 10.1016/S0014-5793(01)02980-5; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Furrer EM, 2007, FEBS LETT, V581, P572, DOI 10.1016/j.febslet.2006.12.059; Goddard TD, 2007, J STRUCT BIOL, V157, P281, DOI 10.1016/j.jsb.2006.06.010; Goswami P, 2011, EMBO J, V30, P439, DOI 10.1038/emboj.2010.321; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Hess B, 2008, J CHEM THEORY COMPUT, V4, P116, DOI 10.1021/ct700200b; Hisamitsu T, 2006, BIOCHEMISTRY-US, V45, P13346, DOI 10.1021/bi0608616; Hu NJ, 2011, NATURE, V478, P408, DOI 10.1038/nature10450; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Hunte C, 2005, NATURE, V435, P1197, DOI 10.1038/nature03692; Ishmukhametov RR, 2005, BBA-BIOENERGETICS, V1706, P110, DOI 10.1016/j.bbabio.2004.09.012; Jones TA, 1997, METHOD ENZYMOL, V277, P173, DOI 10.1016/S0076-6879(97)77012-5; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kawate T, 2006, STRUCTURE, V14, P673, DOI 10.1016/j.str.2006.01.013; Klauda JB, 2010, J PHYS CHEM B, V114, P7830, DOI 10.1021/jp101759q; Kleywegt G.J., 1994, PROTEIN CRYSTALLOGR, V31, P9; Knight SD, 2000, ACTA CRYSTALLOGR D, V56, P42, DOI 10.1107/S0907444999012913; Kozachkov L, 2013, MOL MEMBR BIOL, V30, P90, DOI 10.3109/09687688.2012.693209; Kuwabara N, 2004, J BIOL CHEM, V279, P40567, DOI 10.1074/jbc.M401132200; Li H, 2005, PROTEINS, V61, P704, DOI 10.1002/prot.20660; Mackerell AD, 2004, J COMPUT CHEM, V25, P1400, DOI 10.1002/jcc.20065; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Maes M, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.391128; Mager T, 2011, J BIOL CHEM, V286, P23570, DOI 10.1074/jbc.M111.230235; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Michaud-Agrawal N, 2011, J COMPUT CHEM, V32, P2319, DOI 10.1002/jcc.21787; MIYAMOTO S, 1992, J COMPUT CHEM, V13, P952, DOI 10.1002/jcc.540130805; Noumi T, 1997, J BIOCHEM-TOKYO, V121, P661; Padan E, 2004, BBA-BIOENERGETICS, V1658, P2, DOI 10.1016/j.bbabio.2004.04.018; Padan E, 2008, TRENDS BIOCHEM SCI, V33, P435, DOI 10.1016/j.tibs.2008.06.007; PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; PINNER E, 1994, J BIOL CHEM, V269, P26274; Potterton L, 2004, ACTA CRYSTALLOGR D, V60, P2288, DOI 10.1107/S0907444904023716; Reyes N, 2009, NATURE, V462, P880, DOI 10.1038/nature08616; Rimon A, 2007, J BIOL CHEM, V282, P26810, DOI 10.1074/jbc.M704469200; Schushan M, 2012, J BIOL CHEM, V287, P18249, DOI 10.1074/jbc.M111.336446; Scott KA, 2008, STRUCTURE, V16, P621, DOI 10.1016/j.str.2008.01.014; Screpanti E, 2007, J STRUCT BIOL, V159, P261, DOI 10.1016/j.jsb.2007.01.011; Slotboom DJ, 2008, METHODS, V46, P73, DOI 10.1016/j.ymeth.2008.06.012; Sonoda Y, 2011, STRUCTURE, V19, P17, DOI 10.1016/j.str.2010.12.001; Stansfeld PJ, 2011, J CHEM THEORY COMPUT, V7, P1157, DOI 10.1021/ct100569y; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; TAGLICHT D, 1991, J BIOL CHEM, V266, P11289; TAGLICHT D, 1993, J BIOL CHEM, V268, P5382; Vinothkumar KR, 2005, EMBO J, V24, P2720, DOI 10.1038/sj.emboj.7600727; Wagner S, 2008, P NATL ACAD SCI USA, V105, P14371, DOI 10.1073/pnas.0804090105; WEST IC, 1974, BIOCHEM J, V144, P87, DOI 10.1042/bj1440087; Wiedenmann A, 2008, BBA-BIOENERGETICS, V1777, P1301, DOI 10.1016/j.bbabio.2008.06.008; Wiedenmann A, 2009, MOL MICROBIOL, V72, P479, DOI 10.1111/j.1365-2958.2009.06658.x; Williams KA, 1999, EMBO J, V18, P3558, DOI 10.1093/emboj/18.13.3558; Williams KA, 2000, NATURE, V403, P112, DOI 10.1038/47534; Winter G, 2010, J APPL CRYSTALLOGR, V43, P186, DOI 10.1107/S0021889809045701	69	165	166	1	131	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 26	2013	501	7468					573	+		10.1038/nature12484	http://dx.doi.org/10.1038/nature12484			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	223RP	23995679	Green Submitted, Green Accepted, Green Published			2022-12-24	WOS:000324826300064
J	Corti, D; Bianchi, S; Vanzetta, F; Minola, A; Perez, L; Agatic, G; Guarino, B; Silacci, C; Marcandalli, J; Marsland, BJ; Piralla, A; Percivalle, E; Sallusto, F; Baldanti, F; Lanzavecchia, A				Corti, Davide; Bianchi, Siro; Vanzetta, Fabrizia; Minola, Andrea; Perez, Laurent; Agatic, Gloria; Guarino, Barbara; Silacci, Chiara; Marcandalli, Jessica; Marsland, Benjamin J.; Piralla, Antonio; Percivalle, Elena; Sallusto, Federica; Baldanti, Fausto; Lanzavecchia, Antonio			Cross-neutralization of four paramyxoviruses by a human monoclonal antibody	NATURE			English	Article							RESPIRATORY SYNCYTIAL VIRUS; MEMORY B-CELLS; HUMAN METAPNEUMOVIRUS; FUSION PROTEIN; F-GLYCOPROTEIN; IN-VITRO; INFECTION; GENERATION; PREFUSION; INFANTS	Broadly neutralizing antibodies reactive against most and even all variants of the same viral species have been described for influenza and HIV-1 (ref. 1). However, whether a neutralizing antibody could have the breadth of range to target different viral species was unknown. Human respiratory syncytial virus (HRSV) and human metapneumovirus (HMPV) are common pathogens that cause severe disease in premature newborns, hospitalized children(2,3) and immune-compromised patients(2,4,5), and play a role in asthma exacerbations(6). Although antisera generated against either HRSV or HMPV are not cross-neutralizing(7), we speculated that, because of the repeated exposure to these viruses, cross-neutralizing antibodies may be selected in some individuals. Here we describe a human monoclonal antibody (MPE8) that potently cross-neutralizes HRSV and HMPV as well as two animal paramyxoviruses: bovine RSV (BRSV) and pneumonia virus of mice (PVM). In its germline configuration, MPE8 is HRSV-specific and its breadth is achieved by somatic mutations in the light chain variable region. MPE8 did not result in the selection of viral escape mutants that evaded antibody targeting and showed potent prophylactic efficacy in animal models of HRSV and HMPV infection, as well as prophylactic and therapeutic efficacy in the more relevant model of lethal PVM infection. The core epitope of MPE8 was mapped on two highly conserved anti-parallel beta-strands on the pre-fusion viral F protein, which are rearranged in the post-fusion F protein conformation. Twenty-six out of the thirty HRSV-specific neutralizing antibodies isolated were also found to be specific for the pre-fusion F protein. Taken together, these results indicate that MPE8 might be used for the prophylaxis and therapy of severe HRSV and HMPV infections and identify the pre-fusion F protein as a candidate HRSV vaccine.	[Corti, Davide; Bianchi, Siro; Vanzetta, Fabrizia; Agatic, Gloria; Guarino, Barbara] Humabs BioMed SA, CH-6500 Bellinzona, Switzerland; [Corti, Davide; Minola, Andrea; Perez, Laurent; Silacci, Chiara; Marcandalli, Jessica; Sallusto, Federica; Lanzavecchia, Antonio] Univ Svizzera Italiana, Inst Res Biomed, CH-6500 Bellinzona, Switzerland; [Marsland, Benjamin J.] Univ Lausanne, Serv Pneumol, CHUV, CH-1011 Lausanne, Switzerland; [Piralla, Antonio; Percivalle, Elena; Baldanti, Fausto] IRCCS, Policlin San Matteo, I-27100 Pavia, Italy; [Lanzavecchia, Antonio] ETH, Inst Microbiol, CH-8093 Zurich, Switzerland	Universita della Svizzera Italiana; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); IRCCS Fondazione San Matteo; University of Pavia; Swiss Federal Institutes of Technology Domain; ETH Zurich	Lanzavecchia, A (corresponding author), Univ Svizzera Italiana, Inst Res Biomed, Via Vincenzo Vela 6, CH-6500 Bellinzona, Switzerland.	davide.corti@humabs.ch; lanzavecchia@irb.usi.ch	Perez, Laurent/ABA-4145-2021; Piralla, Antonio/K-4756-2018; Baldanti, Fausto/J-4924-2018; percivalle, elena/K-7994-2016	Perez, Laurent/0000-0002-8860-7928; Piralla, Antonio/0000-0002-6062-2579; Baldanti, Fausto/0000-0002-3358-8969; percivalle, elena/0000-0002-3355-1410; Bianchi, Siro/0000-0002-5100-8905; Zatta, Fabrizia/0000-0003-4945-8058; Guarino, Barbara/0000-0003-3759-3252; Corti, Davide/0000-0002-5797-1364	European Research Council [250348 IMMUNExplore]; Swiss National Science Foundation [141254]; Helmut Horten Foundation	European Research Council(European Research Council (ERC)European Commission); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Helmut Horten Foundation	We would like to thank M. Nussenzweig and H. Wardemann for providing reagents for antibody cloning and expression, I. Capua, B. Zecchin and L. Selli for experiments involving BRSV and R. Wepf for electron microscopy. This work was supported by the European Research Council (grant no. 250348 IMMUNExplore) and the Swiss National Science Foundation (grant no. 141254). A. L. is supported by the Helmut Horten Foundation.	Adams O, 2010, CLIN INFECT DIS, V51, P185, DOI 10.1086/653534; [Anonymous], 2013, FIELDS VIROLOGY; BEELER JA, 1989, J VIROL, V63, P2941, DOI 10.1128/JVI.63.7.2941-2950.1989; Bonville CA, 2004, J VIROL, V78, P7984, DOI 10.1128/JVI.78.15.7984-7989.2004; Calder LJ, 2000, VIROLOGY, V271, P122, DOI 10.1006/viro.2000.0279; Connolly SA, 2006, P NATL ACAD SCI USA, V103, P17903, DOI 10.1073/pnas.0608678103; Corti D, 2013, ANNU REV IMMUNOL, V31, P705, DOI 10.1146/annurev-immunol-032712-095916; de Fontbrune FS, 2007, CLIN INFECT DIS, V45, P1019, DOI 10.1086/521912; Domachowske Joseph B, 2004, Pediatr Infect Dis J, V23, pS228, DOI 10.1097/01.inf.0000144672.81955.a4; Durbin JE, 2002, J IMMUNOL, V168, P2944, DOI 10.4049/jimmunol.168.6.2944; Edwards KM, 2013, NEW ENGL J MED, V368, P633, DOI 10.1056/NEJMoa1204630; Edwards MR, 2012, NAT REV MICROBIOL, V10, P459, DOI 10.1038/nrmicro2801; Falsey AR, 2005, NEW ENGL J MED, V352, P1749, DOI 10.1056/NEJMoa043951; Greensill J, 2003, EMERG INFECT DIS, V9, P372, DOI 10.3201/eid0903.020289; GROOTHUIS JR, 1995, PEDIATRICS, V95, P463; Hall CB, 2009, NEW ENGL J MED, V360, P588, DOI 10.1056/NEJMoa0804877; Kwakkenbos MJ, 2010, NAT MED, V16, P123, DOI 10.1038/nm.2071; Lefranc MP, 2009, NUCLEIC ACIDS RES, V37, pD1006, DOI 10.1093/nar/gkn838; Magro M, 2012, P NATL ACAD SCI USA, V109, P3089, DOI 10.1073/pnas.1115941109; McLellan JS, 2013, SCIENCE, V340, P1113, DOI 10.1126/science.1234914; McLellan JS, 2010, J VIROL, V84, P12236, DOI 10.1128/JVI.01579-10; Null D, 1998, PEDIATRICS, V102, P531, DOI 10.1542/peds.102.3.531; Shah JN, 2011, BLOOD, V117, P2755, DOI 10.1182/blood-2010-08-263400; Slootstra JW, 1996, MOL DIVERS, V1, P87, DOI 10.1007/BF01721323; Swanson KA, 2011, P NATL ACAD SCI USA, V108, P9619, DOI 10.1073/pnas.1106536108; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tiller T, 2008, J IMMUNOL METHODS, V329, P112, DOI 10.1016/j.jim.2007.09.017; Timmerman P, 2007, J MOL RECOGNIT, V20, P283, DOI 10.1002/jmr.846; Traggiai E, 2004, NAT MED, V10, P871, DOI 10.1038/nm1080; Ulbrandt ND, 2006, J VIROL, V80, P7799, DOI 10.1128/JVI.00318-06; van den Hoogen BG, 2001, NAT MED, V7, P719, DOI 10.1038/89098; Williams JV, 2004, NEW ENGL J MED, V350, P443, DOI 10.1056/NEJMoa025472; Wyde PR, 2003, ANTIVIR RES, V60, P51, DOI 10.1016/S0166-3542(03)00153-0; Zhao XD, 2004, VIROLOGY, V318, P608, DOI 10.1016/j.virol.2003.10.018; Zhu Q, 2012, J INFECT DIS, V205, P635, DOI 10.1093/infdis/jir790	35	175	199	2	43	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 19	2013	501	7467					439	+		10.1038/nature12442	http://dx.doi.org/10.1038/nature12442			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219XT	23955151				2022-12-24	WOS:000324545700050
J	Nishihara, R; Wu, KN; Lochhead, P; Morikawa, T; Liao, XY; Qian, ZR; Inamura, K; Kim, SA; Kuchiba, A; Yamauchi, M; Imamura, Y; Willett, WC; Rosner, BA; Fuchs, CS; Giovannucci, E; Ogino, S; Chan, AT				Nishihara, Reiko; Wu, Kana; Lochhead, Paul; Morikawa, Teppei; Liao, Xiaoyun; Qian, Zhi Rong; Inamura, Kentaro; Kim, Sun A.; Kuchiba, Aya; Yamauchi, Mai; Imamura, Yu; Willett, Walter C.; Rosner, Bernard A.; Fuchs, Charles S.; Giovannucci, Edward; Ogino, Shuji; Chan, Andrew T.			Long-Term Colorectal-Cancer Incidence and Mortality after Lower Endoscopy	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							RANDOMIZED CONTROLLED-TRIAL; COLLEGE-OF-RADIOLOGY; SOCIETY TASK-FORCE; NEGATIVE COLONOSCOPY; AMERICAN-COLLEGE; SCREENING COLONOSCOPY; INTERVAL CANCERS; FAMILY-HISTORY; COLON-CANCER; RISK	BackgroundColonoscopy and sigmoidoscopy provide protection against colorectal cancer, but the magnitude and duration of protection, particularly against cancer of the proximal colon, remain uncertain. MethodsWe examined the association of the use of lower endoscopy (updated biennially from 1988 through 2008) with colorectal-cancer incidence (through June 2010) and colorectal-cancer mortality (through June 2012) among participants in the Nurses' Health Study and the Health Professionals Follow-up Study. ResultsAmong 88,902 participants followed over a period of 22 years, we documented 1815 incident colorectal cancers and 474 deaths from colorectal cancer. With endoscopy as compared with no endoscopy, multivariate hazard ratios for colorectal cancer were 0.57 (95% confidence interval [CI], 0.45 to 0.72) after polypectomy, 0.60 (95% CI, 0.53 to 0.68) after negative sigmoidoscopy, and 0.44 (95% CI, 0.38 to 0.52) after negative colonoscopy. Negative colonoscopy was associated with a reduced incidence of proximal colon cancer (multivariate hazard ratio, 0.73; 95% CI, 0.57 to 0.92). Multivariate hazard ratios for death from colorectal cancer were 0.59 (95% CI, 0.45 to 0.76) after screening sigmoidoscopy and 0.32 (95% CI, 0.24 to 0.45) after screening colonoscopy. Reduced mortality from proximal colon cancer was observed after screening colonoscopy (multivariate hazard ratio, 0.47; 95% CI, 0.29 to 0.76) but not after sigmoidoscopy. As compared with colorectal cancers diagnosed in patients more than 5 years after colonoscopy or without any prior endoscopy, those diagnosed in patients within 5 years after colonoscopy were more likely to be characterized by the CpG island methylator phenotype (CIMP) (multivariate odds ratio, 2.19; 95% CI, 1.14 to 4.21) and microsatellite instability (multivariate odds ratio, 2.10; 95% CI, 1.10 to 4.02). ConclusionsColonoscopy and sigmoidoscopy were associated with a reduced incidence of cancer of the distal colorectum; colonoscopy was also associated with a modest reduction in the incidence of proximal colon cancer. Screening colonoscopy and sigmoidoscopy were associated with reduced colorectal-cancer mortality; only colonoscopy was associated with reduced mortality from proximal colon cancer. Colorectal cancer diagnosed within 5 years after colonoscopy was more likely than cancer diagnosed after that period or without prior endoscopy to have CIMP and microsatellite instability.	[Nishihara, Reiko; Lochhead, Paul; Morikawa, Teppei; Liao, Xiaoyun; Qian, Zhi Rong; Inamura, Kentaro; Kim, Sun A.; Kuchiba, Aya; Yamauchi, Mai; Imamura, Yu; Fuchs, Charles S.; Ogino, Shuji] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Nishihara, Reiko; Lochhead, Paul; Morikawa, Teppei; Liao, Xiaoyun; Qian, Zhi Rong; Inamura, Kentaro; Kim, Sun A.; Kuchiba, Aya; Yamauchi, Mai; Imamura, Yu; Fuchs, Charles S.; Ogino, Shuji] Harvard Univ, Sch Med, Boston, MA USA; [Nishihara, Reiko; Wu, Kana; Kuchiba, Aya; Willett, Walter C.; Giovannucci, Edward] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; [Willett, Walter C.; Giovannucci, Edward; Ogino, Shuji] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Rosner, Bernard A.] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; [Wu, Kana; Willett, Walter C.; Rosner, Bernard A.; Fuchs, Charles S.; Giovannucci, Edward; Chan, Andrew T.] Brigham & Womens Hosp, Dept Med, Channing Div Network Med, Boston, MA 02115 USA; [Ogino, Shuji] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; [Chan, Andrew T.] Massachusetts Gen Hosp, Div Gastroenterol, Boston, MA 02114 USA; [Lochhead, Paul] Univ Aberdeen, Inst Med Sci, Gastrointestinal Res Grp, Aberdeen, Scotland; [Morikawa, Teppei] Tokyo Univ Hosp, Dept Pathol, Tokyo 113, Japan; [Inamura, Kentaro] NCI, Human Carcinogenesis Lab, NIH, Bethesda, MD 20892 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Massachusetts General Hospital; University of Aberdeen; University of Tokyo; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Chan, AT (corresponding author), Massachusetts Gen Hosp, Div Gastroenterol, 55 Fruit St,GRJ 825C, Boston, MA 02114 USA.	achan@partners.org	Chan, Andrew T/P-8293-2014; Inamura, Kentaro/G-4229-2018; Kim, Sun A/L-4239-2013	Chan, Andrew T/0000-0001-7284-6767; Inamura, Kentaro/0000-0001-6444-3861; Kim, Sun A/0000-0002-0891-2093; Ogino, Shuji/0000-0002-3909-2323	National Institutes of Health; Chief Scientist Office [CAF/10/15] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [R01CA137178, P01CA087969, P50CA127003, UM1CA167552, R01CA151993, P01CA055075] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK043351, K24DK098311] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Chief Scientist Office; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Funded by the National Institutes of Health and others.	[Anonymous], 2008, ANN INTERN MED, V149, P627; Arain MA, 2010, AM J GASTROENTEROL, V105, P1189, DOI 10.1038/ajg.2009.699; Atkin WS, 2010, LANCET, V375, P1624, DOI 10.1016/S0140-6736(10)60551-X; Baxter NN, 2012, J CLIN ONCOL, V30, P2664, DOI 10.1200/JCO.2011.40.4772; Brenner H, 2012, GUT, V61, P1576, DOI 10.1136/gutjnl-2011-301531; Brenner H, 2012, J CLIN ONCOL, V30, P2969, DOI 10.1200/JCO.2011.41.3377; Brenner H, 2011, J CLIN ONCOL, V29, P3761, DOI 10.1200/JCO.2011.35.9307; Brenner H, 2010, J NATL CANCER I, V102, P89, DOI 10.1093/jnci/djp436; Bressler B, 2007, GASTROENTEROLOGY, V132, P96, DOI 10.1053/j.gastro.2006.10.027; Bretthauer M, 2009, NEW ENGL J MED, V361, P300, DOI 10.1056/NEJMe0903924; Burnett-Hartman AN, 2013, CANCER RES, V73, P2863, DOI 10.1158/0008-5472.CAN-12-3462; Cottet V, 2012, GUT, V61, P1180, DOI 10.1136/gutjnl-2011-300295; GIOVANNUCCI E, 1995, ANN INTERN MED, V122, P327, DOI 10.7326/0003-4819-122-5-199503010-00002; Hoff G, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1846; Imperiale TF, 2008, NEW ENGL J MED, V359, P1218, DOI 10.1056/NEJMoa0803597; Inadomi JM, 2012, NEW ENGL J MED, V366, P2421, DOI 10.1056/NEJMe1204099; Kaminski MF, 2010, NEW ENGL J MED, V362, P1795, DOI 10.1056/NEJMoa0907667; Lakoff J, 2008, CLIN GASTROENTEROL H, V6, P1117, DOI 10.1016/j.cgh.2008.05.016; Levin B, 2008, CA-CANCER J CLIN, V58, P130, DOI 10.3322/CA.2007.0018; Liao XY, 2012, NEW ENGL J MED, V367, P1596, DOI 10.1056/NEJMoa1207756; Lieberman DA, 2007, GASTROENTEROLOGY, V133, P1077, DOI 10.1053/j.gastro.2007.07.006; Lieberman DA, 2012, GASTROENTEROLOGY, V143, P844, DOI 10.1053/j.gastro.2012.06.001; McFarland EG, 2008, RADIOLOGY, V248, P717, DOI 10.1148/radiol.2483080842; Ogino S, 2013, JNCI-J NATL CANCER I, V105, P130, DOI 10.1093/jnci/djs482; Ogino S, 2009, GUT, V58, P90, DOI 10.1136/gut.2008.155473; Pohl H, 2013, GASTROENTEROLOGY, V144, P74, DOI 10.1053/j.gastro.2012.09.043; Rex DK, 2012, AM J GASTROENTEROL, V107, P1315, DOI 10.1038/ajg.2012.161; Rex DK, 2009, AM J GASTROENTEROL, V104, P739, DOI 10.1038/ajg.2009.104; Sanduleanu S, 2012, NAT REV GASTRO HEPAT, V9, P550, DOI 10.1038/nrgastro.2012.136; Sarna L, 2008, QUAL LIFE RES, V17, P1217, DOI 10.1007/s11136-008-9404-8; Schoen RE, 2012, NEW ENGL J MED, V366, P2345, DOI 10.1056/NEJMoa1114635; Segnan N, 2011, J NATL CANCER I, V103, P1310, DOI 10.1093/jnci/djr284; Shaukat A, 2012, DIGEST DIS SCI, V57, P913, DOI 10.1007/s10620-011-1974-6; Singh H, 2006, JAMA-J AM MED ASSOC, V295, P2366, DOI 10.1001/jama.295.20.2366; Spiegelman D, 2007, CANCER CAUSE CONTROL, V18, P571, DOI 10.1007/s10552-006-0090-y; van Dam RM, 2008, BRIT MED J, V337, pa1440, DOI [DOI 10.1136/BMJ.A1440, 10.1136/bmj.a1440]; Wark PA, 2009, INT J CANCER, V125, P413, DOI 10.1002/ijc.24288; WINAWER SJ, 1993, NEW ENGL J MED, V329, P1977, DOI 10.1056/NEJM199312303292701; Zauber AG, 2012, NEW ENGL J MED, V366, P687, DOI 10.1056/NEJMoa1100370	39	937	966	4	72	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 19	2013	369	12					1095	1105		10.1056/NEJMoa1301969	http://dx.doi.org/10.1056/NEJMoa1301969			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	220BD	24047059	Green Accepted			2022-12-24	WOS:000324554800007
J	Chefdeville, S; Kalugina, Y; van de Meerakker, SYT; Naulin, C; Lique, F; Costes, M				Chefdeville, Simon; Kalugina, Yulia; van de Meerakker, Sebastiaan Y. T.; Naulin, Christian; Lique, Francois; Costes, Michel			Observation of Partial Wave Resonances in Low-Energy O-2-H-2 Inelastic Collisions	SCIENCE			English	Article							ORBITING RESONANCES; SCATTERING; STATES; AR	Partial wave resonances predicted to occur in bimolecular collision processes have proven challenging to observe experimentally. Here, we report crossed-beam experiments and quantum-scattering calculations on inelastic collisions between ground-state O-2 and H-2 molecules that provide state-to-state cross sections for rotational excitation of O-2 (rotational state N = 1, j = 0) to O-2 (N = 1, j = 1) in the vicinity of the thermodynamic threshold at 3.96 centimeter(-1). The close agreement between experimental and theoretical results confirms the classically forbidden character of this collision-induced transition, which occurs exclusively in a purely quantum mechanical regime via shape and Feshbach resonances arising from partial waves with total angular momentum (J) = 2 to 4.	[Chefdeville, Simon; Naulin, Christian; Costes, Michel] Univ Bordeaux, Inst Sci Mol, F-33400 Talence, France; [Chefdeville, Simon; Naulin, Christian; Costes, Michel] CNRS, UMR 5255, F-33400 Talence, France; [Kalugina, Yulia; Lique, Francois] Univ Havre, CNRS, Lab Ondes & Milieux Complexes, UMR 6294, F-76058 Le Havre, France; [Kalugina, Yulia] Tomsk State Univ, Dept Opt & Spectroscopy, Tomsk 634050, Russia; [van de Meerakker, Sebastiaan Y. T.] Radboud Univ Nijmegen, Inst Mol & Mat, NL-6525 AJ Nijmegen, Netherlands	UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); Universite Le Havre Normandie; Tomsk State University; Radboud University Nijmegen	Costes, M (corresponding author), Univ Bordeaux, Inst Sci Mol, F-33400 Talence, France.	francois.lique@univ-lehavre.fr; michel.costes@u-bordeaux1.fr	Lique, François/B-9626-2011; Naulin, Christian/S-3963-2019; Kalugina, Yulia/L-9997-2018; LIQUE, François/ABG-5769-2020; van de Meerakker, Sebastiaan Y.T./D-4581-2012	Lique, François/0000-0002-0664-2536; Naulin, Christian/0000-0002-4356-0484; Kalugina, Yulia/0000-0001-7642-3518; LIQUE, François/0000-0002-0664-2536; 	Agence Nationale de la Recherche [ANR-12-BS05-0011-02]; Conseil Regional d'Aquitaine [2007.1221]; Partenariat Hubert Curien Van Gogh [2013-28484TH]; Netherlands Organisation for Scientific Research (NWO) via a VIDI; High Performance Computing SKIF-Cyberia (Tomsk State University); CNRS national program Physique et Chimie du Milieu Interstellaire; Contrat de Projets Etat-Region Haute-Normandie/Centre National de Recherche Technologique/Energie, Electronique, Materiaux	Agence Nationale de la Recherche(French National Research Agency (ANR)); Conseil Regional d'Aquitaine(Region Nouvelle-Aquitaine); Partenariat Hubert Curien Van Gogh; Netherlands Organisation for Scientific Research (NWO) via a VIDI(Netherlands Organization for Scientific Research (NWO)); High Performance Computing SKIF-Cyberia (Tomsk State University); CNRS national program Physique et Chimie du Milieu Interstellaire; Contrat de Projets Etat-Region Haute-Normandie/Centre National de Recherche Technologique/Energie, Electronique, Materiaux(Region Normandie)	This work extends the objectives of ANR-12-BS05-0011-02 contract with the Agence Nationale de la Recherche and contract 2007.1221 with the Conseil Regional d'Aquitaine, for which financial support is gratefully acknowledged. S. C., S.Y.T.v.d.M., C.N., and M. C. acknowledge support of Partenariat Hubert Curien Van Gogh 2013-28484TH contract. S.Y.T.v.d.M. acknowledges support from the Netherlands Organisation for Scientific Research (NWO) via a VIDI grant and from the Universite de Bordeaux for a visiting professorship. Y.K. acknowledges the support of High Performance Computing SKIF-Cyberia (Tomsk State University). Y.K. and F. L. acknowledge the financial support of the CNRS national program Physique et Chimie du Milieu Interstellaire and of the Contrat de Projets Etat-Region Haute-Normandie/Centre National de Recherche Technologique/Energie, Electronique, Materiaux.	ALEXANDER MH, 1983, J CHEM PHYS, V79, P302, DOI 10.1063/1.445578; ALEXANDER MH, 1994, J CHEM PHYS, V101, P2887, DOI 10.1063/1.468431; Chandler DW, 2010, J CHEM PHYS, V132, DOI 10.1063/1.3357286; Chefdeville S, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.023201; COLBERT DT, 1992, J CHEM PHYS, V96, P1982, DOI 10.1063/1.462100; Dong WR, 2010, SCIENCE, V327, P1501, DOI 10.1126/science.1185694; FESHBACH H, 1958, ANN PHYS-NEW YORK, V5, P357, DOI 10.1016/0003-4916(58)90007-1; GRACE RS, 1977, J CHEM PHYS, V67, P2443, DOI 10.1063/1.435217; Henson AB, 2012, SCIENCE, V338, P234, DOI 10.1126/science.1229141; Hutson J. M, MOLSCAT COMPUTER COD; Kalugina Y, 2012, PHYS CHEM CHEM PHYS, V14, P16458, DOI 10.1039/c2cp42212c; Lara M, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.133201; Larsson B, 2007, ASTRON ASTROPHYS, V466, P999, DOI 10.1051/0004-6361:20065500; LEVINE RD, 1987, MOL REACTION DYNAMIC; Lique F, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2723733; Lique F, 2010, J CHEM PHYS, V132, DOI 10.1063/1.3299283; Pentlehner D, 2009, REV SCI INSTRUM, V80, DOI 10.1063/1.3117196; PRATT ST, 1984, CHEM PHYS LETT, V105, P28, DOI 10.1016/0009-2614(84)80408-X; Schatz GC, 2000, SCIENCE, V288, P1599, DOI 10.1126/science.288.5471.1599; SCHUTTE A, 1972, PHYS REV LETT, V29, P979, DOI 10.1103/PhysRevLett.29.979; Skodje RT, 2000, PHYS REV LETT, V85, P1206, DOI 10.1103/PhysRevLett.85.1206; TOENNIES JP, 1979, J CHEM PHYS, V71, P614, DOI 10.1063/1.438414; YOKELSON RJ, 1992, J CHEM PHYS, V97, P6153, DOI 10.1063/1.463724	23	96	96	1	75	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 6	2013	341	6150					1094	1096		10.1126/science.1241395	http://dx.doi.org/10.1126/science.1241395			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	211TG	24009389				2022-12-24	WOS:000323933100039
J	King, IF; Yandava, CN; Mabb, AM; Hsiao, JS; Huang, HS; Pearson, BL; Calabrese, JM; Starmer, J; Parker, JS; Magnuson, T; Chamberlain, SJ; Philpot, BD; Zylka, MJ				King, Ian F.; Yandava, Chandri N.; Mabb, Angela M.; Hsiao, Jack S.; Huang, Hsien-Sung; Pearson, Brandon L.; Calabrese, J. Mauro; Starmer, Joshua; Parker, Joel S.; Magnuson, Terry; Chamberlain, Stormy J.; Philpot, Benjamin D.; Zylka, Mark J.			Topoisomerases facilitate transcription of long genes linked to autism	NATURE			English	Article							RNA-POLYMERASE-II; DE-NOVO MUTATIONS; SPECTRUM DISORDERS; EXPRESSION SIGNATURES; BETA; CHROMATIN; UBE3A; CAMPTOTHECIN; TEMPLATE; ANGELMAN	Topoisomerases are expressed throughout the developing and adult brain and are mutated in some individuals with autism spectrum disorder (ASD). However, how topoisomerases are mechanistically connected to ASD is unknown. Here we find that topotecan, a topoisomerase 1 (TOP1) inhibitor, dose-dependently reduces the expression of extremely long genes in mouse and human neurons, including nearly all genes that are longer than 200 kilobases. Expression of long genes is also reduced after knockdown of Top1 or Top2b in neurons, highlighting that both enzymes are required for full expression of long genes. By mapping RNA polymerase II density genome-wide in neurons, we found that this length-dependent effect on gene expression was due to impaired transcription elongation. Interestingly, many high-confidence ASD candidate genes are exceptionally long and were reduced in expression after TOP1 inhibition. Our findings suggest that chemicals and genetic mutations that impair topoisomerases could commonly contribute to ASD and other neurodevelopmental disorders.	[King, Ian F.; Mabb, Angela M.; Huang, Hsien-Sung; Pearson, Brandon L.; Philpot, Benjamin D.; Zylka, Mark J.] Univ N Carolina, Dept Cell Biol & Physiol, Chapel Hill, NC 27599 USA; [Yandava, Chandri N.; Philpot, Benjamin D.; Zylka, Mark J.] Univ N Carolina, Carolina Inst Dev Disabil, Chapel Hill, NC 27599 USA; [Hsiao, Jack S.; Chamberlain, Stormy J.] Univ Connecticut, Ctr Hlth, Dept Genet & Dev Biol, Farmington, CT 06032 USA; [Calabrese, J. Mauro; Starmer, Joshua; Parker, Joel S.; Magnuson, Terry] Univ N Carolina, Dept Genet, Chapel Hill, NC 27599 USA; [Parker, Joel S.; Magnuson, Terry] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Philpot, Benjamin D.; Zylka, Mark J.] Univ N Carolina, UNC Neurosci Ctr, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of Connecticut; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Philpot, BD (corresponding author), Univ N Carolina, Dept Cell Biol & Physiol, Chapel Hill, NC 27599 USA.	bphilpot@med.unc.edu; zylka@med.unc.edu	HSIAO, JACK S/R-6661-2016; Pearson, Brandon/AAC-5261-2020; Parker, Joel/AAG-1108-2019	HSIAO, JACK S/0000-0002-0105-0419; Pearson, Brandon/0000-0003-4807-137X; Mabb, Angela/0000-0002-3000-8690; Huang, Hsien-Sung/0000-0003-2657-3635; King, Ian/0000-0003-3405-9767	NICHD NIH HHS [T32HD040127, P30 HD003110, T32 HD040127, R01HD068730, R01 HD068730, P30HD03110] Funding Source: Medline; NIGMS NIH HHS [R01 GM101974, R01GM101974] Funding Source: Medline; NIMH NIH HHS [R01 MH093372, R01MH093372] Funding Source: Medline; NINDS NIH HHS [P30NS045892, P30 NS045892] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD068730, T32HD040127, P30HD003110] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM101974] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH093372] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS045892] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Abrahams BS, 2008, NAT REV GENET, V9, P341, DOI 10.1038/nrg2346; Babak T, 2008, CURR BIOL, V18, P1735, DOI 10.1016/j.cub.2008.09.044; Baranello L, 2012, BBA-GENE REGUL MECH, V1819, P632, DOI 10.1016/j.bbagrm.2011.12.007; Basu SN, 2009, NUCLEIC ACIDS RES, V37, pD832, DOI 10.1093/nar/gkn835; Ben-David E., 2012, MOL PSYCHIAT; Betancur C, 2009, TRENDS NEUROSCI, V32, P402, DOI 10.1016/j.tins.2009.04.003; Capranico G, 2010, BBA-REV CANCER, V1806, P240, DOI 10.1016/j.bbcan.2010.06.003; Carson JP, 2004, CANCER RES, V64, P2096, DOI 10.1158/0008-5472.CAN-03-2029; Chamberlain SJ, 2010, P NATL ACAD SCI USA, V107, P17668, DOI 10.1073/pnas.1004487107; Christensen J, 2013, JAMA-J AM MED ASSOC, V309, P1696, DOI 10.1001/jama.2013.2270; Collins I, 2001, MOL CELL BIOL, V21, P8437, DOI 10.1128/MCB.21.24.8437-8451.2001; Cook EH, 1997, AM J HUM GENET, V60, P928; Delorme R, 2013, NAT MED, V19, P685, DOI 10.1038/nm.3193; Forsberg EC, 2000, BLOOD, V96, P334, DOI 10.1182/blood.V96.1.334.013k17_334_339; Groschel B, 2005, J VIROL, V79, P5695, DOI 10.1128/JVI.79.9.5695-5704.2005; Hammer E, 2007, FEBS LETT, V581, P5418, DOI 10.1016/j.febslet.2007.10.040; Huang HS, 2012, NATURE, V481, P185, DOI 10.1038/nature10726; Iorio F, 2010, P NATL ACAD SCI USA, V107, P14621, DOI 10.1073/pnas.1000138107; Iossifov I, 2012, NEURON, V74, P285, DOI 10.1016/j.neuron.2012.04.009; Joshi RS, 2012, NUCLEIC ACIDS RES, V40, P7907, DOI 10.1093/nar/gks626; Lamb J, 2006, SCIENCE, V313, P1929, DOI 10.1126/science.1132939; Landers M, 2004, NUCLEIC ACIDS RES, V32, P3480, DOI 10.1093/nar/gkh670; LIU LF, 1987, P NATL ACAD SCI USA, V84, P7024, DOI 10.1073/pnas.84.20.7024; Ljungman M, 1996, CARCINOGENESIS, V17, P31, DOI 10.1093/carcin/17.1.31; Lyu YL, 2006, MOL CELL BIOL, V26, P7929, DOI 10.1128/MCB.00617-06; Mabb AM, 2011, TRENDS NEUROSCI, V34, P293, DOI 10.1016/j.tins.2011.04.001; MacIsaac JL, 2012, NUCLEIC ACIDS RES, V40, P1523, DOI 10.1093/nar/gkr871; Meng LY, 2012, HUM MOL GENET, V21, P3001, DOI 10.1093/hmg/dds130; Moreno-De-Luca D, 2012, MOL PSYCHIAT; Muse GW, 2007, NAT GENET, V39, P1507, DOI 10.1038/ng.2007.21; Naughton C, 2013, NAT STRUCT MOL BIOL, V20, P387, DOI 10.1038/nsmb.2509; Neale BM, 2012, NATURE, V485, P242, DOI 10.1038/nature11011; O'Roak BJ, 2012, NATURE, V485, P246, DOI 10.1038/nature10989; Peca J, 2012, CURR OPIN NEUROBIOL, V22, P866, DOI 10.1016/j.conb.2012.02.015; Plaschkes I, 2005, J COMP NEUROL, V493, P357, DOI 10.1002/cne.20793; Pommier Y, 2013, ACS CHEM BIOL, V8, P82, DOI 10.1021/cb300648v; Rahl PB, 2010, CELL, V141, P432, DOI 10.1016/j.cell.2010.03.030; Ronan JL, 2013, NAT REV GENET, V14, P347, DOI 10.1038/nrg3413; Sanders SJ, 2012, NATURE, V485, P237, DOI 10.1038/nature10945; Sano K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004103; State MW, 2011, NAT NEUROSCI, V14, P1499, DOI 10.1038/nn.2924; STEWART AF, 1990, CELL, V60, P141; Tiwari VK, 2012, P NATL ACAD SCI USA, V109, pE934, DOI 10.1073/pnas.1119798109; Troester MA, 2004, ENVIRON HEALTH PERSP, V112, P1607, DOI [10.1289/txg.7204, 10.1289/ehp.7204]; Vos SM, 2011, NAT REV MOL CELL BIO, V12, P827, DOI 10.1038/nrm3228; WU HY, 1988, CELL, V53, P433, DOI 10.1016/0092-8674(88)90163-8; Zeitlinger J, 2007, NAT GENET, V39, P1512, DOI 10.1038/ng.2007.26; Zhao X, 2007, P NATL ACAD SCI USA, V104, P12831, DOI 10.1073/pnas.0705803104	48	255	266	0	73	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 5	2013	501	7465					58	+		10.1038/nature12504	http://dx.doi.org/10.1038/nature12504			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	211ER	23995680	Green Submitted, Green Accepted			2022-12-24	WOS:000323888300031
J	Aragona, M; Panciera, T; Manfrin, A; Giulitti, S; Michielin, F; Elvassore, N; Dupont, S; Piccolo, S				Aragona, Mariaceleste; Panciera, Tito; Manfrin, Andrea; Giulitti, Stefano; Michielin, Federica; Elvassore, Nicola; Dupont, Sirio; Piccolo, Stefano			A Mechanical Checkpoint Controls Multicellular Growth through YAP/TAZ Regulation by Actin-Processing Factors	CELL			English	Article							HIPPO SIGNALING-PATHWAY; CELL CONTACT INHIBITION; TISSUE ARCHITECTURE; YAP PATHWAY; F-ACTIN; CANCER; PROLIFERATION; TAZ; TRANSDUCTION; INACTIVATION	Key cellular decisions, such as proliferation or growth arrest, typically occur at spatially defined locations within tissues. Loss of this spatial control is a hallmark of many diseases, including cancer. Yet, how these patterns are established is incompletely understood. Here, we report that physical and architectural features of a multicellular sheet inform cells about their proliferative capacity through mechanical regulation of YAP and TAZ, known mediators of Hippo signaling and organ growth. YAP/TAZ activity is confined to cells exposed to mechanical stresses, such as stretching, location at edges/curvatures contouring an epithelial sheet, or stiffness of the surrounding extracellular matrix. We identify the F-actin-capping/severing proteins Cofilin, CapZ, and Gelsolin as essential gatekeepers that limit YAP/TAZ activity in cells experiencing low mechanical stresses, including contact inhibition of proliferation. We propose that mechanical forces are overarching regulators of YAP/TAZ in multicellular contexts, setting responsiveness to Hippo, WNT, and GPCR signaling.	[Aragona, Mariaceleste; Panciera, Tito; Manfrin, Andrea; Dupont, Sirio; Piccolo, Stefano] Univ Padua, Sch Med, Dept Mol Med, I-35131 Padua, Italy; [Giulitti, Stefano; Michielin, Federica; Elvassore, Nicola] Univ Padua, Dept Ind Engn DII, I-35131 Padua, Italy	University of Padua; University of Padua	Dupont, S (corresponding author), Univ Padua, Sch Med, Dept Mol Med, Viale Colombo 3, I-35131 Padua, Italy.	dupont@bio.unipd.it; piccolo@bio.unipd.it	Dupont, Sirio/AAP-8133-2021; Manfrin, Andrea/AAC-1066-2020; Aragona, Mariaceleste/AAB-7307-2021	Manfrin, Andrea/0000-0002-1519-6582; Aragona, Mariaceleste/0000-0002-2239-3541; Panciera, Tito/0000-0002-9272-5716; PICCOLO, STEFANO/0000-0002-2037-0004; MICHIELIN, FEDERICA/0000-0003-2065-6851; Dupont, Sirio/0000-0002-6869-1966	AIRC-PI; PRIN-Miur; University of Padua; AIRC Special Program Molecular Clinical Oncology; HSFP; Excellence-IIT; Epigenetics Flagship project CNR-Miur	AIRC-PI(Fondazione AIRC per la ricerca sul cancro); PRIN-Miur(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN)); University of Padua; AIRC Special Program Molecular Clinical Oncology(Fondazione AIRC per la ricerca sul cancro); HSFP; Excellence-IIT; Epigenetics Flagship project CNR-Miur	We thank Michelangelo Cordenonsi, Francesca Zanconato, Elena Enzo, and Oliver Wessely for thoughtful discussion. This work is supported by AIRC-PI, PRIN-Miur and by a University of Padua grant to S. D. and by AIRC Special Program Molecular Clinical Oncology "5 per mille," HSFP, Excellence-IIT, and Epigenetics Flagship project CNR-Miur grants to S.P.	Azzolin L, 2012, CELL, V151, P1443, DOI 10.1016/j.cell.2012.11.027; Berrier AL, 2007, J CELL PHYSIOL, V213, P565, DOI 10.1002/jcp.21237; Butcher DT, 2009, NAT REV CANCER, V9, P108, DOI 10.1038/nrc2544; Cordenonsi M, 2011, CELL, V147, P759, DOI 10.1016/j.cell.2011.09.048; Discher DE, 2009, SCIENCE, V324, P1673, DOI 10.1126/science.1171643; Dupont S, 2011, NATURE, V474, P179, DOI 10.1038/nature10137; Fan R, 2013, P NATL ACAD SCI USA, V110, P2569, DOI 10.1073/pnas.1216462110; Fernandez BG, 2011, DEVELOPMENT, V138, P2337, DOI 10.1242/dev.063545; Guo CL, 2012, P NATL ACAD SCI USA, V109, P5576, DOI 10.1073/pnas.1114781109; Halder G, 2012, NAT REV MOL CELL BIO, V13, P591, DOI 10.1038/nrm3416; Harvey KF, 2013, NAT REV CANCER, V13, P246, DOI 10.1038/nrc3458; Huang S, 1999, NAT CELL BIOL, V1, pE131, DOI 10.1038/13043; Kim M, 2013, EMBO J, V32, P1543, DOI 10.1038/emboj.2013.102; Kim NG, 2011, P NATL ACAD SCI USA, V108, P11930, DOI 10.1073/pnas.1103345108; Lei QY, 2008, MOL CELL BIOL, V28, P2426, DOI 10.1128/MCB.01874-07; Luni C, 2013, BIOPHYS J, V104, P934, DOI 10.1016/j.bpj.2012.12.049; McClatchey AI, 2012, CURR OPIN CELL BIOL, V24, P685, DOI 10.1016/j.ceb.2012.06.009; Miranti CK, 2002, NAT CELL BIOL, V4, pE83, DOI 10.1038/ncb0402-e83; Nelson CM, 2006, ANNU REV CELL DEV BI, V22, P287, DOI 10.1146/annurev.cellbio.22.010305.104315; Nelson CM, 2005, P NATL ACAD SCI USA, V102, P11594, DOI 10.1073/pnas.0502575102; Pan DJ, 2010, DEV CELL, V19, P491, DOI 10.1016/j.devcel.2010.09.011; Paszek MJ, 2005, CANCER CELL, V8, P241, DOI 10.1016/j.ccr.2005.08.010; Pollard TD, 2009, SCIENCE, V326, P1208, DOI 10.1126/science.1175862; Ramos A, 2012, TRENDS CELL BIOL, V22, P339, DOI 10.1016/j.tcb.2012.04.006; Reginensi A, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003380; Rohn JL, 2011, J CELL BIOL, V194, P789, DOI 10.1083/jcb.201103168; Sansores-Garcia L, 2011, EMBO J, V30, P2325, DOI 10.1038/emboj.2011.157; Sasai Y, 2013, NATURE, V493, P318, DOI 10.1038/nature11859; Schlegelmilch K, 2011, CELL, V144, P782, DOI 10.1016/j.cell.2011.02.031; Schwartz MA, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a005066; Vogel V, 2006, NAT REV MOL CELL BIO, V7, P265, DOI 10.1038/nrm1890; Wada KI, 2011, DEVELOPMENT, V138, P3907, DOI 10.1242/dev.070987; Yu FX, 2012, CELL, V150, P780, DOI 10.1016/j.cell.2012.06.037; Zeng Q, 2008, CANCER CELL, V13, P188, DOI 10.1016/j.ccr.2008.02.011; Zhao B, 2007, GENE DEV, V21, P2747, DOI 10.1101/gad.1602907; Zhao B, 2012, GENE DEV, V26, P54, DOI 10.1101/gad.173435.111; Zhou DW, 2009, CANCER CELL, V16, P425, DOI 10.1016/j.ccr.2009.09.026	37	990	1008	20	262	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	AUG 29	2013	154	5					1047	1059		10.1016/j.cell.2013.07.042	http://dx.doi.org/10.1016/j.cell.2013.07.042			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	209OE	23954413	Bronze, Green Submitted			2022-12-24	WOS:000323767300018
J	Toyama, BH; Savas, JN; Park, SK; Harris, MS; Ingolia, NT; Yates, JR; Hetzer, MW				Toyama, Brandon H.; Savas, Jeffrey N.; Park, Sung Kyu; Harris, Michael S.; Ingolia, Nicholas T.; Yates, John R., III; Hetzer, Martin W.			Identification of Long-Lived Proteins Reveals Exceptional Stability of Essential Cellular Structures	CELL			English	Article							POSTTRANSLATIONAL MODIFICATIONS; PROTEOMIC ANALYSIS; IN-VIVO; LENS; TURNOVER; BRAIN; CELLS; CRYSTALLIN; DYNAMICS; PATTERNS	Intracellular proteins with long lifespans have recently been linked to age-dependent defects, ranging from decreased fertility to the functional decline of neurons. Why long-lived proteins exist in metabolically active cellular environments and how they are maintained over time remains poorly understood. Here, we provide a system-wide identification of proteins with exceptional lifespans in the rat brain. These proteins are inefficiently replenished despite being translated robustly throughout adulthood. Using nucleoporins as a paradigm for long-term protein persistence, we found that nuclear pore complexes (NPCs) are maintained over a cell's life through slow but finite exchange of even its most stable subcomplexes. This maintenance is limited, however, as some nucleoporin levels decrease during aging, providing a rationale for the previously observed age-dependent deterioration of NPC function. Our identification of a long-lived proteome reveals cellular components that are at increased risk for damage accumulation, linking long-term protein persistence to the cellular aging process.	[Toyama, Brandon H.; Hetzer, Martin W.] Salk Inst Biol Studies, Mol & Cell Biol Lab, La Jolla, CA 92037 USA; [Savas, Jeffrey N.; Park, Sung Kyu; Yates, John R., III] Scripps Res Inst, Dept Physiol Chem, La Jolla, CA 92037 USA; [Harris, Michael S.; Ingolia, Nicholas T.] Carnegie Inst Sci, Dept Embryol, Baltimore, MD 21218 USA; [Harris, Michael S.] Johns Hopkins Univ, Dept Biol, Baltimore, MD 21218 USA	Salk Institute; Scripps Research Institute; Carnegie Institution for Science; Johns Hopkins University	Yates, JR (corresponding author), Scripps Res Inst, Dept Physiol Chem, La Jolla, CA 92037 USA.	jyates@scripps.edu; hetzer@salk.edu		Toyama, Brandon/0000-0002-8355-9138	Hewitt Foundation; National Institutes of Health (NIH) [R01GM098749]; Glenn Aging Foundation; American Cancer Society [P30CA014195]; Ellison Medical Foundation; NIH [F32AG039127, P41 RR011823, P01 AG031097, R01 MH067880]; Searle Scholars Program; NATIONAL CANCER INSTITUTE [R01CA118232, P30CA014195] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR011823] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM098749, P41GM103533] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH067880] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG031097, F32AG039127] Funding Source: NIH RePORTER	Hewitt Foundation; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Glenn Aging Foundation; American Cancer Society(American Cancer Society); Ellison Medical Foundation(Lawrence Ellison Foundation); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Searle Scholars Program; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank members of the Hetzer laboratory and E. Q. Toyama for critical reading of the manuscript. B. H. T is supported by the Hewitt Foundation; M. W. H by the National Institutes of Health (NIH) grant R01GM098749, the Glenn Aging Foundation, the American Cancer Society Award Number P30CA014195, and the Ellison Medical Foundation; J.N.S. by NIH fellowship F32AG039127; J.R.Y. and J.N.S. by NIH P41 RR011823, P01 AG031097, and R01 MH067880; N.T.I. by the Searle Scholars Program. The RAW files and complete parameter files will be publically available at http://fields.scripps.edu/published/ELLP2/ upon publication. B. H. T. performed all biochemical fractionations, sorted NeuN nuclei and performed validation, conducted pore counting, and determined Nup protein levels in aging. J.N.S. performed isotopic labeling of rats and ran MS samples. B. H. T., J.N.S., and S. K. P, with direction from J.R.Y., analyzed the MS data. B. H. T., M. S. H., and N.T.I. determined protein translation rates. B. H. T. and M. W. H. wrote the manuscript.	Ahmad K, 2002, MOL CELL, V9, P1191, DOI 10.1016/S1097-2765(02)00542-7; ARBER N, 1988, LIVER, V8, P80; Bassnett S, 2002, EXP EYE RES, V74, P1, DOI 10.1006/exer.2001.1111; Bassnett S, 2011, PHILOS T R SOC B, V366, P1250, DOI 10.1098/rstb.2010.0302; Belle A, 2006, P NATL ACAD SCI USA, V103, P13004, DOI 10.1073/pnas.0605420103; BLOBEL G, 1966, SCIENCE, V154, P1662, DOI 10.1126/science.154.3757.1662; Bloemendal H, 2004, PROG BIOPHYS MOL BIO, V86, P407, DOI 10.1016/j.pbiomolbio.2003.11.012; Cambridge SB, 2011, J PROTEOME RES, V10, P5275, DOI 10.1021/pr101183k; COMMERFORD SL, 1982, P NATL ACAD SCI-BIOL, V79, P1163, DOI 10.1073/pnas.79.4.1163; Cronshaw JA, 2002, J CELL BIOL, V158, P915, DOI 10.1083/jcb.200206106; D'Angelo MA, 2008, TRENDS CELL BIOL, V18, P456, DOI 10.1016/j.tcb.2008.07.009; D'Angelo MA, 2009, CELL, V136, P284, DOI 10.1016/j.cell.2008.11.037; DUERRE JA, 1974, J NEUROCHEM, V23, P541, DOI 10.1111/j.1471-4159.1974.tb06057.x; Fontoura BMA, 1999, J CELL BIOL, V144, P1097, DOI 10.1083/jcb.144.6.1097; Guttinger S, 2009, NAT REV MOL CELL BIO, V10, P178, DOI 10.1038/nrm2641; Hake SB, 2006, J BIOL CHEM, V281, P559, DOI 10.1074/jbc.M509266200; Haus JM, 2007, J APPL PHYSIOL, V103, P2068, DOI 10.1152/japplphysiol.00670.2007; Hoelz A, 2011, ANNU REV BIOCHEM, V80, P613, DOI 10.1146/annurev-biochem-060109-151030; Ingolia NT, 2009, SCIENCE, V324, P218, DOI 10.1126/science.1168978; Kimura H, 2001, J CELL BIOL, V153, P1341, DOI 10.1083/jcb.153.7.1341; Kireeva ML, 2002, MOL CELL, V9, P541, DOI 10.1016/S1097-2765(02)00472-0; Kragstrup TW, 2011, SCAND J MED SCI SPOR, V21, P749, DOI 10.1111/j.1600-0838.2011.01377.x; Kuhn HG, 1996, J NEUROSCI, V16, P2027; Lee CK, 2000, NAT GENET, V25, P294, DOI 10.1038/77046; Li JY, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002879; LOVTRUPREIN H, 1966, J CELL BIOL, V30, P405, DOI 10.1083/jcb.30.2.405; MASTERS PM, 1977, NATURE, V268, P71, DOI 10.1038/268071a0; McClatchy DB, 2007, J PROTEOME RES, V6, P2005, DOI 10.1021/pr060599n; McDonald WH, 2004, RAPID COMMUN MASS SP, V18, P2162, DOI 10.1002/rcm.1603; Park SK, 2008, NAT METHODS, V5, P319, DOI [10.1038/NMETH.1195, 10.1038/nmeth.1195]; PIHA RS, 1966, J BIOL CHEM, V241, P2397; Price JC, 2010, P NATL ACAD SCI USA, V107, P14508, DOI 10.1073/pnas.1006551107; Rabut G, 2004, NAT CELL BIOL, V6, P1114, DOI 10.1038/ncb1184; RODRIGUE.G, 1971, BRAIN RES, V31, P179, DOI 10.1016/0006-8993(71)90642-1; ROY D, 1976, P NATL ACAD SCI USA, V73, P3484, DOI 10.1073/pnas.73.10.3484; Savas JN, 2012, SCIENCE, V335, P942, DOI 10.1126/science.1217421; Schwartz BE, 2005, GENE DEV, V19, P804, DOI 10.1101/gad.1259805; SHAPIRO SD, 1991, J CLIN INVEST, V87, P1828, DOI 10.1172/JCI115204; Sharma KK, 2009, BBA-GEN SUBJECTS, V1790, P1095, DOI 10.1016/j.bbagen.2009.05.008; Spalding KL, 2005, CELL, V122, P133, DOI 10.1016/j.cell.2005.04.028; Tachibana-Konwalski K, 2010, GENE DEV, V24, P2505, DOI 10.1101/gad.605910; Tsukada Y, 1992, MYELIN BIOL CHEM, P449; Vabulas RM, 2005, SCIENCE, V310, P1960, DOI 10.1126/science.1121925; Verzijl N, 2000, J BIOL CHEM, V275, P39027, DOI 10.1074/jbc.M006700200; Walther DM, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.004523; Washburn MP, 2001, NAT BIOTECHNOL, V19, P242, DOI 10.1038/85686; Wilmarth PA, 2006, J PROTEOME RES, V5, P2554, DOI 10.1021/pr050473a; WU RS, 1982, CELL, V31, P367, DOI 10.1016/0092-8674(82)90130-1	48	332	332	0	44	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 29	2013	154	5					971	982		10.1016/j.cell.2013.07.037	http://dx.doi.org/10.1016/j.cell.2013.07.037			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	209OE	23993091	Bronze, Green Accepted			2022-12-24	WOS:000323767300012
J	Klitzman, R; Appelbaum, PS; Chung, W				Klitzman, Robert; Appelbaum, Paul S.; Chung, Wendy			Return of Secondary Genomic Findings vs Patient Autonomy Implications for Medical Care	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Klitzman, Robert] Columbia Univ, Masters Bioeth Program, New York, NY 10032 USA; [Klitzman, Robert; Appelbaum, Paul S.] Columbia Univ, Dept Psychiat, Div Law Eth & Psychiat, New York, NY 10032 USA; [Chung, Wendy] Columbia Univ, Dept Pediat, New York, NY 10032 USA; [Chung, Wendy] Columbia Univ, Dept Med, New York, NY 10032 USA	Columbia University; Columbia University; Columbia University; Columbia University	Klitzman, R (corresponding author), Columbia Univ, Div Psychiat Law & Eth, 1051 Riverside Dr,Unit 15, New York, NY 10032 USA.	rlk2@columbia.edu	Appelbaum, Paul/AFU-3908-2022	Appelbaum, Paul/0000-0002-1940-0042	NHGRI NIH HHS [P20 HG005535, R01 HG006600, P50 HG007257, P20 HG005535-02, R21 HG006596] Funding Source: Medline; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG007257, R01HG006600, P20HG005535, R21HG006596] Funding Source: NIH RePORTER	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Fallat ME, 2013, PEDIATRICS, V131, P620, DOI 10.1542/peds.2012-3680; Green R, 2013, ACMG RECOMMENDATIONS; Green R. C., ACMG RECOMMENDATIONS; Joly Y, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-25; Ross LF, 2013, GENET MED, V15, P321, DOI [10.1038/gim.2012.176, 10.1038/gim.2013.39]; Wheeler DA, 2008, NATURE, V452, P872, DOI 10.1038/nature06884; Wolf SM, 2013, SCIENCE, V340, P1049, DOI 10.1126/science.1239119	7	62	63	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 24	2013	310	4					369	370		10.1001/jama.2013.41709	http://dx.doi.org/10.1001/jama.2013.41709			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	187LV	23917282	Green Accepted			2022-12-24	WOS:000322121500009
J	Peralta, EA; Soong, K; England, RJ; Colby, ER; Wu, Z; Montazeri, B; McGuinness, C; McNeur, J; Leedle, KJ; Walz, D; Sozer, EB; Cowan, B; Schwartz, B; Travish, G; Byer, RL				Peralta, E. A.; Soong, K.; England, R. J.; Colby, E. R.; Wu, Z.; Montazeri, B.; McGuinness, C.; McNeur, J.; Leedle, K. J.; Walz, D.; Sozer, E. B.; Cowan, B.; Schwartz, B.; Travish, G.; Byer, R. L.			Demonstration of electron acceleration in a laser-driven dielectric microstructure	NATURE			English	Article								The enormous size and cost of current state-of-the-art accelerators based on conventional radio-frequency technology has spawned great interest in the development of new acceleration concepts that are more compact and economical. Micro-fabricated dielectric laser accelerators (DLAs) are an attractive approach, because such dielectric microstructures can support accelerating fields one to two orders of magnitude higher than can radio-frequency cavity-based accelerators. DLAs use commercial lasers as a power source, which are smaller and less expensive than the radio-frequency klystrons that power today's accelerators. In addition, DLAs are fabricated via low-cost, lithographic techniques that can be used for mass production. However, despite several DLA structures having been proposed recently(1-4), no successful demonstration of acceleration in these structures has so far been shown. Here we report high-gradient (beyond 250 MeV m(-1)) acceleration of electrons in a DLA. Relativistic (60-MeV) electrons are energy-modulated over 563 +/- 104 optical periods of a fused silica grating structure, powered by a 800-nm-wavelength mode-locked Ti:sapphire laser. The observed results are in agreement with analytical models and electrodynamic simulations. By comparison, conventional modern linear accelerators operate at gradients of 10-30 MeV m(-1), and the first linear radio-frequency cavity accelerator was ten radio-frequency periods (one metre) long with a gradient of approximately 1.6 MeV m(-1) (ref. 5). Our results set the stage for the development of future multi-staged DLA devices composed of integrated on-chip systems. This would enable compact table-top accelerators on the MeV-GeV (10(6)-10(9) eV) scale for security scanners and medical therapy, university-scale X-ray light sources for biological and materials research, and portable medical imaging devices, and would substantially reduce the size and cost of a future collider on the multi-TeV (10(12) eV) scale.	[Peralta, E. A.; Soong, K.; McGuinness, C.; Byer, R. L.] Stanford Univ, Dept Appl Phys, Stanford, CA 94305 USA; [England, R. J.; Colby, E. R.; Wu, Z.; Walz, D.] SLAC Natl Accelerator Lab, Menlo Pk, CA 94025 USA; [Montazeri, B.; Leedle, K. J.] Stanford Univ, Dept Elect Engn, Stanford, CA 94305 USA; [McNeur, J.; Sozer, E. B.; Travish, G.] Univ Calif Los Angeles, Dept Phys & Astron, Los Angeles, CA 90024 USA; [Cowan, B.; Schwartz, B.] Tech X Corp, Boulder, CO 80303 USA	Stanford University; Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory; Stanford University; University of California System; University of California Los Angeles; Tech-X Corporation	Byer, RL (corresponding author), Stanford Univ, Dept Appl Phys, Stanford, CA 94305 USA.	rlbyer@stanford.edu	Wu, Ziran/G-2308-2014; Travish, Gil/H-4937-2011; Sozer, Esin B/AAA-5318-2020	Wu, Ziran/0000-0003-2009-991X; Travish, Gil/0000-0002-4787-0949; Sozer, Esin/0000-0002-6244-3670	US DoE [DE-FG03-92ER40693]; DARPA [N66001-11-1-4199]; NSF [ECS-9731293]; US Defense Threat Reduction Agency (DTRA) [HDTRA1-09-1-0043]	US DoE(United States Department of Energy (DOE)); DARPA(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); NSF(National Science Foundation (NSF)); US Defense Threat Reduction Agency (DTRA)(United States Department of DefenseDefense Threat Reduction Agency)	We thank R. Noble, J. Spencer, O. Solgaard and J. Harris for discussions, J. Nelson, D. McCormick and K. Jobe for technical assistance at SLAC, and M. Tang, M. Mansourpour, N. Latta, M. Stevens, J. Conway and U. Thumser for technical assistance at the Stanford Nanofabrication Facility (SNF). This work was supported by the US DoE (grant no. DE-FG03-92ER40693) and DARPA (grant no. N66001-11-1-4199). Device fabrication took place at SNF, which is supported by the NSF under grant ECS-9731293. Work by G. T., J. M. and E. B. S. supported by US Defense Threat Reduction Agency (DTRA) grant HDTRA1-09-1-0043.	Breuer J., PHYS REV LE IN PRESS; Colby E.R., 2011, P 2011 PARTICLE ACCE, P262; Cowan BM, 2008, PHYS REV SPEC TOP-AC, V11, DOI 10.1103/PhysRevSTAB.11.011301; Duris JP, 2012, PHYS REV SPEC TOP-AC, V15, DOI 10.1103/PhysRevSTAB.15.061301; Ganter R, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.064801; GINZTON EL, 1948, REV SCI INSTRUM, V19, P89, DOI 10.1063/1.1741225; Lin XE, 2001, PHYS REV SPEC TOP-AC, V4, DOI 10.1103/PhysRevSTAB.4.051301; MARSHALL TC, 1985, FREE ELECT LASERS, P24; Mizrahi A, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.016505; MIZUNO K, 1987, NATURE, V328, P45, DOI 10.1038/328045a0; Moulton PF, 2009, IEEE J SEL TOP QUANT, V15, P85, DOI 10.1109/JSTQE.2008.2010719; PALMER RB, 1972, J APPL PHYS, V43, P3014, DOI 10.1063/1.1661650; Peralta EA, 2012, AIP CONF PROC, V1507, P169, DOI 10.1063/1.4773690; PIESTRUP MA, 1975, J APPL PHYS, V46, P132, DOI 10.1063/1.321334; Plettner T, 2008, NUCL INSTRUM METH A, V593, P63, DOI 10.1016/j.nima.2008.04.063; Plettner T, 2006, PHYS REV SPEC TOP-AC, V9, DOI 10.1103/PhysRevSTAB.9.111301; Plettner T, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.134801; Plettner T, 2011, J MOD OPTIC, V58, P1518, DOI 10.1080/09500340.2011.611914; Roberts Thomas J., 2007, 2007 IEEE Particle Accelerator Conference, P3468, DOI 10.1109/PAC.2007.4440461; Sears CMS, 2008, PHYS REV SPEC TOP-AC, V11, DOI 10.1103/PhysRevSTAB.11.061301; SHIMODA K, 1962, APPL OPTICS, V1, P33, DOI 10.1364/AO.1.000033; Siemann RH, 2004, PHYS REV SPEC TOP-AC, V7, DOI 10.1103/PhysRevSTAB.7.061303; Soong K, 2012, AIP CONF PROC, V1507, P511, DOI 10.1063/1.4773749; TAKEDA Y, 1968, NUCL INSTRUM METHODS, V62, P306, DOI 10.1016/0029-554X(68)90378-9; Thompson MC, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.214801; vanSteenbergen A, 1996, PHYS REV LETT, V77, P2690, DOI 10.1103/PhysRevLett.77.2690; WARNER C, 1954, PHYS REV, V93, P406, DOI 10.1103/PhysRev.93.406	27	312	315	11	186	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 7	2013	503	7474					91	+		10.1038/nature12664	http://dx.doi.org/10.1038/nature12664			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247AS	24077116				2022-12-24	WOS:000326585600037
J	Konno, H; Konno, K; Barber, GN				Konno, Hiroyasu; Konno, Keiko; Barber, Glen N.			Cyclic Dinucleotides Trigger ULK1 (ATG1) Phosphorylation of STING to Prevent Sustained Innate Immune Signaling	CELL			English	Article							TOLL-LIKE RECEPTORS; GMP-AMP SYNTHASE; DNA SENSOR; CGAS; 2ND-MESSENGER; AUTOPHAGY; PATHWAY; DISEASE; ADAPTER; FAMILY	Activation of the stimulator of interferon genes (STING) pathway by microbial or self-DNA, as well as cyclic dinucleotides (CDNs), results in the induction of numerous genes that suppress pathogen replication and facilitate adaptive immunity. However, sustained gene transcription is rigidly prevented to avoid lethal STING-dependent proinflammatory disease by mechanisms that remain unknown. We demonstrate here that, after autophagy-dependent STING delivery of TANK-binding kinase 1 (TBK1) to endosomal/lysosomal compartments and activation of transcription factors interferon regulatory factor 3 (IRF3) and NF-kB, STING is subsequently phosphorylated by serine/threonine UNC-51-like kinase (ULK1/ATG1), and IRF3 function is suppressed. ULK1 activation occurred following disassociation from its repressor AMP activated protein kinase (AMPK) and was elicited by CDNs generated by the cGAMP synthase, cGAS. Thus, although CDNs may initially facilitate STING function, they subsequently trigger negative-feedback control of STING activity, thus preventing the persistent transcription of innate immune genes.	[Konno, Hiroyasu; Konno, Keiko; Barber, Glen N.] Univ Miami, Sch Med, Dept Cell Biol, Miami, FL 33136 USA; [Konno, Hiroyasu; Konno, Keiko; Barber, Glen N.] Univ Miami, Sch Med, Sylvester Comprehens Canc Ctr, Miami, FL 33136 USA	University of Miami; University of Miami	Barber, GN (corresponding author), Univ Miami, Sch Med, Dept Cell Biol, Miami, FL 33136 USA.	gbarber@med.miami.edu			 [R01AI079336];  [UO1AI083015]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI079336, U01AI083015] Funding Source: NIH RePORTER	; ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank Delia Gutman for technical assistance, Biju Issac for gene array analysis, and George McNamara for confocal microscopy analysis. This work was funded in part by grants R01AI079336 and UO1AI083015.	Abe T, 2013, MOL CELL, V50, P5, DOI 10.1016/j.molcel.2013.01.039; Ablasser A, 2013, NATURE, V498, P380, DOI 10.1038/nature12306; Ahn J, 2012, P NATL ACAD SCI USA, V109, P19386, DOI 10.1073/pnas.1215006109; Alers S, 2012, MOL CELL BIOL, V32, P2, DOI 10.1128/MCB.06159-11; Alexander A, 2011, FEBS LETT, V585, P952, DOI 10.1016/j.febslet.2011.03.010; Blasius AL, 2010, IMMUNITY, V32, P305, DOI 10.1016/j.immuni.2010.03.012; Burdette DL, 2011, NATURE, V478, P515, DOI 10.1038/nature10429; Civril F, 2013, NATURE, V498, P332, DOI 10.1038/nature12305; Diner EJ, 2013, CELL REP, V3, P1355, DOI 10.1016/j.celrep.2013.05.009; Fu D, 2011, P NATL ACAD SCI USA, V108, P1403, DOI 10.1073/pnas.1018376108; Gall A, 2012, IMMUNITY, V36, P120, DOI 10.1016/j.immuni.2011.11.018; Gao P, 2013, CELL, V153, P1094, DOI 10.1016/j.cell.2013.04.046; Hardie DG, 2012, CHEM BIOL, V19, P1222, DOI 10.1016/j.chembiol.2012.08.019; Henault J, 2012, IMMUNITY, V37, P986, DOI 10.1016/j.immuni.2012.09.014; Ishikawa H, 2008, NATURE, V455, P674, DOI 10.1038/nature07317; Ishikawa H, 2009, NATURE, V461, P788, DOI 10.1038/nature08476; Jin L, 2008, MOL CELL BIOL, V28, P5014, DOI 10.1128/MCB.00640-08; Kawai T, 2011, IMMUNITY, V34, P637, DOI 10.1016/j.immuni.2011.05.006; Kranzusch PJ, 2013, CELL REP, V3, P1362, DOI 10.1016/j.celrep.2013.05.008; Mizushima N, 2010, CURR OPIN CELL BIOL, V22, P132, DOI 10.1016/j.ceb.2009.12.004; Saitoh T, 2009, P NATL ACAD SCI USA, V106, P20842, DOI 10.1073/pnas.0911267106; Sun LJ, 2013, SCIENCE, V339, P786, DOI 10.1126/science.1232458; Sun WX, 2009, P NATL ACAD SCI USA, V106, P8653, DOI 10.1073/pnas.0900850106; Tamura T, 2008, ANNU REV IMMUNOL, V26, P535, DOI 10.1146/annurev.immunol.26.021607.090400; Tanaka Y, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002521; Tooze SA, 2010, IUBMB LIFE, V62, P503, DOI 10.1002/iub.334; Woodward JJ, 2010, SCIENCE, V328, P1703, DOI 10.1126/science.1189801; Zhang X, 2013, MOL CELL, V51, P226, DOI 10.1016/j.molcel.2013.05.022; Zhong B, 2008, IMMUNITY, V29, P538, DOI 10.1016/j.immuni.2008.09.003	29	404	430	3	84	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 24	2013	155	3					688	698		10.1016/j.cell.2013.09.049	http://dx.doi.org/10.1016/j.cell.2013.09.049			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	246WQ	24119841	Green Accepted, Bronze			2022-12-24	WOS:000326571800021
J	Abad, M; Mosteiro, L; Pantoja, C; Canamero, M; Rayon, T; Ors, I; Grana, O; Megias, D; Dominguez, O; Martinez, D; Manzanares, M; Ortega, S; Serrano, M				Abad, Maria; Mosteiro, Lluc; Pantoja, Cristina; Canamero, Marta; Rayon, Teresa; Ors, Inmaculada; Grana, Osvaldo; Megias, Diego; Dominguez, Orlando; Martinez, Dolores; Manzanares, Miguel; Ortega, Sagrario; Serrano, Manuel			Reprogramming in vivo produces teratomas and iPS cells with totipotency features	NATURE			English	Article							EMBRYONIC STEM-CELLS; TRANSCRIPTION FACTORS; DIRECT CONVERSION; MOUSE; EXPRESSION; FIBROBLASTS; GENERATION; GENE; DIFFERENTIATION; NEURONS	Reprogramming of adult cells to generate induced pluripotent stem cells (iPS cells) has opened new therapeutic opportunities; however, little is known about the possibility of in vivo reprogramming within tissues. Here we show that transitory induction of the four factors Oct4, Sox2, Klf4 and c-Myc in mice results in teratomas emerging from multiple organs, implying that full reprogramming can occur in vivo. Analyses of the stomach, intestine, pancreas and kidney reveal groups of dedifferentiated cells that express the pluripotency marker NANOG, indicative of in situ reprogramming. By bone marrow transplantation, we demonstrate that haematopoietic cells can also be reprogrammed in vivo. Notably, reprogrammable mice present circulating iPS cells in the blood and, at the transcriptome level, these in vivo generated iPS cells are closer to embryonic stem cells (ES cells) than standard in vitro generated iPS cells. Moreover, in vivo iPS cells efficiently contribute to the trophectoderm lineage, suggesting that they achieve a more plastic or primitive state than ES cells. Finally, intraperitoneal injection of in vivo iPS cells generates embryo-like structures that express embryonic and extraembryonic markers. We conclude that reprogramming in vivo is feasible and confers totipotency features absent in standard iPS or ES cells. These discoveries could be relevant for future applications of reprogramming in regenerative medicine.	[Abad, Maria; Mosteiro, Lluc; Pantoja, Cristina; Serrano, Manuel] Spanish Natl Canc Res Ctr CNIO, Tumour Suppress Grp, E-28029 Madrid, Spain; [Canamero, Marta] Spanish Natl Canc Res Ctr CNIO, Histopathol Unit, E-28029 Madrid, Spain; [Rayon, Teresa; Ors, Inmaculada; Manzanares, Miguel] Spanish Natl Cardiovasc Res Ctr CNIC, Cardiovasc Dev & Repair Dept, E-28029 Madrid, Spain; [Grana, Osvaldo] Spanish Natl Canc Res Ctr CNIO, Bioinformat Unit, E-28029 Madrid, Spain; [Megias, Diego] Spanish Natl Canc Res Ctr CNIO, Confocal Microscopy Unit, E-28029 Madrid, Spain; [Dominguez, Orlando] Spanish Natl Canc Res Ctr CNIO, Genom Unit, E-28029 Madrid, Spain; [Martinez, Dolores] Spanish Natl Canc Res Ctr CNIO, Flow Cytometry Unit, E-28029 Madrid, Spain; [Ortega, Sagrario] Spanish Natl Canc Res Ctr CNIO, Transgen Mice Unit, E-28029 Madrid, Spain	Centro Nacional de Investigaciones Oncologicas (CNIO); Centro Nacional de Investigaciones Oncologicas (CNIO); Centro Nacional de Investigaciones Cardiovasculares (CNIC); Centro Nacional de Investigaciones Oncologicas (CNIO); Centro Nacional de Investigaciones Oncologicas (CNIO); Centro Nacional de Investigaciones Oncologicas (CNIO); Centro Nacional de Investigaciones Oncologicas (CNIO); Centro Nacional de Investigaciones Oncologicas (CNIO)	Serrano, M (corresponding author), Spanish Natl Canc Res Ctr CNIO, Tumour Suppress Grp, E-28029 Madrid, Spain.	mserrano@cnio.es	Abad, Maria/AAI-2366-2019; Serrano, Manuel/H-2634-2015; Manzanares, Miguel/E-1702-2015; Martinez, Lola/ABG-2474-2020; Manzanares, Miguel/AAZ-8305-2021; Rayon, Teresa/AAA-6592-2020; Dominguez, Orlando/M-7515-2018; Martinez, Lola/L-2308-2014; /AAI-3238-2021; Abad, Maria/I-3911-2015; Megías, Diego/L-6008-2014; Vivancos, Ana/AAG-8331-2019	Abad, Maria/0000-0002-1462-2498; Serrano, Manuel/0000-0001-7177-9312; Manzanares, Miguel/0000-0003-4849-2836; Manzanares, Miguel/0000-0003-4849-2836; Rayon, Teresa/0000-0001-5173-1442; Martinez, Lola/0000-0001-6273-6724; Abad, Maria/0000-0002-1462-2498; Vivancos, Ana/0000-0003-2888-6512; Mosteiro, Lluc/0000-0003-4041-9706; Megias, Diego/0000-0003-0755-0518; Pantoja, Cristina/0000-0003-0180-5823; Grana-Castro, Osvaldo/0000-0003-1615-4242	CNIO; Spanish Ministry of Economy (MINECO, SAF); Regional Government of Madrid (ReCaRe); European Union (RISK-IR); Botin Foundation; Ramon Areces Foundation; AXA Foundation; MINECO(BFU); Regional Government of Madrid (Cell-DD); ProCNIC Foundation	CNIO; Spanish Ministry of Economy (MINECO, SAF); Regional Government of Madrid (ReCaRe); European Union (RISK-IR); Botin Foundation; Ramon Areces Foundation; AXA Foundation; MINECO(BFU); Regional Government of Madrid (Cell-DD); ProCNIC Foundation	We are grateful to M. Torres for advice, and to K. Hochedlinger and R. Jaenisch for reagents. We also thank F. Beier, R. Serrano and N. Soberon for technical support. Work in the laboratory of M. S. is funded by the CNIO and by grants from the Spanish Ministry of Economy (MINECO, SAF), the Regional Government of Madrid (ReCaRe), the European Union (RISK-IR), the European Research Council (ERC Advanced Grant), the Botin Foundation, the Ramon Areces Foundation and the AXA Foundation. Work in the laboratory of M. M. is funded by grants from the MINECO(BFU), the Regional Government of Madrid (Cell-DD) and the ProCNIC Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Assou S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039306; Banga A, 2012, P NATL ACAD SCI USA, V109, P15336, DOI 10.1073/pnas.1201701109; BEDDINGTON RSP, 1989, DEVELOPMENT, V105, P733; Carey BW, 2010, NAT METHODS, V7, P56, DOI [10.1038/NMETH.1410, 10.1038/nmeth.1410]; Carey BW, 2009, P NATL ACAD SCI USA, V106, P157, DOI 10.1073/pnas.0811426106; Cobaleda C, 2007, NATURE, V449, P473, DOI 10.1038/nature06159; Conley BJ, 2004, FETAL DIAGN THER, V19, P218, DOI 10.1159/000076701; Dieguez-Hurtado R, 2011, GENESIS, V49, P36, DOI 10.1002/dvg.20685; DOMINGUEZ O, 1994, NUCLEIC ACIDS RES, V22, P3247, DOI 10.1093/nar/22.15.3247; Eminli S, 2009, NAT GENET, V41, P968, DOI 10.1038/ng.428; Festing M. F. W., 2002, DESIGN ANIMAL EXPT R; Finch AJ, 2009, MOL CELL BIOL, V29, P5306, DOI 10.1128/MCB.01745-08; Glover CH, 2006, PLOS COMPUT BIOL, V2, P1463, DOI 10.1371/journal.pcbi.0020158; Gordon EJ, 2008, DEV DYNAM, V237, P1901, DOI 10.1002/dvdy.21605; Haenebalcke L, 2013, CELL REP, V3, P335, DOI 10.1016/j.celrep.2013.01.016; Halley JD, 2012, STEM CELL RES, V8, P324, DOI 10.1016/j.scr.2011.11.001; Hanna J, 2010, P NATL ACAD SCI USA, V107, P9222, DOI 10.1073/pnas.1004584107; Hochedlinger K, 2005, CELL, V121, P465, DOI 10.1016/j.cell.2005.02.018; Hughes ED, 2007, MAMM GENOME, V18, P549, DOI 10.1007/s00335-007-9054-0; Koh KP, 2011, CELL STEM CELL, V8, P200, DOI 10.1016/j.stem.2011.01.008; Koo TB, 2005, REPRODUCTION, V129, P651, DOI 10.1530/rep.1.00656; Kurian L, 2013, NAT METHODS, V10, P77, DOI [10.1038/NMETH.2255, 10.1038/nmeth.2255]; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lu CW, 2008, NAT GENET, V40, P921, DOI 10.1038/ng.173; Macfarlan TS, 2012, NATURE, V487, P57, DOI 10.1038/nature11244; Maherali N, 2008, CELL STEM CELL, V3, P595, DOI 10.1016/j.stem.2008.11.008; Marks H, 2012, CELL, V149, P590, DOI 10.1016/j.cell.2012.03.026; Ng RK, 2008, NAT CELL BIOL, V10, P1280, DOI 10.1038/ncb1786; Pease S, 2011, ADV PROTOCOLS ANIMAL; Pettitt SJ, 2009, NAT METHODS, V6, P493, DOI 10.1038/nmeth.1342; Pfister S, 2007, GENE EXPR PATTERNS, V7, P558, DOI 10.1016/j.modgep.2007.01.005; Qian L, 2012, NATURE, V485, P593, DOI 10.1038/nature11044; Robinton DA, 2012, NATURE, V481, P295, DOI 10.1038/nature10761; Rouaux C, 2013, NAT CELL BIOL, V15, P214, DOI 10.1038/ncb2660; Song KH, 2012, NATURE, V485, P599, DOI 10.1038/nature11139; Stadtfeld M, 2010, NAT METHODS, V7, P53, DOI [10.1038/NMETH.1409, 10.1038/nmeth.1409]; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Thier M, 2012, CELL STEM CELL, V10, P473, DOI 10.1016/j.stem.2012.03.003; Torper O, 2013, P NATL ACAD SCI USA, V110, P7038, DOI 10.1073/pnas.1303829110; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Yamanaka S, 2009, NATURE, V460, P49, DOI 10.1038/nature08180; Yao XQ, 2012, FEBS LETT, V586, P2522, DOI 10.1016/j.febslet.2012.06.018; Zhou Q, 2008, NATURE, V455, P627, DOI 10.1038/nature07314	44	299	313	1	127	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 17	2013	502	7471					340	+		10.1038/nature12586	http://dx.doi.org/10.1038/nature12586			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	235GY	24025773	Green Published			2022-12-24	WOS:000325706300046
J	Nishiyama, A; Yamaguchi, L; Sharif, J; Johmura, Y; Kawamura, T; Nakanishi, K; Shimamura, S; Arita, K; Kodama, T; Ishikawa, F; Koseki, H; Nakanishi, M				Nishiyama, Atsuya; Yamaguchi, Luna; Sharif, Jafar; Johmura, Yoshikazu; Kawamura, Takeshi; Nakanishi, Keiko; Shimamura, Shintaro; Arita, Kyohei; Kodama, Tatsuhiko; Ishikawa, Fuyuki; Koseki, Haruhiko; Nakanishi, Makoto			Uhrf1-dependent H3K23 ubiquitylation couples maintenance DNA methylation and replication	NATURE			English	Article							UBIQUITIN LIGASE ACTIVITY; SRA DOMAIN; EPIGENETIC INHERITANCE; STATISTICAL-MODEL; MAMMALIAN-CELLS; GENE-EXPRESSION; UHRF1; PROTEIN; RECOGNITION; DNMT1	Faithful propagation of DNA methylation patterns during DNA replication is critical for maintaining cellular phenotypes of individual differentiated cells(1-5). Although it is well established that Uhrf1 (ubiquitin-like with PHD and ring finger domains 1; also known as Np95 and ICBP90) specifically binds to hemi-methylated DNA through its SRA (SET and RING finger associated) domain and has an essential role in maintenance of DNA methylation by recruiting Dnmt1 to hemi-methylated DNA sites(6-10), the mechanism by which Uhrf1 coordinates the maintenance of DNA methylation and DNA replication is largely unknown. Here we show that Uhrf1-dependent histone H3 ubiquitylation has a prerequisite role in the maintenance DNA methylation. Using Xenopus egg extracts, we successfully reproduce maintenance DNA methylation in vitro. Dnmt1 depletion results in a marked accumulation of Uhrf1-dependent ubiquitylation of histone H3 at lysine 23. Dnmt1 preferentially associates with ubiquitylated H3 in vitro though a region previously identified as a replication foci targeting sequence(11). The RING finger mutant of Uhrf1 fails to recruit Dnmt1 to DNA replication sites and maintain DNA methylation in mammalian cultured cells. Our findings represent the first evidence, to our knowledge, of the mechanistic link between DNA methylation and DNA replication through histone H3 ubiquitylation.	[Nishiyama, Atsuya; Yamaguchi, Luna; Johmura, Yoshikazu; Nakanishi, Makoto] Nagoya City Univ, Grad Sch Med Sci, Dept Cell Biol, Mizuho Ku, Nagoya, Aichi 4678601, Japan; [Sharif, Jafar; Koseki, Haruhiko] RIKEN Ctr Integrat Med Sci, Tsurumi Ku, Yokohama, Kanagawa 2300045, Japan; [Kawamura, Takeshi; Kodama, Tatsuhiko] Univ Tokyo, RCAST, Lab Syst Biol & Med, Meguro Ku, Tokyo 1538904, Japan; [Nakanishi, Keiko] Aichi Human Serv Ctr, Inst Dev Res, Dept Perinatol, Kasugai, Aichi 4800392, Japan; [Shimamura, Shintaro] Akita Univ, Grad Sch Med, Dept Mol Med & Biochem, Akita 0108543, Japan; [Arita, Kyohei] Yokohama City Univ, Grad Sch Med Life Sci, Tsurumi Ku, Yokohama, Kanagawa 2300045, Japan; [Ishikawa, Fuyuki] Kyoto Univ, Grad Sch Biostudies, Dept Gene Mech, Sakyo Ku, Kyoto 6068501, Japan	Nagoya City University; RIKEN; University of Tokyo; Akita University; Yokohama City University; Kyoto University	Nakanishi, M (corresponding author), Nagoya City Univ, Grad Sch Med Sci, Dept Cell Biol, Mizuho Ku, 1 Kawasumi,Mizuho Cho, Nagoya, Aichi 4678601, Japan.	anishiya@med.nagoya-cu.ac.jp; mkt-naka@med.nagoya-cu.ac.jp	Koseki, Haruhiko/I-3825-2014; Nishiyama, Atsuya/D-7894-2017; Arita, Kyohei/AAJ-6402-2020; Ishikawa, Fuyuki/AAU-4056-2021	Koseki, Haruhiko/0000-0001-8424-5854; Nishiyama, Atsuya/0000-0002-8416-3776; Arita, Kyohei/0000-0002-9762-8405; Ishikawa, Fuyuki/0000-0002-5580-2305	MEXT Japan; Japan Society for the Promotion of Science; Grants-in-Aid for Scientific Research [24113711, 24659137] Funding Source: KAKEN	MEXT Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We are grateful to T. S. Takahashi, K. Shintomi, K. Muraki, H. Nakaoka, M. Iwabuchi and K. Ohsumi for reagents and technical advice, J. Maller for Xenopus Orc2 antibody, H. Miyoshi for lentiviral vectors, K. Helin for reading of the manuscript and M. Orii for designing the schematic diagram shown in Supplementary Fig. 1. We thank A. Hosoi and C. Yamada-Namikawa for technical assistance. M.N. was supported by a Grant-in-Aid for Scientific Research on Innovative Areas 'Cell fate control', Scientific Research (A), and Challenging Exploratory Research from MEXT Japan. A.N. was supported by a Research Activity Start-up and Grant-in-Aid for Young Scientists (B) from the Japan Society for the Promotion of Science.	Achour M, 2008, ONCOGENE, V27, P2187, DOI 10.1038/sj.onc.1210855; Alabert C, 2012, NAT REV MOL CELL BIO, V13, P153, DOI 10.1038/nrm3288; Arita K, 2008, NATURE, V455, P818, DOI 10.1038/nature07249; Arita K, 2012, P NATL ACAD SCI USA, V109, P12950, DOI 10.1073/pnas.1203701109; Avvakumov GV, 2008, NATURE, V455, P822, DOI 10.1038/nature07273; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Bostick M, 2007, SCIENCE, V317, P1760, DOI 10.1126/science.1147939; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; Citterio E, 2004, MOL CELL BIOL, V24, P2526, DOI 10.1128/MCB.24.6.2526-2535.2004; Daigo K, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.015073; Felle M, 2011, NUCLEIC ACIDS RES, V39, P8355, DOI 10.1093/nar/gkr528; Fujinoki M, 2003, J BIOCHEM, V133, P361, DOI 10.1093/jb/mvg048; Hashimoto H, 2008, NATURE, V455, P826, DOI 10.1038/nature07280; Hu LL, 2011, CELL RES, V21, P1374, DOI 10.1038/cr.2011.124; Jenkins Y, 2005, MOL BIOL CELL, V16, P5621, DOI 10.1091/mbc.E05-03-0194; Jones PA, 2009, NAT REV GENET, V10, P805, DOI 10.1038/nrg2651; Karagianni P, 2008, MOL CELL BIOL, V28, P705, DOI 10.1128/MCB.01598-07; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Kim W, 2011, MOL CELL, V44, P325, DOI 10.1016/j.molcel.2011.08.025; LEONHARDT H, 1992, CELL, V71, P865, DOI 10.1016/0092-8674(92)90561-P; Lutzmann M, 2008, MOL CELL, V31, P190, DOI 10.1016/j.molcel.2008.07.001; Margueron R, 2010, NAT REV GENET, V11, P285, DOI 10.1038/nrg2752; Muraki K, 2011, GENES CELLS, V16, P728, DOI 10.1111/j.1365-2443.2011.01520.x; Nady N, 2011, J BIOL CHEM, V286, P24300, DOI 10.1074/jbc.M111.234104; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; Nishiyama A, 2011, GENE DEV, V25, P165, DOI 10.1101/gad.614411; Peng JM, 2003, NAT BIOTECHNOL, V21, P921, DOI 10.1038/nbt849; Plechanovova A, 2012, NATURE, V489, P115, DOI 10.1038/nature11376; Probst AV, 2009, NAT REV MOL CELL BIO, V10, P192, DOI 10.1038/nrm2640; Rajakumara E, 2011, MOL CELL, V43, P275, DOI 10.1016/j.molcel.2011.07.006; Rothbart SB, 2012, NAT STRUCT MOL BIOL, V19, P1155, DOI 10.1038/nsmb.2391; Sharif J, 2007, NATURE, V450, P908, DOI 10.1038/nature06397; Shimamura S, 2008, CANCER SCI, V99, P1960, DOI 10.1111/j.1349-7006.2008.00913.x; Song JK, 2011, SCIENCE, V331, P1036, DOI 10.1126/science.1195380; Takebayashi S, 2007, MOL CELL BIOL, V27, P8243, DOI 10.1128/MCB.00899-07	35	222	231	1	53	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 10	2013	502	7470					249	+		10.1038/nature12488	http://dx.doi.org/10.1038/nature12488			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231RU	24013172				2022-12-24	WOS:000325436100054
J	Salzberg, Y; Diaz-Balzac, CA; Ramirez-Suarez, NJ; Attreed, M; Tecle, E; Desbois, M; Kaprielian, Z; Bulow, HE				Salzberg, Yehuda; Diaz-Balzac, Carlos A.; Ramirez-Suarez, Nelson J.; Attreed, Matthew; Tecle, Eillen; Desbois, Muriel; Kaprielian, Zaven; Buelow, Hannes E.			Skin-Derived Cues Control Arborization of Sensory Dendrites in Caenorhabditis elegans	CELL			English	Article							C-ELEGANS; SELF-AVOIDANCE; DROSOPHILA; GENE; MECHANISMS; EXPRESSION; MOLECULES; GUIDANCE; HOMOLOG; NEURONS	Sensory dendrites depend on cues from their environment to pattern their growth and direct them toward their correct target tissues. Yet, little is known about dendrite-substrate interactions during dendrite morphogenesis. Here, we describe MNR-1/menorin, which is part of the conserved Fam151 family of proteins and is expressed in the skin to control the elaboration of "menorah"-like dendrites of mechanosensory neurons in Caenorhabditis elegans. We provide biochemical and genetic evidence that MNR-1 acts as a contact-dependent or short-range cue in concert with the neural cell adhesion molecule SAX-7/L1CAM in the skin and through the neuronal leucine-rich repeat transmembrane receptor DMA-1 on sensory dendrites. Our data describe an unknown pathway that provides spatial information from the skin substrate to pattern sensory dendrite development nonautonomously.	[Salzberg, Yehuda; Diaz-Balzac, Carlos A.; Ramirez-Suarez, Nelson J.; Attreed, Matthew; Tecle, Eillen; Desbois, Muriel; Buelow, Hannes E.] Yeshiva Univ Albert Einstein Coll Med, Dept Genet, Bronx, NY 10461 USA; [Kaprielian, Zaven] Yeshiva Univ Albert Einstein Coll Med, Dept Pathol, Bronx, NY 10461 USA; [Kaprielian, Zaven; Buelow, Hannes E.] Yeshiva Univ Albert Einstein Coll Med, Dominick P Purpura Dept Neurosci, Bronx, NY 10461 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Bulow, HE (corresponding author), Yeshiva Univ Albert Einstein Coll Med, Dept Genet, 1300 Morris Pk Ave, Bronx, NY 10461 USA.	hannes.buelow@einstein.yu.edu	Desbois, Muriel/AAD-3598-2022; Diaz-Balzac, Carlos/AGE-0313-2022	Desbois, Muriel/0000-0002-8070-2525; Diaz-Balzac, Carlos/0000-0002-4723-1282; Tecle, Eillen/0000-0003-4253-1128; Salzberg, Yehuda/0000-0003-0605-8038; Kaprielian, Zaven/0000-0003-3364-3806; Ramirez, Nelson/0000-0001-7394-860X	NIH [T32GM007288, F31HD066967, T32GM007491, F31 NS076243, T32GM07491, 5R01HD055380, R21NS081505, P30HD071593, P30CA013330]; Fulbright fellowship; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD055380, P30HD071593, F31HD066967] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA013330] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007491, T32GM007288] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F31NS076243, R21NS081505] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fulbright fellowship; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Kang Shen (Stanford University) for communicating results prior to publication; N. Baker, S. Emmons, A. Melendez, R. Townley, and members of the Bulow laboratory for discussions and comments on the manuscript; Ji Sze, O. Hobert, and J. Culotti for DNA clones; the Caenorhabditis Genetics Center, L. Chen, and S. Mitani for strains; C. Rubin for the alpha-mCherry antibody; M. Akabas for the use of his cell culture facility; B. Calder and A. Fiser for advice on bioinformatic analyses; M. Lazaro-Pena for injections; S. Bhatt and B. Gonzalez for constructing strains; and C. Crocker for artwork. This work was funded in part by the NIH (T32GM007288 and F31HD066967 to C.A.D.-B., T32GM007491 and F31 NS076243 to M.A., T32GM07491 to E.T., 5R01HD055380 and R21NS081505 to H.E.B., and P30HD071593 and P30CA013330 to Albert Einstein College of Medicine). N.R. is the recipient of a Fulbright fellowship. H.E.B. is an Alfred P. Sloan fellow.	Abedin M, 2008, SCIENCE, V319, P946, DOI 10.1126/science.1151084; Aguirre-Chen C, 2011, DEVELOPMENT, V138, P507, DOI 10.1242/dev.060939; Chen LH, 2010, DEV DYNAM, V239, P1490, DOI 10.1002/dvdy.22269; Corty MM, 2009, DEVELOPMENT, V136, P1049, DOI 10.1242/dev.014423; Doitsidou M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015435; Dong XT, 2013, CELL, V155, P296, DOI 10.1016/j.cell.2013.08.059; DUERR JS, 2006, WORMBOOK, V19, P1; Fares H, 2001, GENETICS, V159, P133; Fujisawa K, 2007, SCIENCE, V317, P1934, DOI 10.1126/science.1144874; Hadwiger G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010161; Halevi S, 2002, EMBO J, V21, P1012, DOI 10.1093/emboj/21.5.1012; Hall DH, 2011, TRENDS NEUROSCI, V34, P443, DOI 10.1016/j.tins.2011.07.004; Han C, 2012, NEURON, V73, P64, DOI 10.1016/j.neuron.2011.10.036; Honig MG, 2005, DEV BIOL, V282, P257, DOI 10.1016/j.ydbio.2005.03.013; Jan YN, 2010, NAT REV NEUROSCI, V11, P316, DOI 10.1038/nrn2836; Kaufmann WE, 2000, CEREB CORTEX, V10, P981, DOI 10.1093/cercor/10.10.981; Kim E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053419; Kim ME, 2012, NEURON, V73, P79, DOI 10.1016/j.neuron.2011.10.033; Kulkarni VA, 2012, MOL CELL NEUROSCI, V50, P10, DOI 10.1016/j.mcn.2012.03.005; Li LS, 2011, CELL, V147, P1615, DOI 10.1016/j.cell.2011.11.027; Liu OW, 2012, NAT NEUROSCI, V15, P57, DOI 10.1038/nn.2978; MARTIN P, 1989, DEVELOPMENT, V106, P335; McAllister AK, 1997, NEURON, V18, P767, DOI 10.1016/S0896-6273(00)80316-5; McKay SJ, 2003, COLD SPRING HARB SYM, V68, P159, DOI 10.1101/sqb.2003.68.159; Moresco EMY, 2005, J NEUROSCI, V25, P6105, DOI 10.1523/JNEUROSCI.1432-05.2005; Oren-Suissa M, 2010, SCIENCE, V328, P1285, DOI 10.1126/science.1189095; Parrish JZ, 2007, ANNU REV NEUROSCI, V30, P399, DOI 10.1146/annurev.neuro.29.051605.112907; Pocock R, 2008, MOL CELL NEUROSCI, V37, P56, DOI 10.1016/j.mcn.2007.08.014; Ruiz-Trillo I, 2007, TRENDS GENET, V23, P113, DOI 10.1016/j.tig.2007.01.005; Schmid RS, 2008, CURR OPIN NEUROBIOL, V18, P245, DOI 10.1016/j.conb.2008.07.015; Smith CJ, 2013, NEURON, V79, P266, DOI 10.1016/j.neuron.2013.05.009; Smith CJ, 2012, NAT NEUROSCI, V15, P731, DOI 10.1038/nn.3065; Smith CJ, 2010, DEV BIOL, V345, P18, DOI 10.1016/j.ydbio.2010.05.502; Tsalik EL, 2003, DEV BIOL, V263, P81, DOI 10.1016/S0012-1606(03)00447-0; Wang F, 2012, CURR BIOL, V22, P373, DOI 10.1016/j.cub.2012.01.040; Wang XL, 2008, J CELL BIOL, V180, P233, DOI 10.1083/jcb.200704178; WAY JC, 1989, GENE DEV, V3, P1823, DOI 10.1101/gad.3.12a.1823; Yamamoto M, 2006, CURR BIOL, V16, P1678, DOI 10.1016/j.cub.2006.06.061	38	103	106	0	12	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 10	2013	155	2					308	320		10.1016/j.cell.2013.08.058	http://dx.doi.org/10.1016/j.cell.2013.08.058			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	235LH	24120132	Green Accepted, Bronze			2022-12-24	WOS:000325719800009
J	Allen, AS; Berkovic, SF; Cossette, P; Delanty, N; Dlugos, D; Eichler, EE; Epstein, MP; Glauser, T; Goldstein, DB; Han, YJ; Heinzen, EL; Hitomi, Y; Howell, KB; Johnson, MR; Kuzniecky, R; Lowenstein, DH; Lu, YF; Madou, MRZ; Marson, AG; Mefford, HC; Nieh, SE; O'Brien, TJ; Ottman, R; Petrovski, S; Poduri, A; Ruzzo, EK; Scheffer, IE; Sherr, EH; Yuskaitis, CJ; Abou-Khalil, B; Alldredge, BK; Bautista, JF; Berkovic, SF; Boro, A; Cascino, GD; Consalvo, D; Crumrine, P; Devinsky, O; Dlugos, D; Epstein, MP; Fiol, M; Fountain, NB; French, J; Friedman, D; Geller, EB; Glauser, T; Glynn, S; Haut, SR; Hayward, J; Helmers, SL; Joshi, S; Kanner, A; Kirsch, HE; Knowlton, RC; Kossoff, E; Kuperman, R; Kuzniecky, R; Lowenstein, DH; McGuire, SM; Motika, PV; Novotny, EJ; Ottman, R; Paolicchi, JM; Parent, JM; Park, K; Poduri, A; Scheffer, IE; Shellhaas, RA; Sherr, EH; Shih, JJ; Singh, R; Sirven, J; Smith, MC; Sullivan, J; Thio, LL; Venkat, A; Vining, EPG; Von Allmen, GK; Weisenberg, JL; Widdess-Walsh, P; Winawer, MR				Allen, Andrew S.; Berkovic, Samuel F.; Cossette, Patrick; Delanty, Norman; Dlugos, Dennis; Eichler, Evan E.; Epstein, Michael P.; Glauser, Tracy; Goldstein, David B.; Han, Yujun; Heinzen, Erin L.; Hitomi, Yuki; Howell, Katherine B.; Johnson, Michael R.; Kuzniecky, Ruben; Lowenstein, Daniel H.; Lu, Yi-Fan; Madou, Maura R. Z.; Marson, Anthony G.; Mefford, Heather C.; Nieh, Sahar Esmaeeli; O'Brien, Terence J.; Ottman, Ruth; Petrovski, Slave; Poduri, Annapurna; Ruzzo, Elizabeth K.; Scheffer, Ingrid E.; Sherr, Elliott H.; Yuskaitis, Christopher J.; Abou-Khalil, Bassel; Alldredge, Brian K.; Bautista, Jocelyn F.; Berkovic, Samuel F.; Boro, Alex; Cascino, Gregory D.; Consalvo, Damian; Crumrine, Patricia; Devinsky, Orrin; Dlugos, Dennis; Epstein, Michael P.; Fiol, Miguel; Fountain, Nathan B.; French, Jacqueline; Friedman, Daniel; Geller, Eric B.; Glauser, Tracy; Glynn, Simon; Haut, Sheryl R.; Hayward, Jean; Helmers, Sandra L.; Joshi, Sucheta; Kanner, Andres; Kirsch, Heidi E.; Knowlton, Robert C.; Kossoff, Erich; Kuperman, Rachel; Kuzniecky, Ruben; Lowenstein, Daniel H.; McGuire, Shannon M.; Motika, Paul V.; Novotny, Edward J.; Ottman, Ruth; Paolicchi, Juliann M.; Parent, Jack M.; Park, Kristen; Poduri, Annapurna; Scheffer, Ingrid E.; Shellhaas, Renee A.; Sherr, Elliott H.; Shih, Jerry J.; Singh, Rani; Sirven, Joseph; Smith, Michael C.; Sullivan, Joseph; Thio, Liu Lin; Venkat, Anu; Vining, Eileen P. G.; Von Allmen, Gretchen K.; Weisenberg, Judith L.; Widdess-Walsh, Peter; Winawer, Melodie R.			De novo mutations in epileptic encephalopathies	NATURE			English	Article							EPILEPSIES; DISEASE	Epileptic encephalopathies are a devastating group of severe childhood epilepsy disorders for which the cause is often unknown(1). Here we report a screen for de novo mutations in patients with two classical epileptic encephalopathies: infantile spasms (n = 149) and Lennox-Gastaut syndrome (n = 115). We sequenced the exomes of 264 probands, and their parents, and confirmed 329 de novo mutations. A likelihood analysis showed a significant excess of de novo mutations in the similar to 4,000 genes that are the most intolerant to functional genetic variation in the human population (P = 2.9 x 10(-3)). Among these are GABRB3, with de novo mutations in four patients, and ALG13, with the same de novo mutation in two patients; both genes show clear statistical evidence of association with epileptic encephalopathy. Given the relevant site-specific mutation rates, the probabilities of these outcomes occurring by chance are P = 4.1 x 10(-10) and P = 7.8 x 10(-12), respectively. Other genes with de novo mutations in this cohort include CACNA1A, CHD2, FLNA, GABRA1, GRIN1, GRIN2B, HNRNPU, IQSEC2, MTOR and NEDD4L. Finally, we show that the de novo mutations observed are enriched in specific gene sets including genes regulated by the fragile X protein (P < 10(-8)), as has been reported previously for autism spectrum disorders(2).	[Allen, Andrew S.] Duke Univ, Med Ctr, Dept Biostat & Bioinformat, Duke Clin Res Inst, Durham, NC 27710 USA; [Allen, Andrew S.] Duke Univ, Med Ctr, Ctr Human Genome Variat, Durham, NC 27710 USA; [Berkovic, Samuel F.; Petrovski, Slave] Univ Melbourne Austin Hlth, Dept Med, Epilepsy Res Ctr, Heidelberg, Vic 3084, Australia; [Cossette, Patrick] Univ Montreal, CHUM Hop Notre Dame Montre, Montreal, PQ H2L 4M1, Canada; [Cossette, Patrick] CHUM Res Ctr, Montreal, PQ H2L 4M1, Canada; [Delanty, Norman] Royal Coll Surg, Dublin 9, Ireland; [Delanty, Norman] Beaumont Hosp, Dept Neurol, Dublin 9, Ireland; [Dlugos, Dennis; Venkat, Anu] Univ Penn, Perelman Sch Med, Childrens Hosp Philadelphia, Dept Neurol & Pediat, Philadelphia, PA 19104 USA; [Eichler, Evan E.] Univ Washington, Sch Med, Dept Gen Sci, Seattle, WA 98195 USA; [Eichler, Evan E.] Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA; [Epstein, Michael P.] Emory Univ, Sch Med, Dept Human Genet, Atlanta, GA 30322 USA; [Glauser, Tracy] Cincinnati Childrens Hosp Med Ctr, Div Neurol, Cincinnati, OH 45229 USA; [Goldstein, David B.; Han, Yujun; Heinzen, Erin L.; Hitomi, Yuki; Lu, Yi-Fan; Petrovski, Slave; Ruzzo, Elizabeth K.] Duke Univ, Sch Med, Ctr Human Genome Variat, Durham, NC 27708 USA; [Howell, Katherine B.] Royal Childrens Hosp Melbourne, Dept Neurol, Parkville, Vic 3052, Australia; [Johnson, Michael R.] Ctr Clin Translat Div Brain Sci, London SW7 2AZ, England; [Kuzniecky, Ruben; French, Jacqueline; Friedman, Daniel] NYU, Sch Med, Dept Neurol, Comprehens Epilepsy Ctr, New York, NY 10016 USA; [Lowenstein, Daniel H.; Madou, Maura R. Z.; Kirsch, Heidi E.; Sullivan, Joseph] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA; [Marson, Anthony G.] Univ Liverpool, Ctr Clin Sci, Dept Mol & Clin Pharmacol, Liverpool L9 7LJ, Merseyside, England; [Mefford, Heather C.] Univ Washington, Div Med Genet, Dept Pediat, Seattle, WA 98115 USA; [Nieh, Sahar Esmaeeli] Univ Calif San Francisco, San Francisco, CA 94143 USA; [O'Brien, Terence J.; Petrovski, Slave] Royal Melbourne Hosp, Dept Med, Parkville, Vic 3146, Australia; [O'Brien, Terence J.; Petrovski, Slave] Royal Melbourne Hosp, Dept Neurol, Parkville, Vic 3146, Australia; [Ottman, Ruth] Columbia Univ, Dept Epidemiol, New York, NY 10027 USA; [Ottman, Ruth] Columbia Univ, Dept Neurol, New York, NY 10027 USA; [Ottman, Ruth] Columbia Univ, GH Sergievsky Ctr, New York, NY 10027 USA; [Ottman, Ruth] New York State Psychiat Inst & Hosp, Div Epidemiol, New York, NY 10032 USA; [Poduri, Annapurna] Boston Childrens Hosp, Dept Neurol, Div Epilepsy & Clin Neurophysiol, Boston, MA 02115 USA; [Scheffer, Ingrid E.] Univ Melbourne Austin Hlth, Dept Med, Epilepsy Res Ctr, Heidelberg, Vic 3084, Australia; [Scheffer, Ingrid E.] Univ Melbourne, Florey Inst, Parkville, Vic 3052, Australia; [Scheffer, Ingrid E.] Univ Melbourne, Dept Pediat, Royal Childrens Hosp, Parkville, Vic 3052, Australia; [Sherr, Elliott H.] Univ Calif San Francisco, Pediat & Inst Human Genet, Dept Neurol, San Francisco, CA 94158 USA; [Yuskaitis, Christopher J.] Harvard Univ, Sch Med, Boston Childrens Hosp, Dept Neurol, Boston, MA 02115 USA; [Abou-Khalil, Bassel; Paolicchi, Juliann M.] Vanderbilt Univ, Med Ctr, Dept Neurol, Nashville, TN 37232 USA; [Alldredge, Brian K.] Univ Calif San Francisco, Sch Med, UCSF Sch Pharm, Dept Clin Pharm,Dept Neurol, San Francisco, CA 94143 USA; [Bautista, Jocelyn F.] Cleveland Clin Neurol Inst, Cleveland Clin Lerner Coll Med & Epilepsy Ctr, Dept Neurol, Cleveland, OH 44195 USA; [Boro, Alex] Albert Einstein Coll Med, Montefiore Med Ctr, Dept Neurol, Bronx, NY 10467 USA; [Cascino, Gregory D.] Mayo Clin, Div Epilepsy, Rochester, MN 55905 USA; [Consalvo, Damian] Ramos Meji Hosp, Div Neurol, Epilepsy Ctr, RA-1221 Buenos Aires, DF, Argentina; [Crumrine, Patricia] Univ Pittsburgh, UPMC, Med Epilepsy Program & EEG & Child Neurol, Childrens Hosp Pittsburgh,Sch Med, Pittsburgh, PA 15224 USA; [Devinsky, Orrin] NYU, Sch Med, St Barnabas Epilepsy Ctr, New York, NY 10016 USA; [Fiol, Miguel] Univ Minnesota, Sch Med, Epilepsy Care Ctr, Dept Neurol, Minneapolis, MN 55414 USA; [Fountain, Nathan B.] Univ Virginia, FE Dreifuss Comprehens Epilepsy Program, Charlottesville, VA 22908 USA; [Geller, Eric B.; Widdess-Walsh, Peter] St Barnabas Hosp, Div Neurol, Livingston, NJ 07039 USA; [Glynn, Simon] Univ Michigan Hlth Syst, Dept Neurol, Comprehens Epilepsy Program, Ann Arbor, MI 48109 USA; [Haut, Sheryl R.] Montefiore Med Ctr, Comprehens Epilepsy Ctr, Bronx, NY 10467 USA; [Hayward, Jean] Kaiser Permanente Grp, Oakland, CA 94618 USA; [Helmers, Sandra L.] Emory Univ, Sch Med, Atlanta, GA 30322 USA; [Joshi, Sucheta] Univ Michigan, Ann Arbor, MI 48109 USA; [Kanner, Andres; Smith, Michael C.] Rush Univ, Med Ctr, Rush Epilepsy Ctr, Dept Neurol Sci, Chicago, IL 60612 USA; [Kirsch, Heidi E.] Univ Calif San Francisco, Dept Radiol, San Francisco, CA 94143 USA; [Knowlton, Robert C.] Univ Texas Houston, Sch Med, Houston, TX 77030 USA; [Kossoff, Erich] Johns Hopkins Univ Hosp, Child Neurol Pediat Neurol Residency Program, Baltimore, MD 21287 USA; [Kuperman, Rachel] Childrens Hosp, Epilepsy Program, Oakland, CA 94609 USA; [Kuperman, Rachel] Res Ctr Oakland, Oakland, CA 94609 USA; [McGuire, Shannon M.] Childrens Hosp Epilepsy Ctr New Orleans, New Orleans, LA 70118 USA; [Motika, Paul V.] Oregon Hlth & Sci Univ, Comprehens Epilepsy Ctr, Portland, OR 97239 USA; [Novotny, Edward J.] Univ Washington, Sch Med, Seattle Childrens Hosp, Dept Neurol, Seattle, WA 98105 USA; [Novotny, Edward J.] Univ Washington, Sch Med, Seattle Childrens Hosp, Dept Pediat, Seattle, WA 98105 USA; [Paolicchi, Juliann M.] Weill Cornell Med Ctr, New York, NY 10065 USA; [Parent, Jack M.] Univ Michigan, Med Ctr, Dept Neurol & Neurosci, Grad Program, Ann Arbor, MI 49108 USA; [Parent, Jack M.] Ann Arbor Vet Adm Healthcare Syst, Ann Arbor, MI 48105 USA; [Park, Kristen] Univ Colorado, Childrens Hosp Colorado, Sch Med, Dept Neurol, Denver, CO 80045 USA; Univ Colorado, Childrens Hosp Colorado, Sch Med, Dept Pediat, Denver, CO 80045 USA; [Shellhaas, Renee A.] Univ Michigan, Ann Arbor, MI USA; [Shih, Jerry J.] Mayo Clin, Dept Neurol, Jacksonville, FL 32224 USA; [Singh, Rani] Univ Michigan Hlth Syst, Div Pediat Neurol, Ann Arbor, MI 48109 USA; [Sirven, Joseph] Mayo Clin, Dept Neurol, Scottsdale, AZ 85259 USA; [Thio, Liu Lin] Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA; [Vining, Eileen P. G.] Dept Neurol, Baltimore, MD 21287 USA; [Von Allmen, Gretchen K.] Univ Texas Houston, Sch Med, Div Child & Adolescent Neurol, Dept Pediat, Houston, TX 77030 USA; [Weisenberg, Judith L.] Washington Univ, Sch Med, Div Pediat Neurol, Dept Neurol, St Louis, MO 63110 USA; [Winawer, Melodie R.] Columbia Univ, Dept Neurol, New York, NY 10032 USA; [Winawer, Melodie R.] Columbia Univ, GH Sergievsky Ctr, New York, NY 10032 USA	Duke University; Duke University; University of Melbourne; Universite de Montreal; Universite de Montreal; Royal College of Surgeons - Ireland; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Washington; University of Washington Seattle; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; Emory University; Cincinnati Children's Hospital Medical Center; Duke University; Royal Children's Hospital Melbourne; New York University; University of California System; University of California San Francisco; University of Liverpool; University of Washington; University of Washington Seattle; University of California System; University of California San Francisco; Royal Melbourne Hospital; Royal Melbourne Hospital; Columbia University; Columbia University; Columbia University; New York State Psychiatry Institute; Harvard University; Boston Children's Hospital; University of Melbourne; Florey Institute of Neuroscience & Mental Health; University of Melbourne; Royal Children's Hospital Melbourne; University of Melbourne; University of California System; University of California San Francisco; Harvard University; Boston Children's Hospital; Harvard Medical School; Vanderbilt University; University of California System; University of California San Francisco; Case Western Reserve University; Cleveland Clinic Foundation; Montefiore Medical Center; Yeshiva University; Albert Einstein College of Medicine; Mayo Clinic; Hospital Ramos Mejia; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; New York University; University of Minnesota System; University of Minnesota Twin Cities; University of Virginia; University of Michigan System; University of Michigan; Montefiore Medical Center; Yeshiva University; Albert Einstein College of Medicine; Kaiser Permanente; Emory University; University of Michigan System; University of Michigan; Rush University; University of California System; University of California San Francisco; University of Texas System; University of Texas Health Science Center Houston; Johns Hopkins University; Johns Hopkins Medicine; Children's Hospital Los Angeles; Children's Hospital Oakland Research Institute; Children's Hospital of New Orleans; Oregon Health & Science University; Seattle Children's Hospital; University of Washington; University of Washington Seattle; Seattle Children's Hospital; University of Washington; University of Washington Seattle; Cornell University; University of Michigan System; University of Michigan; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Michigan System; University of Michigan; Mayo Clinic; University of Michigan System; University of Michigan; Mayo Clinic; Mayo Clinic Phoenix; Washington University (WUSTL); University of Texas System; University of Texas Health Science Center Houston; Washington University (WUSTL); Columbia University; Columbia University	Allen, AS (corresponding author), Duke Univ, Med Ctr, Dept Biostat & Bioinformat, Duke Clin Res Inst, Durham, NC 27710 USA.		Ottman, Ruth/O-2371-2013; Resource Center, NINDS Human Genetics/AGF-2474-2022; O'Brien, Terence/AAU-5525-2021; Scheffer, Ingrid E/G-1668-2013; French, Jacqueline A/G-6795-2013; O'Brien, Terence/L-8102-2013; Thio, Liu Lin/A-4318-2008; Bautista, Jocelyn F./AAP-6901-2021; Hitomi, Yuki/V-8236-2019; Goldstein, David/AAY-8125-2020; Marson, Anthony/AAW-9776-2020; Novotny, Edward J./ABG-9577-2021; Ruzhnikov, Maura RZ/L-8859-2019; Shellhaas, Renee/H-6697-2019	Ottman, Ruth/0000-0001-7074-242X; Scheffer, Ingrid E/0000-0002-2311-2174; French, Jacqueline A/0000-0003-2242-8027; O'Brien, Terence/0000-0002-7198-8621; Thio, Liu Lin/0000-0002-9779-7903; Marson, Anthony/0000-0002-6861-8806; Ruzhnikov, Maura RZ/0000-0001-9610-1612; Shellhaas, Renee/0000-0002-3175-3908; Widdess-Walsh, Peter/0000-0003-4217-2575; Kirsch, Heidi/0000-0002-3144-2085; Park, Kristen/0000-0001-5527-3047; Buerki, Sarah Elisabeth/0000-0003-3054-1791; Petrovski, Slave/0000-0002-1527-961X; Delaney, Norman/0000-0002-3953-9842; Allen, Andrew/0000-0002-7232-2143; Cascino, Gregory/0000-0002-5380-2977; Novotny, Edward/0000-0001-9726-0447; Devinsky, Orrin/0000-0003-0044-4632; Berkovic, Samuel/0000-0003-4580-841X	National Institute of Neurological Disorders and Stroke [NS053998, NS077364, NS077274, NS077303, NS077276]; Richard Thalheimer Philanthropic Fund; ARRA [1RC2NS070342]; NIAID [R56AI098588]; Ellison Medical Foundation New Scholar award [AG-NS-0441-08]; SAID-Frederick, Inc. [M11-074]; Center for HIV/AIDS Vaccine Immunology ("CHAVI") from the National Institute of Allergy and Infectious Diseases, National Institutes of Health [UO1AIO67854]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000005] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI098588, U01AI067854] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [RC2NS070342, U01NS077303, U01NS077274, U01NS053998, U01NS077276, U01NS077364] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Richard Thalheimer Philanthropic Fund; ARRA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Ellison Medical Foundation New Scholar award(Lawrence Ellison Foundation); SAID-Frederick, Inc.; Center for HIV/AIDS Vaccine Immunology ("CHAVI") from the National Institute of Allergy and Infectious Diseases, National Institutes of Health; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We are grateful to the patients, their families, clinical research coordinators and referring physicians for participating in the Epilepsy Phenome/Genome Project (EPGP) and providing the phenotype data and DNA samples used in this study. We thank the following professional and lay organizations for substantial assistance in publicizing EPGP and therefore enabling us to recruit participants effectively: AED Pregnancy Registry, American Epilepsy Society, Association of Child Neurology Nurses, California School Nurses Organization, Child Neurology Society, Citizens United for Research in Epilepsy, Dravet Syndrome Foundation, Epilepsy Alliance of Orange County, Epilepsy Foundation, Epilepsy Therapy Project, Finding a Cure for Epilepsy and Seizures, IDEA League, InfantileSpasms.com, Lennox-Gastaut Syndrome Foundation, PatientsLikeMe, People Against Childhood Epilepsy, PVNH Support & Awareness, and Seizures & Epilepsy Education. We thank the EPGP Administrative Core (C. Freyer, K. Schardein, R.N., M. S., R. Fahlstrom, M. P. H., S. Cristofaro, R.N., B.S.N. and K. McGovern), EPGP Bioinformatics Core (G. Nesbitt, K. McKenna, V. Mays), staff at the Coriell Institute - NINDS Genetics Repository (C. Tarn, A. Scutti), and members of the Duke Center for Human Genome Variation (B. Krueger, J. Bridgers, J. Keebler, H. Shin Kim, E. Campbell, K. Cronin, L. Hong and M. McCall) for their dedication and commitment to this work. We also thank S. Shinnar (Albert Einstein College of Medicine) and N. Risch (University of California, San Francisco) for valuable input into the creation of EPGP and Epi4K, and R. Stewart, K. Gwinn and R. Corriveau from the National Institute of Neurological Disorders and Stroke for their careful oversight and guidance of both EPGP and Epi4K. This work was supported by grants from the National Institute of Neurological Disorders and Stroke (The Epilepsy Phenome/Genome Project NS053998; Epi4K Project 1-Epileptic Encephalopathies NS077364; Epi4K-Administrative Core NS077274; Epi4K-Sequencing, Biostatistics and Bioinformatics Core NS077303 and Epi4K-Phenotyping and Clinical Informatics Core NS077276); Finding a Cure for Epilepsy and Seizures; and the Richard Thalheimer Philanthropic Fund. We would like to acknowledge the following individuals and groups for their contribution of control samples: J. Hoover-Fong, N. Sobreira and D. Valle; The MURDOCK Study Community Registry and Biorepository (D. Murdock); S. Sisodiya; D. Attix; O. Chiba-Falek; V. Shashi; P. Lugar; W. Lowe; S. Palmer; D. Marchuk; Z. Farfel, D. Lancet, E. Pras; Q. Zhao; D. Daskalakis; R. Brown; E. Holtzman; R. Gbadegesin; M. Winn; S. Kerns; and H. Oster. The collection of control samples was funded in part by ARRA 1RC2NS070342, NIAID R56AI098588, the Ellison Medical Foundation New Scholar award AG-NS-0441-08, an award from SAID-Frederick, Inc. (M11-074), and with federal funds by the Center for HIV/AIDS Vaccine Immunology ("CHAVI") under a grant from the National Institute of Allergy and Infectious Diseases, National Institutes of Health (UO1AIO67854).	Berg AT, 2010, EPILEPSIA, V51, P676, DOI 10.1111/j.1528-1167.2010.02522.x; Claes L, 2001, AM J HUM GENET, V68, P1327, DOI 10.1086/320609; de Ligt J, 2012, NEW ENGL J MED, V367, P1921, DOI 10.1056/NEJMoa1206524; DeLorey TM, 1998, J NEUROSCI, V18, P8505; Fox JW, 1998, NEURON, V21, P1315, DOI 10.1016/S0896-6273(00)80651-0; Gleeson JG, 1998, CELL, V92, P63, DOI 10.1016/S0092-8674(00)80899-5; Heinzen EL, 2012, AM J HUM GENET, V91, P293, DOI 10.1016/j.ajhg.2012.06.016; Hitomi Y., 2013, ANN NEUROL; Iossifov I, 2012, NEURON, V74, P285, DOI 10.1016/j.neuron.2012.04.009; Kalscheuer VM, 2003, AM J HUM GENET, V72, P1401, DOI 10.1086/375538; Kamiya K, 2004, J NEUROSCI, V24, P2690, DOI 10.1523/JNEUROSCI.3089-03.2004; Karn CF, 2013, CLIN TRIALS, V10, P568, DOI 10.1177/1740774513484392; Kasperaviciute D, 2010, BRAIN, V133, P2136, DOI 10.1093/brain/awq130; Klassen T, 2011, CELL, V145, P1036, DOI 10.1016/j.cell.2011.05.025; Kong A, 2012, NATURE, V488, P471, DOI 10.1038/nature11396; Kryukov GV, 2007, AM J HUM GENET, V80, P727, DOI 10.1086/513473; Lee JH, 2012, NAT GENET, V44, P941, DOI 10.1038/ng.2329; Lemke JR, 2012, EPILEPSIA, V53, P1387, DOI 10.1111/j.1528-1167.2012.03516.x; Mulley JC, 2011, EPILEPSIA, V52, P423, DOI 10.1111/j.1528-1167.2010.02932.x; Neale BM, 2012, NATURE, V485, P242, DOI 10.1038/nature11011; O'Roak BJ, 2012, NATURE, V485, P246, DOI 10.1038/nature10989; Otsuka M, 2010, EPILEPSIA, V51, P2449, DOI 10.1111/j.1528-1167.2010.02767.x; Petrovski S., 2013, PLOS GEN IN PRESS; Rauch A, 2012, LANCET, V380, P1674, DOI 10.1016/S0140-6736(12)61480-9; Saitsu H, 2008, NAT GENET, V40, P782, DOI 10.1038/ng.150; Sanders SJ, 2012, NATURE, V485, P237, DOI 10.1038/nature10945; Steffens M, 2012, HUM MOL GENET, V21, P5359, DOI 10.1093/hmg/dds373; Tanaka M., 2012, JASPERS BASIC MECH E; Timal S, 2012, HUM MOL GENET, V21, P4151, DOI 10.1093/hmg/dds123; Veeramah KR, 2012, AM J HUM GENET, V90, P502, DOI 10.1016/j.ajhg.2012.01.006; Vissers LELM, 2010, NAT GENET, V42, P1109, DOI 10.1038/ng.712	31	1033	1063	6	158	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 12	2013	501	7466					217	+		10.1038/nature12439	http://dx.doi.org/10.1038/nature12439			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	215XR	23934111	Green Accepted, Green Submitted			2022-12-24	WOS:000324244900040
J	D'Angelo, G; Uemura, T; Chuang, CC; Polishchuk, E; Santoro, M; Ohvo-Rekila, H; Sato, T; Di Tullio, G; Varriale, A; D'Auria, S; Daniele, T; Capuani, F; Johannes, L; Mattjus, P; Monti, M; Pucci, P; Williams, RL; Burke, JE; Platt, FM; Harada, A; De Matteis, MA				D'Angelo, Giovanni; Uemura, Takefumi; Chuang, Chia-Chen; Polishchuk, Elena; Santoro, Michele; Ohvo-Rekila, Henna; Sato, Takashi; Di Tullio, Giuseppe; Varriale, Antonio; D'Auria, Sabato; Daniele, Tiziana; Capuani, Fabrizio; Johannes, Ludger; Mattjus, Peter; Monti, Maria; Pucci, Piero; Williams, Roger L.; Burke, John E.; Platt, Frances M.; Harada, Akihiro; De Matteis, Maria Antonietta			Vesicular and non-vesicular transport feed distinct glycosylation pathways in the Golgi	NATURE			English	Article							GLYCOSPHINGOLIPID SYNTHESIS; GLUCOSYLCERAMIDE; TOXIN; BINDING; SURFACE; SPHINGOLIPIDS; 4-PHOSPHATE; PTDINS(4)P; PROTEINS; SYNTHASE	Newly synthesized proteins and lipids are transported across the Golgi complex via different mechanisms whose respective roles are not completely clear. We previously identified a non-vesicular intra-Golgi transport pathway for glucosylceramide (GlcCer)-the common precursor of the different series of glycosphingolipids-that is operated by the cytosolic GlcCer-transfer protein FAPP2 (also known as PLEKHA8) (ref. 1). However, the molecular determinants of the FAPP2-mediated transfer of GlcCer from the cis-Golgi to the trans-Golgi network, as well as the physiological relevance of maintaining two parallel transport pathways of GlcCer-vesicular and non-vesicular-through the Golgi, remain poorly defined. Here, using mouse and cell models, we clarify the molecular mechanisms underlying the intra-Golgi vectorial transfer of GlcCer by FAPP2 and show that GlcCer is channelled by vesicular and non-vesicular transport to two topologically distinct glycosylation tracks in the Golgi cisternae and the trans-Golgi network, respectively. Our results indicate that the transport modality across the Golgi complex is a key determinant for the glycosylation pattern of a cargo and establish a new paradigm for the branching of the glycosphingolipid synthetic pathway.	[D'Angelo, Giovanni; Polishchuk, Elena; Santoro, Michele; Capuani, Fabrizio; De Matteis, Maria Antonietta] Telethon Inst Genet & Med, I-80131 Naples, Italy; [D'Angelo, Giovanni; Varriale, Antonio; D'Auria, Sabato] CNR, Inst Prot Biochem, I-80131 Naples, Italy; [Uemura, Takefumi; Sato, Takashi; Harada, Akihiro] Gunma Univ, Inst Mol & Cellular Regulat, Dept Mol & Cellular Biol, Lab Mol Traff, Gunma 3718512, Japan; [Chuang, Chia-Chen; Platt, Frances M.] Univ Oxford, Dept Pharmacol, Oxford OX1 3QT, England; [Ohvo-Rekila, Henna; Mattjus, Peter] Abo Akad Univ, Dept Biosci, FI-20520 Turku, Finland; [Di Tullio, Giuseppe; Daniele, Tiziana] Ist Ric Farmacol Mario Negri, Consorzio Mario Negri Sud, Dept Cell Biol & Oncol, I-66030 Chieti, Italy; [Johannes, Ludger] Inst Curie, Ctr Rech, F-75248 Paris 05, France; [Johannes, Ludger] CNRS, UMR144, F-75248 Paris, France; [Monti, Maria; Pucci, Piero] Univ Naples Federico II, Dipartimento Sci Chim, I-80145 Naples, Italy; [Monti, Maria; Pucci, Piero] Univ Naples Federico II, CEINGE Biotecnol Avanzate, I-80145 Naples, Italy; [Williams, Roger L.; Burke, John E.] MRC Lab Mol Biol, Cambridge CB2 0QH, England; [Harada, Akihiro] Osaka Univ, Dept Cell Biol, Suita, Osaka 5650871, Japan	Fondazione Telethon; Telethon Institute of Genetics & Medicine (TIGEM); Consiglio Nazionale delle Ricerche (CNR); Istituto di Biochimica delle Proteine (IBP-CNR); Gunma University; University of Oxford; Abo Akademi University; Consorzio Mario Negri Sud; Istituto di Ricerche Farmacologiche Mario Negri IRCCS; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Sorbonne Universite; University of Naples Federico II; CEINGE Biotecnologie Avanzate; University of Naples Federico II; MRC Laboratory Molecular Biology; Osaka University	De Matteis, MA (corresponding author), Telethon Inst Genet & Med, Via Pietro Castellino 111, I-80131 Naples, Italy.	dematteis@tigem.it	Daniele, Tiziana/AAN-1916-2020; Johannes, Ludger/M-9778-2017; Varriale, Antonio/AAL-1439-2020; Johannes, Ludger/W-8593-2019; Capuani, Fabrizio/B-7829-2008; d'auria, sabato/C-3565-2015; Burke, John/H-3922-2019; Mattjus, Peter/ABE-3596-2021; Mattjus, Peter/AAQ-7531-2021; MONTI, Maria/J-2816-2018; De Matteis, Maria Antonietta/AHE-5161-2022	Johannes, Ludger/0000-0002-2168-0004; Johannes, Ludger/0000-0002-2168-0004; Capuani, Fabrizio/0000-0003-2026-6335; d'auria, sabato/0000-0001-9320-494X; Burke, John/0000-0001-7904-9859; Mattjus, Peter/0000-0001-8991-5933; MONTI, Maria/0000-0002-7775-7154; De Matteis, Maria Antonietta/0000-0003-0053-3061; Daniele, Tiziana/0000-0002-6465-1078; Platt, Frances/0000-0001-7614-0403; DANGELO, GIOVANNI/0000-0001-5466-8709; Williams, Roger/0000-0001-7754-4207; PUCCI, Pietro/0000-0002-5885-1495; D'Angelo, Giovanni/0000-0002-0734-4127	Telethon [GSP08002, GGP06166]; Associazione Italiana per la Ricerca sul Cancro (AIRC) [IG 8623]; EU (FP7 Lipidomicnet); AIRC [MFAG 10585]; Academy of Finland; Sigrid Juselius Foundation; Study Abroad Scholarship from the Taiwan Ministry of Education; MRC [MC_U105184308] Funding Source: UKRI; British Heart Foundation [PG/11/109/29247] Funding Source: researchfish; Medical Research Council [MC_U105184308] Funding Source: researchfish	Telethon(Fondazione Telethon); Associazione Italiana per la Ricerca sul Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro); EU (FP7 Lipidomicnet); AIRC(Fondazione AIRC per la ricerca sul cancro); Academy of Finland(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Study Abroad Scholarship from the Taiwan Ministry of Education; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank A. Luini, C. Wilson and D. Priestman for discussions, A. Egorova for help with electron microscopy, G. Liebisch, A. Sigruener and G. Schmitz for lipidomic analysis. M. A. D. M. acknowledges the support of Telethon (GSP08002 and GGP06166), Associazione Italiana per la Ricerca sul Cancro (AIRC) (IG 8623), and the EU (FP7 Lipidomicnet). G.D.'A. acknowledges the support of AIRC (MFAG 10585). P. M. acknowledges the support of Academy of Finland and Sigrid Juselius Foundation. C.-C. C. was funded by a Study Abroad Scholarship from the Taiwan Ministry of Education.	Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Burke JE, 2012, P NATL ACAD SCI USA, V109, P15259, DOI 10.1073/pnas.1205508109; CHEGE NW, 1990, J CELL BIOL, V111, P893, DOI 10.1083/jcb.111.3.893; D'Angelo G, 2008, CURR OPIN CELL BIOL, V20, P360, DOI 10.1016/j.ceb.2008.03.013; D'Angelo G, 2008, J CELL SCI, V121, P1955, DOI 10.1242/jcs.023630; D'Angelo G, 2007, NATURE, V449, P62, DOI 10.1038/nature06097; D'Angelo G, 2009, J BIOL CHEM, V284, P34849, DOI 10.1074/jbc.M109.068403; FUTERMAN AH, 1991, BIOCHEM J, V280, P295, DOI 10.1042/bj2800295; Godi A, 2004, NAT CELL BIOL, V6, P393, DOI 10.1038/ncb1119; Hakomori SI, 2008, BBA-GEN SUBJECTS, V1780, P325, DOI 10.1016/j.bbagen.2007.08.015; Halter D, 2007, J CELL BIOL, V179, P101, DOI 10.1083/jcb.200704091; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; He J, 2011, J BIOL CHEM, V286, P18650, DOI 10.1074/jbc.M111.233015; ICHIKAWA S, 1994, P NATL ACAD SCI USA, V91, P2703, DOI 10.1073/pnas.91.7.2703; JACEWICZ M, 1986, J EXP MED, V163, P1391, DOI 10.1084/jem.163.6.1391; JECKEL D, 1992, J CELL BIOL, V117, P259, DOI 10.1083/jcb.117.2.259; Kamlekar RK, 2013, BBA-MOL CELL BIOL L, V1831, P417, DOI 10.1016/j.bbalip.2012.10.010; Maccioni HJF, 2011, J NEUROCHEM, V117, P589, DOI 10.1111/j.1471-4159.2011.07232.x; Mallard Frederic, 2003, Methods Mol Med, V73, P209; Moto YH, 2008, NEUROREPORT, V19, P621, DOI 10.1097/WNR.0b013e3282fb7d99; Muramatsu K, 2008, BIOCHEM BIOPH RES CO, V370, P419, DOI 10.1016/j.bbrc.2008.03.103; Ohvo-Rekila H, 2011, BBA-BIOMEMBRANES, V1808, P47, DOI 10.1016/j.bbamem.2010.08.018; Okuda T, 2006, J BIOL CHEM, V281, P10230, DOI 10.1074/jbc.M600057200; PIETRO ES, 2009, PLOS BIOL, V0007; Psotka MA, 2009, INFECT IMMUN, V77, P959, DOI 10.1128/IAI.00679-08; Sato T, 2007, NATURE, V448, P366, DOI 10.1038/nature05929; VANHEYNINGEN S, 1974, SCIENCE, V183, P656, DOI 10.1126/science.183.4125.656; Yamaji T, 2010, J BIOL CHEM, V285, P35505, DOI 10.1074/jbc.M110.154229; Yan XG, 2004, MOL CELL PROTEOMICS, V3, P10, DOI 10.1074/mcp.R300010-MCP200; Zhai XH, 2009, J BIOL CHEM, V284, P13620, DOI 10.1074/jbc.M809089200	30	104	108	1	65	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 5	2013	501	7465								10.1038/nature12423	http://dx.doi.org/10.1038/nature12423			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8YC	23913272				2022-12-24	WOS:000339424700002
J	Liu, SH; Zhang, Y; Moayeri, M; Liu, J; Crown, D; Fattah, RJ; Wein, AN; Yu, ZX; Finkel, T; Leppla, SH				Liu, Shihui; Zhang, Yi; Moayeri, Mahtab; Liu, Jie; Crown, Devorah; Fattah, Rasem J.; Wein, Alexander N.; Yu, Zu-Xi; Finkel, Toren; Leppla, Stephen H.			Key tissue targets responsible for anthrax-toxin-induced lethality	NATURE			English	Article							CAPILLARY MORPHOGENESIS PROTEIN-2; BACILLUS-ANTHRACIS; CRE-RECOMBINASE; INHALATIONAL ANTHRAX; CELLULAR RECEPTOR; KINASE-KINASE; IN-VIVO; CELLS; MOUSE; MICE	Bacillus anthracis, the causative agent of anthrax disease, is lethal owing to the actions of two exotoxins: anthrax lethal toxin (LT) and oedema toxin (ET). The key tissue targets responsible for the lethal effects of these toxins are unknown. Here we generated cell-type-specific anthrax toxin receptor capillary morphogenesis protein-2 (CMG2)-null mice and cell-type-specific CMG2-expressing mice and challenged them with the toxins. Our results show that lethality induced by LT and ET occurs through damage to distinct cell types; whereas targeting cardiomyocytes and vascular smooth muscle cells is required for LT-induced mortality, ET-induced lethality occurs mainly through its action in hepatocytes. Notably, and in contradiction to what has been previously postulated, targeting of endothelial cells by either toxin does not seem to contribute significantly to lethality. Our findings demonstrate that B. anthracis has evolved to use LT and ET to induce host lethality by coordinately damaging two distinct vital systems.	[Liu, Shihui; Zhang, Yi; Moayeri, Mahtab; Crown, Devorah; Fattah, Rasem J.; Wein, Alexander N.; Leppla, Stephen H.] NIAID, Microbial Pathogenesis Sect, Parasit Dis Lab, NIH, Bethesda, MD 20892 USA; [Liu, Jie; Finkel, Toren] NHLBI, Ctr Mol Med, NIH, Bethesda, MD 20892 USA; [Yu, Zu-Xi] NHLBI, Pathol Core Facil, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Liu, SH (corresponding author), NIAID, Microbial Pathogenesis Sect, Parasit Dis Lab, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	shliu@niaid.nih.gov; sleppla@niaid.nih.gov		Wein, Alex/0000-0002-8813-3523; Liu, Shihui/0000-0003-3444-1069; Moayeri, Mahtab/0000-0002-4448-8883	National Institute of Allergy and Infectious Diseases; National Heart, Lung, and Blood Institute, National Institutes of Health; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZICHL005904] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001032] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008169] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Heart, Lung, and Blood Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by the intramural research programs of the National Institute of Allergy and Infectious Diseases and the National Heart, Lung, and Blood Institute, National Institutes of Health. We thank L. Feigenbaum and the staff at SAIC/NCI Frederick for generation of the founder CMG2 transgenic mice. We thank A. Kulkarni, B. Hall, B. Klaunberg, S. Anderson, I. Sastalla, C. Leysath and C. Bachran for discussions, and D. Despres for help with echocardiography.	Agah R, 1997, J CLIN INVEST, V100, P169, DOI 10.1172/JCI119509; Alva JA, 2006, DEV DYNAM, V235, P759, DOI 10.1002/dvdy.20643; ARORA N, 1992, J BIOL CHEM, V267, P15542; Bolcome RE, 2008, P NATL ACAD SCI USA, V105, P2439, DOI 10.1073/pnas.0712195105; Bradley KA, 2001, NATURE, V414, P225, DOI 10.1038/n35101999; Bradley SV, 2007, HUM MOL GENET, V16, P1279, DOI 10.1093/hmg/ddm076; Braunstein EM, 2002, DEV DYNAM, V224, P90, DOI 10.1002/dvdy.10091; Dal Molin F, 2008, TOXICON, V52, P824, DOI 10.1016/j.toxicon.2008.08.011; Duesbery NS, 1998, SCIENCE, V280, P734, DOI 10.1126/science.280.5364.734; Firoved AM, 2005, AM J PATHOL, V167, P1309, DOI 10.1016/S0002-9440(10)61218-7; Ghosh CC, 2012, P NATL ACAD SCI USA, V109, P10024, DOI 10.1073/pnas.1120755109; Guarner J, 2003, AM J PATHOL, V163, P701, DOI 10.1016/S0002-9440(10)63697-8; Guichard A., 2012, MICROBES INFECT, V5, P48; Guichard A, 2010, NATURE, V467, P854, DOI 10.1038/nature09446; Gupta PK, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003130; Hall BE, 2010, LAB INVEST, V90, P543, DOI 10.1038/labinvest.2010.5; Holtwick R, 2002, P NATL ACAD SCI USA, V99, P7142, DOI 10.1073/pnas.102650499; Hu HJ, 2006, CELL MICROBIOL, V8, P1634, DOI 10.1111/j.1462-5822.2006.00738.x; Jernigan JA, 2001, EMERG INFECT DIS, V7, P933, DOI 10.3201/eid0706.010604; Lepore JJ, 2005, GENESIS, V41, P179, DOI 10.1002/gene.20112; LEPPLA SH, 1982, P NATL ACAD SCI-BIOL, V79, P3162, DOI 10.1073/pnas.79.10.3162; Levinsohn JL, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002638; Liu SH, 2003, J BIOL CHEM, V278, P5227, DOI 10.1074/jbc.M210321200; Liu SH, 2007, CELL MICROBIOL, V9, P977, DOI 10.1111/j.1462-5822.2006.00845.x; Liu SH, 2012, P NATL ACAD SCI USA, V109, P13817, DOI 10.1073/pnas.1206933109; Liu SL, 2009, P NATL ACAD SCI USA, V106, P12424, DOI 10.1073/pnas.0905409106; Lui SH, 2010, CELL HOST MICROBE, V8, P455, DOI 10.1016/j.chom.2010.10.004; Mabry R, 2006, CLIN VACCINE IMMUNOL, V13, P671, DOI 10.1128/CVI.00023-06; Maddugoda MP, 2011, CELL HOST MICROBE, V10, P464, DOI 10.1016/j.chom.2011.09.014; Moayeri M, 2003, J CLIN INVEST, V112, P670, DOI [10.1172/JCI200317991, 10.1172/JCI17991]; Moayeri M, 2009, MOL ASPECTS MED, V30, P439, DOI 10.1016/j.mam.2009.07.003; Moayeri M, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000456; Newman ZL, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000906; PEZARD C, 1991, INFECT IMMUN, V59, P3472, DOI 10.1128/IAI.59.10.3472-3477.1991; Pomerantsev AP, 2011, PROTEIN EXPRES PURIF, V80, P80, DOI 10.1016/j.pep.2011.05.016; Pomerantsev AP, 2006, INFECT IMMUN, V74, P682, DOI 10.1128/IAI.74.1.682-693.2006; Postic C, 1999, J BIOL CHEM, V274, P305, DOI 10.1074/jbc.274.1.305; Reynolds LE, 2006, METH MOLEC MED, V120, P503; Rosovitz MJ, 2003, J BIOL CHEM, V278, P30936, DOI 10.1074/jbc.M301154200; Scobie HM, 2003, P NATL ACAD SCI USA, V100, P5170, DOI 10.1073/pnas.0431098100; SIRARD JC, 1994, J BACTERIOL, V176, P5188, DOI 10.1128/jb.176.16.5188-5192.1994; Vitale G, 1998, BIOCHEM BIOPH RES CO, V248, P706, DOI 10.1006/bbrc.1998.9040; Vitale G, 2000, BIOCHEM J, V352, P739, DOI 10.1042/0264-6021:3520739; Warfel JM, 2005, AM J PATHOL, V166, P1871, DOI 10.1016/S0002-9440(10)62496-0	44	77	80	0	37	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 5	2013	501	7465					63	+		10.1038/nature12510	http://dx.doi.org/10.1038/nature12510			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	211ER	23995686	Green Accepted			2022-12-24	WOS:000323888300032
J	Miyamoto, K; Teperek, M; Yusa, K; Allen, GE; Bradshaw, CR; Gurdon, JB				Miyamoto, Kei; Teperek, Marta; Yusa, Kosuke; Allen, George E.; Bradshaw, Charles R.; Gurdon, J. B.			Nuclear Wave1 Is Required for Reprogramming Transcription in Oocytes and for Normal Development	SCIENCE			English	Article							N-WASP; ACTIN	Eggs and oocytes have a remarkable ability to induce transcription of sperm after normal fertilization and in somatic nuclei after somatic cell nuclear transfer. This ability of eggs and oocytes is essential for normal development. Nuclear actin and actin-binding proteins have been shown to contribute to transcription, although their mode of action is elusive. Here, we find that Xenopus Wave1, previously characterized as a protein involved in actin cytoskeleton organization, is present in the oocyte nucleus and is required for efficient transcriptional reprogramming. Moreover, Wave1 knockdown in embryos results in abnormal development and defective hox gene activation. Nuclear Wave1 binds by its WHD domain to active transcription components, and this binding contributes to the action of RNA polymerase II. We identify Wave1 as a maternal reprogramming factor that also has a necessary role in gene activation in development.	[Miyamoto, Kei; Teperek, Marta; Allen, George E.; Bradshaw, Charles R.; Gurdon, J. B.] Wellcome Trust Canc Res UK Gurdon Inst, Cambridge CB2 1QN, England; [Miyamoto, Kei; Teperek, Marta; Allen, George E.; Bradshaw, Charles R.; Gurdon, J. B.] Univ Cambridge, Dept Zool, Cambridge CB2 3EJ, England; [Yusa, Kosuke] Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England	University of Cambridge; Wellcome Trust Sanger Institute	Miyamoto, K (corresponding author), Wellcome Trust Canc Res UK Gurdon Inst, Henry Wellcome Bldg Canc & Dev Biol,Tennis Court, Cambridge CB2 1QN, England.	k.miyamoto@gurdon.cam.ac.uk; j.gurdon@gurdon.cam.ac.uk		Bradshaw, Charles/0000-0002-3528-458X; Teperek, Marta/0000-0001-8520-5598; Miyamoto, Kei/0000-0003-2912-6777; GURDON, JOHN/0000-0002-5621-3799	Herchel Smith Postdoctoral Fellowship; Great Britain Sasakawa Foundation; Wellcome Trust [WT089613, WT077187, 101050/Z/13/Z]; Medical Research Council [G1001690/1]; MRC [G1001690] Funding Source: UKRI	Herchel Smith Postdoctoral Fellowship; Great Britain Sasakawa Foundation; Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We are grateful to D. Simpson for preparing eggs and oocytes; to A. Meissner for dox-inducible mouse embryo fibroblasts; to S. Suetsugu, T. Takenawa, and H. Miki for hWAVE1 constructs; and to Gurdon laboratory members for their critical reading of the manuscript. K. M. is a Research Fellow at Wolfson College and is supported by the Herchel Smith Postdoctoral Fellowship and the Great Britain Sasakawa Foundation. M. T. is funded by the Wellcome Trust (WT089613). K.Y. was supported by Wellcome Trust (WT077187). Gurdon laboratory is supported by grants from the Wellcome Trust (101050/Z/13/Z) and Medical Research Council (G1001690/1) to J.B.G. RNA-seq data were deposited in NCBI (SRA091722).	Campellone KG, 2010, NAT REV MOL CELL BIO, V11, P237, DOI 10.1038/nrm2867; Ferrai C, 2009, MOL BIOL CELL, V20, P3543, DOI 10.1091/mbc.E09-02-0114; Fricke R, 2009, CURR BIOL, V19, P1429, DOI 10.1016/j.cub.2009.07.058; Gao SR, 2002, BIOL REPROD, V67, P928, DOI 10.1095/biolreprod.102.004606; GURDON JB, 1968, J EMBRYOL EXP MORPH, V20, P401; Ho HYH, 2004, CELL, V118, P203, DOI 10.1016/j.cell.2004.06.027; Hulstrand AM, 2010, METHODS, V51, P75, DOI 10.1016/j.ymeth.2009.12.015; Jullien J, 2011, NAT REV MOL CELL BIO, V12, P453, DOI 10.1038/nrm3140; Kim K, 2010, NATURE, V467, P285, DOI 10.1038/nature09342; Koche RP, 2011, CELL STEM CELL, V8, P96, DOI 10.1016/j.stem.2010.12.001; Miki H, 1998, EMBO J, V17, P6932, DOI 10.1093/emboj/17.23.6932; Miyamoto K, 2011, GENE DEV, V25, P946, DOI 10.1101/gad.615211; Ogushi S, 2008, SCIENCE, V319, P613, DOI 10.1126/science.1151276; Rawe VY, 2004, DEV BIOL, V276, P253, DOI 10.1016/j.ydbio.2004.07.043; Takenawa T, 2007, NAT REV MOL CELL BIO, V8, P37, DOI 10.1038/nrm2069; Taylor MD, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000813; Wu XY, 2006, NAT CELL BIOL, V8, P756, DOI 10.1038/ncb1433; Yokoyama A, 2002, BLOOD, V100, P3710, DOI 10.1182/blood-2002-04-1015	18	59	60	1	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 30	2013	341	6149					1002	1005		10.1126/science.1240376	http://dx.doi.org/10.1126/science.1240376			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	208BZ	23990560	Green Accepted			2022-12-24	WOS:000323652300043
J	Suweis, S; Simini, F; Banavar, JR; Maritan, A				Suweis, Samir; Simini, Filippo; Banavar, Jayanth R.; Maritan, Amos			Emergence of structural and dynamical properties of ecological mutualistic networks	NATURE			English	Article							NESTEDNESS ANALYSIS; STABILITY; ARCHITECTURE; EVOLUTION; BIODIVERSITY; COMMUNITIES; ECOSYSTEMS; DIVERSITY; SYSTEMS	Mutualistic networks are formed when the interactions between two classes of species are mutually beneficial. They are important examples of cooperation shaped by evolution. Mutualism between animals and plants has a key role in the organization of ecological communities(1-3). Such networks in ecology have generally evolved a nested architecture(4,5) independent of species composition and latitude(6,7); specialist species, with only few mutualistic links, tend to interact with a proper subset of the many mutualistic partners of any of the generalist species(1). Despite sustained efforts(5,8-10) to explain observed network structure on the basis of community-level stability or persistence, such correlative studies have reached minimal consensus(11-13). Here we show that nested interaction networks could emerge as a consequence of an optimization principle aimed at maximizing the species abundance in mutualistic communities. Using analytical and numerical approaches, we show that because of the mutualistic interactions, an increase in abundance of a given species results in a corresponding increase in the total number of individuals in the community, and also an increase in the nestedness of the interaction matrix. Indeed, the species abundances and the nestedness of the interaction matrix are correlated by a factor that depends on the strength of the mutualistic interactions. Nestedness and the observed spontaneous emergence of generalist and specialist species occur for several dynamical implementations of the variational principle under stationary conditions. Optimized networks, although remaining stable, tend to be less resilient than their counterparts with randomly assigned interactions. In particular, we show analytically that the abundance of the rarest species is linked directly to the resilience of the community. Our work provides a unifying framework for studying the emergent structural and dynamical properties of ecological mutualistic networks(2,5,10,14).	[Suweis, Samir; Maritan, Amos] Univ Padua, Ist Nazl Fis Nucl, Dipartimento Fis & Astron G Galilei, I-35131 Padua, Italy; [Suweis, Samir; Maritan, Amos] Univ Padua, Ist Nazl Fis Nucl, CNISM, I-35131 Padua, Italy; [Simini, Filippo] Northeastern Univ, Ctr Complex Network Res, Boston, MA 02115 USA; [Simini, Filippo] Northeastern Univ, Dept Phys Biol & Comp Sci, Boston, MA 02115 USA; [Simini, Filippo] Budapest Univ Technol & Econ, Inst Phys, H-1111 Budapest, Hungary; [Banavar, Jayanth R.] Univ Maryland, Dept Phys, College Pk, MD 20742 USA	Istituto Nazionale di Fisica Nucleare (INFN); University of Padua; Istituto Nazionale di Fisica Nucleare (INFN); University of Padua; Northeastern University; Northeastern University; Budapest University of Technology & Economics; University System of Maryland; University of Maryland College Park	Suweis, S (corresponding author), Univ Padua, Ist Nazl Fis Nucl, Dipartimento Fis & Astron G Galilei, Via Marzolo 8, I-35131 Padua, Italy.	suweis@pd.infn.it; amos.maritan@pd.infn.it		Maritan, Amos/0000-0002-3535-7873; Suweis, Samir/0000-0002-1603-8375	Cariparo foundation	Cariparo foundation(Fondazione Cariparo)	A.M. and S.S. acknowledge the Cariparo foundation for financial support. We thank S. Allesina, T. Cooke, J. Grilli and L. Mari for discussions and Studio 7 a.m. for graphics support.	Allesina S, 2012, NATURE, V487, P175, DOI 10.1038/487175a; Allesina S, 2012, NATURE, V483, P205, DOI 10.1038/nature10832; Almeida-Neto M, 2008, OIKOS, V117, P1227, DOI 10.1111/j.0030-1299.2008.16644.x; Bascompte J, 2003, P NATL ACAD SCI USA, V100, P9383, DOI 10.1073/pnas.1633576100; Bascompte J, 2007, ANNU REV ECOL EVOL S, V38, P567, DOI 10.1146/annurev.ecolsys.38.091206.095818; Bastolla U, 2009, NATURE, V458, P1018, DOI 10.1038/nature07950; Campbell C, 2012, PHYS REV E, V86, DOI 10.1103/PhysRevE.86.021924; Douglas M. W., 2011, P R SOC B, V278, P2401; Guimaraes PR, 2007, CURR BIOL, V17, P1797, DOI 10.1016/j.cub.2007.09.059; Guimaraes PR, 2011, ECOL LETT, V14, P877, DOI 10.1111/j.1461-0248.2011.01649.x; Holland JN, 2002, AM NAT, V159, P231, DOI 10.1086/338510; Ives AR, 2007, SCIENCE, V317, P58, DOI 10.1126/science.1133258; James A, 2012, NATURE, V487, P227, DOI 10.1038/nature11214; Krishna A, 2008, OIKOS, V117, P1609, DOI 10.1111/j.1600-0706.2008.16540.x; May RM, 2008, NATURE, V451, P893, DOI 10.1038/451893a; McCann KS, 2000, NATURE, V405, P228, DOI 10.1038/35012234; Montoya JM, 2006, NATURE, V442, P259, DOI 10.1038/nature04927; Nowak MA, 2006, SCIENCE, V314, P1560, DOI 10.1126/science.1133755; Nowak MA, 2010, NATURE, V466, P1057, DOI 10.1038/nature09205; Okuyama T, 2008, ECOL LETT, V11, P208, DOI 10.1111/j.1461-0248.2007.01137.x; PASCUAL M, 2006, ECOLOGICAL NETWORKS; Proulx SR, 2005, TRENDS ECOL EVOL, V20, P345, DOI 10.1016/j.tree.2005.04.004; Saavedra S, 2009, NATURE, V457, P463, DOI 10.1038/nature07532; Saavedra S, 2011, NATURE, V478, P233, DOI 10.1038/nature10433; Staniczenko PPA, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2422; Thebault E, 2010, SCIENCE, V329, P853, DOI 10.1126/science.1188321; Thompson AR, 2006, J ANIM ECOL, V75, P1239, DOI 10.1111/j.1365-2656.2006.01145.x; Twardochleb LA, 2012, ECOL APPL, V22, P1162, DOI 10.1890/11-0871.1; Ulrich W, 2009, OIKOS, V118, P3, DOI 10.1111/j.1600-0706.2008.17053.x; Zhang F, 2011, ECOL LETT, V14, P797, DOI 10.1111/j.1461-0248.2011.01647.x	30	172	174	7	295	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 22	2013	500	7463					449	452		10.1038/nature12438	http://dx.doi.org/10.1038/nature12438			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	203TJ	23969462	Green Submitted			2022-12-24	WOS:000323316100033
J	Ziller, MJ; Gu, HC; Muller, F; Donaghey, J; Tsai, LTY; Kohlbacher, O; De Jager, PL; Rosen, ED; Bennett, DA; Bernstein, BE; Gnirke, A; Meissner, A				Ziller, Michael J.; Gu, Hongcang; Mueller, Fabian; Donaghey, Julie; Tsai, Linus T. -Y.; Kohlbacher, Oliver; De Jager, Philip L.; Rosen, Evan D.; Bennett, David A.; Bernstein, Bradley E.; Gnirke, Andreas; Meissner, Alexander			Charting a dynamic DNA methylation landscape of the human genome	NATURE			English	Article							MAMMALIAN DEVELOPMENT; CELLS; WIDE; METHYLOME; DISEASE; MOUSE; PLURIPOTENT; SELECTION; TRAITS; LOCI	DNA methylation is a defining feature of mammalian cellular identity and is essential for normal development(1,2). Most cell types, except germ cells and pre-implantation embryos(3-5), display relatively stable DNA methylation patterns, with 70-80% of all CpGs being methylated(6). Despite recent advances, we still have a limited understanding of when, where and how many CpGs participate in genomic regulation. Here we report the in-depth analysis of 42 whole-genome bisulphite sequencing data sets across 30 diverse human cell and tissue types. We observe dynamic regulation for only 21.8% of autosomal CpGs within a normal developmental context, most of which are distal to transcription start sites. These dynamic CpGs co-localize with gene regulatory elements, particularly enhancers and transcription-factor-binding sites, which allow identification of key lineage-specific regulators. In addition, differentially methylated regions (DMRs) often contain single nucleotide polymorphisms associated with cell-type-related diseases as determined by genome-wide association studies. The results also highlight the general inefficiency of whole-genome bisulphite sequencing, as 70-80% of the sequencing reads across these data sets provided little or no relevant information about CpG methylation. To demonstrate further the utility of our DMR set, we use it to classify unknown samples and identify representative signature regions that recapitulate major DNA methylation dynamics. In summary, although in theory every CpG can change its methylation state, our results suggest that only a fraction does so as part of coordinated regulatory programs. Therefore, our selected DMRs can serve as a starting point to guide new, more effective reduced representation approaches to capture the most informative fraction of CpGs, as well as further pinpoint putative regulatory elements.	[Ziller, Michael J.; Gu, Hongcang; Donaghey, Julie; De Jager, Philip L.; Rosen, Evan D.; Bernstein, Bradley E.; Gnirke, Andreas; Meissner, Alexander] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Ziller, Michael J.; Donaghey, Julie; Meissner, Alexander] Harvard Stem Cell Inst, Cambridge, MA 02138 USA; [Ziller, Michael J.; Mueller, Fabian; Donaghey, Julie; Meissner, Alexander] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [Tsai, Linus T. -Y.; Rosen, Evan D.] Beth Israel Deaconess Med Ctr, Div Endocrinol, Boston, MA 02215 USA; [Kohlbacher, Oliver] Univ Tubingen, Ctr Bioinformat, D-72074 Tubingen, Germany; [Kohlbacher, Oliver] Univ Tubingen, Quantitat Biol Ctr, D-72074 Tubingen, Germany; [De Jager, Philip L.] Brigham & Womens Hosp, Inst Neurosci, Program Translat NeuroPsychiat Genom, Dept Neurol, Boston, MA 02115 USA; [De Jager, Philip L.] Brigham & Womens Hosp, Inst Neurosci, Program Translat NeuroPsychiat Genom, Dept Psychiat, Boston, MA 02115 USA; [Bennett, David A.] Rush Univ, Med Ctr, Rush Alzheimers Dis Ctr, Chicago, IL 60612 USA; [Bernstein, Bradley E.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard University; Harvard University; Beth Israel Deaconess Medical Center; Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Rush University; Harvard University; Massachusetts General Hospital	Meissner, A (corresponding author), Broad Inst MIT & Harvard, Cambridge, MA 02142 USA.	alexander_meissner@harvard.edu	Kohlbacher, Oliver/AAF-3297-2021; Kohlbacher, Oliver/B-7310-2008; Müller, Fabian/HGD-0719-2022	Kohlbacher, Oliver/0000-0003-1739-4598; Kohlbacher, Oliver/0000-0003-1739-4598; Müller, Fabian/0000-0001-5809-2321; Tsai, Linus/0000-0002-0134-6949; Gu, Hongcang/0000-0002-1439-7606	National Institutes of Health (NIH) Roadmap Epigenomics Project [ES017690]; NIH [P30AG10161, R01AG17917, R01AG15819, R01AG36042, U01ES017155, P01GM099117]; Pew Charitable Trusts; New York Stem Cell Foundation; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [U01ES017155] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM099117] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG036042, R01AG015819, P30AG010161, R01AG017917] Funding Source: NIH RePORTER	National Institutes of Health (NIH) Roadmap Epigenomics Project; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pew Charitable Trusts; New York Stem Cell Foundation; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We would like to thank K. Clement, P. Samavarchi-Tehrani, Z. Smith, M. Chan and R. Karnik for discussions and feedback. We would also like to thank F. Kelley, T. Durham, C. Epstein, N. Shoresh, G. Lauwers and the Massachusetts General Hospital tissue repository for assisting in sample and data management. E.D.R. is supported by the National Institutes of Health (NIH) Roadmap Epigenomics Project (ES017690). D.A.B. is supported by NIH grants P30AG10161, R01AG17917, R01AG15819 and R01AG36042. A.M. is supported by the Pew Charitable Trusts and is a New York Stem Cell Foundation, Robertson Investigator. This work was funded by NIH grants (U01ES017155 and P01GM099117) and The New York Stem Cell Foundation.	Bell CG, 2012, EPIGENETICS-US, V7, P1188, DOI 10.4161/epi.22127; Bergman Y, 2013, NAT STRUCT MOL BIOL, V20, P274, DOI 10.1038/nsmb.2518; Berman BP, 2012, NAT GENET, V44, P40, DOI 10.1038/ng.969; Bestor TH, 2000, HUM MOL GENET, V9, P2395, DOI 10.1093/hmg/9.16.2395; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Cohen NM, 2011, CELL, V145, P773, DOI 10.1016/j.cell.2011.04.024; Dedeurwaerder S, 2011, EPIGENOMICS-UK, V3, P771, DOI [10.2217/EPI.11.105, 10.2217/epi.11.105]; Ehrlich M, 2009, EPIGENOMICS-UK, V1, P239, DOI 10.2217/EPI.09.33; Gerstein MB, 2012, NATURE, V489, P91, DOI 10.1038/nature11245; Gnirke A, 2009, NAT BIOTECHNOL, V27, P182, DOI 10.1038/nbt.1523; Hackett JA, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2011.0328; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Irizarry RA, 2009, NAT GENET, V41, P178, DOI 10.1038/ng.298; Laurent L, 2010, GENOME RES, V20, P320, DOI 10.1101/gr.101907.109; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; Lienert F, 2011, NAT GENET, V43, P1091, DOI 10.1038/ng.946; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; Maurano MT, 2012, SCIENCE, V337, P1190, DOI 10.1126/science.1222794; Meissner A, 2008, NATURE, V454, P766, DOI 10.1038/nature07107; Nazor KL, 2012, CELL STEM CELL, V10, P620, DOI 10.1016/j.stem.2012.02.013; Ravasi T, 2010, CELL, V140, P744, DOI 10.1016/j.cell.2010.01.044; Reik W, 2007, NATURE, V447, P425, DOI 10.1038/nature05918; Seisenberger S, 2012, MOL CELL, V48, P849, DOI 10.1016/j.molcel.2012.11.001; Smith ZD, 2013, NAT REV GENET, V14, P204, DOI 10.1038/nrg3354; Smith ZD, 2012, NATURE, V484, P339, DOI 10.1038/nature10960; Stadler MB, 2011, NATURE, V480, P490, DOI 10.1038/nature10716; Thurman RE, 2012, NATURE, V489, P75, DOI 10.1038/nature11232; Varley KE, 2013, GENOME RES, V23, P555, DOI 10.1101/gr.147942.112; Weber M, 2005, NAT GENET, V37, P853, DOI 10.1038/ng1598; Zhu J, 2013, CELL, V152, P642, DOI 10.1016/j.cell.2012.12.033	30	860	888	6	170	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 22	2013	500	7463					477	481		10.1038/nature12433	http://dx.doi.org/10.1038/nature12433			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	203TJ	23925113	Green Accepted, Green Submitted			2022-12-24	WOS:000323316100039
J	Vannier, JB; Sandhu, S; Petalcorin, MIR; Wu, XL; Nabi, Z; Ding, H; Boulton, SJ				Vannier, Jean-Baptiste; Sandhu, Sumit; Petalcorin, Mark I. R.; Wu, Xiaoli; Nabi, Zinnatun; Ding, Hao; Boulton, Simon J.			RTEL1 Is a Replisome-Associated Helicase That Promotes Telomere and Genome-Wide Replication	SCIENCE			English	Article							DNA-REPLICATION; MUTATIONS; REPAIR	Regulator of telomere length 1 (RTEL1) is an essential DNA helicase that disassembles telomere loops (T loops) and suppresses telomere fragility to maintain the integrity of chromosome ends. We established that RTEL1 also associates with the replisome through binding to proliferating cell nuclear antigen (PCNA). Mouse cells disrupted for the RTEL1-PCNA interaction (PIP mutant) exhibited accelerated senescence, replication fork instability, reduced replication fork extension rates, and increased origin usage. Although T-loop disassembly at telomeres was unaffected in the mutant cells, telomere replication was compromised, leading to fragile sites at telomeres. RTEL1-PIP mutant mice were viable, but loss of the RTEL1-PCNA interaction accelerated the onset of tumorigenesis in p53-deficient mice. We propose that RTEL1 plays a critical role in both telomere and genome-wide replication, which is crucial for genetic stability and tumor avoidance.	[Vannier, Jean-Baptiste; Petalcorin, Mark I. R.; Boulton, Simon J.] Canc Res UK, London Res Inst, DNA Damage Response Lab, S Mimms EN6 3LD, Herts, England; [Sandhu, Sumit; Wu, Xiaoli; Nabi, Zinnatun; Ding, Hao] Univ Manitoba, Dept Biochem & Med Genet, Winnipeg, MB R3E 3J7, Canada; [Ding, Hao] Manitoba Inst Child Hlth, Winnipeg, MB R3E 3P4, Canada	Cancer Research UK; University of Manitoba	Ding, H (corresponding author), Univ Manitoba, Dept Biochem & Med Genet, Winnipeg, MB R3E 3J7, Canada.	dingh@cc.umanitoba.ca; simon.boulton@cancer.org.uk		Petalcorin, Mark/0000-0001-8211-9440	Cancer Research UK; European Research Council (ERC); Royal Society Wolfson Research Merit Award; Canada Research Chair program; Canada Institute of Health Research; Manitoba Institute of Child Health; Terry Fox Research Institute; ERC; Natural Sciences and Engineering Research Council of Canada; Manitoba Health Research Council; Cancer Research UK [11581] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); European Research Council (ERC)(European Research Council (ERC)European Commission); Royal Society Wolfson Research Merit Award(Royal Society of London); Canada Research Chair program(Canada Research Chairs); Canada Institute of Health Research(Canadian Institutes of Health Research (CIHR)); Manitoba Institute of Child Health; Terry Fox Research Institute; ERC(European Research Council (ERC)European Commission); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Manitoba Health Research Council; Cancer Research UK(Cancer Research UK)	We thank the Protein Analysis and Proteomics group at London Reasearch Institute for mass spectrometry and J. Mendez for MCM2 antibody. Research in the DNA damage response lab of S. J. B. is funded by Cancer Research UK and by a European Research Council (ERC) Advanced Investigator Grant (RecMitMei). S. J. B. is a recipient of a Royal Society Wolfson Research Merit Award. The laboratory of H. D. is supported by Canada Research Chair program, Canada Institute of Health Research, Manitoba Institute of Child Health, and Terry Fox Research Institute. J.-B.V. is funded by a long-term fellowship from ERC, and S. S. and Z.N. are supported by the fellowships from Natural Sciences and Engineering Research Council of Canada (to S. S.) and the Manitoba Health Research Council (to Z.N.).	Ballew BJ, 2013, HUM GENET, V132, P473, DOI 10.1007/s00439-013-1265-8; Barber LJ, 2008, CELL, V135, P261, DOI 10.1016/j.cell.2008.08.016; Chapman JR, 2012, MOL CELL, V47, P497, DOI 10.1016/j.molcel.2012.07.029; Chuang LC, 2009, MOL CELL, V35, P206, DOI 10.1016/j.molcel.2009.06.014; Ding H, 2004, CELL, V117, P873, DOI 10.1016/j.cell.2004.05.026; Egan KM, 2011, J NEURO-ONCOL, V104, P535, DOI 10.1007/s11060-010-0506-0; Essers J, 2005, MOL CELL BIOL, V25, P9350, DOI 10.1128/MCB.25.21.9350-9359.2005; Gari K, 2012, SCIENCE, V337, P243, DOI 10.1126/science.1219664; Gilbertson RJ, 2008, ANNU REV PATHOL-MECH, V3, P341, DOI 10.1146/annurev.pathmechdis.3.121806.151518; JACKS T, 1994, CURR BIOL, V4, P1, DOI 10.1016/S0960-9822(00)00002-6; Le Guen T, 2013, HUM MOL GENET, V22, P3239, DOI 10.1093/hmg/ddt178; Montagnoli A, 2008, NAT CHEM BIOL, V4, P357, DOI 10.1038/nchembio.90; Sfeir A, 2009, CELL, V138, P90, DOI 10.1016/j.cell.2009.06.021; Shete S, 2009, NAT GENET, V41, P899, DOI 10.1038/ng.407; Uringa EJ, 2012, MOL BIOL CELL, V23, P2782, DOI 10.1091/mbc.E12-03-0179; Vannier JB, 2012, CELL, V149, P795, DOI 10.1016/j.cell.2012.03.030; Walne AJ, 2013, AM J HUM GENET, V92, P448, DOI 10.1016/j.ajhg.2013.02.001; Youds JL, 2010, SCIENCE, V327, P1254, DOI 10.1126/science.1183112	18	142	146	1	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 11	2013	342	6155					239	242		10.1126/science.1241779	http://dx.doi.org/10.1126/science.1241779			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232EV	24115439				2022-12-24	WOS:000325475200043
J	Spencer, SL; Cappell, SD; Tsai, FC; Overton, KW; Wang, CL; Meyer, T				Spencer, Sabrina L.; Cappell, Steven D.; Tsai, Feng-Chiao; Overton, K. Wesley; Wang, Clifford L.; Meyer, Tobias			The Proliferation-Quiescence Decision Is Controlled by a Bifurcation in CDK2 Activity at Mitotic Exit	CELL			English	Article							CELL-CYCLE CONTROL; RESTRICTION POINT; RETINOBLASTOMA PROTEIN; GENE-PRODUCT; DEPHOSPHORYLATION; DIFFERENTIATION; CANCER	Tissue homeostasis in metazoans is regulated by transitions of cells between quiescence and proliferation. The hallmark of proliferating populations is progression through the cell cycle, which is driven by cyclin-dependent kinase (CDK) activity. Here, we introduce a live-cell sensor for CDK2 activity and unexpectedly found that proliferating cells bifurcate into two populations as they exit mitosis. Many cells immediately commit to the next cell cycle by building up CDK2 activity from an intermediate level, while other cells lack CDK2 activity and enter a transient state of quiescence. This bifurcation is directly controlled by the CDK inhibitor p21 and is regulated by mitogens during a restriction window at the end of the previous cell cycle. Thus, cells decide at the end of mitosis to either start the next cell cycle by immediately building up CDK2 activity or to enter a transient G0-like state by suppressing CDK2 activity.	[Spencer, Sabrina L.; Cappell, Steven D.; Tsai, Feng-Chiao; Meyer, Tobias] Stanford Univ, Dept Chem & Syst Biol, Stanford, CA 94305 USA; [Overton, K. Wesley; Wang, Clifford L.] Stanford Univ, Dept Chem Engn, Stanford, CA 94305 USA	Stanford University; Stanford University	Spencer, SL (corresponding author), Stanford Univ, Dept Chem & Syst Biol, Stanford, CA 94305 USA.	spencer1@stanford.edu; tobias1@stanford.edu	Cappell, Steven/O-4072-2018	Cappell, Steven/0000-0002-2885-7327; Tsai, Feng-Chiao/0000-0001-9615-6023; SPENCER, SABRINA/0000-0002-5798-3007; Meyer, Tobias/0000-0003-4339-3804; Overton, Wes/0000-0002-0768-3778	Damon Runyon Cancer Research Foundation [DRG-[2043-10], DRG-[2141-12]]; American Cancer Society Robert and Mary Ann Forsland Postdoctoral Fellowship [PF-13-304-01-CCG]; NIH [CA120732, MH095087]; NATIONAL CANCER INSTITUTE [R21CA120732, R33CA120732] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM030179] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH095087] Funding Source: NIH RePORTER	Damon Runyon Cancer Research Foundation; American Cancer Society Robert and Mary Ann Forsland Postdoctoral Fellowship; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank Jia-Yun Chen, Sean Collins, James Ferrell, Xuedong Liu, Julien Sage, Matthew Scott, and John Albeck for helpful discussions; Matthew Clutter, Garry Nolan, Ben Ho Park, Kyuho Han, and Akiko Seki for reagents; and the Stanford Shared FACS Facility for cell sorting. S.L.S and S.D.C were supported by the Damon Runyon Cancer Research Foundation (DRG-[2043-10] and DRG-[2141-12]). S.L.S was also supported by an American Cancer Society Robert and Mary Ann Forsland Postdoctoral Fellowship (PF-13-304-01-CCG). T.M. was supported by NIH grants CA120732 and MH095087.	Abbas T, 2009, NAT REV CANCER, V9, P400, DOI 10.1038/nrc2657; Bachman KE, 2004, CANCER BIOL THER, V3, P221, DOI 10.4161/cbt.3.2.666; BUCHKOVICH K, 1989, CELL, V58, P1097, DOI 10.1016/0092-8674(89)90508-4; CHEN PL, 1989, CELL, V58, P1193, DOI 10.1016/0092-8674(89)90517-5; Coller HA, 2007, NAT REV MOL CELL BIO, V8, P667, DOI 10.1038/nrm2223; Coudreuse D, 2010, NATURE, V468, P1074, DOI 10.1038/nature09543; Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X; DOU QP, 1993, CANCER RES, V53, P1493; DULIC V, 1992, SCIENCE, V257, P1958, DOI 10.1126/science.1329201; Gu JM, 2004, MOL BIOL CELL, V15, P3320, DOI 10.1091/mbc.E04-03-0227; Hahn AT, 2009, CELL CYCLE, V8, P1044, DOI 10.4161/cc.8.7.8042; Hitomi M, 1999, MOL CELL BIOL, V19, P4623; Hochegger H, 2008, NAT REV MOL CELL BIO, V9, P910, DOI 10.1038/nrm2510; Iwamoto M, 2010, CHEM BIOL, V17, P981, DOI 10.1016/j.chembiol.2010.07.009; KOFF A, 1992, SCIENCE, V257, P1689, DOI 10.1126/science.1388288; Lanni JS, 1998, MOL CELL BIOL, V18, P1055, DOI 10.1128/MCB.18.2.1055; LUDLOW JW, 1990, CELL, V60, P387, DOI 10.1016/0092-8674(90)90590-B; LUDLOW JW, 1993, MOL CELL BIOL, V13, P367, DOI 10.1128/MCB.13.1.367; Massague J, 2004, NATURE, V432, P298, DOI 10.1038/nature03094; O'Farrell PH, 2011, PHILOS T R SOC B, V366, P3498, DOI 10.1098/rstb.2011.0079; OHTSUBO M, 1995, MOL CELL BIOL, V15, P2612; PARDEE AB, 1974, P NATL ACAD SCI USA, V71, P1286, DOI 10.1073/pnas.71.4.1286; PRESCOTT DM, 1968, CANCER RES, V28, P1815; Sakaue-Sawano A, 2008, CELL, V132, P487, DOI 10.1016/j.cell.2007.12.033; Trimarchi JM, 2002, NAT REV MOL CELL BIO, V3, P11, DOI 10.1038/nrm714; Uetake Y, 2010, CURR BIOL, V20, P1666, DOI 10.1016/j.cub.2010.08.018; WEINBERG RA, 1995, CELL, V81, P323, DOI 10.1016/0092-8674(95)90385-2; Yao G, 2008, NAT CELL BIOL, V10, P476, DOI 10.1038/ncb1711; ZETTERBERG A, 1995, CURR OPIN CELL BIOL, V7, P835, DOI 10.1016/0955-0674(95)80067-0; ZETTERBERG A, 1985, P NATL ACAD SCI USA, V82, P5365, DOI 10.1073/pnas.82.16.5365	30	354	355	1	42	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 10	2013	155	2					369	383		10.1016/j.cell.2013.08.062	http://dx.doi.org/10.1016/j.cell.2013.08.062			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	235LH	24075009	Bronze, Green Accepted			2022-12-24	WOS:000325719800014
J	Reinhardt, K; Dowling, DK; Morrow, EH				Reinhardt, Klaus; Dowling, Damian K.; Morrow, Edward H.			Mitochondrial Replacement, Evolution, and the Clinic	SCIENCE			English	Editorial Material							GENE-THERAPY; DISEASE; MTDNA		[Reinhardt, Klaus] Univ Tubingen, D-72076 Tubingen, Germany; [Reinhardt, Klaus] Univ Sheffield, Dept Anim & Plant Sci, Sheffield S10 2TN, S Yorkshire, England; [Dowling, Damian K.] Monash Univ, Sch Biol Sci, Clayton, Vic 3800, Australia; [Morrow, Edward H.] Univ Sussex, Sch Life Sci, Evolut Behav & Environm Grp, Brighton BN1 9QG, E Sussex, England	Eberhard Karls University of Tubingen; University of Sheffield; Monash University; University of Sussex	Reinhardt, K (corresponding author), Univ Tubingen, D-72076 Tubingen, Germany.	k.reinhardt@uni-tuebingen.de	Morrow, Edward H/Q-6730-2019; Dowling, Damian/C-9016-2009	Morrow, Edward H/0000-0002-1853-7469; Dowling, Damian/0000-0003-2209-3458				Craven L, 2010, NATURE, V465, P82, DOI 10.1038/nature08958; Frank SA, 1996, NATURE, V383, P224, DOI 10.1038/383224a0; Gemmell NJ, 2004, TRENDS ECOL EVOL, V19, P238, DOI 10.1016/j.tree.2004.02.002; Haites N, 2011, SCI REV SAFETY EFFIC; HFEA, MIT PUBL CONS 2012; HFEA, HFEA LAUNCH PUBL CON; Innocenti P, 2011, SCIENCE, V332, P845, DOI 10.1126/science.1201157; Nuffield Council on Bioethics, 2012, NOV TECHN PREV MIT D; Paull D, 2013, NATURE, V493, P632, DOI 10.1038/nature11800; Sato A, 2005, P NATL ACAD SCI USA, V102, P16765, DOI 10.1073/pnas.0506197102; Tachibana M, 2013, NATURE, V493, P627, DOI 10.1038/nature11647; Tachibana M, 2009, NATURE, V461, P367, DOI 10.1038/nature08368; Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606; Woodson JD, 2008, NAT REV GENET, V9, P383, DOI 10.1038/nrg2348	14	118	118	5	108	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 20	2013	341	6152					1345	1346		10.1126/science.1237146	http://dx.doi.org/10.1126/science.1237146			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	220PK	24052294				2022-12-24	WOS:000324597200027
J	Pinsky, ML; Worm, B; Fogarty, MJ; Sarmiento, JL; Levin, SA				Pinsky, Malin L.; Worm, Boris; Fogarty, Michael J.; Sarmiento, Jorge L.; Levin, Simon A.			Marine Taxa Track Local Climate Velocities	SCIENCE			English	Article							RANGE SHIFTS; IMPACTS	Organisms are expected to adapt or move in response to climate change, but observed distribution shifts span a wide range of directions and rates. Explanations often emphasize biological distinctions among species, but general mechanisms have been elusive. We tested an alternative hypothesis: that differences in climate velocity-the rate and direction that climate shifts across the landscape-can explain observed species shifts. We compiled a database of coastal surveys around North America from 1968 to 2011, sampling 128 million individuals across 360 marine taxa. Climate velocity explained the magnitude and direction of shifts in latitude and depth much more effectively than did species characteristics. Our results demonstrate that marine species shift at different rates and directions because they closely track the complex mosaic of local climate velocities.	[Pinsky, Malin L.; Levin, Simon A.] Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA; [Pinsky, Malin L.] Rutgers State Univ, Dept Ecol Evolut & Nat Resources, New Brunswick, NJ 08901 USA; [Pinsky, Malin L.] Rutgers State Univ, Inst Marine & Coastal Sci, New Brunswick, NJ 08901 USA; [Worm, Boris] Dalhousie Univ, Dept Biol, Halifax, NS B3H 4R2, Canada; [Fogarty, Michael J.] Northeast Fisheries Sci Ctr, Woods Hole, MA 02453 USA; [Sarmiento, Jorge L.] Princeton Univ, Atmospher & Ocean Sci Program, Princeton, NJ 08544 USA	Princeton University; Rutgers State University New Brunswick; Rutgers State University New Brunswick; Dalhousie University; National Oceanic Atmospheric Admin (NOAA) - USA; Princeton University	Pinsky, ML (corresponding author), Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA.	malin.pinsky@rutgers.edu	Pinsky, Malin L./K-2884-2015; Levin, Simon A/J-1218-2014	Pinsky, Malin L./0000-0002-8523-8952; Levin, Simon A/0000-0002-8216-5639; Worm, Boris/0000-0002-5742-8716	David H. Smith Conservation Research Fellowship; Natural Sciences and Engineering Research Council of Canada; Nippon Foundation-University of British Columbia Nereus Program; NSF	David H. Smith Conservation Research Fellowship; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Nippon Foundation-University of British Columbia Nereus Program; NSF(National Science Foundation (NSF))	We thank H. Benoit, B. Brodie, D. Clark, L. Col, J. Hare, B. Horness, R. Lauth, M. McClure, N. Peaks, J. Pearl, J. Rester, and M. Wilkins for assistance with data; C. Beaulieu, P. Kareiva, R. Rykaczewski, A. Smith, C. Stock, and J. Watson for helpful conversations; and M. Tingley, O. Jensen, and K. Hunter-Thomson for comments on the manuscript. Funding was provided by a David H. Smith Conservation Research Fellowship (M.L.P.), the Natural Sciences and Engineering Research Council of Canada (B.W.), the Nippon Foundation-University of British Columbia Nereus Program (J.L.S.), and NSF (S.A.L.). M.L.P. designed the study; M.L.P. and M.J.F. assembled the data; M.L.P., B.W., and M.J.F. analyzed the data; and M.L.P. and B.W. wrote the paper. S.A.L. and J.L.S. supervised the project. Locations of source data used in our analysis can be found in the supplementary materials.	Angert AL, 2011, ECOL LETT, V14, P677, DOI 10.1111/j.1461-0248.2011.01620.x; Burrows MT, 2011, SCIENCE, V334, P652, DOI 10.1126/science.1210288; Chavez FP, 2011, ANNU REV MAR SCI, V3, P227, DOI 10.1146/annurev.marine.010908.163917; Chen IC, 2011, SCIENCE, V333, P1024, DOI 10.1126/science.1206432; Cheung WWL, 2009, FISH FISH, V10, P235, DOI 10.1111/j.1467-2979.2008.00315.x; Chevin LM, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000357; Dulvy NK, 2008, J APPL ECOL, V45, P1029, DOI 10.1111/j.1365-2664.2008.01488.x; Heikkinen RK, 2007, GLOBAL ECOL BIOGEOGR, V16, P754, DOI 10.1111/j.1466-8238.2007.00345.x; La Sorte FA, 2012, J ANIM ECOL, V81, P914, DOI 10.1111/j.1365-2656.2012.01958.x; Lenoir J, 2010, ECOGRAPHY, V33, P295, DOI 10.1111/j.1600-0587.2010.06279.x; Loarie SR, 2009, NATURE, V462, P1052, DOI 10.1038/nature08649; Moritz C, 2008, SCIENCE, V322, P261, DOI 10.1126/science.1163428; Mueter FJ, 2008, ECOL APPL, V18, P309, DOI 10.1890/07-0564.1; Nye JA, 2009, MAR ECOL PROG SER, V393, P111, DOI 10.3354/meps08220; Ohlemuller R, 2011, SCIENCE, V334, P613, DOI 10.1126/science.1214215; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Perry AL, 2005, SCIENCE, V308, P1912, DOI 10.1126/science.1111322; Sunday JM, 2012, NAT CLIM CHANGE, V2, P686, DOI 10.1038/NCLIMATE1539; Tingley MW, 2012, GLOBAL CHANGE BIOL, V18, P3279, DOI 10.1111/j.1365-2486.2012.02784.x; Zhu K, 2012, GLOBAL CHANGE BIOL, V18, P1042, DOI 10.1111/j.1365-2486.2011.02571.x	20	784	795	9	302	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 13	2013	341	6151					1239	1242		10.1126/science.1239352	http://dx.doi.org/10.1126/science.1239352			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	215ZA	24031017				2022-12-24	WOS:000324248800043
J	Dolen, G; Darvishzadeh, A; Huang, KW; Malenka, RC				Doelen, Guel; Darvishzadeh, Ayeh; Huang, Kee Wui; Malenka, Robert C.			Social reward requires coordinated activity of nucleus accumbens oxytocin and serotonin	NATURE			English	Article							HYPOTHALAMO-NEUROHYPOPHYSEAL SYSTEM; MEDIUM SPINY NEURONS; CONCURRENT ACTIVATION; AFFILIATIVE BEHAVIOR; FOREBRAIN CIRCUIT; INDIRECT PATHWAYS; GENE-EXPRESSION; EVOLUTION; DOPAMINE; INNERVATION	Social behaviours in species as diverse as honey bees and humans promote group survival but often come at some cost to the individual. Although reinforcement of adaptive social interactions is ostensibly required for the evolutionary persistence of these behaviours, the neural mechanisms by which social reward is encoded by the brain are largely unknown. Here we demonstrate that in mice oxytocin acts as a social reinforcement signal within the nucleus accumbens core, where it elicits a presynaptically expressed long-term depression of excitatory synaptic transmission in medium spiny neurons. Although the nucleus accumbens receives oxytocin-receptor-containing inputs from several brain regions, genetic deletion of these receptors specifically from dorsal raphe nucleus, which provides serotonergic (5-hydroxytryptamine; 5-HT) innervation to the nucleus accumbens, abolishes the reinforcing properties of social interaction. Furthermore, oxytocin-induced synaptic plasticity requires activation of nucleus accumbens 5-HT1B receptors, the blockade of which prevents social reward. These results demonstrate that the rewarding properties of social interaction in mice require the coordinated activity of oxytocin and 5-HT in the nucleus accumbens, a mechanistic insight with implications for understanding the pathogenesis of social dysfunction in neuropsychiatric disorders such as autism.	[Doelen, Guel; Darvishzadeh, Ayeh; Huang, Kee Wui; Malenka, Robert C.] Stanford Univ, Sch Med, Dept Psychiat & Behav Sci, Nancy Pritzker Lab, Stanford, CA 94305 USA	Stanford University	Malenka, RC (corresponding author), Stanford Univ, Sch Med, Dept Psychiat & Behav Sci, Nancy Pritzker Lab, 265 Campus Dr, Stanford, CA 94305 USA.	malenka@stanford.edu	Dolen, Gul/J-3073-2015	Dolen, Gul/0000-0003-1780-995X	National Institutes of Health [NIH NS069375]; Simons Foundation Autism Research Initiative; Berry Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS069375] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P01DA008227, R21DA032955] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Simons Foundation Autism Research Initiative; Berry Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank members of the Malenka laboratory for comments; A. Andalman, W. Xu, B. K. Lim and T. Sudhof for technical advice; and the SIM1 Animal Care facility for husbandry support. The OT-neurophysin antibody was a gift of H. Gainer. OTR-Venus reporter mice were a gift of L. J. Young. D1-TdTomato BAC transgenic mice were provided by N. Calakos. The rabies virus complementary DNA plasmid and viral component-expressing plasmids were gifts from K. Conzelmann and I. Wickersham. HHK-B19G cells were a gift from E. Callaway. AAVs were produced by the Stanford NGVVC (supported by National Institutes of Health grant NIH NS069375). The AAV-DJ helper plasmid was a gift from M. Kay. This work was supported by funding from the Simons Foundation Autism Research Initiative (R. C. M.), N. I. H. (R. C. M.), and a Berry Foundation Postdoctoral Fellowship (G.D.)	Andalman AS, 2009, P NATL ACAD SCI USA, V106, P12518, DOI 10.1073/pnas.0903214106; ANDERSON PK, 1965, SCIENCE, V148, P1753, DOI 10.1126/science.148.3678.1753; Aronov D, 2008, SCIENCE, V320, P630, DOI 10.1126/science.1155140; BENBARAK Y, 1985, J NEUROSCI, V5, P81; Boureau YL, 2011, NEUROPSYCHOPHARMACOL, V36, P74, DOI 10.1038/npp.2010.151; BROG JS, 1993, J COMP NEUROL, V338, P255, DOI 10.1002/cne.903380209; Brunner D, 1999, BEHAV NEUROSCI, V113, P587; Capper-Loup C, 2002, J NEUROSCI, V22, P6218; Cui GH, 2013, NATURE, V494, P238, DOI 10.1038/nature11846; Doya K, 2002, NEURAL NETWORKS, V15, P495, DOI 10.1016/S0893-6080(02)00044-8; Furay AR, 2011, BEHAV BRAIN RES, V224, P350, DOI 10.1016/j.bbr.2011.06.016; Gong SC, 2003, NATURE, V425, P917, DOI 10.1038/nature02033; Grimm D, 2008, J VIROL, V82, P5887, DOI 10.1128/JVI.00254-08; HERMES MLHJ, 1988, J COMP NEUROL, V273, P252, DOI 10.1002/cne.902730209; Hodgson SR, 2010, BEHAV PHARMACOL, V21, P112, DOI 10.1097/FBP.0b013e328337be25; Holy TE, 2005, PLOS BIOL, V3, P2177, DOI 10.1371/journal.pbio.0030386; Insel TR, 2003, PHYSIOL BEHAV, V79, P351, DOI 10.1016/S0031-9384(03)00148-3; Kelley AE, 2002, J NEUROSCI, V22, P3306; Knobloch HS, 2012, NEURON, V73, P553, DOI 10.1016/j.neuron.2011.11.030; Lammel S, 2012, NATURE, V491, P212, DOI 10.1038/nature11527; Lee HJ, 2008, ENDOCRINOLOGY, V149, P3256, DOI 10.1210/en.2007-1710; Lee HJ, 2009, PROG NEUROBIOL, V88, P127, DOI 10.1016/j.pneurobio.2009.04.001; Lobo MK, 2011, FRONT NEUROANAT, V5, DOI 10.3389/fnana.2011.00041; Mathur BN, 2011, J NEUROSCI, V31, P7402, DOI 10.1523/JNEUROSCI.6250-10.2011; Mebatsion T, 1996, CELL, V84, P941, DOI 10.1016/S0092-8674(00)81072-7; Nakamura K, 2008, J NEUROSCI, V28, P5331, DOI 10.1523/JNEUROSCI.0021-08.2008; Nambu A, 2008, CURR OPIN NEUROBIOL, V18, P595, DOI 10.1016/j.conb.2008.11.001; Orabona GM, 2009, BRAIN RES, V1264, P127, DOI 10.1016/j.brainres.2008.11.107; Panksepp JB, 2007, GENES BRAIN BEHAV, V6, P661, DOI 10.1111/j.1601-183X.2006.00295.x; Panksepp J, 2011, SCIENCE, V334, P1358, DOI 10.1126/science.1216480; Panksepp JB, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000351; Perreault ML, 2011, FRONT NEUROANAT, V5, DOI 10.3389/fnana.2011.00031; PHILLIPSON OT, 1985, NEUROSCIENCE, V16, P275, DOI 10.1016/0306-4522(85)90002-8; RIEDMAN ML, 1982, Q REV BIOL, V57, P405, DOI 10.1086/412936; Rosen GJ, 2008, NEUROSCIENCE, V155, P809, DOI 10.1016/j.neuroscience.2008.05.039; Ross HE, 2009, NEUROSCIENCE, V162, P892, DOI 10.1016/j.neuroscience.2009.05.055; Shuen JA, 2008, J NEUROSCI, V28, P2681, DOI 10.1523/JNEUROSCI.5492-07.2008; Shultz S, 2011, NATURE, V479, P219, DOI 10.1038/nature10601; Silverman JL, 2010, NAT REV NEUROSCI, V11, P490, DOI 10.1038/nrn2851; Tanaka SC, 2004, NAT NEUROSCI, V7, P887, DOI 10.1038/nn1279; Tzschentke TM, 2007, ADDICT BIOL, V12, P227, DOI 10.1111/j.1369-1600.2007.00070.x; WHITNALL MH, 1985, J NEUROSCI, V5, P98; Wickersham IR, 2007, NAT METHODS, V4, P47, DOI 10.1038/NMETH999; Wickersham IR, 2010, NAT PROTOC, V5, P595, DOI 10.1038/nprot.2009.248; Yamasue H, 2012, J NEUROSCI, V32, P14109, DOI 10.1523/JNEUROSCI.3327-12.2012; Yoshida M, 2009, J NEUROSCI, V29, P2259, DOI 10.1523/JNEUROSCI.5593-08.2009; Young LJ, 2004, NAT NEUROSCI, V7, P1048, DOI 10.1038/nn1327	47	640	647	4	232	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 12	2013	501	7466					179	+		10.1038/nature12518	http://dx.doi.org/10.1038/nature12518			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	215XR	24025838	Green Accepted			2022-12-24	WOS:000324244900032
J	Jagannath, A; Butler, R; Godinho, SIH; Couch, Y; Brown, LA; Vasudevan, SR; Flanagan, KC; Anthony, D; Churchill, GC; Wood, MJA; Steiner, G; Ebeling, M; Hossbach, M; Wettstein, JG; Duffield, GE; Gatti, S; Hankins, MW; Foster, RG; Peirson, SN				Jagannath, Aarti; Butler, Rachel; Godinho, Sofia I. H.; Couch, Yvonne; Brown, Laurence A.; Vasudevan, Sridhar R.; Flanagan, Kevin C.; Anthony, Daniel; Churchill, Grant C.; Wood, Matthew J. A.; Steiner, Guido; Ebeling, Martin; Hossbach, Markus; Wettstein, Joseph G.; Duffield, Giles E.; Gatti, Silvia; Hankins, Mark W.; Foster, Russell G.; Peirson, Stuart N.			The CRTC1-SIK1 Pathway Regulates Entrainment of the Circadian Clock	CELL			English	Article							SUPRACHIASMATIC NUCLEUS; GENE-EXPRESSION; KINASE 1; LIGHT; MELANOPSIN; CREB; PHOSPHORYLATION; PACEMAKER; PERIOD; CONE	Retinal photoreceptors entrain the circadian system to the solar day. This photic resetting involves cAMP response element binding protein (CREB)mediated upregulation of Per genes within individual cells of the suprachiasmatic nuclei (SCN). Our detailed understanding of this pathway is poor, and it remains unclear why entrainment to a new time zone takes several days. By analyzing the light-regulated transcriptome of the SCN, we have identified a key role for salt inducible kinase 1 (SIK1) and CREB-regulated transcription coactivator 1 (CRTC1) in clock re-setting. An entrainment stimulus causes CRTC1 to coactivate CREB, inducing the expression of Per1 and Sik1. SIK1 then inhibits further shifts of the clock by phosphorylation and deactivation of CRTC1. Knockdown of Sik1 within the SCN results in increased behavioral phase shifts and rapid re-entrainment following experimental jet lag. Thus SIK1 provides negative feedback, acting to suppress the effects of light on the clock. This pathway provides a potential target for the regulation of circadian rhythms.	[Jagannath, Aarti; Butler, Rachel; Godinho, Sofia I. H.; Brown, Laurence A.; Hankins, Mark W.; Foster, Russell G.; Peirson, Stuart N.] Univ Oxford, John Radcliffe Hosp, Nuffield Lab Ophthalmol, Nuffield Dept Clin Neurosci, Oxford OX3 9DU, England; [Couch, Yvonne; Vasudevan, Sridhar R.; Anthony, Daniel; Churchill, Grant C.] Univ Oxford, Dept Pharmacol, Oxford OX1 3QT, England; [Flanagan, Kevin C.; Duffield, Giles E.] Univ Notre Dame, Dept Biol Sci, Galvin Life Sci Ctr, Notre Dame, IN 46556 USA; [Wood, Matthew J. A.] Univ Oxford, Dept Physiol Anat & Genet, Oxford OX1 3QX, England; [Jagannath, Aarti; Butler, Rachel; Godinho, Sofia I. H.; Steiner, Guido; Ebeling, Martin; Wettstein, Joseph G.; Gatti, Silvia] pRED Pharma Res & Dev F Hoffmann Roche, CH-4070 Basel, Switzerland; [Hossbach, Markus] Axolabs GmbH, D-95326 Kulmbach, Germany	University of Oxford; University of Oxford; University of Notre Dame; University of Oxford; Roche Holding	Foster, RG (corresponding author), Univ Oxford, John Radcliffe Hosp, Nuffield Lab Ophthalmol, Nuffield Dept Clin Neurosci, Levels 5-6 West Wing,Headley Way, Oxford OX3 9DU, England.	russell.foster@eye.ox.ac.uk; stuart.peirson@eye.ox.ac.uk	Jagannath, Aarti/GQA-7297-2022; Vasudevan, Sridhar/B-1841-2015; Wood, Matthew/HDN-1469-2022; Anthony, Daniel/F-7765-2010	Vasudevan, Sridhar/0000-0003-0516-2984; Anthony, Daniel/0000-0003-1380-6655; FOSTER, RUSSELL/0000-0001-6055-2067; Wood, Matthew/0000-0002-5436-6011; Brown, Laurence/0000-0001-8116-4100; Jagannath, Aarti/0000-0003-2132-8200	Wellcome Trust [090684/Z/09/Z]; F. Hoffmann-La Roche Neuroscience DTA grant; F. Hoffmann-La Roche AG postdoctoral fellowship; NIGMS [R01-GM087508]; NSF REU Fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM087508] Funding Source: NIH RePORTER; Biotechnology and Biological Sciences Research Council [BB/G008523/1] Funding Source: researchfish; Medical Research Council [G0900887] Funding Source: researchfish; Parkinson&quot;s UK [G-0503] Funding Source: researchfish; BBSRC [BB/G008523/1] Funding Source: UKRI; MRC [G0900887] Funding Source: UKRI	Wellcome Trust(Wellcome TrustEuropean Commission); F. Hoffmann-La Roche Neuroscience DTA grant; F. Hoffmann-La Roche AG postdoctoral fellowship; NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NSF REU Fellowship(National Science Foundation (NSF)NSF - Office of the Director (OD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Parkinson&quot;s UK(Parkinson&apos;s UK); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was funded by grants from the Wellcome Trust (090684/Z/09/Z) and a F. Hoffmann-La Roche Neuroscience DTA grant awarded to R. G. F., M. W. H., and S.N.P., which supported R. B. and S. I. H. G. A.J. is a recipient of the F. Hoffmann-La Roche AG postdoctoral fellowship. The work was also supported by a grant from NIGMS (R01-GM087508 to G. E. D.) and an NSF REU Fellowship (to K. C. F.). We are grateful to J. Gamsby and J. Dunlap for provision of PER2::LUC MEFs and Dr. P. Nolan for provision of Per2::Luc U2OS cells. G. S., M. E., J. G. W., and S. G. are employees of F. Hoffmann-La Roche.	Albrecht U, 1997, CELL, V91, P1055, DOI 10.1016/S0092-8674(00)80495-X; Albrecht U, 2012, NEURON, V74, P246, DOI 10.1016/j.neuron.2012.04.006; Altarejos JY, 2011, NAT REV MOL CELL BIO, V12, P141, DOI 10.1038/nrm3072; Aschoff J, 1981, BIOL RHYTHMS; Balsalobre A, 1998, CELL, V93, P929, DOI 10.1016/S0092-8674(00)81199-X; Butcher GQ, 2002, J BIOL CHEM, V277, P29519, DOI 10.1074/jbc.M203301200; Cagnol S, 2013, ONCOGENE, V32, P564, DOI 10.1038/onc.2012.88; Ch'ng TH, 2012, CELL, V150, P207, DOI 10.1016/j.cell.2012.05.027; Cheng HYM, 2007, NEURON, V54, P813, DOI 10.1016/j.neuron.2007.05.017; Chiu JC, 2011, CELL, V145, P357, DOI 10.1016/j.cell.2011.04.002; Doi M, 2007, J BIOL RHYTHM, V22, P127, DOI 10.1177/0748730406298332; Duffield GE, 2002, CURR BIOL, V12, P551, DOI 10.1016/S0960-9822(02)00765-0; Foster RG, 2005, NAT REV NEUROSCI, V6, P407, DOI 10.1038/nrn1670; Freedman MS, 1999, SCIENCE, V284, P502, DOI 10.1126/science.284.5413.502; Fukushima T, 1997, NEUROSCI LETT, V227, P45, DOI 10.1016/S0304-3940(97)00297-8; Gau D, 2002, NEURON, V34, P245, DOI 10.1016/S0896-6273(02)00656-6; GINTY DD, 1993, SCIENCE, V260, P238, DOI 10.1126/science.8097062; Godinho SIH, 2007, SCIENCE, V316, P897, DOI 10.1126/science.1141138; Guler AD, 2008, NATURE, V453, P102, DOI 10.1038/nature06829; Hannibal J, 2000, J COMP NEUROL, V418, P147; Hashimoto YK, 2008, J CELL BIOCHEM, V104, P1724, DOI 10.1002/jcb.21737; Hastings MH, 2003, NAT REV NEUROSCI, V4, P649, DOI 10.1038/nrn1177; Hattar S, 2003, NATURE, V424, P76, DOI 10.1038/nature01761; Hattar S, 2002, SCIENCE, V295, P1065, DOI 10.1126/science.1069609; Hirota T, 2012, SCIENCE, V337, P1094, DOI 10.1126/science.1223710; Kanyo R, 2009, ENDOCRINOLOGY, V150, P4221, DOI 10.1210/en.2009-0275; Katoh Y, 2006, FEBS J, V273, P2730, DOI 10.1111/j.1742-4658.2006.05291.x; Kim DY, 2001, J NEUROSCI, V21, P4026, DOI 10.1523/JNEUROSCI.21-11-04026.2001; Lall GS, 2010, NEURON, V66, P417, DOI 10.1016/j.neuron.2010.04.037; Lamia KA, 2009, SCIENCE, V326, P437, DOI 10.1126/science.1172156; Lee B, 2010, J BIOL RHYTHM, V25, P410, DOI 10.1177/0748730410381229; Lin JT, 1997, MOL BRAIN RES, V46, P303, DOI 10.1016/S0169-328X(97)00005-3; Lowrey PL, 2000, SCIENCE, V288, P483, DOI 10.1126/science.288.5465.483; Lucas RJ, 2003, SCIENCE, V299, P245, DOI 10.1126/science.1077293; Lupi D, 2006, CHRONOBIOL INT, V23, P167, DOI 10.1080/07420520500545870; Meijer JH, 2003, J BIOL RHYTHM, V18, P235, DOI 10.1177/0748730403253370; Meng QJ, 2010, P NATL ACAD SCI USA, V107, P15240, DOI 10.1073/pnas.1005101107; Morris ME, 1998, SCIENCE, V279, P1544, DOI 10.1126/science.279.5356.1544; MROSOVSKY N, 1987, NATURE, V330, P372, DOI 10.1038/330372a0; Pendergast JS, 2010, J NEUROSCI, V30, P12179, DOI 10.1523/JNEUROSCI.2607-10.2010; Porterfield VM, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-98; RALPH MR, 1990, SCIENCE, V247, P975, DOI 10.1126/science.2305266; Ruby NF, 2002, SCIENCE, V298, P2211, DOI 10.1126/science.1076701; Schwartz WJ, 2011, P NATL ACAD SCI USA, V108, P17219, DOI 10.1073/pnas.1107848108; Screaton RA, 2004, CELL, V119, P61, DOI 10.1016/j.cell.2004.09.015; Sjostrom M, 2007, P NATL ACAD SCI USA, V104, P16922, DOI 10.1073/pnas.0706838104; Stokkan KA, 2001, SCIENCE, V291, P490, DOI 10.1126/science.291.5503.490; Travnickova-Bendova Z, 2002, P NATL ACAD SCI USA, V99, P7728, DOI 10.1073/pnas.102075599; van Oosterhout F, 2012, CURR BIOL, V22, P1397, DOI 10.1016/j.cub.2012.05.032; Vitaterna MH, 2006, P NATL ACAD SCI USA, V103, P9327, DOI 10.1073/pnas.0603601103; Wulff K, 2010, NAT REV NEUROSCI, V11, P589, DOI 10.1038/nrn2868; Zaidi FH, 2007, CURR BIOL, V17, P2122, DOI 10.1016/j.cub.2007.11.034; Zhang EE, 2009, CELL, V139, P199, DOI 10.1016/j.cell.2009.08.031; Zhang XQ, 2005, P NATL ACAD SCI USA, V102, P892, DOI 10.1073/pnas.0408936102	54	124	129	4	50	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 29	2013	154	5					1100	1111		10.1016/j.cell.2013.08.004	http://dx.doi.org/10.1016/j.cell.2013.08.004			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	209OE	23993098	hybrid, Green Published			2022-12-24	WOS:000323767300022
J	Yang, LQ; Lin, CR; Jin, CY; Yang, JC; Tanasa, B; Li, WB; Merkurjev, D; Ohgi, KA; Meng, D; Zhang, J; Evans, CP; Rosenfeld, MG				Yang, Liuqing; Lin, Chunru; Jin, Chunyu; Yang, Joy C.; Tanasa, Bogdan; Li, Wenbo; Merkurjev, Daria; Ohgi, Kenneth A.; Meng, Da; Zhang, Jie; Evans, Christopher P.; Rosenfeld, Michael G.			lncRNA-dependent mechanisms of androgen-receptor-regulated gene activation programs	NATURE			English	Article							LONG NONCODING RNA; PROSTATE-CANCER; CELL-GROWTH; EXPRESSION; TRANSCRIPTION; ENHANCERS; IDENTIFICATION; ACETYLATION; METHYLATION; MACROPHAGE	Although recent studies have indicated roles of long non-coding RNAs (lncRNAs) in physiological aspects of cell-type determination and tissue homeostasis(1), their potential involvement in regulated gene transcription programs remains rather poorly understood. The androgen receptor regulates a large repertoire of genes central to the identity and behaviour of prostate cancer cells(2), and functions in a ligand-independent fashion in many prostate cancers when they become hormone refractory after initial androgen deprivation therapy(3). Here we report that two lncRNAs highly overexpressed in aggressive prostate cancer, PRNCR1 (also known as PCAT8) and PCGEM1, bind successively to the androgen receptor and strongly enhance both ligand-dependent and ligand-independent androgen-receptor-mediated gene activation programs and proliferation in prostate cancer cells. Binding of PRNCR1 to the carboxy-terminally acetylated androgen receptor on enhancers and its association with DOT1L appear to be required for recruitment of the second lncRNA, PCGEM1, to the androgen receptor amino terminus that is methylated by DOT1L. Unexpectedly, recognition of specific protein marks by PCGEM1-recruited pygopus 2 PHD domain enhances selective looping of androgen-receptor-bound enhancers to target gene promoters in these cells. In 'resistant' prostate cancer cells, these overexpressed lncRNAs can interact with, and are required for, the robust activation of both truncated and full-length androgen receptor, causing ligand-independent activation of the androgen receptor transcriptional program and cell proliferation. Conditionally expressed short hairpin RNA targeting these lncRNAs in castration-resistant prostate cancer cell lines strongly suppressed tumour xenograft growth in vivo. Together, these results indicate that these overexpressed lncRNAs can potentially serve as a required component of castration-resistance in prostatic tumours.	[Yang, Liuqing; Lin, Chunru; Jin, Chunyu; Tanasa, Bogdan; Li, Wenbo; Merkurjev, Daria; Ohgi, Kenneth A.; Zhang, Jie; Rosenfeld, Michael G.] Univ Calif San Diego, Dept Med, Howard Hughes Med Inst, La Jolla, CA 92093 USA; [Yang, Liuqing; Lin, Chunru] Univ Texas MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, Houston, TX 77030 USA; [Yang, Joy C.; Evans, Christopher P.] Univ Calif Davis, Sch Med, Dept Urol, Sacramento, CA 95817 USA; [Tanasa, Bogdan] Scripps Res Inst, Grad Program, Kellogg Sch Sci & Technol, La Jolla, CA 92037 USA; [Merkurjev, Daria] Univ Calif San Diego, Dept Bioengn, Bioinformat & Syst Biol Program, La Jolla, CA 92093 USA; [Meng, Da] Univ Calif San Diego, Dept Biol Sci, Neurosci Grad Program, La Jolla, CA 92093 USA	Howard Hughes Medical Institute; University of California System; University of California San Diego; University of Texas System; UTMD Anderson Cancer Center; University of California System; University of California Davis; Scripps Research Institute; University of California System; University of California San Diego; University of California System; University of California San Diego	Rosenfeld, MG (corresponding author), Univ Calif San Diego, Dept Med, Howard Hughes Med Inst, La Jolla, CA 92093 USA.	lyang7@mdanderson.org; clin2@mdanderson.org; mrosenfeld@ucsd.edu	Jin, Chunyu/A-4506-2016; li, wenbo/GZM-8930-2022	Meng, Da/0000-0003-4451-4049	National Institutes of Health (NIH) [DK039949, DK18477, NS034934, CA173903]; Department of Defense [PC111467, SV2C-AACR-DT0812]; Prostate Cancer Foundation; NIH Pathway to Independence Award [1K99DK094981-01, 4R00CA166527-02]; US Army Medical Research and Material Command Era of Hope Postdoctoral award [W81XWH-08-1-0554]; Cancer Prevention Research Institute of Texas First-time Faculty Recruitment Award [R1218]; Cancer Research Institute Postdoctoral Fellowship; NATIONAL CANCER INSTITUTE [R00CA166527, P30CA023100, R01CA173903] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R00DK094981, R01DK039949, T32DK007541, K99DK094981, R37DK039949, R01DK018477] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS034934] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); Prostate Cancer Foundation; NIH Pathway to Independence Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US Army Medical Research and Material Command Era of Hope Postdoctoral award; Cancer Prevention Research Institute of Texas First-time Faculty Recruitment Award; Cancer Research Institute Postdoctoral Fellowship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We are grateful to X. Dai for providing the PYGO2 shRNA and cDNA constructs and J. Hightower for assistance with figure presentation. This work was supported by National Institutes of Health (NIH) grants DK039949, DK18477, NS034934 and CA173903, Department of Defense grant and initially by a grant from Prostate Cancer Foundation to M.G.R.; by Department of Defense grant PC111467 and SV2C-AACR-DT0812 to C. D. E; by grants from the NIH Pathway to Independence Award (1K99DK094981-01) to C.-R.L.; by US Army Medical Research and Material Command Era of Hope Postdoctoral award (W81XWH-08-1-0554), NIH Pathway to Independence Award (4R00CA166527-02) and Cancer Prevention Research Institute of Texas First-time Faculty Recruitment Award (R1218) to L.-Q.Y.; C.-Y.J. is the recipient of a Cancer Research Institute Postdoctoral Fellowship. M. G. R. is an Investigator of the Howard Hughes Medical Institute.	Chu C, 2011, MOL CELL, V44, P667, DOI 10.1016/j.molcel.2011.08.027; Chung SY, 2011, CANCER SCI, V102, P245, DOI 10.1111/j.1349-7006.2010.01737.x; Fu MF, 2003, MOL CELL BIOL, V23, P8563, DOI 10.1128/MCB.23.23.8563-8575.2003; Gu BN, 2012, CELL CYCLE, V11, P79, DOI 10.4161/cc.11.1.18402; Gu BN, 2009, J CELL BIOL, V185, P811, DOI 10.1083/jcb.200810133; Gupta RA, 2010, NATURE, V464, P1071, DOI 10.1038/nature08975; Heinlein CA, 2004, ENDOCR REV, V25, P276, DOI 10.1210/er.2002-0032; Heintzman ND, 2009, NATURE, V459, P108, DOI 10.1038/nature07829; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Hu R, 2009, CANCER RES, V69, P16, DOI 10.1158/0008-5472.CAN-08-2764; Kypta RM, 2012, NAT REV UROL, V9, P418, DOI 10.1038/nrurol.2012.116; Lam MTY, 2013, NATURE, V498, P511, DOI 10.1038/nature12209; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li WB, 2013, NATURE, V498, P516, DOI 10.1038/nature12210; Liao DF, 1997, J BIOL CHEM, V272, P6146, DOI 10.1074/jbc.272.10.6146; Liu W, 2010, NATURE, V466, P508, DOI 10.1038/nature09272; Petrovics G, 2004, ONCOGENE, V23, P605, DOI 10.1038/sj.onc.1207069; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Saeed AI, 2006, METHOD ENZYMOL, V411, P134, DOI 10.1016/S0076-6879(06)11009-5; Scher HI, 2005, J CLIN ONCOL, V23, P8253, DOI 10.1200/JCO.2005.03.4777; Sun AJ, 2010, INT J CANCER, V126, P764, DOI 10.1002/ijc.24778; Taberlay PC, 2011, CELL, V147, P1283, DOI 10.1016/j.cell.2011.10.040; Tsai MC, 2010, SCIENCE, V329, P689, DOI 10.1126/science.1192002; Wang D, 2011, NATURE, V474, P390, DOI 10.1038/nature10006; Wang QB, 2005, MOL CELL, V19, P631, DOI 10.1016/j.molcel.2005.07.018; Yang LQ, 2011, CELL, V147, P773, DOI 10.1016/j.cell.2011.08.054; Zang CZ, 2009, BIOINFORMATICS, V25, P1952, DOI 10.1093/bioinformatics/btp340; Zhao J, 2010, MOL CELL, V40, P939, DOI 10.1016/j.molcel.2010.12.011; Zippo A, 2009, CELL, V138, P1122, DOI 10.1016/j.cell.2009.07.031	30	502	547	8	217	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 29	2013	500	7464					598	+		10.1038/nature12451	http://dx.doi.org/10.1038/nature12451			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	207TD	23945587	Green Accepted, Green Submitted			2022-12-24	WOS:000323625900039
J	Hertz, NT; Berthet, A; Sos, ML; Thorn, KS; Burlingame, AL; Nakamura, K; Shokat, KM				Hertz, Nicholas T.; Berthet, Amandine; Sos, Martin L.; Thorn, Kurt S.; Burlingame, Al L.; Nakamura, Ken; Shokat, Kevan M.			A Neo-Substrate that Amplifies Catalytic Activity of Parkinson's-Disease-Related Kinase PINK1	CELL			English	Article							PROTEIN-KINASE; ENZYMATIC SYNTHESIS; TYROSINE KINASE; MITOCHONDRIAL FISSION; OXIDATIVE STRESS; CELLS; MUTATIONS; APOPTOSIS; NUCLEOTIDES; SPECIFICITY	Mitochondria have long been implicated in the pathogenesis of Parkinson's disease (PD). Mutations in the mitochondrial kinase PINK1 that reduce kinase activity are associated with mitochondrial defects and result in an autosomal-recessive form of early-onset PD. Therapeutic approaches for enhancing the activity of PINK1 have not been considered because no allosteric regulatory sites for PINK1 are known. Here, we show that an alternative strategy, a neo-substrate approach involving the ATP analog kinetin triphosphate (KTP), can be used to increase the activity of both PD-related mutant PINK1(G309D) and PINK1(WT). Moreover, we show that application of the KTP precursor kinetin to cells results in biologically significant increases in PINK1 activity, manifest as higher levels of Parkin recruitment to depolarized mitochondria, reduced mitochondrial motility in axons, and lower levels of apoptosis. Discovery of neo-substrates for kinases could provide a heretofore-unappreciated modality for regulating kinase activity.	[Hertz, Nicholas T.; Sos, Martin L.; Shokat, Kevan M.] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94158 USA; [Hertz, Nicholas T.; Sos, Martin L.; Shokat, Kevan M.] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA; [Hertz, Nicholas T.] Univ Calif San Francisco, Grad Program Chem & Chem Biol, San Francisco, CA 94158 USA; [Nakamura, Ken] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94158 USA; [Nakamura, Ken] Univ Calif San Francisco, Grad Programs Neurosci & Biomed Sci, San Francisco, CA 94158 USA; [Burlingame, Al L.] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94158 USA; [Thorn, Kurt S.] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA; [Berthet, Amandine; Nakamura, Ken] Gladstone Inst Neurol Dis, San Francisco, CA 94158 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; The J David Gladstone Institutes	Shokat, KM (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94158 USA.	kevan.shokat@ucsf.edu	Sos, Martin L/I-1852-2014	Thorn, Kurt/0000-0001-9310-288X; Nakamura, Ken/0000-0002-9192-182X; Hertz, Nicholas/0000-0002-6527-6898	Genentech; Michael J. Fox Foundation; Burroughs-Wellcome Medical Scientist Fund Career Award; National Institute of Neurological Disorders and Stroke [1KO8NS062954-01A1, P30NS069496]; Prostate Cancer Foundation (PCF); NIH [NCRR RR015804, NCRR RR001614];  [RO1 EB001987]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR015804, P41RR001614] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB001987] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103481] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS069496, K08NS062954] Funding Source: NIH RePORTER	Genentech(Roche HoldingGenentech); Michael J. Fox Foundation; Burroughs-Wellcome Medical Scientist Fund Career Award(Burroughs Wellcome Fund); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Prostate Cancer Foundation (PCF); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Laura Lavery for providing recombinantly expressed TRAP1, Michael Lopez for synthesis of 9-methyl-kinetin, Xiaoxi Zhuang (University of Chicago) for C57BL/6 background PINK1<SUP>-/-</SUP> mice, and Valerie Ohman for excellent administrative assistance. We thank Zachary A. Knight, Robert H. Edwards, and Daniel de Roulet, Jr. for critical reading of the manuscript. N.T.H. was supported by a Genentech predoctoral grant. K. M. S. was supported by RO1 EB001987, and early work was supported by the Michael J. Fox Foundation. K.N. and A. B. were supported by a Burroughs-Wellcome Medical Scientist Fund Career Award and grant awards 1KO8NS062954-01A1 and P30NS069496 from the National Institute of Neurological Disorders and Stroke. M. L. S. is supported by a Young Investigator Award from the Prostate Cancer Foundation (PCF) and is a fellow of the International Association for the Study of Lung Cancer (IASLC). Mass spectrometry was made possible by NIH grants NCRR RR015804 and NCRR RR001614. Imaging data were collected at the Nikon Imaging Center at QB3/UCSF. N.T.H. and K. M. S. are inventors on a patent application related to kinetin and PINK1. UCSF has licensed the patent application to Mitokinin LLC. N.T.H. and K. M. S. are cofounders and members of Mitokinin LLC.	Adams JM, 1998, SCIENCE, V281, P1322, DOI 10.1126/science.281.5381.1322; Allen JJ, 2007, NAT METHODS, V4, P511, DOI 10.1038/nmeth1048; Arena G, 2013, CELL DEATH DIFFER, V20, P920, DOI 10.1038/cdd.2013.19; Axelrod FB, 2011, PEDIATR RES, V70, P480, DOI 10.1203/PDR.0b013e31822e1825; Beilina A, 2005, P NATL ACAD SCI USA, V102, P5703, DOI 10.1073/pnas.0500617102; Blethrow JD, 2008, P NATL ACAD SCI USA, V105, P1442, DOI 10.1073/pnas.0708966105; Cardona F, 2011, HUM MUTAT, V32, P369, DOI 10.1002/humu.21444; CASTAGNA M, 1982, J BIOL CHEM, V257, P7847; Clark IE, 2006, NATURE, V441, P1162, DOI 10.1038/nature04779; Deng H, 2005, BIOCHEM BIOPH RES CO, V337, P1133, DOI 10.1016/j.bbrc.2005.09.178; Deng HS, 2008, P NATL ACAD SCI USA, V105, P14503, DOI 10.1073/pnas.0803998105; Ferrando IM, 2012, MOL CELL PROTEOMICS, V11, P355, DOI 10.1074/mcp.M111.015750; FERRER A, 1985, BIOCHEM BIOPH RES CO, V132, P497, DOI 10.1016/0006-291X(85)91161-1; Gao YJ, 2011, PROTEIN CELL, V2, P99, DOI 10.1007/s13238-011-1021-6; Gautier CA, 2008, P NATL ACAD SCI USA, V105, P11364, DOI 10.1073/pnas.0802076105; Geisler S, 2010, AUTOPHAGY, V6, P871, DOI 10.4161/auto.6.7.13286; Gross A, 1999, GENE DEV, V13, P1899, DOI 10.1101/gad.13.15.1899; Haque ME, 2008, P NATL ACAD SCI USA, V105, P1716, DOI 10.1073/pnas.0705363105; Hardie DG, 2012, NAT REV MOL CELL BIO, V13, P251, DOI 10.1038/nrm3311; Heinis C, 2006, ACS CHEM BIOL, V1, P575, DOI 10.1021/cb6003146; Henchcliffe C, 2008, NAT CLIN PRACT NEURO, V4, P600, DOI 10.1038/ncpneuro0924; Hindie V, 2009, NAT CHEM BIOL, V5, P758, DOI 10.1038/nchembio.208; Hua ZL, 2011, NEURON, V71, P474, DOI 10.1016/j.neuron.2011.06.010; Ishii Y, 2003, BBA-MOL CELL RES, V1643, P11, DOI 10.1016/j.bbamcr.2003.08.004; Ishii Y, 2002, CELL GROWTH DIFFER, V13, P19; Kissil JL, 1997, ONCOGENE, V15, P403, DOI 10.1038/sj.onc.1201172; Kitada T, 1998, NATURE, V392, P605, DOI 10.1038/33416; Klinkenberg M, 2010, NEUROSCIENCE, V166, P422, DOI 10.1016/j.neuroscience.2009.12.068; Kondapalli C, 2012, OPEN BIOL, V2, DOI 10.1098/rsob.120080; KORNBERG A, 1955, J BIOL CHEM, V215, P417; Krishnan P, 2002, J BIOL CHEM, V277, P5453, DOI 10.1074/jbc.M109025200; Kulkarni RN, 1999, CELL, V96, P329, DOI 10.1016/S0092-8674(00)80546-2; Lang AE, 1998, NEW ENGL J MED, V339, P1044, DOI 10.1056/NEJM199810083391506; LIEBERMAN I, 1955, J BIOL CHEM, V215, P429; LIEBERMAN I, 1955, J BIOL CHEM, V215, P403; Liu Y, 1998, BIOORGAN MED CHEM, V6, P1219, DOI 10.1016/S0968-0896(98)00099-6; Meissner C, 2011, J NEUROCHEM, V117, P856, DOI 10.1111/j.1471-4159.2011.07253.x; Merrick KA, 2011, MOL CELL, V42, P624, DOI 10.1016/j.molcel.2011.03.031; Mills RD, 2008, J NEUROCHEM, V105, P18, DOI 10.1111/j.1471-4159.2008.05249.x; Nakamura K, 2011, J BIOL CHEM, V286, P20710, DOI 10.1074/jbc.M110.213538; Narendra DP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000298; Niefind K, 1999, NAT STRUCT BIOL, V6, P1100, DOI 10.1038/70033; NISHIZUKA Y, 1984, NATURE, V308, P693, DOI 10.1038/308693a0; Nunnari J, 2012, CELL, V148, P1145, DOI 10.1016/j.cell.2012.02.035; PARKIN DW, 1984, J BIOL CHEM, V259, P9411; Petit A, 2005, J BIOL CHEM, V280, P34025, DOI 10.1074/jbc.M505143200; Pridgeon JW, 2007, PLOS BIOL, V5, P1494, DOI 10.1371/journal.pbio.0050172; Qiao YF, 2006, SCIENCE, V311, P1293, DOI 10.1126/science.1122224; Ray AS, 2004, BIOCHEM PHARMACOL, V68, P1825, DOI 10.1016/j.bcp.2004.07.010; Rugarli EI, 2012, EMBO J, V31, P1336, DOI 10.1038/emboj.2012.38; Samaranch L, 2010, BRAIN, V133, P1128, DOI 10.1093/brain/awq051; Shah K, 1997, P NATL ACAD SCI USA, V94, P3565, DOI 10.1073/pnas.94.8.3565; Shetty RS, 2011, HUM MOL GENET, V20, P4093, DOI 10.1093/hmg/ddr333; Shin JH, 2011, CELL, V144, P689, DOI 10.1016/j.cell.2011.02.010; Song S, 2013, J BIOL CHEM, V288, P5660, DOI 10.1074/jbc.M112.430801; Ultanir SK, 2012, NEURON, V73, P1127, DOI 10.1016/j.neuron.2012.01.019; Valente EM, 2004, SCIENCE, V304, P1158, DOI 10.1126/science.1096284; Vela JE, 2007, J CHROMATOGR B, V848, P335, DOI 10.1016/j.jchromb.2006.10.063; Wang HL, 2007, NEUROBIOL DIS, V28, P216, DOI 10.1016/j.nbd.2007.07.010; Wang XN, 2011, CELL, V147, P893, DOI 10.1016/j.cell.2011.10.018; Wei LY, 2010, BIOORG MED CHEM LETT, V20, P3897, DOI 10.1016/j.bmcl.2010.05.019; Xiong H, 2009, J CLIN INVEST, V119, P650, DOI 10.1172/JCI37617; Youle RJ, 2011, NAT REV MOL CELL BIO, V12, P9, DOI 10.1038/nrm3028; Zhou ZR, 2012, BIOCHEM J, V441, P143, DOI 10.1042/BJ20110699	64	182	189	2	38	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 15	2013	154	4					737	747		10.1016/j.cell.2013.07.030	http://dx.doi.org/10.1016/j.cell.2013.07.030			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	202GQ	23953109	Bronze, Green Accepted			2022-12-24	WOS:000323202500007
J	Kasahara, A; Cipolat, S; Chen, Y; Dorn, GW; Scorrano, L				Kasahara, Atsuko; Cipolat, Sara; Chen, Yun; Dorn, Gerald W., II; Scorrano, Luca			Mitochondrial Fusion Directs Cardiomyocyte Differentiation via Calcineurin and Notch Signaling	SCIENCE			English	Article							EMBRYONIC STEM-CELLS; OPTIC ATROPHY; TRANSCRIPTION; DROSOPHILA; FISSION	Mitochondrial morphology is crucial for tissue homeostasis, but its role in cell differentiation is unclear. We found that mitochondrial fusion was required for proper cardiomyocyte development. Ablation of mitochondrial fusion proteins Mitofusin 1 and 2 in the embryonic mouse heart, or gene-trapping of Mitofusin 2 or Optic atrophy 1 in mouse embryonic stem cells (ESCs), arrested mouse heart development and impaired differentiation of ESCs into cardiomyocytes. Gene expression profiling revealed decreased levels of transcription factors transforming growth factor-beta/bone morphogenetic protein, serum response factor, GATA4, and myocyte enhancer factor 2, linked to increased Ca2+-dependent calcineurin activity and Notch1 signaling that impaired ESC differentiation. Orchestration of cardiomyocyte differentiation by mitochondrial morphology reveals how mitochondria, Ca2+, and calcineurin interact to regulate Notch1 signaling.	[Kasahara, Atsuko] Univ Geneva, Dept Cell Physiol & Metab, CH-1206 Geneva, Switzerland; [Cipolat, Sara; Scorrano, Luca] Venetian Inst Mol Med, Dulbecco Telethon Inst, I-35129 Padua, Italy; [Chen, Yun; Dorn, Gerald W., II] Washington Univ, Sch Med, Dept Internal Med, Ctr Pharmacogen, St Louis, MO 63110 USA; [Scorrano, Luca] Univ Padua, Dept Biol, I-35121 Padua, Italy	University of Geneva; Fondazione Telethon; Dulbecco Telethon Institute (DTI); Veneto Institute Molecular Medicine; Washington University (WUSTL); University of Padua	Dorn, GW (corresponding author), Washington Univ, Sch Med, Dept Internal Med, Ctr Pharmacogen, St Louis, MO 63110 USA.	gdorn@DOM.wustl.edu; luca.scorrano@unipd.it	Scorrano, Luca/A-6652-2008; Scorrano, Luca/K-3967-2019	Scorrano, Luca/0000-0002-8515-8928; Scorrano, Luca/0000-0002-8515-8928	ISHR-ES/SERVIER; Associazione Italiana Ricerca sul Cancro (AIRC); Telethon [GGP06254A, GPP10005B]; AIRC; SNF [31-118171]; Oncosuisse; ERC StG [282280]; NIH [R01 HL59888]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL059888] Funding Source: NIH RePORTER	ISHR-ES/SERVIER(Servier); Associazione Italiana Ricerca sul Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro); Telethon(Fondazione Telethon); AIRC(Fondazione AIRC per la ricerca sul cancro); SNF; Oncosuisse; ERC StG; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank F. Radtke and R. Kopan for plasmids, B. Wehrle-Haller for help with TIRF imaging, and D. Martinvalet and N. Demaurex for helpful discussions. L. S. is a Dulbecco Telethon Institute Senior Scientist. A. K. received the ISHR-ES/SERVIER Research Fellowship, and S. C. received an Associazione Italiana Ricerca sul Cancro (AIRC) Fellowship. This work was supported by Telethon GGP06254A, GPP10005B; AIRC; SNF 31-118171; Oncosuisse; ERC StG 282280 (to L. S.); and NIH R01 HL59888 (to G. W. D.). The data presented in this paper are tabulated in the main paper and the supplementary materials.	Alavi MV, 2007, BRAIN, V130, P1029, DOI 10.1093/brain/awm005; Cereghetti GM, 2008, P NATL ACAD SCI USA, V105, P15803, DOI 10.1073/pnas.0808249105; Chen HC, 2007, CELL, V130, P548, DOI 10.1016/j.cell.2007.06.026; Chen Y, 2013, SCIENCE, V340, P471, DOI 10.1126/science.1231031; Chen Y, 2011, CIRC RES, V109, P1327, DOI 10.1161/CIRCRESAHA.111.258723; Chung Susan, 2007, Nat Clin Pract Cardiovasc Med, V4 Suppl 1, pS60, DOI 10.1038/ncpcardio0766; Costa V, 2010, EMBO MOL MED, V2, P490, DOI 10.1002/emmm.201000102; De Strooper B, 1999, NATURE, V398, P518, DOI 10.1038/19083; Dolmetsch RE, 1997, NATURE, V386, P855, DOI 10.1038/386855a0; Dorn GW, 2011, CIRC RES, V108, P12, DOI 10.1161/CIRCRESAHA.110.236745; Green DR, 2004, SCIENCE, V305, P626, DOI 10.1126/science.1099320; Hoth M, 1997, J CELL BIOL, V137, P633, DOI 10.1083/jcb.137.3.633; KELLER GM, 1995, CURR OPIN CELL BIOL, V7, P862, DOI 10.1016/0955-0674(95)80071-9; Mandal S, 2011, STEM CELLS, V29, P486, DOI 10.1002/stem.590; Mitra K, 2012, J CELL BIOL, V197, P487, DOI 10.1083/jcb.201110058; Molkentin JD, 1998, CELL, V93, P215, DOI 10.1016/S0092-8674(00)81573-1; Nemir M, 2006, CIRC RES, V98, P1471, DOI 10.1161/01.RES.0000226497.52052.2a; Rand MD, 2000, MOL CELL BIOL, V20, P1825, DOI 10.1128/MCB.20.5.1825-1835.2000; Roti G, 2013, CANCER CELL, V23, P390, DOI 10.1016/j.ccr.2013.01.015; Shen HX, 2006, GENE DEV, V20, P675, DOI 10.1101/gad.1383706; Wasilewski M, 2012, CURR BIOL, V22, P1228, DOI 10.1016/j.cub.2012.04.054	21	228	230	2	58	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 8	2013	342	6159					734	737		10.1126/science.1241359	http://dx.doi.org/10.1126/science.1241359			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247UK	24091702				2022-12-24	WOS:000326647600042
J	Tang, ZM; Lin, MG; Stowe, TR; Chen, S; Zhu, MY; Stearns, T; Franco, B; Zhong, Q				Tang, Zaiming; Lin, Mary Grace; Stowe, Timothy Richard; Chen, She; Zhu, Muyuan; Stearns, Tim; Franco, Brunella; Zhong, Qing			Autophagy promotes primary ciliogenesis by removing OFD1 from centriolar satellites	NATURE			English	Article							PRIMARY CILIA; SELECTIVE AUTOPHAGY; JOUBERT-SYNDROME; BBS PROTEINS; DISEASE; UBIQUITIN; GENE; IDENTIFICATION; DEGRADATION; MECHANISMS	The primary cilium is a microtubule-based organelle that functions in sensory and signalling pathways. Defects in ciliogenesis can lead to a group of genetic syndromes known as ciliopathies(1-3). However, the regulatory mechanisms of primary ciliogenesis in normal and cancer cells are incompletely understood. Here we demonstrate that autophagic degradation of a ciliopathy protein, OFD1 (oral-facial-digital syndrome 1), at centriolar satellites promotes primary cilium biogenesis. Autophagy is a catabolic pathway in which cytosol, damaged organelles and protein aggregates are engulfed in autophagosomes and delivered to lysosomes for destruction(4). We show that the population of OFD1 at the centriolar satellites is rapidly degraded by autophagy upon serum starvation. In autophagy-deficient Atg5 or Atg3 null mouse embryonic fibroblasts, OFD1 accumulates at centriolar satellites, leading to fewer and shorter primary cilia and a defective recruitment of BBS4 (Bardet-Biedl syndrome 4) to cilia. These defects are fully rescued by OFD1 partial knockdown that reduces the population of OFD1 at centriolar satellites. More strikingly, OFD1 depletion at centriolar satellites promotes cilia formation in both cycling cells and transformed breast cancer MCF7 cells that normally do not form cilia. This work reveals that removal of OFD1 by autophagy at centriolar satellites represents a general mechanism to promote ciliogenesis in mammalian cells. These findings define a newly recognized role of autophagy in organelle biogenesis.	[Tang, Zaiming; Zhong, Qing] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Ctr Autophagy Res, Dallas, TX 75390 USA; [Tang, Zaiming; Zhong, Qing] Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA; [Tang, Zaiming; Lin, Mary Grace; Zhong, Qing] Univ Calif Berkeley, Dept Mol & Cell Biol, Div Biochem Biophys & Struct Biol, Berkeley, CA 94720 USA; [Tang, Zaiming; Zhu, Muyuan] Zhejiang Univ, Coll Life Sci, State Key Lab Plant Physiol & Biochem, Hangzhou 310058, Zhejiang, Peoples R China; [Stowe, Timothy Richard; Stearns, Tim] Stanford Univ, Dept Biol, Stanford, CA 94305 USA; [Chen, She] Natl Inst Biol Sci, Beijing 102206, Peoples R China; [Franco, Brunella] Univ Naples Federico II, Dept Translat Med Sci, Med Genet Serv, Naples, Italy; [Franco, Brunella] Telethon Inst Genet & Med TIGEM, Naples, Italy	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of California System; University of California Berkeley; Zhejiang University; Stanford University; National Institute of Biological Sciences, Beijing; University of Naples Federico II; Fondazione Telethon; Telethon Institute of Genetics & Medicine (TIGEM)	Zhong, Q (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Internal Med, Ctr Autophagy Res, Dallas, TX 75390 USA.	qing.zhong@utsouthwestern.edu	Zhong, Qing/GLT-4858-2022; FRANCO, Brunella/S-2882-2018	Zhong, Qing/0000-0001-6979-955X; FRANCO, Brunella/0000-0001-5588-4569; Stearns, Tim/0000-0002-0671-6582	Polycystic Kidney Disease Foundation; American Cancer Society [RSG-11-274-01-CCG]; National Cancer Institute [CA133228]; Italian Telethon Foundation [TGM11CB3]; EU [241955]; China Scholarship Council; NATIONAL CANCER INSTITUTE [R01CA133228] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM052022] Funding Source: NIH RePORTER	Polycystic Kidney Disease Foundation; American Cancer Society(American Cancer Society); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Italian Telethon Foundation(Fondazione Telethon); EU(European Commission); China Scholarship Council(China Scholarship Council); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank D. Moughon and W. Fan for initial purification of LC3 complex; N. Mizushima for Atg5<SUP>+/+</SUP> and Atg5<SUP>-/-</SUP> MEFs and M. Komatsu for Atg3<SUP>+/+</SUP> and Atg3<SUP>-/-</SUP> MEFs; H. Zhou for helpful discussions and quantitative RT-PCR data analysis; A. Kodani and J. F. Reiter for reagents, helpful discussions and technical assistance; and B. Levine for helpful discussions and critical reading of the manuscript. The electron microscopy studies were performed by C. Miller and V. Gattone II at the Indiana University School of Medicine Electron Microscopy Center that is supported by the Polycystic Kidney Disease Foundation. This work was supported by grants from the American Cancer Society (RSG-11-274-01-CCG) and National Cancer Institute (CA133228) to Q.Z. and grants from the Italian Telethon Foundation (TGM11CB3) and the EU FP7/2007-2013 Programme (Syscilia grant agreement no. 241955) to B. F. The work was partially supported by China Scholarship Council to Z.T.	Bimonte S, 2011, DEV BIOL, V349, P179, DOI 10.1016/j.ydbio.2010.09.020; Cantagrel V, 2008, AM J HUM GENET, V83, P170, DOI 10.1016/j.ajhg.2008.06.023; Chen DD, 2012, MOL CELL, V45, P629, DOI 10.1016/j.molcel.2011.12.036; Coene KLM, 2009, AM J HUM GENET, V85, P465, DOI 10.1016/j.ajhg.2009.09.002; Fan WL, 2010, AUTOPHAGY, V6, P614, DOI 10.4161/auto.6.5.12189; Feather SA, 1997, HUM MOL GENET, V6, P1163, DOI 10.1093/hmg/6.7.1163; Ferrante MI, 2006, NAT GENET, V38, P112, DOI 10.1038/ng1684; Ferrante MI, 2001, AM J HUM GENET, V68, P569, DOI 10.1086/318802; Field M, 2012, EUR J HUM GENET, V20, P806, DOI 10.1038/ejhg.2012.9; Giorgio G, 2007, MOL BIOL CELL, V18, P4397, DOI 10.1091/mbc.E07-03-0198; Goetz SC, 2010, NAT REV GENET, V11, P331, DOI 10.1038/nrg2774; Han YG, 2009, NAT MED, V15, P1062, DOI 10.1038/nm.2020; Hildebrandt F, 2011, NEW ENGL J MED, V364, P1533, DOI 10.1056/NEJMra1010172; Johansen T, 2011, AUTOPHAGY, V7, P279, DOI 10.4161/auto.7.3.14487; Kirkin V, 2009, MOL CELL, V34, P259, DOI 10.1016/j.molcel.2009.04.026; Kirkin V, 2009, MOL CELL, V33, P505, DOI 10.1016/j.molcel.2009.01.020; Kuma A, 2004, NATURE, V432, P1032, DOI 10.1038/nature03029; Levine B, 2004, DEV CELL, V6, P463, DOI 10.1016/S1534-5807(04)00099-1; Lopes CAM, 2011, J CELL SCI, V124, P600, DOI 10.1242/jcs.077156; Nachury MV, 2007, CELL, V129, P1201, DOI 10.1016/j.cell.2007.03.053; Nigg EA, 2009, CELL, V139, P663, DOI 10.1016/j.cell.2009.10.036; Novak I, 2010, EMBO REP, V11, P45, DOI 10.1038/embor.2009.256; Orvedahl A, 2011, NATURE, V480, P113, DOI 10.1038/nature10546; Sang LY, 2011, CELL, V145, P513, DOI 10.1016/j.cell.2011.04.019; Seeley ES, 2009, CANCER RES, V69, P422, DOI 10.1158/0008-5472.CAN-08-1290; Singla V, 2010, DEV CELL, V18, P410, DOI 10.1016/j.devcel.2009.12.022; Sou Y, 2008, MOL BIOL CELL, V19, P4762, DOI 10.1091/mbc.E08-03-0309; Stowe TR, 2012, MOL BIOL CELL, V23, P3322, DOI 10.1091/mbc.E12-02-0134; Sun QM, 2008, P NATL ACAD SCI USA, V105, P19211, DOI 10.1073/pnas.0810452105; Thurston TLM, 2009, NAT IMMUNOL, V10, P1215, DOI 10.1038/ni.1800; Wong SY, 2009, NAT MED, V15, P1055, DOI 10.1038/nm.2011; Yuan K, 2010, J HISTOCHEM CYTOCHEM, V58, P857, DOI 10.1369/jhc.2010.955856; Zhang YX, 2009, CELL, V136, P308, DOI 10.1016/j.cell.2008.12.022; Zullo A, 2010, HUM MOL GENET, V19, P2792, DOI 10.1093/hmg/ddq180	34	262	280	7	54	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 10	2013	502	7470					254	+		10.1038/nature12606	http://dx.doi.org/10.1038/nature12606			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231RU	24089205	Green Accepted, Green Submitted			2022-12-24	WOS:000325436100055
J	Depoorter, MA; Bamber, JL; Griggs, JA; Lenaerts, JTM; Ligtenberg, SRM; van den Broeke, MR; Moholdt, G				Depoorter, M. A.; Bamber, J. L.; Griggs, J. A.; Lenaerts, J. T. M.; Ligtenberg, S. R. M.; van den Broeke, M. R.; Moholdt, G.			Calving fluxes and basal melt rates of Antarctic ice shelves	NATURE			English	Article							SOUTHERN-OCEAN; MASS-BALANCE; BENEATH; GREENLAND; ICEBERGS; IRON; FLOW	Iceberg calving has been assumed to be the dominant cause of mass loss for the Antarctic ice sheet, with previous estimates of the calving flux exceeding 2,000 gigatonnes per year(1,2). More recently, the importance of melting by the ocean has been demonstrated close to the grounding line and near the calving front(3-5). So far, however, no study has reliably quantified the calving flux and the basal mass balance (the balance between accretion and ablation at the ice-shelf base) for the whole of Antarctica. The distribution of fresh water in the Southern Ocean and its partitioning between the liquid and solid phases is therefore poorly constrained. Here we estimate the mass balance components for all ice shelves in Antarctica, using satellite measurements of calving flux and grounding-line flux, modelled ice-shelf snow accumulation rates(6) and a regional scaling that accounts for unsurveyed areas. We obtain a total calving flux of 1,321 +/- 144 gigatonnes per year and a total basal mass balance of -1,454 +/- 174 gigatonnes per year. This means that about half of the ice-sheet surface mass gain is lost through oceanic erosion before reaching the ice front, and the calving flux is about 34 per cent less than previous estimates derived from iceberg tracking(1,2,7). In addition, the fraction of mass loss due to basal processes varies from about 10 to 90 per cent between ice shelves. We find a significant positive correlation between basal mass loss and surface elevation change for ice shelves experiencing surface lowering(8) and enhanced discharge(9). We suggest that basal mass loss is a valuable metric for predicting future ice-shelf vulnerability to oceanic forcing.	[Depoorter, M. A.; Bamber, J. L.; Griggs, J. A.] Univ Bristol, Sch Geog Sci, Bristol Glaciol Ctr, Bristol BS8 1SS, Avon, England; [Lenaerts, J. T. M.; Ligtenberg, S. R. M.; van den Broeke, M. R.] Univ Utrecht, Inst Marine & Atmospher Res Utrecht, NL-3584 CC Utrecht, Netherlands; [Moholdt, G.] Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA	University of Bristol; Utrecht University; University of California System; University of California San Diego; Scripps Institution of Oceanography	Depoorter, MA (corresponding author), Univ Bristol, Sch Geog Sci, Bristol Glaciol Ctr, Bristol BS8 1SS, Avon, England.	mathieu.depoorter@bristol.ac.uk; j.bamber@bristol.ac.uk	Bamber, Jonathan/C-7608-2011; Ligtenberg, Stefan/AAF-8290-2020; Van den Broeke, Michiel R./F-7867-2011; Lenaerts, Jan/D-9423-2012	Bamber, Jonathan/0000-0002-2280-2819; Van den Broeke, Michiel R./0000-0003-4662-7565; Lenaerts, Jan/0000-0003-4309-4011	European Union [226375]; Netherlands Polar Programme; NERC [NE/I027401/1]; Natural Environment Research Council [NE/I027401/1] Funding Source: researchfish	European Union(European Commission); Netherlands Polar Programme; NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was supported by funding from the ice2sea programme of the European Union Seventh Framework Programme, grant number 226375. This work is ice2sea contribution number 139. M.R.v.d.B., J.T.M.L. and S.R.M.L. acknowledge funding from the Netherlands Polar Programme. J.L.B. was supported by NERC grant NE/I027401/1.	Alderkamp AC, 2012, DEEP-SEA RES PT II, V71-76, P32, DOI 10.1016/j.dsr2.2012.03.005; De Angelis H, 2003, SCIENCE, V299, P1560, DOI 10.1126/science.1077987; Determann J., 1998, ANTARCT RES SER, V75, P285; DOAKE CSM, 1991, NATURE, V350, P328, DOI 10.1038/350328a0; Dupont TK, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2004GL022024; Fricker HA, 2001, GEOPHYS RES LETT, V28, P2241, DOI 10.1029/2000GL012461; Griggs JA, 2011, J GLACIOL, V57, P485, DOI 10.3189/002214311796905659; Hellmer HH, 2012, NATURE, V485, P225, DOI 10.1038/nature11064; Hellmer HH, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL019506; Holland PR, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL038162; JACOBS SS, 1992, J GLACIOL, V38, P375, DOI 10.3189/S0022143000002252; JENKINS A, 1991, J GEOPHYS RES-OCEANS, V96, P791, DOI 10.1029/90JC01952; Joughin I, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL017609; King MA, 2012, NATURE, V491, P586, DOI 10.1038/nature11621; Lenaerts JTM, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2011GL050713; Ligtenberg SRM, 2011, CRYOSPHERE, V5, P809, DOI 10.5194/tc-5-809-2011; Nicholls KW, 1997, GEOPHYS RES LETT, V24, P167, DOI 10.1029/96GL03922; Orheim O., 1985, GLACIERS ICE SHEETS, P210; POTTER JR, 1984, J GLACIOL, V30, P161, DOI 10.3189/S002214300000589X; Pritchard HD, 2012, NATURE, V484, P502, DOI 10.1038/nature10968; Pritchard HD, 2009, NATURE, V461, P971, DOI 10.1038/nature08471; Raiswell R, 2008, GEOCHEM T, V9, DOI 10.1186/1467-4866-9-7; Rignot E, 2002, SCIENCE, V296, P2020, DOI 10.1126/science.1070942; Rignot E, 2011, SCIENCE, V333, P1427, DOI 10.1126/science.1208336; Silva TAM, 2006, J GEOPHYS RES-OCEANS, V111, DOI 10.1029/2004JC002843; Smith KL, 2007, SCIENCE, V317, P478, DOI 10.1126/science.1142834; Timmermann R, 2012, ANN GLACIOL, V53, P303, DOI 10.3189/2012AoG60A156; Whitehouse MJ, 2012, DEEP-SEA RES PT II, V59, P47, DOI 10.1016/j.dsr2.2011.05.010; Yu JY, 2010, J GEOPHYS RES-SOL EA, V115, DOI 10.1029/2010JB007456; ZOTIKOV IA, 1980, SCIENCE, V207, P1463, DOI 10.1126/science.207.4438.1463; Zwally HJ, 2005, J GLACIOL, V51, P509, DOI 10.3189/172756505781829007	31	392	402	10	167	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 3	2013	502	7469					89	+		10.1038/nature12567	http://dx.doi.org/10.1038/nature12567			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	227IM	24037377				2022-12-24	WOS:000325106000036
J	Nguyen, VQ; Ranjan, A; Stengel, F; Wei, D; Aebersold, R; Wu, C; Leschziner, AE				Nguyen, Vu Q.; Ranjan, Anand; Stengel, Florian; Wei, Debbie; Aebersold, Ruedi; Wu, Carl; Leschziner, Andres E.			Molecular Architecture of the ATP-Dependent Chromatin-Remodeling Complex SWR1	CELL			English	Article							NUCLEOSOME CORE PARTICLE; ACTIN-RELATED PROTEINS; ELECTRON-MICROSCOPY; CRYSTAL-STRUCTURE; CONFORMATIONAL-CHANGES; HISTONE H2AZ; DOMAIN; REVEALS; TILT; RSC	The ATP-dependent chromatin-remodeling complex SWR1 exchanges a variant histone H2A.Z/H2B dimer for a canonical H2A/H2B dimer at nucleosomes flanking histone-depleted regions, such as promoters. This localization of H2A.Z is conserved throughout eukaryotes. SWR1 is a 1 megadalton complex containing 14 different polypeptides, including the AAA+ ATPases Rvb1 and Rvb2. Using electron microscopy, we obtained the three-dimensional structure of SWR1 and mapped its major functional components. Our data show that SWR1 contains a single heterohexameric Rvb1/Rvb2 ring that, together with the catalytic subunit Swr1, brackets two independently assembled multisubunit modules. We also show that SWR1 undergoes a large conformational change upon engaging a limited region of the nucleosome core particle. Our work suggests an important structural role for the Rvbs and a distinct substrate-handling mode by SWR1, thereby providing a structural framework for understanding the complex dimer-exchange reaction.	[Nguyen, Vu Q.; Leschziner, Andres E.] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; [Ranjan, Anand; Wei, Debbie; Wu, Carl] NCI, Lab Biochem & Mol Biol, Ctr Canc Res, Bethesda, MD 20892 USA; [Stengel, Florian; Aebersold, Ruedi] ETH, Inst Mol Syst Biol, Dept Biol, CH-8092 Zurich, Switzerland; [Aebersold, Ruedi] Univ Zurich, Fac Sci, CH-8057 Zurich, Switzerland; [Wu, Carl] HHMI Janelia Farm Res Campus, Ashburn, VA 20147 USA	Harvard University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Zurich; Howard Hughes Medical Institute	Leschziner, AE (corresponding author), Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA.	aleschziner@mcb.harvard.edu		Leschziner, Andres/0000-0002-7732-7023; Stengel, Florian/0000-0003-1447-4509	National Science Foundation (NSF) [ECS-0335765]; Harvard's FAS Science Division Research Computing Group; National Institutes of Health (NIH) [GM007598]; NSF Graduate Research Fellowship; Leukemia and Lymphoma Society; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM092895, T32GM007598] Funding Source: NIH RePORTER	National Science Foundation (NSF)(National Science Foundation (NSF)); Harvard's FAS Science Division Research Computing Group; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF Graduate Research Fellowship(National Science Foundation (NSF)); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We would like to thank Sjors Scheres (LMB-MRC, Cambridge), Pawel Penczek (University of Texas, Houston), John Rubinstein (University of Toronto), and Niko Grigorieff (Janelia Farm) for technical advice, Katerina Toropova, Rogelio Hernandez-Lopez, and Michael Cianfrocco in the Leschziner Lab for contributions during this work, Samara Reck-Peterson (Harvard Medical School), Andrew Richardson, Yoel Stuart, Beka Buckman, and Steve Klosterman (Harvard University) for feedback on the manuscript, Rachelle Gaudet and Nicole Francis (Harvard University) for advice, and Locksley for moral support. EM data were collected at Harvard's Center for Nanoscale Systems, a member of the National Nanotechnology Infrastructure Network and supported by the National Science Foundation (NSF) (ECS-0335765). Computation was performed in part on the Odyssey cluster supported by Harvard's FAS Science Division Research Computing Group. V. Q. N. was supported by the Joint Training Program in Molecules, Cells and Organisms funded by the National Institutes of Health (NIH) (GM007598) and a NSF Graduate Research Fellowship. A. R. was supported in part by a fellowship from the Leukemia and Lymphoma Society. F. S. is a Sir Henry Wellcome Fellow (Wellcome Trust Grant 095951). A. E. L. was supported in part by a fellowship from the Alfred P. Sloan Foundation. This project was supported by grants from the NIH (R01 GM092895A) (to A. E. L.), ETH Zurich (to R. A.), the Commission of the European Communities through the PROSPETS consortium (EU FP7 projects 201648 and 233226 to R. A.), the European Research Council (ERC-2008AdG 233226 to R. A.), the Center for Cancer Research, National Cancer Insti-tute (to A. R., D. W., and C. W.), and the Howard Hughes Medical Institute (C. W.).	Albert I, 2007, NATURE, V446, P572, DOI 10.1038/nature05632; Altaf M, 2010, J BIOL CHEM, V285, P15966, DOI 10.1074/jbc.M110.117069; Badis G, 2008, MOL CELL, V32, P878, DOI 10.1016/j.molcel.2008.11.020; Boyer LA, 2004, NAT REV MOL CELL BIO, V5, P158, DOI 10.1038/nrm1314; Chaban Y, 2008, NAT STRUCT MOL BIOL, V15, P1272, DOI 10.1038/nsmb.1524; Cheung KLY, 2010, J MOL BIOL, V404, P478, DOI 10.1016/j.jmb.2010.10.003; Cheung KLY, 2010, BIOCHEM CELL BIOL, V88, P77, DOI [10.1139/O09-159, 10.1139/o09-159]; Chittuluru JR, 2011, NAT STRUCT MOL BIOL, V18, P1196, DOI 10.1038/nsmb.2128; Clapier CR, 2012, NATURE, V492, P280, DOI 10.1038/nature11625; Clapier CR, 2009, ANNU REV BIOCHEM, V78, P273, DOI 10.1146/annurev.biochem.77.062706.153223; Dang WW, 2007, MOL CELL BIOL, V27, P8306, DOI 10.1128/MCB.01351-07; De Carlo S, 2010, METHOD ENZYMOL, V481, P127, DOI 10.1016/S0076-6879(10)81006-7; Dechassa ML, 2008, MOL CELL BIOL, V28, P6010, DOI 10.1128/MCB.00693-08; Draker R, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003047; Fan JY, 2004, MOL CELL, V16, P655, DOI 10.1016/j.molcel.2004.10.023; Fan JY, 2002, NAT STRUCT BIOL, V9, P172, DOI 10.1038/nsb767; Fenn S, 2011, EMBO J, V30, P2153, DOI 10.1038/emboj.2011.118; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; Galarneau L, 2000, MOL CELL, V5, P927, DOI 10.1016/S1097-2765(00)80258-0; Gangaraju VK, 2009, MOL CELL, V35, P58, DOI 10.1016/j.molcel.2009.05.013; Gorynia S, 2011, J STRUCT BIOL, V176, P279, DOI 10.1016/j.jsb.2011.09.001; Gribun A, 2008, J MOL BIOL, V376, P1320, DOI 10.1016/j.jmb.2007.12.049; Hartley PD, 2009, CELL, V137, P445, DOI 10.1016/j.cell.2009.02.043; Hota SK, 2011, BBA-GENE REGUL MECH, V1809, P476, DOI 10.1016/j.bbagrm.2011.05.007; Jacobson RH, 2000, SCIENCE, V288, P1422, DOI 10.1126/science.288.5470.1422; Jonsson ZO, 2004, MOL CELL, V16, P465, DOI 10.1016/j.molcel.2004.09.033; Kapoor P, 2013, NAT STRUCT MOL BIOL, V20, P426, DOI 10.1038/nsmb.2529; Kastner B, 2008, NAT METHODS, V5, P53, DOI 10.1038/NMETH1139; Kobor MS, 2004, PLOS BIOL, V2, P587, DOI 10.1371/journal.pbio.0020131; Krogan NJ, 2003, MOL CELL, V12, P1565, DOI 10.1016/S1097-2765(03)00497-0; Leitner A, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.014126; Leitner A, 2010, MOL CELL PROTEOMICS, V9, P1634, DOI 10.1074/mcp.R000001-MCP201; Leschziner A, 2010, METHOD ENZYMOL, V482, P237, DOI 10.1016/S0076-6879(10)82010-5; Leschziner AE, 2007, P NATL ACAD SCI USA, V104, P4913, DOI 10.1073/pnas.0700706104; Leschziner AE, 2011, CURR OPIN STRUC BIOL, V21, P709, DOI 10.1016/j.sbi.2011.10.002; Lewis R, 2008, NUCLEIC ACIDS RES, V36, P1881, DOI 10.1093/nar/gkn040; Lopez-Perrote A, 2012, NUCLEIC ACIDS RES, V40, P11086, DOI 10.1093/nar/gks871; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Luk E, 2010, CELL, V143, P725, DOI 10.1016/j.cell.2010.10.019; Matias PM, 2006, J BIOL CHEM, V281, P38918, DOI 10.1074/jbc.M605625200; Mindell JA, 2003, J STRUCT BIOL, V142, P334, DOI 10.1016/S1047-8477(03)00069-8; Mizuguchi G, 2004, SCIENCE, V303, P343, DOI 10.1126/science.1090701; Pamblanco M, 2001, FEBS LETT, V496, P31, DOI 10.1016/S0014-5793(01)02397-3; Papamichos-Chronakis M, 2011, CELL, V144, P200, DOI 10.1016/j.cell.2010.12.021; Park YJ, 2004, J BIOL CHEM, V279, P24274, DOI 10.1074/jbc.M313152200; Puri T, 2007, J MOL BIOL, V366, P179, DOI 10.1016/j.jmb.2006.11.030; Racki LR, 2009, NATURE, V462, P1016, DOI 10.1038/nature08621; Raisner RM, 2005, CELL, V123, P233, DOI 10.1016/j.cell.2005.10.002; Rinner O, 2008, NAT METHODS, V5, P315, DOI [10.1038/NMETH.1192, 10.1038/nmeth.1192]; Saha A, 2002, GENE DEV, V16, P2120, DOI 10.1101/gad.995002; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Scheres SHW, 2012, J MOL BIOL, V415, P406, DOI 10.1016/j.jmb.2011.11.010; Schubert HL, 2013, P NATL ACAD SCI USA, V110, P3345, DOI 10.1073/pnas.1215379110; Shen XT, 2000, NATURE, V406, P541, DOI 10.1038/35020123; Stark H, 2010, METHOD ENZYMOL, V481, P109, DOI 10.1016/S0076-6879(10)81005-5; Sunada R, 2005, YEAST, V22, P753, DOI 10.1002/yea.1239; Suto RK, 2000, NAT STRUCT BIOL, V7, P1121; Szerlong H, 2008, NAT STRUCT MOL BIOL, V15, P469, DOI 10.1038/nsmb.1403; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; Tolstorukov MY, 2009, GENOME RES, V19, P967, DOI 10.1101/gr.084830.108; Torreira E, 2008, STRUCTURE, V16, P1511, DOI 10.1016/j.str.2008.08.009; Udugama M, 2011, MOL CELL BIOL, V31, P662, DOI 10.1128/MCB.01035-10; vanHeel M, 1996, J STRUCT BIOL, V116, P17, DOI 10.1006/jsbi.1996.0004; Venters BJ, 2009, GENOME RES, V19, P360, DOI 10.1101/gr.084970.108; White CL, 2001, EMBO J, V20, P5207, DOI 10.1093/emboj/20.18.5207; Wu WH, 2009, J BIOL CHEM, V284, P6200, DOI 10.1074/jbc.M808830200; Wu WH, 2005, NAT STRUCT MOL BIOL, V12, P1064, DOI 10.1038/nsmb1023; Yamada K, 2011, NATURE, V472, P448, DOI 10.1038/nature09947; Zhang ZH, 2011, SCIENCE, V332, P977, DOI 10.1126/science.1200508; Zofall M, 2006, NAT STRUCT MOL BIOL, V13, P339, DOI 10.1038/nsmb1071	71	110	113	1	48	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 12	2013	154	6					1220	1231		10.1016/j.cell.2013.08.018	http://dx.doi.org/10.1016/j.cell.2013.08.018			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	215VQ	24034246	Green Published, hybrid			2022-12-24	WOS:000324239300012
J	Ellison, GM; Vicinanza, C; Smith, AJ; Aquila, I; Leone, A; Waring, CD; Henning, BJ; Stirparo, GG; Papait, R; Scarfo, M; Agosti, V; Viglietto, G; Condorelli, G; Indolfi, C; Ottolenghi, S; Torella, D; Nadal-Ginard, B				Ellison, Georgina M.; Vicinanza, Carla; Smith, Andrew J.; Aquila, Iolanda; Leone, Angelo; Waring, Cheryl D.; Henning, Beverley J.; Stirparo, Giuliano Giuseppe; Papait, Roberto; Scarfo, Marzia; Agosti, Valter; Viglietto, Giuseppe; Condorelli, Gianluigi; Indolfi, Ciro; Ottolenghi, Sergio; Torella, Daniele; Nadal-Ginard, Bernardo			Adult c-kit(pos) Cardiac Stem Cells Are Necessary and Sufficient for Functional Cardiac Regeneration and Repair	CELL			English	Article							PROGENITOR CELLS; SELF-RENEWAL; HEART; EXPRESSION; CARDIOMYOCYTES; DIFFERENTIATION; CARDIOMYOPATHY; MYOCARDIUM; PRECURSORS; INFARCTION	The epidemic of heart failure has stimulated interest in understanding cardiac regeneration. Evidence has been reported supporting regeneration via transplantation of multiple cell types, as well as replication of postmitotic cardiomyocytes. In addition, the adult myocardium harbors endogenous c-kit(pos) cardiac stem cells (eCSCs), whose relevance for regeneration is controversial. Here, using different rodent models of diffuse myocardial damage causing acute heart failure, we show that eCSCs restore cardiac function by regenerating lost cardiomyocytes. Ablation of the eCSC abolishes regeneration and functional recovery. The regenerative process is completely restored by replacing the ablated eCSCs with the progeny of one eCSC. eCSCs recovered from the host and recloned retain their regenerative potential in vivo and in vitro. After regeneration, selective suicide of these exogenous CSCs and their progeny abolishes regeneration, severely impairing ventricular performance. These data show that c-kit(pos) eCSCs are necessary and sufficient for the regeneration and repair of myocardial damage.	[Ellison, Georgina M.; Vicinanza, Carla; Waring, Cheryl D.; Henning, Beverley J.; Torella, Daniele; Nadal-Ginard, Bernardo] Liverpool John Moores Univ, Stem Cell & Regenerat Biol Unit BioStem, Liverpool L3 3AF, Merseyside, England; [Ellison, Georgina M.; Vicinanza, Carla; Aquila, Iolanda; Leone, Angelo; Indolfi, Ciro; Torella, Daniele] Magna Graecia Univ Catanzaro, Dept Med & Surg Sci, Lab Mol & Cellular Cardiol, I-88100 Catanzaro, Italy; [Agosti, Valter; Viglietto, Giuseppe] Magna Graecia Univ Catanzaro, Dept Expt & Clin Med, Mol Oncol Lab, I-88100 Catanzaro, Italy; [Agosti, Valter; Viglietto, Giuseppe] Magna Graecia Univ Catanzaro, CIS Genom & Mol Pathol, I-88100 Catanzaro, Italy; [Ellison, Georgina M.; Smith, Andrew J.; Nadal-Ginard, Bernardo] Kings Coll London, Sch Biomed Sci, Ctr Human & Aerosp Physiol Sci, London SE1 1UL, England; [Ellison, Georgina M.; Smith, Andrew J.; Nadal-Ginard, Bernardo] Kings Coll London, Ctr Stem Cells & Regenerat Med, London SE1 1UL, England; [Stirparo, Giuliano Giuseppe; Papait, Roberto; Condorelli, Gianluigi] Humanitas Clin & Res Ctr, I-20098 Rozzano Milan, Italy; [Papait, Roberto; Condorelli, Gianluigi] Natl Res Council Italy CNR, Inst Genet & Biomed Res, I-20098 Rozzano Milan, Italy; [Scarfo, Marzia; Viglietto, Giuseppe] IRGS Biogem, I-83031 Avellino, Italy; [Condorelli, Gianluigi] Univ Milan, I-20098 Milan, Italy; [Ottolenghi, Sergio] Univ Milano Bicocca, Dept Biotechnol & Biosci, I-20126 Milan, Italy	Liverpool John Moores University; Magna Graecia University of Catanzaro; Magna Graecia University of Catanzaro; Magna Graecia University of Catanzaro; University of London; King's College London; University of London; King's College London; Consiglio Nazionale delle Ricerche (CNR); Istituto di Ricerca Genetica e Biomedica (IRGB-CNR); University of Milan; University of Milano-Bicocca	Torella, D (corresponding author), Liverpool John Moores Univ, Stem Cell & Regenerat Biol Unit BioStem, Liverpool L3 3AF, Merseyside, England.	dtorella@unicz.it; bernardo.nadalginard@kcl.ac.uk	Papait, Roberto/AAB-8291-2022; Ellison-Hughes, Georgina M./B-4597-2016; VICINANZA, CARLA/ABF-9921-2020; Viglietto, Giuseppe/AAC-2852-2019; Aquila, Iolanda/AAC-2417-2022; Papait, Roberto/AAC-7659-2022; Condorelli, Gianluigi/Q-6736-2017	Ellison-Hughes, Georgina M./0000-0002-2733-3361; VICINANZA, CARLA/0000-0001-8660-6668; Viglietto, Giuseppe/0000-0003-2327-7515; Aquila, Iolanda/0000-0001-5096-9424; Papait, Roberto/0000-0002-9552-8259; AGOSTI, Valter/0000-0001-6785-093X; TORELLA, Daniele/0000-0002-4915-5084; Stirparo, Giuliano/0000-0002-5911-8682; INDOLFI, Ciro/0000-0003-1241-6487; Smith, Andrew/0000-0001-7283-5611; Condorelli, Gianluigi/0000-0003-0481-6843; Cottle, Beverley/0000-0001-5751-1328	CARE-MI FP7 [Health-F5-2010-242038]; Endostem FP7 [Health F5-2010-241440]; Marie Curie International Reintegration FP7 Grant [PIRG02-GA-2007-224853]; FIRB-Futuro-in-Ricerca [RBFR081CCS]; Italian Ministry of Health [GR-2008-1142673]; Associazione Italiana per la Ricerca sul Cancro (AIRC) MFAG; Istituto Superiore di Sanita [RF-CAL-2008-1261292]	CARE-MI FP7; Endostem FP7; Marie Curie International Reintegration FP7 Grant; FIRB-Futuro-in-Ricerca(Ministry of Education, Universities and Research (MIUR)Fund for Investment in Basic Research (FIRB)); Italian Ministry of Health(Ministry of Health, Italy); Associazione Italiana per la Ricerca sul Cancro (AIRC) MFAG; Istituto Superiore di Sanita	This work was supported by grants from the CARE-MI FP7 (Health-F5-2010-242038), Endostem FP7 (Health F5-2010-241440) large-scale collaborative projects, Marie Curie International Reintegration FP7 Grant (PIRG02-GA-2007-224853), FIRB-Futuro-in-Ricerca (RBFR081CCS), Italian Ministry of Health (GR-2008-1142673), Associazione Italiana per la Ricerca sul Cancro (AIRC) MFAG-2008, and Istituto Superiore di Sanita (RF-CAL-2008-1261292). We sincerely thank Tammie Bishop (University of Oxford) and Ludwig Thierfelder (Max-Delbrueck Center for Molecular Medicine) for providing the MerCreMer mice; Edmondo Battista and Filippo Causa (Center for Advanced Biomaterials for Healthcare, Italian Institute of Technology and Interdisciplinary Research Center on Biomaterials, University Federico II) for their technical help in manufacturing the fibrin-based PEGylated hydrogel; and Aurora Nocera and Emilia Dora Giovannone (CIS of Genomics and Molecular Pathology, Magna Graecia University) for their excellent technical help in cardiomyocyte FACS sorting.	Akashi YJ, 2008, CIRCULATION, V118, P2754, DOI 10.1161/CIRCULATIONAHA.108.767012; Askari AT, 2003, LANCET, V362, P697, DOI 10.1016/S0140-6736(03)14232-8; Beltrami AP, 2003, CELL, V114, P763, DOI 10.1016/S0092-8674(03)00687-1; Bergmann O, 2009, SCIENCE, V324, P98, DOI 10.1126/science.1164680; Cairns LA, 2003, BLOOD, V102, P3954, DOI 10.1182/blood-2003-04-1296; Chong JJH, 2011, CELL STEM CELL, V9, P527, DOI 10.1016/j.stem.2011.10.002; Czechowicz A, 2007, SCIENCE, V318, P1296, DOI 10.1126/science.1149726; Dong F, 2012, CIRCULATION, V126, P314, DOI 10.1161/CIRCULATIONAHA.111.082453; Ellison Georgina M, 2007, Nat Clin Pract Cardiovasc Med, V4 Suppl 1, pS52, DOI 10.1038/ncpcardio0773; Ellison GM, 2007, J BIOL CHEM, V282, P11397, DOI 10.1074/jbc.M607391200; Ellison GM, 2011, J AM COLL CARDIOL, V58, P977, DOI 10.1016/j.jacc.2011.05.013; Ellison Georgina M, 2010, Front Biosci (Schol Ed), V2, P641; Guenechea G, 1999, BLOOD, V93, P1097, DOI 10.1182/blood.V93.3.1097.403k04_1097_1105; Jesty SA, 2012, P NATL ACAD SCI USA, V109, P13380, DOI 10.1073/pnas.1208114109; Kajstura J, 2012, CIRCULATION, V126, P1869, DOI 10.1161/CIRCULATIONAHA.112.118380; Loffredo FS, 2011, CELL STEM CELL, V8, P389, DOI 10.1016/j.stem.2011.02.002; LOMPRE AM, 1984, J BIOL CHEM, V259, P6437; Montarras D, 2005, SCIENCE, V309, P2064, DOI 10.1126/science.1114758; Oh H, 2003, P NATL ACAD SCI USA, V100, P12313, DOI 10.1073/pnas.2132126100; Orford KW, 2008, NAT REV GENET, V9, P115, DOI 10.1038/nrg2269; Orlic D, 2001, NATURE, V410, P701, DOI 10.1038/35070587; Qian L, 2012, NATURE, V485, P593, DOI 10.1038/nature11044; Rossi DJ, 2008, CELL, V132, P681, DOI 10.1016/j.cell.2008.01.036; Sata M, 2002, NAT MED, V8, P403, DOI 10.1038/nm0402-403; SCHNEIDER JW, 1994, SCIENCE, V264, P1467, DOI 10.1126/science.8197461; Senyo SE, 2013, NATURE, V493, P433, DOI 10.1038/nature11682; Smart N, 2011, NATURE, V474, P640, DOI 10.1038/nature10188; Song KH, 2012, NATURE, V485, P599, DOI 10.1038/nature11139; Takeuchi JK, 2009, NATURE, V459, P708, DOI 10.1038/nature08039; Tallini YN, 2009, P NATL ACAD SCI USA, V106, P1808, DOI 10.1073/pnas.0808920106; Torella D, 2007, CELL MOL LIFE SCI, V64, P661, DOI 10.1007/s00018-007-6519-y; Vincent SD, 2010, CURR TOP DEV BIOL, V90, P1, DOI 10.1016/S0070-2153(10)90001-X; Waring CD, 2014, EUR HEART J, V35, P2722, DOI 10.1093/eurheartj/ehs338; Weissman IL, 2000, SCIENCE, V287, P1442, DOI 10.1126/science.287.5457.1442; Wilson A, 2008, CELL, V135, P1118, DOI 10.1016/j.cell.2008.10.048; Yoon CH, 2010, CIRCULATION, V121, P2001, DOI 10.1161/CIRCULATIONAHA.109.909291; Zaruba MM, 2010, CIRCULATION, V121, P1992, DOI 10.1161/CIRCULATIONAHA.109.909093; Zhang G, 2006, TISSUE ENG, V12, P9, DOI 10.1089/ten.2006.12.9	38	387	402	0	69	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	AUG 15	2013	154	4					827	842		10.1016/j.cell.2013.07.039	http://dx.doi.org/10.1016/j.cell.2013.07.039			16	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	202GQ	23953114	Bronze			2022-12-24	WOS:000323202500014
J	Reichstein, M; Bahn, M; Ciais, P; Frank, D; Mahecha, MD; Seneviratne, SI; Zscheischler, J; Beer, C; Buchmann, N; Frank, DC; Papale, D; Rammig, A; Smith, P; Thonicke, K; van der Velde, M; Vicca, S; Walz, A; Wattenbach, M				Reichstein, Markus; Bahn, Michael; Ciais, Philippe; Frank, Dorothea; Mahecha, Miguel D.; Seneviratne, Sonia I.; Zscheischler, Jakob; Beer, Christian; Buchmann, Nina; Frank, David C.; Papale, Dario; Rammig, Anja; Smith, Pete; Thonicke, Kirsten; van der Velde, Marijn; Vicca, Sara; Walz, Ariane; Wattenbach, Martin			Climate extremes and the carbon cycle	NATURE			English	Article							PRECIPITATION MANIPULATION EXPERIMENTS; AGRICULTURAL SOIL-EROSION; EUROPE-WIDE REDUCTION; TREE MORTALITY; FIRE EMISSIONS; DIOXIDE UPTAKE; ICE STORMS; LAND-USE; FOREST; DROUGHT	The terrestrial biosphere is a key component of the global carbon cycle and its carbon balance is strongly influenced by climate. Continuing environmental changes are thought to increase global terrestrial carbon uptake. But evidence is mounting that climate extremes such as droughts or storms can lead to a decrease in regional ecosystem carbon stocks and therefore have the potential to negate an expected increase in terrestrial carbon uptake. Here we explore the mechanisms and impacts of climate extremes on the terrestrial carbon cycle, and propose a pathway to improve our understanding of present and future impacts of climate extremes on the terrestrial carbon budget.	[Reichstein, Markus; Frank, Dorothea; Mahecha, Miguel D.; Zscheischler, Jakob; Beer, Christian] Max Planck Inst Biogeochem, D-07745 Jena, Germany; [Bahn, Michael] Univ Innsbruck, Inst Ecol, A-6020 Innsbruck, Austria; [Ciais, Philippe] UVSQ, CNRS, CEA, IPSL,Lab Sci Climat & Environm, F-91191 Gif Sur Yvette, France; [Seneviratne, Sonia I.; Zscheischler, Jakob; Buchmann, Nina] ETH, CH-8092 Zurich, Switzerland; [Zscheischler, Jakob] Max Planck Inst Intelligent Syst, D-72076 Tubingen, Germany; [Beer, Christian] Stockholm Univ, Dept Appl Environm Sci ITM, S-10691 Stockholm, Sweden; [Beer, Christian] Bert Bolin Ctr Climate Res, S-10691 Stockholm, Sweden; [Frank, David C.] Swiss Fed Res Inst WSL, CH-8903 Birmensdorf, Switzerland; [Frank, David C.] Univ Bern, Oeschger Ctr Climate Change Res, CH-3012 Bern, Switzerland; [Papale, Dario] Univ Tuscia, Dept Innovat Biol Agrofood & Forest Syst DIBAF, I-01100 Viterbo, Italy; [Rammig, Anja; Thonicke, Kirsten] Potsdam Inst Climate Impact Res PIK, D-14773 Potsdam, Germany; [Smith, Pete] Univ Aberdeen, Inst Biol & Environm Sci, Aberdeen AB24 3UU, Scotland; [van der Velde, Marijn] Int Inst Appl Syst Anal, Ecosyst Serv & Management Program, A-2361 Laxenburg, Austria; [Vicca, Sara] Univ Antwerp, Dept Biol, Res Grp Plant & Vegetat Ecol, B-2610 Antwerp, Belgium; [Walz, Ariane] Univ Potsdam, Inst Earth & Environm Sci, D-14476 Potsdam, Germany; [Wattenbach, Martin] GFZ German Res Ctr Geosci, Helmholtz Ctr Potsdam, Sect Hydrol 5 4, D-14473 Potsdam, Germany	Max Planck Society; University of Innsbruck; UDICE-French Research Universities; Universite Paris Cite; Universite Paris Saclay; CEA; Centre National de la Recherche Scientifique (CNRS); Swiss Federal Institutes of Technology Domain; ETH Zurich; Max Planck Society; Stockholm University; Swiss Federal Institutes of Technology Domain; Swiss Federal Institute for Forest, Snow & Landscape Research; University of Bern; Tuscia University; Potsdam Institut fur Klimafolgenforschung; University of Aberdeen; International Institute for Applied Systems Analysis (IIASA); University of Antwerp; University of Potsdam; Helmholtz Association; Helmholtz-Center Potsdam GFZ German Research Center for Geosciences	Reichstein, M (corresponding author), Max Planck Inst Biogeochem, D-07745 Jena, Germany.	markus.reichstein@bgc-jena.mpg.de	Reichstein, Markus/A-7494-2011; Frank, David/C-7764-2013; Walz, Ariane/F-1517-2013; Beer, Christian/D-2296-2013; Mahecha, Miguel D/F-2443-2010; Ciais, Philippe/A-6840-2011; Seneviratne, Sonia I./G-8761-2011; Smith, Pete/G-1041-2010; van der Velde, Marijn/B-3305-2009; Bahn, Michael/I-3536-2013; Zscheischler, Jakob/ABE-7324-2021; Buchmann, Nina/E-6095-2011; Vicca, Sara/I-3637-2012; Papale, Dario/W-7302-2019; Wattenbach, Martin/D-1482-2013	Reichstein, Markus/0000-0001-5736-1112; Walz, Ariane/0000-0001-5616-4424; Beer, Christian/0000-0002-5377-3344; Mahecha, Miguel D/0000-0003-3031-613X; Ciais, Philippe/0000-0001-8560-4943; Seneviratne, Sonia I./0000-0001-9528-2917; Smith, Pete/0000-0002-3784-1124; van der Velde, Marijn/0000-0002-9103-7081; Bahn, Michael/0000-0001-7482-9776; Zscheischler, Jakob/0000-0001-6045-1629; Buchmann, Nina/0000-0003-0826-2980; Vicca, Sara/0000-0001-9812-5837; Papale, Dario/0000-0001-5170-8648; Frank, David/0000-0001-5463-5640; Rammig, Anja/0000-0001-5425-8718; Wattenbach, Martin/0000-0002-1843-1031	European Community [FP7-ENV-2008-1-226701]; Royal Society-Wolfson Research Merit Award; Austrian Science Fund (FWF) [P 22214] Funding Source: researchfish	European Community(European Commission); Royal Society-Wolfson Research Merit Award(Royal Society of London); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work emerged from the CARBO-Extreme project, funded by the European Community's Seventh Framework Programme under grant agreement (FP7-ENV-2008-1-226701). We acknowledge the World Climate Research Programme's Working Group on Coupled Modelling, which is responsible for CMIP, and we thank the climate modelling groups (listed in the reference annotation to ref. 4 of this paper) for producing and making available their model output. For CMIP the US Department of Energy's Program for Climate Model Diagnosis and Intercomparison provides coordinating support and led development of software infrastructure in partnership with the Global Organization for Earth System Science Portals. J.Z. is part of the International Max Planck Research School for Global Biogeochemical Cycles. P.S. is a Royal Society-Wolfson Research Merit Award holder. S.V. is a postdoctoral research associate of the Fund for Scientific Research-Flanders. M.B. acknowledges the Austrian Science Fund (FWF).	Adams H. D., 2010, EOS T AM GEOPHYS UN, V91, P153, DOI DOI 10.1029/2010EO170003; Adrian R, 2009, LIMNOL OCEANOGR, V54, P2283, DOI 10.4319/lo.2009.54.6_part_2.2283; Alencar A, 2006, EARTH INTERACT, V10; Allen CD, 2010, FOREST ECOL MANAG, V259, P660, DOI 10.1016/j.foreco.2009.09.001; Anderegg WRL, 2012, P NATL ACAD SCI USA, V109, P233, DOI 10.1073/pnas.1107891109; Aragao LEOC, 2007, GEOPHYS RES LETT, V34, DOI [10.1029/2006GL028946., 10.1029/2006GL028946]; Arnone JA, 2008, NATURE, V455, P383, DOI 10.1038/nature07296; Aubinet M, 2009, AGR FOREST METEOROL, V149, P407, DOI 10.1016/j.agrformet.2008.09.003; Babst F, 2012, ENVIRON RES LETT, V7, DOI 10.1088/1748-9326/7/4/045705; Baldocchi D., 2012, EOS T AM GEOPHYS UN, V93, P217, DOI [10.1029/2012EO230001, DOI 10.1029/2012EO230001]; Ballantyne AP, 2012, NATURE, V488, P70, DOI 10.1038/nature11299; Beier C, 2012, ECOL LETT, V15, P899, DOI 10.1111/j.1461-0248.2012.01793.x; Bigler C, 2007, OIKOS, V116, P1983, DOI 10.1111/j.2007.0030-1299.16034.x; Breda N, 2006, ANN FOREST SCI, V63, P625, DOI 10.1051/forest:2006042; Chambers JQ, 2007, SCIENCE, V318, P1107, DOI 10.1126/science.1148913; Changnon SA, 1999, B AM METEOROL SOC, V80, P1819, DOI 10.1175/1520-0477(1999)080<1819:IOENOG>2.0.CO;2; Changnon SA, 2003, J APPL METEOROL, V42, P630, DOI 10.1175/1520-0450(2003)042<0630:COISIT>2.0.CO;2; Chen GS, 2012, CLIMATIC CHANGE, V114, P379, DOI 10.1007/s10584-012-0410-z; Choat B, 2012, NATURE, V491, P752, DOI 10.1038/nature11688; Ciais P, 2005, NATURE, V437, P529, DOI 10.1038/nature03972; Coles S, 2001, INTRO STAT MODELING; Craine JM, 2012, P NATL ACAD SCI USA, V109, P3401, DOI 10.1073/pnas.1118438109; De Boeck HJ, 2011, BIOGEOSCIENCES, V8, P1121, DOI 10.5194/bg-8-1121-2011; De Boeck HJ, 2011, NEW PHYTOL, V189, P806, DOI 10.1111/j.1469-8137.2010.03515.x; de Vries FT, 2012, NAT CLIM CHANGE, V2, P276, DOI [10.1038/nclimate1368, 10.1038/NCLIMATE1368]; Dinsmore KJ, 2010, GLOBAL CHANGE BIOL, V16, P2750, DOI 10.1111/j.1365-2486.2009.02119.x; Fisher JI, 2008, ECOL LETT, V11, P554, DOI 10.1111/j.1461-0248.2008.01169.x; Friedlingstein P, 2006, J CLIMATE, V19, P3337, DOI 10.1175/JCLI3800.1; Fuhrer J, 2006, CLIMATIC CHANGE, V79, P79, DOI 10.1007/s10584-006-9106-6; Ghil M, 2011, NONLINEAR PROC GEOPH, V18, P295, DOI 10.5194/npg-18-295-2011; Gilgen AK, 2009, BIOGEOSCIENCES, V6, P2525, DOI 10.5194/bg-6-2525-2009; Goebel MO, 2011, GLOBAL CHANGE BIOL, V17, P2640, DOI 10.1111/j.1365-2486.2011.02414.x; Granier A, 2007, AGR FOREST METEOROL, V143, P123, DOI 10.1016/j.agrformet.2006.12.004; Gu L, 2008, BIOSCIENCE, V58, P253, DOI 10.1641/B580311; Heimann M, 2008, NATURE, V451, P289, DOI 10.1038/nature06591; Irland LC, 2000, SCI TOTAL ENVIRON, V262, P231, DOI 10.1016/S0048-9697(00)00525-8; Jentsch A, 2007, FRONT ECOL ENVIRON, V5, P365, DOI 10.1890/1540-9295(2007)5[365:ANGOCE]2.0.CO;2; Jung BJ, 2012, J HYDROL, V440, P90, DOI 10.1016/j.jhydrol.2012.03.030; Jung M, 2011, J GEOPHYS RES-BIOGEO, V116, DOI 10.1029/2010JG001566; Jung M, 2010, NATURE, V467, P951, DOI 10.1038/nature09396; Kanamori H, 2005, ANNU REV EARTH PL SC, V33, P195, DOI 10.1146/annurev.earth.33.092203.122626; Knapp AK, 2002, SCIENCE, V298, P2202, DOI 10.1126/science.1076347; Kurz WA, 2008, NATURE, V452, P987, DOI 10.1038/nature06777; Le Quere C, 2009, NAT GEOSCI, V2, P831, DOI 10.1038/ngeo689; Lewis SL, 2011, SCIENCE, V331, P554, DOI 10.1126/science.1200807; Lindroth A, 2009, GLOBAL CHANGE BIOL, V15, P346, DOI 10.1111/j.1365-2486.2008.01719.x; Lobell DB, 2012, NAT CLIM CHANGE, V2, P186, DOI [10.1038/nclimate1356, 10.1038/NCLIMATE1356]; Luyssaert S, 2012, BIOGEOSCIENCES, V9, P3357, DOI 10.5194/bg-9-3357-2012; Marcolla B, 2011, AGR FOREST METEOROL, V151, P1233, DOI 10.1016/j.agrformet.2011.04.015; Matsui T, 1997, FIELD CROP RES, V51, P213, DOI 10.1016/S0378-4290(96)03451-X; Moreira F, 2011, J ENVIRON MANAGE, V92, P2389, DOI 10.1016/j.jenvman.2011.06.028; Muhr J, 2009, GLOBAL CHANGE BIOL, V15, P782, DOI 10.1111/j.1365-2486.2008.01695.x; Negron-Juarez R, 2010, J GEOPHYS RES-BIOGEO, V115, DOI 10.1029/2009JG001221; Negron-Juarez RI, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL043733; Nepstad DC, 2007, ECOLOGY, V88, P2259, DOI 10.1890/06-1046.1; Niall S, 2005, INT J CLIMATOL, V25, P1933, DOI 10.1002/joc.1233; Page SE, 2002, NATURE, V420, P61, DOI 10.1038/nature01131; Page SE, 2011, GLOBAL CHANGE BIOL, V17, P798, DOI 10.1111/j.1365-2486.2010.02279.x; Pan YD, 2011, SCIENCE, V333, P988, DOI 10.1126/science.1201609; Paris J.-D., 2012, EGU GEN ASS C; Peters W, 2010, GLOBAL CHANGE BIOL, V16, P1317, DOI 10.1111/j.1365-2486.2009.02078.x; Phillips OL, 2009, SCIENCE, V323, P1344, DOI 10.1126/science.1164033; Porter JR, 2005, PHILOS T R SOC B, V360, P2021, DOI 10.1098/rstb.2005.1752; Quinton JN, 2010, NAT GEOSCI, V3, P311, DOI [10.1038/NGEO838, 10.1038/ngeo838]; Reichstein M, 2007, GLOBAL CHANGE BIOL, V13, P634, DOI 10.1111/j.1365-2486.2006.01224.x; Rosenzweig C, 2002, GLOBAL ENVIRON CHANG, V12, P197, DOI 10.1016/S0959-3780(02)00008-0; Sanchez JL, 1996, J APPL METEOROL, V35, P1535, DOI 10.1175/1520-0450(1996)035<1535:CDTHSF>2.0.CO;2; Scheffer M, 2001, NATURE, V413, P591, DOI 10.1038/35098000; Schiermeier Q, 2010, NATURE, V463, P284, DOI 10.1038/463284a; Schmidt MWI, 2011, NATURE, V478, P49, DOI 10.1038/nature10386; Schulze ED, 2000, SCIENCE, V289, P2058, DOI 10.1126/science.289.5487.2058; Schwalm CR, 2010, GLOBAL CHANGE BIOL, V16, P657, DOI 10.1111/j.1365-2486.2009.01991.x; Seneviratne SI, 2006, NATURE, V443, P205, DOI 10.1038/nature05095; Seneviratne SI, 2012, MANAGING THE RISKS OF EXTREME EVENTS AND DISASTERS TO ADVANCE CLIMATE CHANGE ADAPTATION, P109; Seneviratne SI, 2010, EARTH-SCI REV, V99, P125, DOI 10.1016/j.earscirev.2010.02.004; Simelton E, 2011, FOOD SECUR, V3, P35, DOI 10.1007/s12571-011-0114-7; Smit HJ, 2008, AGR SYST, V98, P208, DOI 10.1016/j.agsy.2008.07.004; Smith MD, 2011, J ECOL, V99, P656, DOI 10.1111/j.1365-2745.2011.01798.x; Smith MD, 2009, ECOLOGY, V90, P3279, DOI 10.1890/08-1815.1; SPERRY JS, 1992, PLANT PHYSIOL, V100, P605, DOI 10.1104/pp.100.2.605; Stevens B, 2009, NATURE, V461, P607, DOI 10.1038/nature08281; Sun Y, 2012, ENVIRON RES LETT, V7, DOI 10.1088/1748-9326/7/3/035702; Taylor KE, 2012, B AM METEOROL SOC, V93, P485, DOI 10.1175/BAMS-D-11-00094.1; van der Velde M, 2012, CLIMATIC CHANGE, V113, P751, DOI 10.1007/s10584-011-0368-2; van der Velde M, 2010, AGR ECOSYST ENVIRON, V135, P90, DOI 10.1016/j.agee.2009.08.017; van der Werf GR, 2010, ATMOS CHEM PHYS, V10, P11707, DOI 10.5194/acp-10-11707-2010; van der Werf GR, 2004, SCIENCE, V303, P73, DOI 10.1126/science.1090753; van Mantgem PJ, 2009, SCIENCE, V323, P521, DOI 10.1126/science.1165000; Van Oost K, 2007, SCIENCE, V318, P626, DOI 10.1126/science.1145724; Vicca S, 2012, NEW PHYTOL, V195, P518, DOI 10.1111/j.1469-8137.2012.04224.x; Wang XB, 2006, CATENA, V66, P221, DOI 10.1016/j.catena.2006.02.006; Wang YF, 2011, SCI TOTAL ENVIRON, V410, P182, DOI 10.1016/j.scitotenv.2011.09.067; Yu ZC, 2012, BIOGEOSCIENCES, V9, P4071, DOI 10.5194/bg-9-4071-2012; Zavalloni C, 2008, PLANT SOIL, V308, P119, DOI 10.1007/s11104-008-9612-6; Zeng HC, 2009, P NATL ACAD SCI USA, V106, P7888, DOI 10.1073/pnas.0808914106; Zhao YX, 2005, CLIMATIC CHANGE, V70, P73, DOI 10.1007/s10584-005-5938-8; Zheng BY, 2012, GLOBAL CHANGE BIOL, V18, P2899, DOI 10.1111/j.1365-2486.2012.02724.x; Zscheischler J, 2013, ECOL INFORM, V15, P66, DOI 10.1016/j.ecoinf.2013.03.004	99	1016	1070	125	1548	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	AUG 15	2013	500	7462					287	295		10.1038/nature12350	http://dx.doi.org/10.1038/nature12350			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201AF	23955228				2022-12-24	WOS:000323112400023
J	Israelsen, WJ; Dayton, TL; Davidson, SM; Fiske, BP; Hosios, AM; Bellinger, G; Li, J; Yu, YM; Sasaki, M; Horner, JW; Burga, LN; Xie, JX; Jurczak, MJ; DePinho, RA; Clish, CB; Jacks, T; Kibbey, RG; Wulf, GM; Di Vizio, D; Mills, GB; Cantley, LC; Vander Heiden, MG				Israelsen, William J.; Dayton, Talya L.; Davidson, Shawn M.; Fiske, Brian P.; Hosios, Aaron M.; Bellinger, Gary; Li, Jie; Yu, Yimin; Sasaki, Mika; Horner, James W.; Burga, Laura N.; Xie, Jianxin; Jurczak, Michael J.; DePinho, Ronald A.; Clish, Clary B.; Jacks, Tyler; Kibbey, Richard G.; Wulf, Gerburg M.; Di Vizio, Dolores; Mills, Gordon B.; Cantley, Lewis C.; Vander Heiden, Matthew G.			PKM2 Isoform-Specific Deletion Reveals a Differential Requirement for Pyruvate Kinase in Tumor Cells	CELL			English	Article							GENE-TRANSCRIPTION; HNRNP PROTEINS; M2 ISOFORM; CANCER; GROWTH; METABOLISM; PROMOTES; ACTIVATION; MICE; PHOSPHORYLATION	The pyruvate kinase M2 isoform (PKM2) is expressed in cancer and plays a role in regulating anabolic metabolism. To determine whether PKM2 is required for tumor formation or growth, we generated mice with a conditional allele that abolishes PKM2 expression without disrupting PKM1 expression. PKM2 deletion accelerated mammary tumor formation in a Brca1-loss-driven model of breast cancer. PKM2 null tumors displayed heterogeneous PKM1 expression, with PKM1 found in nonproliferating tumor cells and no detectable pyruvate kinase expression in proliferating cells. This suggests that PKM2 is not necessary for tumor cell proliferation and implies that the inactive state of PKM2 is associated with the proliferating cell population within tumors, whereas nonproliferating tumor cells require active pyruvate kinase. Consistent with these findings, variable PKM2 expression and heterozygous PKM2 mutations are found in human tumors. These data suggest that regulation of PKM2 activity supports the different metabolic requirements of proliferating and nonproliferating tumor cells.	[Israelsen, William J.; Dayton, Talya L.; Davidson, Shawn M.; Fiske, Brian P.; Hosios, Aaron M.; Bellinger, Gary; Yu, Yimin; Jacks, Tyler; Vander Heiden, Matthew G.] MIT, Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA; [Li, Jie; Mills, Gordon B.] Univ Texas MD Anderson Canc Ctr, Dept Syst Biol, Houston, TX 77030 USA; [Sasaki, Mika; Burga, Laura N.; Wulf, Gerburg M.; Cantley, Lewis C.] Beth Israel Deaconess Med Ctr, Div Signal Transduct, Dept Med, Boston, MA 02115 USA; [Horner, James W.; DePinho, Ronald A.; Vander Heiden, Matthew G.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Xie, Jianxin] Cell Signaling Technol, Danvers, MA 01923 USA; [Jurczak, Michael J.; Kibbey, Richard G.] Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06510 USA; [Clish, Clary B.] Broad Inst, Cambridge, MA 02142 USA; [Kibbey, Richard G.] Yale Univ, Sch Med, Dept Cellular & Mol Physiol, New Haven, CT 06510 USA; [Di Vizio, Dolores] Cedars Sinai Med Ctr, Div Canc Biol & Therapeut, Los Angeles, CA 90048 USA; [Di Vizio, Dolores] Boston Childrens Hosp, Urol Dis Res Ctr, Boston, MA 02115 USA; [Di Vizio, Dolores] Harvard Univ, Sch Med, Dept Surg, Boston, MA 02115 USA; [Cantley, Lewis C.] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA	Massachusetts Institute of Technology (MIT); University of Texas System; UTMD Anderson Cancer Center; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Dana-Farber Cancer Institute; Yale University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Yale University; Cedars Sinai Medical Center; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Vander Heiden, MG (corresponding author), MIT, Koch Inst Integrat Canc Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	mvh@mit.edu	Clish, Clary/AAB-7124-2019; Clish, Clary B/ABB-9374-2021; Burga, Laura/AAT-9385-2020; Cantley, Lewis C/D-1800-2014; Wulf, Gerburg/AAS-6713-2021	Clish, Clary B/0000-0001-8259-9245; Cantley, Lewis C/0000-0002-1298-7653; Israelsen, William/0000-0002-3653-9353; DePinho, Ronald/0000-0002-5625-577X; Dayton, Talya/0000-0002-7994-7963; Jurczak, Michael/0000-0002-6335-6915; Fiske, Brian/0000-0001-5891-4268	NIH [R01CA168653, 5P01CA117969, P30CA147882, 5P30CA14051, 5K08CA136983, DK059635, R01DK092606, R00CA131472, R01GM056203]; ADA grant [7-12-BS-09]; Belfer Foundation; Smith Family Foundation; Burroughs Wellcome Fund; Damon Runyon Cancer Research Foundation; Stern family; NATIONAL CANCER INSTITUTE [P30CA016672, P30CA147882, K08CA136983, P50CA098258, P30CA014051, P01CA117969, R00CA131472, R01CA168653] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U2CDK059635, R01DK092606, U24DK059635] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056203] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ADA grant; Belfer Foundation; Smith Family Foundation; Burroughs Wellcome Fund(Burroughs Wellcome Fund); Damon Runyon Cancer Research Foundation; Stern family; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Chu-Xia Deng for sharing the BRCA1 mouse model; Luigi Terracciano and Luigi Tornillo for providing the multitissue TMA; and Cynthia Clower, Sarah-Maria Fendt, Andrea J. Howell, Vivian M. Liu, Sophia Lunt, Katherine R. Mattaini, Benjamin A. Olenchock, and Kerry Pierce for technical assistance. Eric L. Bell provided advice and reagents. Denise G. Crowley, Michael Brown, and Kathleen S. Cormier assisted with histology. This work was supported, in part, by NIH grants R01CA168653, 5P01CA117969, P30CA147882, 5P30CA14051, 5K08CA136983, DK059635, R01DK092606, R00CA131472, and R01GM056203 and ADA grant 7-12-BS-09. R.A.D. and J.W.H. acknowledge support from the Belfer Foundation. M.G.V.H. acknowledges additional support from the Smith Family Foundation, the Burroughs Wellcome Fund, the Damon Runyon Cancer Research Foundation, and the Stern family. C.B.C. is a shareholder in Agios Pharmaceuticals. M.G.V.H. is a shareholder and Scientific Advisory Board member at Agios Pharmaceuticals. L.C.C. owns equity in and receives compensation from Agios Pharmaceuticals and serves on the Board of Directors and Scientific Advisory Board.	Allali-Hassani A, 2009, BIOCHEM J, V424, P15, DOI 10.1042/BJ20090723; Anastasiou D, 2012, NAT CHEM BIOL, V8, P839, DOI 10.1038/NCHEMBIO.1060; Anastasiou D, 2011, SCIENCE, V334, P1278, DOI 10.1126/science.1211485; Ayala JE, 2010, DIS MODEL MECH, V3, P525, DOI 10.1242/dmm.006239; Baumhoer D, 2008, AM J CLIN PATHOL, V129, P899, DOI 10.1309/HCQWPWD50XHD2DW6; Cairns RA, 2011, NAT REV CANCER, V11, P85, DOI 10.1038/nrc2981; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Chaneton B, 2012, NATURE, V491, P458, DOI 10.1038/nature11540; Chaneton B, 2012, TRENDS BIOCHEM SCI, V37, P309, DOI 10.1016/j.tibs.2012.04.003; Chen M, 2012, NAT STRUCT MOL BIOL, V19, P346, DOI 10.1038/nsmb.2219; Christofk HR, 2008, NATURE, V452, P230, DOI 10.1038/nature06734; Christofk HR, 2008, NATURE, V452, P181, DOI 10.1038/nature06667; Clower CV, 2010, P NATL ACAD SCI USA, V107, P1894, DOI 10.1073/pnas.0914845107; Commisso C, 2013, NATURE, V497, P633, DOI 10.1038/nature12138; Cortes-Cros M, 2013, P NATL ACAD SCI USA, V110, P489, DOI 10.1073/pnas.1212780110; David CJ, 2010, NATURE, V463, P364, DOI 10.1038/nature08697; Dombrauckas JD, 2005, BIOCHEMISTRY-US, V44, P9417, DOI 10.1021/bi0474923; Gao XL, 2012, MOL CELL, V45, P598, DOI 10.1016/j.molcel.2012.01.001; Goldberg MS, 2012, J EXP MED, V209, P217, DOI 10.1084/jem.20111487; Heiden MGV, 2010, SCIENCE, V329, P1492, DOI 10.1126/science.1188015; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hitosugi T, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000431; IMAMURA K, 1972, J BIOCHEM-TOKYO, V71, P1043, DOI 10.1093/oxfordjournals.jbchem.a129852; Jain M, 2012, SCIENCE, V336, P1040, DOI 10.1126/science.1218595; Jurczak MJ, 2012, J BIOL CHEM, V287, P2558, DOI 10.1074/jbc.M111.316760; Keller KE, 2012, SCIENCE, V338, P1069, DOI 10.1126/science.1224409; Liang H, 2012, GENOME RES, V22, P2120, DOI 10.1101/gr.137596.112; Luo WB, 2011, CELL, V145, P732, DOI 10.1016/j.cell.2011.03.054; Lv L, 2011, MOL CELL, V42, P719, DOI 10.1016/j.molcel.2011.04.025; Maquat LE, 2004, NAT REV MOL CELL BIO, V5, P89, DOI 10.1038/nrm1310; Mazurek S, 2011, INT J BIOCHEM CELL B, V43, P969, DOI 10.1016/j.biocel.2010.02.005; NOGUCHI T, 1986, J BIOL CHEM, V261, P3807; Parnell KM, 2013, MOL CANCER THER, V12, P1453, DOI 10.1158/1535-7163.MCT-13-0026; Schraml P, 1999, CLIN CANCER RES, V5, P1966; Sonveaux P, 2008, J CLIN INVEST, V118, P3930, DOI 10.1172/JCI36843; Vander Heiden MG, 2001, MOL CELL BIOL, V21, P5899, DOI 10.1128/MCB.21.17.5899-5912.2001; Varghese B, 2010, MOL ENDOCRINOL, V24, P2356, DOI 10.1210/me.2010-0219; VAUPEL P, 1989, CANCER RES, V49, P6449; Wang ZX, 2012, J MOL CELL BIOL, V4, P79, DOI 10.1093/jmcb/mjr030; Xu XL, 1999, NAT GENET, V22, P37, DOI 10.1038/8743; Yang WW, 2012, NAT CELL BIOL, V14, P1295, DOI 10.1038/ncb2629; Yang WW, 2012, CELL, V150, P685, DOI 10.1016/j.cell.2012.07.018; Yang WW, 2011, NATURE, V480, P118, DOI 10.1038/nature10598	43	345	358	4	85	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 10	2013	155	2					397	409		10.1016/j.cell.2013.09.025	http://dx.doi.org/10.1016/j.cell.2013.09.025			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	235LH	24120138	Green Accepted, Bronze, Green Published			2022-12-24	WOS:000325719800016
J	Sanjuan-Pla, A; Macaulay, IC; Jensen, CT; Woll, PS; Luis, TC; Mead, A; Moore, S; Carella, C; Matsuoka, S; Jones, TB; Chowdhury, O; Stenson, L; Lutteropp, M; Green, JCA; Facchini, R; Boukarabila, H; Grover, A; Gambardella, A; Thongjuea, S; Carrelha, J; Tarrant, P; Atkinson, D; Clark, SA; Nerlov, C; Jacobsen, SEW				Sanjuan-Pla, Alejandra; Macaulay, Iain C.; Jensen, Christina T.; Woll, Petter S.; Luis, Tiago C.; Mead, Adam; Moore, Susan; Carella, Cintia; Matsuoka, Sahoko; Jones, Tiphaine Bouriez; Chowdhury, Onima; Stenson, Laura; Lutteropp, Michael; Green, Joanna C. A.; Facchini, Raffaella; Boukarabila, Hanane; Grover, Amit; Gambardella, Adriana; Thongjuea, Supat; Carrelha, Joana; Tarrant, Paul; Atkinson, Deborah; Clark, Sally-Ann; Nerlov, Claus; Jacobsen, Sten Eirik W.			Platelet-biased stem cells reside at the apex of the haematopoietic stem-cell hierarchy	NATURE			English	Article							SELF-RENEWAL; IN-VIVO; DIFFERENTIATION; THROMBOPOIETIN; RECONSTITUTION; HETEROGENEITY; PROGENITORS; GENERATION	The blood system is maintained by a small pool of haematopoietic stem cells (HSCs), which are required and sufficient for replenishing all human blood cell lineages at millions of cells per second throughout life. Megakaryocytes in the bone marrow are responsible for the continuous production of platelets in the blood, crucial for preventing bleeding-a common and life-threatening side effect of many cancer therapies-and major efforts are focused at identifying the most suitable cellular and molecular targets to enhance platelet production after bone marrow transplantation or chemotherapy(1). Although it has become clear that distinct HSC subsets exist that are stably biased towards the generation of lymphoid or myeloid blood cells(2-4), we are yet to learn whether other types of lineage-biased HSC exist or understand their inter-relationships and how differently lineage-biased HSCs are generated and maintained. The functional relevance of notable phenotypic and molecular similarities between megakaryocytes and bone marrow cells with an HSC cell-surface phenotype(5-8) remains unclear. Here we identify and prospectively isolate a molecularly and functionally distinct mouse HSC subset primed for platelet-specific gene expression, with enhanced propensity for short-and long-term reconstitution of platelets. Maintenance of platelet-biased HSCs crucially depends on thrombopoietin, the primary extrinsic regulator of platelet development(9). Platelet-primed HSCs also frequently have a long-term myeloid lineage bias, can self-renew and give rise to lymphoid-biased HSCs. These findings show that HSC subtypes can be organized into a cellular hierarchy, with platelet-primed HSCs at the apex. They also demonstrate that molecular and functional priming for platelet development initiates already in a distinct HSC population. The identification of a platelet-primed HSC population should enable the rational design of therapies enhancing platelet output.	[Sanjuan-Pla, Alejandra; Moore, Susan; Nerlov, Claus] Univ Edinburgh, Inst Stem Cell Res, Edinburgh EH9 16UU, Midlothian, Scotland; [Sanjuan-Pla, Alejandra; Moore, Susan; Nerlov, Claus] Univ Edinburgh, MRC Ctr Regenerat Med, Edinburgh EH9 16UU, Midlothian, Scotland; [Sanjuan-Pla, Alejandra; Moore, Susan; Carella, Cintia; Nerlov, Claus] EMBL Mouse Biol Program, I-00015 Monterotondo, Italy; [Macaulay, Iain C.; Jensen, Christina T.; Woll, Petter S.; Luis, Tiago C.; Mead, Adam; Matsuoka, Sahoko; Jones, Tiphaine Bouriez; Chowdhury, Onima; Stenson, Laura; Lutteropp, Michael; Green, Joanna C. A.; Facchini, Raffaella; Boukarabila, Hanane; Grover, Amit; Gambardella, Adriana; Thongjuea, Supat; Carrelha, Joana; Tarrant, Paul; Atkinson, Deborah; Clark, Sally-Ann; Nerlov, Claus; Jacobsen, Sten Eirik W.] Univ Oxford, Weatherall Inst Mol Med, MRC Mol Haematol Unit, Oxford OX3 9DS, England; [Macaulay, Iain C.; Jensen, Christina T.; Woll, Petter S.; Luis, Tiago C.; Mead, Adam; Matsuoka, Sahoko; Jones, Tiphaine Bouriez; Chowdhury, Onima; Stenson, Laura; Lutteropp, Michael; Green, Joanna C. A.; Facchini, Raffaella; Boukarabila, Hanane; Carrelha, Joana; Tarrant, Paul; Atkinson, Deborah; Clark, Sally-Ann; Jacobsen, Sten Eirik W.] Univ Oxford, Weatherall Inst Mol Med, Haematopoiet Stem Cell Biol Lab, Oxford OX3 9DS, England	University of Edinburgh; University of Edinburgh; European Molecular Biology Laboratory (EMBL); University of Oxford; University of Oxford	Jacobsen, SEW (corresponding author), Univ Oxford, Weatherall Inst Mol Med, MRC Mol Haematol Unit, Oxford OX3 9DS, England.	claus.nerlov@imm.ox.ac.uk; sten.jacobsen@imm.ox.ac.uk	Jacobsen, Sten Eirik W/D-3974-2018; Sanjuan-Pla, Alejandra/GRX-9588-2022; Mead, Adam/A-8796-2012; carella, Cintia/K-3227-2018	Jacobsen, Sten Eirik W/0000-0002-1362-3659; Sanjuan-Pla, Alejandra/0000-0002-0170-5542; Mead, Adam/0000-0001-8522-1002; carella, Cintia/0000-0001-9557-3300; Carrelha, Joana/0000-0002-0324-2617; Facchini, Raffaella/0000-0002-6026-6893; Woll, Petter S./0000-0002-2340-2526; Cunha Luis, Tiago/0000-0002-6305-1257; Thongjuea, Supat/0000-0002-9129-4694; Macaulay, Iain/0000-0002-6761-757X	Medical Research Council, UK [H4RPLK0]; MRC; European Commission; Association for International Cancer Research; Spanish Ministry of Education and Science; Medical Research Council [G84/6443, G0900892, G0700711B, G0801073, MC_UU_12009/7, MC_PC_12020, G0501838, G0701761, MC_UU_12009/5] Funding Source: researchfish; MRC [MC_UU_12009/7, G0501838, G0801073, G0900892, G84/6443, MC_UU_12009/5, MC_PC_12020, G0701761] Funding Source: UKRI	Medical Research Council, UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Commission(European CommissionEuropean Commission Joint Research Centre); Association for International Cancer Research; Spanish Ministry of Education and Science(Spanish Government); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The authors thank the Biomedical Services at Oxford University, B. Wu and H. Ferry for technical assistance, and M. Jose Fernandez Nestosa, S. Luc and N. Buza-Vidas for discussions and experimental contributions. This work was supported by the Medical Research Council, UK Grant H4RPLK0 (to S.E.W.J.) and an MRC Program Grant and Strategic Award (to C. N.), by the European Commission FP7 CardioCell (to C. N.) and EuroSyStem (to S.E.W.J.) projects, and by the Association for International Cancer Research (to C. N.). A. S.-P. was supported by a postdoctoral BEOI fellowship from the Spanish Ministry of Education and Science.	Adolfsson J, 2005, CELL, V121, P295, DOI 10.1016/j.cell.2005.02.013; Akashi K, 2003, BLOOD, V101, P383, DOI 10.1182/blood-2002-06-1780; Benveniste P, 2010, CELL STEM CELL, V6, P48, DOI 10.1016/j.stem.2009.11.014; Bereshchenko O, 2009, CANCER CELL, V16, P390, DOI 10.1016/j.ccr.2009.09.036; Copley MR, 2012, CELL STEM CELL, V10, P690, DOI 10.1016/j.stem.2012.05.006; Denis C, 1998, P NATL ACAD SCI USA, V95, P9524, DOI 10.1073/pnas.95.16.9524; deSauvage FJ, 1996, J EXP MED, V183, P651, DOI 10.1084/jem.183.2.651; Dykstra B, 2007, CELL STEM CELL, V1, P218, DOI 10.1016/j.stem.2007.05.015; Forsberg EC, 2006, STEM CELL REV, V2, P23, DOI 10.1007/s12015-006-0005-z; Gekas C, 2013, BLOOD, V121, P4463, DOI 10.1182/blood-2012-09-457929; Goodell MA, 1996, J EXP MED, V183, P1797, DOI 10.1084/jem.183.4.1797; Huang H, 2009, J CELL BIOCHEM, V107, P857, DOI 10.1002/jcb.22184; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Kent DG, 2009, BLOOD, V113, P6342, DOI 10.1182/blood-2008-12-192054; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Luc S, 2012, NAT IMMUNOL, V13, P412, DOI 10.1038/ni.2255; Mansson R, 2007, IMMUNITY, V26, P407, DOI 10.1016/j.immuni.2007.02.013; Moreira Pedro N., 2006, V349, P151; Morita Y, 2010, J EXP MED, V207, P1173, DOI 10.1084/jem.20091318; Muller-Sieburg CE, 2002, BLOOD, V100, P1302, DOI 10.1182/blood.V100.4.1302.h81602001302_1302_1309; Nash RA, 1996, ONCOLOGIST, V1, P371; Osawa M, 1996, SCIENCE, V273, P242, DOI 10.1126/science.273.5272.242; Pronk CJH, 2007, CELL STEM CELL, V1, P428, DOI 10.1016/j.stem.2007.07.005; Qian H, 2007, CELL STEM CELL, V1, P671, DOI 10.1016/j.stem.2007.10.008; Shimazu T, 2012, BLOOD, V119, P4889, DOI 10.1182/blood-2011-10-388736; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Yoshihara H, 2007, CELL STEM CELL, V1, P685, DOI 10.1016/j.stem.2007.10.020	28	363	374	1	35	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 10	2013	502	7470					232	+		10.1038/nature12495	http://dx.doi.org/10.1038/nature12495			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231RU	23934107				2022-12-24	WOS:000325436100050
J	Erkens, GB; Hanelt, I; Goudsmits, JMH; Slotboom, DJ; van Oijen, AM				Erkens, Guus B.; Hanelt, Inga; Goudsmits, Joris M. H.; Slotboom, Dirk Jan; van Oijen, Antoine M.			Unsynchronised subunit motion in single trimeric sodium-coupled aspartate transporters	NATURE			English	Article							PYROCOCCUS-HORIKOSHII; INDIVIDUAL SUBUNITS; IMAGE REGISTRATION; HOMOLOG; DYNAMICS; CONDUCTANCE; TRANSLATION; SUBSTRATE; GLT(PH)	Excitatory amino acid transporters (EAATs) are secondary transport proteins that mediate the uptake of glutamate and other amino acids(1). EAATs fulfil an important role in neuronal signal transmission by clearing the excitatory neurotransmitters from the synaptic cleft after depolarization of the postsynaptic neuron. An intensively studied model system for understanding the transport mechanism of EAATs is the archaeal aspartate transporter Glt(Ph)(2-6). Each subunit in the homotrimeric Glt(Ph) supports the coupled translocation of one aspartate molecule and three Na+ ions(2) as well as an uncoupled flux of Cl- ions(7). Recent crystal structures of Glt(Ph)(3,5,6,8) revealed three possible conformations for the subunits, but it is unclear whether the motions of individual subunits are coordinated to support transport. Here, we report the direct observation of conformational dynamics in individual Glt(Ph) trimers embedded in the membrane by applying single-molecule fluorescence resonance energy transfer (FRET). By analysing the transporters in a lipid bilayer instead of commonly used detergent micelles, we achieve conditions that approximate the physiologically relevant ones. From the kinetics of FRET level transitions we conclude that the three Glt(Ph) subunits undergo conformational changes stochastically and independently of each other.	[Erkens, Guus B.; Hanelt, Inga; Goudsmits, Joris M. H.; Slotboom, Dirk Jan; van Oijen, Antoine M.] Univ Groningen, Zernike Inst Adv Mat, NL-9747 AG Groningen, Netherlands; [Hanelt, Inga; Slotboom, Dirk Jan; van Oijen, Antoine M.] Univ Groningen, Groningen Biomol Sci & Biotechnol Inst, NL-9747 AG Groningen, Netherlands; [Slotboom, Dirk Jan; van Oijen, Antoine M.] Univ Groningen, Ctr Synthet Biol, NL-9747 AG Groningen, Netherlands	University of Groningen; University of Groningen; University of Groningen	van Oijen, AM (corresponding author), Univ Groningen, Zernike Inst Adv Mat, Nijenborgh 4, NL-9747 AG Groningen, Netherlands.	d.j.slotboom@rug.nl; a.m.van.oijen@rug.nl	van Oijen, Antoine/I-3167-2014; Hänelt, Inga/N-2982-2016; Institute, Zernike/W-7033-2019	van Oijen, Antoine/0000-0002-1794-5161; Hänelt, Inga/0000-0003-1495-3163; 	Netherlands Organization for Scientific Research (NWO) [Vici 680-47-607, Vidi 700.54.423, Vici 865.11.001]; European Research Council (ERC Starting) [281098]; European Research Council (ERC) [282083]; Deutsche Forschungsgemeinschaft [HA 6322/1-1]	Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); European Research Council (ERC Starting); European Research Council (ERC)(European Research Council (ERC)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	The authors would like to thank M. Punter for developing software and algorithms for data analysis, V. Krasnikov for his help with the design, construction and maintenance of the single-molecule fluorescence microscopes and I. Kusters for sharing experience on liposome tethering and single-molecule imaging of membrane proteins. A.M.v.O. acknowledges funding from the Netherlands Organization for Scientific Research (NWO; Vici 680-47-607) and the European Research Council (ERC Starting 281098). D.J.S. acknowledges funding from the Netherlands Organization for Scientific Research (NWO; Vidi 700.54.423, Vici 865.11.001) and the European Research Council (ERC Starting 282083). I. H. acknowledges the Deutsche Forschungsgemeinschaft (HA 6322/1-1) for providing funding.	Akyuz N., 2013, NATURE; Blanchard SC, 2004, P NATL ACAD SCI USA, V101, P12893, DOI 10.1073/pnas.0403884101; Boudker O, 2007, NATURE, V445, P387, DOI 10.1038/nature05455; Cordes T, 2009, J AM CHEM SOC, V131, P5018, DOI 10.1021/ja809117z; Dorwart MR, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000555; Floyd DL, 2010, BIOPHYS J, V99, P360, DOI 10.1016/j.bpj.2010.04.049; Georgieva ER, 2013, NAT STRUCT MOL BIOL, V20, P215, DOI 10.1038/nsmb.2494; Grewer C, 2005, BIOCHEMISTRY-US, V44, P11913, DOI 10.1021/bi050987n; Groeneveld M, 2010, BIOCHEMISTRY-US, V49, P3511, DOI 10.1021/bi100430s; Guizar-Sicairos M, 2008, OPT LETT, V33, P156, DOI 10.1364/OL.33.000156; Hanelt I, 2013, NAT STRUCT MOL BIOL, V20, P210, DOI 10.1038/nsmb.2471; Hedde PN, 2009, NAT METHODS, V6, P689, DOI 10.1038/nmeth1009-689; Joo C, 2008, ANNU REV BIOCHEM, V77, P51, DOI 10.1146/annurev.biochem.77.070606.101543; Kanner BI, 2008, CHEM REV, V108, P1654, DOI 10.1021/cr078246a; Kapanidis AN, 2005, ACCOUNTS CHEM RES, V38, P523, DOI 10.1021/ar0401348; Koch HP, 2007, J NEUROSCI, V27, P2943, DOI 10.1523/JNEUROSCI.0118-07.2007; Koch HP, 2005, J NEUROSCI, V25, P1730, DOI 10.1523/JNEUROSCI.4138-04.2005; Reddy BS, 1996, IEEE T IMAGE PROCESS, V5, P1266, DOI 10.1109/83.506761; Reyes N, 2009, NATURE, V462, P880, DOI 10.1038/nature08616; Ryan RM, 2007, NAT STRUCT MOL BIOL, V14, P365, DOI 10.1038/nsmb1230; Ryan RM, 2009, J BIOL CHEM, V284, P17540, DOI 10.1074/jbc.M109.005926; Tanner NA, 2010, METHOD ENZYMOL, V475, P259, DOI 10.1016/S0076-6879(10)75011-4; van der Heide T, 2000, P NATL ACAD SCI USA, V97, P7102, DOI 10.1073/pnas.97.13.7102; Verdon G, 2012, NAT STRUCT MOL BIOL, V19, P355, DOI 10.1038/nsmb.2233; Verhalen B, 2012, J BIOL CHEM, V287, P1112, DOI 10.1074/jbc.M111.301192; Yernool D, 2004, NATURE, V431, P811, DOI 10.1038/nature03018; Zhao YF, 2011, NATURE, V474, P109, DOI 10.1038/nature09971; Zhao YF, 2010, NATURE, V465, P188, DOI 10.1038/nature09057	28	95	95	0	73	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 3	2013	502	7469					119	+		10.1038/nature12538	http://dx.doi.org/10.1038/nature12538			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	227IM	24091978				2022-12-24	WOS:000325106000043
J	Helmstaedter, M; Briggman, KL; Turaga, SC; Jain, V; Seung, HS; Denk, W				Helmstaedter, Moritz; Briggman, Kevin L.; Turaga, Srinivas C.; Jain, Viren; Seung, H. Sebastian; Denk, Winfried			Connectomic reconstruction of the inner plexiform layer in the mouse retina	NATURE			English	Article							GANGLION-CELLS; BIPOLAR CELLS; DIRECTION-SELECTIVITY; ELECTRON-MICROSCOPY; AMACRINE CELLS; SYNAPTIC CONNECTIONS; RABBIT RETINA; MICROCIRCUITRY; CIRCUIT; MORPHOLOGIES	Comprehensive high-resolution structural maps are central to functional exploration and understanding in biology. For the nervous system, in which high resolution and large spatial extent are both needed, such maps are scarce as they challenge data acquisition and analysis capabilities. Here we present for the mouse inner plexiform layer-the main computational neuropil region in the mammalian retina-the dense reconstruction of 950 neurons and their mutual contacts. This was achieved by applying a combination of crowd-sourced manual annotation and machine-learning-based volume segmentation to serial block-face electron microscopy data. We characterize a new type of retinal bipolar interneuron and show that we can subdivide a known type based on connectivity. Circuit motifs that emerge from our data indicate a functional mechanism for a known cellular response in a ganglion cell that detects localized motion, and predict that another ganglion cell is motion sensitive.	[Helmstaedter, Moritz; Briggman, Kevin L.; Denk, Winfried] Max Planck Inst Med Res, D-69120 Heidelberg, Germany; [Turaga, Srinivas C.; Jain, Viren; Seung, H. Sebastian] MIT, Howard Hughes Med Inst, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA	Max Planck Society; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT)	Helmstaedter, M (corresponding author), Max Planck Inst Neurobiol, D-82152 Martinsried, Germany.	mhelmstaedter@neuro.mpg.de		Turaga, Srinivas/0000-0003-3247-6487	Max-Planck Society; DFG; Gatsby Charitable Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [ZIANS003133] Funding Source: NIH RePORTER	Max-Planck Society(Max Planck SocietyFoundation CELLEX); DFG(German Research Foundation (DFG)); Gatsby Charitable Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank J. Diamond, T. Euler, R. Masland, M. Meister and J. Sanes for discussions, J. Kornfeld and F. Svara for programming and continually improving KNOSSOS, M. Muller and J. Tritthardt for programming and building instrumentation, C. Roome for IT support, and A. Borst, M. Fee, T. Gollisch and A. Karpova for comments on the manuscript. We especially thank F. Isensee for help with synapse identification. We thank P. Bastians, A. Biasotto, F. Drawitsch, H. Falk, A. Gable, M. Grohmann, A. Gabelein, J. Hanne, F. Isensee, H. Jakobi, M. Kotchourko, E. Moller, J. Pollmann, C. Rohrig, A. Rommerskirchen, L. Schreiber, C. Willburger, H. Wissler and J. Youm for reconstruction management and annotator training, and N. Abazova, S. Abele, O. Aderhold, C. Altburger, T. Amberger, K. Aninditha, A. Antunes, E. Atsiatorme, H. Augenstein, I. Bartsch, I. Barz, P. Bastians, J. Bauer, H. Bauersachs, R. Bay, J. Becker, M. Beez, S. Bender, M. Berberich, I. Bertlich, J. Bewersdorf, A. Biasotto, P. Biti, M. Bittmann, K. Bretzel, J. Briegel, E. Buckler, A. Buntjer, C. Burkhardt, S. Buhler, S. Daum, N. Demir, E. Demirel, S. Dettmer, M. Diemer, J. Dietrich, S. Dittrich, C. Domnick, F. Drawitsch, C. Eck, L. Ehm, S. Ehrhardt, T. Eliguezel, K. Ernst, O. Eryilmaz, F. Euler, H. Falk, K. Fischer, K. Foerster, R. Foitzik, A. Foltin, R. Foltin, S. Freiss, A. Gable, P. Gallandi, K. Garbe, A. Gebhardt, F. Gebhart, S. Gottwalt, A. Greis, M. Grohmann, A. Gromann, S. Grobner, E. Grun, M. Grun, K. Guo, A. Gabelein, K. Haase, J. Hammerich, J. Hanne, B. Hauber, M. Hensen, F. Hentzschel, M. Herberz, M. Heumannskamper, C. Hilbert, L. Hofmann, P. Hofmann, T. Hondrich, U. Hausler, M. Horeth, J. Hugle, F. Isensee, A. Ivanova, F. Jahnke, H. Jakobi, M. Joel, M. Jonczyk, A. Joschko, A. Junger, K. Kappler, S. Kaspar, C. Kehrel, J. Kern, K. Kessler, S. Khoury, M. Kiapes, M. Kirchberger, A. Klein, C. Klein, S. Klein, J. Kratzer, C. Kraut, P. Kremer, P. Kretzer, F. Kroller, D. Kruger, M. Kuderer, S. Kull, S. Kwakman, S. Laiouar, L. Lebelt, H. Lesch, R. Lichtenberger, J. Liermann, C. Lieven, J. Lin, B. Linser, S. Lorger, J. Lott, D. Luft, L. Lust, J. Loffler, C. Marschall, B. Martin, D. Maton, B. Mayer, S. Mayorca, de. Ituarte, M. Meleux, C. Meyer, M. Moll, T. Moll, L. Mroszewski, E. Moller, M. Muller, L. Munster, N. Nasresfahani, J. Nassal, M. Neuschwanger, C. Nguyen, J. Nguyen, N. Nitsche, S. Oberrauch, F. Obitz, D. Ollech, C. Orlik, T. Otolski, S. Oumohand, A. Palfi, J. Pesch, M. Pfarr, S. Pfarr, M. Pohrath, J. Pollmann, M. Prokscha, S. Putzke, E. Rachmad, M. Reichert, J. Reinhardt, M. Reitz, J. Remus, M. Richter, M. Richter, J. Ricken, N. Rieger, F. Rodriguez. Jahnke, A. Rommerskirchen, M. Roth, I. Rummer, J. Ratzer, C. Rohrig, J. Rother, V. Saratov, E. Sauter, T. Schackel, M. Schamberger, M. Scheller, J. Schied, M. Schiedeck, J. Schiele, K. Schleich, M. Schlosser, S. Schmidt, C. Schneeweis, K. Schramm, M. Schramm, L. Schreiber, D. Schwarz, A. Schurholz, L. Schutz, A. Seitz, C. Sellmann, E. Serger, J. Sieber, L. Silbermann, I. Sonntag, T. Speck, Y. Sohngen, T. Tannig, N. Tisch, V. Tran, J. Trendel, M. Uhrig, D. Vecsei, F. Viehweger, V. Viehweger, R. Vogel, A. Vogel, J. Volz, P. Weber, K. Wegmeyer, J. Wiederspohn, E. Wiegand, R. Wiggers, C. Willburger, H. Wissler, V. Wissdorf, S. Worner, J. Youm, A. Zegarra, J. Zeilfelder, F. Zickgraf and T. Ziegler for cell reconstruction. This work was supported by the Max-Planck Society and the DFG (Leibniz prize to W.D.). H.S.S. is grateful for support from the Gatsby Charitable Foundation.	AMTHOR FR, 1989, J COMP NEUROL, V280, P97, DOI 10.1002/cne.902800108; AMTHOR FR, 1984, BRAIN RES, V298, P187, DOI 10.1016/0006-8993(84)91167-3; Andres B, 2012, LECT NOTES COMPUT SC, V7574, P778, DOI 10.1007/978-3-642-33712-3_56; Asari H, 2012, NAT NEUROSCI, V15, P1581, DOI 10.1038/nn.3241; Badea TC, 2004, J COMP NEUROL, V480, P331, DOI 10.1002/cne.20304; Binding J, 2013, MICROSC MICROANAL, V19, P38, DOI 10.1017/S1431927612013852; Binzegger T, 2004, J NEUROSCI, V24, P8441, DOI 10.1523/JNEUROSCI.1400-04.2004; Briggman KL, 2012, CURR OPIN NEUROBIOL, V22, P154, DOI 10.1016/j.conb.2011.10.022; Briggman KL, 2011, NATURE, V471, P183, DOI 10.1038/nature09818; Calkins DJ, 2007, J NEUROSCI, V27, P2646, DOI 10.1523/JNEUROSCI.4739-06.2007; Denk W, 2004, PLOS BIOL, V2, P1900, DOI 10.1371/journal.pbio.0020329; Denk W, 2012, NAT REV NEUROSCI, V13, P351, DOI 10.1038/nrn3169; Euler T, 2002, NATURE, V418, P845, DOI 10.1038/nature00931; FAMIGLIETTI EV, 1991, J COMP NEUROL, V309, P40, DOI 10.1002/cne.903090105; Fried SI, 2002, NATURE, V420, P411, DOI 10.1038/nature01179; Fyk-Kolodziej B, 2007, J COMP NEUROL, V501, P891, DOI 10.1002/cne.21287; Helmstaedter M, 2007, BRAIN RES REV, V55, P193, DOI 10.1016/j.brainresrev.2007.07.011; Helmstaedter M, 2011, NAT NEUROSCI, V14, P1081, DOI 10.1038/nn.2868; Hill SL, 2012, P NATL ACAD SCI USA, V109, pE2885, DOI 10.1073/pnas.1202128109; Joo HR, 2011, VISUAL NEUROSCI, V28, P29, DOI 10.1017/S0952523810000374; Kim IJ, 2010, J NEUROSCI, V30, P1452, DOI 10.1523/JNEUROSCI.4779-09.2010; KOLB H, 1981, VISION RES, V21, P1081, DOI 10.1016/0042-6989(81)90013-4; LEVICK WR, 1967, J PHYSIOL-LONDON, V188, P285, DOI 10.1113/jphysiol.1967.sp008140; Macneil MA, 1999, J COMP NEUROL, V413, P305; Markram H, 1997, J PHYSIOL-LONDON, V500, P409, DOI 10.1113/jphysiol.1997.sp022031; Masland RH, 2001, NAT NEUROSCI, V4, P877, DOI 10.1038/nn0901-877; Masland RH, 2012, NEURON, V76, P266, DOI 10.1016/j.neuron.2012.10.002; MCGUIRE BA, 1984, J NEUROSCI, V4, P2920; Mishchenko Y, 2010, NEURON, V67, P1009, DOI 10.1016/j.neuron.2010.08.014; Olveczky BP, 2003, NATURE, V423, P401, DOI 10.1038/nature01652; PETERS A, 1979, TRENDS NEUROSCI, V2, P183, DOI 10.1016/0166-2236(79)90074-2; Seung HS, 2009, NEURON, V62, P17, DOI 10.1016/j.neuron.2009.03.020; Siegert S, 2009, NAT NEUROSCI, V12, P1197, DOI 10.1038/nn.2370; Sivyer B, 2011, J COMP NEUROL, V519, P3128, DOI 10.1002/cne.22720; Stepanyants A, 2005, TRENDS NEUROSCI, V28, P387, DOI 10.1016/j.tins.2005.05.006; STERLING P, 1983, ANNU REV NEUROSCI, V6, P149, DOI 10.1146/annurev.ne.06.030183.001053; STEVENS JK, 1980, BRAIN RES REV, V2, P265, DOI 10.1016/0165-0173(80)90010-7; STRETTOI E, 1992, J COMP NEUROL, V325, P152, DOI 10.1002/cne.903250203; Studer D, 2000, J MICROSC-OXFORD, V197, P94, DOI 10.1046/j.1365-2818.2000.00638.x; Tsukamoto Y, 2001, J NEUROSCI, V21, P8616, DOI 10.1523/JNEUROSCI.21-21-08616.2001; Turaga S. C., 2009, P ADV NEUR INF PROC, V22, P1; Turaga SC, 2010, NEURAL COMPUT, V22, P511, DOI 10.1162/neco.2009.10-08-881; Vaney DI, 2012, NAT REV NEUROSCI, V13, P194, DOI 10.1038/nrn3165; Varshney LR, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001066; Wassle H, 2009, J NEUROSCI, V29, P106, DOI 10.1523/JNEUROSCI.4442-08.2009; Wang S, 2007, 2007 IEEE INTERNATIONAL SYMPOSIUM ON NANOSCALE ARCHITECTURE, P1; WASSLE H, 1978, PROC R SOC SER B-BIO, V200, P441, DOI 10.1098/rspb.1978.0026; Wei W, 2011, NATURE, V469, P402, DOI 10.1038/nature09600; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; Zhang YF, 2012, P NATL ACAD SCI USA, V109, pE2391, DOI 10.1073/pnas.1211547109; Zhou ZJ, 2008, J PHYSIOL-LONDON, V586, P4371, DOI 10.1113/jphysiol.2008.159020	51	595	606	10	145	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 8	2013	500	7461					168	+		10.1038/nature12346	http://dx.doi.org/10.1038/nature12346			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	197CH	23925239				2022-12-24	WOS:000322825500027
J	Penmatsa, A; Wang, KH; Gouaux, E				Penmatsa, Aravind; Wang, Kevin H.; Gouaux, Eric			X-ray structure of dopamine transporter elucidates antidepressant mechanism	NATURE			English	Article							AMINOBUTYRIC-ACID TRANSPORTER; HIGH-LEVEL EXPRESSION; SEROTONIN TRANSPORTER; BINDING-SITE; NEUROTRANSMITTER TRANSPORTERS; STRUCTURE REFINEMENT; BACTERIAL HOMOLOG; N-GLYCOSYLATION; CHLORIDE; SODIUM	Antidepressants targeting Na+/Cl--coupled neurotransmitter uptake define a key therapeutic strategy to treat clinical depression and neuropathic pain. However, identifying the molecular interactions that underlie the pharmacological activity of these transport inhibitors, and thus the mechanism by which the inhibitors lead to increased synaptic neurotransmitter levels, has proven elusive. Here we present the crystal structure of the Drosophila melanogaster dopamine transporter at 3.0 angstrom resolution bound to the tricyclic antidepressant nortriptyline. The transporter is locked in an outward-open conformation with nortriptyline wedged between transmembrane helices 1, 3,6 and 8, blocking the transporter from binding substrate and from isomerizing to an inward-facing conformation. Although the overall structure of the dopamine transporter is similar to that of its prokaryotic relative LeuT, there are multiple distinctions, including a kink in transmembrane helix 12 halfway across the membrane bilayer, a latch-like carboxy-terminal helix that caps the cytoplasmic gate, and a cholesterol molecule wedged within a groove formed by transmembrane helices 1a, 5 and 7. Taken together, the dopamine transporter structure reveals the molecular basis for antidepressant action on sodium-coupled neurotransmitter symporters and elucidates critical elements of eukaryotic transporter structure and modulation by lipids, thus expanding our understanding of the mechanism and regulation of neurotransmitter uptake at chemical synapses.	[Penmatsa, Aravind; Wang, Kevin H.; Gouaux, Eric] Oregon Hlth & Sci Univ, Vollum Inst, Portland, OR 97239 USA; [Gouaux, Eric] Oregon Hlth & Sci Univ, Howard Hughes Med Inst, Portland, OR 97239 USA	Oregon Health & Science University; Howard Hughes Medical Institute; Oregon Health & Science University	Gouaux, E (corresponding author), Oregon Hlth & Sci Univ, Vollum Inst, 3181 South West Sam Jackson Pk Rd, Portland, OR 97239 USA.	gouauxe@ohsu.edu	Gouaux, Eric/Y-4370-2019; Penmatsa, Aravind/AAQ-2688-2020	Gouaux, Eric/0000-0002-8549-2360; Penmatsa, Aravind/0000-0001-9519-5055	American Heart Association; National Institute of Mental Health; National Institutes of Health; NATIONAL INSTITUTE OF MENTAL HEALTH [R37MH070039] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank D. Cawley for generating monoclonal antibodies and S. Amara for providing the wild-type Drosophila DAT construct. We would like to thank H. Wang and D. Claxton for comments and suggestions along with other Gouaux laboratory members for discussions during manuscript preparation. We thank L. Vaskalis for assistance with figures and H. Owen for help with manuscript preparation. We thank the staff of the Northeastern Collaborative Access Team (NECAT) at the Advanced Photon Source (APS) for assistance with data collection. This work was supported by a postdoctoral fellowship from the American Heart Association (A. P.), a National Institute of Mental Health research award (K. H. W.) and by the National Institutes of Health (E. G.) E. G. is an investigator with the Howard Hughes Medical Institute.	Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Andersen J, 2009, J BIOL CHEM, V284, P10276, DOI 10.1074/jbc.M806907200; Anderson IM, 2000, J AFFECT DISORDERS, V58, P19, DOI 10.1016/S0165-0327(99)00092-0; AXELROD J, 1961, SCIENCE, V133, P383, DOI 10.1126/science.133.3450.383; Baconguis I, 2012, NATURE, V489, P400, DOI 10.1038/nature11375; Bennett ER, 2000, J BIOL CHEM, V275, P34106, DOI 10.1074/jbc.M004229200; Berton O, 2006, NAT REV NEUROSCI, V7, P137, DOI 10.1038/nrn1846; Beuming T, 2008, NAT NEUROSCI, V11, P780, DOI 10.1038/nn.2146; Bismuth Y, 1997, J BIOL CHEM, V272, P16096, DOI 10.1074/jbc.272.26.16096; Buck KJ, 1995, MOL PHARMACOL, V48, P1030; Cao YW, 1998, J NEUROSCI, V18, P7739; Chen JG, 1997, J BIOL CHEM, V272, P28321, DOI 10.1074/jbc.272.45.28321; Chen R, 2007, MOL CELL BIOCHEM, V298, P41, DOI 10.1007/s11010-006-9348-7; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Dukkipati A, 2008, PROTEIN EXPRES PURIF, V62, P160, DOI 10.1016/j.pep.2008.08.004; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Forrest LR, 2007, P NATL ACAD SCI USA, V104, P12761, DOI 10.1073/pnas.0705600104; GIROS B, 1992, MOL PHARMACOL, V42, P383; Harding MM, 2002, ACTA CRYSTALLOGR D, V58, P872, DOI 10.1107/S0907444902003712; Henry LK, 2006, J BIOL CHEM, V281, P2012, DOI 10.1074/jbc.M505055200; Holton KL, 2005, NAT NEUROSCI, V8, P881, DOI 10.1038/nn1478; Hong WC, 2010, J BIOL CHEM, V285, P32616, DOI 10.1074/jbc.M110.150565; JESSELL TM, 1993, CELL, V72, P1, DOI 10.1016/S0092-8674(05)80025-X; Kantcheva AK, 2013, P NATL ACAD SCI USA, V110, P8489, DOI 10.1073/pnas.1221279110; Kawate T, 2006, STRUCTURE, V14, P673, DOI 10.1016/j.str.2006.01.013; KITAYAMA S, 1992, P NATL ACAD SCI USA, V89, P7782, DOI 10.1073/pnas.89.16.7782; Krishnamurthy H, 2012, NATURE, V481, P469, DOI 10.1038/nature10737; Kristensen AS, 2011, PHARMACOL REV, V63, P585, DOI 10.1124/pr.108.000869; KUHN R, 1958, AM J PSYCHIAT, V115, P459, DOI 10.1176/ajp.115.5.459; Kurian MA, 2009, J CLIN INVEST, V119, P1595, DOI 10.1172/JCI39060; Li LB, 2004, J BIOL CHEM, V279, P21012, DOI 10.1074/jbc.M311972200; Loland CJ, 2002, P NATL ACAD SCI USA, V99, P1683, DOI 10.1073/pnas.032386299; Masson J, 1999, PHARMACOL REV, V51, P439; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MELDRUM BS, 1995, EPILEPSIA, V36, pS30; Norregaard L, 1998, EMBO J, V17, P4266, DOI 10.1093/emboj/17.15.4266; NORTH P, 1983, J BIOL CHEM, V258, P1242; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PLETSCHER A, 1991, EXPERIENTIA, V47, P4, DOI 10.1007/BF02041242; Porzgen P, 2001, MOL PHARMACOL, V59, P83; Quick M, 2007, P NATL ACAD SCI USA, V104, P3603, DOI 10.1073/pnas.0609573104; RADIAN R, 1986, J BIOL CHEM, V261, P5437; Reeves PJ, 2002, P NATL ACAD SCI USA, V99, P13419, DOI 10.1073/pnas.212519299; Rudnick G, 1998, METHOD ENZYMOL, V296, P233; Scanlon SM, 2001, BIOCHEMISTRY-US, V40, P10507, DOI 10.1021/bi010730z; Serrano-Vega MJ, 2008, P NATL ACAD SCI USA, V105, P877, DOI 10.1073/pnas.0711253105; Shannon JR, 2000, NEW ENGL J MED, V342, P541, DOI 10.1056/NEJM200002243420803; Singh SK, 2007, NATURE, V448, P952, DOI 10.1038/nature06038; Singh SK, 2008, SCIENCE, V322, P1655, DOI 10.1126/science.1166777; Sitte HH, 2004, MOL INTERV, V4, P38, DOI 10.1124/mi.4.1.38; Sorensen L, 2012, J BIOL CHEM, V287, P43694, DOI 10.1074/jbc.M112.342212; TALVENHEIMO J, 1983, J BIOL CHEM, V258, P6115; Tatsumi M, 1997, EUR J PHARMACOL, V340, P249, DOI 10.1016/S0014-2999(97)01393-9; Tavoulari S, 2009, J NEUROSCI, V29, P9635, DOI 10.1523/JNEUROSCI.0440-09.2009; Terwilliger TC, 2008, ACTA CRYSTALLOGR D, V64, P61, DOI 10.1107/S090744490705024X; Torres GE, 2003, J BIOL CHEM, V278, P2731, DOI 10.1074/jbc.M201926200; Waldman ID, 1998, AM J HUM GENET, V63, P1767, DOI 10.1086/302132; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978; Zhou Z, 2007, SCIENCE, V317, P1390, DOI 10.1126/science.1147614; Zhou Z, 2009, NAT STRUCT MOL BIOL, V16, P652, DOI 10.1038/nsmb.1602; Zomot E, 2007, NATURE, V449, P726, DOI 10.1038/nature06133	61	432	435	4	158	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 7	2013	503	7474					85	+		10.1038/nature12533	http://dx.doi.org/10.1038/nature12533			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247AS	24037379	Green Accepted			2022-12-24	WOS:000326585600036
J	Goujon, C; Moncorge, O; Bauby, H; Doyle, T; Ward, CC; Schaller, T; Hue, S; Barclay, WS; Schulz, R; Malim, MH				Goujon, Caroline; Moncorge, Olivier; Bauby, Helene; Doyle, Tomas; Ward, Christopher C.; Schaller, Torsten; Hue, Stephane; Barclay, Wendy S.; Schulz, Reiner; Malim, Michael H.			Human MX2 is an interferon-induced post-entry inhibitor of HIV-1 infection	NATURE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; PRIMARY HUMAN MACROPHAGES; INFLUENZA-VIRUS; NUCLEAR IMPORT; HUMAN-CELLS; IN-VIVO; ANTIVIRAL FUNCTION; NONDIVIDING CELLS; PROTEIN; EXPRESSION	Animal cells harbour multiple innate effector mechanisms that inhibit virus replication. For the pathogenic retrovirus human immunodeficiency virus type 1 (HIV-1), these include widely expressed restriction factors(1), such as APOBEC3 proteins(2), TRIM5-alpha(3), BST2 (refs 4, 5) and SAMHD1 (refs 6, 7), as well as additional factors that are stimulated by type 1 interferon (IFN)(8-14). Here we use both ectopic expression and gene-silencing experiments to define the human dynamin-like, IFN-induced myxovirus resistance 2 (MX2, also known as MXB) protein as a potent inhibitor of HIV-1 infection and as a key effector of IFN-alpha-mediated resistance to HIV-1 infection. MX2 suppresses infection by all HIV-1 strains tested, has equivalent or reduced effects on divergent simian immunodeficiency viruses, and does not inhibit other retroviruses such as murine leukaemia virus. The Capsid region of the viral Gag protein dictates susceptibility to MX2, and the block to infection occurs at a late post-entry step, with both the nuclear accumulation and chromosomal integration of nascent viral complementary DNA suppressed. Finally, human MX1 (also known as MXA), a closely related protein that has long been recognized as a broadly acting inhibitor of RNA and DNA viruses, including the orthomyxovirus influenza A virus(15,16), does not affect HIV-1, whereas MX2 is ineffective against influenza virus. MX2 is therefore a cell-autonomous, anti-HIV-1 resistance factor whose purposeful mobilization may represent a new therapeutic approach for the treatment of HIV/AIDS.	[Goujon, Caroline; Bauby, Helene; Doyle, Tomas; Ward, Christopher C.; Schaller, Torsten; Malim, Michael H.] Kings Coll London, Dept Infect Dis, London SE1 9RT, England; [Moncorge, Olivier; Barclay, Wendy S.] Univ London Imperial Coll Sci Technol & Med, Div Infect Dis, Virol Sect, London W2 1PG, England; [Hue, Stephane] UCL, Div Infect & Immun, Ctr Med Mol Virol, London WC1 6RT, England; [Schulz, Reiner] Kings Coll London, Dept Med & Mol Genet, London SE1 9RT, England	University of London; King's College London; Imperial College London; University of London; University College London; University of London; King's College London	Malim, MH (corresponding author), Kings Coll London, Dept Infect Dis, London SE1 9RT, England.	michael.malim@kcl.ac.uk	Moncorge, Olivier/E-3233-2017; Bauby, Hélène/C-8965-2014; Goujon, Caroline/B-3914-2014; Schulz, Reiner/A-5940-2011; Schaller, Torsten/ABC-9153-2020	Moncorge, Olivier/0000-0003-0512-1824; Bauby, Hélène/0000-0003-1419-7652; Goujon, Caroline/0000-0001-8571-1108; Schulz, Reiner/0000-0001-5047-7921; Schaller, Torsten/0000-0001-9597-4112; Barclay, Wendy/0000-0002-3948-0895; Ward, Christopher/0000-0001-7120-3700; Hue, Stephane/0000-0002-8580-6905; Malim, Michael/0000-0002-7699-2064	UK Medical Research Council; National Institutes of Health [DA033773]; European Commission [PIEF-GA-2009-237501]; Wellcome Trust; Department of Health via a National Institute for Health Research comprehensive Biomedical Research Centre; King's College London; King's College Hospital NHS Foundation Trust; MRC [G1000196, G1001081] Funding Source: UKRI; Engineering and Physical Sciences Research Council [836374] Funding Source: researchfish; Medical Research Council [G1000196, G1001081] Funding Source: researchfish; National Institute for Health Research [ACF-2011-17-013] Funding Source: researchfish; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA033773] Funding Source: NIH RePORTER	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); European Commission(European CommissionEuropean Commission Joint Research Centre); Wellcome Trust(Wellcome TrustEuropean Commission); Department of Health via a National Institute for Health Research comprehensive Biomedical Research Centre(National Institute for Health Research (NIHR)); King's College London; King's College Hospital NHS Foundation Trust; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We wish to thank L. Apolonia, A. Cimarelli, B. Hahn, T. Hatziioannou, J. Kappes, P. Mangeot, S. Papaioannou, N. Parrish, N. Sherer and C. Swanson for the provision of reagents and for discussions, and M. Mirza, E. Papouli, Q. Oscar Y. Li and G. Pacini for technical assistance. This work was supported by the UK Medical Research Council, the National Institutes of Health (DA033773), the European Commission's Seventh Framework Programme (FP7/2007-2013) under grant agreement no. PIEF-GA-2009-237501 (to C.G.), a Wellcome Trust Research Training Fellowship (to T.D.) and the Department of Health via a National Institute for Health Research comprehensive Biomedical Research Centre award to Guy's and St. Thomas' NHS Foundation Trust in partnership with King's College London and King's College Hospital NHS Foundation Trust.	ADACHI A, 1986, J VIROL, V59, P284, DOI 10.1128/JVI.59.2.284-291.1986; Asmuth DM, 2010, J INFECT DIS, V201, P1686, DOI 10.1086/652420; Bamming D, 2009, J BIOL CHEM, V284, P9700, DOI 10.1074/jbc.M807365200; Bitzegeio J, 2013, J VIROL, V87, P3549, DOI 10.1128/JVI.03219-12; Brass AL, 2008, SCIENCE, V319, P921, DOI 10.1126/science.1152725; Brass AL, 2009, CELL, V139, P1243, DOI 10.1016/j.cell.2009.12.017; Cauldwell AV, 2013, J VIROL, V87, P1278, DOI 10.1128/JVI.02597-12; Cordeil S, 2013, J VIROL, V87, P2587, DOI 10.1128/JVI.02553-12; Donnelly MLL, 2001, J GEN VIROL, V82, P1013, DOI 10.1099/0022-1317-82-5-1013; Fouchier RAM, 1997, EMBO J, V16, P4531, DOI 10.1093/emboj/16.15.4531; Gaddis NC, 2004, J VIROL, V78, P12041, DOI 10.1128/JVI.78.21.12041-12046.2004; Gao S, 2011, IMMUNITY, V35, P514, DOI 10.1016/j.immuni.2011.07.012; Goujon C, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-23; Goujon C, 2010, J VIROL, V84, P9254, DOI 10.1128/JVI.00854-10; Haller O, 2011, J INTERF CYTOK RES, V31, P79, DOI 10.1089/jir.2010.0076; HO DD, 1985, LANCET, V1, P602; Hrecka K, 2011, NATURE, V474, P658, DOI 10.1038/nature10195; Jarrosson-Wuilleme L, 2006, J VIROL, V80, P1152, DOI 10.1128/JVI.80.3.1152-1159.2006; Kim BH, 2012, CELL HOST MICROBE, V12, P432, DOI 10.1016/j.chom.2012.09.007; King MC, 2004, P NATL ACAD SCI USA, V101, P8957, DOI 10.1073/pnas.0403167101; Konig R, 2008, CELL, V135, P49, DOI 10.1016/j.cell.2008.07.032; Laguette N, 2011, NATURE, V474, P654, DOI 10.1038/nature10117; Lee K, 2010, CELL HOST MICROBE, V7, P221, DOI 10.1016/j.chom.2010.02.007; Malim MH, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006940; Mangeot PE, 2002, MOL THER, V5, P283, DOI 10.1006/mthe.2002.0541; Mangeot PE, 2011, MOL THER, V19, P1656, DOI 10.1038/mt.2011.138; Markusic D, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni062; Melen K, 1996, J BIOL CHEM, V271, P23478, DOI 10.1074/jbc.271.38.23478; MEYLAN PRA, 1993, VIROLOGY, V193, P138, DOI 10.1006/viro.1993.1110; Mitchell PS, 2012, CELL HOST MICROBE, V12, P598, DOI 10.1016/j.chom.2012.09.005; Naldini L, 1996, SCIENCE, V272, P263, DOI 10.1126/science.272.5259.263; Neil SJD, 2008, NATURE, V451, P425, DOI 10.1038/nature06553; NEUMANN G, 1995, J GEN VIROL, V76, P1709, DOI 10.1099/0022-1317-76-7-1709; Newman ENC, 2005, CURR BIOL, V15, P166, DOI 10.1016/j.cub.2004.12.068; O'Doherty U, 2002, J VIROL, V76, P10942, DOI 10.1128/JVI.76.21.10942-10950.2002; O'Rourke JP, 2002, J VIROL, V76, P1510, DOI 10.1128/JVI.76.3.1510-1515.2002; Ochsenbauer C, 2012, J VIROL, V86, P2715, DOI 10.1128/JVI.06157-11; PAVLOVIC J, 1990, J VIROL, V64, P3370, DOI 10.1128/JVI.64.7.3370-3375.1990; Pear WS, 1998, BLOOD, V92, P3780, DOI 10.1182/blood.V92.10.3780.422k15_3780_3792; Pertel T, 2011, NATURE, V472, P361, DOI 10.1038/nature09976; Pillai SK, 2012, P NATL ACAD SCI USA, V109, P3035, DOI 10.1073/pnas.1111573109; PITOSSI F, 1993, J VIROL, V67, P6726, DOI 10.1128/JVI.67.11.6726-6732.1993; Ponten A, 1997, J VIROL, V71, P2591, DOI 10.1128/JVI.71.4.2591-2599.1997; RYANGRAHAM MA, 1995, VIROLOGY, V213, P158, DOI 10.1006/viro.1995.1556; Saenz DT, 2005, J VIROL, V79, P15175, DOI 10.1128/JVI.79.24.15175-15188.2005; SAKAI H, 1992, ARCH VIROL, V125, P1, DOI 10.1007/BF01309624; Sauter D, 2009, CELL HOST MICROBE, V6, P409, DOI 10.1016/j.chom.2009.10.004; Sayah DM, 2004, NATURE, V430, P569, DOI 10.1038/nature02777; Schaller T, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002439; Schindler M, 2003, J VIROL, V77, P10548, DOI 10.1128/JVI.77.19.10548-10556.2003; Schoggins JW, 2011, NATURE, V472, P481, DOI 10.1038/nature09907; Shah VB, 2013, J VIROL, V87, P422, DOI 10.1128/JVI.07177-11; Sheehy AM, 2002, NATURE, V418, P646, DOI 10.1038/nature00939; Shi W, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq871; SIMON JHM, 1995, J VIROL, V69, P4166, DOI 10.1128/JVI.69.7.4166-4172.1995; Soares MA, 1997, VIROLOGY, V228, P394, DOI 10.1006/viro.1996.8387; Stremlau M, 2004, NATURE, V427, P848, DOI 10.1038/nature02343; Trichas G, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-40; Van Damme N, 2008, CELL HOST MICROBE, V3, P245, DOI 10.1016/j.chom.2008.03.001; Wei XP, 2002, ANTIMICROB AGENTS CH, V46, P1896, DOI 10.1128/AAC.46.6.1896-1905.2002; YEE JK, 1994, P NATL ACAD SCI USA, V91, P9564, DOI 10.1073/pnas.91.20.9564	61	408	419	4	90	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 24	2013	502	7472					559	+		10.1038/nature12542	http://dx.doi.org/10.1038/nature12542			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	238YN	24048477	Green Accepted			2022-12-24	WOS:000325988400056
J	Kanai, R; Ogawa, H; Vilsen, B; Cornelius, F; Toyoshima, C				Kanai, Ryuta; Ogawa, Haruo; Vilsen, Bente; Cornelius, Flemming; Toyoshima, Chikashi			Crystal structure of a Na+-bound Na+,K+-ATPase preceding the E1P state	NATURE			English	Article							CYTOPLASMIC-BINDING SITES; RAT-KIDNEY NA+,K+-ATPASE; SODIUM-POTASSIUM PUMP; ALPHA-SUBUNIT; TRANSMEMBRANE SEGMENT; CALCIUM-PUMP; K+-ATPASE; TERMINAL TYROSINES; CATION-BINDING; NA,K-ATPASE	Na+,K+-ATPase pumps three Na+ ions out of cells in exchange for two K+ taken up from the extracellular medium per ATP molecule hydrolysed, thereby establishing Na+ and K+ gradients across the membrane in all animal cells. These ion gradients are used in many fundamental processes, notably excitation of nerve cells. Here we describe 2.8 angstrom-resolution crystal structures of this ATPase from pig kidney with bound Na+, ADP and aluminium fluoride, a stable phosphate analogue, with and without oligomycin that promotes Na+ occlusion. These crystal structures represent a transition state preceding the phosphorylated intermediate (E1P) in which three Na+ ions are occluded. Details of the Na+-binding sites show how this ATPase functions as a Na+-specific pump, rejecting K+ and Ca2+, even though its affinity for Na+ is low (millimolar dissociation constant). A mechanism for sequential, cooperative Na+ binding can now be formulated in atomic detail.	[Kanai, Ryuta; Ogawa, Haruo; Toyoshima, Chikashi] Univ Tokyo, Inst Mol & Cellular Biosci, Bunkyo Ku, Tokyo 1130032, Japan; [Vilsen, Bente; Cornelius, Flemming] Aarhus Univ, Dept Biomed, DK-8000 Aarhus C, Denmark	University of Tokyo; Aarhus University	Toyoshima, C (corresponding author), Univ Tokyo, Inst Mol & Cellular Biosci, Bunkyo Ku, Tokyo 1130032, Japan.	ct@iam.u-tokyo.ac.jp	Toyoshima, Chikashi/R-4153-2019; Cornelius, Flemming/C-1912-2019	Cornelius, Flemming/0000-0003-1566-0020; Vilsen, Bente/0000-0002-4727-9382; Toyoshima, Chikashi/0000-0001-9640-0778	Ministry of Education, Culture, Sports, Science and Technology of Japan [2009B0025]; Lundbeck Foundation; Novo Nordisk Foundation; Fabrikant Vilhelm Pedersen og Hustrus Legat; Danish Medical Research Council; FI/Danish-Japanese cooperation program from the Danish Agency for Science Technology and Innovation; Lundbeck Foundation [R118-2012-11726, R48-2009-4638] Funding Source: researchfish	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Lundbeck Foundation(Lundbeckfonden); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Fabrikant Vilhelm Pedersen og Hustrus Legat; Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); FI/Danish-Japanese cooperation program from the Danish Agency for Science Technology and Innovation; Lundbeck Foundation(Lundbeckfonden)	We thank S. Hasegawa and H. Okumura of the Japan Synchrotron Radiation Research Institute (JASRI) for data collection at BL41XU of SPring-8, and J. Petersen, A. M. Beck Sorensen and A. Lillevang for technical assistance with membrane purification. We are grateful to D. B. McIntosh for help in improving the manuscript, and J. Tsueda for help in preparing figures. This work is a part of a long-term project (2009B0025) at SPring-8 and was supported by a Specially Promoted Project Grant from the Ministry of Education, Culture, Sports, Science and Technology of Japan (to C. T.) as well as by research grants from the Lundbeck Foundation (to B. V.), the Novo Nordisk Foundation, Fabrikant Vilhelm Pedersen og Hustrus Legat (to B. V. and F. C.), the Danish Medical Research Council (to B. V. and F. C.) and the FI/Danish-Japanese cooperation program from the Danish Agency for Science Technology and Innovation (to F.C.).	Abe K, 2009, EMBO J, V28, P1637, DOI 10.1038/emboj.2009.102; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; ALBERS RW, 1967, ANNU REV BIOCHEM, V36, P727, DOI 10.1146/annurev.bi.36.070167.003455; Apell HJ, 2001, J MEMBRANE BIOL, V180, P1, DOI 10.1007/s002320010053; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BROWN ID, 1976, ACTA CRYSTALLOGR B, V32, P1957, DOI 10.1107/S0567740876006869; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CLARKE DM, 1989, NATURE, V339, P476, DOI 10.1038/339476a0; CORNELIUS F, 1988, BIOCHIM BIOPHYS ACTA, V944, P223, DOI 10.1016/0005-2736(88)90435-X; Einholm AP, 2010, J BIOL CHEM, V285, P26245, DOI 10.1074/jbc.M110.123976; ESMANN M, 1985, BIOCHEM BIOPH RES CO, V127, P857, DOI 10.1016/S0006-291X(85)80022-X; Fabiola F, 2002, PROTEIN SCI, V11, P1415, DOI 10.1110/ps.4890102; Glynn I. M., 1985, ENZYMES BIOL MEMBR, P35; GUARDIA E, 1991, J CHEM PHYS, V95, P2823, DOI 10.1063/1.460934; Hayward S, 1999, PROTEINS, V36, P425, DOI 10.1002/(SICI)1097-0134(19990901)36:4<425::AID-PROT6>3.3.CO;2-J; Ho BK, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-49; Imagawa T, 2005, J BIOL CHEM, V280, P18736, DOI 10.1074/jbc.M500137200; Jacobsen MD, 2002, BIOCHEMISTRY-US, V41, P1451, DOI 10.1021/bi015891h; JEWELLMOTZ EA, 1993, BIOCHEMISTRY-US, V32, P13523, DOI 10.1021/bi00212a018; JORGENSEN PL, 1974, BIOCHIM BIOPHYS ACTA, V356, P36, DOI 10.1016/0005-2736(74)90292-2; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Kuntzweiler TA, 1996, J BIOL CHEM, V271, P29682, DOI 10.1074/jbc.271.47.29682; Laursen M, 2013, P NATL ACAD SCI USA, V110, P10958, DOI 10.1073/pnas.1222308110; MCDONALD IK, 1994, J MOL BIOL, V238, P777, DOI 10.1006/jmbi.1994.1334; Meier S, 2010, J GEN PHYSIOL, V135, P115, DOI 10.1085/jgp.200910301; Morth JP, 2007, NATURE, V450, P1043, DOI 10.1038/nature06419; Morth JP, 2011, NAT REV MOL CELL BIO, V12, P60, DOI 10.1038/nrm3031; Morth JP, 2009, PHILOS T R SOC B, V364, P217, DOI 10.1098/rstb.2008.0201; Nayal M, 1996, J MOL BIOL, V256, P228, DOI 10.1006/jmbi.1996.0081; Ogawa H, 2009, P NATL ACAD SCI USA, V106, P13742, DOI 10.1073/pnas.0907054106; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pedersen PA, 1998, BIOCHEMISTRY-US, V37, P17818, DOI 10.1021/bi981898w; Pintschovius J, 1999, BIOPHYS J, V76, P827, DOI 10.1016/S0006-3495(99)77246-2; POST RL, 1972, J BIOL CHEM, V247, P6530; Schack VR, 2008, J BIOL CHEM, V283, P27982, DOI 10.1074/jbc.M803506200; Schack VR, 2012, J BIOL CHEM, V287, P2191, DOI 10.1074/jbc.M111.323022; Schneeberger A, 2001, J MEMBRANE BIOL, V179, P263, DOI 10.1007/s002320010051; SCHULZ S, 1995, EUR BIOPHYS J BIOPHY, V23, P413, DOI 10.1007/BF00196828; Shinoda T, 2009, NATURE, V459, P446, DOI 10.1038/nature07939; Sorensen TLM, 2004, SCIENCE, V304, P1672, DOI 10.1126/science.1099366; Toustrup-Jensen MS, 2009, J BIOL CHEM, V284, P18715, DOI 10.1074/jbc.M109.015099; Toyoshima C, 2004, NATURE, V430, P529, DOI 10.1038/nature02680; Toyoshima C, 2000, NATURE, V405, P647, DOI 10.1038/35015017; Toyoshima C, 2013, NATURE, V495, P260, DOI 10.1038/nature11899; Toyoshima C, 2011, STRUCTURE, V19, P1732, DOI 10.1016/j.str.2011.10.016; Vedovato N, 2010, J GEN PHYSIOL, V136, P63, DOI 10.1085/jgp.201010407; VILSEN B, 1993, BIOCHEMISTRY-US, V32, P13340, DOI 10.1021/bi00211a048; VILSEN B, 1995, BIOCHEMISTRY-US, V34, P1455, DOI 10.1021/bi00004a041; Vilsen B, 1997, ANN NY ACAD SCI, V834, P297, DOI 10.1111/j.1749-6632.1997.tb52260.x; Winther AML, 2013, NATURE, V495, P265, DOI 10.1038/nature11900; Yaragatupalli S, 2009, P NATL ACAD SCI USA, V106, P15507, DOI 10.1073/pnas.0903752106	51	209	212	2	116	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 10	2013	502	7470					201	+		10.1038/nature12578	http://dx.doi.org/10.1038/nature12578			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231RU	24089211				2022-12-24	WOS:000325436100043
J	Hansen, SG; Piatak, M; Ventura, AB; Hughes, CM; Gilbride, RM; Ford, JC; Oswald, K; Shoemaker, R; Li, Y; Lewis, MS; Gilliam, AN; Xu, GW; Whizin, N; Burwitz, BJ; Planer, SL; Turner, JM; Legasse, AW; Axthelm, MK; Nelson, JA; Fruh, K; Sacha, JB; Estes, JD; Keele, BF; Edlefsen, PT; Lifson, JD; Picker, LJ				Hansen, Scott G.; Piatak, Michael, Jr.; Ventura, Abigail B.; Hughes, Colette M.; Gilbride, Roxanne M.; Ford, Julia C.; Oswald, Kelli; Shoemaker, Rebecca; Li, Yuan; Lewis, Matthew S.; Gilliam, Awbrey N.; Xu, Guangwu; Whizin, Nathan; Burwitz, Benjamin J.; Planer, Shannon L.; Turner, John M.; Legasse, Alfred W.; Axthelm, Michael K.; Nelson, Jay A.; Frueh, Klaus; Sacha, Jonah B.; Estes, Jacob D.; Keele, Brandon F.; Edlefsen, Paul T.; Lifson, Jeffrey D.; Picker, Louis J.			Immune clearance of highly pathogenic SIV infection	NATURE			English	Article							RHESUS MACAQUES; VIRUS; HIV; PROTECTION; RESPONSES; MODEL; ASSAY; CURE	Established infections with the human and simian immunodeficiency viruses (HIV and SIV, respectively) are thought to be permanent with even the most effective immune responses and antiretroviral therapies only able to control, but not clear, these infections(1-4). Whether the residual virus that maintains these infections is vulnerable to clearance is a question of central importance to the future management of millions of HIV-infected individuals. We recently reported that approximately 50% of rhesus macaques (RM; Macaca mulatta) vaccinated with SIV protein-expressing rhesus cytomegalovirus (RhCMV/SIV) vectors manifest durable, aviraemic control of infection with the highly pathogenic strain SIV mac239 (ref. 5). Here we show that regardless of the route of challenge, RhCMV/SIV vector-elicited immune responses control SIV mac239 after demonstrable lymphatic and haematogenous viral dissemination, and that replication-competent SIV persists in several sites for weeks to months. Over time, however, protected RM lost signs of SIV infection, showing a consistent lack of measurable plasma-or tissue-associated virus using ultrasensitive assays, and a loss of T-cell reactivity to SIV determinants not in the vaccine. Extensive ultrasensitive quantitative PCR and quantitative PCR with reverse transcription analyses of tissues from RhCMV/SIV vector-protected RM necropsied 69-172 weeks after challenge did not detect SIV RNA or DNA sequences above background levels, and replication-competent SIV was not detected in these RM by extensive co-culture analysis of tissues or by adoptive transfer of 60 million haematolymphoid cells to naive RM. These data provide compelling evidence for progressive clearance of a pathogenic lentiviral infection, and suggest that some lentiviral reservoirs may be susceptible to the continuous effector memory T-cell-mediated immune surveillance elicited and maintained by cytomegalovirus vectors.	[Hansen, Scott G.; Ventura, Abigail B.; Hughes, Colette M.; Gilbride, Roxanne M.; Ford, Julia C.; Lewis, Matthew S.; Gilliam, Awbrey N.; Xu, Guangwu; Whizin, Nathan; Burwitz, Benjamin J.; Planer, Shannon L.; Turner, John M.; Legasse, Alfred W.; Axthelm, Michael K.; Nelson, Jay A.; Frueh, Klaus; Sacha, Jonah B.; Picker, Louis J.] Oregon Hlth & Sci Univ, Vaccine & Gene Therapy Inst, Beaverton, OR 97006 USA; [Hansen, Scott G.; Ventura, Abigail B.; Hughes, Colette M.; Gilbride, Roxanne M.; Ford, Julia C.; Lewis, Matthew S.; Gilliam, Awbrey N.; Xu, Guangwu; Whizin, Nathan; Burwitz, Benjamin J.; Planer, Shannon L.; Turner, John M.; Legasse, Alfred W.; Axthelm, Michael K.; Nelson, Jay A.; Frueh, Klaus; Sacha, Jonah B.; Picker, Louis J.] Oregon Hlth & Sci Univ, Oregon Natl Primate Res Ctr, Beaverton, OR 97006 USA; [Piatak, Michael, Jr.; Oswald, Kelli; Shoemaker, Rebecca; Li, Yuan; Estes, Jacob D.; Keele, Brandon F.; Lifson, Jeffrey D.] SAIC Frederick Inc, AIDS & Canc Virus Program, Frederick Natl Lab, Frederick, MD 21702 USA; [Edlefsen, Paul T.] Fred Hutchinson Canc Res Ctr, Stat Ctr HIV AIDS Res & Prevent, Vaccine & Infect Dis Div, Seattle, WA 98109 USA	Oregon Health & Science University; Oregon Health & Science University; Oregon National Primate Research Center; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; Fred Hutchinson Cancer Center	Lifson, JD (corresponding author), SAIC Frederick Inc, AIDS & Canc Virus Program, Frederick Natl Lab, Frederick, MD 21702 USA.	lifsonj@mail.nih.gov; pickerl@ohsu.edu		Frueh, Klaus/0000-0001-8014-3877	AIDS Vaccine Research in Nonhuman Primates Consortium of the National Institute of Allergy and Infectious Diseases (NIAID) [U19 AI095985]; NIAID [RO1 AI060392, R37 AI054292, P01 AI094417, U19 AI096109]; Bill & Melinda Gates Foundation; International AIDS Vaccine Initiative (IAVI); US Agency for International Development (USAID); National Center for Research Resources [P51OD011092]; National Cancer Institute [HHSN261200800001E]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI095985, R37AI054292, R01AI060392, P01AI094417, U19AI096109] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE021291] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [U42OD010426, U24OD010850, P51OD011092] Funding Source: NIH RePORTER	AIDS Vaccine Research in Nonhuman Primates Consortium of the National Institute of Allergy and Infectious Diseases (NIAID); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); International AIDS Vaccine Initiative (IAVI); US Agency for International Development (USAID)(United States Agency for International Development (USAID)); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the AIDS Vaccine Research in Nonhuman Primates Consortium of the National Institute of Allergy and Infectious Diseases (NIAID; U19 AI095985), as well as other NIAID grants (RO1 AI060392, R37 AI054292, P01 AI094417 and U19 AI096109); the Bill & Melinda Gates Foundation-supported Collaboration for AIDS Vaccine Discovery (CAVD); the International AIDS Vaccine Initiative (IAVI) and its donors, particularly the US Agency for International Development (USAID); the National Center for Research Resources (P51OD011092); and the National Cancer Institute (contract HHSN261200800001E). We thank A. Sylwester, A. Okoye, C. Kahl, S. Hagen, R. Lum, Y. Fukazawa, S. Shiigi and L. Boshears for technical or administrative assistance; C. Miller, N. Miller and T. Friedrich for provision of SIV stocks; K. Reimann for provision of the CD8-depleting monoclonal antibody; D. Watkins for MHC typing; D. Montefiori for neutralizing antibody assays; and A. Townsend for figure preparation.	Agresti A, 1998, AM STAT, V52, P119, DOI 10.2307/2685469; Burton DR, 2012, CELL HOST MICROBE, V12, P396, DOI 10.1016/j.chom.2012.09.008; Chun TW, 2012, AIDS, V26, P1261, DOI 10.1097/QAD.0b013e328353f3f1; Cline AN, 2005, J MED PRIMATOL, V34, P303; Deeks SG, 2007, IMMUNITY, V27, P406, DOI 10.1016/j.immuni.2007.08.010; Deeks SG, 2012, NAT REV IMMUNOL, V12, P607, DOI 10.1038/nri3262; dos Santos PR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019493; Fisher RA, 1935, J R STAT SOC, V98, P39, DOI 10.2307/2342435; Haase AT, 2011, ANNU REV MED, V62, P127, DOI 10.1146/annurev-med-080709-124959; Hansen SG, 2013, SCIENCE, V340, P940, DOI 10.1126/science.1237874; Hansen SG, 2011, NATURE, V473, P523, DOI 10.1038/nature10003; Hansen SG, 2009, NAT MED, V15, P293, DOI 10.1038/nm.1935; HARRINGTON DP, 1982, BIOMETRIKA, V69, P553, DOI 10.2307/2335991; Keele BF, 2009, J EXP MED, V206, P1117, DOI 10.1084/jem.20082831; Lewin SR, 2011, J INT AIDS SOC, V14, DOI 10.1186/1758-2652-14-4; Lifson JD, 2000, J VIROL, V74, P2584, DOI 10.1128/JVI.74.6.2584-2593.2000; Loffredo JT, 2007, J VIROL, V81, P8827, DOI 10.1128/JVI.00895-07; Montefiori DC., 2005, CURR PROTOC IMMUNOL, VChapter 12:12.11.11-12.11.15, DOI [10.1002/0471142735.im1211s64, DOI 10.1002/0471142735.IM1211S64]; Okoye A, 2009, J EXP MED, V206, P1575, DOI 10.1084/jem.20090356; Palmer S, 2003, J CLIN MICROBIOL, V41, P4531, DOI 10.1128/JCM.41.10.4531-4536.2003; Picker LJ, 2012, ANNU REV MED, V63, P95, DOI 10.1146/annurev-med-042010-085643; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Sacha JB, 2010, NAT PROTOC, V5, P239, DOI 10.1038/nprot.2009.227; Saez-Cirion A, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003211; Shen AD, 2007, J VIROL, V81, P1660, DOI 10.1128/JVI.01396-06; Tabb B, 2013, J INFECT DIS, V207, P880, DOI 10.1093/infdis/jis643; Venneti S, 2008, AM J PATHOL, V172, P1603, DOI 10.2353/ajpath.2008.070967; Wolfe D. A., 1973, NONPARAMETRIC STAT M	28	430	450	0	70	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 3	2013	502	7469					100	+		10.1038/nature12519	http://dx.doi.org/10.1038/nature12519			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	227IM	24025770	Green Accepted			2022-12-24	WOS:000325106000039
J	Braberg, H; Jin, HY; Moehle, EA; Chan, YJA; Wang, SY; Shales, M; Benschop, JJ; Morris, JH; Qiu, CX; Hu, FQ; Tang, LK; Fraser, JS; Holstege, FCP; Hieter, P; Guthrie, C; Kaplan, CD; Krogan, NJ				Braberg, Hannes; Jin, Huiyan; Moehle, Erica A.; Chan, Yujia A.; Wang, Shuyi; Shales, Michael; Benschop, Joris J.; Morris, John H.; Qiu, Chenxi; Hu, Fuqu; Tang, Leung K.; Fraser, James S.; Holstege, Frank C. P.; Hieter, Philip; Guthrie, Christine; Kaplan, Craig D.; Krogan, Nevan J.			From Structure to Systems: High-Resolution, Quantitative Genetic Analysis of RNA Polymerase II	CELL			English	Article							START SITE SELECTION; ELONGATION COMPLEX; FUNCTIONAL DISSECTION; HIGH-THROUGHPUT; INTERACTION MAP; REVEALS LINKS; TRANSCRIPTION; YEAST; SUB1; INITIATION	RNA polymerase II (RNAPII) lies at the core of dynamic control of gene expression. Using 53 RNAPII point mutants, we generated a point mutant epistatic miniarray profile (pE-MAP) comprising similar to 60,000 quantitative genetic interactions in Saccharomyces cerevisiae. This analysis enabled functional assignment of RNAPII subdomains and uncovered connections between individual regions and other protein complexes. Using splicing microarrays and mutants that alter elongation rates in vitro, we found an inverse relationship between RNAPII speed and in vivo splicing efficiency. Furthermore, the pE-MAP classified fast and slow mutants that favor upstream and downstream start site selection, respectively. The striking coordination of polymerization rate with transcription initiation and splicing suggests that transcription rate is tuned to regulate multiple gene expression steps. The pE-MAP approach provides a powerful strategy to understand other multifunctional machines at amino acid resolution.	[Braberg, Hannes; Wang, Shuyi; Shales, Michael; Fraser, James S.; Krogan, Nevan J.] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA; [Moehle, Erica A.; Guthrie, Christine] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA; [Benschop, Joris J.] Univ Calif San Francisco, San Francisco, CA 94158 USA; [Braberg, Hannes; Wang, Shuyi; Shales, Michael; Fraser, James S.; Krogan, Nevan J.] Calif Inst Quantitat Biosci, San Francisco, CA 94158 USA; [Jin, Huiyan; Qiu, Chenxi; Hu, Fuqu; Tang, Leung K.; Kaplan, Craig D.] Texas A&M Univ, Dept Biochem & Biophys, College Stn, TX 77843 USA; [Chan, Yujia A.; Hieter, Philip] Univ British Columbia, Michael Smith Labs, Dept Med Genet, Vancouver, BC V6T 1Z4, Canada; [Chan, Yujia A.; Hieter, Philip] Univ British Columbia, Michael Smith Labs, Dept Biochem, Vancouver, BC V6T 1Z4, Canada; [Benschop, Joris J.; Holstege, Frank C. P.] Univ Med Ctr Utrecht, NL-3508 AB Utrecht, Netherlands; [Krogan, Nevan J.] J David Gladstone Inst, San Francisco, CA 94158 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Texas A&M University System; Texas A&M University College Station; University of British Columbia; University of British Columbia; Utrecht University; Utrecht University Medical Center; University of California System; University of California San Francisco; The J David Gladstone Institutes	Guthrie, C (corresponding author), Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA.	christineguthrie@gmail.com; cdkaplan@tamu.edu; nevan.krogan@ucsf.edu	Holstege, Frank/AAM-9944-2021; Benschop, Joris j/C-7809-2012; Kaplan, Craig/AAO-4500-2021	Kaplan, Craig/0000-0002-7518-695X; Morris, John "Scooter"/0000-0003-0290-7979; Qiu, Chenxi/0000-0002-0314-5307; Chan, Yujia Alina/0000-0002-0731-637X; /0000-0002-7635-5604; Fraser, James/0000-0002-5080-2859	QB3 at UCSF; NIH [R01GM084448, R01GM084279, P50GM081879, R01GM098101, R01GM036659, R01GM097260, DP5OD009180]; NSF; Helen Hay Whitney Fellowship; UCSF Biophysics Graduate Program; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI027763] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM081879, R01GM084448, R01GM021119, R01GM097260, R01GM084279, R01GM098101, P41GM103311, R01GM036659] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP5OD009180] Funding Source: NIH RePORTER	QB3 at UCSF; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); Helen Hay Whitney Fellowship; UCSF Biophysics Graduate Program; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The authors wish to thank members of the Krogan, Kaplan, and Guthrie labs; David Agard, Brad Cairns, Ada Cheng, C. James Ingles, Paivand Jalalian, Tanja Kortemme, Andrej Sali, and Keith Yamamoto for helpful discussion; Steve Buratowski, Olga Calvo, and Eva Nogales for sharing results prior to publication; Steve Hahn and Mike Hampsey for providing tfg2 and sua7 mutant plasmids, respectively; Colm Ryan for help with statistical analysis; and Ricardo Almeida and Jiewei Xu for assistance with growth assays. This work was supported by grants from QB3 at UCSF and the NIH (R01GM084448, R01GM084279, P50GM081879, and R01GM098101 to N.J.K.; R01GM036659 to Roger D. Kornberg for support of C. D. K. for a portion of this work; R01GM097260 to C. D. K.; R01GM021119 to C. G.; and DP5OD009180 to J.S.F.). C. G. is an ACS Research Professor of Molecular Genetics. E. A. M. was supported by an NSF graduate research fellowship. C. D. K. acknowledges a Helen Hay Whitney Fellowship for the early stages of this work. H. B. was supported by the UCSF Biophysics Graduate Program. N.J.K. is a Searle Scholar and a Keck Young Investigator. The content is solely the responsibility of the authors and does not necessarily represent the official views of any of the acknowledged funding agencies.	Aguilar PS, 2010, NAT STRUCT MOL BIOL, V17, P901, DOI 10.1038/nsmb.1829; Aitken S, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002215; Alexander RD, 2010, MOL CELL, V40, P582, DOI 10.1016/j.molcel.2010.11.005; ARCHAMBAULT J, 1993, MICROBIOL REV, V57, P703, DOI 10.1128/MMBR.57.3.703-724.1993; Arribere JA, 2013, GENOME RES, V23, P977, DOI 10.1101/gr.150342.112; Bassik MC, 2013, CELL, V152, P909, DOI 10.1016/j.cell.2013.01.030; Beltrao P, 2010, CELL, V141, P739, DOI 10.1016/j.cell.2010.05.019; Benschop JJ, 2010, MOL CELL, V38, P916, DOI 10.1016/j.molcel.2010.06.002; Bentley DL, 2005, CURR OPIN CELL BIOL, V17, P251, DOI 10.1016/j.ceb.2005.04.006; Butland G, 2008, NAT METHODS, V5, P789, DOI 10.1038/NMETH.1239; Carrozza MJ, 2005, CELL, V123, P581, DOI 10.1016/j.cell.2005.10.023; Chen HT, 2007, NAT STRUCT MOL BIOL, V14, P696, DOI 10.1038/nsmb1272; Clark TA, 2002, SCIENCE, V296, P907, DOI 10.1126/science.1069415; Collins SR, 2007, MOL CELL PROTEOMICS, V6, P439, DOI 10.1074/mcp.M600381-MCP200; Collins SR, 2007, NATURE, V446, P806, DOI 10.1038/nature05649; Collins SR, 2010, METHOD ENZYMOL, V470, P205, DOI 10.1016/S0076-6879(10)70009-4; Costanzo M, 2010, SCIENCE, V327, P425, DOI 10.1126/science.1180823; Cramer P, 1997, P NATL ACAD SCI USA, V94, P11456, DOI 10.1073/pnas.94.21.11456; Cramer Patrick, 2001, Science (Washington D C), V292, P1863, DOI 10.1126/science.1059493; de la Mata M, 2003, MOL CELL, V12, P525, DOI 10.1016/j.molcel.2003.08.001; de la Mata M, 2011, GENET RES INT, V2011, DOI 10.4061/2011/309865; EDWARDS AM, 1991, J BIOL CHEM, V266, P71; Eichner J, 2010, EMBO J, V29, P706, DOI 10.1038/emboj.2009.386; Fiedler D, 2009, CELL, V136, P952, DOI 10.1016/j.cell.2008.12.039; Gaj T, 2013, TRENDS BIOTECHNOL, V31, P397, DOI 10.1016/j.tibtech.2013.04.004; Garcia A, 2012, MOL BIOL CELL, V23, P4297, DOI 10.1091/mbc.E12-04-0331; Ghazy MA, 2004, MOL CELL BIOL, V24, P10975, DOI 10.1128/MCB.24.24.10975-10985.2004; GIARDINA C, 1993, SCIENCE, V261, P759, DOI 10.1126/science.8342041; Gnatt AL, 2001, SCIENCE, V292, P1876, DOI 10.1126/science.1059495; Goel S, 2012, J BIOL CHEM, V287, P557, DOI 10.1074/jbc.M111.281576; Greger IH, 1998, EMBO J, V17, P4771, DOI 10.1093/emboj/17.16.4771; Harel-Sharvit L, 2010, CELL, V143, P552, DOI 10.1016/j.cell.2010.10.033; Hazelbaker DZ, 2013, MOL CELL, V49, P55, DOI 10.1016/j.molcel.2012.10.014; He Y, 2013, NATURE, V495, P481, DOI 10.1038/nature11991; Howe KJ, 2003, RNA, V9, P993, DOI 10.1261/rna.5390803; Ip JY, 2011, GENOME RES, V21, P390, DOI 10.1101/gr.111070.110; Kaplan C, 2008, NATION, V286, P30; Kaplan CD, 2005, J BIOL CHEM, V280, P913, DOI 10.1074/jbc.M411108200; Kaplan CD, 2013, BBA-GENE REGUL MECH, V1829, P39, DOI 10.1016/j.bbagrm.2012.09.007; Kaplan CD, 2012, PLOS GENET, V8, P172, DOI 10.1371/journal.pgen.1002627; Keogh MC, 2005, CELL, V123, P593, DOI 10.1016/j.cell.2005.10.025; Kettenberger H, 2004, MOL CELL, V16, P955, DOI 10.1016/j.molcel.2004.11.040; Knaus R, 1996, EMBO J, V15, P1933, DOI 10.1002/j.1460-2075.1996.tb00544.x; Kuehner JN, 2006, J BIOL CHEM, V281, P14119, DOI 10.1074/jbc.M601937200; Laufer C, 2013, NAT METHODS, V10, P427, DOI [10.1038/NMETH.2436, 10.1038/nmeth.2436]; Lin YY, 2012, NATURE, V482, P251, DOI 10.1038/nature10804; Malagon F, 2006, GENETICS, V172, P2201, DOI 10.1534/genetics.105.052415; Mason PB, 2005, MOL CELL, V17, P831, DOI 10.1016/j.molcel.2005.02.017; Oesterreich FC, 2010, MOL CELL, V40, P571, DOI 10.1016/j.molcel.2010.11.004; Ohkuni K, 2011, CURR BIOL, V21, P1695, DOI 10.1016/j.cub.2011.08.056; Pan XW, 2004, MOL CELL, V16, P487, DOI 10.1016/j.molcel.2004.09.035; Perales R, 2009, MOL CELL, V36, P178, DOI 10.1016/j.molcel.2009.09.018; PINTO I, 1994, J BIOL CHEM, V269, P30569; Roguev A, 2008, SCIENCE, V322, P405, DOI 10.1126/science.1162609; Roguev A, 2007, NAT METHODS, V4, P861, DOI 10.1038/NMETH1098; Roguev A, 2013, NAT METHODS, V10, P432, DOI [10.1038/nmeth.2398, 10.1038/NMETH.2398]; Rojas-Duran MF, 2012, RNA, V18, P2299, DOI 10.1261/rna.035865.112; Rosonina E, 2009, MOL CELL BIOL, V29, P2308, DOI 10.1128/MCB.01841-08; Ryan CJ, 2012, MOL CELL, V46, P691, DOI 10.1016/j.molcel.2012.05.028; Schuldiner M, 2006, METHODS, V40, P344, DOI 10.1016/j.ymeth.2006.07.034; Schuldiner M, 2005, CELL, V123, P507, DOI 10.1016/j.cell.2005.08.031; Shaw RJ, 2000, MOL CELL BIOL, V20, P7427, DOI 10.1128/MCB.20.20.7427-7437.2000; Sikorski TW, 2011, MOL CELL, V44, P397, DOI 10.1016/j.molcel.2011.09.013; SPENCER F, 1990, GENETICS, V124, P237; Tan Q, 2003, MOL CELL BIOL, V23, P3329, DOI 10.1128/MCB.23.9.3329-3338.2003; Tavenet A, 2009, P NATL ACAD SCI USA, V106, P14265, DOI 10.1073/pnas.0900162106; Tong AHY, 2004, SCIENCE, V303, P808, DOI 10.1126/science.1091317; Trcek T, 2011, CELL, V147, P1484, DOI 10.1016/j.cell.2011.11.051; Typas A, 2008, NAT METHODS, V5, P781, DOI 10.1038/NMETH.1240; Wang D, 2006, CELL, V127, P941, DOI 10.1016/j.cell.2006.11.023; Wilmes GM, 2008, MOL CELL, V32, P735, DOI 10.1016/j.molcel.2008.11.012; Winston F, 1998, COLD SPRING HARB SYM, V63, P553, DOI 10.1101/sqb.1998.63.553; Wu WH, 1999, GENETICS, V153, P643	73	98	99	0	32	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 15	2013	154	4					775	788		10.1016/j.cell.2013.07.033	http://dx.doi.org/10.1016/j.cell.2013.07.033			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	202GQ	23932120	Green Accepted, Bronze			2022-12-24	WOS:000323202500010
J	Pi, HJ; Hangya, B; Kvitsiani, D; Sanders, JI; Huang, ZJ; Kepecs, A				Pi, Hyun-Jae; Hangya, Balazs; Kvitsiani, Duda; Sanders, Joshua I.; Huang, Z. Josh; Kepecs, Adam			Cortical interneurons that specialize in disinhibitory control	NATURE			English	Article							GABAERGIC NEURONS; IMMUNOREACTIVE INTERNEURONS; DISYNAPTIC INHIBITION; MOLECULAR COMPOSITION; TRANSGENIC MICE; PYRAMIDAL CELLS; VISUAL-CORTEX; INNERVATION; SELECTIVITY; ACTIVATION	In the mammalian cerebral cortex the diversity of interneuronal subtypes underlies a division of labour subserving distinct modes of inhibitory control(1-7). A unique mode of inhibitory control may be provided by inhibitory neurons that specifically suppress the firing of other inhibitory neurons. Such disinhibition could lead to the selective amplification of local processing and serve the important computational functions of gating and gain modulation(8,9). Although several interneuron populations are known to target other interneurons to varying degrees(10-15), little is known about interneurons specializing in disinhibition and their in vivo function. Here we show that a class of interneurons that express vasoactive intestinal polypeptide (VIP) mediates disinhibitory control in multiple areas of neocortex and is recruited by reinforcement signals. By combining optogenetic activation with single-cell recordings, we examined the functional role of VIP interneurons in awake mice, and investigated the underlying circuit mechanisms in vitro in auditory and medial prefrontal cortices. We identified a basic disinhibitory circuit module in which activation of VIP interneurons transiently suppresses primarily somatostatin- and a fraction of parvalbumin-expressing inhibitory interneurons that specialize in the control of the input and output of principal cells, respectively(3,6,16,17). During the performance of an auditory discrimination task, reinforcement signals (reward and punishment) strongly and uniformly activated VIP neurons in auditory cortex, and in turn VIP recruitment increased the gain of a functional subpopulation of principal neurons. These results reveal a specific cell type and microcircuit underlying disinhibitory control in cortex and demonstrate that it is activated under specific behavioural conditions.	[Pi, Hyun-Jae; Hangya, Balazs; Kvitsiani, Duda; Sanders, Joshua I.; Huang, Z. Josh; Kepecs, Adam] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; [Hangya, Balazs] Hungarian Acad Sci, Inst Expt Med, Lab Cerebral Cortex Res, H-1083 Budapest, Hungary	Cold Spring Harbor Laboratory; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Institute of Experimental Medicine	Kepecs, A (corresponding author), Cold Spring Harbor Lab, 1 Bungtown Rd, Cold Spring Harbor, NY 11724 USA.	kepecs@cshl.edu	Hangya, Balazs/H-5964-2019; Core, Vector/CAF-4832-2022	Hangya, Balazs/0000-0003-2709-7407; Kvitsiani, Duda/0000-0003-3175-1774; Kepecs, Adam/0000-0003-0049-8120; Huang, Z. Josh/0000-0003-0592-028X	NIH NINDS [R01NS075531]; Klingenstein Foundation; John Merck Foundation; Sloan Foundation; NIH NIMH [U01MH078844]; Swartz Foundation; EU; Robert Lee and Clara Guthrie Patterson Trust; Human Frontier Science Program; NATIONAL INSTITUTE OF MENTAL HEALTH [U01MH078844] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS075531] Funding Source: NIH RePORTER	NIH NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Klingenstein Foundation(Klingenstein Philanthropies); John Merck Foundation; Sloan Foundation(Alfred P. Sloan Foundation); NIH NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Swartz Foundation; EU(European Commission); Robert Lee and Clara Guthrie Patterson Trust; Human Frontier Science Program(Human Frontier Science Program); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We are grateful to B. Mensh, S. Ranade, N. Spruston and A. M. Zador for comments and discussions; S. Ranade and R. Eifert for assistance for microdrive design; S. G. Koh, A. Reid, H. Li and Y. Kim for help with experimental setup; A. M. Zador for use of in vitro electrophysiology equipment; B. Burbach for technical assistance; and J. Kuhl for help with figures. This research was supported by grants from NIH NINDS R01NS075531, the Klingenstein, John Merck, and Sloan Foundations to A.K. and from NIH NIMH U01MH078844 to Z.J.H. B.H. received support from the Swartz Foundation and Marie Curie International Outgoing Fellowship within the EU Seventh Framework Programme for Research and Technological Development. D.K. received support from The Robert Lee and Clara Guthrie Patterson Trust Postdoctoral Fellowship and Human Frontier Science Program.	Acsady L, 1996, NEUROSCIENCE, V73, P317, DOI 10.1016/0306-4522(95)00609-5; Alitto HJ, 2013, FRONT SYST NEUROSCI, V6, DOI 10.3389/fnsys.2012.00079; Arroyo S, 2012, J NEUROSCI, V32, P3859, DOI 10.1523/JNEUROSCI.0115-12.2012; Ascoli GA, 2008, NAT REV NEUROSCI, V9, P557, DOI 10.1038/nrn2402; Carandini M, 1997, J NEUROSCI, V17, P8621; Cardin JA, 2009, NATURE, V459, P663, DOI 10.1038/nature08002; Chattopadhyaya B, 2004, J NEUROSCI, V24, P9598, DOI 10.1523/JNEUROSCI.1851-04.2004; Csicsvari J, 1998, NEURON, V21, P179, DOI 10.1016/S0896-6273(00)80525-5; David C, 2007, EUR J NEUROSCI, V25, P2329, DOI 10.1111/j.1460-9568.2007.05496.x; Gentet LJ, 2012, NAT NEUROSCI, V15, P607, DOI 10.1038/nn.3051; Hajos N, 1996, EUR J NEUROSCI, V8, P1415, DOI 10.1111/j.1460-9568.1996.tb01604.x; Isaacson JS, 2011, NEURON, V72, P231, DOI 10.1016/j.neuron.2011.09.027; Jiang XL, 2013, NAT NEUROSCI, V16, P210, DOI 10.1038/nn.3305; Kapfer C, 2007, NAT NEUROSCI, V10, P743, DOI 10.1038/nn1909; Katona I, 2006, J NEUROSCI, V26, P5628, DOI 10.1523/JNEUROSCI.0309-06.2006; Kawaguchi Y, 1997, J NEUROPHYSIOL, V78, P1743, DOI 10.1152/jn.1997.78.3.1743; Kvitsiani D, 2013, NATURE, V498, P363, DOI 10.1038/nature12176; Lee SH, 2012, NATURE, V488, P379, DOI 10.1038/nature11312; Letzkus JJ, 2011, NATURE, V480, P331, DOI 10.1038/nature10674; Lorincz A, 2008, J NEUROSCI, V28, P14329, DOI 10.1523/JNEUROSCI.4833-08.2008; Lovett-Barron M, 2012, NAT NEUROSCI, V15, P423, DOI 10.1038/nn.3024; Madisen L, 2012, NAT NEUROSCI, V15, P793, DOI 10.1038/nn.3078; Oliva AA, 2000, J NEUROSCI, V20, P3354, DOI 10.1523/JNEUROSCI.20-09-03354.2000; Paspalas CD, 2001, BRAIN RES, V891, P158, DOI 10.1016/S0006-8993(00)03193-0; Pfeffer CK, 2013, NAT NEUROSCI, V16, P1068, DOI 10.1038/nn.3446; Rudy B, 2011, DEV NEUROBIOL, V71, P45, DOI 10.1002/dneu.20853; Salinas Emilio, 2000, Neuron, V27, P15, DOI 10.1016/S0896-6273(00)00004-0; Schmitzer-Torbert N, 2005, NEUROSCIENCE, V131, P1, DOI 10.1016/j.neuroscience.2004.09.066; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Silberberg G, 2007, NEURON, V53, P735, DOI 10.1016/j.neuron.2007.02.012; Sohal VS, 2009, NATURE, V459, P698, DOI 10.1038/nature07991; Taniguchi H, 2011, NEURON, V71, P995, DOI 10.1016/j.neuron.2011.07.026; Varga V, 2008, J PHYSIOL-LONDON, V586, P3893, DOI 10.1113/jphysiol.2008.155242; Williford T, 2006, J NEUROPHYSIOL, V96, P40, DOI 10.1152/jn.01207.2005; Xu H, 2013, NEURON, V77, P155, DOI 10.1016/j.neuron.2012.11.004; Xu XM, 2010, J COMP NEUROL, V518, P389, DOI 10.1002/cne.22229; Zhang F, 2011, CELL, V147, P1446, DOI 10.1016/j.cell.2011.12.004	37	642	648	3	117	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 28	2013	503	7477					521	+		10.1038/nature12676	http://dx.doi.org/10.1038/nature12676			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	258MU	24097352	Green Accepted			2022-12-24	WOS:000327464200042
J	Dona, E; Barry, JD; Valentin, G; Quirin, C; Khmelinskii, A; Kunze, A; Durdu, S; Newton, LR; Fernandez-Minan, A; Huber, W; Knop, M; Gilmour, D				Dona, Erika; Barry, Joseph D.; Valentin, Guillaume; Quirin, Charlotte; Khmelinskii, Anton; Kunze, Andreas; Durdu, Sevi; Newton, Lionel R.; Fernandez-Minan, Ana; Huber, Wolfgang; Knop, Michael; Gilmour, Darren			Directional tissue migration through a self-generated chemokine gradient	NATURE			English	Article							COLLECTIVE CELL-MIGRATION; LATERAL-LINE; CXCR7; RECEPTOR; GUIDANCE; TARGET; LIGAND; CXCL12	The directed migration of cell collectives is a driving force of embryogenesis(1-3). The predominant view in the field is that cells in embryos navigate along pre-patterned chemoattractant gradients(2). One hypothetical way to free migrating collectives from the requirement of long-range gradients would be through the self-generation of local gradients that travel with them(4,5), a strategy that potentially allows self-determined directionality. However, a lack of tools for the visualization of endogenous guidance cues has prevented the demonstration of such self-generated gradients in vivo. Here we define the in vivo dynamics of one key guidance molecule, the chemokine Cxcl12a, by applying a fluorescent timer approach to measure ligand-triggered receptor turnover in living animals. Using the zebrafish lateral line primordium as a model, we show that migrating cell collectives can self-generate gradients of chemokine activity across their length via polarized receptor-mediated internalization. Finally, by engineering an external source of the atypical receptor Cxcr7 that moves with the primordium, we show that a self-generated gradient mechanism is sufficient to direct robust collective migration. This study thus provides, to our knowledge, the first in vivo proof for self-directed tissue migration through local shaping of an extracellular cue and provides a framework for investigating self-directed migration in many other contexts including cancer invasion(6).	[Dona, Erika; Barry, Joseph D.; Valentin, Guillaume; Quirin, Charlotte; Kunze, Andreas; Durdu, Sevi; Newton, Lionel R.; Fernandez-Minan, Ana; Huber, Wolfgang; Gilmour, Darren] EMBL Heidelberg, D-69117 Heidelberg, Germany; [Khmelinskii, Anton; Knop, Michael] Heidelberg Univ, Zentrum Mol Biol, Deutsch Krebsforschungszentrum, DKFZ ZMBH Allianz, D-69120 Heidelberg, Germany	European Molecular Biology Laboratory (EMBL); Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg	Gilmour, D (corresponding author), EMBL Heidelberg, Meyerhofstr 1, D-69117 Heidelberg, Germany.	gilmour@embl.de	Valentin, Guillaume/AAL-9185-2020; Khmelinskii, Anton/B-2830-2008	Gilmour, Darren/0000-0001-7613-090X; Khmelinskii, Anton/0000-0002-0256-5190; Dona, Erika/0000-0001-9268-3619; Fernandez-Minan, Ana/0000-0002-9502-6785; Barry, Joseph/0000-0002-1177-5771; Kunze, Andreas/0000-0002-4955-1052; Valentin, Guillaume/0000-0003-4596-6282; Huber, Wolfgang/0000-0002-0474-2218; Durdu, Sevi/0000-0001-9746-6779	European Commission's FP7 Network of Excellence 'Systems Microscopy'; Marie Curie FP6; European Molecular Biology Organization; Deutsche Forschungsgemeinschaft [SFB 488]	European Commission's FP7 Network of Excellence 'Systems Microscopy'; Marie Curie FP6; European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	We are grateful to J. Ellenberg, F. Peri and S. De Renzis for comments on the manuscript, S. Streichan and the Gilmour laboratory for suggestions. We thank R. Koester and M. Distel for the lateral line Gal4-driver, E. Busch-Nentwich and D. Stemple for the cxcr7 mutant identified by the Zebrafish Mutation Project, the European Molecular Biology Laboratory (EMBL) Monoclonal Antibody Facility for Cxcr7 and Cxcr4b antibodies, the EMBL Advanced Light Microscopy Facility for imaging assistance, B. Klaus from the EMBL Centre for Statistical Data Analysis for advice and A. Gruia for fish care. We acknowledge funding from the European Commission's FP7 Network of Excellence 'Systems Microscopy' (W. H. and J. D. B.), Marie Curie FP6 (A. F.-M.), European Molecular Biology Organization (A.Kh) and Deutsche Forschungsgemeinschaft SFB 488 (D.G.).	Boldajipour B, 2008, CELL, V132, P463, DOI 10.1016/j.cell.2007.12.034; Canals M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034192; Dambly-Chaudiere C, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-23; David NB, 2002, P NATL ACAD SCI USA, V99, P16297, DOI 10.1073/pnas.252339399; Distel M, 2009, P NATL ACAD SCI USA, V106, P13365, DOI 10.1073/pnas.0903060106; Friedl P, 2012, NAT CELL BIOL, V14, P777, DOI 10.1038/ncb2548; Friedl P, 2009, NAT REV MOL CELL BIO, V10, P445, DOI 10.1038/nrm2720; Ghysen A, 2007, GENE DEV, V21, P2118, DOI 10.1101/gad.1568407; Gilmour D, 2004, NAT NEUROSCI, V7, P491, DOI 10.1038/nn1235; Haas P, 2006, DEV CELL, V10, P673, DOI 10.1016/j.devcel.2006.02.019; Hernandez L, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr3074; Kettleborough RNW, 2013, NATURE, V496, P494, DOI 10.1038/nature11992; Khmelinskii A, 2012, NAT BIOTECHNOL, V30, P708, DOI 10.1038/nbt.2281; Knaut H, 2003, NATURE, V421, P279, DOI 10.1038/nature01338; Kwan KM, 2007, DEV DYNAM, V236, P3088, DOI 10.1002/dvdy.21343; Lee E, 2013, PIGM CELL MELANOMA R, V26, P58, DOI 10.1111/pcmr.12024; Levoye A, 2009, BLOOD, V113, P6085, DOI 10.1182/blood-2008-12-196618; Luker KE, 2012, ONCOGENE, V31, P4750, DOI 10.1038/onc.2011.633; Minina S, 2007, CURR BIOL, V17, P1164, DOI 10.1016/j.cub.2007.05.073; Montell DJ, 2008, SCIENCE, V322, P1502, DOI 10.1126/science.1164073; Muller A, 2001, NATURE, V410, P50, DOI 10.1038/35065016; Nakayama M, 2013, NAT CELL BIOL, V15, P249, DOI 10.1038/ncb2679; Naumann U, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009175; Pau G, 2010, BIOINFORMATICS, V26, P979, DOI 10.1093/bioinformatics/btq046; Peri F, 2008, CELL, V133, P916, DOI 10.1016/j.cell.2008.04.037; Preibisch S, 2009, BIOINFORMATICS, V25, P1463, DOI 10.1093/bioinformatics/btp184; Rajagopal S, 2010, P NATL ACAD SCI USA, V107, P628, DOI 10.1073/pnas.0912852107; Rorth P, 2011, DEV CELL, V20, P9, DOI 10.1016/j.devcel.2010.12.014; Scherber C, 2012, INTEGR BIOL-UK, V4, P259, DOI 10.1039/c2ib00106c; Siekmann AF, 2009, GENE DEV, V23, P2272, DOI 10.1101/gad.1813509; Streichan SJ, 2011, PHYS BIOL, V8, DOI 10.1088/1478-3975/8/4/045004; Valentin G, 2007, CURR BIOL, V17, P1026, DOI 10.1016/j.cub.2007.05.020; Weijer CJ, 2009, J CELL SCI, V122, P3215, DOI 10.1242/jcs.036517; Westerfield M., 1993, ZEBRAFISH BOOK GUIDE; Zhang YM, 2000, NAT BIOTECHNOL, V18, P1314, DOI 10.1038/82449	35	232	239	3	98	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 14	2013	503	7475					285	+		10.1038/nature12635	http://dx.doi.org/10.1038/nature12635			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	250YX	24067609				2022-12-24	WOS:000326894200056
J	Gao, DX; Wu, JX; Wu, YT; Du, FH; Aroh, C; Yan, N; Sun, LJ; Chen, ZJJ				Gao, Daxing; Wu, Jiaxi; Wu, You-Tong; Du, Fenghe; Aroh, Chukwuemika; Yan, Nan; Sun, Lijun; Chen, Zhijian J.			Cyclic GMP-AMP Synthase Is an Innate Immune Sensor of HIV and Other Retroviruses	SCIENCE			English	Article							DNA SENSOR; 2ND-MESSENGER; DINUCLEOTIDE	Retroviruses, including HIV, can activate innate immune responses, but the host sensors for retroviruses are largely unknown. Here we show that HIV infection activates cyclic guanosine monophosphate-adenosine monophosphate (cGAMP) synthase (cGAS) to produce cGAMP, which binds to and activates the adaptor protein STING to induce type I interferons and other cytokines. Inhibitors of HIV reverse transcriptase, but not integrase, abrogated interferon-beta induction by the virus, suggesting that the reverse-transcribed HIV DNA triggers the innate immune response. Knockout or knockdown of cGAS in mouse or human cell lines blocked cytokine induction by HIV, murine leukemia virus, and simian immunodeficiency virus. These results indicate that cGAS is an innate immune sensor of HIV and other retroviruses.	[Gao, Daxing; Wu, Jiaxi; Wu, You-Tong; Du, Fenghe; Sun, Lijun; Chen, Zhijian J.] Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA; [Du, Fenghe; Sun, Lijun; Chen, Zhijian J.] Univ Texas SW Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA; [Aroh, Chukwuemika; Yan, Nan] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA; [Aroh, Chukwuemika; Yan, Nan] Univ Texas SW Med Ctr Dallas, Dept Microbiol, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Chen, ZJJ (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA.	Zhijian.Chen@UTSouthwestern.edu	Wu, Jiaxi/K-3322-2016; Gao, Daxing/J-4733-2017; Sun, Lijun/ABD-4470-2021; Chen, Zhijian/C-6039-2012	Wu, Jiaxi/0000-0002-6976-4784; Gao, Daxing/0000-0002-1493-4467; Chen, Zhijian/0000-0002-8475-8251	NIH [R01-AI093967, RO1-AI098569]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI093967, R01AI098569] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank X. Chen for assistance with mass spectrometry. The data presented in this manuscript are tabulated in the main paper and in the supplementary materials. Materials including the cGAS knockout cell lines may be requested upon signing of a materials transfer agreement. This work was supported by NIH grants to Z.J.C. (R01-AI093967) and N.Y. (RO1-AI098569). Z.J.C is an investigator of the Howard Hughes Medical Institute.	Ablasser A, 2013, NATURE, V498, P380, DOI 10.1038/nature12306; Barber GN, 2011, IMMUNOL REV, V243, P99, DOI 10.1111/j.1600-065X.2011.01051.x; Cermak T, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr218; Crow YJ, 2006, NAT GENET, V38, P917, DOI 10.1038/ng1845; Diner EJ, 2013, CELL REP, V3, P1355, DOI 10.1016/j.celrep.2013.05.009; Gao P, 2013, CELL, V153, P1094, DOI 10.1016/j.cell.2013.04.046; Iwasaki A, 2010, SCIENCE, V327, P291, DOI 10.1126/science.1183021; Levy DE, 2002, NAT REV MOL CELL BIO, V3, P651, DOI 10.1038/nrm909; Luban J, 2012, CELL HOST MICROBE, V12, P408, DOI 10.1016/j.chom.2012.10.002; Manel N, 2011, CELL, V147, P271, DOI 10.1016/j.cell.2011.09.010; Manel N, 2010, NATURE, V467, P214, DOI 10.1038/nature09337; Medzhitov R, 2008, NATURE, V455, P591, DOI 10.1038/455591a; Ronald PC, 2010, SCIENCE, V330, P1061, DOI 10.1126/science.1189468; Stetson DB, 2008, CELL, V134, P587, DOI 10.1016/j.cell.2008.06.032; Sun LJ, 2013, SCIENCE, V339, P786, DOI 10.1126/science.1232458; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Wu JX, 2013, SCIENCE, V339, P826, DOI 10.1126/science.1229963; Yan N, 2012, NAT IMMUNOL, V13, P214, DOI 10.1038/ni.2229; Yan N, 2010, NAT IMMUNOL, V11, P1005, DOI 10.1038/ni.1941; Zhang X, 2013, MOL CELL, V51, P226, DOI 10.1016/j.molcel.2013.05.022	20	655	695	7	182	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 23	2013	341	6148					903	906		10.1126/science.1240933	http://dx.doi.org/10.1126/science.1240933			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204MY	23929945	Green Accepted			2022-12-24	WOS:000323370600047
J	Halbach, F; Reichelt, P; Rode, M; Conti, E				Halbach, Felix; Reichelt, Peter; Rode, Michaela; Conti, Elena			The Yeast Ski Complex: Crystal Structure and RNA Channeling to the Exosome Complex	CELL			English	Article							MESSENGER-RNA; QUALITY-CONTROL; MEIOTIC RECOMBINATION; RIBOSOMAL-RNA; NUCLEAR-RNA; SACCHAROMYCES-CEREVISIAE; EUKARYOTIC EXOSOME; POLY(A) POLYMERASE; DEGRADATION; PROTEIN	The Ski complex is a conserved multiprotein assembly required for the cytoplasmic functions of the exosome, including RNA turnover, surveillance, and interference. Ski2, Ski3, and Ski8 assemble in a tetramer with 1: 1: 2 stoichiometry. The crystal structure of an S. cerevisiae 370 kDa core complex shows that Ski3 forms an array of 33 TPR motifs organized in N-terminal and C-terminal arms. The C-terminal arm of Ski3 and the two Ski8 subunits position the helicase core of Ski2 centrally within the complex, enhancing RNA binding. The Ski3 N-terminal arm and the Ski2 insertion domain allosterically modulate the ATPase and helicase activities of the complex. Biochemical data suggest that the Ski complex can thread RNAs directly to the exosome, coupling the helicase and the exoribonuclease through a continuous RNA channel. Finally, we identify a Ski8-binding motif common to Ski3 and Spo11, rationalizing the moonlighting properties of Ski8 in mRNA decay and meiosis.	[Halbach, Felix; Reichelt, Peter; Rode, Michaela; Conti, Elena] Max Planck Inst Biochem, Dept Struct Cell Biol, D-82152 Martinsried, Germany	Max Planck Society	Conti, E (corresponding author), Max Planck Inst Biochem, Dept Struct Cell Biol, Klopferspitz 18A, D-82152 Martinsried, Germany.	conti@biochem.mpg.de		Conti, Elena/0000-0003-1254-5588	Boehringer Ingelheim Fonds; Max Planck Gesellschaft; European Research Council (ERC) [294371]; European Research Council (ITN RNPnet); Deutsche Forschungsgemeinschaft [DFG SFB646, SFB1035, GRK1721, FOR1680]; Deutsche Forschungsgemeinschaft (CIPSM)	Boehringer Ingelheim Fonds(Boehringer Ingelheim); Max Planck Gesellschaft(Max Planck Society); European Research Council (ERC)(European Research Council (ERC)); European Research Council (ITN RNPnet); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Deutsche Forschungsgemeinschaft (CIPSM)(German Research Foundation (DFG))	We thank the MPI-Biochemistry Core Facility and Crystallization Facility, F. Bonneau for help with biochemical assays, E. Kowalinski, J. Ebert, and D. Makino for exosome samples or plasmids, and S. Chakrabarti for Upf1 samples. We also thank the staff of the Swiss Light Source synchrotron for assistance during data collection and Z. Storchova, S. Jentsch, and the CSH course on yeast genetics for guidance and training in the in vivo experiments. We also thank M. Krause for the drawing in Figure 6B and the members of our lab for discussions and for critical reading of the manuscript. This study was supported by the Boehringer Ingelheim Fonds (to F. H.), the Max Planck Gesellschaft, the European Research Council (ERC Advanced Investigator Grant 294371 and ITN RNPnet), and the Deutsche Forschungsgemeinschaft (DFG SFB646, SFB1035, GRK1721, FOR1680, and CIPSM; to E. C.). F. H. purified proteins and conducted crystallization and structure determination as well as all in vitro assays. P. R. generated and analyzed yeast strains. M. R. carried out the insect-cell expression. E. C. supervised the project. F. H. and E. C. wrote the manuscript.	Allmang C, 1999, EMBO J, V18, P5399, DOI 10.1093/emboj/18.19.5399; Anderson JSJ, 1998, EMBO J, V17, P1497, DOI 10.1093/emboj/17.5.1497; Araki Y, 2001, EMBO J, V20, P4684, DOI 10.1093/emboj/20.17.4684; Arora C, 2004, MOL CELL, V13, P549, DOI 10.1016/S1097-2765(04)00063-2; Bergerat A, 1997, NATURE, V386, P414, DOI 10.1038/386414a0; Bernstein J, 2010, BIOCHEMISTRY-US, V49, P10357, DOI 10.1021/bi101518x; Bonneau F, 2009, CELL, V139, P547, DOI 10.1016/j.cell.2009.08.042; Bradley MJ, 2012, METHOD ENZYMOL, V511, P29, DOI 10.1016/B978-0-12-396546-2.00002-4; Brown JT, 2000, RNA, V6, P449, DOI 10.1017/S1355838200991787; Buttner K, 2007, NAT STRUCT MOL BIOL, V14, P647, DOI 10.1038/nsmb1246; Chakrabarti S, 2011, MOL CELL, V41, P693, DOI 10.1016/j.molcel.2011.02.010; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cheng ZH, 2004, PROTEIN SCI, V13, P2673, DOI 10.1110/ps.04856504; D'Andrea LD, 2003, TRENDS BIOCHEM SCI, V28, P655, DOI 10.1016/j.tibs.2003.10.007; Das AK, 1998, EMBO J, V17, P1192, DOI 10.1093/emboj/17.5.1192; de la Cruz J, 1998, EMBO J, V17, P1128, DOI 10.1093/emboj/17.4.1128; DeLaBarre B, 2006, ACTA CRYSTALLOGR D, V62, P923, DOI 10.1107/S0907444906012650; Dziembowski A, 2007, NAT STRUCT MOL BIOL, V14, P15, DOI 10.1038/nsmb1184; Garneau NL, 2007, NAT REV MOL CELL BIO, V8, P113, DOI 10.1038/nrm2104; Halbach F, 2012, RNA, V18, P124, DOI 10.1261/rna.029553.111; HIRANO T, 1990, CELL, V60, P319, DOI 10.1016/0092-8674(90)90746-2; Houseley J, 2006, NAT REV MOL CELL BIO, V7, P529, DOI 10.1038/nrm1964; Houseley J, 2009, CELL, V136, P763, DOI 10.1016/j.cell.2009.01.019; Jackson RN, 2010, EMBO J, V29, P2205, DOI 10.1038/emboj.2010.107; JOHNSON AW, 1995, MOL CELL BIOL, V15, P2719; Karpenahalli MR, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-2; Kish-Trier E, 2013, ANNU REV BIOPHYS, V42, P29, DOI 10.1146/annurev-biophys-083012-130417; Klauer AA, 2013, NUCLEIC ACIDS RES, V41, P533, DOI 10.1093/nar/gks1013; LaCava J, 2005, CELL, V121, P713, DOI 10.1016/j.cell.2005.04.029; LARIMER FW, 1990, GENE, V95, P85, DOI 10.1016/0378-1119(90)90417-P; Lebreton A, 2008, BBA-GENE REGUL MECH, V1779, P558, DOI 10.1016/j.bbagrm.2008.02.003; Liu QS, 2006, CELL, V127, P1223, DOI 10.1016/j.cell.2006.10.037; Lorentzen E, 2006, CELL, V125, P651, DOI 10.1016/j.cell.2006.05.002; Lucius AL, 2003, BIOPHYS J, V85, P2224, DOI 10.1016/S0006-3495(03)74648-7; Lykke-Andersen S, 2009, J CELL SCI, V122, P1487, DOI 10.1242/jcs.047399; Madrona AY, 2004, PROTEIN SCI, V13, P1557, DOI 10.1110/ps.04704704; Makino DL, 2013, NATURE, V495, P70, DOI 10.1038/nature11870; Mitchell P, 2003, MOL CELL, V11, P1405, DOI 10.1016/S1097-2765(03)00190-4; Mitchell P, 1997, CELL, V91, P457, DOI 10.1016/S0092-8674(00)80432-8; Nichols MD, 1999, EMBO J, V18, P6177, DOI 10.1093/emboj/18.21.6177; Orban TI, 2005, RNA, V11, P459, DOI 10.1261/rna.7231505; Pyle AM, 2008, ANNU REV BIOPHYS, V37, P317, DOI 10.1146/annurev.biophys.37.032807.125908; Schaeffer D, 2009, NAT STRUCT MOL BIOL, V16, P56, DOI 10.1038/nsmb.1528; Schrodinger LCC, 2022, PYMOL MOL GRAPHICS S; SIKORSKI RS, 1990, CELL, V60, P307, DOI 10.1016/0092-8674(90)90745-Z; Stirnimann CU, 2010, TRENDS BIOCHEM SCI, V35, P565, DOI 10.1016/j.tibs.2010.04.003; Synowsky SA, 2008, PROTEIN SCI, V17, P119, DOI 10.1110/ps.073155908; Van Hoof A, 2000, MOL CELL BIOL, V20, P441, DOI 10.1128/MCB.20.2.441-452.2000; van Hoof A, 2000, MOL CELL BIOL, V20, P8230, DOI 10.1128/MCB.20.21.8230-8243.2000; van Hoof A, 1999, CELL, V99, P347, DOI 10.1016/S0092-8674(00)81520-2; van Hoof A, 2002, SCIENCE, V295, P2262, DOI 10.1126/science.1067272; Vanacova S, 2005, PLOS BIOL, V3, P986, DOI 10.1371/journal.pbio.0030189; Vanacova S, 2007, EMBO REP, V8, P651, DOI 10.1038/sj.embor.7401005; Wang LN, 2005, RNA, V11, P1291, DOI 10.1261/rna.2060405; Wasmuth EV, 2012, MOL CELL, V48, P133, DOI 10.1016/j.molcel.2012.07.012; Weir JR, 2010, P NATL ACAD SCI USA, V107, P12139, DOI 10.1073/pnas.1004953107; Wyers F, 2005, CELL, V121, P725, DOI 10.1016/j.cell.2005.04.030	57	115	119	2	39	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	AUG 15	2013	154	4					814	826		10.1016/j.cell.2013.07.017	http://dx.doi.org/10.1016/j.cell.2013.07.017			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	202GQ	23953113	Bronze			2022-12-24	WOS:000323202500013
J	Dalton, RP; Lyons, DB; Lomvardas, S				Dalton, Ryan P.; Lyons, David B.; Lomvardas, Stavros			Co-Opting the Unfolded Protein Response to Elicit Olfactory Receptor Feedback	CELL			English	Article							MAMMALIAN ODORANT RECEPTORS; PLASMA-CELL DIFFERENTIATION; TRANSCRIPTION FACTOR XBP-1; FUNCTIONAL EXPRESSION; GENE-EXPRESSION; SENSORY NEURONS; TRANSLATIONAL CONTROL; MOUSE; ATF5; SURVIVAL	Olfactory receptor (OR) expression requires the transcriptional activation of 1 out of 1,000s of OR alleles and a feedback signal that preserves this transcriptional choice. The mechanism by which olfactory sensory neurons (OSNs) detect ORs to signal to the nucleus remains elusive. Here, we show that OR proteins generate this feedback by activating the unfolded protein response (UPR). OR expression induces Perk-mediated phosphorylation of the translation initiation factor eif2 alpha causing selective translation of activating transcription factor 5 (ATF5). ATF5 induces the transcription of adenylyl cyclase 3 (Adcy3), which relieves the UPR. Our data provide a role for the UPR in defining neuronal identity and cell fate commitment and support a two-step model for the feedback signal: (1) OR protein, as a stress stimulus, alters the translational landscape of the OSN and induces Adcy3 expression; (2), Adcy3 relieves that stress, restores global translation, and makes OR choice permanent.	[Dalton, Ryan P.; Lyons, David B.; Lomvardas, Stavros] Univ Calif San Francisco, Dept Anat, San Francisco, CA 94158 USA; [Dalton, Ryan P.; Lomvardas, Stavros] Univ Calif San Francisco, Grad Program Neurosci, San Francisco, CA 94158 USA; [Lyons, David B.; Lomvardas, Stavros] Univ Calif San Francisco, Tetrad Grad Program, San Francisco, CA 94158 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Lomvardas, S (corresponding author), Univ Calif San Francisco, Dept Anat, San Francisco, CA 94158 USA.	stavros.lomvardas@ucsf.edu		Lyons, David/0000-0002-5721-4080; Lomvardas, Stavros/0000-0002-7668-3026	McKnight Endowment fund for Neuroscience; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007810] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD006667] Funding Source: NIH RePORTER	McKnight Endowment fund for Neuroscience; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We would like to thank Drs. Richard Axel, Nirao Shah, Peter Walter, Zachary Knight, and Gilad Barnea and members of the Lomvardas lab for input, suggestions and discussions and for critical comments on the manuscript. Natalia Zyma, Zoe Evans, and Shohei Kitano provided excellent technical assistance for this project. We are also grateful to Dr. David Ron for allowing us access to the Perk KO mice and to Dr. Peter Walter for transferring Perk +/- mice to our colony and for inspiring this project. Finally we would like to thank Dr. Townes and Dr. Glimcher for the ATF4 and Xbp1 KO mice, respectively. This project was funded by a scholar award from the McKnight Endowment fund for Neuroscience.	Barnea G, 2004, SCIENCE, V304, P1468, DOI 10.1126/science.1096146; BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; CHESS A, 1994, CELL, V78, P823, DOI 10.1016/S0092-8674(94)90562-2; Clowney EJ, 2012, CELL, V151, P724, DOI 10.1016/j.cell.2012.09.043; Clowney EJ, 2011, GENOME RES, V21, P1249, DOI 10.1101/gr.120162.110; Colquitt BM, 2013, P NATL ACAD SCI USA, V110, P14682, DOI 10.1073/pnas.1302759110; Dey S, 2011, P NATL ACAD SCI USA, V108, P16651, DOI 10.1073/pnas.1018140108; Feinstein P, 2004, CELL, V117, P817, DOI 10.1016/j.cell.2004.05.011; Feinstein P, 2004, CELL, V117, P833, DOI 10.1016/j.cell.2004.05.013; Fleischmann A, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001568; Hansen MB, 2002, GENOMICS, V80, P344, DOI 10.1006/geno.2002.6838; Harding HP, 2000, MOL CELL, V5, P897, DOI 10.1016/S1097-2765(00)80330-5; Harding HP, 2000, MOL CELL, V6, P1099, DOI 10.1016/S1097-2765(00)00108-8; Imai T, 2006, SCIENCE, V314, P657, DOI 10.1126/science.1131794; Iwakoshi NN, 2003, NAT IMMUNOL, V4, P321, DOI 10.1038/ni907; Iwakoshi NN, 2003, IMMUNOL REV, V194, P29, DOI 10.1034/j.1600-065X.2003.00057.x; Lewcock JW, 2004, P NATL ACAD SCI USA, V101, P1069, DOI 10.1073/pnas.0307986100; Lomvardas S, 2006, CELL, V126, P403, DOI 10.1016/j.cell.2006.06.035; Lyons DB, 2013, CELL, V154, P325, DOI 10.1016/j.cell.2013.06.039; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Magklara A, 2013, TRENDS CELL BIOL, V23, P449, DOI 10.1016/j.tcb.2013.04.005; Magklara A, 2011, CELL, V145, P555, DOI 10.1016/j.cell.2011.03.040; Matsunami H, 2005, CHEM SENSES, V30, pI95, DOI 10.1093/chemse/bjh131; Matsunami H, 2009, ANN NY ACAD SCI, V1170, P153, DOI 10.1111/j.1749-6632.2009.03888.x; Nguyen MQ, 2007, CELL, V131, P1009, DOI 10.1016/j.cell.2007.10.050; Niimura Y, 2005, P NATL ACAD SCI USA, V102, P6039, DOI 10.1073/pnas.0501922102; PACE U, 1985, NATURE, V316, P255, DOI 10.1038/316255a0; Reimold AM, 2001, NATURE, V412, P300, DOI 10.1038/35085509; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Saito H, 2004, CELL, V119, P679, DOI 10.1016/j.cell.2004.11.021; Sammeta N, 2007, J COMP NEUROL, V502, P1138, DOI 10.1002/cne.21365; Sammeta N, 2010, J COMP NEUROL, V518, P1825, DOI 10.1002/cne.22305; Scheuner D, 2001, MOL CELL, V7, P1165, DOI 10.1016/S1097-2765(01)00265-9; Serizawa S, 2003, SCIENCE, V302, P2088, DOI 10.1126/science.1089122; Shykind BM, 2004, CELL, V117, P801, DOI 10.1016/j.cell.2004.05.015; SPEAKE B K, 1980, Biochemical Society Transactions, V8, P166; Wang SZ, 2012, P NATL ACAD SCI USA, V109, P18589, DOI 10.1073/pnas.1210479109; Watatani Y, 2008, J BIOL CHEM, V283, P2543, DOI 10.1074/jbc.M707781200; Zhang XM, 2002, NAT NEUROSCI, V5, P124, DOI 10.1038/nn800; Zhou DH, 2008, J BIOL CHEM, V283, P7064, DOI 10.1074/jbc.M708530200; Zhuang HY, 2007, J BIOL CHEM, V282, P15284, DOI 10.1074/jbc.M700386200	41	84	85	0	16	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 10	2013	155	2					321	332		10.1016/j.cell.2013.09.033	http://dx.doi.org/10.1016/j.cell.2013.09.033			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	235LH	24120133	Green Accepted, Bronze			2022-12-24	WOS:000325719800010
J	Doksani, Y; Wu, JY; de Lange, T; Zhuang, XW				Doksani, Ylli; Wu, John Y.; de Lange, Titia; Zhuang, Xiaowei			Super-Resolution Fluorescence Imaging of Telomeres Reveals TRF2-Dependent T-loop Formation	CELL			English	Article							END-PROTECTION PROBLEM; DNA-DAMAGE RESPONSE; MAMMALIAN TELOMERES; DYSFUNCTIONAL TELOMERES; HOLLIDAY JUNCTIONS; NUCLEAR-MATRIX; POT1 PROTEINS; IN-VITRO; TRF2; COMPLEX	We have applied a super-resolution fluorescence imaging method, stochastic optical reconstruction microscopy (STORM), to visualize the structure of functional telomeres and telomeres rendered dysfunctional through removal of shelterin proteins. The STORM images showed that functional telomeres frequently exhibit a t-loop configuration. Conditional deletion of individual components of shelterin showed that TRF2 was required for the formation and/or maintenance of t-loops, whereas deletion of TRF1, Rap1, or the POT1 proteins (POT1a and POT1b) had no effect on the frequency of t-loop occurrence. Within the shelterin complex, TRF2 uniquely serves to protect telomeres from two pathways that are initiated on free DNA ends: classical nonhomologous end-joining (NHEJ) and ATM-dependent DNA damage signaling. The TRF2-dependent remodeling of telomeres into t-loop structures, which sequester the ends of chromosomes, can explain why NHEJ and the ATM signaling pathway are repressed when TRF2 is present.	[Doksani, Ylli; de Lange, Titia] Rockefeller Univ, Lab Cell Biol & Genet, New York, NY 10065 USA; [Wu, John Y.] Harvard Univ, Howard Hughes Med Inst, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; [Wu, John Y.; Zhuang, Xiaowei] Harvard Univ, Howard Hughes Med Inst, Dept Chem & Chem Biol, Cambridge, MA 02138 USA; [Zhuang, Xiaowei] Harvard Univ, Howard Hughes Med Inst, Dept Phys, Cambridge, MA 02138 USA	Rockefeller University; Harvard University; Howard Hughes Medical Institute; Harvard University; Howard Hughes Medical Institute; Harvard University; Howard Hughes Medical Institute	de Lange, T (corresponding author), Rockefeller Univ, Lab Cell Biol & Genet, New York, NY 10065 USA.	delange@mail.rockefeller.edu; zhuang@chemistry.harvard.edu	de Lange, Titia/B-8263-2011	de Lange, Titia/0000-0002-9267-367X; Doksani, Ylli/0000-0002-2392-5722	National Science Foundation; NIH [AG016642, GM049046, GM068518, GM096450]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM096450, R01GM068518, R01GM049046, R37GM049046] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG016642] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We are grateful to members of the de Lange and Zhuang labs for comments on this manuscript. Y.D. is an Ellison Medical Foundation/AFAR Fellow of the Life Sciences Research Foundation. J.Y.W. was supported as a National Science Foundation Graduate Research fellow. This work was supported by grants from the NIH to T.d.L. (AG016642 and GM049046) and to X.Z. (GM068518 and GM096450). T.d.L. is an American Cancer Society Research Professor. X.Z. is a Howard Hughes Medical Institute Investigator.	Amiard S, 2007, NAT STRUCT MOL BIOL, V14, P147, DOI 10.1038/nsmb1192; Arat NO, 2012, J BIOL CHEM, V287, P41583, DOI 10.1074/jbc.M112.415984; Artandi SE, 2010, CARCINOGENESIS, V31, P9, DOI 10.1093/carcin/bgp268; Azzalin CM, 2007, SCIENCE, V318, P798, DOI 10.1126/science.1147182; Bates M, 2007, SCIENCE, V317, P1749, DOI 10.1126/science.1146598; Bianchi A, 1999, EMBO J, V18, P5735, DOI 10.1093/emboj/18.20.5735; Bianchi A, 1997, EMBO J, V16, P1785, DOI 10.1093/emboj/16.7.1785; Callegari AJ, 2007, CELL CYCLE, V6, P660, DOI 10.4161/cc.6.6.3984; Celli GB, 2005, NAT CELL BIOL, V7, P712, DOI 10.1038/ncb1275; Chapman JR, 2013, MOL CELL, V49, P858, DOI 10.1016/j.molcel.2013.01.002; Cotta-Ramusino C, 2011, SCIENCE, V332, P1313, DOI 10.1126/science.1203430; de Lange T, 2009, SCIENCE, V326, P948, DOI 10.1126/science.1170633; DELANGE T, 1992, EMBO J, V11, P717, DOI 10.1002/j.1460-2075.1992.tb05104.x; Denchi EL, 2007, NATURE, V448, P1068, DOI 10.1038/nature06065; Diotti R, 2011, NUCLEUS-PHILA, V2, P119, DOI 10.4161/nucl.2.2.15135; Feuerhahn S, 2010, FEBS LETT, V584, P3812, DOI 10.1016/j.febslet.2010.07.032; Gong Y, 2010, MOL CELL, V40, P377, DOI 10.1016/j.molcel.2010.10.016; Griffith J, 1998, J MOL BIOL, V278, P79, DOI 10.1006/jmbi.1998.1686; Griffith JD, 1999, CELL, V97, P503, DOI 10.1016/S0092-8674(00)80760-6; Guo X, 2007, EMBO J, V26, P4709, DOI 10.1038/sj.emboj.7601893; Hockemeyer D, 2008, GENE DEV, V22, P1773, DOI 10.1101/gad.1679208; Hockemeyer D, 2006, CELL, V126, P63, DOI 10.1016/j.cell.2006.04.044; Huang B, 2008, SCIENCE, V319, P810, DOI 10.1126/science.1153529; Huang B, 2010, CELL, V143, P1047, DOI 10.1016/j.cell.2010.12.002; Huang B, 2008, NAT METHODS, V5, P1047, DOI 10.1038/nmeth.1274; Karlseder J, 1999, SCIENCE, V283, P1321, DOI 10.1126/science.283.5406.1321; Kibe T, 2010, MOL CELL BIOL, V30, P1059, DOI 10.1128/MCB.01498-09; KIPLING D, 1990, NATURE, V347, P400, DOI 10.1038/347400a0; Lieber MR, 2010, ANNU REV BIOCHEM, V79, P181, DOI 10.1146/annurev.biochem.052308.093131; Luderus ME, 1996, J CELL BIOL, V135, P867, DOI 10.1083/jcb.135.4.867; Martinez P, 2010, NAT CELL BIOL, V12, P768, DOI 10.1038/ncb2081; Martinez P, 2009, GENE DEV, V23, P2060, DOI 10.1101/gad.543509; McClintock B, 1941, GENETICS, V26, P234; McClintock B., 1938, COLLECTED PAPERS B M, P1; Nam EA, 2011, BIOCHEM J, V436, P527, DOI 10.1042/BJ20102162; Nikitina T, 2004, J CELL BIOL, V166, P161, DOI 10.1083/jcb.200403118; Nora GJ, 2010, NUCLEIC ACIDS RES, V38, P3984, DOI 10.1093/nar/gkq144; O'Sullivan RJ, 2010, NAT REV MOL CELL BIO, V11, P171, DOI 10.1038/nrm2848; Okamoto K, 2013, NATURE, V494, P502, DOI 10.1038/nature11873; ORRWEAVER TL, 1981, P NATL ACAD SCI-BIOL, V78, P6354, DOI 10.1073/pnas.78.10.6354; Palm W, 2009, MOL CELL BIOL, V29, P471, DOI 10.1128/MCB.01352-08; Palm W, 2008, ANNU REV GENET, V42, P301, DOI 10.1146/annurev.genet.41.110306.130350; Pierron G, 1999, CHROMOSOME RES, V7, P581, DOI 10.1023/A:1009253917125; Pipkin ME, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl006; Poulet A, 2009, EMBO J, V28, P641, DOI 10.1038/emboj.2009.11; Rai R, 2010, EMBO J, V29, P2598, DOI 10.1038/emboj.2010.142; Savage SA, 2010, GENET MED, V12, P753, DOI 10.1097/GIM.0b013e3181f415b5; Sfeir A, 2012, SCIENCE, V336, P593, DOI 10.1126/science.1218498; Sfeir A, 2010, SCIENCE, V327, P1657, DOI 10.1126/science.1185100; Sfeir A, 2009, CELL, V138, P90, DOI 10.1016/j.cell.2009.06.021; Smogorzewska A, 2002, CURR BIOL, V12, P1635, DOI 10.1016/S0960-9822(02)01179-X; Stansel RM, 2001, EMBO J, V20, P5532; Stracker TH, 2011, NAT REV MOL CELL BIO, V12, P90, DOI 10.1038/nrm3047; Takai KK, 2011, MOL CELL, V44, P647, DOI 10.1016/j.molcel.2011.08.043; Tejera AM, 2010, DEV CELL, V18, P775, DOI [10.1016/j.devcel.2010.03.011, 10.1016/j.devce1.2010.03.011]; van Steensel B, 1998, CELL, V92, P401, DOI 10.1016/S0092-8674(00)80932-0; Verdun RE, 2006, CELL, V127, P709, DOI 10.1016/j.cell.2006.09.034; Wu P, 2012, CELL, V150, P39, DOI 10.1016/j.cell.2012.05.026; Zimmermann M, 2013, SCIENCE, V339, P700, DOI 10.1126/science.1231573	59	297	306	4	159	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 10	2013	155	2					345	356		10.1016/j.cell.2013.09.048	http://dx.doi.org/10.1016/j.cell.2013.09.048			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	235LH	24120135	Green Accepted, Bronze			2022-12-24	WOS:000325719800012
J	Schneeberger, M; Dietrich, MO; Sebastian, D; Imbernon, M; Castano, C; Garcia, A; Esteban, Y; Gonzalez-Franquesa, A; Rodriguez, IC; Bortolozzi, A; Garcia-Roves, PM; Gomis, R; Nogueiras, R; Horvath, TL; Zorzano, A; Claret, M				Schneeberger, Marc; Dietrich, Marcelo O.; Sebastian, David; Imbernon, Monica; Castano, Carlos; Garcia, Ainhoa; Esteban, Yaiza; Gonzalez-Franquesa, Alba; Castrillon Rodriguez, Ignacio; Bortolozzi, Analia; Garcia-Roves, Pablo M.; Gomis, Ramon; Nogueiras, Ruben; Horvath, Tamas L.; Zorzano, Antonio; Claret, Marc			Mitofusin 2 in POMC Neurons Connects ER Stress with Leptin Resistance and Energy Imbalance	CELL			English	Article							ENDOPLASMIC-RETICULUM STRESS; DIET-INDUCED OBESITY; MITOCHONDRIAL FUSION; HOMEOSTASIS REGULATION; SKELETAL-MUSCLE; AGRP NEURONS; FOOD-INTAKE; MFN2; METABOLISM; INSULIN	Mitofusin 2 (MFN2) plays critical roles in both mitochondrial fusion and the establishment of mitochondria- endoplasmic reticulum (ER) interactions. Hypothalamic ER stress has emerged as a causative factor for the development of leptin resistance, but the underlying mechanisms are largely unknown. Here, we show that mitochondria-ER contacts in anorexigenic pro-opiomelanocortin (POMC) neurons in the hypothalamus are decreased in diet-induced obesity. POMC-specific ablation of Mfn2 resulted in loss of mitochondria-ER contacts, defective POMC processing, ER stress-induced leptin resistance, hyperphagia, reduced energy expenditure, and obesity. Pharmacological relieve of hypothalamic ER stress reversed these metabolic alterations. Our data establish MFN2 in POMC neurons as an essential regulator of systemic energy balance by fine-tuning the mitochondrial-ER axis homeostasis and function. This previously unrecognized role for MFN2 argues for a crucial involvement in mediating ER stress-induced leptin resistance.	[Schneeberger, Marc; Castano, Carlos; Garcia, Ainhoa; Esteban, Yaiza; Gonzalez-Franquesa, Alba; Garcia-Roves, Pablo M.; Gomis, Ramon; Claret, Marc] Inst Invest Biomed August Pi & Sunyer IDIBAPS, Diabet & Obes Res Lab, Barcelona 08036, Spain; [Schneeberger, Marc; Gomis, Ramon] Univ Barcelona, Sch Med, Hosp Clin, Dept Endocrinol & Nutr, E-08036 Barcelona, Spain; [Schneeberger, Marc; Sebastian, David; Castano, Carlos; Garcia, Ainhoa; Esteban, Yaiza; Castrillon Rodriguez, Ignacio; Garcia-Roves, Pablo M.; Gomis, Ramon; Zorzano, Antonio; Claret, Marc] Ctr Invest Biomed Red Diabet & Enfermedades Metab, Barcelona 08036, Spain; [Dietrich, Marcelo O.; Horvath, Tamas L.] Yale Univ, Sch Med, Comparat Med Sect, Program Integrat Cell Signaling & Neurobiol Metab, New Haven, CT 06520 USA; [Dietrich, Marcelo O.] Univ Fed Rio Grande do Sul, Dept Biochem, BR-90035 Porto Alegre, RS, Brazil; [Sebastian, David; Castrillon Rodriguez, Ignacio; Zorzano, Antonio] Inst Res Biomed IRB Barcelona, Barcelona 08028, Spain; [Sebastian, David; Castrillon Rodriguez, Ignacio; Zorzano, Antonio] Univ Barcelona, Fac Biol, Dept Bioquim & Biol Mol, E-08028 Barcelona, Spain; [Imbernon, Monica; Nogueiras, Ruben] Univ Santiago de Compostela, Inst Invest Sanitaria, Sch Med, Dept Physiol, Santiago De Compostela 15782, Spain; [Imbernon, Monica; Nogueiras, Ruben] Ctr Invest Biomed Red Fisiopatol Obesidad & Nutr, Santiago De Compostela 15782, Spain; [Bortolozzi, Analia] IIBB CSIC IDIBAPS, Dept Neurochem & Neuropharmacol, Barcelona 08036, Spain; [Bortolozzi, Analia] Ctr Invest Biomed Red Salud Mental CIBERSAM, Barcelona 08036, Spain	University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; University of Barcelona; Hospital Clinic de Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERDEM; Yale University; Universidade Federal do Rio Grande do Sul; Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona; University of Barcelona; Universidade de Santiago de Compostela; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas de Barcelona (IIBB); University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; CIBER - Centro de Investigacion Biomedica en Red; CIBERSAM	Claret, M (corresponding author), Inst Invest Biomed August Pi & Sunyer IDIBAPS, Diabet & Obes Res Lab, Barcelona 08036, Spain.	mclaret@clinic.ub.es	Pane, Marc Schneeberger/ABG-7816-2020; Gonzalez-Franquesa, Alba/G-1691-2015; Zorzano, Antonio/R-5479-2018; Schneeberger Pane, Marc/ABC-2627-2021; Bortolozzi, Analia/R-6159-2018; Dietrich, Marcelo/A-9928-2009; Roves, Pablo Garcia/A-7113-2015; Nogueiras, Ruben/AAS-9427-2021; García Alamán, Ainhoa/AFP-1866-2022; Sebastián, David/ABH-1574-2020; Esteban, Yaiza/AAD-8116-2020; Castaño, Carlos/AAS-3591-2021; Garcia-Roves, Pablo M./X-4585-2018	Gonzalez-Franquesa, Alba/0000-0001-9081-753X; Schneeberger Pane, Marc/0000-0001-7369-104X; Bortolozzi, Analia/0000-0002-2069-9192; Dietrich, Marcelo/0000-0001-9781-2221; Nogueiras, Ruben/0000-0002-9976-9930; García Alamán, Ainhoa/0000-0002-1703-7905; Castaño, Carlos/0000-0003-1671-7826; Esteban, Yaiza/0000-0002-7283-5977; Imbernon, Monica/0000-0003-4359-4817; Claret, Marc/0000-0001-7766-9296; Sebastian, David/0000-0002-7260-3869; Garcia-Roves, Pablo M./0000-0002-8371-2067	RecerCaixa Grant [2010ACUP_ 00275]; EFSD/Lilly Fellowship Award; Ministerio de Ciencia e Innovacion (MICINN), Instituto de Salud Carlos III (ISCIII) Grant [PI10/01074]; MICINN Grant [SAF2010-19527, BFU2011-24679]; Ministerio de Economia y Competitividad (MINECO) Grant [BFU2012-35255]; Xunta de Galicia Grant [EM2012/039, 2012-CP069]; CIBERobn; European Community's Seventh Framework Programme Grant [ERC-2011-StGOBESITY53- 281408]; MINECO Grant [SAF2008-03803]; Generalitat de Catalunya Grant [2009SGR915]; CIBERDEM; INTERREG IVB- SUDOE-FEDER (DIOMED) [SOE1/P1/E178]; European Commission; MITIN Grant [HEALTH-F4-2008223450]; ISCIII Grant [PI10/00290]; NIH [DP1DK006850, R01AG040236, P01NS062686]; American Diabetes Association, Helmholtz society (ICEMED); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, Brazil [401476/2012-0]; University of Barcelona; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [DP1DK098058] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS062686] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG040236] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD006850] Funding Source: NIH RePORTER	RecerCaixa Grant; EFSD/Lilly Fellowship Award; Ministerio de Ciencia e Innovacion (MICINN), Instituto de Salud Carlos III (ISCIII) Grant; MICINN Grant(Spanish Government); Ministerio de Economia y Competitividad (MINECO) Grant; Xunta de Galicia Grant(Xunta de Galicia); CIBERobn; European Community's Seventh Framework Programme Grant; MINECO Grant(Spanish Government); Generalitat de Catalunya Grant(Generalitat de Catalunya); CIBERDEM; INTERREG IVB- SUDOE-FEDER (DIOMED); European Commission(European CommissionEuropean Commission Joint Research Centre); MITIN Grant; ISCIII Grant; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association, Helmholtz society (ICEMED); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); University of Barcelona; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We are grateful to Dr Gregory S Barsh (Stanford University) for providing Pomc-cre mice, Dr Maria Calvo and Anna Bosch from the Confocal microscopy unit (SCT-UB), Merce` Monfar (UPV-CBATEG), and members from the Diabetes and Obesity Lab. This work has been supported by: RecerCaixa Grant 2010ACUP_ 00275 (M. C.); EFSD/Lilly Fellowship Award (M. C.); Ministerio de Ciencia e Innovacion (MICINN), Instituto de Salud Carlos III (ISCIII) Grant PI10/01074 (M. C.); MICINN Grant SAF2010-19527 (R.G.); Ministerio de Economia y Competitividad (MINECO) Grant BFU2012-35255 (RN); Xunta de Galicia Grant EM2012/039 and 2012-CP069 (R. N.); CIBERobn (R. N.); European Community's Seventh Framework Programme Grant ERC-2011-StGOBESITY53- 281408 (R. N.); MINECO Grant SAF2008-03803 (A. Z.); Generalitat de Catalunya Grant 2009SGR915 (A. Z.); CIBERDEM (A. Z.); INTERREG IVB- SUDOE-FEDER (DIOMED, SOE1/P1/E178) (A. Z.); European Commission Seventh Framework Programme (FP7), MITIN Grant HEALTH-F4-2008223450 (A. Z.); MICINN Grant BFU2011-24679 (P. M. G.-R.); ISCIII Grant PI10/00290 (A. B.). T. L. H. and M. O. D. are supported by NIH (DP1DK006850, R01AG040236, P01NS062686), American Diabetes Association, Helmholtz society (ICEMED) and by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (401476/2012-0, Brazil). M. S. is a recipient of an undergraduate grant from the University of Barcelona. M. C. is a recipient of a Miguel Servet contract (CP09/00233) from MICINN-ISCIII. P. M. G.-R. is a recipient of a Ramon y Cajal contract (RYC-2009-05158) from MICINN. Some of these grants are cofinanced by the European Regional Development Fund "A way to build Europe.'' This work was carried out in part at the Esther Koplowitz Centre, Barcelona.	Al-Qassab H, 2009, CELL METAB, V10, P343, DOI 10.1016/j.cmet.2009.09.008; Bach D, 2005, DIABETES, V54, P2685, DOI 10.2337/diabetes.54.9.2685; Bach D, 2003, J BIOL CHEM, V278, P17190, DOI 10.1074/jbc.M212754200; Bjorbaek C, 2009, J INVEST MED, V57, P789, DOI 10.2310/JIM.0b013e3181bb0d49; Chen HC, 2003, J CELL BIOL, V160, P189, DOI 10.1083/jcb.200211046; Chen HC, 2007, CELL, V130, P548, DOI 10.1016/j.cell.2007.06.026; Claret M, 2007, J CLIN INVEST, V117, P2325, DOI 10.1172/JCI31516; Claret M, 2011, DIABETES, V60, P735, DOI 10.2337/db10-1055; Czyzyk TA, 2012, FASEB J, V26, P3483, DOI 10.1096/fj.12-208041; de Brito OM, 2008, NATURE, V456, P605, DOI 10.1038/nature07534; Diano S, 2011, NAT MED, V17, P1121, DOI 10.1038/nm.2421; Dieguez C, 2011, NEUROENDOCRINOLOGY, V94, P1, DOI 10.1159/000328122; Dietrich MO, 2013, CELL, V155, P188, DOI 10.1016/j.cell.2013.09.004; Gamber KM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030485; Gyengesi E, 2012, CURR NEUROPHARMACOL, V10, P344, DOI 10.2174/157015912804143496; Hernandez-Alvarez MI, 2009, DIABETOLOGIA, V52, P1618, DOI 10.1007/s00125-009-1403-y; Hosoi T, 2008, MOL PHARMACOL, V74, P1610, DOI 10.1124/mol.108.050070; Hernandez-Alvarez MI, 2010, DIABETES CARE, V33, P645, DOI 10.2337/dc09-1305; Kitamura T, 2006, NAT MED, V12, P534, DOI 10.1038/nm1392; Lee S, 2012, HUM MOL GENET, V21, P4827, DOI 10.1093/hmg/dds352; Mandl J, 2009, TRENDS ENDOCRIN MET, V20, P194, DOI 10.1016/j.tem.2009.01.003; Misko AL, 2012, J NEUROSCI, V32, P4145, DOI 10.1523/JNEUROSCI.6338-11.2012; Munzberg H, 2003, ENDOCRINOLOGY, V144, P2121, DOI 10.1210/en.2002-221037; Myers MG, 2012, NATURE, V491, P357, DOI 10.1038/nature11705; Ngoh GA, 2012, J BIOL CHEM, V287, P20321, DOI 10.1074/jbc.M112.359174; Novak A, 2000, GENESIS, V28, P147, DOI 10.1002/1526-968X(200011/12)28:3/4<147::AID-GENE90>3.0.CO;2-G; Ozcan L, 2009, CELL METAB, V9, P35, DOI 10.1016/j.cmet.2008.12.004; Papanicolaou KN, 2012, AM J PHYSIOL-HEART C, V302, pH167, DOI 10.1152/ajpheart.00833.2011; Papanicolaou KN, 2011, MOL CELL BIOL, V31, P1309, DOI 10.1128/MCB.00911-10; Pham AH, 2012, HUM MOL GENET, V21, P4817, DOI 10.1093/hmg/dds311; Rowland AA, 2012, NAT REV MOL CELL BIO, V13, P607, DOI 10.1038/nrm3440; Sebastian D, 2012, P NATL ACAD SCI USA, V109, P5523, DOI 10.1073/pnas.1108220109; Sisley S, 2011, REV ENDOCR METAB DIS, V12, P219, DOI 10.1007/s11154-011-9189-x; Wallingford N, 2009, J CLIN INVEST, V119, P2291, DOI 10.1172/JCI37209; Wardlaw SL, 2011, EUR J PHARMACOL, V660, P213, DOI 10.1016/j.ejphar.2010.10.107; Williams KW, 2012, NAT NEUROSCI, V15, P1350, DOI 10.1038/nn.3217; Won JC, 2009, OBESITY, V17, P1861, DOI 10.1038/oby.2009.194; Xu AW, 2005, J CLIN INVEST, V115, P951, DOI 10.1172/JCI200524301; Youle RJ, 2012, SCIENCE, V337, P1062, DOI 10.1126/science.1219855; Zhang XQ, 2008, CELL, V135, P61, DOI 10.1016/j.cell.2008.07.043; Zorzano A, 2010, SEMIN CELL DEV BIOL, V21, P566, DOI 10.1016/j.semcdb.2010.01.002	41	368	377	2	42	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	SEP 26	2013	155	1					172	187		10.1016/j.cell.2013.09.003	http://dx.doi.org/10.1016/j.cell.2013.09.003			16	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	224UX	24074867	Green Submitted, Bronze, Green Accepted			2022-12-24	WOS:000324916700018
J	Flavell, SW; Pokala, N; Macosko, EZ; Albrecht, DR; Larsch, J; Bargmann, CI				Flavell, Steven W.; Pokala, Navin; Macosko, Evan Z.; Albrecht, Dirk R.; Larsch, Johannes; Bargmann, Cornelia I.			Serotonin and the Neuropeptide PDF Initiate and Extend Opposing Behavioral States in C. elegans	CELL			English	Article							NEURAL CIRCUIT; SLEEP; PROTEIN; RECEPTORS	Foraging animals have distinct exploration and exploitation behaviors that are organized into discrete behavioral states. Here, we characterize a neuromodulatory circuit that generates long-lasting roaming and dwelling states in Caenorhabditis elegans. We find that two opposing neuromodulators, serotonin and the neuropeptide pigment dispersing factor (PDF), each initiate and extend one behavioral state. Serotonin promotes dwelling states through the MOD-1 serotonin-gated chloride channel. The spontaneous activity of serotonergic neurons correlates with dwelling behavior, and optogenetic modulation of the critical MOD-1-expressing targets induces prolonged dwelling states. PDF promotes roaming states through a Gas-coupled PDF receptor; optogenetic activation of cAMP production in PDF receptor-expressing cells induces prolonged roaming states. The neurons that produce and respond to each neuromodulator form a distributed circuit orthogonal to the classical wiring diagram, with several essential neurons that express each molecule. The slow temporal dynamics of this neuromodulatory circuit supplement fast motor circuits to organize long-lasting behavioral states.	[Flavell, Steven W.; Pokala, Navin; Macosko, Evan Z.; Albrecht, Dirk R.; Larsch, Johannes; Bargmann, Cornelia I.] Rockefeller Univ, Howard Hughes Med Inst, Lulu & Anthony Wang Lab Neural Circuits & Behav, New York, NY 10065 USA	Howard Hughes Medical Institute; Rockefeller University	Bargmann, CI (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, Lulu & Anthony Wang Lab Neural Circuits & Behav, New York, NY 10065 USA.	cori@mail.rockefeller.edu	Macosko, Evan/X-4664-2019; Larsch, Johannes/AAN-1985-2021; Pokala, Navin/AAH-5719-2019	Larsch, Johannes/0000-0001-5664-433X; Pokala, Navin/0000-0003-2323-6190; Flavell, Steven/0000-0001-9464-1877; Bargmann, Cornelia/0000-0002-8484-0618	G. Harold and Leila Y. Mathers Foundation; Ellison Medical Foundation; Helen Hay Whitney postdoctoral fellowship; NIH [GM07739]; Boehringer Ingelheim Fonds PhD Fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007739] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R25MH094612] Funding Source: NIH RePORTER	G. Harold and Leila Y. Mathers Foundation; Ellison Medical Foundation(Lawrence Ellison Foundation); Helen Hay Whitney postdoctoral fellowship; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Boehringer Ingelheim Fonds PhD Fellowship(Boehringer Ingelheim); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank H. R. Horvitz, S. Mitani, the National BioResource Project (NBRP), and the Caenorhabditis Genetics Center (CGC) for strains; L. Looger for GCaMP5; A. Gordus and A. Katsov for help with data analysis; I. Shachrai for initiating optogenetic experiments; Y. Saheki, A. Bendesky, J. Garrison, J. Greene, and other members of our laboratory for helpful discussions; and S. Kuehn and R. Axel for comments on the manuscript. This work was supported by the G. Harold and Leila Y. Mathers Foundation and the Ellison Medical Foundation (C. I. B.), a Helen Hay Whitney postdoctoral fellowship (S. W. F.), NIH grant GM07739 (E.Z.M.), and a Boehringer Ingelheim Fonds PhD Fellowship (J. L.). C. I. B. is an Investigator of the Howard Hughes Medical Institute.	Akerboom J, 2012, J NEUROSCI, V32, P13819, DOI 10.1523/JNEUROSCI.2601-12.2012; Barrios A, 2012, NAT NEUROSCI, V15, P1675, DOI 10.1038/nn.3253; Ben Arous J., 2009, NAT NEUROSCI, V4; CHALFIE M, 1985, J NEUROSCI, V5, P956; Chase Daniel L, 2007, WormBook, P1; Chow BY, 2010, NATURE, V463, P98, DOI 10.1038/nature08652; Conradt B, 1999, CELL, V98, P317, DOI 10.1016/S0092-8674(00)81961-3; Edwards SL, 2008, PLOS BIOL, V6, P1715, DOI 10.1371/journal.pbio.0060198; Frank MG, 2002, NEUROPSYCHOPHARMACOL, V27, P869, DOI 10.1016/S0893-133X(02)00353-6; Frokjaer-Jensen C, 2008, NAT GENET, V40, P1375, DOI 10.1038/ng.248; Goulding EH, 2008, P NATL ACAD SCI USA, V105, P20575, DOI 10.1073/pnas.0809053106; Gurel G, 2012, GENETICS, V192, P1359, DOI 10.1534/genetics.112.142125; Hedlund PB, 2005, BIOL PSYCHIAT, V58, P831, DOI 10.1016/j.biopsych.2005.05.012; HORVITZ HR, 1982, SCIENCE, V216, P1012, DOI 10.1126/science.6805073; Janssen T, 2008, J BIOL CHEM, V283, P15241, DOI 10.1074/jbc.M709060200; Lebestky T, 2009, NEURON, V64, P522, DOI 10.1016/j.neuron.2009.09.031; Li Chris, 2008, WormBook, P1, DOI 10.1895/wormbook.1.142.1; Li ZY, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1780; Omura D.T., 2008, THESIS MIT CAMBRIDGE; Osborne KA, 1997, SCIENCE, V277, P834, DOI 10.1126/science.277.5327.834; Owen-Smith N, 2010, PHILOS T R SOC B, V365, P2267, DOI 10.1098/rstb.2010.0095; Ranganathan R, 2000, NATURE, V408, P470, DOI 10.1038/35044083; Ryu MH, 2010, J BIOL CHEM, V285, P41501, DOI 10.1074/jbc.M110.177600; Saifee O, 2011, ANESTHESIOLOGY, V115, P1162, DOI 10.1097/ALN.0b013e318239355d; Saper CB, 2010, NEURON, V68, P1023, DOI 10.1016/j.neuron.2010.11.032; Sawin ER, 2000, NEURON, V26, P619, DOI 10.1016/S0896-6273(00)81199-X; Schultheis C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018766; Sehgal A, 2011, CELL, V146, P194, DOI 10.1016/j.cell.2011.07.004; Shtonda BB, 2006, J EXP BIOL, V209, P89, DOI 10.1242/jeb.01955; Sze JY, 2000, NATURE, V403, P560, DOI 10.1038/35000609; Vosko AM, 2007, GEN COMP ENDOCR, V152, P165, DOI 10.1016/j.ygcen.2007.04.018	31	199	203	6	69	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 29	2013	154	5					1023	1035		10.1016/j.cell.2013.08.001	http://dx.doi.org/10.1016/j.cell.2013.08.001			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	209OE	23972393	Bronze, Green Accepted			2022-12-24	WOS:000323767300016
J	Libuda, DE; Uzawa, S; Meyer, BJ; Villeneuve, AM				Libuda, Diana E.; Uzawa, Satoru; Meyer, Barbara J.; Villeneuve, Anne M.			Meiotic chromosome structures constrain and respond to designation of crossover sites	NATURE			English	Article							SYNAPTONEMAL COMPLEX; CROSSING-OVER; C-ELEGANS; CAENORHABDITIS-ELEGANS; CHIASMA FORMATION; STRAND-EXCHANGE; SYNAPSIS; MEIOSIS; RECOMBINATION; INTERFERENCE	Crossover recombination events between homologous chromosomes are required to form chiasmata, temporary connections between homologues that ensure their proper segregation at meiosis I-1. Despite this requirement for crossovers and an excess of the double-strand DNA breaks that are the initiating events for meiotic recombination, most organisms make very few crossovers per chromosome pair(2). Moreover, crossovers tend to inhibit the formation of other crossovers nearby on the same chromosome pair, a poorly understood phenomenon known as crossover interference(3,4). Here we show that the synaptonemal complex, a meiosis-specific structure that assembles between aligned homologous chromosomes, both constrains and is altered by crossover recombination events. Using a cytological marker of crossover sites in Caenorhabditis elegans(5), we show that partial depletion of the synaptonemal complex central region proteins attenuates crossover interference, increasing crossovers and reducing the effective distance over which interference operates, indicating that synaptonemal complex proteins limit crossovers. Moreover, we show that crossovers are associated with a local 0.4-0.5-micrometre increase in chromosome axis length. We propose that meiotic crossover regulation operates as a self-limiting system in which meiotic chromosome structures establish an environment that promotes crossover formation, which in turn alters chromosome structure to inhibit other crossovers at additional sites.	[Libuda, Diana E.; Villeneuve, Anne M.] Stanford Univ, Dept Dev Biol, Sch Med, Stanford, CA 94305 USA; [Uzawa, Satoru; Meyer, Barbara J.] Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA; [Uzawa, Satoru; Meyer, Barbara J.] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Villeneuve, Anne M.] Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA	Stanford University; Howard Hughes Medical Institute; University of California System; University of California Berkeley; University of California System; University of California Berkeley; Stanford University	Villeneuve, AM (corresponding author), Stanford Univ, Dept Dev Biol, Sch Med, Stanford, CA 94305 USA.	annev@stanford.edu		Meyer, Barbara/0000-0002-6530-4588; Libuda, Diana/0000-0002-4944-1814	National Institutes of Health (NIH) [P40 OD010440, K99 HD076165, R01 GM067268]; Helen Hay Whitney Foundation; Katharine McCormick Advanced Postdoctoral Fellowship; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K99HD076165] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067268] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD010440] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Helen Hay Whitney Foundation; Katharine McCormick Advanced Postdoctoral Fellowship; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank A. Dernburg and M. Zetka for antibodies and the CGC (funded by National Institutes of Health (NIH) P40 OD010440) for strains. We thank K. Hillers and K. Zawadzki for comments on the manuscript. This work was supported by a Helen Hay Whitney Foundation Postdoctoral Fellowship, a Katharine McCormick Advanced Postdoctoral Fellowship, and NIH K99 HD076165 to D.E.L. and by NIH R01 GM067268 to A.M.V. B.J.M. is an investigator of the Howard Hughes Medical Institute.	Bishop DK, 2004, CELL, V117, P9, DOI 10.1016/S0092-8674(04)00297-1; Borner GV, 2004, CELL, V117, P29, DOI 10.1016/S0092-8674(04)00292-2; Chen H, 1996, J STRUCT BIOL, V116, P56, DOI 10.1006/jsbi.1996.0010; Chen SY, 2008, DEV CELL, V15, P401, DOI 10.1016/j.devcel.2008.07.006; Colaiacovo MP, 2003, DEV CELL, V5, P463, DOI 10.1016/S1534-5807(03)00232-6; Cole F, 2012, NAT CELL BIOL, V14, P424, DOI 10.1038/ncb2451; de Boer E, 2006, P NATL ACAD SCI USA, V103, P9607, DOI 10.1073/pnas.0600418103; Dernburg AF, 1998, CELL, V94, P387, DOI 10.1016/S0092-8674(00)81481-6; EGEL R, 1978, HEREDITY, V41, P233, DOI 10.1038/hdy.1978.92; Fung JC, 2004, CELL, V116, P795, DOI 10.1016/S0092-8674(04)00249-1; Goodyer W, 2008, DEV CELL, V14, P263, DOI 10.1016/j.devcel.2007.11.016; Hayashi M, 2010, GENETICS, V186, P45, DOI 10.1534/genetics.110.115501; Hillers KJ, 2003, CURR BIOL, V13, P1641, DOI 10.1016/j.cub.2003.08.026; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; Macqueen AJ, 2005, CELL, V123, P1037, DOI 10.1016/j.cell.2005.09.034; MacQueen AJ, 2002, GENE DEV, V16, P2428, DOI 10.1101/gad.1011602; MAGUIRE MP, 1988, GENOME, V30, P469, DOI 10.1139/g88-078; Martinez-Perez E, 2005, GENE DEV, V19, P2727, DOI 10.1101/gad.1338505; Martinez-Perez E, 2009, CURR OPIN GENET DEV, V19, P105, DOI 10.1016/j.gde.2009.02.005; MCPEEK MS, 1995, GENETICS, V139, P1031; Mets DG, 2009, CELL, V139, P73, DOI 10.1016/j.cell.2009.07.035; Muller HJ, 1916, AM NAT, V50, P193, DOI 10.1086/279534; Page SL, 2003, SCIENCE, V301, P785, DOI 10.1126/science.1086605; Phillips CM, 2005, CELL, V123, P1051, DOI 10.1016/j.cell.2005.09.035; Reynolds A, 2013, NAT GENET, V45, P269, DOI 10.1038/ng.2541; Rosu S, 2011, SCIENCE, V334, P1286, DOI 10.1126/science.1212424; SIGURDSON DC, 1986, MOL GEN GENET, V202, P212, DOI 10.1007/BF00331639; Smolikov S, 2007, GENETICS, V176, P2015, DOI 10.1534/genetics.107.072413; Storlazzi A, 1996, P NATL ACAD SCI USA, V93, P9043, DOI 10.1073/pnas.93.17.9043; Sturtevant AH, 1913, J EXP ZOOL, V14, P43, DOI 10.1002/jez.1400140104; Yokoo R, 2012, CELL, V149, P75, DOI 10.1016/j.cell.2012.01.052; Zetka MC, 1999, GENE DEV, V13, P2258, DOI 10.1101/gad.13.17.2258	32	93	95	0	37	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 31	2013	502	7473					703	+		10.1038/nature12577	http://dx.doi.org/10.1038/nature12577			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243CC	24107990	Green Accepted			2022-12-24	WOS:000326293200052
J	Kabeche, L; Compton, DA				Kabeche, Lilian; Compton, Duane A.			Cyclin A regulates kinetochore microtubules to promote faithful chromosome segregation	NATURE			English	Article							ERROR-CORRECTION; CELL-CYCLE; MITOSIS; ORIENTATION; ANAPHASE; DESTRUCTION; ANEUPLOIDY; ATTACHMENT; METAPHASE; DYNAMICS	The most conspicuous event in the cell cycle is the alignment of chromosomes in metaphase. Chromosome alignment fosters faithful segregation through the formation of bi-oriented attachments of kinetochores to spindle microtubules. Notably, numerous kinetochore-microtubule (k-MT) attachment errors are present in early mitosis (prometaphase) 1, and the persistence of those errors is the leading cause of chromosome mis-segregation in aneuploid human tumour cells that continually mis-segregate whole chromosomes and display chromosomal instability(2-7). How robust error correction is achieved in prometaphase to ensure error-free mitosis remains unknown. Here we show that k-MT attachments in prometaphase cells are considerably less stable than in metaphase cells. The switch to more stable k-MT attachments in metaphase requires the proteasome-dependent destruction of cyclin A in prometaphase. Persistent cyclin A expression prevents k-MT stabilization even in cells with aligned chromosomes. By contrast, k-MTs are prematurely stabilized in cyclin-A-deficient cells. Consequently, cells lacking cyclin A display higher rates of chromosome mis-segregation. Thus, the stability of k-MT attachments increases decisively in a coordinated fashion among all chromosomes as cells transit from prometaphase to metaphase. Cyclin A creates a cellular environment that promotes microtubule detachment from kinetochores in prometaphase to ensure efficient error correction and faithful chromosome segregation.	[Kabeche, Lilian; Compton, Duane A.] Geisel Sch Med Dartmouth, Dept Biochem, Hanover, NH 03755 USA; [Kabeche, Lilian; Compton, Duane A.] Norris Cotton Canc Ctr, Lebanon, NH 03756 USA	Dartmouth College; Norris Cotton Cancer Center	Compton, DA (corresponding author), Geisel Sch Med Dartmouth, Dept Biochem, Hanover, NH 03755 USA.	duane.a.compton@dartmouth.edu		Compton, Duane/0000-0002-4445-9118; Kabeche, Lilian/0000-0001-9917-856X	National Institutes of Health [GM51542, GM008704]; John H. Copenhaver Jr and William H. Thomas, MD 1952 Junior Fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM051542, R01GM051542, T32GM008704] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); John H. Copenhaver Jr and William H. Thomas, MD 1952 Junior Fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health grants GM51542 (D. A. C.) and GM008704 (L. K.) and the John H. Copenhaver Jr and William H. Thomas, MD 1952 Junior Fellowship (L. K.). We thank J. Pines and J. DeLuca for providing reagents.	Bakhoum SF, 2012, CURR OPIN CELL BIOL, V24, P64, DOI 10.1016/j.ceb.2011.11.012; Bakhoum SF, 2009, CURR BIOL, V19, P1937, DOI 10.1016/j.cub.2009.09.055; Bakhoum SF, 2009, NAT CELL BIOL, V11, P27, DOI 10.1038/ncb1809; Cimini D, 2003, J CELL SCI, V116, P4213, DOI 10.1242/jcs.00716; Cimini D, 2001, J CELL BIOL, V153, P517, DOI 10.1083/jcb.153.3.517; DeLuca KF, 2011, J CELL SCI, V124, P622, DOI 10.1242/jcs.072629; den Elzen N, 2001, J CELL BIOL, V153, P121, DOI 10.1083/jcb.153.1.121; Di Fiore B, 2010, J CELL BIOL, V190, P501, DOI 10.1083/jcb.201001083; Gong D, 2010, MOL BIOL CELL, V21, P3149, DOI 10.1091/mbc.E10-05-0393; HOLLOWAY SL, 1993, CELL, V73, P1393, DOI 10.1016/0092-8674(93)90364-V; Indjeian VB, 2007, CURR BIOL, V17, P1837, DOI 10.1016/j.cub.2007.09.056; Kelly AE, 2009, CURR OPIN CELL BIOL, V21, P51, DOI 10.1016/j.ceb.2009.01.004; Lengauer C, 1998, NATURE, V396, P643, DOI 10.1038/25292; Liu D, 2009, SCIENCE, V323, P1350, DOI 10.1126/science.1167000; Loncarek J, 2007, NATURE, V450, P745, DOI 10.1038/nature06344; Manning AL, 2010, EMBO J, V29, P3531, DOI 10.1038/emboj.2010.230; Mihaylov IS, 2002, MOL CELL BIOL, V22, P1868, DOI 10.1128/MCB.22.6.1868-1880.2002; Musacchio A, 2007, NAT REV MOL CELL BIO, V8, P379, DOI 10.1038/nrm2163; NICKLAS RB, 1994, J CELL BIOL, V126, P1241, DOI 10.1083/jcb.126.5.1241; Pagliuca FW, 2011, MOL CELL, V43, P406, DOI 10.1016/j.molcel.2011.05.031; Pines J, 2006, TRENDS CELL BIOL, V16, P55, DOI 10.1016/j.tcb.2005.11.006; Reed SI, 2003, NAT REV MOL CELL BIO, V4, P855, DOI 10.1038/nrm1246; Skoufias DA, 2001, P NATL ACAD SCI USA, V98, P4492, DOI 10.1073/pnas.081076898; SURANA U, 1993, EMBO J, V12, P1969, DOI 10.1002/j.1460-2075.1993.tb05846.x; Thompson SL, 2008, J CELL BIOL, V180, P665, DOI 10.1083/jcb.200712029; Thompson SL, 2011, P NATL ACAD SCI USA, V108, P17974, DOI 10.1073/pnas.1109720108; Trunnell NB, 2011, MOL CELL, V41, P263, DOI 10.1016/j.molcel.2011.01.012; ZHAI Y, 1995, J CELL BIOL, V131, P721, DOI 10.1083/jcb.131.3.721	28	97	99	0	44	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 3	2013	502	7469					110	+		10.1038/nature12507	http://dx.doi.org/10.1038/nature12507			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	227IM	24013174	Green Accepted			2022-12-24	WOS:000325106000041
J	Nagano, T; Lubling, Y; Stevens, TJ; Schoenfelder, S; Yaffe, E; Dean, W; Laue, ED; Tanay, A; Fraser, P				Nagano, Takashi; Lubling, Yaniv; Stevens, Tim J.; Schoenfelder, Stefan; Yaffe, Eitan; Dean, Wendy; Laue, Ernest D.; Tanay, Amos; Fraser, Peter			Single-cell Hi-C reveals cell-to-cell variability in chromosome structure	NATURE			English	Article							GENE-REGULATION; NUCLEAR-ORGANIZATION; YEAST GENOME; CONFORMATION; ARCHITECTURE; TRANSCRIPTION; ASSOCIATIONS; TERRITORIES; PRINCIPLES; LANDSCAPE	Large-scale chromosome structure and spatial nuclear arrangement have been linked to control of gene expression and DNA replication and repair. Genomic techniques based on chromosome conformation capture (3C) assess contacts for millions of loci simultaneously, but do so by averaging chromosome conformations from millions of nuclei. Here we introduce single-cell Hi-C, combined with genome-wide statistical analysis and structural modelling of single-copy X chromosomes, to show that individual chromosomes maintain domain organization at the megabase scale, but show variable cell-to-cell chromosome structures at larger scales. Despite this structural stochasticity, localization of active gene domains to boundaries of chromosome territories is a hallmark of chromosomal conformation. Single-cell Hi-C data bridge current gaps between genomics and microscopy studies of chromosomes, demonstrating how modular organization underlies dynamic chromosome structure, and how this structure is probabilistically linked with genome activity patterns.	[Nagano, Takashi; Schoenfelder, Stefan; Fraser, Peter] Babraham Inst, Nucl Dynam Programme, Cambridge CB22 3AT, England; [Lubling, Yaniv; Yaffe, Eitan; Tanay, Amos] Weizmann Inst Sci, Dept Comp Sci & Appl Math, IL-76100 Rehovot, Israel; [Lubling, Yaniv; Yaffe, Eitan; Tanay, Amos] Weizmann Inst Sci, Dept Regulat Biol, IL-76100 Rehovot, Israel; [Stevens, Tim J.; Laue, Ernest D.] Univ Cambridge, Dept Biochem, Cambridge CB2 1GA, England; [Dean, Wendy] Babraham Inst, Epigenet Programme, Cambridge CB22 3AT, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; Weizmann Institute of Science; Weizmann Institute of Science; University of Cambridge; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute	Fraser, P (corresponding author), Babraham Inst, Nucl Dynam Programme, Cambridge CB22 3AT, England.	e.d.laue@bioc.cam.ac.uk; amos.tanay@weizmann.ac.il; peter.fraser@babraham.ac.uk	Dean, Wendy/GSE-3948-2022	Laue, Ernest/0000-0002-7476-4148; Dean, Wendy/0000-0001-9441-5044; Stevens, Tim/0000-0001-6475-2074; Yaffe, Eitan/0000-0002-2896-3349; Lubling, Yaniv/0000-0003-3461-9621; Fraser, Peter/0000-0002-0041-1227	Medical Research Council; Biotechnology and Biological Sciences Research Council; MODHEP project; Israel Science Foundation; Wellcome Trust; BBSRC [BBS/E/B/000C0404, BBS/E/B/0000C151] Funding Source: UKRI; MRC [G0800036, G117/530] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/B/000C0404, BBS/E/B/0000C151] Funding Source: researchfish; Medical Research Council [G0800036, G117/530] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MODHEP project; Israel Science Foundation(Israel Science Foundation); Wellcome Trust(Wellcome Trust); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The authors thank I. Clay, S. Wingett, K. Tabbada, D. Bolland, S. Walker, S. Andrews, M. Spivakov, N. Cope, L. Harewood and W. Boucher for assistance. This work was supported by the Medical Research Council, the Biotechnology and Biological Sciences Research Council (to P. F.), the MODHEP project, the Israel Science Foundation (to A. T.) and the Wellcome Trust (to E.D.L.).	Branco MR, 2006, PLOS BIOL, V4, P780, DOI 10.1371/journal.pbio.0040138; Chuang CH, 2006, CURR BIOL, V16, P825, DOI 10.1016/j.cub.2006.03.059; Chubb JR, 2002, CURR BIOL, V12, P439, DOI 10.1016/S0960-9822(02)00695-4; Cremer T, 2001, NAT REV GENET, V2, P292, DOI 10.1038/35066075; Deaton AM, 2011, GENOME RES, V21, P1074, DOI 10.1101/gr.118703.110; Dekker J, 2002, SCIENCE, V295, P1306, DOI 10.1126/science.1067799; Dixon JR, 2012, NATURE, V485, P376, DOI 10.1038/nature11082; Dostie J, 2006, GENOME RES, V16, P1299, DOI 10.1101/gr.5571506; Duan Z, 2010, NATURE, V465, P363, DOI 10.1038/nature08973; Dundr M, 2007, J CELL BIOL, V179, P1095, DOI 10.1083/jcb.200710058; Fraser P, 2007, NATURE, V447, P413, DOI 10.1038/nature05916; Gibcus JH, 2013, MOL CELL, V49, P773, DOI 10.1016/j.molcel.2013.02.011; Heard E, 2007, CURR OPIN CELL BIOL, V19, P311, DOI 10.1016/j.ceb.2007.04.016; Jhunjhunwala S, 2008, CELL, V133, P265, DOI 10.1016/j.cell.2008.03.024; Kalhor R, 2012, NAT BIOTECHNOL, V30, P90, DOI 10.1038/nbt.2057; Lanctot C, 2007, NAT REV GENET, V8, P104, DOI 10.1038/nrg2041; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Marti-Renom MA, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002125; Misteli T, 2007, CELL, V128, P787, DOI 10.1016/j.cell.2007.01.028; Muller I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011560; Nora EP, 2012, NATURE, V485, P381, DOI 10.1038/nature11049; Osborne CS, 2007, PLOS BIOL, V5, P1763, DOI 10.1371/journal.pbio.0050192; Osborne CS, 2004, NAT GENET, V36, P1065, DOI 10.1038/ng1423; Peric-Hupkes D, 2010, MOL CELL, V38, P603, DOI 10.1016/j.molcel.2010.03.016; Rapkin LM, 2012, MICRON, V43, P150, DOI 10.1016/j.micron.2011.11.007; Schoenfelder S, 2010, NAT GENET, V42, P53, DOI 10.1038/ng.496; Sexton T, 2012, CELL, V148, P458, DOI 10.1016/j.cell.2012.01.010; Simonis M, 2006, NAT GENET, V38, P1348, DOI 10.1038/ng1896; Tanizawa H, 2010, NUCLEIC ACIDS RES, V38, P8164, DOI 10.1093/nar/gkq955; van de Werken HJG, 2012, NAT METHODS, V9, P969, DOI [10.1038/NMETH.2173, 10.1038/nmeth.2173]; Yaffe E, 2011, NAT GENET, V43, P1059, DOI 10.1038/ng.947; Zhao Z, 2006, NAT GENET, V38, P1341, DOI 10.1038/ng1891	32	894	979	6	205	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 3	2013	502	7469					59	+		10.1038/nature12593	http://dx.doi.org/10.1038/nature12593			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	227IM	24067610	Green Submitted, Green Accepted			2022-12-24	WOS:000325106000030
J	Ng, KM; Ferreyra, JA; Higginbottom, SK; Lynch, JB; Kashyap, PC; Gopinath, S; Naidu, N; Choudhury, B; Weimer, BC; Monack, DM; Sonnenburg, JL				Ng, Katharine M.; Ferreyra, Jessica A.; Higginbottom, Steven K.; Lynch, Jonathan B.; Kashyap, Purna C.; Gopinath, Smita; Naidu, Natasha; Choudhury, Biswa; Weimer, Bart C.; Monack, Denise M.; Sonnenburg, Justin L.			Microbiota-liberated host sugars facilitate post-antibiotic expansion of enteric pathogens	NATURE			English	Article							CLOSTRIDIUM-DIFFICILE; ESCHERICHIA-COLI; CARBON NUTRITION; SIALIC ACIDS; MOUSE MODEL; TYPHIMURIUM; TRANSMISSION; DIVERSITY; DISRUPTS; PROVIDES	The human intestine, colonized by a dense community of resident microbes, is a frequent target of bacterial pathogens. Undisturbed, this intestinal microbiota provides protection from bacterial infections. Conversely, disruption of the microbiota with oral antibiotics often precedes the emergence of several enteric pathogens(1-4). How pathogens capitalize upon the failure of microbiota-afforded protection is largely unknown. Here we show that two antibiotic-associated pathogens, Salmonella enterica serovar Typhimurium (S. typhimurium) and Clostridium difficile, use a common strategy of catabolizing microbiota-liberated mucosal carbohydrates during their expansion within the gut. S. typhimurium accesses fucose and sialic acid within the lumen of the gut in a microbiota-dependent manner, and genetic ablation of the respective catabolic pathways reduces its competitiveness in vivo. Similarly, C. difficile expansion is aided by microbiota-induced elevation of sialic acid levels in vivo. Colonization of gnotobiotic mice with a sialidase-deficient mutant of Bacteroides thetaiotaomicron, a model gut symbiont, reduces free sialic acid levels resulting in C. difficile downregulating its sialic acid catabolic pathway and exhibiting impaired expansion. These effects are reversed by exogenous dietary administration of free sialic acid. Furthermore, antibiotic treatment of conventional mice induces a spike in free sialic acid and mutants of both Salmonella and C. difficile that are unable to catabolize sialic acid exhibit impaired expansion. These data show that antibiotic-induced disruption of the resident microbiota and subsequent alteration in mucosal carbohydrate availability are exploited by these two distantly related enteric pathogens in a similar manner. This insight suggests new therapeutic approaches for preventing diseases caused by antibiotic-associated pathogens.	[Ng, Katharine M.; Ferreyra, Jessica A.; Higginbottom, Steven K.; Lynch, Jonathan B.; Kashyap, Purna C.; Gopinath, Smita; Monack, Denise M.; Sonnenburg, Justin L.] Stanford Univ, Sch Med, Dept Microbiol & Immunol, Stanford, CA 94305 USA; [Naidu, Natasha; Choudhury, Biswa] Univ Calif San Diego, Glycobiol Res & Training Ctr, San Diego, CA 92093 USA; [Weimer, Bart C.] Univ Calif Davis, Dept Populat Hlth & Reprod, Davis, CA 95616 USA	Stanford University; University of California System; University of California San Diego; University of California System; University of California Davis	Sonnenburg, JL (corresponding author), Stanford Univ, Sch Med, Dept Microbiol & Immunol, Stanford, CA 94305 USA.	jsonnenburg@stanford.edu	Weimer, Bart/AAK-8501-2021; Weimer, Bart C/G-6928-2012	Weimer, Bart/0000-0002-7471-1978; Weimer, Bart C/0000-0002-7471-1978; Gopinath, Smita/0000-0003-3672-3780; Lynch, Jonathan/0000-0001-5221-7090; Ng, Katharine Michelle/0000-0003-3494-5697; higginbottom, steven/0000-0002-4609-6840; Monack, Denise/0000-0003-3804-2209	NSF [R01-DK085025]; Burroughs Wellcome Fund; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI089722, T32AI007328] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK085025] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); Burroughs Wellcome Fund(Burroughs Wellcome Fund); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank E. Sonnenburg for comments on the manuscript; M. St. Onge for technical assistance; and A. Shen, N. Minton and R. Knight for valuable help and reagents. This research was supported by R01-DK085025 (to J.L.S.), NSF graduate fellowships (to K. M. N. and J.A.F) and a Stanford Graduate Fellowship (to K. M. N.). J.L.S. holds an Investigators in the Pathogenesis of Infectious Disease Award from the Burroughs Wellcome Fund.	Adams CM, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003165; Backhed F, 2005, SCIENCE, V307, P1915, DOI 10.1126/science.1104816; Barman M, 2008, INFECT IMMUN, V76, P907, DOI 10.1128/IAI.01432-07; Caporaso JG, 2012, ISME J, V6, P1621, DOI 10.1038/ismej.2012.8; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Chang DE, 2004, P NATL ACAD SCI USA, V101, P7427, DOI 10.1073/pnas.0307888101; Chen XH, 2008, GASTROENTEROLOGY, V135, P1984, DOI 10.1053/j.gastro.2008.09.002; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Dethlefsen L, 2008, PLOS BIOL, V6, P2383, DOI 10.1371/journal.pbio.0060280; Doorduyn Y, 2006, EPIDEMIOL INFECT, V134, P617, DOI 10.1017/S0950268805005406; Fabich AJ, 2008, INFECT IMMUN, V76, P1143, DOI 10.1128/IAI.01386-07; Hapfelmeier S, 2005, TRENDS MICROBIOL, V13, P497, DOI 10.1016/j.tim.2005.08.008; Heap JT, 2010, J MICROBIOL METH, V80, P49, DOI 10.1016/j.mimet.2009.10.018; HOYER LL, 1992, MOL MICROBIOL, V6, P873, DOI 10.1111/j.1365-2958.1992.tb01538.x; Kamada N, 2012, SCIENCE, V336, P1325, DOI 10.1126/science.1222195; KELLY CP, 1994, NEW ENGL J MED, V330, P257, DOI 10.1056/NEJM199401273300406; Lawley TD, 2008, INFECT IMMUN, V76, P403, DOI 10.1128/IAI.01189-07; Lawley TD, 2009, INFECT IMMUN, V77, P3661, DOI 10.1128/IAI.00558-09; Lozupone C, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-371; Lupp C, 2007, CELL HOST MICROBE, V2, P119, DOI 10.1016/j.chom.2007.06.010; Maltby R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053957; MANZI AE, 1990, ANAL BIOCHEM, V188, P20, DOI 10.1016/0003-2697(90)90523-C; Marcobal A, 2010, J AGR FOOD CHEM, V58, P5334, DOI 10.1021/jf9044205; Martens EC, 2008, CELL HOST MICROBE, V4, P447, DOI 10.1016/j.chom.2008.09.007; O'Connor JR, 2006, MOL MICROBIOL, V61, P1335, DOI 10.1111/j.1365-2958.2006.05315.x; Pacheco AR, 2012, NATURE, V492, P113, DOI 10.1038/nature11623; PAVIA AT, 1990, J INFECT DIS, V161, P255, DOI 10.1093/infdis/161.2.255; Pepin J, 2005, CLIN INFECT DIS, V41, P1254, DOI 10.1086/496986; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Sebaihia M, 2006, NAT GENET, V38, P779, DOI 10.1038/ng1830; Sonnenburg ED, 2010, CELL, V141, P1241, DOI 10.1016/j.cell.2010.05.005; Sonnenburg JL, 2005, SCIENCE, V307, P1955, DOI 10.1126/science.1109051; Stecher B, 2007, PLOS BIOL, V5, P2177, DOI 10.1371/journal.pbio.0050244; Stecher B, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000711; Stevens JR, 2008, P C APPL STAT AGR KA, P47; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; VIMR ER, 1985, J BACTERIOL, V164, P845, DOI 10.1128/JB.164.2.845-853.1985; Vimr ER, 2004, MICROBIOL MOL BIOL R, V68, P132, DOI 10.1128/MMBR.68.1.132-153.2004; Winter SE, 2010, NATURE, V467, P426, DOI 10.1038/nature09415	39	610	628	8	237	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 3	2013	502	7469					96	+		10.1038/nature12503	http://dx.doi.org/10.1038/nature12503			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	227IM	23995682	Green Accepted, Green Submitted			2022-12-24	WOS:000325106000038
J	Rangamani, P; Lipshtat, A; Azeloglu, EU; Calizo, RC; Hu, MF; Ghassemi, S; Hone, J; Scarlata, S; Neves, SR; Iyengar, R				Rangamani, Padmini; Lipshtat, Azi; Azeloglu, Evren U.; Calizo, Rhodora Cristina; Hu, Mufeng; Ghassemi, Saba; Hone, James; Scarlata, Suzanne; Neves, Susana R.; Iyengar, Ravi			Decoding Information in Cell Shape	CELL			English	Article							SIGNALING NETWORK; DYNAMICS; PROTEIN; FIBROBLASTS; MECHANISMS; CURVATURE; SURFACES; RECEPTOR; CASCADE; MODEL	Shape is an indicator of cell health. But how is the information in shape decoded? We hypothesize that decoding occurs by modulation of signaling through changes in plasma membrane curvature. Using analytical approaches and numerical simulations, we studied how elongation of cell shape affects plasma membrane signaling. Mathematical analyses reveal transient accumulation of activated receptors at regions of higher curvature with increasing cell eccentricity. This distribution of activated receptors is periodic, following the Mathieu function, and it arises from local imbalance between reaction and diffusion of soluble ligands and receptors in the plane of the membrane. Numerical simulations show that transient microdomains of activated receptors amplify signals to downstream protein kinases. For growth factor receptor pathways, increasing cell eccentricity elevates the levels of activated cytoplasmic Src and nuclear MAPK1,2. These predictions were experimentally validated by changing cellular eccentricity, showing that shape is a locus of retrievable information storage in cells.	[Rangamani, Padmini; Lipshtat, Azi; Azeloglu, Evren U.; Neves, Susana R.; Iyengar, Ravi] Icahn Sch Med Mt Sinai, Dept Pharmacol & Syst Therapeut, New York, NY 10029 USA; [Rangamani, Padmini; Lipshtat, Azi; Azeloglu, Evren U.; Neves, Susana R.; Iyengar, Ravi] Icahn Sch Med Mt Sinai, Syst Biol Ctr, New York, NY 10029 USA; [Hu, Mufeng; Ghassemi, Saba; Hone, James] Columbia Univ, Dept Mech Engn, New York, NY 10027 USA; [Calizo, Rhodora Cristina; Scarlata, Suzanne] SUNY Stony Brook, Dept Physiol & Biophys, Stony Brook, NY 11794 USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Columbia University; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Iyengar, R (corresponding author), Icahn Sch Med Mt Sinai, Dept Pharmacol & Syst Therapeut, New York, NY 10029 USA.	ravi.iyengar@mssm.edu	Lipshtat, Azi/B-9268-2008; Hone, James C/E-1879-2011	Lipshtat, Azi/0000-0002-4421-4997; Hone, James C/0000-0002-8084-3301; Azeloglu, Evren/0000-0001-6137-109X; Neves-Zaph, Susana/0000-0002-3388-0054	NIH [GM-072853, 1 S10 RR0 9145-01]; Systems Biology Center Grant [GM-071558]; NIH-NCI [5R24 CA095823-04]; NSF [DBI-9724504]; NIDDK [DK007645]; NIH from NIGMS [P41-GM103313]; NATIONAL CANCER INSTITUTE [R24CA095823] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR009145] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007645] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM072853, P41GM103313, P50GM071558] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Systems Biology Center Grant; NIH-NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NSF(National Science Foundation (NSF)); NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIH from NIGMS; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Robert Blitzer, Marc Birtwistle, and the anonymous reviewers for very useful comments on the manuscript. We also thank T. Raymond Solano and Rumana Huq for their technical assistance. Primary cardiac fibroblasts were a kind gift from Dr. Kevin D. Costa; EGFR-eGFP was a kind gift from Linda Pike. This work was supported by NIH Grant (GM-072853 to R.I. and S.S.) and Systems Biology Center Grant (GM-071558). E.U.A. is a Howard Hughes Medical Institute Fellow of the Life Sciences Research Foundation. Confocal laser scanning microscopy was performed at the MSSM Microscopy Shared Resource Facility, supported with funding from NIH-NCI shared resources (5R24 CA095823-04), NSF Major Research Instrumentation (DBI-9724504), and NIH shared instrumentation (1 S10 RR0 9145-01) grants. Virtual Cell is supported by NIH grant P41-GM103313 from NIGMS. P.R. was supported by a fellowship from training grant (DK007645) from NIDDK.	Ahmed I, 2007, MOL CELL BIOCHEM, V301, P241, DOI 10.1007/s11010-007-9417-6; Allen JA, 2007, NAT REV NEUROSCI, V8, P128, DOI 10.1038/nrn2059; Asthagiri AR, 2001, BIOTECHNOL PROGR, V17, P227, DOI 10.1021/bp010009k; Bhalla US, 2002, SCIENCE, V297, P1018, DOI 10.1126/science.1068873; Bhalla US, 1999, SCIENCE, V283, P381, DOI 10.1126/science.283.5400.381; Campello S, 2010, EMBO REP, V11, P678, DOI 10.1038/embor.2010.115; Dean JL, 2010, ONCOGENE, V29, P68, DOI 10.1038/onc.2009.313; Dobereiner HG, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.108105; Dubin-Thaler BJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003735; Dubin-Thaler BJ, 2004, BIOPHYS J, V86, P1794, DOI 10.1016/S0006-3495(04)74246-0; Eggeling C, 2009, NATURE, V457, P1159, DOI 10.1038/nature07596; FOLKMAN J, 1978, NATURE, V273, P345, DOI 10.1038/273345a0; Freche D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025122; Fujioka A, 2006, J BIOL CHEM, V281, P8917, DOI 10.1074/jbc.M509344200; Gera L, 2011, J PHARMACOL EXP THER, V337, P33, DOI 10.1124/jpet.110.177147; Giannone G, 2007, CELL, V128, P561, DOI 10.1016/j.cell.2006.12.039; Hall A, 2005, BIOCHEM SOC T, V33, P891, DOI 10.1042/BST0330891; Harvey CD, 2008, P NATL ACAD SCI USA, V105, P19264, DOI 10.1073/pnas.0804598105; Iglic A, 2006, J THEOR BIOL, V240, P368, DOI 10.1016/j.jtbi.2005.09.020; James J, 2008, CELL MOTIL CYTOSKEL, V65, P841, DOI 10.1002/cm.20305; Kalluri R, 2006, NAT REV CANCER, V6, P392, DOI 10.1038/nrc1877; Kalluri R, 2009, J CLIN INVEST, V119, P1417, DOI 10.1172/JCI39675; KAPLAN KB, 1992, J CELL BIOL, V118, P321, DOI 10.1083/jcb.118.2.321; Kim YS, 1999, ONCOGENE, V18, P5936, DOI 10.1038/sj.onc.1203005; Lacayo CI, 2007, PLOS BIOL, V5, P2035, DOI 10.1371/journal.pbio.0050233; Lingwood D, 2010, SCIENCE, V327, P46, DOI 10.1126/science.1174621; Liu P, 2007, BIOPHYS J, V93, P684, DOI 10.1529/biophysj.106.102087; Loew LM, 2001, TRENDS BIOTECHNOL, V19, P401, DOI 10.1016/S0167-7799(01)01740-1; McLachlan N. W., 1947, THEORY APPL MATHIEU; McMahon HT, 2005, NATURE, V438, P590, DOI 10.1038/nature04396; Mogilner A, 2009, CURR BIOL, V19, pR762, DOI 10.1016/j.cub.2009.06.053; Philip F, 2007, J BIOL CHEM, V282, P19203, DOI 10.1074/jbc.M701558200; Pike LJ, 2009, J LIPID RES, V50, pS323, DOI 10.1194/jlr.R800040-JLR200; Qin D, 2010, NAT PROTOC, V5, P491, DOI 10.1038/nprot.2009.234; Rangamani P, 2011, BIOPHYS J, V100, P845, DOI 10.1016/j.bpj.2010.12.3732; Schoeberl B, 2002, NAT BIOTECHNOL, V20, P370, DOI 10.1038/nbt0402-370; Ten Klooster JP, 2006, BIOCHEM J, V397, P39, DOI 10.1042/BJ20051957; Westphal RS, 2000, EMBO J, V19, P4589, DOI 10.1093/emboj/19.17.4589; Xiong YG, 2010, BIOPHYS J, V98, P2136, DOI 10.1016/j.bpj.2010.01.059; Young B, 2006, WHEATERS FUNCTIONAL	40	101	101	1	48	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	SEP 12	2013	154	6					1356	1369		10.1016/j.cell.2013.08.026	http://dx.doi.org/10.1016/j.cell.2013.08.026			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	215VQ	24034255	Green Accepted, Bronze			2022-12-24	WOS:000324239300022
J	Ablasser, A; Schmid-Burgk, JL; Hemmerling, I; Horvath, GL; Schmidt, T; Latz, E; Hornung, V				Ablasser, Andrea; Schmid-Burgk, Jonathan L.; Hemmerling, Inga; Horvath, Gabor L.; Schmidt, Tobias; Latz, Eicke; Hornung, Veit			Cell intrinsic immunity spreads to bystander cells via the intercellular transfer of cGAMP	NATURE			English	Article							CYCLIC GMP-AMP; TRANSCRIPTION FACTOR; DNA SENSOR; INTERFERON; 2ND-MESSENGER; COMMUNICATION; DINUCLEOTIDE; RESPONSES; ADAPTER	The innate immune defence of multicellular organisms against microbial pathogens requires cellular collaboration. Information exchange allowing immune cells to collaborate is generally attributed to soluble protein factors secreted by pathogen-sensing cells. Cytokines, such as type I interferons (IFNs), serve to alert noninfected cells to the possibility of pathogen challenge(1). Moreover, in conjunction with chemokines they can instruct specialized immune cells to contain and eradicate microbial infection. Several receptors and signalling pathways exist that couple pathogen sensing to the induction of cytokines, whereas cytosolic recognition of nucleic acids seems to be exquisitely important for the activation of type I IFNs, master regulators of antiviral immunity(2). Cytosolic DNA is sensed by the receptor cyclic GMP-AMP (cGAMP) synthase (cGAS), which catalyses the synthesis of the second messenger cGAMP(2'-5')(3-8). This molecule in turn activates the endoplasmic reticulum (ER)-resident receptor STING(9-11), thereby inducing an antiviral state and the secretion of type I IFNs. Here we find in murine and human cells that cGAS-synthesized cGAMP (2'-5') is transferred from producing cells to neighbouring cells through gap junctions, where it promotes STING activation and thus antiviral immunity independently of type I IFN signalling. In line with the limited cargo specificity of connexins, the proteins that assemble gap junction channels, most connexins tested were able to confer this bystander immunity, thus indicating a broad physiological relevance of this local immune collaboration. Collectively, these observations identify cGAS-triggered cGAMP(2'-5') transfer as a novel host strategy that serves to rapidly convey antiviral immunity in a transcription-independent, horizontal manner.	[Ablasser, Andrea; Schmid-Burgk, Jonathan L.; Hemmerling, Inga; Schmidt, Tobias; Hornung, Veit] Univ Bonn, Univ Hosp, Inst Clin Chem & Clin Pharmacol, D-53127 Bonn, Germany; [Horvath, Gabor L.; Latz, Eicke] Univ Bonn, Univ Hosp, Inst Innate Immun, D-53127 Bonn, Germany; [Latz, Eicke] Univ Massachusetts, Sch Med, Div Infect Dis & Immunol, Dept Med, Worcester, MA 01605 USA	University of Bonn; University of Bonn; University of Massachusetts System; University of Massachusetts Worcester	Hornung, V (corresponding author), Univ Bonn, Univ Hosp, Inst Clin Chem & Clin Pharmacol, D-53127 Bonn, Germany.	veit.hornung@uni-bonn.de	Schmid-Burgk, Jonathan/GSN-3512-2022; Latz, Eicke/H-3951-2014; Horvath, Gabor L/J-3917-2014; Hornung, Veit/C-3565-2012	Latz, Eicke/0000-0003-1488-5666; Horvath, Gabor L/0000-0003-0309-595X; Hornung, Veit/0000-0002-4150-194X; Schmid-Burgk, Jonathan/0000-0003-0988-2487; Schmidt, Tobias/0000-0003-3102-3515	Studienstiftung des Deutschen Volkes; BONFOR; excellence cluster ImmunoSensation; German Research Foundation [SFB670, SFB704]; European Research Council [ERC 243046]	Studienstiftung des Deutschen Volkes; BONFOR; excellence cluster ImmunoSensation; German Research Foundation(German Research Foundation (DFG)); European Research Council(European Research Council (ERC)European Commission)	We thank M. Pellegrin for providing us with LL171 cells; W. Kastenmuller for MVA NP-S-GFP; J. Bennink for vaccinia virus; K.-P. Hopfner for recombinant cGAS; and K. Willecke for connexin expression constructs and anti-CX43 antibody. J.L.S.-B. is supported by the Studienstiftung des Deutschen Volkes. I.H. is supported by a BONFOR-funded thesis project. A.A., E.L. and V.H. are supported by the excellence cluster ImmunoSensation. V.H. is supported by grants from the German Research Foundation (SFB670 and SFB704) and the European Research Council (ERC 243046).	Ablasser A, 2013, NATURE, V498, P380, DOI 10.1038/nature12306; Ablasser A, 2013, CELL RES, V23, P585, DOI 10.1038/cr.2013.28; Ablasser A, 2009, NAT IMMUNOL, V10, P1065, DOI 10.1038/ni.1779; BUTTERWECK A, 1994, J MEMBRANE BIOL, V141, P247; Cavlar T, 2013, EMBO J, V32, P1440, DOI 10.1038/emboj.2013.86; Civril F, 2013, NATURE, V498, P332, DOI 10.1038/nature12305; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Diner EJ, 2013, CELL REP, V3, P1355, DOI 10.1016/j.celrep.2013.05.009; Gall A, 2012, IMMUNITY, V36, P120, DOI 10.1016/j.immuni.2011.11.018; Gao P, 2013, CELL, V153, P1094, DOI 10.1016/j.cell.2013.04.046; Goubau D, 2013, IMMUNITY, V38, P855, DOI 10.1016/j.immuni.2013.05.007; Hamada N, 2007, J RADIAT RES, V48, P87, DOI 10.1269/jrr.06084; Ishikawa H, 2008, NATURE, V455, P674, DOI 10.1038/nature07317; Ishikawa H, 2009, NATURE, V461, P788, DOI 10.1038/nature08476; Juul MH, 2000, CELL ADHES COMMUN, V7, P501, DOI 10.3109/15419060009040307; Kasper CA, 2010, IMMUNITY, V33, P804, DOI 10.1016/j.immuni.2010.10.015; Kastenmuller W, 2013, IMMUNITY, V38, P502, DOI 10.1016/j.immuni.2012.11.012; Laird DW, 2006, BIOCHEM J, V394, P527, DOI 10.1042/BJ20051922; Langlois S, 2008, MOL BIOL CELL, V19, P912, DOI 10.1091/mbc.E07-06-0596; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Patel SJ, 2009, P NATL ACAD SCI USA, V106, P12867, DOI 10.1073/pnas.0809292106; Sadler AJ, 2008, NAT REV IMMUNOL, V8, P559, DOI 10.1038/nri2314; Schmid-Burgk JL, 2013, NAT BIOTECHNOL, V31, P76, DOI 10.1038/nbt.2460; Stetson DB, 2006, IMMUNITY, V24, P93, DOI 10.1016/j.immuni.2005.12.003; Sun LJ, 2013, SCIENCE, V339, P786, DOI 10.1126/science.1232458; Sun WX, 2009, P NATL ACAD SCI USA, V106, P8653, DOI 10.1073/pnas.0900850106; UZE G, 1994, J MOL BIOL, V243, P245, DOI 10.1006/jmbi.1994.1651; Wu JX, 2013, SCIENCE, V339, P826, DOI 10.1126/science.1229963; Zhang X, 2013, MOL CELL, V51, P226, DOI 10.1016/j.molcel.2013.05.022; Zhong B, 2008, IMMUNITY, V29, P538, DOI 10.1016/j.immuni.2008.09.003	30	364	389	5	90	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 28	2013	503	7477					530	+		10.1038/nature12640	http://dx.doi.org/10.1038/nature12640			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	258MU	24077100	Green Accepted			2022-12-24	WOS:000327464200044
J	Webster, CR; Mahaffy, PR; Atreya, SK; Flesch, GJ; Farley, KA				Webster, Christopher R.; Mahaffy, Paul R.; Atreya, Sushil K.; Flesch, Gregory J.; Farley, Kenneth A.		MSL Sci Team	Low Upper Limit to Methane Abundance on Mars	SCIENCE			English	Article							MARTIAN DUST DEVILS; OXIDANT ENHANCEMENT; ATMOSPHERE; ORIGIN; SEARCH; STORMS; LIFE	By analogy with Earth, methane in the Martian atmosphere is a potential signature of ongoing or past biological activity. During the past decade, Earth-based telescopic observations reported "plumes" of methane of tens of parts per billion by volume (ppbv), and those from Mars orbit showed localized patches, prompting speculation of sources from subsurface bacteria or nonbiological sources. From in situ measurements made with the Tunable Laser Spectrometer (TLS) on Curiosity using a distinctive spectral pattern specific to methane, we report no detection of atmospheric methane with a measured value of 0.18 +/- 0.67 ppbv corresponding to an upper limit of only 1.3 ppbv (95% confidence level), which reduces the probability of current methanogenic microbial activity on Mars and limits the recent contribution from extraplanetary and geologic sources.	[Webster, Christopher R.; Flesch, Gregory J.] CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; [Mahaffy, Paul R.] NASA, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA; [Atreya, Sushil K.] Univ Michigan, Dept Atmospher Ocean & Space Sci, Ann Arbor, MI 48109 USA; [Farley, Kenneth A.] CALTECH, Dept Geol & Planetary Sci, Pasadena, CA 91125 USA	California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; University of Michigan System; University of Michigan; California Institute of Technology	Webster, CR (corresponding author), CALTECH, Jet Prop Lab, 4800 Oak Grove Dr, Pasadena, CA 91109 USA.	chris.r.webster@jpl.nasa.gov	FABRE, Cécile/B-5827-2012; Hayes, Alexander G/P-2024-2014; Dworkin, Jason P./C-9417-2012; Benna, Mehdi/F-3489-2012; Muller, Jan-Peter/Q-8886-2019; Glavin, Daniel P/D-6194-2012; Rodriguez-Manfredi, Jose/L-8001-2014; Malakhov, Alexey Vladimirovich/F-7953-2017; Avalos, Juan Jose Blanco/AAB-9447-2021; Franz, Heather B/F-3508-2012; Prats, Benito/F-9467-2019; Navarro-González, Rafael/D-1748-2009; Webster, Chris/M-9315-2019; Gomez-Elvira, Javier/K-5829-2014; Blanco, Juan Jose/E-3627-2014; Farley, Kenneth/AAE-7735-2020; Balic-Zunic, Tonci/A-6362-2013; De Pablo, Miguel Ángel/J-6442-2014; GEFFROY, Claude/AAB-9152-2019; Zorzano, María-Paz/F-2184-2015; Stipp, Susan L.S./B-8494-2019; Gómez, Felipe/L-7315-2014; szopa, cyril/C-6865-2015; Ramos, Miguel/K-2230-2014; Teinturier, Samuel/AAS-8663-2020; Rodriguez-Manfredi, Jose/AAG-9826-2021; Steele, Andrew/A-3573-2013; Lemmon, Mark T/E-9983-2010; Martin-Torres, Javier/G-6329-2015; Harri, Ari-Matti/C-7142-2012; Vicenzi, Edward/T-9430-2017	FABRE, Cécile/0000-0001-8627-4050; Hayes, Alexander G/0000-0001-6397-2630; Dworkin, Jason P./0000-0002-3961-8997; Muller, Jan-Peter/0000-0002-5077-3736; Glavin, Daniel P/0000-0001-7779-7765; Rodriguez-Manfredi, Jose/0000-0003-0461-9815; Malakhov, Alexey Vladimirovich/0000-0003-4292-7077; Avalos, Juan Jose Blanco/0000-0002-8666-0696; Prats, Benito/0000-0003-3869-3351; Navarro-González, Rafael/0000-0002-6078-7621; Gomez-Elvira, Javier/0000-0002-9068-9846; Blanco, Juan Jose/0000-0002-8666-0696; Balic-Zunic, Tonci/0000-0003-1687-1233; De Pablo, Miguel Ángel/0000-0002-4496-2741; GEFFROY, Claude/0000-0002-2731-9658; Zorzano, María-Paz/0000-0002-4492-9650; Stipp, Susan L.S./0000-0001-7009-643X; Gómez, Felipe/0000-0001-9977-7060; szopa, cyril/0000-0002-0090-4056; Ramos, Miguel/0000-0003-3648-6818; Teinturier, Samuel/0000-0003-1755-9524; Rodriguez-Manfredi, Jose/0000-0003-0461-9815; Steele, Andrew/0000-0001-9643-2841; Lemmon, Mark T/0000-0002-4504-5136; Martin-Torres, Javier/0000-0001-6479-2236; Harri, Ari-Matti/0000-0001-8541-2802; Vicenzi, Edward/0000-0003-2085-6546; Wilson, Sharon/0000-0001-8872-8546; Farley, Kenneth/0000-0002-7846-7546	National Aeronautics and Space Administration (NASA); UK Space Agency [ST/I003118/1] Funding Source: researchfish	National Aeronautics and Space Administration (NASA)(National Aeronautics & Space Administration (NASA)); UK Space Agency	The research described here was carried out in part at the Jet Propulsion Laboratory, California Institute of Technology, under a contract with the National Aeronautics and Space Administration (NASA). Data described in the paper are further described in the supplementary materials and have been submitted to NASA's Planetary Data System under an arrangement with the Mars Science Laboratory project.	Atreya SK, 2003, PLANET SPACE SCI, V51, P105, DOI 10.1016/S0032-0633(02)00144-7; Atreya SK, 2007, PLANET SPACE SCI, V55, P358, DOI 10.1016/j.pss.2006.02.005; Atreya SK, 2006, ASTROBIOLOGY, V6, P439, DOI 10.1089/ast.2006.6.439; Atreya SK, 2011, PLANET SPACE SCI, V59, P133, DOI 10.1016/j.pss.2010.10.008; Christensen P. R., 2003, EOS T S, V84; Delory GT, 2006, ASTROBIOLOGY, V6, P451, DOI 10.1089/ast.2006.6.451; Encrenaz T, 2011, ASTRON ASTROPHYS, V530, DOI 10.1051/0004-6361/201116820; Farrell W. M., 2006, J GEOPHYS RES, V33; Fonti S, 2010, ASTRON ASTROPHYS, V512, DOI 10.1051/0004-6361/200913178; Formisano V, 2004, SCIENCE, V306, P1758, DOI 10.1126/science.1101732; Geminale A, 2011, PLANET SPACE SCI, V59, P137, DOI 10.1016/j.pss.2010.07.011; Kerr RA, 2012, SCIENCE, V338, P733, DOI 10.1126/science.338.6108.733; Krashnopolsky VA, 2004, ICARUS, V172, P537, DOI 10.1016/j.icarus.2004.07.004; Krasnopolsky V. A., 2011, EPSC ABSTR, V6, P49; Krasnopolsky VA, 2006, ICARUS, V180, P359, DOI 10.1016/j.icarus.2005.10.015; Krasnopolsky VA, 2012, ICARUS, V217, P144, DOI 10.1016/j.icarus.2011.10.019; Lefevre F, 2009, NATURE, V460, P720, DOI 10.1038/nature08228; Mahaffy PR, 2012, SPACE SCI REV, V170, P401, DOI 10.1007/s11214-012-9879-z; Michelsen HA, 1999, GEOPHYS RES LETT, V26, P291, DOI 10.1029/1998GL900282; Mumma MJ, 2009, SCIENCE, V323, P1041, DOI 10.1126/science.1165243; Villanueva GL, 2013, ICARUS, V223, P11, DOI 10.1016/j.icarus.2012.11.013; Webster CR, 2013, SCIENCE, V341, P260, DOI 10.1126/science.1237961; Wong AS, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2002JE002003; Zahnle K, 2011, ICARUS, V212, P493, DOI 10.1016/j.icarus.2010.11.027	24	90	93	1	128	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 18	2013	342	6156					355	357		10.1126/science.1242902	http://dx.doi.org/10.1126/science.1242902			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	235XG	24051245				2022-12-24	WOS:000325755100043
J	Khurana, E; Fu, Y; Colonna, V; Mu, XJ; Kang, HM; Lappalainen, T; Sboner, A; Lochovsky, L; Chen, JM; Harmanci, A; Das, J; Abyzov, A; Balasubramanian, S; Beal, K; Chakravarty, D; Challis, D; Chen, Y; Clarke, D; Clarke, L; Cunningham, F; Evani, US; Flicek, P; Fragoza, R; Garrison, E; Gibbs, R; Guemues, ZH; Herrero, J; Kitabayashi, N; Kong, Y; Lage, K; Liluashvili, V; Lipkin, SM; MacArthur, DG; Marth, G; Muzny, D; Pers, TH; Ritchie, GRS; Rosenfeld, JA; Sisu, C; Wei, XM; Wilson, M; Xue, YL; Yu, FL; Dermitzakis, ET; Yu, HY; Rubin, MA; Tyler-Smith, C; Gerstein, M				Khurana, Ekta; Fu, Yao; Colonna, Vincenza; Mu, Xinmeng Jasmine; Kang, Hyun Min; Lappalainen, Tuuli; Sboner, Andrea; Lochovsky, Lucas; Chen, Jieming; Harmanci, Arif; Das, Jishnu; Abyzov, Alexej; Balasubramanian, Suganthi; Beal, Kathryn; Chakravarty, Dimple; Challis, Daniel; Chen, Yuan; Clarke, Declan; Clarke, Laura; Cunningham, Fiona; Evani, Uday S.; Flicek, Paul; Fragoza, Robert; Garrison, Erik; Gibbs, Richard; Guemues, Zeynep H.; Herrero, Javier; Kitabayashi, Naoki; Kong, Yong; Lage, Kasper; Liluashvili, Vaja; Lipkin, Steven M.; MacArthur, Daniel G.; Marth, Gabor; Muzny, Donna; Pers, Tune H.; Ritchie, Graham R. S.; Rosenfeld, Jeffrey A.; Sisu, Cristina; Wei, Xiaomu; Wilson, Michael; Xue, Yali; Yu, Fuli; Dermitzakis, Emmanouil T.; Yu, Haiyuan; Rubin, Mark A.; Tyler-Smith, Chris; Gerstein, Mark		1000 Genomes Project Consortium	Integrative Annotation of Variants from 1092 Humans: Application to Cancer Genomics	SCIENCE			English	Article							TERT PROMOTER MUTATIONS; NATURAL-SELECTION; POSITIVE SELECTION; COPY NUMBER; ELEMENTS; NETWORK; REGIONS	Interpreting variants, especially noncoding ones, in the increasing number of personal genomes is challenging. We used patterns of polymorphisms in functionally annotated regions in 1092 humans to identify deleterious variants; then we experimentally validated candidates. We analyzed both coding and noncoding regions, with the former corroborating the latter. We found regions particularly sensitive to mutations ("ultrasensitive") and variants that are disruptive because of mechanistic effects on transcription-factor binding (that is, "motif-breakers"). We also found variants in regions with higher network centrality tend to be deleterious. Insertions and deletions followed a similar pattern to single-nucleotide variants, with some notable exceptions (e. g., certain deletions and enhancers). On the basis of these patterns, we developed a computational tool (FunSeq), whose application to similar to 90 cancer genomes reveals nearly a hundred candidate noncoding drivers.	[Khurana, Ekta; Fu, Yao; Mu, Xinmeng Jasmine; Lochovsky, Lucas; Chen, Jieming; Harmanci, Arif; Abyzov, Alexej; Balasubramanian, Suganthi; Sisu, Cristina; Wilson, Michael; Gerstein, Mark] Yale Univ, Program Computat Biol & Bioinformat, New Haven, CT 06520 USA; [Khurana, Ekta; Harmanci, Arif; Abyzov, Alexej; Balasubramanian, Suganthi; Kong, Yong; Sisu, Cristina; Gerstein, Mark] Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA; [Colonna, Vincenza; Chen, Yuan; Xue, Yali; Tyler-Smith, Chris] Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England; [Colonna, Vincenza] CNR, Inst Genet & Biophys, I-80131 Naples, Italy; [Kang, Hyun Min] Univ Michigan, Ctr Stat Genet, Ann Arbor, MI 48109 USA; [Lappalainen, Tuuli; Dermitzakis, Emmanouil T.] Univ Geneva, Sch Med, Dept Genet Med & Dev, CH-1211 Geneva, Switzerland; [Lappalainen, Tuuli; Dermitzakis, Emmanouil T.] Univ Geneva, iGE3, CH-1211 Geneva, Switzerland; [Lappalainen, Tuuli; Dermitzakis, Emmanouil T.] Swiss Inst Bioinformat, CH-1211 Geneva, Switzerland; [Sboner, Andrea; Chakravarty, Dimple; Kitabayashi, Naoki; Rubin, Mark A.] Weill Cornell Med Coll, Inst Precis Med, New York, NY 10065 USA; [Sboner, Andrea; Chakravarty, Dimple; Kitabayashi, Naoki; Rubin, Mark A.] Weill Cornell Med Coll, Dept Pathol & Lab Med, New York, NY 10065 USA; New York Presbyterian Hosp, New York, NY 10065 USA; [Sboner, Andrea; Guemues, Zeynep H.; Liluashvili, Vaja] Weill Cornell Med Coll, HRH Prince Alwaleed Bin Talal Bin Abdulaziz Alsau, New York, NY 10021 USA; [Chen, Jieming] Yale Univ, Integrated Grad Program Phys & Engn Biol, New Haven, CT 06520 USA; [Das, Jishnu; Yu, Haiyuan] Cornell Univ, Dept Biol Stat & Computat Biol, Ithaca, NY 14853 USA; [Das, Jishnu; Fragoza, Robert; Wei, Xiaomu; Yu, Haiyuan] Cornell Univ, Inst Cell & Mol Biol, Ithaca, NY 14853 USA; [Beal, Kathryn; Clarke, Laura; Cunningham, Fiona; Flicek, Paul; Herrero, Javier; Ritchie, Graham R. S.] European Bioinformat Inst, European Mol Biol Lab, Cambridge CB10 1SD, England; [Challis, Daniel; Evani, Uday S.; Gibbs, Richard; Muzny, Donna; Yu, Fuli] Baylor Coll Med, Human Genome Sequencing Ctr, Houston, TX 77030 USA; [Clarke, Declan] Yale Univ, Dept Chem, New Haven, CT 06520 USA; [Fragoza, Robert] Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14853 USA; [Garrison, Erik; Marth, Gabor] Boston Coll, Dept Biol, Chestnut Hill, MA 02467 USA; [Guemues, Zeynep H.; Liluashvili, Vaja] Weill Cornell Med ical Coll, Dept Physiol & Biophys, New York, NY 10065 USA; [Kong, Yong] Yale Univ, Keck Biotechnol Resource Lab, New Haven, CT 06511 USA; [Lage, Kasper] Massachusetts Gen Hosp, MassGeneral Hosp Children, Pediat Surg Res Labs, Boston, MA 02114 USA; [Lage, Kasper; MacArthur, Daniel G.] Massachusetts Gen Hosp, Analyt & Translat Genet Unit, Boston, MA 02114 USA; [Lage, Kasper] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Lage, Kasper; Pers, Tune H.] Tech Univ Denmark, Dept Syst Biol, Ctr Biol Sequence Anal, DK-2800 Lyngby, Denmark; [Lage, Kasper] Univ Copenhagen, Ctr Prot Res, Copenhagen, Denmark; [Lipkin, Steven M.; Wei, Xiaomu] Weill Cornell Med Coll, Dept Med, New York, NY 10065 USA; [MacArthur, Daniel G.] Broad Inst Harvard & Massachusetts Inst Technol M, Program Med & Populat Genet, Cambridge, MA 02142 USA; [Pers, Tune H.] Childrens Hosp, Div Endocrinol, Boston, MA 02115 USA; [Pers, Tune H.] Childrens Hosp, Ctr Basic & Translat Obes Res, Boston, MA 02115 USA; [Pers, Tune H.] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Rosenfeld, Jeffrey A.] Rutgers New Jersey Med Sch, Dept Med, Newark, NJ 07101 USA; [Rosenfeld, Jeffrey A.] Rutgers State Univ, IST High Performance & Res Comp, Newark, NJ 07101 USA; [Rosenfeld, Jeffrey A.] Amer Museum Nat Hist, Sackler Inst Comparat Genom, New York, NY 10024 USA; [Wilson, Michael] Yale Univ, Ctr Child Study, New Haven, CT 06520 USA; [Gerstein, Mark] Yale Univ, Dept Comp Sci, New Haven, CT 06520 USA	Yale University; Yale University; Wellcome Trust Sanger Institute; Consiglio Nazionale delle Ricerche (CNR); Istituto di Genetica e Biofisica "Adriano Buzzati-Traverso" (IGB-CNR); University of Michigan System; University of Michigan; University of Geneva; University of Geneva; Swiss Institute of Bioinformatics; Cornell University; Cornell University; NewYork-Presbyterian Hospital; Cornell University; Yale University; Cornell University; Cornell University; University of Texas System; University of Texas Austin; European Molecular Biology Laboratory (EMBL); Baylor College of Medicine; Yale University; Cornell University; Boston College; Qatar Foundation (QF); Weill Cornell Medical College Qatar; Yale University; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Technical University of Denmark; University of Copenhagen; Cornell University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University Newark; Rutgers State University New Brunswick; American Museum of Natural History (AMNH); Yale University; Yale University	Tyler-Smith, C (corresponding author), Wellcome Trust Sanger Inst, Wellcome Trust Genome Campus, Cambridge CB10 1SA, England.	cts@sanger.ac.uk; mark.gerstein@yale.edu	Mu, Xinmeng/P-2562-2016; Ye, Kai/B-3640-2012; Kalra, D/H-6661-2019; Altshuler, David M/A-4476-2009; Kong, Yong/B-5105-2014; Mills, Ryan/F-4225-2010; Sisu, Cristina/K-8994-2019; Li, Yingrui/K-1064-2015; Sboner, Andrea/C-6487-2008; Rodriguez-Flores, Juan L/AAJ-7565-2020; Das, Jishnu/AAK-4950-2020; Lappalainen, Tuuli/AAE-6532-2020; Wang, Jun/A-7261-2013; Wilson, Richard K./AAF-4139-2019; Chakravarty, Dimple/N-3325-2014; Moreno-Estrada, Andres/AAP-4657-2021; Moreno-Estrada, Andres/R-3950-2017; Abyzov, Alexej/M-4284-2013; Evani, Uday/AAA-8112-2022; Garcia-Montero, Andres C/B-6558-2017; Das, Jishnu/C-6924-2015; Angius, Andrea/P-9549-2015; Herrero, Javier/H-6971-2019; Abyzov, Alexej/AAT-4615-2020; Browning, Brian L/A-1178-2010; Myers, Simon/A-6792-2015; Coin, Lachlan/A-9001-2014; Taras, Oleksyk/J-8805-2013; Colonna, Vincenza/H-2021-2014; Cooper, David N./H-4384-2011	Mu, Xinmeng/0000-0002-8079-0828; Kalra, D/0000-0001-5254-4067; Altshuler, David M/0000-0002-7250-4107; Kong, Yong/0000-0002-2881-5274; Mills, Ryan/0000-0003-3425-6998; Sisu, Cristina/0000-0001-9371-0797; Sboner, Andrea/0000-0001-6915-3070; Rodriguez-Flores, Juan L/0000-0002-0394-8062; Das, Jishnu/0000-0002-5747-064X; Lappalainen, Tuuli/0000-0002-7746-8109; Wilson, Richard K./0000-0002-1992-1358; Chakravarty, Dimple/0000-0002-8588-8461; Moreno-Estrada, Andres/0000-0001-8329-8292; Moreno-Estrada, Andres/0000-0001-8329-8292; Garcia-Montero, Andres C/0000-0003-4360-1386; Das, Jishnu/0000-0002-5747-064X; Angius, Andrea/0000-0003-2596-6461; Herrero, Javier/0000-0001-7313-717X; Browning, Brian L/0000-0001-6454-6633; Sherry, Stephen/0000-0002-7982-076X; Leinonen, Rasko/0000-0002-2639-7187; Frankish, Adam/0000-0002-4333-628X; Myers, Simon/0000-0002-2585-9626; CUCCA, Francesco/0000-0002-7414-1995; Walter, Klaudia/0000-0003-4448-0301; Coin, Lachlan/0000-0002-4300-455X; Kim, Kicheol/0000-0003-3667-9900; Sebat, Jonathan/0000-0002-9087-526X; MacArthur, Daniel/0000-0002-5771-2290; Shriver, Mark/0000-0003-0006-0479; McLaren, William/0000-0001-6218-1116; Hodgkinson, Alan/0000-0003-1636-491X; Angius, Andrea/0000-0001-9372-1162; Wilson, Michael/0000-0001-5892-6074; Fuchsberger, Christian/0000-0002-5918-8947; Clarke, Laura/0000-0002-5989-6898; Streeter, Ian/0000-0003-4024-3552; Taras, Oleksyk/0000-0002-8148-3918; Harrow, Jennifer/0000-0003-0338-3070; Colonna, Vincenza/0000-0002-3966-0474; maschio, andrea/0000-0002-4238-9144; Kulesha, Eugene/0000-0002-4285-6232; Chinwalla, Asif/0000-0001-7831-3996; Keinan, Alon/0000-0002-9760-1122; MCLELLAN, MICHAEL/0000-0002-2703-8784; Schaffner, Stephen/0000-0001-6699-3568; Borodina, Tatiana/0000-0002-6978-016X; Pers, Tune/0000-0003-0207-4831; Gumus, Zeynep/0000-0002-7364-2202; Radhakrishnan, Rajesh/0000-0001-7170-699X; Bustamante, Carlos D./0000-0002-4187-7920; Sandoval, Karla/0000-0002-6175-2463; Schneider, Valerie/0000-0002-3442-1888; Ritchie, Graham/0000-0002-6456-9736; Rubin, Mark/0000-0002-8321-9950; Abyzov, Alexej/0000-0001-5405-6729; Chen, Jieming/0000-0003-3767-9486; Michaelson, Jacob/0000-0001-9713-0992; Clark, Andrew/0000-0001-7159-8511; Keane, Thomas/0000-0001-7532-6898; Balasubramanian, Suganthi/0000-0003-2243-5948; Flicek, Paul/0000-0002-3897-7955; Cooper, David N./0000-0002-8943-8484; Tabrizi, Shervin/0000-0003-2780-8432; Eberle, Michael/0000-0001-8965-1253	Danish Council for Independent Research Medical Sciences; European Molecular Biology Laboratory; Wellcome Trust [WT085532, WT095908]; Wellcome-Trust Sanger Institute [098051]; National Cancer Institute (NCI) [R01CA152057]; Early Detection Research Network NCI [U01 CA111275]; Prostate Cancer Foundation [HG005718, HG007000]; National Human Genome Research Institute [R01HG4719, U01HG6513]; National Institute of General Medical Sciences [GM104424]; NATIONAL CANCER INSTITUTE [R01CA167824, R01CA166661, U01CA111275, R01CA152057] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000457] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [G12RR003050] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003079, R01HG002898, R01HG004719, U01HG005718, U01HG006513, U41HG007000] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM097358, R01GM104424] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [P20MD006899, G12MD007579] Funding Source: NIH RePORTER	Danish Council for Independent Research Medical Sciences(Det Frie Forskningsrad (DFF)); European Molecular Biology Laboratory; Wellcome Trust(Wellcome TrustEuropean Commission); Wellcome-Trust Sanger Institute(Wellcome Trust); National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Early Detection Research Network NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Prostate Cancer Foundation; National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	We thank G. Boysen and C. O'Reilly for help with SNV experimental validation, K. Yip for target-gene identification, and Z. Liu for Web site design. T. H. P. is supported by the Danish Council for Independent Research Medical Sciences (FSS). Funding at the European Bioinformatics Institute is provided by European Molecular Biology Laboratory and the Wellcome Trust (WT085532 and WT095908). C.T.-S. acknowledges grant 098051 from the Wellcome-Trust Sanger Institute. Funding for the Institute for Precision Medicine (Weill Cornell Medical College/New York Presbyterian) is provided by National Cancer Institute (NCI) grant R01CA152057 (A. S., M. G., and M. A. R.) and Early Detection Research Network NCI U01 CA111275 (M. A. R.). M. A. R. also thanks the Prostate Cancer Foundation. M. G. also acknowledges grants HG005718 and HG007000. G. M. acknowledges National Human Genome Research Institute grants R01HG4719 and U01HG6513. H.Y. and S. M. L. are supported by NCI grant CA167824, National Institute of General Medical Sciences grant GM104424, and a Clinical and Translational Science Center Pilot Award and Cornell Seed Grant for intercampus collaborations. H. M. K., T. L., A. S., L. L., J.C., A. H., and J.D. contributed equally.	Akiyama M, 2005, J CLIN INVEST, V115, P1777, DOI 10.1172/JCI24834; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Baca SC, 2013, CELL, V153, P666, DOI 10.1016/j.cell.2013.03.021; Barbieri CE, 2012, NAT GENET, V44, P685, DOI 10.1038/ng.2279; Barreiro LB, 2008, NAT GENET, V40, P340, DOI 10.1038/ng.78; Bejerano G, 2004, SCIENCE, V304, P1321, DOI 10.1126/science.1098119; Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; Berger MF, 2011, NATURE, V470, P214, DOI 10.1038/nature09744; Carroll SB, 2008, CELL, V134, P25, DOI 10.1016/j.cell.2008.06.030; Chen R, 2012, CELL, V148, P1293, DOI 10.1016/j.cell.2012.02.009; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Fraser HB, 2002, SCIENCE, V296, P750, DOI 10.1126/science.1068696; Gerstein MB, 2012, NATURE, V489, P91, DOI 10.1038/nature11245; Grossman SR, 2013, CELL, V152, P703, DOI 10.1016/j.cell.2013.01.035; Hamblin MT, 2000, AM J HUM GENET, V66, P1669, DOI 10.1086/302879; Hammerman PS, 2012, NATURE, V489, P519, DOI 10.1038/nature11404; Haygood R, 2007, NAT GENET, V39, P1140, DOI 10.1038/ng2104; Hermanns P, 2005, HUM MOL GENET, V14, P3723, DOI 10.1093/hmg/ddi403; Hernandez RD, 2011, SCIENCE, V331, P920, DOI 10.1126/science.1198878; Horn S, 2013, SCIENCE, V339, P959, DOI 10.1126/science.1230062; Huang FW, 2013, SCIENCE, V339, P957, DOI 10.1126/science.1229259; Hudson TJ, 2010, NATURE, V464, P993, DOI 10.1038/nature08987; Khurana E, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002886; Killela PJ, 2013, P NATL ACAD SCI USA, V110, P6021, DOI 10.1073/pnas.1303607110; Kim PM, 2007, P NATL ACAD SCI USA, V104, P20274, DOI 10.1073/pnas.0710183104; Lee W, 2009, HUM GENET, V126, P481, DOI 10.1007/s00439-009-0677-y; Levy S, 2007, PLOS BIOL, V5, P2113, DOI 10.1371/journal.pbio.0050254; Maurano MT, 2012, SCIENCE, V337, P1190, DOI 10.1126/science.1222794; Mills RE, 2011, NATURE, V470, P59, DOI 10.1038/nature09708; Mu XJ, 2011, NUCLEIC ACIDS RES, V39, P7058, DOI 10.1093/nar/gkr342; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Nik-Zainal S, 2012, CELL, V149, P979, DOI 10.1016/j.cell.2012.04.024; Ohashi J, 2004, AM J HUM GENET, V74, P1198, DOI 10.1086/421330; Rausch T, 2012, CELL, V148, P59, DOI 10.1016/j.cell.2011.12.013; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Sabeti PC, 2006, SCIENCE, V312, P1614, DOI 10.1126/science.1124309; Solis C, 2001, J CLIN INVEST, V107, P753, DOI 10.1172/JCI10642; Stenson PD, 2009, GENOME MED, V1, DOI 10.1186/gm13; Vernot B, 2012, GENOME RES, V22, P1689, DOI 10.1101/gr.134890.111; Visel A, 2010, NATURE, V464, P409, DOI 10.1038/nature08801; Wang XJ, 2012, NAT BIOTECHNOL, V30, P159, DOI 10.1038/nbt.2106; Ward LD, 2012, NAT BIOTECHNOL, V30, P1095, DOI 10.1038/nbt.2422; Ward LD, 2012, SCIENCE, V337, P1675, DOI 10.1126/science.1225057; Xue YL, 2009, GENETICS, V183, P1065, DOI 10.1534/genetics.109.107722; Yip KY, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-9-r48; Yngvadottir B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-9-237; Zhang ZD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r26	48	254	260	1	98	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 4	2013	342	6154					84	+	1235587	10.1126/science.1235587	http://dx.doi.org/10.1126/science.1235587			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	227PP	24092746	Green Accepted, Green Published			2022-12-24	WOS:000325126100049
J	Lappalainen, T; Sammeth, M; Friedlander, MR; 't Hoen, PAC; Monlong, J; Rivas, MA; Gonzalez-Porta, M; Kurbatova, N; Griebel, T; Ferreira, PG; Barann, M; Wieland, T; Greger, L; van Iterson, M; Almlof, J; Ribeca, P; Pulyakhina, I; Esser, D; Giger, T; Tikhonov, A; Sultan, M; Bertier, G; MacArthur, DG; Lek, M; Lizano, E; Buermans, HPJ; Padioleau, I; Schwarzmayr, T; Karlberg, O; Ongen, H; Kilpinen, H; Beltran, S; Gut, M; Kahlem, K; Amstislavskiy, V; Stegle, O; Pirinen, M; Montgomery, SB; Donnelly, P; McCarthy, MI; Flicek, P; Strom, TM; Lehrach, H; Schreiber, S; Sudbrak, R; Carracedo, A; Antonarakis, SE; Haesler, R; Syvaenen, AC; Van Ommen, GJ; Brazma, A; Meitinger, T; Rosenstiel, P; Guigo, R; Gut, IG; Estivill, X; Dermitzakis, ET				Lappalainen, Tuuli; Sammeth, Michael; Friedlaender, Marc R.; 't Hoen, Peter A. C.; Monlong, Jean; Rivas, Manuel A.; Gonzalez-Porta, Mar; Kurbatova, Natalja; Griebel, Thasso; Ferreira, Pedro G.; Barann, Matthias; Wieland, Thomas; Greger, Liliana; van Iterson, Maarten; Almloef, Jonas; Ribeca, Paolo; Pulyakhina, Irina; Esser, Daniela; Giger, Thomas; Tikhonov, Andrew; Sultan, Marc; Bertier, Gabrielle; MacArthur, Daniel G.; Lek, Monkol; Lizano, Esther; Buermans, Henk P. J.; Padioleau, Ismael; Schwarzmayr, Thomas; Karlberg, Olof; Ongen, Halit; Kilpinen, Helena; Beltran, Sergi; Gut, Marta; Kahlem, Katja; Amstislavskiy, Vyacheslav; Stegle, Oliver; Pirinen, Matti; Montgomery, Stephen B.; Donnelly, Peter; McCarthy, Mark I.; Flicek, Paul; Strom, Tim M.; Lehrach, Hans; Schreiber, Stefan; Sudbrak, Ralf; Carracedo, Angel; Antonarakis, Stylianos E.; Haesler, Robert; Syvaenen, Ann-Christine; Van Ommen, Gert-Jan; Brazma, Alvis; Meitinger, Thomas; Rosenstiel, Philip; Guigo, Roderic; Gut, Ivo G.; Estivill, Xavier; Dermitzakis, Emmanouil T.		Geuvadis Consortium	Transcriptome and genome sequencing uncovers functional variation in humans	NATURE			English	Article							GENE-EXPRESSION; LANDSCAPE; VARIANTS	Genome sequencing projects are discovering millions of genetic variants in humans, and interpretation of their functional effects is essential for understanding the genetic basis of variation in human traits. Here we report sequencing and deep analysis of messenger RNA and microRNA from lymphoblastoid cell lines of 462 individuals from the 1000 Genomes Project-the first uniformly processed high-throughput RNA-sequencing data from multiple human populations with high-quality genome sequences. We discover extremely widespread genetic variation affecting the regulation of most genes, with transcript structure and expression level variation being equally common but genetically largely independent. Our characterization of causal regulatory variation sheds light on the cellular mechanisms of regulatory and loss-of-function variation, and allows us to infer putative causal variants for dozens of disease-associated loci. Altogether, this study provides a deep understanding of the cellular mechanisms of transcriptome variation and of the landscape of functional variants in the human genome.	[Lappalainen, Tuuli; Giger, Thomas; Padioleau, Ismael; Ongen, Halit; Kilpinen, Helena; Montgomery, Stephen B.; Antonarakis, Stylianos E.; Dermitzakis, Emmanouil T.] Univ Geneva, Sch Med, Dept Genet Med & Dev, CH-1211 Geneva, Switzerland; [Lappalainen, Tuuli; Padioleau, Ismael; Ongen, Halit; Kilpinen, Helena; Antonarakis, Stylianos E.; Dermitzakis, Emmanouil T.] Univ Geneva, iG3, CH-1211 Geneva, Switzerland; [Lappalainen, Tuuli; Padioleau, Ismael; Ongen, Halit; Kilpinen, Helena; Dermitzakis, Emmanouil T.] Swiss Inst Bioinformat, CH-1211 Geneva, Switzerland; [Sammeth, Michael; Griebel, Thasso; Ribeca, Paolo; Beltran, Sergi; Gut, Marta; Kahlem, Katja; Gut, Ivo G.] Ctr Nacl Anal Genom, Barcelona 08028, Catalonia, Spain; [Sammeth, Michael; Friedlaender, Marc R.; Monlong, Jean; Ferreira, Pedro G.; Bertier, Gabrielle; Lizano, Esther; Guigo, Roderic; Estivill, Xavier] CRG, Barcelona 08003, Catalonia, Spain; [Sammeth, Michael; Friedlaender, Marc R.; Monlong, Jean; Ferreira, Pedro G.; Bertier, Gabrielle; Lizano, Esther; Guigo, Roderic; Estivill, Xavier] UPF, Barcelona 08003, Catalonia, Spain; [Sammeth, Michael; Friedlaender, Marc R.; Monlong, Jean; Ferreira, Pedro G.; Lizano, Esther; Guigo, Roderic; Estivill, Xavier] CRG Hosp del Mar Res Inst, Barcelona 08003, Catalonia, Spain; [Friedlaender, Marc R.; Lizano, Esther; Estivill, Xavier] CRG CIBERESP, Barcelona 08003, Catalonia, Spain; ['t Hoen, Peter A. C.; van Iterson, Maarten; Pulyakhina, Irina; Buermans, Henk P. J.; Van Ommen, Gert-Jan] Leiden Univ, Med Ctr, Dept Human Genet, NL-2300 RC Leiden, Netherlands; [Rivas, Manuel A.; Pirinen, Matti; Donnelly, Peter; McCarthy, Mark I.] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England; [Gonzalez-Porta, Mar; Kurbatova, Natalja; Greger, Liliana; Tikhonov, Andrew; Stegle, Oliver; Flicek, Paul; Brazma, Alvis] EBI, EMBL, Hinxton CB10 1SD, England; [Barann, Matthias; Esser, Daniela; Schreiber, Stefan; Haesler, Robert; Rosenstiel, Philip] Univ Kiel, Inst Clin Mol Biol, D-24105 Kiel, Germany; [Wieland, Thomas; Schwarzmayr, Thomas; Strom, Tim M.; Meitinger, Thomas] Helmholtz Zentrum Munchen, Inst Human Genet, D-85764 Neuherberg, Germany; [Almloef, Jonas; Karlberg, Olof; Syvaenen, Ann-Christine] Uppsala Univ, Dept Med Sci, Mol Med & Sci Life Lab, S-75185 Uppsala, Sweden; [Sultan, Marc; Amstislavskiy, Vyacheslav; Lehrach, Hans; Sudbrak, Ralf] Max Planck Inst Mol Genet, D-14195 Berlin, Germany; [MacArthur, Daniel G.; Lek, Monkol] Massachusetts Gen Hosp, Analyt & Translat Genet Unit, Boston, MA 02114 USA; [MacArthur, Daniel G.; Lek, Monkol] Broad Inst Harvard & MIT, Program Med & Populat Genet, Cambridge, MA 02142 USA; [Buermans, Henk P. J.] Leiden Genome Technol Ctr, NL-2300 RC Leiden, Netherlands; [McCarthy, Mark I.] Univ Oxford, Oxford Ctr Diabet Endocrinol & Metab, Oxford OX3 7BN, England; [Strom, Tim M.; Meitinger, Thomas] Tech Univ Munich, Inst Human Genet, D-81675 Munich, Germany; [Lehrach, Hans; Sudbrak, Ralf] Dahlem Ctr Genome Res & Med Syst Biol, D-14195 Berlin, Germany; [Carracedo, Angel] Univ Santiago de Compostela, CIBERER, Genom Med Grp, Fdn Publ Galega Med Xen SERGAS, Santiago De Compostela, Spain; [Meitinger, Thomas] Deutsch Forschungszentrum Herz Kreislauferkrankun, Partner Site Munich Heart Alliance, D-81675 Munich, Germany	University of Geneva; University of Geneva; Swiss Institute of Bioinformatics; Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); Pompeu Fabra University; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Oxford; Wellcome Centre for Human Genetics; European Molecular Biology Laboratory (EMBL); University of Kiel; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Uppsala University; Max Planck Society; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University of Oxford; Technical University of Munich; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Universidade de Santiago de Compostela; Munich Heart Alliance	Lappalainen, T (corresponding author), Univ Geneva, Sch Med, Dept Genet Med & Dev, CH-1211 Geneva, Switzerland.	tuuli.e.lappalainen@gmail.com; emmanouil.dermitzakis@unige.ch	Sammeth, Michael/C-1157-2014; Padioleau, Ismaël/AAE-8927-2019; Antonarakis, Stylianos E/N-8866-2014; Hoen, Peter A 't/D-3950-2018; Rosenstiel, Philip/A-5137-2009; Estivill, Xavier/A-3125-2013; Häsler, Robert/A-4908-2009; Rivas, Manuel/ABE-8173-2020; Lappalainen, Tuuli/AAE-6532-2020; Almlöf, Jonas/E-1608-2017; Beltran, Sergi/I-3408-2015; Guigo, Roderic/D-1303-2010; Ferreira, Pedro/HDO-1346-2022; Stegle, Oliver/AAU-9177-2020; Carracedo, Angel/D-4257-2012; Esser, Daniela/ABB-9383-2020; Sudbrak, Ralf/HHZ-8821-2022; Meitinger, Thomas/O-1318-2015; Ferreira, Pedro G/J-6379-2013; Gut, Ivo/ABF-3188-2020; Veltman, Joris A/F-5128-2010; Monlong, Jean/AAZ-8589-2020; Topolsky, Ivan/W-1929-2018; McCarthy, Mark/M-3763-2015	Sammeth, Michael/0000-0002-6528-9883; Padioleau, Ismaël/0000-0003-4935-3248; Antonarakis, Stylianos E/0000-0001-8907-5823; Hoen, Peter A 't/0000-0003-4450-3112; Rosenstiel, Philip/0000-0002-9692-8828; Estivill, Xavier/0000-0002-0723-2256; Häsler, Robert/0000-0003-4174-8229; Rivas, Manuel/0000-0003-1457-9925; Lappalainen, Tuuli/0000-0002-7746-8109; Almlöf, Jonas/0000-0002-1211-9821; Beltran, Sergi/0000-0002-2810-3445; Guigo, Roderic/0000-0002-5738-4477; Stegle, Oliver/0000-0002-8818-7193; Carracedo, Angel/0000-0003-1085-8986; Ferreira, Pedro G/0000-0003-3838-8664; Gut, Ivo/0000-0001-7219-632X; Veltman, Joris A/0000-0002-3218-8250; Monlong, Jean/0000-0002-9737-5516; Pirinen, Matti/0000-0002-1664-1350; Gonzalez-Porta, Mar/0000-0002-1661-7254; Bertier, Gabrielle/0000-0002-3319-3721; Lizano, Esther/0000-0003-3304-9807; Ongen, Halit/0000-0002-4197-5790; Flicek, Paul/0000-0002-3897-7955; Kilpinen, Helena/0000-0001-6692-6154; Topolsky, Ivan/0000-0002-7561-0810; Montgomery, Stephen/0000-0002-5200-3903; Kurbatova, Natalja/0000-0002-3973-2909; Friedlander, Marc/0000-0001-6577-4363; Meitinger, Thomas/0000-0002-8838-8403; MacArthur, Daniel/0000-0002-5771-2290; McCarthy, Mark/0000-0002-4393-0510; Brazma, Alvis/0000-0001-5988-7409	European Commission [261123]; Swiss National Science Foundation [130326, 130342, 127375, 144082]; Louis Jeantet Foundation; ERC [260927, 294653, 249968]; NIH-NIMH [MH090941]; Spanish Plan Nacional (NOVADIS) [SAF2008-00357]; Generalitat de Catalunya AGAUR [2009 SGR-1502]; Instituto de Salud Carlos III (FIS/FEDER) [PI11/00733, PS09/02368]; Spanish Plan Nacional [BIO2011-26205]; ESGI; READNA [2008-201418]; Spanish Ministry of Economy and Competitiveness (MINECO); Generalitat de Catalunya; DFG Cluster of Excellence Inflammation at Interfaces; INTERREG4A project HIT-ID; BMBF IHEC project DEEP [SP 2.3]; German Centre for Cardiovascular Research (DZHK); German Ministry of Education and Research [01GR0802, 01GM0867, 01GR0804, 16EX1020C]; EurocanPlatform [FP7 260791]; ENGAGE [HEALTH-F4-2007-201413]; CAGEKID [241669]; Centre for Medical Systems Biology; Swedish Research Council [C0524801, A028001]; Knut and Alice Wallenberg Foundation [2011.0073]; German Federal Ministry of Education and Research [01GS08201]; Max Planck Society; Wellcome Trust [WT085532, 081917, 090367, 090532, 098381, 076113, 083270]; European Molecular Biology Laboratory; Medical Research Council UK [G0601261]; Wellcome Trust Centre for Human Genetics [090532/Z/09/Z, 075491/Z/04/B]; WTCCC2 project [085475/B/08/Z, 085475/Z/08/Z]; Royal Society Wolfson Merit Award; Wellcome Trust Senior Investigator Award [095552/Z/11/Z]; EMBO long-term fellowship EMBO-ALTF [2010-337]; NIH-NIGMS [R01 GM104371]; Marie Curie; Clarendon Fund of the University of Oxford; Nuffield Department of Medicine; EMBO long-term fellowship [ALTF225-2011]; Emil Aaltonen Foundation; Academy of Finland; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM104371] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH090941] Funding Source: NIH RePORTER; Medical Research Council [G0601261] Funding Source: researchfish; MRC [G0601261] Funding Source: UKRI	European Commission(European CommissionEuropean Commission Joint Research Centre); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Louis Jeantet Foundation; ERC(European Research Council (ERC)European Commission); NIH-NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Spanish Plan Nacional (NOVADIS); Generalitat de Catalunya AGAUR(Agencia de Gestio D'Ajuts Universitaris de Recerca Agaur (AGAUR)Generalitat de Catalunya); Instituto de Salud Carlos III (FIS/FEDER); Spanish Plan Nacional(Spanish Government); ESGI; READNA; Spanish Ministry of Economy and Competitiveness (MINECO)(Spanish Government); Generalitat de Catalunya(Generalitat de Catalunya); DFG Cluster of Excellence Inflammation at Interfaces(German Research Foundation (DFG)); INTERREG4A project HIT-ID; BMBF IHEC project DEEP; German Centre for Cardiovascular Research (DZHK); German Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); EurocanPlatform; ENGAGE; CAGEKID; Centre for Medical Systems Biology; Swedish Research Council(Swedish Research CouncilEuropean Commission); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Max Planck Society(Max Planck SocietyFoundation CELLEX); Wellcome Trust(Wellcome Trust); European Molecular Biology Laboratory; Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust Centre for Human Genetics(Wellcome Trust); WTCCC2 project; Royal Society Wolfson Merit Award(Royal Society of London); Wellcome Trust Senior Investigator Award(Wellcome Trust); EMBO long-term fellowship EMBO-ALTF; NIH-NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Marie Curie(European Commission); Clarendon Fund of the University of Oxford; Nuffield Department of Medicine; EMBO long-term fellowship(European Molecular Biology Organization (EMBO)); Emil Aaltonen Foundation; Academy of Finland(Academy of Finland); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We would like to thank E. Falconnet, L. Romano, A. Planchon, D. Bielsen, A. Yurovsky, A. Buil, J. Bryois, A. Nica, I. Topolsky, N. Fusi, S. Waszak, C. Bustamante, J. Rung, N. Kolesnikov, A. Roa, E. Bragin, S. Brent, J. Gonzalez, M. Morell, A. Puig, E. Palumbo, M. Ventayol Garcia, J. F. J. Laros, J. Blanc, R. Birkelund, G. Plaja, M. Ingham, J. Camps, M. Bayes, L. Agueda, A. Gouin, M.-L. Yaspo, E. Graf, A. Walther, C. Fischer, S. Loesecke, B. Schmick, D. Balzereit, S. Dokel, M. Linser, A. Kovacsovics, M. Friskovec, C. von der Lancken, M. Schlapkohl, A. Hellmann, M. Schilhabel, the SNP&SEQ Technology Platform in Uppsala, S. Sauer, the Vital-IT high-performance computing centre of the SIB Swiss Institute of Bioinformatics, B. Goldstein and others at the Coriell Institute, and J. Cooper, E. Burnett, K. Ball and others at the European Collection of Cell Cultures (ECACC) and the 1000 Genomes Consortium. This project was funded by the European Commission 7th Framework Program (FP7) (261123; GEUVADIS); the Swiss National Science Foundation (130326, 130342), the Louis Jeantet Foundation, and ERC (260927) (E. T. D.); NIH-NIMH (MH090941) (E. T. D., M. I. M., R. G.); Spanish Plan Nacional SAF2008-00357 (NOVADIS), the Generalitat de Catalunya AGAUR 2009 SGR-1502, and the Instituto de Salud Carlos III (FIS/FEDER PI11/00733) (X. E.); Spanish Plan Nacional (BIO2011-26205) and ERC (294653) (R. G.); ESGI, READNA (FP7 Health-F4-2008-201418), Spanish Ministry of Economy and Competitiveness (MINECO) and the Generalitat de Catalunya (I. G. G.); DFG Cluster of Excellence Inflammation at Interfaces, the INTERREG4A project HIT-ID, and the BMBF IHEC project DEEP SP 2.3 (P.Ro.); German Centre for Cardiovascular Research (DZHK) and the German Ministry of Education and Research (01GR0802, 01GM0867, 01GR0804, 16EX1020C) (T. M.); EurocanPlatform (FP7 260791), ENGAGE and CAGEKID (241669) (A. B.); FP7/2007-2013, ENGAGE project, HEALTH-F4-2007-201413, and the Centre for Medical Systems Biology within the framework of The Netherlands Genomics Initiative (NGI)/Netherlands Organisation for Scientific and Research (NWO) (P. AC. H and G.-J.v.O.); The Swedish Research Council (C0524801, A028001) and the Knut and Alice Wallenberg Foundation (2011.0073) (A.-C. S.); The Swiss National Science Foundation (127375, 144082) and ERC (249968) (S. E. A.); Instituto de Salud Carlos III (FIS/FEDER PS09/02368) (A. C.); German Federal Ministry of Education and Research (01GS08201) (R. S.); Max Planck Society (H. L.); Wellcome Trust (WT085532) and the European Molecular Biology Laboratory (P. F.); ENGAGE, Wellcome Trust (081917, 090367, 090532, 098381), and Medical Research Council UK (G0601261) (M. I. M.); Wellcome Trust Centre for Human Genetics (090532/Z/09/Z, 075491/Z/04/B), Wellcome Trust (098381, 090367, 076113, 083270), the WTCCC2 project (085475/B/08/Z, 085475/Z/08/Z), Royal Society Wolfson Merit Award, Wellcome Trust Senior Investigator Award (095552/Z/11/Z) (P. D.); EMBO long-term fellowship EMBO-ALTF 2010-337 (H. K.); NIH-NIGMS (R01 GM104371) (D. G. M.); Marie Curie FP7 fellowship (O.S.); Scholarship by the Clarendon Fund of the University of Oxford, and the Nuffield Department of Medicine (M. A. R.); EMBO long-term fellowship ALTF225-2011 (M. R. F.); Emil Aaltonen Foundation and Academy of Finland fellowships (T.L.).	Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Barbosa-Morais NL, 2012, SCIENCE, V338, P1587, DOI 10.1126/science.1230612; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Cordaux R, 2009, NAT REV GENET, V10, P691, DOI 10.1038/nrg2640; Degner JF, 2012, NATURE, V482, P390, DOI 10.1038/nature10808; Djebali S, 2012, NATURE, V489, P101, DOI 10.1038/nature11233; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Ebert MS, 2012, CELL, V149, P515, DOI 10.1016/j.cell.2012.04.005; Emilsson V, 2008, NATURE, V452, P423, DOI 10.1038/nature06758; Gaffney DJ, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-1-r7; Gonzalez-Porta M, 2012, GENOME RES, V22, P528, DOI 10.1101/gr.121947.111; Grundberg E, 2012, NAT GENET, V44, P1084, DOI 10.1038/ng.2394; Harrow J, 2012, GENOME RES, V22, P1760, DOI 10.1101/gr.135350.111; Hindorff LA, CATALOG PUBLISHED GE; Hoen P. A. C., NATURE BIOT IN PRESS; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Lee Y, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002998; MacArthur DG, 2012, SCIENCE, V335, P823, DOI 10.1126/science.1215040; Marco-Sola S, 2012, NAT METHODS, V9, P1185, DOI [10.1038/NMETH.2221, 10.1038/nmeth.2221]; McDaniell R, 2010, SCIENCE, V328, P235, DOI 10.1126/science.1184655; Merkin J, 2012, SCIENCE, V338, P1593, DOI 10.1126/science.1228186; Montgomery SB, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002144; Montgomery SB, 2010, NATURE, V464, P773, DOI 10.1038/nature08903; Nagy E, 1998, TRENDS BIOCHEM SCI, V23, P198, DOI 10.1016/S0968-0004(98)01208-0; Nica AC, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000895; Nicolae DL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000888; O'Seaghdha CM, 2010, HUM MOL GENET, V19, P4296, DOI 10.1093/hmg/ddq342; Pantano L, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp1127; Parts L, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002704; Pickrell JK, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001236; Pickrell JK, 2010, NATURE, V464, P768, DOI 10.1038/nature08872; Stegle O, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000770; Stranger BE, 2007, NAT GENET, V39, P1217, DOI 10.1038/ng2142; Veyrieras JB, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000214; Xiao CC, 2009, CELL, V136, P26, DOI 10.1016/j.cell.2008.12.027	35	1172	1185	5	174	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 26	2013	501	7468					506	511		10.1038/nature12531	http://dx.doi.org/10.1038/nature12531			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	223RP	24037378	Green Accepted, Green Submitted			2022-12-24	WOS:000324826300049
J	Orru, V; Steri, M; Sole, G; Sidore, C; Virdis, F; Dei, M; Lai, S; Zoledziewska, M; Busonero, F; Mulas, A; Floris, M; Mentzen, WI; Urru, SAM; Olla, S; Marongiu, M; Piras, MG; Lobina, M; Maschio, A; Pitzalis, M; Urru, MF; Marcelli, M; Cusano, R; Deidda, F; Serra, V; Oppo, M; Pilu, R; Reinier, F; Berutti, R; Pireddu, L; Zara, I; Porcu, E; Kwong, A; Brennan, C; Tarrier, B; Lyons, R; Kang, HM; Uzzau, S; Atzeni, R; Valentini, M; Firinu, D; Leoni, L; Rotta, G; Naitza, S; Angius, A; Congia, M; Whalen, MB; Jones, CM; Schlessinger, D; Abecasis, GR; Fiorillo, E; Sanna, S; Cucca, F				Orru, Valeria; Steri, Maristella; Sole, Gabriella; Sidore, Carlo; Virdis, Francesca; Dei, Mariano; Lai, Sandra; Zoledziewska, Magdalena; Busonero, Fabio; Mulas, Antonella; Floris, Matteo; Mentzen, Wieslawa I.; Urru, Silvana A. M.; Olla, Stefania; Marongiu, Michele; Piras, Maria G.; Lobina, Monia; Maschio, Andrea; Pitzalis, Maristella; Urru, Maria F.; Marcelli, Marco; Cusano, Roberto; Deidda, Francesca; Serra, Valentina; Oppo, Manuela; Pilu, Rosella; Reinier, Frederic; Berutti, Riccardo; Pireddu, Luca; Zara, Ilenia; Porcu, Eleonora; Kwong, Alan; Brennan, Christine; Tarrier, Brendan; Lyons, Robert; Kang, Hyun M.; Uzzau, Sergio; Atzeni, Rossano; Valentini, Maria; Firinu, Davide; Leoni, Lidia; Rotta, Gianluca; Naitza, Silvia; Angius, Andrea; Congia, Mauro; Whalen, Michael B.; Jones, Chris M.; Schlessinger, David; Abecasis, Goncalo R.; Fiorillo, Edoardo; Sanna, Serena; Cucca, Francesco			Genetic Variants Regulating Immune Cell Levels in Health and Disease	CELL			English	Article							GENOME-WIDE ASSOCIATION; CD4 T-CELLS; SUSCEPTIBILITY LOCI; MULTIPLE-SCLEROSIS; DIABETES-MELLITUS; HUMAN IMMUNOLOGY; DENDRITIC CELLS; SELF-TOLERANCE; POPULATION; EXPRESSION	The complex network of specialized cells and molecules in the immune system has evolved to defend against pathogens, but inadvertent immune system attacks on "self'' result in autoimmune disease. Both genetic regulation of immune cell levels and their relationships with autoimmunity are largely undetermined. Here, we report genetic contributions to quantitative levels of 95 cell types encompassing 272 immune traits, in a cohort of 1,629 individuals from four clustered Sardinian villages. Wefirst estimated trait heritability, showing that it can be substantial, accounting for up to 87% of the variance (mean 41%). Next, by assessing similar to 8.2 million variants that we identified and confirmed in an extended set of 2,870 individuals, 23 independent variants at 13 loci associated with at least one trait. Notably, variants at three loci (HLA, IL2RA, and SH2B3/ATXN2) overlap with known autoimmune disease associations. These results connect specific cellular phenotypes to specific genetic variants, helping to explicate their involvement in disease.	[Orru, Valeria; Steri, Maristella; Sole, Gabriella; Sidore, Carlo; Virdis, Francesca; Dei, Mariano; Lai, Sandra; Zoledziewska, Magdalena; Busonero, Fabio; Mulas, Antonella; Mentzen, Wieslawa I.; Olla, Stefania; Marongiu, Michele; Piras, Maria G.; Lobina, Monia; Maschio, Andrea; Pitzalis, Maristella; Cusano, Roberto; Deidda, Francesca; Serra, Valentina; Pilu, Rosella; Porcu, Eleonora; Naitza, Silvia; Angius, Andrea; Whalen, Michael B.; Fiorillo, Edoardo; Sanna, Serena; Cucca, Francesco] CNR, IRGB, I-09042 Monserrato, Italy; [Sidore, Carlo; Maschio, Andrea; Kwong, Alan; Kang, Hyun M.; Abecasis, Goncalo R.] Univ Michigan, Ctr Stat Genet, Ann Arbor, MI 48109 USA; [Sidore, Carlo; Mulas, Antonella; Lobina, Monia; Serra, Valentina; Berutti, Riccardo; Porcu, Eleonora; Uzzau, Sergio; Cucca, Francesco] Univ Sassari, Dipartimento Sci Biomed, I-07100 Sassari, Italy; [Floris, Matteo; Urru, Silvana A. M.; Urru, Maria F.; Marcelli, Marco; Cusano, Roberto; Deidda, Francesca; Oppo, Manuela; Pilu, Rosella; Reinier, Frederic; Berutti, Riccardo; Pireddu, Luca; Zara, Ilenia; Atzeni, Rossano; Valentini, Maria; Leoni, Lidia; Angius, Andrea; Jones, Chris M.] CRS4, I-09010 Cagliari, Italy; [Pireddu, Luca] Univ Cagliari, I-09010 Cagliari, Italy; [Uzzau, Sergio] Porto Conte Ric Srl, Lab Prote, I-07041 Tramariglio, Alghero, Italy; [Firinu, Davide] Univ Cagliari, Dipartimento Allergol & Immunol, I-09124 Cagliari, Italy; [Rotta, Gianluca] BD Biosci Italia, I-20090 Milan, Italy; [Congia, Mauro] Univ Cagliari, Dipartimento Sci Biomed & Biotecnol, I-09124 Cagliari, Italy; [Schlessinger, David] NIA, Genet Lab, Baltimore, MD 21224 USA; [Brennan, Christine; Tarrier, Brendan; Lyons, Robert] Univ Michigan, Sch Med, Sequencing Core, Ann Arbor, MI 48109 USA	Consiglio Nazionale delle Ricerche (CNR); Istituto di Ricerca Genetica e Biomedica (IRGB-CNR); University of Michigan System; University of Michigan; University of Sassari; University of Cagliari; Porto Conte Ricerche; University of Cagliari; University of Cagliari; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); University of Michigan System; University of Michigan	Fiorillo, E (corresponding author), CNR, IRGB, I-09042 Monserrato, Italy.	edoardo.fiorillo@irgb.cnr.it; serena.sanna@irgb.cnr.it; francesco.cucca@irgb.cnr.it	Uzzau, Sergio/F-3233-2015; marcelli, marco/AGR-6853-2022; sanna, serena/H-3009-2019; Valeria, Orru/AAY-3805-2020; NAITZA, SILVIA/AAB-8775-2022; Fiorillo, Edoardo/AAY-3804-2020; Floris, Matteo/ABH-1274-2020; Steri, Maristella/AAX-8760-2020; Piras, Maria Grazia/P-2061-2018; Maschio, Andrea/AAX-8185-2020; Mulas, Antonella/B-4231-2015; Sidore, Carlo/AAV-7967-2020; Lobina, Monia/P-1690-2018; Dei, Mariano/AAY-3870-2020; Congia, Mauro/AAC-2718-2019; Angius, Andrea/P-9549-2015; Deidda, Francesca/P-1541-2018; Naitza, Silvia/D-5620-2017; firinu, davide/AAF-4366-2020; Lai, Sandra/AAY-4176-2020; Angius, Andrea/B-8966-2015; Sole, Gabriella/I-4820-2013; Serra, Valentina/Q-2925-2018	Uzzau, Sergio/0000-0001-6246-2794; sanna, serena/0000-0002-3768-1749; NAITZA, SILVIA/0000-0002-0108-757X; Floris, Matteo/0000-0003-4385-9336; Steri, Maristella/0000-0001-5869-3872; Piras, Maria Grazia/0000-0001-9004-0900; Sidore, Carlo/0000-0001-7504-7477; Lobina, Monia/0000-0003-3620-3160; Angius, Andrea/0000-0003-2596-6461; Deidda, Francesca/0000-0003-3447-7440; Sole, Gabriella/0000-0001-5292-5038; maschio, andrea/0000-0002-4238-9144; Zoledziewska, Magdalena/0000-0002-3033-6133; Serra, Valentina/0000-0002-5782-8752; Angius, Andrea/0000-0001-9372-1162; WHALEN, MICHAELBERNARD/0000-0001-7300-8511; Firinu, Davide/0000-0002-5768-391X; LAI, SANDRA/0000-0003-4198-9989; Dei, Mariano/0000-0002-7404-508X; Valentini, Maria/0000-0002-4288-8621; Pireddu, Luca/0000-0002-4663-5613; Cusano, Roberto/0000-0001-5543-7881; Rotta, Gianluca/0000-0002-5613-9453; CUCCA, Francesco/0000-0002-7414-1995; Congia, Mauro/0000-0003-1688-304X; Orru, Valeria/0000-0002-6047-4625; urru, silvana anna maria/0000-0001-6213-1290; Mulas, Antonella/0000-0002-6856-1483; Marongiu, Michele/0000-0002-7289-9815; Atzeni, Rossano/0000-0003-0020-0013; Pitzalis, Maristella/0000-0003-4975-6987	Intramural Research Program of the NIH, National Institute on Aging [N01-AG-1-2109, HHSN271201100005C]; Italian grants [FISM 2011/R/13]; Farmaci e Reti Biotecnologiche di Qualita [FaReBio2011]; MIUR/CNR; National Human Genome Research Institute [HG005581, HG005552, HG007022]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [RC2HG005552, U01HG006513, RC2HG005581, R01HG007022] Funding Source: NIH RePORTER	Intramural Research Program of the NIH, National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Italian grants; Farmaci e Reti Biotecnologiche di Qualita; MIUR/CNR(Ministry of Education, Universities and Research (MIUR)Consiglio Nazionale delle Ricerche (CNR)); National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work is dedicated to the memory of Professor Antonio Cao, mentor and leader, who passed away while this manuscript was in preparation. We thank all of the volunteers who generously participated in this study and made this research possible. We thank John Todd and Marcella Devoto for critical revisions of the manuscript, Manuela Sironi and Rachele Cagliani for advice on balancing selection tests, Luiz Pereira for web server implementation, and Manuela Uda for her previous leadership on the ProgeNIA/SardiNIA study. This research was supported, in part, by the Intramural Research Program of the NIH, National Institute on Aging, with contracts N01-AG-1-2109 and HHSN271201100005C; by Italian grants FISM 2011/R/13 "Approccio razionale per la ricerca di composti per la cura della sclerosi multipla basato sull'analisi dei target biologici individuati dagli studi di associazione sull'intero genoma in Sardegna'' and FaReBio2011 "Farmaci e Reti Biotecnologiche di Qualita` ''; by funds MIUR/CNR for rare diseases and molecular screening, PNR- CNR Aging Program 2012-2014, Giovani Ricercatori 2007 (D. lgs 502/92) from the Italian Ministry of Health to F.C.; and by National Human Genome Research Institute grants HG005581, HG005552, and HG007022 to G.R.A.	Allen HL, 2010, NATURE, V467, P832, DOI 10.1038/nature09410; Auer PL, 2012, AM J HUM GENET, V91, P794, DOI 10.1016/j.ajhg.2012.08.031; Barreiro LB, 2010, NAT REV GENET, V11, P17, DOI 10.1038/nrg2698; Barrett JC, 2009, NAT GENET, V41, P1330, DOI 10.1038/ng.483; Bayes B, 2007, TRANSPL P, V39, P2248, DOI 10.1016/j.transproceed.2007.06.021; Borsellino G, 2007, BLOOD, V110, P1225, DOI 10.1182/blood-2006-12-064527; Buchholz VR, 2011, CURR OPIN IMMUNOL, V23, P549, DOI 10.1016/j.coi.2011.05.002; Chalmin F, 2012, IMMUNITY, V36, P362, DOI 10.1016/j.immuni.2011.12.019; Chatenoud L, 2010, NAT REV ENDOCRINOL, V6, P149, DOI 10.1038/nrendo.2009.275; Chen WM, 2007, AM J HUM GENET, V81, P913, DOI 10.1086/521580; Cortes A, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3204; Davis MM, 2008, IMMUNITY, V29, P835, DOI 10.1016/j.immuni.2008.12.003; Dendrou CA, 2009, NAT GENET, V41, P1011, DOI 10.1038/ng.434; Devalliere J, 2011, BIOCHEM PHARMACOL, V82, P1391, DOI 10.1016/j.bcp.2011.06.023; Enciso-Mora V, 2010, NAT GENET, V42, P1126, DOI 10.1038/ng.696; Fletcher JM, 2009, J IMMUNOL, V183, P7602, DOI 10.4049/jimmunol.0901881; Gorlova O, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002178; Hamza TH, 2010, NAT GENET, V42, P781, DOI 10.1038/ng.642; Huang J, 2012, EUR J HUM GENET, V20, P801, DOI 10.1038/ejhg.2012.3; Li GL, 2012, CELL, V148, P84, DOI 10.1016/j.cell.2011.12.014; Li Y, 2009, ANNU REV GENOM HUM G, V10, P387, DOI 10.1146/annurev.genom.9.081307.164242; Lowe CE, 2007, NAT GENET, V39, P1074, DOI 10.1038/ng2102; Mackay F, 2009, NAT REV IMMUNOL, V9, P491, DOI 10.1038/nri2572; Maecker HT, 2012, NAT REV IMMUNOL, V12, P191, DOI 10.1038/nri3158; Marrosu MG, 2001, HUM MOL GENET, V10, P2907, DOI 10.1093/hmg/10.25.2907; McGovern DPB, 2010, NAT GENET, V42, P332, DOI 10.1038/ng.549; Miyara M, 2009, IMMUNITY, V30, P899, DOI 10.1016/j.immuni.2009.03.019; Nalls MA, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002113; Ohnmacht C, 2009, J EXP MED, V206, P549, DOI 10.1084/jem.20082394; Okada Y, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002067; Pilia G, 2006, PLOS GENET, V2, P1207, DOI 10.1371/journal.pgen.0020132; Pruim RJ, 2010, BIOINFORMATICS, V26, P2336, DOI 10.1093/bioinformatics/btq419; Pulte ED, 2007, THROMB RES, V121, P309, DOI 10.1016/j.thromres.2007.04.008; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Sansoni P, 2008, EXP GERONTOL, V43, P61, DOI 10.1016/j.exger.2007.06.008; Shevach EM, 2000, ANNU REV IMMUNOL, V18, P423, DOI 10.1146/annurev.immunol.18.1.423; Steinman RM, 2007, NATURE, V449, P419, DOI 10.1038/nature06175; Takada K, 2009, J EXP MED, V206, P2253, DOI 10.1084/jem.20082553; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; Trynka G, 2011, NAT GENET, V43, P1193, DOI 10.1038/ng.998; Uda M, 2008, P NATL ACAD SCI USA, V105, P1620, DOI 10.1073/pnas.0711566105; Vendrame F, 2010, DIABETES, V59, P947, DOI 10.2337/db09-0498; Voight BF, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002793; Wing K, 2010, NAT IMMUNOL, V11, P7, DOI 10.1038/ni.1818; Wu ZP, 2010, J IMMUNOL, V185, P231, DOI 10.4049/jimmunol.0903625	45	214	218	0	38	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	SEP 26	2013	155	1					242	256		10.1016/j.cell.2013.08.041	http://dx.doi.org/10.1016/j.cell.2013.08.041			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	224UX	24074872	Green Accepted, Bronze			2022-12-24	WOS:000324916700023
J	Li, XD; Wu, JX; Gao, DX; Wang, H; Sun, LJ; Chen, ZJJ				Li, Xiao-Dong; Wu, Jiaxi; Gao, Daxing; Wang, Hua; Sun, Lijun; Chen, Zhijian J.			Pivotal Roles of cGAS-cGAMP Signaling in Antiviral Defense and Immune Adjuvant Effects	SCIENCE			English	Article							CYCLIC GMP-AMP; CYTOSOLIC DNA; RIG-I; INNATE; 2ND-MESSENGER; SENSOR; DINUCLEOTIDE; RECOGNITION	Invasion of microbial DNA into the cytoplasm of animal cells triggers a cascade of host immune reactions that help clear the infection; however, self DNA in the cytoplasm can cause autoimmune diseases. Biochemical approaches led to the identification of cyclic guanosine monophosphate-adenosine monophosphate (cGAMP) synthase (cGAS) as a cytosolic DNA sensor that triggers innate immune responses. Here, we show that cells from cGAS-deficient (cGas(-/-)) mice, including fibroblasts, macrophages, and dendritic cells, failed to produce type I interferons and other cytokines in response to DNA transfection or DNA virus infection. cGas(-/-) mice were more susceptible to lethal infection with herpes simplex virus 1 (HSV1) than wild-type mice. We also show that cGAMP is an adjuvant that boosts antigen-specific T cell activation and antibody production in mice.	[Li, Xiao-Dong; Wu, Jiaxi; Gao, Daxing; Wang, Hua; Sun, Lijun; Chen, Zhijian J.] Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA; [Sun, Lijun; Chen, Zhijian J.] Univ Texas SW Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas	Sun, LJ (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA.	Lijun.Sun@UTSouthwestern.edu; Zhijian.Chen@UTSouthwestern.edu	Gao, Daxing/J-4733-2017; Chen, Zhijian/C-6039-2012; Sun, Lijun/ABD-4470-2021; Wu, Jiaxi/K-3322-2016	Gao, Daxing/0000-0002-1493-4467; Chen, Zhijian/0000-0002-8475-8251; Wu, Jiaxi/0000-0002-6976-4784; Li, Xiao-Dong/0000-0002-4349-6996	NIH [AI-093967, 5T32AI070116]; Cancer Prevention and Research Institute of Texas [RP110430]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI093967, T32AI070116] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Prevention and Research Institute of Texas; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank R. Hammer and the transgenic core facility at University of Texas Southwestern Medical Center for performing in vitro fertilization, S. Murray for technical assistance in HSV1 infection in mice, and N. DeLuca and D. Knipe for providing HSV1 strains d109 and 7134, respectively. This work was supported by grants from NIH (AI-093967) and the Cancer Prevention and Research Institute of Texas (RP110430). H.W. was supported by an NIH postdoctoral training grant (5T32AI070116). Z.J.C. is an investigator of Howard Hughes Medical Institute. The University of Texas has filed a patent on using cGAMP and its derivatives as vaccine adjuvants (U.S. patents 61/829,251 and 61/739.072; pharmaceutical targeting of a mammalian cyclic di-nucleotide signaling pathway). Materials including the cGas<SUP>-/-</SUP> mice may be requested upon signing a materials transfer agreement. The data presented in this manuscript are tabulated in the main paper and the supplementary materials.	Ablasser A, 2013, NATURE, V498, P380, DOI 10.1038/nature12306; Ablasser A, 2009, NAT IMMUNOL, V10, P1065, DOI 10.1038/ni.1779; Chen WX, 2010, VACCINE, V28, P3080, DOI 10.1016/j.vaccine.2010.02.081; Chiu YH, 2009, CELL, V138, P576, DOI 10.1016/j.cell.2009.06.015; Desmet CJ, 2012, NAT REV IMMUNOL, V12, P479, DOI 10.1038/nri3247; Diner EJ, 2013, CELL REP, V3, P1355, DOI 10.1016/j.celrep.2013.05.009; Gao P, 2013, CELL, V153, P1094, DOI 10.1016/j.cell.2013.04.046; Ishikawa H, 2011, CELL MOL LIFE SCI, V68, P1157, DOI 10.1007/s00018-010-0605-2; Ishikawa H, 2009, NATURE, V461, P788, DOI 10.1038/nature08476; Melroe GT, 2004, J VIROL, V78, P8411, DOI 10.1128/JVI.78.16.8411-8420.2004; O'Neill LAJ, 2013, SCIENCE, V339, P763, DOI 10.1126/science.1234724; Samaniego LA, 1998, J VIROL, V72, P3307, DOI 10.1128/JVI.72.4.3307-3320.1998; Sauer JD, 2011, INFECT IMMUN, V79, P688, DOI 10.1128/IAI.00999-10; Stetson DB, 2006, IMMUNITY, V24, P93, DOI 10.1016/j.immuni.2005.12.003; Sun LJ, 2013, SCIENCE, V339, P786, DOI 10.1126/science.1232458; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Unterholzner L, 2010, NAT IMMUNOL, V11, P997, DOI 10.1038/ni.1932; Wu JX, 2013, SCIENCE, V339, P826, DOI 10.1126/science.1229963; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087; Zhang X, 2013, MOL CELL, V51, P226, DOI 10.1016/j.molcel.2013.05.022; Zhang ZQ, 2011, NAT IMMUNOL, V12, P959, DOI 10.1038/ni.2091	21	668	711	8	162	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 20	2013	341	6152					1390	1394		10.1126/science.1244040	http://dx.doi.org/10.1126/science.1244040			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	220PK	23989956	Green Accepted			2022-12-24	WOS:000324597200046
J	Maeda, K; Anand, K; Chiapparino, A; Kumar, A; Poletto, M; Kaksonen, M; Gavin, AC				Maeda, Kenji; Anand, Kanchan; Chiapparino, Antonella; Kumar, Arun; Poletto, Mattia; Kaksonen, Marko; Gavin, Anne-Claude			Interactome map uncovers phosphatidylserine transport by oxysterol-binding proteins	NATURE			English	Article							SACCHAROMYCES-CEREVISIAE; PLASMA-MEMBRANE; MOLECULAR REPLACEMENT; GLOBAL ANALYSIS; YEAST; IDENTIFICATION; SEQUENCE; LOCALIZATION; ORGANIZATION; METABOLISM	The internal organization of eukaryotic cells into functionally specialized, membrane-delimited organelles of unique composition implies a need for active, regulated lipid transport. Phosphatidylserine (PS), for example, is synthesized in the endoplasmic reticulum and then preferentially associates-through mechanisms not fully elucidated-with the inner leaflet of the plasma membrane(1-3). Lipids can travel via transport vesicles. Alternatively, several protein families knownas lipid-transfer proteins (LTPs) can extract a variety of specific lipids from biological membranes and transport them, within a hydrophobic pocket, through aqueous phases(4-7). Here we report the development of an integrated approach that combines protein fractionation and lipidomics to characterize the LTP-lipid complexes formed in vivo. We applied the procedure to 13 LTPs in the yeast Saccharomyces cerevisiae: the six Sec14 homology (Sfh) proteins and the seven oxysterol-binding homology (Osh) proteins. We found that Osh6 and Osh7 have an unexpected specificity for PS. In vivo, they participate in PS homeostasis and the transport of this lipid to the plasma membrane. The structure of Osh6 bound to PS reveals unique features that are conserved among other metazoan oxysterol-binding proteins (OSBPs) and are required for PS recognition. Our findings represent the first direct evidence, to our knowledge, for the non-vesicular transfer of PS from its site of biosynthesis (the endoplasmic reticulum) to its site of biological activity (the plasma membrane). We describe a new subfamily of OSBPs, including human ORP5 and ORP10, that transfer PS and propose new mechanisms of action for a protein family that is involved in several human pathologies such as cancer, dyslipidaemia and metabolic syndrome.	[Maeda, Kenji; Anand, Kanchan; Chiapparino, Antonella; Kumar, Arun; Poletto, Mattia; Kaksonen, Marko; Gavin, Anne-Claude] European Mol Biol Lab, D-69117 Heidelberg, Germany	European Molecular Biology Laboratory (EMBL)	Gavin, AC (corresponding author), European Mol Biol Lab, Meyerhofstr 1, D-69117 Heidelberg, Germany.	gavin@embl.de		KUMAR, ARUN/0000-0001-8706-8558; Kaksonen, Marko/0000-0003-3645-7689; Chiapparino, Antonella/0000-0001-6336-2736; Maeda, Kenji/0000-0002-9080-5691; Gavin, Anne-Claude/0000-0003-4917-2340	Federal Ministry of Education and Research (BMBF) [01GS0865]; European Molecular Biology Laboratory; EU Marie Curie Actions Interdisciplinary Postdoctoral Cofunded Programme; Marie Curie reintegration grant (ERG); Danish Natural Science Research Council [09-064986/FNU]	Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); European Molecular Biology Laboratory; EU Marie Curie Actions Interdisciplinary Postdoctoral Cofunded Programme; Marie Curie reintegration grant (ERG)(European Commission); Danish Natural Science Research Council(Danish Natural Science Research Council)	We are grateful to C. Schultz and C. Muller for inspiring comments on the manuscript, and to the EMBL Proteomics and the Protein Expression and Purification Core Facilities, E. M. Vilalta, V. Rybin, O. Gallego, M. Skruzny, A. Picco, S. Glatt, F. Voigt and A. Scholz for expert help and the sharing of reagents. The authors thank the beam line staff at the European Synchrotron Radiation Facility (ESRF), beam line ID23-1, Grenoble, France where crystallographic data collection was performed. We also thank C. Muller's group and other members of M.K.'s and A.-C.G.'s groups for continuous discussions and support. We are grateful to C. Boone, S. Emr and E. Hurt for sharing reagents. This work was partially funded by the Federal Ministry of Education and Research (BMBF; 01GS0865) in the framework of the IG-Cellular System genomics to A.-C.G.; A. K. is supported by the European Molecular Biology Laboratory and the EU Marie Curie Actions Interdisciplinary Postdoctoral Cofunded Programme. K. A. acknowledges support from Marie Curie reintegration grant (ERG). K. M. is supported by the Danish Natural Science Research Council (09-064986/FNU).	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkp985, 10.1093/nar/gkr1065]; Beh CT, 2001, GENETICS, V157, P1117; Burgett AWG, 2011, NAT CHEM BIOL, V7, P639, DOI 10.1038/nchembio.625; CHEN J, 1995, P NATL ACAD SCI USA, V92, P4947, DOI 10.1073/pnas.92.11.4947; Churchward Matthew A, 2008, J Chem Biol, V1, P79, DOI 10.1007/s12154-008-0007-1; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; D'Angelo G, 2008, CURR OPIN CELL BIOL, V20, P360, DOI 10.1016/j.ceb.2008.03.013; de Saint-Jean M, 2011, J CELL BIOL, V195, P965, DOI 10.1083/jcb.201104062; Tommaso P, 2011, NUCLEIC ACIDS RES, V39, pW13, DOI 10.1093/nar/gkr245; Ejsing CS, 2009, P NATL ACAD SCI USA, V106, P2136, DOI 10.1073/pnas.0811700106; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fairn GD, 2011, NAT CELL BIOL, V13, P1424, DOI 10.1038/ncb2351; Fairn GD, 2011, J CELL BIOL, V194, P257, DOI 10.1083/jcb.201012028; Felsenstein J., 1993, PHYLIP PHYLOGENY INF; FISCHL AS, 1983, J BACTERIOL, V154, P304, DOI 10.1128/JB.154.1.304-311.1983; Gallego O, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.87; Gavin AC, 2006, NATURE, V440, P631, DOI 10.1038/nature04532; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; Holthuis JCM, 2005, NAT REV MOL CELL BIO, V6, P209, DOI 10.1038/nrm1591; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Im YJ, 2005, NATURE, V437, P154, DOI 10.1038/nature03923; Janke C, 2004, YEAST, V21, P947, DOI 10.1002/yea.1142; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Letunic I, 2007, BIOINFORMATICS, V23, P127, DOI 10.1093/bioinformatics/btl529; Lev S, 2010, NAT REV MOL CELL BIO, V11, P739, DOI 10.1038/nrm2971; Leventis PA, 2010, ANNU REV BIOPHYS, V39, P407, DOI 10.1146/annurev.biophys.093008.131234; Li XY, 2010, CELL, V143, P639, DOI 10.1016/j.cell.2010.09.048; Li XM, 2000, MOL BIOL CELL, V11, P1989, DOI 10.1091/mbc.11.6.1989; Li XM, 2002, J CELL BIOL, V157, P63, DOI 10.1083/jcb.200201037; Ngo MH, 2010, BIOCHEM J, V429, P13, DOI 10.1042/BJ20100263; Panaretou Barry, 2006, Methods Mol Biol, V313, P27; Park WS, 2008, MOL CELL, V30, P381, DOI 10.1016/j.molcel.2008.04.008; Pei JM, 2008, NUCLEIC ACIDS RES, V36, P2295, DOI 10.1093/nar/gkn072; Pichler H, 2001, EUR J BIOCHEM, V268, P2351, DOI 10.1046/j.1432-1327.2001.02116.x; Raychaudhuri S, 2006, J CELL BIOL, V173, P107, DOI 10.1083/jcb.200510084; Read RJ, 2001, ACTA CRYSTALLOGR D, V57, P1373, DOI 10.1107/S0907444901012471; Riekhof WR, 2007, J BIOL CHEM, V282, P36853, DOI 10.1074/jbc.M706718200; Rossanese OW, 2001, J CELL BIOL, V153, P47, DOI 10.1083/jcb.153.1.47; ROSSMANN MG, 1990, ACTA CRYSTALLOGR A, V46, P73, DOI 10.1107/S0108767389009815; Schulz TA, 2009, J CELL BIOL, V187, P889, DOI 10.1083/jcb.200905007; Slaughter BD, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2370; Spira F, 2012, NAT CELL BIOL, V14, P640, DOI 10.1038/ncb2487; Stefan CJ, 2011, CELL, V144, P389, DOI 10.1016/j.cell.2010.12.034; Stefan CJ, 2002, MOL BIOL CELL, V13, P542, DOI 10.1091/mbc.01-10-0476; Tong AHY, 2007, METHOD MICROBIOL, V36, P369, DOI 10.1016/S0580-9517(06)36016-3; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Weerheim AM, 2002, ANAL BIOCHEM, V302, P191, DOI 10.1006/abio.2001.5552; Yeung T, 2008, SCIENCE, V319, P210, DOI 10.1126/science.1152066; Yu JW, 2004, MOL CELL, V13, P677, DOI 10.1016/S1097-2765(04)00083-8; Yu JW, 2001, J BIOL CHEM, V276, P44179, DOI 10.1074/jbc.M108811200	52	222	230	3	81	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 12	2013	501	7466					257	+		10.1038/nature12430	http://dx.doi.org/10.1038/nature12430			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	215XR	23934110				2022-12-24	WOS:000324244900048
J	Kuroki, S; Matoba, S; Akiyoshi, M; Matsumura, Y; Miyachi, H; Mise, N; Abe, K; Ogura, A; Wilhelm, D; Koopman, P; Nozaki, M; Kanai, Y; Shinkai, Y; Tachibana, M				Kuroki, Shunsuke; Matoba, Shogo; Akiyoshi, Mika; Matsumura, Yasuko; Miyachi, Hitoshi; Mise, Nathan; Abe, Kuniya; Ogura, Atsuo; Wilhelm, Dagmar; Koopman, Peter; Nozaki, Masami; Kanai, Yoshiakira; Shinkai, Yoichi; Tachibana, Makoto			Epigenetic Regulation of Mouse Sex Determination by the Histone Demethylase Jmjd1a	SCIENCE			English	Article							GENE-EXPRESSION; SRY; MICE; JHDM2A; SPERMATOGENESIS; TRANSCRIPTION; ACTIVATION; OBESITY; SOX9	Developmental gene expression is defined through cross-talk between the function of transcription factors and epigenetic status, including histone modification. Although several transcription factors play crucial roles in mammalian sex determination, how epigenetic regulation contributes to this process remains unknown. We observed male-to-female sex reversal in mice lacking the H3K9 demethylase Jmjd1a and found that Jmjd1a regulates expression of the mammalian Y chromosome sex-determining gene Sry. Jmjd1a directly and positively controls Sry expression by regulating H3K9me2 marks. These studies reveal a pivotal role of histone demethylation in mammalian sex determination.	[Kuroki, Shunsuke; Akiyoshi, Mika; Matsumura, Yasuko; Miyachi, Hitoshi; Tachibana, Makoto] Kyoto Univ, Inst Virus Res, Expt Res Ctr Infect Dis, Sakyo Ku, Kyoto 606, Japan; [Matoba, Shogo; Mise, Nathan; Abe, Kuniya; Ogura, Atsuo] RIKEN Tsukuba Inst, Bioresource Ctr, Tsukuba, Ibaraki, Japan; [Wilhelm, Dagmar; Koopman, Peter] Univ Queensland, Inst Mol Biosci, Brisbane, Qld 4072, Australia; [Nozaki, Masami] Osaka Univ, Microbial Dis Res Inst, Suita, Osaka 5650871, Japan; [Kanai, Yoshiakira] Univ Tokyo, Dept Vet Anat, Bunkyo Ku, Tokyo 1138657, Japan; [Shinkai, Yoichi] RIKEN Adv Sci Inst, Cellular Memory Lab, Wako, Saitama 3510198, Japan; [Tachibana, Makoto] Kyoto Univ, Grad Sch Biostudies, Sakyo Ku, Kyoto, Japan	Kyoto University; RIKEN; University of Queensland; Osaka University; University of Tokyo; RIKEN; Kyoto University	Shinkai, Y (corresponding author), RIKEN Adv Sci Inst, Cellular Memory Lab, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.	yshinkai@riken.jp; mtachiba@virus.kyoto-u.ac.jp	Shinkai, Yoichi/N-3909-2014; 名丹, 三瀬/AAD-1036-2021; Koopman, Peter A/C-9416-2009; Ogura, Atsuo/J-3916-2014; MATOBA, Shogo/D-9995-2016; Wilhelm, Dagmar/B-6915-2009	Shinkai, Yoichi/0000-0002-6051-2484; Koopman, Peter A/0000-0001-6939-0914; Ogura, Atsuo/0000-0003-0447-1988; MATOBA, Shogo/0000-0003-0474-232X; Wilhelm, Dagmar/0000-0002-7757-4075; Kanai, Yoshiakira/0000-0003-2116-7806; Tachibana, Makoto/0000-0001-7977-1120	Funding Program for Next Generation World-Leading Researchers; Grants-in-Aid for Scientific Research [25112001] Funding Source: KAKEN	Funding Program for Next Generation World-Leading Researchers(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We are especially grateful to T. Nakano for critical advice during the manuscript preparation. We thank K. Morohashi for antibodies to Nr5a1; H. Kimura for antibodies to histone; and T. Hara for fluorescence-activated cell sorting analysis support. We are also grateful to T. Matsui, G. Nagamatsu, and the members of the Tachibana laboratory for technical support. This work was supported by grants from the Funding Program for Next Generation World-Leading Researchers (M.T.). The microarray data have been deposited in the Gene Expression Omnibus and given the accession number GSE49513.	Albrecht KH, 2001, DEV BIOL, V240, P92, DOI 10.1006/dbio.2001.0438; Bullejos M, 2001, DEV DYNAM, V221, P201, DOI 10.1002/dvdy.1134; Hiramatsu R, 2009, DEVELOPMENT, V136, P129, DOI 10.1242/dev.029587; Inagaki T, 2009, GENES CELLS, V14, P991, DOI 10.1111/j.1365-2443.2009.01326.x; Kashimada K, 2010, DEVELOPMENT, V137, P3921, DOI 10.1242/dev.048983; Katoh-Fukui Y, 2012, ENDOCRINOLOGY, V153, P913, DOI 10.1210/en.2011-1055; Kent J, 1996, DEVELOPMENT, V122, P2813; Kidokoro T, 2005, DEV BIOL, V278, P511, DOI 10.1016/j.ydbio.2004.11.006; Kooistra SM, 2012, NAT REV MOL CELL BIO, V13, P297, DOI 10.1038/nrm3327; KOOPMAN P, 1991, NATURE, V351, P117, DOI 10.1038/351117a0; Liu ZL, 2010, J BIOL CHEM, V285, P2758, DOI 10.1074/jbc.M109.066845; Loffler KA, 2003, ENDOCRINOLOGY, V144, P3237, DOI 10.1210/en.2002-0095; MOROHASHI K, 1992, J BIOL CHEM, V267, P17913; Okada Y, 2007, NATURE, V450, P119, DOI 10.1038/nature06236; Sekido R, 2009, TRENDS GENET, V25, P19, DOI 10.1016/j.tig.2008.10.008; Tachibana M, 2007, EMBO J, V26, P3346, DOI 10.1038/sj.emboj.7601767; Tateishi K, 2009, NATURE, V458, P757, DOI 10.1038/nature07777; Wilhelm D, 2009, MECH DEVELOP, V126, P324, DOI 10.1016/j.mod.2009.02.006; Yamane K, 2006, CELL, V125, P483, DOI 10.1016/j.cell.2006.03.027	19	170	177	2	76	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 6	2013	341	6150					1106	1109		10.1126/science.1239864	http://dx.doi.org/10.1126/science.1239864			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	211TG	24009392	Green Published			2022-12-24	WOS:000323933100043
J	Wilson, MD; Harreman, M; Taschner, M; Reid, J; Walker, J; Erdjument-Bromage, H; Tempst, P; Svejstrup, JQ				Wilson, Marcus D.; Harreman, Michelle; Taschner, Michael; Reid, James; Walker, Jane; Erdjument-Bromage, Hediye; Tempst, Paul; Svejstrup, Jesper Q.			Proteasome-Mediated Processing of Def1, a Critical Step in the Cellular Response to Transcription Stress	CELL			English	Article							RNA-POLYMERASE-II; DAMAGE-INDUCED UBIQUITYLATION; DNA-DAMAGE; NUCLEAR EXPORT; PROTEIN LOCALIZATION; UBIQUITIN LIGASE; LARGE SUBUNIT; DEGRADATION; ELONGATION; ELONGIN	DNA damage triggers polyubiquitylation and degradation of the largest subunit of RNA polymerase II (RNAPII), a "mechanism of last resort" employed during transcription stress. In yeast, this process is dependent on Def1 through a previously unresolved mechanism. Here, we report that Def1 becomes activated through ubiquitylation- and proteasome-dependent processing. Def1 processing results in the removal of a domain promoting cytoplasmic localization, resulting in nuclear accumulation of the clipped protein. Nuclear Def1 then binds RNAPII, utilizing a ubiquitin-binding domain to recruit the Elongin-Cullin E3 ligase complex via a ubiquitin-homology domain in the Ela1 protein. This facilitates polyubiquitylation of Rpb1, triggering its protea-some-mediated degradation. Together, these results outline the multistep mechanism of Rpb1 polyubiquitylation triggered by transcription stress and uncover the key role played by Def1 as a facilitator of Elongin-Cullin ubiquitin ligase function.	[Wilson, Marcus D.; Harreman, Michelle; Taschner, Michael; Reid, James; Walker, Jane; Svejstrup, Jesper Q.] Canc Res UK London Res Inst, Clare Hall Labs, Mech Transcript Lab, S Mimms EN6 3LD, Herts, England; [Erdjument-Bromage, Hediye; Tempst, Paul] Mem Sloan Kettering Canc Ctr, Mol Biol Programme, New York, NY 10021 USA	Cancer Research UK; Memorial Sloan Kettering Cancer Center	Svejstrup, JQ (corresponding author), Canc Res UK London Res Inst, Clare Hall Labs, Mech Transcript Lab, S Mimms EN6 3LD, Herts, England.	j.svejstrup@cancer.org.uk		Tempst, Paul/0000-0002-6680-3987; Erdjument-Bromage, Hediye/0000-0003-0224-3594; Wilson, Marcus/0000-0001-9551-5514; Svejstrup, Jesper/0000-0003-4964-6147; Taschner, Michael/0000-0002-8881-3705; Taschner, Michael/0000-0002-3789-5077	Cancer Research UK; European Research Council; Cancer Research UK [11567] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); European Research Council(European Research Council (ERC)European Commission); Cancer Research UK(Cancer Research UK)	This work was supported by grants from Cancer Research UK and European Research Council (to J.Q.S.). We thank Fermentation Services and the Protein Analysis and Proteomics Laboratory at the London Research Institute (LRI) for their expert assistance. We thank William Tansey, Raymond Deshaies, Pamela Silver, Anita Corbett, and Frank Uhlmann for providing reagents. We thank Peter Verrijzer, Helle Ulrich, Kay Hofmann, Nico Dantuma, Anita Corbett, James Omichinski, and members of the Svejstrup laboratory for comments on the manuscript.	Anindya R, 2007, MOL CELL, V28, P386, DOI 10.1016/j.molcel.2007.10.008; Anindya R, 2010, MOL CELL, V38, P637, DOI 10.1016/j.molcel.2010.04.017; ASO T, 1995, SCIENCE, V269, P1439, DOI 10.1126/science.7660129; Bassermann F, 2014, BBA-MOL CELL RES, V1843, P150, DOI 10.1016/j.bbamcr.2013.02.028; Beaudenon SL, 1999, MOL CELL BIOL, V19, P6972; Branzei D, 2010, NAT REV MOL CELL BIO, V11, P208, DOI 10.1038/nrm2852; Bregman DB, 1996, P NATL ACAD SCI USA, V93, P11586, DOI 10.1073/pnas.93.21.11586; Brykailo MA, 2007, NUCLEIC ACIDS RES, V35, P6862, DOI 10.1093/nar/gkm776; Chan WM, 2011, HUM MOL GENET, V20, P1738, DOI 10.1093/hmg/ddr049; Chen YB, 2005, J BIOL CHEM, V280, P24784, DOI 10.1074/jbc.M413562200; Collins GA, 2010, YEAST, V27, P965, DOI 10.1002/yea.1805; Dikic I, 2009, NAT REV MOL CELL BIO, V10, P659, DOI 10.1038/nrm2767; Gaillard H, 2013, BBA-GENE REGUL MECH, V1829, P141, DOI 10.1016/j.bbagrm.2012.09.008; GARRETT KP, 1995, P NATL ACAD SCI USA, V92, P7172, DOI 10.1073/pnas.92.16.7172; GERACE L, 1995, CELL, V82, P341, DOI 10.1016/0092-8674(95)90420-4; Harreman M, 2009, P NATL ACAD SCI USA, V106, P20705, DOI 10.1073/pnas.0907052106; Hobson DJ, 2012, MOL CELL, V48, P365, DOI 10.1016/j.molcel.2012.08.027; Hofmann K, 2009, DNA REPAIR, V8, P544, DOI 10.1016/j.dnarep.2009.01.003; Hoppe T, 2000, CELL, V102, P577, DOI 10.1016/S0092-8674(00)00080-5; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Huibregtse JM, 1997, P NATL ACAD SCI USA, V94, P3656, DOI 10.1073/pnas.94.8.3656; Hutten S, 2007, TRENDS CELL BIOL, V17, P193, DOI 10.1016/j.tcb.2007.02.003; Jariel-Encontre I, 2008, BBA-REV CANCER, V1786, P153, DOI 10.1016/j.bbcan.2008.05.004; Jordan PW, 2007, PLOS GENET, V3, P2368, DOI 10.1371/journal.pgen.0030222; Kee Y, 2005, EMBO J, V24, P2414, DOI 10.1038/sj.emboj.7600710; Koth CM, 2000, J BIOL CHEM, V275, P11174, DOI 10.1074/jbc.275.15.11174; Kravtsova-Ivantsiv Y, 2009, MOL CELL, V33, P496, DOI 10.1016/j.molcel.2009.01.023; Kushnirov VV, 2000, YEAST, V16, P857, DOI 10.1002/1097-0061(20000630)16:9<857::AID-YEA561>3.0.CO;2-B; Lee MS, 1996, GENE DEV, V10, P1233, DOI 10.1101/gad.10.10.1233; Nagata S, 2000, EXP CELL RES, V256, P12, DOI 10.1006/excr.2000.4834; PALOMBELLA VJ, 1994, CELL, V78, P773, DOI 10.1016/S0092-8674(94)90482-0; Pan Y, 2006, MOL CELL BIOL, V26, P3365, DOI 10.1128/MCB.26.9.3365-3377.2006; Piwko W, 2006, NAT STRUCT MOL BIOL, V13, P691, DOI 10.1038/nsmb1122; Ponting CP, 2002, NUCLEIC ACIDS RES, V30, P3643, DOI 10.1093/nar/gkf498; Rape M, 2002, NAT CELL BIOL, V4, pE113, DOI 10.1038/ncb0502-e113; Rape M, 2001, CELL, V107, P667, DOI 10.1016/S0092-8674(01)00595-5; Reid J, 2004, J BIOL CHEM, V279, P29875, DOI 10.1074/jbc.C400185200; Ribar B, 2007, MOL CELL BIOL, V27, P3211, DOI 10.1128/MCB.00091-07; Ribar B, 2006, MOL CELL BIOL, V26, P3999, DOI 10.1128/MCB.00293-06; Schlacher K, 2007, NAT REV MOL CELL BIO, V8, P587, DOI 10.1038/nrm2198; Shih SC, 2003, EMBO J, V22, P1273, DOI 10.1093/emboj/cdg140; Sigurdsson S, 2010, MOL CELL, V38, P202, DOI 10.1016/j.molcel.2010.02.026; Somesh BP, 2007, CELL, V129, P57, DOI 10.1016/j.cell.2007.01.046; Somesh BP, 2005, CELL, V121, P913, DOI 10.1016/j.cell.2005.04.010; Strom AC, 2001, GENOME BIOL, V2; Suzuki T, 2011, J BIOSCI BIOENG, V112, P107, DOI 10.1016/j.jbiosc.2011.04.007; Svejstrup JQ, 2010, TRENDS BIOCHEM SCI, V35, P333, DOI 10.1016/j.tibs.2010.02.001; Taura T, 1998, P NATL ACAD SCI USA, V95, P7427, DOI 10.1073/pnas.95.13.7427; Tkach JM, 2012, NAT CELL BIOL, V14, P966, DOI 10.1038/ncb2549; VANGOOL AJ, 1994, EMBO J, V13, P5361, DOI 10.1002/j.1460-2075.1994.tb06871.x; Verma R, 2011, MOL CELL, V41, P82, DOI 10.1016/j.molcel.2010.12.017; Welchman RL, 2005, NAT REV MOL CELL BIO, V6, P599, DOI 10.1038/nrm1700; Wilson MD, 2013, BBA-GENE REGUL MECH, V1829, P151, DOI 10.1016/j.bbagrm.2012.08.002; Wilson MD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046398; Woudstra EC, 2002, NATURE, V415, P929, DOI 10.1038/415929a; Yasukawa T, 2008, EMBO J, V27, P3256, DOI 10.1038/emboj.2008.249	56	49	49	0	21	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 29	2013	154	5					983	995		10.1016/j.cell.2013.07.028	http://dx.doi.org/10.1016/j.cell.2013.07.028			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	209OE	23993092	hybrid, Green Published			2022-12-24	WOS:000323767300013
J	Cao, G; Platisa, J; Pieribone, VA; Raccuglia, D; Kunst, M; Nitabach, MN				Cao, Guan; Platisa, Jelena; Pieribone, Vincent A.; Raccuglia, Davide; Kunst, Michael; Nitabach, Michael N.			Genetically Targeted Optical Electrophysiology in Intact Neural Circuits	CELL			English	Article							SENSITIVE FLUORESCENT PROTEIN; DROSOPHILA ANTENNAL LOBE; PDF NEURONS; ACTION-POTENTIALS; CIRCADIAN CONTROL; VOLTAGE SENSOR; CLOCK NEURONS; FLY BRAIN; CI-VSP; MELANOGASTER	Nervous systems process information by integrating the electrical activity of neurons in complex networks. This motivates the long-standing interest in using optical methods to simultaneously monitor the membrane potential of multiple genetically targeted neurons via expression of genetically encoded fluorescent voltage indicators (GEVIs) in intact neural circuits. No currently available GEVIs have demonstrated robust signals in intact brain tissue that enable reliable recording of individual electrical events simultaneously in multiple neurons. Here, we show that the recently developed "ArcLight" GEVI robustly reports both subthreshold events and action potentials in genetically targeted neurons in the intact Drosophila fruit fly brain and reveals electrical signals in neurite branches. In the same way that genetically encoded fluorescent sensors have revolutionized the study of intracellular Ca2+ signals, ArcLight now enables optical measurement in intact neural circuits of membrane potential, the key cellular parameter that underlies neuronal information processing.	[Cao, Guan; Pieribone, Vincent A.; Raccuglia, Davide; Kunst, Michael; Nitabach, Michael N.] Yale Univ, Sch Med, Dept Cellular & Mol Physiol, New Haven, CT 06520 USA; [Pieribone, Vincent A.] Yale Univ, Sch Med, Dept Neurobiol, New Haven, CT 06520 USA; [Nitabach, Michael N.] Yale Univ, Sch Med, Dept Genet, New Haven, CT 06520 USA; [Nitabach, Michael N.] Yale Univ, Sch Med, Program Cellular Neurosci Neurodegenerat & Repair, New Haven, CT 06520 USA; [Platisa, Jelena; Pieribone, Vincent A.] John B Pierce Lab, New Haven, CT 06519 USA; [Platisa, Jelena] Univ Belgrade, Fac Phys Chem, Belgrade 11000, Serbia	Yale University; Yale University; Yale University; Yale University; Yale University; The John B Pierce Laboratory, Inc; University of Belgrade	Nitabach, MN (corresponding author), Yale Univ, Sch Med, Dept Cellular & Mol Physiol, 333 Cedar St, New Haven, CT 06520 USA.	michael.nitabach@yale.edu	Platisa, Jelena/P-4987-2019; Platisa, Jelena/R-3785-2017	Platisa, Jelena/0000-0003-4813-609X; Platisa, Jelena/0000-0003-4813-609X; Kunst, Michael/0000-0003-4159-8056; Pieribone, Vincent/0000-0002-5836-5454; Raccuglia, Davide/0000-0003-1999-1505	National Institute of Neurological Disorders and Stroke (NINDS); National Institute of General Medical Sciences, National Institutes of Health (NIH) [R01NS055035, R01NS056443, R01GM098931, R01NS083875]; NINDS, NIH [R01NS083875, U24NS057631]; John B. Pierce Laboratory; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM098931] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS056443, U24NS057631, R01NS083875, R01NS055035] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke (NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute of General Medical Sciences, National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); John B. Pierce Laboratory; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The authors thank the Bloomington Stock Center (Bloomington, IN), Loren Looger, and Vivek Jayaraman (both at Janelia Farm Research Campus, Howard Hughes Medical Institute) for Drosophila stocks, Lawrence B. Cohen (Yale University School of Medicine) and the members of the Nitabach and Pieribone labs for discussion, and Glenn Turner (Cold Spring Harbor Laboratory) for advice concerning in vivo imaging of fly olfactory responses. Work in the laboratory of M.N.N. is supported in part by the National Institute of Neurological Disorders and Stroke (NINDS) and National Institute of General Medical Sciences, National Institutes of Health (NIH) (R01NS055035, R01NS056443, R01GM098931, and R01NS083875). Work in the laboratory of V. A. P. is supported in part by NINDS, NIH (U24NS057631 and R01NS083875) and The John B. Pierce Laboratory.	Akemann W, 2012, J NEUROPHYSIOL, V108, P2323, DOI 10.1152/jn.00452.2012; Akemann W, 2010, NAT METHODS, V7, P643, DOI [10.1038/nmeth.1479, 10.1038/NMETH.1479]; Akerboom J, 2012, J NEUROSCI, V32, P13819, DOI 10.1523/JNEUROSCI.2601-12.2012; Ataka K, 2002, BIOPHYS J, V82, P509, DOI 10.1016/S0006-3495(02)75415-5; Baines RA, 2001, J NEUROSCI, V21, P1523, DOI 10.1523/JNEUROSCI.21-05-01523.2001; Baker BJ, 2008, BRAIN CELL BIOL, V36, P53, DOI 10.1007/s11068-008-9026-7; Barnett L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043454; Cao G, 2008, J NEUROSCI, V28, P6493, DOI 10.1523/JNEUROSCI.1503-08.2008; Choi C, 2012, CELL REP, V2, P332, DOI 10.1016/j.celrep.2012.06.021; COHEN LB, 1968, NATURE, V218, P438, DOI 10.1038/218438a0; Dimitrov D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000440; Fiala Andre, 2003, Sci STKE, V2003, pPL6, DOI 10.1126/stke.2003.174.pl6; Grienberger C, 2012, NEURON, V73, P862, DOI 10.1016/j.neuron.2012.02.011; Groth AC, 2004, GENETICS, V166, P1775, DOI 10.1534/genetics.166.4.1775; Hallem EA, 2006, CELL, V125, P143, DOI 10.1016/j.cell.2006.01.050; Ignell R, 2009, P NATL ACAD SCI USA, V106, P13070, DOI 10.1073/pnas.0813004106; Jin L, 2012, NEURON, V75, P779, DOI 10.1016/j.neuron.2012.06.040; Kralj JM, 2012, NAT METHODS, V9, P90, DOI [10.1038/NMETH.1782, 10.1038/nmeth.1782]; Kreher SA, 2008, NEURON, V59, P110, DOI 10.1016/j.neuron.2008.06.010; Lundby A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002514; McCarthy EV, 2011, J NEUROSCI, V31, P8181, DOI 10.1523/JNEUROSCI.2017-10.2011; Nitabach MN, 2008, CURR BIOL, V18, pR84, DOI 10.1016/j.cub.2007.11.061; Nitabach MN, 2006, J NEUROSCI, V26, P479, DOI 10.1523/JNEUROSCI.3915-05.2006; Nitabach MN, 2002, CELL, V109, P485, DOI 10.1016/S0092-8674(02)00737-7; Pfeiffer BD, 2010, GENETICS, V186, P735, DOI 10.1534/genetics.110.119917; Popovic MA, 2011, J PHYSIOL-LONDON, V589, P4167, DOI 10.1113/jphysiol.2011.209015; Renn SCP, 1999, CELL, V99, P791, DOI 10.1016/S0092-8674(00)81676-1; Root CM, 2008, NEURON, V59, P311, DOI 10.1016/j.neuron.2008.07.003; Root CM, 2011, CELL, V145, P133, DOI 10.1016/j.cell.2011.02.008; Sakai R, 2001, EUR J NEUROSCI, V13, P2314, DOI 10.1046/j.0953-816x.2001.01617.x; SALZBERG BM, 1973, NATURE, V246, P508, DOI 10.1038/246508a0; Shang YH, 2007, CELL, V128, P601, DOI 10.1016/j.cell.2006.12.034; Sheeba V, 2008, CURR BIOL, V18, P1537, DOI 10.1016/j.cub.2008.08.033; Siegel MS, 1997, NEURON, V19, P735, DOI 10.1016/S0896-6273(00)80955-1; Silbering AF, 2008, J NEUROSCI, V28, P13075, DOI 10.1523/JNEUROSCI.2973-08.2008; Sjulson L, 2008, J NEUROSCI, V28, P5582, DOI 10.1523/JNEUROSCI.0055-08.2008; Stensmyr MC, 2012, CELL, V151, P1345, DOI 10.1016/j.cell.2012.09.046; STOCKER RF, 1983, CELL TISSUE RES, V232, P237, DOI 10.1007/BF00213783; Stocker RF, 1997, J NEUROBIOL, V32, P443, DOI 10.1002/(SICI)1097-4695(199705)32:5<443::AID-NEU1>3.0.CO;2-5; STOCKER RF, 1990, CELL TISSUE RES, V262, P9, DOI 10.1007/BF00327741; Taghert PH, 2012, NEURON, V76, P82, DOI 10.1016/j.neuron.2012.08.035; Tian L, 2012, PROG BRAIN RES, V196, P79, DOI 10.1016/B978-0-444-59426-6.00005-7; Villalba-Galea CA, 2009, J GEN PHYSIOL, V134, P5, DOI 10.1085/jgp.200910215; Vosshall LB, 2000, CELL, V102, P147, DOI 10.1016/S0092-8674(00)00021-0; Wang JW, 2003, CELL, V112, P271, DOI 10.1016/S0092-8674(03)00004-7; Wilson RI, 2004, SCIENCE, V303, P366, DOI 10.1126/science.1090782; Wu Y, 2008, J BIOL RHYTHM, V23, P117, DOI 10.1177/0748730407312984	47	176	181	0	59	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	AUG 15	2013	154	4					904	913		10.1016/j.cell.2013.07.027	http://dx.doi.org/10.1016/j.cell.2013.07.027			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	202GQ	23932121	Green Accepted, Bronze			2022-12-24	WOS:000323202500019
J	Venkiteswaran, G; Lewellis, SW; Wang, J; Reynolds, E; Nicholson, C; Knaut, H				Venkiteswaran, Gayatri; Lewellis, Stephen W.; Wang, John; Reynolds, Eric; Nicholson, Charles; Knaut, Holger			Generation and Dynamics of an Endogenous, Self-Generated Signaling Gradient across a Migrating Tissue	CELL			English	Article							COLLECTIVE CELL-MIGRATION; LATERAL-LINE; RECEPTOR CXCR4; CHEMOKINE; GUIDANCE; ACTIVATION; UBIQUITINATION; MORPHOGENESIS; CHEMOTAXIS; DROSOPHILA	In animals, many cells reach their destinations by migrating toward higher concentrations of an attractant. However, the nature, generation, and interpretation of attractant gradients are poorly understood. Using a GFP fusion and a signaling sensor, we analyzed the distribution of the attractant chemokine Sdf1 during migration of the zebrafish posterior lateral line primordium, a cohort of about 200 cells that migrates over a stripe of cells uniformly expressing sdf1. We find that a small fraction of the total Sdf1 pool is available to signal and induces a linear Sdf1signaling gradient across the primordium. This signaling gradient is initiated at the rear of the primordium, equilibrates across the primordium within 200 min, and operates near steady state. The rear of the primordium generates this gradient through continuous sequestration of Sdf1 protein by the alternate Sdf1-receptor Cxcr7. Modeling shows that this is a physically plausible scenario.	[Venkiteswaran, Gayatri; Lewellis, Stephen W.; Wang, John; Reynolds, Eric; Knaut, Holger] NYU, Langone Med Ctr, Skirball Inst Biomol Med, Dev Genet Program, New York, NY 10016 USA; [Reynolds, Eric] Charite, D-10117 Berlin, Germany; [Nicholson, Charles] NYU, Langone Med Ctr, Dept Neurosci & Physiol, New York, NY 10016 USA; [Knaut, Holger] NYU, Langone Med Ctr, Kimmel Ctr Stem Cell Biol, New York, NY 10016 USA	New York University; NYU Langone Medical Center; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; New York University; NYU Langone Medical Center; New York University; NYU Langone Medical Center	Knaut, H (corresponding author), NYU, Langone Med Ctr, Skirball Inst Biomol Med, Dev Genet Program, 550 1St Ave, New York, NY 10016 USA.	holger.knaut@med.nyu.edu		Wang, John/0000-0001-5048-0952; Nicholson, Charles/0000-0002-7346-0484; Knaut, Holger/0000-0002-8399-8720	Wellcome Trust [WT 077047/Z/05/Z]; NIH [NS069839, NS28642, HD007520]; American Heart Association fellowship [12POST12060278]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD007520] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR024708] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS028642, R01NS069839] Funding Source: NIH RePORTER	Wellcome Trust(Wellcome TrustEuropean Commission); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association fellowship(American Heart Association); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank J. Torres-Vazquez, F. Schnorrer, J. Nance, R. Lehmann, R. Cinalli, J. Hubbard, and J. Treisman for critical comments; D. Gilmour, P. Krieg, and A. J. Hudspeth for reagents; F. Fuentes for excellent fish care; K. Cadwell and G. David for cell lines; M. Stadtfeld for recombinant LIF; and A. Sfeir and M. Tahiliani for advice and reagents for tissue culture experiments. For providing the zebrafish knockout allele cxcr7b sa16, we thank E. Busch-Nentwich and D. Stemple, Sanger Institute Zebrafish Mutation Resource, sponsored by the Wellcome Trust (grant number WT 077047/Z/05/Z). This work was supported by NIH grants NS069839 (H. K.), NS28642 (C. N.), and HD007520 (S. W. L.) and by an American Heart Association fellowship 12POST12060278 (G.V.).	Affolter M, 2008, DEVELOPMENT, V135, P2055, DOI 10.1242/dev.014498; Aman A, 2010, DEV BIOL, V341, P20, DOI 10.1016/j.ydbio.2009.11.014; Sanchez-Alcaniz JA, 2011, NEURON, V69, P77, DOI 10.1016/j.neuron.2010.12.006; Boldajipour B, 2008, CELL, V132, P463, DOI 10.1016/j.cell.2007.12.034; Breau MA, 2012, DEVELOPMENT, V139, P2246, DOI 10.1242/dev.080275; Cai HQ, 2011, SEMIN CELL DEV BIOL, V22, P834, DOI 10.1016/j.semcdb.2011.07.020; Crank J., 1975, MATH DIFFUSION; CRICK F, 1970, NATURE, V225, P420, DOI 10.1038/225420a0; Crump MP, 1997, EMBO J, V16, P6996, DOI 10.1093/emboj/16.23.6996; Dambly-Chaudiere C, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-23; David NB, 2002, P NATL ACAD SCI USA, V99, P16297, DOI 10.1073/pnas.252339399; Duchesne L, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001361; Entchev EV, 2000, CELL, V103, P981, DOI 10.1016/S0092-8674(00)00200-2; FISHER PR, 1989, J CELL BIOL, V108, P973, DOI 10.1083/jcb.108.3.973; Friedl P, 2009, NAT REV MOL CELL BIO, V10, P445, DOI 10.1038/nrm2720; Ghysen A, 2007, GENE DEV, V21, P2118, DOI 10.1101/gad.1568407; Haas P, 2006, DEV CELL, V10, P673, DOI 10.1016/j.devcel.2006.02.019; Hatzikirou H, 2008, CURR TOP DEV BIOL, V81, P401, DOI 10.1016/S0070-2153(07)81014-3; KELLER EF, 1971, J THEOR BIOL, V30, P225, DOI 10.1016/0022-5193(71)90050-6; Kicheva A, 2007, SCIENCE, V315, P521, DOI 10.1126/science.1135774; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Li Q, 2004, DEV BIOL, V269, P123, DOI 10.1016/j.ydbio.2004.01.020; Marchese A, 2001, J BIOL CHEM, V276, P45509, DOI 10.1074/jbc.C100527200; Marchese A, 2003, DEV CELL, V5, P709, DOI 10.1016/S1534-5807(03)00321-6; MATO JM, 1975, P NATL ACAD SCI USA, V72, P4991, DOI 10.1073/pnas.72.12.4991; Minina S, 2007, CURR BIOL, V17, P1164, DOI 10.1016/j.cub.2007.05.073; Montell DJ, 2008, SCIENCE, V322, P1502, DOI 10.1126/science.1164073; Montell DJ, 2003, NAT REV MOL CELL BIO, V4, P13, DOI 10.1038/nrm1006; Muller P, 2013, DEVELOPMENT, V140, P1621, DOI 10.1242/dev.083519; Muller P, 2012, SCIENCE, V336, P721, DOI 10.1126/science.1221920; Muller P, 2011, DEV CELL, V21, P145, DOI 10.1016/j.devcel.2011.06.001; Nechiporuk A, 2008, SCIENCE, V320, P1774, DOI 10.1126/science.1156547; Parent CA, 1999, SCIENCE, V284, P765, DOI 10.1126/science.284.5415.765; Rajagopal S, 2010, P NATL ACAD SCI USA, V107, P628, DOI 10.1073/pnas.0912852107; Raz E, 2009, DEVELOPMENT, V136, P1223, DOI 10.1242/dev.022418; Rorth P, 2007, TRENDS CELL BIOL, V17, P575, DOI 10.1016/j.tcb.2007.09.007; Rorth P, 2011, DEV CELL, V20, P9, DOI 10.1016/j.devcel.2010.12.014; Rorth P, 2009, ANNU REV CELL DEV BI, V25, P407, DOI 10.1146/annurev.cellbio.042308.113231; Schuster K, 2010, P NATL ACAD SCI USA, V107, P19531, DOI 10.1073/pnas.1002171107; Swaney KF, 2010, ANNU REV BIOPHYS, V39, P265, DOI 10.1146/annurev.biophys.093008.131228; Teleman AA, 2000, CELL, V103, P971, DOI 10.1016/S0092-8674(00)00199-9; Thisse C, 2008, NAT PROTOC, V3, P59, DOI 10.1038/nprot.2007.514; Valentin G, 2007, CURR BIOL, V17, P1026, DOI 10.1016/j.cub.2007.05.020; Wang XB, 2010, NAT CELL BIOL, V12, P591, DOI 10.1038/ncb2061; Wartlick O., 2009, COLD SPRING HARB PER, V1; Weber M, 2013, SCIENCE, V339, P328, DOI 10.1126/science.1228456; Weijer CJ, 2009, J CELL SCI, V122, P3215, DOI 10.1242/jcs.036517; Yu SR, 2009, NATURE, V461, P533, DOI 10.1038/nature08391	48	131	131	0	26	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 24	2013	155	3					674	687		10.1016/j.cell.2013.09.046	http://dx.doi.org/10.1016/j.cell.2013.09.046			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	246WQ	24119842	Green Accepted, Bronze			2022-12-24	WOS:000326571800020
J	Mangravite, LM; Engelhardt, BE; Medina, MW; Smith, JD; Brown, CD; Chasman, DI; Mecham, BH; Howie, B; Shim, H; Naidoo, D; Feng, QP; Rieder, MJ; Chen, YDI; Rotter, JI; Ridker, PM; Hopewell, JC; Parish, S; Armitage, J; Collins, R; Wilke, RA; Nickerson, DA; Stephens, M; Krauss, RM				Mangravite, Lara M.; Engelhardt, Barbara E.; Medina, Marisa W.; Smith, Joshua D.; Brown, Christopher D.; Chasman, Daniel I.; Mecham, Brigham H.; Howie, Bryan; Shim, Heejung; Naidoo, Devesh; Feng, QiPing; Rieder, Mark J.; Chen, Yii-Der I.; Rotter, Jerome I.; Ridker, Paul M.; Hopewell, Jemma C.; Parish, Sarah; Armitage, Jane; Collins, Rory; Wilke, Russell A.; Nickerson, Deborah A.; Stephens, Matthew; Krauss, Ronald M.			A statin-dependent QTL for GATM expression is associated with statin-induced myopathy	NATURE			English	Article							LIPID-LOWERING RESPONSE; SIMVASTATIN THERAPY; GENE-EXPRESSION; CHOLESTEROL; TRANSFORMATION; DISCOVERY; RISK; LOCI	Statins are prescribed widely to lower plasma low-density lipoprotein (LDL) concentrations and cardiovascular disease risk(1) and have been shown to have beneficial effects in a broad range of patients(2,3). However, statins are associated with an increased risk, albeit small, of clinical myopathy(4) and type 2 diabetes(5). Despite evidence for substantial genetic influence on LDL concentrations(6), pharmacogenomic trials have failed to identify genetic variations with large effects on either statin efficacy(7-9) or toxicity(10), and have produced little information regarding mechanisms that modulate statin response. Here we identify a downstream target of statin treatment by screening for the effects of in vitro statin exposure on genetic associations with gene expression levels in lymphoblastoid cell lines derived from 480 participants of a clinical trial of simvastatin treatment(7). This analysis identified six expression quantitative trait loci (eQTLs) that interacted with simvastatin exposure, including rs9806699, a cis-eQTL for the gene glycine amidinotransferase (GATM) that encodes the rate-limiting enzyme in creatine synthesis. We found this locus to be associated with incidence of statin-induced myotoxicity in two separate populations (meta-analysis odds ratio = 0.60). Furthermore, we found that GATM knockdown in hepatocyte-derived cell lines attenuated transcriptional response to sterol depletion, demonstrating that GATM may act as a functional link between statin-mediated lowering of cholesterol and susceptibility to statin-induced myopathy.	[Mangravite, Lara M.; Mecham, Brigham H.] Sage Bionetworks, Seattle, WA 98109 USA; [Engelhardt, Barbara E.; Howie, Bryan; Shim, Heejung; Stephens, Matthew] Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; [Medina, Marisa W.; Naidoo, Devesh; Krauss, Ronald M.] Childrens Hosp Oakland, Res Inst, Oakland, CA 94609 USA; [Smith, Joshua D.; Rieder, Mark J.; Nickerson, Deborah A.] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Brown, Christopher D.] Univ Penn, Dept Genet, Philadelphia, PA 19103 USA; [Chasman, Daniel I.; Ridker, Paul M.] Brigham & Womens Hosp, Div Preventat Med, Ctr Cardiovasc Dis Prevent, Boston, MA 02115 USA; [Feng, QiPing; Wilke, Russell A.] Vanderbilt Univ, Med Ctr, Div Clin Pharmacol, Dept Med, Nashville, TN 37232 USA; [Chen, Yii-Der I.; Rotter, Jerome I.] Harbor UCLA Med Ctr, Los Angeles BioMed Res Inst, Inst Translat Genom & Populat Sci, Torrance, CA 90502 USA; [Hopewell, Jemma C.; Parish, Sarah; Armitage, Jane; Collins, Rory] Univ Oxford, Clin Trial Serv Unit, Oxford OX3 7LF, England; [Hopewell, Jemma C.; Parish, Sarah; Armitage, Jane; Collins, Rory] Univ Oxford, Epidemiol Studies Unit, Oxford OX3 7LF, England; [Stephens, Matthew] Univ Chicago, Dept Stat, Chicago, IL 60637 USA	University of Chicago; Children's Hospital Oakland Research Institute; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Benioff Children's Hospital Oakland; University of Washington; University of Washington Seattle; University of Pennsylvania; Harvard University; Brigham & Women's Hospital; Vanderbilt University; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; Lundquist Institute; University of Oxford; University of Oxford; University of Chicago	Mangravite, LM (corresponding author), Sage Bionetworks, 1100 Fairview Ave North, Seattle, WA 98109 USA.	lara.mangravite@sagebase.org; mstephens@uchicago.edu; rkrauss@chori.org	Rotter, Jerome/AAY-6598-2021	Hopewell, Jemma/0000-0002-3870-8018; Brown, Christopher/0000-0002-3785-5008; Mangravite, Lara/0000-0001-7841-3612; Shim, Heejung/0000-0002-1375-9310; Venkatasubramanian, Siddharth/0000-0002-5860-0768; Engelhardt, Barbara/0000-0002-6139-7334	US National Institutes of Health (NIH) [U01 HL69757]; Bioinformatics Research Development Fund; NIH [K99/R00HG006265, HG002585]; Medical Research Council; British Heart Foundation; National Health Service Genetic Knowledge Park; Centre National de Genotypage; Merck; Roche Vitamins; BHF Centre of Research Excellence, Oxford, UK; AstraZeneca; MRC [MC_U137686853] Funding Source: UKRI; Medical Research Council [MC_U137686853] Funding Source: researchfish; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000124] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL069757, R01HL104133] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R00HG006265, K99HG006265, R01HG002585] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK063491] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bioinformatics Research Development Fund; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); National Health Service Genetic Knowledge Park; Centre National de Genotypage; Merck(Merck & Company); Roche Vitamins; BHF Centre of Research Excellence, Oxford, UK; AstraZeneca(AstraZeneca); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This project was funded by a grant from the US National Institutes of Health (NIH), U01 HL69757. B.E.E. was funded through the Bioinformatics Research Development Fund, supported by K. and G. Gould and NIH grant K99/R00HG006265. M.S. was funded by NIH grant HG002585. We acknowledge the efforts of T. Kitchner and R. Mareedu for case validation in the Marshfield cohort. SEARCH was supported by the Medical Research Council, British Heart Foundation, National Health Service Genetic Knowledge Park, Centre National de Genotypage and Merck. The Heart Protection Study was funded by grants from the Medical Research Council, British Heart Foundation, Roche Vitamins and Merck. J.C.H. acknowledges support from the BHF Centre of Research Excellence, Oxford, UK. Genetic analysis in JUPITER was funded by a grant from AstraZeneca to D.I.C. and P.M.R.	Baigent C, 2005, LANCET, V366, P1267, DOI 10.1016/S0140-6736(05)67394-1; Barber MJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009763; Brem RB, 2005, NATURE, V436, P701, DOI 10.1038/nature03865; Brown MS, 1997, CELL, V89, P331, DOI 10.1016/S0092-8674(00)80213-5; Caliskan M, 2011, HUM MOL GENET, V20, P1643, DOI 10.1093/hmg/ddr041; Chasman DI, 2004, JAMA-J AM MED ASSOC, V291, P2821, DOI 10.1001/jama.291.23.2821; Choe CU, 2013, HUM MOL GENET, V22, P110, DOI 10.1093/hmg/dds407; Choy E, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000287; Edvardson S, 2010, MOL GENET METAB, V101, P228, DOI 10.1016/j.ymgme.2010.06.021; Ernst J, 2012, NAT METHODS, V9, P215, DOI 10.1038/nmeth.1906; Fernandez Genaro, 2011, Cleve Clin J Med, V78, P393, DOI 10.3949/ccjm.78a.10073; Grundberg E, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001279; Guan YT, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000279; Hopewell JC, 2013, EUR HEART J, V34, P982, DOI 10.1093/eurheartj/ehs344; Ide T, 2009, MOL CELL, V36, P379, DOI 10.1016/j.molcel.2009.09.031; Innocenti F, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002078; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kottgen A, 2009, NAT GENET, V41, P712, DOI 10.1038/ng.377; Leek JT, 2007, PLOS GENET, V3, P1724, DOI 10.1371/journal.pgen.0030161; Link E, 2008, NEW ENGL J MED, V359, P789, DOI 10.1056/NEJMoa0801936; Mangravite LM, 2010, ARTERIOSCL THROM VAS, V30, P1485, DOI 10.1161/ATVBAHA.110.203273; Maranville JC, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002162; Mareedu Ravi K, 2009, Prev Cardiol, V12, P88, DOI 10.1111/j.1751-7141.2009.00028.x; Mecham BH, 2010, BIOINFORMATICS, V26, P1308, DOI 10.1093/bioinformatics/btq118; Medina MW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019420; Morley M, 2004, NATURE, V430, P743, DOI 10.1038/nature02797; PRESSMAN S, 1991, AM J HUM GENET, V49, P467; Rajpathak SN, 2009, DIABETES CARE, V32, P1924, DOI 10.2337/dc09-0738; Ridker PM, 2008, NEW ENGL J MED, V359, P2195, DOI 10.1056/NEJMoa0807646; Romanoski CE, 2010, AM J HUM GENET, V86, P399, DOI 10.1016/j.ajhg.2010.02.002; Servin B, 2007, PLOS GENET, V3, P1296, DOI 10.1371/journal.pgen.0030114; Simon JA, 2006, AM J CARDIOL, V97, P843, DOI 10.1016/j.amjcard.2005.09.134; Smirnov DA, 2012, GENOME RES, V22, P332, DOI 10.1101/gr.122044.111; Stephens M, 2009, NAT REV GENET, V10, P681, DOI 10.1038/nrg2615; Storey JD, 2002, J ROY STAT SOC B, V64, P479, DOI 10.1111/1467-9868.00346; Stranger BE, 2007, NAT GENET, V39, P1217, DOI 10.1038/ng2142; Subramanian A, 2007, BIOINFORMATICS, V23, P3251, DOI 10.1093/bioinformatics/btm369; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; Trompet S, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-131; Wilke RA, 2007, NAT REV DRUG DISCOV, V6, P904, DOI 10.1038/nrd2423	40	156	157	0	44	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 17	2013	502	7471					377	+		10.1038/nature12508	http://dx.doi.org/10.1038/nature12508			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	235GY	23995691	Green Accepted, Green Submitted			2022-12-24	WOS:000325706300054
J	Oury, F; Khrimian, L; Denny, CA; Gardin, A; Chamouni, A; Goeden, N; Huang, YY; Lee, H; Srinivas, P; Gao, XB; Suyama, S; Langer, T; Mann, JJ; Horvath, TL; Bonnin, A; Karsenty, G				Oury, Franck; Khrimian, Lori; Denny, Christine A.; Gardin, Antoine; Chamouni, Alexandre; Goeden, Nick; Huang, Yung-yu; Lee, Hojoon; Srinivas, Prashanth; Gao, Xiao-Bing; Suyama, Shigetomo; Langer, Thomas; Mann, John. J.; Horvath, Tamas L.; Bonnin, Alexandre; Karsenty, Gerard			Maternal and Offspring Pools of Osteocalcin Influence Brain Development and Functions	CELL			English	Article							INHIBITS BONE-FORMATION; DEFICIENT MICE; CLEIDOCRANIAL DYSPLASIA; ENERGY-METABOLISM; SEROTONIN; MASS; HYDROXYLASE; EXPRESSION; INSULIN; ANXIETY	The powerful regulation of bone mass exerted by the brain suggests the existence of bone-derived signals modulating this regulation or other functions of the brain. We show here that the osteoblast-derived hormone osteocalcin crosses the blood-brain barrier, binds to neurons of the brainstem, midbrain, and hippocampus, enhances the synthesis of monoamine neurotransmitters, inhibits GABA synthesis, prevents anxiety and depression, and favors learning and memory independently of its metabolic functions. In addition to these postnatal functions, maternal osteocalcin crosses the placenta during pregnancy and prevents neuronal apoptosis before embryos synthesize this hormone. As a result, the severity of the neuroanatomical defects and learning and memory deficits of Osteocalcin(-/-) mice is determined by the maternal genotype, and delivering osteocalcin to pregnant Osteocalcin(-/-) mothers rescues these abnormalities in their Osteocalcin(-/-) progeny. This study reveals that the skeleton via osteocalcin influences cognition and contributes to the maternal influence on fetal brain development.	[Oury, Franck; Khrimian, Lori; Gardin, Antoine; Chamouni, Alexandre; Srinivas, Prashanth; Karsenty, Gerard] Columbia Univ, Dept Genet & Dev, New York, NY 10032 USA; [Denny, Christine A.] Columbia Univ, Dept Psychiat, New York, NY 10032 USA; [Goeden, Nick; Bonnin, Alexandre] Univ So Calif, Keck Sch Med, Zilkha Neurogenet Inst, Dept Cell & Neurobiol, Los Angeles, CA 90089 USA; [Huang, Yung-yu; Mann, John. J.] Columbia Univ, Dept Psychiat, Div Mol Imaging & Neuropathol, New York, NY 10471 USA; [Huang, Yung-yu; Mann, John. J.] New York State Psychiat Inst & Hosp, New York, NY 10471 USA; [Lee, Hojoon] Columbia Univ, Dept Biochem & Mol Biophys, New York, NY 10032 USA; [Gao, Xiao-Bing; Suyama, Shigetomo; Horvath, Tamas L.] Yale Univ, Sch Med, Comparat Med Sect, Program Integrat Cell Signaling & Neurobiol Metab, New Haven, CT 06520 USA; [Langer, Thomas] Sanofi Aventis Deutschland GmbH, R&D Biotherapeut BioInnovat, D-65926 Frankfurt, Germany	Columbia University; Columbia University; University of Southern California; Columbia University; New York State Psychiatry Institute; Columbia University; Yale University; Sanofi-Aventis	Karsenty, G (corresponding author), Columbia Univ, Dept Genet & Dev, New York, NY 10032 USA.	gk2172@columbia.edu	Langer, Thomas/AAB-7609-2020; Gao, Xiao-Bing/C-3121-2011; Denny, Christine Ann A/I-5235-2015	Gao, Xiao-Bing/0000-0002-2035-4936; Denny, Christine Ann A/0000-0002-6926-2020; OURY, FRANCK/0000-0003-0562-9900; Karsenty, Gerard/0000-0002-9253-7627; Lee, Hojoon/0000-0001-6214-629X	NIH; Sanofi Aventis; Pioneer award; Human frontier scientific program; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR045548] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [DP1DK098058] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007088] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG032959] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Sanofi Aventis(Sanofi-Aventis); Pioneer award; Human frontier scientific program; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank Drs. P. Ducy, C. Zuker, and R. Hen for critical reading of the manuscript or experimental advice and Drs. R. Allikmets and J. Kong for performing the electroretinogram. This work was supported by grants from the NIH (G.K.), Sanofi Aventis (G.K.), Pioneer award (T.L.H.), and Human frontier scientific program (F.O.).	Bach H, 2011, J NEUROCHEM, V118, P1067, DOI 10.1111/j.1471-4159.2011.07379.x; Banks WA, 1996, PEPTIDES, V17, P305, DOI 10.1016/0196-9781(96)00025-3; Broad KD, 2011, P NATL ACAD SCI USA, V108, P15237, DOI 10.1073/pnas.1106022108; Challis JRG, 2012, NAT REV ENDOCRINOL, V8, P629, DOI 10.1038/nrendo.2012.183; CRAWLEY JN, 1985, NEUROSCI BIOBEHAV R, V9, P37, DOI 10.1016/0149-7634(85)90030-2; Cryan JF, 2005, NEUROSCI BIOBEHAV R, V29, P571, DOI 10.1016/j.neubiorev.2005.03.009; Daubner SC, 2011, ARCH BIOCHEM BIOPHYS, V508, P1, DOI 10.1016/j.abb.2010.12.017; David DJ, 2009, NEURON, V62, P479, DOI 10.1016/j.neuron.2009.04.017; Denny CA, 2012, HIPPOCAMPUS, V22, P1188, DOI 10.1002/hipo.20964; Ducy P, 1996, NATURE, V382, P448, DOI 10.1038/382448a0; Ducy P, 2000, CELL, V100, P197, DOI 10.1016/S0092-8674(00)81558-5; Ducy P, 1997, CELL, V89, P747, DOI 10.1016/S0092-8674(00)80257-3; Elefteriou F, 2004, P NATL ACAD SCI USA, V101, P3258, DOI 10.1073/pnas.0308744101; ENNACEUR A, 1988, BEHAV BRAIN RES, V31, P47, DOI 10.1016/0166-4328(88)90157-X; Ferron M, 2010, CELL, V142, P296, DOI 10.1016/j.cell.2010.06.003; Gardier AM, 1996, FUND CLIN PHARMACOL, V10, P16, DOI 10.1111/j.1472-8206.1996.tb00145.x; Goeden N, 2013, NAT PROTOC, V8, P66, DOI 10.1038/nprot.2012.144; Guntur AR, 2012, ENDOCR PRACT, V18, P758, DOI 10.4158/EP12141.RA; HALES CN, 1992, DIABETOLOGIA, V35, P595, DOI 10.1007/BF00400248; Holmes A, 2000, PHYSIOL BEHAV, V71, P509, DOI 10.1016/S0031-9384(00)00373-5; Hsu CL, 2012, OSTEOPOROSIS INT, V23, P2409, DOI 10.1007/s00198-012-1992-z; Jansson T, 2007, CLIN SCI, V113, P1, DOI 10.1042/CS20060339; Karsenty G, 2012, NATURE, V481, P314, DOI 10.1038/nature10763; Kim JE, 2004, AM J PATHOL, V165, P1875, DOI 10.1016/S0002-9440(10)63240-3; Lawlor DA, 2012, NAT REV ENDOCRINOL, V8, P679, DOI 10.1038/nrendo.2012.176; Lee B, 1997, NAT GENET, V16, P307, DOI 10.1038/ng0797-307; Lee NK, 2007, CELL, V130, P456, DOI 10.1016/j.cell.2007.05.047; Lira A, 2003, BIOL PSYCHIAT, V54, P960, DOI 10.1016/S0006-3223(03)00696-6; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; Mundlos S, 1997, CELL, V89, P773, DOI 10.1016/S0092-8674(00)80260-3; Nagamatsu LS, 2012, ARCH INTERN MED, V172, P666, DOI 10.1001/archinternmed.2012.379; Oury F, 2013, J CLIN INVEST, V123, P2421, DOI 10.1172/JCI65952; Oury F, 2011, CELL, V144, P796, DOI 10.1016/j.cell.2011.02.004; Oury F, 2010, GENE DEV, V24, P2330, DOI 10.1101/gad.1977210; Palmiter RD, 2008, ANN NY ACAD SCI, V1129, P35, DOI 10.1196/annals.1417.003; Pi M, 2012, ENDOCRINOLOGY, V153, P2062, DOI 10.1210/en.2011-2117; Pogoda P, 2006, J BONE MINER RES, V21, P1591, DOI 10.1359/JBMR.060709; Seibel MJ, 2002, CURR OPIN CLIN NUTR, V5, P525, DOI 10.1097/00075197-200209000-00011; SOULE AB, 1946, J BONE JOINT SURG, V28, P81; Takeda S, 2002, CELL, V111, P305, DOI 10.1016/S0092-8674(02)01049-8; Tanaka DH, 2006, DEVELOPMENT, V133, P2167, DOI 10.1242/dev.02382; Vaira S, 2012, ENDOCRINOLOGY, V153, P5622, DOI 10.1210/en.2012-1462; Van den Bergh BRH, 2005, NEUROSCI BIOBEHAV R, V29, P237, DOI 10.1016/j.neubiorev.2004.10.007; Walther DJ, 2003, SCIENCE, V299, P76, DOI 10.1126/science.1078197; Weinstock M, 2008, NEUROSCI BIOBEHAV R, V32, P1073, DOI 10.1016/j.neubiorev.2008.03.002; Yadav VK, 2009, CELL, V138, P976, DOI 10.1016/j.cell.2009.06.051	46	236	256	3	43	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	SEP 26	2013	155	1					228	241		10.1016/j.cell.2013.08.042	http://dx.doi.org/10.1016/j.cell.2013.08.042			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	224UX	24074871	Green Accepted, Bronze			2022-12-24	WOS:000324916700022
J	Plaks, V; Koopman, CD; Werb, Z				Plaks, Vicki; Koopman, Charlotte D.; Werb, Zena			Circulating Tumor Cells	SCIENCE			English	Editorial Material							SURVIVAL; DISSEMINATION; PROGRESSION		[Plaks, Vicki; Koopman, Charlotte D.; Werb, Zena] Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Plaks, V (corresponding author), Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA.	zena.werb@ucsf.edu			NATIONAL CANCER INSTITUTE [R01CA057621] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [U01ES019458] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA057621] Funding Source: Medline; NIEHS NIH HHS [U01 ES019458] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Alix-Panabieres C, 2013, CLIN CHEM, V59, P110, DOI 10.1373/clinchem.2012.194258; Baccelli I, 2013, NAT BIOTECHNOL, V31, P539, DOI 10.1038/nbt.2576; Chaffer CL, 2011, SCIENCE, V331, P1559, DOI 10.1126/science.1203543; Chambers AF, 2002, NAT REV CANCER, V2, P563, DOI 10.1038/nrc865; Cohen SJ, 2008, J CLIN ONCOL, V26, P3213, DOI 10.1200/JCO.2007.15.8923; Cristofanilli M, 2004, NEW ENGL J MED, V351, P781, DOI 10.1056/NEJMoa040766; de Bono JS, 2008, CLIN CANCER RES, V14, P6302, DOI 10.1158/1078-0432.CCR-08-0872; Hayashi N, 2012, INT J CLIN ONCOL, V17, P96, DOI 10.1007/s10147-011-0260-0; Heitzer E, 2013, CANCER RES, V73, P2965, DOI 10.1158/0008-5472.CAN-12-4140; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Pantel K, 2012, CLIN CHEM, V58, P936, DOI 10.1373/clinchem.2011.175570; Rhim AD, 2012, CELL, V148, P349, DOI 10.1016/j.cell.2011.11.025; Strati A, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3395; Wang DJ, 2010, TRENDS BIOTECHNOL, V28, P281, DOI 10.1016/j.tibtech.2010.03.002; Yu M, 2013, SCIENCE, V339, P580, DOI 10.1126/science.1228522; Zong CH, 2012, SCIENCE, V338, P1622, DOI 10.1126/science.1229164	16	457	491	11	203	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 13	2013	341	6151					1186	1188		10.1126/science.1235226	http://dx.doi.org/10.1126/science.1235226			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	215ZA	24031008	Green Accepted			2022-12-24	WOS:000324248800028
J	Puri, C; Renna, M; Bento, CF; Moreau, K; Rubinsztein, DC				Puri, Claudia; Renna, Maurizio; Bento, Carla F.; Moreau, Kevin; Rubinsztein, David C.			Diverse Autophagosome Membrane Sources Coalesce in Recycling Endosomes	CELL			English	Article							EPIDERMAL-GROWTH-FACTOR; TRANS-GOLGI NETWORK; PLASMA-MEMBRANE; ENDOPLASMIC-RETICULUM; TRANSFERRIN RECEPTOR; TOMOGRAPHY REVEALS; MDCK CELLS; ENDOCYTOSIS; RAB11; PATHWAY	Autophagic protein degradation is mediated by autophagosomes that fuse with lysosomes, where their contents are degraded. The membrane origins of autophagosomes may involve multiple sources. However, it is unclear if and where distinct membrane sources fuse during autophagosome biogenesis. Vesicles containing mATG9, the only trans-membrane autophagy protein, are seen in many sites, and fusions with other autophagic compartments have not been visualized in mammalian cells. We observed that mATG9 traffics from the plasma membrane to recycling endosomes in carriers that appear to be routed differently from ATG16L1-containing vesicles, another source of autophagosome membrane. mATG9- and ATG16L1-containing vesicles traffic to recycling endosomes, where VAMP3-dependent heterotypic fusions occur. These fusions correlate with autophagosome formation, and both processes are enhanced by perturbing membrane egress from recycling endosomes. Starvation, a primordial autophagy activator, reduces membrane recycling from recycling endosomes and enhances mATG9-ATG16L1 vesicle fusion. Thus, this mechanism may fine-tune physiological autophagic responses.	[Puri, Claudia; Renna, Maurizio; Bento, Carla F.; Moreau, Kevin; Rubinsztein, David C.] Univ Cambridge, Cambridge Inst Med Res, Dept Med Genet, Cambridge CB2 0XY, England	University of Cambridge	Rubinsztein, DC (corresponding author), Univ Cambridge, Cambridge Inst Med Res, Dept Med Genet, Hills Rd, Cambridge CB2 0XY, England.	dcr1000@hermes.cam.ac.uk	Rubinsztein, David C/C-3472-2011	Renna, Maurizio/0000-0001-6522-1750; Bento, Carla F./0000-0001-8377-4543	Wellcome Trust	Wellcome Trust(Wellcome TrustEuropean Commission)	We thank Dr. H.G. Wang, Dr. J.A. Mercer, Prof. DeCamilli, and Dr. B. Beau-melle for kindly providing reagents. We thank Drs. Fiona Menzies and Mariella Vicinanza for critical reading and Dr. J.D. Cooper for the statistics. We are grateful to the Wellcome Trust (Principal Research Fellowship to DCR and Strategic Grant to Cambridge Institute for Medical Research) for funding.	Ang AL, 2004, J CELL BIOL, V167, P531, DOI 10.1083/jcb.200408165; Axe EL, 2008, J CELL BIOL, V182, P685, DOI 10.1083/jcb.200803137; Bonifacino JS, 2006, NAT REV MOL CELL BIO, V7, P568, DOI 10.1038/nrm1985; GALLI T, 1994, J CELL BIOL, V125, P1015, DOI 10.1083/jcb.125.5.1015; Gravotta D, 2007, P NATL ACAD SCI USA, V104, P1564, DOI 10.1073/pnas.0610700104; Hailey DW, 2010, CELL, V141, P656, DOI 10.1016/j.cell.2010.04.009; Hamasaki M, 2013, NATURE, V495, P389, DOI 10.1038/nature11910; Hayashi-Nishino M, 2010, AUTOPHAGY, V6, P301, DOI 10.4161/auto.6.2.11134; Lapierre LA, 2001, MOL BIOL CELL, V12, P1843, DOI 10.1091/mbc.12.6.1843; Longatti A, 2012, J CELL BIOL, V197, P659, DOI 10.1083/jcb.201111079; Luo S, 2010, CELL DEATH DIFFER, V17, P268, DOI 10.1038/cdd.2009.121; Fader CM, 2009, BBA-MOL CELL RES, V1793, P1901, DOI 10.1016/j.bbamcr.2009.09.011; Mari M, 2010, J CELL BIOL, V190, P1005, DOI 10.1083/jcb.200912089; Maxfield FR, 2004, NAT REV MOL CELL BIO, V5, P121, DOI 10.1038/nrm1315; Mizushima N, 2003, J CELL SCI, V116, P1679, DOI 10.1242/jcs.00381; Moreau K, 2012, J CELL BIOL, V196, P483, DOI 10.1083/jcb.201110114; Moreau K, 2011, CELL, V146, P303, DOI 10.1016/j.cell.2011.06.023; Ohsumi Y, 2004, SEMIN CELL DEV BIOL, V15, P231, DOI 10.1016/j.semcdb.2003.12.004; Orsi A, 2012, MOL BIOL CELL, V23, P1860, DOI 10.1091/mbc.E11-09-0746; Prekeris R, 1998, J CELL BIOL, V143, P957, DOI 10.1083/jcb.143.4.957; Puri C, 2010, ONCOGENE, V29, P188, DOI 10.1038/onc.2009.328; Ravikumar B, 2004, NAT GENET, V36, P585, DOI 10.1038/ng1362; Ravikumar B, 2010, NAT CELL BIOL, V12, P747, DOI 10.1038/ncb2078; Ren MD, 1998, P NATL ACAD SCI USA, V95, P6187, DOI 10.1073/pnas.95.11.6187; Rubinsztein DC, 2011, CELL, V146, P682, DOI 10.1016/j.cell.2011.07.030; Rubinsztein DC, 2009, AUTOPHAGY, V5, P585, DOI 10.4161/auto.5.5.8823; Sonnichsen B, 2000, J CELL BIOL, V149, P901, DOI 10.1083/jcb.149.4.901; STENMARK H, 1994, EMBO J, V13, P1287, DOI 10.1002/j.1460-2075.1994.tb06381.x; Stoorvogel W, 1996, J CELL BIOL, V132, P21, DOI 10.1083/jcb.132.1.21; Thompson HM, 2006, NAT CHEM BIOL, V2, P355, DOI 10.1038/nchembio0706-355; Tosoni D, 2005, CELL, V123, P875, DOI 10.1016/j.cell.2005.10.021; Ullrich O, 1996, J CELL BIOL, V135, P913, DOI 10.1083/jcb.135.4.913; van der Vaart A, 2010, MOL BIOL CELL, V21, P2270, DOI 10.1091/mbc.E09-04-0345; Warren RA, 1997, J BIOL CHEM, V272, P2116; Warren RA, 1998, J BIOL CHEM, V273, P17056, DOI 10.1074/jbc.273.27.17056; Wilcke M, 2000, J CELL BIOL, V151, P1207, DOI 10.1083/jcb.151.6.1207; WILEY HS, 1988, J CELL BIOL, V107, P801, DOI 10.1083/jcb.107.2.801; Yamazaki Y, 2013, EMBO J, V32, P524, DOI 10.1038/emboj.2013.1; Yla-Anttila P, 2009, AUTOPHAGY, V5, P1180; Young AJ, 2006, MED SCI SPORT EXER, V38, P1, DOI 10.1249/01.mss.0000196708.08925.8b	40	294	302	1	42	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	SEP 12	2013	154	6					1285	1299		10.1016/j.cell.2013.08.044	http://dx.doi.org/10.1016/j.cell.2013.08.044			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	215VQ	24034251	Green Published, hybrid			2022-12-24	WOS:000324239300017
J	Bhogaraju, S; Cajanek, L; Fort, C; Blisnick, T; Weber, K; Taschner, M; Mizuno, N; Lamla, S; Bastin, P; Nigg, EA; Lorentzen, E				Bhogaraju, Sagar; Cajanek, Lukas; Fort, Cecile; Blisnick, Thierry; Weber, Kristina; Taschner, Michael; Mizuno, Naoko; Lamla, Stefan; Bastin, Philippe; Nigg, Erich A.; Lorentzen, Esben			Molecular Basis of Tubulin Transport Within the Cilium by IFT74 and IFT81	SCIENCE			English	Article							FLAGELLAR LENGTH CONTROL; INTRAFLAGELLAR TRANSPORT; CHLAMYDOMONAS; PROTEIN; COMPLEX; TURNOVER; CILIOGENESIS; MOTILITY; DYNEIN; CELLS	Intraflagellar transport (IFT) of ciliary precursors such as tubulin from the cytoplasm to the ciliary tip is involved in the construction of the cilium, a hairlike organelle found on most eukaryotic cells. However, the molecular mechanisms of IFT are poorly understood. Here, we found that the two core IFT proteins IFT74 and IFT81 form a tubulin-binding module and mapped the interaction to a calponin homology domain of IFT81 and a highly basic domain in IFT74. Knockdown of IFT81 and rescue experiments with point mutants showed that tubulin binding by IFT81 was required for ciliogenesis in human cells.	[Bhogaraju, Sagar; Weber, Kristina; Taschner, Michael; Mizuno, Naoko; Lorentzen, Esben] Max Planck Inst Biochem, Dept Struct Cell Biol, D-82152 Martinsried, Germany; [Cajanek, Lukas; Nigg, Erich A.] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland; [Fort, Cecile; Blisnick, Thierry; Bastin, Philippe] Inst Pasteur, Trypanosome Cell Biol Unit, F-75015 Paris, France; [Fort, Cecile; Blisnick, Thierry; Bastin, Philippe] CNRS, URA2581, F-75015 Paris, France; [Lamla, Stefan] Max Planck Inst Biochem, Dept Cell Biol, D-82152 Martinsried, Germany	Max Planck Society; University of Basel; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); Max Planck Society	Lorentzen, E (corresponding author), Max Planck Inst Biochem, Dept Struct Cell Biol, Klopferspitz 18, D-82152 Martinsried, Germany.	lorentze@biochem.mpg.de	Bastin, Philippe/E-6688-2017; Cajanek, Lukas/ABG-6559-2020; Mizuno, Naoko/AAY-1926-2021; Bastin, Philippe/B-1402-2014; Lorentzen, Esben/AAX-8077-2020; Bastin, Philippe/O-4230-2019	Cajanek, Lukas/0000-0003-2914-8589; Mizuno, Naoko/0000-0002-1594-2821; Bastin, Philippe/0000-0002-3042-8679; Bhogaraju, Sagar/0000-0001-9998-5927; Taschner, Michael/0000-0002-3789-5077; nigg, erich/0000-0003-4835-5719; Taschner, Michael/0000-0002-8881-3705; Lorentzen, Esben/0000-0001-6493-7220	DGF [LO1627/1-1]; European Research Council (ERC) [310343]; European Molecular Biology Organization; Agence Nationale de la Recherche [ANR-11-BSV8-016]; Ministere de l'Enseignement et de la Recherche [ED387]; University of Basel; Swiss National Science Foundation [31003A_132428/1]; Austrian Science Fund [J3148-B12]; International Max Planck Research School for Molecular and Cellular Life Sciences (IMPRS); FEBS long-term fellowship	DGF(German Research Foundation (DFG)); European Research Council (ERC)(European Research Council (ERC)European Commission); European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); Agence Nationale de la Recherche(French National Research Agency (ANR)); Ministere de l'Enseignement et de la Recherche; University of Basel; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Austrian Science Fund(Austrian Science Fund (FWF)); International Max Planck Research School for Molecular and Cellular Life Sciences (IMPRS); FEBS long-term fellowship	We thank the staff at SLS for help with x-ray diffraction data collection; the crystallization facility of the Max Planck Institute of Biochemistry (Munich) for access to crystallization screening; the staff at Biozentrum Imaging Core Facility for assistance; C. Basquin for static light-scattering experiments; C. Jung for help with microscale thermophoresis; and S. Chakrabarti, A. Cook, and B. D. Engel for carefully reading and correcting the manuscript. B. D. Engel is additionally acknowledged for assistance with Fig. 4 and for many valuable discussions concerning ciliary length control. We thank the Plateforme d'Imagerie Dynamique for providing access to their equipment and Jean-Yves Tinevez for technical advice. We acknowledge M. Morawetz and M. Stiegler for technical assistance with molecular biology. This work was funded by an Emmy Noether grant (DGF; LO1627/1-1), the European Research Council (ERC grant 310343), and the European Molecular Biology Organization Young Investigator program. Work at the Institut Pasteur was funded by Agence Nationale de la Recherche grant ANR-11-BSV8-016. C. F. is funded by a fellowship from the Ministere de l'Enseignement et de la Recherche (ED387). E.A.N. acknowledges support from the University of Basel and the Swiss National Science Foundation (31003A_132428/1). M. T. is the recipient of an Erwin Schroedinger stipend granted by the Austrian Science Fund J3148-B12, S. B was supported by the International Max Planck Research School for Molecular and Cellular Life Sciences (IMPRS), and L. C. was supported by the FEBS long-term fellowship. The authors declare that they have no conflict of interest. The data presented in this paper are tabulated in the main paper and the supplementary materials. Structural coordinates have been deposited at the Protein DataBank, accession nos. 4LVP and 4LVR.	Buisson J, 2013, J CELL SCI, V126, P327, DOI 10.1242/jcs.117069; Ciferri C, 2008, CELL, V133, P427, DOI 10.1016/j.cell.2008.03.020; Cole DG, 1998, J CELL BIOL, V141, P993, DOI 10.1083/jcb.141.4.993; Finetti F, 2009, NAT CELL BIOL, V11, P1332, DOI 10.1038/ncb1977; Hao LM, 2011, NAT CELL BIOL, V13, P790, DOI 10.1038/ncb2268; HILLER G, 1978, CELL, V14, P795, DOI 10.1016/0092-8674(78)90335-5; Hou YQ, 2007, J CELL BIOL, V176, P653, DOI 10.1083/jcb.200608041; Ishikawa H, 2011, NAT REV MOL CELL BIO, V12, P222, DOI 10.1038/nrm3085; JOHNSON KA, 1992, J CELL BIOL, V119, P1605, DOI 10.1083/jcb.119.6.1605; Kim J, 2010, NATURE, V464, P1048, DOI 10.1038/nature08895; KOZMINSKI KG, 1995, J CELL BIOL, V131, P1517, DOI 10.1083/jcb.131.6.1517; KOZMINSKI KG, 1993, P NATL ACAD SCI USA, V90, P5519, DOI 10.1073/pnas.90.12.5519; Lucker BF, 2005, J BIOL CHEM, V280, P27688, DOI 10.1074/jbc.M505062200; Marshall WF, 2005, MOL BIOL CELL, V16, P270, DOI 10.1091/mbc.E04-07-0586; Marshall WF, 2001, J CELL BIOL, V155, P405, DOI 10.1083/jcb.200106141; Pazour GJ, 1999, J CELL BIOL, V144, P473, DOI 10.1083/jcb.144.3.473; Pazour GJ, 2005, J CELL BIOL, V170, P103, DOI 10.1083/jcb.200504008; Piperno G, 1997, P NATL ACAD SCI USA, V94, P4457, DOI 10.1073/pnas.94.9.4457; Qin HM, 2004, J CELL BIOL, V164, P255, DOI 10.1083/jcb.200308132; Rosenbaum JL, 2002, NAT REV MOL CELL BIO, V3, P813, DOI 10.1038/nrm952; Sharma N, 2011, MOL BIOL CELL, V22, P806, DOI 10.1091/mbc.E10-03-0269; Song L, 2001, J BIOL CHEM, V276, P29754, DOI 10.1074/jbc.M103184200; STEPHENS RE, 1977, DEV BIOL, V61, P311, DOI 10.1016/0012-1606(77)90301-3	23	196	205	0	27	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 30	2013	341	6149					1009	1012		10.1126/science.1240985	http://dx.doi.org/10.1126/science.1240985			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	208BZ	23990561	Green Accepted			2022-12-24	WOS:000323652300045
J	Little, SC; Tikhonov, M; Gregor, T				Little, Shawn C.; Tikhonov, Mikhail; Gregor, Thomas			Precise Developmental Gene Expression Arises from Globally Stochastic Transcriptional Activity	CELL			English	Article							FINGER PROTEIN; ZYGOTIC GENOME; DROSOPHILA; NOISE; HUNCHBACK; TIME; SEGMENTATION; VARIABILITY; LIMITS; RNA	Early embryonic patterning events are strikingly precise, a fact that appears incompatible with the stochastic gene expression observed across phyla. Using single-molecule mRNA quantification in Drosophila embryos, we determine the magnitude of fluctuations in the expression of four critical patterning genes. The accumulation of mRNAs is identical across genes and fluctuates by only similar to 8% between neighboring nuclei, generating precise protein distributions. In contrast, transcribing loci exhibit an intrinsic noise of similar to 45% independent of specific promoter-enhancer architecture or fluctuating inputs. Precise transcript distribution in the syncytium is recovered via straightforward spatiotemporal averaging, i.e., accumulation and diffusion of transcripts during nuclear cycles, without regulatory feedback. Common expression characteristics shared between genes suggest that fluctuations in mRNA production are context independent and are a fundamental property of transcription. The findings shed light on how the apparent paradox between stochastic transcription and developmental precision is resolved.	[Little, Shawn C.] Princeton Univ, Howard Hughes Med Inst, Dept Mol Biol, Princeton, NJ 08544 USA; [Tikhonov, Mikhail; Gregor, Thomas] Princeton Univ, Joseph Henry Labs Phys, Princeton, NJ 08544 USA; [Tikhonov, Mikhail; Gregor, Thomas] Princeton Univ, Lewis Sigler Inst Integrat Genom, Princeton, NJ 08544 USA	Howard Hughes Medical Institute; Princeton University; Princeton University; Princeton University	Gregor, T (corresponding author), Princeton Univ, Joseph Henry Labs Phys, Princeton, NJ 08544 USA.	tg2@princeton.edu		Gregor, Thomas/0000-0001-9460-139X; Tikhonov, Mikhail/0000-0002-9558-1121; Little, Shawn/0000-0002-2815-3696	NIH [P50 GM071508, R01 GM097275]; Searle Scholar Award [10-SSP-274]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM097275, P50GM071508] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Searle Scholar Award; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We gratefully acknowledge E. Wieschaus for insightful discussions and continuous support. We thank W. Bialek, S. Blythe, B. Chun, G. Deshpande, S. Di Talia, H. Garcia, S. Kyin, M. Petkova, R. Samanta, T. Schupbach, G. Tkacik, and the Bloomington Drosophila Stock Center. This work was supported by NIH Grants P50 GM071508 and R01 GM097275, and by Searle Scholar Award 10-SSP-274 to T.G.	Ajuria L, 2011, DEVELOPMENT, V138, P915, DOI 10.1242/dev.057729; Arias AM, 2006, NAT REV GENET, V7, P34, DOI 10.1038/nrg1750; Balaban NQ, 2004, SCIENCE, V305, P1622, DOI 10.1126/science.1099390; Bar-Even A, 2006, NAT GENET, V38, P636, DOI 10.1038/ng1807; Chen HT, 2012, CELL, V149, P618, DOI 10.1016/j.cell.2012.03.018; Chubb JR, 2006, CURR BIOL, V16, P1018, DOI 10.1016/j.cub.2006.03.092; Cohen AA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004901; DAVIS I, 1991, CELL, V67, P927, DOI 10.1016/0092-8674(91)90366-7; De Renzis S, 2007, PLOS BIOL, V5, P1036, DOI 10.1371/journal.pbio.0050117; DRIEVER W, 1988, CELL, V54, P95, DOI 10.1016/0092-8674(88)90183-3; Dubuis JO, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2012.72; EDGAR BA, 1986, CELL, V47, P747, DOI 10.1016/0092-8674(86)90517-9; Erdmann T, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.258101; FOE VE, 1983, J CELL SCI, V61, P31; Gandhi SJ, 2011, NAT STRUCT MOL BIOL, V18, P27, DOI 10.1038/nsmb.1934; Gergen J. P., 1986, S SOC DEV BIOL, V43, P195; Golding I, 2005, CELL, V123, P1025, DOI 10.1016/j.cell.2005.09.031; Gregor T, 2007, CELL, V130, P153, DOI 10.1016/j.cell.2007.05.025; Holloway DM, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001069; IRVINE KD, 1991, DEVELOPMENT, V111, P407; Kaern M, 2005, NAT REV GENET, V6, P451, DOI 10.1038/nrg1615; KORNBERG TB, 1993, CURR OPIN GENET DEV, V3, P585, DOI 10.1016/0959-437X(93)90094-6; Lagha M, 2012, TRENDS GENET, V28, P409, DOI 10.1016/j.tig.2012.03.006; Lander AD, 2013, SCIENCE, V339, P923, DOI 10.1126/science.1224186; Le TT, 2005, P NATL ACAD SCI USA, V102, P9160, DOI 10.1073/pnas.0503311102; Lecuyer Eric, 2008, V420, P289, DOI 10.1007/978-1-59745-583-1_18; Lestas I, 2010, NATURE, V467, P174, DOI 10.1038/nature09333; Li GW, 2011, NATURE, V475, P308, DOI 10.1038/nature10315; Li XY, 2008, PLOS BIOL, V6, P365, DOI 10.1371/journal.pbio.0060027; Liang HL, 2008, NATURE, V456, P400, DOI 10.1038/nature07388; Little SC, 2011, DEV CELL, V21, P2, DOI 10.1016/j.devcel.2011.06.003; Little SC, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000596; Liu F, 2013, P NATL ACAD SCI USA, V110, P6724, DOI 10.1073/pnas.1220912110; Maamar H, 2007, SCIENCE, V317, P526, DOI 10.1126/science.1140818; Manu, 2009, PLOS BIOL, V7, P591, DOI 10.1371/journal.pbio.1000049; MARGOLIS JS, 1995, DEVELOPMENT, V121, P3067; Mirouze N, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002048; Munsky B, 2012, SCIENCE, V336, P183, DOI 10.1126/science.1216379; Nachman I, 2007, CELL, V131, P544, DOI 10.1016/j.cell.2007.09.044; Newman JRS, 2006, NATURE, V441, P840, DOI 10.1038/nature04785; OBRIEN T, 1993, MOL CELL BIOL, V13, P3456, DOI 10.1128/MCB.13.6.3456; Pare A, 2009, CURR BIOL, V19, P2037, DOI 10.1016/j.cub.2009.10.028; Perry MW, 2012, CURR BIOL, V22, P2247, DOI 10.1016/j.cub.2012.09.051; Porcher A, 2010, DEVELOPMENT, V137, P2795, DOI 10.1242/dev.051300; Raj A, 2006, PLOS BIOL, V4, P1707, DOI 10.1371/journal.pbio.0040309; Raj A, 2010, NATURE, V463, P913, DOI 10.1038/nature08781; Rao CV, 2002, NATURE, V420, P231, DOI 10.1038/nature01258; Raser JM, 2005, SCIENCE, V309, P2010, DOI 10.1126/science.1105891; Reiter M, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr505; Saffer AM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002418; Sauer F, 1996, PHILOS T ROY SOC B, V351, P579, DOI 10.1098/rstb.1996.0057; SHERMOEN AW, 1991, CELL, V67, P303, DOI 10.1016/0092-8674(91)90182-X; Sigal A, 2006, NATURE, V444, P643, DOI 10.1038/nature05316; So LH, 2011, NAT GENET, V43, P554, DOI 10.1038/ng.821; Stewart-Ornstein J, 2012, MOL CELL, V45, P483, DOI 10.1016/j.molcel.2011.11.035; Taniguchi Y, 2010, SCIENCE, V329, P533, DOI 10.1126/science.1188308; TAUTZ D, 1987, NATURE, V327, P383, DOI 10.1038/327383a0; THUMMEL CS, 1990, CELL, V61, P101, DOI 10.1016/0092-8674(90)90218-4; TREISMAN J, 1989, NATURE, V341, P335, DOI 10.1038/341335a0; TSAI CC, 1994, DEVELOPMENT, V120, P1671; Wilkie GS, 1999, CURR BIOL, V9, P1263, DOI 10.1016/S0960-9822(99)80509-0; XU T, 1993, DEVELOPMENT, V117, P1223; Zenklusen D, 2008, NAT STRUCT MOL BIOL, V15, P1263, DOI 10.1038/nsmb.1514	63	179	181	0	46	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 15	2013	154	4					789	800		10.1016/j.cell.2013.07.025	http://dx.doi.org/10.1016/j.cell.2013.07.025			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	202GQ	23953111	Green Accepted, Bronze			2022-12-24	WOS:000323202500011
J	Crane, PK; Walker, R; Hubbard, RA; Li, G; Nathan, DM; Zheng, H; Haneuse, S; Craft, S; Montine, TJ; Kahn, SE; McCormick, W; McCurry, SM; Bowen, JD; Larson, EB				Crane, Paul K.; Walker, Rod; Hubbard, Rebecca A.; Li, Ge; Nathan, David M.; Zheng, Hui; Haneuse, Sebastien; Craft, Suzanne; Montine, Thomas J.; Kahn, Steven E.; McCormick, Wayne; McCurry, Susan M.; Bowen, James D.; Larson, Eric B.			Glucose Levels and Risk of Dementia	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ALZHEIMERS-DISEASE; COGNITIVE IMPAIRMENT; APOLIPOPROTEIN-E; FOLLOW-UP; INSULIN; METABOLISM; EPIDEMIC; BRAIN	BACKGROUND Diabetes is a risk factor for dementia. It is unknown whether higher glucose levels increase the risk of dementia in people without diabetes. METHODS We used 35,264 clinical measurements of glucose levels and 10,208 measurements of glycated hemoglobin levels from 2067 participants without dementia to examine the relationship between glucose levels and the risk of dementia. Participants were from the Adult Changes in Thought study and included 839 men and 1228 women whose mean age at baseline was 76 years; 232 participants had diabetes, and 1835 did not. We fit Cox regression models, stratified according to diabetes status and adjusted for age, sex, study cohort, educational level, level of exercise, blood pressure, and status with respect to coronary and cerebrovascular diseases, atrial fibrillation, smoking, and treatment for hypertension. RESULTS During a median follow-up of 6.8 years, dementia developed in 524 participants (74 with diabetes and 450 without). Among participants without diabetes, higher average glucose levels within the preceding 5 years were related to an increased risk of dementia (P=0.01); with a glucose level of 115 mg per deciliter (6.4 mmol per liter) as compared with 100 mg per deciliter (5.5 mmol per liter), the adjusted hazard ratio for dementia was 1.18 (95% confidence interval [CI], 1.04 to 1.33). Among participants with diabetes, higher average glucose levels were also related to an increased risk of dementia (P=0.002); with a glucose level of 190 mg per deciliter (10.5 mmol per liter) as compared with 160 mg per deciliter (8.9 mmol per liter), the adjusted hazard ratio was 1.40 (95% CI, 1.12 to 1.76). CONCLUSIONS Our results suggest that higher glucose levels may be a risk factor for dementia, even among persons without diabetes.	[Crane, Paul K.; McCormick, Wayne; Larson, Eric B.] Univ Washington, Dept Med, Seattle, WA USA; [Li, Ge] Univ Washington, Dept Psychiat & Behav Sci, Seattle, WA 98195 USA; [Montine, Thomas J.] Univ Washington, Dept Pathol, Seattle, WA 98195 USA; [McCurry, Susan M.] Univ Washington, Dept Psychosocial & Community Hlth, Seattle, WA 98195 USA; [Walker, Rod; Hubbard, Rebecca A.; Larson, Eric B.] Grp Hlth Res Inst, Seattle, WA USA; [Kahn, Steven E.] VA Puget Sound Hlth Care Syst, Dept Med, Seattle, WA USA; [Kahn, Steven E.] Univ Washington, Seattle, WA 98195 USA; [Bowen, James D.] Swedish Neurosci Inst, Seattle, WA USA; [Nathan, David M.] Massachusetts Gen Hosp, Diabet Ctr, Boston, MA 02114 USA; [Nathan, David M.] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; [Zheng, Hui] Massachusetts Gen Hosp, Ctr Biostat, Boston, MA 02114 USA; Harvard Univ, Sch Med, Boston, MA USA; [Haneuse, Sebastien] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; [Craft, Suzanne] Wake Forest Sch Med, Dept Internal Med, Winston Salem, NC USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; US Department of Veterans Affairs; Veterans Health Administration (VHA); Vet Affairs Puget Sound Health Care System; University of Washington; University of Washington Seattle; Swedish Medical Center; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Wake Forest University	Crane, PK (corresponding author), Univ Washington, Harborview Med Ctr, Box 359780,325 9th Ave, Seattle, WA 98104 USA.	pcrane@uw.edu	Hubbard, Rebecca/Y-6500-2019; McCurry, Susan M/E-4731-2015	Hubbard, Rebecca/0000-0003-0879-0994; McCurry, Susan M/0000-0001-8624-3772; Kahn, Steven/0000-0001-7307-9002; Walker, Rod/0000-0002-8464-9805; Kielstein, Jan/0000-0001-8110-9064; Crane, Paul/0000-0003-4278-7465	National Institutes of Health [U01 AG 06781]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK017047] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [U01AG006781] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Funded by the National Institutes of Health.; Supported by a grant (U01 AG 06781, to Dr. Larson) from the National Institutes of Health.	American Psychiatric Association, 1994, DIAGN STAT MAN MENT, V4th ed.; Arterburn DE, 2004, J AM GERIATR SOC, V52, P1907, DOI 10.1111/j.1532-5415.2004.52517.x; Bartl J, 2013, J NEURAL TRANSM, V120, P113, DOI 10.1007/s00702-012-0852-5; Candeias E, 2012, IUBMB LIFE, V64, P951, DOI 10.1002/iub.1098; Christman AL, 2011, DIABETOLOGIA, V54, P1645, DOI 10.1007/s00125-011-2095-7; Correia SC, 2012, BRAIN RES, V1441, P64, DOI 10.1016/j.brainres.2011.12.063; EMI M, 1988, GENOMICS, V3, P373, DOI 10.1016/0888-7543(88)90130-9; Enzinger C, 2005, NEUROLOGY, V64, P1704, DOI 10.1212/01.WNL.0000161871.83614.BB; Friedman J., 2001, ELEMENTS STAT LEARNI, DOI 10.1007/978-0-387-21606-5; Gorelick PB, 2011, STROKE, V42, P2672, DOI 10.1161/STR.0b013e3182299496; HIXSON JE, 1990, J LIPID RES, V31, P545; Kalbfleisch J.D., 2002, STAT ANAL FAILURE TI; Kloppenborg RP, 2008, EUR J PHARMACOL, V585, P97, DOI 10.1016/j.ejphar.2008.02.049; Kukull WA, 2002, ARCH NEUROL-CHICAGO, V59, P1737, DOI 10.1001/archneur.59.11.1737; Lam DW, 2012, CURR OPIN ENDOCRINOL, V19, P93, DOI 10.1097/MED.0b013e328350583a; Larson EB, 2006, ANN INTERN MED, V144, P73, DOI 10.7326/0003-4819-144-2-200601170-00004; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Nalivaeva NN, 2012, J NEUROCHEM, V120, P167, DOI 10.1111/j.1471-4159.2011.07510.x; Nathan DM, 2008, DIABETES CARE, V31, P1473, DOI 10.2337/dc08-0545; Nathan DM, 2009, DIABETES CARE, V32, P207; Ohara T, 2011, NEUROLOGY, V77, P1126, DOI 10.1212/WNL.0b013e31822f0435; Pandini G, 2013, ENDOCRINOLOGY, V154, P375, DOI 10.1210/en.2012-1661; Ravona-Springer R, 2012, J ALZHEIMERS DIS, V30, P299, DOI 10.3233/JAD-2012-120106; Reitz C, 2011, NAT REV NEUROL, V7, P137, DOI [10.1038/nrneurol.2011.2, 10.1101/cshperspect.a006239]; Ronnemaa E, 2009, DIABETOLOGIA, V52, P1504, DOI 10.1007/s00125-009-1393-9; Sonnen JA, 2007, ANN NEUROL, V62, P406, DOI 10.1002/ana.21208; Strachan MWJ, 2011, DIABETIC MED, V28, P141, DOI 10.1111/j.1464-5491.2010.03199.x; Teng E L, 1994, Int Psychogeriatr, V6, P45, DOI 10.1017/S1041610294001602; van den Berg E, 2006, DIABETOLOGIA, V49, P2015, DOI 10.1007/s00125-006-0333-1; Yaffe K, 2006, J NUTR HEALTH AGING, V10, P292	30	488	508	6	104	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 8	2013	369	6					540	548		10.1056/NEJMoa1215740	http://dx.doi.org/10.1056/NEJMoa1215740			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	197HX	24195563	Green Accepted			2022-12-24	WOS:000322842000010
